PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stapledon, CJM; Tsangari, H; Solomon, LB; Campbell, DG; Hurtado, P; Krishnan, R; Atkins, GJ				Stapledon, Catherine J. M.; Tsangari, Helen; Solomon, Lucian B.; Campbell, David G.; Hurtado, Plinio; Krishnan, Ravi; Atkins, Gerald J.			Human osteocyte expression of Nerve Growth Factor: The effect of Pentosan Polysulphate Sodium (PPS) and implications for pain associated with knee osteoarthritis	PLOS ONE			English	Article							TANEZUMAB; NGF; OSTEOBLASTS; PHENOTYPE; PROMOTES; EFFICACY; KINASE; SAFETY; CELLS; TRKA	Pentosan polysulphate sodium (PPS) is a promising therapeutic agent for blocking knee pain in individuals with knee osteoarthritis (KOA). The mode of action of PPS in this context is unknown. We hypothesised that the osteocyte, being the principal cell type in the subchondral bone, was capable of expressing the pain mediator Nerve Growth Factor (NGF), and that this may be altered in the presence of PPS. We tested the expression of NGF and the response to PPS in the presence or absence of the proinflammatory cytokine tumour necrosis factor-alpha (TNF alpha), in human osteocytes. For this we differentiated human primary osteoblasts grown from subchondral bone obtained at primary knee arthroplasty for KOA to an osteocyte-like stage over 28d. We also tested NGF expression in fresh osteocytes obtained by sequential digestion from KOA bone and by immunofluorescence in KOA bone sections. We demonstrate for the first time the production and secretion of NGF/proNGF by this cell type derived from patients with KOA, implicating osteocytes in the pain response in this pathological condition and possibly others. PPS inhibited TNF alpha-induced levels of proNGF secretion and TNF alpha induced NGF mRNA expression. Together, this provides evidence that PPS may act to suppress the release of NGF in the subchondral bone to ameliorate pain associated with knee osteoarthritis.	[Stapledon, Catherine J. M.; Tsangari, Helen; Solomon, Lucian B.; Campbell, David G.; Atkins, Gerald J.] Univ Adelaide, Ctr Orthopaed & Trauma Res, Adelaide, SA, Australia; [Solomon, Lucian B.] Royal Adelaide Hosp, Orthopaed & Trauma Serv, Adelaide, SA, Australia; [Campbell, David G.] Calvary Wakefield Hosp, Wakefield Orthopaed Clin, Adelaide, SA, Australia; [Hurtado, Plinio] Royal Adelaide Hosp, Renal Unit, Adelaide, SA, Australia; [Krishnan, Ravi] Paradigm Biopharmaceut Ltd, Melbourne, Vic, Australia	University of Adelaide; Royal Adelaide Hospital; Royal Adelaide Hospital	Atkins, GJ (corresponding author), Univ Adelaide, Ctr Orthopaed & Trauma Res, Adelaide, SA, Australia.; Krishnan, R (corresponding author), Paradigm Biopharmaceut Ltd, Melbourne, Vic, Australia.	rkrishnan@paradigmbiopharma.com; Gerald.atkins@adelaide.edu.au	Campbell, David/AAM-9263-2020	Campbell, David/0000-0002-1572-9529; Atkins, Gerald/0000-0002-3123-9861; Hurtado, Plinio Reinaldo/0000-0002-0913-7797; Solomon, Lucian/0000-0001-6254-2372; Stapledon, Catherine/0000-0002-2827-2396	Paradigm Biopharmaceuticals Ltd; National Health and Medical Research Council of Australia (NHMRC) [1106029]; Australian Postgraduate Award scholarship	Paradigm Biopharmaceuticals Ltd; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarship	This study was funded by a research grant from Paradigm Biopharmaceuticals Ltd (https://paradigmbiopharma.com/) and from a Project Grant awarded to GJA from the National Health and Medical Research Council of Australia (NHMRC) (Project ID1106029). CJMS was supported by an Australian Postgraduate Award scholarship. GJA is an NHMRC Senior Research Fellow. Paradigm Biopharmaceuticals Ltd provided additional funding in the form of salary to RK. The specific roles of these authors are articulated in the `author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond those specifieThe authors thank the nursing and surgical staff of the Orthopaedic and Trauma Services of the Royal Adelaide Hospital and the Calvary Wakefield Hospital for the provision of patient samples.; The authors also thank Dr. Sonja Klebe (Flinders University) for the kind provision of NCI-H266 cells. This study was funded by a research grant from Paradigm Biopharmaceuticals Ltd (https://paradigmbiopharma.com/) and from a Project Grant awarded to GJA from the National Health and Medical Research Council of Australia (NHMRC) (Project ID1106029). CJMS was supported by an Australian Postgraduate Award scholarship. GJA is an NHMRC Senior Research Fellow. Paradigm Biopharmaceuticals Ltd provided additional funding in the form of salary to RK. The specific roles of these authors are articulated in the `author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond those specified.	Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Ayers DC, 2015, CLIN ORTHOP RELAT R, V473, P76, DOI 10.1007/s11999-014-3716-5; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bradshaw Ralph A., 2015, Advances in Biological Regulation, V58, P16, DOI 10.1016/j.jbior.2014.11.003; Bwalya EC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177144; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Chevalier X, 2013, NAT REV RHEUMATOL, V9, P400, DOI 10.1038/nrrheum.2013.44; DAWES J, 1986, THROMB RES, V44, P683, DOI 10.1016/0049-3848(86)90169-6; Ekman EF, 2014, J RHEUMATOL, V41, P2249, DOI 10.3899/jrheum.131294; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giusto LL, 2018, EXPERT OPIN PHARMACO, V19, P1097, DOI 10.1080/14656566.2018.1491968; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Kumagai K, SODIUM PENTOSAN POLY; Kumarasinghe DD, 2012, OSTEOARTHR CARTILAGE, V20, P1357, DOI 10.1016/j.joca.2012.07.005; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Malerba F, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00063; Manni L, 1998, RHEUMATOL INT, V18, P97, DOI 10.1007/s002960050065; Ormsby RT, 2016, ACTA BIOMATER, V33, P242, DOI 10.1016/j.actbio.2016.01.016; Prideaux M, 2016, BONE, V88, P64, DOI 10.1016/j.bone.2016.04.017; Prideaux M, 2016, CURR OPIN PHARMACOL, V28, P24, DOI 10.1016/j.coph.2016.02.003; Rouillard AD, HARMONIZOME COLLECTI, DOI [10.1093/database/baw100, DOI 10.1093/DATABASE/BAW100]; Sampson MJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1754-3; Schnitzer TJ, 2015, ANN RHEUM DIS, V74, P1202, DOI 10.1136/annrheumdis-2013-204905; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; Takano S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5706359; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Yang DQ, 2018, MBIO, V9, DOI 10.1128/mBio.00415-18; Zhang J, 2015, INT J CLIN EXP MED, V8, P634	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222602	10.1371/journal.pone.0222602	http://dx.doi.org/10.1371/journal.pone.0222602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557169	gold, Green Published			2022-12-27	WOS:000532345500024
J	Akhloufi, H; Verhaegh, SJC; Jaspers, MWM; Melles, DC; van Der Sijs, H; Verbon, A				Akhloufi, H.; Verhaegh, S. J. C.; Jaspers, M. W. M.; Melles, D. C.; van Der Sijs, H.; Verbon, A.			A usability study to improve a clinical decision support system for the prescription of antibiotic drugs	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; POINT-PREVALENCE; ADOPTION	Objective A clinical decision support system (CDSS) for empirical antibiotic treatment has the potential to increase appropriate antibiotic use. Before using such a system on a broad scale, it needs to be tailored to the users preferred way of working. We have developed a CDSS for empirical antibiotic treatment in hospitalized adult patients. Here we determined in a usability study if the developed CDSS needed changes. Methods Four prespecified patient cases, based on real life clinical scenarios, were evaluated by 8 medical residents in the study. The "think-aloud" method was used, and sessions were recorded and analyzed afterwards. Usability was assessed by 3 evaluators using an augmented classification scheme, which combines the User Action Framework with severity rating of the usability problems and the assessment of the potential impact of these problems on the final task outcomes. Results In total 51 usability problems were identified, which could be grouped into 29 different categories. Most (n = 17/29) of the usability problems were cosmetic problems or minor problems. Eighteen (out of 29) of the usability categories could have an ordering error as a result. Classification of the problems showed that some of the problems would get a low priority based on their severity rating, but got a high priority for their impact on the task outcome. This effectively provided information to prioritize system redesign efforts. Conclusion Usability studies improve lay-out and functionality of a CDSS for empirical antibiotic treatment, even after development by a multidisciplinary system.	[Akhloufi, H.; Verhaegh, S. J. C.; Melles, D. C.; Verbon, A.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Akhloufi, H.; Verbon, A.] Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands; [Jaspers, M. W. M.] Acad Med Ctr, Ctr Human Factors Engn Hlth Informat Technol HIT, Dept Med Informat, Amsterdam, Netherlands; [van Der Sijs, H.] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Verbon, A (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.; Verbon, A (corresponding author), Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands.	a.verbon@erasmusmc.nl			Netherlands Organization for Health Research and Development (ZonMW) [836021021]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMW) [grant number 836021021] to AV. The funding source had no involvement in study design, in the collection, analysis and interpretation of the data or in writing this report. Also there was no involvement in the decision to submit the article for publication.	Akhloufi H, 2015, EUR J CLIN MICROBIOL, V34, P1631, DOI 10.1007/s10096-015-2398-6; [Anonymous], 1994, HDB USABILITY TESTIN; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Beaulieu J, 2013, AM J HEALTH-SYST PH, V70, P1103, DOI 10.2146/ajhp120589; Camins BC, 2009, INFECT CONT HOSP EP, V30, P931, DOI 10.1086/605924; Diasinos N, 2015, INTERN MED J, V45, P55, DOI 10.1111/imj.12627; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; Filice GA, 2013, INFECT CONT HOSP EP, V34, P558, DOI 10.1086/670627; Ingram PR, 2012, INTERN MED J, V42, P719, DOI 10.1111/j.1445-5994.2012.02809.x; James BC, 2001, NEW ENGL J MED, V345, P991, DOI 10.1056/NEJM200109273451311; Jaspers MWM, 2009, INT J MED INFORM, V78, P340, DOI 10.1016/j.ijmedinf.2008.10.002; Jordan P. W., 1996, USABILITY EVALUATION; Kallen MC, 2017, INFECT DIS REP, V9, P13, DOI 10.4081/idr.2017.6821; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kerremans JJ, 2012, J CLIN MICROBIOL, V50, P2066, DOI 10.1128/JCM.06051-11; Khairat S, 2018, JMIR RES PROTOC, V7, P87, DOI 10.2196/11239; Khajouei R, 2011, J BIOMED INFORM, V44, P948, DOI 10.1016/j.jbi.2011.07.002; Leibovici L, 1997, J INTERN MED, V242, P395, DOI 10.1046/j.1365-2796.1997.00232.x; Litvin CB, 2012, INT J MED INFORM, V81, P521, DOI 10.1016/j.ijmedinf.2012.03.002; Macefield R., 2009, J USABILITY STUD, P5, DOI [10.1016/j.jclinepi.2013.08.015, DOI 10.1016/J.JCLINEPI.2013.08.015]; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Mullett Charles J, 2003, AMIA Annu Symp Proc, P480; Mullett CJ, 2004, INT J MED INFORM, V73, P455, DOI 10.1016/j.ijmedinf.2004.04.002; Nielsen J., 1993, USABILITY ENG; Nielsen J., 2012, MANY TEST USERS USAB; Nielsen Jakob, 1994, HEURISTIC EVALUATION; O'Neill J, 2014, ANTIMICROBIAL RESIST; Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372; Phillips Ira E, 2008, AMIA Annu Symp Proc, P1093; Rawson TM, 2017, CLIN MICROBIOL INFEC, V23, P524, DOI 10.1016/j.cmi.2017.02.028; Rodrigues JF, 2012, INFECT CONT HOSP EP, V33, P435, DOI 10.1086/664923; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Schulz L, 2013, INFECT CONT HOSP EP, V34, P1259, DOI 10.1086/673977; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Tsopra R, 2019, J AM MED INFORM ASSN, V26, P1010, DOI 10.1093/jamia/ocz057; Tsopra R, 2014, J AM MED INFORM ASSN, V21, pE107, DOI 10.1136/amiajnl-2013-002042; Vincent WR, 2009, J AM MED INFORM ASSN, V16, P47, DOI 10.1197/jamia.M2559; VIRZI RA, 1992, HUM FACTORS, V34, P457, DOI 10.1177/001872089203400407; Warner H, 1999, J AM MED INFORM ASSN, P440; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Yen PY, 2012, J AM MED INFORM ASSN, V19, P413, DOI 10.1136/amiajnl-2010-000020	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223073	10.1371/journal.pone.0223073	http://dx.doi.org/10.1371/journal.pone.0223073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553785	Green Published, gold			2022-12-27	WOS:000532319200054
J	Martin-Sosa, E; Martinez-Reina, J; Mayo, J; Ojeda, J				Martin-Sosa, E.; Martinez-Reina, J.; Mayo, J.; Ojeda, J.			Influence of musculotendon geometry variability in muscle forces and hip bone-on-bone forces during walking	PLOS ONE			English	Article							JOINT; SENSITIVITY; GAIT; PREDICTIONS; LOADS	Inverse dynamics problems are usually solved in the analysis of human gait to obtain reaction forces and moments at the joints. However, these actions are not the actual forces and moments supported by the joint structure, because they do not consider the forces of the muscles acting across the joint. Therefore, to analyse bone-on bone forces it is necessary to estimate those muscle forces. Usually, this problem is addressed by means of optimization algorithms. One of the parameters required to solve this problem is the musculotendon geometry. These data are usually taken from cadavers or MRI data from several subjects, different from the analysed subject. Then, the model is scaled to the subject morphology. This procedure constitutes a source of error. The goals of this work were two. First, to perform a sensitivity analysis of the influence of muscle insertion locations on the muscle forces acting on the hip joint and on the hip joint bone-on-bone forces. Second, to compare the hip joint bone-on-bone forces during gait cycle obtained through muscle insertion locations taken from a musculoskeletal model template and a scaling procedure to those obtained from a subject-specific model using an MRI of the subject. The problem was solved using OpenSim. Results showed that anatomical variability should be analysed from two perspectives. One the one hand, throughout the gait cycle, in a global way. On the other hand, at a characteristic instant of the gait cycle. Variations of +/- 1 cm in the position of the attachment points of certain muscles caused variations of up to 14.21% in averaged deviation of the muscle forces and 58.96% in the peak force in the modified muscle and variations up to 57.23% in the averaged deviation of the muscle force and up to 117.23% in the peak force in the rest of muscles. Then, the influence of that variability on muscle activity patterns and hip bone-on-bone forces could be described more precisely. A biomechanical analysis of a subject-specific musculoskeletal model was carried out. Using MRI data, variations up to 5 cm in the location of the insertion points were introduced. These modifications showed significant differences between the baseline model and the customized model: within the range [-12%, 10%] for muscle forces and around 35% of body weight for hip bone-on-bone forces.	[Martin-Sosa, E.; Martinez-Reina, J.; Mayo, J.; Ojeda, J.] Univ Seville, Dept Ingn Mecan & Fabricac, Seville, Spain	University of Sevilla	Ojeda, J (corresponding author), Univ Seville, Dept Ingn Mecan & Fabricac, Seville, Spain.	joaquinojeda@us.es	Ojeda, Joaquín/AAA-3222-2021; Ojeda, Joaquín/I-2380-2014; Sosa, Ezequiel Martín/AAA-3224-2021	Ojeda, Joaquín/0000-0002-6894-197X; Ojeda, Joaquín/0000-0002-6894-197X; Sosa, Ezequiel Martín/0000-0002-7484-3364	Ministry of Economy, Industry and Competitiveness [DPI2016-80796-P]	Ministry of Economy, Industry and Competitiveness	The authors thank the Ministry of Economy, Industry and Competitiveness for funding the project DPI2016-80796-P.	Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Ardestani MM, 2016, J BIOMECH, V49, P1620, DOI 10.1016/j.jbiomech.2016.03.047; Bergmann G, 2008, CHARITE UNIVERSITAET; Bosmans L, 2015, J BIOMECH, V48, P2116, DOI 10.1016/j.jbiomech.2015.02.052; Brand R A, 1994, J Arthroplasty, V9, P45, DOI 10.1016/0883-5403(94)90136-8; BRAND RA, 1986, J BIOMECH, V19, P589, DOI 10.1016/0021-9290(86)90164-8; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; Damm P, 2017, J BIOMECH, V60, P197, DOI 10.1016/j.jbiomech.2017.06.047; Daysal GA, 2007, OSTEOARTHR CARTILAGE, V15, P1446, DOI 10.1016/j.joca.2007.05.016; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Graham DF, 2016, J BIOMECH, V49, P2619, DOI 10.1016/j.jbiomech.2016.05.033; HINRICHSEN GJ, 1968, ANGLE ORTHOD, V38, P155; Lu T. W., 1999, GAIT POSTURE, V30, P296; Michnik R., 2012, 3 INT C INF TECHN BI, P464; Ojeda J, 2016, MULTIBODY SYST DYN, V37, P291, DOI 10.1007/s11044-016-9508-9; Ojeda J., THESIS; Quental C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025325; Roemer K, 2010, MATH COMP MODEL DYN, V16, P391, DOI 10.1080/13873954.2010.507090; Saliba CM, 2017, J BIOMECH, V57, P125, DOI 10.1016/j.jbiomech.2017.03.005; Slater AA, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2329-7; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Sutherland DH, 2002, GAIT POSTURE, V16, P159, DOI 10.1016/S0966-6362(02)00004-8; Thambyah A, 2005, KNEE, V12, P383, DOI 10.1016/j.knee.2004.12.005; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; VANDERHELM FCT, 1991, J BIOMECH, V24, P1151, DOI 10.1016/0021-9290(91)90007-A; Vaughan C., 1999, DYNAMICS HUMAN GAIT; Wang X., 2017, J HEALTHC ENG, V2017, DOI DOI 10.1155/2017/6375976; Wesseling M, 2016, COMPUT METHOD BIOMEC, V19, P1475, DOI 10.1080/10255842.2016.1154547; Winter D.A., 2005, BIOMECHANICS MOTOR C, V3rd ed.	29	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222491	10.1371/journal.pone.0222491	http://dx.doi.org/10.1371/journal.pone.0222491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553756	Green Published, gold			2022-12-27	WOS:000532319200028
J	Petit, J; Loubiere, S; Tinland, A; Vargas-Moniz, M; Spinnewijn, F; Manning, R; Santinello, M; Wolf, J; Bokszczanin, A; Bernad, R; Kallmen, H; Ornelas, J; Auquier, P				Petit, Junie; Loubiere, Sandrine; Tinland, Aurlie; Vargas-Moniz, Maria; Spinnewijn, Freek; Manning, Rachel; Santinello, Massimo; Wolf, Judith; Bokszczanin, Anna; Bernad, Roberto; Kallmen, Hakan; Ornelas, Jose; Auquier, Pascal		HOME-EU Consortium Study Grp	European public perceptions of homelessness: A knowledge, attitudes and practices survey	PLOS ONE			English	Article							UNITED-STATES; HEALTH; BELIEFS; OPINION; PEOPLE; ADAPTATION; PREVALENCE; IMPACT; POLICY; USERS	Background Addressing Citizen's perspectives on homelessness is crucial for the design of effective and durable policy responses, and available research in Europe is not yet substantive. We aim to explore citizens' opinions about homelessness and to explain the differences in attitudes within the general population of eight European countries: France, Ireland, Italy, the Netherlands, Poland, Portugal, Spain, and Sweden. Methods A nationally representative telephone survey of European citizens was conducted in 2017. Three domains were investigated: Knowledge, Attitudes, and Practices about homelessness. Based on a multiple correspondence analysis (MCA), a generalized linear model for clustered and weighted samples was used to probe the associations between groups with opposing attitudes. Results Response rates ranged from 30.4% to 33.5% (N = 5,295). Most respondents (57%) had poor knowledge about homelessness. Respondents who thought the government spent too much on homelessness, people who are homeless should be responsible for housing, people remain homeless by choice, or homelessness keeps capabilities/empowerment intact (regarding meals, family contact, and access to work) clustered together (negative attitudes, 30%). Respondents who were willing to pay taxes, welcomed a shelter, or acknowledged people who are homeless may lack some capabilities (i.e. agreed on discrimination in hiring) made another cluster (positive attitudes, 58%). Respondents living in semi-urban or urban areas (ORs 1.33 and 1.34) and those engaged in practices to support people who are homeless (ORs > 1.4; p<0.005) were more likely to report positive attitudes, whereas those from France and Poland (p<0.001) were less likely to report positive attitudes. Conclusion The majority of European citizens hold positive attitudes towards people who are homeless, however there remain significant differences between and within countries. Although it is clear that there is strong support for increased government action and more effective solutions for Europe's growing homelessness crisis, there also remain public opinion barriers rooted in enduring negative perceptions.	[Petit, Junie; Loubiere, Sandrine; Tinland, Aurlie; Auquier, Pascal] Aix Marseille Univ, Sch Med La Timone Med Campus, CEReSS Hlth Serv Res & Qual Life Ctr, Blvd Jean Moulin, Marseille, France; [Loubiere, Sandrine; Tinland, Aurlie; Auquier, Pascal] AP HM, Support Unit Clin Res & Econ Evaluat, Dept Res & Innovat, Blvd Jean Moulin, Marseille, France; [Vargas-Moniz, Maria; Ornelas, Jose] ISPA Inst Univ, APPsyCI Appl Psychol Res Ctr Capabil & Inclus, Rua Jardim do Tabaco, Lisbon, Portugal; [Spinnewijn, Freek] FEANTSA, European Federat Natl Org Working Homeless, Chaussee Louvain, Brussels, Belgium; [Manning, Rachel] Univ Limerick, Dept Psychol, Limerick, Ireland; [Santinello, Massimo] Univ Padua, Dept Dev & Social Psychol, Via Venezia, Padua, Italy; [Wolf, Judith] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Impuls Netherlands Ctr Social Care Res, Geert Grootepl, NL-6500 EZ Nijmegen, Netherlands; [Bokszczanin, Anna] Opole Univ, Inst Psychol, Pl Staszica, Opole, Poland; [Bernad, Roberto] Rais Fdn, C Ardemans, Madrid, Spain; [Kallmen, Hakan] Karolinska Inst, Stockholm Ctr Psychiat Res & Educ, STAD, Norra Stati Onsgatan, Stockholm, Sweden	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Instituto Superior Psicologia Aplicada (ISPA); University of Limerick; University of Padua; Radboud University Nijmegen; University of Opole; Karolinska Institutet	Loubiere, S (corresponding author), Aix Marseille Univ, Sch Med La Timone Med Campus, CEReSS Hlth Serv Res & Qual Life Ctr, Blvd Jean Moulin, Marseille, France.; Loubiere, S (corresponding author), AP HM, Support Unit Clin Res & Econ Evaluat, Dept Res & Innovat, Blvd Jean Moulin, Marseille, France.	Sandrine.loubiere@univ-amu.fr	Wolf, Judith/H-8122-2014; Skałacka, Katarzyna/AAT-1920-2021; Bokszczanin, Anna/ABG-9078-2020; Vargas-Moniz, Maria/AGU-8767-2022; Rogowska, Aleksandra Maria/J-3398-2013; Ornelas, Jose/P-3940-2014	Wolf, Judith/0000-0001-7106-9142; Skałacka, Katarzyna/0000-0003-2188-7547; Bokszczanin, Anna/0000-0002-0499-8133; Vargas-Moniz, Maria/0000-0002-4875-9118; Rogowska, Aleksandra Maria/0000-0002-4621-8916; Zmaczynska, Barbara/0000-0001-5472-2576; manning, rachel/0000-0003-2254-1484; Ornelas, Jose/0000-0002-8972-7518	European Commission [H2020-SC6-REVINEQUAL-2016/GA726997]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by the European Commission through a grant, as part of the H2020 research project HOME-EU: Reversing Homelessness in Europe H2020-SC6-REVINEQUAL-2016/GA726997. The grant agreement between the European Commission and each research unit involved allows complete liberty and autonomy of researchers in the design of the study; the European Commission will take no part in data collection procedures, analyses, interpretation of the data, or decision to submit results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CPG MAN DENG INF AD, P65; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Beijer U, 2016, SCAND J PUBLIC HEALT, V44, P784, DOI 10.1177/1403494816671601; Bernad R, 2016, EUR J HOMELESSNESS, V10; Burstein P, 2003, POLIT RES QUART, V56, P29, DOI 10.1177/106591290305600103; Busch-Geertsema V., 2014, EUROPEAN J HOMELESSN, V8, P13; CBS-Statistics Netherlands, 2016, DAKL PERS; Department of Housing Planning and Local Government, 2018, HOM DAT; Department of Housing Planning and Local Government, 2017, HOM DAT; de Rada VD, 2011, QUAL QUANT, V45, P817, DOI 10.1007/s11135-010-9373-1; Doherty J, 2008, SURVEILL SOC, V5, P290; European Commission, 2013, CONFR HOM EUR UN SOC; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; FEANTSA, 2017, HOM COUNTR PROF POL; FEANTSA, 2017, COUNTR PROF IT; FEANTSA, 2017, HOM COUNTR PROF PORT; Feantsa The Foundation Abbe Pierre, 2018, 3 OV HOUS EXCL EUR 2, P57; Fitzpatrick S, 2007, INT REV HOMELESSNESS; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Hobden KL., 2007, CAN J URBAN RES, V16, P76; Hwang SW, 2013, AM J PUBLIC HEALTH, V103, pS294, DOI 10.2105/AJPH.2013.301369; ISTAT [National Institute of Statistics], 2016, HOMELESS; KOTHANDAPANI V, 1971, J PERS SOC PSYCHOL, V19, P321, DOI 10.1037/h0031448; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Lancione M, 2018, HOUSING STUD, V33, P40, DOI 10.1080/02673037.2017.1344200; LEE BA, 1990, SOC FORCES, V69, P253, DOI 10.2307/2579617; LINK BG, 1995, AM J COMMUN PSYCHOL, V23, P533, DOI 10.1007/BF02506967; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; O'Sullivan E., 2008, SUSTAINABLE SOLUTI B, V2, P29; Parsell C, 2012, HOUS THEORY SOC, V29, P420, DOI 10.1080/14036096.2012.667834; Petit JM, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0317-x; Phillips L, 2015, J POVERTY, V19, P1, DOI 10.1080/10875549.2014.951981; Pleace N., 2013, COSTS HOMELESSNESS E; R Development Core Team, 2009, R LANG ENV STAT COMP; Rogers ES, 1997, PSYCHIATR SERV, V48, P1042; Sahlin I., 2015, EUR J HOMELESSNESS, V9; Shapiro RY, 2011, PUBLIC OPIN QUART, V75, P982, DOI 10.1093/poq/nfr053; Socialstyrelsen-The National Board of Health and Welfare, 2017, HEML 2017 OMF KAR, P109; Stuckler D, 2017, EUR J PUBLIC HEALTH, V27, P18, DOI 10.1093/eurpub/ckx167; The Center for Social Justice, 2017, HOUS LED SOL ROUGH S; The Foundation Abbe Pierre Feantsa, 2017, 2 OV HOUS EXCL EUR 2, P67; Tinland A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-309; TNS Opinion & Social, 2010, POV SOC EXCL; Tompsett CJ, 2006, AM J COMMUN PSYCHOL, V37, P47, DOI 10.1007/s10464-005-9007-2; TORO PA, 1992, AM J COMMUN PSYCHOL, V20, P53, DOI 10.1007/BF00942181; Toro PA, 2007, J SOC ISSUES, V63, P505, DOI 10.1111/j.1540-4560.2007.00521.x; Tsai J, 2017, AM J COMMUN PSYCHOL, V60, P599, DOI 10.1002/ajcp.12198; Yaouancq F, 2013, HEBERGEMENT SANS DOM, V4; Zaretzky K, 2013, 128 AUSTR HOUS URB R	51	5	5	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221896	10.1371/journal.pone.0221896	http://dx.doi.org/10.1371/journal.pone.0221896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553769	Green Published, gold			2022-12-27	WOS:000532319200008
J	Westbury, MV; Petersen, B; Lorenzen, ED				Westbury, Michael, V; Petersen, Bent; Lorenzen, Eline D.			Genomic analyses reveal an absence of contemporary introgressive admixture between fin whales and blue whales, despite known hybrids	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; GENE PREDICTION; B-PHYSALUS; MODEL	Fin whales (Balaenoptera physalus) and blue whales (B. musculus) are the two largest species on Earth and are widely distributed across the world's oceans. Hybrids between these species appear to be relatively widespread and have been reported in both the North Atlantic and North Pacific; they are also relatively common, and have been proposed to occur once in every thousand fin whales. However, despite known hybridization, fin and blue whales are not sibling species. Rather, the closest living relative of fin whales are humpback whales (Megaptera novaeangliae). To improve the quality of fin whale data available for analysis, we assembled and annotated a fin whale nuclear genome using in-silico mate pair libraries and previously published short-read data. Using this assembly and genomic data from a humpback, blue, and bowhead whale, we investigated whether signatures of introgression between the fin and blue whale could be found. We find no signatures of contemporary admixture in the fin and blue whale genomes, although our analyses support ancestral gene flow between the species until 2.4-1.3 Ma. We propose the following explanations for our findings; i) fin/blue whale hybridization does not occur in the populations our samples originate from, ii) contemporary hybrids are a recent phenomenon and the genetic consequences have yet to become widespread across populations, or iii) fin/blue whale hybrids are under large negative selection, preventing them from backcrossing and contributing to the parental gene pools.	[Westbury, Michael, V; Petersen, Bent; Lorenzen, Eline D.] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Petersen, Bent] AIMST Univ, Fac Appl Sci, Ctr Excellence Omics Driven Computat Biodiscovery, Bedong, Kedah, Malaysia	University of Copenhagen; AIMST University	Westbury, MV; Lorenzen, ED (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark.	m.westbury@snm.ku.dk; elinelorenzen@snm.ku.dk	Lorenzen, Eline/GRF-1592-2022	Petersen, Bent/0000-0002-2472-8317; Westbury, Michael/0000-0003-0478-3930	Villum Fonden [13151]; Independent Research Fund Denmark [8021-00218B]; Villum Fonden Young Investigator Programme [13151]	Villum Fonden(Villum Fonden); Independent Research Fund Denmark; Villum Fonden Young Investigator Programme(Villum Fonden)	This work was supported by Villum Fonden (https://veluxfoundations.dk) Young Investigator Programme, grant no 13151 and the Independent Research Fund Denmark (https://dff.dk), grant no 8021-00218B. Both awarded to EDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Villum Fonden Young Investigator Programme, grant no 13151 and the Independent Research Fund Denmark, grant no 8021-00218B. We would like to thank Binia De Cahsan for providing the whale illustrations in Fig 1.	Aguilar A, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P368; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Arnason U, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9873; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Bushnell B., 2014, BBTOOLS SOFTWARE PAC; Cahill JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0138; Cipriano F, 1999, NATURE, V397, P307, DOI 10.1038/16823; Cocks AH., 1887, ZOOLOGIST, V11, P207; Grau JH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy029; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hubley R., 2013, REPEATMASKER OPEN 40; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Nowak R.M., 1999, WALKERS MAMMALS WORL, V1; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sears R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P120; Smit A.F., 2008, REPEATMODELER OPEN 1; SPILLIAERT R, 1991, J HERED, V82, P269, DOI 10.1093/oxfordjournals.jhered.a111085; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222004	10.1371/journal.pone.0222004	http://dx.doi.org/10.1371/journal.pone.0222004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553763	Green Published, gold			2022-12-27	WOS:000532319200009
J	Sivey, P; McAllister, R; Vally, H; Burgess, A; Kelly, AM				Sivey, Peter; McAllister, Richard; Vally, Hassan; Burgess, Anna; Kelly, Anne-Maree			Anatomy of a demand shock: Quantitative analysis of crowding in hospital emergency departments in Victoria, Australia during the 2009 influenza pandemic	PLOS ONE			English	Article							A(H1N1) INFECTION; H1N1 INFLUENZA; ACCESS BLOCK; SURVEILLANCE; IMPACT; CARE	Objective An infectious disease outbreak such as the 2009 influenza pandemic is an unexpected demand shock to hospital emergency departments (EDs). We analysed changes in key performance metrics in (EDs) in Victoria during this pandemic to assess the impact of this demand shock. Design and setting Descriptive time-series analysis and longitudinal regression analysis of data from the Victorian Emergency Minimum Dataset (VEMD) using data from the 38 EDs that submit data to the state's Department of Health and Human Services. Main outcome measures Daily number of presentations, influenza-like-illness (ILI) presentations, daily mean waiting time (time to first being seen by a doctor), daily number of patients who did-not-wait and daily number of access-blocked patients (admitted patients with length of stay > 8 hours) at a system and hospital-level. Results During the influenza pandemic, mean waiting time increased by up to 25%, access block increased by 32% and did not wait presentations increased by 69% above pre-pandemic levels. The peaks of all three crowding variables corresponded approximately to the peak in admitted ILI presentations. Longitudinal fixed-effects regression analysis estimated positive and statistically significant associations between mean waiting times, did not wait presentations and access block and ILI presentations. Conclusions This pandemic event caused excess demand leading to increased waiting times, did-not-wait patients and access block. Increases in admitted patients were more strongly associated with crowding than non-admitted patients during the pandemic period, so policies to divert or mitigate low-complexity non-admitted patients are unlikely to be effective in reducing ED crowding.	[Sivey, Peter] RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia; [McAllister, Richard] Australian Govt, Dept Educ & Training, Canberra, ACT, Australia; [Vally, Hassan] La Trobe Univ, Dept Publ Hlth, Melbourne, Vic, Australia; [Burgess, Anna] Dept Hlth & Human Serv Victoria, Melbourne, Vic, Australia; [Kelly, Anne-Maree] Univ Melbourne, Joseph Epstein Ctr Emergency Med Res Western Hlth, Parkville, Vic, Australia; [Kelly, Anne-Maree] Univ Melbourne, Sch Med, Western Clin Sch, Parkville, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); La Trobe University; University of Melbourne; University of Melbourne	Sivey, P (corresponding author), RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia.	peter.sivey@rmit.edu.au	Vally, Hassan/AAG-1307-2022; Vally, Hassan/AFK-2936-2022	Vally, Hassan/0000-0001-5281-7459; Vally, Hassan/0000-0001-5281-7459; Sivey, Peter/0000-0002-3703-615X	La Trobe University	La Trobe University	PM and RM would also like to acknowledge funding from the La Trobe University "Building Healthy Communities" Research Focus Area. The funders played no role in the research; https://www.latrobe.edu.au/research/research-focus-areas/building-healthy-communities.	Andrew E, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5636; Baker AW, 2012, AM J INFECT CONTROL, V40, P606, DOI 10.1016/j.ajic.2011.12.009; Costello BE, 2010, ANN EMERG MED, V56, P643, DOI 10.1016/j.annemergmed.2010.03.001; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; Gaudette E., 2014, 2014005 CES U SO CAL; Goodacre S, 2005, EMERG MED J, V22, P93, DOI 10.1136/emj.2003.007690; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Harris A, 2010, EMERG MED J, V27, P508, DOI 10.1136/emj.2009.072546; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Jeng K, 2012, J CLIN VIROL, V54, P332, DOI 10.1016/j.jcv.2012.05.002; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Lau K, 2019, HEALTH ECON, V28, P175, DOI 10.1002/hec.3834; Lindstrom SJ, 2013, INTERN MED J, V43, P1246, DOI 10.1111/imj.12275; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; Martin S, 2007, J HEALTH ECON, V26, P263, DOI 10.1016/j.jhealeco.2006.08.006; Moore K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-338; Nichol KL, 2006, VACCINE, V24, P6726, DOI 10.1016/j.vaccine.2006.05.064; Richardson DB, 2009, MED J AUSTRALIA, V190, P369, DOI 10.5694/j.1326-5377.2009.tb02451.x; Schull MJ, 2007, ANN EMERG MED, V49, P257, DOI 10.1016/j.annemergmed.2006.06.027; Schull MJ, 2004, ANN EMERG MED, V44, P61, DOI 10.1016/j.annemergmed.2003.12.008; Sivey P, 2018, HEALTH ECON, V27, pE30, DOI 10.1002/hec.3610; Stang AS, 2015, ACAD EMERG MED, V22, P643, DOI 10.1111/acem.12682; StataCorp, 2021, STATA RELEASE 17 STA; Sugerman D, 2011, CLIN INFECT DIS, V52, pS177, DOI 10.1093/cid/ciq035; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222851	10.1371/journal.pone.0222851	http://dx.doi.org/10.1371/journal.pone.0222851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550288	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000532307700027
J	Zhang, HW; Lin, CW; Kok, VC; Tseng, CH; Lin, YP; Li, TC; Sung, FC; Wen, CP; Hsiung, CA; Hsu, CY				Zhang, Han-Wei; Lin, Chao-Wen; Kok, Victor C.; Tseng, Chun-Hung; Lin, Yuan-Pei; Li, Tsai-Chung; Sung, Fung-Chang; Wen, Chi Pang; Hsiung, Chao A.; Hsu, Chung Y.			Incidence of retinal vein occlusion with longterm exposure to ambient air pollution	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NONMETHANE HYDROCARBONS; PARTICULATE MATTER; UNITED-STATES; POPULATION; DISEASE; MORTALITY	This study aimed to investigate whether long-term exposure to airborne hydrocarbons, including volatile organic compounds, increases the risk of developing retinal vein occlusion (RVO) among the population of Taiwan. A retrospective cohort study involving 855,297 people was conducted. Cox proportional hazards regression analysis fitted the multiple pollutant models for two targeted pollutants, including total hydrocarbons (THC), nonmethane hydrocarbons (NMHC) were used, and the risk of RVO was estimated. The chi-squared test and one-way analysis of variance were used to test differences in demographics and comorbidity distribution among tertiles of the targeted pollutants. Before controlling for multiple pollutants, hazard ratios for the overall population were 19.88 (95% CI: 17.56-22.50) at 0.51-ppm increases in THC and 4.33 (95% CI: 3.97-4.73) at 0.27-ppm increases in NMHC. The highest adjusted hazard ratios for different multiple pollutant models of each targeted pollutant were statistically significant (all p values were.0.05) for all patients at 29.67 (95% CI: 25.57-34.42) for THC and 16.24 (95% CI: 14.14-18.65) for NMHC. Our findings suggest that long-term exposure to THC and NMHC contribute to RVO development.	[Zhang, Han-Wei] China Med Univ, PhD Program Aging, Taichung, Taiwan; [Zhang, Han-Wei; Lin, Yuan-Pei] Natl Chiao Tung Univ, Inst Elect Control Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan; [Zhang, Han-Wei; Wen, Chi Pang; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Lin, Chao-Wen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Kok, Victor C.] Asia Univ Taiwan, Dis Informat Res Grp, Taichung, Taiwan; [Kok, Victor C.] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Coll Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Dept Healthcare Adm, Coll Hlth Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Zhang, HW (corresponding author), China Med Univ, PhD Program Aging, Taichung, Taiwan.; Zhang, HW (corresponding author), Natl Chiao Tung Univ, Inst Elect Control Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan.; Zhang, HW (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.	omnizhang@nhri.org.tw	Kok, Victor C/C-1437-2013	Kok, Victor C/0000-0003-3440-8154				Adar SD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000372; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chen RJ, 2013, NEUROLOGY, V81, P1064, DOI 10.1212/WNL.0b013e3182a4a43c; Chen YY, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8629429; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Deobhakta A, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/438412; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Guo SJ, 2012, ENVIRON ENG SCI, V29, P262, DOI 10.1089/ees.2010.0421; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Hwang SH, 2016, JAMA OPHTHALMOL, V134, P503, DOI 10.1001/jamaophthalmol.2016.0139; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Knudtson MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P807, DOI 10.1001/archopht.123.6.807; Laouri M, 2011, EYE, V25, P981, DOI 10.1038/eye.2011.92; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lin YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082678; Louwies T, 2013, ENVIRON HEALTH PERSP, V121, P1011, DOI 10.1289/ehp.1205721; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mo ZW, 2017, SCI TOTAL ENVIRON, V593, P641, DOI 10.1016/j.scitotenv.2017.03.123; Moghadamnia MT, 2017, PEERJ, V5, DOI 10.7717/peerj.3574; National Health Insurance Research Database, INTR NAT HLTH INS RE; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Peters A, 2009, CIRCULATION, V120, P924, DOI 10.1161/CIRCULATIONAHA.109.895524; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Song PG, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010427; Tomasini Dawn N, 2007, Optometry, V78, P402, DOI 10.1016/j.optm.2006.12.017; Villeneuve PJ, 2002, ANN EPIDEMIOL, V12, P568, DOI 10.1016/S1047-2797(01)00292-7; Wang M, 2015, ATMOS CHEM PHYS, V15, P1489, DOI 10.5194/acp-15-1489-2015; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, OPHTHALMOLOGY, V112, P540, DOI 10.1016/j.ophtha.2004.10.039; Yen YC, 2013, BRIT J OPHTHALMOL, V97, P1192, DOI 10.1136/bjophthalmol-2013-303265; Zhang RH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00827; Zhang X, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0157-5	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222895	10.1371/journal.pone.0222895	http://dx.doi.org/10.1371/journal.pone.0222895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550294	gold, Green Published, Green Submitted			2022-12-27	WOS:000532307700031
J	John, M; Duguid, S; Tomasello, M; Melis, AP				John, Maria; Duguid, Shona; Tomasello, Michael; Melis, Alicia P.			How chimpanzees (Pan troglodytes) share the spoils with collaborators and bystanders	PLOS ONE			English	Article							FOOD; HARASSMENT; BEHAVIOR	Chimpanzees hunt cooperatively in the wild, but the factors influencing food sharing after the hunt are not well understood. In an experimental study, groups of three captive chimpanzees obtained a monopolizable food resource, either via two individuals cooperating (with the third as bystander) or via one individual acting alone alongside two bystanders. The individual that obtained the resource first retained most of the food but the other two individuals attempted to obtain food from the "captor" by begging. We found the main predictor of the overall amount of food obtained by bystanders was proximity to the food at the moment it was obtained by the captor. Whether or not an individual had cooperated to obtain the food had no effect. Interestingly, however, cooperators begged more from captors than did bystanders, suggesting that they were more motivated or had a greater expectation to obtain food. These results suggest that while chimpanzee captors in cooperative hunting may not reward cooperative participation directly, cooperators may influence sharing behavior through increased begging.	[John, Maria] Dr Maria John Commun, Leipzig, Germany; [Duguid, Shona; Melis, Alicia P.] UCL, Dept Expt Psychol, London, England; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of London; University College London; Duke University	Duguid, S (corresponding author), UCL, Dept Expt Psychol, London, England.	shona.duguid@ucl.ac.uk		Duguid, Shona/0000-0003-4844-0673	Max Planck Society; Templeton World Charity Foundation [TWCF0264]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Templeton World Charity Foundation(Templeton World Charity Foundation)	The study was funded by the Max Planck Society. S. Duguid wrote the manuscript supported by a grant awarded to A. P. Melis from the Templeton World Charity Foundation (TWCF0264).; We are very thankful to L. Ajarova, J. Rukundo, T. Mukungu, the trustees and all staff of the Chimpanzee Sanctuary and Wildlife Conservation Trust (CSWCT) (www.ngambaisland.org) for their continuous help and support. In particular, we appreciate the hard work of the animal caregivers and their support helping us to conduct the experiments. We thank also Roger Mundry for his advice and support with the statistical analyses. We also appreciate permission from the Ugandan National Council for Science and Technology and the Uganda Wildlife Authority for allowing us to conduct our research in Uganda. Shona Duguid was supported by a grant from the Templeton World Charity Foundation while writing the paper.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2000, CHIMPANZEES TAI FORE; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Dobson A.J., 2002, INTRO GEN LINEAR MOD; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Gurven M, 2004, BEHAV ECOL SOCIOBIOL, V56, P366, DOI 10.1007/s00265-004-0793-6; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Liebal K, 2017, ANIM BEHAV, V133, P91, DOI 10.1016/j.anbehav.2017.09.006; McGrath MC, 2019, NAT HUM BEHAV, V3, P354, DOI 10.1038/s41562-019-0530-9; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2013, J EXP CHILD PSYCHOL, V114, P364, DOI 10.1016/j.jecp.2012.08.006; Melis AP, 2011, ANIM BEHAV, V82, P485, DOI 10.1016/j.anbehav.2011.05.024; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mitani JC, 1999, AM J PHYS ANTHROPOL, V109, P439, DOI 10.1002/(SICI)1096-8644(199908)109:4<439::AID-AJPA2>3.0.CO;2-3; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Newton-Fisher NE, 2013, HDB PALEOANTHROPOLOG, VII, P1; Nissen HW, 1936, J COMP PSYCHOL, V22, P383, DOI 10.1037/h0062234; R Development Core Team, 2009, R LANG ENV STAT COMP; Samuni L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1643; Samuni L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0142-3; Samuni L, 2017, P NATL ACAD SCI USA, V114, P268, DOI 10.1073/pnas.1616812114; Schmelz M, 2017, P NATL ACAD SCI USA, V114, P7462, DOI 10.1073/pnas.1700351114; Silk JB, 2013, ANIM BEHAV, V85, P941, DOI 10.1016/j.anbehav.2013.02.014; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222795	10.1371/journal.pone.0222795	http://dx.doi.org/10.1371/journal.pone.0222795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545837	Green Published, gold			2022-12-27	WOS:000532303200035
J	Ni, GY; Huang, KS; Luan, Y; Cao, ZZ; Chen, S; Ma, BW; Yuan, JW; Wu, XL; Chen, GQ; Wang, TF; Li, HJ; Walton, S; Liu, F; Chen, BB; Wang, YJ; Pan, X; Liu, XS; Frazer, IH				Ni, Guoying; Huang, Kunsong; Luan, Yi; Cao, Zaizai; Chen, Shu; Ma, Bowei; Yuan, Jianwei; Wu, Xiaolian; Chen, Guoqiang; Wang, Tianfang; Li, Hejie; Walton, Shelley; Liu, Fang; Chen, Bobei; Wang, Yuejian; Pan, Xuan; Liu, Xiaosong; Frazer, Ian H.			Human papillomavirus infection among head and neck squamous cell carcinomas in southern China	PLOS ONE			English	Article							DNA EXTRACTION; EPIDEMIOLOGY; DIAGNOSIS; LESIONS; CANCER; UPDATE	Human papillomavirus (HPV) related tumours account for a significant proportion of head and neck squamous cell carcinomas (HNSCCs) in developed countries. They respond better to chemo- and radio-therapy, and have a better stage specific prognosis. To establish their prevalence in China, we assessed a series of histology confirmed HNSCCs collected in Zhejiang and Guangdong provinces by PCR for HPV DNA and by immunohistochemistry for p16 protein status. Among 303 HNSCCs, HPV DNA was detected in 26.4%, with HPV16 DNA in 71% of these. Of HNSCC located in the oropharynx, 38.55% (32/83) were HPV+ve. In this series, p16 status was a relatively poor predictor of HPV status as detected by PCR. The stage specific survival time of HPV+ HNSCCs was significantly longer than for HPV-HNSCC. HPV status should be assessed for oropharyngeal cancers in China to assist with appropriate management, and prophylaxis against HPV infection should be considered to reduce the incidence of this disease.	[Ni, Guoying; Huang, Kunsong; Ma, Bowei; Yuan, Jianwei; Pan, Xuan; Liu, Xiaosong] Guangdong Pharmaceut Univ, Clin Med Sch, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Ni, Guoying; Wang, Tianfang; Li, Hejie] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia; [Luan, Yi; Chen, Shu; Wu, Xiaolian; Chen, Guoqiang; Liu, Fang; Wang, Yuejian; Liu, Xiaosong] Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China; [Cao, Zaizai; Chen, Bobei] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Walton, Shelley; Liu, Xiaosong] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia; [Frazer, Ian H.] Univ Queensland, Fac Med, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia	Guangdong Pharmaceutical University; University of the Sunshine Coast; Wenzhou Medical University; University of the Sunshine Coast; University of Queensland	Liu, XS (corresponding author), Guangdong Pharmaceut Univ, Clin Med Sch, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.; Liu, XS (corresponding author), Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China.; Liu, XS (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia.	xiaosongl@yahoo.com	Wang, Tianfang/L-5192-2016; Walton, Shelley/A-9767-2012	Wang, Tianfang/0000-0002-4876-7767; Walton, Shelley/0000-0002-5857-6913; Ma, Bowei/0000-0002-3035-5115	Foshan City Council Research Platform Fund [2015AG1003, FS0AA-KJ218-1301-0039]; Science and Technology Research program of Guangdong province [2016A020213001]; National Natural Science Foundation of China [81472451]	Foshan City Council Research Platform Fund; Science and Technology Research program of Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was partly supported by the by Foshan City Council Research Platform Fund (No.: 2015AG1003, FS0AA-KJ218-1301-0039) to XSL. SC, TFW, GYN, https://kjyw.fskw.gov.cn/stmsres/; Science and Technology Research program of Guangdong province (No: 2016A020213001) to XSL.TFW, GYN, SC, http://pro.gdstc.gov.cn/egrantweb/; National Natural Science Foundation of China (No: 81472451) to XSL. TFW, GYN, SC, https://isisn.nsfc.gov.cn/egrantweb/.All the funding received during this study were external to our organization. There was no additional external funding received for this study.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ceccarelli Manuela, 2018, Oncotarget, V9, P17171, DOI 10.18632/oncotarget.24660; Chor JSY, 2016, J MED VIROL, V88, P877, DOI 10.1002/jmv.24405; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gotz C, 2019, MOL CLIN ONCOL, V10, P17, DOI 10.3892/mco.2018.1749; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guo LW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00619; Janecka A, 2015, ANAL BIOCHEM, V476, P8, DOI 10.1016/j.ab.2015.01.019; Kobayashi K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090241; Kounis NG, 2016, CLIN CHEM LAB MED, V54, P1545, DOI 10.1515/cclm-2016-0010; Lam EWH, 2016, CANCER EPIDEM BIOMAR, V25, P165, DOI 10.1158/1055-9965.EPI-15-0869; LeConte BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203403; Lee LA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002069; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Li S, 2015, ORAL ONCOL, V51, P1082, DOI 10.1016/j.oraloncology.2015.10.014; Liu J, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0345-5; Marur S, 2016, MAYO CLIN PROC, V91, P386, DOI 10.1016/j.mayocp.2015.12.017; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Ni GY, 2015, CELL IMMUNOL, V293, P126, DOI 10.1016/j.cellimm.2014.12.012; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pesek M, 2013, Ceska Gynekol, V78, P195; Pinatti LM, 2018, J DENT RES, V97, P691, DOI 10.1177/0022034517744213; Rabelo-Goncalves E, 2014, PATHOL RES PRACT, V210, P142, DOI 10.1016/j.prp.2013.11.003; Richards Lisa, 2010, Nat Rev Clin Oncol, V7, P481, DOI 10.1038/nrclinonc.2010.123; Smola Sigrun, 2017, Ther Adv Vaccines, V5, P69, DOI 10.1177/2051013617717914; Sun PM, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e50; Syrjanen S, 2018, EUR J ORAL SCI, V126, P49, DOI 10.1111/eos.12538; Termine N, 2008, ANN ONCOL, V19, P1681, DOI 10.1093/annonc/mdn372; Tong FJ, 2018, CELL PHYSIOL BIOCHEM, V49, P206, DOI 10.1159/000492858; van der Sluis TC, 2015, CURR OPIN IMMUNOL, V35, P9, DOI 10.1016/j.coi.2015.05.002; Vokes EE, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv344; Wei W, 2012, ONCOL REP, V28, P1750, DOI 10.3892/or.2012.1990; Wiegand S, 2018, EUR ARCH OTO-RHINO-L, V275, P1365, DOI 10.1007/s00405-018-4954-z; Zhang YR, 2016, ONCOTARGET, V7, P62411, DOI 10.18632/oncotarget.11498	34	18	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221045	10.1371/journal.pone.0221045	http://dx.doi.org/10.1371/journal.pone.0221045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545798	Green Published, gold			2022-12-27	WOS:000532303200010
J	Wei, XY; You, L; Wang, D; Huang, H; Li, SJ; Wang, DM				Wei, Xiaoyu; You, Lv; Wang, Dan; Huang, He; Li, Shijun; Wang, Dingming			Antimicrobial resistance and molecular genotyping of Salmonella enterica serovar Enteritidis clinical isolates from Guizhou province of Southwestern China	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ABUSE; SURVEILLANCE; PROFILES	Salmonella enterica serovar Enteritidis (S. Enteritidis) is the most common and essential serotype that causes salmonellosis in Guizhou province. This study aimed to investigate the antimicrobial resistance (AMR) and molecular genotyping of 79 S. Enteritidis clinical isolates from 2011 to 2016 in Guizhou, China. Antimicrobial resistance and minimum inhibitory concentrations (MICs) of S. Enteritidis clinical isolates were detected by micro broth dilution method against ten classes 16 antimicrobial agents, and molecular genotyping were examined by pulsed-field gel electrophoresis (PFGE) and multiple-locus variable-number tandem repeat analysis (MLVA). All (100%) isolates showed resistance to at least one antimicrobial. Resistance to nalidixic acid (98.7%) was the highest, followed by sulfamethoxazole (87.3%) and ampicillin (77.2%). The majority of isolates (92.4%) showed decreased susceptibility to ciprofloxacin. Resistance to the third and fourth-generation cephalosporins was observed. Twenty-six AMR profiles were observed, and the predominant AMR profile was ampicillin-streptomycin-sulfamethoxazole-amoxicillin/clavulanic acid-nalidixic acid. A high burden of multidrug resistance (MDR) (81.0%) was found. Seventy-nine S. Enteritidis isolates were divided into 33 different pulsotypes (PTs), and the most frequent PT was PT18. Twenty-six different MLVA types (MTs) were generated with seven VNTR loci analysis of these isolates. The dominant PTs and MTs were persistent during 2011-2016. S. Enteritidis clinical isolates showed higher genetic diversity using PFGE combined with MLVA grouped into 60 PT-MT genotypes. No correlation was observed between genotypes, AMR profiles and geographic location. These data revealed the characteristics of AMR and molecular genotyping of S. Enteritidis clinical isolates in Guizhou province. These results highlight that strengthening the AMR and molecular genotyping surveillance is essential to prevent and control salmonellosis in Guizhou. PFGE combined with MLVA should be powerful tools for the molecular genotyping of S. Enteritidis isolates.	[Wei, Xiaoyu; You, Lv; Li, Shijun] Guizhou Prov Ctr Dis Control & Prevent, Lab Bacterial Infect Dis Expt Ctr, Guiyang, Peoples R China; [Wang, Dan; Huang, He; Wang, Dingming] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Peoples R China		Wei, XY; Li, SJ (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Lab Bacterial Infect Dis Expt Ctr, Guiyang, Peoples R China.	weixyuse18@163.com; zjumedjun@163.com		Wei, Xiaoyu/0000-0002-9948-664X	Science and Technology Foundation Planning Project of Guizhou Province of China [Qian Ke He Basis [2017]1094]; Science and Technology Foundation of the Health Department of Guizhou Province of China [gzwjkj2016-1-003]; Program of Scientific and Technological Innovation Team of Guizhou Province [Qian Ke He Platform Talent [2018]5606]	Science and Technology Foundation Planning Project of Guizhou Province of China; Science and Technology Foundation of the Health Department of Guizhou Province of China; Program of Scientific and Technological Innovation Team of Guizhou Province	This work was funded by (to XYW) the Science and Technology Foundation Planning Project of Guizhou Province of China (Qian Ke He Basis [2017]1094), (to XYW) The Science and Technology Foundation of the Health Department of Guizhou Province of China (gzwjkj2016-1-003), and (to SJL) the Program of Scientific and Technological Innovation Team of Guizhou Province (Qian Ke He Platform Talent [2018]5606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campioni F, 2015, APMIS, V123, P422, DOI 10.1111/apm.12367; Cao Z, 2016, CHINA ANIMAL HUSBAND, V43, P1737, DOI [10.16431/j.cnki.1671-7236.2016.07.012, DOI 10.16431/J.CNKI.1671-7236.2016.07.012]; CDC. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 2018, HUM IS SURV REP 2015; Chiou CS, 2015, INT J FOOD MICROBIOL, V214, P1, DOI 10.1016/j.ijfoodmicro.2015.07.016; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Diao BaoWei, 2013, Disease Surveillance, V28, P1021; English BK, 2010, ADV EXP MED BIOL, V659, P73, DOI 10.1007/978-1-4419-0981-7_6; Fardsanei F, 2018, J GLOB ANTIMICROB RE, V12, P220, DOI 10.1016/j.jgar.2017.10.005; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Garca V, 2019, MICROB DRUG RESIST, V25, P219, DOI 10.1089/mdr.2018.0139; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Kang Xi-lin, 2018, Zhongguo Kangshengsu Zazhi, V43, P1073; Ke BX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-338; Kim J, 2014, FOODBORNE PATHOG DIS, V11, P38, DOI 10.1089/fpd.2013.1579; Kozoderovic G, 2011, FOLIA MICROBIOL, V56, P66, DOI 10.1007/s12223-011-0003-7; Ktari S, 2016, APMIS, V124, P194, DOI 10.1111/apm.12484; Li J, 2011, GUIZHOU AGR SCI, V39, P132; Lin, 2012, CHINESE J FOOD HYG, V24, P387; Liu Y, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0119-3; Lou Jing, 2013, Disease Surveillance, V28, P434; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mao X., 2011, CHIN J DIS CONTROL P, V15, P622; Muvhali M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2751-8; NAIR US, 1995, J AM VET MED ASSOC, V206, P1339; Peters T, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.9.30477; Ren H, 2016, HEILONGJIANG ANIMAL, P257; Song QF, 2018, INFECT DRUG RESIST, V11, P267, DOI 10.2147/IDR.S157460; Song QF, 2016, J FOOD SCI, V81, pM1778, DOI 10.1111/1750-3841.13339; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Utrarachkij F, 2016, J INFECT CHEMOTHER, V22, P209, DOI 10.1016/j.jiac.2015.12.011; Wang WenXia, 2011, Guizhou Agricultural Sciences, P133; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Wang Y, 2014, GUIZHOU MED J, V38, P164, DOI [10.3969/j.ISSN.1000-744X.2014.02.030, DOI 10.3969/J.ISSN.1000-744X.2014.02.030]; Wang Y, 2017, FOODBORNE PATHOG DIS, V14, P393, DOI 10.1089/fpd.2016.2237; Wang Z, 2017, INFECT CONT HOSP EP, V38, P758, DOI 10.1017/ice.2017.60; Wei XiaoYu, 2012, Modern Preventive Medicine, V39, P5351; Wei ZQ, 2019, FOODBORNE PATHOG DIS, V16, P244, DOI 10.1089/fpd.2018.2557; World Health Organization, 2010, WHO REC MAN DIARRH P; Wu Q, 2015, STUDIES TRACE ELEMEN, V32, P41; Xu L, 2018, J INFECT DEV COUNTR, V12, P573, DOI 10.3855/jidc.9733; You Lyu, 2018, Chinese Journal of Zoonoses, V34, P712; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001; Yuan H, 2014, B DIS CONTROL PREVEN, V29, P63, DOI [10.13215/j.cnki.jbyfkztb.1405006, DOI 10.13215/J.CNKI.JBYFKZTB.1405006]; Zhang ZK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173881; Zhou XJ, 2018, FOODBORNE PATHOG DIS, V15, P346, DOI 10.1089/fpd.2017.2387	45	2	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221492	10.1371/journal.pone.0221492	http://dx.doi.org/10.1371/journal.pone.0221492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31546249	gold, Green Published			2022-12-27	WOS:000532303200011
J	Chahal, KK; Li, J; Kufareva, I; Parle, M; Durden, DL; Wechsler-Reya, RJ; Chen, CC; Abagyan, R				Chahal, Kirti Kandhwal; Li, Jie; Kufareva, Irina; Parle, Milind; Durden, Donald L.; Wechsler-Reya, Robert J.; Chen, Clark C.; Abagyan, Ruben			Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; ACTIVITY PREDICTION; GLIOBLASTOMA CELLS; PATHWAY INHIBITOR; KINASE INHIBITOR; STRUCTURAL BASIS; IMATINIB; RESISTANCE; GROWTH; IDENTIFICATION	Dysregulation of the seven-transmembrane (7TM) receptor Smoothened (SMO) and other components of the Hedgehog (Hh) signaling pathway contributes to the development of cancers including basal cell carcinoma (BCC) and medulloblastoma (MB). However, SMO-specific antagonists produced mixed results in clinical trials, marked by limited efficacy and high rate of acquired resistance in tumors. Here we discovered that Nilotinib, an approved inhibitor of several kinases, possesses an anti-Hh activity, at clinically achievable concentrations, due to direct binding to SMO and inhibition of SMO signaling. Nilotinib was more efficacious than the SMO-specific antagonist Vismodegib in inhibiting growth of two Hh-dependent MB cell lines. It also reduced tumor growth in subcutaneous MB mouse xenograft model. These results indicate that in addition to its known activity against several tyrosine-kinase-mediated proliferative pathways, Nilotinib is a direct inhibitor of the Hh pathway. The newly discovered extension of Nilotinib's target profile holds promise for the treatment of Hh-dependent cancers.	[Chahal, Kirti Kandhwal; Kufareva, Irina; Abagyan, Ruben] Univ Calif San Diego UCSD, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Chahal, Kirti Kandhwal; Parle, Milind] GJ Univ Sci & Technol, Dept Pharmaceut Sci, Hisar, Haryana, India; [Li, Jie; Chen, Clark C.] Dept Neurosurg, Minneapolis, MN 55455 USA; [Durden, Donald L.] UCSD, Dept Pediat, Moores Canc Ctr, Sch Med, La Jolla, CA USA; [Durden, Donald L.] Rady Childrens Hosp, La Jolla, CA USA; [Wechsler-Reya, Robert J.] NCI, Tumor Initiat & Maintenance Program, Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	University of California System; University of California San Diego; Guru Jambheshwar University of Science & Technology; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute	Abagyan, R (corresponding author), Univ Calif San Diego UCSD, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Chen, CC (corresponding author), Dept Neurosurg, Minneapolis, MN 55455 USA.	ccchen@umn.edu; ruben@ucsd.edu		Abagyan, Ruben/0000-0001-9309-2976; Chahal, Kirti Kandhwal/0000-0002-5520-4161	NIH [R01 GM071872, 1R01NS097649-01, R01 AI118985, R01 GM117424]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Sontag Foundation Distinguished Scientist Award; Kimmel Scholar Award; BWF [1006774.01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117424, R35GM131881, R01GM071872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097649, R01NS102432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Sontag Foundation Distinguished Scientist Award; Kimmel Scholar Award; BWF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project is partially funded by NIH grant R01 GM071872 (to R.A.) and 1R01NS097649-01, the Doris Duke Charitable Foundation Clinical Scientist Development Award, The Sontag Foundation Distinguished Scientist Award, the Kimmel Scholar Award, and BWF 1006774.01 (to C.C.C.). The part of the project was also supported by NIH grant R01 AI118985 and R01 GM117424 (to I.K.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Akare UR, 2014, BIOINFORMATION, V10, P737, DOI 10.6026/97320630010737; Au K, 2015, J NEURO-ONCOL, V122, P471, DOI 10.1007/s11060-015-1744-y; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Blagosklonny MV, 2002, LEUKEMIA, V16, P570, DOI 10.1038/sj.leu.2402409; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Campbell V, 2015, STEM CELLS CLONING, V8, P27, DOI 10.2147/SCCAA.S58613; Caro I, 2010, CLIN CANCER RES, V16, P3335, DOI 10.1158/1078-0432.CCR-09-2570; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chahal KK, 2018, ANTI-CANCER DRUG, V29, P387, DOI 10.1097/CAD.0000000000000609; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen YC, 2014, FUTURE MED CHEM, V6, P1741, DOI [10.4155/fmc.14.113, 10.4155/FMC.14.113]; Chilton-Macneill S, PEDIAT DEV PATHOL OF; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cochrane CR, 2015, CANCERS, V7, P1554, DOI 10.3390/cancers7030851; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eleutherakis-Papaiakovou V, 2004, ANN ONCOL, V15, P1151, DOI 10.1093/annonc/mdh300; Emmenegger BA, 2008, J CHILD NEUROL, V23, P1172, DOI 10.1177/0883073808321062; Fossati P, 2009, CANCER TREAT REV, V35, P79, DOI 10.1016/j.ctrv.2008.09.002; Gendreau SB, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B192; Giles FJ, 2013, EUR J CLIN PHARMACOL, V69, P813, DOI 10.1007/s00228-012-1385-4; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Gonda TJ, 2015, NAT REV CANCER, V15, P686, DOI 10.1038/nrc4018; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Heikens J, 1998, EUR J CANCER, V34, P1592, DOI 10.1016/S0959-8049(98)00212-3; Higdon R, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5010005; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Huang P, 2018, CELL; Huang PX, 2016, CELL, V166, P1176, DOI 10.1016/j.cell.2016.08.003; Irvine DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25476; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kieran MW, 2014, NEURO-ONCOLOGY, V16, P1037, DOI 10.1093/neuonc/nou109; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012; Kufareva I, 2012, CURR TOP MED CHEM, V12, P1869, DOI 10.2174/156802612804547335; Larsen AR, 2015, MOL CANCER THER, V14, P3, DOI 10.1158/1535-7163.MCT-14-0755-T; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee MJ, 2012, P NATL ACAD SCI USA, V109, P7859, DOI 10.1073/pnas.1114718109; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malancona S, 2011, BIOORG MED CHEM LETT, V21, P4422, DOI 10.1016/j.bmcl.2011.06.024; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; Martarelli D, 2008, CANCER CHEMOTH PHARM, V61, P809, DOI 10.1007/s00280-007-0538-0; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Miller-Moslin K, 2009, J MED CHEM, V52, P3954, DOI 10.1021/jm900309j; Morgillo F, 2017, J MED CHEM, V60, P7447, DOI 10.1021/acs.jmedchem.7b00794; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Parkkila S, 2009, BIOORGANIC MED CHEM, V19; Peukert S, 2009, BIOORGANIC MED CHEM, V19; Razis E, 2009, CLIN CANCER RES, V15, P6258, DOI 10.1158/1078-0432.CCR-08-1867; Reinwald M, 2014, BIOMED RES INT, V2014, P15; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Shi D, 2019, J CHEM INF MODEL, V59, P3006, DOI 10.1021/acs.jcim.9b00031; Singh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150836; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smoll NR, 2012, J CLIN NEUROSCI, V19, P1541, DOI 10.1016/j.jocn.2012.04.009; Soria JC, 2009, J CLIN ONCOL, V27, P1359, DOI 10.1200/JCO.2008.20.8595; Su B, 2009, BIOORG MED CHEM LETT, V19, P6733, DOI 10.1016/j.bmcl.2009.09.109; SU G, 2011, CHEM BIOL, V10, DOI DOI 10.1186/1475-2840-10-19; Therapeutic Goods Administration, 2011, AUSTR PUBL ASS REP N; Totrov M, 1997, PROTEINS, P215; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JB, 2012, BIOORGAN MED CHEM, V20, P6751, DOI 10.1016/j.bmc.2012.09.030; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Yang B, 2012, BIOORGANIC MED CHEM, V22; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	91	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0214901	10.1371/journal.pone.0214901	http://dx.doi.org/10.1371/journal.pone.0214901			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539380	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900002
J	Itohiya, H; Matsushima, Y; Shirakawa, S; Kajiyama, S; Yashima, A; Nagano, T; Gomi, K				Itohiya, Hiroo; Matsushima, Yuji; Shirakawa, Satoshi; Kajiyama, Sohtaro; Yashima, Akihiro; Nagano, Takatoshi; Gomi, Kazuhiro			Organic resolution function and effects of platinum nanoparticles on bacteria and organic matter	PLOS ONE			English	Article							METAL NANOPARTICLES; PERIODONTAL-DISEASE; VISUALIZATION; COMBINATION; GOLD	Rapid progress has been made in terms of metal nanoparticles studied in numerous fields. Metal nanoparticles have also been used in medical research, and antibacterial properties and anticancer effects have been reported. However, the underlying mechanism responsible for these effects has not been fully elucidated. Therefore, the present study focused on platinum nanoparticles (PtNPs) and examined their antibacterial properties and functional potential for decomposing organic matter, considering potential applications in the dental field. PtNPs were allowed to react with dental-related bacteria (Streptococcus mutans; Enterococcus faecalis, caries; Porphyromonas gingivalis, and endodontic and periodontal lesions). Antibacterial properties were evaluated by measuring colony formation. In addition, PtNPs were allowed to react with albumin and lipopolysaccharides (LPSs), and the functional potential to decompose organic matter was evaluated. All evaluations were performed in vitro. Colony formation in all bacterial species was completely suppressed by PtNPs at concentrations of > 5 ppm. The addition of PtNPs at concentrations of > 10 ppm significantly increased fragmentation and decomposition. The addition of PtNPs at concentrations of >125 pico/mL to 1 EU/mL LPS resulted in significant amounts of decomposition and elimination. The results revealed that PtNPs had antibacterial effects against dental-related bacteria and proteolytic potential to decompose proteins and LPS, an inflammatory factor associated with periodontal disease. Therefore, the use and application of PtNPs in periodontal and endodontic treatment is considered promising.	[Itohiya, Hiroo; Matsushima, Yuji; Shirakawa, Satoshi; Kajiyama, Sohtaro; Yashima, Akihiro; Nagano, Takatoshi; Gomi, Kazuhiro] Tsurumi Univ, Sch Dent Med, Dept Periodontol, Tsurumi Ku, Yokohama, Kanagawa, Japan	Tsurumi University	Gomi, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Periodontol, Tsurumi Ku, Yokohama, Kanagawa, Japan.	gomi-k@tsurumi-u.ac.jp		Gomi, Kazuhiro/0000-0003-4484-6238				BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Corain B, 2008, METAL NANOCLUSTERS IN CATALYSIS AND MATERIALS SCIENCE: THE ISSUE OF SIZE CONTROL, P1; Gopal J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01260; HANAZAWA S, 1985, INFECT IMMUN, V50, P262, DOI 10.1128/IAI.50.1.262-270.1985; Horie M, 2014, J TOXICOL SCI, V39, P897, DOI 10.2131/jts.39.897; Konieczny P, 2013, INT J NANOMED, V8, P3963, DOI 10.2147/IJN.S49612; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu Z, 2013, J MATER SCI-MATER M, V24, P1465, DOI 10.1007/s10856-013-4894-5; Ma S, 2012, DENT MATER J, V31, P150, DOI 10.4012/dmj.2011-180; Mafune F, 2003, J PHYS CHEM B, V107, P4218, DOI 10.1021/jp021580k; Mao BH, 2016, NANOTOXICOLOGY, V10, P1021, DOI 10.1080/17435390.2016.1189614; Mathur A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141301; Mayer ABR, 2001, POLYM ADVAN TECHNOL, V12, P96, DOI 10.1002/1099-1581(200101/02)12:1/2<96::AID-PAT943>3.0.CO;2-G; McGuffie MJ, 2016, NANOMED-NANOTECHNOL, V12, P33, DOI 10.1016/j.nano.2015.10.002; Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015; Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; SCHMID G, 1994, CLUSTERS COLLOIDS TH; Silvert PY, 1996, J MATER CHEM, V6, P573, DOI 10.1039/jm9960600573; Slavin YN, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0308-z; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Su YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15824; Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; Veerapandian M, 2011, APPL MICROBIOL BIOT, V90, P1655, DOI 10.1007/s00253-011-3291-6; Wang LL, 2017, INT J NANOMED, V12, P1227, DOI 10.2147/IJN.S121956; Wieckowski A., 2003, CATALYSIS ELECTROCAT; Yamada M, 2015, WIRES NANOMED NANOBI, V7, P428, DOI 10.1002/wnan.1322; Yang XL, 2017, ACS NANO, V11, P5737, DOI 10.1021/acsnano.7b01240; Yhee JY, 2015, CURR PHARM DESIGN, V21, P3158, DOI 10.2174/1381612821666150531165059	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222634	10.1371/journal.pone.0222634	http://dx.doi.org/10.1371/journal.pone.0222634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536547	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800065
J	Navarro, VJ; Belle, SH; D'Amato, M; Adfhal, N; Brunt, EM; Fried, MW; Reddy, KR; Wahed, AS; Harrison, S				Navarro, Victor J.; Belle, Steven H.; D'Amato, Massimo; Adfhal, Nezam; Brunt, Elizabeth M.; Fried, Michael W.; Reddy, K. Rajender; Wahed, Abdus S.; Harrison, Stephen			Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial	PLOS ONE			English	Article							LIPID-PEROXIDATION; MILK THISTLE; LIVER	The botanical product silymarin, an extract of milk thistle, is commonly used by patients to treat chronic liver disease and may be a treatment for NASH due to its antioxidant properties. We aimed to assess the safety and efficacy of higher than customary doses of silymarin in non -cirrhotic patients with NASH. This exploratory randomized double-blind placebo controlled multicenter Phase II trial tested a proprietary standardized silymarin preparation (Legalon (R), Rottapharm vertical bar Madaus, Mylan) and was conducted at 5 medical centers in the United States. Eligible adult patients had liver biopsy within 12 months showing NASH without cirrhosis with NAFLD Activity Score (NAS) >= 4 per site pathologist's assessment. Participants were randomized to Legalon (R) 420 mg, 700 mg, or placebo t.i.d. for 48 weeks. The primary endpoint was histological improvement >= 2 points in NAS. Of 116 patients screened, 78 were randomized. There were no significant differences in adverse events among the treatment groups. After 48-50 weeks, 4/27 (15%) in the 700 mg dose, 5/26 (19%) participants randomized to 420 mg, and 3/25 (12%) of placebo recipients reached the primary endpoint (p = 0.79) among all randomized participants, indicating no benefit from silymarin in the intention to treat analysis Review by a central pathologist demonstrated that a substantial number of participants (49, 63%) did not meet histological entry criteria and that fibrosis stage improved most in the placebo treated group, although not significantly different from other groups. Silymarin (Legalon (R)) at the higher than customary doses tested in this study is safe and well tolerated. The effect of silymarin in patients with NASH remains inconclusive due to the substantial number of patients who entered the study but did not meet entry histological criteria, the lack of a statistically significant improvement in NAS of silymarin treated patients, and the unanticipated effect of placebo on fibrosis indicate the need for additional clinical trials.	[Navarro, Victor J.] Einstein Med Ctr, Dept Digest Dis & Transplantat, Philadlephia, PA 19141 USA; [Navarro, Victor J.] Sidney Kimmel Med Coll, Philadlephia, PA 19107 USA; [Belle, Steven H.; Wahed, Abdus S.] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [D'Amato, Massimo] Rottapharm Biotech, Clin Res, Monza, MB, Italy; [Adfhal, Nezam] Beth Israel Deaconess Med Ctr, Dept Med, Div Hepatol, Boston, MA 02215 USA; [Brunt, Elizabeth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, CB 8118, St Louis, MO USA; [Fried, Michael W.] Univ N Carolina, Liver Ctr, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA; [Reddy, K. Rajender] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Harrison, Stephen] Brooke Army Med Ctr, Dept Med, Div Gastroenterol, Ft Sam Houston, TX 78234 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rottapharm; Harvard University; Beth Israel Deaconess Medical Center; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; San Antonio Military Medical Center; United States Department of Defense; United States Army	Navarro, VJ (corresponding author), Einstein Med Ctr, Dept Digest Dis & Transplantat, Philadlephia, PA 19141 USA.; Navarro, VJ (corresponding author), Sidney Kimmel Med Coll, Philadlephia, PA 19107 USA.	navarrov@einstein.edu			National Institutes of Health (NIH) National Center for Complementary and Alternative Medicine (NCCAM) [1U01AT003574, 1U01AT003566, 1U01AT003571, 1U01AT003560, 1U01AT003573]; Mylan	National Institutes of Health (NIH) National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Mylan	This research was supported from the following sources: The National Institutes of Health (NIH) National Center for Complementary and Alternative Medicine (NCCAM) Victor Navarro-1U01AT003574; Steven H. Belle-1U01AT003566; Nezam Afdhal-1U01AT003571; Michael W. Fried-1U01AT003560; K. Rajender Reddy1U01AT003573; sponsorship was assumed by Rottapharm vertical bar Madaus (now Mylan) during the course of the trial. Stephen Harrison joined after transfer of the study to Rottapharm/Madaus. In addition, Rottapharm vertical bar Madaus provided silymarin and placebo. No conflicts of interest exist as this was an investigator-initiated trial. Mylan, formerly Rottapharm vertical bar Madaus, manufacturer of the silymarin formulation used in this study, as corporate entity had no direct or indirect role nor involvement in the design of the trial, data collection or preparation or submission of the manuscript for publication of this registered (http://clinicaltrials.gov/ct2/show/NCT00680407) investigator-initiated trial. None of the authors has a personal conflict of interest with the manufacturer of any of the marketed silymarin formulations. Dr. Massimo D'Amato was an employee of the Italian subsidiary of Rottapharm vertical bar Madaus at the time of the study, but left Rottapharm vertical bar Madaus to join Rottapharm Biotech in 2014 and participated in the preparation of the manuscript as an independent scientist. Rottapharm Biotech is an independent company from Mylan, does not market Legalon nor any sylimarin formulation and as corporate entity had no role in the conception, design and performance of this study, nor in the decision to submit the manuscript for publication.	Abenavoli L, 2010, PHYTOTHER RES, V24, P1423, DOI 10.1002/ptr.3207; BOSISIO E, 1992, PHARMACOL RES, V25, P147, DOI 10.1016/1043-6618(92)91383-R; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; CARINI R, 1992, BIOCHEM PHARMACOL, V43, P2111, DOI 10.1016/0006-2952(92)90168-I; Fried MW, 2012, JAMA-J AM MED ASSOC, V308, P274, DOI 10.1001/jama.2012.8265; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Kheong CW, 2017, CLIN GASTROENTEROL H, V15, P1940, DOI 10.1016/j.cgh.2017.04.016; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Mira L, 1994, BIOCH PHARAMACOL, V42, P964; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Saller R, 2001, DRUGS, V61, P2035, DOI 10.2165/00003495-200161140-00003; Zhong S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009061	13	37	38	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221683	10.1371/journal.pone.0221683	http://dx.doi.org/10.1371/journal.pone.0221683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536511	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800018
J	Goisauf, M; Martin, G; Bentzen, HB; Budin-Ljosne, I; Ursin, L; Durnova, A; Leitsalu, L; Smith, K; Casati, S; Lavitrano, M; Mascalzoni, D; Boeckhout, M; Mayrhofer, MT				Goisauf, Melanie; Martin, Gillian; Bentzen, Heidi Beate; Budin-Ljosne, Isabelle; Ursin, Lars; Durnova, Anna; Leitsalu, Liis; Smith, Katharine; Casati, Sara; Lavitrano, Marialuisa; Mascalzoni, Deborah; Boeckhout, Martin; Mayrhofer, Michaela Th.			Data in question: A survey of European biobank professionals on ethical, legal and societal challenges of biobank research	PLOS ONE			English	Article							RESEARCH PARTICIPANTS; INFORMED-CONSENT; PERSPECTIVES; PERCEPTIONS; ATTITUDES; FEEDBACK; SCIENCE; ISSUES	Biobanks have evolved, and their governance procedures have undergone important transformations. Our paper examines this issue by focusing on the perspective of the professionals working in management or scientific roles in research-based biobanks, who have an important impact on shaping these transformations. In particular, it highlights that recent advances in molecular medicine and genomic research have raised a range of ethical, legal and societal implications (ELSI) related to biobank-based research, impacting directly on regulations and local practices of informed consent (IC), private-public partnerships (PPPs), and engagement of participants. In our study, we investigate the ways that these concerns influence biobanking practices and assess the level of satisfaction of the cross-national biobanking research communities with the ELSI related procedures that are currently in place. We conducted an online survey among biobankers and researchers to investigate secondary use of data, informing and/or re-contacting participants, sharing of data with third parties from industry, participant engagement, and collaboration with industrial partners. Findings highlight the need for a more inclusive and transparent biobanking practice where biobanks are seen in a more active role in providing information and communicating with participants; the need to improve the current IC procedures and the role of biobanks in sharing of samples and data with industry partners and different countries, and the need for practical, tangible and hands-on ethical and legal guidance.	[Goisauf, Melanie; Martin, Gillian; Durnova, Anna; Leitsalu, Liis; Mayrhofer, Michaela Th.] ERIC, BBMRI, Graz, Austria; [Martin, Gillian] Univ Malta, Dept Sociol, Msida, Malta; [Bentzen, Heidi Beate] Univ Oslo, Norwegian Res Ctr Comp & Law, Fac Law, Oslo, Norway; [Bentzen, Heidi Beate] Univ Oslo, Ctr Med Eth, Fac Med, Oslo, Norway; [Budin-Ljosne, Isabelle] Norwegian Inst Publ Hlth, Oslo, Norway; [Ursin, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Durnova, Anna] Inst Adv Studies, Vienna, Austria; [Leitsalu, Liis] Univ Tartu, Inst Genom, Estonian Genome Ctr, Tartu, Estonia; [Smith, Katharine] Imperial Coll London, Inst Global Hlth Innovat, Ctr Hlth Policy, London, England; [Casati, Sara; Lavitrano, Marialuisa] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy; [Mascalzoni, Deborah] Univ Uppsala CRB, Dept Publ Hlth, Ctr Res Eth & Bioeth, Uppsala, Sweden; [Mascalzoni, Deborah] EURAC Res, Inst Biomed, Bolzano, Italy; [Boeckhout, Martin] Univ Med Ctr Utrecht, Dept Med Humanities, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Malta; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); Norwegian University of Science & Technology (NTNU); University of Tartu; Imperial College London; University of Milano-Bicocca; European Academy of Bozen-Bolzano; Utrecht University; Utrecht University Medical Center	Goisauf, M (corresponding author), ERIC, BBMRI, Graz, Austria.	melanie.goisauf@bbmri-eric.eu; michaela.th.mayrhofer@bbmri-eric.eu	Durnová, Anna/M-5633-2016	Durnová, Anna/0000-0001-5789-1850; Lavitrano, Marialuisa/0000-0003-4852-1318; Goisauf, Melanie/0000-0002-3909-8071; Martin, Gillian/0000-0002-5281-8117; Mascalzoni, Deborah/0000-0003-4156-1464; Mayrhofer, Michaela Th./0000-0001-6932-0473; Bentzen, Heidi Beate/0000-0001-8285-818X	BBMRI-ERIC in relation; BBMRI-ERIC Common Service ELSI; EU [676550]; Biobank Norway - Research Council of Norway [245464]; NordForsk [81105]; Research Council of Norway [238999]; BBMRI-NL; Dutch government (NWO) [184033111]; RD-Connect - 7th Framework Programme of the European Union's Research and Innovation programme [305444]; IMI's Big Data for Better Outcomes (BD4BO) programme [116055]; European Cooperation in Science and Technology programme (COST)	BBMRI-ERIC in relation; BBMRI-ERIC Common Service ELSI; EU(European Commission); Biobank Norway - Research Council of Norway; NordForsk; Research Council of Norway(Research Council of Norway); BBMRI-NL; Dutch government (NWO); RD-Connect - 7th Framework Programme of the European Union's Research and Innovation programme; IMI's Big Data for Better Outcomes (BD4BO) programme; European Cooperation in Science and Technology programme (COST)	MG, GM, MTM, AD, LL, MB, SC, and ML received funding from BBMRI-ERIC in relation to their affiliation with the BBMRI-ERIC Common Service ELSI and ADOPT BBMRI-ERIC project supported by EU Horizon 2020 (https://ec.europa.eu/programmes/horizon2020/en), grant number 676550. IBL received funding from Biobank Norway funded by The Research Council of Norway (https://www.forskningsradet.no/en/), grant number 245464. HBB and DM received funding from NordForsk (https://www.nordforsk.org/en?set_language=en) project "Governance of Health Data in Cyberspace", grant number 81105. HBB received funding from The Research Council of Norway (https://www.forskningsradet.no/en/) project "Legal Regulation of Information Processing relating to Personalized Cancer Medicine", grant number 238999. MB received funding from BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO) (https://www.nwo.nl/en), grant number 184033111. DM received funding from RD-Connect supported by the 7th Framework Programme of the European Union's Research and Innovation programme (https://ec.europa.eu/research/fp7/index_en.cfm), grant number 305444. KS received funding from the IMI's Big Data for Better Outcomes (BD4BO) programme (https://www.imi.europa.eu/projects-results/project-factsheets/bd4bo) DO-IT project, grant number 116055. This work was co-funded by the European Cooperation in Science and Technology programme (COST), Action IS1303 Citizen's Health through public-private Initiatives: Public health, Market and Ethical perspectives (CHIP ME) (https://www.cost.eu/actions/IS1303/#tabs vertical bar Name: overview) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarden E, 2017, SCI PUBL POLICY, V44, P753, DOI 10.1093/scipol/scx010; [Anonymous], 2005, EXPL REP CETS 195 AD; Bredenoord AL, 2011, HUM MUTAT, V32, P861, DOI 10.1002/humu.21518; Budin-Ljosne I, 2016, BIOPRESERV BIOBANK, V14, P241, DOI 10.1089/bio.2015.0115; Burgess MM, 2014, PUBLIC UNDERST SCI, V23, P48, DOI 10.1177/0963662512472160; Burton PRA, 2017, INT J EPIDEMIOL, V46, P1729, DOI 10.1093/ije/dyx195; Caenazzo L., 2016, J BIOMED CLIN RES, V9, P17, DOI [10.1515/jbcr-2016-0002, DOI 10.1515/JBCR-2016-0002]; Cambon-Thomsen A, 2004, NAT REV GENET, V5, P866, DOI 10.1038/nrg1473; Caulfield T, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002654; Caulfield T, 2014, J LAW BIOSCI, V1, P94, DOI 10.1093/jlb/lst004; Concannon TW, 2014, J GEN INTERN MED, V29, P1692, DOI 10.1007/s11606-014-2878-x; D'Abramo F, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0053-5; European Commission, 2017, SPECIAL EUROBAROMETE; Felt U, 2010, MINERVA, V48, P219, DOI 10.1007/s11024-010-9155-x; Goisauf M, 2019, PUBLIC UNDERST SCI, V28, P275, DOI 10.1177/0963662518806451; Gottweis H, 2011, NAT REV GENET, V12, P738, DOI 10.1038/nrg3083; Hmlinen I, 2019, BIOPRESERV BIOBANK, V17, P46, DOI 10.1089/bio.2018.0024; Harris JR, 2012, EUR J HUM GENET, V20, P1105, DOI 10.1038/ejhg.2012.96; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hemminki E., 2009, GENOMICS SOC POLICY, V5, P67, DOI [10.1186/1746-5354-5-2-67, DOI 10.1186/1746-5354-5-2-67]; Hoeyer K, 2006, SOCIOL HEALTH ILL, V28, P785, DOI 10.1111/j.1467-9566.2006.00542.x; Hofman P, 2014, VIRCHOWS ARCH, V464, P3, DOI 10.1007/s00428-013-1524-z; Ipsos MORI, 2016, ONE WAY MIRR PUBL AT; Joly Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129893; Kaye J, 2015, EUR J HUM GENET, V23, P141, DOI 10.1038/ejhg.2014.71; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Lipworth W, 2011, SOCIOL HEALTH ILL, V33, P792, DOI 10.1111/j.1467-9566.2011.01342.x; Liu AG, 2015, ADV EXP MED BIOL, V864, P55, DOI 10.1007/978-3-319-20579-3_5; Lunshof JE, 2014, SCIENCE, V343, P373, DOI 10.1126/science.1249382; Master Z, 2015, EUR J HUM GENET, V23, P569, DOI 10.1038/ejhg.2014.143; Mayrhofer M.T., 2009, INT J RISK ASSESSMEN, V12, P64, DOI [10.1504/IJRAM.2009.024130, DOI 10.1504/IJRAM.2009.024130]; Mayrhofer MT, 2018, BIOPRESERV BIOBANK, V16, P458, DOI 10.1089/bio.2018.0018; Mayrhofer MT, 2016, BUNDESGESUNDHEITSBLA, V59, P379, DOI 10.1007/s00103-015-2301-8; Mayrhofer MT, 2013, HIST PHIL LIFE SCI, V35, P449; McCormack P, 2016, EUR J HUM GENET, V24, P1403, DOI 10.1038/ejhg.2016.30; Meslin EM, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0077-y; Mester JL, 2015, CANCER EPIDEM BIOMAR, V24, P708, DOI 10.1158/1055-9965.EPI-13-1375; Murad AM, 2017, AM J MED GENET A, V173, P930, DOI 10.1002/ajmg.a.38114; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; Ormond KE, 2010, STANFORD J LAW SCI P, V1, P80; Petersen I, 2014, J EMPIR RES HUM RES, V9, P48, DOI 10.1177/1556264614540600; Rensch S., 2018, EU PUBLIC PRIVATE PA; Sanderson SC, 2017, AM J HUM GENET, V100, P414, DOI 10.1016/j.ajhg.2017.01.021; Secko DM, 2009, SOC SCI MED, V68, P781, DOI 10.1016/j.socscimed.2008.11.020; Spjuth O, 2016, EUR J HUM GENET, V24, P521, DOI 10.1038/ejhg.2015.165; Steinsbekk KS, 2013, MED HEALTH CARE PHIL, V16, P151, DOI 10.1007/s11019-011-9353-9; Steinsbekk KS, 2011, PUBLIC HEALTH ETH-UK, V4, P236, DOI 10.1093/phe/phr031; Teare HJA, 2017, EUR J HUM GENET, V25, P816, DOI 10.1038/ejhg.2017.57; Thorogood A, 2019, EUR J HUM GENET, V27, P535, DOI 10.1038/s41431-018-0311-3; Tierney WM, 2016, J GEN INTERN MED, V31, P228, DOI 10.1007/s11606-015-3495-z	50	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221496	10.1371/journal.pone.0221496	http://dx.doi.org/10.1371/journal.pone.0221496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB3PW	31532777	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000488470200001
J	Ntamba, YL; Mavoko, HM; Kalabuanga, M; Fungula, B; Nsengi, PMN; Lutete, GT; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Ntamba, Yves Lula; Mavoko, Hypolite Muhindo; Kalabuanga, Marion; Fungula, Blaise; Nsengi, Pierre-Michel Ntamabyaliro; Lutete, Gaston Tona; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Lutumba, Pascal			Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo	PLOS ONE			English	Article							COMBINATION THERAPIES; PHARMACOVIGILANCE; EFFICACY; COUNTRIES	Introduction Artemisinin-based combination therapy is currently the best option for the treatment of uncomplicated malaria. Quinine is recommended as a rescue treatment. Safety information during repeated treatment with the same drug is scarce. We report safety data from the Quinact randomized clinical trial (RCT) that was designed to assess efficacy and safety of artesunate-amodiaquine (ASAQ), artemether-lumefantrine (AL) and quinine+clindamycin (QnC). Methodology Males and females aged 12 to 59 months with uncomplicated malaria were treated with ASAQ and followed up during 42 days (preRCT). Clinical failures were randomized to one of the 3 treatments and followed up for 28 days (RCT). Subsequent failures were repeatedly treated with ASAQ several times as needed (postRCT1, postRCT2 and so on) until a 28days follow up period without parasitaemia. Results Eight hundred and sixty-five, 242 and 64 patients were recruited respectively in preRCT, RCT and postRCTs. In preRCT, 433 (50.0%) patients experienced at least one drug-related adverse event (AE). The most reported AEs were anorexia (22.9%), asthenia (19.4%), and abnormal behavior (14.6%). Twenty-nine AEs (3.5%) were reported to be severe. In RCT, at least one drug-related AE was reported in 54.7%, 21.5% and 40.0% of patient randomized respectively to ASAQ, AL and QnC (p< 0.001). During postRCT1 (n = 64), postRCT 2 (n = 17) and postRCT3 (n = 7), respectively 32.8%, 35.3% and 71.4% of patients experienced at least one drug-related AE. Three serious adverse events occurred but not judged related to study medication. Conclusion The proportion of AEs did not increase over the treatment courses with ASAQ. However, continuous monitoring is important.	[Ntamba, Yves Lula; Nsengi, Pierre-Michel Ntamabyaliro; Lutete, Gaston Tona] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Ntamba, Yves Lula; Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med, Global Hlth Inst, Antwerp, Belgium; [Mavoko, Hypolite Muhindo; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Kalabuanga, Marion; Fungula, Blaise] Lisungi Hlth Ctr, Kinshasa, DEM REP CONGO	Universite de Kinshasa; University of Antwerp; Universite de Kinshasa	Ntamba, YL (corresponding author), Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO.; Ntamba, YL (corresponding author), Univ Antwerp, Fac Med, Global Hlth Inst, Antwerp, Belgium.	yveslula@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Lula, Yves/0000-0001-9196-7150	Fonds Wetenschappelijk Onderzoek (FWO) [G.078.11]; Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS) [ZRDC2012MP076]; European and Developing Countries Clinical Trials Partnership (EDCTP) [MS.2010.10800.004]; Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC) [FEE/06/12]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS); European and Developing Countries Clinical Trials Partnership (EDCTP); Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC)	The Quinact trial was co-funded by Fonds Wetenschappelijk Onderzoek (FWO, Grant reference G.078.11 to JPVg), Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS, Grant reference ZRDC2012MP076 to JPVg, PL), European and Developing Countries Clinical Trials Partnership (EDCTP, Grant reference MS.2010.10800.004 to JPVg) and the Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC, Grant reference FEE/06/12 to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0301-z; Andrade RJ, 2007, WORLD J GASTROENTERO, V13, P329, DOI 10.3748/wjg.v13.i3.329; [Anonymous], 2003, ASS MON ANT DRUG EFF; [Anonymous], 1999, GUIDELINES PREPARING; [Anonymous], 1996, INT C HARM TECHN REQ; Anstey NM, 2015, LANCET INFECT DIS, V15, P692, DOI 10.1016/S1473-3099(15)70024-1; Bassi PU, 2013, DRUG SAFETY, V36, P747, DOI 10.1007/s40264-013-0044-8; Bethell D, 2010, CLIN INFECT DIS, V51, pE105, DOI 10.1086/657402; Chau TTH, 1996, CLIN INFECT DIS, V23, P1274, DOI 10.1093/clinids/23.6.1274; Chinawa JM, 2013, NIGER J PAED, V40, P416; Dodoo ANO, 2014, DRUG SAFETY, V37, P433, DOI 10.1007/s40264-014-0164-9; Ekong M B, 2008, Niger J Physiol Sci, V23, P51; Falade C., 2009, MALARIA J, V8, P1; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; IFPMA, 2016, MSSODI62261900 IFPMA; Kuemmerle A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-57; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Maketa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0595-5; Mavoko HM, 2017, LANCET GLOB HEALTH, V5, pE60, DOI 10.1016/S2214-109X(16)30236-4; Mavoko HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157074; Mavoko HM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-307; Mehta U, 2007, DRUG SAFETY, V30, P899, DOI 10.2165/00002018-200730100-00008; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Ndiaye JLA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-237; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Ngasala BE, 2011, CLIN INFECT DIS, V52, P873, DOI 10.1093/cid/cir066; Ngouesse B, 2001, AM J TROP MED HYG, V65, P711, DOI 10.4269/ajtmh.2001.65.711; Olsson S, 2010, DRUG SAFETY, V33, P689, DOI 10.2165/11536390-000000000-00000; Pirmohamed M, 2007, BRIT MED J, V335, P462, DOI 10.1136/bmj.39323.586123.BE; PNLP, 2012, GUID TECHN PREV PRIS; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; Sanofi-Aventis, 2014, ART AM TABL SUMM PRO; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Stergachis A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-148; Sweetman S. C., 2007, MARTINDALE COMPLETE; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; Thiam S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-54; WHO, 2015, WHO ADV REACT TERM W; WHO Evidence Review Group Meeting, 2016, WHO EV REV GROUP M C; World Health Organization, 2007, PRACT HDB PHARM ANT; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yeka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113311	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222379	10.1371/journal.pone.0222379	http://dx.doi.org/10.1371/journal.pone.0222379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527899	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400017
J	Spenlingwimmer, T; Zipperle, J; Jafarmadar, M; Osuchowski, MF; Drechsler, S				Spenlingwimmer, Tanja; Zipperle, Johannes; Jafarmadar, Mohammad; Osuchowski, Marcin Filip; Drechsler, Susanne			Comparison of post-traumatic changes in circulating and bone marrow leukocytes between BALB/c and CD-1 mouse strains	PLOS ONE			English	Article							MULTIPLE-TRAUMA; MODEL; SUSCEPTIBILITY; POLYTRAUMA; CELLS; MICE; INFLAMMATION; ASSOCIATION; RESPONSES	This manuscript emerged from a larger third-party funded project investigating a new polytrauma model and its influence upon secondary sepsis. The present sub-study compared selected leukocyte subpopulations in the circulation and bone marrow after polytrauma in BALB/c versus CD-1 mice. Animals underwent unilateral femur fracture, splenectomy and hemorrhagic shock. We collected blood and bone marrow for flow cytometry analysis at 24h and 48h post-trauma. Circulating granulocytes (Ly6G+CD11+) increased in both strains after trauma. Only in BALB/c mice circulating CD8+ T-lymphocytes decreased within 48h by 30%. Regulatory T-cells (T-regs, CD4+CD25+CD127(low)) increased in both strains by approx. 32%. Circulating Tregs and lymphocytes (CD11b-Ly6G-MHC-2+) were always at least 1.5-fold higher in BALB/c, while the bone marrow MHC-2 expression decreased in CD-1 mice (p<0.05). Overall, immune responses to polytrauma were similar in both strains. Additionally, BALB/c expressed higher level of circulating regulatory T-cells and MHC-2-positive lymphocytes compared to CD-1 mice.	[Spenlingwimmer, Tanja; Zipperle, Johannes; Jafarmadar, Mohammad; Osuchowski, Marcin Filip; Drechsler, Susanne] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Drechsler, S (corresponding author), AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	susanne.drechsler@trauma.lbg.ac.at		Zipperle, Johannes/0000-0002-8222-3413; Osuchowski, Marcin/0000-0002-1321-9883; Drechsler, Susanne/0000-0002-0758-303X	FWF Austrian Science Fund [T707-B13]	FWF Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by FWF Austrian Science Fund, Grant Number T707-B13 awarded to SD (www.fwf.ac.at).The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BRETT SJ, 1982, PARASITOLOGY, V85, P85, DOI 10.1017/S0031182000054172; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Cahill LS, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-60; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Charles River International, 2011, CD 1 IGS MIC NOM CRL; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; Dai HL, 2013, INJURY, V44, P1521, DOI 10.1016/j.injury.2013.03.015; Denton MD, 1999, J EXP MED, V190, P555, DOI 10.1084/jem.190.4.555; Doeing Diana C, 2003, BMC Clin Pathol, V3, P3; Drechsler S, 2018, SCI REP, V8, P1, DOI 10.1038/s41598-017-17765-5; Ehrnthaller C, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0236-7; European Commission, 2016, 7 REP STAT NUMB AN U; Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Gentile LF, 2013, CRIT CARE MED, V41, P1075, DOI 10.1097/CCM.0b013e318275d1f9; Jensen VS, 2016, AM J TRANSL RES, V8, P3574; Johnson M., 2012, MAT METHODS, V2, DOI 10.13070; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Li P, 2017, NUCLEIC ACIDS RES, V45, pD908, DOI 10.1093/nar/gkw974; LUEKER DC, 1975, J PARASITOL, V61, P158, DOI 10.2307/3279135; MA L, 1989, J TRAUMA, V29, P1245, DOI 10.1097/00005373-198909000-00010; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martin MD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01527; Matsutani T, 2005, CYTOKINE, V30, P168, DOI 10.1016/j.cyto.2004.12.019; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mira JC, 2018, METHODS MOL BIOL, V1717, P1, DOI 10.1007/978-1-4939-7526-6_1; Morgan AP, 2016, G3-GENES GENOM GENET, V6, P263, DOI 10.1534/g3.115.022087; Nashef A, 2017, METHODS MOL BIOL, V1488, P551, DOI 10.1007/978-1-4939-6427-7_27; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Rau CD, 2015, G3-GENES GENOM GENET, V5, P2021, DOI 10.1534/g3.115.020784; RICHARDSON SH, 1986, INFECT IMMUN, V54, P522, DOI 10.1128/IAI.54.2.522-528.1986; Smith CM, 2016, MBIO, V7, DOI [10.1128/mbio.01516-16, 10.1128/mBio.01516-16]; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Turnbull IR, 2016, SHOCK, V45, P555, DOI 10.1097/SHK.0000000000000538; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vester H, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0180-y; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winter JM, 2017, CELL SYST, V4, P31, DOI 10.1016/j.cels.2016.10.018	45	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222594	10.1371/journal.pone.0222594	http://dx.doi.org/10.1371/journal.pone.0222594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527918	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400031
J	Tlili, H; Hanen, N; Ben Arfa, A; Neffati, M; Boubakri, A; Buonocore, D; Dossena, M; Verri, M; Doria, E				Tlili, Hajer; Hanen, Najjaa; Ben Arfa, Abdelkerim; Neffati, Mohamed; Boubakri, Abdelbasset; Buonocore, Daniela; Dossena, Maurizia; Verri, Manuela; Doria, Enrico			Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia	PLOS ONE			English	Article							MARRUBIUM-VULGARE L.; ANTIOXIDANT ACTIVITY; THYMELAEA-HIRSUTA; INHIBITION; SAPONINS	Recently, much attention has been paid to the extracts obtained from plant species in order to analyse their biological activities. Due to the climate diversity in Tunisia, the traditional pharmacopoeia consists of a wide arsenal of medicinal plant species since long used in folk medicine, in foods as spices, and in aromatherapy. Although many of these species are nearly facing extinction, only a small proportion of them have been scientifically studied. Therefore, this study explores the biochemical properties of seven spontaneous plants, which were harvested in the arid Tunisian desert: Marrubium vulgare (L.), Rhus tripartita (Ucria) D.C., Thymelaea hirsute (L.) Endl., Plantago ovata (Forsk.), Herniaria fontanesii (J. Gay.), Ziziphus lotus (L.) and Hyoscyamus albus (L.). Extracts from these plants were found to contain different types of secondary metabolites (polyphenols, flavonoids, condensed tannins, crude saponins, carotenoids and alkaloids) that are involved in important biological activities. The biological activity of the extracts obtained from each Tunisian plant was assessed: first of all, leukaemia and colon cancer cell lines (K-562 and CaCo-2 respectively) were treated with different concentrations of extracts, and then the anti-proliferative activity was observed. The results showed, in particular, how the plant extract from Rhus tripartita significantly inhibits cell proliferation, especially on the K-562 tumour cell line. Subsequently, the anti-inflammatory activity was also assessed, and the results showed that Herniaria fontanesii and Marrubium vulgare possess the highest activity in the group of analysed plants. Finally, the greatest acetylcholinesterase inhibitory effect was exhibited by the extract obtained from Rhus tripartita. In conclusion, all the Tunisian plants we analysed were shown to contain a remarkable amount of different bio-active compounds, thus confirming their involvement in several biological activities. Rhus tripartita and Ziziphus lotus were shown to be particularly effective in anti-proliferative activity, while Herniaria fontanesii were shown to have the best anti-inflammatory activity.	[Tlili, Hajer; Hanen, Najjaa; Ben Arfa, Abdelkerim; Neffati, Mohamed; Boubakri, Abdelbasset] Inst Arid Reg IRA, Lab Pastoral Ecosyst & Valorisat Spontaneous Plan, Medenine, Tunisia; [Buonocore, Daniela; Dossena, Maurizia; Verri, Manuela; Doria, Enrico] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy	Institut des Regions Arides; University of Pavia	Doria, E (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.	enrico.doria@unipv.it	Boubakri, Abdelbasset/AAY-8784-2020	Boubakri, Abdelbasset/0000-0001-8755-8362; Doria, Enrico/0000-0002-6805-0202; Verri, Manuela/0000-0003-3734-9540				Abdoul-Azize S, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/2867470; Abdoul-Azize S, 2013, INT IMMUNOPHARMACOL, V15, P364, DOI 10.1016/j.intimp.2012.11.013; Adewusi EA, 2011, S AFR J BOT, V77, P638, DOI 10.1016/j.sajb.2010.12.009; Adzu B, 2003, ACTA TROP, V87, P245, DOI 10.1016/S0001-706X(03)00114-1; Akrout A, 2011, FOOD CHEM TOXICOL, V49, P342, DOI 10.1016/j.fct.2010.11.003; Ben Barka Z, 2016, BIOMED PHARMACOTHER, V83, P827, DOI 10.1016/j.biopha.2016.07.055; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Biradar S.R., 2013, AM J LIFE SCI, V1, P243, DOI [10.11648/j.ajls.20130106.1, DOI 10.11648/J.AJLS.20130106.1, 10.11648/j.ajls.20130106.11, DOI 10.11648/J.AJLS.20130106.11]; Borgi W, 2004, S AFRICAN J BOT, V74, P320; BORRIS RP, 1988, J ETHNOPHARMACOL, V24, P41, DOI 10.1016/0378-8741(88)90138-9; Chao HC, 2013, EXP DERMATOL, V22, P131, DOI 10.1111/exd.12089; Chatterjee P, 2012, J ADV PHARM TECHNOL, V3, P136, DOI 10.4103/2231-4040.97298; Chevallier A., 1996, ENCY MED PLANTS; CORDELL GA, 1995, PHYTOCHEMISTRY, V40, P1585, DOI 10.1016/0031-9422(95)00444-C; Cuenod A, 1954, FLORE ANAL SYNOPTIQU; Doit C, 1997, ANTIMICROB AGENTS CH, V41, P2050, DOI 10.1128/AAC.41.9.2050; El Amrani F, 2009, J MED PLANTS RES, V3, P625; El-Saltani Alghazeer Hussein, 2012, NATURAL SCI, V4, P324; El-Seedi HR, 2013, J ETHNOPHARMACOL, V145, P746, DOI 10.1016/j.jep.2012.12.007; Essawi T, 2000, J ETHNOPHARMACOL, V70, P343, DOI 10.1016/S0378-8741(99)00187-7; Essawy SS, 2014, SAUDI PHARM J, V22, P472, DOI 10.1016/j.jsps.2013.12.004; Fan FY, 2017, MOLECULES, V22, DOI 10.3390/molecules22030484; Fawole OA, 2010, J ETHNOPHARMACOL, V127, P235, DOI 10.1016/j.jep.2009.11.015; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Giancarlo S, 2006, NAT PROD RES, V20, P882, DOI 10.1080/14786410500520186; Haddadian K, 2014, INDIAN J TRADIT KNOW, V13, P681; Hajipoor K, 2015, IJBPAS, V4, P4016; Harrison A. P., 2006, American Journal of Pharmacology and Toxicology, V1, P26; Hernandez MF, 2010, FOOD CHEM, V120, P1076, DOI 10.1016/j.foodchem.2009.11.055; Itidel C, 2013, IND CROP PROD, V51, P171, DOI 10.1016/j.indcrop.2013.09.002; Kabbaj F.Z., 2012, PHYTOPHARMACOLOGY, V2, P243; Kaur R., 2015, INT J PHARM BIOL SCI, V6, P826; Kawano M, 2007, EXP DERMATOL, V16, P977, DOI 10.1111/j.1600-0625.2007.00618.x; Khadri A, 2010, LWT-FOOD SCI TECHNOL, V43, P331, DOI 10.1016/j.lwt.2009.08.004; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Le Floc'h E., 1983, CONTRIBUTION ETUDE E; Le Houerou HN, 1969, ANN I NAT RECH AGR T, V42; Lodhi S, 2017, J INTERCULT ETHNOPHA, V6, P429, DOI 10.5455/jice.20170713060840; Loizzo MR, 2010, NUTR RES, V30, P823, DOI 10.1016/j.nutres.2010.09.016; Lola-Luz T, 2014, AGR FOOD SCI, V23, P28, DOI 10.23986/afsci.8832; Madland E., 2013, EXTRACTION ISOLATION; Mamta S, 2017, ASIAN J PHARM CLIN R, V10, P202; Marrif HI, 1995, J ETHNOPHARMACOL, V49, P51, DOI 10.1016/0378-8741(95)01302-4; Mbark AN, 2000, PHARMAZIE, V55, P690; Medoua GN, 2009, FOOD CHEM, V115, P260, DOI 10.1016/j.foodchem.2008.12.007; Mohammed I., 2015, J PHARMACOGN PHYTOCH, V4, P276; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Najjaa H, 2017, MED AROMATIC PLANTS, P3; Nargund L. V. G., 1993, Indian Journal of Experimental Biology, V31, P395; Ohtera A, 2013, BIOCHEM BIOPH RES CO, V440, P204, DOI 10.1016/j.bbrc.2013.09.003; Orhan IE, 2010, IND CROP PROD, V32, P566, DOI 10.1016/j.indcrop.2010.07.005; Ouelbani R, 2016, J ETHNOPHARMACOL, V194, P196, DOI 10.1016/j.jep.2016.08.016; Parveen M, 2014, NAT PROD RES, V28, P646, DOI 10.1080/14786419.2014.891201; Perk AA, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0124-6; Renault JH, 1997, PHYTOCHEMISTRY, V44, P1321, DOI 10.1016/S0031-9422(96)00721-2; Rhiouani H, 2008, J ETHNOPHARMACOL, V118, P378, DOI 10.1016/j.jep.2008.05.009; Sakat S.S., 2010, INT J PHARM PHARM SC, V2, P82; Saso L, 2001, ARCH PHARM RES, V24, P150, DOI 10.1007/BF02976483; Schlemper V, 1996, PHYTOMEDICINE, V3, P211, DOI 10.1016/S0944-7113(96)80038-9; Souri E, 2008, DARU, V16, P83; Sung Bokyung, 2016, J Cancer Prev, V21, P216, DOI 10.15430/JCP.2016.21.4.216; Talukder P, 2016, J SCI FOOD AGR, V96, P232, DOI 10.1002/jsfa.7086; Trigui M, 2013, IND CROP PROD, V41, P150, DOI 10.1016/j.indcrop.2012.04.011; Wu T, 2013, FOOD CHEM, V138, P1333, DOI 10.1016/j.foodchem.2012.10.086; Zaabat N, 2011, FOOD CHEM TOXICOL, V49, P3328, DOI 10.1016/j.fct.2011.08.026; Ziyyat A, 1997, J ETHNOPHARMACOL, V58, P45, DOI 10.1016/S0378-8741(97)00077-9	67	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0213049	10.1371/journal.pone.0213049	http://dx.doi.org/10.1371/journal.pone.0213049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527869	Green Submitted, Green Published, gold			2022-12-27	WOS:000532231400001
J	Rahman, MM; Shimizu, K; Yamauchi, M; Takase, H; Ugawa, S; Okada, A; Inoshima, Y				Rahman, Md Matiur; Shimizu, Kaori; Yamauchi, Marika; Takase, Hiroshi; Ugawa, Shinya; Okada, Ayaka; Inoshima, Yasuo			Acidification effects on isolation of extracellular vesicles from bovine milk	PLOS ONE			English	Article							EXOSOMES; MICRORNAS; PROTEINS; CELLS; RNA	Bovine milk extracellular vesicles (EVs) attract research interest as carriers of biologically active cargo including miRNA from donor to recipient cells to facilitate intercellular communication. Since toxicity of edible milk seems to be negligible, milk EVs are applicable to use for therapeutics in human medicine. Casein separation is an important step in obtaining pure EVs from milk, and recent studies reported that adding hydrochloric acid (HCI) and acetic acid (AA) to milk accelerates casein aggregation and precipitation to facilitate EV isolation and purification; however, the effects of acidification on EVs remain unclear. In this study, we evaluated the acidification effects on milk-derived EVs with that by standard ultracentrifugation (UC). We separated casein from milk by either UC method or treatment with HCI or AA, followed by evaluation of EVs in milk serum (whey) by transmission electron microcopy (TEM), spectrophotometry, and tunable resistive pulse sensing analysis to determine EVs morphology, protein concentration, and EVs size and concentration, respectively. Moreover, we used anti-CD9, -CD63, -CD81, -MFG-E8, -HSP70, and -Alix antibodies for the detection of EVs surface and internal marker proteins by western blot (WB). Morphological features of EVs were spherical shape and similar structure was observed in isolated EVs by TEM. However, some of the EVs isolated by HCI and AA had shown rough surface. Although protein concentration was higher in whey obtained by UC, EV concentration was significantly higher in whey following acid treatment. Moreover, although all of the targeted EVs-marker-proteins were detected by WB, HCI- or AA-treatments partially degraded CD9 and CD81. These findings indicated that acid treatment successfully separated casein from milk to allow efficient EV isolation and purification but resulted in partial degradation of EV-surface proteins. Our results suggest that following acid treatment, appropriate EV-surface-marker antibodies should be used for accurate assess the obtained EVs for downstream applications. This study describes the acidification effects on EVs isolated from bovine milk for the first time.	[Rahman, Md Matiur; Inoshima, Yasuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan; [Rahman, Md Matiur; Shimizu, Kaori; Yamauchi, Marika; Okada, Ayaka; Inoshima, Yasuo] Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Gifu, Japan; [Rahman, Md Matiur] Sylhet Agr Univ, Dept Med, Sylhet, Bangladesh; [Takase, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Core Lab, Mizuho Ku, Mizuho Cho, Nagoya, Aichi, Japan; [Ugawa, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Anat & Neurosci, Mizuho Ku, Mizuho Cho, Nagoya, Aichi, Japan; [Okada, Ayaka; Inoshima, Yasuo] Gifu Univ, GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan; [Inoshima, Yasuo] Gifu Univ, Joint Grad Sch Vet Sci, Gifu, Gifu, Japan	Gifu University; Gifu University; Sylhet Agricultural University; Nagoya City University; Nagoya City University; Gifu University; Gifu University	Inoshima, Y (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, Joint Grad Sch Vet Sci, Gifu, Gifu, Japan.	inoshima@gifu-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan; OGAWA Science and Technology Foundation; Morinaga Foundation for Health and Nutrition	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); OGAWA Science and Technology Foundation; Morinaga Foundation for Health and Nutrition	This study was partially supported by a research project grant for Improving Animal Disease Prevention Technologies to Combat Antimicrobial Resistance (2017-2021 FY to YI) from the Ministry of Agriculture, Forestry, and Fisheries of Japan. This study was also supported in part by the OGAWA Science and Technology Foundation and the Morinaga Foundation for Health and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban JJ, 2015, BIOCHEM BIOPH RES CO, V461, P76, DOI 10.1016/j.bbrc.2015.03.172; Benmoussa A, 2016, J NUTR, V146, P2206, DOI 10.3945/jn.116.237651; Cai MC, 2018, CELL STRESS CHAPERON, V23, P663, DOI 10.1007/s12192-018-0876-3; Crookenden MA, 2016, J DAIRY SCI, V99, P7661, DOI 10.3168/jds.2015-10786; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Gheinani AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22142-x; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McMahon DJ, 2008, J DAIRY SCI, V91, P1709, DOI 10.3168/jds.2007-0819; Melnik BC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-103; Oehmcke S, 2012, CELL MICROBIOL, V14, P107, DOI 10.1111/j.1462-5822.2011.01705.x; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Samuel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06288-8; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Shandilya S, 2017, J AGR FOOD CHEM, V65, P9506, DOI 10.1021/acs.jafc.7b03123; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Somiya M, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1440132; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Vaswani K, 2017, REPROD BIOL, V17, P341, DOI 10.1016/j.repbio.2017.09.007; Wang HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/864894; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077359; Yamada T, 2012, J VET MED SCI, V74, P1523, DOI 10.1292/jvms.12-0032; Yamauchi M, 2019, DRUG DEV IND PHARM, V45, P359, DOI 10.1080/03639045.2018.1539743	33	25	26	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222613	10.1371/journal.pone.0222613	http://dx.doi.org/10.1371/journal.pone.0222613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525238	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700041
J	Ueno, H; Ito, R; Abe, S; Ogino, H; Maruyama, M; Miyashita, H; Miyamoto, Y; Moritoh, Y; Tsujihata, Y; Takeuchi, K; Nishigaki, N				Ueno, Hikaru; Ito, Ryo; Abe, Shin-ichi; Ogino, Hitomi; Maruyama, Minoru; Miyashita, Hirohisa; Miyamoto, Yasufumi; Moritoh, Yusuke; Tsujihata, Yoshiyuki; Takeuchi, Koji; Nishigaki, Nobuhiro			GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; INSULIN-SECRETION; BODY-WEIGHT; FATTY-ACIDS; BRAIN-STEM; BETA-CELLS; TAK-875; MECHANISMS; RESISTANCE	GPR40/FFAR1 is a Gq protein-coupled receptor expressed in pancreatic beta cells and enteroendocrine cells, and mediates insulin and incretin secretion to regulate feeding behavior. Several GPR40 full agonists have been reported to reduce food intake in rodents by regulating gut hormone secretion in addition to their potent glucose-lowering effects; however, detailed mechanisms of feeding suppression are still unknown. In the present study, we characterized T-3601386, a novel compound with potent full agonistic activity for GPR40, by using in vitro Ca2+ mobilization assay in Chinese hamster ovary (CHO) cells expressing FFAR1 and in vivo hormone secretion assay. We also evaluated feeding suppression and weight loss after the administration of T-3601386 and investigated the involvement of the vagal nerve in these effects. T-3601386, but not a partial agonist fasiglifam, increased intracellular Ca2+ levels in CHO cells with low FFAR1 expression, and single dosing of T-3601386 in diet -induced obese (DIO) rats elevated plasma incretin levels, suggesting full agonistic properties of T-3601386 against GPR40. Multiple doses of T-3601386, but not fasiglifam, in DIO rats showed dose-dependent weight loss accompanied by feeding suppression and durable glucagon-like peptide -1 elevation, all of which were completely abolished in Ffar1(-/-) mice. Immunohistochemical analysis in the nuclei of the solitary tract demonstrated that T-3601386 increased the number of c-Fos positive cells, which also disappeared in Ffar1(-/-) mice. Surgical vagotomy and drug-induced deafferentation counteracted the feeding suppression and weight loss induced by the administration of T-3601386. These results suggest that T-3601386 exerts incretin release and weight loss in a GPR40-dependent manner, and that afferent vagal nerves are important for the feeding suppression induced by GPR40 full agonism. Our novel findings raise the possibility that GPR40 full agonist can induce periphery-derived weight reduction, which may provide benefits such as less adverse effects in central nervous system compared to centrally-acting anti-obesity drugs.	[Ueno, Hikaru; Ito, Ryo; Abe, Shin-ichi; Ogino, Hitomi; Maruyama, Minoru; Miyashita, Hirohisa; Miyamoto, Yasufumi; Tsujihata, Yoshiyuki; Takeuchi, Koji; Nishigaki, Nobuhiro] Takeda Pharmaceut Co Ltd, Cardiovasc Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Moritoh, Yusuke] SCOHIA PHARMA Inc, Res & Dev Div, Fujisawa, Kanagawa, Japan; [Ueno, Hikaru] Takeda Pharmaceut Co Ltd, T CiRA Discovery, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Ueno, H (corresponding author), Takeda Pharmaceut Co Ltd, Cardiovasc Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.; Ueno, H (corresponding author), Takeda Pharmaceut Co Ltd, T CiRA Discovery, Fujisawa, Kanagawa, Japan.	hikaru.ueno@takeda.com	Nishigaki, Nobuhiro/AAZ-3584-2021	Nishigaki, Nobuhiro/0000-0002-7524-1429; Abe, Shin-ichi/0000-0003-4104-749X; Ueno, Hikaru/0000-0002-5595-8342	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. During the time this study was conducted, Takeda also provided support in the form of salaries for authors [HU, RI, SA, HO, MM, YMi, YT, KT, NN]. SCOHIA PHARMA Inc. did provide a salary for an author [YMo], but did not fund this study. These companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Camilleri M, 2015, GASTROENTEROLOGY, V148, P1219, DOI 10.1053/j.gastro.2014.09.016; Chepurny OG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22106-1; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Egerod KL, 2018, MOL METAB, V12, P62, DOI 10.1016/j.molmet.2018.03.016; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Fujiwara K, 2012, J NEUROCHEM, V121, P66, DOI 10.1111/j.1471-4159.2011.07563.x; Gorski JN, 2017, AM J PHYSIOL-ENDOC M, V313, pE37, DOI 10.1152/ajpendo.00435.2016; Gram DX, 2005, EUR J PHARMACOL, V509, P211, DOI 10.1016/j.ejphar.2004.12.039; Grill HJ, 2009, INT J OBESITY, V33, pS11, DOI 10.1038/ijo.2009.10; Hafizur R. M., 2015, INTEGR OBES DIABETES, V1, P44, DOI [DOI 10.15761/I0D.1000111, DOI 10.15761/IOD.1000111]; Ho JD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01240-w; IKEDA H, 1981, DIABETES, V30, P1045, DOI 10.2337/diabetes.30.12.1045; Ito R, 2013, BRIT J PHARMACOL, V170, P568, DOI 10.1111/bph.12297; Ito R, 2016, J PHARMACOL EXP THER, V357, P217, DOI 10.1124/jpet.115.230730; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Iwasaki Y, 2017, NEUROPEPTIDES, V65, P77, DOI 10.1016/j.npep.2017.05.003; Iwasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067198; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsuda-Nagasumi K, 2013, DIABETES OBES METAB, V15, P538, DOI 10.1111/dom.12065; Miwatashi S, 2018, [No title captured], Patent No. [WO2018181847A1, 2018181847]; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Nio Y, 2017, ENDOCRINOLOGY, V158, P1298, DOI 10.1210/en.2016-1825; Pachanski MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186033; Paxinos G, 2004, RAT BRAIN; Portha B, 2003, ANIMAL MODELS DIABET, P231; Schwartz GJ, 2006, PHILOS T R SOC B, V361, P1275, DOI 10.1098/rstb.2006.1862; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Ueno H, 2019, J PHARMACOL EXP THER, V370, P172, DOI 10.1124/jpet.118.255885; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Yamada Y, 2008, HORM METAB RES, V40, P539, DOI 10.1055/s-2008-1076699; Yamane S, 2012, J DIABETES INVEST, V3, P80, DOI 10.1111/j.2040-1124.2011.00143.x	50	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222653	10.1371/journal.pone.0222653	http://dx.doi.org/10.1371/journal.pone.0222653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525244	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700044
J	Il Lim, H; Jun, SJ; Lee, SW				Il Lim, Hong; Jun, Sang Jin; Lee, Sung Woo			Glomerular hyperfiltration may be a novel risk factor of restrictive spirometry pattern: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2015	PLOS ONE			English	Article							LUNG-FUNCTION; RENAL HYPERFILTRATION; METABOLIC SYNDROME; INSULIN-RESISTANCE; CLINICAL-SIGNIFICANCE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR RISK; PULMONARY-FUNCTION; PHYSICAL-ACTIVITY; VITAL CAPACITY	Background and objectives There have been limited studies regarding the association between glomerular hyperfiltration (GHF) and restrictive spirometry pattern (RSP) in Korean adults. Methods We used data of 23,189 adults from the Korea National Health and Nutritional Examination Survey 2009-2015 with a complete data set including spirometry, serum creatinine, and anthropometric measurements. Spirometry data included the forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). We defined GHF as the > 90th percentile of age & sex adjusted estimated glomerular filtration rate (eGFR), and RSP was defined as an FVC < 80%-predicted value and an FEV1/FVC ratio >= 0.7. Results Participants with RSP showed higher blood pressure, fasting glucose, and triglyceride, reduced high density lipoprotein cholesterol, and central obesity, which resulted in a higher prevalence of metabolic syndrome (MetS) compared to those without RSP. Multivariate logistic regression revealed that the odds for RSP were significantly increased with an increased number of MetS components. In addition, increased eGFR was associated with decreased FVC, showing an inverted J-shaped relationship in a multivariate generalized additive model analysis. In the multivariate logistic regression analysis, the adjusted odds ratio and 95% confidence interval of GHF for RSP was 1.184 (1.026-1.368, P = 0.021), which was evident in groups without metabolic disorders. Conclusions We concluded that GHF was associated with increased odds for RSP, particularly in groups without metabolic disorders. Further prospective studies are needed to confirm our study results.	[Il Lim, Hong; Jun, Sang Jin; Lee, Sung Woo] Eulji Univ, Nowon Eulji Med Ctr, Dept Internal Med, Seoul, South Korea	Eulji University	Lee, SW (corresponding author), Eulji Univ, Nowon Eulji Med Ctr, Dept Internal Med, Seoul, South Korea.	neplsw@gmail.com		sangjin, Jeon/0000-0002-8975-9333; Lee, Sung Woo/0000-0002-4419-3938				Aaron SD, 1999, CHEST, V115, P869, DOI 10.1378/chest.115.3.869; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bankir L, 2015, AM J PHYSIOL-RENAL, V309, pF2, DOI 10.1152/ajprenal.00614.2014; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bjornstad P, 2015, NEPHROL DIAL TRANSPL, V30, P1706, DOI 10.1093/ndt/gfv121; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Cornelis T, 2011, SEMIN NEPHROL, V31, P4, DOI 10.1016/j.semnephrol.2010.10.002; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, DIABETIC MED, V19, P167, DOI 10.1046/j.1464-5491.2002.00652.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Fragoso CAV, 2011, J INVEST MED, V59, P1089, DOI 10.2310/JIM.0b013e31822bb213; Godfrey MS, 2016, CHEST, V149, P238, DOI 10.1378/chest.15-1045; Har R, 2013, DIABETOLOGIA, V56, P1166, DOI 10.1007/s00125-013-2857-5; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hwang HJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0106-4; Jankowich M, 2018, ANN AM THORAC SOC, V15, P1186, DOI 10.1513/AnnalsATS.201803-184OC; Kleiven O, 2018, SCAND J MED SCI SPOR, V28, P172, DOI 10.1111/sms.12878; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee HM, 2009, CHEST, V136, P171, DOI 10.1378/chest.08-1901; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Litonjua AA, 2005, RESP MED, V99, P1583, DOI 10.1016/j.rmed.2005.03.023; Low S, 2018, DIABETES VASC DIS RE, V15, P417, DOI 10.1177/1479164118776465; Melsom T, 2019, AM J KIDNEY DIS, V73, P777, DOI 10.1053/j.ajkd.2018.11.011; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Min HK, 2019, KIDNEY RES CLIN PRAC, V38, P196, DOI 10.23876/j.krcp.18.0147; Moualla M, 2017, THORAX, V72, P1113, DOI 10.1136/thoraxjnl-2016-209125; Mukai H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195585; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Navaneethan SD, 2016, AM J KIDNEY DIS, V68, P414, DOI 10.1053/j.ajkd.2016.03.415; Park JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188903; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sasaki M, 2011, ACTA MED OKAYAMA, V65, P81; Senechal M, 2014, MED SCI SPORT EXER, V46, P1475, DOI 10.1249/MSS.0000000000000266; Silva B, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2040030; Sperandio EF, 2016, J BRAS PNEUMOL, V42, P22, DOI 10.1590/S1806-37562016000000030; Sumida K, 2017, AM J KIDNEY DIS, V70, P675, DOI 10.1053/j.ajkd.2017.05.021; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Venkateshiah SB, 2008, LUNG, V186, P19, DOI 10.1007/s00408-007-9052-8; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu IH, 2017, CHEST, V152, P394, DOI 10.1016/j.chest.2017.03.039; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472; Yilmaz S, 2016, MED SCI MONITOR, V22, P2779, DOI 10.12659/MSM.897480; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125	53	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223050	10.1371/journal.pone.0223050	http://dx.doi.org/10.1371/journal.pone.0223050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553782	gold, Green Published			2022-12-27	WOS:000532319200049
J	Pham-Duc, P; Cook, MA; Cong-Hong, H; Nguyen-Thuy, H; Padungtod, P; Nguyen-Thi, H; Dang-Xuan, S				Phuc Pham-Duc; Cook, Meghan A.; Hanh Cong-Hong; Hang Nguyen-Thuy; Padungtod, Pawin; Hien Nguyen-Thi; Sinh Dang-Xuan			Knowledge, attitudes and practices of livestock and aquaculture producers regarding antimicrobial use and resistance in Vietnam	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ONE HEALTH	The use of antibiotics in livestock production is considered a major driver of antibiotic resistance on a global scale. In Vietnam, small- and medium-scale livestock producers dominate the domestic market and regulatory pushes have done little to decrease antibiotic use. In order to inform future policy directions, this study aims to explore knowledge, attitudes, and practices amongst livestock producers to identify their perspectives on antibiotic use and resistance. A total of 392 small- and medium-scale producers specialized in pig, poultry and aquaculture production participated in the study. The results showed that the primary reason for antibiotic use reported by producers was for the treatment of infections (69%). However, prophylactic use was also evident, with farmers reporting other reasons for antibiotic use such as "animals display abnormal symptoms or behaviour" (55%), the "weather is about to change" (25%), or "animals on neighboring farms fall ill" (27%). Only one-fifth of producers demonstrated favorable attitudes towards antibiotic use and preventing antibiotic resistance. Moreover, administering antibiotics remained the preferred countermeasure directly applied by farmers at the first indication of disease (17%), compared to enacting hygiene (10%) or quarantine (5%) measures. The results showed divergent trends amongst producers, with pig producers demonstrating higher levels of knowledge, more favorable attitudes, and higher self-reported utilization of good practice. Better knowledge, attitudes, and practices were also associated with producers who engaged in efforts to explore information on antibiotic use and resistance, which improved incrementally with the number of sources consulted and hours invested. However, there were some areas where increased knowledge or more favorable attitude scores did not translate into better practices. For instance, producers with higher levels of formal education performed significantly better than those with lower education in terms of knowledge and attitude, though both groups reported similar practices. The findings of this study may support future interventions to prevent both antibiotic misuse and the development of antimicrobial resistance.	[Phuc Pham-Duc; Cook, Meghan A.; Hanh Cong-Hong; Hien Nguyen-Thi; Sinh Dang-Xuan] Hanoi Univ Publ Hlth, Ctr Publ Hlth & Ecosyst Res, Hanoi, Vietnam; [Phuc Pham-Duc; Hanh Cong-Hong; Sinh Dang-Xuan] Vietnam Union Sci & Technol Assoc, Inst Environm & Sustainable Dev, Hanoi, Vietnam; [Hanh Cong-Hong] Vietnam Acad Sci & Technol, Inst Mat Sci, Hanoi, Vietnam; [Hang Nguyen-Thuy; Padungtod, Pawin] Food & Agr Org United Nat, Country Off Vietnam, Hanoi, Vietnam; [Sinh Dang-Xuan] Int Livestock Res Inst ILRI, Hanoi, Vietnam	Hanoi University of Public Health; Vietnam Academy of Science & Technology (VAST); Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Livestock Research Institute (ILRI)	Dang-Xuan, S (corresponding author), Hanoi Univ Publ Hlth, Ctr Publ Hlth & Ecosyst Res, Hanoi, Vietnam.; Dang-Xuan, S (corresponding author), Vietnam Union Sci & Technol Assoc, Inst Environm & Sustainable Dev, Hanoi, Vietnam.; Dang-Xuan, S (corresponding author), Int Livestock Res Inst ILRI, Hanoi, Vietnam.	dxs@huph.edu.vn	Dang, Sinh/AAU-7680-2020	Dang, Sinh/0000-0002-0522-7808; Cook, Meghan/0000-0002-7964-6781; Nguyen Thi, Hien/0000-0003-1444-3120	United States Agency for International Development (USAID) [GHA-G-00-06-00001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was conducted with financial support from the United States Agency for International Development (USAID) grant number GHA-G-00-06-00001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre E, 2017, FOOD DRUG LAW J, V72, P295; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Cassou E., 2018, CHALLENGE AGR POLLUT; CDDEP, 2015, STATE WORLDS ANTIBIO; Dang Pham Kim, 2013, Food and Public Health, V3, P267; Dang Pham Kim, 2013, Food and Public Health, V3, P247; Davies PR, 2012, TRANSBOUND EMERG DIS, V59, P18, DOI 10.1111/j.1865-1682.2012.01312.x; Goff DA, 2017, LANCET INFECT DIS, V17, pE56, DOI 10.1016/S1473-3099(16)30386-3; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; MARD, STAT AN FARM HONG KE; Nadimpalli M, 2018, CLIN INFECT DIS, V66, P963, DOI 10.1093/cid/cix879; Robinson TP, 2016, LANCET, V387, pE1, DOI 10.1016/S0140-6736(15)00730-8; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Takele Beyene, 2016, Journal of Veterinary Science and Technology, V7, P285; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tiongco M. M., 2011, FARM POLICY J, V8, P39; Tuyet-Hanh TT, 2017, INT J PUBLIC HEALTH, V62, pS75, DOI 10.1007/s00038-016-0912-y; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; WHO, 2017, GUID US MED IMP ANT; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Bank, 2017, VIETN FOOD SAF RISK	22	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223115	10.1371/journal.pone.0223115	http://dx.doi.org/10.1371/journal.pone.0223115			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553776	Green Published, gold			2022-12-27	WOS:000532319200055
J	Ku, CC; Dodd, PJ				Ku, Chu-Chang; Dodd, Peter J.			Forecasting the impact of population ageing on tuberculosis incidence	PLOS ONE			English	Article							UNITED-STATES; OLDER-ADULTS; HONG-KONG; FERTILITY; MORTALITY; DYNAMICS; TIME	Background Tuberculosis (TB) disease reactivates from distant latent infection or recent (re)infection. Progression risks increase with age. Across the World Health Organisation Western Pacific region, many populations are ageing and have the highest per capita TB incidence rates in older age groups. However, methods for analysing age-specific TB incidence and forecasting epidemic trends while accounting for demographic change remain limited. Methods We applied the Lee-Carter models, which were originally developed for mortality modelling, to model the temporal trends in age-specific TB incidence data from 2005 to 2018 in Taiwan. Females and males were modelled separately. We combined our demographic forecasts, and age-specific TB incidence forecasts to project TB incidence until 2035. We compared TB incidence projections with demography fixed in 2018 to projections accounting for demographic change. Results Our models quantified increasing incidence rates with age and declining temporal trends. By 2035, the forecast suggests that the TB incidence rate in Taiwan will decrease by 54% (95% Prediction Interval (PI): 45%-59%) compared to 2015, while most age-specific incidence rates will reduce by more than 60%. In 2035, adults aged 65 and above will make up 78% of incident TB cases. Forecast TB incidence in 2035 accounting for demographic change will be 39% (95% PI: 36%-42%) higher than without population ageing. Conclusions Age-specific incidence forecasts coupled with demographic forecasts can inform the impact of population ageing on TB epidemics. The TB control programme in Taiwan should develop plans specific to older age groups and their care needs.	[Ku, Chu-Chang; Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Sheffield	Ku, CC (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	cku1@sheffield.ac.uk	辜, 鉅璋/ACM-0702-2022	辜, 鉅璋/0000-0002-4719-117X; Dodd, Pete/0000-0001-5825-9347	Medical Research Council UK [MR/P022081/1]; MRC [MR/P022081/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council UK (grant MR/P022081/1 to PJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arregui Sergio, 2018, Proc Natl Acad Sci U S A, V115, pE3238, DOI 10.1073/pnas.1720606115; Bras AL, 2014, INT J TUBERC LUNG D, V18, P1202, DOI 10.5588/ijtld.14.0158; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Brouhns N, 2002, INSUR MATH ECON, V31, P373, DOI 10.1016/S0167-6687(02)00185-3; Coale Aj., 1990, ASIAN PACIFIC POPULA, Vvol. 4; Cowan SK, 2013, POPUL DEV REV, V39, P289, DOI 10.1111/j.1728-4457.2013.00592.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Hagiya H, 1997, EPIDEMIOL INFECT, V2018, P1; Harris RC, 2019, LANCET GLOB HEALTH, V7, pE209, DOI 10.1016/S2214-109X(18)30452-2; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Hyndman RJ, 2008, INT J FORECASTING, V24, P323, DOI 10.1016/j.ijforecast.2008.02.009; Iqbal SA, 2018, AM J PUBLIC HEALTH, V108, pS315, DOI [10.2105/ajph.2018.304687, 10.2105/AJPH.2018.304687]; Kainz A, 2015, NEPHROL DIAL TRANSPL, V30, P113, DOI 10.1093/ndt/gfv073; Lee R., 2000, N AM I CAN ACTUARIAL, V4, P80, DOI 10.1080/10920277.2000.10595882; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; National Development Council Taiwan, 2018, POP PROJ R O C TAIW; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; R Core Team, 2018, R LANG ENV STAT COMP; Renshaw AE, 2008, INSUR MATH ECON, V42, P797, DOI 10.1016/j.insmatheco.2007.08.009; Rueda-Sabater C, 2008, J APPL STAT, V35, P1053, DOI 10.1080/02664760802192999; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; United Nations Publications, 2017, WORLD POP AG 2015; van Aart C, 2017, INT J TUBERC LUNG D, V21, P486, DOI 10.5588/ijtld.16.0548; Villegas AM, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i03; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; World Health Organization, 2014, GLOB STRAT TARG TUB; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354; Yue JC, 2018, INSUR MATH ECON, V78, P316, DOI 10.1016/j.insmatheco.2017.09.016	35	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222937	10.1371/journal.pone.0222937	http://dx.doi.org/10.1371/journal.pone.0222937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550293	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000532307700035
J	Tichelman, E; Westerneng, M; Witteveen, AB; van Baar, AL; van der Horst, HE; de Jonge, A; Berger, MY; Schellevis, FG; Burger, H; Peters, LL				Tichelman, Elke; Westerneng, Myrte; Witteveen, Anke B.; van Baar, Anneloes L.; van der Horst, Henriette E.; de Jonge, Ank; Berger, Marjolein Y.; Schellevis, Francois G.; Burger, Huibert; Peters, Lilian L.			eCorrelates of prenatal and postnatal mother-to-infant bonding quality: A systematic review	PLOS ONE			English	Review							MATERNAL-FETAL ATTACHMENT; DEPRESSION; PREGNANCY; INTERVENTIONS; COHORT; ADOLESCENTS; EXPERIENCE; AGREEMENT; HEALTH; SCALES	Background Mother-to-infant bonding is defined as the emotional tie experienced by a mother towards her child, which is considered to be important for the socio-emotional development of the child. Numerous studies on the correlates of both prenatal and postnatal mother-to-infant bonding quality have been published over the last decades. An up-to-date systematic review of these correlates is lacking, however. Objective To systematically review correlates of prenatal and postnatal mother-to-infant bonding quality in the general population, in order to enable targeted interventions. Methods MEDLINE, Embase, CINAHL, and PsychINFO were searched through May 2018. Reference checks were performed. Case-control, cross-sectional or longitudinal cohort studies written in English, German, Swedish, Spanish, Norwegian, French or Dutch defining mother-to-infant bonding quality as stipulated in the protocol (PROSPERO CRD42016040183) were included. Two investigators independently reviewed abstracts, full-text articles and extracted data. Methodological quality was assessed using the National Institute of Health Quality Assessment Tool for Observational Cohort and Cross-sectional studies and was rated accordingly as poor, fair or good. Clinical and methodological heterogeneity were examined. Main results 131 studies were included. Quality was fair for 20 studies, and poor for 111 studies. Among 123 correlates identified, 3 were consistently associated with mother-to-infant bonding quality: 1) duration of gestation at assessment was positively associated with prenatal bonding quality, 2) depressive symptoms were negatively associated with postnatal mother-to-infant bonding quality, and 3) mother-to-infant bonding quality earlier in pregnancy or postpartum was positively associated with mother-to-infant bonding quality later in time. Conclusion Our review suggests that professionals involved in maternal health care should consider monitoring mother-to-infant bonding already during pregnancy. Future research should evaluate whether interventions aimed at depressive symptoms help to promote mother-to-infant bonding quality. More high-quality research on correlates for which inconsistent results were found is needed.	[Tichelman, Elke; Westerneng, Myrte; Witteveen, Anke B.; de Jonge, Ank; Peters, Lilian L.] Vrije Univ Amsterdam, Amsterdam UMC, Midwifery Sci, AVAG,Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Tichelman, Elke; Berger, Marjolein Y.; Burger, Huibert; Peters, Lilian L.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands; [van Baar, Anneloes L.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands; [van der Horst, Henriette E.; Schellevis, Francois G.] Vrije Univ Amsterdam, Amsterdam UMC, Dept Gen Practice & Elderly Care Med, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Utrecht University; University of Amsterdam; Vrije Universiteit Amsterdam; Netherlands Institute for Health Services Research	Tichelman, E (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Midwifery Sci, AVAG,Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands.; Tichelman, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands.	e.tichelman@umcg.nl	de Jonge, Ank/F-6475-2013; Witteveen, Anke/ABG-2957-2020	Witteveen, Anke/0000-0002-9636-7522; Tichelman, Elke/0000-0002-4690-6188	Midwifery Academy Amsterdam Groningen; department of Midwifery Science	Midwifery Academy Amsterdam Groningen; department of Midwifery Science	This work was funded by the Midwifery Academy Amsterdam Groningen and the department of Midwifery Science which is located in Amsterdam (VU Medical Center Amsterdam) and Groningen (University Medical Center Groningen). The funding organizations had no role in study design, data collection, analysis, interpretation, in writing of the paper, or in the decision to submit the paper for publication.	Altman DG, 1991, PRACTICAL STAT MED R; Barrett J, 2012, SOC NEUROSCI-UK, V7, P252, DOI 10.1080/17470919.2011.609907; Benoit Diane, 2004, Paediatr Child Health, V9, P541; Boekhorst MGBM, 2019, J AFFECT DISORDERS, V248, P139, DOI 10.1016/j.jad.2019.01.021; Bowlby, 1982, ATTACHMENT LOSS, VI, DOI DOI 10.1177/000306518403200125; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; Cannella BL, 2005, J ADV NURS, V50, P60, DOI 10.1111/j.1365-2648.2004.03349.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CRANLEY MS, 1981, NURS RES, V30, P281, DOI 10.1097/00006199-198109000-00008; Cunen NB, 2017, WOMEN BIRTH, V30, pE141, DOI 10.1016/j.wombi.2016.11.005; de Cock ESA, 2016, J FAM PSYCHOL, V30, P125, DOI 10.1037/fam0000138; Dennis CL, 2005, BMJ-BRIT MED J, V331, P15, DOI 10.1136/bmj.331.7507.15; Dudek J, 2018, CHILD DEV, P1; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Forray Ariadna, 2016, F1000Res, V5, DOI 10.12688/f1000research.7645.1; FULLER J R, 1990, Health Care for Women International, V11, P433; Hakanen H, 2019, J AFFECT DISORDERS, V257, P83, DOI 10.1016/j.jad.2019.06.048; Rodrigo MJ, 2011, DEV PSYCHOPATHOL, V23, P163, DOI 10.1017/S0954579410000714; Kinsey CB, 2014, MIDWIFERY, V30, pE188, DOI 10.1016/j.midw.2014.02.006; Kinsey CB, 2013, MIDWIFERY, V29, P1314, DOI 10.1016/j.midw.2012.12.019; Klaus M.H., 1996, BONDING BUILDING FDN; Klaus MH, 1976, MOTHER INFANT BONDIN; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Laxton-Kane M, 2002, J REPROD INFANT PSYC, V20, P253, DOI 10.1080/0264683021000033174; Limlomwongse N, 2006, ARCH WOMEN MENT HLTH, V9, P131, DOI 10.1007/s00737-005-0115-7; Lindgren K, 2001, RES NURS HEALTH, V24, P203, DOI 10.1002/nur.1023; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martin G, 2004, J NERV MENT DIS, V192, P650, DOI 10.1097/01.nmd.0000142028.10056.c6; Mason ZS, 2011, J REPROD INFANT PSYC, V29, P382, DOI 10.1080/02646838.2011.629994; McElwain NL, 2006, J FAM PSYCHOL, V20, P247, DOI 10.1037/0893-3200.20.2.247; Mercer RT, 2006, JOGNN-J OBST GYN NEO, V35, P568, DOI 10.1111/J.1552-6909.2006.00080.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morrell CJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20370; National Heart Lung and Blood Institute, 2014, QUAL ASS TOOL OBS CO; Nunnally J. C., 1994, PSYCHOMETRIC THEORY, V3; OAKLEYBROWNE MA, 1995, J AFFECT DISORDERS, V34, P13, DOI 10.1016/0165-0327(94)00099-U; Ocaktan E, 2006, ANKARA U TIP FAKULTE, V59, P151; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Parfitt Y, 2013, INFANT BEHAV DEV, V36, P599, DOI 10.1016/j.infbeh.2013.06.003; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Rowe HJ, 2013, J PEDIATR ADOL GYNEC, V26, P327, DOI 10.1016/j.jpag.2013.06.009; Sato T, 1998, PSYCHOL MED, V28, P737, DOI 10.1017/S0033291797006430; Schmid B, 2011, J PSYCHIATR RES, V45, P1387, DOI 10.1016/j.jpsychires.2011.05.010; Siddiqui A, 2000, EARLY HUM DEV, V59, P13, DOI 10.1016/S0378-3782(00)00076-1; Slagt-Tichelman E, 2019, TIJDSCHR VERLOS, V3, P16; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Spielberger CD, 1970, MANUAL STATE TRAIT A; Steiner B, 2014, J CRIM JUST, V42, P462, DOI 10.1016/j.jcrimjus.2014.08.001; Thoppil J, 2005, AM J OBSTET GYNECOL, V192, P1446, DOI 10.1016/j.ajog.2004.12.073; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Van den Bergh B, 2009, J REPROD INFANT PSYC, V27, P114, DOI 10.1080/02646830802007480; Yarcheski A, 2009, INT J NURS STUD, V46, P708, DOI 10.1016/j.ijnurstu.2008.10.013; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; 2015, OBSTET GYNECOL, V125, P1268, DOI DOI 10.1097/01.AOG.0000465192.34779.	58	60	60	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222998	10.1371/journal.pone.0222998	http://dx.doi.org/10.1371/journal.pone.0222998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550274	Green Published, gold			2022-12-27	WOS:000532307700040
J	Costa, ACS; Pereira, DE; Verissimo, CM; Bomfim, MAD; Queiroga, RCRE; Madruga, MS; Alves, S; Bessa, RJB; Oliveira, MEG; Soares, JKB				Costa, Ana C. S.; Pereira, Diego E.; Verissimo, Caio M.; Bomfim, Marcos A. D.; Queiroga, Rita C. R. E.; Madruga, Marta S.; Alves, Susana; Bessa, Rui J. B.; Oliveira, Maria E. G.; Soares, Juliana K. B.			Developing cookies formulated with goat cream enriched with conjugated linoleic acid	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; MILK; BISCUITS; SUGAR; QUALITY; PERFORMANCE; CALCIUM; BAKING; IMPACT; WHEAT	Goat fat is one of the best sources of conjugated linoleic acid (CLA), a fatty acid which has health benefits. However, though CLA is generated in ruminants, CLA consumption is limited to meats and milk products. This study aimed to replace vegetable fat with goat milk fat enriched with CLA. From differing fat sources, four cookie recipes were developed: CVF-vegetable fat cookies; CB-butter cookies; CG-goat milk fat cookies without CLA; CGCLA-goat milk fat cookies with CLA. The cookies were evaluated using physical (color and texture), physical-chemical parameters (lipids, proteins, total sugars, fiber, ash, moisture and Aw), consumer testing (n = 123), and lipid profiles. The CGCLA presented higher values in the color parameters. The highest and the lowest scores obtained for hardness were respectively 5.54 (CB) and 2.21 (CVF). Lipids and total sugars varied inversely; the highest percentages of lipids were in the CVF and CG samples which obtained lower total sugar content. There were no differences in acceptance or preference for the four formulations. The goat cream formulations (CG and CGCLA) were as well accepted as the CFV formulation. For lipid profiles, CFV presented the highest percentage of trans-fatty acids (TFA) at 16.76%. CGCLA presented 70% more CLA than either CB or CG, certifying that CGCLA presents CLA in relevant quantities, even after cooking. The CGCLA presented higher levels of CLA, and in this study it was verified that goat milk cream enriched with CLA can be used in producing cookies, adding functional and nutritional properties, and offering another alternative(s) to produce food from goat milk fat.	[Costa, Ana C. S.; Pereira, Diego E.; Verissimo, Caio M.; Queiroga, Rita C. R. E.; Madruga, Marta S.; Oliveira, Maria E. G.; Soares, Juliana K. B.] Univ Fed Paraiba, Food Sci & Technol Program, Joao Pessoa, Paraiba, Brazil; [Costa, Ana C. S.; Verissimo, Caio M.] Univ Fed Rural Pernambuco, Dept Rural Technol, Recife, PE, Brazil; [Bomfim, Marcos A. D.] Embrapa Goats & Sheep, Sobral, Brazil; [Queiroga, Rita C. R. E.; Oliveira, Maria E. G.] Univ Fed Paraiba, Dept Nutr, Bromatol Lab, Joao Pessoa, Paraiba, Brazil; [Alves, Susana; Bessa, Rui J. B.] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal; [Soares, Juliana K. B.] Univ Fed Campina Grande, Dept Nutr, Cuite, Brazil	Universidade Federal da Paraiba; Universidade Federal Rural de Pernambuco (UFRPE); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal da Paraiba; Universidade de Lisboa; Universidade Federal de Campina Grande	Costa, ACS (corresponding author), Univ Fed Paraiba, Food Sci & Technol Program, Joao Pessoa, Paraiba, Brazil.; Costa, ACS (corresponding author), Univ Fed Rural Pernambuco, Dept Rural Technol, Recife, PE, Brazil.	acarolinasc@hotmail.com	Alves, Susana/Q-3889-2019; Bessa, Rui J. B./B-8006-2008	Alves, Susana/0000-0002-3171-9566; Bessa, Rui J. B./0000-0003-4109-3488; COSTA, ANA CAROLINA/0000-0001-5466-6463; Bomfim, Marcos Antonio Delmondes/0000-0002-1707-2970; PEREIRA, DIEGO/0000-0002-3563-3794				Abd El-Salam MH, 2014, J FOOD COMPOS ANAL, V33, P117, DOI 10.1016/j.jfca.2012.08.004; de Assis POA, 2016, INT DAIRY J, V56, P45, DOI 10.1016/j.idairyj.2015.11.002; Arimi JM, 2010, FOOD RES INT, V43, P1650, DOI 10.1016/j.foodres.2010.05.004; Association of Official Agricultural Chemists, 2012, OFF METH AN ASS OFF; Barbosa MQ, 2018, FOOD FUNCT, V9, P2891, DOI [10.1039/C7FO01764B, 10.1039/c7fo01764b]; Bertolin TE, 2013, FOOD SCI TECH-BRAZIL, V33, P345, DOI 10.1590/S0101-20612013005000054; Bick Marília Alessandra, 2014, Braz. J. Food Technol., V17, P121, DOI 10.1590/bjft.2014.015; Biguzzi C, 2014, FOOD QUAL PREFER, V35, P41, DOI 10.1016/j.foodqual.2014.02.001; Chung HJ, 2014, LWT-FOOD SCI TECHNOL, V57, P260, DOI 10.1016/j.lwt.2014.01.018; Commission Internationale de l'Eclairage-CIE, 1978, CIE PUBLICATION; Costa N, 2016, FOOD CONTROL, V64, P128, DOI 10.1016/j.foodcont.2015.12.010; Drewnowski A, 1998, FOOD QUAL PREFER, V9, P13, DOI 10.1016/S0950-3293(97)00017-7; Dutcosky S.D., 2013, ANALISE SENSORIAL AL; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganguly R, 2016, J NUTR BIOCHEM, V31, P60, DOI 10.1016/j.jnutbio.2015.12.018; Ganguly R, 2015, FOOD CHEM TOXICOL, V78, P170, DOI 10.1016/j.fct.2015.02.004; Gokmen V, 2008, J CEREAL SCI, V48, P843, DOI 10.1016/j.jcs.2008.06.007; Gomes LC, 2015, SMALL RUMINANT RES, V124, P81, DOI 10.1016/j.smallrumres.2015.01.013; Gomez-Cortes P, 2018, TRENDS FOOD SCI TECH, V81, P1, DOI 10.1016/j.tifs.2018.08.014; Henneberg JWJ., 1864, BEITRAGE BEGRUNDUNG; Koba K, 2014, OBES RES CLIN PRACT, V8, pE525, DOI 10.1016/j.orcp.2013.10.001; Laguna L, 2014, LWT-FOOD SCI TECHNOL, V56, P494, DOI 10.1016/j.lwt.2013.12.025; Laguna L, 2011, LWT-FOOD SCI TECHNOL, V44, P737, DOI 10.1016/j.lwt.2010.05.034; Lara E, 2011, LWT-FOOD SCI TECHNOL, V44, P622, DOI 10.1016/j.lwt.2010.10.007; Lopez-Aliaga I, 2005, J DAIRY SCI, V88, P1024, DOI 10.3168/jds.S0022-0302(05)72770-3; Marques GD, 2016, LWT-FOOD SCI TECHNOL, V67, P118, DOI 10.1016/j.lwt.2015.11.044; Mele MC, 2013, PROSTAG LEUKOTR ESS, V89, P115, DOI 10.1016/j.plefa.2013.05.005; Nurgel C, 2004, J SCI FOOD AGR, V84, P1675, DOI 10.1002/jsfa.1860; Palmquist DL, 2003, J ANIM SCI, V81, P3250; Pareyt B, 2009, J FOOD ENG, V90, P400, DOI 10.1016/j.jfoodeng.2008.07.010; Park Y, 2009, J FOOD COMPOS ANAL, V22, pS4, DOI 10.1016/j.jfca.2008.12.002; Park Y, 2009, FOOD SCI BIOTECHNOL, V18, P586; PELEG M, 1992, J TEXTURE STUD, V23, P427, DOI 10.1111/j.1745-4603.1992.tb00032.x; Piclin N, 2008, J SENS STUD, V23, P558, DOI 10.1111/j.1745-459X.2008.00172.x; Razzaghi A, 2015, ANIM FEED SCI TECH, V210, P46, DOI 10.1016/j.anifeedsci.2015.09.014; Ripolles D, 2016, INT DAIRY J, V60, P70, DOI 10.1016/j.idairyj.2016.02.031; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Sharma P, 2013, FOOD BIOPROCESS TECH, V6, P1374, DOI 10.1007/s11947-011-0777-2; Soares JKB, 2013, NEUROSCI LETT, V552, P25, DOI 10.1016/j.neulet.2013.07.028; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Tarancon P, 2013, FOOD RES INT, V53, P134, DOI 10.1016/j.foodres.2013.03.053; Santos LAT, 2015, FOOD CONTROL, V47, P141, DOI 10.1016/j.foodcont.2014.06.046; Tran NM, 2019, J MULTIVARIATE ANAL, V171, P1, DOI 10.1016/j.jmva.2018.10.004; Umesha SS, 2015, LWT-FOOD SCI TECHNOL, V62, P654, DOI 10.1016/j.lwt.2014.02.018; Verruck S, 2019, J FUNCT FOODS, V52, P243, DOI 10.1016/j.jff.2018.11.017	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0212534	10.1371/journal.pone.0212534	http://dx.doi.org/10.1371/journal.pone.0212534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545797	Green Published, gold			2022-12-27	WOS:000532303200001
J	Kong, DJ; Liu, NN; Wang, WY; Akhtar, K; Li, N; Ren, GX; Feng, YZ; Yang, GH				Kong, Dejie; Liu, Nana; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe			Soil respiration from fields under three crop rotation treatments and three straw retention treatments	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSION; GAS EMISSIONS; TILLAGE; RESIDUE; WHEAT; DYNAMICS; SYSTEM; YIELD; FLUX; TEMPERATURE	Straw retention is an effective method to conserve soil water content and improve soil carbon stocks. However, how soil carbon dynamics respond to different straw retention practices remains unclear. In this study, we investigated soil respiration and soil carbon sequestration at depths of 0-100 cm. We conducted a two-year field experiment with three crop rotation treatments and three straw retention treatments in northwest China. The straw retention treatments included no straw retention (NS), retention of half the straw (HS), and retention of the total amount of straw (TS). The crop rotations treatments included winter wheat plus summer soybean (WS), winter wheat plus summer maize (WM), and winter wheat plus summer fallow (WF). Mean soil respiration rates under WS, WM, and WF treatments were 5.14, 6.53, and 5.49 mu mol.m(-2).s(-1); and 5.67, 5.47, and 6.03 mu mol.m(-2).s(-1) under TS, HS, and NS treatments. The mean soil water content were 15.50%, 15.57%, and 15.74% under WS, WM, and WF rotations, and 15.81%, 15.41%, and 15.50% under TS, HS, and NS treatments. The soil organic carbon (SOC) concentration was higher with increased straw retention, and lower at deeper soil depths. Mean SOC concentrations under different rotations and straw treatments of TS, HS, and NS, respectively were as follows: WS: 6.91, 6.63, 6.39 g/kg; WM: 6.90, 6.72, 6.57 g/kg; and WF: 6.49, 6.52, 6.37 g/kg. Soil temperature was the main determinant of soil respiration rates. We conclude that WS rotation resulted in lower soil respiration, WM rotation resulted in a higher soil carbon sequestration potential, and WF rotation resulted in higher soil water content. However, continued, long-term monitoring is needed to confirm the effect of rotations and straw retention on soil respiration and carbon sequestration in dryland cropping systems in northern China.	[Kong, Dejie; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Kong, Dejie] NingXia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Yinchuan, Ningxia, Peoples R China; [Kong, Dejie; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe] Res Ctr Recycling Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Liu, Nana] Ningxia Agr Inst Survey Design, Yinchuan, Ningxia, Peoples R China	Northwest A&F University - China	Feng, YZ; Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Feng, YZ; Yang, GH (corresponding author), Res Ctr Recycling Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	fengyz@nwsuaf.edu.cn; ygh@nwsuaf.edu.cn	德杰, 孔/GRR-8605-2022	德杰, 孔/0000-0001-5749-5890	Shaanxi Provincial Government [2016KTCL02-11]; NingXia Academy of Agriculture and Forestry Sciences [QCYL2018-09]	Shaanxi Provincial Government; NingXia Academy of Agriculture and Forestry Sciences	This study was supported by Shaanxi Provincial Government (Projects 2016KTCL02-11) and supported by NingXia Academy of Agriculture and Forestry Sciences (Projects QCYL2018-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Shaanxi Provincial Government (Projects 2016KTCL02-11) and supported by NingXia Academy of Agriculture and Forestry Sciences (Projects QCYL2018-09). We are thankful to Gaihe Yang for technical support, Guangxin Ren and Yongzhong Feng for his assistance in field management and measurements. Kashif Akhar and Huiying Li performed field experiment, Nana Liu and Weiyu Wang contributed reagents/materials/analysis tools: Dejie Kong wrote the paper. We are thankful to the anonymous reviewers for their constructive comments.	Al-Kaisi MM, 2005, J ENVIRON QUAL, V34, P437, DOI 10.2134/jeq2005.0437; Brankatschk G, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0464-4; Brye KR, 2006, SOIL SCI SOC AM J, V70, P1145, DOI 10.2136/sssaj2005.0151; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Chen GQ, 2010, ENERG POLICY, V38, P6180, DOI 10.1016/j.enpol.2010.06.004; Chen SuYing, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P519, DOI 10.3724/SP.J.1011.2013.00519; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Di Bene C, 2016, ITAL J AGRON, V11, P209, DOI 10.4081/ija.2016.763; Gullett B, 2003, ATMOS ENVIRON, V37, P4893, DOI 10.1016/j.atmosenv.2003.08.011; Hu ZH, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1394-z; Huang Y, 2004, SOIL BIOL BIOCHEM, V36, P973, DOI 10.1016/j.soilbio.2004.02.009; Ji SN, 2001, SOIL SCI SOC AM J, V65, P442, DOI 10.2136/sssaj2001.652442x; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Lai R, 2017, CATENA, V151, P202, DOI 10.1016/j.catena.2016.12.013; Li LJ, 2013, EUR J SOIL BIOL, V54, P1, DOI 10.1016/j.ejsobi.2012.11.002; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Liu Q., 2016, SCI REPORTS, V6; Liu Y, 2016, CLEAN-SOIL AIR WATER, V44, P867, DOI 10.1002/clen.201400478; Lokupitiya E, 2006, J ENVIRON QUAL, V35, P1413, DOI 10.2134/jeq2005.0157; Lu F, 2015, MITIG ADAPT STRAT GL, V20, P1545, DOI 10.1007/s11027-014-9564-5; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; Miao YX, 2011, AGRON SUSTAIN DEV, V31, P397, DOI 10.1051/agro/2010034; Mu L, 2014, SPAN J AGRIC RES, V12, P265, DOI 10.5424/sjar/2014121-4895; Parkin TB, 2003, SOIL SCI SOC AM J, V67, P1763, DOI 10.2136/sssaj2003.1763; Plaza-Bonilla D., 2015, AGRONOMY SUSTAINABLE, V35; Quemada M, 1997, PLANT SOIL, V189, P127, DOI 10.1023/A:1004281804058; Ren C., 2016, SCI REPORTS, V6; Ren CJ, 2018, FOREST ECOL MANAG, V409, P170, DOI 10.1016/j.foreco.2017.11.011; Ren CJ, 2018, SOIL BIOL BIOCHEM, V116, P4, DOI 10.1016/j.soilbio.2017.09.028; Sainju UM, 2006, SOIL SCI SOC AM J, V70, P668, DOI 10.2136/sssaj2005.0089; Sainju UM, 2016, PLOS ONE, V11; Sainju UM, 2008, J ENVIRON QUAL, V37, P98, DOI 10.2134/jeq2006.0392; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Singh RJ, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5085-2; Suh SU, 2006, ECOL RES, V21, P405, DOI 10.1007/s11284-005-0137-7; Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140; Tufekcioglu A, 2001, PLANT SOIL, V229, P117, DOI 10.1023/A:1004818422908; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; Wang XJ, 2018, FIELD CROP RES, V218, P11, DOI 10.1016/j.fcr.2017.12.003; Wang YJ, 2010, AGR SCI CHINA, V9, P1807, DOI 10.1016/S1671-2927(09)60279-0; Wang YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0077810, 10.1371/journal.pone.0101303]; Wang ZT, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0366-x; Wuest SB, 2013, SOIL SCI SOC AM J, V77, P279, DOI 10.2136/sssaj2012.0110; Yang F, 2017, J ARID LAND, V9, P568, DOI 10.1007/s40333-017-0060-0; Zeng XY, 2007, RENEW SUST ENERG REV, V11, P976, DOI 10.1016/j.rser.2005.10.003; Zhang H, 2017, J ARID LAND, V9, P666, DOI 10.1007/s40333-017-0027-1; Zhang Ping, 2015, SCI REPORTS, V5	49	12	13	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0219253	10.1371/journal.pone.0219253	http://dx.doi.org/10.1371/journal.pone.0219253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545801	gold, Green Published			2022-12-27	WOS:000532303200009
J	Maastrup, R; Walloee, S; Kronborg, H				Maastrup, Ragnhild; Walloee, Sisse; Kronborg, Hanne			Nipple shield use in preterm infants: Prevalence, motives for use and association with exclusive breastfeeding-Results from a national cohort study	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; MOTHERS; DURATION	Background and aim Prevalence and motives for nipple shield use are not well studied in preterm infants and recommendations of nipple shield use in preterm infants are inconsistent. The aim of this study was to determine the prevalence of nipple shield use, explore the motives for nipple shield use and elucidate the association with exclusive breastfeeding in preterm infants. Methods The study was part of a prospective survey of a Danish national cohort of preterm infants based on questionnaires answered by the 1221 mothers of 1488 preterm infants with gestational age of 24-36 weeks. Data on nipple shield use was available for 1407 infants. Results Nipple shields were used by 54% of the mother-infant dyads for many different motives and was more often related to breastfeeding problems associated with the infant than with the mother. The most common motive for nipple shield use was "infant slipped the nipple" (52%). The lower the gestational age, the more frequently nipple shields were used for motives related to the infant. For those using a nipple shield, only the motive "infant fell asleep at the breast" was associated with a higher risk of not breastfeeding exclusively at discharge (OR 1.90 (95% CI 1.15; 3.13), p = 0.012), and "breast too engorged" with a lower risk of not breastfeeding exclusively (OR 0.32 (0.16; 0.63), p = 0.001), but overall nipple shield use was associated with failure of exclusive breastfeeding. Conclusion The present study does not give justifiable motives for nipple shield use, except for "breast too engorged". Nipple shields should not be recommended for infants falling asleep at the breast, instead, staff and mothers should be patient, allowing the dyad time skin-to-skin. The results indicate that the use of a nipple shield does not promote exclusive breastfeeding in preterm infants.	[Maastrup, Ragnhild] Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark; [Maastrup, Ragnhild; Walloee, Sisse] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark; [Walloee, Sisse] Slagelse Hosp, Dept Obstet & Gynecol, Slagelse, Denmark; [Kronborg, Hanne] Aarhus Univ, Dept Publ Hlth, Sect Nursing, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University	Maastrup, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark.; Maastrup, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark.	ragnhild.maastrup@regionh.dk		Maastrup, Ragnhild/0000-0001-8719-5717; Walloee, Sisse/0000-0002-9212-2122	Swedish Research Council; Soester Marie Dalgaards Foundation; Rigshospitalet, Copenhagen University Hospital; Department of Neonatology, Rigshospitalet, Copenhagen University Hospital; Novo Nordisk Foundation [NNF15OC0018156]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soester Marie Dalgaards Foundation; Rigshospitalet, Copenhagen University Hospital; Department of Neonatology, Rigshospitalet, Copenhagen University Hospital; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors disclosed receipt of the following financial support for the research and authorship of this article: Funding to support the research was received from The Swedish Research Council http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html (RM); Soester Marie Dalgaards Foundation https://www.diakonissestiftelsen.dk/default.aspx?ID%20=% 201177 (RM); Rigshospitalet, Copenhagen University Hospital https://www.rigshospitalet.dk/(RM); Department of Neonatology, Rigshospitalet, Copenhagen University Hospital https://www.rigshospitalet.dk/afdelinger-og-klinikker/julianemarie/neonatalklinikken/Sider/default.aspx (RM), and Novo Nordisk Foundation, grant number NNF15OC0018156 https://novonordiskfonden.dk/en/(RM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius A., 2007, NEONATAL NURSING, V3, P96; Altman D.G., 1991, PRACTICAL STAT MED R; [Anonymous], 2013, WMA DECL HELS ETH PR; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Clum D, 1996, J Hum Lact, V12, P287, DOI 10.1177/089033449601200413; Eglash A, 2010, BREASTFEED MED, V5, P147, DOI 10.1089/bfm.2010.0006; Ekstrom A, 2014, BREASTFEED MED, V9, P458, DOI 10.1089/bfm.2014.0026; Flacking R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1183-6; Froh EB, 2015, J PEDIATR NURS, V30, P521, DOI 10.1016/j.pedn.2015.01.023; Hanna S, 2013, MIDWIFERY, V29, P616, DOI 10.1016/j.midw.2012.05.005; Kronborg H, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12251; Labbok MH, 2012, BREASTFEED MED, V7, P397, DOI 10.1089/bfm.2012.9975; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108208; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089077; Maastrup R, 2012, J HUM LACT, V28, P370, DOI 10.1177/0890334412440846; Meier P P, 2000, J Hum Lact, V16, P106, DOI 10.1177/089033440001600205; Meier PP, 2013, PEDIATR CLIN N AM, V60, P209, DOI 10.1016/j.pcl.2012.10.007; Nyqvist KH, 2013, J HUM LACT, V29, P300, DOI 10.1177/0890334413489775; Nyqvist KH, 2015, NEO BFHI BABY FRIEND; Pincombe J, 2008, MIDWIFERY, V24, P55, DOI 10.1016/j.midw.2006.06.009; WHO UNICEF, 2009, BAB FRIENDL HOSP IN; Winterstein AG, 2013, JAMA PEDIATR, V167, P1118, DOI 10.1001/jamapediatrics.2013.2636	22	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222811	10.1371/journal.pone.0222811	http://dx.doi.org/10.1371/journal.pone.0222811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539900	Green Published, gold			2022-12-27	WOS:000532297900031
J	Shinohara, N; Mizukoshi, A; Uchiyama, M; Tanaka, H				Shinohara, Naohide; Mizukoshi, Atsushi; Uchiyama, Mayumi; Tanaka, Hirofumi			Emission characteristics of diethylhexyl phthalate (DEHP) from building materials determined using a passive flux sampler and micro-chamber	PLOS ONE			English	Article							SEMIVOLATILE ORGANIC-COMPOUNDS; PREDICTING EMISSIONS; HISTORY METHOD; PVC; EXPOSURE; AIR; PLASTICIZER; ASSOCIATION; PARAMETERS; SYMPTOMS	Emission rates of diethylhexyl phthalate (DEHP) from building materials, such as vinyl floorings and wall paper, determined using a passive flux sampler (PFS) were constant over the week-long measurement period. Emission rates for vinyl floorings and wallpaper were linearly correlated to the inverse of diffusion distance, which corresponds to the internal depth of the PFS. Surface-air DEHP concentrations (y(0)) were estimated as 1.3-2.3 mu g/m(3) for materials having a boundary layer molecular diffusion rate-limiting step. The partition coefficient (Kmaterial-air) was estimated as 3.3-7.5 x 10(10) for these materials. Additionally, emission rates of DEHP from same building materials determined using a micro-chamber were 4.5-6.1 mu g/m(2)/h. Mass transfer coefficients in the micro-chamber (h(m)) were estimated by comparing the results using the PFS and micro-chamber, and these were 1.1-1.2 x 10(-3) and 8.1 x 10(-4) m/s for vinyl floorings (smooth surface) and wallpaper (rough surface), respectively. The thickness of boundary layer on the surface of building materials in the micro-chamber were estimated to be 2.5-2.6 and 3.7 mm for vinyl floorings and wallpaper, respectively.	[Shinohara, Naohide] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan; [Mizukoshi, Atsushi] Kindai Univ, Dept Environm Med & Behav Sci, Fac Med, Osakasayama, Osaka, Japan; [Uchiyama, Mayumi; Tanaka, Hirofumi] MC Evolve Technol Corp, Inashiki, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Shinohara, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan.	n-shinohara@aist.go.jp	Mizukoshi, Atsushi/H-2783-2018; Shinohara, Naohide/L-8743-2018	Mizukoshi, Atsushi/0000-0002-2281-3526; Shinohara, Naohide/0000-0001-7675-6929	LIXIL JS Foundation [12-27]	LIXIL JS Foundation	This study was funded by a grant entitled "Dermal exposure assessment of phthalate esters in building materials: Development of test method of dermal exposure" (No. 12-27), from the LIXIL JS Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MC Evolve Technologies Corporation provided support in the form of salaries for authors MU and HT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2004, INDOOR AIR, V14, P120, DOI 10.1046/j.1600-0668.2003.00220.x; Benning JL, 2013, ENVIRON SCI TECHNOL, V47, P2696, DOI 10.1021/es304725b; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Cao J, 2017, INDOOR AIR, V27, P417, DOI 10.1111/ina.12312; Cao JP, 2016, ENVIRON SCI TECHNOL, V50, P825, DOI 10.1021/acs.est.5b04404; Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x; Clausen PA, 2004, ENVIRON SCI TECHNOL, V38, P2531, DOI 10.1021/es0347944; Clausen PA, 2012, ENVIRON SCI TECHNOL, V46, P909, DOI 10.1021/es2035625; Clausen PA, 2010, ATMOS ENVIRON, V44, P2760, DOI 10.1016/j.atmosenv.2010.04.020; Fujii M, 2003, ATMOS ENVIRON, V37, P5495, DOI 10.1016/j.atmosenv.2003.09.026; Hoshino K, 2006, J ENV ENG T AIJ, V604, P51; Hoshino K, 2007, J ENV ENG, V618, P69; ISO, 2011, 16000252011 ISO; JIS, 2008, A19042008 JIS; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Liang YR, 2014, ENVIRON SCI TECHNOL, V48, P4475, DOI 10.1021/es405809r; Liu C, 2016, BUILD ENVIRON, V95, P283, DOI 10.1016/j.buildenv.2015.09.028; Liu C, 2012, ATMOS ENVIRON, V55, P347, DOI 10.1016/j.atmosenv.2012.03.030; Liu Z, 2013, BUILD ENVIRON, V64, P7, DOI 10.1016/j.buildenv.2013.02.012; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; MOE, 1988, HDB ENV CHEM SUBST S, P411; Murakami S, ANN M ARCH I JAP 200, VD-2, P807; Strommen MR, 1999, ENVIRON SCI TECHNOL, V33, P1738, DOI 10.1021/es981035q; Tanabe S., 2010, S LAT TRENDS INT STA; Tanaka H., 2014, COMMUNICATION; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Wu Y, 2016, INDOOR AIR, V26, P903, DOI 10.1111/ina.12270; Xiong JY, 2016, BUILD ENVIRON, V95, P314, DOI 10.1016/j.buildenv.2015.09.027; Xiong JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049342; Xu Y, 2006, ENVIRON SCI TECHNOL, V40, P456, DOI 10.1021/es051517j; Xu Y, 2012, ENVIRON SCI TECHNOL, V46, P12534, DOI 10.1021/es302319m	34	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222557	10.1371/journal.pone.0222557	http://dx.doi.org/10.1371/journal.pone.0222557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539387	Green Submitted, Green Published, gold			2022-12-27	WOS:000532297900016
J	Yuan, YD; Yu, MY; Zhang, B; Liu, X; Zhang, JC				Yuan, Yingdan; Yu, Maoyun; Zhang, Bo; Liu, Xin; Zhang, Jinchi			Comparative nutritional characteristics of the three major Chinese Dendrobium species with different growth years	PLOS ONE			English	Article							GENETIC DIVERSITY; AMINO-ACID; POLYSACCHARIDE; HERB	Dendrobium, an important medicinal plant, is a source of widely used herbal medicine to nourish the stomach and treat throat inflammation. The present study is aimed at distinguishing and evaluating three major Dendrobium species by comparing physiochemical characteristics and understanding differences between different growth years in the Ta-pieh Mountains. Polysaccharides and total alkaloids of Dendrobium were determined, and the amino acids and trace elements were determined by UPLC (Ultra High-Performance Liquid Chromatography) and ICP-MS (Inductively coupled plasma mass spectrometry). It can be seen from the results that the polysaccharide content of these three kinds of Dendrobium in different growth years ranges from 249.31 mg.g(-1) to 547.66 mg.g(-1), and the highest content is in the 3-year-old Dendrobium huoshanense. The total alkaloid content ranges from 0.21 mg.g(-1) to 0.54 mg.g(-1), and the highest content is also the 3-year-old Dendrobium huoshanense. We determined the amino acid content of these three Dendrobium in different growth years, and we can see that each of the three kinds of Dendrobium contain seven kinds of amino acids required by the human body. We conducted a safety evaluation of the essential trace elements of Dendrobium, and the results showed that the dosage of 12g.d(-1) Dendrobium prescribed in China Pharmacopoeia is in accordance with the recommended daily intake of trace elements recommended by the Food and Drug Administration of the United States, and will not cause trace element poisoning. Linear discriminant analysis was carried out on the basis of amino acids and trace elements and confirmed the applicability of multi-elemental analysis for identifying different Dendrobium species.	[Yuan, Yingdan; Liu, Xin; Zhang, Jinchi] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Yuan, Yingdan; Liu, Xin; Zhang, Jinchi] Nanjing Forestry Univ, Jiangsu Prov Key Lab Soil & Water Conservat & Eco, Nanjing, Jiangsu, Peoples R China; [Yu, Maoyun] Anhui Tongjisheng Biotechnol Co Ltd, Luan, Anhui, Peoples R China; [Yu, Maoyun] West Anhui Univ, Cultivat & Industrializat Ctr Rare Med Plants Ta, Luan, Anhui, Peoples R China; [Zhang, Bo] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Nanjing Forestry University; Nanjing Forestry University; West Anhui University; University of Miami	Zhang, JC (corresponding author), Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Zhang, JC (corresponding author), Nanjing Forestry Univ, Jiangsu Prov Key Lab Soil & Water Conservat & Eco, Nanjing, Jiangsu, Peoples R China.	zhang8811@njfu.edu.cn		Zhang, Jinchi/0000-0002-0517-7214	National traditional Chinese medicine standardization project [ZYYS-2014 [12]]; National Special Fund for Forestry Scientific Research in the Public Interest [201504406]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Key University Science Research Project of Jiangsu Province [15KJA220004]; National Key R&D program of China [2017YFC0505505]; Zhejiang Natural Science Foundation Project [LY15C160005]; Anhui Tongjisheng Biotechnology Co., Ltd	National traditional Chinese medicine standardization project; National Special Fund for Forestry Scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Key University Science Research Project of Jiangsu Province; National Key R&D program of China; Zhejiang Natural Science Foundation Project; Anhui Tongjisheng Biotechnology Co., Ltd	This project was supported by the National traditional Chinese medicine standardization project (ZYYS-2014 [12]), the National Special Fund for Forestry Scientific Research in the Public Interest (grant no. 201504406), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Key University Science Research Project of Jiangsu Province (15KJA220004), National Key R&D program of China (2017YFC0505505) and Zhejiang Natural Science Foundation Project (LY15C160005). Anhui Tongjisheng Biotechnology Co., Ltd provided support in the form of salaries for authors [MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab K., 2011, International Food Research Journal, V18, P265; Al-Omari S, 2011, X-RAY SPECTROM, V40, P31, DOI 10.1002/xrs.1288; Bulpitt CJ, 2007, J ROY SOC MED, V100, P558, DOI 10.1258/jrsm.100.12.558; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Cai XY, 2011, SCI HORTIC-AMSTERDAM, V129, P877, DOI 10.1016/j.scienta.2011.06.001; Celik U, 2007, FOOD CONTROL, V18, P258, DOI 10.1016/j.foodcont.2005.10.004; Chang CC, 2010, J NAT PROD, V73, P229, DOI 10.1021/np900252f; Chen X., 2001, NAT PROD RES, V13, P70, DOI [DOI 10.16333/J.1001-6880.2001.01.020, 10.16333/j.1001-6880.2001.01.020]; Dolowy M, 2014, BIOMED CHROMATOGR, V28, P84, DOI 10.1002/bmc.3016; Dong XL, 2017, INT J FOOD PROP, V20, P1666, DOI 10.1080/10942912.2016.1217009; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Furuta E, 2016, TOXICOL ENVIRON CHEM, V98, P814, DOI 10.1080/02772248.2015.1135927; GELENBERG AJ, 1980, AM J PSYCHIAT, V137, P622, DOI 10.1176/ajp.137.5.622; Gharibzahedi SMT, 2017, TRENDS FOOD SCI TECH, V62, P119, DOI 10.1016/j.tifs.2017.02.017; Guo X, 2013, GENE, V527, P131, DOI 10.1016/j.gene.2013.05.073; Hou Pi-yong, 2005, Zhongguo Zhongyao Zazhi, V30, P729; Jin Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146607; Li XX, 2008, GENETICA, V133, P159, DOI 10.1007/s10709-007-9196-8; Liu Zhen-peng, 2015, Zhongguo Zhong Yao Za Zhi, V40, P1468; Mehari T. F., 2015, Journal of Environmental Protection, V6, P573, DOI 10.4236/jep.2015.66052; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ni ZL, 2018, ANAL LETT, V51, P648, DOI 10.1080/00032719.2017.1345931; Reddy P, 2018, J DIABETES COMPLICAT, V32, P465, DOI 10.1016/j.jdiacomp.2018.02.005; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Shiau YJ, 2005, IN VITRO CELL DEV-PL, V41, P666, DOI 10.1079/IVP2005685; Si HY, 2018, NAT PROD RES, V32, P252, DOI 10.1080/14786419.2017.1350670; [宋奇超 Song Qichao], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P1507; Su-Fang L, 2006, CHINESE TRADITIONAL, V89, P370; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Veljkovic JN, 2016, CHEM PAP, V70, P488, DOI 10.1515/chempap-2015-0215; Wei XY, 2005, CHINESE J MODERN APP; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu XL, 2016, IND CROP PROD, V94, P385, DOI 10.1016/j.indcrop.2016.08.041; Xiang X, 2018, J SEP SCI, V41, P996, DOI 10.1002/jssc.201700802; Xu H, 2006, PLANTA MED, V72, P89, DOI 10.1055/s-2005-916228; Xu J, 2013, PHYTOCHEM REV, V12, P341, DOI 10.1007/s11101-013-9310-8; Yang F, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1843-6; Yohei M, 2011, PLOS ONE, V6; Yuan YD, 2019, MICROSC RES TECHNIQ, V82, P483, DOI 10.1002/jemt.23191; Yuan YD, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5305-6; Zhang Ailian, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2632; Zhang QiXiang, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P1761; Zhao P, 2007, PLANT CELL TISS ORG, V90, P131, DOI 10.1007/s11240-006-9181-4; Zhou J., 2005, CHINESE AGR SCI B	44	12	12	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222666	10.1371/journal.pone.0222666	http://dx.doi.org/10.1371/journal.pone.0222666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KB2PL	31539401	Green Published, gold			2022-12-27	WOS:000506341600001
J	Fata, A; Bojdy, A; Maleki, M; Farash, BRH; Ghazvini, K; Tajzadeh, P; Vakili, V; Moghaddas, E; Mastroeni, P; Rahmani, S				Fata, Abdolmajid; Bojdy, Amin; Maleki, Masoud; Farash, Bibi Razieh Hosseini; Ghazvini, Kiarash; Tajzadeh, Parastoo; Vakili, Vida; Moghaddas, Elham; Mastroeni, Pietro; Rahmani, Shadi			Fish tank granuloma: An emerging skin disease in Iran mimicking Cutaneous Leishmaniasis	PLOS ONE			English	Article							MYCOBACTERIUM-MARINUM INFECTION; DIAGNOSIS; PCR; DNA	Objective Mycobacterium marinum causes a rare cutaneous disease known as fish tank granuloma (FTG). The disease manifestations resemble those associated with Cutaneous Leishmaniasis (CL). The aim of this study was to determine whether FTG was the cause of cutaneous lesions in patients who were referred to the Parasitology laboratory of Imam Reza Hospital in Mashhad to be investigated for CL. Materials/Methods One hundered patients, clinically diagnosed with CL between April 2014 and March 2015, were included in this study. Ziehl-Neelsen staining was performed to identify acid-fast Mycobacterium in addition to bacterial cultures using Lowenstein-Jensen medium. Skin lesion samples were also collected and kept on DNA banking cards for PCR testing. Results Twenty-nine of the 100 individuals with skin lesions, and therefore suspected of suffering from CL, tested positive for Mycobacterium marinum by PCR. Of these, 21 (72.4%) were male and 8(27.6%) were female. In 97% of these cases the lesions were located on hands and fingers. These patients had a history of manipulating fish and had been in contact with aquarium water. A sporotrichoid appearance was observed in 58.6% of the patients with mycobacterial lesions; 67% of patients had multiple head appearance. Conclusion Patients suspected to have CL and who test negative for CL could be affected by FTG. Therefore, after obtaining an accurate case history, molecular diagnosis is recommended for cases that give a negative result by conventional methods.	[Fata, Abdolmajid; Farash, Bibi Razieh Hosseini] Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Mashhad, Khorasan E Raza, Iran; [Fata, Abdolmajid; Farash, Bibi Razieh Hosseini; Moghaddas, Elham; Rahmani, Shadi] Mashhad Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Mashhad, Khorasan E Raza, Iran; [Bojdy, Amin] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Infect Dis, Mashhad, Khorasan E Raza, Iran; [Maleki, Masoud] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Dermatol, Mashhad, Khorasan E Raza, Iran; [Ghazvini, Kiarash] Mashhad Univ Med Sci, Quem Hosp, Dept Microbiol, Mashhad, Khorasan E Raza, Iran; [Tajzadeh, Parastoo] Mashhad Univ Med Sci, Fac Nursing, Dept Med Lab Sci, Mashhad, Khorasan E Raza, Iran; [Vakili, Vida] Mashhad Univ Med Sci, Fac Med, Dept Social Med, Mashhad, Khorasan E Raza, Iran; [Mastroeni, Pietro] Univ Cambridge, Dept Vet Med, Cambridge, England	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; University of Cambridge	Farash, BRH (corresponding author), Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Mashhad, Khorasan E Raza, Iran.; Farash, BRH (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Mashhad, Khorasan E Raza, Iran.	hoseinifr@mums.ac.ir	moghaddas, elham/K-8397-2016; Tajzadeh, Parastoo/AAQ-2325-2020	Mastroeni, Pietro/0000-0003-3838-4962; Hosseini Farash, Bibi Razieh/0000-0003-2748-9435	Faculty of Medicine, Mashhad University of Medical Sciences [930798, A-820]	Faculty of Medicine, Mashhad University of Medical Sciences	This paper described work that was part of MSc thesis No. A-820 the research project No. 930798 approved and supported by Deputy of Research, Faculty of Medicine, Mashhad University of Medical Sciences.; This paper described work that was part of MSc thesis No. A-820 the research project No. 930798 approved and supported by Deputy of Research, Faculty of Medicine, Mashhad University of Medical Sciences. The authors also thank the colleagues in leishmaniasis laboratory of Emam Reza Hospital, Mashhad University of Medical Sciences, who provided the insight and expertise that assisted the research.	Abedi-Astaneh F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161317; Akilov OE, 2007, INT J DERMATOL, V46, P132, DOI 10.1111/j.1365-4632.2007.03154.x; Ang P, 2000, INT J DERMATOL, V39, P343, DOI 10.1046/j.1365-4362.2000.00916.x; [Anonymous], 2017, CUTANEOUS LEISHMANIA; Asakura T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003131; Attarzadeh A, 2017, ROM REP PHYS, V69; Babamahmoodi F, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10120; Baransk-Arybak W, POSTEPY DERMATOL ALE; Bartralot R, 2000, J CUTAN PATHOL, V27, P124, DOI 10.1034/j.1600-0560.2000.027003124.x; Beldi N, 2017, VECTOR-BORNE ZOONOT, V17, P416, DOI 10.1089/vbz.2016.2071; COLLINS CH, 1985, J HYG-CAMBRIDGE, V94, P135, DOI 10.1017/S0022172400061349; de Vries HJC, 2015, AM J CLIN DERMATOL, V16, P99, DOI 10.1007/s40257-015-0114-z; Dodiuk-Gad R, 2007, J AM ACAD DERMATOL, V57, P413, DOI 10.1016/j.jaad.2007.01.042; Dolenc-Voljc M, 2010, ACTA DERMATOVEN ALP, V19, P35; EDELSTEIN H, 1994, ARCH INTERN MED, V154, P1359, DOI 10.1001/archinte.154.12.1359; Farash BRH, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.8274; Fata A, 2009, IRAN J PARASITOL, V4, P37; Fata A, 2017, J PARAMED SCI REHABI, V6, P80, DOI [10.22038/jpsr.2017.14754.1376, DOI 10.22038/JPSR.2017.14754.1376]; GLUCKMAN SJ, 1995, CLIN DERMATOL, V13, P273, DOI 10.1016/0738-081X(95)00023-9; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hamzavi Y, 2015, IRAN J PARASITOL, V10, P78; Holakouie-Naieni K, 2017, ACTA TROP, V166, P67, DOI 10.1016/j.actatropica.2016.11.004; Hosseini F., 2013, International Research Journal of Biological Sciences, V2, P1; Izadi S, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.32885; Johnson MG, 2015, INFECTION, V43, P655, DOI 10.1007/s15010-015-0776-8; JOHNSTON JM, 1987, CLIN DERMATOL, V5, P68, DOI 10.1016/S0738-081X(87)80011-1; Karim S, 2013, CAN FAM PHYSICIAN, V59, P51; Khajedaluee M., 2014, Medical Journal of Mashhad University of Medical Sciences, V57, P647; Khazaei S, 2015, ARCH CLIN INFECT DIS, V10, DOI 10.5812/archcid.28511; Kox LFF, 1995, NEUROLOGY, V45, P2228, DOI 10.1212/WNL.45.12.2228; Lewis FMT, 2003, CLIN INFECT DIS, V37, P390, DOI 10.1086/376628; LORIA PR, 1976, ARCH DERMATOL, V112, P517, DOI 10.1001/archderm.112.4.517; Miranda A, 2012, T ROY SOC TROP MED H, V106, P544, DOI 10.1016/j.trstmh.2012.05.005; Nazari M, 2017, ASIAN PAC J TROP MED, V10, P88, DOI 10.1016/j.apjtm.2016.12.001; Nazzaro G, 2014, JAMA DERMATOL, V150, P1204, DOI 10.1001/jamadermatol.2014.1015; Neitzke-Abreu HC, 2014, IDCases, V1, P60, DOI 10.1016/j.idcr.2014.07.003; Neonakis IK, 2008, J MICROBIOL METH, V75, P1, DOI 10.1016/j.mimet.2008.05.023; Pate M, 2005, DIS AQUAT ORGAN, V64, P29, DOI 10.3354/dao064029; Pourmohammadi B, 2010, IRAN J PARASITOL, V5, P1; Rakotosamimanana N, 2017, INT J INFECT DIS, V56, P248, DOI 10.1016/j.ijid.2016.12.005; Steinbrink J, 2017, CUTIS, V100, P331; Streit M, 2008, HAUTARZT, V59, P59, DOI 10.1007/s00105-007-1447-1; Vanhooteghem O, 2017, EUR J DERMATOL, V27, P299, DOI 10.1684/ejd.2017.2976; Veraldi S, 2016, GIORN ITAL DERMAT V, V151, P569; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Wortmann G, 2007, AM J TROP MED HYG, V76, P906, DOI 10.4269/ajtmh.2007.76.906	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221367	10.1371/journal.pone.0221367	http://dx.doi.org/10.1371/journal.pone.0221367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536497	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800017
J	Genovart, M; Pradel, R				Genovart, Meritxell; Pradel, Roger			Transience effect in capture-recapture studies: The importance of its biological meaning	PLOS ONE			English	Article							OF-FIT TESTS; SURVIVAL; MODELS; SEX; ANIMALS; AGE	Capture-recapture (CR) models are an essential tool for estimating demographic parameters in most animal and some plant populations. To avoid drawing incorrect conclusions in any statistical inference, a crucial prerequisite is to assess the goodness of fit of a general model to the data. In CR models, a frequent cause of lack of fit, is the so-called transience effect, which is due to a lower expectation of re-observation of individuals marked for the first time as compared to other individuals. The transience effect may result either from different biological causes or from the sampling procedure. A transience effect is usually treated by distinguishing at least two age-classes in the survival probability, but other approaches may be more suitable. Here we develop a conceptual and analytical framework for including a transience effect in capture-recapture models. We show the implementation of two additional parametrizations that incorporate a transience effect. With these parametrizations, we can directly estimate the "transience probability" defined as the probability that a newly caught individual disappear from the population beyond what is expected based on the behavior of the previously caught individuals in the same sample. Additionally, these parametrizations allow testing biological hypotheses concerning drivers affecting this probability. Results from our case study show differences between parametrizations, with the parametrization most currently used giving different estimates, especially when including covariates. We advocate for a unifying framework for treating a transience effect, that helps clarifying the ideas and terminology, and where the biological reasons should be the rule for choosing the appropriate analytical procedure. This framework will also open new and powerful ways for the detection and exploration of ecological processes such as the costs of the first reproduction or the deleterious effects of some types of marking.	[Genovart, Meritxell] CSIC, CEAB, Theoret & Computat Ecol, Blanes, Catalonia, Spain; [Genovart, Meritxell] IMEDEA CSIC UIB, Esporles, Spain; [Pradel, Roger] Univ Montpellier, Univ Paul Valery Montpellier 3, CNRS, CEFE,EPHE,IRD, Montpellier, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Genovart, M (corresponding author), CSIC, CEAB, Theoret & Computat Ecol, Blanes, Catalonia, Spain.; Genovart, M (corresponding author), IMEDEA CSIC UIB, Esporles, Spain.	m.genovart@csic.es	Genovart, Meritxell/L-4873-2014	Genovart, Meritxell/0000-0003-2919-1288	Spanish Ministry of Science [CGL2017-85210]; Consell Insular de Menorca (2016-2018); project PICS INTERACT 2016, CSICCNRS [07699/PIC2016FR8]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consell Insular de Menorca (2016-2018); project PICS INTERACT 2016, CSICCNRS	This work was supported from the Spanish Ministry of Science (CGL2017-85210 to MG), Consell Insular de Menorca (2016-2018, to MG) and project PICS INTERACT 2016, CSICCNRS (n degrees 07699/PIC2016FR8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown WS, 2007, COPEIA, P656; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cayuela H, BIOL J LINNEAN SOC; Choquet R, 2005, U CARE2 2 USERS MANU; Cooch EG, 2008, GOODNESS FIT TESTING; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Genovart M, 2013, J ANIM ECOL, V82, P121, DOI 10.1111/j.1365-2656.2012.02015.x; Genovart M, 2012, J ANIM ECOL, V81, P970, DOI 10.1111/j.1365-2656.2012.01991.x; Gimenez O, 2007, ECOL MODEL, V206, P431, DOI 10.1016/j.ecolmodel.2007.03.040; Gimenez O, 2018, METHODS ECOL EVOL, V9, P1749, DOI 10.1111/2041-210X.13014; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Kery M, 2004, CONSERV BIOL, V18, P570, DOI 10.1111/j.1523-1739.2004.00105.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Nott MP, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P727; Oro D., ESTIMATING COSTS 1 R; Perret N, 2003, J ANIM ECOL, V72, P567, DOI 10.1046/j.1365-2656.2003.00726.x; POLLOCK KH, 1985, BIOMETRICS, V41, P399, DOI 10.2307/2530865; Pollock KH, 1980, CAPTURE RECAPTURE MO, P32; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1995, J APPL STAT, V22, P695, DOI 10.1080/02664769524559; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032666; Roff Derek A., 1992; Royle JA, 2008, BIOMETRICS, V64, P364, DOI 10.1111/j.1541-0420.2007.00891.x; Sanz-Aguilar A, 2010, J ORNITHOL, V151, P133, DOI 10.1007/s10336-009-0435-x; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Schmidt BR, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-19; Stearns S.C., 1992, pi; Tavecchia G, 2001, ECOLOGY, V82, P165, DOI 10.1890/0012-9658(2001)082[0165:SAARVI]2.0.CO;2; Weinbach A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33111-9	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222241	10.1371/journal.pone.0222241	http://dx.doi.org/10.1371/journal.pone.0222241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536520	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800032
J	Hausken, K; Levavi-Sivan, B				Hausken, Krist; Levavi-Sivan, Berta			Synteny and phylogenetic analysis of paralogous thyrostimulin beta subunits (GpB5) in vertebrates	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; AMINO-ACID-SEQUENCE; HETERODIMERIC GLYCOPROTEIN HORMONE; LEUCINE-RICH REPEAT; SEA LAMPREY; TSH RECEPTOR; THYROTROPIN; PROTEIN; GONADOTROPIN; EXPRESSION	At some point early in the vertebrate lineage, two whole genome duplication events (1R, 2R) took place that allowed for the diversification and sub-/neo-functionalization of the glycoprotein hormones (GpHs). All jawed vertebrates possess the GpHs luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH), each of which are heterodimers with a common alpha subunit and unique beta subunits. In 2002, a novel glycoprotein hormone named thyrostimulin was described to have unique GpA2 and GpB5 subunits that were homologous to the vertebrate alpha and beta subunits. The presence of GpA2 and GpB5 in representative protostomes and deuterostomes indicates their ancestry in the GpH family. There are several reports of GpH subunit evolution, but none have included GpA2 and GpB5 for species in each major vertebrate class. Thus, we addressed the ancestry of two paralogous GpB5 subunits (GpB5a and GpB5b) that were previously only recognized in two teleost species. Our search for orthologous GpB5a and GpB5b sequences in representative vertebrates and phylogenetic analysis, in addition to the currently published evolutionary scenarios of the GpH family, supports that GpB5a and GpB5b are paralogs that arose from the first vertebrate whole genome duplication event (1R). Syntenic analysis supports lineage specific losses of GpB5a in chondrichthyes, basal actinopterygians, and tetrapods, and retention in coelacanth and teleosts. Additionally, we were unable to identify GpA2 transcripts from tilapia mRNA, suggesting that this species does not produce heterodimeric thyrostimulin. While the conserved or even species-specific functional role of thyrostimulin or its individual subunits are still unknown in vertebrates, the analyses presented here provide context for future studies on the functional divergence of the GpH family.	[Hausken, Krist; Levavi-Sivan, Berta] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel	Hebrew University of Jerusalem	Levavi-Sivan, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.	berta.sivan@mail.huji.ac.il		Levavi-Sivan, Berta/0000-0002-0183-9524; Hausken, Krist/0000-0003-2432-6702	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [642893]; Israel Science Foundation (ISF) [1540/17]; BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award [FU-561-2017]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant; Israel Science Foundation (ISF)(Israel Science Foundation); BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement no 642893 IMPRESS to BLS. The research was funded by the Israel Science Foundation (ISF) no. 1540/17 to BLS. This research was supported by BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award No. FU-561-2017 to KNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Alvarez E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-90; Benton M.J., 2005, VERTEBRATE PALAEONTO; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Buechi HB, 2017, GEN COMP ENDOCR, V246, P309, DOI 10.1016/j.ygcen.2017.01.007; Cahoreau C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00026; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Hausken KN, 2018, GEN COMP ENDOCR, V264, P16, DOI 10.1016/j.ygcen.2018.04.010; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karponis Dimitrios, 2017, Endocr Regul, V51, P117, DOI 10.1515/enr-2017-0012; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; LIAO TH, 1971, J BIOL CHEM, V246, P850; LIU WK, 1972, J BIOL CHEM, V247, P4365; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; Marquis TJ, 2017, CELL TISSUE RES, V367, P311, DOI 10.1007/s00441-016-2502-y; Maugars G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135184; Maugars G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111361; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Nguyen NTT, 2018, NUCLEIC ACIDS RES, V46, pD816, DOI 10.1093/nar/gkx1003; Ohno S., 1970, EVOLUTION GENE DUPLI; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; PAPKOFF H, 1971, J AM CHEM SOC, V93, P1531; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Rocco DA, 2016, GEN COMP ENDOCR, V234, P20, DOI 10.1016/j.ygcen.2015.12.011; Roch GJ, 2014, GENOME BIOL EVOL, V6, P1466, DOI 10.1093/gbe/evu118; Sacerdot C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1559-1; SHOME B, 1974, J CLIN ENDOCR METAB, V39, P203, DOI 10.1210/jcem-39-1-203; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; Sower SA, 2015, ENDOCRINOLOGY, V156, P3026, DOI 10.1210/en.2014-1797; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Sun SC, 2010, J BIOL CHEM, V285, P3758, DOI 10.1074/jbc.M109.066266; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tando Y, 2009, ZOOL SCI, V26, P409, DOI 10.2108/zsj.26.409; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; Ulloa-Aguirre A, 2001, ARCH MED RES, V32, P520, DOI 10.1016/S0188-4409(01)00319-8; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Van Hiel MB, 2012, PEPTIDES, V34, P193, DOI 10.1016/j.peptides.2011.11.004; van Zeijl CJJ, 2010, MOL CELL ENDOCRINOL, V321, P231, DOI 10.1016/j.mce.2010.03.002; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; WAKO H, 1995, BBA-PROTEIN STRUCT M, V1247, P104, DOI 10.1016/0167-4838(94)00216-4; WALLIS M, 1975, BIOL REV, V50, P35, DOI 10.1111/j.1469-185X.1975.tb00989.x; Wang P, 2018, ENDOCRINOLOGY, V159, P3536, DOI 10.1210/en.2018-00550; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yebra-Pimentel ES, 2019, FISH SHELLFISH IMMUN, V88, P508, DOI 10.1016/j.fsi.2019.03.014	69	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222808	10.1371/journal.pone.0222808	http://dx.doi.org/10.1371/journal.pone.0222808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536580	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800088
J	Roosenschoon, BJ; Kamperman, AM; Deen, ML; van Weeghel, J; Mulder, CL				Roosenschoon, Bert-Jan; Kamperman, Astrid M.; Deen, Mathijs L.; van Weeghel, Jaap; Mulder, Cornelis L.			Determinants of clinical, functional and personal recovery for people with schizophrenia and other severe mental illnesses: A cross-sectional analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; RELIABILITY; REMISSION; VALIDITY; CRITERIA; SCALE; ASSOCIATIONS; PREDICTION; RATIONALE; PSYCHOSIS	Objective To analyze the relationships between insight, medication adherence, addiction, coping and social support-components of Illness Management and Recovery (IMR)-as determinants of clinical, functional and personal recovery in patients with schizophrenia and other severe mental illnesses. Our rationale lay in the interrelations between these concepts suggested in a conceptual framework of IMR. Methods The cross-sectional design used baseline data of outpatient participants in a randomized clinical trial on IMR (N = 187). We used structural equation modeling (SEM) to describe pathways between degrees of insight, medication adherence, addiction, coping and social support, and degree of clinical, functional and personal recovery. We also explored whether clinical recovery mediated functional and personal recovery. Results Our final model showed that coping was associated with clinical, functional and personal recovery. Direct associations between coping and functional and personal recovery were stronger than indirect associations via clinical recovery. Although SEM also showed a significant but weak direct pathway between social support and functional recovery, there were no significant pathways either between social support and clinical or personal recovery, or between insight, medication adherence, addiction and any type of recovery. Conclusions Coping may be a determinant of all three types of recovery, and social support a determinant of functional recovery. Clinical recovery appears not to be a prerequisite for functional or personal recovery. While our results also suggest the relevance of improving coping skills and of enhancing social support, they only partially support the conceptual framework of IMR.	[Roosenschoon, Bert-Jan; Kamperman, Astrid M.; Mulder, Cornelis L.] Erasmus MC, ESPRI Epidemiol & Social Psychiat Res Inst, Dept Psychiat, Rotterdam, Netherlands; [Roosenschoon, Bert-Jan; Deen, Mathijs L.; van Weeghel, Jaap] Parnassia Psychiat Inst, The Hague, Netherlands; [Deen, Mathijs L.] Leiden Univ, Fac Social & Behav Sci, Inst Psychol, Leiden, Netherlands; [van Weeghel, Jaap] Tilburg Univ, TRANZO Sci Ctr Care & Welf, Dept Social & Behav Sci, Tilburg, Netherlands; [Mulder, Cornelis L.] Antes Bavo Europoort, Parnassia Psychiat Inst, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Parnassia Psychiatric Institute; Leiden University; Leiden University - Excl LUMC; Tilburg University; Parnassia Psychiatric Institute	Roosenschoon, BJ (corresponding author), Erasmus MC, ESPRI Epidemiol & Social Psychiat Res Inst, Dept Psychiat, Rotterdam, Netherlands.; Roosenschoon, BJ (corresponding author), Parnassia Psychiat Inst, The Hague, Netherlands.	b.roosenschoon@parnassiagroep.nl	Kamperman, Astrid/J-8046-2015; Mulder, Cornelis Lambert/HGU-3446-2022	Kamperman, Astrid/0000-0003-4455-6492; Deen, Mathijs/0000-0002-3570-5524	Parnassia Psychiatric Institute (The Hague/Rotterdam); Janssen-Cilag B.V. [14H1ZDZ67890]	Parnassia Psychiatric Institute (The Hague/Rotterdam); Janssen-Cilag B.V.	Most of the study was funded by Parnassia Psychiatric Institute (The Hague/Rotterdam) https://www.parnassiagroep.nl/.The remainder was funded by an unconditional educational grant from Janssen-Cilag B.V. (14H1ZDZ67890) https://www.janssen.com/netherlands/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini M, 2016, SCHIZOPHR RES, V171, P27, DOI 10.1016/j.schres.2016.01.012; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; Bellack AS, 2006, SCHIZOPHRENIA BULL, V32, P432, DOI 10.1093/schbul/sbj044; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BIRCHWOOD M, 1994, ACTA PSYCHIAT SCAND, V89, P62, DOI 10.1111/j.1600-0447.1994.tb01487.x; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Bullock WA, 2005, MEASURING PROMISE RE; Carrion RE, 2013, JAMA PSYCHIAT, V70, P1133, DOI 10.1001/jamapsychiatry.2013.1909; Cavelti M, 2012, EUR PSYCHIAT, V27, P19, DOI 10.1016/j.eurpsy.2011.01.007; Chesney MA, 2006, BRIT J HEALTH PSYCH, V11, P421, DOI 10.1348/135910705X53155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Beurs E., 2008, BRIEF SYMPTOM INVENT; Deegan P. E., 2002, OCCUP THER MENT HEAL, V17, P5, DOI [10.1300/J004v17n03_02, DOI 10.1300/J004V17N03_02, 10.1300/J004v17n03, DOI 10.1300/J004V17N03]; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Frese FJ, 2009, SCHIZOPHRENIA BULL, V35, P370, DOI 10.1093/schbul/sbn175; Galderisi S, 2016, SCHIZOPHR RES, V175, P154, DOI 10.1016/j.schres.2016.04.043; HARDING CM, 1987, AM J PSYCHIAT, V144, P727; HARDING CM, 1987, AM J PSYCHIAT, V144, P718; Harvey PD, 2009, SCHIZOPHRENIA BULL, V35, P300, DOI 10.1093/schbul/sbn171; HENDRIKS VM, 1989, J SUBST ABUSE TREAT, V6, P133, DOI 10.1016/0740-5472(89)90041-X; Hoyle, 2012, HDB STRUCTURAL EQUAT; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM Corp, 2017, IBM SPSS STAT WINDOW; ICF (The International Classification of Functioning DaH, 2002, COMM LANG FUNCT DIS; Iffland JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121807; Jaaskelainen E, 2013, SCHIZOPHRENIA BULL, V39, P1296, DOI 10.1093/schbul/sbs130; JORESKOG KG, 1970, BIOMETRIKA, V57, P239, DOI 10.2307/2334833; Kortrijk HE, 2012, COMPR PSYCHIAT, V53, P1174, DOI 10.1016/j.comppsych.2012.05.001; Leamy M, 2011, BRIT J PSYCHIAT, V199, P445, DOI 10.1192/bjp.bp.110.083733; Liberman RP, 2002, INT REV PSYCHIATR, V14, P245, DOI 10.1080/0954026021000016897; LIBERMAN RP, 1986, SCHIZOPHRENIA BULL, V12, P631, DOI 10.1093/schbul/12.4.631; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mead S, 2000, COMMUNITY MENT HLT J, V36, P315, DOI 10.1023/A:1001917516869; Moradi M, 2007, AUTHORIZED TRANSLATI; Mueser K. T., 2002, ILLNESS MANAGEMENT R; Mueser KT, 2006, SCHIZOPHRENIA BULL, V32, pS32, DOI 10.1093/schbul/sbl022; Muthen L. K., 2017, MPLUS USERS GUIDE ST, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Patterson TL, 2010, ANNU REV CLIN PSYCHO, V6, P139, DOI 10.1146/annurev.clinpsy.121208.131339; Prochaska J. O., 1984, TRANSTHEORETICAL APP; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Robinson DG, 2004, AM J PSYCHIAT, V161, P473, DOI 10.1176/appi.ajp.161.3.473; Roosenschoon BJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0774-0; San L, 2007, EUR PSYCHIAT, V22, P490, DOI 10.1016/j.eurpsy.2007.06.005; Satorra A, 1999, EC WORKING PAPERS, V412; Savalei V, 2014, STRUCT EQU MODELING, V21, P149, DOI 10.1080/10705511.2013.824793; Savalei V, 2010, STRUCT EQU MODELING, V17, P241, DOI 10.1080/10705511003659375; Slade M, 2012, EPIDEMIOL PSYCH SCI, V21, P353, DOI 10.1017/S2045796012000133; Slade M., 2009, PERSONAL RECOVERY ME; Slade M, 2014, WORLD PSYCHIATRY, V13, P12, DOI 10.1002/wps.20084; STRAUSS JS, 1974, ARCH GEN PSYCHIAT, V31, P37; Tait L, 2003, BRIT J PSYCHIAT, V182, P123, DOI 10.1192/bjp.182.2.123; Tait Lynda, 2002, J Ment Health, V11, P191, DOI 10.1080/09638230020023570-2; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Van Eck RM, 2018, SCHIZOPHRENIA BULL, V44, P631, DOI 10.1093/schbul/sbx088; van Nieuwenhuizen C, 2014, INT J SOC PSYCHIATR, V60, P162, DOI 10.1177/0020764012472302; Whitley R, 2010, PSYCHIAT SERV, V61, P1248, DOI 10.1176/ps.2010.61.12.1248; Wunderink L, 2009, SCHIZOPHRENIA BULL, V35, P362, DOI 10.1093/schbul/sbn143; Young SL, 2003, MENTAL HLTH RECOVERY; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	61	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222378	10.1371/journal.pone.0222378	http://dx.doi.org/10.1371/journal.pone.0222378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532805	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600029
J	Pausch, F; Bischof, K; Trimborn, S				Pausch, Franziska; Bischof, Kai; Trimborn, Scarlett			Iron and manganese co-limit growth of the Southern Ocean diatom Chaetoceros debilis	PLOS ONE			English	Article							PHYTOPLANKTON COMMUNITIES; SUPEROXIDE DISMUTASES; PHOTOSYSTEM-II; DRAKE PASSAGE; TRACE-METALS; LIGHT; RESPONSES; PRYMNESIOPHYCEAE; PHOTOSYNTHESIS; TRANSPORT	In some parts of the Southern Ocean (SO), even though low surface concentrations of iron (Fe) and manganese (Mn) indicate FeMn co-limitation, we still lack an understanding on how Mn and Fe availability influences SO phytoplankton ecophysiology. Therefore, this study investigated the effects of Fe and Mn limitation alone as well as their combination on growth, photophysiology and particulate organic carbon production of the bloom forming Antarctic diatom Chaetoceros debilis. Our results clearly show that growth, photochemical efficiency and carbon production of C. debilis were co-limited by Fe and Mn as highest values were only reached when both nutrients were provided. Even though Mn-deficient cells had higher photochemical efficiencies than Fe-limited ones, they, however, displayed similar low growth and POC production rates, indicating that Mn limitation alone drastically impeded the cell's performance. These results demonstrate that similar to low Fe concentrations, low Mn availability inhibits growth and carbon production of C. debilis. As a result from different species-specific trace metal requirements, SO phytoplankton species distribution and productivity may therefore not solely depend on the input of Fe alone, but also critically on Mn acting together as important drivers of SO phytoplankton ecology and biogeochemistry.	[Pausch, Franziska; Trimborn, Scarlett] Helmholtz Ctr Polar & Marine Res, EcoTrace, Alfred Wegener Inst, Bremen, Germany; [Pausch, Franziska; Bischof, Kai; Trimborn, Scarlett] Univ Bremen, Marine Bot, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Pausch, F (corresponding author), Helmholtz Ctr Polar & Marine Res, EcoTrace, Alfred Wegener Inst, Bremen, Germany.; Pausch, F (corresponding author), Univ Bremen, Marine Bot, Bremen, Germany.	Franziska.Pausch@awi.de	Trimborn, Scarlett/AAM-1061-2021	Trimborn, Scarlett/0000-0003-1434-9927; Pausch, Franziska/0000-0002-4207-1304; Bischof, Kai/0000-0002-4497-1920	Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace) [VH-NG-901]; Deutsche Forschungsgemeinschaft [TR 899/4-1]	Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	ST and FP were funded by the Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace, VH-NG-901). ST was funded by Deutsche Forschungsgemeinschaft (TR 899/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Assmy P, 2007, DEEP-SEA RES PT I, V54, P340, DOI 10.1016/j.dsr.2006.12.005; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Browning TJ, 2014, GEOPHYS RES LETT, V41, P2851, DOI 10.1002/2014GL059364; BUMA AGJ, 1991, LIMNOL OCEANOGR, V36, P1865, DOI 10.4319/lo.1991.36.8.1865; Cutter G.A., 2017, SAMPLING SAMPLE HAND, P139, DOI [10.25607/OBP-2, DOI 10.25607/OBP-2]; de Jong J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001679; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; Gerringa LJA, 2000, MAR CHEM, V68, P335, DOI 10.1016/S0304-4203(99)00092-4; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hathorne EC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003907; Hoffmann LJ, 2008, POLAR BIOL, V31, P1067, DOI 10.1007/s00300-008-0448-6; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Koch F, 2019, LIMNOL OCEANOGR, V64, P357, DOI 10.1002/lno.11045; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Middag R, 2011, DEEP-SEA RES PT II, V58, P2661, DOI 10.1016/j.dsr2.2010.10.043; Middag R, 2013, LIMNOL OCEANOGR, V58, P287, DOI 10.4319/lo.2013.58.1.0287; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Petrou K, 2014, MAR BIOL, V161, P925, DOI 10.1007/s00227-014-2392-z; Raiswell R, 2006, GEOCHIM COSMOCHIM AC, V70, P2765, DOI 10.1016/j.gca.2005.12.027; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Rapp I, 2017, ANAL CHIM ACTA, V976, P1, DOI 10.1016/j.aca.2017.05.008; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1990, NEW PHYTOL, V116, P1, DOI 10.1111/j.1469-8137.1990.tb00505.x; Reinbothe C, 2006, P NATL ACAD SCI USA, V103, P4777, DOI 10.1073/pnas.0511066103; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Sedwick PN, 1997, GEOPHYS RES LETT, V24, P2515, DOI 10.1029/97GL02596; Smetacek V, 2004, ANTARCT SCI, V16, P541, DOI 10.1017/S0954102004002317; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Sunda WG, 1996, LIMNOL OCEANOGR, V41, P373, DOI 10.4319/lo.1996.41.3.0373; SUNDA WG, 1983, LIMNOL OCEANOGR, V28, P924, DOI 10.4319/lo.1983.28.5.0924; Thomson PG, 2006, POLAR BIOL, V29, P337, DOI 10.1007/s00300-005-0060-y; Timmermans KR, 2001, MAR ECOL PROG SER, V217, P287, DOI 10.3354/meps217287; Trimborn S, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00167; Trimborn S, 2017, MAR ECOL PROG SER, V578, P35, DOI 10.3354/meps12250; Trimborn S, 2015, DEEP-SEA RES PT I, V98, P115, DOI 10.1016/j.dsr.2014.12.010; Tsuda A, 2005, PROG OCEANOGR, V64, P189, DOI 10.1016/j.pocean.2005.02.008; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; van Leeuwe MA, 1998, J PHYCOL, V34, P496, DOI 10.1046/j.1529-8817.1998.340496.x; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	57	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221959	10.1371/journal.pone.0221959	http://dx.doi.org/10.1371/journal.pone.0221959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525212	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700018
J	Amaral, P; de Carvalho, LR; Rocha, TAH; da Silva, NC; Vissoci, JRN				Amaral, Pedro; de Carvalho, Lucas Resende; Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina; Nickenig Vissoci, Joao Ricardo			Geospatial modeling of microcephaly and zika virus spread patterns in Brazil	PLOS ONE			English	Article							HEALTH	Microcephaly and Zika Virus infection (ZIKV) were declared Public Health Emergencies of International Concern by the World Health Organization in 2016. Brazil was considered the epicenter of the outbreak. However, the occurrence of both ZIKV and microcephaly in Brazil was not evenly distributed across the country. To better understand this phenomenon, we investigate regional characteristics at the municipal level that can be associated with the incidence of microcephaly, our response variable, and its relationship with ZIKV and other predictors. All epidemiological data in this study was provided by the Ministry of Health official database (DATASUS). Microcephaly was only confirmed after birth and the diagnostic was made regardless of the mother's ZIKV status. Using exploratory spatial data analysis and spatial autoregressive Tobit models, our results show that microcephaly incidence is significantly, at 95% confidence level, related not only to ZIKV, but also to access to primary care, population size, gross national product, mobility and environmental attributes of the municipalities. There is also a significant spatial autocorrelation of the dependent variable. The results indicate that municipalities that show a high incidence of microcephaly tend to be clustered in space and that incidence of microcephaly varies considerably across regions when correlated only with ZIKV, i.e. that ZIKV alone cannot explain the differences in microcephaly across regions and their correlation is mediated by regional attributes.	[Amaral, Pedro; de Carvalho, Lucas Resende] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil; [Hernandes Rocha, Thiago Augusto] PAHO WHO, Brasilia, DF, Brazil; [Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina] Univ Fed Minas Gerais, Ctr Higher Studies & Res Adm, CEPEAD UFMG, Belo Horizonte, MG, Brazil; [Nickenig Vissoci, Joao Ricardo] Duke Univ, Duke Sch Med, Dept Surg, Div Emergency Med, Durham, NC USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Duke University	Amaral, P (corresponding author), Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil.	pedroamaral@cedeplar.ufmg.br	Carvalho, Lucas Resende de/AAB-7031-2019; Rocha, Thiago/AAW-3805-2020; Amaral, Pedro/AAQ-1486-2021	Carvalho, Lucas Resende de/0000-0002-3618-3967; Rocha, Thiago/0000-0002-6262-3276; Amaral, Pedro/0000-0002-2505-035X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PV, 2014, PAP REG SCI, V93, DOI 10.1111/pirs.12034; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Brasil-SINAN/SUS. Ministry of Health, 2019, SUST INF AGR NOT SI; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115; ESRI, 2014, ARCGIS DESKT; European Centre for Disease Prevention and Control, 2017, CURR ZIK TRANSM WORL; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gelman Andrew, 1995, BAYESIAN DATA ANAL; IBGE, 2013, PROD INT BRUT MUN; IBGE (Instituto Brasileiro de Geografia e Estatistica), 2016, EST POP; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Kesrouani A, 2001, EARLY HUM DEV, V63, P79, DOI 10.1016/S0378-3782(01)00123-2; Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135; LeSage J, 2009, STAT TEXTB MONOGR, P1; LOWRES N, 2019, PLOS MED, V16, DOI DOI 10.1371/JOURNAL.PMED.1002755; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, P1; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Ribeiro LC de Q, 2013, IBEU MUNICIPAL INDIC; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392; Wilhelm S, 2013, R J, V5, P130; World Health Organization, 2016, ZIK VIR COMPL PUBL H; Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00186615, 10.1590/0102-311X00186615]	29	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222668	10.1371/journal.pone.0222668	http://dx.doi.org/10.1371/journal.pone.0222668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557165	Green Published, gold			2022-12-27	WOS:000532345500027
J	Gough, N; Koffman, J; Ross, JR; Riley, J; Judson, I				Gough, Nicholas; Koffman, Jonathan; Ross, Joy R.; Riley, Julia; Judson, Ian			Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma	PLOS ONE			English	Article							CELL LUNG-CANCER; PROGNOSTIC-FACTORS; EUROPEAN-ORGANIZATION; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; SUPPORTIVE CARE; RESPONSE SHIFT; OPEN-LABEL; DOXORUBICIN; GEMCITABINE	Objective Soft tissue sarcoma (STS) is a rare cancer type that when locally advanced or metastatic, is predominantly treated with palliative chemotherapy with the aim of improving both quantity and quality of life. Given modest survival data after commencing first line chemotherapy, this study examines (i) what constitutes health related quality of life (HRQoL), (ii) whether the most commonly used HRQoL assessment tool measures this and (iii) to what extent HRQoL, and its components, change during and after treatment. Design Mixed-methods longitudinal study of 66 sarcoma patients living with STS (42 commencing chemotherapy, 24 under surveillance after completing chemotherapy) involving serial EORTC QLQ-C30 questionnaires and nested-qualitative semi-structured interviews with a sub-sample of participants. EORTC QLQ-C30 score change from baseline to primary evaluation point was examined using a paired t-test. Interviews were analysed using the framework approach before both datasets were integrated. Results Five main factors, including control of pain, were identified by study participants as important components of HRQoL; these are examined within the EORTC QLQ-C30. However, others e.g. independence loss and common causes of anxiety, are not. Whilst social and psychological domains are addressed by the EORTC QLQ-C30, the quantitative change over time did reflect qualitative descriptions of decline. The mean overall EORTC QLQ-C30 HRQoL score deteriorated from baseline (60.4) to the primary evaluation point (50.2) [change of -10.2, t-test: -2.70, p = 0.01] for those receiving chemotherapy; this was in concordance with patients' qualitative accounts. Baseline overall HRQoL scores were higher in the surveillance group suggesting a correlation with chemotherapy response and longer-term improvement in HRQoL. The evidence from both HRQoL scores and qualitative accounts indicated that the presence and control of physical symptoms were particularly important in maintaining HRQoL. Whilst fatigue deteriorated on chemotherapy (baseline 41.7 to 52.8; change of +11.1, t-test +2.51, p<0.05), pain (baseline 41.5 to 32.1; change -9.4, t-test -2.06 p<0.05) and sleep disturbance (43.1 to 28.5; change -14.6, t-test -3.05, p< 0.05) both improved. Conclusion A key finding was that the EORTC QLQ-C30 assesses some but not all of the patient-reported components of HRQoL in sarcoma patients highlighting the need for either STS specific modules within the EORTC QLQ-C30 or a completely new STS specific HRQoL tool. First line palliative chemotherapy improves specific symptoms known to be prevalent and to influence HRQoL in this patient group which in some patients may translate to sustained improvement in HRQoL: further exploration and validation of these findings in larger prospective studies are warranted.	[Gough, Nicholas] Guys & St Thomass Hosp NHS Fdn Trust, Palliat Care Dept, London, England; [Gough, Nicholas; Judson, Ian] Inst Canc Res, London, England; [Koffman, Jonathan] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Ross, Joy R.; Riley, Julia] Royal Marsden NHS Fdn Trust, Royal Marsden & Royal Brompton Palliat Care Serv, London, England; [Ross, Joy R.; Riley, Julia] Imperial Coll, Natl Heart & Lung Inst, London, England; [Judson, Ian] Royal Marsden NHS Fdn Trust, Sarcoma Unit, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; Royal Marsden NHS Foundation Trust; Imperial College London; Royal Marsden NHS Foundation Trust	Gough, N (corresponding author), Guys & St Thomass Hosp NHS Fdn Trust, Palliat Care Dept, London, England.; Gough, N (corresponding author), Inst Canc Res, London, England.	nicholas.gough@gstt.nhs.uk		Koffman, Jonathan/0000-0001-8513-5681; Gough, Nicholas/0000-0002-9251-3561	Sarcoma UK; NHS; Royal Marsden Palliative Care Research fund	Sarcoma UK; NHS; Royal Marsden Palliative Care Research fund	This research was funded jointly by a charitable grant from Sarcoma UK and by the Royal Marsden Palliative Care Research fund which is supported by charitable donations. The authors would like to acknowledge NHS funding to the Royal Marsden/ICR National Institute for Health Research (NIHR) Biomedical Research Centre, UK.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Aktas A, 2010, PALLIATIVE MED, V24, P373, DOI 10.1177/0269216310367842; Anderson H, 2000, BRIT J CANCER, V83, P447, DOI 10.1054/bjoc.2000.1307; [Anonymous], 2014, ANN ONCOL S3, V25; Armstrong Terri S, 2003, Oncol Nurs Forum, V30, P601, DOI 10.1188/03.ONF.601-606; Bando H, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.12; Basch E, 2012, J CLIN ONCOL, V30, P4249, DOI 10.1200/JCO.2012.42.5967; BENJAMIN RS, 1987, J CLIN ONCOL, V5, P833, DOI 10.1200/JCO.1987.5.6.833; CANNON S, 1989, SOCIOL HEALTH ILL, V11, P62, DOI 10.1111/1467-9566.ep10844052; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Coens C, 2015, CANCER; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Crino L, 1999, J CLIN ONCOL, V17, P3522, DOI 10.1200/JCO.1999.17.11.3522; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Delgado-Guay M, 2011, J PAIN SYMPTOM MANAG, V41, P819, DOI 10.1016/j.jpainsymman.2010.07.015; Etkind SN, 2015, J PAIN SYMPTOM MANAG, V49, P611, DOI 10.1016/j.jpainsymman.2014.07.010; Fayers PMaM D., 2007, QUALITY LIFE; Gough N, 2017, J PAIN SYMPTOM MANAG, V53, P588, DOI 10.1016/j.jpainsymman.2016.10.357; Gough Nicholas J., 2011, Sarcoma, V2011, P325189, DOI 10.1155/2011/325189; Greene J. C., 2007, MIXED METHODS SOCIAL; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; Gronchi A, 2017, LANCET ONCOL, V18, P812, DOI 10.1016/S1470-2045(17)30334-0; GROND S, 1994, J PAIN SYMPTOM MANAG, V9, P372, DOI 10.1016/0885-3924(94)90174-0; Henderson M, 2005, J PAIN SYMPTOM MANAG, V29, P116, DOI 10.1016/j.jpainsymman.2004.12.001; Iop A, 2004, ANN ONCOL, V15, P712, DOI 10.1093/annonc/mdh102; Johnson RBAJO, 2007, DEFINITION MIXED MET, V1; Judson I, 2011, COMMUNICATION; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Karavasilis V, 2008, CANCER-AM CANCER SOC, V112, P1585, DOI 10.1002/cncr.23332; Lowe M, 2011, LUNG CANCER, V74, P344, DOI 10.1016/j.lungcan.2011.03.011; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Network NCI, 2013, BON SOFT TISS SARC U; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-85; Osoba David, 2011, Ther Adv Med Oncol, V3, P57, DOI 10.1177/1758834010395342; PETEET JR, 1992, RADIOLOGY, V182, P99, DOI 10.1148/radiology.182.1.1727318; Poveda A., 2005, Sarcoma, V9, P127, DOI 10.1080/13577140500287024; Preston NJ, 2013, PALLIATIVE MED, V27, P899, DOI 10.1177/0269216313486952; Quinten C, 2014, CANCER-AM CANCER SOC, V120, P302, DOI 10.1002/cncr.28382; Reichardt Peter, 2012, Sarcoma, V2012, P740279, DOI 10.1155/2012/740279; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Scott N, 2008, EORTC QLQ C30 REFERE; Seddon B, 2017, LANCET ONCOL, V18, P1397, DOI 10.1016/S1470-2045(17)30622-8; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Sinha S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7170; Sleijfer S, 2005, ONCOLOGIST, V10, P833, DOI 10.1634/theoncologist.10-10-833; Sleijfer SJ, 2012, YOU DECIDE WHETHER O; Sleijfer S, 2010, EUR J CANCER, V46, P72, DOI 10.1016/j.ejca.2009.09.022; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steinhauser KE, 2006, PALLIATIVE MED, V20, P745, DOI 10.1177/0269216306073112; Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6; Van Glabbeke M, 1999, J CLIN ONCOL, V17, P150, DOI 10.1200/JCO.1999.17.1.150; VANGLABBEKE M, 2002, EUR J CANCER, V38, P543, DOI DOI 10.1016/S0959-8049(01)00398-7; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078; WHO, 1948, PREAMBL CONST WHO AD; Winnette R, 2016, PATIENT EXPERIENCE S; Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7; Younger E, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.11575	59	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0210731	10.1371/journal.pone.0210731	http://dx.doi.org/10.1371/journal.pone.0210731			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557183	gold, Green Published			2022-12-27	WOS:000532345500001
J	Woldesenbet, SA; Kalou, M; Mhlongo, D; Kufa, T; Makhanya, M; Adelekan, A; Diallo, K; Maleka, M; Singh, B; Parekh, B; Mohlala, A; Manyike, PT; Tucker, TJ; Puren, AJ				Woldesenbet, Selamawit Alemu; Kalou, Mireille; Mhlongo, Dumisani; Kufa, Tendesayi; Makhanya, Makhosazana; Adelekan, Adeboye; Diallo, Karidia; Maleka, Mahlatse; Singh, Beverley; Parekh, Bharat; Mohlala, Amanda; Manyike, Peter T.; Tucker, Tim J.; Puren, Adrian J.			An overview of the quality assurance programme for HIV rapid testing in South Africa: Outcome of a 2-year phased implementation of quality assurance program	PLOS ONE			English	Article								Objective This is the first large-scale assessment of the implementation of HIV Rapid Test Quality Improvement Initiative in South Africa. Methods We used a quasi-experimental one group post-test only design. The intervention implemented starting April 2014 comprised health-care worker training on quality assurance (QA) of HIV rapid testing and enrolment of the facilities in proficiency testing (PT), targeting 2,077 healthcare facilities in 32 high HIV burden districts. Following the intervention, two consecutive rounds of site assessments were undertaken. The first, conducted after a median of 7.5 months following the training, included 1,915 facilities that participated in the QA training, while the second, conducted after a median of one-year following the first-round assessment included 517 (27.0%) of the 1,915 facilities. In both assessments, the Stepwise-Process-for-Improving-the-quality-of-HIV-Rapid-Testing (SPI-RT) checklist was used to score facilities' performance in 7 domains: training, physical facility, safety, pre-testing, testing, post-testing and external quality assessment. Facilities' level of readiness for national certification was assessed. Result Between 2016 and 2017, there were four PT cycles. PT participation increased from 32.4% (620/1,915) in 2016 to 91.5% (1,753/1,915) in 2017. In each PT cycle, PT results were returned by 76%-87% of facilities and a satisfactory result (> 80%) was achieved by >= 95% of facilities. In the SPI-RT assessment, in round-one, 22.3% of facilities were close to or eligible for national certification-this significantly increased to 38.8% in round-two (P-value< 0.001). The median SPI-RT score for the domains HIV pre-testing (83.3%) and post-testing (72.2%) remained the same between the two rounds. The median score for the testing domain increased by 5.6% (to 77.8%). Conclusion Facilities performance on the domains that are critical for accuracy of diagnosis (i.e. pretesting, testing and post-testing) remained largely unchanged. This study provided several recommendations to improve QA implementation in South Africa, including the need to improve routine use of internal quality control for corrective actions.	[Woldesenbet, Selamawit Alemu; Kufa, Tendesayi; Singh, Beverley; Puren, Adrian J.] Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Woldesenbet, Selamawit Alemu; Kufa, Tendesayi] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Kalou, Mireille; Parekh, Bharat] Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA; [Mhlongo, Dumisani] Natl Hlth Lab Serv, Natl Clin Lab Interface Programme, Johannesburg, South Africa; [Makhanya, Makhosazana; Adelekan, Adeboye; Diallo, Karidia] Ctr Dis Control & Prevent South Africa, Lab Branch, Pretoria, South Africa; [Maleka, Mahlatse] Acad Affairs Res & Qual Assurance Natl Hlth Lab S, Johannesburg, South Africa; [Mohlala, Amanda; Manyike, Peter T.; Tucker, Tim J.] Strateg Evaluat Advisory & Dev SEAD Consulting, Cape Town, South Africa; [Tucker, Tim J.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Puren, Adrian J.] Univ Witwatersrand, Virol Dept, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; University of Cape Town; University of Witwatersrand	Woldesenbet, SA (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa.; Woldesenbet, SA (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	selamawitw@nicd.ac.za		PAREKH, BHARAT/0000-0002-1088-4263; Woldesenbet, Selamawit/0000-0002-5023-3561; Kufa, Tendesayi/0000-0002-9797-616X	United States President's Emergency Plan for AIDS Relief (PEPFAR) [U2GGH001631]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The programme received financial support from the United States President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement between the National Health Laboratory Service (NHLS) and the Centers for Disease Control and Prevention (CDC) [Grant Number = U2GGH001631]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. AJP is the principal investigator and senior (last) author in this paper and he received this award. The URL/website of the funder is https://www.cdc.gov.	Balisanga H, 2016, INT J INFECT DIS, V52, P62, DOI 10.1016/j.ijid.2016.08.029; Black V, 2009, BJOG-INT J OBSTET GY, V116, P1805, DOI 10.1111/j.1471-0528.2009.02357.x; Bock P, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21780; Hsiao NY, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21758; Hunter J, 2017, S AFRICAN HLTH REV 2; Jaya Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183044; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21755; Kosack CS, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21345; Kufa T, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21753; Kufa T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007391; Maleka M., 2017, NHLS HIV PROFICIENCY; Maleka M., 2016, NHLS HIV PROFICIENCY; Mashamba-Thompson TP, 2018, S AFR J HIV MED, V19, P1; Massyn N., 2018, DISTRICT HLTH BAROME; Matsoso MP, 2018, LANCET GLOB HEALTH, V6, pE1153, DOI 10.1016/S2214-109X(18)30323-1; Mayaphi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164943; Meyers AFA, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i2.557; Mhlongo D, 2014, USE INTERNAL QUALITY; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Mwisongo A, 2016, AFR HEALTH SCI, V16, P646, DOI 10.4314/ahs.v16i3.2; NDOH, ID CLIN MAN VERS 18; PEPFAR, 2015, ACH EP CONTR S AFR P; PEPFAR, COUNTR REG OP PLAN C; QA/ QI Stakeholders Meeting, 2015, QA QI STAK M 22 23 O; SEAD, 2010, AN POCT VCT PERF S A; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Tucker TJ, 2017, CURR OPIN HIV AIDS, V12, P105, DOI 10.1097/COH.0000000000000350; UNAIDS data, 2018, SOURC UNAIDS SPEC AN; WHO/CDC, 2005, HIV RAP TEST TRAIN P; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organization, CONS GUID HIV TEST S; Yao K, 2010, AM J CLIN PATHOL, V134, P568, DOI 10.1309/AJCPOPXR8MNTZ5PY	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221906	10.1371/journal.pone.0221906	http://dx.doi.org/10.1371/journal.pone.0221906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557176	Green Published, gold, Green Submitted			2022-12-27	WOS:000532345500013
J	Lu, XX; Chu, CC; Liu, X; Gao, YC; Wu, MM; Guo, F; Li, YH; Geng, C; Huang, Y; Zhang, Y; Zhao, SZ				Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue; Zhang, Yan; Zhao, Shaozhen			High-throughput RNA-sequencing identifies mesenchymal stem cell-induced immunological signature in a rat model of corneal allograft rejection	PLOS ONE			English	Article							STROMAL CELLS; TRANSPLANTATION; EXPRESSION; GRAFT; HSP70	Objective The immune rejection mediated by CD4(+) T cell and antigen presenting macrophages is the leading cause of corneal transplantation failure. Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess robust immunomodulatory potentials, and have been shown by us and others to promote corneal allograft survival. However, the immunological mechanism underlying the protective effects of BM-MSCs remains unclear. Therefore, in the current study, this mechanism was investigated in a BM-MSC-treated rat model of corneal allograft rejection, in the hope to facilitate the search for novel interventional targets to corneal allograft rejection. Methods Lewis rats were subjected to corneal transplantation and then received subconjunctival injections of BM-MSCs (2x106 cells / 100 mu l PBS) immediately and at day 3 post-transplantation. The control group received the injections of PBS with the same volume. The clinical parameters of the corneal allografts, including opacity, edema, and neovascularization, were regularly evaluated after transplantation. On day 10 post-transplantation, the corneal allografts were collected and subjected to flow cytometry and high-throughput RNA sequencing (RNA-seq). GO enrichment and KEGG pathways were analyzed. The quantitative realtime PCR (qPCR) and immunohistochemistry (IHC) were employed to validate the expression of the selected target genes at transcript and protein levels, respectively. Results BM-MSC subconjunctival administration prolonged the corneal allograft survival, with reduced opacity, alleviated edema, and diminished neovascularization. Flow cytometry showed reduced CD4(+) T cells and CD68(+) macrophages as well as boosted regulatory T cells (Tregs) in the BM-MSC-treated corneal allografts as compared with the PBS-treated counterparts. Moreover, the RNA-seq and qPCR results demonstrated that the transcript abundance of Cytotoxic T-Lymphocyte Associated Protein 4 (Ctla4), Protein Tyrosine Phosphatase, Receptor Type C (Ptprc), and C-X-C Motif Chemokine Ligand 9 (Cxcl9) genes were increased in the allografts of BM-MSC group compared with PBS group; whereas the expression of Heat Shock Protein Family A (Hsp70) Member 8 (Hspa8) gene was downregulated. The expression of these genes was confirmed by IHC at protein level. Conclusion Subconjunctival injections of BM-MSCs promoted corneal allograft survival, reduced CD4(+) and CD68(+) cell infiltration, and enriched Treg population in the allografts. The BM-MSCinduced upregulation of Ctla4, Ptprc, Cxcl9 genes and downregulation of Hspa8 gene might contribute to the protective effects of BM-MSCs and subserve the potential interventional targets to corneal allograft rejection.	[Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue; Zhang, Yan; Zhao, Shaozhen] Tianjin Med Univ, Tianjin Key Lab Retinal Funct & Dis, Eye Inst, Eye Hosp, Tianjin, Peoples R China; [Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue] Tianjin Med Univ, Sch Optometry, Eye Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhang, Y; Zhao, SZ (corresponding author), Tianjin Med Univ, Tianjin Key Lab Retinal Funct & Dis, Eye Inst, Eye Hosp, Tianjin, Peoples R China.	yanzhang04@tmu.edu.cn; szhao04@tmu.edu.cn		Zhang, Yan/0000-0003-2050-6343	National Natural Science Foundation of China [81770890, 81600705]; Tianjin Municipal Science and Technology Commission [17JCZDJC35600]; training program for young and middle-aged backbone talents in colleges and universities in Tianjin; High-level Innovative Talent Program for Distinguished Scholar [YDYYRCXM-B2018-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; training program for young and middle-aged backbone talents in colleges and universities in Tianjin; High-level Innovative Talent Program for Distinguished Scholar	This work was supported by the National Natural Science Foundation of China (81770890 to S.Z.; 81600705 to Y.H.), the key projects of Tianjin Municipal Science and Technology Commission (17JCZDJC35600 to Y.Z.), the training program for young and middle-aged backbone talents in colleges and universities in Tianjin to Y.Z., and the the High-level Innovative Talent Program for Distinguished Scholar (YDYYRCXM-B2018-02 to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzegar A, 2016, J IMMUNOL, V196, P3983, DOI 10.4049/jimmunol.1600251; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Ben Nasr M, 2015, PHARMACOL RES, V98, P1, DOI 10.1016/j.phrs.2015.03.019; Camirand G, 2014, J CLIN INVEST, V124, P4603, DOI 10.1172/JCI74087; Chai YJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030297; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Davies R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00281; Di GH, 2017, INVEST OPHTH VIS SCI, V58, P4344, DOI 10.1167/iovs.17-21506; Ezzelarab MB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00250; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jia Z, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0802-6; Jia Z, 2012, EXP EYE RES, V102, P44, DOI 10.1016/j.exer.2012.06.008; Judge TA, 1996, J IMMUNOL, V156, P2294; Khiew SH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92033; Kobolak J, 2016, METHODS, V99, P62, DOI 10.1016/j.ymeth.2015.09.016; Koper OM, 2018, ADV CLIN EXP MED, V27, P849, DOI 10.17219/acem/68846; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin DFP, 1997, CLIN EXP IMMUNOL, V107, P381, DOI 10.1111/j.1365-2249.1997.279-ce1171.x; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Leibler C, 2019, KIDNEY INT, V95, P774, DOI 10.1016/j.kint.2018.10.028; Lohan P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02666; Lu XX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0593-3; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mirabelli P, 2014, EXP EYE RES, V125, P118, DOI 10.1016/j.exer.2014.06.006; Moravej A, 2017, IMMUNOL LETT, V182, P39, DOI 10.1016/j.imlet.2017.01.005; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiao SK, 2016, CELL PHYSIOL BIOCHEM, V40, P1656, DOI 10.1159/000453215; Rafiee P, 2006, AM J PHYSIOL-CELL PH, V291, pC931, DOI 10.1152/ajpcell.00474.2005; Sakurai J, 2000, J IMMUNOL, V164, P664, DOI 10.4049/jimmunol.164.2.664; Shalini PU, 2017, CELL IMMUNOL, V314, P18, DOI 10.1016/j.cellimm.2017.01.008; Sheu CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030308; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Tabbara Khalid F., 2008, International Ophthalmology, V28, P223, DOI 10.1007/s10792-007-9100-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trieb M, 2001, TRANSPL INT, V14, P281, DOI 10.1007/s001470100325; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vellasamy S, 2016, CYTOTHERAPY, V18, P1270, DOI 10.1016/j.jcyt.2016.06.017; Xie CY, 2017, STEM CELL TRANSL MED, V6, P1120, DOI 10.1002/sctm.16-0204; Xilouri M, 2016, AGEING RES REV, V32, P13, DOI 10.1016/j.arr.2016.07.001; Ye H, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1853-7; Young JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01169; Yuan J, 2009, J OCUL PHARMACOL TH, V25, P345, DOI 10.1089/jop.2008.0125	49	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222515	10.1371/journal.pone.0222515	http://dx.doi.org/10.1371/journal.pone.0222515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545822	gold, Green Published			2022-12-27	WOS:000532303200018
J	Bottoms, L; Leighton, D; Carpenter, R; Anderson, S; Langmead, L; Ramage, J; Faulkner, J; Coleman, E; Fairhurst, C; Seed, M; Tew, G				Bottoms, Lindsay; Leighton, Dean; Carpenter, Roger; Anderson, Simon; Langmead, Louise; Ramage, John; Faulkner, James; Coleman, Elizabeth; Fairhurst, Caroline; Seed, Michael; Tew, Garry			Affective and enjoyment responses to 12 weeks of high intensity interval training and moderate continuous training in adults with Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; LOW-VOLUME; PHYSICAL-EXERCISE; SPRINT INTERVAL; HEALTH; ADAPTATIONS; HIT	The aim was to undertake secondary data analysis from a three-arm randomised feasibility trial of high intensity interval training (HIIT), moderate intensity continuous training (MICT), and usual care control in adults with Crohn's disease (CD; n = 36), with a primary focus on exploring affective and enjoyment responses. Twenty-five participants with quiescent or mildly-active CD were randomised to one of the two exercise groups: HIIT (n = 13) and MICT (n = 12). Both groups were offered thrice weekly sessions for 12 weeks. MICT consisted of cycling for 30 minutes at 35% peak power (Wpeak), whereas HIIT involved ten 1-minute bouts at 90% Wpeak, interspersed with 1-minute bouts at 15% Wpeak. Heart rate (HR), differentiated ratings of perceived exertion for legs (RPE-L) and central (RPE-C), along with feeling state (Feeling Scale; FS) were measured at 92.5% of each session. Enjoyment was measured at the end of training using the Physical Activity Enjoyment Scale (PACES). Post-hoc exploratory analysis involved a mixed-model two-way ANOVA to compare HR, RPE-L, RPE-C and FS for the exercise sessions in weeks 1, 6 and 12 between groups. Overall, HR was greater (p < 0.01) during HIIT (173 +/- 8 bpm) compared with MICT (128 +/- 6 bpm). Similarly, RPE-L and RPE-C responses were greater overall (p = 0.03 and p = 0.03, respectively) during HIIT (5.5 +/- 1.6 and 5.1 +/- 1.7, respectively) compared to MICT (3.3 +/- 1.5 and 2.9 +/- 1.5, respectively). Overall, FS was 2.2 +/- 1.9 for HIIT and 2.1 +/- 1.4 for MICT with no effect of treatment group (p = 0.25) or time (p = 0.94). There was also no significant difference in PACES scores between HIIT (99.4 +/- 12.9) and MICT (101.3 +/- 17.4; p = 0.78). The findings suggest HIIT and MICT protocols elicited similar enjoyment and affect in adults with quiescent or mildly-active CD.	[Bottoms, Lindsay] Univ Hertfordshire, Dept Psychol & Sports Sci, Life & Med Sci, Hatfield, Herts, England; [Leighton, Dean] Queen Mary Univ London, Ctr Immunobiol, London, England; [Carpenter, Roger; Seed, Michael] Univ East London, Sch Hlth Sport & Biosci, Stratford Campus, London, England; [Anderson, Simon] Guys & St Thomas NHS Fdn Trust, London, England; [Langmead, Louise] Barts & London NHS Trust, Digest Dis Clin Acad Unit, London, England; [Ramage, John] Hampshire Hosp NHS Fdn Trust, Basingstoke, Hants, England; [Faulkner, James] Univ Winchester, Dept Sport Exercise & Hlth, Winchester, Hants, England; [Coleman, Elizabeth; Fairhurst, Caroline] Univ York, York Trials Unit, York, N Yorkshire, England; [Tew, Garry] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England	University of Hertfordshire; University of London; Queen Mary University London; University of East London; Guy's & St Thomas' NHS Foundation Trust; Barts Health NHS Trust; University of Winchester; University of York - UK; Northumbria University	Bottoms, L (corresponding author), Univ Hertfordshire, Dept Psychol & Sports Sci, Life & Med Sci, Hatfield, Herts, England.	l.bottoms@herts.ac.uk	Ramage, John/ABG-4603-2020	Ramage, John/0000-0003-4824-6600; Seed, Michael/0000-0001-7053-4743; Bottoms, Lindsay/0000-0003-4632-3764; Tew, Garry/0000-0002-8610-0613	Living with IBD Research Programme at Crohn's and Colitis UK [SP2015/1]	Living with IBD Research Programme at Crohn's and Colitis UK	This work was supported by the Living with IBD Research Programme at Crohn's and Colitis UK (grant number: SP2015/1). This funding source had no role in the design or execution of this study or in the analysis and interpretation of the data. The funders website is crohnsandcolitisuk.org.uk.	American College of Sports Medicine (ACSM), 2009, ACSMS GUIDELINES EXE; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Biddle SJH, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0254-9; Bilski J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/429031; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; Health Do, 2011, START ACT STAY ACT R; Heisz JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168534; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; Klare P, 2015, DIGESTION, V91, P239, DOI 10.1159/000371795; Kong ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158589; Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P835, DOI 10.1139/apnm-2013-0512; Loudon CP, 1999, AM J GASTROENTEROL, V94, P697, DOI 10.1111/j.1572-0241.1999.00939.x; Luces Carlvin, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P471, DOI 10.1586/14737167.6.4.471; Malik AA, 2017, EUR J SPORT SCI, V17, P1335, DOI 10.1080/17461391.2017.1364300; Mijwel S, 2019, J CANCER SURVIV, V13, P244, DOI 10.1007/s11764-019-00747-z; Minghetti A, 2018, PSYCHIAT RES, V265, P292, DOI 10.1016/j.psychres.2018.04.053; Ng V, 2007, CLIN J SPORT MED, V17, P384; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Oliveira BRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079965; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Oliveira BRR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197124; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Schneider SM, 2008, INFLAMM BOWEL DIS, V14, P1562, DOI 10.1002/ibd.20504; Tew GA, 2017, BRIT J SURG, V104, P1791, DOI 10.1002/bjs.10669; Tew GA, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0936-x; Tew Garry A, 2017, Pilot Feasibility Stud, V3, P17, DOI 10.1186/s40814-017-0133-z; Tew GA, 2016, INFLAMM BOWEL DIS, V22, P2933, DOI 10.1097/MIB.0000000000000962; Thum JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166299; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Vella CA, 2017, EUR J SPORT SCI, V17, P1203, DOI 10.1080/17461391.2017.1359679; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Wiroth JB, 2005, INFLAMM BOWEL DIS, V11, P296, DOI 10.1097/01.MIB.0000160810.76729.9c; Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc	39	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222060	10.1371/journal.pone.0222060	http://dx.doi.org/10.1371/journal.pone.0222060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539378	Green Published, Green Accepted, gold			2022-12-27	WOS:000532297900005
J	Kosilek, RP; Baumeister, SE; Ittermann, T; Grundling, M; Brunkhorst, FM; Felix, SB; Abel, P; Friesecke, S; Apfelbacher, C; Brandl, M; Schmidt, K; Hoffmann, W; Schmidt, CO; Chenot, JF; Volzke, H; Gensichen, JS				Kosilek, Robert P.; Baumeister, Sebastian E.; Ittermann, Till; Gruendling, Matthias; Brunkhorst, Frank M.; Felix, Stephan B.; Abel, Peter; Friesecke, Sigrun; Apfelbacher, Christian; Brandl, Magdalena; Schmidt, Konrad; Hoffmann, Wolfgang; Schmidt, Carsten O.; Chenot, Jean-Francois; Voelzke, Henry; Gensichen, Jochen S.			The association of intensive care with utilization and costs of outpatient healthcare services and quality of life	PLOS ONE			English	Article							RESOURCE UTILIZATION; SURVIVORS; OUTCOMES; UNIT; IMPACT; PHARMACISTS; ICU; POPULATION; MORTALITY; EUROQOL	Background Little is known about outpatient health services use following critical illness and intensive care. We examined the association of intensive care with outpatient consultations and quality of life in a population-based sample. Methods Cross-sectional analysis of data from 6,686 participants of the Study of Health in Pomerania (SHIP), which consists of two independent population-based cohorts. Statistical modeling was done using Poisson regression, negative binomial and generalized linear models for consultations, and a fractional response model for quality of life (EQ-5D-3L index value), with results expressed as prevalence ratios (PR) or percent change (PC). Entropy balancing was used to adjust for observed confounding. Results ICU treatment in the previous year was reported by 139 of 6,686 (2,1%) participants, and was associated with a higher probability (PR 1.05 [CI:1.03;1.07]), number (PC +58.0% [CI:22.8;103.2]) and costs (PC +64.1% [CI:32.0;103.9]) of annual outpatient consultations, as well as with a higher number of medications (PC +37.8% [CI:17.7;61.5]). Participants with ICU treatment were more likely to visit a specialist (PR 1.13 [CI:1.09; 1.16]), specifically internal medicine (PR 1.67 [CI:1.45;1.92]), surgery (PR 2.42 [CI:1.92;3.05]), psychiatry (PR 2.25 [CI:1.30;3.90]), and orthopedics (PR 1.54 [CI:1.11;2.14]). There was no significant effect regarding general practitioner consultations. ICU treatment was also associated with lower health-related quality of life (EQ-5D index value: PC -13.7% [CI:-27.0;-0.3]). Furthermore, quality of life was inversely associated with outpatient consultations in the previous month, more so for participants with ICU treatment. Conclusions Our findings suggest that ICU treatment is associated with an increased utilization of outpatient specialist services, higher medication intake, and impaired quality of life.	[Kosilek, Robert P.; Gensichen, Jochen S.] LMU Munchen, Inst Gen Practice & Family Med, Munich, Germany; [Baumeister, Sebastian E.] LMU Munchen, UNIKA T Augsburg, Chair Epidemiol, Augsburg, Germany; [Baumeister, Sebastian E.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Independent Res Grp Clin Epidemiol, Munich, Germany; [Baumeister, Sebastian E.; Ittermann, Till; Hoffmann, Wolfgang; Schmidt, Carsten O.; Chenot, Jean-Francois; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Gruendling, Matthias] Univ Med Greifswald, Dept Anesthesiol, Greifswald, Germany; [Brunkhorst, Frank M.] Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care CSCC, Jena, Germany; [Felix, Stephan B.; Abel, Peter; Friesecke, Sigrun] Univ Med Greifswald, Dept Internal Med B, Med Intens Care Unit, Greifswald, Germany; [Felix, Stephan B.; Voelzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Apfelbacher, Christian; Brandl, Magdalena] Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany; [Apfelbacher, Christian] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Family Med & Primary Care, Singapore, Singapore; [Schmidt, Konrad] Charite Univ Med Berlin, Inst Gen Practice & Family Med, Berlin, Germany; [Schmidt, Konrad] Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Voelzke, Henry] German Ctr Diabet Res, Site Greifswald, Greifswald, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Greifswald Medical School; Friedrich Schiller University of Jena; Greifswald Medical School; German Centre for Cardiovascular Research; University of Regensburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Kosilek, RP (corresponding author), LMU Munchen, Inst Gen Practice & Family Med, Munich, Germany.	robert_philipp.kosilek@med.uni-muenchen.de	Baumeister, Sebastian-Edgar/P-7894-2019; Chenot, Jean-Francois/F-8241-2011; Schmidt, Konrad/V-5469-2017; Schmidt, Carsten Oliver/AAH-2778-2019	Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Chenot, Jean-Francois/0000-0001-8877-2950; Schmidt, Konrad/0000-0001-5879-0664; Schmidt, Carsten Oliver/0000-0001-5266-9396	German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701]; DZHK (German Center for Cardiovascular Research)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK (German Center for Cardiovascular Research)	The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net (CMR) (http://www.medizin.uni-greifswald.de/icm) of the University of Greifswald, funded by grants from the German Federal Ministry of Education and Research (BMBF grants 01ZZ96030 and 01ZZ0701). This study was further supported by the DZHK (German Center for Cardiovascular Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN R., 1968, Research Ser.; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; [Anonymous], 2012, BEVOLKERUNG ZUM STIC; [Anonymous], 2012, INTENSIVMEDIZINISCHE; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Basu A, 2012, MED DECIS MAKING, V32, P56, DOI 10.1177/0272989X11416988; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Bock JO, 2015, GESUNDHEITSWESEN, V77, P53, DOI 10.1055/s-0034-1374621; Brandstetter S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0544-5; Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Esper AM, 2011, CRIT CARE MED, V39, P2728, DOI 10.1097/CCM.0b013e318236f27e; Garland A, 2015, ANN AM THORAC SOC, V12, P202, DOI 10.1513/AnnalsATS.201405-201CME; Gayat E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1922-8; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Hainmueller J, 2013, J STAT SOFTW, V54; Held N, 2019, TURK THORAC J, V20, P147, DOI 10.5152/TurkThoracJ.2018.18172; Hill AD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1248-y; Hua M, 2015, CRIT CARE MED, V43, P430, DOI 10.1097/CCM.0000000000000717; Jeitziner MM, 2015, J CLIN NURS, V24, P1347, DOI 10.1111/jocn.12749; Jensen JF, 2015, INTENS CARE MED, V41, P763, DOI 10.1007/s00134-015-3689-1; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Kane SL, 2003, INTENS CARE MED, V29, P691, DOI 10.1007/s00134-003-1705-3; Kawachi I, 1997, SOC SCI MED, V45, P1121, DOI 10.1016/S0277-9536(97)00044-0; Krauth C, 2005, GESUNDHEITSWESEN, V67, P736, DOI 10.1055/s-2005-858698; Linko R, 2010, CRIT CARE, V14, DOI 10.1186/cc8957; Lone NI, 2016, AM J RESP CRIT CARE, V194, P198, DOI 10.1164/rccm.201511-2234OC; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Ramos-Goni JM, 2011, STATA J, V11, P120, DOI 10.1177/1536867X1101100108; Marra A, 2018, CRIT CARE MED, V46, P1393, DOI 10.1097/CCM.0000000000003218; Marti J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0178-8; Morandi A, 2013, J AM GERIATR SOC, V61, P1128, DOI 10.1111/jgs.12329; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; Rawal G, 2017, J TRANSL INTERN MED, V5, P90, DOI 10.1515/jtim-2016-0016; Reijneveld SA, 2001, INT J EPIDEMIOL, V30, P1407, DOI 10.1093/ije/30.6.1407; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Ruhl AP, 2017, INTENS CARE MED, V43, P980, DOI 10.1007/s00134-017-4827-8; Ruhl AP, 2015, ANN AM THORAC SOC, V12, P392, DOI 10.1513/AnnalsATS.201409-422OC; Stollings JL, 2018, ANN PHARMACOTHER, V52, P713, DOI 10.1177/1060028018759343; Szakmany A, 2019, CRIT CARE MED, V47, P15, DOI 10.1097/CCM.0000000000003424; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Vijayaraghavan BKT, 2018, INTENS CARE MED, V44, P1542, DOI 10.1007/s00134-018-5117-9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams TA, 2010, ANAESTH INTENS CARE, V38, P732, DOI 10.1177/0310057X1003800417; Zhao QY, 2017, J CAUSAL INFERENCE, V5, DOI 10.1515/jci-2016-0010	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222671	10.1371/journal.pone.0222671	http://dx.doi.org/10.1371/journal.pone.0222671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539397	Green Submitted, Green Published, gold			2022-12-27	WOS:000532297900024
J	Salinas-de-Leon, P; Fierro-Arcos, D; Suarez-Moncada, J; Proano, A; Guachisaca-Salinas, J; Paez-Rosas, D				Salinas-de-Leon, Pelayo; Fierro-Arcos, Denisse; Suarez-Moncada, Jennifer; Proano, Alberto; Guachisaca-Salinas, Jacob; Paez-Rosas, Diego			A matter of taste: Spatial and ontogenetic variations on the trophic ecology of the tiger shark at the Galapagos Marine Reserve	PLOS ONE			English	Article							GALEOCERDO-CUVIER; STABLE-ISOTOPES; DISCRIMINATION FACTORS; CARBON ISOTOPES; CHELONIA-MYDAS; MIXING MODELS; DIET; DELTA-C-13; PATTERNS; TISSUES	Sharks are top predators across ocean food webs and have a major ecological role in marine ecosyst ems. Investigating the trophic ecology of this group of species is thus essential to understand ecosystem functioning and inform specific management actions aimed at shark conservation. The Galapagos Islands represent one of the last ocean wildernesses, where populations of sharks and other top marine predators come close to a pristine status. Here we provide the first study on the trophic ecology of the tiger shark (Galeocerdo cuvier) within the Galapagos Marine Reserve (GMR), using a combination of stable isotope analysis, satellite tracking, and passive acoustic telemetry to investigate ontogenetic and spatial variations at two regions. The mean estimated delta C-13 and delta(15N) at Isabela island (western region) were -13.9 +/- 0.5% and 13.7 +/- 0.7%; and for Santa Cruz island (central region) were -13.8 +/- 0.3% and 13.4 +/- 0.7%, respectively. Green sea turtles (Chelonia mydas) were the main prey item for large tiger sharks (>280 cm TL), while smaller sharks mainly fed on squid and pelagic fish. Tiger sharks exhibited a high degree of philopatry around green sea-turtle nesting areas, with the majority of sharks detected around green sea-turtle nesting areas for at least 10 months after their capture date, and some individuals were even present during the entire three-year study period. Although we did not report statistically significant differences between the two regions, isotopic and electronic tagging data suggest that tiger sharks in the Galapagos could be segregated into specific populations separated by geographical scales of < 100 km. The high productivity of the archipelago, along with the protection from industrial fishing granted by the GMR, result in abundant and predictable sources of prey. This high food abundance, combined with the presence of suitable habitats throughout the tiger shark life cycle, might result in a reduction of migratory behaviours when compared to movement patterns of tiger sharks in other ocean basins. Additional studies using genetic tools could provide further evidence on the presence of separate management units, as it has been recently revealed for other shark species inhabiting the GMR.	[Salinas-de-Leon, Pelayo; Fierro-Arcos, Denisse] Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador; [Salinas-de-Leon, Pelayo] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Suarez-Moncada, Jennifer; Proano, Alberto; Paez-Rosas, Diego] Galapagos Natl Pk, Puerto Ayora, Galapagos Islan, Ecuador; [Guachisaca-Salinas, Jacob] Univ Guayaquil, Fac Ciencias Nat, Guayaquil, Ecuador; [Paez-Rosas, Diego] Univ San Francisco Quito, Galapagos Sci Ctr, Isla San Cristobal, Galapagos Islan, Ecuador	National Geographic Society	Salinas-de-Leon, P (corresponding author), Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador.; Salinas-de-Leon, P (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.	pelayo.salinas@fcdarwin.org.ec	Páez-Rosas, Diego/X-3047-2019	Páez-Rosas, Diego/0000-0002-2446-9888; Salinas-de-Leon, Pelayo/0000-0001-9155-8373; Fierro Arcos, Denisse/0000-0002-5039-6272	IWC Schaffhausen; Helmsley Charitable Trust; National Geographic Pristine Seas; OCEARCH	IWC Schaffhausen; Helmsley Charitable Trust; National Geographic Pristine Seas(National Geographic Society); OCEARCH	This study was supported by IWC Schaffhausen (http://www.iwc.com/en/), The Helmsley Charitable Trust (https://helmsleytrust.org/), National Geographic Pristine Seas (https://www.nationalgeographic.org/projects/pristineseas/) and OCEARCH (www.ocearch.org) provided financial support for the acquisition of equipment, laboratory analysis, field costs and/or staff time. These funds were granted to the Charles Darwin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Marrero D, 2018, MAR ECOL PROG SER, V593, P73, DOI 10.3354/meps12505; Afonso AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184763; Aines AC, 2018, ENVIRON BIOL FISH, V101, P403, DOI 10.1007/s10641-017-0706-y; [Anonymous], 2017, TURK J ZOOL, V7; [Anonymous], 1984, TETHYS, V10, P195; Beebe W, 1926, ARCTURUS ADVENTURE A; Beebe William, 1924, GALAPAGOS WORLDS END; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bui R, 2012, R PACKAGE VERSION, P3; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; De Crosta MA, 1984, AGE DETERMINATION GR; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Dicken ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177897; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; ESTEVEZ S, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0115946; Evans JS, 2018, PACKAGE SPATIALECO; Ferreira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116916; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2016, BEHAV ECOL SOCIOBIOL, V70, P1777, DOI 10.1007/s00265-016-2183-2; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2006, OIKOS, V114, P257; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jonsen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep20625; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lea JSE, 2018, ICES J MAR SCI, V75, P1383, DOI 10.1093/icesjms/fsx238; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Paez-Rosas D, 2018, PEERJ, V6, DOI 10.7717/peerj.4818; Paez-Rosas D, 2014, RAPID COMMUN MASS SP, V28, P2550, DOI 10.1002/rcm.7047; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Pazmino DA, 2017, CONSERV GENET, V18, P1151, DOI 10.1007/s10592-017-0967-1; Penn M.J., 2022, PLOS ONE, V17, pe0268511, DOI [DOI 10.1371/JOURNAL.PONE, 10.1371/journal.pone.0268511, DOI 10.1371/JOURNAL.PONE.0268511]; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Development Core Team, 2009, R LANG ENV STAT COMP; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Reyes H, 2014, RESERVA MARINA GALAP; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; de Leon PS, 2016, PEERJ, V4, DOI 10.7717/peerj.1911; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shiffman DS, 2012, MAR FRESHWATER RES, V63, P635, DOI 10.1071/MF11235; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; White ER, 2015, CONSERV BIOL, V29, P1186, DOI 10.1111/cobi.12478; Wirsing AJ, 2007, OECOLOGIA, V153, P1031, DOI 10.1007/s00442-007-0802-3	75	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222754	10.1371/journal.pone.0222754	http://dx.doi.org/10.1371/journal.pone.0222754			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539419	Green Published, gold			2022-12-27	WOS:000532297900027
J	Haseeb, K; Abbas, N; Saleem, MQ; Sheta, OE; Awan, K; Islam, N; Rehman, WU; Salam, T				Haseeb, Khalid; Abbas, Naveed; Saleem, Muhammad Qaisar; Sheta, Osama E.; Awan, Khalid; Islam, Naveed; Rehman, Waheed ur; Salam, Tabinda			RCER: Reliable Cluster-based Energy-aware Routing protocol for heterogeneous Wireless Sensor Networks	PLOS ONE			English	Article							AD HOC NETWORKS; EFFICIENT; ALGORITHM; LIFETIME; MOBILE; DELAY	Nowadays, because of the unpredictable nature of sensor nodes, propagating sensory data raises significant research challenges in Wireless Sensor Networks (WSNs). Recently, different cluster-based solutions are designed for the improvement of network stability and lifetime, however, most of the energy efficient solutions are developed for homogeneous networks, and use only a distance parameter for the data communication. Although, some existing solutions attempted to improve the selection of next-hop based on energy factor, nevertheless, such solutions are unstable and lack a reducing data delivery interruption in overloaded links. The aim of our proposed solution is to develop Reliable Cluster-based Energy-aware Routing (RCER) protocol for heterogeneous WSN, which lengthen network lifetime and decreases routing cost. Our proposed RCER protocol make use of heterogeneity nodes with respect to their energy and comprises of two main phases; firstly, the network field is parted in geographical clusters to make the network more energy-efficient and secondly; RCER attempts optimum routing for improving the next-hop selection by considering residual-energy, hop-count and weighted value of Round Trip Time (RTT) factors. Moreover, based on computing the measurement of wireless links and nodes status, RCER restore routing paths and provides network reliability with improved data delivery performance. Simulation results demonstrate significant development of RCER protocol against their competing solutions.	[Haseeb, Khalid; Abbas, Naveed; Islam, Naveed] Islamia Coll Peshawar, Dept Comp Sci, Peshawar, Pakistan; [Saleem, Muhammad Qaisar] Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Islamabad, Pakistan; [Sheta, Osama E.] Zagazig Univ, Coll Sci, Zagazig, Egypt; [Awan, Khalid] Comsats Univ Islamabad, Dept Comp Sci, Attock, Pakistan; [Rehman, Waheed ur] Univ Peshawar, Dept Comp Sci, Peshawar, Pakistan; [Salam, Tabinda] Shaheed Benazir Bhutto Women Univ, Dept Comp Sci, Peshawar, Pakistan	University of Peshawar; National University of Sciences & Technology - Pakistan; Egyptian Knowledge Bank (EKB); Zagazig University; COMSATS University Islamabad (CUI); University of Peshawar	Haseeb, K (corresponding author), Islamia Coll Peshawar, Dept Comp Sci, Peshawar, Pakistan.	khalid.haseeb@icp.edu.pk	Rehman, Waheed ur/AAI-4104-2021; Haseeb, Khalid/J-5472-2017	islam, naveed/0000-0003-0648-8804; Haseeb, Khalid/0000-0001-6657-9308				Afsar M.M., 2014, SOFT COMPUTING IND A, P177, DOI 10.1007/978-3-319-00930-8_16; Afsar MM, 2014, J NETW COMPUT APPL, V46, P198, DOI 10.1016/j.jnca.2014.09.005; Afsharfarnia A, 2014, NEW CLUSTERING ALGOR, V12, P411; Aqeel-ur-Rehman, 2014, COMPUT STAND INTER, V36, P263, DOI 10.1016/j.csi.2011.03.004; Bajaber F, 2008, DYNAMIC STATIC CLUST, P524; Baranidharan B., 2013, INDIAN J SCI TECHNOL, V7, P301, DOI 10.17485/ijst/2014/v7i3.2; Batra PK, 2016, WIREL NETW, V22, P49, DOI 10.1007/s11276-015-0951-y; Beldiceanu N, 2016, COMPUTING, P1; Boukerche A, 2011, COMPUT NETW, V55, P3032, DOI 10.1016/j.comnet.2011.05.010; Cassandras CG, 2014, IEEE TRANS CONTROL N, V1, P86, DOI 10.1109/TCNS.2014.2304367; Coner DE, 1995, INTERNETWORKING TCP; Cota-Ruiz J, 2016, IEEE SENS J, V16, P4631, DOI 10.1109/JSEN.2016.2543680; Deng XH, 2016, PEER PEER NETW APPL, V9, P616, DOI 10.1007/s12083-015-0331-5; Ding M, 2003, IEEE VTS VEH TECHNOL, P2168, DOI 10.1109/VETECF.2003.1285913; Elhoseny M, 2017, IEEE SENSOR LETT, V1, DOI 10.1109/LSENS.2017.2724846; Farooq MO, 2010, MR LEACH MULT ROUT L, P262; Ganeriwal S., 2003, P 1 INT C EMB NETW S, P138, DOI DOI 10.1145/958491.958508; Gou H, 2009, PARTITION BASED LEAC, P40; Guo S, 2014, IEEE T COMPUT, V63, P2787, DOI 10.1109/TC.2013.142; Guo WJ, 2014, J NETW COMPUT APPL, V38, P185, DOI 10.1016/j.jnca.2013.04.001; Hamid Z, 2016, MULTIMED TOOLS APPL, V75, P8195, DOI 10.1007/s11042-015-2737-8; Han Z, 2014, IEEE T NUCL SCI, V61, P732, DOI 10.1109/TNS.2014.2309351; Heinzelman W. R., 2000, ENERGY EFFICIENT COM, V00, P1; Hezaveh M, 2015, PROCEEDINGS OF THE 2015 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM), P659, DOI 10.1109/INM.2015.7140352; Jadoon RN, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8071023; Jannatul Ferdous Mst., 2009, Proceedings of the 2009 12th International Conference on Computer and Information Technology (ICCIT 2009), P37, DOI 10.1109/ICCIT.2009.5407170; Ji X, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7080809; Karim Lutful, 2009, GLOBECOM 2009 2009 I, P1; Khalil E.A., 2016, J SUPERCOMPUT, V6, P1; Kim K. T., 2010, TREE BASED CLUSTERIN, P680; Kumar D, 2009, COMPUT COMMUN, V32, P662, DOI 10.1016/j.comcom.2008.11.025; Kumar S, 2015, WIRELESS PERS COMMUN, V85, P2643, DOI 10.1007/s11277-015-2925-x; Lazarescu MT, 2013, IEEE J EM SEL TOP C, V3, P45, DOI 10.1109/JETCAS.2013.2243032; Liao Y, 2013, IEEE SENS J, V13, P1498, DOI 10.1109/JSEN.2012.2227704; Lou C, 2016, PEER PEER NETW APPL, V9, P384, DOI 10.1007/s12083-015-0345-z; Misra S, 2010, MULTIMED TOOLS APPL, V47, P121, DOI 10.1007/s11042-009-0410-9; Mittal N, 2017, WIREL NETW, V23, P1809, DOI 10.1007/s11276-016-1255-6; Muruganathan SD, 2005, IEEE COMMUN MAG, pS8, DOI 10.1109/MCOM.2005.1404592; Nitesh K, 2015, PROCEDIA COMPUT SCI, V46, P1140, DOI 10.1016/j.procs.2015.01.026; Rao PCS, 2017, WIREL NETW, V23, P759, DOI 10.1007/s11276-015-1148-0; Rawat P, 2014, J SUPERCOMPUT, V68, P1, DOI 10.1007/s11227-013-1021-9; Selvi GV, 2015, J WIRELESS COMMUN NE, V3, P327; Song YM, 2014, IEEE T NETW SERV MAN, V11, P417, DOI 10.1109/TNSM.2014.2346080; Tunca C, 2014, IEEE COMMUN SURV TUT, V16, P877, DOI 10.1109/SURV.2013.100113.00293; Tyagi S, 2013, J NETW COMPUT APPL, V36, P623, DOI 10.1016/j.jnca.2012.12.001; Ulema M, 2006, J NETW SYST MANAG, V14, P327, DOI 10.1007/s10922-006-9033-x; Wang SS, 2013, IEEE SENS J, V13, P728, DOI 10.1109/JSEN.2012.2225423; Xu ZZ, 2015, SENSORS-BASEL, V15, P26583, DOI 10.3390/s151026583; Yang M, 2015, MOBILE NETW APPL, V20, P4, DOI 10.1007/s11036-014-0533-8; Yao YJ, 2013, IEEE INT CONF MOB, P182, DOI 10.1109/MASS.2013.44; Zhang B, 2016, J NETW SYST MANAG, P1; Zhang DG, 2017, J NETW COMPUT APPL, V88, P1, DOI 10.1016/j.jnca.2017.03.025; Zhang XM, 2013, IEEE T MOBILE COMPUT, V12, P424, DOI 10.1109/TMC.2011.277	53	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222009	10.1371/journal.pone.0222009	http://dx.doi.org/10.1371/journal.pone.0222009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31537014	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800023
J	Lin, DPY; Chen, JKC; Tung, TH; Li, LPH				Lin, David Po-Yi; Chen, Joshua Kuang-Chao; Tung, Tao-Hsin; Li, Lieber Po-Hung			Differences in the impedance of cochlear implant devices within 24 hours of their implantation	PLOS ONE			English	Article							ELECTRODE; INSERTION	Cochlear implantation is a surgical procedure, which is performed on severely hearing-impaired patients. Impedance field telemetry is commonly used to determine the integrity of the cochlear implant device during and after surgery. At the Department of Otolaryngology, Cheng Hsin General Hospital (Taipei, Taiwan), the cochlear implant devices are switched on within 24 hours of their implantation. In the present study, the impedance changes of Advanced Bionics (TM) cochlear implant devices were compared with previous studies and other devices. The aim was to confirm previous hypotheses and to explore other potential associated factors that could influence impedance following cochlear implantation. The current study included 12 patients who underwent cochlear implantation at Cheng Hsin General Hospital with Advanced Bionics cochlear implant devices. The cochlear devices were all switched on within 24 hours of their implantation. The impedance was measured and compared across all contact channels of the electrode, both intra-operatively and post-operatively. The intra-operative impedance was compared with the switch-on impedance (within 24 hours of the cochlear implantation); the impedance was notably increased for all contact channels at switch-on. Of the 16 channels examined, 4 channels had a significant increase in impedance between the intra-operative measurement and the switch-on measurement. To the best of our knowledge, the impedance of a cochlear implant device can be affected by the diameter of the electrode, the position of the electrode arrays in the scala tympani, sheath formation and fibrosis surrounding the electrode after implantation and electrical stimulation during or after surgery. When the results of the current study were compared with previous studies, it was found that the impedance changes were opposite to that of Cochlear (TM) implant devices. This may be explained by the position of the electrode arrays, sheath formation, the blow-out effect and differences in electrical stimulation.	[Lin, David Po-Yi; Li, Lieber Po-Hung] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chen, Joshua Kuang-Chao] Far Eastern Mem Hosp, Cochlear Implant Ctr, New Taipei, Taiwan; [Tung, Tao-Hsin] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Li, Lieber Po-Hung] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Li, Lieber Po-Hung] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei, Taiwan	Cheng Hsin General Hospital; Far Eastern Memorial Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Li, LPH (corresponding author), Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan.; Li, LPH (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Li, LPH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei, Taiwan.	phli@gm.ym.edu.tw	Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022		Cheng Hsin General Hospital [10511]	Cheng Hsin General Hospital	This work was supported by Cheng Hsin General Hospital (10511) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Vinamra, 2012, Cochlear Implants Int, V13, P113, DOI 10.1179/1754762811Y.0000000015; Chen JKC, 2016, OTOLARYNG HEAD NECK, V154, P771, DOI 10.1177/0194599816631514; Chen JKC, 2015, ACTA OTO-LARYNGOL, V135, P592, DOI 10.3109/00016489.2015.1006335; Chen JKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071929; Chen JKC, 2010, PEDIATRICS, V125, pE793, DOI 10.1542/peds.2008-3620; Dhanasingh A, 2017, HEARING RES, V356, P93, DOI 10.1016/j.heares.2017.10.005; Gazibegovic D, 2017, EUR ARCH OTO-RHINO-L, V274, P1147, DOI 10.1007/s00405-016-4255-3; Hu HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173367; Ishai R, 2017, HEARING RES, V348, P44, DOI 10.1016/j.heares.2017.02.012; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Newbold Carrie, 2014, Cochlear Implants Int, V15, P191, DOI 10.1179/1754762813Y.0000000050; Su GL, 2008, HEARING RES, V241, P64, DOI 10.1016/j.heares.2008.04.011; Tykocinski M, 2005, OTOL NEUROTOL, V26, P948, DOI 10.1097/01.mao.0000185056.99888.f3	14	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222711	10.1371/journal.pone.0222711	http://dx.doi.org/10.1371/journal.pone.0222711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536550	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800075
J	Morais, TG; Teixeira, RFM; Domingos, T				Morais, Tiago G.; Teixeira, Ricardo F. M.; Domingos, Tiago			Detailed global modelling of soil organic carbon in cropland, grassland and forest soils	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; LIFE-CYCLE ASSESSMENT; LAND-USE IMPACTS; CLIMATE-CHANGE; PROJECTED CHANGES; MINERAL SOILS; STOCKS; DYNAMICS; ROTHC; SEQUESTRATION	Assessments of the global carbon (C) cycle typically rely on simplified models which consider large areas as homogeneous in terms of the response of soils to land use or consider very broad land classes. For example, "cropland" is typically modelled as an aggregation of distinct practices and individual crops over large regions. Here, we use the process-based Rothamsted soil Carbon Model (RothC model), which has a history of being successfully applied at a global scale, to calculate attainable SOC stocks and C mineralization rates for each of c. 17,000 regions (combination of soil type and texture, climate type, initial land use and country) in the World, under near-past climate conditions. We considered 28 individual crops and, for each, multiple production practices, plus 16 forest types and 1 grassland class (total of 80 classes). We find that conversion to cropland can result in SOC increases, particularly when the soil remains covered with crop residues (an average gain of 12 t C/ha) or using irrigation (4 t C/ha), which are mutually reinforcing effects. Attainable SOC stocks vary significantly depending on the land use class, particularly for cropland. Common aggregations in global modelling of a single agricultural class would be inaccurate representations of these results. Attainable SOC stocks obtained here were compared to long-term experiment data and are well aligned with the literature. Our results provide a regional and detailed understanding of C sequestration that will also enable better greenhouse gas reporting at national level as alternatives to IPCC tier 2 defaults.	[Morais, Tiago G.; Teixeira, Ricardo F. M.; Domingos, Tiago] Univ Lisbon, MARETEC Marine Environm & Technol Ctr, Inst Super Tecn, LARSyS, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Morais, TG (corresponding author), Univ Lisbon, MARETEC Marine Environm & Technol Ctr, Inst Super Tecn, LARSyS, Lisbon, Portugal.	tiago.g.morais@tecnico.ulisboa.pt	Teixeira, Ricardo F.M./D-5872-2017; Domingos, Tiago/D-4558-2012	Teixeira, Ricardo F.M./0000-0001-9915-6264; Domingos, Tiago/0000-0002-6194-0405; G. Morais, Tiago/0000-0001-6558-0331	FCT/MCTES (PIDDAC) [UID/EEA/50009/2019]; Fundacao para a Ciencia e Tecnologia [SusAn/0001/2016, SFRH/BD/115407/2016, SFRH/BPD/111730/2015]	FCT/MCTES (PIDDAC)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT/MCTES (PIDDAC) through project UID/EEA/50009/2019 and by project "Animal Future -Steering Animal Production Systems towards Sustainable Future", funded by the Fundacao para a Ciencia e Tecnologia (SusAn/0001/2016). T.G. Morais was supported by grant SFRH/BD/115407/2016 and R. F.M. Teixeira by grant SFRH/BPD/111730/2015 from Fundacao para a Ciencia e Tecnologia.; This work was supported by FCT/MCTES (PIDDAC) through project UID/EEA/50009/2019 and by project "Animal Future-Steering Animal Production Systems towards Sustainable Future", funded by the Fundacao para a Ciencia e Tecnologia (SusAn/0001/2016). T.G. Morais was supported by grant SFRH/BD/115407/2016 and R.F.M. Teixeira by grant SFRH/BPD/111730/2015 from Fundacao para a Ciencia e Tecnologia.	Aguilera E, 2018, SCI TOTAL ENVIRON, V621, P634, DOI 10.1016/j.scitotenv.2017.11.243; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Alvaro-Fuentes J, 2012, SOIL TILL RES, V120, P32, DOI 10.1016/j.still.2012.01.009; [Anonymous], 2009, WORLD BORDERS DATASE; APA, 2018, PORT NAT INV REP GRE; Arnell NW, 2013, NAT CLIM CHANGE, V3, P512, DOI [10.1038/nclimate1793, 10.1038/NCLIMATE1793]; Bationo A, 2001, NUTR CYCL AGROECOSYS, V61, P131, DOI 10.1023/A:1013355822946; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Batjes NH, 2011, AGR ECOSYST ENVIRON, V142, P365, DOI 10.1016/j.agee.2011.06.007; Berhongaray G, 2013, AGR ECOSYST ENVIRON, V181, P241, DOI 10.1016/j.agee.2013.10.002; Bidet-Caulet A, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.005.2007; Borgen SK, 2013, SOIL CARBON SEQUESTR, V27, P101; Brandao M, 2013, INT J LIFE CYCLE ASS, V18, P1243, DOI 10.1007/s11367-012-0381-3; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P974, DOI 10.2136/sssaj2000.643974x; Buchholz T, 2014, GCB BIOENERGY, V6, P305, DOI 10.1111/gcbb.12044; Cagnarini C, 2019, EUR J SOIL SCI, V70, P819, DOI 10.1111/ejss.12802; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; Campbell EE, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/123004; Chapagain A. K., 2004, VALUE WATER RES REPO, V1, P1, DOI DOI 10.5194/HESS-15-1577-2011; CITEPA, 2017, RAPP NAT INV FRANC T; CLARIVATE ANALYTICS, 2017, INCITES J CITATION R; Coleman K, 1997, GEODERMA, V81, P29, DOI 10.1016/S0016-7061(97)00079-7; Curran M, 2016, ENVIRON SCI TECHNOL, V50, P2782, DOI 10.1021/acs.est.5b04681; de Brogniez D, 2015, EUR J SOIL SCI, V66, P121, DOI 10.1111/ejss.12193; Del Grosso SJ, 2016, ADV AGR SYST MODEL, V6, P89, DOI 10.2134/advagricsystmodel6.2013.0001.5; Ding SN, 2016, J ARID LAND, V8, P579, DOI 10.1007/s40333-016-0007-x; Doetterl S, 2015, NAT GEOSCI, V8, P780, DOI [10.1038/NGEO2516, 10.1038/ngeo2516]; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/NCLIMATE2941, 10.1038/nclimate2941]; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Eggleston H.S., 2006, 2006 IPCC GUIDELINES, DOI DOI 10.11-10.89; Environment and Climate Change Canada (ECCC), 2019, TEMP CHANG CAN; ESDAC, 2017, LUCAS 2009 TOPSOIL D; FAO/IIASA, 2012, GLOB AGR ZON GAEZ V3, DOI [10.1029/97GB03657, DOI 10.1029/97GB03657]; FAO IIASA ISRIC ISSCAS JRC, 2012, HARM WORLD SOIL DAT, P3123; Farina R, 2013, GEODERMA, V200, P18, DOI 10.1016/j.geoderma.2013.01.021; Frank AB, 2006, SOIL TILL RES, V89, P78, DOI 10.1016/j.still.2005.06.009; Giardina CP, 2014, NAT CLIM CHANGE, V4, P822, DOI [10.1038/nclimate2322, 10.1038/NCLIMATE2322]; Gottschalk P, 2012, BIOGEOSCIENCES, V9, P3151, DOI 10.5194/bg-9-3151-2012; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hu T, 2018, AGR ECOSYST ENVIRON, V251, P141, DOI 10.1016/j.agee.2017.09.024; Ingram JSI, 2001, AGR ECOSYST ENVIRON, V87, P111, DOI 10.1016/S0167-8809(01)00145-1; IPCC, 1997, IPCC GUID NAT GREENH, V2; IPCC, 2003, GOOD PRACTICE GUIDAN; Jarvis SC, 1996, ADV AGRON, V57, P187, DOI 10.1016/S0065-2113(08)60925-6; Jebari A, 2016, THESIS; Jebari A, 2018, J ENVIRON QUAL, V47, P644, DOI 10.2134/jeq2017.07.0294; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Joshi MM, 2013, CLIM DYNAM, V41, P1853, DOI 10.1007/s00382-013-1664-5; Koven CD, 2017, NAT CLIM CHANGE, V7, P817, DOI [10.1038/NCLIMATE3421, 10.1038/nclimate3421]; Kutsch W.L., 2009, SOIL CARBON DYNAMICS, DOI [10.1017/CBO9780511711794, DOI 10.1017/CBO9780511711794]; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150709; Legaz BV, 2017, J CLEAN PROD, V140, P502, DOI 10.1016/j.jclepro.2016.05.077; Lehmann J, 2015, NATURE, V528, P60, DOI 10.1038/nature16069; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Liu DL, 2011, GEODERMA, V165, P69, DOI 10.1016/j.geoderma.2011.07.005; Ludwig B, 2003, EUR J SOIL SCI, V54, P117, DOI 10.1046/j.1365-2389.2003.00496.x; Luo YQ, 2015, GLOBAL CHANGE BIOL, V21, P1737, DOI 10.1111/gcb.12766; Luo Z, 2015, BIOGEOSCIENCES, V12, P4373, DOI 10.5194/bg-12-4373-2015; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; Manna MC, 2005, FIELD CROP RES, V93, P264, DOI 10.1016/j.fcr.2004.10.006; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Mila i Canals L, 2007, CES WORKING PAPERS, V2/07; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Monforti F, 2015, RENEW SUST ENERG REV, V44, P519, DOI 10.1016/j.rser.2014.12.033; MORAIS TG, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/su10124437; Morais TG, 2018, J CLEAN PROD, V192, P864, DOI 10.1016/j.jclepro.2018.05.061; Morais TG, 2016, INT J LIFE CYCLE ASS, V21, P1076, DOI 10.1007/s11367-016-1077-x; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; NASA, 2016, GLOB PREC AN; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Pfister S, 2011, ENVIRON SCI TECHNOL, V45, P5761, DOI 10.1021/es1041755; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Popp A, 2014, NAT CLIM CHANGE, V4, P1095, DOI 10.1038/NCLIMATE2444; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Roman P, 2015, FARMERS COMPOST HDB; Rothamsted Research, 2017, ROTH CARB MOD ROTHC; Schrumpf M, 2011, BIOGEOSCIENCES, V8, P1193, DOI 10.5194/bg-8-1193-2011; Shirato Y, 2004, SOIL SCI PLANT NUTR, V50, P149; Smith J, 2005, GLOBAL CHANGE BIOL, V11, P2141, DOI 10.1111/j.1365-2486.2005.001075.x; Smith J, 2007, GLOBAL CHANGE BIOL, V13, P342, DOI 10.1111/j.1365-2486.2006.01297.x; Smith P, 2004, GLOBAL CHANGE BIOL, V10, P1878, DOI 10.1111/j.1365-2486.2004.00854.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Souza DM, 2015, GLOBAL CHANGE BIOL, V21, P32, DOI 10.1111/gcb.12709; Taghizadeh-Toosi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32568; TEIXEIRA RFM, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/su10114089; Teixeira RFM, 2018, ENVIRON SCI TECHNOL, V52, P12436, DOI 10.1021/acs.est.8b00721; Teixeira RFM, 2016, J CLEAN PROD, V112, P4283, DOI 10.1016/j.jclepro.2015.07.118; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Toth G, 2013, ENVIRON MONIT ASSESS, V185, P7409, DOI 10.1007/s10661-013-3109-3; Vaclavik T, 2013, GLOBAL ENVIRON CHANG, V23, P1637, DOI 10.1016/j.gloenvcha.2013.09.004; Wang GC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19327; Weihermuller L, 2013, EUR J SOIL SCI, V64, P567, DOI 10.1111/ejss.12036; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10791	101	27	28	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222604	10.1371/journal.pone.0222604	http://dx.doi.org/10.1371/journal.pone.0222604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536571	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800061
J	Thu, PT; Huang, WC; Chou, TK; Quan, NV; Chien, PV; Li, F; Shao, KT; Liao, TY				Pham The Thu; Huang, Wen-Chien; Chou, Tak-Kei; Nguyen Van Quan; Pham Van Chien; Li, Fan; Shao, Kwang-Tsao; Liao, Te-Yu			DNA barcoding of coastal ray-finned fishes in Vietnam	PLOS ONE			English	Article							FRESH-WATER FISHES; MITOCHONDRIAL-DNA; PERCIFORMES; SUBSTITUTIONS; PHYLOGENY; DIVERSITY; GENERA	DNA barcoding based on a fragment of the cytochrome c oxidase subunit I (COI) gene is widely applied in species identification and biodiversity studies. The aim of this study was to establish a comprehensive barcoding database of coastal ray-finned fishes in Vietnam. A total of 3,638 specimens were collected from fish landing sites in northern, central and southern Vietnam. Seven hundred and sixty-five COI sequences of ray-finned fishes were generated, belonging to 458 species, 273 genera, 113 families and 43 orders. A total of 59 species were newly recorded in Vietnam and sequences of six species were new to the Genbank and BOLD online databases. Only 32 species cannot be annotated to species level because difficulty in morphological identifications and their Kimura-2-Parameter (K2P) genetic distances to most similar sequences were more than 2%. Moreover, intra-specific genetic distances in some species are also higher than 2%, implying the existence of putative cryptic species. The mean K2P genetic distances within species, genera, families, orders and classes were 0.34%, 12.14%, 17.39%, 21.42%, and 24.80, respectively. Species compositions are quite different with only 16 common species among northern, central and southern Vietnam. This may attribute to multiple habitats and environmental factors across the 3,260 km Vietnamese coastline. Our results confirmed that DNA barcoding is an efficient and reliable tool for coastal fish identification in Vietnam, and also established a reliable DNA barcode reference library for these fishes. DNA barcodes will contribute to future efforts to achieve better monitoring, conservation, and management of fisheries in Vietnam.	[Pham The Thu; Nguyen Van Quan; Pham Van Chien] Vietnam Acad Sci & Technol, Inst Marine Environm & Resources, Hai Phong, Vietnam; [Huang, Wen-Chien] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Huang, Wen-Chien] Acad Sinica, Doctoral Degree Program Marine Biotechnol, Taipei, Taiwan; [Huang, Wen-Chien; Chou, Tak-Kei; Li, Fan; Liao, Te-Yu] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Shao, Kwang-Tsao] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Vietnam Academy of Science & Technology (VAST); National Sun Yat Sen University; Academia Sinica - Taiwan; National Sun Yat Sen University; Academia Sinica - Taiwan; National Taiwan Ocean University	Liao, TY (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	swp0117@gmail.com		Huang, Wen Chien/0000-0002-9482-8188; Nguyen, Quan Van/0000-0002-5910-124X	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.06-2018.31]; Ministry of Science and Technology [104-2611-M110-004, 105-2923-B-110-001-MY3, 106-2611M-110-008]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.06-2018.31 to the Vietnamese side and Ministry of Science and Technology (104-2611-M110-004; 105-2923-B-110-001-MY3; 106-2611M-110-008) to the Taiwanese side. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Claudio Oliveira and another anonymous referee for their constructive comments; to Jie-Cheng Chuang and Ming-hsien Chen of Sheng Long Biotech for their kind assistance during the survey in Ninh Thuan; to Zen-Wei Lin, Han-Ting Huang, Chih-Yen Tung, Po-Hao Chiu, Ching-Ju Chen, Jiehong Wei and You-Chen Liu for collecting specimens; to Wei-Cheng Jhuang, Sung-Yu Tsai and Wei-Che Hung for assistance in fish identification; and to Sih-Yu Chen for map drawing.	Abdullah Mohd Lutfi, 2017, Biodiversitas, V18, P1358; Alcantara SG, 2016, MITOCHONDRIAL DNA A, V27, P3837, DOI 10.3109/19401736.2014.958672; Aquino LMG, 2011, MITOCHONDR DNA, V22, P143, DOI 10.3109/19401736.2011.624613; Arroyave J, 2014, ECOL EVOL, V4, P4534, DOI 10.1002/ece3.1321; Ayudhaya Pradipunt Thongtam Na, 2017, Agriculture and Natural Resources, V51, P198, DOI 10.1016/j.anres.2017.07.001; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Bui DC, 2001, P MAR FISH RES RES I, VII, P200; Chang C-H, DNA BARCODES NATIVE, P796; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Dao MS, 2003, ASSESSMENT MANAGEMEN; Duong TY, 2016, VIETNAM J BIOTECHNOL, V14, P29; Everly M, 2018, AM J TRANSPLANT, V18, P443; Fang GH, 2012, ACTA OCEANOL SIN, V31, P1, DOI 10.1007/s13131-012-0231-y; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Guo YS, 2016, MITOCHONDRIAL DNA A, V27, P2198, DOI 10.3109/19401736.2014.982624; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ikejima J, 2004, MOL PHYLOGENET EVOL, V31, P904, DOI 10.1016/j.ympev.2003.10.006; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Kaga T, 2013, ZOOTAXA, V3642, P4; KAUR S, 2015, INT J ENG RES GEN SC, V3, P602; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2018, MOL BIOL EVOL, V35, P1, DOI 10.1093/molbev/msx313; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Landi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106135; Lavery S, 2006, NZ AQUATIC ENV BIODI; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lutaenko KA, 2011, P WORKSH COAST MAR B; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Nguyen H, 2017, VIETNAMS FISHERIES A; Nguyen KH, 2001, FAUNA VIETNAM; Nguyen KH, 1995, COLL MAR RES WORK, VIV, P121; Nguyen NT, 2005, BIODIVERSITY LIVING; Pham TT, 2007, B FS U RYUKYUS, V84; Qu LY, 2017, MITOCHONDRIAL DNA B, V2, P573, DOI 10.1080/23802359.2017.1372707; Randall JE, 2000, RAFFLES B ZOOL, P569; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Rojana-anawat P, 2001, P SEAFDEC SEM FISH R; Seishi K, 2018, FISHES HA LONG BAY; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Takagi, 2014, COASTAL DISASTERS CL, P175, DOI [10.1016/B978-0-12-800007-6.00008-3, DOI 10.1016/B978-0-12-800007-6.00008-3]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang KL, 2013, MITOCHONDR DNA, V24, P55, DOI 10.3109/19401736.2012.710226; Tran TTV, 2017, MITOCHONDRIAL DNA A, V28, P493, DOI 10.3109/24701394.2016.1143467; Tran D, 1985, MARINE RES COLLECTIO, P19; Tran TO, 2015, INT C BIOL ENV FOOD, P62, DOI [10.15242/IICBE.C0515016, DOI 10.15242/IICBE.C0515016]; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vu DHQ, 2015, INT C BIOL ENV FOOD, P58, DOI [10.15242/IICBE.C0515014, DOI 10.15242/IICBE.C0515014]; Wang LJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5013; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Xing BP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198109; ZAKARIAISMAIL M, 1994, HYDROBIOLOGIA, V285, P41, DOI 10.1007/BF00005652; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zhang JB, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/978253	61	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222631	10.1371/journal.pone.0222631	http://dx.doi.org/10.1371/journal.pone.0222631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536551	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800064
J	Sargent, DJ; Buti, M; Surbanovski, N; Brurberg, MB; Alsheikh, M; Kent, MP; Davik, J				Sargent, Daniel J.; Buti, Matteo; Surbanovski, Nada; Brurberg, May Bente; Alsheikh, Muath; Kent, Matthew P.; Davik, Jahn			Identification of QTLs for powdery mildew (Podosphaera aphanis; syn. Sphaerotheca macularis f. sp. fragariae) susceptibility in cultivated strawberry (Fragaria x ananassa)	PLOS ONE			English	Article							RESISTANCE LOCUS; GENE; FIELD; EXPRESSION; INHERITANCE; TUNNEL	Strawberry powdery mildew (Podosphaera aphanis Wallr.) is a pathogen which infects the leaves, fruit, stolon and flowers of the cultivated strawberry (Fragaria xananassa), causing major yield losses, primarily through unmarketable fruit. The primary commercial control of the disease is the application of fungicidal sprays. However, as the use of key active ingredients of commercial fungicides is becoming increasingly restricted, interest in developing novel strawberry cultivars exhibiting resistance to the pathogen is growing rapidly. In this study, a mapping population derived from a cross between two commercial strawberry cultivars ('Sonata' and 'Babette') was genotyped with single nucleotide polymorphism (SNP) markers from the Axiom iStraw90k genotyping array and phenotyped for powdery mildew susceptibility in both glasshouse and field environments. Three distinct, significant QTLs for powdery mildew resistance were identified across the two experiments. Through comparison with previous studies and scrutiny of the F. vesca genome sequence, candidate genes underlying the genetic control of this trait were identified.	[Sargent, Daniel J.; Surbanovski, Nada] PlantSci Consulting Ltd, Maidstone, Kent, England; [Sargent, Daniel J.; Surbanovski, Nada] Fdn Edmund Mach, Trentino, Italy; [Buti, Matteo] Univ Florence, Dept Agr Food Environm & Forestry, Florence, Italy; [Brurberg, May Bente; Davik, Jahn] Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway; [Brurberg, May Bente; Alsheikh, Muath] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Alsheikh, Muath] Graminor Breeding Ltd, Ridabu, Norway; [Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Fondazione Edmund Mach; University of Florence; Norwegian Institute of Bioeconomy Research; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Davik, J (corresponding author), Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway.	jahn.davik@nibio.no	Brurberg, May Bente/HFI-2864-2022; Sargent, Daniel James/A-2933-2014; BUTI, MATTEO/B-8019-2019	Sargent, Daniel James/0000-0002-6686-7147; BUTI, MATTEO/0000-0002-1430-7826; Davik, Jahn/0000-0002-3621-6888	Norwegian Research Council/RFF Hovedstaden [217587]; Autonomous Province of Trento	Norwegian Research Council/RFF Hovedstaden; Autonomous Province of Trento(Autonomous Province of Trento)	JD, MK, and, MBB were partly supported by grant number 217587 from the Norwegian Research Council/RFF Hovedstaden. DJS, MB, NS. were supported by a grant from the Autonomous Province of Trento to the Fondazione Edmund Mach. DJS and NS. are affiliated to PlantSci Consulting Ltd., and MA is affiliated to Graminor Breeding Ltd. These companies did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Asalf B, 2014, PHYTOPATHOLOGY, V104, P954, DOI 10.1094/PHYTO-12-13-0345-R; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Cockerton HM, 2018, THEOR APPL GENET, V131, P1995, DOI 10.1007/s00122-018-3128-0; Colla P, 2012, PHYTOPARASITICA, V40, P515, DOI 10.1007/s12600-012-0252-2; Davik J, 2005, THEOR APPL GENET, V111, P256, DOI 10.1007/s00122-005-2019-3; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; Edger PP, 2019, NAT GENET, V51, P541, DOI 10.1038/s41588-019-0356-4; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; Jambagi S, 2017, J ADV PLANT BIOL, P40, DOI DOI 10.14302/ISSN.2638-4469.JAPB-17-1838; Janisiewicz WJ, 2016, CAN J PLANT PATHOL, V38, P430, DOI 10.1080/07060661.2016.1263807; Jiwan D, 2013, TRANSGENIC RES, V22, P1119, DOI 10.1007/s11248-013-9715-6; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kennedy C, 2013, HORTSCIENCE, V48, P1125, DOI 10.21273/HORTSCI.48.9.1125; Koishihara H, 2015, KOISHIHARA H, Patent No. # US20180112267A1; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liu W, 2014, MOL PLANT, V7, P1740, DOI 10.1093/mp/ssu112; Lyngkjaer MF, 2000, AGRONOMIE, V20, P745, DOI 10.1051/agro:2000173; Miao LX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038400; NELSON MD, 1995, PHYTOPATHOLOGY, V85, P421, DOI 10.1094/Phyto-85-421; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Pessina S, 2016, PLANT BIOTECHNOL J, V14, P2033, DOI 10.1111/pbi.12562; Pessina S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-618; Sargent DJ, 2016, PLANT SCI, V242, P140, DOI 10.1016/j.plantsci.2015.07.004; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; SIMPSON DW, 1987, J HORTIC SCI, V62, P329, DOI 10.1080/14620316.1987.11515788; Sombardier A, 2009, CAN J PLANT PATHOL, V31, P439, DOI 10.1080/07060660909507618; Tennessen JA, 2014, GENOME BIOL EVOL, V6, P3295, DOI 10.1093/gbe/evu261; Verma S, 2017, ACTA HORTIC, V1156, P75, DOI [10.17660/ActaHortic.2017.1156.10, 10.17660/actahortic.2017.1156.10]; WILLIAMS ER, 1986, BIOMETRIKA, V73, P279, DOI 10.1093/biomet/73.2.279; Xiao CL, 2001, PLANT DIS, V85, P901, DOI 10.1094/PDIS.2001.85.8.901; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	36	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222829	10.1371/journal.pone.0222829	http://dx.doi.org/10.1371/journal.pone.0222829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536602	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800093
J	Valentijn, PP; Pereira, F; Sterner, CW; Vrijhoef, HJM; Ruwaard, D; Hegbrant, J; Strippoli, GFM				Valentijn, Pim P.; Pereira, Fernando; Sterner, Christina W.; Vrijhoef, Hubertus J. M.; Ruwaard, Dirk; Hegbrant, Jorgen; Strippoli, Giovanni F. M.			Validation of the Rainbow Model of Integrated Care Measurement Tools (RMIC-MTs) in renal care for patient and care providers	PLOS ONE			English	Article							DISEASE-MANAGEMENT PROGRAMS; HEALTH-CARE; HEART-FAILURE; QUALITY; OUTCOMES; METAANALYSIS; DEPRESSION; CONTINUITY	Introduction Integrated service delivery is considered to be an essential condition for improving the management and health outcomes of people with chronic kidney disease (CKD). However, research on the assessment of integrated care by patients and care providers is hindered by the absence of brief, reliable, and valid measurement tools. Objective The aim of this study was to develop survey instruments for healthcare professionals and patients based on the Rainbow Model of Integrated Care (RMIC), and to evaluate their psychometric properties. Design The development process was based on the US Food and Drug Administration guidelines. This included item generation from systematic reviews of existing tools and expert opinion on clarity and content validity, involving renal care providers and chronic kidney patients. A cross-sectional, multi-centre design was used to test for internal consistency and construct validity. Setting Outpatient clinics in a large renal network. Participants A sample of 30.788 CKD patients, and 8.914 renal care providers. Methods and analysis Both survey instruments were developed using previous qualitative work and published literature. A multidisciplinary expert panel assessed the face and content validity of both instruments and following a pilot study, the psychometric properties of both instruments were explored. Exploratory factor analysis with principal axis factoring and with promax rotation was used to assess the underlying dimensions of both instruments; Cronbach's alpha was used to determine the internal constancy reliability. Results 17.512 patients (response rate: 56.9%) and 8.849 care providers (response rate: 69.5%) responded to the questionnaires. Factor analysis of the patient questionnaire yielded three internally consistent (Cronbach's alpha > 0.7) factors: person-centeredness, clinical coordination, and professional coordination. Factor analysis of the provider questionnaire produced eight internally consistent (Cronbach's alpha > 0.7) factors: person-centeredness, community centeredness, clinical coordination, professional coordination, organisational coordination, system coordination, technical and cultural competence. As hypothesised, care coordination patient and providers scores significantly correlated with questions about quality of care, treatment involvement, reported health, clinics' organisational readiness, and external care coordination capacity. Conclusion This study provides evidence for the reliability and validity of the RMIC patient and provider questionnaires as generic tools to assess the experience with or perception of integrated renal care delivery. The instruments are recommended in future applications testing test-retest reliability, convergent and predictive validity, and responsiveness.	[Valentijn, Pim P.; Vrijhoef, Hubertus J. M.] Maastricht Univ, Med Ctr, Dept Patient & Care, Maastricht, Netherlands; [Valentijn, Pim P.; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands; [Valentijn, Pim P.] Integrated Care Evaluat, Hierden, Netherlands; [Pereira, Fernando] Diaverum, Strategy & Hlth Econ Off, Madrid, Spain; [Sterner, Christina W.] Diaverum, Strategy & Hlth Econ Off, Gothenburg, Sweden; [Vrijhoef, Hubertus J. M.] Vrije Univ Brussel, Dept Family Med, Brussels, Belgium; [Vrijhoef, Hubertus J. M.] Panaxea, Amsterdam, Netherlands; [Hegbrant, Jorgen; Strippoli, Giovanni F. M.] Diaverum Sweden AB, Diaverum Med Sci Off, Lund, Sweden; [Strippoli, Giovanni F. M.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Strippoli, Giovanni F. M.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy	Maastricht University; Maastricht University; Diaverum; Diaverum; Vrije Universiteit Brussel; Diaverum; University of Sydney; Universita degli Studi di Bari Aldo Moro	Valentijn, PP (corresponding author), Maastricht Univ, Med Ctr, Dept Patient & Care, Maastricht, Netherlands.; Valentijn, PP (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands.; Valentijn, PP (corresponding author), Integrated Care Evaluat, Hierden, Netherlands.	valentijn@essenburgh.nl	Vrijhoef, Hubertus/AAR-2387-2020	Vrijhoef, Hubertus/0000-0002-5539-4671; Valentijn, Pim/0000-0002-9788-1275; Abdalla Pereira, Fernando/0000-0001-9549-5330; Ruwaard, Dirk/0000-0003-4887-8413	Diaverum Renal Services Group, Munich, Germany	Diaverum Renal Services Group, Munich, Germany	This work was supported by a research grant from Diaverum Renal Services Group, Munich, Germany.	Angus L, 2018, AUST J PRIM HEALTH, V24, P59, DOI 10.1071/PY17024; Badamgarav E, 2003, AM J PSYCHIAT, V160, P2080, DOI 10.1176/appi.ajp.160.12.2080; Bautista MAC, 2016, MILBANK Q, V94, P862, DOI 10.1111/1468-0009.12233; Berwick DM, 2003, MED CARE, V41, pI30; Boesveld I, 2017, INT J INTEGRATED CAR, V17; Campbell HS, 2014, SUPPORT CARE CANCER, V22, P1071, DOI 10.1007/s00520-013-2061-7; CERNY BA, 1977, MULTIVAR BEHAV RES, V12, P43, DOI 10.1207/s15327906mbr1201_3; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Coyle J, 1999, J ADV NURS, V30, P723, DOI 10.1046/j.1365-2648.1999.01137.x; Dobrow Mark J, 2009, Healthc Policy, V5, P35; Edwards C, 2004, SOCIOL HEALTH ILL, V26, P159, DOI 10.1111/j.1467-9566.2004.00385.x; Elwyn G, 2013, PATIENT EDUC COUNS, V93, P102, DOI 10.1016/j.pec.2013.05.009; Essenburgh Research & Consultancy, 2019, RAINB MOD INT CAR ME; Field A., 2009, DISCOVERING STAT USI, DOI DOI 10.1080/1057610X.2016.1157408; Fishbane S, 2015, CLIN KIDNEY J, V8, P54, DOI 10.1093/ckj/sfu128; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Griffin SJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001481, DOI 10.1002/14651858.CD001481]; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Johnson C, 2011, GUIDELINES DEV QUEST, P1; Kang H, 2016, HEALTH SYST; Kline R.B., 2015, PRINCIPLES PRACTICE, V4th ed., DOI DOI 10.1038/156278A0; Kodner Dennis L, 2009, Healthc Q, V13 Spec No, P6; Kruis AL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009437.pub2; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Mead N, 2002, PATIENT EDUC COUNS, V48, P51, DOI 10.1016/S0738-3991(02)00099-X; Neumeyer-Gromen A, 2004, MED CARE, V42, P1211, DOI 10.1097/00005650-200412000-00008; Norris J, 2015, ACAD MED, V90, P1394, DOI 10.1097/ACM.0000000000000764; Nurjono M, 2014, INT J INTEGR CARE, V14; Orchard CA, 2012, J CONTIN EDUC HEALTH, V32, P58, DOI 10.1002/chp.21123; Pallant J., 2001, SPSS SURVIVAL MANUAL, DOI DOI 10.1111/1753-6405.12166; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; Schroder C, 2011, J INTERPROF CARE, V25, P189, DOI 10.3109/13561820.2010.532620; Singer SJ, 2011, MED CARE RES REV, V68, P112, DOI 10.1177/1077558710371485; Staniszewska SH, 2005, J ADV NURS, V49, P530, DOI 10.1111/j.1365-2648.2004.03326.x; Starfield B, 1998, J FAM PRACTICE, V46, P216; Stevens LA, 2010, AM J KIDNEY DIS, V55, pS23, DOI 10.1053/j.ajkd.2009.09.035; Stewart A.L., 1992, MEASURING FUNCTIONIN; Streiner DL., 2015, HLTH MEASUREMENT SCA, V5th; Uijen AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042256; Uijen AA, 2012, FAM PRACT, V29, P264, DOI 10.1093/fampra/cmr104; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; US Food and Drug Administration, 2009, GUID IND PAT REP OUT; Valentijn P, 2017, INT J INTEGR CARE, V17, DOI [10.5334/ijic.3104, DOI 10.5334/IJIC.3104]; Valentijn PP, 2013, INT J INTEGR CARE, V13; Valentijn PP, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2465; Valentijn PP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1586-0; Valentijn PP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0278-x; Valentijn PP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0634-x; Valentijn PP, 2018, CLIN J AM SOC NEPHRO; van Empel IWH, 2010, HUM REPROD, V25, P2516, DOI 10.1093/humrep/deq219; Vanhaecht K, 2007, HEALTH SERV MANAG RE, V20, P189, DOI 10.1258/095148407781395964; WENSING M, 1994, SOC SCI MED, V38, P45, DOI 10.1016/0277-9536(94)90298-4; World Health Organization, 2015, WHO GLOB STRAT INT P; Zwart DLM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-117	61	17	19	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222593	10.1371/journal.pone.0222593	http://dx.doi.org/10.1371/journal.pone.0222593			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536548	Green Published, gold			2022-12-27	WOS:000532262800058
J	Vredenburg, VT; McNally, SVG; Sulaeman, H; Butler, HM; Yap, T; Koo, MS; Schmeller, DS; Dodge, C; Cheng, T; Lau, G; Briggs, CJ				Vredenburg, Vance T.; McNally, Samuel V. G.; Sulaeman, Hasan; Butler, Helen M.; Yap, Tiffany; Koo, Michelle S.; Schmeller, Dirk S.; Dodge, Celeste; Cheng, Tina; Lau, Gordon; Briggs, Cheryl J.			Pathogen invasion history elucidates contemporary host pathogen dynamics	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; FUNGAL PATHOGEN; AMPHIBIAN DECLINES; CALIFORNIA; POPULATION; CHYTRIDIOMYCOSIS; EMERGENCE; VIRULENCE; COLLAPSE	Amphibians, the most threatened group of vertebrates, are seen as indicators of the sixth mass extinction on earth. Thousands of species are threatened with extinction and many have been affected by an emerging infectious disease, chytridiomycosis, caused by the fungal pathogen, Batrachochytrium dendrobatidis (Bd). However, amphibians exhibit different responses to the pathogen, such as survival and population persistence with infection, or mortality of individuals and complete population collapse after pathogen invasion. Multiple factors can affect host pathogen dynamics, yet few studies have provided a temporal view that encompasses both the epizootic phase (i.e. pathogen invasion and host collapse), and the transition to a more stable co-existence (i.e. recovery of infected host populations). In the Sierra Nevada mountains of California, USA, conspecific populations of frogs currently exhibit dramatically different host/Bd-pathogen dynamics. To provide a temporal context by which present day dynamics may be better understood, we use a Bd qPCR assay to test 1165 amphibian specimens collected between 1900 and 2005. Our historical analyses reveal a pattern of pathogen invasion and eventual spread across the Sierra Nevada over the last century. Although we found a small number of Bd-infections prior to 1970, these showed no sign of spread or increase in infection prevalence over multiple decades. After the late 1970s, when mass die offs were first noted, our data show Bd as much more prevalent and more spatially spread out, suggesting epizootic spread. However, across the similar to 400km(2) area, we found no evidence of a wave-like pattern, but instead discovered multiple, nearly-simultaneous invasions within regions. We found that Bd invaded and spread in the central Sierra Nevada (Yosemite National Park area) about four decades before it invaded and spread in the southern Sierra Nevada (Sequoia and Kings Canyon National Parks area), and suggest that the temporal pattern of pathogen invasion may help explain divergent contemporary host pathogen dynamics.	[Vredenburg, Vance T.; McNally, Samuel V. G.; Sulaeman, Hasan; Butler, Helen M.; Yap, Tiffany; Dodge, Celeste; Cheng, Tina; Lau, Gordon] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Vredenburg, Vance T.; Yap, Tiffany; Koo, Michelle S.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Yap, Tiffany] Ctr Biol Divers, Oakland, CA USA; [Schmeller, Dirk S.] Univ Toulouse, EcoLab, Toulouse, France; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	California State University System; San Francisco State University; University of California System; University of California Berkeley; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Santa Barbara	Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.; Vredenburg, VT (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	vancev@sfsu.edu	Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933; McNally, Sam/0000-0003-4577-9700; Sulaeman, Hasan/0000-0002-3061-2185; Koo, Michelle/0000-0003-0410-722X; Vredenburg, Vance/0000-0002-9682-1190	call "Mountains as Sentinels of Change" by the Belmont-Forum [ANR-15-MASC-0001-P3, DFG-SCHM 3059/6-1, NERC-1633948, NSFC-41661144004]; National Science Foundation [NSF LTREB DEB-1557190, NSF 1633948, NSF 0728279]; Axa Chair for Functional Mountain Ecology by Axa Research Fund; National Institutes of Health [NIH 5R01GM109499]	call "Mountains as Sentinels of Change" by the Belmont-Forum; National Science Foundation(National Science Foundation (NSF)); Axa Chair for Functional Mountain Ecology by Axa Research Fund(AXA Research Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work, as part of the People, Pollution, and Pathogens Project (P3 project), was funded partly through the call "Mountains as Sentinels of Change" by the Belmont-Forum (ANR-15-MASC-0001-P3, DFG-SCHM 3059/6-1, NERC-1633948, and NSFC-41661144004). This work was also funded in part by National Science Foundation (Briggs, NSF LTREB DEB-1557190; Vredenburg, Belmont Forum project NSF 1633948; Vredenburg NSF 0728279), the Axa Chair for Functional Mountain Ecology by Axa Research Fund awarded to Schmeller, and the National Institutes of Health (Briggs, NIH 5R01GM109499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Bataille A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3127; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Becker CG, 2017, FUNGAL ECOL, V26, P45, DOI 10.1016/j.funeco.2016.11.007; Becker RA, 1988, NEW S LANGUAGE PACIF; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; Briggs CJ, 2010, P NATL ACAD SCI USA; Butler H, 2017, SIERRA NEVADA RETROS; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Chaukulkar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197710; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; De Leon ME, 2017, ECOHEALTH, V14, P155, DOI 10.1007/s10393-016-1201-1; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Green DE, 2001, J HERPETOL, V35, P92, DOI 10.2307/1566028; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; Knapp RA, 2016, P NATL ACAD SCI USA, V113, P11889, DOI 10.1073/pnas.1600983113; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; Phillips BL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1290; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Savage AE, 2011, P NATL ACAD SCI USA; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Sette CM, 2015, BIOL CONSERV, V192, P20, DOI 10.1016/j.biocon.2015.08.039; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Voyles J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035374; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Vredenburg VT, 2008, THREATENED AMPHIBIAN, P126; Wake DB, 2008, P NATL ACAD SCI; Yap TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188384; Yap TA, 2016, ECOHEALTH, V13, P145, DOI 10.1007/s10393-015-1071-y	46	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219981	10.1371/journal.pone.0219981	http://dx.doi.org/10.1371/journal.pone.0219981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536501	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800012
J	Cui, XJ; Yu, XY; Sun, G; Hu, T; Likhodii, S; Zhang, JM; Randell, E; Gao, X; Fan, ZZ; Zhang, WD				Cui, Xiujuan; Yu, Xiaoyan; Sun, Guang; Hu, Ting; Likhodii, Sergei; Zhang, Jingmin; Randell, Edward; Gao, Xiang; Fan, Zhaozhi; Zhang, Weidong			Differential metabolomics networks analysis of menopausal status	PLOS ONE			English	Article							ADIPOSE-TISSUE; ACID; PREVALENCE; CHOLINE; SEX	Menopause is an endocrine-related transition that induces a number of physiological and potentially pathological changes in middle-aged and elderly women. The intention of this research was to investigate the influence of menopause on the intricate relationships between major biochemical metabolites. The study involved metabolic profiling of 186 metabolic markers measured in blood plasma collected from 120 healthy female participants. We developed a method of network analysis using differential correlation that enabled us to detect and characterize differences in metabolites and changes in inter-relationships in preand post-menopausal women. A topological analysis was performed on the differential network that uncovered metabolite differences in pre-and post-menopausal women. In this analysis, our method identified two key metabolites, sphingomyelins and phosphatidylcholines, which may be useful in directing further studies into menopause-specific differences in the metabolome, and how these differences may underlie the body's response to stress and disease following the transition from pre- to post-menopausal status for women.	[Cui, Xiujuan; Yu, Xiaoyan; Zhang, Jingmin; Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China; [Cui, Xiujuan] Daqing Oil Field Gen Hosp, Dept Pharm, Daqing, Peoples R China; [Sun, Guang] Mem Univ, Fac Med, Discipline Med, St John, NF, Canada; [Hu, Ting] Mem Univ, Dept Comp Sci, St John, NF, Canada; [Likhodii, Sergei] BC Prov Toxicol Ctr, Prov Hlth Serv Author, Vancouver, BC, Canada; [Randell, Edward] Mem Univ, Fac Med, Dept Lab Med, St John, NF, Canada; [Gao, Xiang] Qingdao Univ, Coll Life Sci, Qingdao, Peoples R China; [Fan, Zhaozhi] Mem Univ, Dept Math & Stat, St John, NF, Canada; [Zhang, Weidong] Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada	Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Qingdao University; Memorial University Newfoundland; Memorial University Newfoundland	Zhang, WD (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China.; Zhang, WD (corresponding author), Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada.	weidongzhang@jlu.edu.cn			Science and Technology Development Plan of Jilin Province, China [20180101302JC]; Youth technology backbone training program of Health department of Jilin Province, China [2017Q020]; Canadian Institutes of Health Research (CIHR) [MOP192552]; Baiqiuen Project of Jilin University [2018A08]	Science and Technology Development Plan of Jilin Province, China; Youth technology backbone training program of Health department of Jilin Province, China; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Baiqiuen Project of Jilin University	This work was supported by the Science and Technology Development Plan of Jilin Province (20180101302JC), Youth technology backbone training program of Health department of Jilin Province (2017Q020), China. Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552). Baiqiuen Project of Jilin University (2018A08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Gao X, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0095-9; Hu T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005986; Hu T, 2016, BIOCOMPUT-PAC SYM, P120; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lizardo DY, 2018, BIOCHEMISTRY-US, V57, P22, DOI 10.1021/acs.biochem.7b00862; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Maynar M, 2001, ENDOCR RES, V27, P357, DOI 10.1081/ERC-100106013; Milewicz A, 2001, Climacteric, V4, P273, DOI 10.1080/713605137; Pinto Rui Climaco, 2017, Adv Exp Med Biol, V965, P163, DOI 10.1007/978-3-319-47656-8_7; Sammaritano LR, 2012, AUTOIMMUN REV, V11, pA430, DOI 10.1016/j.autrev.2011.11.006; Santosa S, 2013, DIABETES, V62, P775, DOI 10.2337/db12-0912; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Twiss JJ, 2007, J AM ACAD NURSE PRAC, V19, P602, DOI 10.1111/j.1745-7599.2007.00260.x; Yamatani H, 2014, MENOPAUSE, V21, P170, DOI 10.1097/GME.0b013e318296431a; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zeisel SH, 2006, NUTR REV, V64, P197, DOI [10.1301/nr.2006.janr.197-203, 10.1111/j.1753-4887.2006.tb00202.x]; ZEISEL SH, 1995, J NUTR, V125, P3049; Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139; Zhang W, 2016, OSTEOARTHR CARTILAGE, V24, P827, DOI 10.1016/j.joca.2015.12.004; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006286	25	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222353	10.1371/journal.pone.0222353	http://dx.doi.org/10.1371/journal.pone.0222353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532787	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600028
J	Kumar, A; Mantovani, EE; Simsek, S; Jain, S; Elias, EM; Mergoum, M				Kumar, Ajay; Mantovani, Eder E.; Simsek, Senay; Jain, Shalu; Elias, Elias M.; Mergoum, Mohamed			Genome wide genetic dissection of wheat quality and yield related traits and their relationship with grain shape and size traits in an elite x non-adapted bread wheat cross	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; REDUCED HEIGHT GENES; SPIKE-RELATED TRAITS; PROTEIN-CONTENT; BAKING QUALITY; WINTER-WHEAT; QTL ANALYSIS; QUANTITATIVE TRAITS; MAKING QUALITY; DWARFING GENES	The genetic gain in yield and quality are two major targets of wheat breeding programs around the world. In this study, a high density genetic map consisting of 10,172 SNP markers identified a total of 43 genomic regions associated with three quality traits, three yield traits and two agronomic traits in hard red spring wheat (HRSW). When compared with six grain shape and size traits, the quality traits showed mostly independent genetic control (similar to 18% common loci), while the yield traits showed moderate association (similar to 53% common loci). Association of genomic regions for grain area (GA) and thousand-grain weight (TGW), with yield suggests that targeting an increase in GA may help enhancing wheat yield through an increase in TGW. Flour extraction (FE), although has a weak positive phenotypic association with grain shape and size, they do not share any common genetic loci. A major contributor to plant height was the Rht8 locus and the reduced height allele was associated with significant increase in grains per spike (GPS) and FE, and decrease in number of spikes per square meter and test weight. Stable loci were identified for almost all the traits. However, we could not find any QTL in the region of major known genes like GPC-B1, Ha, Rht-1, and Ppd-1. Epistasis also played an important role in the genetics of majority of the traits. In addition to enhancing our knowledge about the association of wheat quality and yield with grain shape and size, this study provides novel loci, genetic information and pre-breeding material (combining positive alleles from both parents) to enhance the cultivated gene pool in wheat germplasm. These resources are valuable in facilitating molecular breeding for wheat quality and yield improvement.	[Kumar, Ajay; Mantovani, Eder E.; Simsek, Senay; Elias, Elias M.; Mergoum, Mohamed] North Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Jain, Shalu] North Dakota State Univ, Dept Plant Pathol, Fargo, ND USA; [Mergoum, Mohamed] Dept Crop & Soil Sci, Griffin, GA USA	North Dakota State University Fargo; North Dakota State University Fargo	Kumar, A; Mergoum, M (corresponding author), North Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA.	Ajay.kumar.2@ndsu.edu; mmergoum@uga.edu						AACCI, 2008, APPR METH AACCI; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Assanga SO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189669; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bergman CJ, 2000, J FOOD QUALITY, V23, P391, DOI 10.1111/j.1745-4557.2000.tb00566.x; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Blanco A, 2002, PLANT MOL BIOL, V48, P615, DOI 10.1023/A:1014864230933; Blanco A, 1996, PLANT BREEDING, V115, P310, DOI 10.1111/j.1439-0523.1996.tb00925.x; Bocianowski J, 2014, EUPHYTICA, V196, P105, DOI 10.1007/s10681-013-1018-8; Boehm JD, 2017, J CEREAL SCI, V77, P73, DOI 10.1016/j.jcs.2017.07.007; Bogard M, 2013, MOL BREEDING, V31, P1380; Borojevic K, 2005, J HERED, V96, P455, DOI 10.1093/jhered/esi060; Botwright TL, 2002, AUST J AGR RES, V53, P1137, DOI 10.1071/AR02007; Casebow R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156056; Chai LL, 2018, THEOR APPL GENET, V131, P2621, DOI 10.1007/s00122-018-3177-4; Cui F, 2012, EUPHYTICA, V186, P177, DOI 10.1007/s10681-011-0550-7; Deng ZY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02120; Desiderio F, 2014, MOL BREEDING, V34, P1659, DOI 10.1007/s11032-014-0186-0; Doehlert DC, 2004, CROP SCI, V44, P1178, DOI 10.2135/cropsci2004.1178; Doust AN, 2014, P NATL ACAD SCI USA, V111, P6178, DOI 10.1073/pnas.1308940110; Du YY, 2018, FIELD CROP RES, V215, P149, DOI 10.1016/j.fcr.2017.10.015; Echeverry-Solarte M, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.12.0089; Echeverry-Solarte M, 2015, THEOR APPL GENET, V128, P893, DOI 10.1007/s00122-015-2478-0; Echeverry-Solarte M, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.03.0013; El-Feki WM, 2013, CROP SCI, V53, P1953, DOI 10.2135/cropsci2012.12.0674; Evans L., 1998, FEEDING 10 BILLION P; Evers A. D., 1990, Aspects of Applied Biology, P417; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Farahani H. A., 2011, Advances in Environmental Biology, V5, P1711; Feiz L, 2008, CEREAL CHEM, V85, P44, DOI 10.1094/CCHEM-85-1-0044; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Georges F, 2017, GM CROPS FOOD, V8, P1, DOI 10.1080/21645698.2016.1270489; Groos C, 2004, J CEREAL SCI, V40, P93, DOI 10.1016/j.jcs.2004.08.006; Guedira M, 2010, CROP SCI, V50, P1811, DOI 10.2135/cropsci2009.10.0626; Guedira M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154242; Gupta Pushpendra Kumar, 2007, Journal of Zhejiang University-Science B, V8, P807, DOI 10.1631/jzus.2007.B0807; Heo H. Y., 2013, Plant Breeding and Biotechnology, V1, P347, DOI 10.9787/PBB.2013.1.4.347; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Dao HQ, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1793-0; Igrejas G, 2002, THEOR APPL GENET, V106, P19, DOI 10.1007/s00122-002-0971-8; Institute SAS, 2004, SAS ONL DOC V 9 1 2; Ishikawa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111337; Jiang Y, 2015, GENETICS, V201, P759, DOI 10.1534/genetics.115.177907; Jiang YJ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-11; Kulwal Pawan, 2005, Functional & Integrative Genomics, V5, P254, DOI 10.1007/s10142-005-0136-3; Kumar A., 2018, ECOFRIENDLY AGROBIOL, P245, DOI DOI 10.1007/978-981-10-6934-5_11; Kumar A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0081; Kumar A, 2013, J CEREAL SCI, V57, P21, DOI 10.1016/j.jcs.2012.09.006; Kumar J, 2011, FIELD CROP RES, V123, P226, DOI 10.1016/j.fcr.2011.05.013; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li J, 2012, EUPHYTICA, V183, P207, DOI 10.1007/s10681-011-0448-4; Liu GZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158635; Lumpkin T. A., 2015, ADV WHEAT GENETICS G, P13, DOI [10.1007/978-4-431-55675-6_2, DOI 10.1007/978-4-431-55675-6_2]; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Maphosa L, 2014, THEOR APPL GENET, V127, P1607, DOI 10.1007/s00122-014-2322-y; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; MARSHALL DR, 1984, AUST J AGR RES, V35, P619, DOI 10.1071/AR9840619; Martin JM, 2001, CROP SCI, V41, P228, DOI 10.2135/cropsci2001.411228x; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Michel S, 2018, THEOR APPL GENET, V131, P477, DOI 10.1007/s00122-017-2998-x; Michel S, 2017, J CEREAL SCI, V77, P24, DOI 10.1016/j.jcs.2017.07.012; Monir MM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00627; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Oury FX, 2010, EUPHYTICA, V171, P87, DOI 10.1007/s10681-009-9997-1; Oury FX, 1999, AGRONOMIE, V19, P621, DOI 10.1051/agro:19990706; Pasha I, 2010, FOOD SCI TECHNOL INT, V16, P511, DOI 10.1177/1082013210379691; Patil RM, 2009, J CEREAL SCI, V49, P378, DOI 10.1016/j.jcs.2009.01.001; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Pomeranz Y., 1988, WHEAT CHEM TECHNOLOG, P1; Rebetzke GJ, 2012, FIELD CROP RES, V127, P17, DOI 10.1016/j.fcr.2011.11.003; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; Salmanowicz BP, 2012, INT J MOL SCI, V13, P4186, DOI 10.3390/ijms13044186; Simons K, 2012, CROP SCI, V52, P2182, DOI 10.2135/cropsci2012.03.0175; Smith AB, 2001, AUST J AGR RES, V52, P1207, DOI 10.1071/AR01058; Sourdille P, 1996, THEOR APPL GENET, V93, P580, DOI 10.1007/BF00417951; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Surma M, 2012, PLANT PROD SCI, V15, P192, DOI 10.1626/pps.15.192; Trethowan RM, 2001, PLANT BREEDING, V120, P509, DOI 10.1046/j.1439-0523.2001.00651.x; Tsilo TJ, 2011, CROP SCI, V51, P237, DOI 10.2135/cropsci2009.12.0711; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118144; Xing W, 2014, CAN J PLANT SCI, V94, P633, DOI [10.4141/CJPS2013-297, 10.4141/cjps2013-297]; Xu H, 2017, ROBOTICA, V35, P2076, DOI 10.1017/S0263574716000606; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Yadav S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39084-7; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zhai HJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01617; Zhang XK, 2006, EUPHYTICA, V152, P109, DOI 10.1007/s10681-006-9184-6	97	26	27	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221826	10.1371/journal.pone.0221826	http://dx.doi.org/10.1371/journal.pone.0221826			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532783	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600013
J	Liu, WN; Chang, CF; Chung, CH; Chien, WC; Huang, TC; Wu, YY; Ho, CL; Chen, JH				Liu, Wei-Nung; Chang, Chao-Feng; Chung, Chi-Hsiang; Chien, Wu-Chien; Huang, Tzu-Chuan; Wu, Yi-Ying; Ho, Ching-Liang; Chen, Jia-Hong			Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; IMPROVED SURVIVAL; EPIDEMIOLOGY	Purpose In a retrospective cohort study, we report the current epidemiology of patients with multiple myeloma (MM) and analyze the real-world clinical outcomes of bortezomib-based therapy. Materials and methods This retrospective study was mainly designed to evaluate the characteristics, treatment outcomes, and prognostic factors of patients with MM who received bortezomib-based therapy. We identified 5,726 patients in Taiwan with MM newly diagnosed between 2007 and 2015. Confidential data from the National Health Insurance Research Database (NHIRD) was used under strict guidelines, as it was made available in an electronic format for research purposes. In addition, we analyzed 96 patients who have been diagnosed with MM and were treated at the Tri-Service General Hospital (TSGH) between January 1, 2002, and December 31, 2018. Results Patients receiving first-line treatment with bortezomib had longer overall survival (OS) compared to those who received non-first-line treatment (p<0.001). In addition, the statistically lowest risk of mortality was when patients received first-line bortezomib followed by an autologous hematopoietic stem cell transplant (adjusted hazard ratio = 0.39, p<0.001). In the TSGH study, the patients were enrolled between January 1, 2002, and December 31, 2018, with an initial diagnosis of MM; there were 96 individuals treated with bortezomib. There was no statistically significant difference in the OS or progression-free survival (PFS) according to the gender, myeloma type, International Staging System stage, or treatment regimen. There was a significant difference in the PFS in patients receiving first-line bortezomib treatment with transplantation compared to those without transplantation (p = 0.021). Conclusions Bortezomib as a first-line treatment extended the OS in four-year mortality tracking and lowered the mortality risk according to the NHIRD analysis. In the TSGH analysis, the results indicated that the initial conditions of patients with MM have a lower influence on the OS and PFS after bortezomib-based therapy was administered.	[Liu, Wei-Nung; Huang, Tzu-Chuan; Wu, Yi-Ying; Ho, Ching-Liang; Chen, Jia-Hong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Chang, Chao-Feng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Chien, Wu-Chien] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University	Chen, JH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan.; Chen, JH (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	ndmc_tw.tw@yahoo.com.tw	Chung, Chi-Hsiang/AAY-3386-2021	Wu, Yi-Ying/0000-0003-0411-6265; Chen, Jia-Hong/0000-0001-6770-1598				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; [Anonymous], 2010, LONGITUDINAL HLTH IN; [Anonymous], 2015, NATL HLTH INSURANCE; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Cartwright RA, 1999, BRIT J HAEMATOL, V106, P281, DOI 10.1046/j.1365-2141.1999.01480.x; Chen JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167227; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lin Chung-King, 2009, Hematol Oncol Stem Cell Ther, V2, P385; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Snowden JA, 2011, BRIT J HAEMATOL, V154, P76, DOI 10.1111/j.1365-2141.2011.08574.x; Tang CH, 2018, CANCER EPIDEMIOL, V55, P136, DOI 10.1016/j.canep.2018.06.003	22	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222522	10.1371/journal.pone.0222522	http://dx.doi.org/10.1371/journal.pone.0222522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527921	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400027
J	Meng, JJ; Gao, C; Tang, CL; Wang, HH; Taoid, ZR				Meng, Jingjing; Gao, Chang; Tang, Chulei; Wang, Honghong; Taoid, Zirong			Prevalence of hypochondriac symptoms among health science students in China: A systematic review and meta-analysis	PLOS ONE			English	Review							MEDICAL-STUDENTS; ANXIETY; EDUCATION; CYBERCHONDRIA; DISEASE; COMORBIDITY; DEPRESSION; DISABILITY; OVERLAP	Background Hypochondriac symptoms are commonly reported in health science students. With their incomplete medical knowledge, they may compare their own bodily symptoms with disease symptoms during the process of learning, which can lead to mental distress and the need for repeated medical reassurance. Objective To estimate the prevalence of hypochondriac symptoms in Chinese health science students. Methods A systematic literature search was conducted on PubMed, Web of Science, Embase, China National Knowledge Infrastructure, China Biology Medicine disc, and Wanfang Data on July 1, 2018. Additionally, the references of the retrieved papers were searched. Cross-sectional studies published in either English or Chinese that reported the prevalence of hypochondriac symptoms in health science students were included. The selection process was executed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis, and study quality was assessed with the checklist recommended by the Agency for Healthcare Research and Quality for cross-sectional studies. A random-effects model according to the DerSimonian-Laird method was used to calculate the pooled prevalence. Results Seven cross-sectional studies involving 6,217 Chinese health science students were included. The pooled prevalence of hypochondriac symptoms among health science students was 28.0% (95% CI = 19.0%-38.0%). The symptoms were a little more common in females (30.0%, 95% CI = 19.0%-42.0%) than in males (29.0%, 95% CI = 16.0%-42.0%), but the difference was not significant. No significant differences were found between participants grouped by study year. Only three studies explored the coping styles of students with hypochondriasis, and these revealed a high tendency toward help-seeking behaviors. Conclusion Our systematic review and meta-analysis showed a high prevalence of hypochondriac symptoms among health science students, indicating that it is a noteworthy phenomenon. We suggest that counseling and other support services are necessary for health science students.	[Meng, Jingjing; Gao, Chang; Tang, Chulei; Wang, Honghong] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Taoid, Zirong] Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University	Taoid, ZR (corresponding author), Cent South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China.	tzr7003@163.com		GAO, Chang/0000-0003-2776-7087				Alers M, 2014, PERSPECT MED EDUC, V3, P163, DOI 10.1007/s40037-014-0132-1; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Azuri J, 2010, MED TEACH, V32, pE270, DOI 10.3109/0142159X.2010.490282; Baric H, 2012, MED TEACH, V34, P1056, DOI 10.3109/0142159X.2012.716180; Bati AH, 2018, NURS EDUC TODAY, V71, P169, DOI 10.1016/j.nedt.2018.09.029; Bobevski I, 2016, PSYCHOSOM MED, V78, P13, DOI 10.1097/PSY.0000000000000252; Chen SC, 2015, MED ED RES PRACTICE, V23, P585, DOI [10.13555/j.cnki.c.m.e.2015.04.008, DOI 10.13555/J.CNKI.C.M.E.2015.04.008]; Chen YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055000, 10.1371/journal.pone.0059263]; Chinawa JM, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0105-3; Doherty-Torstrick ER, 2016, PSYCHOSOMATICS, V57, P390, DOI 10.1016/j.psym.2016.02.002; Howes OD, 1998, LANCET, V351, P1332, DOI 10.1016/S0140-6736(05)79059-0; HUNTER RCA, 1964, J NERV MENT DIS, V139, P147, DOI 10.1097/00005053-196408000-00008; KELLNER R, 1986, ARCH GEN PSYCHIAT, V43, P487; Li QL, 2011, CHINESE J REHABILITA, V26, P39, DOI [10.3870/zgkf.2011.01.0018, DOI 10.3870/ZGKF.2011.01.0018]; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu He, 2011, SOFT SCIENCE, V25, P47; Luo BC, 2016, MED PHILOS, V37, P74, DOI DOI 10.12014/J.ISSN.1002-0772.2016.07A.20; Mathes BM, 2018, PSYCHIAT RES, V261, P204, DOI 10.1016/j.psychres.2018.01.002; Melese Biniam, 2016, BMC Res Notes, V9, P485; Meng JJ, 2017, CHINA HIGHER MED ED, P1, DOI [10.3969/j.issn.1002-1701.2017.12.001, DOI 10.3969/J.ISSN.1002-1701.2017.12.001]; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moreira DP, 2013, REV LAT-AM ENFERM, V21, P155, DOI 10.1590/S0104-11692013000700020; Moss-Morris R, 2001, MED EDUC, V35, P724, DOI 10.1046/j.1365-2923.2001.00958.x; Newby JM, 2017, J PSYCHOSOM RES, V101, P31, DOI 10.1016/j.jpsychores.2017.07.010; Pattani R, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1032-8; Pololi LH, 2013, J GEN INTERN MED, V28, P201, DOI 10.1007/s11606-012-2207-1; Puthran R, 2016, MED EDUC, V50, P456, DOI 10.1111/medu.12962; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Rudman A, 2012, INT J NURS STUD, V49, P988, DOI 10.1016/j.ijnurstu.2012.03.010; Sarikaya O, 2006, INT J CLIN PRACT, V60, P1414, DOI 10.1111/j.1742-1241.2006.00869.x; Singh G, 2004, MED EDUC, V38, P479, DOI 10.1046/j.1365-2929.2004.01813.x; Song PP, 2017, BIOSCI TRENDS, V11, P366, DOI 10.5582/bst.2017.01198; Sumathipala A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-54; Sunderland M, 2013, BRIT J PSYCHIAT, V202, P56, DOI 10.1192/bjp.bp.111.103960; Talaei A, 2009, IRAN EUR PSYCHIAT, V24; van Ravesteijn H, 2009, ANN FAM MED, V7, P232, DOI 10.1370/afm.985; Waterman L, 2012, J PSYCHOSOM RES, V72, P508; WOODS SM, 1966, J MED EDUC, V41, P785; Wu H, 2017, MODERN PREVENTIVE ME, V44, P490; Yen S, 2000, J CONSULT CLIN PSYCH, V68, P993, DOI 10.1037/0022-006X.68.6.993; Yin J., 2016, CHINA MED ED TECHNOL, V30, P502, DOI DOI 10.13566/J.CNKI.CMET.CN61-1317/G4.201605002; Zahid MF, 2016, TEACH LEARN MED, V28, P252, DOI 10.1080/10401334.2016.1155459; Zaki N, 2011, MIDDLE EAST CURR PSY, V18, P51, DOI [10.1097/01.XME.0000392849.84304.97, DOI 10.1097/01.XME.0000392849.84304.97]; Zhang J, 2017, PSYCHIAT RES, V255, P256, DOI 10.1016/j.psychres.2017.05.046; Zhang Q, 2013, MED TEACH, V35, P621, DOI 10.3109/0142159X.2013.789495; Zhao F, 2018, VALUE HEALTH, V21, pS182, DOI 10.1016/j.jval.2018.04.1245; Zhu QF, 2017, CHINA J HLTH PSYCHOL, V25, P1292, DOI [10.13342/J.cnki.cjhp.2017.09.004, DOI 10.13342/J.CNKI.CJHP.2017.09.004]	48	4	5	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222663	10.1371/journal.pone.0222663	http://dx.doi.org/10.1371/journal.pone.0222663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527902	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400036
J	Saerchen, E; Liedtke-Gruener, S; Kopp, M; Heisterkamp, A; Lubatschowski, H; Ripken, T				Saerchen, Emanuel; Liedtke-Gruener, Susann; Kopp, Maximilian; Heisterkamp, Alexander; Lubatschowski, Holger; Ripken, Tammo			Femtosecond laser induced step-like structures inside transparent hydrogel due to laser induced threshold reduction	PLOS ONE			English	Article							WAVE-GUIDES; HEAT ACCUMULATION; NANOSURGERY; FABRICATION; MECHANISMS; BREAKDOWN; CATARACT; POLYMERS; PATTERNS; WRITTEN	In the area of laser material processing, versatile applications for cutting glasses and transparent polymers exist. However, parasitic effects such as the creation of step-like structures appear when laser cutting inside a transparent material. To date, these structures were only described empirically. This work establishes the physical and chemical mechanisms behind the observed effects and describes the influence of process and material parameters onto the creation of step-like structures in hydrogel, Dihydroxyethylmethacrylat (HEMA). By focusing laser pulses in HEMA, reduced pulse separation distance below 50 nm and rise in pulse energy enhances the creation of unintended step-like structures. Spatial resolved Raman-spectroscopy was used to measure the laser induced chemical modification, which results into a reduced breakdown threshold. The reduction in threshold influences the position of optical breakdown for the succeeding laser pulses and consequently leads to the step-like structures. Additionally, the experimental findings were supplemented with numerical simulations of the influence of reduced damage threshold onto the position of optical breakdown. In summary, chemical material change was defined as cause of the step-like structures. Furthermore, the parameters to avoid these structures were identified.	[Saerchen, Emanuel; Kopp, Maximilian; Heisterkamp, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Hannover, Germany; [Saerchen, Emanuel; Liedtke-Gruener, Susann; Lubatschowski, Holger] Rowiak GmbH, Hannover, Germany; [Heisterkamp, Alexander; Lubatschowski, Holger] Leibniz Univ Hannover, Inst Fuer Quantenopt, Hannover, Germany; [Liedtke-Gruener, Susann] Leibniz Inst Surface Engn IOM, Leipzig, Germany	Leibniz University Hannover	Ripken, T (corresponding author), Laser Zentrum Hannover eV, Hannover, Germany.	t.ripken@lzh.de		Ripken, Tammo/0000-0003-3512-9544	German Research Association DFG [RI2066/5-1]	German Research Association DFG(German Research Foundation (DFG))	TR received support from the German Research Association DFG (RI2066/5-1). ROWIAK GmbH provided support in the form of salaries for authors [ES, SLG, HL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], THESIS; Bellouard Y, 2011, OPT EXPRESS, V19, P6807, DOI 10.1364/OE.19.006807; Bellucci R, 2013, ESASO COURSE SER, V3, P38, DOI 10.1159/000350902; Close N, 2004, CELL BIOCHEM BIOPHYS, P9; Ding L, 2006, OPT EXPRESS, V14, P11901, DOI 10.1364/OE.14.011901; Donaldson KE, 2013, J CATARACT REFR SURG, V39, P1753, DOI 10.1016/j.jcrs.2013.09.002; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Farjo AA, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.08.013; Ferrer A, 2011, J APPL PHYS, V109, DOI 10.1063/1.3572268; Ganin D, 2015, PHYSCS PROC, V73, P67, DOI 10.1016/j.phpro.2015.09.123; Gattass RR, 2006, THESIS; Giniunas L, 2014, 8 INT C PHOT TECHN L, P5; Hammer DX, 1997, APPL OPTICS, V36, P5630, DOI 10.1364/AO.36.005630; Hammer DX, 1994, P SOC PHOTO-OPT INS, V2134, P24; Heberle J, 2014, J LASER MICRO NANOEN, V9, P103, DOI 10.2961/jlmn.2014.02.0005; Hnatovskya C, 2005, J APPL PHYS, V98, P1; Kazansky PG, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2722240; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kniggendorf AK, 2016, CHEMOSPHERE, V161, P112, DOI 10.1016/j.chemosphere.2016.06.096; Kniggendorf AK, 2014, BIOMED OPT EXPRESS, V5, P2054, DOI 10.1364/BOE.5.002054; Konig K, 1999, CELL MOL BIOL, V45, P195; Korte F, 2003, APPL PHYS A-MATER, V77, P229, DOI 10.1007/s00339-003-2110-z; Kruer W.L., 2003, PHYS LASER PLASMA IN; Lubatschowski H, 2013, KLIN MONATSBL AUGENH, V230, P1207, DOI 10.1055/s-0033-1351058; Lubatschowski H., 2007, OPT PHOTONIK, V2, P49; Lubatschowski H, 2008, J REFRACT SURG, V24, P102, DOI 10.3928/1081597X-20080101-18; Matsuo S, 2015, OPT EXPRESS, V23, P165, DOI 10.1364/OE.23.000165; Mauclair C, 2008, OPT EXPRESS, V16, P5481, DOI 10.1364/OE.16.005481; Mayer WJ, 2014, OPHTHALMOLOGE, V111, P69, DOI 10.1007/s00347-013-2975-y; Miese C, 2011, OPT EXPRESS, V19, P19542, DOI 10.1364/OE.19.019542; Musgraves JD, 2011, OPT MATER EXPRESS, V1, P921, DOI 10.1364/OME.1.000921; Oujja M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3274127; Riau AK, 2014, INVEST OPHTH VIS SCI, V55, P3186, DOI 10.1167/iovs.14-14434; Richter S, 2013, OPT EXPRESS, V21, P15452, DOI 10.1364/OE.21.015452; Saliminia A, 2006, J APPL PHYS, V99, DOI 10.1063/1.2196237; Salomao MQ, 2010, J CATARACT REFR SURG, V36, P1024, DOI 10.1016/j.jcrs.2010.03.025; Schaffer C.B, 2001, INTERACTION FEMTOSEC; Schmidt U, 2005, MACROMOL SYMP, V230, P133, DOI 10.1002/masy.200551152; Schumacher S., 2009, THESIS; Seiler T, 2014, OPHTHALMOLOGE, V111, P539, DOI 10.1007/s00347-013-2993-9; Shah L, 2005, PROC SPIE, V5714, P253, DOI 10.1117/12.590850; Shaltev MV., 2009, THESIS; Tan DZ, 2016, PROG MATER SCI, V76, P154, DOI 10.1016/j.pmatsci.2015.09.002; Tel A, 2014, INT J THERM SCI, V85, P47, DOI 10.1016/j.ijthermalsci.2014.06.005; Terakawa M, 2010, APPL PHYS A-MATER, V100, P1041, DOI 10.1007/s00339-010-5942-3; Tinne N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114437; Toratani E, 2006, MICROELECTRON ENG, V83, P1782, DOI 10.1016/j.mee.2006.01.194; Vartapetov SK, 2015, QUANTUM ELECTRON+, V45, P725, DOI 10.1070/QE2015v045n08ABEH015515; Vitek DN, 2010, OPT EXPRESS, V18, P24673, DOI 10.1364/OE.18.024673; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; Xu L., 2013, THESIS; Xu LS, 2011, OPT MATER EXPRESS, V1, P1416, DOI 10.1364/OME.1.001416; Ya Cheng, 2003, RIKEN Review, P101	54	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222293	10.1371/journal.pone.0222293	http://dx.doi.org/10.1371/journal.pone.0222293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527880	Green Submitted, gold, Green Published			2022-12-27	WOS:000532231400015
J	Djima, MM; Ekouevi, DK; Gregoire, JP; Tchounga, B; Coffie, PA; Tran, VT; Toure, FY; Moisan, J				Djima, Mariam Mama; Ekouevi, Didier Koumavi; Gregoire, Jean-Pierre; Tchounga, Boris; Coffie, Patrick Ahuatchi; Viet-Thi Tran; Toure, Franck Y.; Moisan, Jocelyne			Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Cote d'Ivoire, West Africa: A cross-sectional study	PLOS ONE			English	Article							DRUG-INTERACTIONS; INFECTED PATIENTS; PILL BURDEN; RISK; POLYPHARMACY; THERAPY; PREVALENCE; PREDICTORS; MORTALITY; MEDICINE	Background In Cote d'Ivoire, people living with HIV (PLHIV) have free access to antiretroviral therapy (ART) and cotrimoxazole. Yet, they may use other medications to treat non-HIV diseases. Scarce data are available regarding the use of non-HIV medications in Africa. This study describes the use of non-HIV medications and identifies the factors associated with their use by PLHIV on ART in Cote d'Ivoire. Methods A cross-sectional study was conducted in six HIV clinics in 2016. HIV-1-infected adults receiving ART for at least one year were eligible. A standardized questionnaire was used to collect demographics, HIV characteristics and medication use data. Associated factors were identified using a multivariate adjusted Poisson regression. Results A total of 1,458 participants (74% women) were enrolled. The median age was 44 years, and the median duration of ART was 81 months. A total of 696 (48%) participants reported having used at least one non-HIV medication. Among the 1,519 non-HIV medications used, 550 (36%) had not been prescribed and 397 (26%) were from the nervous system class. Individuals who were more likely to report the use of at least one non-HIV medication included those who had been treated in an Abidjan HIV clinic, had a high school education level, had a monthly income between 152 and 304 euros, had a poor perceived health status, had WHO advanced clinical stage, had used traditional medicine products and had not used cotrimoxazole. Conclusion Almost half PLHIV on ART reported using non-HIV medication. Further research is needed to assess whether the use of non-HIV medication is appropriate given about a third of those medications are not being prescribed.	[Djima, Mariam Mama; Ekouevi, Didier Koumavi; Tchounga, Boris; Coffie, Patrick Ahuatchi; Viet-Thi Tran; Toure, Franck Y.] CHU Treichville, PACCI, Abidjan, Cote Ivoire; [Djima, Mariam Mama] Inst Pasteur Cote dIvoire, Abidjan, Cote Ivoire; [Djima, Mariam Mama; Gregoire, Jean-Pierre; Moisan, Jocelyne] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Ekouevi, Didier Koumavi] Univ Victor Segalen, Ctr Inserm 1219, ISPED, Bordeaux, France; [Ekouevi, Didier Koumavi] Univ Lome, Dept Sante Publ, Lome, Togo; [Gregoire, Jean-Pierre; Moisan, Jocelyne] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada	Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Laval University	Djima, MM (corresponding author), CHU Treichville, PACCI, Abidjan, Cote Ivoire.; Djima, MM (corresponding author), Inst Pasteur Cote dIvoire, Abidjan, Cote Ivoire.; Djima, MM (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	madjimar@gmail.com	Tran, Viet-Thi/F-1023-2018; Tran, Viet-Thi/Q-2789-2019	Tran, Viet-Thi/0000-0003-1863-6739; Tran, Viet-Thi/0000-0003-1863-6739; Tchounga, Boris Kevin/0000-0002-8747-9610; MAMA DJIMA, MARIAM/0000-0001-9099-9417; Gregoire, Jean-Pierre/0000-0002-1467-9750	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS) [12335]	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS)	This work was supported by the French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS) [grant number 12335]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2012, J AM GERIATR SOC, V60, P974, DOI 10.1111/j.1532-5415.2012.03948.x; Adams JL, 2012, INT J PSYCHIAT MED, V43, P105, DOI 10.2190/PM.43.2.a; Ajuoga E, 2008, RES SOC ADMIN PHARM, V4, P292, DOI 10.1016/j.sapharm.2007.08.001; Angwenyi V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199977; [Anonymous], 2011, RAPPORT ANNUEL DACTI; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; Aziz MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194240; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Blot M, 2012, REV MAL RESPIR, V29, P785, DOI 10.1016/j.rmr.2011.10.974; Brown TT, 2017, INTERD T GERONT GERI, V42, P59, DOI 10.1159/000448544; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Diouf A, 2017, REV EPIDEMIOL SANTE, V65, P295, DOI 10.1016/j.respe.2017.02.001; Eholie S P, 2009, Med Trop (Mars), V69, P520; Eholie SP, 2017, TROP MED INT HEALTH, V22, P1186, DOI 10.1111/tmi.12919; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Ford N, 2018, LANCET INFECT DIS, V18, pE76, DOI 10.1016/S1473-3099(17)30482-6; Furler MD, 2004, AIDS PATIENT CARE ST, V18, P568, DOI 10.1089/apc.2004.18.568; Furler MD, 2003, AIDS PATIENT CARE ST, V17, P155, DOI 10.1089/108729103321619764; Gimeno-Gracia M, 2015, HIV CLIN TRIALS, V16, P117, DOI 10.1179/1528433614Z.0000000012; Harris M, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/595762; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Holtzman C, 2013, J GEN INTERN MED, V28, P1302, DOI 10.1007/s11606-013-2449-6; Justice AC, 2018, AIDS, V32, P739, DOI [10.1097/QAD.0000000000001756, 10.1097/qad.0000000000001756]; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kamekis A, 2018, J CLIN PHARM THER, V43, P26, DOI 10.1111/jcpt.12601; Krentz HB, 2012, ANTIVIR THER, V17, P833, DOI 10.3851/IMP2076; Lamas CC, 2017, INFECTION, V45, P801, DOI 10.1007/s15010-017-1041-0; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Marzolini C, 2011, J ANTIMICROB CHEMOTH, V66, P2107, DOI 10.1093/jac/dkr248; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; Moshabela M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-182; Nombela N, 2006, JAIDS-J ACQ IMM DEF, V41, P225, DOI 10.1097/01.qai.0000179456.39185.9b; OMS, 2013, LIGN DIR COMB UT ANT; OMS, 2013, GLOB UPD HIV TREATM; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; PELTZER K, 2008, BMC PUBLIC HEALTH, V8, DOI DOI 10.1186/1471-2458-8-2551471-2458-8-255; Peltzer Karl, 2009, Afr J Tradit Complement Altern Med, V7, P125; Peters B S, 2011, Adv Dent Res, V23, P23, DOI 10.1177/0022034511399082; Radtke KK, 2018, JAIDS-J ACQ IMM DEF, V78, P202, DOI 10.1097/QAI.0000000000001658; Ranzani A, 2018, JAIDS-J ACQ IMM DEF, V78, P193, DOI 10.1097/QAI.0000000000001653; Sander LD, 2015, TROP MED INT HEALTH, V20, P391, DOI 10.1111/tmi.12443; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Seden K, 2013, J ANTIMICROB CHEMOTH, V68, P1, DOI 10.1093/jac/dks346; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Tayebati SK, 2017, INT MARIT HEALTH, V68, P39, DOI 10.5603/IMH.2017.0007; The Joint United Nations Programme on HIV and AIDS, 2010, UNAIDS REP GLOB AIDS; Tseng A, 2013, ANN PHARMACOTHER, V47, P1429, DOI 10.1177/1060028013504075; WHO, 2002, STRAT LOMS MED TRAD; WHO UNAIDS UNICEF, 2012, GLOB HIV AIDS RESP E; Wilson M, 2010, ISSUES COMORBIDITY H; World Health Organization, 2001, Afr Health Sci, V1, P30; Zhou ST, 2014, AIDS PATIENT CARE ST, V28, P311, DOI 10.1089/apc.2014.0010	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221335	10.1371/journal.pone.0221335	http://dx.doi.org/10.1371/journal.pone.0221335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525222	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700011
J	Fantahun, M; Kebede, A; Yenew, B; Gemechu, T; Mamuye, Y; Tadesse, M; Brhane, B; Jibriel, A; Solomon, D; Yaregal, Z				Fantahun, Mengistu; Kebede, Abebaw; Yenew, Bazezew; Gemechu, Tufa; Mamuye, Yeshiwondm; Tadesse, Mengistu; Brhane, Bereket; Jibriel, Aisha; Solomon, Dawit; Yaregal, Zelalem			Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; EXTRAPULMONARY TUBERCULOSIS; RAPID DIAGNOSIS; CULTURE; PCR; MYCOBACTERIA; PERFORMANCE; SAMPLES; COMPLEX; TESTS	Background Tuberculous lymphadenitis (TBLN) diagnosis remains a challenge in resource limited countries like Ethiopia. Most diagnostic centers in Ethiopia use smear microscopy, but it has low sensitivity in detecting tubercle bacilli in fine needle aspiration (FNA) specimens. FNA cytology (FNAC) is another widely applicable diagnostic option but it has low specificity for diagnosing TBLN. In 2014, WHO recommended Xpert MTB/RIF assay to be used in detecting TB from FNA specimen by considering the diagnostic limitations of microscopy and cytology. In Ethiopia, there is limited data on Xpert MTB/RIF performance in detecting TBLN from FNA. Therefore, this study aimed to evaluate the diagnostic performance of Xpert MTB/RIF assay and non-molecular methods (cytology, microscopy and culture) for the diagnosis of TBLN. Methods A cross-sectional study was conducted on 152 presumptive TBLN patients at St. Paul's Hospital Millennium Medical College (SPHMMC) from December 2015 to May 2016 in Addis Ababa, Ethiopia. FNA specimens were collected from each patient. Individual patient specimens were examined by microscopy (acid fast and auramine 0 staining), cytology, Xpert MTB/RIF and culture. Each specimen was directly inoculated and its sediment following decontamination procedure onto two duplicate Lowenstein-Jensen (LJ) media. Composite culture (specimen positive by direct or concentrated or both culturing methods) and composite method (positive by either one of the non-molecular methods) were taken as reference methods. The data was captured and analyzed using software packages SPSS version 20 (SPSS Inc, Chicago, Illinois, USA). Sensitivity, specificity, positive predictive value, and negative predictive value were calculated. Result A total of 152 presumptive TBLN patients were enrolled in this study. Of these, 105(69%), 68(44.7%), 64(42%), 48(32%) and 33(22%) were positive for M. tuberculosis using composite method (positive by either one of the non-molecular method), composite culture, direct, and concentrated culture, respectively. TB positivity rate was 67.8%, 49.3%, 24.3%, and 14.5% using cytology, Xpert MTB/RIF, Auramine 0 (FM) microscopy, and Ziehl Nelson (ZN) microscopy, respectively. Using composite culture as reference, the sensitivity and specificity of Xpert MTB/RIF was 78% (95% CI: 73.7% to 82.3%) and 74% (95%Cl: 69.4% to 78.6%), respectively. However, the sensitivity of Xpert MTB/RF improved from 78% to 92% using composite method as a reference. The high positivity rate observed in purulent (70%) followed by caseous (66.7%) type of aspirates by Xpert MTB/RIF. Conclusion Xpert MTB/RIF assay has both considerable sensitivity and specificity; it may be employed for better diagnosis, management and treatment of presumptive TBLN patients.	[Fantahun, Mengistu; Brhane, Bereket; Jibriel, Aisha; Solomon, Dawit] St Pauls Hosp Millennium Med Coll, Pathol, Addis Ababa, Ethiopia; [Fantahun, Mengistu; Mamuye, Yeshiwondm] St Pauls Hosp Millennium Med Coll, Dept Microbiol, Addis Ababa, Ethiopia; [Kebede, Abebaw; Yenew, Bazezew; Tadesse, Mengistu; Yaregal, Zelalem] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Gemechu, Tufa] Addis Ababa Univ, Pathol, Addis Ababa, Ethiopia	Addis Ababa University	Fantahun, M (corresponding author), St Pauls Hosp Millennium Med Coll, Pathol, Addis Ababa, Ethiopia.; Fantahun, M (corresponding author), St Pauls Hosp Millennium Med Coll, Dept Microbiol, Addis Ababa, Ethiopia.	mengistu.fann@gmail.com	Tessema, Bazezew Yenew/AAO-4148-2020	Yenew, Bazezew/0000-0002-8505-7000	Addis Ababa University; NIH/Fogarty International Center Global Infectious Diseases [D43TW009127]; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	Addis Ababa University; NIH/Fogarty International Center Global Infectious Diseases; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by Addis Ababa University.; We would like to acknowledge Ethiopian Public Health Institute (EPHI), Addis Ababa University, and St. Paul's Hospital Millennium Medical College for their cooperation and all study participants; who were agreed to participate in this study. Moreover, we would like to acknowledge the Pathology department of SPHMMC and EPHI National Tuberculosis Reference Laboratory staffs for their encouragement and support druing the laboratory work. Abebaw Kebede is supported by a fellowship from the NIH/Fogarty International Center Global Infectious Diseases grant D43TW009127.	Abdissa K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0720-z; Ageep A. K., 2012, International Journal of Tropical Medicine, V7, P53; AGUADO JM, 1987, J INFECTION, V14, P191, DOI 10.1016/S0163-4453(87)92177-3; Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2012, GLOB TUB REP 2012; Bezabih M, 2002, CYTOPATHOLOGY, V13, P284, DOI 10.1046/j.1365-2303.2002.00418.x; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; Buli G.A., 2015, AM J PHARM HLTH RES, V3, P116; Chao SS, 2002, OTOLARYNG HEAD NECK, V126, P176, DOI 10.1067/mhn.2002.121912; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Derese Y, 2012, J INFECT DEV COUNTR, V6, P53, DOI 10.3855/jidc.2050; Ergete W, 2000, ETHIOP J HEALTH DEV, V14, P99; Fanny ML, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-191; Garedew L, 2013, SCAND J INFECT DIS, V45, P512, DOI 10.3109/00365548.2013.773068; GRANGE JM, 1989, TUBERCLE, V70, P1, DOI 10.1016/0041-3879(89)90059-7; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Mistry Y, 2012, NJMR, V2, P77; Mittal P, 2011, DIAGN CYTOPATHOL, V39, P822, DOI 10.1002/dc.21472; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Nataraj G, 2002, J Postgrad Med, V48, P113; Nidhi Paliwal, 2011, Indian J Tuberc, V58, P102; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; RADHIKA S, 1989, DIAGN CYTOPATHOL, V5, P260, DOI 10.1002/dc.2840050306; Reddy VCK, 2008, INDIAN J MED MICROBI, V26, P259; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2011, WHOHTMTB20118; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2014, GLOB TUB CONTR 2014; World Health Organization, 2014, WHOHTMTB20141; Zewdie O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2194-2	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222402	10.1371/journal.pone.0222402	http://dx.doi.org/10.1371/journal.pone.0222402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525214	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700027
J	John, GF; Hayworth, JS				John, Gerald F.; Hayworth, Joel S.			Enhanced effectiveness of oil dispersants in destabilizing water-in-oil emulsions	PLOS ONE			English	Article							CRUDE-OIL; CHEMICAL DESTABILIZATION	Oil impacting the northern Gulf of Mexico shoreline from the 2010 Deepwater Horizon accident was predominantly in the form of water-in-oil emulsions (WOE), a chemically weathered, highly viscous, neutrally buoyant material. Once formed, WOE are extremely difficult to destabilize. Commercially-available oil dispersants are largely ineffective de-emulsifiers as a result of the inability of dispersant surfactants to displace asphaltenes stabilizing the oil-water interface. This study investigated the effectiveness of the commercially-available dispersant Corexit 9500A, modified to enhance its polar fraction, in destabilizing WOE. Results suggest that Corexit modified to include between 20-60% fractional amount of either polar additive (1-octanol or hexylamine) will produce a modest increase in WOE instability, with a Corexit to hexylamine ratio of approximately 80/20 providing the most effective enhanced destabilization. Results support the hypothesis that modifying the fraction of polar constituents in commercial dispersants will increase asphaltene solubility, decrease oil-water interface stability, and enhance WOE instability.	[John, Gerald F.] Bryant Univ, Sci & Technol Dept, Smithfield, RI USA; [Hayworth, Joel S.] Auburn Univ, Civil Engn Dept, Auburn, AL 36849 USA	Bryant University; Auburn University System; Auburn University	Hayworth, JS (corresponding author), Auburn Univ, Civil Engn Dept, Auburn, AL 36849 USA.	jsh@auburn.edu			Bureau of Safety and Environmental Enforcement (BSEE), U.S. Department of Interior, Washington, D.C [M11PC00038]; U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE)	Bureau of Safety and Environmental Enforcement (BSEE), U.S. Department of Interior, Washington, D.C; U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE)	This study was funded by a grant to JSH from the Bureau of Safety and Environmental Enforcement (BSEE; https://www.bsee.gov/), U.S. Department of Interior, Washington, D.C., under Contract Number M11PC00038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE) for supporting this study. Thanks also to Pamela Turner, Assistant Research Engineer at the National Center for Asphalt Testing, Auburn, AL, USA for assistance measuring sample viscosity, and to Dr. Vanisree Mulabagal, Dr. T. Prabhakar Clement, and graduate students Jingyi Qui and Lan Liu for their assistance.	[Anonymous], 2010, OIL BUDGET CALCULATO; [Anonymous], 2012, D327912A ASTM INT, DOI 10.1520/D3279-12; [Anonymous], 2016, D400616A ASTM INT, DOI 10.1520/D4006-16; BOERSMA WH, 1990, AICHE J, V36, P321, DOI 10.1002/aic.690360302; Chandrasekar S, 2006, ICES J MAR SCI, V63, P1418, DOI 10.1016/j.icesjms.2006.04.019; Chanton J, 2014, ENVIRON SCI TECHNOL, V49, P8; Clayton J. R, 1993, OIL SPILL DISPERSANT; Council NR, 2005, OIL SPILL DISP EFF E; Daling PS, 1999, SPILL SCI TECHNOL B, V5, P63, DOI 10.1016/S1353-2561(98)00051-6; Djuve J, 2001, COLLOID POLYM SCI, V279, P232, DOI 10.1007/s003960000413; Fingas M, 2003, MAR POLLUT BULL, V47, P369, DOI 10.1016/S0025-326X(03)00212-1; Fingas M, 1994, ARCT MAR OILSP PROGR; Fingas M, 1996, P 19 ARCT MAR OILSP; Fingas MF, 2004, J HAZARD MATER, V107, P1, DOI 10.1016/j.jhazmat.2003.11.005; Fingas MF, 1993, P 16 ARCT MAR OIL SP; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hayworth JS, 2011, ENVIRON SCI TECHNOL, V45, P4201, DOI 10.1021/es201242k; Hayworth JS, 2012, MARINE POLLUTION B, V64, P10; Kaku VJ, 2006, J ENVIRON ENG, V132, P93, DOI 10.1061/(ASCE)0733-9372(2006)132:1(93); Kokal S, 2005, SPE PROD FACIL, V20, P5, DOI 10.2118/77497-PA; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; McLean JD, 1998, STRUCTURE DYNAMICS A; McLean JD, 1997, J COLLOID INTERF SCI, V189, P12; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; OSAT-3, 2013, OSAT3; Pelz O., 2012, SELECTION SURROGATE; Sjoblom J, 2003, ADV COLLOID INTERFAC, V100, P399, DOI 10.1016/S0001-8686(02)00066-0; SJOBLOM J, 1990, COLLOID POLYM SCI, V268, P389, DOI 10.1007/BF01411682; SLRERL ALC Inc M, 2006, DISPERSANT EFFECTIVE; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P5; Venosa AD, 2002, SPILL SCI TECHNOL B, V7, P299, DOI 10.1016/S1353-2561(02)00072-5; Venosa AD, 2013, MAR POLLUT BULL, V66, P73, DOI 10.1016/j.marpolbul.2012.11.009; WASAN DT, 1979, J RHEOL, V23, P181, DOI 10.1122/1.549524	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222460	10.1371/journal.pone.0222460	http://dx.doi.org/10.1371/journal.pone.0222460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525215	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700030
J	Yap, YS; Leong, MC; Chua, YW; Loh, KWJ; Lee, GE; Lim, EH; Dent, R; Ng, RCH; Lim, JHC; Singh, G; Tan, A; Guan, G; Wu, A; Lee, YF; Bhagat, AAS; Lim, DWT				Yap, Yoon-Sim; Leong, Man Chun; Chua, Yong Wei; Loh, Kiley Wei Jen; Lee, Guek Eng; Lim, Elaine Hsuen; Dent, Rebecca; Ng, Raymond Chee Hui; Lim, John Heng-Chi; Singh, Garima; Tan, Angela; Guan, Guofeng; Wu, Andrew; Lee, Yi Fang; Bhagat, Ali Asgar S.; Lim, Darren Wan-Teck			Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform	PLOS ONE			English	Article							CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; ENRICHMENT; ESTROGEN; RECOMMENDATIONS; PROGRESSION; SURVIVAL	Objectives We aimed to study the prevalence of CTCs in breast cancer (BC) patients undergoing neoadjuvant or palliative therapy with a label-free microfluidic platform (ClearCell FX), and its prognostic relevance in metastatic BC (mBC). Materials and methods Peripheral blood samples were collected from 108 BC patients before starting a new line of treatment ("baseline"), majority of whom had mBC (76/108; 70.4%). CTCs were retrieved by dean flow fractionation that enriched for larger cells, and enumerated using immunofluorescence-based staining. Progression-free survival (PFS) in mBC patients was analysed using Kaplan-Meier method; cox proportional hazard models were used for univariable and multivariable analyses. Results The detection rate of CTCs before starting a new line of treatment was 75.9% (n = 108; median: 8 CTCs/7.5 ml blood) at a cut off of >= 2 CTCs. PFS was inferior for mBC patients with baseline CTC count >= 5 CTCs/7.5 ml blood vs. those with <5 CTCs/7.5 ml blood (median PFS: 4.3 vs. 7.0 months; p-value: 0.037). The prognostic relevance of CTCs was most significant in patients with HER2(-) mBC (median PFS: 4.1 vs. 8.3 months; p-value: 0.032), luminal (HR+HER2-) subtype (median PFS: 4.2 vs. 8.3 months; p-value: 0.048), and patients who had one or more prior treatments (median PFS: 4.2 vs. 7.0 months; p-value: 0.02). On multivariable analysis, baseline CTC level (hazard ratio (HR): 1.84, p-value: 0.02) and pre-treatment status (HR: 1.87, p-value: 0.05) were independent predictors of PFS. Conclusions This work demonstrates the prognostic significance of CTCs in mBC detected using a label-free size-based enrichment platform.	[Yap, Yoon-Sim; Loh, Kiley Wei Jen; Lee, Guek Eng; Lim, Elaine Hsuen; Dent, Rebecca; Ng, Raymond Chee Hui; Lim, Darren Wan-Teck] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Leong, Man Chun; Singh, Garima; Tan, Angela; Guan, Guofeng; Wu, Andrew; Lee, Yi Fang; Bhagat, Ali Asgar S.] Biolid Ltd, Singapore, Singapore; [Chua, Yong Wei] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Lim, Elaine Hsuen; Lim, Darren Wan-Teck] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Lim, John Heng-Chi] Natl Canc Ctr Singapore, Clin Trials & Epidemiol Off, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Cancer Centre Singapore (NCCS)	Yap, YS (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.	yap.y.s@nccs.com.sg	Loh, Kiley/AAJ-5190-2021; Lim, Darren Wan-Teck/V-8435-2019; Lim, Darren Wan Teck/L-2007-2016	Lim, Darren Wan-Teck/0000-0002-4655-0206; Lim, Darren Wan Teck/0000-0002-4655-0206; Yap, Yoon-Sim/0000-0002-0347-5066; Bhagat, Ali Asgar/0000-0002-4695-8762; Loh, Kiley Wei-Jen/0000-0003-0638-4677				Adams DL, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0706-4; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Bidard FC, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P2-02-17; Bidard F-C, 2013, CANC METASTASIS REV; Bidard F-C, 2013, CANC RES S, V73, DOI [10.1158/0008-5472.sabcs13-ot1-1-10, DOI 10.1158/0008-5472.SABCS13-OT1-1-10]; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dayyani F, 2009, J CLIN ONCOL, V27; Fraser-Fish J, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw363.24; Gabriel MT, 2016, CLIN CHEM, V62, P571, DOI 10.1373/clinchem.2015.249706; Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Giuliano M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0440-8; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Horiguchi J, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P3-06-29; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Kalinsky K, 2015, CLIN TRANSL ONCOL, V17, P539, DOI 10.1007/s12094-015-1275-1; Karhade M, 2014, BREAST CANCER RES TR, V147, P325, DOI 10.1007/s10549-014-3103-7; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Lee Y, 2018, CYTOM PART A, V93A, P1251, DOI 10.1002/cyto.a.23507; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Lv Q, 2016, CLIN TRANSL ONCOL, V18, P322, DOI 10.1007/s12094-015-1372-1; Mego M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0507-6; Paoletti C, 2016, MOL ONCOL, V10, P1078, DOI 10.1016/j.molonc.2016.04.006; Paolillo C, 2017, CLIN CANCER RES, V23, P6086, DOI 10.1158/1078-0432.CCR-17-1173; Peeters DJE, 2014, BRIT J CANCER, V110, P375, DOI 10.1038/bjc.2013.743; Pierga JY, 2017, ANN ONCOL, V28, P103, DOI 10.1093/annonc/mdw535; Sawada T, 2016, EBIOMEDICINE, V11, P173, DOI 10.1016/j.ebiom.2016.07.027; Tan CL, 2016, ONCOTARGET, V7, P23251, DOI 10.18632/oncotarget.8136; Tewes M, 2009, BREAST CANCER RES TR, V115, P581, DOI 10.1007/s10549-008-0143-x; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Wallwiener M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1423-6; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong NS, 2006, BREAST CANCER RES TR, V99, P63, DOI 10.1007/s10549-006-9181-4; Wong VCL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177276; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	41	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221305	10.1371/journal.pone.0221305	http://dx.doi.org/10.1371/journal.pone.0221305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553731	Green Published, gold			2022-12-27	WOS:000532319200004
J	Lin, SD; Butler, JE; Boswell-Ruys, CL; Hoang, P; Jarvis, T; Gandevia, SC; McCaughey, EJ				Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Jarvis, Tom; Gandevia, Simon C.; McCaughey, Euan J.			The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience	PLOS ONE			English	Article							QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; PREVALENCE; URINARY; IMPACT; SCALE; VALIDATION; SYMPTOMS; CATHETER	Background Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). These problems have a large impact on quality of life and place a significant burden on health systems. Objectives This study aimed to ascertain the frequency of bladder and bowel problems in a select Australian MS cohort and to investigate the relationships between level of disability, bladder and bowel problems, and fatigue. Methods Questionnaires on the nature and severity of MS symptoms were distributed to clients attending an Australian MS centre. Log-binomial regression and multiple linear regression models were used to investigate relationships between disability, fatigue, and bladder and bowel problems. Results and conclusions Of 167 questionnaires distributed, 136 were completed. Bladder problems were reported by 87 (74.4%) respondents, whilst 66 (48.9%) experienced functional constipation and 43 (31.9%) faecal incontinence. This frequency in our select Australian MS population is similar to that reported globally. There was a significant correlation between level of disability and: bladder problems (p = 0.015), faecal incontinence (p = 0.001), fatigue (p<0.001) and constipation (p = 0.016, relative risk: 1.16). Further investigation into the causal relationships between various MS symptoms may be beneficial in the development of novel therapeutic strategies for people with MS.	[Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Gandevia, Simon C.; McCaughey, Euan J.] Neurosci Res Australia, Randwick, NSW, Australia; [Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Gandevia, Simon C.; McCaughey, Euan J.] Univ New South Wales, Sch Med Sci, Kensington, NSW, Australia; [Phu Hoang; Jarvis, Tom] MS Ltd, Continence Clin, Sydney, NSW, Australia; [Phu Hoang] Australian Catholic Univ, Sydney, NSW, Australia; [Jarvis, Tom; Gandevia, Simon C.] Univ New South Wales, Univ New South Wales Med, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Australian Catholic University; University of New South Wales Sydney	McCaughey, EJ (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; McCaughey, EJ (corresponding author), Univ New South Wales, Sch Med Sci, Kensington, NSW, Australia.	e.mccaughey@neura.edu.au	Boswell-Ruys, Claire L/B-7018-2013	Lin, Sophia/0000-0003-3722-4334; Butler, Jane/0000-0002-5834-8152; McCaughey, Euan James/0000-0001-6596-110X	National Multiple Sclerosis Society (NMSS), USA; National Health and Medical Research Council (NHMRC), Australia	National Multiple Sclerosis Society (NMSS), USA(National Multiple Sclerosis Society); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a pilot grant from the National Multiple Sclerosis Society (NMSS), USA and the National Health and Medical Research Council (NHMRC), Australia.PH and TJ are employed by MS Limited. MS Limited provided support in the form of salaries for PH and TJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amarenco G., 2014, Annals of Physical and Rehabilitation Medicine, V57, P277, DOI 10.1016/j.rehab.2014.05.006; Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; [Anonymous], 2017, SPEC NURS AUSTR 2017; Bates D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-78; Bethoux F., 2006, Annales de Readaptation et de Medecine Physique, V49, P355, DOI 10.1016/j.annrmp.2006.04.022; BETTS CD, 1993, J NEUROL NEUROSUR PS, V56, P245, DOI 10.1136/jnnp.56.3.245; Burks Jack, 2013, Int J MS Care, V15, P182, DOI 10.7224/1537-2073.2012-049; CHIA YW, 1995, J NEUROL, V242, P105, DOI 10.1007/BF00887825; Cincotta MC, 2016, MULT SCLER J, V22, P1438, DOI 10.1177/1352458516663854; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crayton H, 2004, NEUROLOGY, V63, pS12, DOI 10.1212/WNL.63.11_suppl_5.S12; DasGupta R, 2003, DRUGS, V63, P153, DOI 10.2165/00003495-200363020-00003; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hennessey A, 1999, J NEUROL, V246, P1027, DOI 10.1007/s004150050508; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; Hunter KF, 2013, NEUROUROL URODYNAM, V32, P944, DOI 10.1002/nau.22356; Jongen PJ, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0100-z; Khan F, 2006, INT J REHABIL RES, V29, P87, DOI 10.1097/01.mrr.0000194393.56772.62; Khan F, 2009, DISABIL REHABIL, V31, P1567, DOI 10.1080/09638280802639566; Kos D, 2008, NEUROREHAB NEURAL RE, V22, P91, DOI 10.1177/1545968306298934; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lekka E, 2006, EUR UROL, V50, P806, DOI 10.1016/j.eururo.2005.12.015; Mills RJ, 2010, J NEUROL NEUROSUR PS, V81, P1049, DOI 10.1136/jnnp.2008.151340; Multiple Sclerosis International Federation, 2013, ATL MS 2013 MAPP MUL; Nortvedt MW, 2007, MULT SCLER J, V13, P106, DOI 10.1177/1352458506071210; Nortvedt MW, 2001, MULT SCLER J, V7, P231, DOI 10.1177/135245850100700404; Olek MJ, 2018, UPTODATE; Preziosi Giuseppe, 2009, Expert Rev Gastroenterol Hepatol, V3, P417, DOI 10.1586/egh.09.31; Rome Foundation, 2006, ROM 3 DIAGN CRIT FUN; Sansoni J, 2011, VALIDATION CLIN TRAN; Sansoni J, 2011, TECHNICAL MANUAL INS; Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac; Schwartz CE, 1996, ARCH PHYS MED REHAB, V77, P165, DOI 10.1016/S0003-9993(96)90162-8; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Wollin Judy, 2005, Br J Nurs, V14, P439	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222731	10.1371/journal.pone.0222731	http://dx.doi.org/10.1371/journal.pone.0222731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536557	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800080
J	Ratnasiri, AWG; Lee, HC; Lakshminrusimha, S; Parry, SS; Arief, VN; DeLacy, IH; Yang, JS; DiLibero, RJ; Logan, J; Basford, KE				Ratnasiri, Anura W. G.; Lee, Henry C.; Lakshminrusimha, Satyan; Parry, Steven S.; Arief, Vivi N.; DeLacy, Ian H.; Yang, Jo-Shing; DiLibero, Ralph J.; Logan, Julia; Basford, Kaye E.			Trends in maternal prepregnancy body mass index (BMI) and its association with birth and maternal outcomes in California, 2007-2016: A retrospective cohort study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; PRETERM BIRTH; FETAL MACROSOMIA; OBESITY; RISK; PREGNANCY; NUTRITION; HEALTH; INFANTS; SMOKING	Objective To determine recent trends in maternal prepregnancy body mass index (BMI) and to quantify its association with birth and maternal outcomes. Methods A population-based retrospective cohort study included resident women with singleton births in the California Birth Statistical Master Files (BSMF) database from 2007 to 2016. There were 4,621,082 women included out of 5,054,968 women registered in the database. 433,886 (8.6%) women were excluded due to invalid or missing information for BMI. Exposures were underweight (BMI < 18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), and obese (>= 30 kg/m(2)) at the onset of pregnancy. Obesity was subcategorized into class I (30.0-34.9 kg/m(2)), class II (35.0-39.9 kg/m(2)), and class III (>= 40 kg/m(2)), while adverse outcomes examined were low birth weight (LBW), very low birth weight (VLBW), macrosomic births, preterm birth (PTB), very preterm birth (VPTB), small-for-gestational-age birth (SGA), large-for-gestational-age birth (LGA), and cesarean delivery (CD). Descriptive analysis, simple linear regression, and multivariate logistic regression were performed, and adjusted odds ratios (AORs) with 95% confidence intervals (CIs) for associations were estimated. Results Over the ten-year study period, the prevalence of underweight and normal weight women at time of birth declined by 10.6% and 9.7%, respectively, while the prevalence of overweight and obese increased by 4.3% and 22.9%, respectively. VLBW increased significantly with increasing BMI, by 24% in overweight women and by 76% in women with class III obesity from 2007 to 2016. Women with class III obesity also had a significant increase in macrosomic birth (170%) and were more likely to deliver PTB (33%), VPTB (66%), LGA (231%), and CD (208%) than women with a normal BMI. However, obese women were less likely to have SGA infants; underweight women were 51% more likely to have SGA infants than women with a normal BMI. Conclusions In California from 2007 to 2016, there was a declining trend in women with prepregnancy normal weight, and a rising trend in overweight and obese women, particularly obesity class III. Both extremes of prepregnancy BMI were associated with an increased incidence of adverse neonatal outcomes; however, the worse outcomes were prominent in those women classified as obese.	[Ratnasiri, Anura W. G.; Parry, Steven S.; DiLibero, Ralph J.] Calif Dept Hlth Care Serv, Benefits Div, Sacramento, CA 95814 USA; [Ratnasiri, Anura W. G.; Arief, Vivi N.; DeLacy, Ian H.; Basford, Kaye E.] Univ Queensland, Fac Sci, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Lee, Henry C.] Stanford Univ, Sch Med, Div Neonatol, Stanford, CA 94305 USA; [Lakshminrusimha, Satyan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Yang, Jo-Shing] Univ Calif San Francisco, Anesthesia Room ML, San Francisco, CA 94143 USA; [Logan, Julia] Calif Publ Employees Retirement Syst, Hlth Plan Adm Div, Sacramento, CA USA; [Basford, Kaye E.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia	California Department of Health Care Services; University of Queensland; Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Queensland	Ratnasiri, AWG (corresponding author), Calif Dept Hlth Care Serv, Benefits Div, Sacramento, CA 95814 USA.; Ratnasiri, AWG (corresponding author), Univ Queensland, Fac Sci, Sch Agr & Food Sci, Brisbane, Qld, Australia.	Anura.Ratnasiri2@dhcs.ca.gov	Basford, Kaye/T-9578-2019; Arief, Vivi N/A-6450-2018; Lee, Henry/GVS-2114-2022; Arief, Vivi/I-7111-2019	Basford, Kaye/0000-0003-0955-4504; Arief, Vivi/0000-0002-3980-1716; Lakshminrusimha, Satyan/0000-0001-6098-2155				Al Wattar BH, 2016, EUR J OBSTET GYN R B, V206, P147, DOI 10.1016/j.ejogrb.2016.09.016; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bodnar LM, 2014, PAEDIATR PERINAT EP, V28, P203, DOI 10.1111/ppe.12120; BOYD ME, 1983, OBSTET GYNECOL, V61, P715; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carmichael SL, 2017, PEDIATR RES, V82, P8, DOI 10.1038/pr.2017.90; CATALANO PM, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1; Christian P, 2015, SEMIN PERINATOL, V39, P361, DOI 10.1053/j.semperi.2015.06.009; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Contu L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051093; Cunningham SA, 2014, NEW ENGL J MED, V370, P1660, DOI 10.1056/NEJMc1402397; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875; Dude AM, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.05.024; Eriksson JG, 2015, ANN MED, V47, P94, DOI 10.3109/07853890.2015.1004360; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Gillman MW, 2007, PEDIATR RES, V61, P625, DOI 10.1203/pdr.0b013e3180459fcd; Girsen AI, 2016, BJOG-INT J OBSTET GY, V123, P2001, DOI 10.1111/1471-0528.14027; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Ho A., 2016, OBSTET GYNAECOL REPR, V26, P259, DOI [10.1016/j.ogrm.2016.06.005, DOI 10.1016/J.OGRM.2016.06.005]; Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Li WD, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0133-7; Lim CC, 2015, BEST PRACT RES CL OB, V29, P309, DOI 10.1016/j.bpobgyn.2014.10.008; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Lindsay KL, 2018, J OBSTET GYNAECOL, V38, P60, DOI 10.1080/01443615.2017.1328670; Lisonkova S, 2017, JAMA-J AM MED ASSOC, V318, P1777, DOI 10.1001/jama.2017.16191; Lynch AM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.011; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; MESHARI AA, 1990, INT J GYNECOL OBSTET, V32, P215, DOI 10.1016/0020-7292(90)90348-O; Moussa HN, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2016-0035; Naess M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166585; Nnam NM, 2015, P NUTR SOC, V74, P454, DOI 10.1017/S0029665115002396; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Oral E, 2001, EUR J OBSTET GYN R B, V99, P167, DOI 10.1016/S0301-2115(01)00416-X; Pai VV, 2018, PEDIATR RES, V83, P1146, DOI 10.1038/pr.2018.47; Parlee SD, 2014, BBA-MOL BASIS DIS, V1842, P495, DOI 10.1016/j.bbadis.2013.07.007; Ratnasiri Anura W G, 2018, Matern Health Neonatol Perinatol, V4, P15, DOI 10.1186/s40748-018-0084-2; Reichman NE, 2008, MATERN CHILD HLTH J, V12, P204, DOI 10.1007/s10995-007-0240-1; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Richards JL, 2016, JAMA-J AM MED ASSOC, V316, P410, DOI 10.1001/jama.2016.9635; Schroeder SA, 2018, NEW ENGL J MED, V379, P684, DOI 10.1056/NEJMe1809004; Scott-Pillai R, 2013, BJOG-INT J OBSTET GY, V120, P932, DOI 10.1111/1471-0528.12193; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Siega-Riz AM, 2013, NUTR REV, V71, pS26, DOI 10.1111/nure.12074; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Hung TH, 2016, TAIWAN J OBSTET GYNE, V55, P575, DOI 10.1016/j.tjog.2016.06.016; Tohyama C, 2019, PREEMPTIVE MED PUBLI; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	62	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222458	10.1371/journal.pone.0222458	http://dx.doi.org/10.1371/journal.pone.0222458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536528	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800042
J	Thibault, F; Bailly, M; Le Rouzic, G; Metrard, G				Thibault, F.; Bailly, M.; Le Rouzic, G.; Metrard, G.			Clinical evaluation of General Electric new Swiftscan solution in bone scintigraphy on NaI-camera: A head to head comparison with Siemens Symbia	PLOS ONE			English	Article								Purpose The General Electric (GE) Swiftscan solution combines a new Low Energy High Resolution and Sensitivity collimator (LEHRS) with image processing (Clarity 2D) and tomographic step and shoot continuous mode. The aim of this study was to compare clinical and physical performances of this new technology in bone scintigraphy. Methods Physical phantom measurements were performed using GE LEHRS, GE Low Energy High Resolution (LEHR) and Siemens LEHR collimators. These measurements were associated with a prospective clinical study. Sixty-seven patients referred for bone scintigraphy were enrolled from February to July 2018. Each patient underwent two acquisitions consecutively on GE and Siemens gamma camera, using respectively Swiftscan solution and LEHR collimator. Results On planar acquisitions, maximum sensitivity was 100 cts/MBq for Siemens LEHR. GE SwiftScan LEHRS and GE LEHR maximum sensitivity were respectively 9% and 22% lower. Using Clarity 2D, GE Swiftscan LEHRS spatial resolution was the best with 9.2 mm versus 10.1 mm and 10.6 mm for GE LEHR and Siemens LEHR collimators. In tomographic mode, the sensitivity of GE Swiftscan solution was superior to both LEHR systems (16% and 25% respectively for Siemens and GE). There was no significant difference in spatial resolution. In clinical use, signal was higher on Siemens system and noise was lower on GE Swiftscan solution. Contrast-to-noise ratios were not significantly different between the two systems. There was a significant image quality improvement with GE SwiftScan in planar images and in whole body scan. No significant difference in image quality was observed on SPECT images. Conclusion New GE SwiftScan collimator design improved sensitivity compared to "classical" GE LEHR collimator without compromising resolution. GE SwiftScan solution enhances planar image quality with a better Clarity 2D resolution recovery and noise treatment. In SPECT mode, GE SwiftScan solution improves volumetric sensitivity without significant impact on image quality, and could lead to time or dose reduction.	[Thibault, F.; Bailly, M.; Le Rouzic, G.; Metrard, G.] CHR Orleans, Nucl Med Dept, Orleans, France	Centre Hospitalier Regional d'Orleans	Metrard, G (corresponding author), CHR Orleans, Nucl Med Dept, Orleans, France.	gilles.metrard@chr-orleans.fr		Thibault, Frederique/0000-0003-1258-7534				Kumita S, 2003, ANN NUCL MED, V17, P517, DOI 10.1007/BF03006446; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Rouzic G, 2018, PHYS MEDICA, V56, P34, DOI [10.1016/j.ejmp.2018.11.008, DOI 10.1016/J.EJMP.2018.11.008]; MOORE SC, 1992, EUR J NUCL MED, V19, P138, DOI 10.1007/BF00184130; Nakajima K, 2017, ANN NUCL MED, V31, P649, DOI 10.1007/s12149-017-1210-3; NEMA, 2000, 12000 NEMA NU; NEMA, 2012, 22012 NEMA NU; Onishi H, 2013, RADIOL PHYS TECHNOL, V6, P42, DOI 10.1007/s12194-012-0168-z; Sarikaya I, 2001, SEMIN NUCL MED, V31, P3, DOI 10.1053/snuc.2001.18736; Seret A, 2009, J NUCL MED TECHNOL, V37, P179, DOI 10.2967/jnmt.108.061275	10	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222490	10.1371/journal.pone.0222490	http://dx.doi.org/10.1371/journal.pone.0222490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536519	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800045
J	Bietti, LM; Bangerter, A; Knutsen, D; Mayor, E				Bietti, Lucas M.; Bangerter, Adrian; Knutsen, Dominique; Mayor, Eric			Cultural transmission in a food preparation task: The role of interactivity, innovation and storytelling	PLOS ONE			English	Article								Interactive conversation drives the transmission of cultural information in small groups and large networks. In formal (e.g. schools) and informal (e.g. home) learning settings, interactivity does not only allow individuals and groups to faithfully transmit and learn new knowledge and skills, but also to boost cumulative cultural evolution. Here we investigate how interactivity affects performance, teaching, learning, innovation and chosen diffusion mode (e.g. instructional discourse vs. storytelling) of previously acquired information in a transmission chain experiment. In our experiment, participants (n = 288) working in 48 chains with three generations of pairs had to learn and complete a collaborative food preparation task (ravioli-making), and then transmit their experience to a new generation of participants in an interactive and non-interactive condition. Food preparation is a real-world task that it is taught and learned across cultures and transmitted over generations in families and groups. Pairs were defined as teachers or learners depending on their role in the transmission chain. The number of good exemplars of ravioli each pair produced was taken as measurement of performance. Contrary to our expectations, the results did not reveal that (1) performance increased over generations or that (2) interactivity in transmission sessions promoted increased performance. However, the results showed that (3) interactivity promoted the transmission of more information from teachers to learners; (4) increased quantity of information transmission from teachers led to higher performance in learners; (5) higher performance generations introduced more innovations in transmission sessions; (6) learners applied those transmitted innovations to their performance which made them persist over generations; (7) storytelling was specialized for the transmission of non-routine, unexpected information. Our findings offer new insights on how interactivity, innovation and storytelling affect the cultural transmission of complex collaborative tasks.	[Bietti, Lucas M.; Bangerter, Adrian; Mayor, Eric] Univ Neuchatel, Inst Work & Org Psychol, Neuchatel, Switzerland; [Bietti, Lucas M.] Ctr Natl Rech Sci CNRS, Telecom Paris, Inst Interdisciplinaire Innovat, UMR 9217, Paris, France; [Knutsen, Dominique] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France	University of Neuchatel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Bietti, LM (corresponding author), Univ Neuchatel, Inst Work & Org Psychol, Neuchatel, Switzerland.; Bietti, LM (corresponding author), Ctr Natl Rech Sci CNRS, Telecom Paris, Inst Interdisciplinaire Innovat, UMR 9217, Paris, France.	bietti@protonmail.com	Bietti, Lucas/GOV-5160-2022; Mayor, eric/AFT-8486-2022	Bietti, Lucas/0000-0002-4380-2615; Mayor, eric/0000-0001-9441-7592	Swiss National Science Foundation Ambizione Grant [PZ00P1_154968]	Swiss National Science Foundation Ambizione Grant	This research was funded by a Swiss National Science Foundation Ambizione Grant [PZ00P1_154968] to L.M.B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; [Anonymous], PERSPECTIVES SOCIALL; Bangerter A, 2000, DISCOURSE PROCESS, V30, P237, DOI 10.1207/S15326950dp3003_2; Bangerter A, 2011, DISCOURSE PROCESS, V48, P183, DOI 10.1080/0163853X.2010.519765; Bartlett F. C., 1932, REMEMBERING; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bietti L.M., 2017, P 39 ANN C COGN SCI, P1641; Bietti LM, 2019, TOP COGN SCI, V11, P710, DOI 10.1111/tops.12358; Boyd B., 2009, ORIGINS STORIES EVOL; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown D. E., 1991, HUMAN UNIVERSALS; Bruner J. S., 1990, ACTS MEANING; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; Caldwell CA, 2018, REV PHILOS PSYCHOL, V9, P751, DOI 10.1007/s13164-017-0346-3; Caldwell CA, 2016, CURR DIR PSYCHOL SCI, V25, P191, DOI 10.1177/0963721416641049; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Clark H.H., 1996, USING LANGUAGE; CLARK HH, 1989, COGNITIVE SCI, V13, P259, DOI 10.1207/s15516709cog1302_7; Currie A, 2017, STUD HIST PHILOS SCI, V62, P14, DOI 10.1016/j.shpsa.2017.03.003; Derex M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9398; Dessalles JL, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P99, DOI 10.1142/9789814295222_0013; Dunbar R, 2010, GROOMING GOSSIP EVOL; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Farmer N, 2018, HEALTH EDUC BEHAV, V45, P167, DOI 10.1177/1090198117736352; Fay N, 2018, EVOL HUM BEHAV, V39, P300, DOI 10.1016/j.evolhumbehav.2018.02.002; Garfield ZH., 2016, SOCIAL LEARNING INNO, P19; Hochberg ME, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0414; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Kline MA, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14001071; Knutsen D, 2016, TOP COGN SCI, V8, P796, DOI 10.1111/tops.12218; Kraut RE, 2003, HUM-COMPUT INTERACT, V18, P13, DOI 10.1207/S15327051HCI1812_2; Labov W., 1976, ESSAYS VERBAL VISUAL, P12; Lombao D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14322-y; Mandelbaum J., 2013, HDB CONVERSATION ANA, P492, DOI DOI 10.1002/9781118325001.CH24; Maswood R, 2019, TOP COGN SCI, V11, P687, DOI 10.1111/tops.12348; McCabe M, 2015, J CONSUM CULT, V15, P48, DOI 10.1177/1469540513493202; McGuigan N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0425; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Mesoudi Alex, 2008, Biological Theory, V3, P63, DOI 10.1162/biot.2008.3.1.63; Miton H, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0677; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; O'Brien Michael J., 2009, INNOVATION CULTURAL; Ramstead MJD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01090; Silva KG, 2010, CHILD DEV, V81, P898, DOI 10.1111/j.1467-8624.2010.01441.x; Smith D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02036-8; Sugiyama MS, 2001, EVOL HUM BEHAV, V22, P221; Tan R, 2011, EVOL HUM BEHAV, V32, P399, DOI 10.1016/j.evolhumbehav.2011.01.001; Utter J, 2018, J NUTR EDUC BEHAV, V50, P494, DOI 10.1016/j.jneb.2018.01.021; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zwirner E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16781	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221278	10.1371/journal.pone.0221278	http://dx.doi.org/10.1371/journal.pone.0221278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532770	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000532239600005
J	Balsalobre-Fernandez, C; Cardiel-Garcia, M; Jimenez, SL				Balsalobre-Fernandez, Carlos; Cardiel-Garcia, Mario; Jimenez, Sergio L.			Bilateral and unilateral load-velocity profiling in a machine-based, single-joint, lower body exercise	PLOS ONE			English	Article							MOVEMENT VELOCITY; INTENSITY	Background To analyze the goodness of fit of the load-velocity relationship in a machine-based, single joint exercise performed both in a bilateral and unilateral manner, as well as to study its accuracy to estimate one repetition maximum (1-RM). Methods Fifteen resistance trained males performed an incremental test in the bilateral and unilateral leg extension exercise up to the 1-RM in two separate occasions. Mean vertical velocity of the weight plates in the leg extension machine was measured for every repetition using a smartphone application (My Lift). Results Linear regression analyses showed a high goodness of fit (R-2 > 0.93) and small standard errors of estimate (SEE < 5%1-RM) both in the bilateral and unilateral leg extension when individual load-velocity regressions for each participant were computed. Unilateral load velocity relationships showed significant differences in the intercept of the regression line with the Y-axis and the velocity at each percentage of the 1-RM (Cohen's d>1.0, p<0.05). Finally, non-significant differences were observed between actual and estimated 1-RM from the load-velocity relationships (r=0.88.0-96, Cohen's d<0.2, p>0.05). Conclusions This proof of concept highlights that computing load-velocity relationships in a machine based, single-joint, angular exercise can be appropriately performed by measuring the mean vertical velocity of the weight plates. These results could help strength and conditioning researchers and coaches who wish to analyze load-velocity relationship in other common machine-based exercises.	[Balsalobre-Fernandez, Carlos] Autonomous Univeris Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain; [Cardiel-Garcia, Mario; Jimenez, Sergio L.] European Univ Madrid, Sch Sports Sci, Madrid, Spain	European University of Madrid	Balsalobre-Fernandez, C (corresponding author), Autonomous Univeris Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain.	carlos.balsalobre@icloud.com	Jiménez, Sergio L./AAD-2148-2020	Jiménez, Sergio L./0000-0002-5069-6099				Balsalobre-Fernandez C, 2021, J STRENGTH COND RES, V35, P724, DOI 10.1519/JSC.0000000000002818; Balsalobre-Fernandez C, 2018, INT J SPORTS SCI COA, V13, P743, DOI 10.1177/1747954117738243; Balsalobre-Fernandez C, 2018, J SPORT SCI, V36, P64, DOI 10.1080/02640414.2017.1280610; Banyard HG, 2019, INT J SPORT PHYSIOL, V14, P246, DOI 10.1123/ijspp.2018-0147; Banyard HG, 2018, INT J SPORT PHYSIOL, V13, P763, DOI 10.1123/ijspp.2017-0610; Banyard HG, 2016, J STRENGTH COND RES, V1, DOI [10.1519/JSC.0000000000001657, DOI 10.1519/JSC.0000000000001]; Bobbert MF, 2012, J APPL PHYSIOL, V112, P1975, DOI 10.1152/japplphysiol.00787.2011; Conceicao F, 2016, J SPORT SCI, V34, P1099, DOI 10.1080/02640414.2015.1090010; Dorrell HF, 2020, J STRENGTH COND RES, V34, P46, DOI 10.1519/JSC.0000000000003089; Garcia-Ramos A, 2021, SPORT BIOMECH, V20, P261, DOI 10.1080/14763141.2018.1544662; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P474, DOI 10.1123/ijspp.2017-0374; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Hernandez-Preciado JA, 2018, J STRENGTH COND RES, V32, P1909, DOI 10.1519/JSC.0000000000002437; Iglesias-Soler E, 2019, SPORT BIOMECH, V18, P174, DOI 10.1080/14763141.2018.1442873; Lake J, 2017, SPORTS, V5, DOI 10.3390/sports5030070; Munoz-Lopez M, 2017, INT J SPORT PHYSIOL, V12, P1249, DOI 10.1123/ijspp.2016-0657; Pareja-Blanco F, 2017, SCAND J MED SCI SPOR, V27, P724, DOI 10.1111/sms.12678; Perez-Castilla A, 2019, J STRENGTH COND RES, DOI [10.1519/JSC.0000000000002968, DOI 10.1519/JSC.0000000000002968]; Rejc E, 2010, EUR J APPL PHYSIOL, V108, P157, DOI 10.1007/s00421-009-1199-y; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Ruf L, 2018, J STRENGTH COND RES, V32, P681, DOI 10.1519/JSC.0000000000002369	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222632	10.1371/journal.pone.0222632	http://dx.doi.org/10.1371/journal.pone.0222632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525245	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700042
J	Zheng, YH; Li, SQ; Xu, SS				Zheng, Yuhua; Li, Shiqi; Xu, Shuangshuang			Transport oil product consumption and GHG emission reduction potential in China: An electric vehicle-based scenario analysis	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; CARBON-DIOXIDE EMISSIONS; CO2 EMISSIONS; ENERGY-CONSUMPTION; ROAD TRANSPORT; DECOMPOSITION ANALYSIS; IMPACTS; ELECTRIFICATION; SECTOR; TERM	China's transport sector is facing enormous challenges from soaring energy consumption and greenhouse gas (GHG) emissions. Transport electrification has been viewed as a major solution to transportation decarbonization, and electric vehicles (EVs) have attracted considerable attention from policymakers. This paper analyzes the effects of the introduction of EVs in China. A system dynamics model is developed and applied to assess the energy -saving and emission -reducing impacts of the projected penetration of EVs until the year 2030. Five types of scenarios of various EV penetration rates, electricity generation mixes, and the speed of technological improvement are discussed. Results confirm that reductions in transport GHG emissions and gasoline and diesel consumption by 3.0%16.2%, 4.4%-16.1%, and 15.8%-34.3%, respectively, will be achieved by 2030 under China's projected EV penetration scenarios. Results also confirm that if EV penetration is accompanied by decarbonized electricity generation, that is, the use of 55% coal by 2030, then total transport GHG emissions will be further reduced by 0.8%-4.4%. Moreover, further reductions of GHG emissions of up to 5.6% could be achieved through technological improvement. The promotion of EVs could substantially affect the reduction of transport GHG emissions in China, despite the uncertainty of the influence intensity, which is dependent on the penetration rate of EVs, the decarbonization of the power sector, and the technological improvement efficiency of EVs and internal combustion engine vehicles.	[Zheng, Yuhua; Li, Shiqi; Xu, Shuangshuang] China Univ Petr, Sch Econ & Management, Beijing, Peoples R China	China University of Petroleum	Zheng, YH (corresponding author), China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.	cupbazyh@163.com		Zheng, Yuhua/0000-0001-7621-744X	China's National Social Science Fund [13ZD159]; Scientific Research Foundation of China University of Petroleum, Beijing [2462015YQ0716]	China's National Social Science Fund; Scientific Research Foundation of China University of Petroleum, Beijing	Y. Z. received the funding (No. 13&ZD159) for this work from China's National Social Science Fund. Y. Z. received the funding (No. 2462015YQ0716) for this work from Scientific Research Foundation of China University of Petroleum, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi P, 2019, J CLEAN PROD, V225, P1209, DOI 10.1016/j.jclepro.2019.03.334; [Anonymous], 2015, CLIMATE CHANGE 2014; BP Group, 2017, EN OUTL; Casals LC, 2016, J CLEAN PROD, V127, P425, DOI 10.1016/j.jclepro.2016.03.120; Dhar S, 2017, J CLEAN PROD, V146, P139, DOI 10.1016/j.jclepro.2016.05.111; Ding Ning, 2015, China Environmental Science, V35, P1592; Doucette RT, 2011, APPL ENERG, V88, P2315, DOI 10.1016/j.apenergy.2011.01.045; Du HB, 2017, J CLEAN PROD, V162, P882, DOI 10.1016/j.jclepro.2017.06.054; Eom J, 2012, ENERG POLICY, V45, P327, DOI 10.1016/j.enpol.2012.02.040; Geng Y, 2013, J CLEAN PROD, V58, P82, DOI 10.1016/j.jclepro.2013.06.034; Green F., 2015, CTR CLIMATE CHANGE E, V3, P4408; [郭栋 Guo Dong], 2016, [系统工程理论与实践, Systems Engineering-Theory & Practice], V36, P1593; Hofmann J, 2016, APPL ENERG, V184, P995, DOI 10.1016/j.apenergy.2016.06.042; Huo H, 2015, ATMOS ENVIRON, V108, P107, DOI 10.1016/j.atmosenv.2015.02.073; Huo H, 2012, ENERG POLICY, V43, P37, DOI 10.1016/j.enpol.2011.09.065; IEA, 2017, GLOBAL EV OUTLOOK 20; International Energy Agency, 2016, WORLD EN OUTL 2016; Jiang Zi-ying, 2015, China Environmental Science, V35, P3502; Kamiya G, 2019, TRANSPORT RES D-TR E, V69, P209, DOI 10.1016/j.trd.2019.01.027; Sumabat AK, 2016, APPL ENERG, V164, P795, DOI 10.1016/j.apenergy.2015.12.023; Lang JL, 2013, ENERGIES, V6, P2663, DOI 10.3390/en6052663; Liao Xia-wei, 2013, China Environmental Science, V33, P553; Liao Xiawei, 2013, Acta Scientiarum Naturalium Universitatis Pekinensis, V49, P885; Lin BQ, 2017, J CLEAN PROD, V150, P175, DOI 10.1016/j.jclepro.2017.02.171; Liu CQ, 2018, REPORT DEV NATL INT; [刘胜强 Liu Shengqiang], 2012, [气候变化研究进展, Advances in Climate Change Research], V8, P48; Liu T, 2018, ENERGY, V160, P544, DOI 10.1016/j.energy.2018.07.022; Liu T, 2018, IEEE T IND INFORM, V14, P1616, DOI 10.1109/TII.2018.2797322; Liu TJ, 2020, IEEE J EM SEL TOP P, V8, P893, DOI 10.1109/JESTPE.2019.2897764; Liu T, 2018, IEEE INT CON AUTO SC, P1, DOI 10.1109/COASE.2018.8560378; Liu Z, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-662-52864-8; Lu IJ, 2007, ENERG POLICY, V35, P3226, DOI 10.1016/j.enpol.2006.11.003; Luo X, 2017, ENERG POLICY, V107, P658, DOI 10.1016/j.enpol.2017.02.049; Mattila T, 2011, ENERG POLICY, V39, P1241, DOI 10.1016/j.enpol.2010.11.051; Ministry of Ecology and Environment of China, 2017, CHIN VEH ENV MAN ANN, V6, P3; Ministry of Industry and Information Technology of the People's Republic of China, 2018, INF DISCL CAT; Ministry of Industry and Information Technology P, CHIN AUT FUEL CONS Q; Mustapa SI, 2016, ENERG POLICY, V89, P171, DOI 10.1016/j.enpol.2015.11.016; Nanaki EA, 2016, RENEW ENERG, V99, P1153, DOI 10.1016/j.renene.2016.08.006; National Bureau of Statistics of China, 2018, CHIN STAT YB 2017; National Bureau of Statistics of People's Republic of China, 1990, CHIN EN STAT YB 1990; National Development and Reform Commission, 2015, GUID DEV REF COMM GU; Ong HC, 2011, RENEW SUST ENERG REV, V15, P3516, DOI 10.1016/j.rser.2011.05.006; Palencia JCG, 2016, APPL ENERG, V181, P96, DOI 10.1016/j.apenergy.2016.08.045; Pasaoglu G, 2012, ENERG POLICY, V40, P404, DOI 10.1016/j.enpol.2011.10.025; Pietzcker RC, 2014, ENERGY, V64, P95, DOI 10.1016/j.energy.2013.08.059; Pongthanaisawan J, 2013, APPL ENERG, V101, P288, DOI 10.1016/j.apenergy.2011.09.026; Qiao QY, 2017, APPL ENERG, V204, P1399, DOI 10.1016/j.apenergy.2017.05.041; Rangaraju S, 2015, APPL ENERG, V148, P496, DOI 10.1016/j.apenergy.2015.01.121; Teixeira ACR, 2016, ENERGY, V115, P1617, DOI 10.1016/j.energy.2016.07.095; Ruhnau O, 2019, ENERGY, V166, P989, DOI 10.1016/j.energy.2018.10.114; Shen W, 2014, ENVIRON SCI TECHNOL, V48, P7069, DOI 10.1021/es500524e; Society of Automotive Engineers of China, 2016, EN SAV NEW EN VEH TE; Tremblay A, 2006, INT J HYDROPOWER DAM, V13, P103; Trost T, 2017, ENERGY, V141, P1215, DOI 10.1016/j.energy.2017.10.006; Upadhyayula VKK, 2019, J CLEAN PROD, V209, P1604, DOI 10.1016/j.jclepro.2018.11.153; Wang N, 2018, ENERGY, V162, P841, DOI 10.1016/j.energy.2018.08.054; Wang Q., 2010, 2010 ENERGY DATA; Wang Y, 2016, RENEWABLE ENERGY RES, V34, P1032; Watabe A, 2019, ENERG POLICY, V130, P227, DOI 10.1016/j.enpol.2019.03.057; Weisser D, 2007, ENERGY, V32, P1543, DOI 10.1016/j.energy.2007.01.008; Wolfram P, 2017, APPL ENERG, V206, P531, DOI 10.1016/j.apenergy.2017.08.219; Wood R, 2009, ENERG POLICY, V37, P4943, DOI 10.1016/j.enpol.2009.06.060; Wu T, 2014, SUSTAINABILITY-BASEL, V6, P4877, DOI 10.3390/su6084877; Wu Y, 2012, ENERG POLICY, V48, P537, DOI 10.1016/j.enpol.2012.05.060; Yang Y, 2017, ENERG POLICY, V107, P561, DOI 10.1016/j.enpol.2017.05.021; Yin X, 2015, ENERG POLICY, V82, P233, DOI 10.1016/j.enpol.2015.03.021; Zhang HJ, 2016, APPL ENERG, V162, P1505, DOI 10.1016/j.apenergy.2015.08.124; Zhang LL, 2019, J CLEAN PROD, V207, P569, DOI 10.1016/j.jclepro.2018.10.003; Zhang M, 2011, APPL ENERG, V88, P2279, DOI 10.1016/j.apenergy.2010.12.077; Zhang X, 2017, GLOBAL ENVIRON CHANG, V44, P83, DOI 10.1016/j.gloenvcha.2017.03.003; Zhao FQ, 2019, J CLEAN PROD, V207, P702, DOI 10.1016/j.jclepro.2018.10.046; Zheng YH, 2013, ENERGY, V57, P336, DOI 10.1016/j.energy.2013.05.004	73	7	7	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222448	10.1371/journal.pone.0222448	http://dx.doi.org/10.1371/journal.pone.0222448			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525217	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700028
J	Blasius, TL; Takao, D; Verhey, KJ				Blasius, T. Lynne; Takao, Daisuke; Verhey, Kristen J.			NPHP proteins are binding partners of nucleoporins at the base of the primary cilium	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; PERMEABILITY BARRIER; INV COMPARTMENT; CILIARY ENTRY; TRANSPORT; DISEASE; INVERSIN; SIGNAL; GENES; LOCALIZATION	Cilia are microtubule-based organelles that protrude from the surface of eukaryotic cells to generate motility and to sense and respond to environmental cues. In order to carry out these functions, the complement of proteins in the cilium must be specific for the organelle. Regulation of protein entry into primary cilia has been shown to utilize mechanisms and components of nuclear gating, including nucleoporins of the nuclear pore complex (NPC). We show that nucleoporins also localize to the base of motile cilia on the surface of trachea epithelial cells. How nucleoporins are anchored at the cilium base has been unclear as transmembrane nucleoporins, which anchor nucleoporins at the nuclear envelope, have not been found to localize at the cilium. Here we use the directed yeast two-hybrid assay to identify direct interactions between nucleoporins and nephronophthisis proteins (NPHPs) which localize to the cilium base and contribute to cilium assembly and identity. We validate NPHP-nucleoporin interactions in mammalian cells using the knocksideways assay and demonstrate that the interactions occur at the base of the primary cilium using bimolecular fluorescence complementation. We propose that NPHP proteins anchor nucleoporins at the base of primary cilia to regulate protein entry into the organelle.	[Blasius, T. Lynne; Takao, Daisuke; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu	Takao, Daisuke/U-1849-2019	Takao, Daisuke/0000-0001-6136-6733	National Institutes of Health [R01GM116204]; Japan Society for the Promotion of Science; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK092926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health to KJV (R01GM116204) and a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science to DT. The work was supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Apelt L, 2016, MOL CELL PROTEOMICS, V15, P2594, DOI 10.1074/mcp.M115.054627; Baade I, 2019, CURR OPIN CELL BIOL, V58, P1, DOI 10.1016/j.ceb.2018.11.004; Borlido J, 2014, CELL CYCLE, V13, P14, DOI 10.4161/cc.27299; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Chatel G, 2011, CELL SIGNAL, V23, P1555, DOI 10.1016/j.cellsig.2011.05.023; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; del Viso F, 2016, DEV CELL, V38, P478, DOI 10.1016/j.devcel.2016.08.002; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Elliott KH, 2019, DEV BIOL, V447, P28, DOI 10.1016/j.ydbio.2018.03.007; Endicott SJ, 2018, CURR BIOL, V28, P1643, DOI 10.1016/j.cub.2018.04.014; Endicott SJ, 2015, DEVELOPMENT, V142, P4068, DOI 10.1242/dev.126953; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Floch AG, 2014, METHOD CELL BIOL, V122, P1, DOI 10.1016/B978-0-12-417160-2.00001-1; Fukui H, 2012, FEBS LETT, V586, P2273, DOI 10.1016/j.febslet.2012.05.064; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Garcia-Gonzalo FR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028134; Goncalves J, 2017, MOL CELLS, V40, P243, DOI 10.14348/molcells.2017.0054; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hampoelz B, 2019, ANNU REV BIOPHYS, V48, P515, DOI 10.1146/annurev-biophys-052118-115308; Han YH, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002063; Hayama R, 2017, CURR OPIN CELL BIOL, V46, P110, DOI 10.1016/j.ceb.2017.05.003; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Hua Kiet, 2017, Cilia, V6, P5, DOI 10.1186/s13630-017-0045-9; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Jensen VL, 2017, CURR OPIN CELL BIOL, V47, P83, DOI 10.1016/j.ceb.2017.03.012; Johnson CA, 2019, DEV CELL, V49, P161, DOI 10.1016/j.devcel.2019.03.009; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; Lin DH, 2019, ANN REV BIOCH; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/NCHEMBIO.1252, 10.1038/nchembio.1252]; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Lu L, 2018, CELL MOL LIFE SCI, V75, P597, DOI 10.1007/s00018-017-2629-3; Madugula V, 2016, J CELL SCI, V129, P3922, DOI 10.1242/jcs.194019; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Matsuura Y, 2016, J MOL BIOL, V428, P2025, DOI 10.1016/j.jmb.2015.09.025; McClure-Begley Tristan D, 2017, Cilia, V6, P8, DOI 10.1186/s13630-017-0052-x; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Mossaid I, 2015, CELLS-BASEL, V4, P706, DOI 10.3390/cells4040706; Nakajima Y, 2018, KIDNEY INT, V93, P1108, DOI 10.1016/j.kint.2017.11.016; Nakano H, 2011, CELL CYCLE, V10, P425, DOI 10.4161/cc.10.3.14721; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pascual-Garcia P, 2019, CURR OPIN CELL BIOL, V58, P126, DOI 10.1016/j.ceb.2019.04.001; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Robinson M.S., 2013, CURR PROTOC CELL BIO, V61, P11; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Schwartz M, 2015, NUCLEUS-PHILA, V6, P40, DOI 10.1080/19491034.2015.1004260; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Takao D, 2017, CURR BIOL, V27, P2296, DOI 10.1016/j.cub.2017.06.044; Takao D, 2014, CURR BIOL, V24, P2288, DOI 10.1016/j.cub.2014.08.012; Torrado B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162033; Tsuji T, 2016, CYTOSKELETON, V73, P45, DOI 10.1002/cm.21264; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; Warburton-Pitt SRF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004866; Warburton-Pitt SRF, 2012, J CELL SCI, V125, P2592, DOI 10.1242/jcs.095539; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wiegering A, 2018, EMBO J, V37, DOI 10.15252/embj.201797791	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222924	10.1371/journal.pone.0222924	http://dx.doi.org/10.1371/journal.pone.0222924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD1OG	31553752	Green Published, gold			2022-12-27	WOS:000489743400001
J	Kim, TY; Chang, HE; Lee, SW; Seo, SH; Hong, YJ; Park, JS; Park, KU				Kim, Tae Yeul; Chang, Ho Eun; Lee, Seong-Wook; Seo, Soo Hyun; Hong, Yun Ji; Park, Jeong Su; Park, Kyoung Un			A novel strategy for interpreting the T-SPOT. TB test results read by an ELISPOT plate imager	PLOS ONE			English	Article							ASSAYS; TUBERCULOSIS; VARIABILITY; DIAGNOSIS	Background The T-SPOT.TB can be read by an ELISPOT plate imager as an alternative to a labor-intensive and time-consuming manual reading, but its accuracy has not been sufficiently discussed to date. Methods 1,423 test results obtained from manual reading using a microscope and an ELISPOT plate imager were compared. The agreement of qualitative test results was assessed using Cohen's kappa coefficient. The relationship of spot counts was studied using Bland-Altman analysis. Results The overall percent agreement of the qualitative test results was 95.43% with a kappa coefficient of 0.91. Positive test results with the maximum net spot count of 8 and borderline test results showed relatively high discordance. The agreement of spot counts in panel A, panel B, and nil control was good, and variability did not increase with higher spot counts. On the basis of study findings, a novel strategy for interpreting the test results by an ELISPOT plate imager was proposed. Conclusions To increase diagnostic accuracy, positive test results with the maximum net spot count of 8 and borderline test results should be manually confirmed. Our strategy could be a practical guide for laboratories to build their own strategies for interpreting the test results by an ELISPOT plate imager.	[Kim, Tae Yeul; Chang, Ho Eun; Seo, Soo Hyun; Hong, Yun Ji; Park, Jeong Su; Park, Kyoung Un] Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea; [Chang, Ho Eun; Lee, Seong-Wook] Dankook Univ, Dept Mol Biol, Yongin, Gyeonggi Do, South Korea; [Hong, Yun Ji; Park, Kyoung Un] Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Dankook University; Seoul National University (SNU)	Park, KU (corresponding author), Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea.; Park, KU (corresponding author), Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul, South Korea.	m91w95pf@snu.ac.kr	Park, Kyoung Un/J-5473-2012	Park, Kyoung Un/0000-0002-2402-7633; Lee, Seong-Wook/0000-0003-1718-7601; Kim, Tae Yeul/0000-0002-6405-5305				Agarwal S, 2016, TUBERCULOSIS, V101, pS92, DOI 10.1016/j.tube.2016.09.013; Al-Orainey IO, 2009, ANN THORAC MED, V4, P5, DOI 10.4103/1817-1737.44778; [Anonymous], 2018, LAT TUB INF UPD CONS; [Anonymous], 2018, GLOB TUB REP 2018; Ashoor I, 2013, AM J TRANSPLANT, V13, P1871, DOI 10.1111/ajt.12286; De Rose R, 2005, J IMMUNOL METHODS, V297, P177, DOI 10.1016/j.jim.2004.12.009; Doan TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188631; Franken WPJ, 2009, CLIN VACCINE IMMUNOL, V16, P1439, DOI 10.1128/CVI.00456-08; Hawkins N, 2006, J IMMUNOL METHODS, V316, P52, DOI 10.1016/j.jim.2006.08.005; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Janetzki S, 2004, J IMMUNOL METHODS, V291, P175, DOI 10.1016/j.jim.2004.06.008; Janetzki S, 2015, NAT PROTOC, V10, P1098, DOI 10.1038/nprot.2015.068; King TC, 2015, AM J RESP CRIT CARE, V192, P367, DOI 10.1164/rccm.201501-0199OC; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rego K, 2018, TUBERCULOSIS, V108, P178, DOI 10.1016/j.tube.2017.12.005; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Sundararaman S, 2015, CELLS-BASEL, V4, P21, DOI 10.3390/cells4010021; Tang Patrick, 2017, Curr Treat Options Infect Dis, V9, P371, DOI 10.1007/s40506-017-0135-7; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222920	10.1371/journal.pone.0222920	http://dx.doi.org/10.1371/journal.pone.0222920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553764	Green Published, gold			2022-12-27	WOS:000532319200044
J	Mekanda, FMO; Monamele, CG; Nemg, FBS; Yonga, GM; Ouapi, D; Beng, VP; Batejat, C; Caro, V; Manuguerra, JC; Demanou, M				Mekanda, Franck-Martin Obam; Monamele, Chavely Gwladys; Nemg, Fredy Brice Simo; Yonga, Gilde Martial; Ouapi, Diane; Beng, Veronique Penlap; Batejat, Christophe; Caro, Valerie; Manuguerra, Jean-Claude; Demanou, Maurice			Molecular characterization of measles virus strains circulating in Cameroon during the 2013-2016 epidemics	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; ELIMINATION; WORLDWIDE; GENOTYPES; PROGRESS	The first genotyping data on measles virus (MeV) strains in Cameroon dates from 1994, while other studies were realized in 2001 and 2011 with the establishment of MeV virological surveillance. However, the genetic data of MeV strains circulating in Cameroon remains fragmented and concentrated in certain regions, hence the need for an update. The objective of this study was to have recent data on MeV genotypes circulating in Cameroon. Ninety throat swabs collected during recent measles outbreaks were analyzed by MeV genotyping RT-PCR using the nucleoprotein gene N. The resulting sequences were analyzed on the basis of 450 nucleotides with MEGA 7 software. Overall genome analysis was performed on 40/90 sequences. The strains were from all ten regions and all belonged to cluster 1 of genotype B3. The genotype B3 has been circulating in Cameroon for long periods of time; efforts must be made in immunization for its elimination.	[Mekanda, Franck-Martin Obam; Monamele, Chavely Gwladys; Nemg, Fredy Brice Simo; Yonga, Gilde Martial; Ouapi, Diane; Demanou, Maurice] Ctr Pasteur Cameroon CPC, Dept Virol, WHO Natl Measles Reference Lab, Yaounde, Centre, Cameroon; [Mekanda, Franck-Martin Obam; Beng, Veronique Penlap] Univ Yaounde I, Fac Sci, Yaounde, Centre, Cameroon; [Batejat, Christophe; Caro, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infecti, Cellule Intervent Biol Urgence CIBU, Paris, France	University of Yaounde I; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Demanou, M (corresponding author), Ctr Pasteur Cameroon CPC, Dept Virol, WHO Natl Measles Reference Lab, Yaounde, Centre, Cameroon.	demanou@pasteur-yaounde.org		Demanou, Maurice/0000-0002-9275-0874; Batejat, Christophe/0000-0002-2344-5710				Alla A, 2006, J MED VIROL, V78, P1465, DOI 10.1002/jmv.20720; Dabbagh A, 2017, MMWR-MORBID MORTAL W, V66, P1148, DOI 10.15585/mmwr.mm6642a6; Demanou M, 2013, VIROL J VIROLOGY J, V10, P1; El Mubarak HS, 2002, J GEN VIROL, V83, P1437, DOI 10.1099/0022-1317-83-6-1437; Eom H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188957; Focus E., 2016, WKLY EPIDEMIOL REC, V21, P265; Gouandjika-Vasilache I, 2006, J MED VIROL, V78, P964, DOI 10.1002/jmv.20648; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; Haddad-Boubaker S, 2010, VIRUS RES, V153, P258, DOI 10.1016/j.virusres.2010.08.011; Hanses F, 1999, J GEN VIROL, V80, P871, DOI 10.1099/0022-1317-80-4-871; HEYMANN DL, 1983, LANCET, V2, P1470; Heymann DL, 1979, YALE J BIOL MED, P1979; Kouomou DW, 2002, J MED VIROL, V68, P433, DOI 10.1002/jmv.10222; Lacroix L, 2008, Rev Med Suisse, V4, P920; Mahamud A, 2013, CLIN INFECT DIS, V57, pE160, DOI 10.1093/cid/cit442; MCBEAN AM, 1976, T ROY SOC TROP MED H, V70, P206, DOI 10.1016/0035-9203(76)90040-7; Mulders MN, 2016, MMWR-MORBID MORTAL W, V65, P438, DOI 10.15585/mmwr.mm6517a3; Ndombo PK, 2018, MOL CHARACTERISATION; Patel MK, 2016, MMWR-MORBID MORTAL W, V65, P1228, DOI 10.15585/mmwr.mm6544a6; Plan S., 2012, GALAXY CLUSTERS GIAN, P44; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Salvi C, 2018, EUROPE OBSERVES 4 FO, P2017; World Health Organization, 2016, WEEKLY EPIDEMIOLOGIC, V91, P287, DOI DOI 10.1186/1750-9378-2-15.VOIR	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222428	10.1371/journal.pone.0222428	http://dx.doi.org/10.1371/journal.pone.0222428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553766	Green Published, gold			2022-12-27	WOS:000532319200026
J	Van Beveren, E; Duplisea, DE; Brosset, P; Castonguay, M				Van Beveren, Elisabeth; Duplisea, Daniel E.; Brosset, Pablo; Castonguay, Martin			Assessment modelling approaches for stocks with spawning components, seasonal and spatial dynamics, and limited resources for data collection	PLOS ONE			English	Article							POPULATION-DYNAMICS; ATLANTIC COD; MANAGEMENT; CATCH; CONSEQUENCES; FISHERY; METAPOPULATIONS; CONNECTIVITY; PRODUCTIVITY; UNCERTAINTY	The true spatiotemporal structure of a fish population is often more complex than represented in assessments because movement between spawning components is disregarded and data at the necessary scale are unavailable. This can generate poor advice. We explore the impacts of modelling choices and their associated risks given limited data and lack of biological knowledge on spawning component structure and connectivity. Pseudo-data for an age structured fish population were simulated with two spawning components that experience various levels of connectivity and that might overlap during a certain period but segregate during reproduction. A variety of implicit spatiotemporal and simpler models were fitted to the pseudo-datasets, mimicking different situations of data availability. To reproduce the true stock characteristics, the spatiotemporal models required total catch data disaggregated by spawning component; however, catch-at-age was not as important nor were disaggregated biomass indices to reproduce true dynamics. Even with just 5% connectivity between spawning components, both the spatiotemporal models and simpler alternatives generally overestimated stock biomass. Although bias was smallest when considering one unit population, spawning components might still need to be considered for management and conservation. In such case, the spatiotemporal model was less influenced by ignored connectivity patterns compared to a model focussing on one spawning component only.	[Van Beveren, Elisabeth; Duplisea, Daniel E.; Brosset, Pablo; Castonguay, Martin] Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ, Canada	Fisheries & Oceans Canada	Van Beveren, E (corresponding author), Fisheries & Oceans Canada, Inst Maurice Lamontagne, Mont Joli, PQ, Canada.	elisabeth.vanbeveren@dfo-mpo.gc.ca	Brosset, Pablo/AAA-3148-2021	Brosset, Pablo/0000-0002-2561-6560; Duplisea, Daniel/0000-0002-0844-359X; Van Beveren, Elisabeth/0000-0002-9378-0215	DFO through an NSERC (Natural Sciences and Engineering Research Council of Canada)	DFO through an NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by DFO through an NSERC (Natural Sciences and Engineering Research Council of Canada) visiting fellowship to EVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Berger AM, 2017, CAN J FISH AQUAT SCI, V74, P1698, DOI 10.1139/cjfas-2017-0150; Bousquet N, 2010, CAN J FISH AQUAT SCI, V67, P1247, DOI 10.1139/F10-051; Cadigan N.G., 2016, 2016022 DFO CAN SCI, P58; Cadigan NG, 2016, CAN J FISH AQUAT SCI, V73, P296, DOI 10.1139/cjfas-2015-0047; Cadrin SX, 2013, STOCK IDENTIFICATION; Cao J, 2014, ICES J MAR SCI, V71, P1443, DOI 10.1093/icesjms/fsu066; Casey J, 2016, J FISH BIOL, V89, P2755, DOI 10.1111/jfb.13151; Cope JM, 2011, FISH RES, V107, P22, DOI 10.1016/j.fishres.2010.10.002; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; DFO, 2019, 201430 DFO, P16; DFO, 2014, 2014030 DFO, P16; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; Fu CH, 2004, N AM J FISH MANAGE, V24, P775, DOI 10.1577/M03-134.1; Goethel DR, 2017, CAN J FISH AQUAT SCI, V74, P1878, DOI 10.1139/cjfas-2016-0290; Goethel DR, 2015, CAN J FISH AQUAT SCI, V72, P582, DOI 10.1139/cjfas-2014-0244; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Guan WJ, 2013, CAN J FISH AQUAT SCI, V70, P1178, DOI 10.1139/cjfas-2012-0364; Gudmundsson G, 2012, CAN J FISH AQUAT SCI, V69, P1760, DOI 10.1139/F2012-095; Hammond TR, 2005, ICES J MAR SCI, V62, P1118, DOI 10.1016/j.icesjms.2005.04.015; Hart Deborah R., 2004, P230; He X, 2011, FISH B-NOAA, V109, P198; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Hurtado-Ferro F, 2014, FISH RES, V158, P102, DOI 10.1016/j.fishres.2013.10.001; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kerr L.A., 2014, STOCK IDENTIFICATION, DOI DOI 10.1016/B978-0-12-397003-9.00021-7; Kerr LA, 2017, CAN J FISH AQUAT SCI, V74, P1990, DOI 10.1139/cjfas-2016-0067; Kerr LA, 2014, ICES J MAR SCI, V71, P1366, DOI 10.1093/icesjms/fsu113; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Kristensen K, 2016, J STAT SOFTW, V70, P1; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Little LR, 2017, CAN J FISH AQUAT SCI, V74, P1950, DOI 10.1139/cjfas-2016-0349; Liu XZ, 2014, CAN J FISH AQUAT SCI, V71, P181, DOI 10.1139/cjfas-2013-0029; Maunder MN, 2008, WORKSH SPAT AN STOCK, P21; McGilliard CR, 2015, CAN J FISH AQUAT SCI, V72, P262, DOI 10.1139/cjfas-2013-0364; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Porch Clay, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P591; Punt AE, 2016, FISH RES, V175, P10, DOI 10.1016/j.fishres.2015.11.008; Punt AE, 2016, FISH FISH, V17, P303, DOI 10.1111/faf.12104; Punt AE, 2015, FISH RES, V168, P85, DOI 10.1016/j.fishres.2015.04.002; Redding SG, NW ATLANTIC MACKEREL; Rudd MB, 2017, FISH FISH, V18, P313, DOI 10.1111/faf.12181; Secor DH, 2009, ICES J MAR SCI, V66, P1726, DOI 10.1093/icesjms/fsp154; Shepherd JG, 2008, HDB FISH BIOL FISHER, V2, P127, DOI [10.1002/9780470693919.ch7, DOI 10.1002/9780470693919.CH7]; TRAC (Transboundary Resources Assessment Committee), 2010, 201001 TRAC; Van Beveren E, 2017, FISH RES, V194, P146, DOI 10.1016/j.fishres.2017.05.015; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222472	10.1371/journal.pone.0222472	http://dx.doi.org/10.1371/journal.pone.0222472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545816	Green Published, gold			2022-12-27	WOS:000532303200017
J	Ejiri, M; Kawai, H; Fujiwara, Y; Ihara, K; Watanabe, Y; Hirano, H; Kim, HK; Ishii, K; Oka, K; Obuchi, S				Ejiri, Manami; Kawai, Hisashi; Fujiwara, Yoshinori; Ihara, Kazushige; Watanabe, Yutaka; Hirano, Hirohiko; Kim, Hun Kyung; Ishii, Kaori; Oka, Koichiro; Obuchi, Shuichi			Social participation reduces isolation among Japanese older people in urban area: A 3-year longitudinal study	PLOS ONE			English	Article							HEALTH-RISK APPRAISAL; INSTRUMENTAL ACTIVITIES; MORTALITY; COMMUNITY; LONELINESS; DEMENTIA; ASSOCIATION; LEISURE; NETWORK	Objectives Social isolation is a particular problem among older people and social participation may reduce future isolation. However, it is unclear which types of activities and which level of participation are effective. This study examines the relationship between social participation and isolation among Japanese older people by employing a 3-year longitudinal study. Methods A mail survey was sent to 3,518 community-dwelling older people in an urban area in 2014 (baseline: BL). We then conducted follow-up mail survey on respondents who were non-isolated at BL in 2017 (follow-up: FL), with isolation being defined as being in contact with others less than once a week. An analysis was carried out on 1,070 subjects (398 men and 672 women). Social participation is defined by participation in group activities (community, senior club, hobbies, sports, volunteering, politics, industry, and religion). A logistic regression analysis was conducted to determine the association between the types of social participation and the number of organization types at BL, and isolation at FL. Results At FL, 75 men (18.8%) and 59 women (8.8%) were considered to be isolated. Among the men, participation in a hobby group and sports group both significantly reduced the degree of isolation. Moreover, participation in two organizations and three or more organizations significantly lowered the risk of isolation when compared to non-participants. Among women, there were no significant associations among particular types of social activities and isolation. On the other hand, participation in one organization and three or more organizations significantly reduced their isolation when compared to non-participants. There was a significant linear trend between the number of types of organizations and isolation, regardless of gender. Conclusions Participation in social activities reduces future isolation in older people. Encouraging participation in social activities could help reduce negative health outcomes associated with social isolation later in life.	[Ejiri, Manami; Kawai, Hisashi; Fujiwara, Yoshinori; Watanabe, Yutaka; Hirano, Hirohiko; Kim, Hun Kyung; Obuchi, Shuichi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Ejiri, Manami] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Ihara, Kazushige] Hirosaki Univ, Fac Med, Aomori, Japan; [Ishii, Kaori; Oka, Koichiro] Waseda Univ, Fac Sport Sci, Saitama, Japan	Tokyo Metropolitan Institute of Gerontology; Waseda University; Hirosaki University; Waseda University	Ejiri, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.; Ejiri, M (corresponding author), Waseda Univ, Grad Sch Sport Sci, Saitama, Japan.	ejiri@tmig.or.jp		Oka, Koichiro/0000-0001-5571-042X; Kawai, Hisashi/0000-0003-3015-6041; Ejiri, Manami/0000-0003-3544-4587	2017 Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [39-64]; 2017 Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology (NCGG), Japan [28-30, 29-42]	2017 Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); 2017 Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology (NCGG), Japan	This work was supported by the 2017 Health and Labour Sciences Research Grants (grant number 39-64) from the Ministry of Health, Labour and Welfare of Japan, as well as the 2017 Research Funding for Longevity Sciences (grant number 28-30, 29-42) from the National Center for Geriatrics and Gerontology (NCGG), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Amagasa S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175392; Cabinet Office Government of Japan, 2017 SURV HLTH ELD; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Choi H, 2015, WORLD J PSYCHIATR, V5, P432, DOI 10.5498/wjp.v5.i4.432; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; Ejiri Manami, 2018, Nihon Koshu Eisei Zasshi, V65, P125, DOI 10.11236/jph.65.3_125; Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Grenade L, 2008, AUST HEALTH REV, V32, P468, DOI 10.1071/AH080468; Havens B, 2004, CAN J AGING, V23, P129, DOI 10.1353/cja.2004.0022; Hawton A, 2011, QUAL LIFE RES, V20, P57, DOI 10.1007/s11136-010-9717-2; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hsu HC, 2007, AGING MENT HEALTH, V11, P699, DOI 10.1080/13607860701366335; Iliffe S, 2007, BRIT J GEN PRACT, V57, P277; Ito D., 2013, JPN J SOC WELF, V54, P56; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Jang YR, 2016, J AGING HEALTH, V28, P3, DOI 10.1177/0898264315584578; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kharicha K, 2007, BRIT J GEN PRACT, V57, P271; Kishimoto Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1189; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lam BP, 2018, SOC SCI MED, V208, P200, DOI 10.1016/j.socscimed.2018.05.049; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Murata C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070717; Nicholson NR, 2012, J PRIM PREV, V33, P137, DOI 10.1007/s10935-012-0271-2; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; Saito M., 2013, JAPANESE J GERONTOLO, V35, P331; Saito Masashige, 2015, Nihon Koshu Eisei Zasshi, V62, P95, DOI 10.11236/jph.62.3_95; Saito Masashige, 2010, Nihon Koshu Eisei Zasshi, V57, P785; Saito Tami, 2015, Nihon Koshu Eisei Zasshi, V62, P596, DOI 10.11236/jph.62.10_596; Shimada K, 2014, J AGING HEALTH, V26, P807, DOI 10.1177/0898264314531616; Shinkai Shoji, 2005, Nihon Koshu Eisei Zasshi, V52, P443; Smith SG, 2018, HEALTH PSYCHOL, V37, P160, DOI 10.1037/hea0000541; Smith TF, 2009, INT PSYCHOGERIATR, V21, P50, DOI 10.1017/S1041610208007850; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Sun W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-297; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Toepoel V, 2013, SOC INDIC RES, V113, P355, DOI 10.1007/s11205-012-0097-6; Tomioka K, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0502-8; Tomioka K, 2017, J AM GERIATR SOC, V65, P107, DOI 10.1111/jgs.14447; Tomioka K, 2016, J EPIDEMIOL, V26, P553, DOI 10.2188/jea.JE20150253; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Yamakita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141638	46	24	24	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222887	10.1371/journal.pone.0222887	http://dx.doi.org/10.1371/journal.pone.0222887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539403	Green Published, gold			2022-12-27	WOS:000532297900038
J	Jarret, T; Stockert, A; Kotz, SA; Tillmann, B				Jarret, Tatiana; Stockert, Anika; Kotz, Sonja A.; Tillmann, Barbara			Implicit learning of artificial grammatical structures after inferior frontal cortex lesions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BROCAS AREA; BASAL GANGLIA; COGNITIVE CONTROL; CHUNK STRENGTH; NEURAL BASIS; BRAIN BASIS; LANGUAGE; SYNTAX; ERP	Objective Previous research associated the left inferior frontal cortex with implicit structure learning. The present study tested patients with lesions encompassing the left inferior frontal gyrus (LIFG; including Brodmann areas 44 and 45) to further investigate this cognitive function, notably by using non-verbal material, implicit investigation methods, and by enhancing potential remaining function via dynamic attending. Patients and healthy matched controls were exposed to an artificial pitch grammar in an implicit learning paradigm to circumvent the potential influence of impaired language processing. Methods Patients and healthy controls listened to pitch sequences generated within a finite-state grammar (exposure phase) and then performed a categorization task on new pitch sequences (test phase). Participants were not informed about the underlying grammar in either the exposure phase or the test phase. Furthermore, the pitch structures were presented in a highly regular temporal context as the beneficial impact of temporal regularity (e.g. meter) in learning and perception has been previously reported. Based on the Dynamic Attending Theory (DAT), we hypothesized that a temporally regular context helps developing temporal expectations that, in turn, facilitate event perception, and thus benefit artificial grammar learning. Results Electroencephalography results suggest preserved artificial grammar learning of pitch structures in patients and healthy controls. For both groups, analyses of event-related potentials revealed a larger early negativity (100-200 msec post-stimulus onset) in response to ungrammatical than grammatical pitch sequence events. Conclusions These findings suggest that (i) the LIFG does not play an exclusive role in the implicit learning of artificial pitch grammars, and (ii) the use of non-verbal material and an implicit task reveals cognitive capacities that remain intact despite lesions to the LIFG. These results provide grounds for training and rehabilitation, that is, learning of non-verbal grammars that may impact the relearning of verbal grammars.	[Jarret, Tatiana; Tillmann, Barbara] Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, U1028, INSERM,CNRS,UMR5292, Villeurbanne, France; [Jarret, Tatiana; Tillmann, Barbara] Univ Lyon 1, Villeurbanne, France; [Stockert, Anika] Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol, Maastricht, Netherlands; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Psychopharmacol, Maastricht, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Leipzig University; Max Planck Society; Maastricht University; Maastricht University	Tillmann, B (corresponding author), Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, U1028, INSERM,CNRS,UMR5292, Villeurbanne, France.; Tillmann, B (corresponding author), Univ Lyon 1, Villeurbanne, France.	Barbara.Tillmann@cnrs.fr		Stockert, Anika/0000-0001-5804-2498	EBRAMUS ITN [238157]; LabEx CeLyA ("Centre Lyonnais d'Acoustique") [ANR-10-LABX-60]	EBRAMUS ITN; LabEx CeLyA ("Centre Lyonnais d'Acoustique")	This research was supported by a grant from EBRAMUS ITN to BT and SAK (Europe BRAin and MUSic) (Grant Agreement number 238157). The team "Auditory cognition and psychoacoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", grant ANR-10-LABX-60 to BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from EBRAMUS ITN to BT and SAK (Europe BRAin and MUSic) (Grant Agreement number 238157). The team "Auditory cognition and psycho acoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", ANR-10-LABX-60). We thank Ina Koch for her help in EEG recordings.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ALTMANN GTM, 1995, J EXP PSYCHOL LEARN, V21, P899, DOI 10.1037/0278-7393.21.4.899; Antonenko D, 2012, NEUROIMAGE, V62, P1667, DOI 10.1016/j.neuroimage.2012.05.074; Bigand E, 1998, CAH PSYCHOL COGN, V17, P577; BRUNNER RJ, 1982, BRAIN LANG, V16, P281, DOI 10.1016/0093-934X(82)90087-6; Carrion RE, 2007, NEUROREPORT, V18, P191, DOI 10.1097/WNR.0b013e328011b8ae; Christiansen MH, 2010, COGNITION, V116, P382, DOI 10.1016/j.cognition.2010.05.015; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Cope TE, 2017, NEUROPSYCHOLOGIA, V104, P201, DOI 10.1016/j.neuropsychologia.2017.08.022; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Folia V, 2010, ARTIFICIAL LANGUAGE, P188; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Francois C, 2010, NEUROREPORT, V21, P928, DOI 10.1097/WNR.0b013e32833ddd5e; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2012, PSYCHOL RES-PSYCH FO, V76, P204, DOI 10.1007/s00426-011-0357-0; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Fu QF, 2013, CONSCIOUS COGN, V22, P22, DOI 10.1016/j.concog.2012.10.008; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Goranskaya D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00551; Goschke T, 2001, J COGNITIVE NEUROSCI, V13, P370, DOI 10.1162/08989290151137412; Horvath RA, 2011, LATERALITY, V16, P620, DOI 10.1080/1357650X.2010.515990; Huber W, 1984, Adv Neurol, V42, P291; Jakuszeit M, 2013, CORTEX, V49, P2861, DOI 10.1016/j.cortex.2013.05.014; Jones D, 2009, HASKELL'09: PROCEEDINGS OF THE 2009 ACM SIGPLAN HASKELL SYMPOSIUM, P81; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Juffs A, 2004, T PHILOL SOC, V102, P199, DOI 10.1111/j.0079-1636.2004.00135.x; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; Kotz SA, 2015, CORTEX, V68, P48, DOI 10.1016/j.cortex.2015.02.021; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; McDonald JL, 2006, J MEM LANG, V55, P381, DOI 10.1016/j.jml.2006.06.006; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2007, HUM BRAIN MAPP, V28, P585, DOI 10.1002/hbm.20287; Opitz B, 2012, CORTEX, V48, P664, DOI 10.1016/j.cortex.2011.02.013; Parkinson RB, 2009, BRAIN LANG, V110, P61, DOI 10.1016/j.bandl.2009.05.005; Patel AD, 2008, APHASIOLOGY, V22, P776, DOI 10.1080/02687030701803804; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Roser ME, 2011, J COGNITIVE NEUROSCI, V23, P1088, DOI 10.1162/jocn.2010.21508; Saffran JR, 2003, ANN NY ACAD SCI, V999, P1, DOI [10.1196/annals.1284.001, DOI 10.1196/ANNALS.1284.001]; Sakai K, 1999, J NEUROSCI, V19, P10074; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Schankin A, 2011, NEUROREPORT, V22, P642, DOI 10.1097/WNR.0b013e328349d146; Schuchard J, 2013, J PSYCHOLINGUIST RES, V27, P1; Seger CA, 2000, PSYCHOBIOLOGY, V28, P283; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Selchenkova T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112233; Selchenkova T, 2014, Q J EXP PSYCHOL, V67, P2360, DOI 10.1080/17470218.2014.929155; Shao J., 1995, JACKKNIFE BOOTSTRAP, DOI [DOI 10.1007/978-1-4612-0795-5, 10.1007/978-1-4612-0795-5]; Tettamanti M, 2002, NEUROIMAGE, V17, P700, DOI 10.1006/nimg.2002.1201; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Udden J., 2018, OXFORD HDB PSYCHOLIN, P755, DOI DOI 10.1093/OXFORDHB/9780198786825.013.33; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Ullman MT, 2006, CORTEX, V42, P480, DOI 10.1016/S0010-9452(08)70382-4; Ullman MT, 2005, BRAIN LANG, V93, P185, DOI 10.1016/j.bandl.2004.10.001; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vaquero JMM, 2006, EXP BRAIN RES, V175, P97, DOI 10.1007/s00221-006-0523-6; Vinter A, 1999, Q J EXP PSYCHOL-A, V52, P857, DOI 10.1080/027249899390846; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759	84	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222385	10.1371/journal.pone.0222385	http://dx.doi.org/10.1371/journal.pone.0222385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539390	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900011
J	Grigoriev, O; Doblhammer, G				Grigoriev, Olga; Doblhammer, Gabriele			Changing educational gradient in long-term care-free life expectancy among German men, 1997-2012	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; HEALTH INEQUALITIES; MORTALITY DIFFERENTIALS; SOCIAL DETERMINANTS; OLD-AGE; SWITZERLAND; POPULATION; AUSTRIA; FINLAND; CENSUS	Background The inverse association between mortality and individual socioeconomic status is well-documented. Due to the lack of appropriate data, little is known about the nature of this association among individuals with long-term care (LTC) needs. Objectives We aim to fill in this knowledge gap by estimating life expectancy (LE), life expectancy without (CFLE) and with (CLE) long-term care by education for older German men; and by assessing the trends in the education-LE/CFLE/CLE gradient over time. Data and methods We apply survival analysis and Gompertz regression to German Socioeconomic Panel data (1997-2012) to estimate the mortality levels and to construct the life tables for three educational categories. Using the administrative data from the health insurance, we adjust mortality rates upward to account for the institutionalized population. We estimate age-specific LTC prevalence from the German Microcensus data (2004, 2012) and compute life expectancy with and without LTC by employing Sullivan's method. Slope and Relative Indices of Inequality are computed to evaluate the magnitude of educational inequalities in CFLE. Results There is a clear and growing educational gradient in LE and CFLE among older men in Germany. In 2004, LE at age 65 among men with low education was 14.2 years, or 3.3 years lower than among highly educated individuals. The CFLE of these two educational categories ranged from 13.6 to almost 17 years. The gradient increased over time and in 2012 the difference constituted 4.6 years. The gaps between educational groups were not pronounced for CLE. The declining health ratio of years without LTC to remaining LE suggests the expansion of LTC needs, irrespective of the educational level. Conclusions Growing inequalities by educational status among older German men with care needs demand the attention of policy-makers. Prompt actions are needed to increase the survival chances of the most vulnerable groups.	[Grigoriev, Olga] Max Planck Inst Demog Res, Rostock, Germany; [Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Bonn, Germany; [Doblhammer, Gabriele] German Ctr Neurodegenerat Dis, Bonn, Germany	Max Planck Society; University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Grigoriev, O (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	ogrigoriev@demogr.mpg.de		Grigoriev, Olga/0000-0001-5356-0835; Doblhammer, Gabriele/0000-0001-7746-0652				Abuladze L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013257; Andreev EM, 2010005 MPIDR; [Anonymous], 2013, WHO HDB HLTH INEQUAL; ARBER S, 1993, SOC SCI MED, V36, P33, DOI 10.1016/0277-9536(93)90303-L; Barth A, 2016, EUR REV AGING PHYS A, V13, DOI 10.1186/s11556-016-0169-8; Beckett M, 2000, J HEALTH SOC BEHAV, V41, P106, DOI 10.2307/2676363; BLOSSFELD HP, 1992, J MARRIAGE FAM, V54, P302, DOI 10.2307/353062; Bohacek R, 2015, SHARE WORKING PAPER; Bopp M, 2003, INT J EPIDEMIOL, V32, P346, DOI 10.1093/ije/dyg072; Chiang C.L., 1984, LIFE TABLES ITS APPL; Crimmins EM, 1996, J GERONTOL B-PSYCHOL, V51, pS111, DOI 10.1093/geronb/51B.3.S111; Culter DM, 2006, 12352 NAT BUR EC RES; Culter DM, 2010, 15678 NAT BUR EC RES; de Gelder R, 2017, INT J PUBLIC HEALTH, V62, P127, DOI 10.1007/s00038-016-0922-9; Deboosere P, 2009, EUR J POPUL, V25, P175, DOI 10.1007/s10680-008-9167-5; Doblhammer G, 2005, WIEN KLIN WOCHENSCHR, V117, P468, DOI 10.1007/s00508-005-0393-0; Doblhammer G, 2008, LEBENSERWARTUNG DEUT, P119; Doblhammer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074915; Elo IT, 2006, EUR J POPUL, V22, P179, DOI 10.1007/s10680-006-0003-5; Federal Ministry of Health, PFLEG ZAHL FAKT; Federal Statistical Office of Germany, SCI US FIL 2004 2012; Federal Statistical Office of Germany, 2017, PFLEG 2015 PFLEG RHA; German Institute for Economic Research (DIW), SCI US FIL 1997 2012; Gerstorf D, 2008, DEV PSYCHOL, V44, P1148, DOI 10.1037/0012-1649.44.4.1148; Grigorieva O., 2015, HLTH ELDERLY GERMANY, P91; Haisken-DeNew J, DESKTOP COMPANION SO; Herd P, 2006, RES AGING, V28, P375, DOI 10.1177/0164027505285845; Hoffmann E, 2010, AGEING CARE NEED QUA, P163; Huisman M, 2004, J EPIDEMIOL COMMUN H, V58, P468, DOI 10.1136/jech.2003.010496; Human Mortality Database, 2018, HUM MORTALITY DATAB; Jagger C., 2014, HLTH EXPECTANCY CALC; Jasilionis D, 2015, INT J PUBLIC HEALTH, V60, P919, DOI 10.1007/s00038-015-0745-0; Kalediene R, 2000, SCAND J PUBLIC HEALT, V28, P4, DOI 10.1177/140349480002800103; Kibele EUB, 2013, J EPIDEMIOL COMMUN H, V67, P453, DOI 10.1136/jech-2012-201761; KLEIN T, 1993, KOLNER Z SOZIOL SOZ, V45, P712; Klein T, 1999, Z SOZIOL, V28, P448; Klotz J, 2008, DEMOGR RES, V19, P1759, DOI 10.4054/DemRes.2008.19.51; KOSKINEN S, 1994, SOC SCI MED, V38, P1385, DOI 10.1016/0277-9536(94)90276-3; Kreft D, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0093-1; Kroger H, 2017, Z SOZIOL, V46, P124, DOI 10.1515/zfsoz-2017-1008; Kroh M., 2014, DOCUMENTATION SAMPLE; Kroll LE, 2009, SOCIOECONOMIC DIFFER; Lampert T, 2014, GBE KOMPAKT, V5; Leopold L, 2018, J HEALTH SOC BEHAV, V59, P94, DOI 10.1177/0022146517751206; Liao YL, 1999, AM J PUBLIC HEALTH, V89, P569, DOI 10.2105/AJPH.89.4.569; Luy M, 2015, COMP POPUL STUD, V40, P399, DOI 10.12765/CPoS-2015-16en; Mackenbach, 2006, HLTH INEQUALITIES EU; Mackenbach JP, 2017, HEALTH PLACE, V47, P44, DOI 10.1016/j.healthplace.2017.07.005; Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Maki N, 2013, SOC SCI MED, V94, P1, DOI 10.1016/j.socscimed.2013.06.009; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Nadash P, 2017, GERONTOLOGIST, P1; PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256; Phillips SP, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27259; Rau R, 2008, EUR J POPUL, V24, P265, DOI 10.1007/s10680-007-9145-3; Reques L, 2014, J EPIDEMIOL COMMUN H, V68, P1151, DOI 10.1136/jech-2014-204186; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Rothgang H, 2010, SOC POLICY ADMIN, V44, P436, DOI 10.1111/j.1467-9515.2010.00722.x; Rueda S, 2008, J EPIDEMIOL COMMUN H, V62, P492, DOI 10.1136/jech.2006.059279; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Samir KC, 2010, VIENNA YB POPUL RES, V8, P201, DOI DOI 10.1553/POPULATIONYEARBOOK2010S201; Schollgen I, 2010, EUR J AGEING, V7, P17, DOI 10.1007/s10433-010-0140-x; Scholz RD, 2017, TRANSFORMATIVE MACHT, P173; Schulz E, 2010, LONG TERM CARE SYSTE, P78; Schumacher R, 2011, DEMOGR RES, V25, P285, DOI 10.4054/DemRes.2011.25.8; Shkolnikov VM, 2008, EUR J PUBLIC HEALTH, V18, P264, DOI 10.1093/eurpub/ckm102; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Sihvonen AP, 1998, SOC SCI MED, V47, P303, DOI 10.1016/S0277-9536(98)00020-3; Spoerri A, 2006, SWISS MED WKLY, V136, P145; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Theobald H, 2010, J ASIAN WOMENS STUDI, V8, P1; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; Valkonen T, 1997, SOC SCI MED, V44, P801, DOI 10.1016/S0277-9536(96)00190-6; Valkonen T., 1989, HLTH INEQUALITIES EU, P142; van den Berg GJ, 2009, SOC SCI MED, V68, P1591, DOI 10.1016/j.socscimed.2009.02.007; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; von Gaudecker HM, 2007, DEMOGR RES, V17, P83, DOI 10.4054/DemRes.2007.17.4; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Wunsch G, 1996, EUR J POPUL, V12, P167, DOI 10.1007/BF01797082	84	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222842	10.1371/journal.pone.0222842	http://dx.doi.org/10.1371/journal.pone.0222842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31537015	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800095
J	Lee, GT; Rosenfeld, JA; Kim, WT; Kwon, YS; Palapattu, G; Mehra, R; Kim, WJ; Kim, IY				Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Palapattu, Ganesh; Mehra, Rohit; Kim, Wun-Jae; Kim, Isaac Yi			TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; ANDROGEN RECEPTOR; IN-VITRO; CELLS; CATENIN; ABIRATERONE; MECHANISMS; SURVIVAL; GROWTH	In treating patients with castration resistant prostate cancer (CRPC), enzalutamide, the second-generation androgen receptor (AR) antagonist, is an accepted standard of care. However, clinical benefits are limited to a median time of 4.8 months because resistance inevitably emerges. To determine the mechanism of treatment resistance, we carried out a RNA sequence analysis and found increased expression levels of neuroendocrine markers in the enzalutamide-resistant LNCaP human prostate cancer (CaP) cell line when compared to the parental cell line. Subsequent studies demonstrated that Transcription Factor-4 (TCF4), a transcription factor implicated in WNT signaling, mediated neuroendocrine differentiation (NED) in response to enzalutamide treatment and was elevated in the enzalutamide-resistant LNCaP. In addition, we observed that PTHrP mediated enzalutamide resistance in tissue culture and inducible TCF4 overexpression resulted in enzalutamide-resistance in a mouse xenograft model. Finally, small molecule inhibitors of TCF4 or PTHrP partially reversed enzalutamide resistance in CaP cells. When tissues obtained from men who died of metastatic CaP were examined, a positive correlation was found between the expression levels of TCF4 and PTHrP. Taken together, the current results indicate that TCF4 induces enzalutamide resistance via NED in CaP.	[Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Kim, Isaac Yi] Rutgers State Univ, Rutgers Canc Inst New Jersey, Sect Urol Oncol, New Brunswick, NJ 08901 USA; [Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Kim, Isaac Yi] Rutgers State Univ, Div Urol, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Cheongju, South Korea; [Palapattu, Ganesh; Mehra, Rohit] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chungbuk National University; University of Michigan System; University of Michigan	Kim, IY (corresponding author), Rutgers State Univ, Rutgers Canc Inst New Jersey, Sect Urol Oncol, New Brunswick, NJ 08901 USA.; Kim, IY (corresponding author), Rutgers State Univ, Div Urol, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.	kimiy@cinj.rutgers.edu			Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program [W81XWH-17-1-0359]; cancer center grant from the National Cancer Institute [P30CA072720]; Marion and Norman Tanzman Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program; cancer center grant from the National Cancer Institute; Marion and Norman Tanzman Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program (W81XWH-17-1-0359), cancer center grant from the National Cancer Institute (Grant P30CA072720), generous support from the Marion and Norman Tanzman Charitable Foundation and Mr. Malcolm Wernik.	Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Aparicio A, 2011, CANCER DISCOV, V1, P466, DOI 10.1158/2159-8290.CD-11-0259; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Bishop JL, 2015, ONCOTARGET, V6, P234, DOI 10.18632/oncotarget.2703; Calcagni A, 2016, ELIFE, V5, DOI 10.7554/eLife.17047; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Dang Q, 2015, MOL ONCOL, V9, P1241, DOI 10.1016/j.molonc.2015.02.010; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; DaSilva JO, 2013, PROSTATE, V73, P801, DOI 10.1002/pros.22624; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ha YS, 2013, DRUG TODAY, V49, P7, DOI 10.1358/dot.2013.49.1.1910724; Ha YS, 2014, EXPERT OPIN DRUG DIS, V9, P837, DOI 10.1517/17460441.2014.918947; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Komiya A, 2013, MOL CLIN ONCOL, V1, P257, DOI 10.3892/mco.2013.69; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Lallous N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0864-1; Lee E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141589; Lee GT, 2014, BRIT J CANCER, V110, P1634, DOI 10.1038/bjc.2014.23; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maroto P, 2016, CRIT REV ONCOL HEMAT, V100, P127, DOI 10.1016/j.critrevonc.2015.07.011; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Prekovic S, 2016, MOL CANCER THER, V15, P1702, DOI 10.1158/1535-7163.MCT-15-0892; Ramadan WH, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S80488; Ramos RN, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/806025; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richie JP, 1996, UROLOGY, V47, P80, DOI 10.1016/S0090-4295(96)80013-6; ROSENBLATT M, 1988, ANN NY ACAD SCI, V548, P137, DOI 10.1111/j.1749-6632.1988.tb18800.x; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Sainio M, 2018, PATHOL RES PRACT, V214, P848, DOI 10.1016/j.prp.2018.04.015; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shore ND, 2016, LANCET ONCOL, V17, P153, DOI 10.1016/S1470-2045(15)00518-5; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060664; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steinestel J, 2015, ONCOTARGET, DOI [10.18632/oncotarget.3925, DOI 10.18632/ONCOTARGET.3925]; Suzman DL, 2014, PROSTATE, V74, P1278, DOI 10.1002/pros.22844; Suzuki K, 2007, PROSTATE CANCER P D, V10, P301, DOI 10.1038/sj.pcan.4500956; Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921; Syed Khaja Azharuddin Sajid, 2011, PLoS One, V6, pe26539, DOI 10.1371/journal.pone.0026539; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Thiele S, 2015, J BONE MINER RES, V30, P488, DOI 10.1002/jbmr.2362; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang HB, 2008, J CELL SCI, V121, P2578, DOI 10.1242/jcs.030742; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b; Wang YF, 2014, J CLIN INVEST, V124, P1646, DOI 10.1172/JCI71812; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061	54	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0213488	10.1371/journal.pone.0213488	http://dx.doi.org/10.1371/journal.pone.0213488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536510	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800001
J	Moore, PJ; Lyons, TJ; Gallacher, J				Moore, P. J.; Lyons, T. J.; Gallacher, J.		Alzheimers Dis Neuroimaging Initia	Using path signatures to predict a diagnosis of Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STRUCTURAL MRI; BIOMARKERS; DEMENTIA	The path signature is a means of feature generation that can encode nonlinear interactions in data in addition to the usual linear terms. It provides interpretable features and its output is a fixed length vector irrespective of the number of input points or their sample times. In this paper we use the path signature to provide features for identifying people whose diagnosis subsequently converts to Alzheimer's disease. In two separate classification tasks we distinguish converters from 1) healthy individuals, and 2) individuals with mild cognitive impairment. The data used are time-ordered measurements of the whole brain, ventricles and hippocampus from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We find two nonlinear interactions which are predictive in both cases. The first interaction is change of hippocampal volume with time, and the second is a change of hippocampal volume relative to the volume of the whole brain. While hippocampal and brain volume changes are well known in Alzheimer's disease, we demonstrate the power of the path signature in their identification and analysis without manual feature selection. Sequential data is becoming increasingly available as monitoring technology is applied, and the path signature method is shown to be a useful tool in the processing of this data.	[Moore, P. J.; Lyons, T. J.] Univ Oxford, Math Inst, Oxford, England; [Gallacher, J.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford; University of Oxford	Moore, PJ (corresponding author), Univ Oxford, Math Inst, Oxford, England.	moorep@maths.ox.ac.uk		Gallacher, John/0000-0002-2394-5299; Moore, Paul/0000-0001-6171-4072	Dementias Platform UK through the UK Medical Research Council (MRC) [MR/L023784/2]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]; MRC; EPSRC [EP/S026347/1]; Alan Turing Institute under EPSRC grant [EP/N510129/1]; Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; MRC [MR/L023784/2] Funding Source: UKRI	Dementias Platform UK through the UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alan Turing Institute under EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Dementias Platform UK funded this project through the UK Medical Research Council (MRC) grant ref MR/L023784/2 (core funding). The Dementias Platform is a multi-million pound public-private partnership, developed and led by the MRC, to accelerate progress in and open up dementias research. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JG is supported by the MRC. TJL is supported by the EPSRC under program grant EP/S026347/1 and by the Alan Turing Institute under EPSRC grant EP/N510129/1. PJM has been supported by the MRC and is currently supported by the Alan Turing Institute under EPSRC grant EP/N510129/1. PJM and TJL are members of the DATASIG team (www.datasig.co.uk).; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database adni.loni.usc.edu. As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_ Acknowledgement_List.pdf. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.;Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.;Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health www.fnih.org.	Arribas IP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0334-0; Boedihardjo H, 2016, ADV MATH, V293, P720, DOI 10.1016/j.aim.2016.02.011; Bron EE, 2015, NEUROIMAGE, V111, P562, DOI 10.1016/j.neuroimage.2015.01.048; Chen K.-T., 1958, T AM MATH SOC, P395, DOI [10.2307/1993193, DOI 10.1090/S0002-9947-1958-0106258-0]; Chevyrev I., 2016, PRIMER SIGNATURE MET; Chincarini A, 2016, NEUROIMAGE, V125, P834, DOI 10.1016/j.neuroimage.2015.10.065; Christ M, 2018, NEUROCOMPUTING, V307, P72, DOI 10.1016/j.neucom.2018.03.067; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Ganz M, 2015, NEUROIMAGE, V122, P131, DOI 10.1016/j.neuroimage.2015.08.006; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Hambly B, 2010, ANN MATH, V171, P109, DOI 10.4007/annals.2010.171.109; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Lebedev AV, 2014, NEUROIMAGE-CLIN, V6, P115, DOI 10.1016/j.nicl.2014.08.023; Li H, 2014, CURR EYE RES, V9, P1, DOI DOI 10.1109/JSTARS.2014.2348173; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Lyons T., 2002, SYSTEM CONTROL ROUGH; Lyons T., 2014, ARXIV14054537; Moore PJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211558; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Sarica A, 2018, EDITORIAL MACHINE LE; Schmitter D, 2015, NEUROIMAGE-CLIN, V7, P7, DOI 10.1016/j.nicl.2014.11.001; Sorensen L, 2017, NEUROIMAGE-CLIN, V13, P470, DOI 10.1016/j.nicl.2016.11.025; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Weiner, 2018, TADPOLE CHALLENGE PR; Weiner MW, 2017, RECENT PUBLICATIONS; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Xie Z., 2017, IEEE T PATTERN ANAL	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222212	10.1371/journal.pone.0222212	http://dx.doi.org/10.1371/journal.pone.0222212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536538	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800030
J	Ngobeni, H; Tempia, S; Cohen, AL; Walaza, S; Kuonza, L; Musekiwa, A; von Gottberg, A; Hellferscee, O; Wolter, N; Treurnicht, FK; Moyes, J; Naby, F; Mekgoe, O; Cohen, C				Ngobeni, Hetani; Tempia, Stefano; Cohen, Adam L.; Walaza, Sibongile; Kuonza, Lazarus; Musekiwa, Alfred; von Gottberg, Anne; Hellferscee, Orienka; Wolter, Nicole; Treurnicht, Florette K.; Moyes, Jocelyn; Naby, Fathima; Mekgoe, Omphile; Cohen, Cheryl			The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged < 5 years in South Africa, 2011-2015	PLOS ONE			English	Article								In 2014, the World Health Organization (WHO) proposed a new severe influenza surveillance case definition, which has not been evaluated in a high human immunodeficiency virus (HIV) prevalence setting. Our study aimed to assess the performance of this proposed case definition in identifying influenza among HIV-uninfected and HIV-infected children aged < 5 years in South Africa. We prospectively enrolled children aged < 5 years hospitalised with physician-diagnosed lower respiratory tract infection (LRTI) at two surveillance sites from January 2011 to December 2015. Epidemiologic and clinical data were collected. We tested nasopharyngeal aspirates for influenza using reverse transcription polymerase chain reaction. We used logistic regression to assess factors associated with influenza positivity among HIV-infected and HIV-uninfected children. We calculated sensitivity and specificity for different signs and symptoms and combinations of these for laboratory-confirmed influenza. We enrolled 2,582 children < 5 years of age with LRTI of whom 87% (2,257) had influenza and HIV results, of these 14% (318) were HIV-infected. The influenza detection rate was 5% (104/1,939) in HIV-uninfected and 5% (16/318) in HIV-infected children. Children with measured fever (.38 degrees C) were two times more likely to test positive for influenza than those without measured fever among the HIV-uninfected (OR 2.2, 95% Confidence Interval (CI) 1.5-3.4; p<0.001). No significant association was observed between fever and influenza infection among HIV-infected children. Cough alone had sensitivity of 95% (95% CI 89-98%) in HIV-uninfected and of 100% (95% CI 79-100%) in HIV-infected children but low specificity: 7% (95% CI 6-8%) and 6% (95% CI 3-9%) in HIV-uninfected and HIV-infected children, respectively. The WHO post-2014 case definition for severe acute respiratory illness (SARI-an acute respiratory infection with history of fever or measured fever of. 38 degrees C and cough; with onset within the last ten days and requires hospitalization), had a sensitivity of 66% (95% CI 56-76%) and specificity of 46% (95% CI 44-48%) among HIV-uninfected and a sensitivity of 63% (95% CI 35-84%) and a specificity of 42% (95% CI 36-48%) among HIV-infected children. The sensitivity and specificity of the WHO post-2014 case definition for SARI were similar among HIV-uninfected and HIV-infected children. Our findings support the adoption of the 2014 WHO case definition for children aged < 5 years irrespective of HIV infection status.	[Ngobeni, Hetani; Kuonza, Lazarus] South African Field Epidemiol Training Programme, Johannesburg, South Africa; [Ngobeni, Hetani; Kuonza, Lazarus; Musekiwa, Alfred] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Tempia, Stefano; Walaza, Sibongile; von Gottberg, Anne; Hellferscee, Orienka; Wolter, Nicole; Treurnicht, Florette K.; Moyes, Jocelyn; Naby, Fathima; Mekgoe, Omphile; Cohen, Cheryl] Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [Tempia, Stefano] MassGenics, Duluth, GA USA; [Cohen, Adam L.] World Hlth Org, Vaccines & Biol, Global Immunizat Monitoring & Surveillance Team, Geneva, Switzerland; [Kuonza, Lazarus; Moyes, Jocelyn; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	University of Pretoria; Centers for Disease Control & Prevention - USA; World Health Organization; University of Witwatersrand; University of Witwatersrand	Ngobeni, H (corresponding author), South African Field Epidemiol Training Programme, Johannesburg, South Africa.; Ngobeni, H (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.	hetani@gmail.com		Musekiwa, Alfred/0000-0001-5880-3680; Kuonza, Lazarus/0000-0001-5338-320X; Tempia, Stefano/0000-0003-4395-347X; von Gottberg, Anne/0000-0002-0243-7455				Africa S, 2015, EPIDEMIOLOGY INFLUEN, V20, P2009; Casalegno J, 2014, PERFORMANCE INFLUENZ, P2009; Dorrington RE, 2020, PROGR 2020 TARGETS H, P1; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Gupta V, 2012, VALIDITY CLIN CASE D, P321; Health Department SA, 2006, PRACTICE GUIDELINES; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Human Science Research Council, 2012, AFRICAN NATL HIV P; Iuliano A.D., 2017, LANCET, V6736, P1, DOI [10.1016/S0140-6736(17)33293-2, DOI 10.1016/S0140-6736(17)33293-2]; Madhi SA, 2000, INCREASED BURDEN RES; Pretorius MA, 2018, RESP VIRAL COINFECTI, V206, P159; Tempia S, EFFECTS ATTRIBUTABLE; Tempia S, 2009, MORTALITY ASS SEAS P, P1998; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; WHO, 2012, WHO INT GLOB EP SURV; World Health Organization, 2011, WHO GLOB TECHN CONS; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577	19	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222294	10.1371/journal.pone.0222294	http://dx.doi.org/10.1371/journal.pone.0222294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536552	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800034
J	Pontikos, N; Chua, S; Foster, PJ; Tuft, SJ; Day, AC				Pontikos, Nikolas; Chua, Sharon; Foster, Paul J.; Tuft, Stephen J.; Day, Alexander C.		UK Biobank Eye Vision Consortium	Frequency and distribution of corneal astigmatism and keratometry features in adult life: Methodology and findings of the UK Biobank study	PLOS ONE			English	Article								Purpose To describe corneal astigmatism in the UK Biobank population and to look for associations with other biometric variables and socio-demographic factors. Methods This analysis included a subsample of 107,452 participants of the UK Biobank study who underwent an enhanced ophthalmic examination including autorefractor keratometry (Tomey RC 5000, Tomey Corp., Nagoya, Japan). Participants were recruited from across the United Kingdom between 2006 and 2010, and all were between 40 to 69 years. After quality control and applying relevant exclusions, data on corneal astigmatism on 83,751 participants were included for analysis. Potential associations were tested through univariable regression and significant parameters carried forward for multivariable analysis. Results In univariable analysis, the characteristics significantly associated with higher corneal astigmatism (P<0.001), by order of magnitude were, female gender, white ethnicity, lighter skin colour, use of UV protection, lower alcohol intake, lower corneal-compensated intraocular pressure (ccIOP), older age at completion of education, younger age, higher Townsend deprivation index, lower height and lower systolic blood pressure. After inclusion in the multivariable analysis, gender, skin colour, alcohol intake, age at completion of full-time education, ccIOP, age and Townsend deprivation score remained significant (all P<0.001). Increased corneal astigmatism was also found to be significantly associated with amblyopia or strabismus. Conclusions This analysis confirms previous associations with astigmatism such as younger age and female gender, and identified novel risk factors including lighter skin colour, lower alcohol intake, later age having completed full time education later, lower ccIOP and higher Townsend deprivation index. Further research is needed to investigate these novel associations.	[Pontikos, Nikolas; Chua, Sharon; Foster, Paul J.; Tuft, Stephen J.; Day, Alexander C.] UCL Inst Ophthalmol, London, England; [Pontikos, Nikolas; Chua, Sharon; Foster, Paul J.; Tuft, Stephen J.; Day, Alexander C.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Pontikos, N (corresponding author), UCL Inst Ophthalmol, London, England.; Pontikos, N (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.	n.pontikos@ucl.ac.uk	Pontikos, Nikolas/U-3642-2018	Pontikos, Nikolas/0000-0003-1782-4711; Foster, Paul/0000-0002-4755-177X	NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Eye Charity Career Development Award [R190031A]; Moorfields Eye Charity	NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Eye Charity Career Development Award; Moorfields Eye Charity	The collection of eye & vision data in UK Biobank was supported in part by a grant from the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology. NP is funded by a Moorfields Eye Charity Career Development Award (https://www.moorfieldseyecharity.org.uk/career-developmentawards) (award number R190031A). The UK Biobank Eye and Vision Consortium was supported by a grant from The Special Trustees of Moorfields Eye Hospital (now Moorfields Eye Charity). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Allen N, 2012, HLTH POLICY TECHNOL; Attebo K, 1999, OPHTHALMOLOGY; Bourne RRA, 2013, LANCET GLOB HLTH; Cooper J, 2018, EYE CONTACT LENS; Cumberland PM, 2015, PLOS ONE; Curragh DS, 2017, ULSTER MED J; Hagishima M, 2010, GRAEFES ARCH CLIN EX; Harvey EM., 2009, OPTOMETRY VISION SCI; Hashemi H, 2018, J CURRENT OPHTHALMOL; Hayashi K, 1995, CORNEA; Hirsch MJ., 1959, OPTOM VIS SCI; Ho JD, 2010, CORNEA; Hohn R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120476; Hoffer KJ., 1980, AM J OPHTHALMOL; Hoffmann PC, 2010, J CATARACT REFRACT S; Hofman A, 2007, EUR J EPIDEMIOL; Hofman A, 2015, EUR J EPIDEMIOL; Jonas JB, 1997, OPHTHALMOLOGY; Khan MI, 2011, J CATARACT REFRACT S; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Mohammadi M, 2016, INT OPHTHALMOL; Morlet N, 2002, BRIT J OPHTHALMOLOGY; Oh EH, 2015, J CATARACT REFR SURG, V41, P1256, DOI 10.1016/j.jcrs.2014.09.043; Ollier W, 2005, PHARMACOGENOMICS; Palmer LJ, 2007, LANCET; Riley AF, 2001, CLIN EXP OPHTHALMOL; Roberts HW, 2020, EUR J OPHTHALMOL, V30, P417, DOI 10.1177/1120672119893291; Saw SM, 2006, INVESTIG OPHTHALMOL; Schulze Schwering M, 2015, GRAEFES ARCH CLIN EX; Schuster AKG, 2017, GRAEFES ARCH CLIN EX; Shah RL, 2018, MOL VIS; Shah RL, 2018, HUM GENET; Tedja MS, 2018, NAT GENET; Ueno Y, 2014, J REFRACT SURG; Verhoeven VJM, 2012, HUM GENET; Yu JG, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0450-2; Yuan XY, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/536412	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218144	10.1371/journal.pone.0218144	http://dx.doi.org/10.1371/journal.pone.0218144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536508	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800006
J	Tamirat, MZ; Koivu, M; Elenius, K; Johnson, MS				Tamirat, Mahlet Z.; Koivu, Marika; Elenius, Klaus; Johnson, Mark S.			Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; KINASE DOMAIN; 1ST-LINE TREATMENT; ACTIVATION; MECHANISM; SENSITIVITY; INHIBITION; PARAMETERS; RELEVANCE	Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor important in diverse biological processes including cell proliferation and survival. Upregulation of EGFR activity due to over-expression or mutation is widely implicated in cancer. Activating somatic mutations of the EGFR kinase are postulated to affect the conformation and/or stability of the protein, shifting the EGFR inactive-active state equilibrium towards the activated state. Here, we examined a common EGFR deletion mutation, Delta(746)ELREA(750), which is frequently observed in non-small cell lung cancer patients. By using molecular dynamics simulation, we investigated the structural effects of the mutation that lead to the experimentally reported increases in kinase activity. Simulations of the active form wild-type and Delta ELREA EGFRs revealed the deletion stabilizes the alpha C helix of the kinase domain, which is located adjacent to the deletion site, by rigidifying the flexible beta 3-alpha C loop that accommodates the ELREA sequence. Consequently, the aC helix is stabilized in the "alpha C-in" active conformation that would prolong the time of the activated state. Moreover, in the mutant kinase, a salt bridge between E762 and K745, which is key for EGFR activity, was also stabilized during the simulation. Additionally, the interaction between EGFR and ATP was favored by Delta ELREA EGFR over wild-type EGFR, as reflected by the number of hydrogen bonds formed and the free energy of binding. Simulation of inactive EGFR suggested the deletion would promote a shift from the inactive conformation towards active EGFR, which is supported by the inward movement of the alpha C helix. The MDS results also align with the effects of tyrosine kinase inhibitors on Delta ELREA and wild-type EGFR lung cancer cell lines, where more pronounced inhibition was observed against Delta ELREA than for wild-type EGFR by inhibitors recognizing the active kinase conformation.	[Tamirat, Mahlet Z.; Johnson, Mark S.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Medic Res Labs, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Inst Biomed, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Abo Akad Univ, Turku, Finland; [Koivu, Marika] Univ Turku, Turku Doctoral Programme Mol Med, Turku, Finland; [Elenius, Klaus] Univ Turku, Dept Oncol & Radiotherapy, Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Turku, Finland	Abo Akademi University; University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Johnson, MS (corresponding author), Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland.	johnson4@abo.fi	Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827; Koivu, Marika/0000-0002-4371-2142; Tamirat, Mahlet/0000-0003-3249-4765	Academy of Finland [308317, 320005, 274728, 316796]; Sigrid Juselius Foundation; Tor, Joe and Pentti Borg memorial fund; Abo Akademi Doctoral Network of Informational and Structural Biology; Cancer Foundation of Finland; Turku University Central Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe and Pentti Borg memorial fund; Abo Akademi Doctoral Network of Informational and Structural Biology; Cancer Foundation of Finland; Turku University Central Hospital	This research is part of the Drug Discovery and Diagnostics strategic area of Abo Akademi University and University of Turku, and was supported by grants to M.S.J. from the Academy of Finland (308317, 320005), Sigrid Juselius Foundation and Tor, Joe and Pentti Borg memorial fund. M.Z.T. is funded by the Abo Akademi Doctoral Network of Informational and Structural Biology. K.E. is supported by Academy of Finland Grants 274728 and 316796, the Cancer Foundation of Finland, and Turku University Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hasenahuer MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189147; [Anonymous], 2018, SCHRODINGER RELEASE; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case D. A., AMBER 2018; de Gunst MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-56; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Furuyama K, 2013, CANCER SCI, V104, P584, DOI 10.1111/cas.12125; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01491-z; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Kurppa KJ, 2016, ONCOGENE, V35, P1283, DOI 10.1038/onc.2015.185; Leahy DJ, 2004, ADV PROTEIN CHEM, V68, P1; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Melvin RL, 2016, J MOL GRAPH MODEL, V67, P44, DOI 10.1016/j.jmgm.2016.05.001; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Oliveira S, 2006, EXPERT OPIN BIOL TH, V6, P605, DOI 10.1517/14712598.6.6.605; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ou SHI, 2017, J THORAC ONCOL, V12, P446, DOI 10.1016/j.jtho.2016.11.2224; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; RStudio Team, 2018, RSTUDIO INT DEV ENV; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sgambato A, 2012, CURR MED CHEM, V19, P3337, DOI 10.2174/092986712801215973; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Su J, 2017, ONCOTARGET, V8, P111246, DOI 10.18632/oncotarget.22768; Sullivan I, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00076; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Vogt PK, 2012, NAT REV CANCER, V12, P639, DOI 10.1038/nrc3320; Wang ZH, 2014, METHOD ENZYMOL, V548, P1, DOI 10.1016/B978-0-12-397918-6.00001-X; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XZ, 2007, J MED GENET, V44, P166, DOI 10.1136/jmg.2006.046102; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222814	10.1371/journal.pone.0222814	http://dx.doi.org/10.1371/journal.pone.0222814			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536605	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800091
J	Bobillo-Perez, S; Sole-Ribalta, A; Balaguer, M; Esteban, E; Girona-Alarcon, M; Hernandez-Platero, L; Segura, S; Felipe, A; Cambra, FJ; Launes, C; Jordan, I				Bobillo-Perez, Sara; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Girona-Alarcon, Monica; Hernandez-Platero, Lluisa; Segura, Susana; Felipe, Aida; Cambra, Francisco Jose; Launes, Cristian; Jordan, Iolanda			Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GUIDED DECISION-MAKING; EARLY-ONSET SEPSIS; NOSOCOMIAL INFECTIONS; MANAGEMENT; MULTICENTER; GUIDELINES; BIOMARKER; EXPOSURE; KINETICS	Introduction and objective Children admitted to the pediatric intensive care unit after cardiovascular surgery usually require treatment with antibiotics due to suspicion of infection. The aim of this study was to assess the effectiveness of procalcitonin in decreasing the duration of antibiotic treatment in children after cardiovascular surgery. Methods Prospective, interventional study carried out in a pediatric intensive care unit. Included patients under 18 years old admitted after cardiopulmonary bypass. Two groups were compared, depending on the implementation of the PCT-guided protocol to stop or de-escalate the antibiotic treatment (Group 1, 2011-2013 and group 2, 2014-2018). This new protocol was based on the decrease of the PCT value by 20% or 50% with respect to the maximum value of PCT. Primary endpoints were mortality, stewardship indication, duration of antibiotic treatment, and antibiotic-free days. Results 886 patients were recruited. There were 226 suspicions of infection (25.5%), and they were confirmed in 38 cases (16.8%). The global rate of infections was 4.3%. 102 patients received broad-spectrum antibiotic (4.7 +/- 1.7 days in group 1, 3.9 +/- 1 days in group 2 with p = 0.160). The rate of de-escalation was higher in group 2 (30/62, 48.4%) than in group 1 (24/ 92, 26.1%) with p = 0.004. A reduction of 1.1 days of antibiotic treatment (group 1, 7.7 +/- 2.2 and group 2, 6.7 +/- 2.2, with p = 0.005) and 2 more antibiotic free-days free in PICU in group 2 were observed (p = 0.001), without adverse outcomes. Conclusions Procalcitonin-guided protocol for stewardship after cardiac surgery seems to be safe and useful to decrease the antibiotic exposure. This protocol could help to reduce the duration of broad-spectrum antibiotics and the duration of antibiotics in total, without developing complications or adverse effects.	[Bobillo-Perez, Sara; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Girona-Alarcon, Monica; Hernandez-Platero, Lluisa; Segura, Susana; Felipe, Aida; Cambra, Francisco Jose; Jordan, Iolanda] Univ Barcelona, Hosp St Joan de Deu, Pediat Intens Care Unit, Barcelona, Spain; [Bobillo-Perez, Sara] Univ Barcelona, Inst Recerca Hosp St Joan de Deu, Disorders Immun & Respirat Pediat Crit Patients R, Barcelona, Spain; [Launes, Cristian] Univ Barcelona, Hosp St Joan de Deu, Pediat Dept, Barcelona, Spain; [Launes, Cristian; Jordan, Iolanda] CIBERESP, Inst Recerca Hosp St Joan de Deu, Pediat Infect Dis Res Grp, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Cambra, FJ (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Pediat Intens Care Unit, Barcelona, Spain.	fjcambra@sjdhospitalbarcelona.org	Pérez, Sara Bobillo/E-8224-2018; lasosa, Francisco José Cambra/ABH-4656-2020; Launes, Cristian/ABD-8312-2020; Girona-Alarcon, Monica/ABH-4405-2020; BOBILLO-PEREZ, SARA/W-8374-2019	Pérez, Sara Bobillo/0000-0001-8889-2995; Launes, Cristian/0000-0002-0913-9303; Girona-Alarcon, Monica/0000-0002-2752-7481; BOBILLO-PEREZ, SARA/0000-0001-8889-2995				Alvarez P, 2012, PEDIATR CARDIOL, V33, P735, DOI 10.1007/s00246-012-0202-2; Andriolo BNG, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010959.pub2; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Perez SB, 2016, BIOMARK INSIGHTS, V11, P123, DOI [10.4137/bmi.s40658, 10.4137/BMI.S40658]; Bobillo S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271917751900; Bobillo-Perez S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918792244; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Carrillo F.J., 2015, J OPEN INNOVAT TECHN, V1, DOI DOI 10.1186/S40852-015-0017-5; Davidson J, 2013, PEDIATR RES, V74, P413, DOI 10.1038/pr.2013.124; Davidson J, 2012, INTENS CARE MED, V38, P1184, DOI 10.1007/s00134-012-2544-x; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034; European Centre for Disease Prevention and Control, 2016, ANN EP REP 2016 HLTH; Gelijns AC, 2014, J AM COLL CARDIOL, V64, P372, DOI 10.1016/j.jacc.2014.04.052; Grisaru-Soen G, 2009, PEDIATR CRIT CARE ME, V10, P202, DOI 10.1097/PCC.0b013e31819a37c5; Guardia Cami M T, 2008, An Pediatr (Barc), V69, P34; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang DT, 2018, NEW ENGL J MED, V379, P236, DOI [10.1056/NEJMoa1802670, 10.1056/nejmoa1802670]; Huang HB, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0338-6; Jaworski R, 2018, ADV MED SCI-POLAND, V63, P112, DOI 10.1016/j.advms.2017.10.003; Garcia IJ, 2012, PEDIATR CRIT CARE ME, V13, P441, DOI 10.1097/PCC.0b013e31823890de; Keren R, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e70; Lacour-Gayet Francois, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P185, DOI 10.1053/j.pcsu.2004.02.011; Launes C, 2016, J INFECTION, V72, P250, DOI 10.1016/j.jinf.2015.12.001; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; O'Keefe Scott, 2017, J Clin Med Res, V9, P10; Sariego-Jamardo A, 2017, J CRIT CARE, V41, P119, DOI 10.1016/j.jcrc.2017.05.009; Schuetz P, 2012, COCHRANE DB SYST REV, P1; Schuetz P, 2017, CPT-PHARMACOMET SYST, P1; Slieker JC, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/3457614; Stocker M, 2017, LANCET, V390, P871, DOI [10.1016/S0140-6736(17)31444-7, 10.1016/s0140-6736(17)31444-7]; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; WHO, 2011, WHO LIB CAT PUBL DAT; Wirz Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2125-7; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	37	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0220686	10.1371/journal.pone.0220686	http://dx.doi.org/10.1371/journal.pone.0220686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532769	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600002
J	Braeye, T; Bauchau, V; Sturkenboom, M; Emborg, HD; Garcia, AL; Huerta, C; Merino, EM; Bollaerts, K				Braeye, Toon; Bauchau, Vincent; Sturkenboom, Miriam; Emborg, Hanne-Dorthe; Garcia, Ana Llorente; Huerta, Consuelo; Merino, Elisa Martin; Bollaerts, Kaatje			Estimation of vaccination coverage from electronic healthcare records; methods performance evaluation - A contribution of the ADVANCE-project	PLOS ONE			English	Article							PARENTAL RECALL; AGE-APPROPRIATE; TIMELINESS	Introduction The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public private collaboration aiming to develop and test a system for rapid benefit-risk (B/R) monitoring of vaccines, using existing electronic healthcare record (eHR) databases in Europe. Part of the data in such sources is missing due to incomplete follow-up hampering the accurate estimation of vaccination coverage. We compared different methods for coverage estimation from eHR databases; naive period prevalence, complete case period prevalence, period prevalence adjusted for follow-up time, Kaplan-Meier (KM) analysis and (adjusted) inverse probability weighing (IPW). Methods We created simulation scenarios with different proportions of completeness of follow-up. Both completeness independent and dependent from vaccination date and status were considered. The root mean squared error (RMSE) and relative difference between the estimated and true coverage were used to assess the performance of the different methods for each of the scenarios. We included data examples on the vaccination coverage of human papilloma virus and pertussis component containing vaccines from the Spanish BIFAP database. Results Under completeness independent from vaccination date or status, several methods provided estimates with bias close to zero. However, when dependence between completeness of follow-up and vaccination date or status was present, all methods generated biased estimates. The IPW/CDF methods were generally the least biased. Preference for a specific method should be based on the type of censoring and type of dependence between completeness of follow-up and vaccination. Additional insights into these aspects, might be gained by applying several methods.	[Braeye, Toon] Sciensano, Brussels, Belgium; [Braeye, Toon] Hasselt Univ, Hasselt, Belgium; [Bauchau, Vincent] GSK Vaccines, Wavre, Belgium; [Sturkenboom, Miriam; Bollaerts, Kaatje] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium; [Sturkenboom, Miriam] VACCINE GRID Fdn, Basel, Switzerland; [Sturkenboom, Miriam] Univ Med Ctr Utrecht, Julius Global Hlth, Utrecht, Netherlands; [Emborg, Hanne-Dorthe] Statens Serum Inst, Copenhagen, Denmark; [Garcia, Ana Llorente; Huerta, Consuelo; Merino, Elisa Martin] Spanish Agcy Med & Med Devices, BIFAP Database, Madrid, Spain	Sciensano; Hasselt University; GlaxoSmithKline; Utrecht University; Utrecht University Medical Center; Statens Serum Institut	Braeye, T (corresponding author), Sciensano, Brussels, Belgium.; Braeye, T (corresponding author), Hasselt Univ, Hasselt, Belgium.	toon.braeye@sciensano.be	Emborg, Hanne-Dorthe/GRS-8769-2022	Huerta, Consuelo/0000-0003-4012-7826; Braeye, Toon/0000-0002-5637-4613	Innovative Medicines Initiative Joint Undertaking under ADVANCE grant from the European Union's Seventh Framework Programme (FP7/2007-2013) [115557]; EFPIA companies	Innovative Medicines Initiative Joint Undertaking under ADVANCE grant from the European Union's Seventh Framework Programme (FP7/2007-2013); EFPIA companies	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under ADVANCE grant agreement no. 115557, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. Co-author V.B received a salary from GSK during the period in which this study was performed. The study sponsors had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the report for publication. The specific roles of these authors are articulated in the `author contributions' section.	Akmatov MK, 2008, VACCINE, V26, P3805, DOI 10.1016/j.vaccine.2008.05.031; Baker MA, 2013, VACCINE, V31, pK98, DOI 10.1016/j.vaccine.2013.04.088; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Bolton P, 1998, PUBLIC HEALTH REP, V113, P521; CHANG MN, 1987, ANN STAT, V15, P1536, DOI 10.1214/aos/1176350608; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Crespo I, 2011, VACCINE, V29, P4244, DOI 10.1016/j.vaccine.2011.03.065; Derrough T, 2017, EUROSURVEILLANCE, V22, P10, DOI [10.2807/1560-7917.es.2017.22.17.30519, 10.2807/1560-7917.ES.2017.22.17.30519]; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Fonteneau L, 2015, REV EPIDEMIOL SANTE, V63, P293, DOI 10.1016/j.respe.2015.06.005; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; Haverkate M, 2011, EXPERT REV VACCINES, V10, P1195, DOI [10.1586/ERV.11.87, 10.1586/erv.11.87]; Hopkins DP, 2015, J PUBLIC HEALTH MAN, V21, P249, DOI 10.1097/PHH.0000000000000092; Kalies H, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-82; Keny A, 2013, J HLTH INFORM AFR, V8, P254, DOI [10.12856/JHIA-2013-v1-i1-40, DOI 10.12856/JHIA-2013-V1-I1-40]; Laubereau B, 2002, EPIDEMIOL INFECT, V128, P185, DOI 10.1017/S0950268801006550; Lernout T, 2014, VACCINE, V32, P284, DOI 10.1016/j.vaccine.2013.10.084; Li LL, 2013, STAT METHODS MED RES, V22, P14, DOI 10.1177/0962280211403597; Lopez N, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0187-4; Martin-Merino E, 2019, PHARMACOEPIDEM DR S, V28, P201, DOI 10.1002/pds.4674; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; Ministerio de sanidad consumo y bienestar social, COB VAC; Molenberghs G., 2005, MODELS DISCRETE LONG; R Core Team, 2018, R LANG ENV STAT COMP; Salvador Rosa A, 2002, Aten Primaria, V30, P655; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Silverman B., 1986, DENSITY ESTIMATION S, V175; Stein-Zamir C, 2017, HUM VACC IMMUNOTHER, V13, P2102, DOI 10.1080/21645515.2017.1341028; TURNBULL BW, 1974, J AM STAT ASSOC, V69, P169, DOI 10.2307/2285518	29	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222296	10.1371/journal.pone.0222296	http://dx.doi.org/10.1371/journal.pone.0222296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532806	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600026
J	Egbuta, MA; McIntosh, S; Waters, DLE; Vancov, T; Liu, L				Egbuta, Mary A.; McIntosh, Shane; Waters, Daniel L. E.; Vancov, Tony; Liu, Lei			Chemical volatiles present in cotton gin trash: A by-product of cotton processing	PLOS ONE			English	Article							ESSENTIAL OIL; QUANTITATIVE-ANALYSIS; GLANDULAR TRICHOMES; BIOACTIVE COMPOUNDS; STEAM DISTILLATION; ETHANOL-PRODUCTION; ALPHA-BISABOLOL; EXTRACTION; IDENTIFICATION; CONSTITUENTS	Cotton gin trash (CGT), a waste product of cotton gins, make up about 10% of each bale of cotton bolls ginned. The current study investigates high value volatile compounds in CGT to add value to this by-product. The volatile compounds in CGT and different parts of the cotton plant were extracted using various methods, identified by gas chromatography-mass spectrometry (GC-MS) or nuclear magnetic resonance (NMR) spectroscopy, and then quantified by gas chromatography-flame ionisation detection (GC-FID) against available standards. Terpenoids including monoterpenoids and sesquiterpenoids were found to be the most abundant, making up 64.66% (area under peak) of total volatiles extracted by hydrodistillation. The major extractable terpenoids in CGT were alpha-pinene (13.69-23.05 mu g/g), beta-caryophyllene (3.99-74.32 mu g/g), alpha-humulene (2.00-25.71 mu g/g), caryophyllene oxide (41.50-102.08 mu g/g) and beta-bisabolol (40.05-137.32 mu g/g). Recoveries varied between different extraction methods. The terpenoids were found to be more abundant in the calyx (659.12 mu g/g) and leaves (627.72 mu g/g) than in stalks (112.97 mu g/g) and stems (24.24 mu g/g) of the cotton plant, indicating the possible biological origin of CGT volatiles. This study is the first to identify and quantify the different terpenoids present in CGT and significantly, beta-bisabolol, an abundant compound (sesquiterpene alcohol) which may have valuable biological prospects. These findings therefore contribute to identifying alternative management strategies and uses of CGT.	[Egbuta, Mary A.; McIntosh, Shane; Waters, Daniel L. E.; Vancov, Tony; Liu, Lei] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [McIntosh, Shane; Vancov, Tony] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Waters, Daniel L. E.] Charles Sturt Univ, ARC ITTC Funct Grains, Wagga Wagga, NSW, Australia	Southern Cross University; NSW Department of Primary Industries; Charles Sturt University	Liu, L (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.	ben.liu@scu.edu.au	mcintosh, shane/AAL-4279-2021; Liu, Lei/AAM-2739-2021	Liu, Lei/0000-0002-3710-7042; Waters, Daniel/0000-0002-8622-3162	Cotton Research Development Corporation (CRDC), Australia; CRDC [DAN1504]	Cotton Research Development Corporation (CRDC), Australia(Cotton R&D Corp); CRDC	The funder, Cotton Research Development Corporation (CRDC), Australia, had a role to play in the decision to publish this manuscript. Approval was sought and received prior to submission of the manuscript. L.L., S.M. and T.V. received the research grant from CRDC, Agreement Number DAN1504 (https://www.crdc.com.au/). M.E. PhD scholarship was paid as part of this award.	Agblevor FA, 2003, APPL BIOCHEM BIOTECH, V105, P219, DOI 10.1385/ABAB:105:1-3:219; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Azwanida N., 2015, MED AROMAT PLANTS, V4, P2167, DOI [10.4172/2167-0412.1000196, DOI 10.4172/2167-0412.1000196]; BELL AA, 1986, COTTON PHYSL BOOK 2, P00597; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berka-Zougali B, 2012, INT J MOL SCI, V13, P4673, DOI 10.3390/ijms13044673; Bourland FM, 2017, J COTTON SCI, V21, P296; Boykin J.C., 2013, P BELTW COTT PROD RE, P774; Braun NA, 2003, J ESSENT OIL RES, V15, P63, DOI 10.1080/10412905.2003.9712064; Cai CP, 2014, MOL BIOL REP, V41, P4941, DOI 10.1007/s11033-014-3360-x; Cavalieri E, 2004, BIOCHEM BIOPH RES CO, V315, P589, DOI 10.1016/j.bbrc.2004.01.088; Chaudhary MR, 2011, HARVESTING GINNING C; Chen QF, 2011, MINI-REV MED CHEM, V11, P1153, DOI 10.2174/138955711797655399; Chen W, 2010, BIOCHEM PHARMACOL, V80, P247, DOI 10.1016/j.bcp.2010.03.021; Chen Y, 2014, REV BRAS FARMACOGN, V24, P626, DOI 10.1016/j.bjp.2014.11.001; Chen Y, 2012, J INTEGR AGR, V11, P1836, DOI 10.1016/S2095-3119(12)60188-9; De Lucca AJ, 2011, J ESSENT OIL RES, V23, P47, DOI 10.1080/10412905.2011.9700457; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Egbuta MA, 2017, MOLECULES, V22, DOI 10.3390/molecules22010093; Eisenring M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00234; ELZEN GW, 1984, J CHEM ECOL, V10, P1251, DOI 10.1007/BF00988552; ELZEN GW, 1985, J AGR FOOD CHEM, V33, P1079, DOI 10.1021/jf00066a015; Fahn A, 2002, ISRAEL J PLANT SCI, V50, pS59; Fisheries QD of A and, 2010, INSECT PEST MANAGEME; Fitriady MA, 2017, AIP CONF PROC, V1803, DOI 10.1063/1.4973159; Hajaji S, 2017, ACTA PARASITOL, V62, P290, DOI 10.1515/ap-2017-0036; Haleem N, 2014, CARBOHYD POLYM, V113, P249, DOI 10.1016/j.carbpol.2014.07.023; Haypek E, 2000, BRAZ J CHEM ENG, V17, P705, DOI 10.1590/S0104-66322000000400034; HEDIN PA, 1972, PHYTOCHEMISTRY, V11, P2356, DOI 10.1016/S0031-9422(00)88415-0; HEDIN PA, 1975, PHYTOCHEMISTRY, V14, P2087, DOI 10.1016/0031-9422(75)83137-2; Hernandez Y, 2009, FOOD CHEM, V114, P734, DOI 10.1016/j.foodchem.2008.10.021; Huang XZ, 2013, PLANT PHYSIOL BIOCH, V73, P302, DOI 10.1016/j.plaphy.2013.10.017; Huchelmann A, 2017, PLANT PHYSIOL, V175, P6, DOI 10.1104/pp.17.00727; Huynh Q, 2012, J PHYS CONF SER, V352, DOI 10.1088/1742-6596/352/1/012053; Jeoh T, 2001, BIOMASS BIOENERG, V21, P109, DOI 10.1016/S0961-9534(01)00028-9; Gil-Chavez GJ, 2013, COMPR REV FOOD SCI F, V12, P5, DOI 10.1111/1541-4337.12005; JOHNS MR, 1992, J SCI FOOD AGR, V58, P49, DOI 10.1002/jsfa.2740580109; Kamatou GPP, 2010, J AM OIL CHEM SOC, V87, P1, DOI 10.1007/s11746-009-1483-3; Kasperbauer MJ, 2004, CROP SCI, V44, P198, DOI 10.2135/cropsci2004.1980; King DJ, 2006, NEW PHYTOL, V172, P440, DOI 10.1111/j.1469-8137.2006.01842.x; Knox O, 2006, COMPOSTING AUSTR COT, P46; Lima F. W. J., 2013, International Journal of Medicinal and Aromatic Plants, V3, P1; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; McIntosh S, 2014, BIORESOURCE TECHNOL, V173, P42, DOI 10.1016/j.biortech.2014.09.063; MINYARD JP, 1968, J ORG CHEM, V33, P909, DOI 10.1021/jo01266a116; Mu'azu K, 2009, NIGER J BASIC APPL S, V17, P218; Okoh OO, 2010, FOOD CHEM, V120, P308, DOI 10.1016/j.foodchem.2009.09.084; Omar J, 2016, J FOOD SCI, V81, pC867, DOI 10.1111/1750-3841.13257; Opitz S, 2008, J CHEM ECOL, V34, P508, DOI 10.1007/s10886-008-9453-z; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; Perveen S.S., 2001, PAK J BIOL SCI, V4, P554; Rassem H.A.H., 2016, AUSTR J BASIC APPL S, V10, P117; Rogers GM, 2002, VET CLIN N AM-FOOD A, V18, P267, DOI 10.1016/S0749-0720(02)00020-8; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Shen JC, 2011, BIOPROC BIOSYST ENG, V34, P33, DOI 10.1007/s00449-010-0444-4; Siddique AB, 2016, ARAB J CHEM, V9, pS1185, DOI 10.1016/j.arabjc.2012.01.004; Srivastava JK, 2010, MOL MED REP, V3, P895, DOI 10.3892/mmr.2010.377; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; THOMPSON AC, 1971, AM J BOT, V58, P803, DOI 10.2307/2441557; THOMPSON AC, 1971, PLANT PHYSIOL, V48, P50, DOI 10.1104/pp.48.1.50; Voon HC, 2012, COMPR REV FOOD SCI F, V11, P34, DOI 10.1111/j.1541-4337.2011.00169.x; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; WEYERSTAHL P, 1989, Flavour and Fragrance Journal, V4, P93, DOI 10.1002/ffj.2730040302; Yang CQ, 2013, PHYTOCHEMISTRY, V96, P46, DOI 10.1016/j.phytochem.2013.09.009; Zhang XZ, 2012, IND CROP PROD, V39, P162, DOI 10.1016/j.indcrop.2012.02.029	66	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222146	10.1371/journal.pone.0222146	http://dx.doi.org/10.1371/journal.pone.0222146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532804	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600023
J	Schumer, G; Hansen, EC; Anders, PJ; Blankenship, SM				Schumer, Gregg; Hansen, Eric C.; Anders, Paul J.; Blankenship, Scott M.			Development of a quantitative polymerase chain reaction assay and environmental DNA sampling methods for Giant Gartersnake (Thamnophis gigas)	PLOS ONE			English	Article							CYTOCHROME-B	The Giant Gartersnake (Thamnophis gigas) is a low density visually evasive species with a low detection probability based on standard field survey methods (e.g., traps, visual census). Habitat loss has resulted in extirpations or serious declines for T. gigas populations throughout the southern two thirds of its historic range. Uncertainty regarding its current distribution and occupancy present management challenges for the species. Enhancing survey sensitivity through development of environmental DNA sampling (eDNA) methods would improve compliance monitoring under the Endangered Species Act, recovery planning for T. gigas, and evaluation of Californias Central Valley tule marsh habitat on which this species depends. To address these needs, we designed and validated diagnostic quantitative Polymerase Chain Reaction (qPCR) assays for identifying portions of the Cytochrome B (CytB) and the Nicotinamide adenine dinucleotide (NADH) dehydrogenase subunit 4 (ND4) genes of the T. gigas mitochondrial genome. The designed ND4 qPCR assay was not specific to T. gigas DNA and amplified DNA from a closely related and spatially co-occurring Thamnophis species (T.s. fitchi). The CytB T. gigas qPCR assay proved specific to a species level with a sensitivity that reliably detected T. gigas DNA at a concentration of 2.0x10-5 ng mu L-1. To assess detection range, coordinated field sampling was conducted at aquatic sites with an observed and documented population of T. gigas. The T. gigas qPCR assay reliably detected DNA from samples taken 300m downstream from the known source. We then used environmental eDNA sampling and qPCR analysis to augment unsuccessful trap surveys in the southern range of T. gigas and detected DNA in 28 of the 52 locations sampled, confirming that T. gigas was still present at some sites where physical trapping failed to identify presence. QPCR-based DNA detection coupled with eDNA sampling methods provides an effective means to obtain critical population metrics from this otherwise cryptic, federally protected and hard to study organism, offering great promise for elucidating patterns of occupancy with greater efficiency and at far less cost than trapping methods, particularly where detection probabilities are low.	[Schumer, Gregg; Blankenship, Scott M.] Cramer Fish Sci Genidaqs, West Sacramento, CA 95691 USA; [Hansen, Eric C.] Eric Hansen Consulting, Sacramento, CA USA; [Anders, Paul J.] Cramer Fish Sci, Moscow, ID USA		Schumer, G (corresponding author), Cramer Fish Sci Genidaqs, West Sacramento, CA 95691 USA.	greggs@fishsciences.net		Blankenship, Scott/0000-0001-6371-9475				Bergman PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153500; Brode J, 1988, SPECIAL PUBLICATION, P25; California Natural Diversity Database, 2016, COMP PRINT SENS SPEC; Casazza Michael L., 2000, Herpetological Review, V31, P91; Dahl T., 1990, WETLANDS LOSSES US 1; Dickert C, 2005, CALIF FISH GAME, V91, P255; Dickert C, 2003, PROGR REPORT SAN JOA; Fish U.S. and Wildlife Service, 2015, 2015 REV DRAFT REC P; Fitch HS, 1940, BIOGEOGRAPHICAL STUD, V44, P1; Frayer WE, 1989, WETLANDS CALIFORNIA, V1; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Halstead BJ, 2009, US GEOLOGICAL SURVEY; Halstead BJ, 2017, EVALUATION EFFICACY; Halstead BJ, 2011, J WILDLIFE MANAGE, V75, P450, DOI 10.1002/jwmg.55; Hansen EC, 2008, IMPLEMENTATION PRIOR; Hansen EC, 2008, COMPLETED PARTIAL FU; Hansen EC, 2011, COMP PATHOLOGY HLTH; Hansen EC, 2004, YEAR 2003 INVESTIGAT; Hansen E, 2017, PLOS BIOL, V15, DOI [10.1371/journal.pbio.200110, 10.1371/journal.pbio.2001110]; Hansen GE, 1996, STATUS GIANT GARTER, P9; Hanson G., 1998, Bericht uber das 4. Alpenlandisches Expertenforum zum Thema 'Zeitgemasse Almbewirtschaftung sowie Bewertung von Almflachen und Waldweiden' am 24. und 25. Marz 1998 an der BAL Gumpenstein., P9; Hanson GE, 1980, STATUS GIANT GARTER; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Sloan J, 2004, PROGR REPORT SAN JOA, P18; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; U.S. Fish and Wildlife Service, 1993, FED REGISTER, V58, P54053; U.S. Fish and Wildlife Service, 1999, DRAFT REC PLAN GIANT; U.S. Fish and Wildlife Service, 2012, SACR FISH WILDL SACR; U.S. Fish and Wildlife Service, 2006, SACR FISH WILDL SACR, V46; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Wylie GD, 2008, SURVEYS CURRENT DIST, P24; Wylie GD, 1997, 1996 PROGR REPORT GI	35	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222493	10.1371/journal.pone.0222493	http://dx.doi.org/10.1371/journal.pone.0222493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525228	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700032
J	Vaca, RA; Golicher, DJ; Rodiles-Hernandez, R; Castillo-Santiago, MA; Bejarano, M; Navarrete-Gutierrez, DA				Abel Vaca, Raul; Golicher, Duncan John; Rodiles-Hernandez, Rocio; Angel Castillo-Santiago, Miguel; Bejarano, Marylin; Alejandro Navarrete-Gutierrez, Dario			Drivers of deforestation in the basin of the Usumacinta River: Inference on process from pattern analysis using generalised additive models	PLOS ONE			English	Article							LAND-COVER CHANGE; DRIVING FORCES; FIRE; FOREST; MEXICO; CONSERVATION; INFORMATION; POPULATION; ECOLOGY; SCIENCE	Quantifying patterns of deforestation and linking these patterns to potentially influencing variables is a key component of modelling and projecting land use change. Statistical methods based on null hypothesis testing are only partially successful for interpreting deforestation in the context of the processes that have led to their formation. Simplifications of cause-consequence relationships that are difficult to support empirically may influence environment and development policies because they suggest simple solutions to complex problems. Deforestation is a complex process driven by multiple proximate and underlying factors and a range of scales. In this study we use a multivariate statistical analysis to provide contextual explanation for deforestation in the Usumacinta River Basin based on partial pattern matching. Our approach avoided testing trivial null hypotheses of lack of association and investigated the strength and form of the response to drivers. As not all factors involved in deforestation are easily mapped as GIS layers, analytical challenges arise due to lack of a one to one correspondence between mappable attributes and drivers. We avoided testing simple statistical hypotheses such as the detectability of a significant linear relationship between deforestation and proximity to roads or water. We developed a series of informative generalised additive models based on combinations of layers that corresponded to hypotheses regarding processes. The importance of the variables representing accessibility was emphasised by the analysis. We provide evidence that land tenure is a critical factor in shaping the decision to deforest and that direct beam insolation has an effect associated with fire frequency and intensity. The effect of winter insolation was found to have many applied implications for land management. The methodology was useful for interpreting the relative importance of sets of variables representing drivers of deforestation. It was an informative approach, thus allowing the construction of a comprehensive understanding of its causes.	[Abel Vaca, Raul; Rodiles-Hernandez, Rocio] Colegio San Luis COLSAN, CONACYT Consorcio Invest Innovac & Desarrollo Zon, Fraccionamiento Colinas Parque, San Luis Potosi, San Luis Potosi, Mexico; [Golicher, Duncan John] Bournemouth Univ, Dept Life & Environm Sci, Poole, Dorset, England; [Angel Castillo-Santiago, Miguel; Alejandro Navarrete-Gutierrez, Dario] Colegio Frontera Sur, Lab Anal Informac Geograf & Estadist, San Cristobal de las Casa, Chiapas, Mexico; [Bejarano, Marylin] Pronat Sur AC, San Cristobal de las Casa, Chiapas, Mexico	Bournemouth University; El Colegio de la Frontera Sur (ECOSUR)	Vaca, RA (corresponding author), Colegio San Luis COLSAN, CONACYT Consorcio Invest Innovac & Desarrollo Zon, Fraccionamiento Colinas Parque, San Luis Potosi, San Luis Potosi, Mexico.	raul.vaca@colsan.edu.mx	Vaca, Raúl/AAF-9324-2020; Castillo-Santiago, Miguel A/B-8371-2014	Vaca, Raúl/0000-0003-0500-1291; Castillo-Santiago, Miguel A/0000-0002-3024-5514; Rodiles-Hernandez, Rocio/0000-0003-0355-5477	Comision Federal de Electricidad (CFE; Federal Electricity Commission); Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology) [265570]; UK Space Agency & Ecometrica Ltd through Forests 2020 project	Comision Federal de Electricidad (CFE; Federal Electricity Commission); Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UK Space Agency & Ecometrica Ltd through Forests 2020 project	This work was supported by the Comision Federal de Electricidad (CFE; Federal Electricity Commission) (https://www.cfe.mx/Pages/Index.aspx) to RRH; the Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology) for grant number 265570 (https://www.conacyt.gob.mx/) to RRH and the he UK Space Agency & Ecometrica Ltd through Forests 2020 project (https://ecometrica.com/space/forests2020) to MACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia J, 2005, WORLD DEV, V33, P219, DOI 10.1016/j.worlddev.2004.07.010; Alvarado E, 2008, ESTUD FRONT, V9, P73; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barbier E.B., 1996, ENVIRON DEV ECON, V1, P203, DOI DOI 10.1017/S1355770X00000590; Beale CM, 2007, ECOGRAPHY, V30, P845, DOI 10.1111/j.2007.0906-7590.05338.x; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Capdepont-Ballina JL, 2014, ESTUDIOS SOCIALES Y, V12, P144; Challenger A, 1998, UTILIZACION CONSERVA; Cherry S, 1998, WILDLIFE SOC B, V26, P947; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Curtin CG, 2002, CONSERV BIOL, V16, P840, DOI 10.1046/j.1523-1739.2002.01212.x; DeFries R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0173; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Ellis EA, 2017, LAND USE POLICY, V69, P474, DOI 10.1016/j.landusepol.2017.09.048; Fletes Ocón Héctor B., 2013, Región y sociedad, V25, P203; Flores-Santiago A., 1986, REV GEOGRAFIA AGRICO, V13-14, P104; Gandin J, 2012, APCBEE PROC, V1, P239, DOI 10.1016/j.apcbee.2012.03.039; Garcia-Barrios L, 2009, BIOSCIENCE, V59, P863, DOI 10.1525/bio.2009.59.10.8; Geist H, 2003, INT FOR REV, V5, P64, DOI 10.1505/IFOR.5.1.64.17426; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Geist HJ, 2001, LUCC REP SER, P136; Pignataro AG, 2016, J ENVIRON MANAGE, V181, P363, DOI 10.1016/j.jenvman.2016.06.036; Geoghegan J., 2004, GeoJournal, V61, P353, DOI 10.1007/s10708-004-5052-x; GRASS Development Team, 2017, GEOGR RES AN SUPP SY; Guerra Martínez Verónica, 2006, Invest. Geog, P7; Hamann R, 1996, ROUNDT M HELD UNPUB; Holland MB, 2014, WORLD DEV, V55, P21, DOI 10.1016/j.worlddev.2013.01.012; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Hudson PH., 2005, RIVERS N AM, V1, P1031, DOI DOI 10.1016/B978-012088253-3/50026-2; Isaac-Marquez R., 2005, UNIV CIENC, V21, P56; Isaac-Márquez Ricardo, 2008, Región y sociedad, V20, P97; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; March Mifsut I.y., 2010, CUENCAS HIDROGR FICA, P193; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; Mena CF, 2006, ENVIRON MANAGE, V37, P802, DOI 10.1007/s00267-003-0230-z; Mendoza E, 1999, BIODIVERS CONSERV, V8, P1621, DOI 10.1023/A:1008916304504; Nahed-Toral J, 2013, J CLEAN PROD, V43, P136, DOI 10.1016/j.jclepro.2012.12.019; Nester MR, 1996, J R STAT SOC C-APPL, V45, P401; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Ramirez-Delgado JP, 2014, GEOCARTO INT, V6049, P1; Ressl R, 2009, REMOTE SENS ENVIRON, V113, P1113, DOI 10.1016/j.rse.2008.10.016; Diaz-Gallegos JR, 2010, SINGAPORE J TROP GEO, V31, P180, DOI 10.1111/j.1467-9493.2010.00396.x; Trejo DAR, 2008, AMBIO, V37, P548, DOI 10.1579/0044-7447-37.7.548; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rzedowski J., 1978, VEGETACION MEXICO; Sanchez-Munguia A., 2005, USO SUELO AGROPECUAR; Sanfiorenzo-Barnhard C, 2009, MT RES DEV, V29, P320, DOI 10.1659/mrd.00013; SENFT RL, 1983, J RANGE MANAGE, V36, P553, DOI 10.2307/3898338; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002; Team RC., 2022, LANG ENV STAT COMP; Therneau TM, 2009, RPART RECURSIVE PART; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vaca RA, 2019, J ENVIRON MANAGE, V230, P392, DOI 10.1016/j.jenvman.2018.09.055; Vaca RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042309; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wyman MS, 2010, APPL GEOGR, V30, P329, DOI 10.1016/j.apgeog.2009.10.001	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222908	10.1371/journal.pone.0222908	http://dx.doi.org/10.1371/journal.pone.0222908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553749	Green Published, gold, Green Accepted			2022-12-27	WOS:000532319200042
J	Armstrong, C; Cassimeris, L; Santos, CD; Micoogullari, Y; Wagner, B; Babasyan, S; Brooks, S; Galantino-Homer, H				Armstrong, Caitlin; Cassimeris, Lynne; Santos, Claire Da Silva; Micoogullari, Yagmur; Wagner, Bettina; Babasyan, Susanna; Brooks, Samantha; Galantino-Homer, Hannah			The expression of equine keratins K42 and K124 is restricted to the hoof epidermal lamellae of Equus caballus	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; GENE CLUSTERS; PROTEINS; NAIL; CELL; MARKERS; DIFFERENTIATION; ORGANIZATION; MODULATORS; BIOMARKERS	The equine hoof inner epithelium is folded into primary and secondary epidermal lamellae which increase the dermo-epidermal junction surface area of the hoof and can be affected by laminitis, a common disease of equids. Two keratin proteins (K), K42 and K124, are the most abundant keratins in the hoof lamellar tissue of Equus caballus. We hypothesize that these keratins are lamellar tissue-specific and could serve as differentiation- and disease-specific markers. Our objective was to characterize the expression of K42 and K124 in equine stratified epithelia and to generate monoclonal antibodies against K42 and K124. By RT-PCR analysis, keratin gene (KRT) KRT42 and KRT124 expression was present in lamellar tissue, but not cornea, haired skin, or hoof coronet. In situ hybridization studies showed that KRT124 localized to the suprabasal and, to a lesser extent, basal cells of the lamellae, was absent from haired skin and hoof coronet, and abruptly transitions from KRT124-negative coronet to KRT124-positive proximal lamellae. A monoclonal antibody generated against full-length recombinant equine K42 detected a lamellar keratin of the appropriate size, but also cross-reacted with other epidermal keratins. Three monoclonal antibodies generated against N- and C-terminal K124 peptides detected a band of the appropriate size in lamellar tissue and did not cross-react with proteins from haired skin, corneal limbus, hoof coronet, tongue, glabrous skin, oral mucosa, or chestnut on immunoblots. K124 localized to lamellar cells by indirect immunofluorescence. This is the first study to demonstrate the localization and expression of a hoof lamellar-specific keratin, K124, and to validate anti-K124 monoclonal antibodies.	[Armstrong, Caitlin; Galantino-Homer, Hannah] Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA; [Cassimeris, Lynne; Santos, Claire Da Silva; Micoogullari, Yagmur] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Wagner, Bettina; Babasyan, Susanna] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Brooks, Samantha] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Brooks, Samantha] Univ Florida, Genet Inst, Gainesville, FL USA; [Micoogullari, Yagmur] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Micoogullari, Yagmur] Harvard Med Sch, Boston, MA 02115 USA	University of Pennsylvania; Lehigh University; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Galantino-Homer, H (corresponding author), Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA.	hghomer@vet.upenn.edu	Brooks, Samantha/ABD-5279-2020	Brooks, Samantha/0000-0002-4500-2689; Wagner, Bettina/0000-0003-2370-6324; Galantino-Homer, Hannah/0000-0002-1435-100X	Lehigh University; Laminitis Research Fund; Raymond Firestone Trust; Tamworth Trust; Animal Health Foundation; American Association of Equine Practitioners Foundation; Grayson-Jockey Club Research Foundation; Bernice Barbour Foundation, Inc. [0048.412012]	Lehigh University; Laminitis Research Fund; Raymond Firestone Trust; Tamworth Trust; Animal Health Foundation; American Association of Equine Practitioners Foundation; Grayson-Jockey Club Research Foundation; Bernice Barbour Foundation, Inc.	This study was supported by: A Faculty Incentive Grant from Lehigh University to LC (https://research.cc.lehigh.edu/finding-funding), Grants from the Laminitis Research Fund to HGH, Raymond Firestone Trust to CA, HGH, and Tamworth Trust to HGH (University of Pennsylvania, School of Veterinary Medicine, https://www.vet.upenn.edu/giving/how-to-support-penn-vet); a grant from the Animal Health Foundation to HGH, (http://www.ahf-laminitis.org/), a grant from the American Association of Equine Practitioners Foundation to HGH (https://foundation.aaep.org/), and a grant from the Grayson-Jockey Club Research Foundation to HGH and BW https://www.grayson-jockeyclub.org/default.asp?section=2&area=Research&menu=2). Tissue bank samples were funded by a grant from the Bernice Barbour Foundation, Inc. to HGH (https://bernicebarbour.org/, #0048.412012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180359; Bragulla H, 2003, J EXP ZOOL PART B, V298B, P140, DOI 10.1002/jez.b.00031; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Carter RA, 2011, EQUINE VET J, V43, P543, DOI 10.1111/j.2042-3306.2010.00325.x; Carter RA, 2010, J ANIM SCI, V88, P3843, DOI 10.2527/jas.2010-2964; Cassimeris L, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1748-x; Clark RK, 2014, EXP DERMATOL, V23, P677, DOI 10.1111/exd.12495; Collins SN, 2010, VET CLIN N AM-EQUINE, V26, P179, DOI 10.1016/j.cveq.2010.01.004; Daradka M, 2004, EQUINE VET J, V36, P236, DOI 10.2746/0425164044877198; Davies HMS, 2007, EQUINE PODIATRY, P42; de Berker D, 2000, BRIT J DERMATOL, V142, P89, DOI 10.1046/j.1365-2133.2000.03246.x; Ehrlich F, 2018, MOL BIOL EVOL; Engiles JB, 2015, VET PATHOL, V52, P928, DOI 10.1177/0300985815588604; Faleiros RR, 2009, J VET INTERN MED, V23, P174, DOI 10.1111/j.1939-1676.2008.0241.x; Fleckman P, 2013, ANAT REC, V296, P521, DOI 10.1002/ar.22660; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALANTINOHOMER H, 2010, J EQUINE VET SCI, V30, P101, DOI DOI 10.1016/j.jevs.2010.01.016; GROSENBAUGH DA, 1992, AM J VET RES, V53, P1859; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hood DM, 1999, VET CLIN N AM-EQUINE, V15, P437, DOI 10.1016/S0749-0739(17)30154-2; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; Karikoski NP, 2014, VET PATHOL; Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; Leise BS, 2015, EQUINE VET J, V47, P478, DOI 10.1111/evj.12283; Liao H, 2007, J DERMATOL SCI, V48, P199, DOI 10.1016/j.jdermsci.2007.07.003; Linardi RL, 2015, VET DERMATOL, V26, P213, DOI 10.1111/vde.12214; Linder S, 2010, EXPERT REV MOL DIAGN, V10, P353, DOI 10.1586/ERM.10.14; Linn SC, 2019, EXP DERMATOL, V28, P383, DOI 10.1111/exd.13759; MacFadden BJ, 1992, FOSSIL HORSES SYSTEM, P229; McGowan KM, 2000, J INVEST DERMATOL, V114, P1101, DOI 10.1046/j.1523-1747.2000.00986.x; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P29, DOI 10.1016/j.cveq.2010.01.005; Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Roland ES, 2005, J BIOMECH, V38, P2102, DOI 10.1016/j.jbiomech.2004.08.024; Schnabel CL, 2018, VET IMMUNOL IMMUNOP, V204, P28, DOI 10.1016/j.vetimm.2018.09.003; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Strnad P, 2012, CURR OPIN GASTROEN, V28, P209, DOI 10.1097/MOG.0b013e3283525cb8; Tong XM, 2004, J INVEST DERMATOL, V122, P965, DOI 10.1111/j.0022-202X.2004.22422.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wagner B, 2003, VET IMMUNOL IMMUNOP, V92, P45, DOI 10.1016/S0165-2427(03)00007-2; Wagner B, 2012, VET IMMUNOL IMMUNOP, V146, P125, DOI 10.1016/j.vetimm.2012.02.007; Wattle O, 2000, ACTA VET SCAND, V41, P363; WATTLE O, 1998, EQUINE VET J S, V26, P66; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Wu P, 2015, P NATL ACAD SCI USA, V112, pE6770, DOI 10.1073/pnas.1520566112; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zimek A, 2006, EUR J CELL BIOL, V85, P83, DOI 10.1016/j.ejcb.2005.10.001	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0219234	10.1371/journal.pone.0219234	http://dx.doi.org/10.1371/journal.pone.0219234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550264	Green Published, Green Submitted, gold			2022-12-27	WOS:000532307700002
J	Goswami, AK; Ramadass, S; Kalaivani, M; Nongkynrih, B; Kant, S; Gupta, SK				Goswami, Anil Kumar; Ramadass, S.; Kalaivani, Mani; Nongkynrih, Baridalyne; Kant, Shashi; Gupta, Sanjeev Kumar			Disability and its association with sociodemographic factors among elderly persons residing in an urban resettlement colony, New Delhi, India	PLOS ONE			English	Article							LIVING ARRANGEMENTS; OLDER-ADULTS; PREVALENCE; HEALTH	Disability prevents an individual from performing to the fullest potential. It is multidimensional. Disability may be physical, mental, social, personal, and environmental or a combination of these. The elderly experience an increased burden of disability, especially in areas where there are limited resources and rapid urbanization. Comparison of reported disability is difficult because several definitions and scales are in use. We used the World Health Organization Disability Assessment Schedule version 2.0 (WHODAS 2.0) to study the prevalence of disability, and its association with sociodemographic factors among elderly persons residing in an urban resettlement colony, New Delhi, India. The WHODAS 2.0 provides continuous summary scores, where higher scores indicate higher disability, and vice versa. Elderly persons aged 60 years and above were selected by simple random sampling in this community-based cross-sectional study. Trained interviewers administered the semi-structured interview schedule and WHODAS 2.0. The prevalence of disability was 7.4% (5.8% - 9.3%) among the 931 participants. The prevalence was higher among females than males. Female sex, elderly aged 70 years and above, and those who were illiterate had increased risk of higher disability scores. Participants who were in government or private service had 50% decreased risk of having higher disability scores. The burden of disability was high among elderly persons residing in this resettlement colony. Community-based holistic interventions are required to mitigate the disability, and to improve the functioning of elderly persons.	[Goswami, Anil Kumar; Ramadass, S.; Nongkynrih, Baridalyne; Kant, Shashi; Gupta, Sanjeev Kumar] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Kalaivani, Mani] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Goswami, AK (corresponding author), All India Inst Med Sci, Ctr Community Med, New Delhi, India.	anilgoswami55@hotmail.com	Sathiyamoorthy, Ramadass/AAA-3735-2022	Sathiyamoorthy, Ramadass/0000-0002-9528-5787; Gupta, Sanjeev/0000-0002-2014-5333	Intramural Research Grant of All India Institute of Medical Sciences, New Delhi, India	Intramural Research Grant of All India Institute of Medical Sciences, New Delhi, India	This study was funded by the Intramural Research Grant of All India Institute of Medical Sciences, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2016, 132 PGDA; Almazan-Isla J, 2014, DISABIL HEALTH J, V7, P78, DOI 10.1016/j.dhjo.2013.08.004; Alvarez AS, 2012, AM J PHYS MED REHAB, V91, pS69, DOI 10.1097/PHM.0b013e31823d4f1c; [Anonymous], 2011, WORLD REP DIS; [Anonymous], 2015, INT J MED PUBLIC HLT; Awasthi A, 2017, DISABIL HEALTH J, V10, P247, DOI 10.1016/j.dhjo.2016.10.011; Central Statistics Office Government of India, 2011, SIT AN ELD IND; Chakrabarty D, 2010, GHANA MED J, V44; Checkley W, 2014, GLOB HEART, V9, P431, DOI 10.1016/j.gheart.2014.11.003; Golandaj JA, 2013, INT J SOCIOL SOC POL, V33, P367, DOI 10.1108/IJSSP-09-2012-0083; Gupta Priti, 2014, Indian J Public Health, V58, P11, DOI 10.4103/0019-557X.128155; Gupta Shubhanshu, 2016, J Family Med Prim Care, V5, P853, DOI 10.4103/2249-4863.201178; Imam AUK, 2016, AMBIO, V45, P442, DOI 10.1007/s13280-015-0763-4; Ingle Gopal K, 2008, Indian J Community Med, V33, P214, DOI 10.4103/0970-0218.43225; Jain M, 2015, HABITAT INT, V48, P87, DOI 10.1016/j.habitatint.2015.03.020; Forjaz MJ, 2015, EUR J INTERN MED, V26, P176, DOI 10.1016/j.ejim.2015.02.016; Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Madden RH, 2014, DISABIL REHABIL, V36, P826, DOI 10.3109/09638288.2013.821182; National Sample Survey Organisation, 2003, DIS PERS IND; Paul Sherin S, 2015, J Family Med Prim Care, V4, P221, DOI 10.4103/2249-4863.154653; Ramadass S, 2018, J Family Med Prim Care, V7, P1177, DOI 10.4103/jfmpc.jfmpc_10_18; Saikia N., 2016, PLOS ONE, V11; Samanta T, 2015, J GERONTOL B-PSYCHOL, V70, P937, DOI 10.1093/geronb/gbu164; Sinalkar D. R., 2015, MEDICAL J DY PATIL U, V8, P594; Singh A, 2016, MALAYS J MED SCI, V23, P44, DOI 10.21315/mjms2016.23.5.6; Ustun B., 2010, MEASURING HLTH DISAB; Velayutham B, 2016, DISABIL HEALTH J, V9, P584, DOI 10.1016/j.dhjo.2016.04.003; Venkatorao T, 2005, Indian J Public Health, V49, P11; Virues-Ortega J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-176; WHO, 2001, WHO INT CLASS FUNCT; Yenneti K, 2017, GEOGR REV, V107, P360, DOI 10.1111/j.1931-0846.2016.12167.x	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222992	10.1371/journal.pone.0222992	http://dx.doi.org/10.1371/journal.pone.0222992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550291	Green Published, gold			2022-12-27	WOS:000532307700039
J	Guevara, M; Vargas, R				Guevara, Mario; Vargas, Rodrigo			Downscaling satellite soil moisture using geomorphometry and machine learning	PLOS ONE			English	Article							PRECIPITATION; PROJECTIONS; VALIDATION; TOPOGRAPHY; FEEDBACKS; PRODUCTS; DYNAMICS; DROUGHT; NETWORK; MODELS	Annual soil moisture estimates are useful to characterize trends in the climate system, in the capacity of soils to retain water and for predicting land and atmosphere interactions. The main source of soil moisture spatial information across large areas (e.g., continents) is satellite-based microwave remote sensing. However, satellite soil moisture datasets have coarse spatial resolution (e.g., 25-50 km grids); and large areas from regional-to-global scales have spatial information gaps. We provide an alternative approach to predict soil moisture spatial patterns (and associated uncertainty) with higher spatial resolution across areas where no information is otherwise available. This approach relies on geomorphometry derived terrain parameters and machine learning models to improve the statistical accuracy and the spatial resolution (from 27km to 1km grids) of satellite soil moisture information across the conterminous United States on an annual basis (1991-2016). We derived 15 primary and secondary terrain parameters from a digital elevation model. We trained a machine learning algorithm (i.e., kernel weighted nearest neighbors) for each year. Terrain parameters were used as predictors and annual satellite soil moisture estimates were used to train the models. The explained variance for all models-years was > 70% (10-fold cross-validation). The 1km soil moisture grids (compared to the original satellite soil moisture estimates) had higher correlations (improving from r(2) = 0.1 to r(2) = 0.46) and lower bias (improving from 0.062 to 0.057 m3/m3) with field soil moisture observations from the North American Soil Moisture Database (n = 668 locations with available data between 19912013; 0-5cm depth). We conclude that the fusion of geomorphometry methods and satellite soil moisture estimates is useful to increase the spatial resolution and accuracy of satellite-derived soil moisture. This approach can be applied to other satellite-derived soil moisture estimates and regions across the world.	[Guevara, Mario; Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA	University of Delaware	Vargas, R (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA.	rvargas@udel.edu	Guevara, Mario/AAH-9539-2019; Vargas, Rodrigo/C-4720-2008	Guevara, Mario/0000-0002-9788-9947; Vargas, Rodrigo/0000-0001-6829-5333	CONACyT [382790]; National Science Foundation CIF21 DIBBs [1724843]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation CIF21 DIBBs	MG acknowledges a fellowship from CONACyT (382790). RV acknowledges support from the National Science Foundation CIF21 DIBBs (Grant #1724843).	Afshar MH, 2017, REMOTE SENS ENVIRON, V196, P224, DOI 10.1016/j.rse.2017.05.017; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Bauer-Marschallingere B, 2019, IEEE T GEOSCI REMOTE, V57, P520, DOI 10.1109/TGRS.2018.2858004; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bindlish R, 2015, IEEE GEOSCI REMOTE S, V12, P923, DOI 10.1109/LGRS.2014.2364151; Borra S, 2010, COMPUT STAT DATA AN, V54, P2976, DOI 10.1016/j.csda.2010.03.004; Brocca L, 2017, WATER-SUI, V9, DOI 10.3390/w9020140; Busch FA, 2012, HYDROL PROCESS, V26, P2696, DOI 10.1002/hyp.8363; Colliander A, 2017, REMOTE SENS ENVIRON, V191, P215, DOI 10.1016/j.rse.2017.01.021; Colliander A, 2017, IEEE GEOSCI REMOTE S, V14, P2107, DOI 10.1109/LGRS.2017.2753203; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cook BD, 2013, REMOTE SENS-BASEL, V5, P4045, DOI 10.3390/rs5084045; Coopersmith EJ, 2016, ADV WATER RESOUR, V98, P122, DOI 10.1016/j.advwatres.2016.10.007; Dai A. G., 2011, Interdisciplinary Reviews: Climate Change, V2, P45, DOI 10.1002/wcc.81; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Dirmeyer PA, 2016, J HYDROMETEOROL, V17, P1049, DOI 10.1175/JHM-D-15-0196.1; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dorigo W, 2017, REMOTE SENS ENVIRON, V203, P185, DOI 10.1016/j.rse.2017.07.001; Dyer J, 2013, J HYDROMETEOROL, V14, P1826, DOI 10.1175/JHM-D-12-0163.1; Easterling DR, 2017, CLIMATE SCI SPECIAL, VI, P207, DOI [DOI 10.7930/J0H993CC, 10.7930/J0H993CC]; Entekhabi D., 2014, SMAP HDB SOIL MOISTU; Entekhabi D, 2010, P IEEE, V98, P704, DOI 10.1109/JPROC.2010.2043918; Florinsky IV, 2012, EURASIAN SOIL SCI+, V45, P445, DOI 10.1134/S1064229312040047; Florinsky IV, 2016, DIGITAL TERRAIN ANALYSIS IN SOIL SCIENCE AND GEOLOGY, 2ND EDITION, P265, DOI 10.1016/B978-0-12-804632-6.00009-2; Greve P, 2018, EARTH SYST DYNAM, V9, P227, DOI 10.5194/esd-9-227-2018; Gruber A, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0170; Guevara M., 1970, PROTOCOL DOWNSCALING, DOI [10.17504/protocols.io.6cahase, DOI 10.17504/PROTOCOLS.IO.6CAHASE]; Guevara M, 2018, SOIL-GERMANY, V4, P173, DOI 10.5194/soil-4-173-2018; He LM, 2017, J GEOPHYS RES-BIOGEO, V122, P1549, DOI 10.1002/2016JG003603; Hechenbichler K., 2006, 399 SFB 386; Hechenbichler K., 2004, WEIGHTED K NEAREST N; Hengl T., 2019, PREDICTIVE SOIL MAPP; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heuvelink G.B. M., 1999, CARTOGRAPHICA, V36, P69; Hiemstra PH, 2009, COMPUT GEOSCI-UK, V35, P1711, DOI 10.1016/j.cageo.2008.10.011; Jin Y, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040579; Kearney MR, 2018, J HYDROL, V561, P662, DOI 10.1016/j.jhydrol.2018.04.040; Lawston PM, 2017, GEOPHYS RES LETT, V44, P11860, DOI 10.1002/2017GL075733; Lindsay JB, 2005, HYDROL PROCESS, V19, P3113, DOI 10.1002/hyp.5835; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Luo YQ, 2016, GLOBAL BIOGEOCHEM CY, V30, P40, DOI 10.1002/2015GB005239; Mason DC, 2016, INT J APPL EARTH OBS, V45, P178, DOI 10.1016/j.jag.2015.02.004; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McColl KA, 2017, NAT GEOSCI, V10, P100, DOI [10.1038/ngeo2868, 10.1038/NGEO2868]; Miralles DG, 2010, J HYDROMETEOROL, V11, P1423, DOI 10.1175/2010JHM1285.1; Molero B, 2016, REMOTE SENS ENVIRON, V180, P361, DOI 10.1016/j.rse.2016.02.045; Montzka C, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10030427; Murguia-Flores F, 2018, GEOSCI MODEL DEV, V11, P2009, DOI 10.5194/gmd-11-2009-2018; Naeimi V, 2012, IEEE T GEOSCI REMOTE, V50, P2566, DOI 10.1109/TGRS.2011.2177667; Naeimi V, 2009, IEEE T GEOSCI REMOTE, V47, P1999, DOI 10.1109/TGRS.2008.2011617; Nelson A, 2009, DEV SOIL SCI, V33, P65, DOI 10.1016/S0166-2481(08)00003-2; Nicolai-Shaw Nadine, 2015, J GEOPHYS RES-ATMOS, V120, P9955, DOI 10.1002/2015JD023305; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; Owe M, 1998, WATER RESOUR RES, V34, P2319, DOI 10.1029/98WR01469; Pellenq J, 2003, J HYDROL, V276, P112, DOI 10.1016/S0022-1694(03)00066-0; Pike RJ, 2009, DEV SOIL SCI, V33, P3, DOI 10.1016/S0166-2481(08)00001-9; Piles M, 2011, IEEE T GEOSCI REMOTE, V49, P3156, DOI 10.1109/TGRS.2011.2120615; Planchon O, 2002, CATENA, V46, P159, DOI 10.1016/S0341-8162(01)00164-3; Quiring SM, 2016, B AM METEOROL SOC, V97, P1441, DOI 10.1175/BAMS-D-13-00263.1; R Core Team, 2018, R LANG ENV STAT COMP; Ranney KJ, 2015, ADV WATER RESOUR, V76, P81, DOI 10.1016/j.advwatres.2014.12.003; Reba ML, 2017, J CONTEMP WAT RES ED, V162, P128, DOI 10.1111/j.1936-704X.2017.03264.x; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Samaniego L, 2018, NAT CLIM CHANGE, V8, P421, DOI 10.1038/s41558-018-0138-5; Schwingshackl C, 2017, J CLIMATE, V30, P7105, DOI [10.1175/JCLI-D-16-0727.1, 10.1175/jcli-d-16-0727.1]; Seneviratne SI, 2013, GEOPHYS RES LETT, V40, P5212, DOI 10.1002/grl.50956; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Singh RS, 2015, WATER RESOUR RES, V51, P2648, DOI 10.1002/2014WR015686; Stocker BD, 2018, NEW PHYTOL, V218, P1430, DOI 10.1111/nph.15123; Tadono T., 2014, ISPRS ANN PHOTOGRAMM, V2, P71, DOI 10.5194/isprsannals-II-4-71-2014; Tuanmu MN, 2014, GLOBAL ECOL BIOGEOGR, V23, P1031, DOI 10.1111/geb.12182; Tuttle S, 2016, SCIENCE, V352, P825, DOI 10.1126/science.aaa7185; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Vargas R, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2030047; Vargas R, 2013, ECOSYSTEMS, V16, P749, DOI 10.1007/s10021-013-9648-1; Vilasa L, 2017, J GEOPHYS RES-ATMOS, V122, P4299, DOI 10.1002/2016JD026099; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Walsh B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14856; Wang A., 2012, TRANSACTIONS OF THE, V28, P164; Warner DL, 2019, AGR FOREST METEOROL, V264, P80, DOI 10.1016/j.agrformet.2018.09.020; Western AW, 1999, WATER RESOUR RES, V35, P797, DOI 10.1029/1998WR900065; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Wilson JP, 2012, GEOMORPHOLOGY, V137, P107, DOI 10.1016/j.geomorph.2011.03.012; Yu G., 2008, DOWNSCALING GLOBAL S, DOI [10.1109/IGARSS.2008.4779325, DOI 10.1109/IGARSS.2008.4779325]	85	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0219639	10.1371/journal.pone.0219639	http://dx.doi.org/10.1371/journal.pone.0219639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550248	gold, Green Published, Green Submitted			2022-12-27	WOS:000532307700003
J	Cohen, Y; Rubin, AE; Galperin, M				Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana			Novel synergistic fungicidal mixtures of oxathiapiprolin protect sunflower seeds from downy mildew caused by Plasmopara halstedii	PLOS ONE			English	Article							BENZOTHIADIAZOLE INDUCES RESISTANCE; SYSTEMIC ACQUIRED-RESISTANCE; INFECTION; METALAXYL	Plenaris (oxathiapiprolin) applied to sunflower seedlings was highly effective in controlling downy mildew incited by the oomycete Plasmopara halstedii. In vitro assays revealed strong suppression of zoospore release and cystospore germination of P.halstedii by Plenaris. Bion (acibenzolar-S-methyl) and Apron (mefenoxam) were partially effective when used singly, but performed synergistically when mixed with Plenaris. Seed treatment (coating) with Plenaris provided dose-dependent control of the disease whereas Bion and Apron provided partial or poor control. However, seeds treated with mixtures containing reduced rates of Plenaris and full rates of Bion and/or Apron provided complete control of the disease due to the synergistic interaction between these components. Such mixtures should be used for seed treatment in the field to minimize selection pressure imposed on the pathogen.	[Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ycohen@biu.ac.il		cohen, yigal/0000-0002-4443-1940				Albourie JM, 1998, EUR J PLANT PATHOL, V104, P235, DOI 10.1023/A:1008691123239; Ban R, 2004, DEV PLANT PATHOL, V16, P265; COHEN Y, 1974, CAN J BOT, V52, P231, DOI 10.1139/b74-027; COHEN Y, 1973, CAN J BOT, V51, P15, DOI 10.1139/b73-003; Cohen Y, 2018, PHYTOPARASITICA, V46, P689, DOI 10.1007/s12600-018-0702-6; Cohen Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204523; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140015; Gascuel Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148513; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Gulya T, 2019, PLANT DIS, V103, P601, DOI 10.1094/PDIS-06-18-0980-FE; Iwebor M., 2018, Helia, V41, P141, DOI 10.1515/helia-2018-0015; Korosi K, 2011, J PHYTOPATHOL, V159, P471, DOI 10.1111/j.1439-0434.2011.01787.x; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1263; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; LEVY Y, 1986, Bulletin OEPP, V16, P651, DOI 10.1111/j.1365-2338.1986.tb00338.x; Miao JQ, 2018, PHYTOPATHOLOGY, V108, P1412, DOI 10.1094/PHYTO-01-18-0010-R; Miao JQ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00615; Molinero-Ruiz M. L., 2005, Helia, V28, P65, DOI 10.2298/HEL0542065M; Molinero-Ruiz ML, 2002, PLANT DIS, V86, P736, DOI 10.1094/PDIS.2002.86.7.736; Pasteris RJ, 2016, BIOORGAN MED CHEM, V24, P354, DOI 10.1016/j.bmc.2015.07.064; Perez L, 2003, CROP PROT, V22, P405, DOI 10.1016/S0261-2194(02)00198-9; Ramasamy AD, 2015, J HORTIC SCI BIOTECH, V90, P63, DOI 10.1080/14620316.2015.11513154; Ruiz M. L. M., 2000, P 15 INT SUNFL C TOU, pG11; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1904-7; Spring O, 2006, J PLANT DIS PROTECT, V113, P224, DOI 10.1007/BF03356185; Spring O., 2000, Helia, V23, P19; Spring O, 2009, FUNGAL ECOL, V2, P75, DOI 10.1016/j.funeco.2008.12.003; Spring O, 2001, Z PFLANZENK PFLANZEN, V108, P329; Spring O, 2018, CRIT REV PLANT SCI, V37, P439, DOI 10.1080/07352689.2018.1530848; Spring O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167015; Tosi L, 1999, J PHYTOPATHOL, V147, P365, DOI 10.1046/j.1439-0434.1999.00097.x; Trojanova Z, 2017, PLANT PATHOL, V66, P171, DOI 10.1111/ppa.12593; Viranyi F., 2015, Helia, V38, P149, DOI 10.1515/helia-2015-0009; Viranyi F, 2018, DATASHEET PLASMOPARA; Weber-Boyvat M, 2013, BIOCHEM PHARMACOL, V86, P89, DOI 10.1016/j.bcp.2013.02.016	36	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222827	10.1371/journal.pone.0222827	http://dx.doi.org/10.1371/journal.pone.0222827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545821	Green Published, gold			2022-12-27	WOS:000532303200037
J	Hayakawa, E; Watanabe, H; Menschaert, G; Holstein, TW; Baggerman, G; Schoofs, L				Hayakawa, Eisuke; Watanabe, Hiroshi; Menschaert, Gerben; Holstein, Thomas W.; Baggerman, Geert; Schoofs, Liliane			A combined strategy of neuropeptide prediction and tandem mass spectrometry identifies evolutionarily conserved ancient neuropeptides in the sea anemone Nematostella vectensis	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; ANTHO-RFAMIDE; DROSOPHILA-MELANOGASTER; ENDOGENOUS PEPTIDES; LOCUSTA-MIGRATORIA; MOLECULAR-CLONING; NERVOUS-SYSTEM; PEPTIDOMICS; HYDRA; PRECURSOR	Neuropeptides are a class of bioactive peptides shown to be involved in various physiological processes, including metabolism, development, and reproduction. Although neuropeptide candidates have been predicted from genomic and transcriptomic data, comprehensive characterization of neuropeptide repertoires remains a challenge owing to their small size and variable sequences. De novo prediction of neuropeptides from genome or transcriptome data is difficult and usually only efficient for those peptides that have identified orthologs in other animal species. Recent peptidomics technology has enabled systematic structural identification of neuropeptides by using the combination of liquid chromatography and tandem mass spectrometry. However, reliable identification of naturally occurring peptides using a conventional tandem mass spectrometry approach, scanning spectra against a protein database, remains difficult because a large search space must be scanned due to the absence of a cleavage enzyme specification. We developed a pipeline consisting of in silico prediction of candidate neuropeptides followed by peptide-spectrum matching. This approach enables highly sensitive and reliable neuropeptide identification, as the search space for peptide-spectrum matching is highly reduced. Nematostella vectensis is a basal eumetazoan with one of the most ancient nervous systems. We scanned the Nematostella protein database for sequences displaying structural hallmarks typical of eumetazoan neuropeptide precursors, including amino- and carboxyterminal motifs and associated modifications. Peptide-spectrum matching was performed against a dataset of peptides that are cleaved in silico from these putative peptide precursors. The dozens of newly identified neuropeptides display structural similarities to bilaterian neuropeptides including tachykinin, myoinhibitory peptide, and neuromedin-U/pyrokinin, suggesting these neuropeptides occurred in the eumetazoan ancestor of all animal species.	[Hayakawa, Eisuke; Schoofs, Liliane] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Hayakawa, Eisuke; Watanabe, Hiroshi] Okinawa Inst Sci & Technol, Evolutionary Neurobiol Unit, Onna, Okinawa, Japan; [Watanabe, Hiroshi; Holstein, Thomas W.] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Menschaert, Gerben] Univ Ghent, Fac Biosci Engn, Lab Bioinformat & Computat Genom, Ghent, Belgium; [Baggerman, Geert] Univ Antwerp, CFP Ceproma, Antwerp, Belgium; [Baggerman, Geert] Appl Bio & Mol Syst ABS, VITO, Mol, Belgium	KU Leuven; Okinawa Institute of Science & Technology Graduate University; Ruprecht Karls University Heidelberg; Ghent University; University of Antwerp; VITO	Hayakawa, E (corresponding author), Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium.; Hayakawa, E (corresponding author), Okinawa Inst Sci & Technol, Evolutionary Neurobiol Unit, Onna, Okinawa, Japan.	eisuke.hayakawa@oist.jp	Watanabe, Hiroshi/GOP-0177-2022; schoofs, liliane/ABD-2943-2020	Watanabe, Hiroshi/0000-0001-8887-5407; Holstein, Thomas/0000-0003-0480-4674; Hayakawa, Eisuke/0000-0003-1054-4266; Baggerman, Geert/0000-0002-0661-931X	KU Leuven Research Foundation [C14/15/049]	KU Leuven Research Foundation	The work was supported by KU Leuven Research Foundation grant C14/15/049 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2017, PEPTIDES, V93, P51, DOI 10.1016/j.peptides.2017.05.005; ANASTASI A, 1963, ARCH BIOCHEM BIOPHYS, V101, P56, DOI 10.1016/0003-9861(63)90533-2; ANCTIL M, 1989, GEN PHARMACOL, V20, P381, DOI 10.1016/0306-3623(89)90277-2; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Boonen K, 2007, GEN COMP ENDOCR, V152, P231, DOI 10.1016/j.ygcen.2007.05.002; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; CHIWAKATA C, 1991, ENDOCRINOLOGY, V128, P2441, DOI 10.1210/endo-128-5-2441; Christie AE, 2014, GEN COMP ENDOCR, V201, P87, DOI 10.1016/j.ygcen.2014.02.015; Clynen E, 2001, EUR J BIOCHEM, V268, P1929, DOI 10.1046/j.1432-1327.2001.02067.x; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Conlon JM, 2005, GEN COMP ENDOCR, V142, P53, DOI 10.1016/j.ygcen.2004.11.016; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; CUPO A, 1983, NEUROPEPTIDES, V3, P309, DOI 10.1016/0143-4179(83)90048-3; Dallas DC, 2015, PROTEOMICS, V15, P1026, DOI 10.1002/pmic.201400310; DARMER D, 1991, P NATL ACAD SCI USA, V88, P2555, DOI 10.1073/pnas.88.6.2555; Darmer D, 1998, BIOCHEM J, V332, P403, DOI 10.1042/bj3320403; De Haes W, 2015, BBA-PROTEINS PROTEOM, V1854, P812, DOI 10.1016/j.bbapap.2014.12.011; DELOOF A, 1990, COMP BIOCHEM PHYS B, V95, P459, DOI 10.1016/0305-0491(90)90003-C; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Duportets L, 1999, PEPTIDES, V20, P899, DOI 10.1016/S0196-9781(99)00079-0; EMESON RB, 1984, J NEUROSCI, V4, P2604; Falth M, 2007, MOL CELL PROTEOMICS, V6, P1188, DOI 10.1074/mcp.M700016-MCP200; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2005, AAPS J, V7, DOI 10.1208/aapsj070244; Fu Q, 2007, J NEUROCHEM, V101, P1099, DOI 10.1111/j.1471-4159.2007.04482.x; Fujisawa T, 2012, INT J DEV BIOL, V56, P543, DOI 10.1387/ijdb.113477tf; Gajewski M, 1996, ROUX ARCH DEV BIOL, V205, P232, DOI 10.1007/BF00365801; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; GRIMMELIKHUIJZEN CJP, 1992, BIOCHEM BIOPH RES CO, V183, P375, DOI 10.1016/0006-291X(92)90491-3; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; HARADA M, 1982, BIOCHIM BIOPHYS ACTA, V705, P288, DOI 10.1016/0167-4838(82)90191-1; Hauser Frank, 2006, Briefings in Functional Genomics & Proteomics, V4, P321, DOI 10.1093/bfgp/eli003; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hayakawa E, 2007, FEBS J, V274, P5438, DOI 10.1111/j.1742-4658.2007.06071.x; Hayakawa E, 2013, J PROTEOME RES, V12, P5410, DOI 10.1021/pr400446z; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Hoshino A, 2012, C SERIES NEUROPEPTID, V1, P1, DOI DOI 10.4199/C00050ED1V01Y201112NPE001; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Jang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01794-9; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; LEUNG PS, 1992, REGUL PEPTIDES, V41, P71, DOI 10.1016/0167-0115(92)90515-V; LEVIEV I, 1995, P NATL ACAD SCI USA, V92, P11647, DOI 10.1073/pnas.92.25.11647; Lim J, 2006, J NEUROCHEM, V96, P1169, DOI 10.1111/j.1471-4159.2005.03614.x; LORENZ MW, 1995, J BIOL CHEM, V270, P21103, DOI 10.1074/jbc.270.36.21103; LUNDQUIST CT, 1994, PEPTIDES, V15, P761, DOI 10.1016/0196-9781(94)90027-2; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; MCFARLANE ID, 1991, J EXP BIOL, V156, P419; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Neupert S, 2009, PEPTIDES, V30, P483, DOI 10.1016/j.peptides.2008.11.009; Oh Y, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001974; Pauls D., 2014, EUPA OPEN PROTEOM, V3, P114; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petruzziello F, 2012, J PROTEOME RES, V11, P886, DOI 10.1021/pr200709j; Peymen K, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007945; Predel R, 2001, J INSECT PHYSIOL, V47, P311, DOI 10.1016/S0022-1910(00)00129-3; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; REINSCHEID RK, 1994, J NEUROCHEM, V62, P1214; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; SCHMUTZLER C, 1992, J BIOL CHEM, V267, P22534; SCHOOFS L, 1991, REGUL PEPTIDES, V36, P111, DOI 10.1016/0167-0115(91)90199-Q; SCHOOFS L, 1988, PEPTIDES, V9, P1027, DOI 10.1016/0196-9781(88)90084-8; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Takahashi T, 2008, ACTA BIOL HUNG, V59, P227, DOI 10.1556/ABiol.59.2008.Suppl.32; Takahashi T, 2000, DEVELOPMENT, V127, P997; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Van Bael S, 2018, J BIOL CHEM, V293, P6052, DOI [10.1074/jbc.RA117.000731, 10.1074/jbc.ra117.000731]; Van Camp KA, 2018, METHODS MOL BIOL, V1719, P241, DOI 10.1007/978-1-4939-7537-2_16; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Watanabe H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6536; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; Yamanaka N, 2010, P NATL ACAD SCI USA, V107, P2060, DOI 10.1073/pnas.0907471107; Yum S, 1998, BIOCHEM BIOPH RES CO, V248, P584, DOI 10.1006/bbrc.1998.8831; Yum S, 1998, FEBS LETT, V439, P31, DOI 10.1016/S0014-5793(98)01314-3; Zhang XZ, 2012, J PROTEOME RES, V11, P2819, DOI 10.1021/pr3001699; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	88	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0215185	10.1371/journal.pone.0215185	http://dx.doi.org/10.1371/journal.pone.0215185			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545805	gold, Green Published, Green Submitted			2022-12-27	WOS:000532303200003
J	Stegemoller, EL; Zaman, A; Uzochukwu, J				Stegemoller, Elizabeth L.; Zaman, Andrew; Uzochukwu, Jennifer			Repetitive finger movement and circle drawing in persons with Parkinson's disease	PLOS ONE			English	Article							CORTICAL OSCILLATIONS; SIZE; PERFORMANCE	Little is known regarding how repetitive finger movement performance impacts other fine motor control tasks, such as circle drawing, in persons with Parkinson's disease (PD). Previous research has shown that impairments in repetitive finger movements emerge at rates near to and above 2 Hz in most persons with PD. Thus, the purpose of this study was to compare circle drawing performance in persons with PD that demonstrate impairment in repetitive finger movement and those that do not. Twenty-two participants with PD and twelve healthy older adults completed the study. Only participants with PD completed the repetitive finger movement task. From the kinematic data for the repetitive finger movement task, participants were grouped into Hasteners and Non-Hasteners. Participants with PD and the healthy older adults completed a series of circle drawing tasks at two different target sizes (1 cm and 2 cm) and three pacing conditions (Self-paced, 1.25 Hz, and 2.5 Hz). Kinematic and electromyography data were recorded and compared between groups. Results revealed that, in general, persons with PD demonstrate impairments in circle drawing and associated electromyography activity compared to healthy older adults. Moreover, persons with PD that hasten during repetitive finger movements demonstrate significantly increased movement rate during circle drawing, while those persons with PD that do not hasten demonstrate a significant increase in width variability. This suggests that differing motor control mechanisms may play a role in the performance of fine motor tasks in persons with PD. Continued research is needed to better understand differences in circle drawing performance among persons with PD to inform future development of patient-centered treatments.	[Stegemoller, Elizabeth L.; Zaman, Andrew; Uzochukwu, Jennifer] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Uzochukwu, Jennifer] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA	Iowa State University; University of Alabama System; University of Alabama Birmingham	Stegemoller, EL (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	esteg@iastate.edu		Stegemoller, Elizabeth/0000-0002-5287-2295				Agostino R, 2013, MOVEMENT DISORD, V18, P560; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; Dounskaia N, 2009, NEUROPSYCHOLOGIA, V47, P2504, DOI 10.1016/j.neuropsychologia.2009.04.020; Ginis P, 2018, ANN PHYS REHABIL MED, V61, P407, DOI 10.1016/j.rehab.2017.08.002; Letanneux A, 2014, MOVEMENT DISORD, V29, P1467, DOI 10.1002/mds.25990; Nackaerts E, 2016, NEUROREHAB NEURAL RE, V30, P431, DOI 10.1177/1545968315601361; PHILLIPS JG, 1994, J NEUROL, V241, P439, DOI 10.1007/BF00900963; Rocha PA, 2014, CLIN NEUROL NEUROSUR, V124, P127, DOI 10.1016/j.clineuro.2014.06.026; Smits EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097614; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Stegemoller EL, 2016, CLIN NEUROPHYSIOL, V127, P664, DOI 10.1016/j.clinph.2015.05.014; Stegemoller EL, 2009, MOVEMENT DISORD, V24, P1162, DOI 10.1002/mds.22535; Stegemoller EL, 2018, NEUROL RES, V22, P1; Stegemoller E, 2016, HUM MOVEMENT SCI, V49, P116, DOI 10.1016/j.humov.2016.06.015; Stegemoller EL, 2017, BEHAV BRAIN RES, V317, P141, DOI 10.1016/j.bbr.2016.09.036; Toma K, 2002, J NEUROPHYSIOL, V88, P3377, DOI 10.1152/jn.00281.2002; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Uzochukwu JC, 2019, J OCC THER, DOI [10.5014/ajot.2019.028738, DOI 10.5014/AJOT.2019.028738]; Van Gemmert AWA, 1999, NEUROPSYCHOLOGIA, V37, P685; Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502; Van Gemmert AWA, 2001, BRAIN COGNITION, V47, P504, DOI 10.1006/brcg.2001.1328; Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111; Zaman A.F., 2018, J NEUROL RES, V8, P26	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222862	10.1371/journal.pone.0222862	http://dx.doi.org/10.1371/journal.pone.0222862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545827	Green Published, gold			2022-12-27	WOS:000532303200038
J	Minami, T; Tachikawa, R; Matsumoto, T; Murase, K; Tanizawa, K; Inouchi, M; Handa, T; Oga, T; Hirai, T; Chin, K				Minami, Takuma; Tachikawa, Ryo; Matsumoto, Takeshi; Murase, Kimihiko; Tanizawa, Kiminobu; Inouchi, Morito; Handa, Tomohiro; Oga, Toru; Hirai, Toyohiro; Chin, Kazuo			Adrenal gland size in obstructive sleep apnea: Morphological assessment of hypothalamic pituitary adrenal axis activity	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; METABOLIC SYNDROME; MAJOR DEPRESSION; VISCERAL FAT; CORTISOL; VOLUME; CT; CATECHOLAMINES; ASSOCIATIONS; POPULATION	Objectives The association of obstructive sleep apnea (OSA) with hypothalamic pituitary adrenal (HPA) axis activation has not been fully understood from results of previous studies using hormonal assessments. We aimed to investigate the relationship between adrenal size, a potential marker reflecting HPA axis activity, and sleep parameters related to OSA. Methods We retrospectively reviewed data on 284 consecutive adult patients aged 20 to 80 y who had undergone polysomnography and abdominal computed tomography (CT). OSA was defined as none/mild (apnea-hypopnea index [AHI] < 15, n = 75), moderate (AHI 15 to 30, n = 80), and severe OSA (AHI >= 30, n = 129). Widths of adrenal body and limbs were measured by abdominal CT. Results Adrenal size was greater in participants with severe OSA than in those with none/mild or moderate OSA (adrenal body width: 6.03 mm, none/mild OSA; 6.09 mm, moderate OSA; 6.78 mm, severe OSA; p < 0.001; adrenal limb width: 3.75 mm, none/mild OSA; 3.95 mm, moderate OSA; 4.26 mm, severe OSA, p < 0.001). Multivariate regression analysis showed that not the 3% oxygen desaturation index and time of SpO(2) < 90% but a higher arousal index was the only determinant factor for increased adrenal limb width (beta = 0.27, p < 0.001) after adjusting for other variables that could affect adrenal size. Neither the arousal index nor hypoxic parameters were associated with adrenal body width. Conclusions Results indicated that adrenal glands may enlarge in response to long-standing sleep fragmentation, suggesting the involvement of OSA in HPA axis augmentation.	[Minami, Takuma; Tachikawa, Ryo; Matsumoto, Takeshi; Handa, Tomohiro; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Murase, Kimihiko; Tanizawa, Kiminobu; Inouchi, Morito; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Oga, Toru] Kawasaki Med Sch, Dept Resp Med, Kurashiki, Okayama, Japan	Kyoto University; Kyoto University; Kawasaki Medical School	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Matsumoto, Takeshi/AAR-4323-2020; Tanizawa, Kiminobu/GPC-4728-2022	Minami, Takuma/0000-0001-7353-1142; Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology [26293198, 17H04182]; Intractable Respiratory Diseases and Pulmonary Hypertension Research Group; Ministry of Health, Labor and Welfare in Japan [H29-intractable diseases-general-027]; Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants; Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan [H28-iryo-ippan-016, H30-iryo-ippan-009]; Japan Agency for Medical Research and Development [JP18ek0210096]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intractable Respiratory Diseases and Pulmonary Hypertension Research Group; Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants; Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (26293198, 17H04182), the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, the Ministry of Health, Labor and Welfare in Japan (H29-intractable diseases-general-027), the Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants, Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan (H28-iryo-ippan-016, H30-iryo-ippan-009), and Japan Agency for Medical Research and Development under Grant Number JP18ek0210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; BaHammam AS, 2016, SLEEP BREATH, V20, P447, DOI 10.1007/s11325-015-1223-x; Barcelo A, 2008, THORAX, V63, P946, DOI 10.1136/thx.2007.093740; Bisogni V, 2016, J THORAC DIS, V8, P243, DOI 10.3978/j.issn.2072-1439.2015.11.14; Bjorvatn B, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12647; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; Carsin-Vu A, 2016, EUR RADIOL, V26, P2494, DOI 10.1007/s00330-015-4063-y; Chin K, 2010, SLEEP, V33, P89, DOI 10.1093/sleep/33.1.89; Chin KZ, 1999, CIRCULATION, V100, P706, DOI 10.1161/01.CIR.100.7.706; Chopra S, 2017, J CLIN ENDOCR METAB, V102, P3172, DOI 10.1210/jc.2017-00619; DOBBIE JW, 1966, J ENDOCRINOL, V34, P479, DOI 10.1677/joe.0.0340479; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Elder GJ, 2014, SLEEP MED REV, V18, P215, DOI 10.1016/j.smrv.2013.05.001; Elmasry A, 2002, EUR RESPIR J, V19, P511, DOI 10.1183/09031936.02.00106402; FOLLENIUS M, 1991, SLEEP, V14, P211; Godoy-Matos AF, 2006, J ENDOCRINOL INVEST, V29, P159, DOI 10.1007/BF03344090; Gulmez I, 1996, ENDOCR J, V43, P573, DOI 10.1507/endocrj.43.573; Harada Yuka, 2014, Ann Am Thorac Soc, V11, P383, DOI 10.1513/AnnalsATS.201306-182OC; Hu MX, 2016, EUR RADIOL, V26, P4475, DOI 10.1007/s00330-016-4331-5; Iber C., 2007, AASM MANUAL SCORING; Imaki T, 2004, ENDOCR J, V51, P89, DOI 10.1507/endocrj.51.89; Jenkins PJ, 1999, BRIT J CANCER, V80, P1815, DOI 10.1038/sj.bjc.6690603; Kritikou I, 2016, EUR RESPIR J, V47, P531, DOI 10.1183/13993003.00319-2015; Lingam RK, 2003, AM J ROENTGENOL, V181, P843, DOI 10.2214/ajr.181.3.1810843; Loredo JS, 1999, CHEST, V116, P655, DOI 10.1378/chest.116.3.655; Ma S, 2008, NEUROSCIENCE, V154, P1639, DOI 10.1016/j.neuroscience.2008.04.068; Mansukhani MP, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0476-2; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Nougaret S, 2010, EUR RADIOL, V20, P2348, DOI 10.1007/s00330-010-1804-9; Rubin RT, 1996, BIOL PSYCHIAT, V40, P89, DOI 10.1016/0006-3223(95)00358-4; RUBIN RT, 1995, ARCH GEN PSYCHIAT, V52, P213; RUBIN RT, 1991, INVEST RADIOL, V26, P465, DOI 10.1097/00004424-199105000-00015; Sasanabe R, 2006, HYPERTENS RES, V29, P315, DOI 10.1291/hypres.29.315; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Schmoller A, 2009, METABOLISM, V58, P848, DOI 10.1016/j.metabol.2009.02.014; Schneller J, 2014, ACAD RADIOL, V21, P1465, DOI 10.1016/j.acra.2014.06.008; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sohaib SA, 1999, AM J ROENTGENOL, V172, P997, DOI 10.2214/ajr.172.4.10587135; SPATHSCHWALBE E, 1991, BIOL PSYCHIAT, V29, P575, DOI 10.1016/0006-3223(91)90093-2; Suzuki M, 1996, SLEEP, V19, P382, DOI 10.1093/sleep/19.5.382; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Taylor KS, 2016, HYPERTENSION, V68, P1467, DOI 10.1161/HYPERTENSIONAHA.116.08212; Tomfohr LM, 2012, SLEEP MED REV, V16, P243, DOI 10.1016/j.smrv.2011.05.003; Tsatsoulis A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030037; Vgontzas AN, 2007, J CLIN ENDOCR METAB, V92, P4199, DOI 10.1210/jc.2007-0774; VINCENT JM, 1994, CLIN RADIOL, V49, P453, DOI 10.1016/S0009-9260(05)81739-8; Yildiz O, 2005, ENDOCR J, V52, P183, DOI 10.1507/endocrj.52.183; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222592	10.1371/journal.pone.0222592	http://dx.doi.org/10.1371/journal.pone.0222592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539392	Green Published, gold			2022-12-27	WOS:000532297900018
J	Ger, RB; Zhou, SH; Elgohari, B; Elhalawani, H; Mackin, DM; Meier, JG; Nguyen, CM; Anderson, BM; Gay, C; Ning, J; Fuller, CD; Li, H; Howell, RM; Layman, RR; Mawlawi, O; Stafford, RJ; Aerts, H; Court, LE				Ger, Rachel B.; Zhou, Shouhao; Elgohari, Baher; Elhalawani, Hesham; Mackin, Dennis M.; Meier, Joseph G.; Nguyen, Callistus M.; Anderson, Brian M.; Gay, Casey; Ning, Jing; Fuller, Clifton D.; Li, Heng; Howell, Rebecca M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Aerts, Hugo; Court, Laurence E.			Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients	PLOS ONE			English	Article							CELL LUNG-CANCER; PROGNOSTIC VALUE; RECONSTRUCTION SETTINGS; TEXTURE FEATURES; IMPACT; CHEMORADIOTHERAPY; VARIABILITY; VOLUME	Radiomics studies require many patients in order to power them, thus patients are often combined from different institutions and using different imaging protocols. Various studies have shown that imaging protocols affect radiomics feature values. We examined whether using data from cohorts with controlled imaging protocols improved patient outcome models. We retrospectively reviewed 726 CT and 686 PET images from head and neck cancer patients, who were divided into training or independent testing cohorts. For each patient, radiomics features with different preprocessing were calculated and two clinical variables-HPV status and tumor volume-were also included. A Cox proportional hazards model was built on the training data by using bootstrapped Lasso regression to predict overall survival. The effect of controlled imaging protocols on model performance was evaluated by subsetting the original training and independent testing cohorts to include only patients whose images were obtained using the same imaging protocol and vendor. Tumor volume, HPV status, and two radiomics covariates were selected for the CT model, resulting in an AUC of 0.72. However, volume alone produced a higher AUC, whereas adding radiomics features reduced the AUC. HPV status and one radiomics feature were selected as covariates for the PET model, resulting in an AUC of 0.59, but neither covariate was significantly associated with survival. Limiting the training and independent testing to patients with the same imaging protocol reduced the AUC for CT patients to 0.55, and no covariates were selected for PET patients. Radiomics features were not consistently associated with survival in CT or PET images of head and neck patients, even within patients with the same imaging protocol.	[Ger, Rachel B.; Mackin, Dennis M.; Nguyen, Callistus M.; Gay, Casey; Li, Heng; Howell, Rebecca M.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Ger, Rachel B.; Zhou, Shouhao; Mackin, Dennis M.; Meier, Joseph G.; Anderson, Brian M.; Fuller, Clifton D.; Li, Heng; Howell, Rebecca M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Court, Laurence E.] MD Anderson Canc Ctr, UTHlth Sci Ctr, Houston Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhou, Shouhao; Ning, Jing] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Elgohari, Baher; Elhalawani, Hesham; Fuller, Clifton D.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Meier, Joseph G.; Anderson, Brian M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Aerts, Hugo] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Ger, RB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Ger, RB (corresponding author), MD Anderson Canc Ctr, UTHlth Sci Ctr, Houston Grad Sch Biomed Sci, Houston, TX 77030 USA.	rbger@mdanderson.org	Anderson, Brian Mark/ABB-1934-2021; Aerts, Hugo/ABF-2821-2020; Fuller, Clifton D./AAB-4012-2019	Anderson, Brian Mark/0000-0002-2748-1444; Aerts, Hugo/0000-0002-2122-2003; Fuller, Clifton D./0000-0002-5264-3994; Mackin, Dennis/0000-0002-2557-5340; Elgohari, Baher/0000-0001-7694-6466; Court, Laurence/0000-0002-3241-6145; Layman, Rick R/0000-0003-0185-3390; Ger, Rachel/0000-0003-1244-7160; Meier, Joseph/0000-0001-6794-9200; Elhalawani, Hesham/0000-0001-9848-2623	NCI Grants [R21CA216572, P30CA016672]; Rosalie B. Hite Graduate Fellowship in Cancer Research - MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences; NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award [P50 CA097007-10]; National Institutes of Health (NIH); National Institute for Dental and Craniofacial Research Award [1R01DE025248-01/R56DE025248-01]; National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program [1R01CA218148-01]; National Science Foundation (NSF), Division of Mathematical Sciences; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award [1R01CA214825-01]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program [R25EB025787]; Elekta AB; NATIONAL CANCER INSTITUTE [R01CA214825, R21CA216572, P30CA016672, R01CA218148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R25EB025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025248] Funding Source: NIH RePORTER	NCI Grants; Rosalie B. Hite Graduate Fellowship in Cancer Research - MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences; NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Dental and Craniofacial Research Award; National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program; National Science Foundation (NSF), Division of Mathematical Sciences(National Science Foundation (NSF)); NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award; National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program; Elekta AB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NCI Grants R21CA216572 and P30CA016672. Rachel Ger is supported by the Rosalie B. Hite Graduate Fellowship in Cancer Research awarded by MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences. Dr. Elhalawani was supported in part by the philanthropic donations from the Family of Paul W. Beach to Dr. G. Brandon Gunn, MD. Drs. Elhalawani and Fuller receive funding and projectrelevant salary support from NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007-10). Dr. Fuller is a Sabin Family Foundation Fellow. Dr. Fuller receives funding and project-relevant salary support from the National Institutes of Health (NIH), including: National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248-01); National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148-01); National Science Foundation (NSF), Division of Mathematical Sciences; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01); and National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). Dr. Fuller has received direct industry grant support and travel funding from Elekta AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Bogowicz M, 2017, ACTA ONCOL, V56, P1531, DOI 10.1080/0284186X.2017.1346382; Bogowicz M, 2017, INT J RADIAT ONCOL, V99, P921, DOI 10.1016/j.ijrobp.2017.06.002; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Cook GJ, 2018, INT J RAD ONCOLOGY B; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fave X, 2016, TRANSL CANCER RES, V5, P349, DOI 10.21037/tcr.2016.07.11; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Feliciani G, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/3574310; Folkert MR, 2017, PHYS MED BIOL, V62, P5327, DOI 10.1088/1361-6560/aa73cc; Foy JJ, 2018, MED IMAGING 2018 COM; Fried DV, 2016, RADIOLOGY, V278, P214, DOI 10.1148/radiol.2015142920; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Ger RB, 2018, COMPUT MED IMAG GRAP, V69, P134, DOI 10.1016/j.compmedimag.2018.09.002; Ger RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31509-z; Ger RB, 2018, JOVE; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Kann BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32441-y; Kuno H, 2017, AM J NEURORADIOL, V38, P2334, DOI 10.3174/ajnr.A5407; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Mackin D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20713-6; Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Orlhac F, 2018, J NUCL MED, V59, P1321, DOI 10.2967/jnumed.117.199935; Ou D, 2017, ORAL ONCOL, V71, P150, DOI 10.1016/j.oraloncology.2017.06.015; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Shiri I, 2017, EUR RADIOL, V27, P4498, DOI 10.1007/s00330-017-4859-z; Thawani R., 2017, LUNG CANC; Vallieres M., 2017, DATA HEAD NECK PET C; Vallieres M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10371-5; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Vial A, 2018, TRANSL CANCER RES, V7, P803, DOI 10.21037/tcr.2018.05.02; Wu J, 2019, INT J RADIAT ONCOL, V104, P942, DOI 10.1016/j.ijrobp.2019.03.036; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Zhang Lifei, 2015, Med Phys, V42, P1341, DOI 10.1118/1.4908210; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	41	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222509	10.1371/journal.pone.0222509	http://dx.doi.org/10.1371/journal.pone.0222509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536526	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800049
J	Rollin, G; Lages, J; Shepelyansky, DL				Rollin, Guillaume; Lages, Josr; Shepelyansky, Dima L.			Wikipedia network analysis of cancer interactions and world influence	PLOS ONE			English	Article							GASTRIC-CANCER; EPIDEMIOLOGY; COUNTRIES; MORTALITY	We apply the Google matrix algorithms for analysis of interactions and influence of 37 cancer types, 203 cancer drugs and 195 world countries using the network of 5 416 537 English Wikipedia articles with all their directed hyperlinks. The PageRank algorithm provides a ranking of cancers which has 60% and 70% overlaps with the top 10 deadliest cancers extracted from World Health Organization GLOBOCAN 2018 and Global Burden of Diseases Study 2017, respectively. The recently developed reduced Google matrix algorithm gives networks of interactions between cancers, drugs and countries taking into account all direct and indirect links between these selected 435 entities. These reduced networks allow to obtain sensitivity of countries to specific cancers and drugs. The strongest links between cancers and drugs are in good agreement with the approved medical prescriptions of specific drugs to specific cancers. We argue that this analysis of knowledge accumulated in Wikipedia provides useful complementary global information about interdependencies between cancers, drugs and world countries.	[Rollin, Guillaume; Lages, Josr] Univ Bourgogne Franche Comte, CNRS, UMR 6213, Inst UTINAM,OSU THETA, Besancon, France; [Shepelyansky, Dima L.] Univ Toulouse, UPS, CNRS, Lab Phys Theor,IRSAMC, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lages, J (corresponding author), Univ Bourgogne Franche Comte, CNRS, UMR 6213, Inst UTINAM,OSU THETA, Besancon, France.	jose.lages@utinam.cnrs.fr	Lages, Jose/D-6660-2013	Lages, Jose/0000-0001-5965-8876; Rollin, Guillaume/0000-0002-3315-6509	French "Investissements d'Avenir" program, project ISITEBFC [ANR-15-IDEX-0003]; Bourgogne Franche-Comte Region 2017-2020 APEX project; Programme Investissements d'Avenir [ANR-11-IDEX-0002-02, ANR-10-LABX-0037-NEXT]	French "Investissements d'Avenir" program, project ISITEBFC(French National Research Agency (ANR)); Bourgogne Franche-Comte Region 2017-2020 APEX project; Programme Investissements d'Avenir(French National Research Agency (ANR))	This work was supported by the French "Investissements d'Avenir" program, project ISITEBFC, contract ANR-15-IDEX-0003 (JL), by the Bourgogne Franche-Comte Region 2017-2020 APEX project, see http://perso.utinam.cnrs.fr/~lages/apex/(JL) and in part by the Programme Investissements d'Avenir ANR-11-IDEX-0002-02, reference ANR-10-LABX-0037-NEXT, project THETRACOM, (DLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altbach P G, 2017, IARC BIENNIAL REPORT; Badmus TA, 2010, UROLOGY, V76, P412, DOI 10.1016/j.urology.2010.03.020; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner H, 2009, EPIDEMIOLOGY STOMACH, P467, DOI [10.1007/978-1-60327-492-0_23, DOI 10.1007/978-1-60327-492-0_23]; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Butler, 2008, NATURE; Callaway Ewen, 2010, Nature, V468, P359, DOI 10.1038/468359a; Cancer Treatment Centers of America, 2018, TYP CANC; Chepelianskii AD, 2010, 10035455 ARXIV; Coquide C, 2019, ARXIV190506489; Coquide C, 2019, LECT NOTES BUS INF P, V373, P208, DOI 10.1007/978-3-030-36691-9_18; Coquide C, 2019, EUR PHYS J B, V92, DOI 10.1140/epjb/e2019-100132-6; Coquide C, 2019, EUR PHYS J B, V92, DOI 10.1140/epjb/e2018-90532-7; EB, 2018, ENCY BRITANNICA; El Zant S, 2018, IEEE ACCESS, V6, P47735, DOI 10.1109/ACCESS.2018.2867327; El Zant S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201397; Ermann L, 2015, REV MOD PHYS, V87, P1261, DOI 10.1103/RevModPhys.87.1261; Frahm K.M., 2016, ARXIV160202394; Frahm KM, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-70526-3; Frahm KM, 2017, WIKIPEDIA NETWORKS 2; GBD. Global Burden of Disease, 2010, LANCET; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Gunturu KS, 2013, THER ADV MED ONCOL, V5, P143, DOI 10.1177/1758834012469429; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kimura T, 2012, CHIN J CANCER, V31, P421, DOI 10.5732/cjc.011.10324; Lages J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190812; Langville Amy, 2012, GOOGLES PAGERANK SCI; Lewoniewski W, 2017, INFORMATICS-BASEL, V4, DOI 10.3390/informatics4040043; Miranda-Filho Adalberto, 2018, Lancet Haematol, V5, pe14, DOI 10.1016/S2352-3026(17)30232-6; National Cancer Institute, 2018, LIST CANC DRUGS; Nielsen FA, 2012, SSRN ELECT J; Reagle J., 2012, GOOD FAITH COLLABORA; Rollin G, 2018, WIKI4CANCERS WIKIPED; Rollin G, 2019, IEEE ACCESS, V7, P26073, DOI 10.1109/ACCESS.2019.2899339; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Union for International Cancer Control, 2018, NEW GLOB CANC DAT GL; Wakai Kenji, 2005, Nihon Rinsho, V63, P207; Witschi H, 2001, TOXICOL SCI, V64, P4, DOI 10.1093/toxsci/64.1.4; Wold Health Organization, 2018, WORLD CANC DAY 2018; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45846; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7	44	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222508	10.1371/journal.pone.0222508	http://dx.doi.org/10.1371/journal.pone.0222508			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536541	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800048
J	Schmidt, AF; Kemp, MW; Milad, M; Miller, LA; Bridges, JP; Clarke, MW; Kannan, PS; Jobe, AH				Schmidt, Augusto F.; Kemp, Matthew W.; Milad, Mark; Miller, Lisa A.; Bridges, James P.; Clarke, Michael W.; Kannan, Paranthaman S.; Jobe, Alan H.			Oral dosing for antenatal corticosteroids in the Rhesus macaque	PLOS ONE			English	Article							INTRAMUSCULAR DEXAMETHASONE; CONTROLLED-TRIAL; PRETERM BIRTH; PHARMACOKINETICS; BIOAVAILABILITY; PREVENTION; REDUCTION; MORTALITY; WOMEN	Antenatal corticosteroids (ACS) are standard of care for women at risk of preterm delivery, although choice of drug, dose or route have not been systematically evaluated. Further, ACS are infrequently used in low resource environments where most of the mortality from prematurity occurs. We report proof of principle experiments to test betamethasone-phosphate (Beta-P) or dexamethasone-phosphate (Dex-P) given orally in comparison to the clinical treatment with the intramuscular combination drug beta-phosphate plus beta-acetate in a Rhesus Macaque model. First, we performed pharmacokinetic studies in non-pregnant monkeys to compare blood levels of the steroids using oral dosing with Beta-P, Dex-P and an effective maternal intramuscular dose of the beta-acetate component of the clinical treatment. We then evaluated maternal and fetal blood steroid levels with limited fetal sampling under ultrasound guidance in pregnant macaques. We found that oral Beta is more slowly cleared from plasma than oral Dex. The blood levels of both drugs were lower in maternal plasma of pregnant than in non-pregnant macaques. Using the pharmacokinetic data, we treated groups of 6-8 pregnant monkeys with oral Beta-P, oral Dex-P, or the maternal intramuscular clinical treatment and saline controls and measured pressure-volume curves to assess corticosteroid effects on lung maturation at 5d. Oral Beta-P improved the pressurevolume curves similarly to the clinical treatment. Oral Dex-P gave more variable and nonsignificant responses. We then compared gene expression in the fetal lung, liver and hippocampus between oral Beta-P and the clinical treatment by RNA-sequencing. The transcriptomes were largely similar with small gene expression differences in the lung and liver, and no differences in the hippocampus between the groups. As proof of principle, ACS therapy can be effective using inexpensive and widely available oral drugs. Clinical dosing strategies must carefully consider the pharmacokinetics of oral Beta-P or Dex-P to minimize fetal exposure while achieving the desired treatment responses.	[Schmidt, Augusto F.; Bridges, James P.; Kannan, Paranthaman S.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Neonatol & Pulm Biol, Cincinnati, OH 45221 USA; [Kemp, Matthew W.; Jobe, Alan H.] Univ Western Australia, Perth, WA, Australia; [Milad, Mark] Milad Pharmaceut Consulting LLC, Plymouth, MI USA; [Miller, Lisa A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Clarke, Michael W.] Univ Western Australia, Ctr Microscopy Characterizat & Anal, Metabol Australia, Perth, WA, Australia; [Schmidt, Augusto F.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; University of California System; University of California Davis; University of Western Australia; University of Miami	Jobe, AH (corresponding author), Univ Western Australia, Perth, WA, Australia.	alan.jobe@cchmc.org	Senthamaraikannan, Paranthaman/H-3992-2018	Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Clarke, Michael/0000-0002-9639-5670; Jobe, Alan/0000-0003-3632-4114; Bridges, James P./0000-0002-4815-117X	Bill and Melinda Gates Foundation [OPP-1132910]; Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy (NCRIS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were fully supported by a research grant OPP-1132910 from the Bill and Melinda Gates Foundation to AHJ, AFS and MWK. MWC is supported by infrastructure funding from the Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy (NCRIS).	Althabe F, 2015, LANCET, V385, P629, DOI 10.1016/S0140-6736(14)61651-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Egerman RS, 1997, OBSTET GYNECOL, V89, P276, DOI 10.1016/S0029-7844(96)00446-2; Egerman RS, 1998, AM J OBSTET GYNECOL, V179, P1120, DOI 10.1016/S0002-9378(98)70116-4; Elliott CL, 1996, ACTA OBSTET GYN SCAN, V75, P213, DOI 10.3109/00016349609047089; Glasziou P, 2017, LANCET, V390, P169, DOI 10.1016/S0140-6736(16)30946-1; Griffin JB, 2019, GLOB HEALTH-SCI PRAC, V7, P215, DOI 10.9745/GHSP-D-18-00402; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2018, AM J OBSTET GYNECOL, V219, P62, DOI 10.1016/j.ajog.2018.04.007; Ke AB, 2019, CLIN PHARMACOL THER, V106, P164, DOI 10.1002/cpt.1438; Kemp MW, 2018, AM J PHYSIOL-REG I, V315, pR825, DOI 10.1152/ajpregu.00193.2017; Kemp MW, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.05.007; Kemp MW, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.08.017; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Queckenberg C, 2011, CLIN THER, V33, P1831, DOI 10.1016/j.clinthera.2011.10.006; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; Santolaya-Forgas J, 1998, AM J OBSTET GYNECOL, V179, P1124, DOI 10.1016/S0002-9378(98)70117-6; Schmidt AF, 2019, PEDIATR RES, V86, P589, DOI 10.1038/s41390-019-0519-0; Schmidt AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45171-6; Schmidt AF, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.11.560; Senthamaraikannan P, 2016, J INFECT DIS, V214, P1597, DOI 10.1093/infdis/jiw408; TAN RC, 1999, AM J PHYSIOL, V277, pL114, DOI DOI 10.1152/AJPLUNG.1999.277.6.L1142; Vogel JP, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000398; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; World Health Organization, 2015, WORLD REP AG HLTH, P3	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222817	10.1371/journal.pone.0222817	http://dx.doi.org/10.1371/journal.pone.0222817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536601	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800092
J	Carter, C; Houser, KV; Yamshchikov, GV; Bellamy, AR; May, J; Enama, ME; Sarwar, U; Larkin, B; Bailer, RT; Koup, R; Chen, GL; Patel, SM; Winokur, P; Belshe, R; Dekker, CL; Graham, BS; Ledgerwood, JE				Carter, Cristina; Houser, Katherine, V; Yamshchikov, Galina, V; Bellamy, Abbie R.; May, Jeanine; Enama, Mary E.; Sarwar, Uzma; Larkin, Brenda; Bailer, Robert T.; Koup, Richard; Chen, Grace L.; Patel, Shital M.; Winokur, Patricia; Belshe, Robert; Dekker, Cornelia L.; Graham, Barney S.; Ledgerwood, Julie E.		VRC 703 Study Team	Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY; UNITED-STATES; VIRUS; PROTECTION; RESPONSES; EFFICACY; AGE	Background Seasonal influenza results in significant morbidity and mortality worldwide, but the currently licensed inactivated vaccines generally have low vaccine efficacies and could be improved. In this phase 1 clinical trial, we compared seasonal influenza vaccine regimens with different priming strategies, prime-boost intervals, and administration routes to determine the impact of these variables on the resulting antibody response. Methods Between August 17, 2012 and January 25, 2013, four sites enrolled healthy adults 18-70 years of age. Subjects were randomized to receive one of the following vaccination regimens: trivalent hemagglutinin (HA) DNA prime followed by trivalent inactivated influenza vaccine (IIV3) boost with a 3.5 month interval (DNA-IIV3), IIV3 prime followed by IIV3 boost with a 10 month interval (IIV3-IIV3), or concurrent DNA and IIV3 prime followed by IIV3 boost with a 10 month interval (DNA/IIV3-IIV3). Each regimen was additionally stratified by an IIV3 administration route of either intramuscular (IM) or intradermal (ID). DNA vaccineswere administered by a needle-free jet injector (Biojector). Study objectives included evaluating the safety and tolerability of each regimen and measuring the antibody response by hemagglutination inhibition (HAI). Results Three hundred and sixteen subjects enrolled. Local reactogenicity was mild to moderate in severity, with higher frequencies recorded following DNA vaccine administered by Biojector compared to IIV3 by either route (p < 0.02 for pain, swelling, and redness) and following IIV3 by ID route compared to IM route (p < 0.001 for swelling and redness). Systemic reactogenicity was similar between regimens. Though no overall differences were observed between regimens, the highest titers post boost were observed in the DNA-IIV3 group by ID route and in the IIV3-IIV3 group by IM route. Conclusions All vaccination regimens were found to be safe and tolerable. While there were no overall differences between regimens, the DNA-IIV3 group by ID route, and the IIV3-IIV3 group by IM route, showed higher responses compared to the other same-route regimens.	[Carter, Cristina; Houser, Katherine, V; Yamshchikov, Galina, V; Enama, Mary E.; Sarwar, Uzma; Larkin, Brenda; Bailer, Robert T.; Koup, Richard; Chen, Grace L.; Graham, Barney S.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Bellamy, Abbie R.; May, Jeanine] Emmes Corp, Rockville, MD USA; [Patel, Shital M.] Baylor Coll Med, Dept Med & Mol Virol, Houston, TX 77030 USA; [Patel, Shital M.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA; [Winokur, Patricia] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Belshe, Robert] St Louis Univ, Div Infect Dis Allergy & Immunol, St Louis, MO 63103 USA; [Dekker, Cornelia L.] Stanford Univ, Med Ctr, Dept Pediat Infect Dis, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation; Baylor College of Medicine; Baylor College of Medicine; University of Iowa; Saint Louis University; Stanford University	Ledgerwood, JE (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Ledgerwood@mail.nih.gov		Winokur, Patricia/0000-0002-4826-1790	National Institute of Allergy and Infectious Diseases (NIAID) Intramural Research program [HHSN272201000049I]; NIH/NCRR CTSA award [UL1 RR025744]	National Institute of Allergy and Infectious Diseases (NIAID) Intramural Research program; NIH/NCRR CTSA award	This clinical study was conducted with funding and support by the National Institute of Allergy and Infectious Diseases (NIAID) Intramural Research program, using resources provided by the American Recovery and Reinvestment Act of 2009 (Recovery Act), and contract HHSN272201000049I awarded to the Emmes Corporation (AB, JM, SP, PW, RB, CD). The Clinical and Translational Research Unit at Stanford University was supported by an NIH/NCRR CTSA award UL1 RR025744. The Emmes Corporation and other funders provided support in the form of salaries for authors AB and JM but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2019, INFL VACC US 2018 19; Crank MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123969; DeZure AD, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0016-6; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Epperson S, 2014, MMWR-MORBID MORTAL W, V63, P483; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; FDA, 2012, APPR LETT FLUZ; FDA, 2011, APPR LETT FLUZ INTR; FDA, 2019, INFL VIR VACC QUADR; FDA, 2007, GUID IND CLIN DAT NE; Frenck RW, 2011, VACCINE, V29, P5666, DOI 10.1016/j.vaccine.2011.06.010; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Gorse GJ, 2013, VACCINE, V31, P6034, DOI 10.1016/j.vaccine.2013.09.012; Gorse GJ, 2013, VACCINE, V31, P2358, DOI 10.1016/j.vaccine.2013.03.008; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Houser KV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206837; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Kim YC, 2012, EUR J PHARM BIOPHARM, V81, P239, DOI 10.1016/j.ejpb.2012.03.010; Ledgerwood JE, 2012, CLIN VACCINE IMMUNOL, V19, P1792, DOI 10.1128/CVI.05663-11; Ledgerwood JE, 2015, CONTEMP CLIN TRIALS, V44, P112, DOI 10.1016/j.cct.2015.08.006; Ledgerwood JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125914; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Marra F, 2013, INFLUENZA OTHER RESP, V7, P584, DOI 10.1111/irv.12000; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; McElhaney JE, 2008, J INFECT DIS, V198, P632, DOI 10.1086/590435; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palache A, 2014, VACCINE, V32, P6369, DOI 10.1016/j.vaccine.2014.07.012; Ray R, 2017, HUM VACC IMMUNOTHER, V13, P1640, DOI 10.1080/21645515.2017.1313375; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Song JM, 2012, MOL THER, V20, P1472, DOI 10.1038/mt.2012.69; Tebas P, 2017, N ENGL J MED; Tsang P, 2014, VACCINE, V32, P2507, DOI 10.1016/j.vaccine.2013.09.074; Young F, 2011, VACCINE, V29, P8788, DOI 10.1016/j.vaccine.2011.09.077; Zimmerman RK, 2016, CLIN INFECT DIS, V63, P1564, DOI 10.1093/cid/ciw635	44	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222178	10.1371/journal.pone.0222178	http://dx.doi.org/10.1371/journal.pone.0222178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532789	gold, Green Published			2022-12-27	WOS:000532239600024
J	Martoni, F; Armstrong, K				Martoni, Francesco; Armstrong, Karen			Resolving an 87-year-old taxonomical curiosity with the description of Psylla frodobagginsi sp. nov. (Hemiptera: Sternorrhyncha: Psyllidae), a second distinct Psylla species on the New Zealand endemic plant kowhai	PLOS ONE			English	Article							PSYLLOIDEA	A recent DNA-based assessment of the psyllid fauna of New Zealand recorded high genetic variation between populations that were expected to belong to the same psyllid species. Among these, a number of populations of the kowhai psyllid Psylla apicalis (Ferris & Klyver, 1932), from a kowhai species, Sophora microphylla Aiton (Fabaceae), presented high genetic variability. This gave new endorsement of an 87-year-old observation made by the entomologists Ferris and Klyver who, when describing the kowhai psyllid, from Sophora tetraptera J.S. Muell., suggested that morphological variations could support more than one species. Accordingly, the morphological assessment conducted here, together with the genetic information now available, resulted in the description of Psylla frodobagginsi sp. nov. as a second New Zealand endemic psyllid species hosted by S. microphylla.	[Martoni, Francesco; Armstrong, Karen] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Martoni, Francesco] AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia	Lincoln University - New Zealand	Martoni, F (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.; Martoni, F (corresponding author), AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia.	francesco.martoni@agriculture.vic.gov.au	Martoni, Francesco/AAB-1742-2019	Martoni, Francesco/0000-0001-8064-4460	Lincoln University	Lincoln University	Thanks to Lincoln University for funding the publication of this manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Martin Steinbauer (La Trobe University, Melbourne) and an anonymous reviewer for comments and suggestions that helped improving a previous version of this manuscript. Thanks to Lincoln University for funding the publication of this manuscript. The basemap of distribution map (Fig 1) was provided by Roger Smith, courtesy of Geographx (https://geographx.co.nz).Thanks to Samuel DJ Brown and Simon R Bulman (The New Zealand Institute of Plant and Food Research), and Mike Bowie (Lincoln University) for providing specimens. Thanks to Hannah Evans for the help during field collections. Thanks to Professor Phil Lester (Victoria University, Wellington), for the encouragements in pursuing the idea of describing this species; and to John Marris (LUNZ), for the helpful comments and suggestions. Many thanks to Marie-Claude Lariviere (NZAC) for providing the holotype of Psylla apicalis. Part of the data published in this article was reported in FM's PhD thesis [32].	Brown SDJ, 2017, ZOOKEYS, P73, DOI 10.3897/zookeys.707.12649; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Burckhardt D, 2012, ZOOTAXA, P1; Cho G, 2019, SYST ENTOMOL, V44, P638, DOI 10.1111/syen.12345; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; Dale PJ., 1985, THESIS; FERRIS G. F., 1932, TRANS AND PROC NEW ZEALAND INST, V63, P34; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henderson R, 2010, NZ INVENTORY BIODIVE, Vtwo, P400; Hollis D., 2004, Australian Psylloidea: jumping plantlice and lerp insects; Hollis D, 1997, J NAT HIST, V31, P237, DOI 10.1080/00222939700770131; ICZN, 1999, INT CODE ZOOLOGICAL; ICZN, 2012, ZOOTAXA, V3450, P1; Rendon-Mera DI, 2017, ZOOTAXA, V4350, P436, DOI 10.11646/zootaxa.4350.3.2; Martoni F., 2017, THESIS; Martoni F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214220; Martoni F, 2018, ZOOKEYS, P91, DOI 10.3897/zookeys.811.28829; Martoni F, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030050; Martoni F, 2017, J ECON ENTOMOL, V110, P2618, DOI 10.1093/jee/tox261; Martoni F, 2016, ZOOTAXA, V4144, P556, DOI 10.11646/zootaxa.4144.4.6; Ouvrard D, 2019, PSYLLIST WORLD PSYLL; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Percy DM, 2018, SYST ENTOMOL, V43, P762, DOI 10.1111/syen.12302; Percy DM, 2018, ZOOKEYS, P75, DOI 10.3897/zookeys.758.23019; Percy DM, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.649.10213; Syfert MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167764; Taylor GS, 2018, AUSTRAL ENTOMOL, V57, P297, DOI 10.1111/aen.12278; Taylor GS, 2016, ZOOTAXA, V4073, P1, DOI 10.11646/zootaxa.4073.1.1; Tolkien JRR, 1954, FELLOWSHIP RING; Tolkien JRR, 1954, THE 2 TOWERS; Tolkien JRR, 1955, RETURN KING; TUTHILL L. D., 1952, PACIFIC SCI, V6, P83	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221316	10.1371/journal.pone.0221316	http://dx.doi.org/10.1371/journal.pone.0221316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532775	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600008
J	Ahmed, OM; Ali, TM; Gaid, MAA; Elberry, AA				Ahmed, Osama M.; Ali, Tarek M.; Gaid, Mohamed A. Abdel; Elberry, Ahmed A.			Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-alpha, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats	PLOS ONE			English	Article							CISPLATIN-INDUCED NEPHROTOXICITY; RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; VITAMIN-D; GENE-EXPRESSION; INDUCED APOPTOSIS; BETA-CELL; KIDNEY; PROTEINURIA; INHIBITION	This study aimed to assess the renopreventive effect of enalapril and/or paricalcitol on streptozotocin (STZ) diabetes-induced nephropathy and to elucidate their mechanisms of action through investigation of the effects on renal oxidative stress, antioxidant defense system and expressions of TNF-alpha, p53, caspase-3, and Bcl-2. Diabetes mellitus was induced in fasting male Wistar rats by single intraperitoneal injection of STZ (45 mg /kg b.w.) dissolved in citrate buffer (pH 4.5). Ten days after STZ injection, the diabetic rats were treated with enalapril (25 mg/l of drinking water) and/or paricalcitol (8 mu g/ kg b.w. per os) dissolved in 5% DMSO daily for 4 weeks. The obtained data revealed that the treatment of diabetic Wistar rats with enalapril and/or paricalcitol led to significant decreases in the elevated serum urea, uric acid, creatinine, sodium and potassium levels; thereby reflecting the improvement of the impaired kidney function. The deteriorated kidney lipid peroxidation, GSH content and GST and catalase activities in diabetic rats were significantly ameliorated as a result of treatment with enalapril and/or paricalcitol. The elevated fasting and post-prandial serum glucose levels and the lowered serum insulin and C-peptide levels were also improved. The treatment with enalapril and paricalcitol in combination was the most potent in decreasing the elevated serum glucose levels. Moreover, the treatment of diabetic rats successfully prevented the diabetes-induced histopathological deleterious changes of kidney and islets of Langerhans of pancreas. In association, the immunohistochemically detected pro-inflammatory cytokine, TNF-alpha, and apoptotic mediators, p53 and caspase-3, were remarkably decreased in kidney of diabetic rats as a result of treatment while the expression of anti-apoptotic protein Bcl-2 was increased. Based on these findings, it can be concluded that enalapril and paricalcitol alone or in combination can prevent STZ diabetes-induced nephropathy through amelioration of the glycemic state and antioxidant defense system together with the suppression of oxidative stress, inflammation and apoptosis. However, the treatment of diabetic rats with enalapril and paricalcitol in combination has no further significant improvement effects on renal function and damage when compared with enalapril or paclitaxel treated diabetic groups.	[Ahmed, Osama M.; Gaid, Mohamed A. Abdel] Beni Suef Univ, Fac Sci, Zool Dept, Expt Obes & Diabet Res Lab,Physiol Div, Bani Suwayf, Egypt; [Ali, Tarek M.] Taif Univ, Coll Appl Med Sci, Dept Clin Labs, At Taif, Saudi Arabia; [Ali, Tarek M.] Beni Suef Univ, Fac Med, Dept Physiol, Bani Suwayf, Egypt; [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt	Egyptian Knowledge Bank (EKB); Beni Suef University; Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University	Ahmed, OM (corresponding author), Beni Suef Univ, Fac Sci, Zool Dept, Expt Obes & Diabet Res Lab,Physiol Div, Bani Suwayf, Egypt.	osama.ahmed@science.bsu.edu.org	Elberry, Ahmed A/I-1539-2012; Ali, Tarek/E-7358-2019; Ahmed, Osama/P-8126-2018	Elberry, Ahmed A/0000-0002-0073-3066; Ali, Tarek/0000-0002-2998-247X; Ahmed, Osama/0000-0003-3781-9709	College of Applied Medical Sciences, Taif University, Taif Saudi Arabia; Faculty of Science, Beni-Suef University, Beni Suef, Egypt	College of Applied Medical Sciences, Taif University, Taif Saudi Arabia; Faculty of Science, Beni-Suef University, Beni Suef, Egypt	This study was partially funded by College of Applied Medical Sciences, Taif University, P. O. Box 888, Taif 21974, Saudi Arabia and Faculty of Science, Beni-Suef University, Beni Suef, Egypt. There was no additional external funding received for this study.	Agrawal NK, 2013, ASIAN J PHARM CLIN R, V6, P66; Ahmed O., 2001, J UNION ARABIAN BIOL, V16, P585; Ahmed OM, 2012, J DIABETES COMPLICAT, V26, P491, DOI 10.1016/j.jdiacomp.2012.05.021; Ali TM, 2016, AM J MED SCI, V352, P208, DOI 10.1016/j.amjms.2016.04.016; Anderson S, 2009, KIDNEY INT, V75, P12, DOI 10.1038/ki.2008.556; Aperis G, 2011, J REN CARE, V37, P80, DOI 10.1111/j.1755-6686.2011.00229.x; Ashour MB., 2017, INT J PREV TREAT, V6, P34, DOI DOI 10.5923/J.IJPT.20170602.03; Banchroft J.D., 1996, THEORY PRACTICE HIST; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bidani AK, 2007, AM J PHYSIOL-RENAL, V292, pF647, DOI 10.1152/ajprenal.00017.2006; BJORCK S, 1992, BMJ-BRIT MED J, V304, P339, DOI 10.1136/bmj.304.6823.339; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Capes SE, 2000, DIABETES CARE, V23, P377, DOI 10.2337/diacare.23.3.377; Chandran G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/608512; CHRISTAKOS S, 1979, ENDOCRINOLOGY, V104, P1495, DOI 10.1210/endo-104-5-1495; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; de Brito Amaral LS, 2018, J DIABETES RES; de Cavanagh EMV, 2001, HYPERTENSION, V38, P1130, DOI 10.1161/hy1101.092845; El-Beshbishy HA, 2011, EUR J PHARMACOL, V668, P278, DOI 10.1016/j.ejphar.2011.06.051; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gheith Osama, 2016, J Nephropharmacol, V5, P49; Gravellone L, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/419524; Hari P, 2013, INDIAN PEDIATR, V50, P923, DOI 10.1007/s13312-013-0262-2; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Hou JT, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4609750; Husain Kazim, 2015, World J Biol Chem, V6, P240, DOI 10.4331/wjbc.v6.i3.240; Hussein AM, 2010, BIOORGAN MED CHEM, V18, P2639, DOI 10.1016/j.bmc.2010.02.028; International Diabetes Federation, 2016, DIABETES ATLAS; Izquierdo MJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-159; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kim JM, 2011, EXP GERONTOL, V46, P542, DOI 10.1016/j.exger.2011.02.011; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Mannervik B, 1981, Methods Enzymol, V77, P231; Martinez-Castelao A, 1998, KIDNEY INT, V54, pS130, DOI 10.1046/j.1523-1755.1998.06826.x; Mizobuchi M, 2007, J AM SOC NEPHROL, V18, P1796, DOI 10.1681/ASN.2006091028; Navarro JF, 2005, KIDNEY INT, V68, P98; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Park JW, 2012, EUR J PHARMACOL, V683, P301, DOI 10.1016/j.ejphar.2012.03.019; Patschan D, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/6232909; Piscitelli P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03551-w; Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792; Pradeep SR, 2018, FOOD FUNCT, V9, P134, DOI [10.1039/c7fo01044c, 10.1039/C7FO01044C]; Preuss HG, 1998, J AM COLL NUTR, V17, P116, DOI 10.1080/07315724.1998.10718736; Rabinovitch A, 2001, ENDOCRINOLOGY, V142, P3649, DOI 10.1210/en.142.8.3649; Rammos G, 2008, INT UROL NEPHROL, V40, P419, DOI 10.1007/s11255-007-9244-4; Rani N, 2016, FREE RADICAL RES, V50, P1226, DOI 10.1080/10715762.2016.1228923; Roa M, 1985, PC STAT ONE WAY ANAL; Sagar P, EXPT TUBOLOINTERSTIT; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Sha JB, 2017, MOL MED REP, V16, P7715, DOI 10.3892/mmr.2017.7522; SHAMISS A, 1995, AM J HYPERTENS, V8, P276, DOI 10.1016/0895-7061(94)00181-A; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stump CS, 2006, MAYO CLIN PROC, V81, P796, DOI 10.4065/81.6.796; Suarez-Martinez Edu, 2014, Ther Adv Cardiovasc Dis, V8, P224, DOI 10.1177/1753944714542593; Suh SH, 2013, KOREAN J PHYSIOL PHA, V17, P435, DOI 10.4196/kjpp.2013.17.5.435; Sznarkowska A, 2010, POSTEP HIG MED DOSW, V64, P396; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Tylicki L, 2012, J NEPHROL, V25, P900, DOI 10.5301/jn.5000134; Vermes E, 2003, CIRCULATION, V107, P1291, DOI 10.1161/01.CIR.0000054611.89228.92; Xin SB, 2016, MED SCI MONITOR, V22, P5173, DOI 10.12659/MSM.898177; Yang ZS, 2015, MOL CELL ENDOCRINOL, V414, P111, DOI 10.1016/j.mce.2015.07.023; Zafar M, 2010, INT J MORPHOL, V28, P135, DOI 10.4067/S0717-95022010000100019; Zhang CL, 2004, ACTA PHARMACOL SIN, V25, P691; Ziamajidi N, 2017, PHARM BIOL, V55, P526, DOI 10.1080/13880209.2016.1255978	71	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0214349	10.1371/journal.pone.0214349	http://dx.doi.org/10.1371/journal.pone.0214349			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527864	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400002
J	Macicame, I; Bhatt, N; Chissumba, RM; Eller, LA; Viegas, E; Araujo, K; Nwoga, C; Li, Q; Milazzo, M; Hills, NK; Lindan, C; Michael, NL; Robb, ML; Jani, I; Polyak, CS				Macicame, Ivalda; Bhatt, Nilesh; Chissumba, Raquel Matavele; Eller, Leigh Anne; Viegas, Edna; Araujo, Khelvon; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Hills, Nancy K.; Lindan, Christina; Michael, Nelson L.; Robb, Merlin L.; Jani, Ilesh; Polyak, Christina S.			HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique	PLOS ONE			English	Article							NEED; SEX	Introduction Mozambique continues to have a significant burden of HIV. Developing strategies to control the HIV epidemic remains a key priority for the Mozambican public health community. The primary aim of this study was to determine HIV prevalence and risk behavior among males and females screened for a HIV vaccine preparedness study in Maputo, Mozambique. Methods Male and female participants between 18-35 years old were recruited from the general community and from female sex worker (FSW) and lesbian, gay, bisexual, and transgender (LGBT) associations in Maputo. All participants were screened for HIV and a questionnaire was administered to each participant to assess HIV risk behavior. Results A total of 1125 adults were screened for HIV infection, among whom 506 (45%) were male. Among men, 5.7% reported having had sex with men (MSM) and 12% of female participants reported having exchanged sex for money, goods or favors in the past 3 months. The overall HIV prevalence was 10.4%; 10.7% of women, and 10.1% of men were HIV infected; 41.4% of MSM were seropositive. HIV infection was associated with older age (25-35 years old) (OR: 6.13, 95% CI: 3.01, 12.5), MSM (OR: 9.07, 95% CI: 3.85, 21.4), self-perception of being at high-risk for HIV (OR: 3.99, 95% CI: 1.27, 12.5) and self-report of a history of a diagnosis of sexually transmitted infection (OR: 3.75, 95% CI: 1.57, 8.98). Conclusion In our cohort, HIV prevalence was much higher among MSM compared to the overall prevalence. Behavioral factors were found to be more associated with HIV prevalence than demographic factors. The study findings demonstrate the critical importance of directing services to minority communities, such as MSM, when prevention strategies are being devised for the general population.	[Macicame, Ivalda; Bhatt, Nilesh; Chissumba, Raquel Matavele; Viegas, Edna; Araujo, Khelvon; Jani, Ilesh] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Eller, Leigh Anne; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Michael, Nelson L.; Robb, Merlin L.; Polyak, Christina S.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA; [Eller, Leigh Anne; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Robb, Merlin L.; Polyak, Christina S.] Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Hills, Nancy K.; Lindan, Christina] Univ Calif San Francisco, San Francisco, CA 94143 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Francisco	Polyak, CS (corresponding author), Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA.; Polyak, CS (corresponding author), Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	cpolyak@hivresearch.org		Nwoga, Chiaka/0000-0002-4514-330X; Matavele Chissumba, Raquel/0000-0003-1957-340X	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067, 3167]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; U.S. National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). This research was funded, in part, by the U.S. National Institute of Allergy and Infectious Diseases. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army, the Department of Defense, or the National Institutes of Health. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. Financial assistance was provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to the Instituto Nacional de Sau ' de (INS) under the terms of the Clinical Services Agreement No. 3167. The funders had no role in the study, data collection, analysis, decision to publish or preparation of the manuscript.	Adamson B, 2017, PHARMACOECON-OPEN, V1, P1, DOI 10.1007/s41669-016-0009-9; Bos JM, 2001, PHARMACOECONOMICS, V19, P937, DOI 10.2165/00019053-200119090-00005; Cai Y, 2016, J INT AIDS SOC, V19, P26, DOI 10.7448/IAS.19.3.20800; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Inguane C, 2015, AIDS BEHAV, V19, P2184, DOI 10.1007/s10461-015-1068-0; Instituto Nacional de Saude INdEI ICF Internacional, INQ IND IM MAL HIV S; Larmarange J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013189; Logie CH, 2017, J INT AIDS SOC, V20, DOI [10.7448/IAS.20.01/21422, 10.7448/IAS.20.1.21385, 10.7448/IAS.20.1.21422]; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Republica de Mocambique MdS, 2006, GUIA TRATAMENTO CONT; UNAIDS, AIDS NUMB 2015; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Viegas EO, 2018, AIDS RES HUM RETROV, V34, P193, DOI [10.1089/aid.2017.0121, 10.1089/AID.2017.0121]; Viegas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121452; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221682	10.1371/journal.pone.0221682	http://dx.doi.org/10.1371/journal.pone.0221682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527868	Green Submitted, Green Published, gold			2022-12-27	WOS:000532231400006
J	Sagara, H; Sekiryu, T; Imaizumi, K; Shintake, H; Sugiyama, U; Maehara, H				Sagara, Hideto; Sekiryu, Tetsuju; Imaizumi, Kimihiro; Shintake, Hiroaki; Sugiyama, Urara; Maehara, Hiroki			Impact of tear metrics on the reliability of perimetry in patients with dry eye	PLOS ONE			English	Article							FALSE-NEGATIVE RESPONSES; OPEN-ANGLE GLAUCOMA; FIELD; INDICATORS; THRESHOLD; FREQUENCY; BLINKING; FATIGUE; QUALITY	Background The application of artificial tears before performing perimetry can improve the reliability and results of perimetry in patients with glaucoma and dry eye (DE). However, the effects of ocular surface and tear film conditions on perimetry measurements and reliability have not been fully characterized. Methods This prospective, cross-sectional, multicenter study investigated tear metrics in perimetry and assessed the relationships that existed among ocular surface condition, tear condition, and perimetry reliability. Forty-three eyes (43 patients) with DE disease according to the 2016 Japanese diagnostic criteria of DE and 43 eyes (43 subjects) of age- and visual field mean deviation-matched normal control subjects were studied. Perimetry was performed using the Humphrey Field Analyzer (30-2 SITA-Standard). Schirmer's test, strip meniscometry value, blink rate, tear film break-up time (TFBUT), fluorescein staining of ocular surface, and Dry Eye-related Quality of Life Score (DEQS) were measured. Blink rate was remeasured during perimetry. TFBUT and fluorescein staining were re-evaluated after perimetry. Perimetry reliability was evaluated with fixation loss, false-positive, and false-negative rates. Results Blink rate during perimetry was significantly lower for both patients with DE and normal controls (both P<0.001). TFBUT after perimetry was significantly higher than before perimetry in patients with DE (P<0.001). Fluorescein staining of ocular surface was significantly increased in patients with DE and normal control subjects (P=0.002 and P<0.001, respectively). Spearman correlation analysis revealed that blink rate during perimetry was negatively correlated with fixation-loss rate (r=-0.393, P=0.009) in patients with DE. Conclusions Performing perimetry was associated with a significant change in tear condition and ocular surface condition in both patients with DE and normal control subjects. The changes in tear condition and ocular surface condition may impact the reliability of perimetry in patients with DE.	[Sagara, Hideto] Marui Eye Clin, Minamisoma City, Fukushima, Japan; [Sagara, Hideto; Sekiryu, Tetsuju; Imaizumi, Kimihiro; Shintake, Hiroaki; Sugiyama, Urara; Maehara, Hiroki] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Minamisoma City, Fukushima, Japan	Fukushima Medical University	Sagara, H (corresponding author), Marui Eye Clin, Minamisoma City, Fukushima, Japan.; Sagara, H (corresponding author), Fukushima Med Univ, Dept Ophthalmol, Sch Med, Minamisoma City, Fukushima, Japan.	hide1234@ruby.ocn.ne.jp		Sekiryu, Tetsuju/0000-0001-8042-2729				Anderson D. R., 1999, AUTOMATED STATIC PER, P80; Arai T, 2018, BRIT J OPHTHALMOL, V102, P525, DOI 10.1136/bjophthalmol-2017-310309; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Carl Zeiss Meditec, 2017, HUMPHR FIELD AN 2 I; Dogru M, 2006, INVEST OPHTH VIS SCI, V47, P1895, DOI 10.1167/iovs.05-0802; HOLLAND MK, 1972, PSYCHOL REP, V31, P119, DOI 10.2466/pr0.1972.31.1.119; Horikoshi N, 2001, JPN J OPHTHALMOL, V45, P503, DOI 10.1016/S0021-5155(01)00371-9; Ibrahim OMA, 2011, INVEST OPHTH VIS SCI, V52, P2194, DOI 10.1167/iovs.10-5986; Ishikawa S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012969; Johnson CA, 2014, J GLAUCOMA, V23, P288, DOI 10.1097/IJG.0b013e31829463ab; Kastelan S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/696328; Kocabeyoglu S, 2013, CAN J OPHTHALMOL, V48, P110, DOI 10.1016/j.jcjo.2012.11.001; Kunimatsu, 2000, Jpn J Ophthalmol, V44, P190, DOI 10.1016/S0021-5155(99)00209-9; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Matsumoto C, 2003, JPN J OPHTHALMOL, V47, P22, DOI 10.1016/S0021-5155(02)00663-9; Milla E, 2012, BRIT J OPHTHALMOL, V96, P826, DOI 10.1136/bjophthalmol-2011-301015; Ohtsuki Masanori, 2001, Nippon Ganka Gakkai Zasshi, V105, P149; Pavlidis M, 2005, GRAEF ARCH CLIN EXP, V243, P228, DOI 10.1007/s00417-004-1033-5; RIEGER G, 1992, BRIT J OPHTHALMOL, V76, P157, DOI 10.1136/bjo.76.3.157; Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schein OD, 1999, ARCH INTERN MED, V159, P1359, DOI 10.1001/archinte.159.12.1359; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; Tsubota K, 2017, OCUL SURF, V15, P65, DOI 10.1016/j.jtos.2016.09.003; Uchida H, 1996, JPN J OPHTHALMOL, V40, P548; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Wang JH, 2008, AM J OPHTHALMOL, V145, P795, DOI 10.1016/j.ajo.2007.12.035; Wang YF, 2011, INVEST OPHTH VIS SCI, V52, P4546, DOI 10.1167/iovs.10-6553; Yamazaki Y, 2002, JPN J OPHTHALMOL, V46, P89, DOI 10.1016/S0021-5155(01)00461-0; Yenice O, 2007, EYE, V21, P214, DOI 10.1038/sj.eye.6702252	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222467	10.1371/journal.pone.0222467	http://dx.doi.org/10.1371/journal.pone.0222467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527920	gold, Green Submitted, Green Published			2022-12-27	WOS:000532231400023
J	Kellaway, SG; Mosinska, K; Mohamed, Z; Ryan, A; Richardson, S; Newbould, M; Banerjee, I; Dunne, MJ; Cosgrove, KE				Kellaway, Sophie G.; Mosinska, Karolina; Mohamed, Zainaba; Ryan, Alexander; Richardson, Stephen; Newbould, Melanie; Banerjee, Indraneel; Dunne, Mark J.; Cosgrove, Karen E.			Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism	PLOS ONE			English	Article							11P15 IMPRINTED GENES; DOUBLE-STRAND BREAKS; BETA-CELLS; MUTATION; INFANCY; INSULIN; EXPRESSION; HYPOGLYCEMIA; PATHWAY; GLUCOSE	Congenital hyperinsulinism (CHI) is characterised by inappropriate insulin secretion causing profound hypoglycaemia and brain damage if inadequately controlled. Pancreatic tissue isolated from patients with diffuse CHI shows abnormal proliferation rates, the mechanisms of which are not fully resolved. Understanding cell proliferation in CHI may lead to new therapeutic options, alongside opportunities to manipulate beta-cell mass in patients with diabetes. We aimed to generate cell-lines from CHI pancreatic tissue to provide in vitro model systems for research. Three pancreatic mesenchymal stem cell-lines (CHIpMSC1-3) were derived from patients with CHI disease variants: focal, atypical and diffuse. All CHIpMSC lines demonstrated increased proliferation compared with control adult-derived pMSCs. Cell cycle alterations including increased CDK1 levels and decreased p27Kip1 nuclear localisation were observed in CHIpMSCs when compared to control pMSCs. In conclusion, CHIpMSCs are a useful in vitro model to further understand the cell cycle alterations leading to increased islet cell proliferation in CHI.	[Kellaway, Sophie G.; Mosinska, Karolina; Ryan, Alexander; Richardson, Stephen; Dunne, Mark J.; Cosgrove, Karen E.] Univ Manchester, Fac Biol Med & Hlth, Sch Med, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England; [Mohamed, Zainaba; Banerjee, Indraneel] Royal Manchester Childrens Hosp, Dept Paediat Endocrinol, Manchester, Lancs, England; [Newbould, Melanie] Royal Manchester Childrens Hosp, Dept Paediat Histopathol, Manchester, Lancs, England; [Kellaway, Sophie G.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Mohamed, Zainaba] Birmingham Childrens Hosp, Birmingham, W Midlands, England	University of Manchester; Royal Manchester Children's Hospital; Royal Manchester Children's Hospital; University of Birmingham; University of Birmingham	Kellaway, SG; Cosgrove, KE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Med, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England.; Kellaway, SG (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England.	s.g.kellaway@bham.ac.uk; karen.e.cosgrove@manchester.ac.uk	Richardson, Stephen/A-4124-2009	Richardson, Stephen/0000-0002-7637-4135; Kellaway, Sophie/0000-0002-4011-7460; Cosgrove, Karen/0000-0002-5162-0985	NC3Rs; Diabetes UK; Research Councils UK Academic Fellowship; Heptares/Innovate UK	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Diabetes UK(Diabetes UK); Research Councils UK Academic Fellowship(UK Research & Innovation (UKRI)); Heptares/Innovate UK(UK Research & Innovation (UKRI)Innovate UK)	This work was funded by NC3Rs (https://www.nc3rs.org.uk/, SGK awarded to MJD, KC), and Diabetes UK (https://www.diabetes.org.uk/, KM awarded to MJD, KC). AR was funded by Heptares/Innovate UK (https://soseiheptares.com/awarded to MJD). KEC was funded by a Research Councils UK Academic Fellowship (https://www.ukri.org/).The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu S, 2010, INT J CLIN EXP PATHO, V3, P691; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Burrow KL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2541275; Chen XF, 2016, NUCLEIC ACIDS RES, V44, P2742, DOI 10.1093/nar/gkv1544; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dunne MJ, 1997, NEW ENGL J MED, V336, P703, DOI 10.1056/NEJM199703063361005; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Eberhardt M, 2006, BIOCHEM BIOPH RES CO, V345, P1167, DOI 10.1016/j.bbrc.2006.05.016; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2450, DOI 10.2337/db12-0777; Fournet JC, 2001, AM J PATHOL, V158, P2177, DOI 10.1016/S0002-9440(10)64689-5; Gallo R, 2007, CELL DEATH DIFFER, V14, P1860, DOI 10.1038/sj.cdd.4402199; Glaser B, 1999, DIABETES, V48, P1652, DOI 10.2337/diabetes.48.8.1652; Glaser B, 2000, ARCH DIS CHILD-FETAL, V82, pF79, DOI 10.1136/fn.82.2.F79; Hall E, 2017, MOL CELLULAR ENDOCRI; Han B, 2017, J CLIN ENDOCR METAB, V102, P3261, DOI 10.1210/jc.2017-00158; Henquin JC, 2013, DIABETES, V62, P1689, DOI 10.2337/db12-1414; Hershko A, 1999, PHILOS T R SOC B, V354, P1571, DOI 10.1098/rstb.1999.0500; Joglekar MV, 2009, J ENDOCRINOL, V201, P27, DOI 10.1677/JOE-08-0497; Kassem SA, 2001, DIABETES, V50, P2763, DOI 10.2337/diabetes.50.12.2763; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Salisbury RJ, 2015, DIABETES, V64, P3182, DOI 10.2337/db14-1202; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shimomura K, 2013, DIABETES, V62, P3797, DOI 10.2337/db12-1611; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Verkarre V, 1998, J CLIN INVEST, V102, P1286, DOI 10.1172/JCI4495; Zhang Z, 2014, MOL MED REP, V10, P683, DOI 10.3892/mmr.2014.2265	35	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222350	10.1371/journal.pone.0222350	http://dx.doi.org/10.1371/journal.pone.0222350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525223	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700026
J	Banigbe, B; Audet, CM; Okonkwo, P; Arije, OO; Bassi, E; Clouse, K; Simmons, M; Aliyu, MH; Freedberg, KA; Ahonkhai, AA				Banigbe, Bolanle; Audet, Carolyn M.; Okonkwo, Prosper; Arije, Olujide O.; Bassi, Elizabeth; Clouse, Kate; Simmons, Melynda; Aliyu, Muktar H.; Freedberg, Kenneth A.; Ahonkhai, Aima A.			Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; INFECTED PATIENTS; FINANCIAL INCENTIVES; AFRICA; TRANSITIONS; CRITERIA; ADULTS; AIDS	The transition to PEPFAR 2.0 with its focus on country ownership was accompanied by substantial funding cuts. We describe the impact of this transition on HIV care in a large network of HIV clinics in Nigeria. We surveyed 30 comprehensive HIV treatment clinics to assess services supported before (October 2013-September 2014) and after (October 2014-September 2015) the PEPFAR funding policy change, the impact of these policy changes on service delivery areas, and response of clinics to the change. We compared differences in support for staffing, laboratory services, and clinical operations pre- and post-policy change using paired t-tests. We used framework analysis to assess answers to open ended questions describing responses to the policy change. Most sites (83%, n = 25) completed the survey. The majority were public (60%, n = 15) and secondary (68%, n = 17) facilities. Clinics had a median of 989 patients in care (IQR: 543-3326). All clinics continued to receive support for first and second line antiretrovirals and CD4 testing after the policy change, while no clinics received support for other routine drug monitoring labs. We found statistically significant reductions in support for viral load testing, staff employment, defaulter tracking, and prevention services (92% vs. 64%, p = 0.02; 80% vs. 20%, 100% vs. 44%, 84% vs. 16%, respectively, p<0.01 for all) after the policy change. Service delivery was hampered by interrupted laboratory services and reduced wages and staff positions leading to reduced provider morale, and compromised quality of care. Almost all sites (96%) introduced user fees to address funding shortages. Clinics in Nigeria are experiencing major challenges in providing routine HIV services as a result of PEPFAR's policy changes. Funding cutbacks have been associated with compromised quality of care, staff shortages, and reliance on fee-based care for historically free services. Sustainable HIV services funding models are urgently needed.	[Banigbe, Bolanle; Okonkwo, Prosper; Bassi, Elizabeth] APIN Publ Hlth Initiat APIN, Abuja, Nigeria; [Audet, Carolyn M.; Clouse, Kate; Simmons, Melynda; Aliyu, Muktar H.; Ahonkhai, Aima A.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA; [Audet, Carolyn M.; Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Audet, Carolyn M.] Friends Global Hlth, Maputo, Mozambique; [Arije, Olujide O.] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria; [Clouse, Kate; Ahonkhai, Aima A.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Massachusetts Gen Hosp, Div Infect Dis & Gen Internal Med, Boston, MA 02114 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Harvard Med Sch, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Vanderbilt University; Vanderbilt University; Obafemi Awolowo University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA.; Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA.; Ahonkhai, AA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis & Gen Internal Med, Boston, MA 02114 USA.; Ahonkhai, AA (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Ahonkhai, AA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	aima.a.ahonkhai@vumc.org	Arije, Olujide O/J-6002-2016	Arije, Olujide O/0000-0001-5192-3698; Ahonkhai, Aimalohi/0000-0003-0666-4767; Clouse, Kate/0000-0002-0190-7398; Ojikutu, Bisola/0000-0001-7957-8881; Aliyu, Muktar/0000-0001-9504-4679	National Institute of Allergy and Infectious Disease [K23 AI106406, R01 AI058736]; centers for disease control and prevention [NU2GGH000924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K23AI106406, R37AI058736] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); centers for disease control and prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by K23 AI106406: AA; National Institute of Allergy and Infectious Disease; https://www.niaid.nih.gov.R01 AI058736: KAF, AA; National Institute of Allergy and Infectious Disease; https://www.niaid.nih.gov.NU2GGH000924: BB, PO; centers for disease control and prevention; cdc.gov.	Ahonkhai AA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-427; APIN Public Health Initiatives, 2018, US PRACT AR; Atun R, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010407; Ayadi F., 2008, J SUSTAINABLE DEV AF, V10, P234; Bassett IV, 2015, CURR OPIN HIV AIDS, V10, P451, DOI 10.1097/COH.0000000000000196; Bisson GP, 2006, AIDS, V20, P1333, DOI 10.1097/01.aids.0000232245.36039.2b; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cailhol J, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-52; Clouse K, 2017, AIDS CARE, V30, P1, DOI DOI 10.1080/09540121; Cromer C, 2004, FAMILY PLANNING GRAD; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; HIV/AIDS Division Federal Ministry of Health, 2014, NAT OP PLAN EL MOTH; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Katz IT, 2015, AIDS CARE, V27, P1298, DOI 10.1080/09540121.2015.1051502; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Kavanagh MM, 2014, JAIDS-J ACQ IMM DEF, V65, P247, DOI 10.1097/QAI.0000000000000093; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Medecins Sans Frontieres, 2010, NO TIM QUIT HIV AIDS; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Odekunle FF, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.143.9987; PEPFAR, 2010, SUMM HIV AIDS PARTN; PEPFAR, C BUDG JUST SUPPL FI; PEPFAR, 2014, PEPFAR 3 0 CONTR EP; PEPFAR, 2016, SUST HIV EP CONTR PF; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Renner M., 2003, QUALITATIVE DATA ANA, P1, DOI DOI 10.1207/S15430421TIP3903; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; UNAIDS, 2014, UNAIDS GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; Vallejo A, 2006, VIRAL IMMUNOL, V19, P759, DOI 10.1089/vim.2006.19.759; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Vogus A, 2015, GLOB HEALTH-SCI PRAC, V3, P274, DOI 10.9745/GHSP-D-14-00227	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221809	10.1371/journal.pone.0221809	http://dx.doi.org/10.1371/journal.pone.0221809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553735	Green Published, gold			2022-12-27	WOS:000532319200006
J	Wang, WY; Chu, CM; Wu, YS; Sung, CS; Ho, ST; Pan, HH; Wang, KY				Wang, Wei-Yun; Chu, Chi-Ming; Wu, Yi-Syuan; Sung, Chun-Sung; Ho, Shung-Tai; Pan, Hsueh-Hsing; Wang, Kwua-Yun			Evaluation of the pain intensity differences among hospitalized cancer patients based on a nursing information system	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; NUMERIC RATING-SCALE; OF-LIFE; MANAGEMENT; CARE; QUALITY; OUTCOMES; DOCUMENTATION; VARIABILITY; INPATIENTS	Evaluating the absolute difference in pain intensity and the percentage difference in pain intensity could facilitate an understanding of pain reduction among cancer patients during repeated hospitalizations. Examinations of the absolute differences in pain intensity and the percentage differences in pain intensity according to the worst pain intensity and last evaluated pain intensity before discharge are lacking. The aim of this study was to evaluate the absolute and percentage difference in pain intensities among cancer patients with moderate or severe pain from their 1st to 18th hospitalizations from 2011-2013. A population-based retrospective cohort study was conducted. Pain intensity was assessed using scales and was recorded in a nursing information system. The absolute and percentage difference in pain intensities were examined via the one-sample Kolmogorov-Smirnov test, and group differences in moderate or severe pain were evaluated with the Mann-Whitney U test. For moderate pain patients, the mean absolute difference in pain intensity was 1.52, and the percentage difference in pain intensity was 29.0%; both these values were significant. More significant changes in the absolute and percentage difference in pain intensities were associated with severe pain patients. Both the average absolute difference in pain intensity (3.09) and the percentage difference in pain intensity (38.5%) in patients with severe pain were significantly higher than the average absolute difference in pain intensity (1.52) and the percentage difference in pain intensity (29.0%) in patients with moderate pain. Cancer patients with moderate and severe pain experienced pain reductions of approximately 30% and 40%, respectively. Early pain management intervention in patients with severe pain is necessary to achieve an obvious analgesic effect, and the formula of the percentage difference in pain intensity should be incorporated into the nursing information system to alert clinicians for early detection of the effectiveness of cancer pain management.	[Wang, Wei-Yun] Triserv Gen Hosp, Dept Nursing, Taipei, Taiwan; [Wang, Wei-Yun; Pan, Hsueh-Hsing; Wang, Kwua-Yun] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wu, Yi-Syuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Sung, Chun-Sung; Ho, Shung-Tai] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Chun-Sung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wang, Kwua-Yun] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Wang, Wei-Yun] Triserv Gen Hosp, Taipei, Taiwan; [Chu, Chi-Ming; Wu, Yi-Syuan; Pan, Hsueh-Hsing] Natl Def Med Ctr, Taipei, Taiwan; [Sung, Chun-Sung; Ho, Shung-Tai; Wang, Kwua-Yun] Taipei Vet Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital	Wang, KY (corresponding author), Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan.; Wang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan.; Wang, KY (corresponding author), Taipei Vet Gen Hosp, Taipei, Taiwan.	kywang7@vghtpe.gov.tw		Chu, Cordia/0000-0002-3683-5638; Wu, Yi-Syuan/0000-0001-9609-6489; /0000-0002-8170-5162	Tri-Service General Hospital [TSGH-C108-165]	Tri-Service General Hospital	This study was financially supported by grants from the Tri-Service General Hospital (TSGH-C108-165).	Alghadir A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001162; Carr ECJ, 2014, J ADV NURS, V70, P1391, DOI 10.1111/jan.12301; Chauny JM, 2014, EUR J PAIN, V18, P1103, DOI 10.1002/j.1532-2149.2014.00452.x; Chen YF, 2013, THESIS NAT DIGITAL L; Costa WA, 2017, CLINICS, V72, P758, DOI 10.6061/clinics/2017(12)07; de Rond MEJ, 2000, PAIN, V89, P25, DOI 10.1016/S0304-3959(00)00344-4; DeRemer CE, 2011, SOUTH MED J, V104, P629, DOI 10.1097/SMJ.0b013e3182296f20; Dijkstra BM, 2014, EUR J PAIN, V18, P3, DOI 10.1002/j.1532-2149.2013.00337.x; Dobscha SK, 2015, PAIN MED, V16, P855, DOI 10.1111/pme.12643; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Farrar JT, 2010, NAT MED, V16, P1284, DOI 10.1038/nm.2249; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Fraenkel L, 2012, J GEN INTERN MED, V27, P555, DOI 10.1007/s11606-011-1926-z; Heden L, 2016, EUR J PAIN, V20, P223, DOI 10.1002/ejp.711; Hirschfeld G, 2013, PAIN, V154, P154, DOI 10.1016/j.pain.2012.10.008; Kim HJ, 2014, PAIN MED, V15, P2037, DOI 10.1111/pme.12578; Krebs EE, 2010, J GEN INTERN MED, V25, P194, DOI 10.1007/s11606-009-1194-3; Li TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108432; Lucenteforte E, 2012, INTERN EMERG MED, V7, P477, DOI 10.1007/s11739-012-0815-8; Marinsek M, 2007, EUR J PAIN, V11, P773, DOI 10.1016/j.ejpain.2006.12.002; Martoni AA, 2007, ANN ONCOL, V18, P158, DOI 10.1093/annonc/mdl314; Mearis M, 2014, J PAIN SYMPTOM MANAG, V48, P451, DOI 10.1016/j.jpainsymman.2013.09.016; O'Malley AS, 2010, J GEN INTERN MED, V25, P177, DOI 10.1007/s11606-009-1195-2; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Rebecca B, 2014, SUPPORT CARE CANCER, V22, P2067, DOI 10.1007/s00520-014-2191-6; Samuels JG, 2009, J NURS CARE QUAL, V24, P223, DOI 10.1097/NCQ.0b013e318194fcec; Voepel-Lewis T, 2010, AM J CRIT CARE, V19, P55, DOI 10.4037/ajcc2010624; Volkman JE, 2015, PAIN MED, V16, P1690, DOI 10.1111/pme.12753; Wang WY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002099; Witkin LR, 2013, PAIN MED, V14, P779, DOI 10.1111/pme.12075; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Zheng NT, 2014, J PAIN SYMPTOM MANAG, V48, P582, DOI 10.1016/j.jpainsymman.2013.11.010; Zylla D, 2014, Br J Anaesth, V113, pi109, DOI 10.1093/bja/aeu351	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222516	10.1371/journal.pone.0222516	http://dx.doi.org/10.1371/journal.pone.0222516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553746	Green Published, Green Submitted, gold			2022-12-27	WOS:000532319200029
J	Mahjoubi, M; Aliyu, H; Cappello, S; Naifer, M; Souissi, Y; Cowan, DA; Cherif, A				Mahjoubi, Mouna; Aliyu, Habibu; Cappello, Simone; Naifer, Mohamed; Souissi, Yasmine; Cowan, Don A.; Cherif, Ameur			The genome of Alcaligenes aquatilis strain BU33N: Insights into hydrocarbon degradation capacity	PLOS ONE			English	Article							SP-NOV.; POLLUTED SEAWATER; OIL-SPILL; CRUDE-OIL; BACTERIUM; ALGORITHM; GENE; TOOL	Environmental contamination with hydrocarbons though natural and anthropogenic activities is a serious threat to biodiversity and human health. Microbial bioremediation is considered as the effective means of treating such contamination. This study describes a biosurfactant producing bacterium capable of utilizing crude oil and various hydrocarbons as the sole carbon source. Strain BU33N was isolated from hydrocarbon polluted sediments from the Bizerte coast (northern Tunisia) and was identified as Alcaligenes aquatilis on the basis of 16S rRNA gene sequence analysis. When grown on crude oil and phenanthrene as sole carbon and energy sources, isolate BU33N was able to degrade similar to 86%, similar to 56% and 70% of TERHc, n-alkanes and phenanthrene, respectively. The draft genome sequence of the A. aquatilis strain BU33N was assembled into one scaffold of 3,838,299 bp (G+C content of 56.1%). Annotation of the BU33N genome resulted in 3,506 protein-coding genes and 56 rRNA genes. A large repertoire of genes related to the metabolism of aromatic compounds including genes encoding enzymes involved in the complete degradation of benzoate were identified. Also genes associated with resistance to heavy metals such as copper tolerance and cobalt-zinc-cadmium resistance were identified in BU33N. This work provides insight into the genomic basis of biodegradation capabilities and bioremediation/detoxification potential of A. aquatilis BU33N.	[Mahjoubi, Mouna; Naifer, Mohamed; Souissi, Yasmine; Cherif, Ameur] Univ Manouba, ISBST, BVBGR LR11ES31, Biotechpole SidiThabet, Ariana, Tunisia; [Aliyu, Habibu] Karlsruhe Inst Technol, Inst Proc Engn Life Sci Tech Biol 2, Karlsruhe, Germany; [Cappello, Simone] CNR Messina Sp San Raineri, Ist Ambiente Marino Costiero IAMC, Messina, Italy; [Cowan, Don A.] Univ Pretoria, Ctr Microbial Ecol & Genom, Pretoria, South Africa	Universite de la Manouba; Helmholtz Association; Karlsruhe Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Pretoria	Cherif, A (corresponding author), Univ Manouba, ISBST, BVBGR LR11ES31, Biotechpole SidiThabet, Ariana, Tunisia.	cherif.ameur@gmail.com	Cherif, Ameur/AAC-6136-2021; Souissi, Yasmine/ABF-1356-2020; Aliyu, Habibu/AFU-6931-2022; Aliyu, Habibu/AAV-7027-2020; Cowan, Don/E-3991-2012	Aliyu, Habibu/0000-0002-9870-8167; Mahjoubi, Mouna/0000-0002-0474-1530; Souissi, Yasmine/0000-0003-3435-3165; Cowan, Don/0000-0001-8059-861X				Abbas S, 2015, ANTON LEEUW INT J G, V108, P859, DOI 10.1007/s10482-015-0540-1; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; [Anonymous], 2009, AM J AGRIC ENV SCI; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cappello S, 2014, BRAZ J MICROBIOL, V45, P1317, DOI 10.1590/S1517-83822014000400023; Crisafi F, 2016, MAR POLLUT BULL, V106, P119, DOI 10.1016/j.marpolbul.2016.03.017; Duran RE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00528; Euzeby JP, 1996, INT J SYST BACTERIOL, V46, P830, DOI 10.1099/00207713-46-3-830; Genovese M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00162; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hassanshahian M, 2014, MAR ENVIRON RES, V95, P28, DOI 10.1016/j.marenvres.2013.12.010; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Jiang Zhibing, 2010, Acta Ecologica Sinica, V30, P8; Joo HS, 2006, WATER RES, V40, P3029, DOI 10.1016/j.watres.2006.06.021; Ju SY, 2016, J BIOTECHNOL, V218, P73, DOI 10.1016/j.jbiotec.2015.12.001; KALMAN S, 1993, APPL ENVIRON MICROB, V59, P1131, DOI 10.1128/AEM.59.4.1131-1137.1993; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Liu XY, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00222-16; Lu CY, 2017, INT J SYST EVOL MICR, V67, P939, DOI 10.1099/ijsem.0.001719; Macchi M, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-017-2391-6; Magthalin CJ, 2016, MATER TODAY-PROC, V3, P3697, DOI 10.1016/j.matpr.2016.11.015; Mahjoubi M, 2013, NEW BIOTECHNOL, V30, P723, DOI 10.1016/j.nbt.2013.03.004; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nakano M, 2014, BIOCONTROL SCI, V19, P23, DOI 10.4265/bio.19.23; Niazy Z, 2016, POLLUTION, V2, P67, DOI 10.7508/pj.2016.01.007; Pal S, 2017, GENOMICS, V109, P374, DOI 10.1016/j.ygeno.2017.06.002; Paliwal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084000; Pan XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep20317; PAOLILLO M, 2019, MICROBIOLOGY RESOURC, V8, DOI DOI 10.1128/MRA.01664-18; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Rani S, 2017, MAR GENOM, V34, P19, DOI 10.1016/j.margen.2017.02.005; Rehfuss M, 2005, SYST APPL MICROBIOL, V28, P421, DOI 10.1016/j.syapm.2005.03.003; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Santisi S, 2015, BRAZ J MICROBIOL, V46, P377, DOI 10.1590/S1517-838246120131276; Schroll G, 2001, SYST APPL MICROBIOL, V24, P37, DOI 10.1078/0723-2020-00001; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; Serrano AE, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0252-4; Singha LP, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01346-17, 10.1128/genomea.01346-17]; Stanton SL, 2013, S AFR J BOT, V86, P41, DOI 10.1016/j.sajb.2013.01.007; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; Yamanashi T, 2015, BIOSCI BIOTECH BIOCH, V79, P830, DOI 10.1080/09168451.2014.993915; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001	50	8	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221574	10.1371/journal.pone.0221574	http://dx.doi.org/10.1371/journal.pone.0221574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550268	Green Published, Green Submitted, gold			2022-12-27	WOS:000532307700008
J	Swider, K; Babel, P; Wronka, E; van Rijn, CM; Oosterman, JM				Swider, Karolina; Babel, Przemyslaw; Wronka, Eligiusz; van Rijn, Clementina M.; Oosterman, Joukje M.			Placebo analgesia induced by verbal suggestion in the context of experimentally induced fear and anxiety	PLOS ONE			English	Article							MOVEMENT-RELATED PAIN; NOCEBO HYPERALGESIA; INDUCED EXPECTATIONS; RESPONSE EXPECTANCY; BACK-PAIN; FMRI; ACQUISITION; MECHANISMS; EXPERIENCE; AVOIDANCE	The role of state anxiety and state fear in placebo effects is still to be determined. We aimed to investigate the effect of fear of movement-related pain (FMRP) and contextual pain related anxiety (CPRA) on the magnitude of placebo analgesia induced by verbal suggestion. Fifty-six female participants completed a modified voluntary joystick movement paradigm (VJMP) where half participated in a predictable pain condition (PC), in which one of the joystick movements is always followed by pain and the other movement is never followed by pain, and half in an unpredictable pain condition (UC), in which pain was delivered unpredictably. By varying the level of pain predictability, FMRP and CPRA were induced in PC and UC respectively. Colour stimuli were presented at the beginning of each trail. Half of the participants were verbally informed that the green or red colour indicated less painful stimuli (experimental groups), the other half did not receive any suggestion (control groups). We measured self-reported pain intensity, expectancy of pain intensity (PC only), pain related fear and anxiety (eyeblink startle response and self-ratings) and avoidance behaviour (movement-onset latency and duration). The results indicate that the placebo effect was successfully induced in both experimental conditions. In the PC, the placebo effect was predicted by expectancy. Despite the fact that FMRP and CPRA were successfully induced, no difference was found in the magnitude of the placebo effect between PC and UC. Concluding, we did not find a divergent effect of fear and anxiety on placebo analgesia.	[Swider, Karolina; van Rijn, Clementina M.; Oosterman, Joukje M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Swider, Karolina; Babel, Przemyslaw] Jagiellonian Univ, Pain Res Grp, Inst Psychol, Krakow, Poland; [Wronka, Eligiusz] Jagiellonian Univ, Inst Psychol, Krakow, Poland	Radboud University Nijmegen; Jagiellonian University; Jagiellonian University	Swider, K (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Swider, K (corresponding author), Jagiellonian Univ, Pain Res Grp, Inst Psychol, Krakow, Poland.	swider.karolina.joanna@gmail.com	van Rijn, Clementina/D-5828-2012; Oosterman, Joukje/D-6125-2012	Oosterman, Joukje/0000-0003-0549-8832	National Science Centre in Poland (Narodowe Centrum Nauki - NCN) [2013/09/N/HS6/02947]; Radboud Fellowship Programme, Donders Centre for Cognition, Radboud University, Nijmegen, The Netherlands	National Science Centre in Poland (Narodowe Centrum Nauki - NCN); Radboud Fellowship Programme, Donders Centre for Cognition, Radboud University, Nijmegen, The Netherlands(Netherlands Government)	This work is the result of research project no. 2013/09/N/HS6/02947, funded by the National Science Centre in Poland (Narodowe Centrum Nauki - NCN) and Radboud Fellowship Programme, Donders Centre for Cognition, Radboud University, Nijmegen, The Netherlands. The funder had no role in the study design, data collection nor analysis, decision to publish, or preparation of the manuscript	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Anxiety Rachman S., 2004, ANXIETY, P1; Aslaksen PM, 2008, PSYCHOSOM MED, V70, P811, DOI 10.1097/PSY.0b013e31818105ed; Babel P, 2008, STUD PSYCHOL, V46, P13; Babel P, 2018, PAIN MED, V19, P1156, DOI 10.1093/pm/pnx177; Babel P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181856; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Buer N, 2002, PAIN, V99, P485, DOI 10.1016/S0304-3959(02)00265-8; Colagiuri B, 2015, J PAIN, V16, P995, DOI 10.1016/j.jpain.2015.06.012; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; deJong PJ, 1996, INT J BEHAV MED, V3, P14, DOI 10.1207/s15327558ijbm0301_2; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Evans FJ, 1977, PSYCHIAT AREAS PROMI, P249; Freeman S, 2015, NEUROIMAGE, V112, P197, DOI 10.1016/j.neuroimage.2015.03.015; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Helsen K, 2011, J PAIN, V12, P1230, DOI 10.1016/j.jpain.2011.07.002; Hubbard CS, 2011, PAIN, V152, P1632, DOI 10.1016/j.pain.2011.03.001; Kirsch I, 1997, APPL PREV PSYCHOL, V6, P69, DOI 10.1016/S0962-1849(05)80012-5; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; Kirsch Irving, 2014, Psychol Conscious (Wash D C), V1, P51; Lachaud CM, 2011, APPL PSYCHOLINGUIST, V32, P389, DOI 10.1017/S0142716410000457; Lyby PS, 2012, PAIN, V153, P1114, DOI 10.1016/j.pain.2012.02.042; McCracken LM, 2007, PAIN, V130, P119, DOI 10.1016/j.pain.2006.11.016; MCGLASHA.TH, 1969, PSYCHOSOM MED, V31, P227, DOI 10.1097/00006842-196905000-00003; Meulders A, 2014, J PAIN, V15, P632, DOI 10.1016/j.jpain.2014.02.009; Meulders A, 2013, J PAIN, V14, P412, DOI 10.1016/j.jpain.2012.12.014; Meulders A, 2012, PAIN, V153, P1504, DOI 10.1016/j.pain.2012.04.013; Meulders A, 2012, PAIN, V153, P1030, DOI 10.1016/j.pain.2012.02.005; Meulders A, 2011, PAIN, V152, P2460, DOI 10.1016/j.pain.2011.05.015; Miller FG, 2010, PERSPECT BIOL MED, V53, P509, DOI 10.1353/pbm.2010.0004; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Oka S, 2010, J PAIN, V11, P239, DOI 10.1016/j.jpain.2009.07.009; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Perusini JN, 2015, LEARN MEMORY, V22, P417, DOI 10.1101/lm.039180.115; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Piedimonte A, 2017, EUR J PAIN, V21, P874, DOI 10.1002/ejp.990; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Schmid J, 2015, NEUROIMAGE, V120, P114, DOI 10.1016/j.neuroimage.2015.06.060; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Spielberger CD, 1988, HDB ANXIETY, P31; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Swider K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158363; Swider K, 2013, PAIN, V154, P1312, DOI 10.1016/j.pain.2013.04.001; Sylvers P, 2011, CLIN PSYCHOL REV, V31, P122, DOI 10.1016/j.cpr.2010.08.004; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Vase L, 2005, PAIN, V115, P338, DOI 10.1016/j.pain.2005.03.014; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; VOUDOURIS NJ, 1985, J PERS SOC PSYCHOL, V48, P47, DOI 10.1037/0022-3514.48.1.47; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222805	10.1371/journal.pone.0222805	http://dx.doi.org/10.1371/journal.pone.0222805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550290	Green Published, gold			2022-12-27	WOS:000532307700025
J	Hassen, AM; Taye, G; Gizaw, M; Hussien, FM				Hassen, Anissa Mohammed; Taye, Girma; Gizaw, Muluken; Hussien, Foziya Mohammed			Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article								Background Breast cancer is the most common cancer affecting women in Ethiopia with increasing burden, and chemotherapy treatment produces a detrimental effect on individual wellbeing. Since last few years quality of life has been the primary goal of cancer treatment, yet little research has been conducted on quality of life of breast cancer patients under chemotherapy. Objective To determine the quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Methods Institution based cross-sectional study was conducted on 404 patients with breast cancer, who took at least one cycle of chemotherapy treatment using face to face interview at oncology unit of Tikur Anbessa specialized hospital day care center from February to April 2018. The validated Amharic version of European organization for research and treatment of cancer core 30 (EORTC QLQ-C30) and quality of life questionnaire specific to breast (QLQ-BR23) was used to measure health related quality of life. Both descriptive and inferential statistics were used. For the purpose of interpretation quality of life score was dichotomized in to two using the calculated mean score, which is 53 as a cutoff point, then, bi-variable and multivariable logistic regression was used to describe association between dependent and independent variables. Hence, patients who score above 53 for quality of life were considered to have good quality of life. Result Of the total sample, overall response rate was 99.77%. The average quality of life score of patients with breast cancer under chemotherapy treatment was 52.98 (SD = 25.61). Majority of patients had scored poor in emotional functioning, sexual functioning, and financial difficulties. Educational status of college and above, being divorced, higher household income, higher scores of physical and social functioning were associated with significantly improved (better) quality of life. Lower scores of fatigue, insomnia, financial difficulties and systemic therapy side effects all were associated with better scores of quality of life of breast cancer patients. Whereas, patients receiving < = 2 cycles of chemotherapy had significantly lower scores of quality of life. Conclusion and recommendation Quality of life of breast cancer patients under chemotherapy treatment is poor in comparison with the reference data and international findings. Therefore, quality of life assessment should be incorporated in patient's treatment protocol. And financial aids may significantly improve the quality of life of breast cancer patients under chemotherapy treatment.	[Hassen, Anissa Mohammed; Hussien, Foziya Mohammed] Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia; [Taye, Girma; Gizaw, Muluken] Addis Ababa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Hassen, AM (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia.	anisa.moh26@gmail.com	Hussien, Foziya Mohammed/CAF-3288-2022; Mohammed, Anissa/GNP-7326-2022	Hussien, Foziya Mohammed/0000-0003-0583-5405; Mohammed, Anissa/0000-0002-1580-4269	Addis Ababa University	Addis Ababa University	The fund was obtained from Addis Ababa University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 1993, JNCI-J NATL CANCER I, V85, P78; Bekele MA, 2016, ASSESSING QUALITY LI; Costanzo E, 2007, BRIT J CANCER, V97, P7; Davies N., 2009, NURSING STANDARD, V23, P8; Dubashi B, 2010, INDIAN J CANCER, V47, P5; Ediebah D, 2014, BRIT J CANCER, V110, P7; Eisenbraun J, 2010, PHYTOMEDICINE, V18, P7; Fayers P., 2011, EORTC QLQ C30 SCORIN; Foubert J., 2006, NURSING STANDARD, V20, P8; Grabsch B, 2006, PALLIAT SUPPORT CARE, V4, P10; Haddou B, 2017, BJMMR, V21, P11; Hoyer M, 2011, ACTA ONCOL, V50, P12; International Agency For Resarch on Cancer, 2012, EST BREAST CANC INC; Ishak W, 2012, INNOV CLIN NEUROSCI, V9, P16; Jaiyesimi A, 2007, AFRICAN J MED MED SC, V36, P8; Jassim G, 2013, BMC, V13, P14; Kantelhardt E, 2014, INT J CANCER, V135, P8; Lobo S, 2014, ACTA PAUL ENFERM, V27, P6; Manandhar S, 2014, ASIAN PAC J CANCER P, V15, P5; Mohsin S, 2015, PAK ARMAED FORCES ME, V66, P5; Nakitare S., 2002, THESIS, P78; Nedjat S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-61; Osoba D., 2011, THER ADV MED ONCOL, V3, P15; Paul B, 2002, ASSESSING QUALITY LI; Perry S, 2007, BIOPROCESS INT, V5, P14; Sabate E., 2003, ADHERENCE LONG TERM, P110; Safaee A, 2008, INDIAN J CANC, V45; Scott NW, 2008, EORTC QLQ C30 REFERE, V2nd, P427; Sharma A, 2013, INT J SURG ONCOLOGY, P6; Smets E, 1998, SUPPPORT CARE CANC, V6, P8; Tigeneh W, 2015, INT J CANC RES MOL M, P1, DOI [10.16966/2381-3318.103, DOI 10.16966/2381-3318.103]; World Health Organization, 2015, CANC GROW PUBL HLTH; World Health Organization. International Agency for Research on Cancer (IARC), 2013, LAT WORLD CANC STAT; Yan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153714	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222629	10.1371/journal.pone.0222629	http://dx.doi.org/10.1371/journal.pone.0222629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539399	gold, Green Published			2022-12-27	WOS:000532297900021
J	de Silva, JR; Amir, A; Lau, YL; Ooi, CH; Fong, MY				de Silva, Jeremy Ryan; Amir, Amirah; Lau, Yee Ling; Ooi, Choo-Huck; Fong, Mun Yik			Distribution of the Duffy genotypes in Malaysian Borneo and its relation to Plasmodium knowlesi malaria susceptibility	PLOS ONE			English	Article							BLOOD-GROUP GENOTYPE; NATURAL-SELECTION; VIVAX; DISEASE; POLYMORPHISM; HUMANS; SABAH	The Duffy blood group plays a key role in Plasmodium knowlesi and Plasmodium vivax invasion into human erythrocytes. The geographical distribution of the Duffy alleles differs between regions with the FY* A allele having high frequencies in many Asian populations, the FY*B allele is found predominately in European populations and the FY*Bes allele found predominantly in African regions. A previous study in Peninsular Malaysia indicated high homogeneity of the dominant FY* A/FY* A genotype. However, the distribution of the Duffy genotypes in Malaysian Borneo is currently unknown. In the present study, the distribution of Duffy blood group genotypes and allelic frequencies among P. knowlesi infected patients as well as healthy individuals in Malaysian Borneo were determined. A total of 79 P. knowlesi patient blood samples and 76 healthy donor samples were genotyped using allele specific polymerase chain reaction (ASP-PCR). Subsequently a P. knowlesi invasion assay was carried out on FY* AB/ FY* A and FY* A/ FY* A Duffy genotype blood to investigate if either genotype conferred increased susceptibility to P. knowlesi invasion. Our results show almost equal distribution between the homozygous FY*A/FY*A and heterozygous FY*A/ FY* B genotypes. This is in stark contrast to the Duffy distribution in Peninsular Malaysia and the surrounding Southeast Asian region which is dominantly FY*A/FY*A. The mean percent invasion of FY*A/FY*A and FY*A/FY*B blood was not significantly different indicating that neither blood group confers increased susceptibility to P. knowlesi invasion.	[de Silva, Jeremy Ryan; Amir, Amirah; Lau, Yee Ling; Fong, Mun Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Ooi, Choo-Huck] Sarawak State Hlth Dept, Jalan Diplomat,Off Jalan Bako, Sarawak, Malaysia	Universiti Malaya	Fong, MY (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fongmy@um.edu.my	Amir, Amirah/AAB-9628-2021; FONG, MUN YIK/B-5443-2010; Lau, Yee Ling/C-6996-2009	Amir, Amirah/0000-0001-9189-8925; Lau, Yee Ling/0000-0002-2037-2165	University Malaya Frontier Research Grant 2017 [FG01517AFR]; Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia [FP036-2015A]	University Malaya Frontier Research Grant 2017; Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia	MYF was funded by the University Malaya Frontier Research Grant 2017 (FG01517AFR) and Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia (FP036-2015A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24623; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Babinszki A, 1999, PRENATAL DIAG, V19, P533, DOI 10.1002/(SICI)1097-0223(199906)19:6<533::AID-PD570>3.0.CO;2-5; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CUTBUSH M, 1950, HEREDITY, V4, P383, DOI 10.1038/hdy.1950.31; De Silva JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108951; Fong MY, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3118-8; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; IKIN EW, 1951, NATURE, V168, P1077, DOI 10.1038/1681077b0; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Lim KL, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1984-8; Liu Z, 2012, CHINESE MED J-PEKING, V125, P1076, DOI 10.3760/cma.j.issn.0366-6999.2012.06.021; Malaysia Ministry of Health, 2018, ZOON MAL PREV PROGR; Martins ML, 2017, MOL CELL PROBE, V35, P20, DOI 10.1016/j.mcp.2017.06.001; MASON SJ, 1977, BRIT J HAEMATOL, V36, P327, DOI 10.1111/j.1365-2141.1977.tb00656.x; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moghaddam EM, 2014, ASIAN PAC J TROP MED, V7, P202, DOI 10.1016/S1995-7645(14)60021-3; MONHATY SS, 2011, J RURAL TROP PUB HLT, V10, P53; Moyes CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002780; Nathalang Oytip, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P204; Nathalang O, 2015, ANN LAB MED, V35, P618, DOI 10.3343/alm.2015.35.6.618; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Noizat-Pirenne F, 2013, CR BIOL, V336, P152, DOI 10.1016/j.crvi.2012.09.011; Peng C T, 2000, Kaohsiung J Med Sci, V16, P63; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Shimizu Y, 2000, HUM BIOL, V72, P511; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2010, Med J Malaysia, V65, P166; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Zhou SH, 2015, J CLIN LAB ANAL, V29, P203, DOI 10.1002/jcla.21751; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222681	10.1371/journal.pone.0222681	http://dx.doi.org/10.1371/journal.pone.0222681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536563	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800069
J	Elnaem, MH; Mohamed, MHN; Huri, HZ				Elnaem, Mohamed Hassan; Mohamed, Mohamad Haniki Nik; Huri, Hasniza Zaman			Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design	PLOS ONE			English	Article							PRIMARY-CARE; INTERVENTION; IMPACT; POPULATION; ATTAINMENT; MELLITUS; QUALITY	Objective Previous reports have highlighted the suboptimal utilization and prescription of statin therapy among patients with type 2 diabetes mellitus (T2DM) in the Malaysian clinical practice. This study aims to test the impact of a pharmacist-led academic detailing program on improving the overall statin therapy prescribing in Malaysian hospital and primary care settings. Methods As a quasi-experimental design with a control group and pre-tests., we examined 1,598 medical records of T2DM subjects in six healthcare facilities in the state of Pahang, Malaysia. In all study sites, there was a pre and post-intervention assessment of the percentage of appropriate statin therapy prescribing that complied with the clinical guidelines with no potential safety issues. The intervention was an academic detailing program offered to the health care providers in three study sites, while the other three sites served as the control group. A comparison of the overall percentage of appropriate statin therapy prescribing before and after the academic detailing was performed in all intervention and control sites. Results Overall, 797 medical records were examined in the pre-intervention phase, and 801 records were evaluated in the post-intervention phase. The academic detailing program was associated with a statistically significant difference in the proportion of appropriate statin therapy prescribing between the post-intervention phase compared to the pre-intervention phase (n = 246, 61.7% versus n = 188, 47.1%), p = 0.001. Whereas, the appropriate statin therapy prescribing in the control study sites experienced a modest change from 53.8% (214/398) to 56.7% (228/402), p = 0.220. The academic detailing showed significant increases in the proportions of appropriate statin therapy prescribing in both hospital and primary care settings. Conclusions The academic detailing program was found to be significantly associated with a positive impact on the overall statin therapy prescribing among patients with T2DM in Malaysian hospital and primary care settings.	[Elnaem, Mohamed Hassan; Mohamed, Mohamad Haniki Nik] Int Islamic Univ Malaysia, Fac Pharm, Dept Pharm Practice, Kuantan, Pahang, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	International Islamic University Malaysia; Universiti Malaya	Elnaem, MH (corresponding author), Int Islamic Univ Malaysia, Fac Pharm, Dept Pharm Practice, Kuantan, Pahang, Malaysia.	drmelnaem@gmail.com	HURI, HASNIZA ZAMAN/B-8612-2010; Elnaem, Mohamed Hassan/O-9248-2017	HURI, HASNIZA ZAMAN/0000-0002-6423-8515; Elnaem, Mohamed Hassan/0000-0003-0873-6541	Research Management Center, International Islamic University Malaysia [RIGS17-122-0697]	Research Management Center, International Islamic University Malaysia	This work is supported by Grant Number: RIGS17-122-0697 from Research Management Center, International Islamic University Malaysia.	Avorn J, 2017, JAMA-J AM MED ASSOC, V317, P361, DOI 10.1001/jama.2016.16036; Benedict AW, 2018, J MANAG CARE SPEC PH, V24, P114, DOI 10.18553/jmcp.2018.24.2.114; Bucheit JD, 2018, J CLIN LIPIDOL, V12, P367, DOI 10.1016/j.jacl.2017.11.010; Costa JD, 2016, J PHARM HEALTH SERV, V7, P105, DOI 10.1111/jphs.12133; Doellner JF, 2017, J AM PHARM ASSOC, V57, pS197, DOI 10.1016/j.japh.2017.03.002; Elnaem MH, 2017, TROP J PHARM RES, V16, P3005, DOI 10.4314/tjpr.v16i12.27; Elnaem MH, 2019, THER CLIN RISK MANAG, V15, P137, DOI 10.2147/TCRM.S182716; Elnaem MH, 2018, J EVAL CLIN PRACT, V24, P521, DOI 10.1111/jep.12903; Falk E, 2017, ATHEROSCLEROSIS, V262, P198, DOI 10.1016/j.atherosclerosis.2017.02.006; Fischer MA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0785-8; Gil-Guillen V, 2015, BRIT J GEN PRACT, V65, pE32, DOI 10.3399/bjgp15X683137; Godman B, 2015, EXPERT REV PHARM OUT, V15, P323, DOI 10.1586/14737167.2015.967221; James P, 2004, DIABETIC MED, V21, P1108, DOI 10.1111/j.1464-5491.2004.01301.x; Kuiper JG, 2017, CLIN THER, V39, P819, DOI 10.1016/j.clinthera.2017.03.001; Lama S, 2017, INT J CLIN PHARM-NET, V39, P919, DOI 10.1007/s11096-017-0483-x; Lowrie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113370; Malaysian Clinical Practice Guideline, 2015, MANAGEMENT TYPE 2 DI, P1; Naughton C, 2007, FAM PRACT, V24, P475, DOI 10.1093/fampra/cmm044; Naugler C, 2017, CAN J CARDIOL, V33, P682, DOI 10.1016/j.cjca.2017.02.005; Renner HM, 2017, J AM PHARM ASSOC, V57, pS236, DOI 10.1016/j.japh.2017.04.009; Said AH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013573; Simon SR, 2005, AM J MED, V118, P521, DOI 10.1016/j.amjmed.2004.12.023; Siti Fauziah A, 2014, MALAYSIAN STAT MED 2; Thomas JS, 2015, QJM-INT J MED, V108, P369, DOI 10.1093/qjmed/hcu213; Tunney RK, 2017, ANN PHARMACOTHER, V51, P394, DOI 10.1177/1060028016687322; Wander GS, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0519-1; Wisniewski CS, 2014, AM J HEALTH-SYST PH, V71, P128, DOI 10.2146/ajhp130225	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0220458	10.1371/journal.pone.0220458	http://dx.doi.org/10.1371/journal.pone.0220458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536502	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000532262800013
J	Maheshwari, P; Kummari, D; Palakolanu, SR; Tejaswi, UN; Nagaraju, M; Rajasheker, G; Jawahar, G; Jalaja, N; Rathnagiri, P; Kishor, PBK				Maheshwari, P.; Kummari, Divya; Palakolanu, Sudhakar Reddy; Tejaswi, U. Nagasai; Nagaraju, M.; Rajasheker, G.; Jawahar, G.; Jalaja, N.; Rathnagiri, P.; Kishor, P. B. Kavi			Genome-wide identification and expression profile analysis of nuclear factor Y family genes in Sorghum bicolor L. (Moench)	PLOS ONE			English	Article							TIME PCR DATA; TRANSCRIPTION FACTOR; DROUGHT TOLERANCE; ABSCISIC-ACID; REGULATORY ELEMENTS; BINDING; STRESS; OVEREXPRESSION; SIGNAL; ABA	Members of the plant Heme Activator Protein (HAP) or NUCLEAR FACTOR Y (NF-Y) are trimeric transcription factor complexes composed of the NF-YA, NF-YB and NF-YC subfamilies. They bind to the CCAAT box in the promoter regions of the target genes and regulate gene expressions. Plant NF-Ys were reported to be involved in adaptation to several abiotic stresses as well as in development. In silico analysis of Sorghum bicolor genome resulted in the identification of a total of 42 NF-Y genes, among which 8 code for the SbNF-YA, 19 for SbNF-YB and 15 for the SbNF-YC subunits. Analysis was also performed to characterize gene structures, chromosomal distribution, duplication status, protein subcellular localizations, conserved motifs, ancestral protein sequences, miRNAs and phylogenetic tree construction. Phylogenetic relationships and ortholog predictions displayed that sorghum has additional NF-YB genes with unknown functions in comparison with Arabidopsis. Analysis of promoters revealed that they harbour many stress-related cis-elements like ABRE and HSE, but surprisingly, DRE and MYB elements were not detected in any of the subfamilies. SbNF-YA1, 2, and 6 were found upregulated under 200 mM salt and 200 mM mannitol stresses. While NF-YA7 appeared associated with high temperature (40 degrees C) stress, NF-YA8 was triggered by both cold (4 degrees C) and high temperature stresses. Among NF-YB genes, 7, 12, 15, and 16 were induced under multiple stress conditions such as salt, mannitol, ABA, cold and high temperatures. Likewise, NF-YC 6, 11, 12, 14, and 15 were enhanced significantly in a tissue specific manner under multiple abiotic stress conditions. Majority of the mannitol (drought)-inducible genes were also induced by salt, high temperature stresses and ABA. Few of the high temperature stress-induced genes are also induced by cold stress (NF-YA2, 4, 6, 8, NF-YB2, 7, 10, 11, 12, 14, 16, 17, NF-YC4, 6, 12, and 13) thus suggesting a cross talk among them. This work paves the way for investigating the roles of diverse sorghum NF-Y proteins during abiotic stress responses and provides an insight into the evolution of diverse NF-Y members.	[Maheshwari, P.; Nagaraju, M.; Rajasheker, G.; Jawahar, G.; Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad, India; [Kummari, Divya; Palakolanu, Sudhakar Reddy] Int Crops Res Inst Semi Arid Trop, Hyderabad, India; [Tejaswi, U. Nagasai; Jalaja, N.] Vignans Fdn Sci Technol & Res, Dept Biotechnol, Guntur, Andhra Pradesh, India; [Nagaraju, M.] ICMR Natl Inst Nutr, Dept Biochem, Hyderabad, India; [Rathnagiri, P.] Genomix CARL Pvt Ltd, Rayalapuram Rd, Kadapa, Andhra Pradesh, India; [Rathnagiri, P.] Genomix Mol Diagnost Pvt Ltd, Hyderabad, India; [Rathnagiri, P.] Genomix Biotech Inc, Atlanta, GA USA	Osmania University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Vignan's Foundation for Science, Technology & Research (VFSTR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Kishor, PBK (corresponding author), Osmania Univ, Dept Genet, Hyderabad, India.	pbkavi@yahoo.com	MARKA, NAGARAJU/Y-7001-2019	Gandra, Jawahar/0000-0003-1217-676X; Kavi Kishor, Polavarapu/0000-0002-9587-7547; Marka, Nagaraju/0000-0002-9170-8543	Council of Scientific and Industrial Research (CSIR), New Delhi, India [381/1442/17/EMR-II, 38(1325)/12/EMR-II]; CSIR; CSIR, New Delhi; UGC, New Delhi; DST-SERB, New Delhi	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); UGC, New Delhi(University Grants Commission, India); DST-SERB, New Delhi	This project was financially supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India (through grant numbers 381/1442/17/EMR-II and 38(1325)/12/EMR-II). We have received financial support from CSIR for the year 2018-2019. For the current financial year 2019-2020, we have not yet received financial support from CSIR. The company Genomix Molecular Diagnostics Pvt Ltd., Kukatpally, Hyderabad, India, provided support in the form of salary for Dr. Rathnagiri Polavarapu (RP). Maheshwari acknowledges the financial support from the CSIR, New Delhi, for Research Associateship. Jawahar acknowledges the financial support from UGC, New Delhi. RG acknowledges the financial support from DST-SERB, New Delhi. The specific roles of this author are articulated in the 'author contributions' section. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PBK is thankful to the CSIR, New Delhi for providing Research Grant and CSIR-Emeritus Fellowship. Maheshwari acknowledges the financial support from the CSIR, New Delhi, for Research Associateship. Jawahar acknowledges the financial support from UGC, New Delhi. RG acknowledges the financial support from DST-SERB, New Delhi. We thank Dr. Prashanth Suravajhala, BISR, Jaipur for his critical comments.	Alam MM, 2015, PLANT BIOTECHNOL J, V13, P85, DOI 10.1111/pbi.12239; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; Chen M, 2014, PLANT BIOTECHNOL J, V12, P447, DOI [10.1111/pbi.12151, 10.1111/pbi.12270]; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; E ZG, 2018, J EXP BOT, V69, P2495, DOI 10.1093/jxb/ery087; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Feng ZJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01142; Frontini M, 2004, CELL CYCLE, V3, P217; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Barbosa EGG, 2013, PLANT MOL BIOL REP, V31, P719, DOI 10.1007/s11105-012-0541-4; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Chu HD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113290; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Han ZM, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01270, 10.3389/fpls.2016.02045, 10.3389/fpls.2016.01270, 10.3389/fpls.2016.01814]; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang MK, 2015, PLANT CELL, V27, P3099, DOI 10.1105/tpc.15.00750; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li LL, 2013, PLANTA, V238, P345, DOI 10.1007/s00425-013-1894-0; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang MX, 2014, PLANTA, V239, P107, DOI 10.1007/s00425-013-1964-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Malviya N, 2016, PHYSIOL MOL BIOL PLA, V22, P33, DOI 10.1007/s12298-016-0349-z; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Nekrutenko A, 2003, GENE, V306, P99, DOI 10.1016/S0378-1119(03)00427-X; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pereira SLS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199187; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Quach T, 2015, MOL GENET GENOMICS, V290, P1095, DOI 10.1007/s00438-014-0978-2; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Stephenson TJ, 2011, FUNCT INTEGR GENOMIC, V11, P327, DOI 10.1007/s10142-011-0212-9; Stief A, 2014, PLANT CELL, V26, P1792, DOI 10.1105/tpc.114.123851; Sun XC, 2014, GENE, V551, P214, DOI 10.1016/j.gene.2014.08.059; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Wang Y, 2018, PLANTA, V247, P559, DOI 10.1007/s00425-017-2809-2; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; Xu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111354; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Hoang XLT, 2017, CURR GENOMICS, V18, P483, DOI [10.2174/1389101918666170227150057, 10.2174/1389202918666170227150057]; Yan DH, 2013, PLANT MOL BIOL REP, V31, P363, DOI 10.1007/s11105-012-0508-5; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang J, 2016, BIOL PLANTARUM, V60, P419, DOI 10.1007/s10535-016-0624-4; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang WJ, 2017, CROP J, V5, P21, DOI 10.1016/j.cj.2016.06.014; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Zhang F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00642; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhang T, 2015, PLANT PHYSIOL BIOCH, V94, P153, DOI 10.1016/j.plaphy.2015.05.001; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29	90	14	17	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222203	10.1371/journal.pone.0222203	http://dx.doi.org/10.1371/journal.pone.0222203			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536532	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000532262800029
J	Rodriguez, RF; Townsend, NE; Aughey, RJ; Billaut, F				Rodriguez, Ramon F.; Townsend, Nathan E.; Aughey, Robert J.; Billaut, Francois			Muscle oxygenation maintained during repeated-sprints despite inspiratory muscle loading	PLOS ONE			English	Article							LEG BLOOD-FLOW; QUADRICEPS MUSCLE; LIMB LOCOMOTOR; EXERCISE; WORK; DEOXYGENATION; SPECTROSCOPY; FATIGUE; PHOSPHOCREATINE; FLUCTUATIONS	A high work of breathing can compromise limb oxygen delivery during sustained high-intensity exercise. However, it is unclear if the same is true for intermittent sprint exercise. This project examined the effect of adding an inspiratory load on locomotor muscle tissue reoxygenation during repeated-sprint exercise. Ten healthy males completed three experiment sessions of ten 10-s sprints, separated by 30-s of passive rest on a cycle ergometer. The first two sessions were "all-out' efforts performed without (CTRL) or with inspiratory loading (INSP) in a randomised and counterbalanced order. The third experiment session (MATCH) consisted of ten 10-s work-matched intervals. Tissue saturation index (TSI) and deoxy-haemoglobin (HHb) of the vastus lateralis and sixth intercostal space was monitored with near-infrared spectroscopy. Vastus lateralis reoxygenation (Delta Reoxy) was calculated as the difference from peak HHb (sprint) to nadir HHb (recovery). Total mechanical work completed was similar between INSP and CTRL (effect size: -0.18, 90% confidence limit +/- 0.43), and differences in vastus lateralis TSI during the sprint (-0.01 +/- 0.33) and recovery (-0.08 +/- 0.50) phases were unclear. There was also no meaningful difference in Delta Reoxy (0.21 +/- 0.37). Intercostal HHb was higher in the INSP session compared to CTRL (0.42 +/- 0.34), whilst the difference was unclear for TSI (-0.01 +/- 0.33). During MATCH exercise, differences in vastus lateralis TSI were unclear compared to INSP for both sprint (0.10 +/- 0.30) and recovery (-0.09 +/- 0.48) phases, and there was no meaningful difference in Delta Reoxy (-0.25 +/- 0.55). Intercostal TSI was higher during MATCH compared to INSP (0.95 +/- 0.53), whereas HHb was lower (-1.09 +/- 0.33). The lack of difference in Delta Reoxy between INSP and CTRL suggests that for intermittent sprint exercise, the metabolic O-2 demands of both the respiratory and locomotor muscles can be met. Additionally, the similarity of the MATCH suggests that Delta Reoxy was maximal in all exercise conditions.	[Rodriguez, Ramon F.; Aughey, Robert J.; Billaut, Francois] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Townsend, Nathan E.] Aspetar, Doha, Qatar; [Billaut, Francois] Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada	Victoria University; Aspetar Orthopaedic & Sports Medicine Hospital; Laval University	Billaut, F (corresponding author), Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia.; Billaut, F (corresponding author), Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada.	francois.billaut@kin.ulaval.ca	; Rodriguez, Ramon F./H-9390-2013; Billaut, Francois/D-1785-2018	Townsend, Nathan/0000-0002-2328-4638; Rodriguez, Ramon F./0000-0001-5806-7652; Billaut, Francois/0000-0002-4373-4245	Graduate Research Office (PhD Student Budget) at Victoria University; Aspetar Orthopaedic and Sports Medicine Hospital	Graduate Research Office (PhD Student Budget) at Victoria University; Aspetar Orthopaedic and Sports Medicine Hospital	Funding was provided by the Graduate Research Office (PhD Student Budget) at Victoria University. Funding was also provided in the form of a salary to NET by his employer, Aspetar Orthopaedic and Sports Medicine Hospital. The specific roles of this author are articulated in the 'author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON EA, 1992, J APPL PHYSIOL, V72, P1818, DOI 10.1152/jappl.1992.72.5.1818; Billaut F, 2013, SCAND J MED SCI SPOR, V23, pe185, DOI 10.1111/sms.12052; Billaut F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077297; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Buchheit M, 2011, EUR J APPL PHYSIOL, V111, P293, DOI 10.1007/s00421-010-1654-9; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DEBLASI RA, 1993, EUR J APPL PHYSIOL, V67, P20, DOI 10.1007/BF00377698; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Esaki K, 2005, EUR J APPL PHYSIOL, V95, P361, DOI 10.1007/s00421-005-0008-5; Forster HV, 2012, COMPR PHYSIOL, V2, P743, DOI 10.1002/cphy.c100045; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Harms CA, 1998, J APPL PHYSIOL, V85, P609, DOI 10.1152/jappl.1998.85.2.609; Harms CA, 1997, J APPL PHYSIOL, V82, P1573, DOI 10.1152/jappl.1997.82.5.1573; HARRIS RC, 1976, PFLUG ARCH EUR J PHY, V367, P137, DOI 10.1007/BF00585149; Hill JM, 2000, BRAIN RES, V856, P240, DOI 10.1016/S0006-8993(99)02366-5; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hureau TJ, 2016, MED SCI SPORT EXER, V48, P391, DOI 10.1249/MSS.0000000000000800; Jones B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120338; Kovacsova Z, 2018, ADV EXP MED BIOL, V1072, P307, DOI 10.1007/978-3-319-91287-5_49; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Legrand R, 2005, MED SCI SPORT EXER, V37, P782, DOI 10.1249/01.MSS.0000161806.47058.40; Matsuura R, 2015, BIOL SPORT, V32, P15, DOI 10.5604/20831862.1125286; Mendez-Villanueva A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051977; Messere A, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.179; Nielsen HB, 2001, ACTA PHYSIOL SCAND, V171, P63, DOI 10.1046/j.1365-201x.2001.171001063.x; Niemeijer VM, 2017, PHYSIOL MEAS, V38, P539, DOI 10.1088/1361-6579/aa5dd5; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Perrey S, 2018, SPORTS MED, V48, P597, DOI 10.1007/s40279-017-0820-1; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Rodriguez RF, 2018, SCAND J MED SCI SPOR, V28, P2263, DOI 10.1111/sms.13238; Rodriguez RF, 2019, RESP PHYSIOL NEUROBI, V260, P114, DOI 10.1016/j.resp.2018.11.006; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; Rossiter HB, 2000, J PHYSIOL-LONDON, V528, P359, DOI 10.1111/j.1469-7793.2000.t01-1-00359.x; SAHLIN K, 1979, SCAND J CLIN LAB INV, V39, P551, DOI 10.3109/00365517909108833; Sheel AW, 2001, J PHYSIOL-LONDON, V537, P277, DOI 10.1111/j.1469-7793.2001.0277k.x; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; St Croix CM, 2000, J PHYSIOL-LONDON, V529, P493, DOI 10.1111/j.1469-7793.2000.00493.x; Takaishi T, 2002, MED SCI SPORT EXER, V34, P520, DOI 10.1097/00005768-200203000-00020; Turner LA, 2016, INT J SPORTS MED, V37, P598, DOI 10.1055/s-0042-104198; Turner LA, 2013, RESP PHYSIOL NEUROBI, V185, P506, DOI 10.1016/j.resp.2012.11.018; Wetter TJ, 1999, J APPL PHYSIOL, V87, P643, DOI 10.1152/jappl.1999.87.2.643; Whipp BJ, 1998, BRIT J SPORT MED, V32, P199, DOI 10.1136/bjsm.32.3.199; Witt JD, 2007, J PHYSIOL-LONDON, V584, P1019, DOI 10.1113/jphysiol.2007.140855; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222487	10.1371/journal.pone.0222487	http://dx.doi.org/10.1371/journal.pone.0222487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536522	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000532262800044
J	Tamaki, S; Kanazawa, A; Sato, J; Tamura, Y; Asahara, T; Takahashi, T; Matsumoto, S; Yamashiro, Y; Watada, H				Tamaki, Shoko; Kanazawa, Akio; Sato, Junko; Tamura, Yoshifumi; Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi; Yamashiro, Yuichiro; Watada, Hirotaka			Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHAIN FATTY-ACIDS; MECHANISMS; SECRETION; OBESITY	Objective To explore clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes mellitus (T2DM). Methods The data of 118 patients with T2DM were obtained from two previous clinical studies, and were retrospectively analyzed regarding the clinical parameters associated with bacterial translocation defined as detection of bacteremia and levels of plasma lipopolysaccharide binding protein (LBP), the latter of which is thought to reflect inflammation caused by endotoxemia. Results LBP level was not significantly different between patients with and without bacteremia. No clinical factors were significantly correlated with the detection of bacteremia. On the other hand, plasma LBP level was significantly correlated with HbA1c (r = 0.312), fasting blood glucose (r = 0.279), fasting C-peptide (r = 0.265), body mass index (r = 0.371), high-density lipoprotein cholesterol (r = -0.241), and inflammatory markers (high-sensitivity C-reactive protein, r = 0.543; and interleukin-6, r = 0.456). Multiple regression analysis identified body mass index, HbA1c, high-sensitivity C-reactive protein, and interleukin-6 as independent determinants of plasma LBP level. Conclusion The plasma LBP level was similar in patients with and without bacteremia. While both bacteremia and LBP are theoretically associated with bacterial translocation, the detection of bacteremia was not associated with LBP level in T2DM.	[Tamaki, Shoko; Kanazawa, Akio; Sato, Junko; Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan; [Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi; Yamashiro, Yuichiro] Juntendo Univ, Probiot Res Lab, Grad Sch Med, Tokyo, Japan; [Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi] Yakult Cent Inst, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Therapeut Innovat Diabet, Grad Sch Med, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Identificat Diabet Therapeut Targets, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Yakult Honsha Company, Limited; Juntendo University; Juntendo University	Kanazawa, A (corresponding author), Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan.	akana@juntendo.ac.jp	Sato, Junko/GQQ-8846-2022; Tamura, Yoshifumi/AFK-2430-2022	Tamura, Yoshifumi/0000-0002-1685-7821; Sato, Junko/0000-0002-9784-5362				Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Christiansen CB, 2018, AM J PHYSIOL-GASTR L, V315, pG53, DOI 10.1152/ajpgi.00346.2017; Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623; Lecube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023366; Moreno-Navarrete JM, 2015, DIABETOLOGIA, V58, P2424, DOI 10.1007/s00125-015-3692-7; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Miura K, 2016, J BIOL CHEM, V291, P11504, DOI 10.1074/jbc.M115.709048; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Novitsky TJ, 1998, ANN NY ACAD SCI, V851, P416, DOI 10.1111/j.1749-6632.1998.tb09018.x; Peraneva L, 2013, ACTA DIABETOL, V50, P351, DOI 10.1007/s00592-012-0421-2; Sato J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12535-9; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Sucajtys-Szulc E, 2018, MOL CELL BIOCHEM, V446, P11, DOI 10.1007/s11010-018-3268-1; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Yamashiro K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171521; Yokoyama Y, 2016, DIGEST SURG, V33, P220, DOI 10.1159/000444459	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222598	10.1371/journal.pone.0222598	http://dx.doi.org/10.1371/journal.pone.0222598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536546	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800060
J	Yang, J; Pak, JH; Maki, M; Kim, SC				Yang, JiYoung; Pak, Jae-Hong; Maki, Masayuki; Kim, Seung-Chul			Multiple origins and the population genetic structure of Rubus takesimensis (Rosaceae) on Ulleung Island: Implications for the genetic consequences of anagenetic speciation	PLOS ONE			English	Article							JUAN FERNANDEZ ARCHIPELAGO; NONCODING REGIONS; SUBGENUS RUBUS; MOLECULAR-DATA; ULLUNG ISLAND; ASTERACEAE; DIVERSITY; NUCLEAR; EVOLUTION; PHYLOGENY	To determine the origin and genetic consequences of anagenesis in Rubus takesimensis on Ulleung Island, Korea, we compared the genetic diversity and population structure of R. takesimensis with those of its continental progenitor R. crataegifolius. We broadly sampled a total of 315 accessions in 35 populations and sequenced five noncoding regions of chloroplast DNA. Rubus takesimensis emerged as nonmonophyletic and several geographically diverse continental populations were likely responsible for the origin of R. takesimensis; the majority of R. takesimensis accessions were sisters to the clade containing accessions of R. crataegifolius, primarily from the Korean peninsula, while rare accessions from three populations shared common ancestors with the ones from the southern part of the Korean peninsula, Jeju Island, and Japan. A few accessions from the Chusan population originated independently from the Korean peninsula. Of 129 haplotypes, 81 and 48 were found exclusively in R. crataegifolius and R. takesimensis, respectively. We found unusually high genetic diversity in two regions on Ulleung Island and no geographic population structure. For R. crataegifolius, two major haplotype groups were found; one for the northern mainland Korean peninsula, and the other for the southern Korean peninsula and the Japanese archipelago. Compared with populations of R. crataegifolius sampled from Japan, much higher haplotype diversity was found in populations from the Korean peninsula. The patterns of genetic consequences in R. takesimensis need to be verified for other endemic species based on chloroplast DNA and independent nuclear markers to synthesize emerging patterns of anagenetic speciation on Ulleung Island.	[Yang, JiYoung; Pak, Jae-Hong] Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Dept Biol, Daegu, Gyeongsangbuk D, South Korea; [Maki, Masayuki] Tohoku Univ, Bot Gardens, Sendai, Miyagi, Japan; [Kim, Seung-Chul] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	Kyungpook National University; Tohoku University; Sungkyunkwan University (SKKU)	Pak, JH (corresponding author), Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Dept Biol, Daegu, Gyeongsangbuk D, South Korea.; Kim, SC (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea.	jhpak@knu.ac.kr; sonchus96@skku.edu	Kim, Seung-Chul/AAR-6157-2020	Kim, Seung-Chul/0000-0003-0559-6782	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A0511910]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education (2016R1A6A1A0511910), to J-HP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice LA, 1999, AM J BOT, V86, P81, DOI 10.2307/2656957; ANTONIUS K, 1994, MOL ECOL, V3, P177, DOI 10.1111/j.1365-294X.1994.tb00119.x; Asker S. E., 1992, APOMIXIS PLANTS; Barker NP, 2009, S AFR J BOT, V75, P560, DOI 10.1016/j.sajb.2009.05.006; Birky CW, 1996, GENETICS, V144, P427; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Cha Jae Seok, 2010, Journal of Korean Nature, V3, P151; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford Daniel J., 2016, KOREAN JOURNAL OF PLANT TAXONOMY, V46, P129, DOI 10.11110/kjpt.2016.46.2.129; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Eliasson U., 1974, OPERA BOTANICA SOC B, V36, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu XY, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Han J-S, 2014, COLLECTION TREATISES, V41, P131; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; Hoerandl Elvira, 2007, V147, P169; ITO M, 1990, BOT MAG TOKYO, V103, P449, DOI 10.1007/BF02491263; JORDANO P, 1982, OIKOS, V38, P183, DOI 10.2307/3544018; Jorgensen TH, 2001, PERSPECT PLANT ECOL, V4, P29, DOI 10.1078/1433-8319-00013; Kim P, 2015, HIST 3 KINGDOMS SAMG; Kim SC, 1996, SYST BOT, V21, P417, DOI 10.2307/2419668; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002139; Kim Y.K., 1985, J JAP ASS MINERAL PE, V80, P128, DOI DOI 10.2465/GANKO1941.80.128; Kollmann J, 2000, AM J BOT, V87, P1592, DOI 10.2307/2656735; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2013, J PLANT RES, V126, P193, DOI 10.1007/s10265-012-0519-1; Lee W, 2017, J PLANT BIOL, V60, P163, DOI 10.1007/s12374-016-0421-9; Levey D.J., 1986, Tasks for Vegetation Science, V15, P147; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Sepulveda P, 2015, SYST BOT, V40, P888, DOI 10.1600/036364415X689311; Lopez-sepulveda P, 2017, PLANT SPEC BIOL, V32, P223, DOI 10.1111/1442-1984.12144; Lopez-Sepulveda P, 2015, J PLANT RES, V128, P73, DOI 10.1007/s10265-014-0666-7; Lopez-Sepulveda P, 2013, AM J BOT, V100, P722, DOI 10.3732/ajb.1200541; MADDISON WP, 1992, MACCLADE VERSION 3 0; Majesky L, 2015, PLANT SYST EVOL, V301, P2105, DOI 10.1007/s00606-015-1218-x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Manos PS, 2001, INT J PLANT SCI, V162, P1361, DOI 10.1086/322949; Mort ME, 2002, SYST BOT, V27, P271; Murai KI, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218400374; MURRAY KG, 1993, VEGETATIO, V108, P217; Naruhashi N., 1980, Acta Horticulturae, P177; Nielsen LR, 2004, HEREDITY, V93, P434, DOI 10.1038/sj.hdy.6800520; Oh Sang-Hun, 2015, Korean Journal of Plant Taxonomy, V45, P213, DOI 10.11110/kjpt.2015.45.3.213; Pfosser M, 2005, PLANT SYST EVOL, V256, P159, DOI 10.1007/s00606-005-0374-9; Pfosser MF, 2002, SYST BOT, V27, P351; Pons O, 1996, GENETICS, V144, P1237; Pusik Kim, 2012, SILLA ANN SAMGUK SAG; Qi XS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-41; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Rejmanek M, 2015, GAYANA BOT, V72, P27, DOI 10.4067/S0717-66432015000100004; ROGSTAD SH, 1991, PLANT SYST EVOL, V175, P115, DOI 10.1007/BF00937841; Sakaguchi S, 2012, MOL ECOL, V21, P3823, DOI 10.1111/j.1365-294X.2012.05652.x; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; SANG T, 1995, SYST BOT, V20, P55, DOI 10.2307/2419632; Sarhanova P, 2017, ANN BOT-LONDON, V120, P317, DOI 10.1093/aob/mcx033; SCHILLING EE, 1994, AM J BOT, V81, P248, DOI 10.2307/2445640; Schneider S, 1999, GENETICS, V152, P1079; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Snow B, 1988, BIRDS BERRIES STUDY, P60; Sochor M, 2016, BOT J LINN SOC, V181, P610, DOI 10.1111/boj.12436; Sochor M, 2015, MOL PHYLOGENET EVOL, V89, P13, DOI 10.1016/j.ympev.2015.04.007; Stuessy TF, 2007, SYST ASSOC SPEC VOL, P117; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; SUZUKI W, 1990, Plant Species Biology, V5, P263, DOI 10.1111/j.1442-1984.1990.tb00186.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Takayama Koji, 2016, Journal of Japanese Botany, V91, P83; Takayama K, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv102; Takayama K, 2015, NEW PHYTOL, V205, P415, DOI 10.1111/nph.13000; Takayama K, 2013, J PLANT RES, V126, P323, DOI 10.1007/s10265-012-0529-z; Takayama K, 2012, ANN BOT-LONDON, V109, P321, DOI 10.1093/aob/mcr280; Thompson MM, 1995, HORTSCIENCE, V30, P1447, DOI 10.21273/HORTSCI.30.7.1447; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang Y, 2013, INT CONF MEAS, P702, DOI 10.1109/ICMTMA.2013.176; WASSMUTH R, 1999, MANUAL FLOWERING PLA, V1; Weber HE, 1996, FOLIA GEOBOT PHYTOTX, V31, P373, DOI 10.1007/BF02815381; Woong Lee, 2010, KOR J PL TAXONOMY, V40, P157; Yang J, 2012, CAN J PLANT SCI, V92, P461, DOI [10.4141/CJPS2011-180, 10.4141/cjps2011-180]; Yang JY, 2006, J PLANT BIOL, V49, P44, DOI 10.1007/BF03030787; Yu Jae-Pyoung, 2013, Journal of Asia-Pacific Biodiversity, V6, P175	94	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222707	10.1371/journal.pone.0222707	http://dx.doi.org/10.1371/journal.pone.0222707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536553	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800074
J	Cunningham, PN; Wang, ZY; Grove, ML; Cooper-DeHoff, RM; Beitelshees, AL; Gong, Y; Gums, JG; Johnson, JA; Turner, ST; Boerwinkle, E; Chapman, AB				Cunningham, Patrick N.; Wang, Zhiying; Grove, Megan L.; Cooper-DeHoff, Rhonda M.; Beitelshees, Amber L.; Gong, Yan; Gums, John G.; Johnson, Julie A.; Turner, Stephen T.; Boerwinkle, Eric; Chapman, Arlene B.			Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers	PLOS ONE			English	Article							INFLUENCING ANTIHYPERTENSIVE RESPONSE; GENOMIC ASSOCIATION ANALYSIS; PLASMA-RENIN ACTIVITY; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; VARIANTS ASSOCIATE; AFRICAN-AMERICANS; DPP6 GENE; NEPHROPATHY; PROTEIN	Background Hypertension (HTN) disproportionately affects African Americans (AAs), who respond better to thiazide diuretics than other antihypertensives. Variants of the APOL1 gene found in AAs are associated with a higher rate of kidney disease and play a complex role in cardiovascular disease. Methods AA subjects from four HTN trials (n = 961) (GERA1, GERA2, PEAR1, and PEAR2) were evaluated for blood pressure (BP) response based on APOL1 genotype after 4-9 weeks of monotherapy with thiazides, beta blockers, or candesartan. APOL1 G1 and G2 variants were determined by direct sequencing or imputation. Results Baseline systolic BP (SBP) and diastolic BP (DBP) levels did not differ based on APOL1 genotype. Subjects with 1-2 APOL1 risk alleles had a greater SBP response to candesartan (-12.2 +/- 1.2 vs -7.5 +/- 1.8 mmHg, p = 0.03; GERA2), and a greater decline in albuminuria with candesartan (-8.3 +/- 3.1 vs +3.7 +/- 4.3 mg/day, p = 0.02). APOL1 genotype did not associate with BP response to thiazides or beta blockers. GWAS was performed to determine associations with BP response to candesartan depending on APOL1 genotype. While no SNPs reached genome wide significance, SNP rs10113352, intronic in CSMD1, predicted greater office SBP response to candesartan (p = 3.7 x 10(-7)) in those with 1-2 risk alleles, while SNP rs286856, intronic in DPP6, predicted greater office SBP response (p = 3.2 x 10(-7)) in those with 0 risk alleles. Conclusions Hypertensive AAs without overt kidney disease who carry 1 or more APOL1 risk variants have a greater BP and albuminuria reduction in response to candesartan therapy. BP response to thiazides or beta blockers did not differ by APOL1 genotype. Future studies confirming this initial finding in an independent cohort are required.	[Cunningham, Patrick N.; Chapman, Arlene B.] Univ Chicago, Sect Nephrol, Chicago, IL 60637 USA; [Wang, Zhiying; Grove, Megan L.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Cooper-DeHoff, Rhonda M.; Gong, Yan; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Cooper-DeHoff, Rhonda M.; Gong, Yan; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Beitelshees, Amber L.] Univ Maryland, Dept Med, Endocrinol Diabet & Nutr Div, Baltimore, MD 21201 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Chicago; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; Mayo Clinic; Baylor College of Medicine	Cunningham, PN (corresponding author), Univ Chicago, Sect Nephrol, Chicago, IL 60637 USA.	pcunning@medicine.bsd.uchicago.edu	Turner, Stephen/GXM-4654-2022	Cunningham, Patrick/0000-0002-4588-8280	National Institutes of Health, Pharmacogenetics Research Network [U01 GM074492]; NIH National Center for Research Resources [M01 RR00082, UL1 RR029890, UL1 RR025008, M01 RR00039, UL1 RR024150]; National Center for Advancing Translational Sciences [UL1 TR000064, UL1 TR000454, UL1 TR000135]; Mayo Foundation; NIH [HL74735, HL53330]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Institutes of Health, Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	PEAR1 and PEAR2 was supported by a grant from the National Institutes of Health (https://www.nih.gov/), grant U01 GM074492, funded as part of the Pharmacogenetics Research Network (JAJ). PEAR1 was also supported by the following grants from the NIH National Center for Research Resources: grant M01 RR00082 and UL1 RR029890 to the University of Florida, grants UL1 RR025008 and M01 RR00039 (ABC) to Emory University, and UL1 RR024150 to Mayo Clinic. PEAR2 was also supported by the National Center for Advancing Translational Sciences under the award number UL1 TR000064 (University of Florida); UL1 TR000454 (Emory University) and UL1 TR000135 (Mayo Clinic), and the Mayo Foundation. GERA was supported by NIH grants HL74735, HL53330 (STT), and the Mayo Foundation (https://www.mayo.edu/research).	Canzanello VJ, 2008, AM J HYPERTENS, V21, P61, DOI 10.1038/ajh.2007.24; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; Chen TK, 2017, KIDNEY INT, V92, P964, DOI 10.1016/j.kint.2017.03.028; Chen TK, 2017, ARTERIOSCL THROM VAS, V37, P1765, DOI [10.1161/ATVBAHA.117.309384, 10.1161/atvbaha.117.309384]; Chittani M, 2015, J HYPERTENS, V33, P1301, DOI 10.1097/HJH.0000000000000541; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Fisher NDL, 1999, KIDNEY INT, V56, P635, DOI 10.1046/j.1523-1755.1999.00579.x; Franceschini N, 2018, JAMA CARDIOL, V3, P712, DOI 10.1001/jamacardio.2018.1827; Freedman BI, 2016, KIDNEY INT, V90, P440, DOI 10.1016/j.kint.2016.04.027; Freedman BI, 2015, KIDNEY INT, V87, P176, DOI 10.1038/ki.2014.255; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Fu YL, 2017, J AM SOC NEPHROL, V28, P1106, DOI 10.1681/ASN.2016050550; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gong Y, 2016, HYPERTENSION, V67, P556, DOI 10.1161/HYPERTENSIONAHA.115.06345; Gong Y, 2012, CIRC-CARDIOVASC GENE, V5, P686, DOI 10.1161/CIRCGENETICS.112.964080; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Hamadeh IS, 2014, CLIN PHARMACOL THER, V96, P175, DOI 10.1038/clpt.2014.62; He J, 2013, CIRC-CARDIOVASC GENE, V6, P598, DOI 10.1161/CIRCGENETICS.113.000307; Honda M, 2006, BIOL PHARM BULL, V29, P772, DOI 10.1248/bpb.29.772; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; Hughson MD, 2018, KIDNEY INT REP, V3, P89, DOI 10.1016/j.ekir.2017.08.007; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Koriyama H, 2010, J ATHEROSCLER THROMB, V17, P1054, DOI 10.5551/jat.4291; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117, DOI 10.1681/ASN.2016050546; Ku E, 2017, KIDNEY INT, V91, P443, DOI 10.1016/j.kint.2016.09.033; Langefeld CD, 2015, KIDNEY INT, V87, P169, DOI 10.1038/ki.2014.254; Larsen CP, 2015, MODERN PATHOL, V28, P95, DOI 10.1038/modpathol.2014.92; Li XG, 2009, CHINESE MED J-PEKING, V122, P2989, DOI 10.3760/cma.j.issn.0366-6999.2009.24.014; Li Y, 2010, GENET EPIDEMIOL, V34, P816; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liao C, 2013, EUR J MED GENET, V56, P484, DOI 10.1016/j.ejmg.2013.06.008; Ma LJ, 2016, KIDNEY INT, V90, P389, DOI 10.1016/j.kint.2016.02.032; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Mukamal KJ, 2016, ARTERIOSCL THROM VAS, V36, P398, DOI 10.1161/ATVBAHA.115.305970; Nadkarni GN, 2017, KIDNEY INT, V92, P793, DOI 10.1016/j.kint.2017.05.030; Nadkarni GN, 2017, J AM COLL CARDIOL, V69, P1564, DOI 10.1016/j.jacc.2017.01.040; Oliveira-Paula GH, 2017, BASIC CLIN PHARMACOL, V120, P284, DOI 10.1111/bcpt.12682; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; Prontera P, 2014, NEUROGENETICS, V15, P237, DOI 10.1007/s10048-014-0418-9; Rau T, 2009, CLIN PHARMACOL THER, V85, P269, DOI 10.1038/clpt.2008.218; Schwartz GL, 2013, AM J HYPERTENS, V26, P957, DOI 10.1093/ajh/hpt047; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; ten Sande JN, 2016, HEART RHYTHM, V13, P905, DOI 10.1016/j.hrthm.2015.12.006; Turner ST, 2013, HYPERTENSION, V62, P391, DOI 10.1161/HYPERTENSIONAHA.111.00436; Turner ST, 2012, HYPERTENSION, V59, P1204, DOI 10.1161/HYP.0b013e31825b30f8; Turner ST, 2010, AM J HYPERTENS, V23, P1014, DOI 10.1038/ajh.2010.98; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Williams SF, 2014, WORLD J CARDIOL, V6, P878, DOI 10.4330/wjc.v6.i9.878; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zineh I, 2004, CLIN PHARMACOL THER, V76, P536, DOI 10.1016/j.clpt.2004.08.020	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221957	10.1371/journal.pone.0221957	http://dx.doi.org/10.1371/journal.pone.0221957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532792	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600017
J	Vankan, E; Schoorel, E; van Kuijk, S; Nijhuis, J; Hermens, R; Scheepers, H				Vankan, Emy; Schoorel, Ellen; van Kuijk, Sander; Nijhuis, Jan; Hermens, Rosella; Scheepers, Hubertina		SIMPLE Study Grp	The effect of the use of a decision aid with individual risk estimation on the mode of delivery after a caesarean section: A prospective cohort study	PLOS ONE			English	Article							SUCCESSFUL VAGINAL BIRTH; PREDICTION MODEL; WOMEN; TRIAL; LABOR; MANAGEMENT; SUCCESS	Objective After one previous caesarean section (CS), pregnant women can deliver by elective repeat CS or have a trial of labor which can end in a vaginal birth after caesarean (VBAC) or an unplanned CS. Despite guidelines describing women's rights to make an informed choice, trial of labor and VBAC rates vary greatly worldwide. Many women are inadequately informed due to caregivers' fear of an increase in CS rates in a high VBAC rate setting. We compared counseling with a decision aid (DA) including a prediction model on VBAC to care as usual. We hypothesize that counselling with the DA does not decrease VBAC rates. In addition, we aimed to study the effects on unplanned CS rate, patient involvement in decision-making and elective repeat CS rates. Methods We performed a prospective cohort study. From 2012 to 2014, 483 women in six hospitals, where the DA was used (intervention group), were compared with 441 women in six matched hospitals (control group). Women with one previous CS, pregnant of a singleton in cephalic presentation, delivering after 37 weeks 0 days were eligible for inclusion. Results There was no significant difference in VBAC rates between the intervention (45%) and control group (46%) (adjusted odds ratio 0,92 (95% Confidence interval 0.69-1.23)). In the intervention group more women (42%) chose an elective repeat CS compared to the control group (31%) (adjusted odds ratio 1.6 (95% Confidence interval 1.18-2.17)). Of women choosing trial of labor, in the intervention group 77% delivered vaginally compared to 67% in the control group, resulting in an unplanned CS adjusted odds ratio of 0,57 (0.40-0.82) in the intervention group. In the intervention group, more women reported to be involved in decision-making (98% vs. 68%, P< 0.001). Conclusions Implementing a decision aid with a prediction model for risk selection suggests unchanged VBAC rates, but 40% reduction in unplanned CS rates, increase in elective repeat CS and improved patient involvement in decision-making.	[Vankan, Emy; Schoorel, Ellen; Nijhuis, Jan; Scheepers, Hubertina] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, Maastricht, Netherlands; [van Kuijk, Sander] Maastricht Univ, Dept Clin Epidemiol & Med Technol Assessment KEMT, Med Ctr, Maastricht, Netherlands; [Hermens, Rosella] Radboud Univ Nijmegen, Sci Inst Qual Healthcare IQ Healthcare, Radboud Inst Hlth Sci RIHS, Med Ctr Nijmegen, Nijmegen, Netherlands	Maastricht University; Maastricht University; Radboud University Nijmegen	Vankan, E (corresponding author), Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, Maastricht, Netherlands.	emy.vankan@maastrichtuniversity.nl	Hermens, Rosella P.M.G./N-3581-2014; van Kuijk, Sander/AAH-3239-2021	Hermens, Rosella P.M.G./0000-0001-7624-7120; van Kuijk, Sander/0000-0003-2796-729X	Netherlands Organization for Health Research and Development (ZonMw) [17100.3006]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was funded by The Netherlands Organization for Health Research and Development (ZonMw) (Grant No 17100.3006). https://www.zonmw.nl/nl/.HS received this award. After The Netherlands Organization for Health Research and Development approved the study protocol and design, they were not involved in collection, analysis, and interpretation of data and writing and submitting the article.	American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P450, DOI DOI 10.1097/AOG.0B013E3181EEB251; [Anonymous], 2015, BIRTH PREV CAES BIRT; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417; Flamm BL, 1997, OBSTET GYNECOL, V90, P907, DOI 10.1016/S0029-7844(97)00531-0; Gardner K, 2014, AUST NZ J OBSTET GYN, V54, P327, DOI 10.1111/ajo.12229; Gonen R, 2004, AM J PERINAT, V21, P447, DOI 10.1055/s-2004-835961; Grobman WA, 2007, OBSTET GYNECOL, V109, P806, DOI 10.1097/01.AOG.0000259312.36053.02; Grobman WA, 2009, AM J PERINAT, V26, P693, DOI 10.1055/s-0029-1239494; Guise Jeanne-Marie, 2010, Evid Rep Technol Assess (Full Rep), P1; Horey D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010041.pub2; JAKOBI P, 1993, J REPROD MED, V38, P729; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; MacDorman M, 2011, CLIN PERINATOL, V38, P179, DOI 10.1016/j.clp.2011.03.007; Macones GA, 2001, AM J OBSTET GYNECOL, V184, P409, DOI 10.1067/mob.2001.109386; Martin Joyce A, 2016, NCHS Data Brief, P1; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; Melman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145771; Metz TD, 2013, OBSTET GYNECOL, V122, P571, DOI 10.1097/AOG.0b013e31829f8ced; Montgomery AA, 2007, BMJ-BRIT MED J, V334, P1307, DOI 10.1136/bmj.39217.671019.55; Naji O, 2013, ULTRASOUND OBST GYN, V41, P672, DOI 10.1002/uog.12423; NICE 4-Year Surveillance, 2017, SUMM NEW EV CES SECT; Ottawa Health Decision Centre, US MAN DEC CONFL SCA; PICKHARDT MG, 1992, AM J OBSTET GYNECOL, V166, P1811, DOI 10.1016/0002-9378(92)91572-R; Schoorel ENC, 2014, BJOG-INT J OBSTET GY, V121, P202, DOI 10.1111/1471-0528.12516; Schoorel ENC, 2014, BJOG-INT J OBSTET GY, V121, P194, DOI 10.1111/1471-0528.12539; Shorten A, 2005, BIRTH-ISS PERINAT C, V32, P252, DOI 10.1111/j.0730-7659.2005.00383.x; Smith GCS, 2005, PLOS MED, V2, P871, DOI 10.1371/journal.pmed.0020252; Srinivas SK, 2007, OBSTET GYNECOL, V109, P800, DOI 10.1097/01.AOG.0000259313.46842.71; Tessmer-Tuck JA, 2014, GYNECOL OBSTET INVES, V77, P121, DOI 10.1159/000357757; TROYER LR, 1992, AM J OBSTET GYNECOL, V167, P1099, DOI 10.1016/S0002-9378(12)80046-9; Vankan E, 2016, ACTA OBSTET GYNECOL; Weinstein D, 1996, AM J OBSTET GYNECOL, V174, P192, DOI 10.1016/S0002-9378(96)70393-9; Yu CH, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-16	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222499	10.1371/journal.pone.0222499	http://dx.doi.org/10.1371/journal.pone.0222499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557177	Green Published, gold			2022-12-27	WOS:000532345500021
J	Abdallah, FF; Darwish, HW; Darwish, IA; Naguib, IA				Abdallah, Fatma F.; Darwish, Hany W.; Darwish, Ibrahim A.; Naguib, Ibrahim A.			Orthogonal projection to latent structures and first derivative for manipulation of PLSR and SVR chemometric models' prediction: A case study	PLOS ONE			English	Article							PYRIDOSTIGMINE BROMIDE; CHROMATOGRAPHIC METHOD; CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; PLASMA; METABOLITES; NEOSTIGMINE; VALIDATION; HYDROCHLOROTHIAZIDE; PHARMACOKINETICS	Novel manipulations of the well-established multivariate calibration models namely; partial least square regression (PLSR) and support vector regression (SVR) are introduced in the presented comparative study. Two preprocessing methods comprising first derivatization and orthogonal projection to latent structures (OPLS) are implemented prior to modeling with PLSR and SVR. Quantitative determination of pyridostigmine bromide (PR) in existence of its two associated substances; impurity a (IMP A) and impurity b (IMP B); was utilized as a case study for achieving comparison. A series consisting of 16 mixtures with numerous percentages of the studied compounds was applied for implementation of a 3 factor 4 level experimental design. Additionally, a series consisting of 9 mixtures was employed in an independent test to verify the predictive power of the suggested models. Significant improvement of predictive abilities of the two studied chemometric models was attained via implementation of OPLS processing method. The root mean square error of prediction RMSEP for the test set mixtures was employed as a key comparison tool. About PLSR model, RMSEP was found 0.5283 without preprocessing method, 1.1750 when first derivative data was used and 0.2890 when OPLS preprocessing method was applied. With regard to SVR model, RMSEP was found 0.2173 without preprocessing method, 0.3516 when first derivative data was used and 0.1819 when OPLS preprocessing method was applied.	[Abdallah, Fatma F.; Naguib, Ibrahim A.] Beni Suef Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Alshaheed Shehata Ahmad Hegazy St, Bani Suwayf, Egypt; [Darwish, Hany W.; Darwish, Ibrahim A.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Darwish, Hany W.] Cairo Univ, Fac Pharm, Analyt Chem Dept, Kasr El Aini St, Cairo, Egypt; [Naguib, Ibrahim A.] Taif Univ, Coll Pharm, Dept Pharmaceut Chem, Al Hawiah, Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); Beni Suef University; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; Taif University	Darwish, HW (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.; Darwish, HW (corresponding author), Cairo Univ, Fac Pharm, Analyt Chem Dept, Kasr El Aini St, Cairo, Egypt.	hdarwish@ksu.edu.sa	darwish, hany/ABD-2160-2020; Naguib, Ibrahim A/ABM-0813-2022	Naguib, Ibrahim A/0000-0002-5923-1466; Darwish, Ibrahim A/0000-0003-3821-623X	Deanship of Scientific Research at King Saud University [RGP-322]	Deanship of Scientific Research at King Saud University(King Saud University)	HWD received funds from Deanship of Scientific Research at King Saud University through the Research Group Project no. RGP-322 and they play no role in the study.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project no. RGP-322.	Abu-Qare AW, 2001, J PHARMACEUT BIOMED, V26, P281, DOI 10.1016/S0731-7085(01)00403-4; Abu-Qare AW, 2001, J CHROMATOGR B, V754, P503, DOI 10.1016/S0378-4347(01)00040-8; Ali NW, 2015, JPC-J PLANAR CHROMAT, V28, P316, DOI 10.1556/1006.2015.28.4.8; Altria KD, 1996, J CAPILLARY ELECTROP, V3, P13; [Anonymous], 2005, MARTINDALE EXTRA PHA, V34th ed.; [Anonymous], 2013, HER MAJESTYS; [Anonymous], 2001, IND MERCK; Bagtash M, 2018, J CHEMOMETR, V32, DOI 10.1002/cem.3014; BARBER HE, 1975, BRIT J PHARMACOL, V55, P335, DOI 10.1111/j.1476-5381.1975.tb06936.x; BIRTLEY RDN, 1966, BRIT J PHARM CHEMOTH, V26, P393, DOI 10.1111/j.1476-5381.1966.tb01919.x; BLICK DW, 1994, TOXICOL APPL PHARM, V126, P311, DOI 10.1006/taap.1994.1121; BREYERPFAFF U, 1985, CLIN PHARMACOL THER, V37, P495, DOI 10.1038/clpt.1985.78; CHAN K, 1976, J CHROMATOGR, V120, P349, DOI 10.1016/S0021-9673(76)80012-X; Cherstniakova S, 2003, CLIN PHARMACOL THER, V73, pP27, DOI 10.1016/S0009-9236(03)90453-X; COHAN SL, 1976, NEUROLOGY, V26, P536, DOI 10.1212/WNL.26.6.536; Cristianini N, 2000, INTRO SUPPORT VECTOR; DAVISON SC, 1980, METHOD FIND EXP CLIN, V2, P77; DERUYTER MGM, 1980, J CHROMATOGR, V183, P193, DOI 10.1016/S0378-4347(00)81693-X; Efron B., 1994, MONOGRAPHS STAT APPL; ELLIN RI, 1982, J CHROMATOGR, V228, P235; Gasteiger J., 2003, HDB CHEMOINFORMATICS, P3; Gunn S. R., 1998, ISIS TECH REP, V14, P5; Hadley M, 2000, J CHROMATOGR B, V745, P177, DOI 10.1016/S0378-4347(00)00153-5; Havel Josef, 2002, J Capill Electrophor Microchip Technol, V7, P107; Ivanovic D, 2007, ACTA CHROMATOGR, V18, P143; KORNFELD P, 1970, NEUROLOGY, V20, P634, DOI 10.1212/WNL.20.7.634; Naguib I.A., 2017, B FAC PHARM CAIRO U, V55, P287, DOI 10.1016/j.bfopcu.2017.09.002; Naguib IA, 2019, J CHROMATOGR SCI, V57, P653, DOI 10.1093/chromsci/bmz043; Naguib IA, 2014, SPECTROCHIM ACTA A, V130, P350, DOI 10.1016/j.saa.2014.04.024; Needham SR, 2003, J CHROMATOGR B, V796, P347, DOI 10.1016/j.jchromb.2003.08.021; Parrella F, THESIS; Sapolsky RM, 1998, NATURE, V393, P308, DOI 10.1038/30606; Scholkopf B., 2002, LEARNING KERNELS; SORENSEN PS, 1984, NEUROLOGY, V34, P1020, DOI 10.1212/WNL.34.8.1020; Suykens JA, 1999, J WORLD SCI; Tapp HS, 2009, TRAC-TREND ANAL CHEM, V28, P1322, DOI 10.1016/j.trac.2009.08.006; The United States Pharmacopeia, 2011, NAT FORM 29; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Urban-Horth JS., 1994, COMPUTER INTENSIVE S; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Xu M., 2011, J ZHANGGUO YAOFANG, V22, P743; Xu Y, 2006, CRIT REV ANAL CHEM, V36, P177, DOI 10.1080/10408340600969486; YAKATAN GJ, 1979, J CHROMATOGR, V164, P399, DOI 10.1016/S0378-4347(00)81242-6; Zhao B, 2006, J PHARM PHARM SCI, V9, P71	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222197	10.1371/journal.pone.0222197	http://dx.doi.org/10.1371/journal.pone.0222197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553757	Green Published, gold			2022-12-27	WOS:000532319200017
J	Fang, F; Tang, JJ; Zhao, YQ; He, JL; Xu, P; Faramand, A				Fang, Fang; Tang, Jingjing; Zhao, Yaqin; He, Jialing; Xu, Ping; Faramand, Andrew			Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low and intermediate risk: A risk specific meta-analysis of randomized controlled trials	PLOS ONE			English	Article							STENOSIS	Background Transcatheter aortic valve implantation (TAVI) is an option for treatment for patients with severe aortic stenosis who are at high risk for death with surgical aortic valve replacement (SAVR). It is unknown whether TAVI can be safely introduced to intermediate- and low-risk patients. Objective To compare the efficacy and safety of TAVI and SAVR in patients with intermediate- and low-surgical risk. Data sources Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched from inception to April 15, 2019. Study selection We included randomized controlled trials comparing TAVI with SAVR in patients with intermediate- and low-surgical risk. Data extraction Meta-analyses were conducted using random-effects models to calculate risk ratios (RR) with corresponding 95% confidence interval (CI). Two independent reviewers completed citation screening, data abstraction, and risk assessment. Primary outcome was a composite of all-cause mortality or disabling stroke at 12 months. Data Synthesis A total of 5 trials randomizing 6390 patients were included. In patients with low risk, TAVI was associated with a significant reduction in the composite of all-cause mortality or disabling stroke compared with SAVR (RR, 0.56; 95%CI, 0.40-0.79; I-2 = 0%). This benefit was not replicated in patients with intermediate risk (RR, 0.96; 95% CI, 0.80-1.15; I-2 = 0%). Similar results were seen separately in all-cause mortality and disabling stroke when TAVI was compared with SAVR. Conclusion For patients with severe aortic stenosis who were at low risk for death from surgery, TAVI achieved superior clinical outcomes compared to SAVR; however, these benefits were not seen in those with intermediate risk. This information may inform discussions about deciding between SAVR and TAVI for patients with low to intermediate risk separately.	[Fang, Fang; Zhao, Yaqin; He, Jialing] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China; [Tang, Jingjing] Chinese Univ Hong Kong, Shenzhen, Guangdong, Peoples R China; [Xu, Ping] Sichuan Univ Lib, Chengdu, Sichuan, Peoples R China; [Faramand, Andrew] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Sichuan University; Chinese University of Hong Kong, Shenzhen; Sichuan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fang, F (corresponding author), Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China.	fangfang1057@outlook.com		Fang, Fang/0000-0002-8711-1920				Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gargiulo G, 2016, ANN INTERN MED, V165, P334, DOI 10.7326/M16-0060; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haussig S, 2014, CIRCULATION, V130, P2321, DOI 10.1161/CIRCULATIONAHA.114.008144; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes DR, 2012, J AM COLL CARDIOL, V59, P2157, DOI 10.1016/j.jacc.2012.01.061; Kheiri B, 2019, CARDIOVASC REVASCULA, V20, P838, DOI 10.1016/j.carrev.2018.12.023; Lazkani M, 2019, CARDIOVASC REVASCULA, V20, P57, DOI 10.1016/j.carrev.2018.04.001; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Serruys PW, 2018, EUROINTERVENTION, V14, P877, DOI 10.4244/EIJ-D-18-00460; Shinichi A., 2014, ONLINE KENSAKU, V35, P154; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5130; Siontis GCM, 2016, EUR HEART J, V37, P3503, DOI 10.1093/eurheartj/ehw225; Siordia JA, 2018, INNOVATIONS, V13, P153, DOI 10.1097/IMI.0000000000000507; Tarantini G, 2018, EUR HEART J, V39, P658, DOI 10.1093/eurheartj/ehx489; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014	23	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221922	10.1371/journal.pone.0221922	http://dx.doi.org/10.1371/journal.pone.0221922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550263	gold, Green Published			2022-12-27	WOS:000532307700009
J	Karr, AF; Taylor, MT; West, SL; Setoguchi, S; Kou, TD; Gerhard, T; Horton, DB				Karr, Alan F.; Taylor, Matthew T.; West, Suzanne L.; Setoguchi, Soko; Kou, Tzuyung D.; Gerhard, Tobias; Horton, Daniel B.			Comparing record linkage software programs and algorithms using real-world data	PLOS ONE			English	Article								Linkage of medical databases, including insurer claims and electronic health records (EHRs), is increasingly common. However, few studies have investigated the behavior and output of linkage software. To determine how linkage quality is affected by different algorithms, blocking variables, methods for string matching and weight determination, and decision rules, we compared the performance of 4 nonproprietary linkage software packages linking patient identifiers from noninteroperable inpatient and outpatient EHRs. We linked datasets using first and last name, gender, and date of birth (DOB). We evaluated DOB and year of birth (YOB) as blocking variables and used exact and inexact matching methods. We compared the weights assigned to record pairs and evaluated how matching weights corresponded to a gold standard, medical record number. Deduplicated datasets contained 69,523 inpatient and 176,154 outpatient records, respectively. Linkage runs blocking on DOB produced weights ranging in number from 8 for exact matching to 64,273 for inexact matching. Linkage runs blocking on YOB produced 8 to 916,806 weights. Exact matching matched record pairs with identical test characteristics (sensitivity 90.48%, specificity 99.78%) for the highest ranked group, but algorithms differentially prioritized certain variables. Inexact matching behaved more variably, leading to dramatic differences in sensitivity (range 0.04-93.36%) and positive predictive value (PPV) (range 86.67-97.35%), even for the most highly ranked record pairs. Blocking on DOB led to higher PPV of highly ranked record pairs. An ensemble approach based on averaging scaled matching weights led to modestly improved accuracy. In summary, we found few differences in the rankings of record pairs with the highest matching weights across 4 linkage packages. Performance was more consistent for exact string matching than for inexact string matching. Most methods and software packages performed similarly when comparing matching accuracy with the gold standard. In some settings, an ensemble matching approach may outperform individual linkage algorithms.	[Karr, Alan F.; West, Suzanne L.] RTI Int, Res Triangle Pk, NC 27709 USA; [Setoguchi, Soko; Gerhard, Tobias; Horton, Daniel B.] Rutgers State Univ, Ctr Pharmacoepidemiol & Treatment Sci, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ USA; [Taylor, Matthew T.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA; [Kou, Tzuyung D.] Bristol Myers Squibb, Hopewell, NJ USA	Research Triangle Institute; Rutgers State University New Brunswick; Jefferson University; Bristol-Myers Squibb	Karr, AF (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	karr@rti.org	Horton, Daniel/R-5623-2017	Horton, Daniel/0000-0002-1831-1339	Bristol-Myers-Squibb (BMS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR070286] Funding Source: NIH RePORTER	Bristol-Myers-Squibb (BMS)(Bristol-Myers Squibb); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Author TDK is employed by Bristol-Myers-Squibb (BMS), which as funder, provided support in the form of salaries and travel expenses for the primary research participants and authors [DBH, TG, AFK, MT, SLW]. BMS researcher TDK participated in collaborative research discussions, but did not have any formal role in the study design, selection of datasets to be linked, selection of data linkage algorithms, data analysis (There was no data collection.), decision to publish, or preparation of the manuscript. At no time did BMS attempt to alter consensus decisions. The manuscript was reviewed by both RTI International (employer of AFK and, at the time, SLW) and BMS (employer of TDK) for adherence to corporate quality standards. Neither organization requested any changes. The specific roles of the authors are articulated in the 'author contributions' section.	Agniel D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1479; Aldridge RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136179; Baldi I, 2010, J EVAL CLIN PRACT, V16, P92, DOI 10.1111/j.1365-2753.2009.01119.x; Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346; Campbell Kevin M, 2008, Health Informatics J, V14, P5, DOI 10.1177/1460458208088855; Contiero P, 2005, METHOD INFORM MED, V44, P66; Cornish RP, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0068-0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Ferrante A, 2012, J BIOMED INFORM, V45, P165, DOI 10.1016/j.jbi.2011.10.006; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Ford JB, 2006, PAEDIATR PERINAT EP, V20, P329, DOI 10.1111/j.1365-3016.2006.00715.x; Gilbert R, 2018, J PUBLIC HEALTH-UK, V40, P191, DOI 10.1093/pubmed/fdx037; Hagger-Johnson G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008118; Harron K, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0306-8; Harron KL, 2017, INT J EPIDEMIOL, V46, P1699, DOI 10.1093/ije/dyx177; Karr A. F., 2006, STAT METHODOL, V3, P137, DOI DOI 10.1016/J.STAMET.2005.08.005; Krewski D., 2005, SURV METHODOL, V31, P13; Lariscy JT, 2011, J AGING HEALTH, V23, P1263, DOI 10.1177/0898264311421369; McDonald L, 2018, EUR J EPIDEMIOL, V33, P601, DOI 10.1007/s10654-018-0389-5; McIllece J, 2014, JSM P SURVEY RES MET, P4392; Moore CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103690; Patorno E, 2018, DIABETES OBES METAB, V20, P974, DOI 10.1111/dom.13184; Randall SM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-64; Sayers A, 2016, INT J EPIDEMIOL, V45, P954, DOI 10.1093/ije/dyv322; Schmidlin K, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-1; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Zhu Y, 2015, J BIOMED INFORM, V56, P80, DOI 10.1016/j.jbi.2015.05.012	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221459	10.1371/journal.pone.0221459	http://dx.doi.org/10.1371/journal.pone.0221459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550255	Green Submitted, Green Published, gold			2022-12-27	WOS:000532307700006
J	Rodriguez-Centeno, J; Manguan-Garcia, C; Perona, R; Sastre, L				Rodriguez-Centeno, Javier; Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro			Structure of Dictyostelium discoideum telomeres. Analysis of possible replication mechanisms	PLOS ONE			English	Article							DNA; COMPLEX; CELLS; RECOMBINATION; MAINTENANCE; SEQUENCE; GENOME; PATHWAY; GENES; TRF1	Telomeres are nucleo-protein structures that protect the ends of eukaryotic chromosomes. They are not completely synthesized during DNA replication and are elongated by specific mechanisms. The structure of the telomeres and the elongation mechanism have not been determined in Dictyostelium discoideum. This organism presents extrachromosomal palindromic elements containing two copies of the rDNA, also present at the end of the chromosomes. In this article the structure of the terminal region of the rDNA is shown to consist of repetitions of the A(G)n sequence where the number of Gs is variable. These repeats extend as a 3' single stranded region. The G-rich region is preceded by four tandem repetitions of two different DNA motifs. D. discoideum telomere reverse transcriptase homologous protein (TERTHP) presented RNase-sensitive enzymatic activity and was required to maintain telomere structure since terthp-mutant strains presented reorganizations of the DNA terminal regions. These modifications were different in several terthp-mutants and changed with their prolonged culture and subcloning. However, the terthp gene is not essential for D. discoideum proliferation. Telomeres could be maintained in terthp-mutant strains by homologous recombination mechanisms such as ALT (Alternative Lengthening of Telomeres) or HAATI (heterochromatin amplification-mediated and telomerase-independent). In agreement with this hypothesis, the expression of mRNAs coding for several proteins involved in homologous recombination was induced in terthp-mutant strains. Extrachromosomal rDNA could serve as substrate in these DNA homologous recombination reactions.	[Rodriguez-Centeno, Javier; Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] UAM, CSIC, Inst Invest Biomed, IdiPaz, Madrid, Spain; [Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] CIBER Enfermedades Raras CIBERER, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sastre, L (corresponding author), UAM, CSIC, Inst Invest Biomed, IdiPaz, Madrid, Spain.; Sastre, L (corresponding author), CIBER Enfermedades Raras CIBERER, Madrid, Spain.	lsastre@iib.uam.es		Rodriguez-Centeno, Javier/0000-0001-8137-2225; Sastre, Leandro/0000-0003-3613-5938	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain - FEDER funds [PI14-01495, PI17-01401]	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain - FEDER funds	RP and LS were funded by grants PI14-01495 and PI17-01401 (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain supported by FEDER funds), https://portalfis.isciii.es/es/Paginas/inicio.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuch AA, 2016, RNA BIOL, V13, P696, DOI 10.1080/15476286.2015.1094596; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070192; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chung I, 2012, NUCLEUS-PHILA, V3, P263, DOI 10.4161/nucl.20326; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; EMERY HS, 1981, CELL, V26, P411, DOI 10.1016/0092-8674(81)90210-5; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fajkus P, 2016, PLANT J, V85, P337, DOI 10.1111/tpj.13115; FIRTEL RA, 1976, J MOL BIOL, V102, P831, DOI 10.1016/0022-2836(76)90294-1; Fulcher N, 2014, CELL MOL LIFE SCI, V71, P847, DOI 10.1007/s00018-013-1469-z; Galardi-Castilla M, 2008, DEV BIOL, V316, P260, DOI 10.1016/j.ydbio.2008.01.026; Giraud-Panis MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00048; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Henson JD, 2010, FEBS LETT, V584, P3800, DOI 10.1016/j.febslet.2010.06.009; HUGHES JE, 1988, NUCLEIC ACIDS RES, V16, P2338, DOI 10.1093/nar/16.5.2338; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Jain D, 2010, NATURE, V467, P223, DOI 10.1038/nature09374; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lazzerini-Denchi E, 2016, NAT REV MOL CELL BIO, V17, P364, DOI 10.1038/nrm.2016.43; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Martinez P, 2015, TRENDS BIOCHEM SCI, V40, P504, DOI 10.1016/j.tibs.2015.06.003; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Nassir N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008188; O'Sullivan RJ, 2014, TRENDS CELL BIOL, V24, P675, DOI 10.1016/j.tcb.2014.07.007; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Perona R, 2016, TELOMERE - A COMPLEX END OF A CHROMOSOME, P77, DOI 10.5772/65353; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Savage SA, 2014, PROG MOL BIOL TRANSL, V125, P41, DOI 10.1016/B978-0-12-397898-1.00002-5; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Sepsiova R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154225; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222909	10.1371/journal.pone.0222909	http://dx.doi.org/10.1371/journal.pone.0222909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550289	Green Published, gold			2022-12-27	WOS:000532307700032
J	Fuertes, E; Carsin, AE; Garcia-Larsen, V; Guerra, S; Pin, I; Leynaert, B; Accordini, S; Martinez-Moratalla, J; Anto, JM; Urrutia, I; Le Gouellec, A; Heinrich, J; Gislason, T; Jogi, R; Janson, C; Jarvis, D; Garcia-Aymerich, J				Fuertes, Elaine; Carsin, Anne-Elie; Garcia-Larsen, Vanessa; Guerra, Stefano; Pin, Isabelle; Leynaert, Benedicte; Accordini, Simone; Martinez-Moratalla, Jesus; Anto, Josep M.; Urrutia, Isabel; Le Gouellec, Audrey; Heinrich, Joachim; Gislason, Thorarinn; Jogi, Rain; Janson, Christer; Jarvis, Debbie; Garcia-Aymerich, Judith			The role of C-reactive protein levels on the association of physical activity with lung function in adults	PLOS ONE			English	Article							RESPIRATORY HEALTH SURVEY; POPULATION; DECLINE; EXERCISE	Objective Regular physical activity may be associated with improved lung function via reduced systemic inflammation, although studies exploring this mechanism are rare. We evaluated the role of C-reactive protein in blood, which is a common marker of systemic inflammation, on the association of physical activity with forced expiratory volume in one second and forced vital capacity. Methods Cross-sectional data on spirometry, C-reactive protein levels and self-reported physical activity (yes/no; >= 2 times and.1hr per week of vigorous physical activity) were available in the European Community Respiratory Health Survey (N = 2347 adults, 49.3% male, 28-56 years-old). A subsample was also assessed 10 years later using the International Physical Activity Questionnaire, and tertiles of Metabolic Equivalent of Task-minutes per week spent in vigorous, moderate and walking activities were calculated (N = 671, 49.6% male, 40-67 years-old). Adjusted cross-sectional mixed linear regression models and the "mediate" package in "R" were used to assess the presence of mediation. Results Despite positive significant associations between nearly all physical activity metrics with forced expiratory volume in one second and forced vital capacity, there was no evidence that C-reactive protein levels played a role. An influence of C-reactive protein levels was only apparent in the smaller subsample when comparing the medium to low tertiles of moderate activity (mean difference [95% CIs]: 21.1ml [5.2, 41.9] for forced expiratory volume in one second and 17.3ml [2.6, 38.0] for forced vital capacity). Conclusions In a population of adults, we found no consistent evidence that the association of physical activity with forced expiratory volume in one second or forced vital capacity is influenced by the level of C-reactive protein in blood.	[Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] ISGlobal, Barcelona, Spain; [Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] Univ Pompeu Fabra UPF, Barcelona, Spain; [Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Fuertes, Elaine; Jarvis, Debbie] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Garcia-Larsen, Vanessa] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Human Nutr, Baltimore, MD USA; [Guerra, Stefano] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA; [Pin, Isabelle] CHU Grenoble Alpes, Dept Pediat, Grenoble, France; [Pin, Isabelle] INSERM, Inst Adv Biosci, Grenoble, France; [Pin, Isabelle] Univ Grenoble Alpes, Grenoble, France; [Leynaert, Benedicte] INSERM, Pathophysiol & Epidemiol Resp Dis, UMR 1152, Paris, France; [Leynaert, Benedicte] Univ Paris Diderot Paris, UMR 1152, Paris, France; [Accordini, Simone] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Martinez-Moratalla, Jesus] Hosp Univ Albacete, Serv Neumol Complejo, Serv Salud Castilla La Mancha SESCAM, Albacete, Spain; [Martinez-Moratalla, Jesus] Univ Castilla La Mancha, Fac Med Albacete, Albacete, Spain; [Urrutia, Isabel] Galdakao Hosp, Dept Resp, Galdakao, Spain; [Le Gouellec, Audrey] Univ Grenoble Alpes, TIMC IMAG, CHU Grenoble Alpes, Grenoble INP,CNRS, Grenoble, France; [Heinrich, Joachim] Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, Munich, Germany; [Heinrich, Joachim] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Gislason, Thorarinn] Landspitali Univ Hosp Reykjavik, Dept Resp Med & Sleep, Reykjavik, Iceland; [Jogi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Jarvis, Debbie] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England	ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Arizona; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Verona; Universidad de Castilla-La Mancha; Galdakao Hospital; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Landspitali National University Hospital; Imperial College London	Fuertes, E (corresponding author), ISGlobal, Barcelona, Spain.; Fuertes, E (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.; Fuertes, E (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.; Fuertes, E (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	e.fuertes@imperial.ac.uk	Carsin, Anne-Elie/AAF-6815-2021; J, Garcia-Aymerich/G-6867-2014; le gouellec, audrey/M-6072-2014; Heinrich, Joachim/N-1720-2013	Carsin, Anne-Elie/0000-0003-3981-977X; J, Garcia-Aymerich/0000-0002-7097-4586; Heinrich, Joachim/0000-0002-9620-1629; Fuertes, Elaine/0000-0003-0205-9025; Leynaert, Benedicte/0000-0001-5045-2492; Jarvis, Deborah/0000-0002-1753-3896; Le Gouellec, audrey/0000-0002-4905-3854	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015) [704268]; European Union [633212]; MRC [MR/L01341X/1, G0901214] Funding Source: UKRI	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The results reported herein correspond to the specific aims of the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015; proposal number 704268; https://ec.europa.eu/research/mariecurieactions/actions/individual-fellowships_ en), awarded to the Principal Investigator EF. These results also correspond to the specific aims of the Ageing Lungs in European Cohorts (ALEC) Study (www.alecstudy.org), awarded to the Principal Investigator DJ, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 633212 (https://ec.europa.eu/programmes/horizon2020/).The local investigators and funding agencies for the participating European Community Respiratory Health Survey (ECRHS II and ECRHS III) centres are reported in the Supplementary File. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ISGlobal is a member of CERCA Programme/Generalitat de Catalunya. An abstract of this work was presented at the European Respiratory Society International Congress in September, 2018. The local investigators and funding agencies for the European Community Respiratory Health Survey (ECRHS II and ECRHS III) are reported in the Supplementary Material (S1 Appendix).	BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Fuertes E, 2018, THORAX, V73, P376, DOI 10.1136/thoraxjnl-2017-210947; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hamer M, 2012, PHYS ACTIVITY INFLAM, DOI [10.1161/CIRCULATIONAHA.112.103879, DOI 10.1161/CIRCULATIONAHA.112.103879]; Haneuse S, 2019, JAMA-J AM MED ASSOC, V321, P602, DOI 10.1001/jama.2018.21554; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Jenkins AR, 2018, CHEST, V153, P1281, DOI 10.1016/j.chest.2018.01.054; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Tingley D., 2014, MEDIATION R PACKAGE; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222578	10.1371/journal.pone.0222578	http://dx.doi.org/10.1371/journal.pone.0222578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545813	Green Published, gold			2022-12-27	WOS:000532303200021
J	Makaruk, H; Porter, JM; Sadowski, J; Bodasinska, A; Zielinski, J; Niznikowski, T; Mastalerz, A				Makaruk, Hubert; Porter, Jared Marak; Sadowski, Jerzy; Bodasinska, Anna; Zielinski, Janusz; Niznikowski, Tomasz; Mastalerz, Andrzej			The effects of combining focus of attention and autonomy support on shot accuracy in the penalty kick	PLOS ONE			English	Article							ADDITIVE BENEFITS; EXTERNAL FOCUS; PERFORMANCE	The penalty kick is of great importance in the sport of soccer. Therefore, the aim of this study was to test predictions of the OPTIMAL theory and identify key attentional and motivational factors that impact the accuracy of the penalty kick. The following six groups of moderately skilled participants performed penalty kicks following instructions that directed their focus of attention or impacted their autonomy support: external focus with autonomy support (EF/AS), external focus alone (EF), internal focus with autonomy support (IF/AS), internal focus alone (IF), autonomy support alone (AS) and control (C) groups. The analysis showed that the EF/AS group demonstrated better kicking accuracy relatively to the IF/AS, IF and C groups, but there were no significant differences between the EF/AS and EF or AS groups. Interestingly, the EF/AS group showed higher self-efficacy compared to the EF, IF/AS, IF and C groups. The finding suggest that a combination of attentional and motivational factors may produce benefits in motor performance.	[Makaruk, Hubert] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Athlet & Swimming, Warsaw, Poland; [Makaruk, Hubert; Sadowski, Jerzy; Bodasinska, Anna; Zielinski, Janusz; Niznikowski, Tomasz] Fac Phys Educ & Sport Biala Podlaska, Biala Podlaska, Poland; [Porter, Jared Marak] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Sadowski, Jerzy] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Theory & Technol Sport, Warsaw, Poland; [Bodasinska, Anna] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Sport Games, Warsaw, Poland; [Niznikowski, Tomasz] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Gymnast, Warsaw, Poland; [Mastalerz, Andrzej] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Biomech, Warsaw, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; University of Tennessee System; University of Tennessee Knoxville; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Makaruk, H (corresponding author), Jozef Pilsudski Univ Phys Educ Warsaw, Dept Athlet & Swimming, Warsaw, Poland.; Makaruk, H (corresponding author), Fac Phys Educ & Sport Biala Podlaska, Biala Podlaska, Poland.	hubert.makaruk@awf-bp.edu.pl	Mastalerz, Andrzej/AAJ-5837-2020; Niźnikowski, Tomasz/HGA-6448-2022; Sadowski, Jerzy/D-4881-2019	Mastalerz, Andrzej/0000-0003-2031-5563; Niźnikowski, Tomasz/0000-0003-1107-7532; Zielinski, Janusz/0000-0001-6708-8383; Makaruk, Hubert/0000-0002-2118-4051				Abdollahipour R, 2017, PSYCHOL SPORT EXERC, V32, P17, DOI 10.1016/j.psychsport.2017.05.004; Almeida CH, 2016, INT J PERF ANAL SPOR, V16, P508, DOI 10.1080/24748668.2016.11868905; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bar-Eli M., 2009, SOCCER SOC, V10, P183; BARELI M, 1988, SOCCER J, V33, P49; Binsch O, 2010, HUM MOVEMENT SCI, V29, P277, DOI 10.1016/j.humov.2009.12.002; Chiviacowsky S, 2014, PSYCHOL SPORT EXERC, V15, P505, DOI 10.1016/j.psychsport.2014.05.003; Dalton K, 2015, INT J SPORTS SCI COA, V10, P815, DOI 10.1260/1747-9541.10.5.815; Englert C, 2015, INT J SPORT EXERC PS, V13, P121, DOI 10.1080/1612197X.2014.932828; Feltz D.L., 2008, SELF EFFICACY SPORT; Franks I. M., 1997, SOCCER J, V42, P30; Graham-Smith P., 1999, J SPORTS SCI, V17, P905, DOI DOI 10.1080/026404199365461; Halperin I, 2017, PSYCHOL RES-PSYCH FO, V81, P1051, DOI 10.1007/s00426-016-0790-1; Iwatsuki T, 2017, HUM MOVEMENT SCI, V55, P264, DOI 10.1016/j.humov.2017.08.016; Kerwin D. G., 2006, ENG SPORT, V6, P321, DOI DOI 10.1007/978-0-387-46050-5_57; Larson-Hall J., 2012, RES METHODS 2 LANGUA, P245; Lees A, 2011, SPORT BIOMECH, V10, P125, DOI 10.1080/14763141.2011.569565; Magill R, 2014, MOTOR LEARNING CONTR, P423; McGarry T, 2000, J SPORT SCI, V18, P401, DOI 10.1080/02640410050074331; Navarro M, 2013, J SPORT SCI, V31, P921, DOI 10.1080/02640414.2012.762602; NAYLOR JC, 1963, J EXP PSYCHOL, V65, P217, DOI 10.1037/h0041060; Pascua LAM, 2015, J SPORT SCI, V33, P58, DOI 10.1080/02640414.2014.922693; Sitzmann T, 2013, PERS PSYCHOL, V66, P531, DOI 10.1111/peps.12035; Timmis MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115179; Turvey M. T., 1996, DEXTERITY ITS DEV, P171; Wood G, 2011, COGN PROCESS, V12, P257, DOI 10.1007/s10339-011-0393-0; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2016, PSYCHON B REV, V23, P1382, DOI 10.3758/s13423-015-0999-9; Wulf G, 2015, HUM MOVEMENT SCI, V40, P176, DOI 10.1016/j.humov.2014.11.015; Wulf G, 2014, HUM MOVEMENT SCI, V37, P12, DOI 10.1016/j.humov.2014.06.004; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T., 2005, THESIS	33	8	9	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0213487	10.1371/journal.pone.0213487	http://dx.doi.org/10.1371/journal.pone.0213487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545800	Green Published, Green Submitted, gold			2022-12-27	WOS:000532303200002
J	Shaharir, SS; Said, MSM; Mohd, R; Cader, RA; Mustafar, R; Rahman, RA				Shaharir, Syahrul Sazliyana; Said, Mohd Shahrir Mohamed; Mohd, Rozita; Cader, Rizna Abdul; Mustafar, Ruslinda; Rahman, Rahana Abdul			Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; INTERNATIONAL CONSENSUS; REVISED CRITERIA; SINGLE-CENTER; DISEASE; OUTCOMES; FLARE; HYDROXYCHLOROQUINE; DEFINITION	Flare of Systemic Lupus Erythematosus (SLE) may occur during pregnancy and puerperium. We studied the prevalence and factors associated with SLE relapse during pregnancy and post-partum period in a multi-ethnic SLE cohort. Consecutive SLE patients who attended the outpatient clinic were reviewed for previous history of pregnancies in our institution. Patients who had a complete antenatal, delivery, and post-partum follow up were included. Their medical records were retrospectively analysed to assess the disease activity at pre-pregnancy/conception, during antenatal, and post-partum period. Presence of flare episodes during pregnancy and puerperium were recorded. The pregnancy outcomes recorded include live birth, foetal loss, prematurity and intra-uterine growth restrictions (IUGR). Univariate and multivariable logistic regression with generalized estimating equations (GEE) analyses were performed to determine the factors associated with disease relapse and the pregnancy outcomes. A total of 120 patients with 196 pregnancies were included, with a live birth rate of 78.6%. Four (2.0%) were diagnosed to have SLE during pregnancy. The flare rate in pregnancy was 40.1% while post-partum 17.4%. Majority of the relapse in pregnancy occurred in haematological system (62.3%) followed by renal (53.2%), musculoskeletal (22.1%), and mucocutaneous (14.3%). In GEE analyses, active disease at conception was the independent predictor of SLE relapse during and after pregnancy, whereas older maternal age and Malay ethnicity were associated with higher flare during post-partum. HCQ use was significantly associated with reduced risk of flare in univariate analysis but it was no longer significant in the GEE analyses. Presence of disease flare in pregnancy was significantly associated with prematurity. In conclusion, pregnancy in SLE need to be planned during quiescent state as pre-pregnant active disease was associated with disease relapse in both during and after pregnancy. Malay patients had an increased risk of post-partum flare but further larger prospective studies are needed to confirm the association between pregnancies in the different ancestral background.	[Shaharir, Syahrul Sazliyana; Said, Mohd Shahrir Mohamed] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Rheumatol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia; [Mohd, Rozita; Cader, Rizna Abdul; Mustafar, Ruslinda] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Nephrol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia; [Rahman, Rahana Abdul] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Obstet & Gynaecol, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Shaharir, SS (corresponding author), Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Rheumatol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia.	ssazliyana@gmail.com	Said, Mohd Shahrir Mohamed/AAR-2680-2020; MOHAMED SAID, PROF DR MOHD SHAHRIR/J-5065-2014	MOHAMED SAID, PROF DR MOHD SHAHRIR/0000-0003-1459-1844				Aly EAH, 2016, MIDDLE EAST FERTIL S, V21, P168, DOI 10.1016/j.mefs.2015.12.003; Andrade RM, 2006, RHEUMATOLOGY, V45, P1380, DOI 10.1093/rheumatology/kel222; Ateka-Barrutia O, 2013, CLIN MED, V13, P580, DOI 10.7861/clinmedicine.13-6-580; Baer AN, 2011, OBSTET GYNECOL SURV, V66, P639, DOI 10.1097/OGX.0b013e318239e1ee; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Buyon JP, 1999, LUPUS, V8, P677, DOI 10.1191/096120399680411272; Calvert N, 2018, CLIN SARCOMA RES, V8, DOI 10.1186/s13569-018-0090-1; Carmona F, 1999, EUR J OBSTET GYN R B, V83, P137, DOI 10.1016/S0301-2115(98)00312-1; Carvalheiras G, 2010, CLIN REV ALLERG IMMU, V38, P302, DOI 10.1007/s12016-009-8161-y; Cervera Ricard, 2002, Autoimmunity Reviews, V1, P354, DOI 10.1016/S1568-9972(02)00082-4; Chakravarty EF, 2005, AM J OBSTET GYNECOL, V192, P1897, DOI 10.1016/j.ajog.2005.02.063; Chen DY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2413637; Chen YE, 2008, CLIN J AM SOC NEPHRO, V3, P46, DOI 10.2215/CJN.03280807; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002/art.22159; Clowse MEB, 2011, J RHEUMATOL, V38, P1012, DOI 10.3899/jrheum.100746; Cortes-Hernandez J, 2002, RHEUMATOLOGY, V41, P643, DOI 10.1093/rheumatology/41.6.643; De Bandt M, 2000, ANN MED INTERNE, V151, P87; Surita FGD, 2007, SAO PAULO MED J, V125, P91, DOI 10.1590/S1516-31802007000200005; Eudy A, 2018, PREGNANCY HYPERTENS, V13, pS26, DOI [10.1016/j.preghy.2018.08.080, DOI 10.1016/J.PREGHY.2018.08.080]; Eudy AM, 2018, ANN RHEUM DIS, V77, P855, DOI 10.1136/annrheumdis-2017-212535; Georgiou PE, 2000, RHEUMATOLOGY, V39, P1014, DOI 10.1093/rheumatology/39.9.1014; Gilda Parastandechehr STF, 2016, CAN PREGNANCY INDUCE, V1, P27; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jamia Azdina Jamal, 2011, Pharmacognosy Journal, V3, P15, DOI 10.5530/pj.2011.24.4; Ko HS, 2011, INT J MED SCI, V8, P577, DOI 10.7150/ijms.8.577; Kobayashi N, 1999, AM J REPROD IMMUNOL, V42, P153; Ku M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159364; Lateef A, 2013, BEST PRACT RES CL RH, V27, P435, DOI 10.1016/j.berh.2013.07.005; Levy RA, 2001, LUPUS, V10, P401, DOI 10.1191/096120301678646137; Lewis MJ, 2017, RHEUMATOLOGY, V56, P67, DOI 10.1093/rheumatology/kew399; LIMA F, 1995, SEMIN ARTHRITIS RHEU, V25, P184, DOI 10.1016/S0049-0172(95)80030-1; LOCKSHIN MD, 1984, AM J MED, V77, P893, DOI 10.1016/0002-9343(84)90538-2; LOCKSHIN MD, 1989, ARTHRITIS RHEUM, V32, P665, DOI 10.1002/anr.1780320602; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Medina-Quinones CV, 2016, ARTHRIT CARE RES, V68, P981, DOI 10.1002/acr.22774; MEEHAN RT, 1987, J RHEUMATOL, V14, P252; MINTZ G, 1986, J RHEUMATOL, V13, P732; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mokbel A, 2013, EGYPT RHEUMATOL, V35, P133, DOI 10.1016/j.ejr.2013.02.002; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; NOSSENT HC, 1990, J RHEUMATOL, V17, P771; Ostensen M, 2004, BEST PRACT RES CL RH, V18, P219, DOI 10.1016/j.berh.2004.01.002; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; PETRI M, 1992, AM J REPROD IMMUNOL, V28, P188, DOI 10.1111/j.1600-0897.1992.tb00788.x; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; Petri M, 2007, RHEUM DIS CLIN N AM, V33, P227, DOI 10.1016/j.rdc.2007.01.003; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; RUBBERT A, 1992, AM J REPROD IMMUNOL, V28, P205, DOI 10.1111/j.1600-0897.1992.tb00792.x; Ruiz-Irastorza G, 2004, ARTHRIT RHEUM-ARTHR, V51, P78, DOI 10.1002/art.20081; Ruiz-Irastorza G, 2011, EUR J CLIN INVEST, V41, P672, DOI 10.1111/j.1365-2362.2010.02443.x; RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133; Ruperto N, 2011, LUPUS, V20, P453, DOI 10.1177/0961203310388445; Saavedra MA, 2015, LUPUS, V24, P180, DOI 10.1177/0961203314552116; Shaharir SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166270; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tandon A, 2004, ARTHRITIS RHEUM-US, V50, P3941, DOI 10.1002/art.20638; Teh CL, 2017, LUPUS, V26, P218, DOI 10.1177/0961203316664996; TINCANI A, 1992, CLIN EXP RHEUMATOL, V10, P439; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; UROWITZ MB, 1993, ARTHRITIS RHEUM, V36, P1392, DOI 10.1002/art.1780361011; WONG KL, 1991, ARCH INTERN MED, V151, P269, DOI 10.1001/archinte.151.2.269; Yang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104375; Yang MJ, 2015, J CHIN MED ASSOC, V78, P235, DOI 10.1016/j.jcma.2014.11.008; Yap DYH, 2015, KIDNEY DIS-BASEL, V1, P100, DOI 10.1159/000430458; Yusoff Z, 2018, SHS WEB C, V45, DOI [10.1051/shsconf/20184505002, DOI 10.1051/SHSCONF/20184505002]; Zhan ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176457; ZHOU YF, 2018, BMJ OPEN, V8, DOI DOI 10.1136/BMJOPEN-2017-020909	69	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222343	10.1371/journal.pone.0222343	http://dx.doi.org/10.1371/journal.pone.0222343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539383	Green Published, gold			2022-12-27	WOS:000532297900010
J	Chen, HH; Lin, CH; Chen, DY; Chao, WC; Chen, YH; Hung, WT; Chou, YY; Wu, YD; Chen, CC				Chen, Hsin-Hua; Lin, Ching-Heng; Chen, Der-Yuan; Chao, Wen-Cheng; Chen, Yi-Hsing; Hung, Wei-Ting; Chou, Yin-Yi; Wu, Yi-Da; Chen, Chien-Chih			Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study	PLOS ONE			English	Article							MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; T-CELL; POLYMYOSITIS; DERMATOMYOSITIS; AUTOANTIBODIES; MYOSITIS; TAIWAN; IPILIMUMAB; ANTIBODIES	Background Breast cancer is one of the most common malignancies among women. However, there remains no consensus in current literature on the incidence of autoimmune diseases among breast cancer patients. The purpose of this study was to evaluate the risks of major autoimmune diseases (MAD) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjogren's syndrome (SS) and dermatomyositis (DMtis)/polymyositis (PM) in female breast cancer patients. Methods Using the Taiwanese National Health Insurance Research Database (NHIRD) records from 2003 to 2013, we identified newly-diagnosed female breast cancer patients and randomly selected females without breast cancer in the period 2007 to 2013 into a control group. We matched the two cohorts using a 1:4 ratio based on age, and the year of index date for comparison of the risk of major autoimmune diseases. We estimated and compared the relative risks of autoimmune diseases in female breast cancer patients and females without breast cancer. Results A total of 54,311 females with breast cancer and 217,244 matched females without breast cancer were included in this study. For SLE, the incidence rates were 2.3 (breast cancer group) vs. 10.0 (control group) per 100,000 women years; for RA rates were 19.3 (breast cancer group) vs. 42.7 (control group) per 100,000 women years; and for SS rates were 20.5 (breast cancer group) vs. 38.2 (control group) per 100,000 women years. After adjusting for potential confounders, the hazard ratios (95% confidence intervals) for female breast cancer patients vs. control group were 0.04 (0.01-0.24) for SLE; 0.03 (0.02-0.04) for RA; and 0.21 (0.09-0.48) for SS. Conclusion Female breast cancer patients had lower risks of SLE, RA and SS when compared to female individuals without breast cancer. However, there was no significant difference in the risk of developing DMtis/PM between both groups.	[Chen, Hsin-Hua; Chen, Chien-Chih] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua; Lin, Ching-Heng; Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Yi-Hsing] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth & Community, Med Res Ctr, Taipei, Taiwan; [Chen, Der-Yuan] China Med Univ Hosp, Rheumatol & Immunol Ctr, Taichung, Taiwan; [Chen, Der-Yuan] China Med Univ Hosp, Rheumatol & Immunol Ctr, Translat Med Lab, Taichung, Taiwan; [Chen, Der-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yi-Hsing; Hung, Wei-Ting; Chou, Yin-Yi; Wu, Yi-Da] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Chien-Chih] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Tunghai University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Chen, CC (corresponding author), Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan.; Chen, CC (corresponding author), Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan.	chiencheh@gmail.com	Huang, James/ADK-6342-2022		Taichung Veterans General Hospital [CE16241B]	Taichung Veterans General Hospital	This study was supported by Taichung Veterans General Hospital grant CE16241B to HHC.	Betteridge ZE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3275; Blair HA, 2017, DRUGS, V77, P1221, DOI 10.1007/s40265-017-0775-4; Chen D, 2014, CLIN EXP RHEUMATOL, V32, P615; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; CHOW WH, 1995, CANCER CAUSE CONTROL, V6, P9, DOI 10.1007/BF00051675; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Fang YF, 2016, CLIN RHEUMATOL, V35, P1977, DOI 10.1007/s10067-016-3296-8; Fasth AER, 2009, J IMMUNOL, V183, P4792, DOI 10.4049/jimmunol.0803688; Hengstman GJD, 2002, J NEUROL, V249, P69, DOI 10.1007/PL00007850; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Khalife Esmat, 2018, Asian Pac J Cancer Prev, V19, P3019; Kuo CF, 2011, BRIT J DERMATOL, V165, P1273, DOI 10.1111/j.1365-2133.2011.10595.x; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lin X, 2014, ANN RHEUM DIS, V73, DOI [10.1136/annrheumdis-2014-205521, 10.1136/annrheumdis-2013-204584]; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mao H, 2010, CURR CANCER DRUG TAR, V10, P728, DOI 10.2174/156800910793605811; MARGUERIE C, 1990, Q J MED, V77, P1019, DOI 10.1093/qjmed/77.1.1019; Mease PJ, 2017, ANN RHEUM DIS, V76, P1550, DOI 10.1136/annrheumdis-2016-210724; Pontarini E, 2018, CURR OPIN RHEUMATOL, V30, P215, DOI 10.1097/BOR.0000000000000473; Rutjes SA, 1997, CLIN EXP IMMUNOL, V109, P32, DOI 10.1046/j.1365-2249.1997.4081308.x; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; See LC, 2013, SEMIN ARTHRITIS RHEU, V43, P381, DOI 10.1016/j.semarthrit.2013.06.001; Selva-O'Callaghan A, 2006, ARTHRIT RHEUM-ARTHR, V55, P791, DOI 10.1002/art.22237; Shah AA, 2017, CLIN EXP RHEUMATOL, V35, pS71; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; Tao JH, 2017, INFLAMMATION, V40, P328, DOI 10.1007/s10753-016-0470-8; Tjarnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Venalis P, 2014, RHEUMATOLOGY, V53, P397, DOI 10.1093/rheumatology/ket279; Zhu T, 2016, CLIN PHARM DRUG DEV, V5, P408, DOI 10.1002/cpdd.251	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222860	10.1371/journal.pone.0222860	http://dx.doi.org/10.1371/journal.pone.0222860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536611	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800097
J	Pero, R; Angrisano, T; Brancaccio, M; Falanga, A; Lombardi, L; Natale, F; Laneri, S; Lombardo, B; Galdiero, S; Scudiero, O				Pero, Raffaela; Angrisano, Tiziana; Brancaccio, Mariarita; Falanga, Annarita; Lombardi, Lucia; Natale, Francesco; Laneri, Sonia; Lombardo, Barbara; Galdiero, Stefania; Scudiero, Olga			Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; CPG ISLAND METHYLATION; PROMOTER METHYLATION; HOST-DEFENSE; CANCER; GENE; INFLAMMATION; RISK; INDUCTION; HEPATITIS	Antimicrobial peptides can protect the gastric mucosa from bacteria, but Helicobacter pylori (H. pylori) can equally colonize the gastric apparatus. To understand beta-defensin function in H. pylori-associated chronic gastritis, we investigated susceptibility, human beta-defensin mRNA expression, and DNA methylation changes to promoters in the gastric mucosa with or without H. pylori infection. We studied the expression of HBD2 (gene name DEFB4A), HBD3 (DEFB103A), and HBD4 (DEFB104) using real-time PCR in 15 control and 10 H. pylori infection patient gastric specimens. This study demonstrates that H. pylori infection is related to gastric enhancement of inducible HBD2, but inducible HBD3 and HBD4 expression levels remained unchanged. HBD2 gene methylation levels were overall higher in H. pylori-negative samples than in H. pylori-positive samples. We also assessed antimicrobial susceptibility using growth on blood agar. The H. pylori strain Tox+ was susceptible to all defensins tested and their analogs (3N, 3NI). These results show that HBD2 is involved in gastritis development driven by H. pylori, which facilitates the creation of an epigenetic field during H. pylori-associated gastric tumorigenesis.	[Pero, Raffaela; Lombardo, Barbara; Scudiero, Olga] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Pero, Raffaela; Scudiero, Olga] Univ Napoli Federico II, Task Force Studi Microbioma, Naples, Italy; [Angrisano, Tiziana; Natale, Francesco] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Brancaccio, Mariarita] Staz Zool Anton Dohrn, Dipartimento Biol Evoluz Organismi Marini, Naples, Italy; [Falanga, Annarita; Laneri, Sonia; Galdiero, Stefania] Univ Napoli Federico II, Dipartimento Farm, Naples, Italy; [Lombardi, Lucia] Univ Napoli Federico II, Dipartimento Agr, Naples, Italy; [Lombardo, Barbara; Scudiero, Olga] CEINGE Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Pero, R; Scudiero, O (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Pero, R; Scudiero, O (corresponding author), Univ Napoli Federico II, Task Force Studi Microbioma, Naples, Italy.; Scudiero, O (corresponding author), CEINGE Biotecnol Avanzate Scarl, Naples, Italy.	pero@unina.it; olga.scudiero@unina.it	Galdiero, Stefania/M-3225-2019; Brancaccio, Mariarita/AAC-4285-2021; Lombardi, Lucia/ABH-2872-2021; Angrisano, Tiziana/AAC-5353-2022; Natale, Francesco/AAG-6525-2019; Scudiero, Olga/AAC-5358-2022; PERO, Raffaela/L-1461-2015	Galdiero, Stefania/0000-0002-7849-7024; Brancaccio, Mariarita/0000-0002-4161-512X; Lombardi, Lucia/0000-0002-5202-9847; Natale, Francesco/0000-0001-5366-9005; Scudiero, Olga/0000-0002-4916-4976; Lombardo, Barbara/0000-0003-3884-1043; PERO, Raffaela/0000-0003-2182-5530	Regione Campania [D62/07000110002, 2012/0140203]	Regione Campania(Regione Campania)	Support for this study was provided by Legge Regionale N.5, Annualita 2007 from Regione Campania, D62/07000110002 to OS, and Finanziamenti per l'Avvio di Ricerche Originali 2012 from University of Naples of "Federico II", 2012/0140203 to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Angrisano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156671; Bajaj-Elliott M, 2002, GUT, V51, P356, DOI 10.1136/gut.51.3.356; Bauer B, 2013, HELICOBACTER, V18, P6, DOI 10.1111/hel.12000; Belot MP, 2018, EPIGENETICS-US, V13, P459, DOI 10.1080/15592294.2018.1469893; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chan AOO, 2006, CURR MOL MED, V6, P401, DOI 10.2174/156652406777435417; Chan AOO, 2003, GUT, V52, P502, DOI 10.1136/gut.52.4.502; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chiariotti L, 2016, ADV EXP MED BIOL, V879, P91, DOI 10.1007/978-3-319-24738-0_5; Chiariotti L, 2013, MED MICROBIOL IMMUN, V202, P327, DOI 10.1007/s00430-013-0301-6; Coretti L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8392523; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; di Martino O, 2016, GENES CELLS, V21, P648, DOI 10.1111/gtc.12373; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; Grubman A, 2010, CELL MICROBIOL, V12, P626, DOI 10.1111/j.1462-5822.2009.01421.x; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Hosaka Y, 2008, EUR J GASTROEN HEPAT, V20, P1151, DOI 10.1097/MEG.0b013e3283052ddb; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Isomoto H, 2005, WORLD J GASTROENTERO, V11, P4782, DOI 10.3748/wjg.v11.i31.4782; Issa JPJ, 2001, CANCER RES, V61, P3573; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Kawauchi K, 2006, WORLD J GASTROENTERO, V12, P5793, DOI 10.3748/wjg.v12.i36.5793; Keller S, 2013, ONCOL LETT, V6, P86, DOI 10.3892/ol.2013.1312; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Lombardi L, 2019, BIOMACROMOLECULES, V20, P1362, DOI 10.1021/acs.biomac.8b01740; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Muhammad JS, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv128; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nigro E, 2015, SCI REP, V21, P5; Nishi Y, 2005, WORLD J GASTROENTERO, V11, P99, DOI 10.3748/wjg.v11.i1.99; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; Ohara T, 2005, HEPATO-GASTROENTEROL, V52, P1320; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Otte JM, 2009, EUR J CLIN INVEST, V39, P126, DOI 10.1111/j.1365-2362.2008.02071.x; Patel SR, 2013, CELL MICROBIOL, V15, P2080, DOI 10.1111/cmi.12174; Pero R, 2017, MOLECULES, V7, P3; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Scudiero O, 2015, INT J NANOMED, V10, P6523, DOI 10.2147/IJN.S89610; Scudiero O, 2013, ANTIMICROB AGENTS CH, V57, P1701, DOI 10.1128/AAC.00934-12; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shin CM, 2010, CANCER SCI, V101, P1337, DOI 10.1111/j.1349-7006.2010.01535.x; Sobiak B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040914; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Taha AS, 2005, DIGEST LIVER DIS, V37, P51, DOI 10.1016/j.dld.2004.07.019; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vordenbaumen S, 2010, J PEDIATR GASTR NUTR, V50, P596, DOI 10.1097/MPG.0b013e3181cd26cd; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Wehkamp J, 2003, J CLIN PATHOL, V56, P352, DOI 10.1136/jcp.56.5.352; Yakirevich E, 2013, GASTROENTEROL CLIN N, V42, P261, DOI 10.1016/j.gtc.2013.01.004; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Zhao CH, 2012, HISTOL HISTOPATHOL, V27, P1271, DOI 10.14670/HH-27.1271	64	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222295	10.1371/journal.pone.0222295	http://dx.doi.org/10.1371/journal.pone.0222295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31537016	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800035
J	Marais, F; Kallon, II; Dudley, LD				Marais, Frederick; Kallon, Idriss Ibrahim; Dudley, Lilian Diana			Continuity of care for TB patients at a South African hospital: A qualitative participatory study of the experiences of hospital staff	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; HEALTH SYSTEMS; CAPE-TOWN; INFECTION; CONTEXT	Background Ensuring effective clinical management and continuity of TB care across hospital and primary health-care services remains challenging in South Africa. The high burden of TB, coupled with numerous health system problems, influence the TB care delivered by hospital staff. Objective To understand factors from the perspectives of hospital staff that influence the clinical management and discharge of TB patients, and to elicit recommendations to improve continuity of care for TB patients. Design Participatory action research was used to engage hospital staff working with TB patients admitted to a central public hospital in the Western Cape province, South Africa. Data were collected through eight focus group discussions with nurses, junior doctors and ward administrators. Data analysis was done using Miles and Huberman's framework to identify emerging patterns and to develop categories with themes and sub-themes. The participants influenced all phases of the research process to inform better practices in TB clinical management and discharge planning at the hospital. Results The emerging themes and sub-themes were categorized into two overall sections: The clinical care management process and the discharge and referral process. Nurses expressed a fear of exposure to TB and MDR-TB due to challenges in clinical and infection-prevention control. Clinical hierarchies, poor interdisciplinary teamwork, limited task shifting and poor communication interfered with effective clinical and discharge processes. A high workload, staff shortages and inadequate skills resulted in insufficient information and health education for TB patients and their caregivers. Despite awareness of the patients' socio-economic challenges, some aspects of care were not patient-centered, and caregivers were not included in discharge planning. Communication between the hospital and referral points was inefficient and poorly supported by information systems. Hospital staff recommended improved infection prevention and control practices and interdisciplinary teamwork in the hospital, that TB education for patients be integrated with hospital staff functions, with more patient-centered discharge planning, and improved communication across hospitals and primary health care levels. Conclusions Interdisciplinary teamwork, more patient-centered care, and better communication within the hospital and with primary health-care services are needed for improved continuity of care for TB patients. Further studies on factors contributing to, and interventions to improve, continuity of TB care in similar hospital settings are needed.	[Marais, Frederick; Dudley, Lilian Diana] Stellenbosch Univ, Fac Med & Hlth Sci, Div Hlth Syst & Publ Hlth, Cape Town, South Africa; [Marais, Frederick] Western Cape Govt Hlth, Cape Town, South Africa; [Kallon, Idriss Ibrahim] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	Stellenbosch University; University of Cape Town	Marais, F (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Hlth Syst & Publ Hlth, Cape Town, South Africa.; Marais, F (corresponding author), Western Cape Govt Hlth, Cape Town, South Africa.	frederick.marais@westerncape.gov.za	Kallon, Idriss/GZK-8516-2022	Kallon, Idriss Ibrahim/0000-0001-8903-4001	South African Medical Research Council Self Initiated Research Grant; South Africa Netherlands Research Programme on Alternative Development (SANPAD)	South African Medical Research Council Self Initiated Research Grant(South African Medical Research Council); South Africa Netherlands Research Programme on Alternative Development (SANPAD)	This work was supported by: L Dudley, South African Medical Research Council Self Initiated Research Grant; L Dudley, 10/61, South Africa Netherlands Research Programme on Alternative Development (SANPAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; Arends T, 2017, THESIS; Atkins S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-275; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Bergold J., 2012, FORUM QUALITATIVE SO, DOI [10.17169/fqs-13.1.1801, DOI 10.17169/FQS-13.1.1801]; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; de Vries E, 2011, SAMJ S AFR MED J, V101, P760; Department of Health, 2013, NAT HLTH CAR FAC BAS; Dudley L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190258; Dyers RE, 2016, SAMJ S AFR MED J, V106, P181, DOI [10.7196/SAMJ.2016.v106i2.10079, 10.7196/SAMJ.2016.V106I2.10079]; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Ford N, 2016, J INT AIDS SOC, V19, P1; Foy R, 2010, ANN INTERN MED, V152, P247, DOI 10.7326/0003-4819-152-4-201002160-00010; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Goncalves-Bradley DC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub5; Grobler L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1601-5; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Jagosh J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1949-1; Janson J, 2012, PUBLIC HEALTH ACTION, V2, P61, DOI 10.5588/pha.12.0003; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kendall EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083480; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kolbe-Alexander T, 2014, J SCI MED SPORT, V18, pe98; Lei X, 2015, INT J INFECT DIS, V34, P20, DOI 10.1016/j.ijid.2015.02.015; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Malotle MM, 2017, PUBLIC HEALTH ACTION, V7, P258, DOI 10.5588/pha.17.0070; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Mayan M. J., 2015, QUALITATIVE HLTH RES, V26, P69; Meiqari L, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0426-1; Miles M., 2013, QUALITATIVE DATA ANA; Minshew N. J., 1997, QUAL REP, V3, P303; National Department of Health SA, 2014, STRAT PLAN 2015 2019; O'Hara LM, 2017, INT J TUBERC LUNG D, V21, P320, DOI 10.5588/ijtld.16.0591; Oni T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-575; Padarath A, 2017, S AFRICAN HLTH REV; Probandari A, 2008, GLOBAL HEALTH ACTION, V1, DOI 10.3402/gha.v1i0.1831; Punch K.F., 2005, INTRO SOCIAL RES QUA; Reeves S, 2017, COCHRANE DB SYST REV, V6, P10; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Sissolak D, 2010, INT J INFECT DIS, V14, pE423, DOI 10.1016/j.ijid.2009.06.030; Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262; Statistics South Africa, 2012, CENS 2011 STAT REL P; Stewart DW, 2014, APPL SOCIAL RES METH, V20, P109; Sullivan SS, 2017, NURS OUTLOOK, V65, P597, DOI 10.1016/j.outlook.2017.01.014; TB DOTS Strategy Coordination, 2014, TB DOTS STRATEGY COO; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Von Holdt K, 2007, STATE NATION S AFRIC, P312; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Western Cape Government: Health, 2013, HEALTHC 2030; WHO, 2016, GLOB TUB REP; WHO, 2014, END TB STRAT	55	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222421	10.1371/journal.pone.0222421	http://dx.doi.org/10.1371/journal.pone.0222421			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532797	Green Submitted, Green Published, gold			2022-12-27	WOS:000532239600030
J	Racicot, FE; Rentz, WF; Tessier, D; Theoret, R				Racicot, Francois-Eric; Rentz, William F.; Tessier, David; Theoret, Raymond			The conditional Fama-French model and endogenous illiquidity: A robust instrumental variables test	PLOS ONE			English	Article							STOCK RETURNS; SAMPLE PROPERTIES; RISK; PERFORMANCE; INVESTMENT; HETEROSKEDASTICITY; SELECTION; EQUILIBRIUM; ESTIMATORS; PORTFOLIOS	We investigate conditional specifications of the five-factor Fama-French (FF) model, augmented with traditional illiquidity measures. The motivation for this time-varying methodology is that the traditional static approach of the FF model may be misspecified, especially for the endogenous illiquidity measures. We focus on the time-varying nature of the Jensen performance measure a and the market systematic risk sensitivity beta, as these parameters are essentially universal in asset pricing models. To tackle endogeneity and other specification errors, we rely on our robust instrumental variables (RIV) algorithm implemented via a GMM approach. In this dynamic or time-varying conditional context, we generally find that the most significant factor is the market one, but illiquidity may matter depending on which states or estimation methods we consider. In particular, sectors whose returns embed a market illiquidity premium are more exposed to a binding funding constraint in times of crisis, which leads to deleveraging and a resulting decrease in systematic risk.	[Racicot, Francois-Eric; Rentz, William F.] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada; [Racicot, Francois-Eric] IPAG Business Sch, Paris, France; [Tessier, David] Univ Quebec Outaouais UQO, Dept Sci Administratives, Gatineau, PQ, Canada; [Theoret, Raymond] Univ Quebec Montreal ESG UQAM, Ecole Sci Gest, Montreal, PQ, Canada; [Theoret, Raymond] ESG UQAM, Chaire Informat Financiere & Organisat, Montreal, PQ, Canada	University of Ottawa; IPAG Business School; University of Quebec; University of Quebec; University of Quebec Montreal	Racicot, FE (corresponding author), Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada.; Racicot, FE (corresponding author), IPAG Business Sch, Paris, France.	Racicot@telfer.uottawa.ca	Racicot, François-Éric/O-3079-2019	Racicot, Francois-Eric/0000-0003-0468-5513	IPAG Business School, Paris, France; Social Sciences and Humanities Research Council (SSHRC) of Canada [435-2019-0078]	IPAG Business School, Paris, France; Social Sciences and Humanities Research Council (SSHRC) of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Financial support from the IPAG Business School, Paris, France (https://www.ipag.edu/en) and the Social Sciences and Humanities Research Council (SSHRC) of Canada, grant no. 435-2019-0078 (http://www.sshrc-crsh.gc.ca/home-accueileng.aspx) is acknowledged. Recipient name: Francois-Eric Racicot. No other funding was obtained for this research.	ABEL AB, 1983, AM ECON REV, V73, P228; Abel AB, 2011, REV ECON STUD, V78, P1179, DOI 10.1093/restud/rdr006; Adrian T, 2018, ANNU REV FINANC ECON, V10, P1, DOI 10.1146/annurev-financial-110217-023113; Adrian T, 2017, ANNU REV FINANC ECON, V9, P43, DOI 10.1146/annurev-financial-110716-032325; Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Amihud Y., 2019, CRIT FINAN REV, V8, P1; Ang A, 2012, J FINANC ECON, V106, P132, DOI 10.1016/j.jfineco.2012.04.008; [Anonymous], 1954, REV INT STATISTIC I; BATES DS, 1991, J FINANC, V46, P1009, DOI 10.2307/2328552; Beckmann J, 2018, EMPIR ECON, V54, P1389, DOI 10.1007/s00181-017-1335-1; Bekaert Geert, 2018, INT FINANCIAL MANAGE, VThird; Bellman R., 1957, DYNAMIC PROGRAMMING; Benninga S, 2014, FINANCIAL MODELING, V4th; Black F., 1976, P BUS EC STAT SECT A, P177; Blau BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188517; Champagne C, 2017, CAN J ADM SCI, V34, P306, DOI 10.1002/cjas.1338; Chow, 1997, DYNAMIC EC; Christopherson JA, 1998, REV FINANC STUD, V11, P111, DOI 10.1093/rfs/11.1.111; Claessens S, 2017, BANK INT SETTLEMENTS, V677; COCHRANE JH, 1991, J FINANC, V46, P209, DOI 10.2307/2328694; Cochrane JH, 1996, J POLIT ECON, V104, P572, DOI 10.1086/262034; Cochrane JH, 2017, REV FINANC, V21, P945, DOI 10.1093/rof/rfx010; Cochrane JH, 2011, J FINANC, V66, P1047, DOI 10.1111/j.1540-6261.2011.01671.x; Damodaran A., 2011, DAMODARAN VALUATION; Diebold FX, 2014, J ECONOMETRICS, V182, P119, DOI 10.1016/j.jeconom.2014.04.012; Erickson T, 2012, REV FINANC STUD, V25, P1286, DOI 10.1093/rfs/hhr120; Fama EF, 2018, J FINANC ECON, V128, P234, DOI 10.1016/j.jfineco.2018.02.012; Fama EF, 2017, J FINANC ECON, V123, P441, DOI 10.1016/j.jfineco.2016.11.004; Fama EF, 2016, REV FINANC STUD, V29, P69, DOI 10.1093/rfs/hhv043; Fama EF, 2015, J FINANC ECON, V116, P1, DOI 10.1016/j.jfineco.2014.10.010; Ferson WE, 1996, J FINANC, V51, P425, DOI 10.2307/2329367; Ferson WE, 2004, CONDITIONAL EV UNPUB; Ghysels E, 1998, J FINANC, V53, P549, DOI 10.1111/0022-1082.224803; Ghysels E., 2018, APPL EC FORECASTING; Goyenko RY, 2009, J FINANC ECON, V92, P153, DOI 10.1016/j.jfineco.2008.06.002; Greene W, 2018, ECONOMETRIC ANAL; Hahn JY, 2003, AM ECON REV, V93, P118, DOI 10.1257/000282803321946912; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; Heij C., 2004, ECONOMETRIC METHODS; Hou KW, 2015, REV FINANC STUD, V28, P650, DOI 10.1093/rfs/hhu068; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; JENSEN MC, 1968, J FINANC, V23, P389, DOI 10.2307/2325404; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kat HM, 2008, J ALTERN INVEST, V10, P8, DOI 10.3905/jai.2008.705529; Kursenko A., 2017, THESIS; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; MERTON RC, 1976, J FINANC ECON, V3, P125, DOI 10.1016/0304-405X(76)90022-2; MOSSIN J, 1966, ECONOMETRICA, V34, P768, DOI 10.2307/1910098; NELSON CR, 1990, J BUS, V63, pS125, DOI 10.1086/296497; NELSON CR, 1990, ECONOMETRICA, V58, P967, DOI 10.2307/2938359; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; NEWEY WK, 1994, REV ECON STUD, V61, P631, DOI 10.2307/2297912; PAGAN A, 1988, J APPL ECONOM, V3, P87, DOI 10.1002/jae.3950030202; PAGAN A, 1986, REV ECON STUD, V53, P517, DOI 10.2307/2297604; PAL M, 1980, J ECONOMETRICS, V14, P349, DOI 10.1016/0304-4076(80)90032-9; PASTOR A, 2019, CRITICAL FINANCE REV, P1, DOI DOI 10.1177/0141778919849688; Pastor L, 2003, J POLIT ECON, V111, P642, DOI 10.1086/374184; Pinto JeraldE., 2015, EQUITY ASSET VALUATI; RACICOT FE, 2014, REV SCI GESTION, V267, P79, DOI DOI 10.3917/RSG.267.0079; Racicot FE, 2018, FINANCE, P45; Racicot FE, 2015, APPL ECON, V47, P981, DOI 10.1080/00036846.2014.985373; ROLL R, 1977, J FINANC ECON, V4, P129, DOI 10.1016/0304-405X(77)90009-5; Sargan J. D., 1975, TESTING MISSPE UNPUB; Sargan J.D., 1988, LECT ADV ECONOMETRIC; SARGAN JD, 1958, ECONOMETRICA, V26, P393, DOI 10.2307/1907619; Schopflocher TP, 2005, BOUND-LAY METEOROL, V115, P341, DOI 10.1007/s10546-004-5642-7; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Sodjahin A, 2017, J ASSET MANAG, V18, P347, DOI 10.1057/s41260-016-0039-y; Taleb N., 1997, DYNAMIC HEDGING MANA; THEIL H, 1961, INT ECON REV, V2, P65, DOI 10.2307/2525589; Tobin J., 1969, J MONEY CREDIT BANK, V1, P15, DOI DOI 10.2307/1991374; Wheelock DC, 2009, FED RESERVE BANK ST, V91, P419; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilkins JE, 1944, ANN MATH STAT, V15, P333, DOI 10.1214/aoms/1177731243	78	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221599	10.1371/journal.pone.0221599	http://dx.doi.org/10.1371/journal.pone.0221599			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532780	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600009
J	Keating, SM; Rountree, W; Grebe, E; Pappas, AL; Stone, M; Hampton, D; Todd, CA; Poniewierski, MS; Sanchez, A; Porth, CG; Denny, TN; Busch, MP				Keating, Sheila M.; Rountree, Wes; Grebe, Eduard; Pappas, Andrea L.; Stone, Mars; Hampton, Dylan; Todd, Christopher A.; Poniewierski, Marek S.; Sanchez, Ana; Porth, Cassandra G.; Denny, Thomas N.; Busch, Michael P.		EQAPOL Limiting Antigen LAg Incide	Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay	PLOS ONE			English	Article							TESTING ALGORITHM; POPULATION; INFECTIONS; INDEX	Laboratory assays for identifying recent HIV-1 infections are widely used for estimating incidence in cross-sectional population-level surveys in global HIV-1surveillance. Adequate assay and laboratory performance are required to ensure accurate incidence estimates. The NIAID-supported External Quality Assurance Program Oversight Laboratory (EQA-POL) established a proficiency testing program for the most widely-used incidence assay, the HIV-1 Limiting Antigen Avidity EIA (LAg), with US Centers for Disease Control and Prevention (CDC)-approved kits manufactured by Sedia Biosciences Corporation and Maxim Biomedical. The objective of this program is to monitor the performance of participating laboratories. Four rounds of blinded external proficiency (EP) panels were distributed to up to twenty testing sites (7 North American, 5 African, 4 Asian, 2 South American and 2 European). These panels consisted of ten plasma samples: three blinded well-characterized HIV-1-seropositive samples that were included as replicates and an HIV-negative control. The seropositive samples spanned the dynamic range of the assay and are categorized as either recent or long-term infection. Participating sites performed the assay according to manufacturers' instructions and completed an online survey to gather information on kit manufacturer, lot of kit used, laboratory procedures and the experience of technicians. On average, fifteen sites participated in each round of testing, with an average of four sites testing with only the Maxim assay, seven testing with only the Sedia assay and five sites utilizing both assays. Overall, the Sedia and Maxim assays yielded similar infection status categorization across the laboratories; however, for most of the nine HIV+ samples tested, there were significant differences in the optical density readouts, ODn (N = 8) and OD (N = 7), between LAg kit manufacturers (p < 0.05 based on mixed effects models. The EQAPOL LAg program is important for monitoring laboratory performance as well as detecting variations between manufacturers of HIV-1 incidence assays.	[Keating, Sheila M.; Grebe, Eduard; Stone, Mars; Hampton, Dylan; Busch, Michael P.] Vitalant Res Inst, San Francisco, CA 94118 USA; [Keating, Sheila M.; Grebe, Eduard; Stone, Mars; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Rountree, Wes; Pappas, Andrea L.; Todd, Christopher A.; Poniewierski, Marek S.; Sanchez, Ana; Porth, Cassandra G.; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Duke University	Busch, MP (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.	MBusch@vitalant.org		Grebe, Eduard/0000-0001-7046-7245; Keating, Sheila/0000-0002-8324-3694	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000045C, HHSN272201700061C, IAA-Y1-HB-5026-01]	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This program was funded by the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract Nos. HHSN272201000045C and HHSN272201700061C entitled "External Quality Assurance Program Oversight Laboratory (EQAPOL)" (PI: T.N.D.) and grant no. IAA-Y1-HB-5026-01 entitled "Global HIV panel project" (PI: M.P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 1997, LANCET, V349, P649, DOI 10.1016/S0140-6736(05)61594-2; Blaizot S, 2017, AIDS RES HUM RETROV, V33, P472, DOI [10.1089/aid.2016.0123, 10.1089/AID.2016.0123]; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Gary MA, 2003, J VIROL METHODS, V113, P79, DOI 10.1016/S0166-0934(03)00222-2; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Highleyman L., 1999, BETA, V12, P78; Janssen RS, 1998, JAMA-J AM MED ASSOC, V281, P1893; Justman JE, 2018, NEW ENGL J MED, V378, P1859, DOI 10.1056/NEJMp1801934; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020027; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Kim AA, 2018, AIDS RES HUM RETROV, V34, P863, DOI [10.1089/aid.2017.0316, 10.1089/AID.2017.0316]; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Mei JV, 2011, J ACQ IMMUN DEF SYND, V58, P7; Murphy G, 2017, EPIDEMIOL INFECT, V145, P925, DOI 10.1017/S0950268816002910; Murphy G, 2008, EURO SURVEILL, V13; Ostrowski M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv138; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Rountree W, 2014, J IMMUNOL METHODS, V409, P72, DOI 10.1016/j.jim.2014.01.007; Schlusser KE, 2017, AIDS RES HUM RETROV, V33, P555, DOI 10.1089/aid.2016.0245; Sempa JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220345; Sharma S, 2019, AIDS, V33, P1335, DOI 10.1097/QAD.0000000000002219; Soodla P, 2018, HIV MED, V19, P33, DOI 10.1111/hiv.12535; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2011, J CLIN MICROBIOL, V49, P2610, DOI 10.1128/JCM.02115-10; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	29	5	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222290	10.1371/journal.pone.0222290	http://dx.doi.org/10.1371/journal.pone.0222290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525218	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700025
J	Harlow, K; Ferreira, CR; Sobreira, TJP; Casey, T; Stewart, K				Harlow, KaLynn; Ferreira, Christina R.; Sobreira, Tiago J. P.; Casey, Theresa; Stewart, Kara			Lipidome profiles of postnatal day 2 vaginal swabs reflect fat composition of gilt's postnatal diet	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; NEONATAL PIGLETS; GENE-EXPRESSION; MILK; RELAXIN; COLOSTRUM; CONSUMPTION; BIOMARKERS; GROWTH; ALPHA	We hypothesized that postnatal development of the vagina is impacted by early nutritional environment. Our objective was to determine if lipid profiles of vaginal swabs were different between postnatal gilts suckled by sow or fed milk replacer the first 48 h after birth, with or without a lard-based fat supplement. Gilts (>1.3 kg) were selected at birth across 8 litters and assigned to one of four treatments: 1) suckled by sow (S, n = 8); 2) suckled by sow plus administration of a fat supplement (SF, n = 5); 3) bottle-fed solely milk replacer (B, n = 8); or 4) bottle-fed solely milk replacer plus administration of a fat supplement (BF, n = 7). At 48 h postnatal, vaginal swabs of gilts were taken with a cytology brush, and lipids were extracted for analysis using multiple reaction monitoring (MRM)-profiling. Lipids extracted from serum collected at 48 h from gilts, milk collected at 24 h from sows, and milk replacer were also analyzed with MRM-profiling. Receiver operating characteristic curve analysis found 18 lipids recovered from vaginal swabs that highly distinguished between S and B gilts [area-under-the-curve (AUC) > 0.9], including phosphatidylethanolamine with 34 carbons and four unsaturations in the fatty acyl residues [PE (34:4)]. Twelve lipids from vaginal swabs highly correlated (r > 0.6; p < 0.01) with nutrition source. Lipids with greater abundance in milk replacer drove association. For example, mean intensity of PE (34:4) was 149-fold higher in milk replacer than colostrum. Consequently, PE (34:4) was found to have 1.6- and 2.12-fold higher levels in serum and vaginal swab samples (p < 0.001), respectively, of B gilts as compared to S gilts. Findings support that vaginal swabs can be used to noninvasively study effects of perinatal nutrition on tissue composition.	[Harlow, KaLynn; Casey, Theresa; Stewart, Kara] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ferreira, Christina R.; Sobreira, Tiago J. P.] Purdue Univ, Bindley Sci Ctr, Metabol Core, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Casey, T (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	theresa-casey@purdue.edu	Ferreira, Christina Ramires/F-4744-2012; Casey, Theresa Marie/F-1171-2015	Ferreira, Christina Ramires/0000-0003-3988-6454; Casey, Theresa Marie/0000-0002-8835-3550; Harlow, KaLynn/0000-0001-9729-5789	Purdue University as part of AgSEED Crossroads	Purdue University as part of AgSEED Crossroads	This activity was funded by Purdue University as part of AgSEED Crossroads funding to support Indiana's Agriculture and Rural Development. https://ag.purdue.edu/agseed/Pages/default.aspx; KS and TC received funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bagnell CA, 2005, ANN NY ACAD SCI, V1041, P248, DOI 10.1196/annals.1282.038; Bartol FF, 2013, J ANIM SCI, V91, P696, DOI 10.2527/jas.2012-5764; BARTOL FF, 1993, J REPROD FERTIL, P99; Bartol FF, 2009, ANN NY ACAD SCI, V1160, P158, DOI 10.1111/j.1749-6632.2008.03820.x; BENEVENGA NJ, 1989, J ANIM SCI, V67, P3331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOURNE FJ, 1978, ANN RECH VET, V9, P239; Cai Y, 2009, INT J DEV BIOL, V53, P925, DOI 10.1387/ijdb.082846yc; Camp ME, 2014, REPRODUCTION, V148, P441, DOI 10.1530/REP-14-0257; Casey T, 2018, J APPL ANIM RES, V46, P667, DOI 10.1080/09712119.2017.1384733; Chen JC, 2011, REPRODUCTION, V141, P675, DOI 10.1530/REP-10-0320; Chong J, 2018, NUCL ACIDS RES; Davidson MH, 2012, J CLIN LIPIDOL, V6, P573, DOI 10.1016/j.jacl.2012.01.002; Delplanque B, 2015, J PEDIATR GASTR NUTR, V61, P8, DOI 10.1097/MPG.0000000000000818; DREW MD, 1990, CAN J ANIM SCI, V70, P655, DOI 10.4141/cjas90-077; Faraggi D, 2003, STAT MED, V22, P2515, DOI 10.1002/sim.1418; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gray CA, 2001, BIOL REPROD, V64, P797, DOI 10.1095/biolreprod64.3.797; HAMOSH M, 1985, PEDIATRICS, V75, P146; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; LANZA I, 1995, AM J VET RES, V56, P739; Le Dividich J, 2005, J AGR SCI-CAMBRIDGE, V143, P469, DOI 10.1017/S0021859605005642; LeDividich J, 1997, J ANIM SCI, V75, P707; Miller DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105056; ODLE J, 1989, J ANIM SCI, V67, P3340; Peaker M, 2002, J MAMMARY GLAND BIOL, V7, P347, DOI 10.1023/A:1022860902083; Su GQ, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0788-3; WIELAND TM, 1993, J ANIM SCI, V71, P1863, DOI 10.2527/1993.7171863x; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yan W, 2008, REPRODUCTION, V135, P705, DOI 10.1530/REP-08-0014; Yan WB, 2006, ENDOCRINOLOGY, V147, P4303, DOI 10.1210/en.2006-0397	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0215186	10.1371/journal.pone.0215186	http://dx.doi.org/10.1371/journal.pone.0215186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557164	Green Submitted, gold, Green Published			2022-12-27	WOS:000532345500002
J	Martins, CAR; Brandao, ML; da Silva, EB				Martins, Carlos A. R.; Brandao Jr, Mauro Luiz; da Silva, Eduardo Brandani			New space-time block codes from spectral norm	PLOS ONE			English	Article							LARGEST EIGENVALUE; RANDOM MATRICES; WISHART; WIRELESS; MIMO; CAPACITY; APPROXIMATION; COMMUNICATION; UNIVERSALITY; PERFORMANCE	Current research proposes a natural environment for space-time codes and a new design criterion is obtained for space-time block codes in multi-antenna communication channels. The objective of this criterion is to minimize the pairwise error probability of the maximum likelihood decoder, endowed with the matrix spectral norm. The random matrix theory is used and an approximation function for the probability density function for the largest eigen-value of a Wishart Matrix is obtained.	[Martins, Carlos A. R.] UTFPR, Dept Math, Pato Branco, PR, Brazil; [Brandao Jr, Mauro Luiz] Univ Estadual Maringa, Dept Elect Engn, BR-87020900 Maringa, Parana, Brazil; [da Silva, Eduardo Brandani] DMA UEM, Ave Colombo 5790,Campus Univ, BR-87020900 Maringa, Parana, Brazil	Universidade Tecnologica Federal do Parana; Universidade Estadual de Maringa	da Silva, EB (corresponding author), DMA UEM, Ave Colombo 5790,Campus Univ, BR-87020900 Maringa, Parana, Brazil.	ebsilva@uem.br		Martins, Carlos Alexandre Ribeiro/0000-0003-4445-084X; BRANDAO, MAURO/0000-0001-7737-3575				Ahmadi A, 2015, IEEE T WIREL COMMUN, V14, P165, DOI 10.1109/TWC.2014.2334615; Alamouti SM, 1998, IEEE J SEL AREA COMM, V16, P1451, DOI 10.1109/49.730453; Alfano G, 2004, INT S INF THEOR ITS; Biglieri E., 2005, INF TECH TRANS PROCE; Bjornson E, 2018, IEEE T WIREL COMMUN, V17, P574, DOI 10.1109/TWC.2017.2768423; Caire G, 2003, IEEE T INFORM THEORY, V49, P1691, DOI 10.1109/TIT.2003.813523; Chiani M, 2003, IEEE T INFORM THEORY, V49, P2363, DOI 10.1109/TIT.2003.817437; Chiani M, 2014, J MULTIVARIATE ANAL, V129, P69, DOI 10.1016/j.jmva.2014.04.002; DYSON FJ, 1962, J MATH PHYS, V3, P1199, DOI 10.1063/1.1703863; DYSON FJ, 1962, J MATH PHYS, V3, P1191, DOI 10.1063/1.1703862; DYSON FJ, 1962, J MATH PHYS, V3, P140, DOI 10.1063/1.1703773; Forrester P., 2010, LOG GASES RANDOM MAT; Foschini G. J., 1998, Wireless Personal Communications, V6, P311, DOI 10.1023/A:1008889222784; GEMAN S, 1980, ANN PROBAB, V8, P252, DOI 10.1214/aop/1176994775; Gesbert D, 2007, IEEE SIGNAL PROC MAG, V24, P36, DOI 10.1109/MSP.2007.904815; Grover R, 2008, IEEE T WIREL COMMUN, V7, P4777, DOI 10.1109/T-WC.2008.070791; Horn R.A., 2013, MATRIX ANAL, P321; Hsu PL, 1939, ANN EUGENIC, V9, P250, DOI 10.1111/j.1469-1809.1939.tb02212.x; Hughes BL, 2003, IEEE T INFORM THEORY, V49, P401, DOI 10.1109/TIT.2002.807283; Jafarkhani H, 2001, IEEE T COMMUN, V49, P1, DOI 10.1109/26.898239; JONSSON D, 1982, J MULTIVARIATE ANAL, V12, P1, DOI 10.1016/0047-259X(82)90080-X; KRISHNAIAH PR, 1971, ANN I STAT MATH, V23, P293, DOI 10.1007/BF02479230; Marcenko V. A., 1967, MATH USSR, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Marzetta TL, 2006, CONF REC ASILOMAR C, P359, DOI 10.1109/ACSSC.2006.354768; Marzetta TL, 2010, IEEE T WIREL COMMUN, V9, P3590, DOI 10.1109/TWC.2010.092810.091092; Raleigh GG, 1998, IEEE T COMMUN, V46, P357, DOI 10.1109/26.662641; Rusek F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2011.2178495; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stenumgaard P, 2013, IEEE COMMUN MAG, V51, P186, DOI 10.1109/MCOM.2013.6515064; SUGIYAMA T, 1967, ANN MATH STAT, V38, P1148, DOI 10.1214/aoms/1177698783; Tao T, 2012, ADV MATH, V231, P74, DOI 10.1016/j.aim.2012.05.006; Tao T, 2011, ELECTRON J PROBAB, V16, P2104, DOI 10.1214/EJP.v16-944; Tao T, 2011, ACTA MATH-DJURSHOLM, V206, P127, DOI 10.1007/s11511-011-0061-3; Tao T, 2010, GEOM FUNCT ANAL, V20, P260, DOI 10.1007/s00039-010-0057-8; Tarokh V, 1999, IEEE T INFORM THEORY, V45, P1456, DOI 10.1109/18.771146; Tarokh V, 1998, IEEE T INFORM THEORY, V44, P744, DOI 10.1109/18.661517; Telatar E, 1999, EUR T TELECOMMUN, V10, P585, DOI 10.1002/ett.4460100604; Tirkkonen A, 2002, IEEE T INFORM THEORY, V48, P384, DOI 10.1109/18.978740; TROTTER HF, 1984, ADV MATH, V54, P67, DOI 10.1016/0001-8708(84)90037-9; Vishwanath S, 2003, IEEE T INFORM THEORY, V49, P2658, DOI 10.1109/TIT.2003.817421; Viswanath P, 2003, IEEE T INFORM THEORY, V49, P1912, DOI 10.1109/TIT.2003.814483; Vlok JD, 2012, IET COMMUN, V6, P1804, DOI 10.1049/iet-com.2011.0843; Vucetic B., 2003, SPACE TIME CODING; WACHTER KW, 1978, ANN PROBAB, V6, P1, DOI 10.1214/aop/1176995607; WIGNER EP, 1951, P CAMB PHILOS SOC, V47, P790, DOI 10.1017/S0305004100027237; WIGNER EP, 1955, ANN MATH, V62, P548, DOI 10.2307/1970079; WIGNER EP, 1958, ANN MATH, V67, P325, DOI 10.2307/1970008; Wishart J, 1928, BIOMETRIKA, V20A, P32, DOI 10.2307/2331939; Yuan JH, 2003, IEEE T COMMUN, V51, P1991, DOI 10.1109/TCOMM.2003.820741; Zanella A, 2008, PDF ITH LARGEST EIGE; Zanella A, 2009, IEEE T COMMUN, V57, P1050, DOI 10.1109/TCOMM.2009.04.070143	54	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222708	10.1371/journal.pone.0222708	http://dx.doi.org/10.1371/journal.pone.0222708			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557175	Green Published, gold			2022-12-27	WOS:000532345500029
J	Miller, AW; Reynolds, AC; Minton, MS				Miller, A. Whitman; Reynolds, Amanda C.; Minton, Mark S.			A spherical falling film gas-liquid equilibrator for rapid and continuous measurements of CO2 and other trace gases	PLOS ONE			English	Article							CARBON-DIOXIDE; SURFACE CONDENSATION; SYSTEMS; WATERS; SPECTROSCOPY; VARIABILITY; FLUXES; FLOW	Use of gas-liquid equilibrators to measure trace gases such as CO2, methane, and radon in water bodies is widespread. Such measurements are critical for understanding a variety of water quality issues such as acidification due to elevated CO2 or other processes related ecosystem metabolism and function. However, because gas-liquid equilibrators rely on generating sufficient surface area for gas exchange between liquid and gas phases, most traditional equilibrators pass water through small orifices or interstitial spaces that rapidly clog in highly productive or turbid waters, conditions that are common in estuaries, coastal bays, and riverine systems. Likewise, in cold temperatures, such equilibrators are subject to freezing. Both situations lead to failure and limit utility, especially for long term, continuous environmental monitoring. Here we describe and test a gas-liquid equilibrator that relies on a continuous falling film of water over a spherical surface to drive gas exchange. Our results demonstrate that this design is accurate in its ability to equilibrate fully to aqueous CO2 concentrations, is functional across a wide range of gas concentrations, and has a response time that is comparable with other equilibrator designs. Because this equilibrator uses free flowing, falling water to produce a surface for gas exchange, our field trials have shown it to be very resistant to clogging and freezing, and therefore well suited to long term deployment in highly productive waters like estuaries where CO2 concentrations fluctuate hourly, daily, and seasonally. When generated across a spherical surface, the falling film is not adversely affected by tilting off vertical, conditions that are common on a ship, small vessel, or buoy.	[Miller, A. Whitman; Reynolds, Amanda C.; Minton, Mark S.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Miller, AW (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	millerw@si.edu		Minton, Mark/0000-0002-9439-4930	Smithsonian Institution Endowment	Smithsonian Institution Endowment	This study was funded in part by the Smithsonian Institution Endowment (https://www.si.edu/) to AWM. No additional external funding was received for this study. The funder had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by funds from the Smithsonian Institution Endowment. We thank Patrick Megonigal, Anson Hines, and William Ball for their useful discussions and intellectual support. We thank William Ball, Joseph Ricigliano, and Alex Lowe for critically reviewing this manuscript prior to submission, and Melissa Hagan and Mary Strecker for figure illustration.	Abril G, 2006, SCI TOTAL ENVIRON, V354, P246, DOI 10.1016/j.scitotenv.2004.12.051; Abril G, 2014, NATURE, V505, P395, DOI 10.1038/nature12797; Awad MM, P INT WAT TECHN C IW, V1, P30; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; BRUMFIELD LK, 1976, J HEAT TRANS-T ASME, V98, P496, DOI 10.1115/1.3450582; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Carey V.P., 1992, LIQUID VAPOR PHASE C; Chen CTA, 2013, BIOGEOSCIENCES, V10, P6509, DOI 10.5194/bg-10-6509-2013; Crawford JT, 2015, ENVIRON SCI TECHNOL, V49, P442, DOI 10.1021/es504773x; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; Friedrichs G, 2010, LIMNOL OCEANOGR-METH, V8, P539, DOI 10.4319/lom.2010.8.539; Gulzow W, 2011, LIMNOL OCEANOGR-METH, V9, P176, DOI 10.4319/lom.2011.9.176; Hassan IA, 2015, J ADV RES FLUID MECH, V14, P14; Jafar F., 2007, 16 AUSTR FLUID MECH, P1193; Joesoef A, 2015, BIOGEOSCIENCES, V12, P6085, DOI 10.5194/bg-12-6085-2015; Johnson JE, 1999, ANAL CHIM ACTA, V395, P119, DOI 10.1016/S0003-2670(99)00361-X; Kortzinger A, 1996, MAR CHEM, V52, P133, DOI 10.1016/0304-4203(95)00083-6; Kortzinger A., 2009, METHODS SEAWATER ANA, P149; Kumar A, 2016, INT J ADV COMPUT SC, V7, P46; Li ZB, 2009, J PHYS CONF SER, V153, DOI 10.1088/1742-6596/153/1/012059; Licor.com, LI 7000 SPEC; Lowe AT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37764-4; Martin CR, 2017, ATMOS MEAS TECH, V10, P2383, DOI 10.5194/amt-10-2383-2017; MUDAWAR I, 1993, INT J HEAT MASS TRAN, V36, P3437, DOI 10.1016/0017-9310(93)90162-Y; Nusselt W, 1916, Z VER DTSCH ING, V60, P569; Nusselt W, 1916, Z VER DTSCH ING, V60, P541; POISSON A, 1993, J GEOPHYS RES-OCEANS, V98, P22759, DOI 10.1029/93JC02501; Ribatski G, 2005, INT J REFRIG, V28, P635, DOI 10.1016/j.ijrefrig.2004.12.002; Roberson J.A., 1988, HYDRAULIC ENG; Sabine CL, 1997, SURFACE WATER ATMOSP; Salisbury JE, 2008, ESTUAR COAST SHELF S, V77, P245, DOI 10.1016/j.ecss.2007.09.033; Santos IR, 2012, ENVIRON SCI TECHNOL, V46, P7685, DOI 10.1021/es301961b; Senseair.com, K30 3 SPEC; Takagi D, 2010, J FLUID MECH, V647, P221, DOI 10.1017/S0022112009993818; Wang ZA, 2016, LIMNOL OCEANOGR, V61, P1916, DOI 10.1002/lno.10347; Webb JR, 2016, LIMNOL OCEANOGR-METH, V14, P323, DOI 10.1002/lom3.10092; Yoon TK, 2016, BIOGEOSCIENCES, V13, P3915, DOI 10.5194/bg-13-3915-2016; Zhang XC, 2018, INT J LOW-CARBON TEC, V13, P424, DOI 10.1093/ijlct/cty042	39	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222303	10.1371/journal.pone.0222303	http://dx.doi.org/10.1371/journal.pone.0222303			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553777	Green Published, gold			2022-12-27	WOS:000532319200024
J	You, YY; Bai, C; Liu, XF; Xia, MH; Jia, T; Li, XG; Zhang, CL; Chen, YC; Zhao, SF; Wang, LQ; Wang, W; Yin, YQ; Xiu, YF; Niu, LL; Zhou, J; Ma, T; Du, Y; Liu, YH				You, Yuyan; Bai, Chao; Liu, Xuefeng; Xia, Maohua; Jia, Ting; Li, Xiaoguang; Zhang, Chenglin; Chen, Yucun; Zhao, Sufen; Wang, Liqin; Wang, Wei; Yin, Yanqiang; Xiu, Yunfang; Niu, Lili; Zhou, Jun; Ma, Tao; Du, Yang; Liu, Yanhui			Genome-wide analysis of methylation in giant pandas with cataract by methylation-dependent restriction-site associated DNA sequencing (MethylRAD)	PLOS ONE			English	Article							AGE-RELATED CATARACT; AILUROPODA-MELANOLEUCA; DENTAL ABNORMALITIES; GENE-EXPRESSION; POLYMORPHISMS; MARKERS; TOOL	The giant panda (Ailuropoda melanoleuca) is a native species to China. They are rare and endangered and are regarded as the 'national treasure' and 'living fossil' in China. For the time being, there are only about 2500 giant pandas in the world. Therefore, we still have to do much more efforts to protect the giant pandas. In captive wildlife, the cataract incidence of mammalian always increases with age. Currently, in China, the proportion of elderly giant pandas who suffering from cataract has reached 20%. The eye disorder thus has a strong influence on the physical health and life quality of the elderly giant pandas. To discover the genes associated with the pathogenesis of cataract in the elderly giant panda and achieve the goal of early assessment and diagnosis of cataract in giant pandas during aging, we performed whole genome methylation sequencing in 3 giant pandas with cataract and 3 healthy giant pandas using methylation-dependent restriction-site associated DNA sequencing (MethylRAD). In the present study, we obtained 3.62M reads, on average, for each sample, and identified 116 and 242 differentially methylated genes (DMGs) between the two groups under the context of CCGG and CCWGG on genome, respectively. Further KEGG and GO enrichment analyses determined a total of 110 DMGs that are involved in the biological functions associated with pathogenesis of cataract. Among them, 6 DMGs including EEA1, GARS, SLITRK4, GSTM3, CASP3, and EGLN3 have been linked with cataract in old age.	[You, Yuyan; Bai, Chao; Liu, Xuefeng; Jia, Ting; Zhang, Chenglin; Zhao, Sufen; Wang, Wei] Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China; [Xia, Maohua; Li, Xiaoguang; Ma, Tao; Du, Yang; Liu, Yanhui] Beijing Zoo, Beijing, Peoples R China; [Chen, Yucun; Xiu, Yunfang] Strait Fuzhou Giant Panda Res & Exchange Ctr, Fuzhou, Peoples R China; [Wang, Liqin; Niu, Lili] Chengdu Zoo, Chengdu, Peoples R China; [Yin, Yanqiang; Zhou, Jun] Chongqing Zoo, Chongqing, Peoples R China		You, YY (corresponding author), Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China.	youyy351@163.com	you, yuyan/AAL-3559-2021; Yin, Yanqiang/AAK-4749-2021; Zhang, Cheng/GRS-8698-2022		National Natural Science Foundation of China [NSFC 31872257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grant of the National Natural Science Foundation of China (NSFC 31872257).	Asbell PA, 2005, LANCET, V365, P599; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Charakidas A, 2005, EUR J OPHTHALMOL, V15, P213, DOI 10.1177/112067210501500206; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dor Y, 2018, LANCET, V392, P777, DOI 10.1016/S0140-6736(18)31268-6; DOSHNA CW, 2002, INVEST OPHTH VIS S1, V43; Galichanin K, 2012, EXP EYE RES, V97, P19, DOI 10.1016/j.exer.2012.02.003; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hasanova N, 2009, BRIT J OPHTHALMOL, V93, P1081, DOI 10.1136/bjo.2008.152272; Ho MC, 2010, J CLIN GERONTOL GERI, V1, P17, DOI 10.1016/j.jcgg.2010.10.006; Huang JY, 2015, INVEST OPHTH VIS SCI, V56; Jin Y, 2012, J COMP PATHOL, V146, P357, DOI 10.1016/j.jcpa.2011.08.001; Jin YP, 2015, J WILDLIFE DIS, V51, P849, DOI 10.7589/2014-12-289; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Li B, 2016, INVEST OPHTH VIS SCI, V57, P4721, DOI 10.1167/iovs.16-19242; Li BY, 2006, AGING CELL, V5, P187, DOI [10.1111/j.1474-9726, DOI 10.1111/J.1474-9726]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mou KH, 2017, J DERMATOL SCI, V85, P162, DOI 10.1016/j.jdermsci.2016.12.011; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shu X, 2018, DNA CELL BIOL, V37, P560, DOI 10.1089/dna.2018.4141; Tinaztepe OE, 2017, CURRENT EYE RES, V42, P1, DOI [10.1080/J.2415465, DOI 10.1080/J.2415465]; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uno H, 1997, AGE, V20, P1, DOI 10.1007/s11357-997-0001-5; Urfer SR, 2011, AGE, V33, P451, DOI 10.1007/s11357-010-9158-4; Wang S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150130; Wang Y, 2015, CURR EYE RES, V40, P815, DOI 10.3109/02713683.2014.957778; Xiao FH, 2016, BRIEF FUNCT GENOMICS, V15, P454, DOI 10.1093/bfgp/elw009; Zhang Y, 2011, MOL VIS, V17, P2325; Zhou P, 2012, FASEB J, V26, P4897, DOI 10.1096/fj.12-213702	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222292	10.1371/journal.pone.0222292	http://dx.doi.org/10.1371/journal.pone.0222292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553743	gold, Green Published			2022-12-27	WOS:000532319200023
J	Kim, MH; Mazenga, AC; Yu, XY; Simon, K; Nyasulu, P; Kazembe, PN; Kalua, T; Abrams, E; Ahmed, S				Kim, Maria H.; Mazenga, Alick C.; Yu, Xiaoying; Simon, Katie; Nyasulu, Phoebe; Kazembe, Peter N.; Kalua, Thokozani; Abrams, Elaine; Ahmed, Saeed			Factors associated with burnout amongst healthcare workers providing HIV care in Malawi	PLOS ONE			English	Article							QUADRUPLE AIM CARE; QUALITY-OF-CARE; PHYSICIAN BURNOUT; JOB-SATISFACTION; PROBLEM DRINKING; D PERSONALITY; SOUTH-AFRICA; STRESS; QUESTIONNAIRE; PERSPECTIVES	Context High rates of burnout have been reported in low and medium income countries and can detrimentally impact healthcare delivery. Understanding factors associated with burnout amongst health care workers providing HIV care may help develop interventions to prevent/treat burnout. Objectives We sought to understand factors associated with burnout amongst health care workers providing HIV care in Malawi. Methods This was a sub-study of a larger cross-sectional study measuring burnout prevalence amongst a convenience sample of healthcare workers providing HIV care in 89 health facilities in eight districts in Malawi. Burnout was measured using the Maslach Burnout Inventory. Anonymously administered surveys included questions about sociodemographics, work characteristics (work load, supervisor support, team interactions), depression, life stressors, assessment of type D personality, and career satisfaction. We performed univariable and multivariable regression analyses to explore associations between variables and burnout. Results We received 535 responses (response rate 99%). Factors associated with higher rates of burnout on multivariable regression analyses included individual level factors: male gender (OR 1.75 [CI 1.17, 2.63]; p = 0.007), marital status (widowed or divorced) (OR 3.24 [CI 1.32, 7.98]; p = 0.011), depression (OR 3.32 [CI 1.21, 9.10]; p = 0.020), type D personality type (OR 2.77 [CI 1.50, 5.12]; p = 0.001) as well as work related factors: working at a health center vs. a rural hospital (OR 2.02 [CI 1.19, 3.40]; p = 0.009); lack of a very supportive supervisor (OR 2.38 [CI 1.32, 4.29]; p = 0.004), dissatisfaction with work/team interaction (OR 1.76 [CI 1.17, 2.66]; p = 0.007), and career dissatisfaction (OR 0.76 [CI 0.60, 0.96]; p = 0.020). Conclusion This study identified several individual level vulnerabilities as well as work related modifiable factors. Improving the supervisory capacity of health facility managers and creating conditions for improved team dynamics may help reduce burnout amongst healthcare workers proving HIV care in Malawi.	[Kim, Maria H.; Mazenga, Alick C.; Simon, Katie; Nyasulu, Phoebe; Kazembe, Peter N.; Ahmed, Saeed] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Kim, Maria H.; Simon, Katie; Kazembe, Peter N.; Ahmed, Saeed] Texas Childrens Hosp, Baylor Coll Med, Int Paediat AIDS Initiat, Houston, TX 77030 USA; [Yu, Xiaoying] Univ Texas Med Branch, Galveston, TX 77555 USA; [Kalua, Thokozani] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Abrams, Elaine] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Abrams, Elaine] Columbia Univ, Coll Phys & Surg, New York, NY USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Columbia University; Columbia University	Kim, MH (corresponding author), Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi.; Kim, MH (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Int Paediat AIDS Initiat, Houston, TX 77030 USA.	mhkim@bcm.edu		Yu, Xiaoying/0000-0003-1659-2365; Simon, Katherine/0000-0001-9232-2653; Kalua, Thokozani/0000-0001-7384-9011	Fogarty International Center of the National Institutes of Health [K01 TW009644];  [674-A-00-10-00093-00]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was made possible through USAID cooperative agreement number 674-A-00-10-00093-00. M.H.K. was supported by the Fogarty International Center of the National Institutes of Health under award number K01 TW009644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2005, J AFFECT DISORDERS, V88, P55, DOI 10.1016/j.jad.2005.06.004; [Anonymous], 2018, MAL MIN HLTH INT HIV; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Armon G, 2014, PERS INDIV DIFFER, V58, P112, DOI 10.1016/j.paid.2013.10.020; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Berman A, 2003, DRUG USE DISORDERS I, DOI [10.1348/135910709X479069, DOI 10.1348/135910709X479069]; Beusenberg M, 1994, USERS GUIDE SELF REP; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Canadas-De la Fuente GA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102102; Chikaphupha KR, 2016, MALAWI MED J, V28, P37, DOI 10.4314/mmj.v28i2.2; Chimwaza W, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-17; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; Coetzee SK, 2013, INT J NURS STUD, V50, P162, DOI 10.1016/j.ijnurstu.2012.11.002; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Dieleman M, 2007, HEALTH POLICY PLANN, V22, P139, DOI 10.1093/heapol/czm006; Dugani S., 2018, GATES OPEN RES, V2, P4, DOI [DOI 10.12688/gatesopenres.12779.3, DOI 10.12688/gatesopenres.12779.1]; Epstein RM, 2016, LANCET, V388, P2216, DOI 10.1016/S0140-6736(16)31332-0; Gorgens-Ekermans G, 2012, J CLIN NURS, V21, P2275, DOI 10.1111/j.1365-2702.2012.04171.x; Guidroz AM, 2012, STRESS HEALTH, V28, P69, DOI 10.1002/smi.1405; Hana J, 2012, MALAWI MED J, V24, P46; Salvagioni DAJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185781; Jordaan I, 2007, S AFR J PSYCHOL, V37, P835, DOI 10.1177/008124630703700411; Khamisa N, 2015, INT J ENV RES PUB HE, V12, P652, DOI 10.3390/ijerph120100652; Kim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192983; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kruse GR, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-55; Lasebikan Victor Olufolahan, 2012, ISRN Nurs, V2012, P402157, DOI 10.5402/2012/402157; Leiter M P, 1999, J Health Hum Serv Adm, V21, P472; Llorent VJ, 2016, CIENC SAUDE COLETIVA, V21, P3286, DOI 10.1590/1413-812320152110.00732015; Manafa O, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-65; Marcelino G, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001050; Maslach C., 1997, EVALUATING STRESS BO, P191; McAuliffe E, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-13; Muula AS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-97; Olley B O, 2003, Afr J Med Med Sci, V32, P297; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Perry L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084215; Pienaar J, 2006, S AFR J EDUC, V26, P541; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Polman R, 2010, BRIT J HEALTH PSYCH, V15, P681, DOI 10.1348/135910709X479069; Ramirez-Baena L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010092; Rothmann S, 2007, S AFR J PSYCHOL, V37, P135, DOI 10.1177/008124630703700110; Salyers MP, 2017, J GEN INTERN MED, V32, P475, DOI 10.1007/s11606-016-3886-9; Schmiedeknecht K, 2015, GLOB HEALTH-SCI PRAC, V3, P85, DOI 10.9745/GHSP-D-14-00170; Seo HS, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016008; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Sikka R, 2015, BMJ QUAL SAF, V24, P608, DOI 10.1136/bmjqs-2015-004160; Smith HK, 2012, TESTING WORK CHARACT; Spector Paul E, 1998, J Occup Health Psychol, V3, P356, DOI 10.1037/1076-8998.3.4.356; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Suner-Soler R., 2014, BURN RES, V1, P82, DOI [DOI 10.1016/J.BURN.2014.07.004, 10.1016/j.burn.2014.07.004]; Tekin A, 2017, ARCH ENVIRON OCCUP H, V72, P173, DOI 10.1080/19338244.2016.1179168; Thorsen VC, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-9; UNICEF, 2017, 2017 18 HLTH BUDG BR; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396; World Health Organization, 2022, GLOBAL HLTH EXPENDIT; Zverev Y, 2008, COLLEGIUM ANTROPOL, V32, P27	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222638	10.1371/journal.pone.0222638	http://dx.doi.org/10.1371/journal.pone.0222638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550281	Green Published, gold			2022-12-27	WOS:000532307700021
J	Diray-Arce, J; Knowles, A; Suvorov, A; O'Brien, J; Hansen, C; Bybee, SM; Gul, B; Khan, MA; Nielsen, BL				Diray-Arce, Joann; Knowles, Alisa; Suvorov, Anton; O'Brien, Jacob; Hansen, Collin; Bybee, Seth M.; Gul, Bilquees; Khan, M. Ajmal; Nielsen, Brent L.			Identification and evolutionary characterization of salt-responsive transcription factors in the succulent halophyte Suaeda fruticosa	PLOS ONE			English	Article							MADS-BOX GENE; TOLERANCE; STRESS; ARABIDOPSIS; ACID; MYB; DIVERGENCE; INSIGHTS; FAMILY; BHLH	Transcription factors are key regulatory elements that affect gene expression in response to specific signals, including environmental stresses such as salinity. Halophytes are specialized plants that have the ability to complete their life cycle in saline environments. In this study we have identified and characterized the evolutionary relationships of putative transcription factors (TF) in an obligate succulent halophyte, Suaeda fruticosa, that are involved in conferring salt tolerance. Using RNA-seq data we have analyzed the expression patterns of certain TF families, predicted protein-protein interactions, and analyzed evolutionary trajectories to elucidate their possible roles in salt tolerance. We have detected the top differentially expressed (DE) transcription factor families (MYB, CAMTA, MADS-box and bZIP) that show the most pronounced response to salinity. The majority of DE genes in the four afore-mentioned TF families cluster together on TF phylogenetic trees, which suggests common evolutionary origins and trajectories. This research represents the first comprehensive TF study of a leaf succulent halophyte including their evolutionary relationships with TFs in other halophyte and salt-senstive plants. These findings provide a foundation for understanding the function of salt-responsive transcription factors in salt tolerance and associated gene regulation in plants.	[Diray-Arce, Joann; Knowles, Alisa; O'Brien, Jacob; Hansen, Collin; Nielsen, Brent L.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Suvorov, Anton; Bybee, Seth M.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Gul, Bilquees; Khan, M. Ajmal] Univ Karachi, Inst Sustainable Halophyte Utilizat, Karachi, Pakistan	Brigham Young University; Brigham Young University; University of Karachi	Nielsen, BL (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brentnielsen@byu.edu	Suvorov, Anton/AAB-1774-2019	Suvorov, Anton/0000-0003-3898-9195; Arce, Joann Diray/0000-0003-2183-4269; Nielsen, Brent/0000-0001-6300-4816	Pakistan-US Science and Technology Cooperation Program (US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan); Department of Microbiology and Molecular Biology at Brigham Young University; Brigham Young University [2014]; Office of Research and Creative Activities, Brigham Young University [2016]	Pakistan-US Science and Technology Cooperation Program (US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan); Department of Microbiology and Molecular Biology at Brigham Young University; Brigham Young University; Office of Research and Creative Activities, Brigham Young University	This research has been supported by a grant from the Pakistan-US Science and Technology Cooperation Program (http://sites.nationalacademies.org/PGA/Pakistan/index.htm; Phase 4 project jointly funded by the US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan to BLN, BG and MAK), by the Department of Microbiology and Molecular Biology at Brigham Young University (to BLN), Brigham Young University (grant number 2014 to JDA), and by the Office of Research and Creative Activities, Brigham Young University (grant number 2016 to BLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Anwer MU, 2014, ELIFE, V3, DOI 10.7554/eLife.02206; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Babitha KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn G, 2014, PLANT J, V80, P82, DOI 10.1111/tpj.12620; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Diray-Arce J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1553-x; DIRAYARCE J, 2016, HALOPHYTES FOOD SECU, P157; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Ganesan G, 2012, J EXP BOT, V63, P4549, DOI 10.1093/jxb/ers135; Ghanekar Ruchi, 2008, Int J Plant Genomics, V2008, P451327, DOI 10.1155/2008/451327; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Haddad F, 2010, METHODS MOL BIOL, V630, P261, DOI 10.1007/978-1-60761-629-0_17; Hameed A, 2012, ACTA PHYSIOL PLANT, V34, P2331, DOI 10.1007/s11738-012-1035-6; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang Y, 2012, J INTEGR PLANT BIOL, V54, P616, DOI 10.1111/j.1744-7909.2012.01149.x; Jin HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150504; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lee S, 2008, PLANT PHYSIOL, V147, P156, DOI 10.1104/pp.107.114256; Liang CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35040; Long YC, 2015, J EXP BOT, V66, P1133, DOI 10.1093/jxb/eru548; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mishra A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00829; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Rahman H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00177; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohini G, 2014, DNA RES, V21, P69, DOI 10.1093/dnares/dst042; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Sharma R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126783; Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toda Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26256; Wang WQ, 2016, J INTEGR PLANT BIOL, V58, P91, DOI 10.1111/jipb.12369; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang TB, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-19; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zhou XF, 2009, PLANT J, V60, P79, DOI 10.1111/j.1365-313X.2009.03931.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	56	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222940	10.1371/journal.pone.0222940	http://dx.doi.org/10.1371/journal.pone.0222940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545841	Green Published, gold			2022-12-27	WOS:000532303200043
J	Robbins, CJ; Allen, HA; Miller, KA; Chapman, P				Robbins, Chloe J.; Allen, Harriet A.; Miller, Karl A.; Chapman, Peter			The 'Saw but Forgot' error: A role for short-term memory failures in understanding junction crashes?	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; SITUATION AWARENESS; WORKING-MEMORY; INATTENTIONAL BLINDNESS; RUTTING MITIGATION; MOTORCYCLES; PERCEPTION; KNOWLEDGE; LOOKING; SEARCH	Motorcyclists are involved in an exceptionally high number of crashes for the distance they travel, with one of the most common incidents being where another road user pulls out into the path of an oncoming motorcycle frequently resulting in a fatal collision. These instances have previously been interpreted as failures of visual attention, sometimes termed 'Look but Fail to See' (LBFTS) crashes, and interventions have focused on improving drivers' visual scanning and motorcycles' visibility. Here we show from a series of three experiments in a high-fidelity driving simulator, that when drivers' visual attention towards and memory for approaching vehicles is experimentally tested, drivers fail to report approaching motorcycles on between 13% and 18% of occasions. This happens even when the driver is pulling out into a safety-critical gap in front of the motorcycle, and often happens despite the driver having directly fixated on the oncoming vehicle. These failures in reporting a critical vehicle were not associated with how long the driver looked at the vehicle for, but were associated with drivers' subsequent visual search and the time that elapsed between fixating on the oncoming vehicle and pulling out of the junction. Here, we raise the possibility that interference in short-term memory might prevent drivers holding important visual information during these complex manoeuvres. This explanation suggests that some junction crashes on real roads that have been attributed to LBFTS errors may have been misclassified and might instead be the result of `Saw but Forgot' (SBF) errors. We provide a framework for understanding the role of short-term memory in such situations, the Perceive Retain Choose (PRC) model, as well as novel predictions and proposals for practical interventions that may prevent this type of crash in the future.	[Robbins, Chloe J.; Allen, Harriet A.; Miller, Karl A.; Chapman, Peter] Univ Nottingham, Sch Psychol, Nottingham, England; [Robbins, Chloe J.] Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England	University of Nottingham; University of Sheffield	Robbins, CJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.; Robbins, CJ (corresponding author), Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England.	chloe.robbins@nottingham.ac.uk		Chapman, Peter/0000-0002-3891-4241; Miller, Karl/0000-0003-3284-8789	Economic and Social Research Council [ES/J500100/1]; ESRC	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the Economic and Social Research Council [grant number ES/J500100/1], an ESRC post-graduate studentship to Chloe Robbins. The funders played no role in the study design, data collection, analysis, decision to publish or the preparation of the manuscript.	ACEM, 2004, 12 ACEM; ADAMS MJ, 1995, HUM FACTORS, V37, P85, DOI 10.1518/001872095779049462; Amin Harsh Jigishbhai, 2015, J. Transp. Lit., V9, P5, DOI 10.1590/2238-1031.jtl.v9n3a1; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1986, WORKING MEMORY OXFOR; Baddeley A, 2012, J COGN PSYCHOL, V24, P6, DOI 10.1080/20445911.2011.613820; Brendel E, 2014, EXP BRAIN RES, V232, P2337, DOI 10.1007/s00221-014-3930-0; Brilon W, 1999, TRANSPORT RES A-POL, V33, P161, DOI 10.1016/S0965-8564(98)00048-2; Brown ID, 2002, BEHAV RES ROAD SAFET; Clarke DD, 2007, ACCIDENT ANAL PREV, V39, P974, DOI 10.1016/j.aap.2007.01.002; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; DeLucia PR, 2013, CURR DIR PSYCHOL SCI, V22, P199, DOI 10.1177/0963721412471679; Department for Transport, 2014, FREE FLOW VEHICLE SP; Department for Transport, 2018, REP ROAD CAS GREAT B; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; Endsley Mica R, 1988, P HUMAN FACTORS SOC, P97; ENDSLEY MR, 1995, HUM FACTORS, V37, P65, DOI 10.1518/001872095779049499; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; FAGOT C, 1995, J EXP PSYCHOL HUMAN, V21, P275, DOI 10.1037/0096-1523.21.2.275; Faul F., 1992, GPOWER PRIORI POSTHO; Fleck MS, 2010, J EXP PSYCHOL-APPL, V16, P60, DOI 10.1037/a0018629; Gaunet F, 2001, COGNITIVE BRAIN RES, V11, P409, DOI 10.1016/S0926-6410(01)00013-1; Groeger J.A., 2002, P AUSTRALASIAN ROAD, P75; Gugerty LJ, 1997, J EXP PSYCHOL-APPL, V3, P42, DOI 10.1037/1076-898X.3.1.42; Hardiess G, 2008, J VISION, V8, DOI 10.1167/8.1.7; Hole GJ, 1996, ERGONOMICS, V39, P946, DOI 10.1080/00140139608964516; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Hurt H., 1981, DOTHS501160 NHTSA US, V1; Iskander J, 2018, ANN IEEE SYST CONF, P482; Johannsdottir KR, 2010, HUM FACTORS, V52, P663, DOI 10.1177/0018720810385427; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; Levin DT, 2000, VIS COGN, V7, P397, DOI 10.1080/135062800394865; Liu DW, 2017, COMMUN NONLINEAR SCI, V47, P139, DOI 10.1016/j.cnsns.2016.11.007; Mack A, 2003, CURR DIR PSYCHOL SCI, V12, P180, DOI 10.1111/1467-8721.01256; Mahon A, 2018, ATTEN PERCEPT PSYCHO, V80, P1691, DOI 10.3758/s13414-018-1553-4; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; National Highway Traffic Safety Administration, 2018, 2017 FAT MOT VEH CRA; Pammer K, 2018, HUM FACTORS, V60, P5, DOI 10.1177/0018720817733901; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; Robbins CJ, 2018, TRANSPORT RES F-TRAF, V58, P944, DOI 10.1016/j.trf.2018.07.023; Robbins CJ, 2018, HUM FACTORS, V60, P889, DOI 10.1177/0018720818778960; Sandamas G, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015595443; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Simons DJ, 2009, PSYCHON B REV, V16, P398, DOI 10.3758/PBR.16.2.398; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; The MathWorks Inc, 2012, MATLAB STAT TOOLB RE; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; World Health Organization, 2021, GLOBAL STATUS REPORT; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	54	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222905	10.1371/journal.pone.0222905	http://dx.doi.org/10.1371/journal.pone.0222905			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545850	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000532303200040
J	Chau, Y; Li, FS; Levsh, O; Weng, JK				Chau, Yasmin; Li, Fu-Shuang; Levsh, Olesya; Weng, Jing-Ke			Exploration of icariin analog structure space reveals key features driving potent inhibition of human phosphodiesterase-5	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; IN-VITRO; SELECTIVITY; VARDENAFIL; EXPRESSION; COMPLEX; ASSAY; PDE5	The natural product icariin inhibits human phosphodiesterase-5 (PDE5) and represents a unique pharmacophore for treating erectile dysfunction, pulmonary hypertension, and other diseases. In this study, we explore the available icariin-derived chemical scaffolds through medicinal chemistry to develop novel icariin PDE5 inhibitors with improved potency and specificity. We synthesized six novel semi-synthetic icariin analogs as well as three naturally occurring icariin analogs, and characterized the structure-activity relationship in the context of human PDE5 inhibition using in vitro enzyme inhibition and kinetics assays and molecular modeling. Mammalian-cell-based assays and in vitro enzyme inhibition assays against human PDE6C further helped to identify the most potent and selective icariin analogs. Our results reveal the synergistic contribution of functional groups at the C3 and C7 positions of the icariin backbone towards PDE5 inhibition. Whereas a hydrophobic and flexible alkanol group at the C7 position is sufficient to enhance icariin analog potency, combining this group with a hydrophilic sugar group at the C3 position leads to further enhancement of potency and promotes specificity towards PDE5 versus PDE6C. In particular, compounds 3 and 7 exhibit Ki values of 0.036 +/- 0.005 mu M and 0.036 +/- 0.007 mu M towards PDE5 respectively, which are approaching those of commercial PDE5 inhibitors, and can effectively reduce GMP levels in cultured human BJ-hTERT cells. This study identifies novel icariin analogs as potent and selective PDE5 inhibitors poised to become lead compounds for further pharmaceutical development.	[Chau, Yasmin; Li, Fu-Shuang; Levsh, Olesya; Weng, Jing-Ke] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chau, Yasmin; Levsh, Olesya; Weng, Jing-Ke] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Weng, JK (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weng, JK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wengj@wi.mit.edu			Pew Scholars Program in the Biomedical Sciences [27345]; Searle Scholars Program [15-SSP-162]	Pew Scholars Program in the Biomedical Sciences; Searle Scholars Program	This work was supported by the Pew Scholars Program in the Biomedical Sciences to J.K.W. (grant number 27345), https://www.pewtrusts.org/, and the Searle Scholars Program to J.K.W. (grant number 15-SSP-162), https://www.searlescholars.net/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luke Whitesell for helpful discussion. This work was supported by the Pew Scholars Program in the Biomedical Sciences (grant number 27345), and the Searle Scholars Program (grant number 15-SSP-162).	Ahmad F, 2015, ORAL DIS, V21, pE25, DOI 10.1111/odi.12275; Aldrich C, 2017, ACS MED CHEM LETT, V8, P379, DOI 10.1021/acsmedchemlett.7b00056; Bisswanger H., 2012, PRACTICAL ENZYMOLOGY; Dell'Agli M, 2005, J AGR FOOD CHEM, V53, P1960, DOI 10.1021/jf048497+; Dell'Agli M, 2008, J NAT PROD, V71, P1513, DOI 10.1021/np800049y; Eardley I, 2002, BRIT J CLIN PHARMACO, V53, p61S, DOI 10.1046/j.0306-5251.2001.00034.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francis SH, 2010, HDB CELL SIGNALING, P1439; Friebe A, 2017, N-S ARCH PHARMACOL, V390, P1177, DOI 10.1007/s00210-017-1429-5; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; Li FS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.109; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Ma HP, 2011, J ETHNOPHARMACOL, V134, P519, DOI 10.1016/j.jep.2011.01.001; Mehrotra N, 2007, INT J IMPOT RES, V19, P253, DOI 10.1038/sj.ijir.3901522; Mostafa T, 2017, SEX MED REV, V5, P170, DOI 10.1016/j.sxmr.2016.02.004; Ning HX, 2006, UROLOGY, V68, P1350, DOI 10.1016/j.urology.2006.09.031; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; de Tejada IS, 2006, EUR UROL, V50, P901, DOI 10.1016/j.eururo.2006.07.041; Shang NN, 2014, BIOCHEM PHARMACOL, V89, P86, DOI 10.1016/j.bcp.2014.02.013; Shen Jingshan, 2008, World Patent, Patent No. [2008014722A1, 2008014722]; Surapisitchat J, 2009, HDB CELL SIGNALING, P1409; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wright PJ, 2006, INT J CLIN PRACT, V60, P967, DOI 10.1111/j.1742-1241.2006.01049.x; Wu H, 2003, PROG DRUG RES, V60, P1; Xin ZC, 2003, ASIAN J ANDROL, V5, P15; Xin ZC, 2001, CHINESE SCI BULL, V46, P1186, DOI 10.1007/BF02900599; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	36	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222803	10.1371/journal.pone.0222803	http://dx.doi.org/10.1371/journal.pone.0222803			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539416	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900030
J	Ortiz-Ceballos, AI; Ortiz-Gamino, D; Andrade-Torres, A; Perez-Rodriguez, P; Lopez-Ortega, M				Ortiz-Ceballos, Angel, I; Ortiz-Gamino, Diana; Andrade-Torres, Antonio; Perez-Rodriguez, Paulino; Lopez-Ortega, Maurilio			Pontoscolex corethrurus: A homeless invasive tropical earthworm?	PLOS ONE			English	Article							NICHE CONSTRUCTION; NATIVE EARTHWORMS; TERRA PRETA; SOIL; BACTERIA; FOREST; GLOSSOSCOLECIDAE; GUT; BIODIVERSITY; CONSEQUENCES	The presence of earthworm species in crop fields is as old as agriculture itself. The earthworms Pontoscolex corethrurus (invasive) and Balanteodrilus pearsei (native) are associated with the emergence of agriculture and sedentism in the region Amazon and Maya, respectively. Both species have shifted their preference from their natural habitat to the cropland niche. They contrast in terms of intensification of agricultural land use (anthropic impact to the symbiotic soil microbiome). P. corethrurus inhabits conventional agroecosystems, while B. pearsei thrives in traditional agroecosystems, i.e., P. corethrurus has not yet been recorded in soils where B. pearsei dwells. The demographic behavior of these two earthworm species was assessed in the laboratory over 100 days, according to their origin (OE; P. corethrurus and B. pearsei) food quality (FQ; soil only, maize stubble, Mucuna pruriens), and soil moisture (SM; 25, 33, 42%). The results showed that OE, FQ, SM, and the OE x FQ interaction were highly significant for the survival, growth, and reproduction of earthworms. P. corethrurus showed a lower survival rate (> mortality). P. corethrurus survivors fed a diet of low-to-intermediate nutritional quality (soil and stubble maize, respectively) showed a greater capacity to grow and reproduce; however, it was surpassed by the native earthworm when fed a high-quality diet (M. pruriens). Besides, P. corethrurus displayed a low cocoon hatching (emergence of juveniles). These results suggest that the presence of the invasive species was associated with a negative interaction with the soil microbiota where the native species dwells, and with the absence of natural mutualistic bacteria (gut, nephridia, and cocoons). These results are consistent with the absence of P. corethrurus in milpa and pasture-type agricultural niches managed by peasants (agroecologists) to grow food regularly through biological soil management. Results reported here suggest that P. corethrurus is an invasive species that is neither wild nor domesticated, that is, its eco-evolutionary phylogeny needs to be derived based on its symbionts.	[Ortiz-Ceballos, Angel, I; Ortiz-Gamino, Diana; Andrade-Torres, Antonio; Lopez-Ortega, Maurilio] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Perez-Rodriguez, Paulino] Colegio Postgrad, Programa Estadist, Campus Montecillo, Montecillo, Estado De Mexic, Mexico	Universidad Veracruzana; Colegio de Postgraduados - Mexico	Ortiz-Ceballos, AI (corresponding author), Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico.	angortiz@uv.mx	Andrade-Torres, Antonio/A-7661-2011; Andrade-Torres, Antonio/GPS-7285-2022; Lopez, Maurilio/AAM-9557-2021; Ortiz-Ceballos, Angel I./A-5780-2011	Andrade-Torres, Antonio/0000-0001-9387-0483; Lopez, Maurilio/0000-0001-6484-1798; Ortiz-Ceballos, Angel I./0000-0001-8700-4503; Perez-Rodriguez, Paulino/0000-0002-3202-1784; Ortiz Gamino, Diana/0000-0002-5062-8440				Aira M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25081-9; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Blakemore RJ, 2009, ANNELIDS IN MODERN BIOLOGY, P254; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Brussaard L, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P201; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Daane LL, 1999, APPL ENVIRON MICROB, V65, P2376; Davidson SK, 2013, MOL PHYLOGENET EVOL, V67, P188, DOI 10.1016/j.ympev.2012.12.005; Davidson SK, 2006, APPL ENVIRON MICROB, V72, P769, DOI 10.1128/AEM.72.1.769-775.2006; de Menezes AB, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy051; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Dupont L, 2012, EUR J SOIL BIOL, V53, P70, DOI 10.1016/j.ejsobi.2012.09.001; Fernandez Marchan Daniel, 2018, European Journal of Soil Biology, V86, P49, DOI 10.1016/j.ejsobi.2018.03.004; Ford A, 2009, J ETHNOBIOL, V29, P213, DOI 10.2993/0278-0771-29.2.213; Fragoso C, 2016, APPL SOIL ECOL, V104, P116, DOI 10.1016/j.apsoil.2015.12.005; Fragoso GC, 2018, IMPORTANCIA LOMBRICE, DOI [10.15468/omvnpi, DOI 10.15468/OMVNPI]; Fuller DQ, 2017, ARCHAEOL INT, V20, P110, DOI 10.5334/ai-359; Fuller DQ, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P304; GILOTVILLENAVE C, 1994, EUR J SOIL BIOL, V30, P125; Glaser B, 2000, ORG GEOCHEM, V31, P669, DOI 10.1016/S0146-6380(00)00044-9; Gong X, 2018, SOIL BIOL BIOCHEM, V121, P120, DOI 10.1016/j.soilbio.2018.03.011; Han G, 2017, ACTA GEOL SIN-ENGL, V91, P1, DOI 10.1111/1755-6724.13059; Huerta E, 2006, CARIBB J SCI, V42, P359; Ikeda H, 2018, ECOL EVOL, V8, P1726, DOI 10.1002/ece3.3777; James SW, 2019, ZOOTAXA, V4545, P124, DOI 10.11646/zootaxa.4545.1.7; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Kowarik I., 2008, URBAN ECOLOGY INT PE, P321, DOI DOI 10.1007/978-0-387-73412-5_20; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LAVELLE P, 1987, BIOL FERT SOILS, V5, P188, DOI 10.1007/BF00256899; Lavelle P., 1981, I ECOLOGIA PUBLICATI, V6, P75; Leon YS, 2004, PEDOBIOLOGIA, V48, P215, DOI 10.1016/j.pedobi.2003.12.006; Levi C., 2018, FRONT ECOL EVOL, V5, P171, DOI [DOI 10.1111/geb.12364, 10.3389/fevo.2017.00171, DOI 10.3389/fevo.2017.00171]; Lima HN, 2002, GEODERMA, V110, P1, DOI 10.1016/S0016-7061(02)00141-6; Liu DF, 2018, SYMBIOSIS, V74, P21, DOI 10.1007/s13199-017-0491-6; Lobe JW, 2014, APPL SOIL ECOL, V83, P133, DOI 10.1016/j.apsoil.2014.03.020; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lund MB, 2010, ENVIRON MICROBIOL, V12, P2142, DOI 10.1111/j.1462-2920.2009.02084.x; Lund MB, 2010, APPL ENVIRON MICROB, V76, P4738, DOI 10.1128/AEM.00108-10; Marichal R, 2010, APPL SOIL ECOL, V46, P443, DOI 10.1016/j.apsoil.2010.09.001; McNeil CL, 2012, QUATERN INT, V249, P19, DOI 10.1016/j.quaint.2011.06.055; Mercuri AM, 2018, NAT PLANTS, V4, P71, DOI 10.1038/s41477-017-0098-1; Moller P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00529; Muller F., 1857, J NAT HIST 2, V20, P13, DOI 10.1080/00222935709487865; Nackley LL, 2017, TRENDS ECOL EVOL, V32, P814, DOI 10.1016/j.tree.2017.08.003; Nozaki M, 2009, SOIL BIOL BIOCHEM, V41, P762, DOI 10.1016/j.soilbio.2009.01.016; Orell T., 2019, NMNH EXTANT SPECIMEN, DOI [10.15468/hnhrg3, DOI 10.15468/HNHRG3]; Ortiz-Ceballos AI, 2005, PEDOBIOLOGIA, V49, P89, DOI 10.1016/j.pedobi.2004.08.006; Ortiz-Ceballos AI, 2004, BIOL FERT SOILS, V39, P438, DOI 10.1007/s00374-004-0732-8; Ortiz-Ceballos AI, 2016, PEERJ, V4, DOI 10.7717/peerj.2032; Ortiz-Gamino D, 2016, PEERJ, V4, DOI 10.7717/peerj.2572; Park IY, 2017, DEV COMP IMMUNOL, V67, P476, DOI 10.1016/j.dci.2016.09.003; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Plaas E, 2019, ECOL ECON, V159, P291, DOI 10.1016/j.ecolecon.2019.02.003; Ponesakki V, 2017, GENOM DATA, V14, P91, DOI 10.1016/j.gdata.2017.10.002; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; RIGHI G, 1984, STUD NEOTROP FAUNA E, V19, P159, DOI 10.1080/01650528409360653; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schaefer CEGR, 2004, AUST J SOIL RES, V42, P401, DOI 10.1071/SR03106; Schramm A, 2003, ENVIRON MICROBIOL, V5, P804, DOI 10.1046/j.1462-2920.2003.00474.x; Schult N, 2016, INVERTEBR BIOL, V135, P314, DOI 10.1111/ivb.12145; Shweta M., 2012, INT J SCI RES PUBL, V2, P1; Simmons W, 2015, PEDOBIOLOGIA, V58, P153, DOI 10.1016/j.pedobi.2015.05.001; Stitzer MC, 2018, NEW PHYTOL, V220, P395, DOI 10.1111/nph.15350; Taheri S, 2018, MOL PHYLOGENET EVOL, V124, P60, DOI 10.1016/j.ympev.2018.02.021; Taheri S, 2018, SOIL BIOL BIOCHEM, V116, P277, DOI 10.1016/j.soilbio.2017.10.030; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Topoliantz S, 2005, APPL SOIL ECOL, V28, P217, DOI 10.1016/j.apsoil.2004.08.003; Ueda M, 2014, CARBOHYD POLYM, V101, P511, DOI 10.1016/j.carbpol.2013.09.057; Uvarov AV, 2009, PEDOBIOLOGIA, V53, P1, DOI 10.1016/j.pedobi.2009.05.001; Vestergard M, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv025; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Watling J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199868; Willcox G., 2012, COMPANION ARCHAEOLOG, P161, DOI 10.1002/; ZACHMANN JE, 1993, APPL ENVIRON MICROB, V59, P1904, DOI 10.1128/AEM.59.6.1904-1910.1993	78	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222337	10.1371/journal.pone.0222337	http://dx.doi.org/10.1371/journal.pone.0222337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539381	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900009
J	Shimoyama, S; Furukawa, T; Ogata, Y; Nikaido, Y; Koga, K; Sakamoto, Y; Ueno, S; Nakamura, K				Shimoyama, Shuji; Furukawa, Tomonori; Ogata, Yoshiki; Nikaido, Yoshikazu; Koga, Kohei; Sakamoto, Yui; Ueno, Shinya; Nakamura, Kazuhiko			Lipopolysaccharide induces mouse translocator protein (18 kDa) expression via the AP-1 complex in the microglial cell line, BV-2	PLOS ONE			English	Article							BENZODIAZEPINE BINDING-SITES; ACTIVATION; SP1; TRANSCRIPTION; RECEPTOR; CHOLESTEROL; INHIBITOR; PATHWAYS; PROMOTER; INJURY	It has been reported that neuroinflammation occurs in the central nervous system (CNS) in patients with neuropathic pain, Alzheimer's disease and autism spectrum disorder. The 18-kDa translocator protein TSPO is used as an imaging target in positron emission tomography to detect neuroinflammation, and its expression is correlated with microglial activation. However, the mechanism underlying the transcriptional regulation of Tspo induced by inflammation is not clear. Here, we revealed that lipopolysaccharide (LPS) -induced Tspo expression was activated by the AP-1 complex in a mouse microglial cell line, BV-2. Knock-down of c-Fos and c-Jun, the components of AP-1, reduced LPS-induced Tspo expression. Furthermore, the enrichment of Sp1 in the proximal promoter region of Tspo was increased in the presence of LPS. In addition, the binding of histone deacetylase 1 (HDAC1) to the enhancer region, which contains the AP-1 site, was decreased by LPS treatment, but there were no significant differences in HDAC1 binding to the proximal promoter region with or without LPS. These results indicated that HDAC1 is involved not in the proximal promoter region but in the enhancer region. Our study revealed that inflammatory signals induce the recruitment of AP -1 to the enhancer region and Sp1 to the proximal promoter region of the Tspo gene and that Sp1 may regulate the basal expression of Tspo.	[Shimoyama, Shuji; Ueno, Shinya; Nakamura, Kazuhiko] Hirosaki Univ, Grad Sch Med, Res Ctr Child Mental Dev, Hirosaki, Aomori, Japan; [Shimoyama, Shuji; Furukawa, Tomonori; Ogata, Yoshiki; Nikaido, Yoshikazu; Koga, Kohei; Ueno, Shinya] Hirosaki Univ, Grad Sch Med, Dept Neurophysiol, Hirosaki, Aomori, Japan; [Sakamoto, Yui; Nakamura, Kazuhiko] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Nikaido, Yoshikazu] Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori, Japan; [Koga, Kohei] Hyogo Coll Med, Dept Neurophysiol, Nishinomiya, Hyogo, Japan	Hirosaki University; Hirosaki University; Hirosaki University; Hirosaki University; Hyogo College of Medicine	Nakamura, K (corresponding author), Hirosaki Univ, Grad Sch Med, Res Ctr Child Mental Dev, Hirosaki, Aomori, Japan.; Nakamura, K (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	nakakazu@hirosaki-u.ac.jp		Shimoyama, Shuji/0000-0001-6777-0438	Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists; Hirosaki University Institutional Research Grant [18K08846]	Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists; Hirosaki University Institutional Research Grant	This work was supported by Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists (to SS), Hirosaki University Institutional Research Grant (to SU and KN) and Grants-in-Aid for Scientific Research (C) #18K08846 (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BEE, 1992, BIOCHEM PHARMACOL, V44, P269, DOI 10.1016/0006-2952(92)90009-8; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Batarseh A, 2012, BBA-GENE REGUL MECH, V1819, P38, DOI 10.1016/j.bbagrm.2011.09.001; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; CHARBONNEAU P, 1986, CIRCULATION, V73, P476, DOI 10.1161/01.CIR.73.3.476; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Donnell SLO, 2002, GLIA, V38, P85, DOI [10.1002/glia.10081, DOI 10.1002/GLIA.10081]; Furukawa T, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.283; GEPPERT TD, 1994, MOL MED, V1, P93; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GROOM GN, 1995, J NUCL MED, V36, P2207; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Imamoto N, 2013, NEUROIMAGE, V79, P121, DOI 10.1016/j.neuroimage.2013.04.039; Jin JF, 2012, CLIN IMMUNOL, V143, P188, DOI 10.1016/j.clim.2012.01.019; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rashid K, 2018, BBA-GENE REGUL MECH, V1861, P1119, DOI 10.1016/j.bbagrm.2018.10.018; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00384; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	42	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222861	10.1371/journal.pone.0222861	http://dx.doi.org/10.1371/journal.pone.0222861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536603	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800098
J	Greene, JR; Merrett, KL; Heyert, AJ; Simmons, LF; Migliori, CM; Vogt, KC; Castro, RS; Phillips, PD; Baker, JL; Lindberg, GE; Fox, DT; Del Sesto, RE; Koppisch, AT				Greene, Joshua R.; Merrett, Kahla L.; Heyert, Alexanndra J.; Simmons, Lucas F.; Migliori, Camille M.; Vogt, Kristen C.; Castro, Rebeca S.; Phillips, Paul D.; Baker, Joseph L.; Lindberg, Gerrick E.; Fox, David T.; Del Sesto, Rico E.; Koppisch, Andrew T.			Scope and efficacy of the broad-spectrum topical antiseptic choline geranate	PLOS ONE			English	Article							IONIC LIQUIDS; IN-VITRO; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISM; BIOFILM RESISTANCE; AMBER; DIVERSITY; IMPACT	Choline geranate (also described as Choline And GEranic acid, or CAGE) has been developed as a novel biocompatible antiseptic material capable of penetrating skin and aiding the transdermal delivery of co-administered antibiotics. The antibacterial properties of CAGE were analyzed against 24 and 72 hour old biofilms of 11 clinically isolated ESKAPE pathogens (defined as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter sp, respectively), including multidrug resistant (MDR) isolates. CAGE was observed to eradicate in vitro biofilms at concentrations as low as 3.56 mM (0.156% v:v) in as little as 2 hours, which represents both an improved potency and rate of biofilm eradication relative to that reported for most common standard-of-care topical antiseptics in current use. In vitro time-kill studies on 24 hour old Staphylococcus aureus biofilms indicate that CAGE exerts its antibacterial effect upon contact and a 0.1% v:v solution reduced biofilm viability by over three orders of magnitude (a 3log10 reduction) in 15 minutes. Furthermore, disruption of the protective layer of exopolymeric substances in mature biofilms of Staphylococcus aureus by CAGE (0.1% v:v) was observed in 120 minutes. Insight into the mechanism of action of CAGE was provided with molecular modeling studies alongside in vitro antibiofilm assays. The geranate ion and geranic acid components of CAGE are predicted to act in concert to integrate into bacterial membranes, affect membrane thinning and perturb membrane homeostasis. Taken together, our results show that CAGE demonstrates all properties required of an effective topical antiseptic and the data also provides insight into how its observed antibiofilm properties may manifest.	[Greene, Joshua R.; Merrett, Kahla L.; Heyert, Alexanndra J.; Simmons, Lucas F.; Phillips, Paul D.; Lindberg, Gerrick E.; Koppisch, Andrew T.] No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA; [Migliori, Camille M.; Del Sesto, Rico E.] Dixie State Univ, Dept Chem, St George, UT 84770 USA; [Vogt, Kristen C.; Castro, Rebeca S.; Baker, Joseph L.] Coll New Jersey, Dept Chem, Ewing, NJ USA; [Lindberg, Gerrick E.; Koppisch, Andrew T.] No Arizona Univ, Ctr Mat Interfaces Res & Applicat, Flagstaff, AZ 86011 USA; [Fox, David T.] Los Alamos Natl Lab, Div Chem, Los Alamos, NM USA	Northern Arizona University; Utah System of Higher Education; Dixie State University; College of New Jersey; Northern Arizona University; United States Department of Energy (DOE); Los Alamos National Laboratory	Koppisch, AT (corresponding author), No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA.; Del Sesto, RE (corresponding author), Dixie State Univ, Dept Chem, St George, UT 84770 USA.; Koppisch, AT (corresponding author), No Arizona Univ, Ctr Mat Interfaces Res & Applicat, Flagstaff, AZ 86011 USA.	delsesto@dixie.edu; Andy.Koppisch@nau.edu		Baker, Joseph/0000-0003-1286-6605; Lindberg, Gerrick/0000-0002-5292-4200	National Science Foundation [CHE-1412628, CHE-1412629, ACI-1550562, ACI-1550528, OAC-1828163, OAC-1826915]; National Institutes of Health/National Institute on Minority Health and Health Disparities [NIH/NIMHD RCMI U54MD012388]; NAU Office of the Vice President for Research via the Faculty Grants program; Arizona's Technology and Research Initiative Fund; National Institute on Minority Health and Health Disparities [U54MD012388] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute on Minority Health and Health Disparities; NAU Office of the Vice President for Research via the Faculty Grants program; Arizona's Technology and Research Initiative Fund; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The material reported within this manuscript is based upon work supported by the following agencies: National Science Foundation through awards CHE-1412628 (A.T.K.), CHE-1412629 (R.E.D.S.), ACI-1550562 (G.E.L.), and ACI-1550528 (J.L.B. and K.C.V.). https://www.nsf.gov/; National Institutes of Health/National Institute on Minority Health and Health Disparities through award NIH/NIMHD RCMI U54MD012388 (Baldwin/Stearns-MPI) to A.T.K., https://www.nimhd.nih.gov/; NAU Office of the Vice President for Research via the Faculty Grants program to A.T.K. The sponsors of this work played no role in the study design, data collection, decision to publish or preparation of the manuscript.; J.L.B. and K.C.V. acknowledge use of the ELSA high performance computing cluster at The College of New Jersey for conducting simulations reported in this paper. This cluster is funded by the National Science Foundation under grant numbers OAC-1828163 and OAC-1826915. Some simulations and analysis were performed with Northern Arizona University's Monsoon computing cluster, which is funded in part by Arizona's Technology and Research Initiative Fund. We are grateful to Aubrey Funke in the Histology and Imaging Core facility at Northern Arizona University for assistance with SEM experiments, to Hunter Burgin for assistance with assay development, and to Nathan Nieto and Emily Cope (NAU Dept of Biological Sciences) for helpful discussions.	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 2013, ANTIBIOTIC RESISTANC; Babuji Y, 2017, INTRO PARSL PYTHON P; Banerjee A, 2018, P NATL ACAD SCI USA, V115, pE11000, DOI 10.1073/pnas.1815526115; Banerjee A, 2018, P NATL ACAD SCI USA, V115, P7296, DOI 10.1073/pnas.1722338115; Banerjee A, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601411; Bertelsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047745; Busetti A, 2010, GREEN CHEM, V12, P420, DOI 10.1039/b919872e; Camplin Aimee L, 2014, Ann Clin Microbiol Antimicrob, V13, P19, DOI 10.1186/1476-0711-13-19; Capriotti K, 2018, J CLIN RES DERMATOL, V5, P1, DOI DOI 10.15226/2378-1726/5/1/00174; Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k; CASE DA, 2016, AMBER 2018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Food Drug Administration HHS, 2017, FED REGISTER, V82, P60474; Frederix M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101115; Garrison AT, 2018, J MED CHEM, V61, P3962, DOI 10.1021/acs.jmedchem.7b01903; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Grage SL, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00065; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Ibsen KN, 2018, ACS BIOMATER SCI ENG, V4, P2370, DOI 10.1021/acsbiomaterials.8b00486; Institute CaLS, 2015, PERF STAND ANT SUS S; International A, E2799 ASTM INT, p[West Conshohocken, 9]; Johani K, 2018, J ANTIMICROB CHEMOTH, V73, P494, DOI 10.1093/jac/dkx391; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Justo JA, 2014, INFECT DRUG RESIST, V7, P343, DOI 10.2147/IDR.S51388; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Leid JG, 2012, J ANTIMICROB CHEMOTH, V67, P138, DOI 10.1093/jac/dkr408; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lovejoy KS, 2012, CRYST GROWTH DES, V12, P5357, DOI 10.1021/cg300969u; Lovejoy KS, 2012, ANAL CHEM, V84, P9169, DOI 10.1021/ac301873s; Lovejoy KS, 2011, ANAL CHEM, V83, P2921, DOI 10.1021/ac102944w; Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; PASENKIEWICZGIERUL, 2007, BIOPHYS J, pA64; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Pendleton JN, 2015, INT J ANTIMICROB AG, V46, P131, DOI 10.1016/j.ijantimicag.2015.02.016; Rogers RD, 2018, P NATL ACAD SCI USA, V115, pE10999, DOI 10.1073/pnas.1814976115; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Skjevik AA, 2015, CHEM COMMUN, V51, P4402, DOI 10.1039/c4cc09584g; Solinski AE, 2017, J AM CHEM SOC, V139, P7188, DOI 10.1021/jacs.7b03879; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tam VH, 2010, ANTIMICROB AGENTS CH, V54, P3717, DOI 10.1128/AAC.00207-10; Tanner EEL, 2018, J CONTROL RELEASE, V286, P137, DOI 10.1016/j.jconrel.2018.07.029; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yoo B, 2016, LANGMUIR, V32, P5403, DOI 10.1021/acs.langmuir.6b00768; Zakrewsky M, 2016, ADV HEALTHC MATER, V5, P1282, DOI 10.1002/adhm.201600086; Zakrewsky M, 2014, P NATL ACAD SCI USA, V111, P13313, DOI 10.1073/pnas.1403995111	58	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222211	10.1371/journal.pone.0222211	http://dx.doi.org/10.1371/journal.pone.0222211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527873	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400012
J	Rhie, A; Son, HY; Kwak, SJ; Lee, S; Kim, DY; Lew, BL; Sim, WY; Seo, JS; Kwon, O; Kim, JI; Jo, SJ				Rhie, Arang; Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Kim, Dong Young; Lew, Bark-Lynn; Sim, Woo-Young; Seo, Jeong-Sun; Kwon, Ohsang; Kim, Jong-Il; Jo, Seong Jin			Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; TRANS-RETINOIC ACID; BINDING-PROTEINS; PROSTATE-CANCER; HAIR FOLLICLE; RECEPTOR GENE; EXPRESSION; METABOLISM; ENZYMES; CYTOCHROME-P450	Dutasteride, a dual inhibitor of both type I and II 5 alpha-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic variants associated with response to dutasteride treatment for MPHL, a total of 42 men with moderate MPHL who had been treated with dutasteride for 6 months were genotyped and analysed by quantitative linear regression, case-control association tests, and Fisher's exact test. The synonymous single nucleotide polymorphism (SNP) rs72623193 in DHRS9 was most significantly associated with response to dutasteride, followed by the non-synonymous SNP rs2241057 in CYP26B1. Additionally, variants in ESR1, SRD5A1, CYP19A1, and RXRG are suggested to be associated with response to dutasteride. Cumulative effect and interaction among these SNPs were presented in both additive and non-additive models.	[Rhie, Arang; Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst GMI, Seoul, South Korea; [Rhie, Arang] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Cutaneous Aging & Hair Res, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Coll Med, Seoul, South Korea; [Lew, Bark-Lynn; Sim, Woo-Young] Kyung Hee Univ, Coll Med, Dept Dermatol, Seoul, South Korea	Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kyung Hee University	Jo, SJ (corresponding author), Seoul Natl Univ, Dept Dermatol, Coll Med, Seoul, South Korea.; Jo, SJ (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Cutaneous Aging & Hair Res, Seoul, South Korea.; Jo, SJ (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Coll Med, Seoul, South Korea.	sj.jo@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; KIM, JONG-IL/D-1019-2011; Rhie, Arang/AAP-8907-2021; SON, HO YOUNG/AAJ-3905-2020; KWON, OHSANG/J-2733-2012	KIM, JONG-IL/0000-0002-7240-3744; Rhie, Arang/0000-0002-9809-8127; Ho-young, Son/0000-0001-6326-5071; KWON, OHSANG/0000-0003-0464-5124; Seungbok, Lee/0000-0002-3145-8714; Jo, Seong Jin/0000-0002-2501-7672	SK Telecom Research Fund [34-2014-0120]	SK Telecom Research Fund	This study was supported by the SK Telecom Research Fund (Grant No. 34-2014-0120 to OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Eun HC, 2010, J AM ACAD DERMATOL, V63, P252, DOI 10.1016/j.jaad.2009.09.018; Everts HB, 2004, J INVEST DERMATOL, V123, P258, DOI 10.1111/j.0022-202X.2004.23223.x; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Everts HB, 2013, J INVEST DERMATOL, V133, P325, DOI 10.1038/jid.2012.393; Hayes VM, 2007, INT J CANCER, V120, P776, DOI 10.1002/ijc.22408; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Heilmann S, 2013, J INVEST DERMATOL, V133, P1489, DOI 10.1038/jid.2013.43; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Hillmer AM, 2009, HUM GENET, V126, P255, DOI 10.1007/s00439-009-0668-z; Kaufman KD, 1998, J AM ACAD DERMATOL, V39, P578, DOI 10.1016/S0190-9622(98)70007-6; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lorie EP, 2009, BRIT J DERMATOL, V160, P26, DOI 10.1111/j.1365-2133.2008.08895.x; Lorie EP, 2009, ARCH DERMATOL RES, V301, P475, DOI 10.1007/s00403-009-0937-7; Lorie EP, 2009, BBA-MOL CELL BIOL L, V1791, P220, DOI 10.1016/j.bbalip.2008.12.004; Markova NG, 2003, MOL GENET METAB, V78, P119, DOI 10.1016/S1096-7192(02)00226-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Oh HS, 1996, P NATL ACAD SCI USA, V93, P12525, DOI 10.1073/pnas.93.22.12525; Ohnemus U, 2004, J INVEST DERMATOL, V122, P7, DOI 10.1046/j.0022-202X.2003.22120.x; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Olsen EA, 2006, J AM ACAD DERMATOL, V55, P1014, DOI 10.1016/j.jaad.2006.05.007; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexer BN, 2002, BIOL REPROD, V67, P1555, DOI 10.1095/biolreprod.102.007021; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Roos TC, 1998, PHARMACOL REV, V50, P315; Sinclair R, 1998, BRIT MED J, V317, P865, DOI 10.1136/bmj.317.7162.865; Soref CM, 2001, J BIOL CHEM, V276, P24194, DOI 10.1074/jbc.M100332200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Whiting DA, 1998, INT J DERMATOL, V37, P561, DOI 10.1046/j.1365-4362.1998.00542.x	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222533	10.1371/journal.pone.0222533	http://dx.doi.org/10.1371/journal.pone.0222533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525235	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700035
J	Mekuria, LA; de Wit, TFR; Spieker, N; Koech, R; Nyarango, R; Ndwiga, S; Fenenga, CJ; Ogink, A; Schultsz, C; van't Hoog, A				Mekuria, Legese A.; de Wit, Tobias F. R.; Spieker, Nicole; Koech, Ramona; Nyarango, Robert; Ndwiga, Stanley; Fenenga, Christine J.; Ogink, Alice; Schultsz, Constance; van't Hoog, Anja			Analyzing data from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in primary care in urban Kenya: A mixed-methods study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIMICROBIAL RESISTANCE; PRACTITIONERS; PHYSICIANS; SETTINGS; CENTERS; DELHI	Background Knowledge of antibiotic prescription practices in low- and middle-income countries is limited due to a lack of adequate surveillance systems. Objective To assess the prescription of antibiotics for the treatment of acute respiratory tract infections (ARIs) in primary care. Method An explanatory sequential mixed-methods study was conducted in 4 private not-for-profit outreach clinics located in slum areas in Nairobi, Kenya. Claims data of patients who received healthcare between April 1 and December 27, 2016 were collected in real-time through a mobile telephone-based healthcare data and payment exchange platform (branded as M-TIBA). These data were used to calculate the percentage of ARIs for which antibiotics were prescribed. In-depth interviews were conducted among 12 clinicians and 17 patients to explain the quantitative results. Results A total of 49,098 individuals were registered onto the platform, which allowed them to access healthcare at the study clinics through M-TIBA. For 36,210 clinic visits by 21,913 patients, 45,706 diagnoses and 85,484 medication prescriptions were recorded. ARIs were the most common diagnoses (17,739; 38.8%), and antibiotics were the most frequently prescribed medications (21,870; 25.6%). For 78.5% (95% CI: 77.9%, 79.1%) of ARI diagnoses, antibiotics were prescribed, most commonly amoxicillin (45%; 95% CI: 44.1%, 45.8%). These relatively high levels of prescription were explained by high patient load, clinician and patient perceptions that clinicians should prescribe, lack of access to laboratory tests, off-loading near-expiry drugs, absence of policy and surveillance, and the use of treatment guidelines that are not up-to-date. Clinicians in contrast reported to strictly follow the Kenyan treatment guidelines. Conclusion This study showed successful quantification of antibiotic prescription and the prescribing pattern using real-world data collected through M-TIBA in private not-for-profit clinics in Nairobi.	[Mekuria, Legese A.; de Wit, Tobias F. R.; Schultsz, Constance; van't Hoog, Anja] Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands; [Mekuria, Legese A.; de Wit, Tobias F. R.; Schultsz, Constance; van't Hoog, Anja] Univ Amsterdam, Med Ctr, Locat AMC, Amsterdam, Netherlands; [de Wit, Tobias F. R.; Fenenga, Christine J.; Ogink, Alice] PharmAccess Fdn, Amsterdam, Netherlands; [Spieker, Nicole; Koech, Ramona] PharmAccess Fdn, Nairobi, Kenya; [Nyarango, Robert; Ndwiga, Stanley] Gertrudes Childrens Hosp, Nairobi, Kenya	University of Amsterdam	Mekuria, LA (corresponding author), Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands.; Mekuria, LA (corresponding author), Univ Amsterdam, Med Ctr, Locat AMC, Amsterdam, Netherlands.	legesealex@gmail.com		van't Hoog, Anja/0000-0002-6358-0394	Gilead Sciences Inc., USA; Joep Lange Institute, the Netherlands; Ministry of Foreign Affairs, the Netherlands; PharmAccess Foundation, the Netherlands	Gilead Sciences Inc., USA(Gilead Sciences); Joep Lange Institute, the Netherlands(Netherlands Government); Ministry of Foreign Affairs, the Netherlands; PharmAccess Foundation, the Netherlands(Netherlands Government)	Legese A. Mekuria is a post-doc researcher at AIGHD. The present study was conducted in an ongoing project supported by Gilead Sciences Inc., USA, Joep Lange Institute, the Netherlands, Ministry of Foreign Affairs, the Netherlands, and PharmAccess Foundation, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank clinicians and patients who participated in the present study. The Gertrude's Foundation is thanked for support of healthcare provision to study participants. The Gertrude's Children's Hospital in Nairobi, Kenya, should receive our sincere appreciation for ethical approval of this study. We would like to extend our thanks to PharmAccess Foundation in Kenya and the Netherlands for technical assistance.	[Anonymous], 2016, DED VERS 7 0 23 WEB; Bagger K, 2015, EUR J GEN PRACT, V21, P118, DOI 10.3109/13814788.2014.1001361; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Bastawrous A, 2013, J ROY SOC MED, V106, P130, DOI 10.1177/0141076812472620; Center for Disease Dynamics Economics & Policy 2015, 2015, STATE WORLDS ANTIBIO; Chirima T, 2016, SA PHARM J, V83, P44; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Cull, 2002, EORTC QUALITY LIFE G; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Ebell MH, 2015, AM J MANAG CARE, V21, pE567; Frieden T., 2019, CENT DIS CONTROL PRE, V114, DOI CS239559-B; Global Antibiotic Resistance Partnership-Kenya Working Group, 2011, SIT AN REC ANT US RE; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Harris AM, 2016, ANN INTERN MED, V164, P425, DOI 10.7326/M15-1840; Holstiege J, 2015, J AM MED INFORM ASSN, V22, P236, DOI 10.1136/amiajnl-2014-002886; Huang Y, 2013, BR J GEN PRACT, pe788; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mash B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032358; Ministry of Medical Services Ministry of Public Health and Sanitation [Republic of Kenya], 2009, CLIN MAN REF GUID, V2; Ncube NBQ, 2017, SAMJ S AFR MED J, V107, P119, DOI [10.7196/samj.2017.v107i2.11276, 10.7196/SAMJ.2017.v107i2.11276]; Ofori-Asenso R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3428-8; Petersen I, 2007, J ANTIMICROB CHEMOTH, V60, pI43, DOI 10.1093/jac/dkm156; Ranji SR, 2006, AHRQ PUBLICATION, V4; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; SAFARICOM UAP INSURANCE COMPANY LTD (UAP) and CAREPAY LIMITED (CarePay), M TIBA PROGR BON SCH; Salvi S, 2015, LANCET GLOB HEALTH, V3, pE776, DOI 10.1016/S2214-109X(15)00152-7; Sanou AM, 2016, ECON MICROBIOL, V6, P556; Seale Anna C, 2017, Wellcome Open Res, V2, P92, DOI 10.12688/wellcomeopenres.12527.1; StataCorp, 2011, STAT STAT SOFTW REL; Strumilo J, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0463-6; Tonkin-Crine SK, 2017, COCHRANE DB SYST REV, V9; Ventola C Lee, 2014, P T, V39, P356; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Wonca International Classification Committee (WICC), INT CLASSIFICATION P; World Health Organization, 2002, WORLD HLTH SURV GUID; World Health Organization, ANT RES; [No title captured], DOI DOI 10.1136/BMJ.I3410	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222651	10.1371/journal.pone.0222651	http://dx.doi.org/10.1371/journal.pone.0222651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557170	Green Published, gold			2022-12-27	WOS:000532345500026
J	Berning, L; Scharf, L; Aplak, E; Stucki, D; von Montfort, C; Reichert, AS; Stahl, W; Brenneisen, P				Berning, Lena; Scharf, Lisa; Aplak, Elif; Stucki, David; von Montfort, Claudia; Reichert, Andreas S.; Stahl, Wilhelm; Brenneisen, Peter			In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; HEME OXYGENASE-1; DOWN-REGULATION; DICHLOROFLUORESCEIN ASSAY; INDUCE APOPTOSIS; CANCER-CELLS; TUMOR-GROWTH; XANTHOHUMOL; PROLIFERATION; PATHWAY	Malignant melanoma is an aggressive type of cancer and the deadliest form of skin cancer. Even though enormous efforts have been undertaken, in particular the treatment options against the metastasizing form are challenging and the prognosis is generally poor. A novel therapeutical approach is the application of secondary plant constituents occurring in food and food products. Herein, the effect of the dietary chalcone cardamonin, inter alia found in Alpinia species, was tested using human malignant melanoma cells. These data were compared to cardamonin treated normal melanocytes and dermal fibroblasts representing healthy cells. To investigate the impact of cardamonin on tumor and normal cells, it was added to monolayer cell cultures and cytotoxicity, proliferation, tumor invasion, and apoptosis were studied with appropriate cell biological and biochemical methods. Cardamonin treatment resulted in an apoptosis-mediated increase in cytotoxicity towards tumor cells, a decrease in their proliferation rate, and a lowered invasive capacity, whereas the viability of melanocytes and fibroblasts was hardly affected at such concentrations. A selective cytotoxic effect of cardamonin on melanoma cells compared to normal (healthy) cells was shown in vitro. This study along with others highlights that dietary chalcones may be a valuable tool in anticancer therapies which has to be proven in the future in vivo.	[Berning, Lena; Scharf, Lisa; Aplak, Elif; Stucki, David; von Montfort, Claudia; Reichert, Andreas S.; Stahl, Wilhelm; Brenneisen, Peter] Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 1, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Brenneisen, P (corresponding author), Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 1, Dusseldorf, Germany.	peter.brenneisen@hhu.de	Wilhelm, Stahl/AHB-3164-2022	Brenneisen, Peter/0000-0003-3405-0287; Stucki, David/0000-0002-0732-2761; Stahl, Wilhelm/0000-0001-8892-8345	Deutsche Forschungsgemeinschaft (DFG) [BR1551/7-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant BR1551/7-1 of the Deutsche Forschungsgemeinschaft (DFG), www.dfg.de.PB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Claudia Wyrich and Heide Krahl for excellent technical assistance. This work was supported by grant BR1551/7-1 of the Deutsche Forschungsgemeinschaft (DFG).	Aghajanpour M, 2017, AM J CANCER RES, V7, P740; Ahmed FF, 2018, EUR J MED CHEM, V151, P705, DOI 10.1016/j.ejmech.2018.03.073; Ajiboye TO, 2014, J BIOCHEM MOL TOXIC, V28, P11, DOI 10.1002/jbt.21517; Alili L, 2013, ANTIOXID REDOX SIGN, V19, P765, DOI 10.1089/ars.2012.4831; Angi M, 2016, ONCOTARGET, V7, P49623, DOI 10.18632/oncotarget.10418; Gandini NA, 2019, ANTIOXID REDOX SIGN, V30, P2030, DOI 10.1089/ars.2018.7554; Atkinson V, 2015, AUST PRESCR, V38, P74, DOI 10.18773/austprescr.2015.028; Banasiak D, 1999, RADIAT ONCOL INVESTI, V7, P77, DOI 10.1002/(SICI)1520-6823(1999)7:2<77::AID-ROI3>3.0.CO;2-M; Bieche I, 2013, INT J CANCER, V133, P2791, DOI 10.1002/ijc.28304; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Brenneisen P, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020031; BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409; Chen T, 2008, CELL MOL LIFE SCI, V65, P2763, DOI 10.1007/s00018-008-8329-2; Csala M, 2015, BBA-MOL BASIS DIS, V1852, P826, DOI 10.1016/j.bbadis.2015.01.015; Cui XJ, 2012, ANTIOXID REDOX SIGN, V16, P1212, DOI 10.1089/ars.2012.4532; De Spirt S, 2016, FREE RADICAL BIO MED, V91, P164, DOI 10.1016/j.freeradbiomed.2015.12.011; De Wever O, 2002, BIOL CHEM, V383, P55; Dimitriou F, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0732-8; Dorsam B, 2018, P NATL ACAD SCI USA, V115, pE4061, DOI 10.1073/pnas.1712345115; EDWARDS ML, 1990, J MED CHEM, V33, P1948, DOI 10.1021/jm00169a021; Edwardson DW, 2015, CURR DRUG METAB, V16, P412, DOI 10.2174/1389200216888150915112039; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emri G, 2018, J PHOTOCH PHOTOBIO B, V185, P169, DOI 10.1016/j.jphotobiol.2018.06.005; Ferguson J, 2017, ONCOTARGET, V8, P32946, DOI 10.18632/oncotarget.16514; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Navarini ALF, 2009, EUR J MED CHEM, V44, P1630, DOI 10.1016/j.ejmech.2008.09.009; Fujimura T, 2019, EXPERT OPIN INV DRUG, V28, P143, DOI 10.1080/13543784.2019.1558442; Gasparovic AC, 2017, FREE RADICAL BIO MED, V111, P226, DOI 10.1016/j.freeradbiomed.2017.01.030; Goncalves LM, 2014, J MED FOOD, V17, P633, DOI 10.1089/jmf.2013.0061; Henmi K, 2009, BIOL PHARM BULL, V32, P1109, DOI 10.1248/bpb.32.1109; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Jaiswal S, 2017, DRUG TEST ANAL, V9, P1124, DOI 10.1002/dta.2128; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Kim MS, 2003, LIFE SCI, V73, P1231, DOI 10.1016/S0024-3205(03)00418-1; Krajnovic T, 2016, PHARMACOL RES, V105, P62, DOI 10.1016/j.phrs.2016.01.011; Kreuzer T, 1997, CANCER BIOTHER RADIO, V12, P131, DOI 10.1089/cbr.1997.12.131; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333; Liao NC, 2019, AM J CHINESE MED, V47, P635, DOI 10.1142/S0192415X19500332; Liu JH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/294303; Liu M, 2017, MOLECULES, V22, DOI 10.3390/molecules22010036; Liu Y, 2016, ONCOL LETT, V12, P3825, DOI 10.3892/ol.2016.5169; Loboda A, 2015, VASC PHARMACOL, V74, P11, DOI 10.1016/j.vph.2015.09.004; Lyles RH, 2008, CONTEMP CLIN TRIALS, V29, P878, DOI 10.1016/j.cct.2008.05.009; Malissen N, 2018, DRUGS, V78, P1197, DOI 10.1007/s40265-018-0945-z; MATSUSHIMA R, 1985, J CHEM SOC PERK T 2, P743, DOI 10.1039/p29850000743; Matthews NH, 2017, CUTANEOUS MELANOMA: ETIOLOGY AND THERAPY, P3, DOI 10.15586/codon.cutaneousmelanoma.2017; Maydt D, 2013, XENOBIOTICA, V43, P711, DOI 10.3109/00498254.2012.754112; Miura K, 2015, NUTR CANCER, V67, P867, DOI 10.1080/01635581.2015.1053499; Mohammadpour A, 2019, J CELL PHYSIOL, V234, P3307, DOI 10.1002/jcp.27286; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Niemeyer ED, 2013, J NAT PROD, V76, P1121, DOI 10.1021/np400195z; Orlikova B, 2011, GENES NUTR, V6, P125, DOI 10.1007/s12263-011-0210-5; Pan L, 2005, MOL NUTR FOOD RES, V49, P837, DOI 10.1002/mnfr.200500065; Pashaiefar H, 2018, GENET TEST MOL BIOMA, V22, P343, DOI 10.1089/gtmb.2018.0085; Payandeh Z, 2019, J CELL PHYSIOL, V234, P14612, DOI 10.1002/jcp.28181; Pesic M, 2015, CHEM-BIOL INTERACT, V232, P85, DOI 10.1016/j.cbi.2015.03.013; Peterson GM, 2018, J CLIN PHARM THER, V43, P925, DOI 10.1111/jcpt.12750; Pizzimenti S, 2013, FREE RADICAL BIO MED, V65, P765, DOI 10.1016/j.freeradbiomed.2013.06.035; Prasad CB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13232-3; Rajanna S, 2015, ANTI-CANCER AGENT ME, V15, P856, DOI 10.2174/1871520615666150202100130; ROTH E, 1988, IN VITRO CELL DEV B, V24, P696; Rubbi CP, 2001, CARCINOGENESIS, V22, P1789, DOI 10.1093/carcin/22.11.1789; Sack M, 2014, MOL CANCER THER, V13, P1740, DOI 10.1158/1535-7163.MCT-13-0950; Sack-Zschauer M, 2017, J BIOMED NANOTECHNOL, V13, P1735, DOI 10.1166/jbn.2017.2452; Saito K, 2018, CANCER SCI, V109, P132, DOI 10.1111/cas.13441; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Shen WD, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2438-3; Shi DH, 2018, PHARMACOL REP, V70, P908, DOI 10.1016/j.pharep.2018.04.005; Shrivastava S, 2017, BIOFACTORS, V43, P152, DOI 10.1002/biof.1315; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skrzypek K, 2013, ANTIOXID REDOX SIGN, V19, P644, DOI 10.1089/ars.2013.5184; Strathmann J, 2010, FASEB J, V24, P2938, DOI 10.1096/fj.10-155846; Su YK, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691689; Tan B, 2017, AMINO ACIDS, V49, P2023, DOI 10.1007/s00726-017-2460-z; Tarhini A, 2018, CANCER TREAT REV, V71, P8, DOI 10.1016/j.ctrv.2018.09.005; Tetz LM, 2013, J PHARMACOL TOX MET, V67, P56, DOI 10.1016/j.vascn.2013.01.195; Trucco LD, 2019, NAT MED, V25, P221, DOI 10.1038/s41591-018-0265-6; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang X, 2014, ANAL METHODS-UK, V6, P3019, DOI 10.1039/c4ay00288a; Wang YM, 2016, RECENT PAT ANTI-CANC, V11, P215, DOI 10.2174/1573406412666160307151904; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068566; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wolff H, 2011, J AGR FOOD CHEM, V59, P12893, DOI 10.1021/jf203689z; Wu N, 2015, TUMOR BIOL, V36, P9667, DOI 10.1007/s13277-015-3673-y; Yadav VR, 2012, BRIT J PHARMACOL, V165, P741, DOI 10.1111/j.1476-5381.2011.01603.x; Yun CW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113466; Zhang JL, 2019, CELL MOL GASTROENTER, V8, P37, DOI 10.1016/j.jcmgh.2019.02.009; Zhang JW, 2017, APOPTOSIS, V22, P158, DOI 10.1007/s10495-016-1313-7; Zhang YF, 2018, ANAL METHODS-UK, V10, P4625, DOI 10.1039/c8ay01339j; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133; Zheng YW, 2011, EXP BRAIN RES, V210, P477, DOI 10.1007/s00221-010-2491-0; Zhou XS, 2019, ANTI-CANCER DRUG, V30, P241, DOI 10.1097/CAD.0000000000000709; Zou CX, 2016, ONCOL REP, V36, P2715, DOI 10.3892/or.2016.5056	97	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222267	10.1371/journal.pone.0222267	http://dx.doi.org/10.1371/journal.pone.0222267			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553748	gold, Green Published			2022-12-27	WOS:000532319200020
J	Fahey, CA; Chevrier, J; Crause, M; Obida, M; Bornman, R; Eskenazi, B				Fahey, Carolyn A.; Chevrier, Jonathan; Crause, Madelein; Obida, Muvhulawa; Bornman, Riana; Eskenazi, Brenda			Seasonality of antenatal care attendance, maternal dietary intake, and fetal growth in the VHEMBE birth cohort, South Africa	PLOS ONE			English	Article							MULTIPLE IMPUTATION; WEIGHT-GAIN; RESTRICTION; WOMEN	Background Seasonality of food availability, physical activity, and infections commonly occurs within rural communities in low and middle-income countries with distinct rainy seasons. To better understand the implications of these regularly occurring environmental stressors for maternal and child health, this study examined seasonal variation in nutrition and health care access of pregnant women and infants in rural South Africa. Methods We analyzed data from the Venda Health Examination of Mothers, Babies and their Environment (VHEMBE) birth cohort study of 752 mother-infant pairs recruited at delivery from August 2012 to December 2013 in the Vhembe District of Limpopo Province, the northernmost region of South Africa. We used truncated Fourier series regression to assess seasonality of antenatal care (ANC) attendance, dietary intake, and birth size. We additionally regressed ANC attendance on daily rainfall values. Models included adjustment for sociodemographic characteristics. Results Maternal ANC attendance, dietary composition, and infant birth size exhibited significant seasonal variation in both unadjusted and adjusted analyses. Adequate frequency of ANC attendance during pregnancy (>= 4 visits) was highest among women delivering during the gardening season and lowest during the lean (rainy) season. High rainfall during the third trimester was also negatively associated with adequate ANC attendance (adjusted OR = 0.59, 95% CI: 0.40, 0.86). Carbohydrate intake declined during the harvest season and increased during the vegetable gardening and lean seasons, while fat intake followed the opposite trend. Infant birth weight, length, and head circumference z-scores peaked following the gardening season and were lowest after the harvest season. Maternal protein intake and ANC <= 12 weeks did not significantly vary by season or rainfall. Conclusions Seasonal patterns were apparent in ANC utilization, dietary intake, and fetal growth in rural South Africa. Interventions to promote maternal and child health in similar settings should consider seasonal factors.	[Fahey, Carolyn A.; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth CERCH, Berkeley, CA 94720 USA; [Chevrier, Jonathan] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Crause, Madelein; Obida, Muvhulawa; Bornman, Riana] Univ Pretoria, Univ Pretoria Inst Sustainable Malaria Control UP, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa	University of California System; University of California Berkeley; McGill University; University of Pretoria	Fahey, CA; Eskenazi, B (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth CERCH, Berkeley, CA 94720 USA.	cfahey@berkeley.edu; eskenazi@berkeley.edu		Fahey, Carolyn A./0000-0001-9865-2397	U.S. National Institute of Environmental Health Sciences (NIEHS) [R01ES020360-01]; Canada Research Chairs program (CRC)	U.S. National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canada Research Chairs program (CRC)(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for the VHEMBE study was provided by the U.S. National Institute of Environmental Health Sciences (NIEHS: https://www.niehs.nih.gov/index.cfm) (B. Eskenazi, Award ID: R01ES020360-01) and the Canada Research Chairs program (CRC: http://www.chairschaires.gc.ca/home-accueil-eng.aspx) (J. Chevrier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; [Anonymous], 2004, 40 FAO UN; [Anonymous], 2008, ANT CAR COV LEAST ON; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Darrow LA, 2009, EPIDEMIOLOGY, V20, P699, DOI 10.1097/EDE.0b013e3181a66e96; De Cock N, 2013, FOOD SECUR, V5, P269, DOI 10.1007/s12571-013-0247-y; Ebonwu J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191903; Famine Early Warning Systems Network, SO AFR SEAS CAL TYP; Ferro-Luzzi A, 1993, NUTR SEASONALITY DIM; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Glassman A, 2013, J HEALTH POPUL NUTR, V31, P48; Haddad DN, 2016, INT J GYNECOL OBSTET, V132, P64, DOI 10.1016/j.ijgo.2015.06.041; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hasan SMT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212116; Hughes MM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-310; Kotir Julius H., 2011, Environment Development and Sustainability, V13, P587, DOI 10.1007/s10668-010-9278-0; Lincetto O, 2006, ANTENATAL CARE OPPOR; MacIntyre UE, 2001, PUBLIC HEALTH NUTR, V4, P53, DOI 10.1079/PHN200040; Matsuoka S, 2010, HEALTH POLICY, V95, P255, DOI 10.1016/j.healthpol.2009.12.011; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Department of Health and ICF, 2019, S AFR DEM HLTH SURV; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134; Reason CJC, 2005, INT J CLIMATOL, V25, P1835, DOI 10.1002/joc.1228; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; Toe LC, 2015, J NUTR, V145, P634, DOI 10.3945/jn.114.203448; Vaitla B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000101; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2011, ANTHR MACR VERS 3 2	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222888	10.1371/journal.pone.0222888	http://dx.doi.org/10.1371/journal.pone.0222888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553767	gold, Green Published			2022-12-27	WOS:000532319200040
J	Lee, SH; Maenner, MJ; Heilig, CM				Lee, Scott H.; Maenner, Matthew J.; Heilig, Charles M.			A comparison of machine learning algorithms for the surveillance of autism spectrum disorder	PLOS ONE			English	Article							DISABILITIES MONITORING NETWORK; UNITED-STATES; PREVALENCE; CHILDREN; SITES	Objective The Centers for Disease Control and Prevention (CDC) coordinates a labor-intensive process to measure the prevalence of autism spectrum disorder (ASD) among children in the United States. Random forests methods have shown promise in speeding up this process, but they lag behind human classification accuracy by about 5%. We explore whether more recently available document classification algorithms can close this gap. Materials and methods Using data gathered from a single surveillance site, we applied 8 supervised learning algorithms to predict whether children meet the case definition for ASD based solely on the words in their evaluations. We compared the algorithms' performance across 10 random train-test splits of the data, using classification accuracy, F1 score, and number of positive calls to evaluate their potential use for surveillance. Results Across the 10 train-test cycles, the random forest and support vector machine with Naive Bayes features (NB-SVM) each achieved slightly more than 87% mean accuracy. The NB-SVM produced significantly more false negatives than false positives (P = 0.027), but the random forest did not, making its prevalence estimates very close to the true prevalence in the data. The best-performing neural network performed similarly to the random forest on both measures. Discussion The random forest performed as well as more recently available models like the NB-SVM and the neural network, and it also produced good prevalence estimates. NB-SVM may not be a good candidate for use in a fully-automated surveillance workflow due to increased false negatives. More sophisticated algorithms, like hierarchical convolutional neural networks, may not be feasible to train due to characteristics of the data. Current algorithms might perform better if the data are abstracted and processed differently and if they take into account information about the children in addition to their evaluations. Conclusion Deep learning models performed similarly to traditional machine learning methods at predicting the clinician-assigned case status for CDC's autism surveillance system. While deep learning methods had limited benefit in this task, they may have applications in other surveillance systems.	[Lee, Scott H.; Maenner, Matthew J.; Heilig, Charles M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lee, SH (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	yle4@cdc.gov		Heilig, Charles/0000-0003-1075-1310; Lee, Scott/0000-0003-4584-6758				Abadi M., 2016, TENSORFLOW LARGE SCA; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators, 2014, MMWR SURVEILL SUMM, V63; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Christensen Deborah L, 2018, MMWR Surveill Summ, V65, P1, DOI [10.15585/mmwr.ss6503a1, 10.15585/mmwr.ss6513a1]; Chung J., 2014, EMPIRICAL EVALUATION, DOI 10.3115/v1/w14-4012; Cortes C., 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Dai A.M., 2015, DOCUMENT EMBEDDING P; Demsar J, 2006, J MACH LEARN RES, V7, P1; Denil M., 2014, ARXIV14063830, P1; Dumais S. T., 1988, P SIGCHI C HUM FACT, P281, DOI DOI 10.1145/57167.57214; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Joulin Armand, 2016, ARXIV160701759; Kalchbrenner N., 2013, P WORKSH CONT VECT S, P119; Kim Y, 2014, P 2014 C EMPIRICAL M, P1746, DOI [10.3115/v1/D14-1181, DOI 10.3115/V1/D14-1181]; Leisenring W, 2000, BIOMETRICS, V56, P345, DOI 10.1111/j.0006-341X.2000.00345.x; Maenner MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168224; Mesnil G., 2014, ARXIV14125335; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; Pascanu T., 2013, INT C MACH LEARN, P1310; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Platt JC, 2000, ADV NEUR IN, P61; R Core Team, R LANG ENV STAT COMP; Ramage D, 2009, P 2009 C EMP METH NA, V1, P248; Rennie J., 2003, P 20 INT C MACH LEAR, ppp; Rice CE, 2007, PAEDIATR PERINAT EP, V21, P179, DOI 10.1111/j.1365-3016.2007.00801.x; Tang D., 2015, PROC C EMPIRICAL MET, P1422, DOI DOI 10.18653/V1/D15-1167; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang B, 2012, ADV ENG FORUM, V2-3, P900, DOI 10.4028/www.scientific.net/AEF.2-3.900; Zhang X, ADV NEURAL INFORM PR, P649	34	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222907	10.1371/journal.pone.0222907	http://dx.doi.org/10.1371/journal.pone.0222907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553774	Green Published, gold, Green Submitted			2022-12-27	WOS:000532319200041
J	Chang, TE; Park, S; Yang, QH; Loustalot, F; Butler, J; Ritchey, MD				Chang, Tiffany E.; Park, Soyoun; Yang, Quanhe; Loustalot, Fleetwood; Butler, Javed; Ritchey, Matthew D.			Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults	PLOS ONE			English	Article							HYDRALAZINE-ISOSORBIDE DINITRATE; CLINICAL EFFECTIVENESS; MEDICARE; IMPACT; MANAGEMENT; BENEFICIARIES; NONADHERENCE; OUTCOMES; THERAPY; COPAYMENT	Background Five guideline-recommended medication categories are available to treat patients who have heart failure (HF) with reduced ejection fraction. However, adherence to these medications is often suboptimal, which places patients at increased risk for poor health outcomes, including hospitalization. We aimed to examine the association between adherence to these medications and potentially preventable HF hospitalizations among younger insured adults with newly diagnosed HF. Methods and results Using the 2008-2012 IBM MarketScan Commercial database, we followed 26,439 individuals aged 18-64 years with newly diagnosed HF and calculated their adherence (using the proportion of days covered (PDC) algorithm) to the five guideline-recommended medication categories: angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers; beta blockers; aldosterone receptor antagonists; hydralazine; and isosorbide dinitrate. We determined the association between PDC and long-term preventable HF hospitalizations (observation years 3-5) as defined by the United States (U.S.) Agency for Healthcare Research and Quality. Overall, 49.0% of enrollees had good adherence (PDC.80%), which was more common among enrollees who were older, male, residing in higher income counties, initially diagnosed with HF in an outpatient setting, and who filled prescriptions for fewer medication categories assessed. Adherence differed by medication category and was lowest for isosorbide dinitrate (PDC = 60.7%). In total, 7.6% of enrollees had preventable HF hospitalizations. Good adherers, compared to poor adherers (PDC< 40%), were 15% less likely to have a preventable hospitalization (HR 0.85, 95% confidence interval, 0.75-0.96). Conclusion We found that approximately half of insured U.S. adults aged 18-64 years with newly diagnosed HF had good adherence to their HF medications. Patients with good adherence, compared to those with poor adherence, were less likely to have a potentially preventable HF hospitalization 3-5 years after their initial diagnosis. Because HF is a chronic condition that requires long-term management, future studies may want to assess the effectiveness of interventions in sustaining adherence.	[Chang, Tiffany E.; Park, Soyoun; Yang, Quanhe; Loustalot, Fleetwood; Ritchey, Matthew D.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Chang, Tiffany E.] IHRC Inc, Atlanta, GA USA; [Butler, Javed] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	Centers for Disease Control & Prevention - USA; University of Mississippi; University of Mississippi Medical Center	Ritchey, MD (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	mritchey@cdc.gov		Park, Soyoun/0000-0003-1862-6370	NIGMS NIH HHS [U54 GM115428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agency for Healthcare Research and Quality, GUID PREV QUAL IND H; Agency for Healthcare Research & Quality, PREV QUAL IND TECHN; Aguilar KM, 2015, J MANAG CARE SPEC PH, V21, P670, DOI 10.18553/jmcp.2015.21.8.670; Ambardekar AV, 2009, AM HEART J, V158, P644, DOI 10.1016/j.ahj.2009.07.034; Andersson C, 2014, HEART FAIL CLIN, V10, P377, DOI 10.1016/j.hfc.2014.04.003; Bagchi AD, 2007, CLIN THER, V29, P1771, DOI 10.1016/j.clinthera.2007.08.015; Bansilal S, 2016, J AM COLL CARDIOL, V68, P789, DOI 10.1016/j.jacc.2016.06.005; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Chang LL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007998; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Cole JA, 2006, PHARMACOTHERAPY, V26, P1157, DOI 10.1592/phco.26.8.1157; Cox ZL, 2017, CLIN CARDIOL, V40, P620, DOI 10.1002/clc.22711; Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011; Gourzoulidis G, 2017, HEALTH POLICY, V121, P363, DOI 10.1016/j.healthpol.2017.02.008; Hansen LG, 2011, WHITE PAPER HLTH RES; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heldenbrand S, 2016, J AM PHARM ASSOC, V56, P293, DOI 10.1016/j.japh.2015.12.014; Hincapie AL, 2015, J MANAG CARE SPEC PH, V21, P391, DOI 10.18553/jmcp.2015.21.5.391; Hood SR, 2018, PHARMACOTHERAPY, V38, P539, DOI 10.1002/phar.2107; IMS Health, 2008, UN SYST CLASS USC; Khazanie P, 2016, CIRC-HEART FAIL, V9, P1, DOI 10.1161/CIRCHEARTFAILURE.115.002444; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Kuhle J, PQA MEASURES USED CM; Lloyd JT, 2019, MED CARE, V57, P218, DOI 10.1097/MLR.0000000000001067; Lopert R, 2012, AM J MANAG CARE, V18, P556; Mockler M, 2009, AM J CARDIOL, V103, P834, DOI 10.1016/j.amjcard.2008.11.058; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Nair KV, 2011, PATIENT PREFER ADHER, V5, P195, DOI 10.2147/PPA.S18481; National Quality Forum, 2010, NAT VOL CONS STAND M; Nau DP, PROPORTION DAYS COVE; Riegel B, 2014, PATIENT PREFER ADHER, V8, P1, DOI 10.2147/PPA.S54520; Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Sherman BW, 2009, AM J MANAG CARE, V15, pE53; Shimp LA, 2012, J AM PHARM ASSOC, V52, P768, DOI 10.1331/JAPhA.2012.11186; Sueta CA, 2015, AM J CARDIOL, V116, P413, DOI 10.1016/j.amjcard.2015.04.058; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Tang J, 2008, STROKE, V39, P1938, DOI 10.1161/STROKEAHA.107.504688; US Food and Drug Administration, NAT DRUG COD DIR; USDHHS HRSA, AR HLTH RES FIL AHRF; Will JC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110260; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang QH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006056; Zhang YT, 2014, J GEN INTERN MED, V29, P602, DOI 10.1007/s11606-013-2692-x; Ziaeian B, 2017, JACC-HEART FAIL, V5, P632, DOI 10.1016/j.jchf.2017.04.008; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222868	10.1371/journal.pone.0222868	http://dx.doi.org/10.1371/journal.pone.0222868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545830	Green Published, gold			2022-12-27	WOS:000532303200039
J	Gong, J; Simon, GE; Liu, S				Gong, Jue; Simon, Gregory E.; Liu, Shan			Machine learning discovery of longitudinal patterns of depression and suicidal ideation	PLOS ONE			English	Article							SYMPTOMS; TIME; TRAJECTORIES; SEVERITY; PHQ-9; RISK	Background and aim Depression is often accompanied by thoughts of self-harm, which are a strong predictor of subsequent suicide attempt and suicide death. Few empirical data are available regarding the temporal correlation between depression symptoms and suicidal ideation. We investigated the anecdotal concern that suicidal ideation may increase during a period of depression improvement. Data Longitudinal Patient Health Questionnaire (PHQ)-9 is a questionnaire of 9 multiple-choice questions to assess the frequency of depressive symptoms within the previous two weeks. We analyzed a chronic depression treatment population's electronic health record (EHR) data, containing 610 patients' longitudinal PHQ-9 scores (62% age 45 and older; 68% female) within 40 weeks. Methods The irregular and sparse EHR data were transformed into continuous trajectories using Gaussian process regression. We first estimated the correlations between the symptoms (total score of the first 8 questions; PHQ-8) and suicide ideation (9th question score; Item 9) using the cross-correlation function. We then used an artificial neural network (ANN) to discover subtypes of depression patterns from the fitted depression trajectories. In addition, we conducted a separate analysis using the unfitted raw PHQ scores to examine PHQ-8's and Item 9's pattern changes. Results Results showed that the majority of patients' PHQ-8 and Item 9 scores displayed strong temporal correlations. We found five patterns in the PHQ-8 and the Item 9 trajectories. We also found 8% - 13% of the patients have experienced an increase in suicidal ideation during the improvement of their PHQ-8. Using a trajectory-based method for subtype pattern detection in depression progression, we provided a better understanding of temporal correlations between depression symptoms over time.	[Gong, Jue; Liu, Shan] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Simon, Gregory E.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Simon, Gregory E.] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kaiser Permanente; University of Washington; University of Washington Seattle	Liu, S (corresponding author), Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA.	liushan@uw.edu			National Science Foundation [CMMI-1824623]	National Science Foundation(National Science Foundation (NSF))	JG and SL are supported by the National Science Foundation grant CMMI-1824623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedani BK, 2017, AM J PREVENTIVE MED; Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; Bayley KB, 2013, MED CARE, V51, pS80, DOI 10.1097/MLR.0b013e31829b1d48; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P188, DOI 10.1093/jpepsy/jst085; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Dong J.L., 1999, P 5 ACM SIGKDD INT C, P43, DOI [10.1145/312129.312191, DOI 10.1145/312129.312191]; Ellis TE, 2012, PSYCHOTHERAPY, V49, P72, DOI 10.1037/a0026746; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gunn J, 2013, J AFFECT DISORDERS, V148, P338, DOI 10.1016/j.jad.2012.12.021; Jacobson O, 2016, P 15 WORKSH BIOM NAT, P191; Kahn MG, 2012, MED CARE, V50, pS60, DOI 10.1097/MLR.0b013e318259bff4; Kaplan D, 2004, SAGE HDB QUANTITATIV, Vxiii; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; Lin Y, 2018, IISE TRANS, V50, P1076, DOI 10.1080/24725854.2018.1470357; Lin Y, 2018, IEEE T RELIAB, V67, P328, DOI 10.1109/TR.2017.2767941; Lin Y, 2016, MATH BIOSCI, V282, P191, DOI 10.1016/j.mbs.2016.10.008; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mittal V, 2009, PSYCHIAT SERV, V60, P384, DOI 10.1176/appi.ps.60.3.384; Musliner KL, 2016, J AFFECT DISORDERS, V192, P199, DOI 10.1016/j.jad.2015.12.030; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rehfeld K, 2011, NONLINEAR PROC GEOPH, V18, P389, DOI 10.5194/npg-18-389-2011; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Simon GE, 2018, AM J PSYCHIAT, V175, P434, DOI [10.1176/appi.ajp.2017.17080844, 10.1176/appi.ajp.2018.17101167]; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Snippe E, 2015, MINDFULNESS, V6, P1053, DOI 10.1007/s12671-014-0354-7; Somaraki V, 2010, LECT NOTES COMPUTER, V6171; Swingler K., 1996, APPL NEURAL NETWORKS; Team TTD, 2016, ABS160502688 ARXIV; Twisk J, 2012, J CLIN EPIDEMIOL, V65, P1078, DOI 10.1016/j.jclinepi.2012.04.010; Valuck RJ, 2012, J AM BOARD FAM MED, V25, P582, DOI 10.3122/jabfm.2012.05.110053; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156; Zhang ZH, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.02.05; Zhong QY, 2018, BMC MED INFORM DECIS, V18, DOI [10.1186/s12911-018-0617-7, 10.1186/S12911-018-0617-7]	36	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222665	10.1371/journal.pone.0222665	http://dx.doi.org/10.1371/journal.pone.0222665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539408	Green Published, gold			2022-12-27	WOS:000532297900023
J	Agbota, G; Polman, K; Wieringa, FT; Campos-Ponce, M; Accrombessi, M; Yovo, E; Roucher, C; Ezinmegnon, S; Marcos, JY; Vachot, L; Tissieres, P; Massougbodji, A; Fievet, N; Cot, M; Briand, V				Agbota, Gino; Polman, Katja; Wieringa, Frank T.; Campos-Ponce, Maiza; Accrombessi, Manfred; Yovo, Emmanuel; Roucher, Clementine; Ezinmegnon, Sem; Marcos, Javier Yugueros; Vachot, Laurence; Tissieres, Pierre; Massougbodji, Achille; Fievet, Nadine; Cot, Michel; Briand, Valerie			Maternal malaria but not schistosomiasis is associated with a higher risk of febrile infection in infant during the first 3 months of life: A mother-child cohort in Benin	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; EARLY-PREGNANCY; PREVALENCE; FALCIPARUM; RECEPTOR; ANEMIA	Background Malaria and schistosomiasis represent two of the most prevalent and disabling parasitic infections in developing countries. Few studies have evaluated the effect of maternal schistosomiasis and malaria in the peri-conceptional period on infant's risk of infection. Methods In Benin, women were followed from the preconception period until delivery. Subsequently, their children were followed from birth to 3 months of age. Pre-pregnancy malaria, malaria in pregnancy (MiP)-determined monthly using a thick blood smear-and urinary schistosomiasis-determined once before pregnancy and once at delivery using urine filtration-were the main maternal exposures. Infant's febrile infection (fever with respiratory, gastrointestinal and/or cutaneous clinical signs anytime during follow-up) was the main outcome. In a secondary analysis, we checked the relation of malaria and schistosomiasis with infant's hemoglobin (Hb) concentration. Both effects were separately assessed using logistic/mixed linear regression models. Results The prevalence of MiP was 35.7% with 10.8% occurring during the 1st trimester, and the prevalence of schistosomiasis was 21.8%. From birth to 3 months, 25.3% of infants had at least one episode of febrile infection. In multivariate analysis, MiP, particularly malaria in the 1st trimester, was significantly associated with a higher risk of infant's febrile infection (aOR = 4.99 [1.1; 22.6], p = 0.03). In secondary results, pre-pregnancy malaria and schistosomiasis were significantly associated with a lower infant's Hb concentration during the first 3 months. Conclusion We evidenced the deleterious effect of maternal parasitic infections on infant's health. Our results argue in favor of the implementation of preventive strategies as early as in the periconception.	[Agbota, Gino; Accrombessi, Manfred; Yovo, Emmanuel; Fievet, Nadine; Cot, Michel; Briand, Valerie] Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, Paris, France; [Agbota, Gino; Massougbodji, Achille] CERPAGE, Cotonou, Benin; [Polman, Katja; Roucher, Clementine] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Campos-Ponce, Maiza] Vrije Univ Amsterdam, Dept Hlth Sci, Infect Dis Sect, Amsterdam, Netherlands; [Wieringa, Frank T.] IRD UM SupAgro, Inst Rech Dev, Nutripass, UMR204, Montpellier, France; [Ezinmegnon, Sem; Marcos, Javier Yugueros; Vachot, Laurence] Med Diagnost Discovery Dept MD3, BioMerieux, Marcy Letoile, France; [Ezinmegnon, Sem; Tissieres, Pierre] Univ Paris Saclay, Inst Biol Integrat Cellule, UMR 9198, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Institute of Tropical Medicine (ITM); Vrije Universiteit Amsterdam; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; bioMerieux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Agbota, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, Paris, France.; Agbota, G (corresponding author), CERPAGE, Cotonou, Benin.	ginodric@yahoo.fr	Wieringa, Frank Tammo/K-7565-2017; Accrombessi, Manfred/W-1546-2017; Cot, Michel/E-7633-2011	Wieringa, Frank Tammo/0000-0002-6010-355X; Accrombessi, Manfred/0000-0001-9550-9413; Cot, Michel/0000-0003-3014-4294; Fievet, Nadine/0000-0003-2272-9794; Campos Ponce, Maiza/0000-0003-1700-4756; AGBOTA, Gino/0000-0001-7726-0984; YOVO, Emmanuel Koffi/0000-0003-1082-5113	Fondation pour la Recherche Medicale (FRM) [ECO20160736054]; French Agence Nationale de la Recherche [ANR-13-JSV1-0004]; Fondation Simone Beer under the Fondation de France [00074147]; bioMerieux	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Simone Beer under the Fondation de France; bioMerieux	Fondation pour la Recherche Medicale (FRM, grant number ECO20160736054) for PhD scholarship. The French Agence Nationale de la Recherche [ANR-13-JSV1-0004, grant 2013] and the Fondation Simone Beer under the auspices of the Fondation de France [00074147, grant 2017] funded RECIPAL project. bioMerieux funded SEPSIS project. NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SE, JYM and LV contributed to data collection in the framework of SEPSIS project and to the final revision of the manuscript in their own names and not on behalf of their employer.	Accrombessi M, 2019, CLIN INFECT DIS, V69, P1385, DOI 10.1093/cid/ciy1073; Accrombessi M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019014; Accrombessi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129510; Ajanga A, 2006, T ROY SOC TROP MED H, V100, P59, DOI 10.1016/j.trstmh.2005.06.024; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Huynh BT, 2015, CLIN INFECT DIS, V60, P598, DOI 10.1093/cid/ciu848; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Collier CH, 2013, MATERN CHILD HLTH J, V17, P1940, DOI 10.1007/s10995-013-1220-2; Colomer J, 1990, Paediatr Perinat Epidemiol, V4, P196, DOI 10.1111/j.1365-3016.1990.tb00638.x; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Friedman JF, 2007, TRENDS PARASITOL, V23, P159, DOI 10.1016/j.pt.2007.02.006; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; King CL, 1998, J IMMUNOL, V160, P3578; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Mischlinger J, 2018, TROP MED INT HEALTH, V23, P980, DOI 10.1111/tmi.13124; Mombo-Ngoma G, 2017, INT J PARASITOL, V47, P69, DOI 10.1016/j.ijpara.2016.11.001; Olveda RM, 2016, LANCET INFECT DIS, V16, P199, DOI 10.1016/S1473-3099(15)00345-X; Onzo-Aboki A, 2019, ACTA TROP, V191, P185, DOI 10.1016/j.actatropica.2019.01.004; PETERS PA, 1976, J PARASITOL, V62, P154, DOI 10.2307/3279081; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; SIEGRIST D, 1992, ACTA TROP, V50, P317, DOI 10.1016/0001-706X(92)90066-7; World Health Organization, FACT SHEETS DET MAL; World Health Organization, 2008, DEF CONCL CONS M H 1; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization, FACT SHEETS DET SCHI; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang YT, 2016, J PEDIATR-US, V175, P106, DOI 10.1016/j.jpeds.2016.05.011	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222864	10.1371/journal.pone.0222864	http://dx.doi.org/10.1371/journal.pone.0222864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP8YO	31536589	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000498544800001
J	Basche, AD; DeLonge, MS				Basche, Andrea D.; DeLonge, Marcia S.			Comparing infiltration rates in soils managed with conventional and alternative farming methods: A meta-analysis	PLOS ONE			English	Article							CLIMATE-CHANGE MITIGATION; ORGANIC-MATTER; WATER INFILTRATION; PHYSICAL-PROPERTIES; CARBON SEQUESTRATION; ECOSYSTEM SERVICES; TILLAGE SYSTEMS; NO-TILL; COVER; CROPS	Identifying agricultural practices that enhance water cycling is critical, particularly with increased rainfall variability and greater risks of droughts and floods. Soil infiltration rates offer useful insights to water cycling in farming systems because they affect both yields (through soil water availability) and other ecosystem outcomes (such as pollution and flooding from runoff). For example, conventional agricultural practices that leave soils bare and vulnerable to degradation are believed to limit the capacity of soils to quickly absorb and retain water needed for crop growth. Further, it is widely assumed that farming methods such as no-till and cover crops can improve infiltration rates. Despite interest in the impacts of agricultural practices on infiltration rates, this effect has not been systematically quantified across a range of practices. To evaluate how conventional practices affect infiltration rates relative to select alternative practices (no-till, cover crops, crop rotation, introducing perennials, crop and livestock systems), we performed a meta-analysis that included 89 studies with field trials comparing at least one such alternative practice to conventional management. We found that introducing perennials (grasses, agroforestry, managed forestry) or cover crops led to the largest increases in infiltration rates (mean responses of 59.2 +/- 20.9% and 34.8 +/- 7.7%, respectively). Also, although the overall effect of no-till was non-significant (5.7 +/- 9.7%), the practice led to increases in wetter climates and when combined with residue retention. The effect of crop rotation on infiltration rate was non-significant (18.5 +/- 13.2%), and studies evaluating impacts of grazing on croplands indicated that this practice reduced infiltration rates (-21.3 +/- 14.9%). Findings suggest that practices promoting ground cover and continuous roots, both of which improve soil structure, were most effective at increasing infiltration rates.	[Basche, Andrea D.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [DeLonge, Marcia S.] Union Concerned Scientists, Food & Environm Program, Oakland, CA USA	University of Nebraska System; University of Nebraska Lincoln	Basche, AD (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	abasche2@unl.edu		Basche, Andrea/0000-0001-6805-8522	Union of Concerned Scientists Kendall Fellowship Program; TomKat Foundation; Grantham Foundation for the Protection of the Environment; Department of Agronomy and Horticulture at the University of NebraskaLincoln	Union of Concerned Scientists Kendall Fellowship Program; TomKat Foundation; Grantham Foundation for the Protection of the Environment; Department of Agronomy and Horticulture at the University of NebraskaLincoln	We would like to thank the Union of Concerned Scientists Kendall Fellowship Program, as well as TomKat Foundation and The Grantham Foundation for the Protection of the Environment, for funding that supported the authors while conducting this research. This project was also supported in part by the Department of Agronomy and Horticulture at the University of NebraskaLincoln. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; Aguilera E, 2013, AGR ECOSYST ENVIRON, V168, P25, DOI 10.1016/j.agee.2013.02.003; Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Alvarez R, 2009, SOIL TILL RES, V104, P1, DOI 10.1016/j.still.2009.02.005; Alvarez R, 2017, SOIL TILL RES, V170, P53, DOI 10.1016/j.still.2017.03.005; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Basche A, 2017, SOIL SCI SOC AM J, V81, P1179, DOI 10.2136/sssaj2017.03.0077; Basche AD, 2017, AGROECOL SUST FOOD, V41, P799, DOI 10.1080/21683565.2017.1330795; Baumhardt RL, 2012, SOIL SCI SOC AM J, V76, P1370, DOI 10.2136/sssaj2011.0331; Bharati L, 2002, AGROFOREST SYST, V56, P249, DOI 10.1023/A:1021344807285; Blanchart E, 2006, EUR J SOIL BIOL, V42, pS136, DOI 10.1016/j.ejsobi.2006.07.018; Briones MJI, 2017, GLOBAL CHANGE BIOL, V23, P4396, DOI 10.1111/gcb.13744; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Castellano MJ, 2007, J ARID ENVIRON, V71, P97, DOI 10.1016/j.jaridenv.2007.03.009; Daryanto S, 2018, EARTH-SCI REV, V185, P357, DOI 10.1016/j.earscirev.2018.06.013; Delgado JA, 2011, J SOIL WATER CONSERV, V66, p118A, DOI 10.2489/jswc.66.4.118A; DeLonge M, 2017, RENEW AGR FOOD SYST, P1; DeLonge MS, 2016, ENVIRON SCI POLICY, V55, P266, DOI 10.1016/j.envsci.2015.09.013; DeLonge MS, 2017, ELEMENTA-SCI ANTHROP, V2, P5; Eagle AJ, 2017, AGRON J, V109, P2441, DOI 10.2134/agronj2017.04.0215; Eldridge DJ, 2016, ECOL APPL, V26, P1273, DOI 10.1890/15-1234; EMERSON WW, 1995, AUST J SOIL RES, V33, P241, DOI 10.1071/SR9950241; Franzluebbers AJ, 2012, RENEW AGR FOOD SYST, V27, P256, DOI 10.1017/S1742170511000378; Gerstner K, 2017, METHODS ECOL EVOL, V8, P777, DOI 10.1111/2041-210X.12758; Gliessman S, 2017, AGROECOL SUST FOOD, V41, P695, DOI 10.1080/21683565.2017.1335152; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Gowda P., 2018, US GLOBAL CHANGE RES, P391, DOI DOI 10.7930/NCA4.2018.CH10; Greenwood KL, 2001, AUST J EXP AGR, V41, P1231, DOI 10.1071/EA00102; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harden JW, 2017, GLOBAL CHANGE BIOL, P1; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hellwinckel C, 2012, CARBON MANAG, V3, P27, DOI 10.4155/CMT.11.79; Hijmans RJ, 2016, AGR ENV LETT, V1, DOI 10.2134/ael2016.05.0022; Hillel D., 1998, ENV SOIL PHYS; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Ilstedt U, 2007, FOREST ECOL MANAG, V251, P45, DOI 10.1016/j.foreco.2007.06.014; Isbell F, 2017, J ECOL, V105, P871, DOI 10.1111/1365-2745.12789; Jagermeyr J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/025002; Ketema H, 2014, SOIL TILL RES, V141, P25, DOI 10.1016/j.still.2014.03.011; Korucu T, 2018, SOIL TILL RES, V180, P99, DOI 10.1016/j.still.2018.03.004; Li Y, 2019, SOIL TILL RES, V194, DOI 10.1016/j.still.2019.06.009; Liang XZ, 2017, P NATL ACAD SCI USA, V114, pE2285, DOI 10.1073/pnas.1615922114; Loecke TD, 2017, BIOGEOCHEMISTRY, V133, P7, DOI 10.1007/s10533-017-0315-z; LOGSDON SD, 1993, SOIL TILL RES, V28, P179, DOI 10.1016/0167-1987(93)90025-K; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; Masri Z, 2006, SOIL TILL RES, V87, P146, DOI 10.1016/j.still.2005.03.003; McDaniel MD, 2014, ECOL APPL, V24, P560, DOI 10.1890/13-0616.1; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Metting F. B., 1993, SOIL MICROBIAL ECOLO; Miles A, 2017, AGROECOL SUST FOOD, V41, P855, DOI 10.1080/21683565.2017.1331179; Minasny B, 2018, EUR J SOIL SCI, V69, P39, DOI 10.1111/ejss.12475; Morris KS, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000142; Palm C, 2014, AGR ECOSYST ENVIRON, V187, P87, DOI 10.1016/j.agee.2013.10.010; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Philibert A, 2012, AGR ECOSYST ENVIRON, V148, P72, DOI 10.1016/j.agee.2011.12.003; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Poeplau C, 2015, AGR ECOSYST ENVIRON, V200, P33, DOI 10.1016/j.agee.2014.10.024; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Raza A, 2012, IMPROVING WATER USE, P167; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rost S, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044002; Schipanski ME, 2016, BIOSCIENCE, V66, P600, DOI 10.1093/biosci/biw052; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Soil Survey Staff, 2012, SOIL SURV STAFF; Sposito G, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2013.02.0041; St-Pierre NR, 2001, J DAIRY SCI, V84, P741, DOI 10.3168/jds.S0022-0302(01)74530-4; Stewart BA, 2015, AGRON J, V107, P1544, DOI 10.2134/agronj14.0038; Stott DE, 2017, PROGR SOIL SCI, P109, DOI 10.1007/978-3-319-43394-3_10; Stroosnijder L, 2012, CURR OPIN ENV SUST, V4, P497, DOI 10.1016/j.cosust.2012.08.011; TRIMBLE SW, 1995, GEOMORPHOLOGY, V13, P233, DOI 10.1016/0169-555X(95)00028-4; U.S. Department of Agriculture Natural Resources Conservation Service, 2016, SOIL HLTH LIT MATR S; USDA-NRCS, 2016, EFF IMPL SOIL HLTH M; van Kessel C, 2013, GLOBAL CHANGE BIOL, V19, P33, DOI 10.1111/j.1365-2486.2012.02779.x; VandenBygaart AJ, 2016, AGR ECOSYST ENVIRON, V216, P98, DOI 10.1016/j.agee.2015.09.013; Walthall C., 2013, USDA TECHNICAL B; Williams A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26896-2; Williams A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160974; ZOMER RJ, 2006, INT WATER MANAGE I R, V101, P1; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	80	70	72	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0215702	10.1371/journal.pone.0215702	http://dx.doi.org/10.1371/journal.pone.0215702			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536506	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800002
J	Bergot, E; De Leotoing, L; Bendjenana, H; Tournier, C; Vainchtock, A; Nachbaur, G; Humbert, M				Bergot, Emmanuel; De Leotoing, Lucie; Bendjenana, Hakim; Tournier, Charlene; Vainchtock, Alexandre; Nachbaur, Gaelle; Humbert, Marc			Hospital burden of pulmonary arterial hypertension in France	PLOS ONE			English	Article							ECONOMIC BURDEN; COSTS; CARE; EPIDEMIOLOGY; GUIDELINES; DIAGNOSIS; OUTCOMES; US	Background & aims Pulmonary arterial hypertension is a severe disease associated with frequent hospitalisations. This retrospective analysis of the French medical information PMSI-MSO database aimed to describe incident cases of patients with pulmonary arterial hypertension hospitalised in France in 2013 and to document associated hospitalisation costs from the national health insurance perspective. Methods Cases of pulmonary arterial hypertension were identified using a diagnostic algorithm. All cases hospitalised in 2013 with no hospitalisation the previous two years were retained. All hospital stays during the year following the index hospitalisation were extracted, and classified as incident stays, monitoring stays or stays due to disease worsening. Costs were attributed from French national tariffs. Results 384 patients in France were hospitalised with incident pulmonary arterial hypertension in 2013. Over the following twelve months, patients made 1,271 stays related to pulmonary arterial hypertension (415 incident stays, 604 monitoring stays and 252 worsening stays). Mean age was 59.6 years and 241 (62.8%) patients were women. Liver disease and connective tissue diseases were documented in 62 patients (16.1%) each. Thirty-one patients (8.1%) died during hospitalisation and four (1.0%) received a lung/heart-lung transplantation. The total annual cost of these hospitalisations was (sic) 3,640,382. (sic) 2,985,936 was attributable to standard tariffs (82.0%), (sic) 463,325 to additional ICU stays (12.7%) and (sic) 191,118 to expensive drugs (5.2%). The mean cost/stay was (sic) 2,864, ranging from (sic) 1,282 for monitoring stays to (sic) 7,285 for worsening stays. Conclusions Although pulmonary arterial hypertension is rare, it carries a high economic burden.	[Bergot, Emmanuel] CHU Caen, Serv Pneumol & Oncol Thorac, Caen, France; [Bergot, Emmanuel] Unicaen, UFR Sante, Caen, France; [De Leotoing, Lucie; Tournier, Charlene; Vainchtock, Alexandre] HEVA, Lyon, France; [Bendjenana, Hakim; Nachbaur, Gaelle] GlaxoSmithKline, Rueil Malmaison, France; [Humbert, Marc] Univ Paris Sud, Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France; [Humbert, Marc] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France; [Humbert, Marc] INSERM, UMR S 999, Le Kremlin Bicetre, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; GlaxoSmithKline; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bergot, E (corresponding author), CHU Caen, Serv Pneumol & Oncol Thorac, Caen, France.; Bergot, E (corresponding author), Unicaen, UFR Sante, Caen, France.	bergot.e@gmail.com	Humbert, Marc/ABD-5112-2021; Humbert, Marc/AAC-8459-2019	Humbert, Marc/0000-0003-0703-2892	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was initiated and funded by GlaxoSmithKline. The sponsor delegated management of the study and data analysis to HEVA (Lyon, France). Representatives of the funders (listed as authors of the study) were involved in study design, the decision to publish, and reviewed the final manuscript before submission. They had no role in data collection or analysis.; The writing and preparation of this manuscript was funded by GlaxoSmithKline. Initial data analyses were undertaken by CT, who is employee of HEVA (Lyon, France) and received funding from GlaxoSmithKline. Editorial support in drafting this manuscript was provided by Adam Doble of Foxymed (Paris, France), and was funded by GlaxoSmithKline. All authors had complete access to the data that supports this publication and have contributed to a draft and approved the manuscript for publication. The corresponding author had the final responsibility to submit for publication.	Angalakuditi Mallik, 2010, J Med Econ, V13, P393, DOI 10.3111/13696998.2010.496694; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P954, DOI 10.1002/pds.4233; Bouee S, 2013, VALUE HEALTH, V16, pA521, DOI 10.1016/j.jval.2013.08.1256; Burke JP, 2015, AM J MANAG CARE, V21, pS47; Chevalier P, 2014, VALUE HEALTH, V17, pA593, DOI 10.1016/j.jval.2014.08.2037; Escribano-Subias P, 2016, INT J CARDIOL, V203, P938, DOI 10.1016/j.ijcard.2015.11.039; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2016, REV ESP CARDIOL, V69, P177, DOI 10.1016/j.rec.2016.01.002; Gu SY, 2016, PHARMACOECONOMICS, V34, P533, DOI 10.1007/s40273-015-0361-0; Heresi GA, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0399-1; Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3; Hoeper MM, 2016, INT J CARDIOL, V203, P612, DOI 10.1016/j.ijcard.2015.11.001; Hoeper MM, 2014, EUR RESPIR REV, V23, P450, DOI 10.1183/09059180.00007814; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Johnson Samuel, 2013, J Med Econ, V16, P1414, DOI 10.3111/13696998.2013.849713; Kirson NY, 2011, APPL HEALTH ECON HEA, V9, P293, DOI 10.2165/11592430-000000000-00000; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Maladie Assurance, 2018, PROP ASS MAL 2019; McGoon MD, 2012, EUR RESPIR REV, V21, P8, DOI 10.1183/09059180.00008211; McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023; Molinari N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0469-6; Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97; Murali S, 2006, CURR OPIN CRIT CARE, V12, P228, DOI 10.1097/01.ccx.0000224867.78581.0c; Provencher S, 2005, CHEST, V128, p622S, DOI 10.1378/chest.128.6_suppl.622S; Said Qayyim, 2012, J Med Econ, V15, P500, DOI 10.3111/13696998.2012.665109; Scan Sante, 2017, PLATEFORME RESTITUTI; Sikirica M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0676-0; Wilkens H, 2010, RESP MED, V104, P902, DOI 10.1016/j.rmed.2010.01.002; World Health Organization, 2010, INT CLASS DIS	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221211	10.1371/journal.pone.0221211	http://dx.doi.org/10.1371/journal.pone.0221211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536491	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800015
J	Ontoria, Y; Cuesta-Gracia, A; Ruiz, JM; Romero, J; Perez, M				Ontoria, Yaiza; Cuesta-Gracia, Ainhoa; Ruiz, Juan M.; Romero, Javier; Perez, Marta			The negative effects of short-term extreme thermal events on the seagrass Posidonia oceanica are exacerbated by ammonium additions	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COLUMN NITRATE ENRICHMENT; CLIMATE-CHANGE; PHOTOSYNTHETIC RESPONSES; PHYSIOLOGICAL-RESPONSES; ENVIRONMENTAL STRESSORS; CYMODOCEA-NODOSA; WATER-QUALITY; HEAT WAVES; IN-SITU	Global warming is increasingly affecting our biosphere. However, in addition to global warming, a panoply of local stressors caused by human activities is having a profound impact on our environment. The risk that these local stressors could modify the response of organisms to global warming has attracted interest and fostered research on their combined effect, especially with a view to identifying potential synergies. In coastal areas, where human activities are heavily concentrated, this scenario is particularly worrying, especially for foundation species such as seagrasses. In this study we explore these potential interactions in the seagrass Posidonia oceanica. This species is endemic to the Mediterranean Sea. It is well known that the Mediterranean is already experiencing the effects of global warming, especially in the form of heat waves, whose frequency and intensity are expected to increase in the coming decades. Moreover, this species is especially sensitive to stress and plays a key role as a foundation species. The aim of this work is thus to evaluate plant responses (in terms of photosynthetic efficiency and growth) to the combined effects of short-term temperature increases and ammonium additions.To achieve this, we conducted a mesocosm experiment in which plants were exposed to three thermal treatments (20 degrees C, 30 degrees C and 35 degrees C) and three ammonium concentrations (ambient, 30 mu M and 120 mu M) in a full factorial experiment. We assessed plant performance by measuring chlorophyll fluorescence variables (maximum quantum yield (F-v/F-m), effective quantum yield of photosystem II (Delta F/F-m'), maximum electron transport rate (ETRmax) and non-photochemical quenching (NPQ)), shoot growth rate and leaf necrosis incidence. At ambient ammonium concentrations, P. oceanica tolerates short-term temperature increases up to 30 degrees C. However, at 35 degrees C, the plant loses functionality as indicated by a decrease in photosynthetic performance, an inhibition of plant growth and an increase of the necrosis incidence in leaves. On the other hand, ammonium additions at control temperatures showed only a minor effect on seagrass performance. However, the combined effects of warming and ammonium were much worse than those of each stressor in isolation, given that photosynthetic parameters and, above all, leaf growth were affected. This serves as a warning that the impact of global warming could be even worse than expected (based on temperature-only approaches) in environments that are already subject to eutrophication, especially in persistent seagrass species living in oligotrophic environments.	[Ontoria, Yaiza; Cuesta-Gracia, Ainhoa; Romero, Javier; Perez, Marta] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain; [Ruiz, Juan M.] Spanish Inst Oceanog, Oceanog Ctr Murcia, Seagrass Ecol Grp, Murcia, Spain	University of Barcelona; Spanish Institute of Oceanography	Ontoria, Y (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.	yaizaontoria@ub.edu	Ontoria, Yaiza/AAA-9113-2021	RUIZ FERNANDEZ, JUAN MANUEL/0000-0002-5974-1407; Ontoria, Yaiza/0000-0002-5157-1570	European Union [CTM2013-48027-C3-1-R, CTM2013-48027-C3-2-R, CTM2017-86695-C3-1-R]; Spanish Government [CTM2013-48027-C3-1-R, CTM2013-48027-C3-2-R, CTM2017-86695-C3-1-R]; Spanish Ministry of Economy and Competitiveness [BES-2014-069593]	European Union(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the European Union and the Spanish Government through the RECCAM (Seagrass meadows resilience to global warming: an analysis based on responses at ecophysiological, population and ecosystem levels, CTM2013-48027-C3-1-R and CTM2013-48027-C3-2-R) and UMBRAL (Responses of benthic marine vegetation to stress: critical transitions, resilience, and management opportunities, CTM2017-86695-C3-1-R) projects; and by the Spanish Ministry of Economy and Competitiveness (via grant BES-2014-069593 awarded to Y. Ontoria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Alcoverro T, 1998, J EXP MAR BIOL ECOL, V230, P1, DOI 10.1016/S0022-0981(98)00022-7; Alcoverro T, 1997, MAR ECOL PROG SER, V146, P155, DOI 10.3354/meps146155; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Beca-Carretero P, 2018, MAR POLLUT BULL, V134, P27, DOI 10.1016/j.marpolbul.2017.12.057; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; BULTHUIS DA, 1987, AQUAT BOT, V27, P27, DOI 10.1016/0304-3770(87)90084-2; BURKHOLDER JM, 1994, MAR ECOL PROG SER, V105, P121, DOI 10.3354/meps105121; BURKHOLDER JM, 1992, MAR ECOL PROG SER, V81, P163, DOI 10.3354/meps081163; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Campbell S, 2003, J EXP MAR BIOL ECOL, V291, P57, DOI 10.1016/S0022-0981(03)00090-X; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Ceccherelli G, 2018, OECOLOGIA, V186, P1137, DOI 10.1007/s00442-018-4075-9; Clarke K.R., 2006, PRIMER V6 USER MANUA; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Diaz-Almela E, 2007, GLOBAL CHANGE BIOL, V13, P224, DOI 10.1111/j.1365-2486.2006.01260.x; Duarte B, 2016, BIOL INVASIONS, V18, P2189, DOI 10.1007/s10530-015-0958-4; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Durako MJ, 2002, AQUAT BOT, V73, P173, DOI 10.1016/S0304-3770(02)00020-7; Egea LG, 2018, MAR POLLUT BULL, V134, P14, DOI 10.1016/j.marpolbul.2018.02.029; Galli G, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00136; Gera A, 2012, ENVIRON MONIT ASSESS, V184, P3675, DOI 10.1007/s10661-011-2215-3; Green E.P., 2003, WORLD ATLAS SEAGRASS, V47, DOI [10.1515/BOT.2004.029, DOI 10.1515/BOT.2004.029]; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Guerrero-Meseguer L, 2017, ENVIRON POLLUT, V230, P40, DOI 10.1016/j.envpol.2017.06.039; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hallett CS, 2018, REG ENVIRON CHANGE, V18, P1357, DOI 10.1007/s10113-017-1264-8; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hendriks IE, 2017, AQUAT BOT, V139, P32, DOI 10.1016/j.aquabot.2017.02.004; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holmer M, 2003, BIOGEOCHEMISTRY, V66, P223, DOI 10.1023/B:BIOG.0000005326.35071.51; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Invers O, 2004, J EXP MAR BIOL ECOL, V303, P97, DOI 10.1016/j.jembe.2003.11.005; IPCC, 2014, CONTRIBUTION WORKING; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, DOI [10.1256/004316502320517344, DOI 10.1256/004316502320517344]; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kaldy JE, 2014, J EXP MAR BIOL ECOL, V453, P108, DOI 10.1016/j.jembe.2013.12.020; Kaldy JE, 2013, BOT MAR, V56, P75, DOI 10.1515/bot-2012-0144; Karydis M, 2012, ENVIRON MONIT ASSESS, V184, P4931, DOI 10.1007/s10661-011-2313-2; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Kilminster K, 2015, SCI TOTAL ENVIRON, V534, P97, DOI 10.1016/j.scitotenv.2015.04.061; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Leoni V, 2008, AQUAT CONSERV, V18, P202, DOI 10.1002/aqc.842; Marba N, 2002, ENVIRON CONSERV, V29, P509, DOI 10.1017/S037689290200036X; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2014, BIOL CONSERV, V176, P183, DOI 10.1016/j.biocon.2014.05.024; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marin L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00921; Marin-Guirao L, 2018, MAR POLLUT BULL, V135, P617, DOI 10.1016/j.marpolbul.2018.07.050; Marin-Guirao L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28615; Marin-Guirao L, 2013, MAR ENVIRON RES, V84, P60, DOI 10.1016/j.marenvres.2012.12.001; Massa SI, 2009, HYDROBIOLOGIA, V619, P195, DOI 10.1007/s10750-008-9609-4; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Moreno-Marin F, 2018, LIMNOL OCEANOGR, V63, P1528, DOI 10.1002/lno.10789; Moreno-Marin F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152971; Mozetic P, 2008, MAR ECOL-EVOL PERSP, V29, P483, DOI 10.1111/j.1439-0485.2008.00257.x; Nixon SW, 2009, GLOBAL LOSS COASTAL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Olsen YS, 2012, ESTUAR COAST, V35, P1205, DOI 10.1007/s12237-012-9521-z; Ontoria Y, 2019, MAR ENVIRON RES, V145, P27, DOI 10.1016/j.marenvres.2019.02.002; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pages JF, 2018, MAR POLLUT BULL, V134, P55, DOI 10.1016/j.marpolbul.2017.10.036; Pages JF, 2010, J EXP MAR BIOL ECOL, V386, P34, DOI 10.1016/j.jembe.2010.02.017; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEREZ M, 1992, AQUAT BOT, V43, P51, DOI 10.1016/0304-3770(92)90013-9; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; PIRC H, 1986, AQUAT BOT, V26, P203, DOI 10.1016/0304-3770(86)90021-5; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 1998, MAR ECOL PROG SER, V171, P123, DOI 10.3354/meps171123; Repolho T, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Roca G, 2016, ECOL INDIC, V63, P310, DOI 10.1016/j.ecolind.2015.12.007; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Ruiz JM, 2001, MAR POLLUT BULL, V42, P749, DOI 10.1016/S0025-326X(00)00215-0; Salo T, 2014, J EXP MAR BIOL ECOL, V457, P143, DOI 10.1016/j.jembe.2014.04.008; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Savva I, 2018, ECOL EVOL, V8, P12032, DOI 10.1002/ece3.4663; Schar C, 2004, NATURE, V432, P559, DOI 10.1038/432559a; SHORT FT, 2001, GLOB SEAGR RES METH, P155, DOI DOI 10.1016/B978-044450891-1/50009-8; Traboni C, 2018, MAR ENVIRON RES, V141, P12, DOI 10.1016/j.marenvres.2018.07.007; Tutar O, 2017, MAR ENVIRON RES, V132, P94, DOI 10.1016/j.marenvres.2017.10.011; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; Vargas-Yanez M, 2007, CAMBIO CLIMATICO MED; Villazan B, 2015, MAR ECOL PROG SER, V536, P149, DOI 10.3354/meps11435; Villazan B, 2013, MAR ECOL PROG SER, V493, P141, DOI 10.3354/meps10517; Villazan B, 2013, MAR ECOL PROG SER, V488, P133, DOI 10.3354/meps10395; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wilkinson AD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45404; York PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076377; ZIEMAN JC, 1974, AQUACULTURE, V4, P139, DOI 10.1016/0044-8486(74)90029-5	108	17	17	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222798	10.1371/journal.pone.0222798	http://dx.doi.org/10.1371/journal.pone.0222798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536606	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800087
J	Yun, HH; Lim, JT; Yang, SH; Park, PS				Yun, Ho Hyun; Lim, Jung Taek; Yang, Se-Hyun; Park, Phil Sun			Occult periprosthetic femoral fractures occur frequently during a long, trapezoidal, double-tapered cementless femoral stem fixation in primary THA	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; MORPHOLOGY; FEMUR; PAIN	The present study aimed to investigate the prevalence and clinical consequences of occult intra-operative periprosthetic femoral fractures in total hip arthroplasty (THA). Between 2012 and 2017, a total of 113 primary THAs were enrolled. The mean age of the patients was 66.4 +/- 7.6 years. We assessed occult intra-operative periprosthetic femoral fractures with the use of computed tomography (CT) and risk factors, including age, sex, body mass index, diagnosis, stem size, and radiographic parameters of proximal femoral geometry were analyzed. We also assessed the differences in thigh pain and stem subsidence and alignment between the patients with and without occult periprosthetic femoral fracture. Occult intra-operative periprosthetic femoral fractures were found in 13 of 113 hips (11.5%). In 9/13 (69.2%) of occult fractures, fracture lines were started from the region below the tip of the lesser trochanter. Six periprosthetic femoral fractures (5.3%) were found during the operation. Out of the five hips that had detected femoral fractures around the lesser trochanter intra-operatively, four hips (80%) showed concurrent occult fractures on different levels. The female sex (P =.01) and canal filling ratio at 7 cm below the tip of the lesser trochanter (P =.01) were significantly different between the patients with and without occult periprosthetic femoral fracture. The sex was significantly associated with an increased risk in predicting an occult intra-operative periprosthetic femoral fracture (odds ratio of male, 0.25 compared with the female; 95% CI, 0.08-0.85; p =.02). There was a significant difference in the incidence of thigh pain between occult fracture group and non-occult fracture group (P <.05). There were no significant differences in stem subsidence and alignment between the patients with and without occult periprosthetic femoral fracture. All 13 cases of occult intra-operative periprosthetic femoral fractures were healed at the final follow-up. Occult periprosthetic femoral fractures are common during a long, trapezoidal, double-tapered cementless femoral stem fixation in primary THA, that CT scans are helpful to identify them, and that these fractures do not adversely affect the implant's survival if a rigid fixation of the implants has been achieved.	[Yun, Ho Hyun; Lim, Jung Taek; Yang, Se-Hyun; Park, Phil Sun] Seoul Vet Hosp, Dept Orthopaed Surg, Seoul, South Korea	Seoul Veterans Hospital	Yun, HH (corresponding author), Seoul Vet Hosp, Dept Orthopaed Surg, Seoul, South Korea.	3188vun@naver.com						Abdel MP, 2016, BONE JOINT J, V98B, P468, DOI 10.1302/0301-620X.98B4.37203; Al-Najjim M, 2016, J ORTHOP, V13, P322, DOI 10.1016/j.jor.2016.06.026; Barrack RL, 2000, J ARTHROPLASTY, V15, P590, DOI 10.1054/arth.2000.6634; Berend KR, 2004, J ARTHROPLASTY, V19, P17, DOI 10.1016/j.arth.2004.06.008; Brown Jonathon M, 2017, Am J Orthop (Belle Mead NJ), V46, P232; Cahir JG, 2007, CLIN RADIOL, V62, P1163, DOI 10.1016/j.crad.2007.04.018; Capello WN, 2014, CLIN ORTHOP RELAT R, V472, P604, DOI 10.1007/s11999-013-3137-x; Cooper HJ, 2011, J ARTHROPLASTY, V26, P78, DOI 10.1016/j.arth.2011.04.003; Dammerer D, 2018, INT ORTHOP; Davidson D, 2008, J BONE JOINT SURG AM, V90A, P2000, DOI 10.2106/JBJS.H.00331; DORR LD, 1993, BONE, V14, P231, DOI 10.1016/8756-3282(93)90146-2; Froimson MI, 2007, J ARTHROPLASTY, V22, P1, DOI 10.1016/j.arth.2006.03.003; Gomez-Barrena E, 2017, CLIN ORTHOP RELAT R, V475, P495, DOI 10.1007/s11999-016-5208-2; Ha YC, 2007, J ARTHROPLASTY, V22, P184, DOI 10.1016/j.arth.2006.02.169; Haidukewych GJ, 2006, J BONE JOINT SURG AM, V88A, P1952, DOI 10.2106/JBJS.E.00890; Hallan G, 2007, J BONE JOINT SURG BR, V89B, P1574, DOI 10.1302/0301-620X.89B12.18969; Hasegawa K, 2017, CLIN ORTHOP RELAT R, V475, P484, DOI 10.1007/s11999-016-5138-z; Imre N, 2012, SURG RADIOL ANAT, V34, P427, DOI 10.1007/s00276-011-0930-7; Ishii S, 2016, J ARTHROPLASTY, V31, P1524, DOI 10.1016/j.arth.2016.01.016; Jo WL, 2016, J ARTHROPLASTY, V31, P1279, DOI 10.1016/j.arth.2015.12.016; Khalily C, 2002, J ARTHROPLASTY, V17, P463, DOI 10.1054/arth.2002.32171; Malekmotiei L, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023699; Melvin JS, 2014, J ARTHROPLASTY, V29, P1285, DOI 10.1016/j.arth.2013.12.024; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; Olory Bruno, 2004, Acta Orthop Belg, V70, P31; Reddy A V Gurava, 2017, J Orthop Case Rep, V7, P31, DOI 10.13107/jocr.2250-0685.792; Reikeras O, 2017, J ARTHROPLASTY, V32, P1543, DOI 10.1016/j.arth.2016.12.008; Ricioli W, 2015, INT ORTHOP, V39, P1939, DOI 10.1007/s00264-015-2961-x; Romagnoli S, 2002, J ARTHROPLASTY, V17, P108, DOI 10.1054/arth.2002.32689; Schiessel A, 2004, SKELETAL RADIOL, V33, P142, DOI 10.1007/s00256-003-0728-8; Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Umer Masood, 2010, J Orthop Surg (Hong Kong), V18, P279; Vidalain JP, 2011, INT ORTHOP, V35, P189, DOI 10.1007/s00264-010-1117-2; Wang FD, 2014, J COMPUT ASSIST TOMO, V38, P828, DOI 10.1097/RCT.0000000000000125; Yeung Y, 2006, J ARTHROPLASTY, V21, P508, DOI 10.1016/j.arth.2005.04.037	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221731	10.1371/journal.pone.0221731	http://dx.doi.org/10.1371/journal.pone.0221731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536499	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800019
J	Huffaker, R; Fearne, A				Huffaker, Ray; Fearne, Andrew			Reconstructing systematic persistent impacts of promotional marketing with empirical nonlinear dynamics	PLOS ONE			English	Article							SINGULAR SPECTRUM ANALYSIS; TIME-SERIES; MODELS	An empirical question of long-standing interest is how price promotions affect a brand's sale shares in the fast-moving consumer-goods market. We investigated this question with concurrent promotions and sales records of specialty beer brands pooled over Tesco stores in the UK. Most brands were continuously promoted, rendering infeasible a conventional approach of establishing impact against an off-promotion sales baseline, and arguing in favor of a dynamics approach. Moreover, promotion/sales records were volatile without easily-discernable regularity. Past work conventionally attributed volatility to the impact of exogenous random shocks on stable markets, and reasoned that promotions have only an ephemeral impact on sales shares in stationary mean-reverting stochastic markets, or a persistent freely-wandering impact in nonstationary markets. We applied new empirical methods from the applied sciences to uncover an overlooked alternative: 'systematic persistence' in which promotional impacts evolve systematically in an endogenously-unstable market governed by deterministic-nonlinear dynamics. We reconstructed real-world market dynamics from the Tesco dataset, and detected deterministic-nonlinear market dynamics. We used reconstructed market dynamics to identify a complex network of systematic interactions between promotions and sales shares among competing brands, and quantified/ characterized the dynamics of these interactions. For the majority of weeks in the study, we found that: (1) A brand's promotions drove down own sales shares (a possibility recognized in the literature), but `cannibalized' sales shares of competing brands (perhaps explaining why brands were promoted despite a negative marginal impact on own sales shares); and (2) Competitive interactions between brands owned by the same multinational brewery differed from those with outside brands. In particular, brands owned by the same brewery enjoyed a `mutually-beneficial' relationship in which an incremental increase in the sales share of one marginally increased the sales share of the other. Alternatively, the sales shares of brands owned by different breweries preyed on each other's market shares.	[Huffaker, Ray] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Fearne, Andrew] Univ East Anglia, Norwich Business Sch, Norwich, Norfolk, England	State University System of Florida; University of Florida; University of East Anglia	Huffaker, R (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	rhuffaker@ufl.edu		Huffaker, Ray/0000-0003-3434-3709	USDA/NIFA	USDA/NIFA(United States Department of Agriculture (USDA))	This work was supported by USDA/NIFA Multistate regional project to Professor Ray Huffaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2018, SIMPLEX PROJECTION; [Anonymous], OR VERS 2019; [Anonymous], 2016, ECONOMIST; BASS FM, 1972, J MARKETING RES, V9, P298, DOI 10.2307/3149541; BLATTBERG RC, 1995, MARKET SCI, V14, pG122, DOI 10.1287/mksc.14.3.G122; Brandt C, 2012, PHYS REV LETT, V88; BREEDEN JL, 1990, PHYS REV A, V42, P5817, DOI 10.1103/PhysRevA.42.5817; Brown T, 1996, VINYL RETEC AND TUTORIAL '96, TECHNICAL PAPERS, P55; Constantine W., 2014, FRACTAL FRACTAL TIME; Csardi G., 2006, INT J COMPLEX SYST, P1695; DEKIMPE MG, 1995, MARKET SCI, V14, P1, DOI 10.1287/mksc.14.1.1; DelVecchio D, 2006, J RETAILING, V82, P203, DOI 10.1016/j.jretai.2005.10.001; Deyle E, 2018, P ROY SOC B-BIOL SCI, V283; Deyle E, 2011, PLOS ONE, V6, P1; Dhrymes P.J., 1972, ANN ECON SOC MEAS, V1, P291; Di Narzo A, 2013, TSERIESCHAOS ANAL NO; DODSON JA, 1978, J MARKETING RES, V15, P72, DOI 10.2307/3150402; Ellenberg J., 2015, NOT BE WRONG; Elsner J., 2010, SINGULAR SPECTRUM AN; FEDER G, 1979, AM J AGR ECON, V61, P97, DOI 10.2307/1239507; Furrer R, 2018, TOOLS SPATIAL DATA; Gabaix Xavier, 2008, FDN POSITIVE NORMATI; Galtier F, 2013, GLOB FOOD SECUR-AGR, V2, P72, DOI 10.1016/j.gfs.2013.02.001; Gammelgaard J, 2013, GLOBAL BREWERY IND M, P1; Gedenik K, 2010, SALES PROMOTION; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Golyandina N, 2014, COMPUT STAT DATA AN, V71, P934, DOI 10.1016/j.csda.2013.04.009; Gotoda H, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.022201; Hassani H., 2007, DATA SCI J, V5, P239, DOI DOI 10.6339/JDS.2007.05(2).396; Huffaker R, 2017, NONLINEAR TIME SERIES ANALYSIS WITH R; Itoh N, 2013, NONLINEAR PROC GEOPH, V20, P467, DOI 10.5194/npg-20-467-2013; Kantz H., 2003, NONLINEAR TIME SERIE, V2nd ed; KAPLAN D, 1995, UNDERSTANDING NONLIN; Moskvina V, 2003, COMMUN STAT-SIMUL C, V32, P319, DOI 10.1081/SAC-120017494; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Rykiel E, 1991, ECOLOGICAL MODELING, V90, P229; Schreiber T, 1997, PHYS REV LETT, V78, P843, DOI 10.1103/PhysRevLett.78.843; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Sprott JC, 2003, CHAOS TIME SERIES AN; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Theiler J., 1990, Lincoln Laboratory Journal, V3, P63; Valera HGA, 2016, AGR ECON-BLACKWELL, V47, P683, DOI 10.1111/agec.12265; Vautard R., 1999, ANAL CLIMATE VARIABI; Williams GP, 1997, CHAOS THEORY TAMED; ZHU Z, 2018, ASIA COMMUN PHOTON	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221167	10.1371/journal.pone.0221167	http://dx.doi.org/10.1371/journal.pone.0221167			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532779	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000532239600003
J	Yue, L; Yan, M; Tremblay, ML; Lin, TJ; Li, H; Yang, T; Song, X; Xie, TH; Xie, ZP				Yue, Lei; Yan, Min; Tremblay, Michel L.; Lin, Tong-Jun; Li, Hua; Yang, Ting; Song, Xia; Xie, Tianhong; Xie, Zhongping			PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INNATE IMMUNE-RESPONSES; SIGNAL-TRANSDUCTION; CYSTIC-FIBROSIS; LUNG; INFECTION; INFLAMMATION; ROLES	Neutrophils play a critical role in host defense against Pseudomonas aeruginosa infection. Mechanisms underlying the negative regulation of neutrophil function in bacterial clearance remain incompletely defined. Here, we demonstrate that protein tyrosine phosphatase-1B (PTP1B) is a negative regulator of P. aeruginosa clearance by neutrophils. PTP1B-deficient neutrophils display greatly enhanced bacterial phagocytosis and killing, which are accompanied by increased Toll-like receptor 4 (TLR4) signaling activation and nitric oxide (NO) production following P. aeruginosa infection. Interestingly, PTP1B deficiency mainly upregulates the production of IL-6 and IFN-beta, leads to enhanced TLR4-dependent STAT1 activation and iNOS expression by neutrophils following P. aeruginosa infection. Further studies reveal that PTP1B and STAT1 are physically associated. These findings demonstrate a negative regulatory mechanism in neutrophil underlying the elimination of P. aeruginosa infection though a PTP1B-STAT1 interaction.	[Yue, Lei; Li, Hua; Yang, Ting; Song, Xia; Xie, Tianhong; Xie, Zhongping] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Yan, Min] Kunming Med Univ, Dept Microbiol & Immunol, Kunming, Yunnan, Peoples R China; [Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming Medical University; McGill University; Dalhousie University; Dalhousie University	Xie, ZP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China.	xz218@126.com		Yue, Lei/0000-0001-5201-4373	National Natural Science Foundation of China [81471564, 81800012, 31560271]; Yunnan Natural Science Foundation [2016FB037, 2017FB019]; PUMC Youth Fund [3332016114]; Fundamental Research Funds for the Central Universities [2016ZX350070]; CAMS Innovation Fund for Medical Sciences [2016-I2M1-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CAMS Innovation Fund for Medical Sciences	This work received grant support from National Natural Science Foundation of China (81800012) (http://www.nsfc.gov.cn), Yunnan Natural Science Foundation (2016FB037, 2017FB019) (http://kjt.yn.gov.cn/), PUMC Youth Fund (3332016114) (http://www.cams.ac.cn) and Fundamental Research Funds for the Central Universities (2016ZX350070) (http://www.cams.ac.cn) to LY. MY has received grant support from National Natural Science Foundation of China (31560271) (http://www.nsfc.gov.cn).TJL has received grant support from National Natural Science Foundation of China (81471564) (http://www.nsfc.gov.cn).ZX is supported by CAMS Innovation Fund for Medical Sciences (2016-I2M1-019) (http://www.cams.ac.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Atherton-Fessler S, 1993, Semin Cell Biol, V4, P433, DOI 10.1006/scel.1993.1051; BERGER M, 1991, CLIN REV ALLERG, V9, P119; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Choi J, 2018, INT J CHRONIC OBSTR, V13, P3077, DOI 10.2147/COPD.S173759; Cigana C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21465; Cilloniz C, 2016, CHEST, V150, P415, DOI 10.1016/j.chest.2016.03.042; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Ji DB, 2011, MOL CARCINOGEN, V50, P945, DOI 10.1002/mc.20762; Jin YH, 2019, EUR REV MED PHARMACO, V23, P5020, DOI 10.26355/eurrev_201906_18094; Junkins RD, 2014, AM J PATHOL, V184, P2310, DOI 10.1016/j.ajpath.2014.05.009; Junkins RD, 2013, J IMMUNOL, V190, P5178, DOI 10.4049/jimmunol.1203196; Kim HY, 2017, MOL IMMUNOL, V82, P75, DOI 10.1016/j.molimm.2016.12.016; Kim YI, 2015, INT J MOL MED, V36, P1165, DOI 10.3892/ijmm.2015.2308; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Lewis RS, 2011, J IMMUNOL, V187, P3798, DOI 10.4049/jimmunol.1002993; Liang XL, 2019, FASEB J, V33, P3562, DOI 10.1096/fj.201802002R; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Manda-Handzlik A, 2015, ADV EXP MED BIOL, V857, P51, DOI 10.1007/5584_2015_117; Miller CC, 2013, J CYST FIBROS, V12, P817, DOI 10.1016/j.jcf.2013.01.008; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; O'Sullivan R, 2008, IMMUNOBIOLOGY, V213, P469, DOI 10.1016/j.imbio.2007.11.007; Parker D, 2016, PHYSIOL REV, V96, P19, DOI 10.1152/physrev.00009.2015; Pike KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005020; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Ryu JC, 2017, MUCOSAL IMMUNOL, V10, P757, DOI 10.1038/mi.2016.73; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; Vareechon C, 2017, CELL HOST MICROBE, V21, P611, DOI 10.1016/j.chom.2017.04.001; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Walford Hannah H, 2013, JAKSTAT, V2, pe25301, DOI 10.4161/jkst.25301; Wiese J, 2017, MAR DRUGS, V15, DOI 10.3390/md15060191; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Yue L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205521; Yue L, 2016, AM J PATHOL, V186, P1234, DOI 10.1016/j.ajpath.2016.01.005; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222753	10.1371/journal.pone.0222753	http://dx.doi.org/10.1371/journal.pone.0222753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532798	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600037
J	Tavano, A; Schroger, E; Kotz, SA				Tavano, Alessandro; Schroger, Erich; Kotz, Sonja A.			Beta power encodes contextual estimates of temporal event probability in the human brain	PLOS ONE			English	Article							ORIENTING ATTENTION; BAND OSCILLATIONS; PARIETAL CORTEX; ELAPSED TIME; SHORT-TERM; EEG; EXPECTATION; COMPONENT; DYNAMICS; REPRESENTATION	To prepare for an impending event of unknown temporal distribution, humans internally increase the perceived probability of event onset as time elapses. This effect is termed the hazard rate of events. We tested how the neural encoding of hazard rate changes by providing human participants with prior information on temporal event probability. We recorded behavioral and electroencephalographic (EEG) data while participants listened to continuously repeating five-tone sequences, composed of four standard tones followed by a nontarget deviant tone, delivered at slow (1.6 Hz) or fast (4 Hz) rates. The task was to detect a rare target tone, which equiprobably appeared at either position two, three or four of the repeating sequence. In this design, potential target position acts as a proxy for elapsed time. For participants uninformed about the target's distribution, elapsed time to uncertain target onset increased response speed, displaying a significant hazard rate effect at both slow and fast stimulus rates. However, only in fast sequences did prior information about the target's temporal distribution interact with elapsed time, suppressing the hazard rate. Importantly, in the fast, uninformed condition pre-stimulus power synchronization in the beta band (Beta 1, 15-19 Hz) predicted the hazard rate of response times. Prior information suppressed pre-stimulus power synchronization in the same band, while still significantly predicting response times. We conclude that Beta 1 power does not simply encode the hazard rate, but-more generally-internal estimates of temporal event probability based upon contextual information.	[Tavano, Alessandro; Schroger, Erich] Univ Leipzig, Inst Psychol, BioCog Cognit Incl Biol Psychol, Leipzig, Germany; [Tavano, Alessandro] Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands	Leipzig University; Max Planck Society; Maastricht University	Tavano, A (corresponding author), Univ Leipzig, Inst Psychol, BioCog Cognit Incl Biol Psychol, Leipzig, Germany.; Tavano, A (corresponding author), Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany.	alessandro.tavano@ae.mpg.de	; Schroger, Erich/C-3079-2009	Tavano, Alessandro/0000-0002-2096-5542; Schroger, Erich/0000-0002-8321-6629	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); DFG [2268/6-1]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project(German Research Foundation (DFG))	ES was awarded a Reinhart-Koselleck Project grant by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). SAK was awarded a DFG grant (2268/6-1).; This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project grant awarded to E. Schroger and by a DFG grant (2268/6-1) awarded to Sonja A. Kotz. The authors would like to thank Matt Craddock, Maren Grigutch, Philipp Ruhnau, Michael Schwartze, Burkhard Maess, Peter Lakatos, David Poeppel, and an anonymous reviewer for insightful discussions and help with the experimental setup and data analyses, and Katrin Ina Koch for data collection.	Ahveninen J, 2002, NEUROIMAGE, V16, P1052, DOI 10.1006/nimg.2002.1142; American National Standards Institute, 1996, S361996 ANSI; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bendixen A, 2008, NEUROIMAGE, V41, P1111, DOI 10.1016/j.neuroimage.2008.03.040; Bermudez MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0468; BERTELSON P, 1967, Q J EXP PSYCHOL, V19, P272, DOI 10.1080/14640746708400102; Bolger D, 2014, J COGNITIVE NEUROSCI, V26, P593, DOI 10.1162/jocn_a_00511; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Chang A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00327; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Cotti J, 2011, NEUROIMAGE, V54, P1221, DOI 10.1016/j.neuroimage.2010.09.038; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2014, PROCD SOC BEHV, V126, P41, DOI 10.1016/j.sbspro.2014.02.311; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Cowan N, 1997, PSYCHON B REV, V4, P393, DOI 10.3758/BF03210799; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Davranche K, 2011, J COGNITIVE NEUROSCI, V23, P3318, DOI 10.1162/jocn_a_00030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 2003, COGNITIVE BRAIN RES, V15, P137, DOI 10.1016/S0926-6410(02)00147-7; Elithorn A, 1955, Q J EXP PSYCHOL, V11, P211; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fujioka T, 2015, J NEUROSCI, V35, P15187, DOI 10.1523/JNEUROSCI.2397-15.2015; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; Gulberti A, 2015, NEUROIMAGE-CLIN, V9, P436, DOI 10.1016/j.nicl.2015.09.013; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hultin L, 1996, ELECTROEN CLIN NEURO, V98, P435, DOI 10.1016/0013-4694(96)95507-8; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Kopell N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00187; Lee JH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003164; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Luce RD, 1986, RESPONSE TIMES THEIR; Luft CDB, 2015, J NEUROPHYSIOL, V113, P3159, DOI 10.1152/jn.00753.2014; Macmillan N. A., 1991, DETECTION THEORY USE; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Michalareas G, 2016, NEURON, V89, P384, DOI 10.1016/j.neuron.2015.12.018; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.004.2007; Nobre K, 2010, ATTENTION TIME; NOVAK GP, 1990, ELECTROEN CLIN NEURO, V75, P255, DOI 10.1016/0013-4694(90)90105-S; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Schroger E, 2015, EUR J NEUROSCI, V41, P641, DOI 10.1111/ejn.12816; Schulze K, 2013, MEMORY, V21, P377, DOI 10.1080/09658211.2012.731070; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sokolov EN, 2002, ORIENTING RESPONSE I, P241; Spitzer B, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0170-17.2017; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Tavano A, 2014, EUR J NEUROSCI, V39, P308, DOI 10.1111/ejn.12404; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Todorovic A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120288; Vangkilde S, 2012, J EXP PSYCHOL HUMAN, V38, P1183, DOI 10.1037/a0026343; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wilsch A, 2015, CEREB CORTEX, V25, P1938, DOI 10.1093/cercor/bhu004; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	82	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222420	10.1371/journal.pone.0222420	http://dx.doi.org/10.1371/journal.pone.0222420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557168	Green Published, gold, Green Submitted			2022-12-27	WOS:000532345500019
J	Babaei, M; Liu, YK; Wuerzberger-Davis, SM; McCaslin, EZ; DiRusso, CJ; Yeo, AT; Kagermazova, L; Miyamoto, S; Gilmore, TD				Babaei, Milad; Liu, Yuekun; Wuerzberger-Davis, Shelly M.; McCaslin, Ethan Z.; DiRusso, Christopher J.; Yeo, Alan T.; Kagermazova, Larisa; Miyamoto, Shigeki; Gilmore, Thomas D.			CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein	PLOS ONE			English	Article							NF-KAPPA-B; ALTERNATIVE PROMOTER; CRISPR; GAMMA; MUTATIONS; GENE; EXPRESSION; DELETION; PATHWAY	The use of alternative promoters for the cell type-specific expression of a given mRNA/protein is a common cell strategy. NEMO is a scaffold protein required for canonical NF-kappa B signaling. Transcription of the NEMO gene is primarily controlled by two promoters: one (promoter B) drives NEMO transcription in most cell types and the second (promoter D) is largely responsible for NEMO transcription in liver cells. Herein, we have used a CRISPR/Cas9-based approach to disrupt a core sequence element of promoter B, and this genetic editing essentially eliminates expression of NEMO mRNA and protein in 293T human kidney cells. By cell subcloning, we have isolated targeted 293T cell lines that express no detectable NEMO protein, have defined genomic alterations at promoter B, and do not support activation of canonical NF-kappa B signaling in response to treatment with tumor necrosis factor. Nevertheless, non-canonical NF-kappa B signaling is intact in these NEMO-deficient cells. Expression of ectopic wildtype NEMO, but not certain human NEMO disease mutants, in the edited cells restores downstream NF-kappa B signaling in response to tumor necrosis factor. Targeting of the promoter B element does not substantially reduce NEMO expression (from promoter D) in the human SNU423 liver cancer cell line. Thus, we have created a strategy for selectively eliminating cell type-specific expression from an alternative promoter and have generated 293T cell lines with a functional knockout of NEMO. The implications of these findings for further studies and for therapeutic approaches to target canonical NF-kappa B signaling are discussed.	[Babaei, Milad; Liu, Yuekun; McCaslin, Ethan Z.; DiRusso, Christopher J.; Yeo, Alan T.; Kagermazova, Larisa; Gilmore, Thomas D.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Carbone Canc Ctr, Dept Oncol, 1400 Univ Ave, Madison, WI 53706 USA	Boston University; University of Wisconsin System; University of Wisconsin Madison	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu		Gilmore, Thomas/0000-0002-1910-768X	National Institutes of Health [CA077474, GM117350]; Boston University Undergraduate Research Opportunities Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Undergraduate Research Opportunities Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (www.nih.gov) grants CA077474 (to S.M.) and GM117350 (to T.D.G.). M. B., Y.L., L.K, and E.Z.M. were supported by funds from the Boston University Undergraduate Research Opportunities Program (www.bu.edu/urop).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoubi TA, 2011, FASEB J, V10, P453; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Cote SM, 2013, BIOCHEMISTRY-US, V52, P9141, DOI 10.1021/bi401368r; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fusco F, 2004, HUM MOL GENET, V13, P1763, DOI 10.1093/hmg/ddh192; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Fusco F, 2012, HUM MOL GENET, V21, P1260, DOI 10.1093/hmg/ddr556; Galgoczy P, 2001, GENE, V271, P93, DOI 10.1016/S0378-1119(01)00492-9; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Herscovitch M, 2008, BIOCHEM BIOPH RES CO, V367, P103, DOI 10.1016/j.bbrc.2007.12.123; Jackson SS, 2015, METHODS MOL BIOL, V1280, P197, DOI 10.1007/978-1-4939-2422-6_11; Kawai T, 2012, BLOOD, V119, P5458, DOI 10.1182/blood-2011-05-354167; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Lawhorn IEB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113232; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; Ngoc LV, 2017, GENE DEV, V31, P6, DOI 10.1101/gad.293837.116; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Maier HJ, 2013, ONCOGENE, V32, P2690, DOI 10.1038/onc.2012.272; Maubach G, 2017, TRENDS MOL MED, V23, P1138, DOI 10.1016/j.molmed.2017.10.004; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan YC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7199; Puar YR, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6030082; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Salt BH, 2008, J ALLERGY CLIN IMMUN, V121, P976, DOI 10.1016/j.jaci.2007.11.014; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shaffer R, 2019, BIOCHEMISTRY-US, V58, P2906, DOI 10.1021/acs.biochem.8b01316; Stepanenko A, 2015, MUTAT RES-FUND MOL M, V771, P56, DOI 10.1016/j.mrfmmm.2014.12.006; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Vacik T, 2017, PROTOPLASMA, V254, P1201, DOI 10.1007/s00709-016-1071-y; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222588	10.1371/journal.pone.0222588	http://dx.doi.org/10.1371/journal.pone.0222588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553754	Green Submitted, gold, Green Published			2022-12-27	WOS:000532319200032
J	Svenson, KL; Long, LL; Ciciotte, SL; Adams, MD				Svenson, Karen L.; Long, Lauren L.; Ciciotte, Steven L.; Adams, Mark D.			A mutation in mouse Kruppel-like factor 15 alters the gut microbiome and response to obesogenic diet	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; KLF15; EXPRESSION; REGULATOR; OBESITY; ENVIRONMENT; HOMEOSTASIS; ACTIVATION; GENOTYPE	We identified a mouse strain, HLB444, carrying an N-ethyl-N-nitrosourea (ENU)-induced mutation in a highly conserved C2H2 zinc-finger DNA binding motif of the transcriptional regulator KLF15 that exhibits resistance to diet-induced obesity. Characterization of the HLB444 mutant model on high-fat and chow diets revealed a number of phenotypic differences compared to wild-type controls. When fed a high fat diet, HLB444 had lower body fat, resistance to hepatosteatosis, lower circulating glucose and improved insulin sensitivity compared to C57BL/6J controls. Gut microbial profiles in HLB444 generated from 16S rRNA sequencing of fecal samples differed from controls under both chow and high fat diets. HLB444 shares similar phenotypic traits with engineered full- and adipose-specific Klf15 knockout strains; however, some phenotypic differences between this mutant and the other models suggest that the Klf15 mutation in HLB444 is a hypomorphic variant. The HLB444 model will inform further annotation of transcriptional functions of KLF15, especially with respect to the role of the first zinc-finger domain.	[Svenson, Karen L.; Ciciotte, Steven L.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Long, Lauren L.; Adams, Mark D.] Jackson Lab, Farmington, CT USA	Jackson Laboratory; Jackson Laboratory	Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	karen.svenson@jax.org		Adams, Mark/0000-0003-3161-7460; Svenson, Karen/0000-0002-7928-1911	National Institutes of Health, NIDDK [DK087790]; Jackson Laboratory Scientific Services award (SSIF2017)	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Jackson Laboratory Scientific Services award (SSIF2017)	This work was supported by a grant to KLS by National Institutes of Health, NIDDK grant number DK087790, and by a Jackson Laboratory Scientific Services award (SSIF2017) to KLS and MDA. Funders played no role in the study design, data collection, data analysis, decision to publish or in preparation of the manuscript.	Aggarwal A, 2017, CELL REP, V21, P2367, DOI 10.1016/j.celrep.2017.11.004; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2005, PERMANOVA FRTRAN COM, DOI [10.1371/journal.pone.0116704, DOI 10.1371/JOURNAL.PONE.0116704]; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradberry J Chris, 2013, P T, V38, P681; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feingold K.R., 2000, ENDOTEXT; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Han SX, 2019, NAT METAB, V1, P422, DOI 10.1038/s42255-019-0054-7; Hodin CM, 2011, AM J PATHOL, V179, P2885, DOI 10.1016/j.ajpath.2011.08.030; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jung DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077851; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leenders JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036754; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liberzon D, 2011, IEEE DECIS CONTR P, P417, DOI 10.1109/CDC.2011.6160335; Lim S, 2014, REV ENDOCR METAB DIS, V15, P329, DOI 10.1007/s11154-014-9298-4; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matoba K, 2017, CELL REP, V21, P3129, DOI 10.1016/j.celrep.2017.11.032; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Oksanen J., 2022, R PACKAGE VERSION; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Pabona JMP, 2010, ENDOCRINOLOGY, V151, P3396, DOI 10.1210/en.2009-1370; Pan FW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0440-5; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Sheng LL, 2018, FASEB J, V32, P6371, DOI 10.1096/fj.201800370R; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svenson KL, 2008, J LIPID RES, V49, P2452, DOI 10.1194/jlr.M800303-JLR200; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Svenson KL, 2002, CIRCULATION; Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038	74	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222536	10.1371/journal.pone.0222536	http://dx.doi.org/10.1371/journal.pone.0222536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553739	Green Submitted, Green Published, gold			2022-12-27	WOS:000532319200030
J	Benjamin, A; Cavalcante, SC; Jamal, LF; Arakaki-Sanchez, D; de Lima, JN; Pilotto, JH; de Oliveira, FI; Souza, TNL; Lourenco, MC; de Mello, MB; do Brasil, PEAA; Barreira, D; Rolla, V				Benjamin, Aline; Cavalcante, Solange Cesar; Jamal, Leda Fatima; Arakaki-Sanchez, Denise; de Lima, Josue Nazareno; Pilotto, Jose Henrique; de Oliveira Junior, Francisco Ivanildo; Lobato Souza, Tamara Newman; Lourenco, Maria Cristina; de Mello, Maeve Brito; Alvarenga Americano do Brasil, Pedro Emmanuel; Barreira, Draurio; Rolla, Valeria			Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIGEN	Background Determine TB-LAM Ag (LAM) is a point of care test developed to diagnose tuberculosis (TB). The aim of this study was to evaluate the diagnostic performance of LAM in people living with HIV using Brazilian public health network algorithm for TB diagnosis. Methods and findings A cross-sectional study design was used to enroll 199 adult patients in two sites in Rio de Janeiro and two in Sao Paulo. The study enrolled HIV-infected patients with CD4 counts <= 200 cells/mm(3) (in the Alere PIMA CD4 assay at study screening), patients coughing for at least 2 weeks or presenting a chest radiography suggestive of TB. LAM, in conjunction with sputum smear microscopy or Xpert MTB/RIF (Xpert) as compared to Mycobacterium tuberculosis culture, which was used as a reference standard. TB prevalence was 24.6%. Overall accuracy of LAM was 79.9% (73.8%-84.9%), positive and negative predictive values were 62.2% (46.1%-75.9%) and 84% (77.5%-88.8%), respectively. The overall LAM sensitivity was 46.9% (33.7%-60.6%) and specificity was 90.7% (84.9%-94.4%). The best performance of LAM was observed among patients with CD4 counts <= 50 cells/mm(3) (sensitivity = 70.4% and specificity = 85.9%). When 2 respiratory smears were used in conjunction with LAM, sensitivity increased 22%, as compared to just 2 smears. Furthermore, LAM when used in conjunction with two respiratory smears, was as sensitive as compared to a single one. However, no improvement in TB diagnosis occurred when LAM was used with Xpert as compared to Xpert alone. Among 14 LAM false positive tests, Non-Tuberculosis Mycobacteria were isolated in three cases. Conclusion LAM is a point of care test that increased TB diagnosis in immunosuppressed HIV-infected patients when used in conjunction with smear microscopy, but not when used with Xpert in Brazilian public health network sites. Use of LAM test should be considered in settings where immunosuppressed HIV patients need rapid TB diagnosis.	[Benjamin, Aline; Cavalcante, Solange Cesar; Rolla, Valeria] Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Reasearch Lab Mycobacteria, Rio De Janeiro, Brazil; [Jamal, Leda Fatima] Hlth Secretariat State Sao Paulo, STD AIDS Reference & Training Ctr, Sao Paulo, Brazil; [Arakaki-Sanchez, Denise; de Lima, Josue Nazareno] Minist Hlth, Natl TB Program, Brasilia, DF, Brazil; [Pilotto, Jose Henrique] Nova Iguacu Gen Hosp, STD AIDS Serv, Rio De Janeiro, Brazil; [Pilotto, Jose Henrique] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [de Oliveira Junior, Francisco Ivanildo; Lobato Souza, Tamara Newman] Inst Infect Dis Emilio Ribas, Sao Paulo, Brazil; [Lourenco, Maria Cristina] Fundacao Oswaldo Cruz, Bacteriol & Bioassay Lab, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil; [de Mello, Maeve Brito] Pan Amer Hlth Org, Washington, DC USA; [Alvarenga Americano do Brasil, Pedro Emmanuel] Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Res Lab Immunizat & Surveillance Hlth, Rio De Janeiro, Brazil; [Barreira, Draurio] Unitaid, Geneva, Switzerland	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Pan American Health Organization; Fundacao Oswaldo Cruz	Benjamin, A (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Reasearch Lab Mycobacteria, Rio De Janeiro, Brazil.	aline.benjamin@ini.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Brasil, Pedro E A A/B-4357-2008; Pilotto, Jose Henrique/AAD-9773-2019; Arakaki-Sanchez, Denise/M-4766-2013	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Brasil, Pedro E A A/0000-0002-6700-2268; Pilotto, Jose Henrique/0000-0003-0521-8597; de Oliveira Junior, Francisco Ivanildo/0000-0003-0767-0536	Brazilian Tuberculosis Control Program; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [NU2GGH001152]	Brazilian Tuberculosis Control Program; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by Brazilian Tuberculosis Control Program and by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement Number NU2GGH001152. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	[Anonymous], 2015, US LAT FLOW UR LIP A; Balcha TT, 2014, TROP MED INT HEALTH, V19, P734, DOI 10.1111/tmi.12308; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2015, RED TEST RAP TUB BRA; Drain PK, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx167; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Gupta-Wright A, 2018, LANCET, V392, P292, DOI [10.1016/S0140-6736(18)31267-4, 10.1016/s0140-6736(18)31267-4]; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Medeiros MF, 2014, APPL IMMUNOHISTO M M, V22, P222, DOI 10.1097/PAI.0b013e31828dc70c; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Ministerio da Saude, REC DIAGN TUB MEIO T, P1405, DOI [10.1183/09031936.00025711, DOI 10.1183/09031936.00025711]; Ministerio da Saude (BR), 2008, MAN NAC VIG LAB TUB; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; Murray JF, 2005, INT J TUBERC LUNG D, V9, P826; N'Dhatz M., 1994, Revue de Pneumologie Clinique, V50, P317; Nahas AA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01205; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	21	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221038	10.1371/journal.pone.0221038	http://dx.doi.org/10.1371/journal.pone.0221038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550246	gold, Green Published			2022-12-27	WOS:000532307700005
J	Knerich, V; Jones, AA; Seyedin, S; Siu, C; Dinh, L; Mostafavi, S; Barr, AM; Panenka, WJ; Thornton, AE; Honer, WG; Rutherford, AR				Knerich, Verena; Jones, Andrea A.; Seyedin, Sam; Siu, Christopher; Dinh, Louie; Mostafavi, Sara; Barr, Alasdair M.; Panenka, William J.; Thornton, Allen E.; Honer, William G.; Rutherford, Alexander R.			Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada	PLOS ONE			English	Article							DRUG-USE; HOMELESS; SEX; YOUTH; RISK; METHAMPHETAMINE; INTERVENTIONS; PREVENTION; MORTALITY; DISORDER	Background The structure of a social network as well as peer behaviours are thought to affect personal substance use. Where substance use may create health risks, understanding the contribution of social networks to substance use may be valuable for the design and implementation of harm reduction or other interventions. We examined the social support network of people living in precarious housing in a socially marginalized neighborhood of Vancouver, and analysed associations between social network structure, personal substance use, and supporters' substance use. Methods An ongoing, longitudinal study recruited 246 participants from four single room occupancy hotels, with 201 providing social network information aligned with a 6-month observation period. Use of tobacco, alcohol, cannabis, cocaine (crack and powder), methamphetamine, and heroin was recorded at monthly visits. Ego- and graph-level measures were calculated; the dispersion and prevalence of substances in the network was described. Logistic mixed effects models were used to estimate the association between ego substance use and peer substance use. Permutation analysis was done to test for randomness of substance use dispersion on the social network. Results The network topology corresponded to residence (Hotel) with two clusters differing in demographic characteristics (Cluster 1 -Hotel A: 94% of members, Cluster 2 -Hotel B: 95% of members). Dispersion of substance use across the network demonstrated differences according to network topology and specific substance. Methamphetamine use (overall 12%) was almost entirely limited to Cluster 1, and absent from Cluster 2. Different patterns were observed for other substances. Overall, ego substance use did not differ over the six-month period of observation. Ego heroin, cannabis, or crack cocaine use was associated with alter use of the same substances. Ego methamphetamine, powder cocaine, or alcohol use was not associated with alter use, with the exception for methamphetamine in a densely using part of the network. For alters using multiple substances, cannabis use was associated with lower ego heroin use, and lower ego crack cocaine use. Permutation analysis also provided evidence that dispersion of substance use, and the association between ego and alter use was not random for all substances. Conclusions In a socially marginalized neighborhood, social network topology was strongly influenced by residence, and in turn was associated with type(s) of substance use. Associations between personal use and supporter's use of a substance differed across substances. These complex associations may merit consideration in the design of interventions to reduce risk and harms associated with substance use in people living in precarious housing.	[Knerich, Verena] Ludwig Maximilians Univ Munchen, Dept Comp Sci, Munich, Germany; [Knerich, Verena] Ludwig Maximilians Univ Munchen, Dept Cultural Anthropol, Munich, Germany; [Knerich, Verena; Jones, Andrea A.; Seyedin, Sam; Siu, Christopher; Panenka, William J.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Dinh, Louie] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Off, Med Genet, Vancouver, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Rutherford, Alexander R.] Simon Fraser Univ, Dept Math, Burnaby, BC, Canada	University of Munich; University of Munich; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University; Simon Fraser University	Rutherford, AR (corresponding author), Simon Fraser Univ, Dept Math, Burnaby, BC, Canada.	arruther@sfu.ca		Dinh, Louie/0000-0003-0457-0142; Panenka, William/0000-0001-7143-6512; Barr, Alasdair/0000-0002-3407-1574	Simon Fraser University Big Data Initiative; Canadian Institutes of Health Research grants [CBG-101827, MOP-137103]; British Columbia Mental Health and Addictions Services; Jack Bell Chair in Schizophrenia at the University of British Columbia	Simon Fraser University Big Data Initiative; Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); British Columbia Mental Health and Addictions Services; Jack Bell Chair in Schizophrenia at the University of British Columbia	VK and ARR were supported in part by the Simon Fraser University Big Data Initiative during this research. The study was funded by Canadian Institutes of Health Research grants CBG-101827 and MOP-137103 (http://www.cihrirsc.gc.ca/).Additional support was provided by British Columbia Mental Health and Addictions Services. WGH was supported by the Jack Bell Chair in Schizophrenia at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; Barman-Adhikari A, 2015, J SOC SOC WORK RES, V6, P433, DOI 10.1086/682709; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; Barrera M., 1980, CONNECTIONS, V3, P8; Bates D.M., LME4 MIXED EFFECTS M; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bertholet N, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-15; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Deans Gregory D, 2013, CMAJ Open, V1, pE68, DOI 10.9778/cmajo.20130002; Dombrowski Kirk, 2013, World J AIDS, V3, P1; Duncan GJ, 2005, J ABNORM CHILD PSYCH, V33, P375, DOI 10.1007/s10802-005-3576-2; El-Bassel N, 1998, SOC SERV REV, V72, P379, DOI 10.1086/515764; El-Bassel N, 2006, J URBAN HEALTH, V83, P602, DOI 10.1007/s11524-006-9075-0; Ferrence R, 2001, ADDICTION, V96, P165, DOI 10.1046/j.1360-0443.2001.96116512.x; Friedman SR, 1997, SEX TRANSM DIS, V24, P322, DOI 10.1097/00007435-199707000-00003; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gaetz S, 2012, CANADIAN DEFINITION; GOEHL L, 1993, AM J DRUG ALCOHOL AB, V19, P251, DOI 10.3109/00952999309001617; Gruenewald PJ, 2013, AM J PUBLIC HEALTH, V103, P1262, DOI 10.2105/AJPH.2012.300779; Hastie TJ., 2017, GEN ADDITIVE MODELS; HONER WG, 1987, LANCET, V2, P451; Honer WG, 2017, CAN J PSYCHIAT, V62, P482, DOI 10.1177/0706743717693781; Hurd YL, 2017, TRENDS NEUROSCI, V40, P124, DOI 10.1016/j.tins.2016.12.006; Jones AA, 2018, JAMA PSYCHIAT, V75, P298, DOI 10.1001/jamapsychiatry.2017.4432; Jones AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008876; Jones AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079754; Kelly JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100121; Krausz M, 2015, LANCET PSYCHIAT, V2, pE5, DOI 10.1016/S2215-0366(15)00045-0; Lakon CM, 2006, SOC SCI MED, V63, P2489, DOI 10.1016/j.socscimed.2006.06.015; Latkin CA, 2017, J URBAN HEALTH, V94, P534, DOI 10.1007/s11524-017-0170-1; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Latkin CA, 2013, AM PSYCHOL, V68, P210, DOI 10.1037/a0032704; Luchenski S, 2018, LANCET, V391, P266, DOI 10.1016/S0140-6736(17)31959-1; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Mason Michael, 2004, Subst Use Misuse, V39, P1751, DOI 10.1081/LSUM-200033222; McDonald LJ, 2011, AM J ADDICTION, V20, P100, DOI 10.1111/j.1521-0391.2010.00117.x; Melander LA, 2016, J CHILD ADOLES SUBST, V25, P78, DOI 10.1080/1067828X.2014.918003; Miller WC, 2018, LANCET, V392, P747, DOI 10.1016/S0140-6736(18)31487-9; Min MO, 2013, J SUBST ABUSE TREAT, V45, P325, DOI 10.1016/j.jsat.2013.04.006; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rice E, 2013, ADDICTION, V108, P1625, DOI 10.1111/add.12255; Rice E, 2012, AM J PUBLIC HEALTH, V102, P141, DOI 10.2105/AJPH.2011.300295; Rice E, 2011, PREV SCI, V12, P80, DOI 10.1007/s11121-010-0191-4; Rothenberg R B, 1995, NIDA Res Monogr, V151, P3; Schroeder JR, 2001, ANN EPIDEMIOL, V11, P389, DOI 10.1016/S1047-2797(01)00225-3; Stone A, 2016, ALCOHOL TREAT Q, V34, P315, DOI 10.1080/07347324.2016.1182818; Tobin KE, 2014, INT J DRUG POLICY, V25, P591, DOI 10.1016/j.drugpo.2013.12.006; Tracy EM, 2016, J SUBST ABUSE TREAT, V62, P55, DOI 10.1016/j.jsat.2015.11.002; Valente T., 2003, CONNECTIONS CONNECT, V25, P11; Valente Thomas W, 2004, Subst Use Misuse, V39, P1685, DOI 10.1081/JA-200033210; Valente TW, 2017, ANNU REV PUBL HEALTH, V38, P103, DOI 10.1146/annurev-publhealth-031816-044528; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1213, DOI 10.1176/appi.ajp.2013.13020215; Wu L., 2019, MIXED EFFECTS MODELS, P113	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222611	10.1371/journal.pone.0222611	http://dx.doi.org/10.1371/journal.pone.0222611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545818	Green Submitted, Green Published, gold			2022-12-27	WOS:000532303200023
J	Sadowski, A; Wojcieszak, MM				Sadowski, Arkadiusz; Wojcieszak, Monika Malgorzata			Geographic differentiation of agritourism activities in Poland vs. cultural and natural attractiveness of destinations at district level	PLOS ONE			English	Article							RURAL TOURISM; SUSTAINABILITY	One of the trends in today's tourism sector is the development of environmentally-friendly tourism activities which rely on natural resources of cultural heritage and on biodiversity. This is definitely the case for agritourism, a form of rural tourism. The purpose of this paper is to identify the development aspects of Polish agritourism with particular emphasis on natural and cultural attractiveness. To demonstrate the relationship between agritourism activities of Polish farms and the cultural and natural attractiveness, the Hellwig's synthetic development indicator was used. As shown by research, the cultural and natural attractiveness of a destination is an important exogenous development factor. Another finding was that the intensified efforts undertaken by the farmers to access EU funds were not focused on areas with valuable natural or cultural resources and an untapped agritourism potential; instead, they were oriented at regions dominated by semi-subsistence or family farms. For a large part of farmers, the new form of support is about to become a source of additional incomes.	[Sadowski, Arkadiusz; Wojcieszak, Monika Malgorzata] Poznan Univ Life Sci, Fac Econ & Social Sci, Dept Econ & Econ Policy Agribusiness, Poznan, Poland	Poznan University of Life Sciences	Sadowski, A (corresponding author), Poznan Univ Life Sci, Fac Econ & Social Sci, Dept Econ & Econ Policy Agribusiness, Poznan, Poland.	sadowski@up.poznan.pl		Wojcieszak-Zbierska, Monika/0000-0002-9962-2648; Sadowski, Arkadiusz/0000-0002-8236-1007				Ackovska M, 2016, BALKAN NEAR E J SOCI, V2, P121; Aganowski M., 2012, ZESZYTY NAUKOWE UNIW, V705, P7; [Anonymous], 2017, REP AG RESTR MOD AGR; [Anonymous], 2016, POL AGR FOOD EC; Arroyo CG, 2013, TOURISM MANAGE, V37, P39, DOI 10.1016/j.tourman.2012.12.007; Aswani S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195440; Badulescu D, 2015, AGR ECON-CZECH, V61, P72, DOI 10.17221/94/2014-AGRICECON; Baer-Nawrocka A, 2018, BERICHTE CABER LANDW, V96, P1, DOI DOI 10.1016/S2212-5671(15)00265-8; Bajgier-Kowalska M., 2016, PRZEDSIBIORCZO EDUKA, V12, P256; Balinska A., 2016, STOWARZYSZENIE EKONO, V21, P21; Barbieri C, 2008, SOCIOL RURALIS, V48, P166, DOI 10.1111/j.1467-9523.2008.00450.x; Barbieri C, 2013, J SUSTAIN TOUR, V21, P252, DOI 10.1080/09669582.2012.685174; Barbu I., 2016, ANALELE U CONSTANTIN, V6, P253; Bedrac M, 2010, EKON POLJOPR, V57, P243; bniewska M., 1997, AGROTURYSTYKA KOSZTY; Boguslavsky M. V., 2014, PROBLEMI SOVREMENNOG, V1, P5; Brandth B, 2011, J RURAL STUD, V27, P35, DOI 10.1016/j.jrurstud.2010.09.002; Brelik A., 2011, OECONOMIA, V10, P19; Central Statsistical Office, 2011, RUR AR POL; Cha F, 2004, J ANKANG NORMAL COLL, V16, P29; Chase LC, 2017, SAGE INT ENCY TRAVEL; Chase LC, 2018, J AGRIC FOOD SYST CO, V8, P13, DOI 10.5304/jafscd.2018.081.016; Chirit<comma>escu V., 2011, AGR EC RURAL DEV, P241; Chrysolite BP, RESPONSIBLE TOURISM, P1; Ciani A, 2017, NEW DIRECT TOUR ANAL, V41, P68; Ciepiela GA, 2010, OECONOMIA, V9, P45; Cigale D., 2012, AGRITOURISM EMBEDDED, P27; Ciszewska A., 2009, TRWALOSC EFEKTYWNOSC; CONG F, 2003, J DALI U, V4, P10; Di Domenico M, DEV TOURISM RES, P21; Dubois C., 2012, AGRITOURISM EMBEDDED, P33; Ehrlich K, 2017, NEW DIRECT TOUR ANAL, V41, P84; Fagioli F. F., 2014, Rivista di Economia Agraria, V69, P155; Ferens E., 2013, ZESZYTY NAUKOWE SGGW, V102, P113; Flanigan S, 2015, J RURAL STUD, V41, P129, DOI 10.1016/j.jrurstud.2015.08.002; Fleischer A, 2005, TOURISM MANAGE, V26, P493, DOI 10.1016/j.tourman.2003.10.003; Gartner W. C., 2004, International Journal of Tourism Research, V6, P151, DOI 10.1002/jtr.481; Gevrenova T., 2015, TRAKIA J SCI, V13, P321, DOI 10.15547/tjs.2015.s.02.068; Hjalager AM, 2010, TOURISM MANAGE, V31, P1, DOI 10.1016/j.tourman.2009.08.012; Iakovidou O., 1997, Medit, V8, P44; Idris K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150741; Jafari J, 2000, ENCY TOURISM; Jalinik M., 2007, TURYSTYKA ROZWOJU OB, P343; Jalinik M., 2009, UWARUNKOWANIA CZYNIK; Jurincic I., 2012, AGRITOURISM EMBEDDED, P44; Kapusta F., 2008, AGROBIZNES; Kizos T, 2007, S EUR SOC POLIT, V12, P59, DOI 10.1080/13608740601155443; Kruczek Z., 2014, REGIONY TURYSTYCZNE; Krzyzanowska K, 2013, BUDOWANIE KONKURENCY; Kurczewski R., 2016, TURYSTYKA WIEJSKA ZA, P9; Kurek W., 2012, TURYSTYKA; Kurtyka-Marcak I, 2017, J AGRIBUSSINESS RURA, V2, P383, DOI [10.17306/J.JARD.2017.00257, DOI 10.17306/J.JARD.2017.00257]; Lijewski T, 2017, GEOGRAFIA TURYSTYKI; Lubke S., 2012, AGRITOURISM EMBEDDED, P60; Lukasiewicz K., 2017, ROCZNIKI NAUKOWE STO, V29, P147; Ma B, 1996, THEORY PRACTICE REGI; Marques H., 2006, Tourism Economics, V12, P147; Marsat J. - B., 2012, AGRITOURISM EMBEDDED, P68; Mikrut K, 2017, NEW DIRECT TOUR ANAL, V41, P156; Mlynarczyk K, 2002, AGROTURYSTYKA; Moller H, 2004, ECOL SOC, V9; Naminse EY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194912; Ollenburg C., 2006, FARM TOURISM AUSTR F; Oppermann M, 1996, ANN TOURISM RES, V23, P86, DOI 10.1016/0160-7383(95)00021-6; Pakurar M, 2008, ECOTOXICOLOGIE ZOOTE, V7, P777; Palka E., 2010, KIERUNKI ROZWOJU POZ, P1; Panasiuk A., 2017, INTERCATHEDRA, V33, P83; Perpar A., 2012, AGRITOURISM EMBEDDED, P84; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Phelan C, 2011, TOUR PLAN DEV, V8, P121, DOI 10.1080/21568316.2011.573912; Phillip S, 2010, TOURISM MANAGE, V31, P754, DOI 10.1016/j.tourman.2009.08.001; Potocnik Slavic I., 2012, AGRITOURISM EMBEDDED, P88; Potocnik-Slavic I, 2013, EUR COUNTRYS, V5, P265, DOI 10.2478/euco-2013-0017; Przezborska L, 2006, AGROTURYSTYKA; Przezborska-Skobiej L., 2015, UWARUNKOWANIA ROZWOJ; Przezborska-Skobiej L, 2016, WIES ROLNICTWO, V2, P173, DOI DOI 10.7366/WIR022016/08; Przezborska-Skobiej L., 2016, TURYSTYKA WIEJSKA ZA; Roberts L., 2001, RURAL TOURISM RECREA; Roman M, 2015, POL J MANAG STUD, V11, P136; Romano A, 2016, PSICOLOG SOC, V11, P3, DOI 10.1482/82878; Rosner A., 2014, MONITORING ROZWOJU O; Sadowski A, 2013, POCZTA GOSPODARSTWA; Schilling BJ, 2014, J AGR RESOUR ECON, V39, P69; Sieczko A., 2015, ASS AGR AGRIBUSINESS, V18, P315; Sikora J, 2012, EC PROBLEMS TURISTS, V1, P219; Sikora J., 2012, AGROTURYSTYKA PRZEDS; Sikora J, 2017, NEW DIRECT TOUR ANAL, V41, P288; Soare I., 2011, Revista de Turism, P66; Sonnino R, 2004, SOCIOL RURALIS, V44, P285, DOI 10.1111/j.1467-9523.2004.00276.x; Streifeneder T, 2016, TOUR MANAG PERSPECT, V20, P251, DOI 10.1016/j.tmp.2016.10.003; Sznajder M., 2009, AGRITOURISM; Sznajder M., 2017, METROPOLITAN COMMUTE; Szwichtenberg A., 1998, TURYZM, V8, P248; Valdivia C, 2014, TOUR MANAG PERSPECT, V11, P18, DOI 10.1016/j.tmp.2014.02.004; Vodopivec Rozman J., 2012, AGRITOURISM EMBEDDED, P30; Vogt L, 2013, EC AGROALIMENTARE, V15, P77; Weaver DB, 1997, TOURISM MANAGE, V18, P357, DOI 10.1016/S0261-5177(97)00039-3; Wiatrak AP, 1996, ZAGADNIENIA EKONOMIK, V1, P35; Wojciechowska J., 2009, PROCESY UWARUNKOWANI; Wojcieszak M, 2018, INTERCATHEDRA, V34, P4; Wojcieszak M., 2016, TURYSTYKA WIEJSKA ZA, P42; Wojcieszak M., 2017, UWARUNKOWANIA ROZWOJ; Woods M, 2011, KEY IDEAS GEOGR, P1; Wysocki F., 2005, STATYSTYKA OPISOWA; Yang ZS, 2010, HABITAT INT, V34, P374, DOI 10.1016/j.habitatint.2009.11.002; Zawadka J., 2016, SCI YB, P396; Zoto S, 2013, EUROPEAN ACAD RES, V1, P20	107	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222576	10.1371/journal.pone.0222576	http://dx.doi.org/10.1371/journal.pone.0222576			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539382	Green Published, gold, Green Submitted			2022-12-27	WOS:000532297900017
J	Altemus, MA; Goo, LE; Little, AC; Yates, JA; Cheriyan, HG; Wu, ZF; Merajver, SD				Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.			Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes	PLOS ONE			English	Article							INDUCIBLE FACTOR; METABOLIC SWITCH; CELL-MIGRATION; TUMOR HYPOXIA; EXPRESSION; HIF-1-ALPHA; FACTOR-1-ALPHA; ADAPTATION; PREDICTS; KINASE-3	In breast cancer, tumor hypoxia has been linked to poor prognosis and increased metastasis. Hypoxia activates transcriptional programs in cancer cells that lead to increased motility and invasion, as well as various metabolic changes. One of these metabolic changes, an increase in glycogen metabolism, has been further associated with protection from reactive oxygen species damage that may lead to premature senescence. Here we report that breast cancer cells significantly increase glycogen stores in response to hypoxia. We found that knockdown of the brain isoform of an enzyme that catalyzes glycogen breakdown, glycogen phosphorylase B (PYGB), but not the liver isoform, PYGL, inhibited glycogen utilization in estrogen receptor negative and positive breast cancer cells; whereas both independently inhibited glycogen utilization in the normal-like breast epithelial cell line MCF-10A. Functionally, PYGB knockdown and the resulting inhibition of glycogen utilization resulted in significantly decreased wound-healing capability in MCF-7 cells and a decrease in invasive potential of MDA-MB-231 cells. Thus, we identify PYGB as a novel metabolic target with potential applications in the management and/or prevention of metastasis in breast cancer.	[Altemus, Megan A.; Cheriyan, Hannah G.] Univ Michigan, Grad Program Canc Biol, Ann Arbor, MI 48109 USA; [Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merajver, SD (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Merajver, SD (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	smeravje@med.umich.edu		Merajver, Sofia/0000-0002-6823-7130; Little, Andrew/0000-0003-0135-1032; Abraham, Hannah/0000-0001-8871-3440; Yates, Joel/0000-0002-1462-8494	Rogel Cancer Center; Rogel Cancer Center Nancy Newton Loeb Fund; NIH [T32CA009676]; RCC core grant [P30 CA046592]; Breast Cancer Research Foundation; Metavivor Foundation; NATIONAL CANCER INSTITUTE [T32CA009676, P30CA046592] Funding Source: NIH RePORTER	Rogel Cancer Center; Rogel Cancer Center Nancy Newton Loeb Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCC core grant; Breast Cancer Research Foundation; Metavivor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MAA was partially supported by the Rogel Cancer Center, the Rogel Cancer Center Nancy Newton Loeb Fund, an NIH T-32 Training Fellowship (T32CA009676), and the RCC core grant (P30 CA046592). This work was also supported by the Breast Cancer Research Foundation, https://www.bcrf.org (to SDM), and the Metavivor Foundation, https://www.metavivor.org (to SDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J.M., 2015, BIOCHEMISTRY-US, DOI [10.1007/978-3-8274-2989-6., DOI 10.1007/978-3-8274-2989-6]; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P7972, DOI 10.1158/1078-0432.CCR-04-1068; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Rao GS, 2000, INT J RADIAT ONCOL, V48, P1519, DOI 10.1016/S0360-3016(00)01358-4; Rousset M, 1981, CANC RES; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schindl M, 2002, CLIN CANC RES; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Tracey WR, 2004, AM J PHYSIOL-HEART C, V286, pH1177, DOI 10.1152/ajpheart.00652.2003; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vigoda A, 2003, MOL CELL BIOCHEM, V254, P311, DOI 10.1023/A:1027302021428; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	46	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0220973	10.1371/journal.pone.0220973	http://dx.doi.org/10.1371/journal.pone.0220973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536495	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800014
J	Bagegni, NA; Tao, Y; Ademuyiwa, FO				Bagegni, Nusayba A.; Tao, Yu; Ademuyiwa, Foluso O.			Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database	PLOS ONE			English	Article							PREOPERATIVE CHEMOTHERAPY; SURVIVAL; PATTERNS; THERAPY; DISEASE	Purpose Triple negative breast cancer (TNBC) patients frequently receive neoadjuvant chemotherapy (NAC). Only 50% will achieve pathological complete response (pCR). In this retrospective study, we evaluated TNBC outcomes with NAC vs. AC. Methods Patients with stages II and III TNBC treated with NAC or AC between 2010 and 2013 were identified from the National Cancer Database. Baseline characteristics were compared with chi(2) and two sample t tests. Kaplan-Meier survival analyses were computed in patients treated with NAC or AC, and log-rank tests used to examine differences. Unadjusted analyses of trends in proportions over time were performed using Cochran-Armitage tests. Logbinomial models were applied to estimate relative risks of non-pCR following NAC. Results Of 19,151 patients, 5,621 (29.4%) received NAC, 13,530 (70.6%) received AC. NAC treated patients had worse OS compared to AC treated patients (73.4% vs. 76.8%; p<0.0001). pCR rate following NAC was 47.4%, and was associated with improved 5 year OS compared to non-pCR (86.2% vs. 62.3%; p<0.0001). In patients who received NAC, age, black race, clinical stage, diagnosis year, and Charlson-Deyo comorbidity score predicted non-pCR status. Use of NAC increased over the study period from 2010 to 2013 (27.8% - 31.2%; p = 0.0002). Conclusions NAC may be inferior to AC in TNBC, likely related to the high frequency of non-pCR following NAC. It is unclear if removing the primary tumor prior to chemotherapy will have a beneficial biologic impact on therapeutic efficacy. These data should be considered hypothesis-generating as it is possible that the findings are due to selection bias, as physicians may use NAC for TNBC patients with more advanced local disease. Although, NAC still has a role in TNBC, developing biomarkers to identify patients likely to achieve pCR and benefit from NAC is an urgent need.	[Bagegni, Nusayba A.; Tao, Yu; Ademuyiwa, Foluso O.] Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Ademuyiwa, FO (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	bisiademuyiwa@wustl.edu		ADEMUYIWA, FOLUSO/0000-0002-6766-2258; Bagegni, Nusayba/0000-0001-9322-2451				Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; Caramelo O, 2019, HERED CANCER CLIN PR, V17, DOI 10.1186/s13053-019-0111-y; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen VE, 2017, ADV RADIAT ONCOL, V2, P105, DOI 10.1016/j.adro.2017.01.012; Clifton K, 2018, BREAST CANCER RES TR, V170, P101, DOI 10.1007/s10549-018-4727-9; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Daly B, 2017, JAMA ONCOL, V3, P928, DOI 10.1001/jamaoncol.2016.6380; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Kennedy CR, 2010, J SURG RES, V163, P52, DOI 10.1016/j.jss.2010.04.015; Kern P, 2015, ANTICANCER RES, V35, P5479; Kuroi K, 2015, BREAST CANCER-TOKYO, V22, P486, DOI 10.1007/s12282-013-0511-1; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Litton JK, 2018, NEW ENGL J MED, V379, P753, DOI 10.1056/NEJMoa1802905; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645; Mauriac L, 1999, ANN ONCOL, V10, P47, DOI 10.1023/A:1008337009350; Mougalian SS, 2015, CANCER-AM CANCER SOC, V121, P2544, DOI 10.1002/cncr.29348; Murphy BL, 2018, ANN SURG ONCOL, V25, P2241, DOI 10.1245/s10434-018-6531-5; National Cancer Institute Surveillance E and End Results (SEER), CANC STAT FACTS FEM; Network NCC, NCCN CLIN PRACT GUID; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plasilova ML, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004614; Puig CA, 2017, ANN SURG ONCOL, V24, P1242, DOI 10.1245/s10434-016-5733-y; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Sikov WM, 2016, SAN ANT BREAST CANC; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Symmans WF, 2017, J CLIN ONCOL, V35, P1049, DOI 10.1200/JCO.2015.63.1010; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	33	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222358	10.1371/journal.pone.0222358	http://dx.doi.org/10.1371/journal.pone.0222358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536530	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800039
J	Bandyopadhyay, A; Bose, I; Chattopadhyay, K				Bandyopadhyay, Arnab; Bose, Indrani; Chattopadhyay, Krishnananda			Osmolytes ameliorate the effects of stress in the absence of the heat shock protein Hsp104 in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST PSI+ PRION; GUANIDINE-HYDROCHLORIDE; MOLECULAR CHAPERONES; INTRACELLULAR TREHALOSE; DESICCATION TOLERANCE; ORGANIC OSMOLYTES; IN-VIVO; DISEASE; AGGREGATION; ACCUMULATION	Aggregation of the prion protein has strong implications in the human prion disease. Sup35p is a yeast prion, and has been used as a model protein to study the disease mechanism. We have studied the pattern of Sup35p aggregation inside live yeast cells under stress, by using confocal microscopy, fluorescence activated cell sorting and western blotting. Heat shock proteins are a family of proteins that are produced by yeast cells in response to exposure to stressful conditions. Many of the proteins behave as chaperones to combat stress-induced protein misfolding and aggregation. In spite of this, yeast also produce small molecules called osmolytes during stress. In our work, we tried to find the reason as to why yeast produce osmolytes and showed that the osmolytes are paramount to ameliorate the long-term effects of lethal stress in Saccharomyces cerevisiae, either in the presence or absence of Hsp104p.	[Bandyopadhyay, Arnab; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India; [Bose, Indrani] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of North Carolina; Western Carolina University	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India.; Bose, I (corresponding author), Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA.	ibose@email.wcu.edu; krish@iicb.res.in		Chattopadhyay, Krishnananda/0000-0002-1449-8909	CSIR (MIND) - UGC	CSIR (MIND) - UGC	This work received funding from CSIR (MIND) to KC and also is funded by a fellowship from UGC to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J., 2004, GUIDE YEAST GENETICS; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alexandre H, 1998, MICROBIOL-SGM, V144, P1103, DOI 10.1099/00221287-144-4-1103; Bandara A, 2009, FEMS YEAST RES, V9, P1208, DOI 10.1111/j.1567-1364.2009.00569.x; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Das A, 2019, INT J BIOL MACROMOL, V127, P365, DOI 10.1016/j.ijbiomac.2019.01.062; Das A, 2017, INT J BIOL MACROMOL, V105, P645, DOI 10.1016/j.ijbiomac.2017.07.074; Desplats P, 2005, PLANT PHYSIOL BIOCH, V43, P133, DOI 10.1016/j.plaphy.2005.01.008; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Gibney PA, 2015, P NATL ACAD SCI USA, V112, P6116, DOI 10.1073/pnas.1506289112; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Gregoire S, 2012, KOREAN J CHEM ENG, V29, P693, DOI 10.1007/s11814-012-0060-x; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hidalgo IH, 2016, BIOTECHNIQUES, V61, P137, DOI 10.2144/000114452; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Kim SH, 2006, BIOCHEM CELL BIOL, V84, P30, DOI 10.1139/O05-148; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Ma JQ, 2014, P NATL ACAD SCI USA, V111, P8476, DOI 10.1073/pnas.1403224111; Mactier R A, 1989, ASAIO Trans, V35, P122, DOI 10.1097/00002480-198904000-00002; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Papp E, 2006, HANDB EXP PHARM, V172, P405; Pasantes-Morales H, 1998, ADV EXP MED BIOL, V442, P209; Ratnakumar S, 2006, FEMS YEAST RES, V6, P902, DOI 10.1111/j.1567-1364.2006.00066.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sabate R, 2012, BIOMACROMOLECULES, V13, P474, DOI 10.1021/bm201527m; Sethi R, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy058; Shaked GA, 2003, BRAIN RES, V983, P137, DOI 10.1016/S0006-8993(03)03045-2; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tapia H, 2015, P NATL ACAD SCI USA, V112, P6122, DOI 10.1073/pnas.1506415112; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	68	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222723	10.1371/journal.pone.0222723	http://dx.doi.org/10.1371/journal.pone.0222723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536559	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800076
J	Christensen, S; Halili, MA; Strange, N; Petit, GA; Huston, WM; Martin, JL; McMahon, RM				Christensen, Signe; Halili, Maria A.; Strange, Natalie; Petit, Guillaume A.; Huston, Wilhelmina M.; Martin, Jennifer L.; McMahon, Roisin M.			Oxidoreductase disulfide bond proteins DsbA and DsbB form an active redox pair in Chlamydia trachomatis, a bacterium with disulfide dependent infection and development	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; CYCLE; BIOGENESIS; SECRETION; ENZYME; IDENTIFICATION; ENTEROTOXIN; COMPONENTS	Chlamydia trachomatis is an obligate intracellular bacterium with a distinctive biphasic developmental cycle that alternates between two distinct cell types; the extracellular infectious elementary body (EB) and the intracellular replicating reticulate body (RB). Members of the genus Chlamydia are dependent on the formation and degradation of protein disulfide bonds. Moreover, disulfide cross-linking of EB envelope proteins is critical for the infection phase of the developmental cycle. We have identified in C. trachomatis a homologue of the Disulfide Bond forming membrane protein Escherichia coli (E. coli) DsbB (hereafter named CtDsbB) and-using recombinant purified proteins-demonstrated that it is the redox partner of the previously characterised periplasmic oxidase C. trachomatis Disulfide Bond protein A (CtDsbA). CtDsbA protein was detected in C. trachomatis inclusion vacuoles at 20 h post infection, with more detected at 32 and similar levels at 44 h post infection as the developmental cycle proceeds. As a redox pair, CtDsbA and CtDsbB largely resemble their homologous counterparts in E. coli; CtDsbA is directly oxidised by CtDsbB, in a reaction in which both periplasmic cysteine pairs of CtDsbB are required for complete activity. In our hands, this reaction is slow relative to that observed for E. coli equivalents, although this may reflect a non-native expression system and use of a surrogate quinone cofactor. CtDsbA has a second non-catalytic disulfide bond, which has a small stabilising effect on the protein's thermal stability, but which does not appear to influence the interaction of CtDsbA with its partner protein CtDsbB. Expression of CtDsbA during the RB replicative phase and during RB to EB differentiation coincided with the oxidation of the chlamydial outer membrane complex (COMC). Together with our demonstration of an active redox pairing, our findings suggest a potential role for CtDsbA and CtDsbB in the critical disulfide bond formation step in the highly regulated development cycle.	[Christensen, Signe] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Christensen, Signe; Halili, Maria A.; Petit, Guillaume A.; Martin, Jennifer L.; McMahon, Roisin M.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Strange, Natalie; Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Christensen, Signe] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Martin, Jennifer L.] Univ Wollongong, Vice Chancellors Unit, Wollongong, NSW, Australia	University of Queensland; Griffith University; University of Technology Sydney; Lund University; University of Wollongong	McMahon, RM (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia.; Huston, WM (corresponding author), Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia.	Wilhelmina.Huston@uts.edu.au; roisin.mcmahon@griffith.edu.au	Christensen, Signe/GQP-7049-2022; Huston, Wilhelmina/S-7269-2019; Halili, Maria A/J-8362-2014; Christensen, Signe/C-7989-2017; McMahon, Roisin/A-9823-2014; Martin, Jennifer L./A-6039-2010; Huston, Wilhelmina/B-9984-2008	Halili, Maria A/0000-0003-4407-5269; Christensen, Signe/0000-0001-9556-1545; Strange, Natalie/0000-0002-9356-8070; McMahon, Roisin/0000-0001-5437-0355; Martin, Jennifer L./0000-0002-9225-8863; Petit, Guillaume Axel/0000-0002-8251-0754; Huston, Wilhelmina/0000-0002-0879-1287	Ramaciotti Health Investment Grant [2017HIG0094]; NHMRC [1099151, 1144046]; Griffith University Postgraduate Research Scholarship; Griffith University International Postgraduate Research Scholarship; UQI Tuition Fee Award; University Technology Sydney Faculty of Science Staff Development Fund; UTS Doctoral Scholarship	Ramaciotti Health Investment Grant; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Griffith University Postgraduate Research Scholarship(Griffith University); Griffith University International Postgraduate Research Scholarship; UQI Tuition Fee Award; University Technology Sydney Faculty of Science Staff Development Fund; UTS Doctoral Scholarship	RMM, MH and GP are supported by a Ramaciotti (www.perpetual.com.au/ramaciotti) Health Investment Grant (2017HIG0094) awarded to RMM. RMM and SC were also supported by a NHMRC (www.nhmrc.gov.au) Project Grant (1099151) awarded to JLM. GP is further supported by a Griffith University Postgraduate Research Scholarship and a Griffith University International Postgraduate Research Scholarship (www.griffith.edu.au/research-study/scholarships).SC was further supported by a UQI Tuition Fee Award (www.scholarships.uq.edu.au/).WMH is supported by University Technology Sydney (www.uts.edu.au) Faculty of Science Staff Development Funding and NS is supported by a UTS Doctoral Scholarship. This work is also supported by a NHMRC Project Grant (1144046) awarded to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1996, INFECT IMMUN, V64, P4378, DOI 10.1128/IAI.64.10.4378-4380.1996; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Betts-Hampikian HJ, 2011, J BACTERIOL, V193, P6950, DOI 10.1128/JB.05163-11; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Chim N, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-23; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Christensen S, 2019, CRIT REV MICROBIOL, V45, P33, DOI 10.1080/1040841X.2018.1538933; Christensen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168485; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOREMAN DT, 1995, MOL MICROBIOL, V18, P237, DOI 10.1111/j.1365-2958.1995.mmi_18020237.x; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Huston WM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-190; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Landeta C, 2018, NAT MICROBIOL, V3, P270, DOI 10.1038/s41564-017-0106-2; de Abreu ICME, 2014, ARQ BRAS ENDOCRINOL, V58, P251, DOI 10.1590/0004-2730000002831; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00938-17, 10.1128/iai.00938-17]; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Miki T, 2008, MICROB PATHOGENESIS, V44, P151, DOI 10.1016/j.micpath.2007.09.001; Mukhopadhyay S, 2006, MOL CELL PROTEOMICS, V5, P2311, DOI 10.1074/mcp.M600214-MCP200; NEWHALL WJ, 1987, INFECT IMMUN, V55, P162, DOI 10.1128/IAI.55.1.162-168.1987; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Raulston JE, 2002, INFECT IMMUN, V70, P535, DOI 10.1128/IAI.70.2.535-543.2002; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; SARDINIA LM, 1988, J GEN MICROBIOL, V134, P997; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; STIRLING P, 1983, FEMS MICROBIOL LETT, V19, P133; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; Vogel H, 2011, METHODS MOL BIOL, V772, P105, DOI 10.1007/978-1-61779-228-1_6; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x; Zhang HZ, 1996, MOL MICROBIOL, V21, P787, DOI 10.1046/j.1365-2958.1996.431403.x; Zheng K, 2014, MBIO, V5, DOI [10.1128/mBio.00942-13, 10.1128/mBio.00958-13]; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222595	10.1371/journal.pone.0222595	http://dx.doi.org/10.1371/journal.pone.0222595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536549	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800059
J	Feuchtner, J; Mathewos, A; Solomon, A; Timotewos, G; Aynalem, A; Wondemagegnehu, T; Gebremedhin, A; Adugna, F; Griesel, M; Wienke, A; Addissie, A; Jemal, A; Kantelhardt, EJ				Feuchtner, Jana; Mathewos, Assefa; Solomon, Asmare; Timotewos, Genebo; Aynalem, Abreha; Wondemagegnehu, Tigeneh; Gebremedhin, Amha; Adugna, Fekadu; Griesel, Mirko; Wienke, Andreas; Addissie, Adamu; Jemal, Ahmedin; Kantelhardt, Eva Johanna			Addis Ababa population-based pattern of cancer therapy, Ethiopia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BREAST-CANCER; CERVICAL-CANCER; BARRIERS; RADIOTHERAPY; DIAGNOSIS; SURVIVAL; SURGERY; WOMEN; CARE	Cancer in Sub-Saharan Africa is becoming an important challenge for health services due to rising numbers of patients. In Addis Ababa with around 3.5 million inhabitants, more than 2000 cases are diagnosed annually. In this retrospective population-based cohort study we assessed completeness of and waiting time for cancer-therapy among patients registered in the Addis Ababa City Cancer Registry (AACCR), Ethiopia. Patient hospital files were retrieved to complete the data from AACCR. A total of 588 files were found (51% of those diagnosed from January to March 2012 and 2014). We analyzed completeness and waiting time of chemotherapy and radiotherapy; with completeness defined as >= 85% therapy received according to local guidelines. Analysis was done for the five most common cancer-types commonly treated with chemotherapy (breast, colorectal, non-Hodgkin's lymphoma, lung and ovarian) and the four most common cancer-types commonly treated with radiotherapy (breast, cervical, head and neck and rectal). In our study, half of the patients (54.1%) received adequately dosed chemotherapy and 24.5% of patients received adequately dosed radiotherapy. The median waiting time was 2.1 months (Range: 0 to 20.72) for chemotherapy and 7 months (Range: 0.17 to 21.8) for radiotherapy. This study underscores the need for health system measures to improve cancer-directed therapy in Ethiopia, especially concerning radiotherapy.	[Feuchtner, Jana; Griesel, Mirko; Wienke, Andreas; Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Mathewos, Assefa; Solomon, Asmare; Timotewos, Genebo; Aynalem, Abreha; Wondemagegnehu, Tigeneh; Adugna, Fekadu] Addis Ababa Univ, Radiotherapy Ctr, Addis Ababa, Ethiopia; [Gebremedhin, Amha] Addis Ababa Univ, Dept Internal Med, Div Hematol, Addis Ababa, Ethiopia; [Addissie, Adamu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Gynaecol, Halle, Germany	Martin Luther University Halle Wittenberg; Addis Ababa University; Addis Ababa University; Addis Ababa University; American Cancer Society; Martin Luther University Halle Wittenberg	Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany.; Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Dept Gynaecol, Halle, Germany.	eva.kantelhardt@uk-halle.de	Wienke, Andreas/AAN-3707-2020	Griesel, Mirko/0000-0002-1633-3788; Endalew, Solomon Asmare/0000-0002-4102-0257	German Ministry of Education and Research [01DG12006]; German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); Surveillance and Health Service Research Program; American Cancer Society; World Health Organization country office; Bayer Foundation	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); Surveillance and Health Service Research Program; American Cancer Society(American Cancer Society); World Health Organization country office(World Health Organization); Bayer Foundation(Bayer AG)	The research leading to these results has received funding from the German Ministry of Education and Research under grant agreement n degrees 01DG12006; the German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); the Surveillance and Health Service Research Program, American Cancer Society and the World Health Organization country office. FJ received a doctoral fellowship by the Bayer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Arndt V, 2003, J CLIN ONCOL, V21, P1440, DOI 10.1200/JCO.2003.08.071; Barton MB, 2006, LANCET ONCOL, V7, P584, DOI 10.1016/S1470-2045(06)70759-8; Bhatia RK, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00088; Birhan W, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-39; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; Cazap E, 2016, J CLIN ONCOL, V34, P14, DOI 10.1200/JCO.2015.61.9189; Dedey F, 2016, HEALTH EDUC BEHAV, V43, P420, DOI 10.1177/1090198115620417; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Dye TD, 2010, CANCER-AM CANCER SOC, V116, P577, DOI 10.1002/cncr.24776; Eber-Schulz P, 2018, BREAST CANCER RES TR, V170, P111, DOI 10.1007/s10549-018-4724-z; Frie KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207928; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Gyorki DE, 2012, ARCH SURG-CHICAGO, V147, P1135, DOI 10.1001/archsurg.2012.1265; Harding R, 2011, EUR J CANCER, V47, P51, DOI 10.1016/j.ejca.2010.08.003; Harford JB, 2015, LANCET ONCOL, V16, pE385, DOI 10.1016/S1470-2045(15)00160-6; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kantelhardt EJ, 2014, ONCOLOGIST, V19, P727, DOI 10.1634/theoncologist.2013-0326; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Otieno E S, 2010, East Afr Med J, V87, P147; Rosenblatt E, 2018, RADIOTHER ONCOL, V128, P400, DOI 10.1016/j.radonc.2018.05.014; Shiferaw S, 2018, CANCER MED-US, V7, P903, DOI 10.1002/cam4.1334; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Timotewos G, 2018, CANCER EPIDEMIOL, V53, P93, DOI 10.1016/j.canep.2018.01.008; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, WHO WHOS CANC PAIN L	31	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219519	10.1371/journal.pone.0219519	http://dx.doi.org/10.1371/journal.pone.0219519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536505	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800010
J	Flaherty, RA; Borges, EC; Sutton, JA; Aronoff, DM; Gaddy, JA; Petroff, MG; Manning, SD				Flaherty, Rebecca A.; Borges, Elena C.; Sutton, Jessica A.; Aronoff, David M.; Gaddy, Jennifer A.; Petroff, Margaret G.; Manning, Shannon D.			Genetically distinct Group B Streptococcus strains induce varying macrophage cytokine responses	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; COLONIZING STRAINS; GENE-EXPRESSION; CORD; INFECTION; DIVERSITY; DISEASE; SEPSIS	Group B Streptococcus (GBS) is an opportunistic pathogen that causes preterm birth and neonatal disease. Although GBS is known to exhibit vast diversity in virulence across strains, the mechanisms of GBS-associated pathogenesis are incompletely understood. We hypothesized that GBS strains of different genotypes would vary in their ability to elicit host inflammatory responses, and that strains associated with neonatal disease would induce different cytokine profiles than those associated with colonization. Using a multi-plexed, antibody-based protein detection array, we found that production of a discrete number of inflammatory mediators by THP-1 macrophage-like cells was universally induced in response to challenge with each of five genetically distinct GBS isolates, while other responses appeared to be strain-specific. Key array responses were validated by ELISA using the initial five strains as well as ten additional strains with distinct genotypic and phenotypic characteristics. Interestingly, IL-6 was significantly elevated following infection with neonatal infection-associated sequence type (ST)-17 strains and among strains possessing capsule (cps) type III. Significant differences in production of IL1-beta, IL-10 and MCP-2 were also identified across STs and cps types. These data support our hypothesis and suggest that unique host innate immune responses reflect strain -specific differences in virulence across GBS isolates. Such data might inform the development of improved diagnostic or prognostic strategies against invasive GBS infections.	[Flaherty, Rebecca A.; Borges, Elena C.; Petroff, Margaret G.; Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Sutton, Jessica A.] Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Sutton, Jessica A.; Aronoff, David M.; Gaddy, Jennifer A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Petroff, Margaret G.] Michigan State Univ, Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA	Michigan State University; Meharry Medical College; Vanderbilt University; Michigan State University	Manning, SD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mannin71@msu.edu	Flaherty, Rebecca/CAJ-5715-2022; Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660; Aronoff, David/0000-0003-4587-6121	National Institutes of Health [AI134036, HD090061, HD091429]; Michigan State University; National Institutes of Health NIAID Training Grant [5T32HL007737-20]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; National Institutes of Health NIAID Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by three grants from the National Institutes of Health (www.nih.gov): AI134036 (DMA, SDM, JAG), HD090061 (JAG, DMA, SDM), and HD091429; and funds from Michigan State University (SDM; www.msu.edu).JAS was supported by National Institutes of Health NIAID Training Grant 5T32HL007737-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AP, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12623; Berner R, 2002, PEDIATR RES, V51, P304, DOI 10.1203/00006450-200203000-00007; Berner R, 2001, PEDIATR RES, V49, P691, DOI 10.1203/00006450-200105000-00014; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Chaudhry H, 2013, IN VIVO, V27, P669; D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Flaherty RA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00211; Horvath B, 2014, J PERINAT MED, V42, P441, DOI 10.1515/jpm-2013-0186; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Korir ML, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02786; Korir ML, 2017, VIRULENCE, V8, P924, DOI 10.1080/21505594.2016.1252016; Korir ML, 2017, CLIN MICROBIOL REV, V30, P973, DOI 10.1128/CMR.00019-17; Korir ML, 2014, INFECT IMMUN, V82, P4587, DOI 10.1128/IAI.02181-14; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rogers LM, 2018, PATHOG IMMUN; Rosati E, 1998, SCAND J IMMUNOL, V47, P314; Singh P, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00015-16; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sugitharini V, 2013, INFLAMM RES, V62, P1025, DOI 10.1007/s00011-013-0661-9; Vallejo JG, 2000, J IMMUNOL, V165, P419, DOI 10.4049/jimmunol.165.1.419; Vanderhoeven JP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003920; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wennekamp J, 2008, IMMUNOL REV, V225, P114, DOI 10.1111/j.1600-065X.2008.00673.x	28	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222910	10.1371/journal.pone.0222910	http://dx.doi.org/10.1371/journal.pone.0222910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536604	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800102
J	Gooch, A; Zhang, P; Hu, ZM; Son, NL; Avila, N; Fischer, J; Roberts, G; Sellon, R; Westenfelder, C				Gooch, Anna; Zhang, Ping; Hu, Zhuma; Son, Natasha Loy; Avila, Nicole; Fischer, Julie; Roberts, Gregory; Sellon, Rance; Westenfelder, Christof			Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776)	PLOS ONE			English	Article							SUSCEPTIBILITY GENES; STROMAL CELLS; CANINE; TRANSPLANTATION; SURVIVAL; HUMANS; KIDNEY; MICE; AUTOANTIBODIES; ANGIOGENESIS	We previously reported that allogeneic, intraperitoneally administered "Neo-Islets," composed of cultured pancreatic islet cells co-aggregated with high numbers of immunoprotective and cytoprotective Adipose-derived Stem Cells, reestablished, through omental engraftment, redifferentiation and splenic and omental up-regulation of regulatory T-cells, normoglycemia in autoimmune Type-1 Diabetic Non-Obese Diabetic (NOD) mice without the use of immunosuppressive agents or encapsulation devices. Based on these observations, we are currently testing this Neo-Islet technology in an FDA guided pilot study (INAD 012776) in insulin-dependent, spontaneously diabetic pet dogs by ultrasound-guided, intraperitoneal administration of 2x10e5 Neo-Islets/kilogram body weight to metabolically controlled (blood glucose, triglycerides, thyroid and adrenal functions) and sedated animals. We report here interim observations on the first 4 canine Neo-Islet-treated, insulin-dependent pet dogs that are now in the early to intermediate-term follow-up phase of the planned 3 year study (> 6 months post treatment). Current results from this translational study indicate that in dogs, Neo-Islets appear to engraft, redifferentiate and physiologically produce insulin, and are rejected by neither auto- nor allo-immune responses, as evidenced by (a) an absent IgG response to the allogeneic cells contained in the administered Neo-Islets, and (b) progressively improved glycemic control that achieves up to a 50% reduction in daily insulin needs paralleled by a statistically significant decrease in serum glucose concentrations. This is accomplished without the use of anti-rejection drugs or encapsulation devices. No adverse or serious adverse events related to the Neo-Islet administration have been observed to date. We conclude that this minimally invasive therapy has significant translational relevance to veterinary and clinical Type 1 diabetes mellitus by achieving complete and at this point partial glycemic control in two species, i.e., diabetic mice and dogs, respectively.	[Gooch, Anna; Zhang, Ping; Hu, Zhuma; Westenfelder, Christof] SymbioCellTech LLC, Salt Lake City, UT 84108 USA; [Son, Natasha Loy; Avila, Nicole; Fischer, Julie] Vet Specialty Hosp, San Diego, CA USA; [Roberts, Gregory; Sellon, Rance] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Westenfelder, Christof] Univ Utah, Dept Med, Div Nephrol, Salt Lake City, UT 84112 USA	Washington State University; Utah System of Higher Education; University of Utah	Westenfelder, C (corresponding author), SymbioCellTech LLC, Salt Lake City, UT 84108 USA.; Westenfelder, C (corresponding author), Univ Utah, Dept Med, Div Nephrol, Salt Lake City, UT 84112 USA.	chistof.westenfelder@hsc.utah.edu		Westenfelder, MD, Christof/0000-0002-2349-9874				Abalovich AG, 2009, TRANSPL P, V41, P328, DOI 10.1016/j.transproceed.2008.08.159; Adin CA, 2017, YALE J BIOL MED, V90, P509; Ahlgren KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105473; ALEJANDRO R, 1988, TRANSPLANTATION, V45, P1036, DOI 10.1097/00007890-198806000-00008; Butte A J, 2001, Pac Symp Biocomput, P6; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; Chen T, 2015, AM J TRANSPLANT, V15, P618, DOI 10.1111/ajt.13049; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; Dolgin E, 2014, NAT MED, V20, P9, DOI 10.1038/nm0114-9; Fall T, 2008, J VET INTERN MED, V22, P1296, DOI 10.1111/j.1939-1676.2008.0199.x; Fall T, 2010, J VET INTERN MED, V24, P1322, DOI 10.1111/j.1939-1676.2010.0630.x; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gilor C, 2016, J VET INTERN MED, V30, P927, DOI 10.1111/jvim.14357; Gregory JM, 2019, DIABETES, V68, P1565, DOI 10.2337/db19-0324; Gregory JM, 2015, DIABETES, V64, P3439, DOI 10.2337/db15-0071; Guptill L, 2003, VET J, V165, P240, DOI 10.1016/S1090-0233(02)00242-3; Holder AL, 2015, VET IMMUNOL IMMUNOP, V167, P130, DOI 10.1016/j.vetimm.2015.07.014; Inverardi L, 2013, MESENCHYMAL STROMAL, P571, DOI [10.1007/978-1-4614-5711-4_33, DOI 10.1007/978-1-4614-5711-4_33]; Lablanche S, 2018, LANCET DIABETES ENDO, V6, P527, DOI 10.1016/S2213-8587(18)30078-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Morgan MJ, 2008, CAN VET J, V49, P583; O'Kell AL, 2017, DIABETES, V66, P1443, DOI 10.2337/db16-1551; Pancotto Theresa E, 2017, J Clin Mov Disord, V4, P5, DOI 10.1186/s40734-017-0053-3; PORKSEN N, 2002, AM J PHYSIOL-ENDOC M, V282, pE69, DOI DOI 10.1152/AJPENDO.00516.2000; Sakata N, 2010, WORLD J GASTROENTERO, V16, P1215, DOI 10.3748/wjg.v16.i10.1215; Shields EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129809; Short AD, 2007, J HERED, V98, P518, DOI 10.1093/jhered/esm048; Togel F, 2009, J CELL MOL MED, V13, P2109, DOI 10.1111/j.1582-4934.2008.00641.x; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tonne JM, 2013, DIS MODEL MECH, V6, P1236, DOI 10.1242/dmm.012591; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vrabelova D, 2014, DOMEST ANIM ENDOCRIN, V47, P119, DOI 10.1016/j.domaniend.2013.01.006; Vrabelova D, 2014, VET SURG, V43, P631, DOI 10.1111/j.1532-950X.2014.12224.x; WARNOCK GL, 1994, TRANSPLANTATION, V57, P17, DOI 10.1097/00007890-199401000-00004; Westenfelder C, 2017, STEM CELL TRANSL MED, V6, P1631, DOI 10.1002/sctm.17-0005; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218688	10.1371/journal.pone.0218688	http://dx.doi.org/10.1371/journal.pone.0218688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536503	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800009
J	Groener, JB; Valkanou, A; Kender, Z; Pfeiffenberger, J; Kihm, L; Fleming, T; Nawroth, PP; Kopf, S				Groener, Jan Benedikt; Valkanou, Aikaterini; Kender, Zoltan; Pfeiffenberger, Jan; Kihm, Lars; Fleming, Thomas; Nawroth, Peter Paul; Kopf, Stefan			Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes	PLOS ONE			English	Article							LIVER; RISK	Asprosin is a counter-regulatory hormone to insulin which plays a role in fasting. It may therefore also play a role in hypoglycaemia unawareness, which has been subsequently examined in this pilot study. Intravenous glucose tolerance test was used to induce controlled hyperglycemia whereas a hyperinsulinemic clamp test was used to induce a controlled hypoglycaemia in 15 patients with diabetes type 1, with and without hypoglycaemia unawareness. Changes in asprosin plasma levels did not differ between patients with and without hypoglycaemia unawareness. However, nine patients with insulin resistance as well as higher liver stiffness values and low-density lipoprotein but lower high-density lipoprotein levels did not show the expected increase in asprosin plasma levels during hypoglycemia. Therefore, insulin resistance and alterations in liver structure, most likely early stages of non-alcoholic fatty liver disease, seem to be relevant in type 1 diabetes and do not only lead to elevated plasma levels of asprosin, but also to a blunted asprosin response in hypoglycemia.	[Groener, Jan Benedikt; Valkanou, Aikaterini; Kender, Zoltan; Kihm, Lars; Fleming, Thomas; Nawroth, Peter Paul; Kopf, Stefan] Univ Hosp Heidelberg, Dept Med Endocrinol & Clin Chem 1, Heidelberg, Germany; [Groener, Jan Benedikt; Kender, Zoltan; Nawroth, Peter Paul; Kopf, Stefan] Deutsch Zentrum Diabetesforsch DZD eV, Munich, Germany; [Groener, Jan Benedikt] Medicover Munchen Neuroendokrinol, Munich, Germany; [Pfeiffenberger, Jan] Univ Hosp Heidelberg, Dept Med Gastroenterol & Hepatol 4, Heidelberg, Germany; [Nawroth, Peter Paul] Helmholtz Zentrum Munich, Inst Diabet & Canc, Joint IDC, Munich, Germany; [Nawroth, Peter Paul] Heidelberg Univ, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg	Groener, JB (corresponding author), Univ Hosp Heidelberg, Dept Med Endocrinol & Clin Chem 1, Heidelberg, Germany.; Groener, JB (corresponding author), Deutsch Zentrum Diabetesforsch DZD eV, Munich, Germany.; Groener, JB (corresponding author), Medicover Munchen Neuroendokrinol, Munich, Germany.	Jan.Groener@hotmail.com			Deutsches Zentrum fu<spacing diaeresis> r Diabetesforschung (DZD) e.V [SFB 1118, SFB 1158]	Deutsches Zentrum fu<spacing diaeresis> r Diabetesforschung (DZD) e.V	This study was funded by the SFB 1118, SFB 1158, and the Deutsches Zentrum fu<spacing diaeresis> r Diabetesforschung (DZD) e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph TE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081649; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Duerrschmid C, 2017, NAT MED, V23, P1444, DOI 10.1038/nm.4432; Gubitosi-Klug RA, 2017, DIABETES CARE, V40, P1010, DOI 10.2337/dc16-2723; Hahn RG, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-12; Hompesch Marcus, 2008, J Diabetes Sci Technol, V2, P896; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Martin-Timon I, 2015, WORLD J DIABETES, V6, P912, DOI 10.4239/wjd.v6.i7.912; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; Novodvorsky P, 2017, DIABETES CARE, V40, P655, DOI 10.2337/dc16-2177; Nowotny B, 2015, DIABETOLOGIA, V58, P255, DOI 10.1007/s00125-014-3457-8; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Peng KP, 2017, AM J MED SCI, V353, P236, DOI 10.1016/j.amjms.2017.01.002; Rao RB, 2017, IOSR J DENT MED SCI, V16, P46; Romere C, 2016, CELL, V165, P566, DOI 10.1016/j.cell.2016.02.063; Schauer IE, 2011, DIABETES, V60, P306, DOI 10.2337/db10-0328; Sini M, 2012, DIGEST LIVER DIS, V44, P487, DOI 10.1016/j.dld.2011.12.010; Smith CB, 2009, DIABETES CARE, V32, P1196, DOI 10.2337/dc08-2259; Sviklane L, 2018, J GASTROEN HEPATOL, V33, P270, DOI 10.1111/jgh.13814; Toonen EJM, 2016, MOL MED, V22, DOI 10.2119/molmed.2016.00033; Wang YR, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9471583; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zhang L, 2019, CLIN CHIM ACTA, V489, P183, DOI 10.1016/j.cca.2017.10.034	24	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222771	10.1371/journal.pone.0222771	http://dx.doi.org/10.1371/journal.pone.0222771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536600	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800083
J	Miller, DR; Lebowitz, JJ; Guenther, DT; Refowich, AJ; Hansen, C; Maurer, AP; Khoshbouei, H				Miller, Douglas R.; Lebowitz, Joseph J.; Guenther, Dylan T.; Refowich, Alexander J.; Hansen, Carissa; Maurer, Andrew P.; Khoshbouei, Habibeh			Methamphetamine regulation of activity and topology of ventral midbrain networks	PLOS ONE			English	Article							INDUCED ENHANCEMENT; DOPAMINE RELEASE; CONNECTIVITY; NEURONS; AMPHETAMINE; SYSTEM	The ventral midbrain supports a variety of functions through the heterogeneity of neurons. Dopaminergic and GABA neurons within this region are particularly susceptible targets of amphetamine-class psychostimulants such as methamphetamine. While this has been evidenced through single-neuron methods, it remains unclear whether and to what extent the local neuronal network is affected and if so, by which mechanisms. Both GABAergic and dopaminergic neurons were heavily featured within the primary ventral midbrain network model system. Using spontaneous calcium activity, our data suggest methamphetamine decreased total network output via a D-2 receptor-dependent manner. Over culture duration, functional connectivity between neurons decreased significantly but was unaffected by methamphetamine. However, across culture duration, exposure to methamphetamine significantly altered changes in network assortativity. Here we have established primary ventral midbrain networks culture as a viable model system that reveals specific changes in network activity, connectivity, and topology modulation by methamphetamine. This network culture system enables control over the type and number of neurons that comprise a network and facilitates detection of emergent properties that arise from the specific organization. Thus, the multidimensional properties of methamphetamine can be unraveled, leading to a better understanding of its impact on the local network structure and function.	[Miller, Douglas R.; Lebowitz, Joseph J.; Guenther, Dylan T.; Refowich, Alexander J.; Hansen, Carissa; Maurer, Andrew P.; Khoshbouei, Habibeh] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maurer, AP; Khoshbouei, H (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL 32610 USA.	drewmaurer@ufl.edu; habibeth@ufl.edu		Guenther, Dylan/0000-0001-5100-0076; Hansen, Carissa/0000-0002-1652-2669; Miller, Douglas/0000-0001-5589-1857	U.S. National Institutes of Health (NIH) [DA026947, NS071122, OD020026, DA026947S1, DA043895]; NIH [RM01MH109548]; McKnight Brain Institute Trainee Enhancement Opportunity	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Brain Institute Trainee Enhancement Opportunity	H.K. acknowledges funding from the U.S. National Institutes of Health (NIH) DA026947, NS071122, OD020026, DA026947S1, DA043895. A.P.M. acknowledges funding from the NIH RM01MH109548. DM Acknowledges funding from the McKnight Brain Institute Trainee Enhancement Opportunity. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari S, 2016, SCI REP, V7, P1, DOI [10.1016/j.bios.2016.07.082, DOI 10.1016/J.BIOS.2016.07.082]; Aertsen AMHJ, 1989, DYNAMICS NEURONAL FI, V61; Balkenius A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129614; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Branch SY, 2012, J NEUROPHYSIOL, V108, P802, DOI 10.1152/jn.00094.2012; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chambers B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005078; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Colon-Perez LM, 2018, NEUROPHARMACOLOGY, V137, P178, DOI 10.1016/j.neuropharm.2018.04.031; Dechery JB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006153; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dubbs A, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00006; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gutierrez A, 2018, NEUROTOX RES, V33, P671, DOI 10.1007/s12640-018-9871-9; Heysieattalab S, 2016, SYNAPSE, V70, P325, DOI 10.1002/syn.21905; Hiolski EM, 2016, NEUROTOXICOLOGY, V56, P215, DOI 10.1016/j.neuro.2016.08.004; Huang YH, 1999, NEUROPSYCHOPHARMACOL, V21, P427, DOI 10.1016/S0893-133X(99)00029-9; Jiao DL, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00162; Krasnova IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019179; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lautenschlager J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00044; Liang X, 2015, J NEUROSCI, V35, P8081, DOI 10.1523/JNEUROSCI.3188-14.2015; Lim S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39243-w; Lin M, 2016, J NEUROSCI, V36, P10376, DOI 10.1523/JNEUROSCI.1392-16.2016; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Moszczynska A, 2017, J PHARMACOL EXP THER, V362, P474, DOI 10.1124/jpet.116.238501; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nephew BC, 2018, J AFFECT DISORDERS, V229, P213, DOI 10.1016/j.jad.2017.12.089; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; O'Neill B, 2017, ACS CHEM NEUROSCI, V8, P310, DOI 10.1021/acschemneuro.6b00300; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Orsini CA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0081-18.2018; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reznichenko L, 2012, J NEUROSCI, V32, P9992, DOI 10.1523/JNEUROSCI.1270-12.2012; Rice ME, 2000, PROG BRAIN RES, V125, P277; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Runfeldt MJ, 2014, J NEUROPHYSIOL, V112, P1205, DOI 10.1152/jn.00071.2014; Saha K, 2014, J BIOL CHEM, V289, P22246, DOI 10.1074/jbc.M114.563056; Sambo D, 2017, FASEB J, V31; Sambo DO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02087-x; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Teller S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003796; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; Woodman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064339; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222957	10.1371/journal.pone.0222957	http://dx.doi.org/10.1371/journal.pone.0222957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536584	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800103
J	Trainito, CI; Sweeney, DC; Cemazar, J; Schmelz, EM; Francais, O; Le Pioufle, B; Davalos, RV				Trainito, Claudia, I; Sweeney, Daniel C.; Cemazar, Jaka; Schmelz, Eva M.; Francais, Olivier; Le Pioufle, Bruno; Davalos, Rafael, V			Characterization of sequentially-staged cancer cells using electrorotation	PLOS ONE			English	Article							DIELECTRIC-PROPERTIES; COMBINED DIELECTROPHORESIS; YEAST-CELLS; SEPARATION; PROGRESSION; BLOOD; SUBPOPULATIONS; WATER	The identification and separation of cells from heterogeneous populations is critical to the diagnosis of diseases. Label-free methodologies in particular have been developed to manipulate individual cells using properties such as density and morphology. The electrical properties of malignant cells, including the membrane capacitance and cytoplasmic conductivity, have been demonstrated to be altered compared to non-malignant cells of similar origin. Here, we exploit these changes to characterize individual cells in a sequentially-staged in vitro cancer model using electrorotation (EROT)-the rotation of a cell induced by a rotating electric field. Using a microfabricated device, a dielectrophoretic force to suspend cells while measuring their angular velocity resulting from an EROT force applied at frequencies between 3 kHz to 10 MHz. We experimentally determine the EROT response for cells at three stages of malignancy and analyze the resultant spectra by considering models that include the effect of the cell membrane alone (single-shell model) and the combined effect of the cell membrane and nucleus (double-shell model). We find that the cell membrane is largely responsible for a given cell's EROT response between 3 kHz and 10 MHz. Our results also indicate that membrane capacitance, membrane conductance, and cytoplasmic conductivity increase with an increasingly malignant phenotype. Our results demonstrate the potential of using electrorotation as a means making of non-invasive measurements to characterize the dielectric properties of cancer cells.	[Trainito, Claudia, I; Francais, Olivier; Le Pioufle, Bruno] ENS Paris Saclay, Inst Alembert, CNRS, SATIE, Paris, France; [Sweeney, Daniel C.; Cemazar, Jaka; Davalos, Rafael, V] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Food & Exercise, Blacksburg, VA USA; [Francais, Olivier] UPE, ESYCOM FRE 2028, ESIEE Paris, Noisy Le Grand, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Universite Gustave-Eiffel; ESIEE Paris	Davalos, RV (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	davalos@vt.edu	Le Pioufle, Bruno/B-6951-2013; Sweeney, Daniel Christopher/AAL-4856-2020	Le Pioufle, Bruno/0000-0002-0010-2475; Sweeney, Daniel Christopher/0000-0002-1289-1627; Trainito, Claudia/0000-0002-2728-9364	LabeX LaSIPS [ANR-10-LABX-0040-LaSIPS, nANR-11-IDEX-0003-02]; COST [TD1104]; NSF CAREER Award [CBET-1055913]; NSF IGERT [DGE-09661]; NIH [R01CA213423]; NATIONAL CANCER INSTITUTE [R01CA213423] Funding Source: NIH RePORTER	LabeX LaSIPS; COST(European Cooperation in Science and Technology (COST)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge the generous financial support provided by the LabeX LaSIPS (ANR-10-LABX-0040-LaSIPS) managed by the French National Research Agency under the "Investissements d'avenir" program (nANR-11-IDEX-0003-02) and COST TD1104, www.electroporation.net.The authors would like to thank the NSF CAREER Award CBET-1055913, the NSF IGERT DGE-09661, and the NIH R01CA213423 for their gracious support of this work.	Alberts B, 2002, MOL BIOL CELL CELL; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; ARNOLD WM, 1988, J ELECTROSTAT, V21, P151, DOI 10.1016/0304-3886(88)90027-7; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030; Bhonsle SP, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-S3; Braschler T, 2008, LAB CHIP, V8, P280, DOI 10.1039/b710303d; Buchner R, 1999, CHEM PHYS LETT, V306, P57, DOI 10.1016/S0009-2614(99)00455-8; Cemazar J, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4939947; Chatterjee Sabarni K, 2005, Future Oncol, V1, P37, DOI 10.1517/14796694.1.1.37; Cohen CA, 2013, CANCER PREV RES, V6, P1182, DOI 10.1158/1940-6207.CAPR-13-0227; Creekmore AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017676; Douglas TA, 2017, ELECTROPHORESIS, V38, P1507, DOI 10.1002/elps.201600530; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; GASCOYNE PRC, 1992, MEAS SCI TECHNOL, V3, P439, DOI 10.1088/0957-0233/3/5/001; GASCOYNE PRC, 1993, BIOCHIM BIOPHYS ACTA, V1149, P119, DOI 10.1016/0005-2736(93)90032-U; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Han SI, 2013, ANALYST, V138, P1529, DOI 10.1039/c3an36261b; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOLZEL R, 1992, BIOCHIM BIOPHYS ACTA, V1104, P195, DOI 10.1016/0005-2736(92)90150-K; Hu Q, 2009, J APPL PHYS, V106, DOI 10.1063/1.3173344; HUANG Y, 1991, MEAS SCI TECHNOL, V2, P1142, DOI 10.1088/0957-0233/2/12/005; Jiang W G, 1995, Eur J Surg Oncol, V21, P307, DOI 10.1016/S0748-7983(95)91690-3; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Kirby RC, 2006, ACM T MATH SOFTWARE, V32, P417, DOI 10.1145/1163641.1163644; MARSZALEK P, 1991, BIOPHYS J, V59, P982, DOI 10.1016/S0006-3495(91)82312-8; Mohamed H, 2009, J CHROMATOGR A, V1216, P8289, DOI 10.1016/j.chroma.2009.05.036; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Morgan H., 2003, AC ELECTROKINETICS; Pethig R., 2005, IEE Proceedings Nanobiotechnology, V152, P189, DOI 10.1049/ip-nbt:20050040; PETHIG R, 1992, J PHYS D APPL PHYS, V25, P881, DOI 10.1088/0022-3727/25/5/022; Pethig R, 2003, IEEE ENG MED BIOL, V22, P43, DOI 10.1109/MEMB.2003.1266046; POHL HA, 1958, J APPL PHYS, V29, P1182, DOI 10.1063/1.1723398; Roberts PC, 2005, NEOPLASIA, V7, P944, DOI 10.1593/neo.05358; Salmanzadeh A, 2013, INTEGR BIOL-UK, V5, P843, DOI [10.1039/c3ib00008g, 10.1039/c3b00008g]; Salmanzadeh A, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788921; Salmanzadeh A, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699973; Salmanzadeh A, 2012, LAB CHIP, V12, P182, DOI 10.1039/c1lc20701f; Salomon S, 2011, ELECTROPHORESIS, V32, P1508, DOI 10.1002/elps.201000675; Sano MB, 2011, BIOSENS BIOELECTRON, V30, P13, DOI 10.1016/j.bios.2011.07.048; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Trainito CI, 2015, ELECTROPHORESIS, V36, P1115, DOI 10.1002/elps.201400482; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wang K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061158; Yang J, 1999, BIOPHYS J, V76, P3307, DOI 10.1016/S0006-3495(99)77483-7; YING H, 1992, PHYS MED BIOL, V37, P1499, DOI 10.1088/0031-9155/37/7/003	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222289	10.1371/journal.pone.0222289	http://dx.doi.org/10.1371/journal.pone.0222289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536516	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800033
J	Peng, X; Zhang, ZS; Ye, DQ; Xing, PQ; Zou, ZX; Lei, HX; Duan, L				Peng, Xing; Zhang, Zhengshan; Ye, Dongqing; Xing, Peiqi; Zou, Zhengxing; Lei, Hongxing; Duan, Lian			Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL PROGENITOR CELLS; FIBROBLAST-GROWTH-FACTOR; CLINICAL-FEATURES; MATRIX METALLOPROTEINASES; INFLAMMATORY MARKERS; ANGIOGENIC FACTORS; SURGICAL-TREATMENT; EXPRESSION; BIOMARKERS	Objective Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with unknown etiology, sharing many similar clinical symptoms with other vascular disorders. This study aimed to investigate gene dysregulation in peripheral blood of MMD and compare it with other vascular disorders. Methods Transcriptomic profiles of 12 MMD patients and 8 healthy controls were obtained using RNA sequencing. Differentially expressed genes (DEGs) were identified and several were validated by quantitative real-time PCR in independent samples. Biological pathway enrichment analysis of DEGs and deconvolution of leukocyte subsets in peripheral blood were performed. Expression profiles for other vascular diseases were downloaded from public database and consistent DEGs were calculated. Gene set enrichment analysis (GSEA) was conducted to compare gene dysregulation pattern between MMD and other vascular diseases. Results A total of 533 DEGs were identified for MMD. Up-regulated genes were mainly involved in extracellular matrix (ECM) organization, whereas down-regulated genes were primarily associated with inflammatory and immune responses. As for cell populations, significantly increased naive B cells and naive CD4 cells as well as obviously decreased resting natural killer cells were observed in peripheral blood of MMD patients. GSEA analysis indicated that only up-regulated genes of ischemic stroke and down-regulated genes of coronary artery disease and myocardial infarction were enriched in up-regulated and down-regulated genes of MMD, respectively. Conclusion Dysregulated genes in peripheral blood of MMD mainly played key roles in ECM organization, inflammatory and immune responses. This gene dysregulation pattern was specific compared with other vascular diseases. Besides, naive B cells, naive CD4 cells and resting natural killer cells were aberrantly disrupted in peripheral blood of MMD patients. These results will help elucidate the complicated pathogenic mechanism of MMD.	[Peng, Xing; Ye, Dongqing; Xing, Peiqi; Lei, Hongxing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Peng, Xing; Xing, Peiqi; Lei, Hongxing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Zhengshan; Zou, Zhengxing; Duan, Lian] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Neurosurg, Beijing, Peoples R China; [Lei, Hongxing] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Lei, HX (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.; Lei, HX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Duan, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Neurosurg, Beijing, Peoples R China.; Lei, HX (corresponding author), Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing, Peoples R China.	leihx@big.ac.cn		Lei, Hongxing/0000-0003-0496-0386	National Basic Research Program of China (973 Program) [2014CB964901]; National Key Research and Development Program of China [2016YFC0901700]; National High-tech R&D Program of China (863 Program) [2015AA020100]; National Natural Science Foundation of China [81571136]; Beijing Municipal Science & Technology Commission [Z171100001017144]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Research and Development Program of China; National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Basic Research Program of China (973 Program; Grant No. 2014CB964901), the National Key Research and Development Program of China (Grant No. 2016YFC0901700), and the National High-tech R&D Program of China (863 Program; Grant No. 2015AA020100) awarded to H.X. Lei. This work was also supported by grants from the National Natural Science Foundation of China (Grant No. 81571136) and the Beijing Municipal Science & Technology Commission (Grant No. Z171100001017144) awarded to L. Duan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245, DOI [10.2176/nmc.52.245, DOI 10.2176/nmc.52.245]; Aziz Hamza, 2007, Genomic Med, V1, P105, DOI 10.1007/s11568-008-9017-x; Bao XY, 2015, CEREBROVASC DIS, V39, P75, DOI 10.1159/000369524; Bao XY, 2012, CEREBROVASC DIS, V34, P305, DOI 10.1159/000343225; Barr TL, 2010, NEUROLOGY, V75, P1009, DOI 10.1212/WNL.0b013e3181f2b37f; Bersano A, 2016, CEREBROVASC DIS, V41, P105, DOI 10.1159/000442298; Bower RS, 2013, STROKE, V44, P1997, DOI 10.1161/STROKEAHA.111.000307; Chen JB, 2015, J NEUROL SCI, V351, P184, DOI 10.1016/j.jns.2015.02.037; Christodoulidis G, 2014, CARDIOL REV, V22, P279, DOI 10.1097/CRD.0000000000000006; DAVIDSON JM, 1993, J CELL PHYSIOL, V155, P149, DOI 10.1002/jcp.1041550119; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Fioranelli M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02031; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fujimura M, 2018, BRAIN RES, V1679, P39, DOI 10.1016/j.brainres.2017.11.013; Fujimura M, 2009, SURG NEUROL, V72, P476, DOI 10.1016/j.surneu.2008.10.009; Fukui M, 2000, NEUROPATHOLOGY, V20, pS61, DOI 10.1046/j.1440-1789.2000.00300.x; Hojo M, 1998, J NEUROSURG, V89, P623, DOI 10.3171/jns.1998.89.4.0623; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Houkin K, 2012, NEUROL MED-CHIR, V52, P267, DOI 10.2176/nmc.52.267; Huang CC, 2011, PHYSIOL GENOMICS, V43, P836, DOI 10.1152/physiolgenomics.00243.2010; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; IKEDA E, 1991, STROKE, V22, P1358, DOI 10.1161/01.STR.22.11.1358; Ikonomidis I, 2012, BIOFACTORS, V38, P320, DOI 10.1002/biof.1024; Im SH, 2005, J NEUROSURG, V102, P1013, DOI 10.3171/jns.2005.102.6.1013; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33; Jiang T, 2013, J NEUROSURG, V118, P1030, DOI 10.3171/2013.1.JNS12565; Jung KH, 2008, J CEREBR BLOOD F MET, V28, P1795, DOI 10.1038/jcbfm.2008.67; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kang HS, 2014, J NEUROSURG, V120, P415, DOI 10.3171/2013.9.JNS131000; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Kim JH, 2010, J NEUROSCI RES, V88, P510, DOI 10.1002/jnr.22228; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Komiyama M, 2001, NEUROL MED-CHIR, V41, P37, DOI 10.2176/nmc.41.37; LAWRENCE R, 1994, J BIOL CHEM, V269, P9603; Lee JH, 2013, CIRCULATION, V127, P2063, DOI 10.1161/CIRCULATIONAHA.112.136473; Lewis DA, 2011, THROMB RES, V128, P536, DOI 10.1016/j.thromres.2011.06.003; Li Hongyu, 2018, Front Biosci (Schol Ed), V10, P185; Li JJ, 2011, CHINESE MED J-PEKING, V124, P3568, DOI 10.3760/cma.j.issn.0366-6999.2011.21.024; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Livesay J, 2019, CASE REP CARDIOL, V2019, DOI 10.1155/2019/7124072; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madjid M, 2011, BRIT MED BULL, V100, P23, DOI 10.1093/bmb/ldr043; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; MASUDA J, 1993, STROKE, V24, P1960, DOI 10.1161/01.STR.24.12.1960; Mejia-Munne JC, 2017, WORLD NEUROSURG, V100, P575, DOI 10.1016/j.wneu.2017.01.012; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Moteki Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001862; Murakami T, 2009, CIRCULATION, V119, P1689, DOI 10.1161/CIRCULATIONAHA.108.827782; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nam TM, 2015, J KOREAN MED SCI, V30, P470, DOI 10.3346/jkms.2015.30.4.470; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Park HJ, 2015, ONCOTARGET, V6, P12970, DOI 10.18632/oncotarget.4001; Rafat N, 2009, STROKE, V40, P432, DOI 10.1161/STROKEAHA.108.529420; RASMUSSEN LM, 1995, AM J PATHOL, V147, P1041; Roder C, 2011, INT J CHEM REACT ENG, V27, P245, DOI 10.1007/s00381-010-1241-8; Sinnaeve PR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007037; Song FH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182294; Sonobe S, 2014, BRAIN RES, V1552, P64, DOI 10.1016/j.brainres.2014.01.011; St Goar FG, 1999, AM J CARDIOL, V83, P1296, DOI 10.1016/S0002-9149(99)00081-8; Subirana I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21482-y; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Voudris KV, 2015, CURR MED CHEM, V22, P2680, DOI 10.2174/0929867322666150420124427; Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001; Weng LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03278-8; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179; Yoshihara T, 2008, J CEREBR BLOOD F MET, V28, P1086, DOI 10.1038/jcbfm.2008.1; Yoshimoto T, 1996, STROKE, V27, P2160, DOI 10.1161/01.STR.27.12.2160; Zhang Q, 2017, J NEUROSURG, V126, P1106, DOI 10.3171/2016.2.JNS152173	76	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221811	10.1371/journal.pone.0221811	http://dx.doi.org/10.1371/journal.pone.0221811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532776	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600012
J	Ritter-Hayashi, D; Vermeulen, P; Knoben, J				Ritter-Hayashi, Daniela; Vermeulen, Patrick; Knoben, Joris			Is this a man's world? The effect of gender diversity and gender equality on firm innovativeness	PLOS ONE			English	Article							LEADER-MEMBER EXCHANGE; TRANSFORMATIONAL LEADERSHIP; UPPER ECHELONS; PERFORMANCE; MANAGEMENT; IMPACT; EXPLORATION; HETEROGENEITY; ORGANIZATION; ANTECEDENTS	Gender diversity is known to have a positive effect on innovation in developed countries. However, it is unclear whether the benefits of gender diversity for innovation also apply to the particular context of developing countries, which is characterized by diverse and lower levels of gender equality. We propose that gender diversity positively impacts innovation in the developing countries participating in our study. In addition, we expect that this effect is moderated by country-specific levels of gender equality. In a cross-country study covering 18,547 firms in 15 developing countries, we find that gender diversity among a firm's owners and workforce as well as having a female top manager benefit innovation in developing countries. Yet, contradictory to our expectations, gender equality does not significantly moderate this relationship. As such, our results underline the importance of enabling and fostering gender diversity and have critical implications for firms and policy makers alike.	[Ritter-Hayashi, Daniela; Vermeulen, Patrick] Radboud Univ Nijmegen, Dept Business Adm, Gelderland, Netherlands; [Knoben, Joris] Radboud Univ Nijmegen, Dept Econ & Business Econ, Gelderland, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Ritter-Hayashi, D (corresponding author), Radboud Univ Nijmegen, Dept Business Adm, Gelderland, Netherlands.	d.ritterhayashi@fm.ru.nl	Knoben, Joris/ABB-4605-2020	Knoben, Joris/0000-0001-8603-8066	UK's Department for International Development (DFID) [EIP-LIC/PO 5639]	UK's Department for International Development (DFID)	This research was conducted within the framework of the research project 'Enabling Innovation and Productivity Growth in Low Income Countries' (EIP-LIC/PO 5639), funded by the UK's Department for International Development (DFID). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshartous D, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889620; Bandiera O, 2013, WORLD BANK RES OBSER, V28, P2, DOI 10.1093/wbro/lks012; Bascle G, 2008, STRATEG ORGAN, V6, P285, DOI 10.1177/1476127008094339; BASS BM, 1990, ORGAN DYN, V18, P19, DOI 10.1016/0090-2616(90)90061-S; Basu R, 1997, J APPL SOC PSYCHOL, V27, P477, DOI 10.1111/j.1559-1816.1997.tb00643.x; Bradley SW, 2012, J MANAGE STUD, V49, P684, DOI [10.1111/J.1467-6486.2012.01043.X, 10.1111/j.1467-6486.2012.01043.x]; Buvinic M, 2016, WORLD BANK RES OBSER, V31, P59, DOI 10.1093/wbro/lku013; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Carpenter MA, 2004, J MANAGE, V30, P749, DOI 10.1016/j.jm.2004.06.001; Casper WJ, 2011, J VOCAT BEHAV, V79, P640, DOI 10.1016/j.jvb.2011.04.011; Cervantes-Godoy D., 2010, OECD FOOD AGR FISHER; Choi SB, 2012, CORP GOV-OXFORD, V20, P267, DOI 10.1111/j.1467-8683.2012.00911.x; Cook A, 2015, STRATEG ORGAN, V13, P117, DOI 10.1177/1476127014564109; COX TH, 1991, ACAD MANAGE J, V34, P827, DOI 10.2307/256391; Damanpour F, 2006, BRIT J MANAGE, V17, P215, DOI 10.1111/j.1467-8551.2006.00498.x; De Dreu CKW, 2001, J APPL PSYCHOL, V86, P1191, DOI 10.1037//0021-9010.86.6.1191; Diaz-Garcia C, 2013, INNOV-ORGAN MANAG, V15, P149, DOI 10.5172/impp.2013.15.2.149; Dwyer S, 2003, J BUS RES, V56, P1009, DOI 10.1016/S0148-2963(01)00329-0; Eagly AH, 2003, LEADERSHIP QUART, V14, P807, DOI 10.1016/j.leaqua.2003.09.004; Eastin J, 2013, WORLD POLIT, V65, P156, DOI 10.1017/S0043887112000275; Economist Intelligence Unit, 2012, WOM EC OPP 2012 IND; Elenkov DS, 2005, J MANAGE, V31, P381, DOI 10.1177/0149206304272151; Fagerberg J, 2002, RES POLICY, V31, P1291, DOI 10.1016/S0048-7333(02)00064-1; Fernandez J, 2015, INT J GEND ENTREP, V7, P148, DOI 10.1108/IJGE-07-2014-0022; Field A., 2018, DISCOVERING STAT USI, V5th ed.; George G, 2016, ACAD MANAGE J, V59, P377, DOI 10.5465/amj.2016.4002; Goedhuys M, 2007, IND CORP CHANGE, V16, P269, DOI 10.1093/icc/dtm003; Goedhuys M, 2014, IND CORP CHANGE, V23, P1, DOI 10.1093/icc/dtt006; GRAEN GB, 1995, LEADERSHIP QUART, V6, P219, DOI 10.1016/1048-9843(95)90036-5; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gumusluoglu L, 2009, J BUS RES, V62, P461, DOI 10.1016/j.jbusres.2007.07.032; Guo S, 2015, PROPENSITY SCORE ANA; HAMBRICK DC, 1984, ACAD MANAGE REV, V9, P193, DOI 10.2307/258434; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Hausman A, 2005, IND MARKET MANAG, V34, P773, DOI 10.1016/j.indmarman.2004.12.009; Hoetker G, 2007, STRATEGIC MANAGE J, V28, P331, DOI 10.1002/smj.582; Hoskisson RE, 2002, ACAD MANAGE J, V45, P697, DOI 10.2307/3069305; Huang FL, 2016, J EXP EDUC, V84, P175, DOI 10.1080/00220973.2014.952397; IPE M., 2003, HUM RESOUR DEV REV, V2, P337, DOI [10.1177/1534484303257985, DOI 10.1177/1534484303257985]; Joshi A, 2011, J MANAGE, V37, P521, DOI 10.1177/0149206310372969; Jung DI, 2003, LEADERSHIP QUART, V14, P525, DOI 10.1016/S1048-9843(03)00050-X; Jung D, 2008, LEADERSHIP QUART, V19, P582, DOI 10.1016/j.leaqua.2008.07.007; Kharistvalashvili N, 2016, EUR J SUSTAIN DEV, V5, P47, DOI 10.14207/ejsd.2016.v5n1p47; Klapper LF, 2011, WORLD BANK RES OBSER, V26, P237, DOI 10.1093/wbro/lkp032; Legitimacy G., 2013, GETTING WOMEN CORPOR, P147; Leonard D, 1998, CALIF MANAGE REV, V40, P112, DOI 10.2307/41165946; Lyngsie J, 2017, STRATEGIC MANAGE J, V38, P487, DOI 10.1002/smj.2510; Ruiz-Jimenez JM, 2016, BRQ-BUS RES Q, V19, P107, DOI 10.1016/j.brq.2015.08.003; Maurer I, 2006, ADMIN SCI QUART, V51, P262, DOI 10.2189/asqu.51.2.262; Miller T, 2009, J MANAGE STUD, V46, P755, DOI 10.1111/j.1467-6486.2009.00839.x; Milliken FJ, 1996, ACAD MANAGE REV, V21, P402, DOI 10.2307/258667; Nielsen S, 2010, EUR MANAG REV, V7, P16, DOI 10.1057/emr.2009.27; Nielsen S, 2009, STRATEG ORGAN, V7, P277, DOI 10.1177/1476127009340496; Ostergaard CR, 2011, RES POLICY, V40, P500, DOI 10.1016/j.respol.2010.11.004; Parrotta P, 2014, J POPUL ECON, V27, P303, DOI 10.1007/s00148-013-0491-7; PRIEM RL, 1995, J MANAGE, V21, P691; Quintana-Garcia C, 2008, RES POLICY, V37, P492, DOI 10.1016/j.respol.2007.12.002; Raudenbusch S. W., 2002, HIERARCHICAL LINEAR; Reinwald M., 2018, ACAD MANAGEMENT P; Ridgeway C., 2002, BLACKWELL HDB SOCIAL, P352; Robson PJA, 2009, SMALL BUS ECON, V32, P331, DOI 10.1007/s11187-008-9121-2; Roper S, 2013, RES POLICY, V42, P1544, DOI 10.1016/j.respol.2013.05.006; Salomon R. M., 2006, Strategic Organization, V4, P135, DOI 10.1177/1476127006064066; Singhathep T, 2015, GEND TECHNOL DEV, V19, P320, DOI 10.1177/0971852415596865; TERI, 2020, STEEL MARK DEV Q4 20; Terjesen S, 2008, J BUS ETHICS, V83, P55, DOI 10.1007/s10551-007-9656-1; Teruel M, 2013, WORKING PAPER; THOMPSON VA, 1965, ADMIN SCI QUART, V10, P1, DOI 10.2307/2391646; Torchia M, 2011, J BUS ETHICS, V102, P299, DOI 10.1007/s10551-011-0815-z; Turner J.C., 1987, REDISCOVERING SOCIAL; United Nations General Assembly, 2015, TRANSF OUR WORLD 203, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Van der Vegt GS, 2003, J MANAGE, V29, P729, DOI 10.1016/S0149-2063(03)00033-3; van der Walt N, 2003, CORP GOV-OXFORD, V11, P218; van Staveren I, 2013, REV SOC ECON, V71, P339, DOI 10.1080/00346764.2012.707398; Wang MZ, 2013, J BUS ETHICS, V117, P449, DOI 10.1007/s10551-012-1546-5; Wolfram H., 2006, WOMEN MANAGEMENT REV, V22, DOI [10.1108/09649420710726201, DOI 10.1108/09649420710726201]; Zhang Y, 2016, ACAD MANAGE J, V59, P1845, DOI 10.5465/amj.2014.0176; Zhang Y, 2012, HUM RELAT, V65, P1487, DOI 10.1177/0018726712453931; Zuraik A, 2019, EUR J INNOV MANAG, V22, P84, DOI 10.1108/EJIM-10-2017-0142	79	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222443	10.1371/journal.pone.0222443	http://dx.doi.org/10.1371/journal.pone.0222443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KF3AJ	31532790	gold, Green Published, Green Submitted			2022-12-27	WOS:000509119100001
J	Vallabhajosyula, S; Dunlay, SM; Barsness, GW; Vallabhajosyula, S; Vallabhajosyula, S; Sundaragiri, PR; Gersh, BJ; Jaffe, AS; Kashani, K				Vallabhajosyula, Saraschandra; Dunlay, Shannon M.; Barsness, Gregory W.; Vallabhajosyula, Saarwaani; Vallabhajosyula, Shashaank; Sundaragiri, Pranathi R.; Gersh, Bernard J.; Jaffe, Allan S.; Kashani, Kianoush			Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock	PLOS ONE			English	Article							DIALYSIS; RISK	Background There are limited data on acute kidney injury (AKI) complicating acute myocardial infarction with cardiogenic shock (AMI-CS). This study sought to evaluate 15-year national prevalence, temporal trends and outcomes of AKI with no need for hemodialysis (AKI-ND) and requiring hemodialysis (AKI-D) following AMI-CS. Methods This was a retrospective cohort study from 2000-2014 from the National Inpatient Sample (20% stratified sample of all community hospitals in the United States). Adult patients (>18 years) admitted with a primary diagnosis of AMI and secondary diagnosis of CS were included. The primary outcome was in-hospital mortality in cohorts with no AKI, AKI-ND, and AKI-D. Secondary outcomes included predictors, resource utilization and disposition. Results During this 15-year period, 440,257 admissions for AMI-CS were included, with AKI in 155,610 (35.3%) and hemodialysis use in 14,950 (3.4%). Older age, black race, non-private insurance, higher comorbidity, organ failure, and use of cardiac and non-cardiac organ support were associated with the AKI development and hemodialysis use. There was a 2.6-fold higher adjusted risk of developing AKI in 2014 compared to 2000. Presence of AKI-ND and AKI-D was associated with a 1.3 and 1.7-fold higher adjusted risk of mortality. Compared to the cohort without AKI, AKI-ND and AKI-D were associated with longer length of stay (9 +/- 10,12 +/- 13, and 18 +/- 19 days respectively; p<0.001) and higher hospitalization costs ($101,859 +/- 116,204, $159,804 +/- 190,766, and $265,875 +/- 254,919 respectively; p<0.001). Conclusion AKI-ND and AKI-D are associated with higher in-hospital mortality and resource utilization in AMI-CS.	[Vallabhajosyula, Saraschandra; Dunlay, Shannon M.; Barsness, Gregory W.; Vallabhajosyula, Saarwaani; Gersh, Bernard J.; Jaffe, Allan S.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Vallabhajosyula, Saraschandra; Vallabhajosyula, Shashaank; Kashani, Kianoush] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55905 USA; [Dunlay, Shannon M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Sundaragiri, Pranathi R.] Mayo Clin, Dept Med, Div Hosp Internal Med, Rochester, MN USA; [Kashani, Kianoush] Mayo Clin, Div Nephrol & Hypertens, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Vallabhajosyula, S (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55905 USA.	Vallabhajosyula.Saraschandra@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Adegbala O, 2019, AM J CARDIOL, V123, P1816, DOI 10.1016/j.amjcard.2019.02.038; Adler C, 2013, RESUSCITATION, V84, P194, DOI 10.1016/j.resuscitation.2012.06.013; Ahmed A, 2015, J CRIT CARE, V30, P988, DOI 10.1016/j.jcrc.2015.05.007; Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202; Chan L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004509; Correa A, 2018, J CARD FAIL, V24, P442, DOI 10.1016/j.cardfail.2018.05.001; Dasta JF, 2019, J PHARM PRACT, V32, P292, DOI 10.1177/0897190019852556; Hsu RK, 2016, CLIN J AM SOC NEPHRO, V11, P14, DOI 10.2215/CJN.04520415; Jentzer JC, 2018, CHEST, V154, P416, DOI 10.1016/j.chest.2017.12.021; Jentzer JC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008169; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kashani K, 2019, CLIN J AM SOC NEPHRO, V14, P941, DOI 10.2215/CJN.01250119; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; Kotecha A, 2018, J CRIT CARE, V43, P122, DOI 10.1016/j.jcrc.2017.08.044; Lauridsen MD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1170-8; Lim HS, 2018, SHOCK, V50, P167, DOI 10.1097/SHK.0000000000001052; Moman RN, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0468-5; Ostermann M, 2019, CHEST, V156, P594, DOI 10.1016/j.chest.2019.04.004; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ronco C, 2017, NEPHROL DIAL TRANSPL, V32, P408, DOI 10.1093/ndt/gfx016; Sakhuja A, 2019, MAYO CLIN PROC, V94, P1509, DOI 10.1016/j.mayocp.2019.01.040; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Sinha SS, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003616; Tumlin JA, 2018, CRIT CARE MED, V46, P949, DOI 10.1097/CCM.0000000000003092; Vallabhajosyula S, 2019, AGING-US, V11, P4774, DOI 10.18632/aging.102104; Vallabhajosyula S, 2019, IJC HEART VASC, V24, DOI 10.1016/j.ijcha.2019.100414; Vallabhajosyula S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0571-2; Vallabhajosyula S, 2020, ASAIO J, V66, P497, DOI 10.1097/MAT.0000000000001039; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954; Vallabhajosyula S, 2019, ESC HEART FAIL, V6, P874, DOI 10.1002/ehf2.12482; Vallabhajosyula S, 2019, AM J CARDIOL, V124, P491, DOI 10.1016/j.amjcard.2019.05.038; Vallabhajosyula S, 2019, JACC-HEART FAIL, V7, P469, DOI 10.1016/j.jchf.2018.12.007; Vallabhajosyula S, 2019, J AM COLL CARDIOL, V73, P1781, DOI 10.1016/j.jacc.2019.01.053; Vallabhajosyula S, 2019, INT J CARDIOL, V285, P6, DOI 10.1016/j.ijcard.2019.03.008; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010193; Vallabhajosyula S, 2019, AM J CARDIOL, V123, P489, DOI 10.1016/j.amjcard.2018.10.029; Vallabhajosyula S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006930; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009608; Vallabhajosyula S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190965; Vallabhajosyula S, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.36; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	42	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222894	10.1371/journal.pone.0222894	http://dx.doi.org/10.1371/journal.pone.0222894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532793	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600038
J	Barker, D; Gillum, KT; Niemuth, NA; Kodihalli, S				Barker, Douglas; Gillum, Karen T.; Niemuth, Nancy A.; Kodihalli, Shantha			Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; A BOTULISM; CLOSTRIDIUM-BARATII; UNITED-STATES; OUTBREAK; IDENTIFICATION; TOXIN; RECOVERY	Botulism neurotoxins are highly toxic and are potential agents for bioterrorism. The development of effective therapy is essential to counter the possible use of these toxins in military and bioterrorism scenarios, and to provide treatment in cases of natural intoxication. Guinea pigs were intoxicated with a lethal dose of botulinum neurotoxin serotypes A, B, C, D, E, F or G, and at onset of the clinical disease intoxicated animals were treated with either BAT (R) [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)] or placebo. BAT product treatment significantly (p<0.0001) enhanced survival compared to placebo for all botulinum neurotoxin serotypes and arrested or mitigated the progression of clinical signs of botulism intoxication. These results demonstrated the therapeutic efficacy of BAT product in guinea pigs and provided supporting evidence of effectiveness for licensure of BAT product under FDA 21 CFR Part 601 (Subpart H Animal Rule) as a therapeutic for botulism intoxication to serotypes A, B, C, D, E, F or G in adults and pediatric patients.	[Barker, Douglas; Kodihalli, Shantha] Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada; [Gillum, Karen T.; Niemuth, Nancy A.] Battelle Biomed Res Ctr, Columbus, OH USA		Kodihalli, S (corresponding author), Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada.	skodihalli@ebsi.com		Barker, Douglas/0000-0002-1174-3964	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHSO100200600017C]	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	This work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHSO100200600017C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; [Anonymous], 2015, PRODUCT DEV ANIMAL R, P54; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219; BALL AP, 1979, Q J MED, V48, P473; Carlella M.A., 1964, PHS999FP1 PUBL, P113; CDC, 2019, BOT ANN SUMM 2017; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Cheng WQ, 2012, J PHARM SCI-US, V101, P1701, DOI 10.1002/jps.23076; CICCARELLI AS, 1977, APPL ENVIRON MICROB, V34, P843, DOI 10.1128/AEM.34.6.843-848.1977; COLEBATCH JG, 1989, LANCET, V2, P1216; DEMARCHI J, 1958, Bull Acad Natl Med, V142, P580; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; Derman Y, 2016, TOXINS, V8, DOI 10.3390/toxins8090257; Emanuel A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209019; Fan YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174187; FDA, 2005, GUID IND EST MAX SAF; GANGAROSA EJ, 1971, AM J EPIDEMIOL, V93, P93, DOI 10.1093/oxfordjournals.aje.a121239; Garcia-Rodriguez C, 2018, TOXINS, V10, DOI 10.3390/toxins10030105; Gelzleichter TR, 1999, J APPL TOXICOL, V19, pS35, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9; Harvey SM, 2002, J CLIN MICROBIOL, V40, P2260, DOI 10.1128/JCM.40.6.2260-2262.2002; Kiris E, 2014, CURR TOP MED CHEM, V14, P2044, DOI 10.2174/1568026614666141022093350; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; KOENIG MG, 1967, AM J MED, V42, P208, DOI 10.1016/0002-9343(67)90020-4; Kongsaengdao S, 2006, CLIN INFECT DIS, V43, P1247, DOI 10.1086/508176; Li MX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197011; MANN JM, 1981, AM J PUBLIC HEALTH, V71, P266, DOI 10.2105/AJPH.71.3.266; McCarty CL, 2015, MMWR-MORBID MORTAL W, V64, P802, DOI 10.15585/mmwr.mm6429a6; MCCROSKEY LM, 1991, J CLIN MICROBIOL, V29, P2618, DOI 10.1128/JCM.29.11.2618-2620.1991; METZGER JF, 1979, REV INFECT DIS, V1, P689; Middlebrook J. L, 1997, TXB MILITARY MED MED, P643; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; OGUMA K, 1990, LANCET, V336, P1449, DOI 10.1016/0140-6736(90)93157-K; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Richardson JS, 2020, CLIN INFECT DIS, V70, P1950, DOI 10.1093/cid/ciz515; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; SEALS JE, 1981, AM J EPIDEMIOL, V113, P436, DOI 10.1093/oxfordjournals.aje.a113111; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Simpson LL, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P891, DOI 10.1016/B978-0-12-369408-9.00046-9; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Takahashi H, 2009, HYBRIDOMA, V28, P63, DOI 10.1089/hyb.2008.0066; TELZAK EE, 1990, J INFECT DIS, V161, P340, DOI 10.1093/infdis/161.2.340; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Townes JM, 1996, ANN INTERN MED, V125, P558, DOI 10.7326/0003-4819-125-7-199610010-00004; WEBER JT, 1993, J INFECT DIS, V167, P451, DOI 10.1093/infdis/167.2.451; Yu PA, 2018, CLIN INFECT DIS, V66, pS57, DOI 10.1093/cid/cix816	50	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222670	10.1371/journal.pone.0222670	http://dx.doi.org/10.1371/journal.pone.0222670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527885	gold, Green Published, Green Submitted			2022-12-27	WOS:000532231400038
J	Lamas-Fernandez, C; Hayward, G; Moore, M; Monks, T				Lamas-Fernandez, Carlos; Hayward, Gail; Moore, Michael; Monks, Thomas			A mathematical model for designing networks of C-Reactive Protein point of care testing	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; LOCATION	One approach to improving antibiotic stewardship in primary care may be to support all General Practitioners (GPs) to have access to point of care C-Reactive Protein tests to guide their prescribing decisions in patients presenting with symptoms of lower respiratory tract infection. However, to date there has been no work to understand how clinical commissioning groups might approach the practicalities of system-wide implementation. We aimed to develop an accessible service delivery modelling tool that, based on open data, could generate a layout of the geographical distribution of point of care facilities that minimised the cost and travel distance for patients across a given region. We considered different implementation models where point of care tests were placed at either GP surgeries, pharmacies or both. We analysed the trade-offs between cost and travel found by running the model under different configurations and analysing the model results in four regions of England (two urban, two rural). Our model suggests that even under assumptions of short travel distances for patients (e.g. under 500m), it is possible to achieve a meaningful reduction in the number of necessary point of care testing facilities to serve a region by referring some patients to be tested at nearby GP surgeries or pharmacies. In our test cases pharmacy-led implementation models resulted in some patients having to travel long distances to obtain a test, beyond the desired travel limits. These results indicate that an efficient implementation strategy for point of care tests over a geographic region, potentially building on primary care networks, might lead to significant cost reduction in equipment and associated personnel training, maintenance and quality control costs; as well as achieving fair access to testing facilities.	[Lamas-Fernandez, Carlos] Univ Southampton, NIHR CLAHRC Wessex, Southampton, Hants, England; [Hayward, Gail] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, NIHR Community Healthcare MIC, Oxford, England; [Moore, Michael] Univ Southampton, Primary Care & Populat Sci, Southampton, Hants, England; [Monks, Thomas] Univ Exeter, Med Sch, Exeter, Devon, England	University of Southampton; University of Oxford; University of Southampton; University of Exeter	Lamas-Fernandez, C (corresponding author), Univ Southampton, NIHR CLAHRC Wessex, Southampton, Hants, England.	C.Lamas-Fernandez@soton.ac.uk	; Moore, Michael/C-3447-2011	Lamas-Fernandez, Carlos/0000-0001-5329-7619; Moore, Michael/0000-0002-5127-4509; Hayward, Gail/0000-0003-0852-627X	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative	This article presents independent research funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex (CLF, TM, MM), and by the National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative (GH). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Javid A, 2017, COMPUT OPER RES, V79, P223, DOI 10.1016/j.cor.2016.05.018; Andre M, 2004, SCAND J INFECT DIS, V36, P192, DOI 10.1080/00365540410019372; [Anonymous], 2017, OPENSTREETMAP CONTRI; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Cals JWL, 2010, ANN FAM MED, V8, P124, DOI 10.1370/afm.1090; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Chan TCY, 2018, OPER RES, V66, P358, DOI 10.1287/opre.2017.1660; Daskin MS, 2005, INT SER OPER RES MAN, V70, P43, DOI 10.1007/1-4020-8066-2_3; Digital NHS, 2018, GP GP PRACT REL DAT; Excellence NI for H and C, 2014, EXCELLENCE NI H C PN; Huddy JR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009959; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L304; Johnson M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024558; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Luxen D., 2011, P 19 ACM SIGSPATIAL, P513, DOI [10.1145/2093973.2094062, DOI 10.1145/2093973.2094062]; Meskarian R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183942; Monks T, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0444-0; Oppong R, 2013, BRIT J GEN PRACT, V63, pE465, DOI 10.3399/bjgp13X669185; Oppong R, 2011, EUR J HEALTH ECON, V12, P319, DOI 10.1007/s10198-010-0239-1; Pope A, 2017, LOCATION PHARM ENGLA	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222676	10.1371/journal.pone.0222676	http://dx.doi.org/10.1371/journal.pone.0222676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527896	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000532231400039
J	Yu, WH; Hao, XH; Yang, FM; Ma, J; Zhao, Y; Li, YY; Wang, JB; Xu, HJ; Chen, LX; Liu, Q; Duan, SQ; Yang, YP; Huang, F; He, ZL				Yu, Wenhai; Hao, Xianhui; Yang, Fengmei; Ma, Jin; Zhao, Yuan; Li, Yanyan; Wang, Junbin; Xu, Hongjie; Chen, Lixiong; Liu, Quan; Duan, Suqin; Yang, Yaping; Huang, Fen; He, Zhanlong			Hematological and biochemical parameters for Chinese rhesus macaque	PLOS ONE			English	Article							MONKEYS MACACA-MULATTA; NONHUMAN-PRIMATES; AGE; VALUES; SEX; COMPLEMENT; GENDER; VIRUS; TRANSPLANTATION; HOMEOSTASIS	Rhesus macaque is an important animal model in biomedical research, especially human disease, developmental, translational, and pre-clinical research. Blood physiological and biochemical parameters are important markers for physiology, pathology, and toxicology research. However, these parameters have not been systematically reported for Chinese rhesus macaques. To characterize the reference for these parameters, this study collected 1805 Chinese rhesus macaques living in Southwestern China. A total of 24 blood physiological indexes and 27 biochemical parameters were determined. Sex and age were found to affect these parameters. In conclusion, a comprehensive and systematic reference of hematological and biochemical parameters for Chinese rhesus macaque was established in this work on the basis of a large cohort. Such reference will benefit biomedical research employing rhesus macaques as animal models.	[Yu, Wenhai; Yang, Fengmei; Ma, Jin; Zhao, Yuan; Li, Yanyan; Wang, Junbin; Xu, Hongjie; Chen, Lixiong; Liu, Quan; Duan, Suqin; Yang, Yaping; He, Zhanlong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Hao, Xianhui; Huang, Fen] Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming University of Science & Technology	He, ZL (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China.; Huang, F (corresponding author), Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China.	huangfen6789@163.com; hzl612@126.com	xu, hong/GSD-8903-2022		PUMC young Fund [3332019008, 2017310038]; Natural Science Foundation of Yunnan province [2018FB132]; Fundamental Research Funds for the Central Universities [2016ZX310179-3, 2016ZX310179-4]; CAMS Innovation Fund for Medical Sciences [2019-I2M-1-004, 2018-I2M-3-002, 2016-I2M-2-1-001]	PUMC young Fund; Natural Science Foundation of Yunnan province(Natural Science Foundation of Yunnan Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CAMS Innovation Fund for Medical Sciences	This study was supported by PUMC young Fund (3332019008 and 2017310038), Natural Science Foundation of Yunnan province to (2018FB132) to WY, the Fundamental Research Funds for the Central Universities (2016ZX310179-3, 2016ZX310179-4) to WY and FY, and CAMS Innovation Fund for Medical Sciences (2019-I2M1-004, 2018-I2M-3-002, 2016-I2M-2-1-001,) to WY, YZ, and ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by PUMC young Fund (3332019008 and 2017310038), Natural Science Foundation of Yunnan province to (2018FB132), the Fundamental Research Funds for the Central Universities (2016ZX310179-3 and 2016ZX310179-4), and CAMS Innovation Fund for Medical Sciences (2019-I2M-1-004, 2018-I2M-3-002 and 2016-I2M-2-1-001).	Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Aoyama A, 2015, AM J TRANSPLANT, V15, P1415, DOI 10.1111/ajt.13130; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Berger M, 2018, J NEUROPHYSIOL, V119, P796, DOI 10.1152/jn.00614.2017; Black MJ, 2015, AM J PHYSIOL-REG I, V309, pR1153, DOI 10.1152/ajpregu.00403.2014; Buchl SJ, 1997, LAB ANIM SCI, V47, P528; Chen YN, 2009, XENOTRANSPLANTATION, V16, P496, DOI 10.1111/j.1399-3089.2009.00554.x; Clarke EV, 2014, J LEUKOCYTE BIOL, V96, P745, DOI 10.1189/jlb.3MR0214-109R; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Dai JJ, 2000, ACTA LAB SCI SINICA, V8, P224; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Eastman AJ, 2018, J INFECT DIS, V217, P656, DOI 10.1093/infdis/jix545; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; GOODRICH JA, 1995, J MED PRIMATOL, V24, P17, DOI 10.1111/j.1600-0684.1995.tb00140.x; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; Han CY, 2016, 3RD INTERNATIONAL CONFERENCE ON EDUCATION REFORM AND MODERN MANAGEMENT, 2016, P190; Harding JD, 2017, ILAR J, V58, P59, DOI 10.1093/ilar/ilw042; Hauser SN, 2018, HEARING RES, V357, P33, DOI 10.1016/j.heares.2017.11.004; He QL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189837; Heald AE, 2015, NEW ENGL J MED, V373, P339, DOI 10.1056/NEJMoa1410345; Hirano Y, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3864; Huang F, 2016, HEPATOLOGY, V64, P350, DOI 10.1002/hep.28668; Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011; Ibanez-Contreras A, 2018, EXP GERONTOL, V101, P80, DOI 10.1016/j.exger.2017.11.003; John WS, 2018, J PHARMACOL EXP THER, V364, P300, DOI 10.1124/jpet.117.244194; Khalil R, 2018, MOL CELL ENDOCRINOL, V465, P61, DOI 10.1016/j.mce.2017.11.011; Kimura T, 2007, J AM ASSOC LAB ANIM, V46, P33; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; Koga T, 2005, INT J TOXICOL, V24, P377, DOI 10.1080/10915810500208058; Kozlosky JC, 2015, REGUL TOXICOL PHARM, V73, P27, DOI 10.1016/j.yrtph.2015.06.008; Kristic J, 2014, J GERONTOL A-BIOL, V69, P779, DOI 10.1093/gerona/glt190; Kuiken T, 2017, VET RES, V48, DOI 10.1186/s13567-017-0486-6; Lee JH, 2012, CLIN TRANSPLANT, V26, P736, DOI 10.1111/j.1399-0012.2012.01607.x; Lemieux I, 2002, EUR J CLIN INVEST, V32, P909, DOI 10.1046/j.1365-2362.2002.01092.x; Li S, 2008, KIDNEY INT, V73, P637, DOI 10.1038/sj.ki.5002747; Loh RKS, 2013, AUST FAM PHYSICIAN, V42, P195; Loria A, 2007, AM J PHYSIOL-RENAL, V293, pF506, DOI 10.1152/ajprenal.00066.2007; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Martin M, 2016, IMMUNOL REV, V274, P218, DOI 10.1111/imr.12462; Mauvais-Jarvis F, 2018, PHYSIOL BEHAV, V187, P20, DOI 10.1016/j.physbeh.2017.08.016; Miller AA, 2007, CLIN EXP PHARMACOL P, V34, P1037, DOI 10.1111/j.1440-1681.2007.04732.x; MOODY DB, 1978, ARCH OTO-RHINO-LARYN, V220, P47, DOI 10.1007/BF00456301; Nikkila M, 1996, ATHEROSCLEROSIS, V119, P181, DOI 10.1016/0021-9150(95)05645-9; Paz MFCJ, 2018, J CELL BIOCHEM, V119, P2923, DOI 10.1002/jcb.26487; Pennisi E, 2007, SCIENCE, V316, P216, DOI 10.1126/science.316.5822.216; PERRETTA G, 1991, J MED PRIMATOL, V20, P345; Pinto-Santini DM, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0379-9; Pucic M, 2012, GLYCOBIOLOGY, V22, P975, DOI 10.1093/glycob/cws062; Rao M, 2017, ONCOTARGET, V8, P85909, DOI 10.18632/oncotarget.20719; Redlberger S, 2017, VET J, V229, P45, DOI 10.1016/j.tvjl.2017.10.017; Sato A, 2005, CONTEMP TOP LAB ANIM, V44, P29; Schmitt CA, 2018, INT J OBESITY, V42, P765, DOI 10.1038/ijo.2017.301; Shen Guo, 2011, Sichuan Journal of Zoology, V30, P254; Thierry B, 2000, J ZOO WILDLIFE MED, V31, P179, DOI 10.1638/1042-7260(2000)031[0179:HAPBVF]2.0.CO;2; Wang Z, 2005, IMMUNOLOGY MACACA MU, V26, P68; Wouters D, 2015, HAEMATOLOGICA, V100, P1388, DOI 10.3324/haematol.2015.128538; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892; Zhao T, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00171	58	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222338	10.1371/journal.pone.0222338	http://dx.doi.org/10.1371/journal.pone.0222338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527891	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400016
J	Machado, WS; Brandao, VLN; Morais, VCL; Detmann, E; Rotta, PP; Marcondes, MI				Machado, Wagner S.; Brandao, Virginia L. N.; Morais, Valber C. L.; Detmann, Edenio; Rotta, Polyana P.; Marcondes, Marcos, I			Supplementation strategies affect the feed intake and performance of grazing replacement heifers	PLOS ONE			English	Article							DAIRY HEIFERS; PROTEIN SUPPLEMENTATION; TROPICAL FORAGE; MILK-PRODUCTION; FED DIETS; PASTURE; CATTLE; FIBER; COWS; SUBSTITUTION	The literature lacks studies investigating the performance of supplemented replacement heifers grazing on intensively managed warm-season pasture. Our objective was to evaluate the effects of supplement composition (energetic or protein) on the performance, muscle development, thermogenisis, nutrient intake, and digestibility of replacement Holstein heifers grazing Mombasa grass. Eighteen Holstein heifers with an average age and initial body weight (BW) of 12.57 +/- 2.54 mo and 218.76 +/- 47.6 kg, respectively, were submitted to a randomized block design, with six replicates on a rotational grazing system of Panicum maximum cv. Mombasa pasture. Treatments were: control (CON; mineral salt ad libitum); energy supplement (ENE; corn meal as supplement, 8% CP and 3.78 Mcal/kg DE); and protein supplement (PRO; corn and soybean meal, 25% CP and 3.66 Mcal/kg DE). Supplements were individually fed at 0.5% BW. The experiment lasted 120 days, subdivided into three periods. Titanium dioxide and indigestible neutral detergent fiber (iNDF) were used to estimate the intakes and digestibility of the nutrients. BW, wither height, thoracic circumference, body length, and ultrasound of ribeye fat thickness measurements were taken once per period. Body condition score (BCS) was assessed twice during the experiment. The MIXED procedure of SAS, including period as a repeated measure, was used and significance was declared at P < 0.05. Dry matter intake (DMI), CP intake (CPI) and DE intake were greater in heifers fed PRO compared to CON and ENE. Heifers supplemented with ENE had the lowest DMI. Treatment affected pasture intake/BW; it was similar between PRO and CON heifers, and lower for the ENE treatment. A treatment x period interaction was observed for NDF intake (%BW), in which heifers fed PRO and CON had the greatest NDF intake and ENE had the lowest. The digestibility of DM was the greatest in PRO-supplemented heifers and the lowest in CON heifers. Heifers fed ENE had decreased CP digestibility compared to PRO and CON heifers. Average daily gain (ADG) and thoracic circumference gain were greatest in the PRO treatment. BCS was greater in PRO compared to CON and ENE heifers. Supplementing Holstein heifers at 0.5% BW using PRO supplementation resulted in better animal performance, primarily greater ADG, than feeding ENE or not supplementing (CON). In conclusion, our results indicate that dairy heifers should be fed a protein supplement when grazing intensively managed Mombaca grass pasture.	[Machado, Wagner S.; Morais, Valber C. L.; Detmann, Edenio; Rotta, Polyana P.; Marcondes, Marcos, I] Vicosa Fed Univ, Anim Sci Dept, Dept Zootecnia, Av PH Rolfs Sn, Vicosa, MG, Brazil; [Brandao, Virginia L. N.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Marcondes, MI (corresponding author), Vicosa Fed Univ, Anim Sci Dept, Dept Zootecnia, Av PH Rolfs Sn, Vicosa, MG, Brazil.	marcos.marcondes@ufv.br	Marcondes, Marcos/AAH-7553-2020; Brandao, Virginia/AAB-5041-2019; Rotta, Polyana/AAT-8719-2020	Marcondes, Marcos/0000-0003-4843-2809; Brandao, Virginia/0000-0002-7413-9676; Rotta, Polyana/0000-0002-1185-8120	Brazilian governamental foundation: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian governamental foundation: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian governamental foundation: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Brazilian governamental foundation: Instituto de Ciencia e Tecnologia de Ciencia Animal (INCT-CA)	Brazilian governamental foundation: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian governamental foundation: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian governamental foundation: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian governamental foundation: Instituto de Ciencia e Tecnologia de Ciencia Animal (INCT-CA)	The Brazilian governamental foundations: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Instituto de Ciencia e Tecnologia de Ciencia Animal (INCT-CA) contributed to this study by providing scholarships and funds for laboratory analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE A, 1981, ANIM FEED SCI TECH, V6, P15, DOI 10.1016/0377-8401(81)90026-2; Albino RL, 2015, J DAIRY RES, V82, P113, DOI 10.1017/S0022029914000697; Allen MS, 1996, J ANIM SCI, V74, P3063; [Anonymous], [No title captured]; Bargo F, 2003, J DAIRY SCI, V86, P1, DOI 10.3168/jds.S0022-0302(03)73581-4; de Moraes EHBK, 2006, REV BRAS ZOOTECN, V35, P2135, DOI 10.1590/S1516-35982006000700034; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Boval M, 2015, ANIMAL, V9, P973, DOI 10.1017/S1751731114003279; Costa VAC, 2009, REV BRAS ZOOTECN, V38, P1803, DOI 10.1590/S1516-35982009000900024; Carnevalli RA, 2006, TROP GRASSLANDS, V40, P165; Danes MAC, 2013, J DAIRY SCI, V96, P407, DOI 10.3168/jds.2012-5607; Detmann E, 2004, REV BRAS ZOOTECN, V33, P169, DOI 10.1590/S1516-35982004000100021; Dixon RM, 2000, AUST J PLANT PHYSL, V27, P645, DOI [10.1071/PP97167, DOI 10.1071/PP97167]; Dobos RC, 2004, ENVIRON MODELL SOFTW, V19, P967, DOI 10.1016/j.envsoft.2003.11.013; DUBLE RL, 1971, AGRON J, V63, P795, DOI 10.2134/agronj1971.00021962006300050042x; FAVERDIN P, 1991, LIVEST PROD SCI, V27, P137, DOI 10.1016/0301-6226(91)90092-5; Figueiras JF, 2016, ASIAN AUSTRAL J ANIM, V29, P1710, DOI 10.5713/ajas.16.0125; Forbes AB, 2007, VET PARASITOL, V150, P321, DOI 10.1016/j.vetpar.2007.09.031; Franco MD, 2017, ASIAN AUSTRAL J ANIM, V30, P797, DOI 10.5713/ajas.16.0629; Gabler MT, 2000, J DAIRY SCI, V83, P1104, DOI 10.3168/jds.S0022-0302(00)74975-7; Gomes RA, 2016, J ANIM SCI, V94, P1105, DOI 10.2527/jas.2015-0004; GRAINGER C, 1989, AUST J EXP AGR, V29, P355, DOI 10.1071/EA9890355; GRIGSBY KN, 1993, J ANIM SCI, V71, P1057, DOI 10.2527/1993.7141057x; HANNAH SM, 1991, J ANIM SCI, V69, P2624; Harsh S, 2001, NO PROFITABILITY PRO; HOOVER WH, 1986, J DAIRY SCI, V69, P2755, DOI 10.3168/jds.S0022-0302(86)80724-X; Igarasi MS, 2008, REV BRAS ZOOTECN, V37, P513, DOI 10.1590/S1516-35982008000300017; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217, DOI 10.3168/jds.S0022-0302(82)82180-2; LITTLE W, 1979, ANIM PROD, V29, P131, DOI 10.1017/S0003356100012228; Macdonald KA, 2005, J DAIRY SCI, V88, P3363, DOI 10.3168/jds.S0022-0302(05)73020-4; MATHEWS BW, 1994, J DAIRY SCI, V77, P244, DOI 10.3168/jds.S0022-0302(94)76947-2; National Research Council, 2001, NUTR REQ DAIR CATTL, DOI [10.17226/9825, DOI 10.17226/25806, DOI 10.17226/9825]; Orr RJ, 2004, APPL ANIM BEHAV SCI, V87, P205, DOI 10.1016/j.applanim.2004.01.009; Palhano AL, 2007, REV BRAS ZOOTECN, V36, P1014, DOI 10.1590/S1516-35982007000500005; PARSONS AJ, 1988, GRASS FORAGE SCI, V43, P49, DOI 10.1111/j.1365-2494.1988.tb02140.x; Valente TNP, 2011, REV BRAS ZOOTECN, V40, P2565, DOI 10.1590/S1516-35982011001100039; Rodriguez-Hernandez K, 2018, J DAIRY SCI, V101, P1206, DOI 10.3168/jds.2017-13584; ROONEY LW, 1986, J ANIM SCI, V63, P1607, DOI 10.2527/jas1986.6351607x; Rosenvold K, 2001, J ANIM SCI, V79, P382; Silveira A. L. F., 2008, Archivos de Zootecnia, V57, P179; Sollenberger LE, 2005, CROP SCI, V45, P896, DOI 10.2135/cropsci2004.0216; Stiglbauer KE, 2013, J DAIRY SCI, V96, P1290, DOI 10.3168/jds.2012-5845; Stockdale CR, 2000, AUST J EXP AGR, V40, P913, DOI 10.1071/EA00034; da Silveira MCT, 2010, SCI AGR, V67, P136, DOI 10.1590/S0103-90162010000200002; Zanton GI, 2005, J DAIRY SCI, V88, P3860, DOI 10.3168/jds.S0022-0302(05)73071-X	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221651	10.1371/journal.pone.0221651	http://dx.doi.org/10.1371/journal.pone.0221651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525216	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700014
J	Little, JP; Rayward, L; Pearcy, MJ; Izatt, MT; Green, D; Labrom, RD; Askin, GN				Little, J. Paige; Rayward, Lionel; Pearcy, Mark J.; Izatt, Maree T.; Green, Daniel; Labrom, Robert D.; Askin, Geoffrey N.			Predicting spinal profile using 3D non-contact surface scanning: Changes in surface topography as a predictor of internal spinal alignment	PLOS ONE			English	Article							IDIOPATHIC SCOLIOSIS; MORPHOLOGY	Introduction 3D non-contact surface scanners capture highly accurate, calibrated images of surface topography for 3D structures. This study sought to establish the efficacy and accuracy of using 3D surface scanning to characterise spinal curvature and sagittal plane contour. Methods 10 healthy female adults with a mean age of 25 years, (standard deviation: 3.6 years) underwent both MRI and 3D surface scanning (3DSS) (Artec Eva, Artec Group Inc., Luxembourg) while lying in the lateral decubitus position on a rigid substrate. Prior to 3DSS, anatomical landmarks on the spinous processes of each participant were demarcated using stickers attached to the skin surface. Following 3DSS, oil capsules (fiducial markers) were overlaid on the stickers and the subject underwent MRI. MRI stacks were processed to measure the thoracolumbar spinous process locations, providing an anatomical reference. 3D coordinates for the markers (surface stickers and MRI oil capsules) and for the spinous processes mapped the spinal column profiles and were compared to assess the quality of fit between the 3DSS and MRI marker positions. Results The RMSE for the polynomials fit to the spinous process, fiducial and surface marker profiles ranged from 0.17-1.15mm for all subjects. The MRI fiducial marker location was well aligned with the spinous process profile in the thoracic and upper lumbar spine for nine of the subjects. Over the 10 subjects, the mean RMSE between the MRI and 3D scan sagittal profiles for all surface markers was 9.8mm (SD 4.2mm). Curvature was well matched for seven of the subjects, with two showing differing curvatures across the lumbar spine due to inconsistent subject positioning. Conclusion Comparison of the observed trends for vertebral position measured from MRI and 3DSS, suggested the surface markers may provide a useful method for measuring internal changes in sagittal curvature or skeletal changes.	[Little, J. Paige; Rayward, Lionel; Pearcy, Mark J.; Izatt, Maree T.; Labrom, Robert D.; Askin, Geoffrey N.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Biomech & Spine Res Grp, Brisbane, Qld, Australia; [Green, Daniel] Sealy Australia, Wacol, Australia; [Labrom, Robert D.] Wesley Hosp, Brisbane, Qld, Australia; [Askin, Geoffrey N.] Mater Hlth Serv, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Wesley Hospital; Mater Health Services	Little, JP (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Biomech & Spine Res Grp, Brisbane, Qld, Australia.	j2.little@qut.edu.au	Izatt, Maree T./ABF-8372-2021; Rayward, Lionel/ABE-2280-2021	Izatt, Maree T./0000-0002-4926-3077; Rayward, Lionel/0000-0001-5066-5631; Labrom, Robert/0000-0003-0601-1475; Little, J Paige/0000-0001-8377-5343; Askin, Geoffrey/0000-0002-1734-0082; Pearcy, Mark/0000-0002-1108-6503	Sealy of Australia	Sealy of Australia	This work was supported by Sealy of Australia who provided support in the form of salary for authors [JPL, DG], and a student scholarship [LR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk-Pawelec K, 2012, BIOL SPORT, V29, P129, DOI 10.5604/20831862.988969; Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Catan H, 2007, EUR SPINE J, V16, P1203, DOI 10.1007/s00586-006-0281-y; Clin J, 2011, MED BIOL ENG COMPUT, V49, P743, DOI 10.1007/s11517-011-0737-z; Ebrahim M, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2013, VOL 2; FROBIN W, 1981, PHOTOGRAMM ENG REM S, V47, P1717; Ghaneei M, 2019, COMPUT METHOD BIOMEC, V22, P696, DOI 10.1080/10255842.2019.1584795; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Gorton GE, 2012, SPINE, V37, P957, DOI 10.1097/BRS.0b013e31823a012e; Grant CA, 2019, MED ENG PHYS, V63, P63, DOI 10.1016/j.medengphy.2018.11.004; Haex B., 2005, BACK BED ERGONOMIC A; Izatt M., 2019, BRIT MED J OPEN; Knott P., 2016, SCOLIOSIS SPINAL DIS, P11; Kotwicki T, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-18; Lain A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00257; Liljenqvist UR, 2002, J BONE JOINT SURG AM, V84A, P359, DOI 10.2106/00004623-200203000-00005; Morl F, 2006, EUR SPINE J, V15, P742, DOI 10.1007/s00586-005-0960-0; Ng K., 2018, SCOLIOSIS SPINAL DIS, V13, P28; Niven L, 2009, J ARCHAEOL SCI, V36, P2018, DOI 10.1016/j.jas.2009.05.021; Patias P, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-12; Petit Y, 2002, CAN J SURG, V45, P453; Schmid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135689; Stern D, 2011, PHYS MED BIOL, V56, P7505, DOI 10.1088/0031-9155/56/23/011	23	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222453	10.1371/journal.pone.0222453	http://dx.doi.org/10.1371/journal.pone.0222453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557174	Green Published, gold			2022-12-27	WOS:000532345500020
J	Curra, C; Kehrer, J; Lemgruber, L; Silva, PAGC; Bertuccini, L; Superti, F; Pace, T; Ponzi, M; Frischknecht, F; Siden-Kiamos, I; Mair, GR				Curra, Chiara; Kehrer, Jessica; Lemgruber, Leandro; Silva, Patricia A. G. C.; Bertuccini, Lucia; Superti, Fabiana; Pace, Tomasino; Ponzi, Marta; Frischknecht, Friedrich; Siden-Kiamos, Inga; Mair, Gunnar R.			Malaria transmission through the mosquito requires the function of the OMD protein	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; GLIDING MOTILITY; ACTIN; REVEALS; MIDGUT; CTRP; DISRUPTION; INFECTION; INVASION; EGRESS	Ookinetes, one of the motile and invasive forms of the malaria parasite, rely on gliding motility in order to establish an infection in the mosquito host. Here we characterize the protein PBANKA_0407300 which is conserved in the Plasmodium genus but lacks significant similarity to proteins of other eukaryotes. It is expressed in gametocytes and throughout the invasive mosquito stages of P. berghei, but is absent from asexual blood stages. Mutants lacking the protein developed morphologically normal ookinetes that were devoid of productive motility although some stretching movement could be detected. We therefore named the protein Ookinete Motility Deficient (OMD). Several key factors known to be involved in motility however were normally expressed and localized in the mutant. Importantly, the mutant failed to establish an infection in the mosquito which resulted in a total malaria transmission blockade.	[Curra, Chiara; Siden-Kiamos, Inga] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Kehrer, Jessica; Lemgruber, Leandro; Frischknecht, Friedrich; Mair, Gunnar R.] Heidelberg Univ, Med Sch, Ctr Infect Dis, Integrat Parasitol, Heidelberg, Germany; [Silva, Patricia A. G. C.; Mair, Gunnar R.] Inst Med Mol, Lisbon, Portugal; [Bertuccini, Lucia; Superti, Fabiana; Ponzi, Marta] Natl Inst Hlth, Core Facil, Rome, Italy; [Bertuccini, Lucia; Superti, Fabiana] Natl Inst Hlth, Natl Ctr Innovat Technol Publ Hlth, Rome, Italy; [Pace, Tomasino; Ponzi, Marta] Natl Inst Hlth, Dept Infect Dis, Rome, Italy; [Mair, Gunnar R.] Iowa State Univ, Biomed Sci, Ames, IA 50011 USA; [Lemgruber, Leandro] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Foundation for Research & Technology - Hellas (FORTH); Ruprecht Karls University Heidelberg; Universidade de Lisboa; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Iowa State University; University of Glasgow	Siden-Kiamos, I (corresponding author), FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece.; Mair, GR (corresponding author), Heidelberg Univ, Med Sch, Ctr Infect Dis, Integrat Parasitol, Heidelberg, Germany.; Mair, GR (corresponding author), Inst Med Mol, Lisbon, Portugal.; Mair, GR (corresponding author), Iowa State Univ, Biomed Sci, Ames, IA 50011 USA.	inga@imbb.forth.gr; mair@iastate.edu	Bertuccini, Lucia/AAI-6683-2021; , Fabiana/F-2100-2015	Bertuccini, Lucia/0000-0002-4278-2376; Curra, Chiara/0000-0001-7851-1087; , Fabiana/0000-0003-4909-7598; Lemgruber, Leandro/0000-0003-2832-6806; Frischknecht, Friedrich/0000-0002-8332-6668; Siden-Kiamos, Inga/0000-0003-1572-5840; Mair, Gunnar/0000-0002-5187-3691	CellNetworks cluster of Heidelberg University through EcTop2 [EXC81]; CellNetworks cluster of Heidelberg University [EXC81]; European Research Council [ERC-SG 281719]; EU FP7 research network EVIMalaR; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MIC/122082/2010, PTDC/BIA-BCM/105610/2008, SFRH/BPD/72619/2010]; project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action" - Italian Nation; General Secretariat for Research and Technology, Ministry of Education, Greece [MIS-448301 (2013SE01380036)]; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission; I-MOVE Fellowship Programme [PCOFUND-GA-2010-267332]	CellNetworks cluster of Heidelberg University through EcTop2; CellNetworks cluster of Heidelberg University; European Research Council(European Research Council (ERC)European Commission); EU FP7 research network EVIMalaR; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action" - Italian Nation; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission; I-MOVE Fellowship Programme	This work was supported by the CellNetworks cluster of Heidelberg University (EXC81; German Research Foundation) through EcTop2 and a postdoctoral fellowship to LL; the European Research Council (ERC-SG 281719) and the EU FP7 research network EVIMalaR to FF; the Fundacao para a Ciencia e a Tecnologia (FCT) grants PTDC/SAU-MIC/122082/2010 and PTDC/BIA-BCM/105610/2008 to GRM, and SFRH/BPD/72619/2010 to PAGC; the project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action", funded by the Italian National Research Programme PRIN-2015 to MP; the framework of the BIOSYS research project, Action KRIPIS, project No MIS-448301 (2013SE01380036) funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission to ISK. CC was supported by a fellowship from the I-MOVE Fellowship Programme - PCOFUND-GA-2010-267332 (Marie Curie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Collins MN, 2011, STRUCTURE, V19, P324, DOI 10.1016/j.str.2010.11.017; Curra C, 2017, EXP PARASITOL, V181, P82, DOI 10.1016/j.exppara.2017.08.001; Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Gomes-Santos CSS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002046; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Jacot D, 2016, CELL HOST MICROBE, V20, P731, DOI 10.1016/j.chom.2016.10.020; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Siden-Kiamos I, 2012, MOL BIOCHEM PARASIT, V181, P186, DOI 10.1016/j.molbiopara.2011.11.002; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222226	10.1371/journal.pone.0222226	http://dx.doi.org/10.1371/journal.pone.0222226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553751	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000532319200018
J	Bechel, MA; Pah, AR; Shi, HY; Mehrotra, S; Persell, SD; Weiner, S; Wunderink, RG; Amaral, LAN; Weiss, CH				Bechel, Meagan A.; Pah, Adam R.; Shi, Hanyu; Mehrotra, Sanjay; Persell, Stephen D.; Weiner, Shayna; Wunderink, Richard G.; Amaral, Luis A. Nunes; Weiss, Curtis H.			A quantitative approach for the analysis of clinician recognition of acute respiratory distress syndrome using electronic health record data	PLOS ONE			English	Article							TIDAL VOLUME VENTILATION; ACUTE LUNG INJURY; MECHANICAL VENTILATION; PROTECTIVE VENTILATION; UNDERUSE; BARRIERS; OUTCOMES	Importance Despite its efficacy, low tidal volume ventilation (LTVV) remains severely underutilized for patients with acute respiratory distress syndrome (ARDS). Physician under-recognition of ARDS is a significant barrier to LTVV use. We propose a computational method that addresses some of the limitations of the current approaches to automated measurement of whether ARDS is recognized by physicians. Objective To quantify patient and physician factors affecting physicians' tidal volume selection and to build a computational model of physician recognition of ARDS that accounts for these factors. Design, setting, and participants In this cross-sectional study, electronic health record data were collected for 361 ARDS patients and 388 non-ARDS hypoxemic (control) patients in nine adult intensive care units at four hospitals between June 24 and December 31, 2013. Methods Standardized tidal volumes (mL/kg predicted body weight) were chosen as a proxy for physician decision-making behavior. Using data-science approaches, we quantified the effect of eight factors (six severity of illness, two physician behaviors) on selected standardized tidal volumes in ARDS and control patients. Significant factors were incorporated in computational behavioral models of physician recognition of ARDS. Results Hypoxemia severity and ARDS documentation in physicians' notes were associated with lower standardized tidal volumes in the ARDS cohort. Greater patient height was associated with lower standardized tidal volumes (which is already normalized for height) in both ARDS and control patients. The recognition model yielded a mean (99% confidence interval) physician recognition of ARDS of 22% (9%-42%) for mild, 34% (19%-49%) for moderate, and 67% (41%-100%) for severe ARDS. Conclusions and relevance In this study, patient characteristics and physician behaviors were demonstrated to be associated with differences in ventilator management in both ARDS and control patients. Our model of physician ARDS recognition measurement accounts for these clinical variables, providing an electronic approach that moves beyond relying on chart documentation or resource intensive approaches.	[Bechel, Meagan A.] Northwestern Univ, Feinberg Sch Med, Med Scientist Training Program, Chicago, IL 60611 USA; [Bechel, Meagan A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Pah, Adam R.; Amaral, Luis A. Nunes] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Pah, Adam R.] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA; [Shi, Hanyu; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Mehrotra, Sanjay] Northwestern Univ, Dept Ind Engn & Management Sci, Evanston, IL 60208 USA; [Persell, Stephen D.] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA; [Persell, Stephen D.] Northwestern Univ, Ctr Primary Care Innovat, Inst Publ Hlth & Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Weiner, Shayna] Michigan Oncol Qual Consortium, Ann Arbor, MI USA; [Wunderink, Richard G.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Amaral, Luis A. Nunes] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Weiss, Curtis H.] NorthShore Univ HealthSyst, Div Pulm Crit Care Allergy & Immunol, Evanston, IL 60201 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; NorthShore University Health System	Weiss, CH (corresponding author), NorthShore Univ HealthSyst, Div Pulm Crit Care Allergy & Immunol, Evanston, IL 60201 USA.	CWeiss@northshore.org		Weiss, Curtis/0000-0002-3102-5273; Bechel, Meagan/0000-0003-0600-3774	National Institute of General Medical Sciences [T32GM008152]; National Heart, Lung, and Blood Institute [K23HL118139, R01HL140362-01A1]; Francis Family Foundation (Parker B. Francis Fellowship Program); Department of Defense Army Research Office [W911NF-14-1-0259]; National Center for Advancing Translational Sciences [5UL1RR025741, 8UL1TR000150]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118139, R01HL140362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Francis Family Foundation (Parker B. Francis Fellowship Program); Department of Defense Army Research Office(United States Department of Defense); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institute of General Medical Sciences, Grant T32GM008152 (MB); the National Heart, Lung, and Blood Institute, Grant K23HL118139 and Grant R01HL140362-01A1 (CHW); the Francis Family Foundation (Parker B. Francis Fellowship Program, CHW); the Department of Defense Army Research Office, Grant W911NF-14-1-0259 (MB, LANA, CHW); the National Center for Research Resources, Grant 5UL1RR025741, which is now at the National Center for Advancing Translational Sciences, Grant 8UL1TR000150 (Northwestern University Clinical and Translational Sciences Institute Enterprise Data Warehouse); and John and Leslie McQuown (LANA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Francis Family Foundation, or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adler-Milstein J, 2017, J AM MED INFORM ASSN, V24, P1142, DOI 10.1093/jamia/ocx080; Aynes RBRH, 2001, CLIN DECISION SUPPOR, V8, P527, DOI [10.1136/jamia.2001.0080527, DOI 10.1136/JAMIA.2001.0080527]; Balas E A, 2000, Yearb Med Inform, P65; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Checkley W, 2008, AM J RESP CRIT CARE, V177, P1215, DOI 10.1164/rccm.200709-1424OC; Chen YF, 2014, MINERVA ANESTESIOL, V80, P1158; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; David W, 2003, J AM MED INFORM ASSN, V10, P523; Dennison CR, 2007, CRIT CARE MED, V35, P2747, DOI 10.1097/01.CCM.0000287591.09487.70; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, P97; Fletcher RH, 2014, CLIN EPIDEMIOLOGY ES, P131; Gattinoni L, 2016, EPIDEMIOLOGY PATTERN, DOI [10.1001/jama.2016.0291, DOI 10.1001/JAMA.2016.0291]; Gilovich T, 2012, HEURISTICS BIASES, P559; Han SH, 2011, CRIT CARE, V15, DOI 10.1186/cc10524; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; Lorenzi NM, 2008, J AM MED INFORM ASSN, V15, P290, DOI 10.1197/jamia.M2583; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Mikkelsen ME, 2008, RESP CARE, V53, P455; Needham DM, 2015, AM J RESP CRIT CARE, V191, P177, DOI 10.1164/rccm.201409-1598OC; Needham DM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2124; Owyang CG, 2019, J CRIT CARE, V52, P40, DOI 10.1016/j.jcrc.2019.03.008; Priming Parkin M., 2008, ENCY SURVEY RES METH, P611; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Sasko B, 2018, SIZE MATTERS OBSERVA, Vv, P1; Spece LJ, 2019, J CRIT CARE, P72, DOI [10.1097/01.CCM.0000287591.09487.70, DOI 10.1097/01.CCM.0000287591.09487.70]; TENNEY SM, 1967, RESP PHYSIOL, V3, P130, DOI 10.1016/0034-5687(67)90002-3; Umoh NJ, 2008, CRIT CARE MED, V36, P1463, DOI 10.1097/CCM.0b013e31816fc3d0; Walkey AJ, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.015; Weiss CH, 2016, CRIT CARE MED, VV, P1; Young MP, 2004, CRIT CARE MED, V32, P1260, DOI 10.1097/01.CCM.0000127784.54727.56	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222826	10.1371/journal.pone.0222826	http://dx.doi.org/10.1371/journal.pone.0222826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539417	Green Published, gold			2022-12-27	WOS:000532297900033
J	Christenson, A; Johansson, E; Reynisdottir, S; Torgerson, J; Hemmingsson, E				Christenson, Anne; Johansson, Eva; Reynisdottir, Signy; Torgerson, Jarl; Hemmingsson, Erik			"...or else I close my ears" How women with obesity want to be approached and treated regarding gestational weight management: A qualitative interview study	PLOS ONE			English	Article							MATERNAL OBESITY; FOCUS GROUPS; INDIVIDUAL INTERVIEWS; GAIN; CARE; PREGNANCY; OUTCOMES; INTERVENTIONS; PERSPECTIVES; METAANALYSIS	Introduction The importance of helping pregnant women maintain a healthy lifestyle and prevent excessive gestational weight gain is well recognized, but pregnant women do not always perceive communication about body weight as respectful or helpful. Furthermore, fear of inducing shame or guilt can prohibit some midwives from talking about body weight, especially if the woman has obesity. We aimed to explore what women of reproductive age with obesity regard to be the most important and relevant aspects when discussing gestational weight management. Methods Qualitative interview study using focus groups and individual semi-structured interviews with 17 women of reproductive age (19-39 y) with obesity. Thematic analysis was used to analyze the data. Results We identified three themes: 1) Importance of obtaining vital medical information; 2) A wish to feel understood and treated with respect; 3) Midwives' approach is crucial in sensitive key situations, which include bringing up the subject of body weight, weighing, providing weightrelated information, coaching lifestyle modification, dealing with emotional reactions and ending a conversation. Conclusions A majority of the interviewed women wished to receive information about risks about obesity and gestational weight gain, and recommendations on weight management. However, the risk of midwives offending someone by raising the topic may be increased if the pregnant woman believe that gestational weight gain is uncontrollable by the individual. Also, several situations during maternity care meetings can be stigmatizing and make women less receptive to advice or support. Women suggest that a good working alliance is likely to be achieved if midwives have knowledge about the causes of obesity, take interest in the patients' background, have a non-judgmental approach and refrain from giving unsolicited advice.	[Christenson, Anne; Reynisdottir, Signy] Acad Specialist Ctr, Stockholm Hlth Serv, Obes Ctr, Stockholm, Sweden; [Christenson, Anne] Karolinska Inst, Dept Med, Stockholm, Sweden; [Johansson, Eva] Karolinska Inst, Dept Publ Hlth Sci IHCAR, Stockholm, Sweden; [Torgerson, Jarl] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hemmingsson, Erik] Swedish Sch Sports & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Swedish School of Sport & Health Sciences	Christenson, A (corresponding author), Acad Specialist Ctr, Stockholm Hlth Serv, Obes Ctr, Stockholm, Sweden.; Christenson, A (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	anne.christenson@ki.es						Allen-Walker V, 2017, MIDWIFERY, V49, P95, DOI 10.1016/j.midw.2016.12.006; Barter C., 2000, INT J SOC RES METHOD, V3, P307, DOI [10.1080/13645570050178594, DOI 10.1080/13645570050178594]; Beckman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181715; Bjermo H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1624-6; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brownfoot FC, 2016, BJOG-INT J OBSTET GY, V123, P254, DOI 10.1111/1471-0528.13735; Bye A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1745-x; CATALANO PM, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1; Christensen AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166167; Christenson A, 2018, MIDWIFERY, V63, P1, DOI 10.1016/j.midw.2018.04.020; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; DEJONG W, 1980, J HEALTH SOC BEHAV, V21, P75, DOI 10.2307/2136696; Dencker A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0969-x; Denison FC, 2019, BJOG-INT J OBSTET GY, V126, pE62, DOI 10.1111/1471-0528.15386; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Devlieger R, 2016, EUR J OBSTET GYN R B, V201, P203, DOI 10.1016/j.ejogrb.2016.04.005; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Farpour-Lambert NJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00546; Fieril KP, 2017, MIDWIFERY, V44, P1, DOI 10.1016/j.midw.2016.10.011; Forsberg L, 2012, CLIN ACQUISITION RET; Foster H.J., 2014, BR J MIDWIFERY, V22, P254, DOI [DOI 10.12968/BJOM.2014.22.4.254, DOI 10.12968/BJ0M.2014.22.4.254]; Gresham E, 2016, PUBLIC HEALTH NUTR, V19, P2975, DOI 10.1017/S1368980016001245; Guest G, 2017, INT J SOC RES METHOD, V20, P693, DOI 10.1080/13645579.2017.1281601; Haby K, 2015, MIDWIFERY, V31, P685, DOI 10.1016/j.midw.2015.03.014; Hansson LM, 2014, BODY IMAGE, V11, P43, DOI 10.1016/j.bodyim.2013.10.004; Heslehurst N, 2013, MIDWIFERY, V29, P736, DOI 10.1016/j.midw.2012.07.007; Hill B, 2013, OBES REV, V14, P435, DOI 10.1111/obr.12022; Holton S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1538-7; Jelsma JGM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1471-9; Jones C, 2017, MIDWIFERY, V53, P87, DOI 10.1016/j.midw.2017.07.011; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; Kaplowitz MD, 2000, QUAL QUANT, V34, P419, DOI 10.1023/A:1004844425448; Knight-Agarwal CR, 2016, WOMEN BIRTH, V29, P189, DOI 10.1016/j.wombi.2015.10.008; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Lavender T, 2016, HEALTH EXPECT, V19, P222, DOI 10.1111/hex.12339; Lindhardt CL, 2014, ACTA OBSTET GYN SCAN, V93, P698, DOI 10.1111/aogs.12401; Lindhardt CL, 2015, MIDWIFERY, V31, P678, DOI 10.1016/j.midw.2015.03.010; Lindholm ES, 2010, ACTA OBSTET GYN SCAN, V89, P840, DOI 10.3109/00016340903428370; Lindsay AC, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111412; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Lundahl B, 2013, PATIENT EDUC COUNS, V93, P157, DOI 10.1016/j.pec.2013.07.012; Malta MB, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0957-1; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McDonald SD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.039; McDowell M, 2019, J MIDWIFERY WOM HEAL, V64, P46, DOI 10.1111/jmwh.12927; Mirijello A, 2015, J AFFECT DISORDERS, V179, P95, DOI 10.1016/j.jad.2015.03.030; Nilses C, 2017, SEX REPROD HEALTHC, V11, P47, DOI 10.1016/j.srhc.2016.08.004; Nyman VMK, 2010, MIDWIFERY, V26, P424, DOI 10.1016/j.midw.2008.10.008; Olander EK, 2016, NURS EDUC TODAY, V42, P59, DOI 10.1016/j.nedt.2016.04.009; Oliver I, 2012, IEEE IC COMP COM NET; Organization WH, 2018, OBESITY OVERWEIGHT D; Patton MQ., 2015, QUALITATIVE RES EVAL, V4th, DOI [10.1016/j.ymeth.2015.04.005, DOI 10.1016/J.YMETH.2015.04.005]; Puhl RM, 2018, PEDIATR OBES, V13, P533, DOI 10.1111/ijpo.12275; Robillard PY, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00615; Rohatgi KW, 2017, PEERJ, V5, DOI 10.7717/peerj.4091; Rosenthal M, 2016, CURR PHARM TEACH LEA, V8, P509, DOI 10.1016/j.cptl.2016.03.021; Ruifrok AE, 2014, AM J PERINAT, V31, P353, DOI 10.1055/s-0033-1352484; Santos S, 2019, BJOG-INT J OBSTET GY, V126, P984, DOI 10.1111/1471-0528.15661; Schoenberg N.E., 2000, INT J SOC RES METHOD, V3, P63, DOI [DOI 10.1080/136455700294932, 10.1080/136455700294932]; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Sogg S, 2018, SURG OBES RELAT DIS, V14, P682, DOI 10.1016/j.soard.2018.01.013; The national board of health and welfare, 2016, SWED PREGN DAT BAS; Universal health coverage and universal access, 2013, B WHO; Vieten C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1757-6; Wahedi M, 2016, BR J MIDWIFERY, V24, P724, DOI DOI 10.12968/BJ0M.2016.24.10.724; Yang ZJ, 2019, AUST NZ J OBSTET GYN, V59, P367, DOI 10.1111/ajo.12866	68	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222543	10.1371/journal.pone.0222543	http://dx.doi.org/10.1371/journal.pone.0222543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536545	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800053
J	Kitanaka, N; Nakano, R; Sakai, M; Kitanaka, T; Namba, S; Konno, T; Nakayama, T; Sugiya, H				Kitanaka, Nanako; Nakano, Rei; Sakai, Manabu; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Nakayama, Tomohiro; Sugiya, Hiroshi			ERK1/ATF-2 signaling axis contributes to interleukin-1 beta-induced MMP-3 expression in dermal fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PRO-INFLAMMATORY CYTOKINES; AP-1 TARGET GENES; N-TERMINAL KINASE; MATRIX METALLOPROTEINASES; C-JUN; TRANSCRIPTION FACTOR; SKIN FIBROBLASTS; GROWTH-FACTORS; WOUND REPAIR	Matrix metalloproteinases (MMPs) play a pivotal role in tissue remodeling by degrading the extracellular matrix (ECM) components. This mechanism is implicated in a variety of physiological and pathological cellular processes including wound healing. One of the key proteins involved in this process is the proinflammatory cytokine interleukin-1 beta (IL-1 beta, which induces the expression of MMP-3 mRNA and the secretion of MMP-3 protein by dermal fibroblasts. In this study, we first investigated the contribution of activating transcription factor 2 (ATF-2) to IL-1 beta-induced MMP-3 expression in dermal fibroblasts. Our results showed that in cells transfected with ATF-2 siRNA or treated with the ATF-2 inhibitor SBI-0087702, IL-1 beta induced MMP-3 mRNA expression was reduced. We also demonstrated that IL-1 beta stimulates the phosphorylation of ATF-2. These observations suggest that ATF-2 plays an important role in IL-1 beta-induced MMP-3 expression. Next, we investigated the role of MAPK signaling in ATF-2 activation. In cells treated with the extracellular signal-regulated kinase (ERK) inhibitor FR180240, as well as in cells transfected with ERK1 and ERK2 siRNAs, IL 1 beta-induced MMP-3 mRNA expression was reduced. In addition, we showed that IL-1 beta induced the phosphorylation of ERK1/2. These observations suggest that ERK1 and ERK2 are involved in IL-1 beta-induced MMP-3 expression. However, ERK1 and ERK2 do seem to play different roles. While the ERK inhibitor FR180204 inhibited IL-1 beta-induced ATF-2 phosphorylation, only in cells transfected with ERK1 siRNA, but not ERK2 siRNA, IL-1 beta-induced ATF-2 phosphorylation was reduced. These findings suggest that the ERK1/ATF-2 signaling axis contributes to IL-1 beta-induced MMP-3 expression in dermal fibroblasts.	[Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan; [Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Internal Med 3, Fujisawa, Kanagawa, Japan; [Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Radiotherapy 4, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN, Lab Cellular Funct Convers Technol, Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan; [Sakai, Manabu] Nihon Univ, Labs Vet Internal Med, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Labs Vet Radiotherapy, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University; RIKEN; Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan.; Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Internal Med 3, Fujisawa, Kanagawa, Japan.; Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Radiotherapy 4, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022	Namba, Shinichi/0000-0002-9182-3656	Ministry of Education, Science, Sports, and Culture of Japan [18K14594]; Nihon University Multidisciplinary Research Grant [17-019]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University Multidisciplinary Research Grant	This research is supported by Grant-inAid for Scientific Research (#18K14594 to RN) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp/jgrantsinaid/).This research is supported by Nihon University Multidisciplinary Research Grant for 2017 (17-019 to TN) (http://www.nihon-u.ac.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFIZ HA, 1992, MOL ENDOCRINOL, V6, P2079, DOI 10.1210/me.6.12.2079; Agren MS, 2015, EUR J CELL BIOL, V94, P12, DOI 10.1016/j.ejcb.2014.10.001; Angel P, 2002, BIOCHEM PHARMACOL, V64, P949, DOI 10.1016/S0006-2952(02)01158-9; Babaei S, 2015, J INVEST SURG, V28, P196, DOI 10.3109/08941939.2014.1002642; Baecker V, 2012, IMAGEJ US DEV C; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599; Chambers M, 2013, EXP CELL RES, V319, P1398, DOI 10.1016/j.yexcr.2013.04.010; Chaudhary AK, 2013, MUTAT RES-REV MUTAT, V753, P7, DOI 10.1016/j.mrrev.2013.01.002; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gao D, 2011, J CELL PHYSIOL, V226, P2869, DOI 10.1002/jcp.22630; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hosseini M, 2006, INVEST OPHTH VIS SCI, V47, P1469, DOI 10.1167/iovs.05-0451; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-110; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Hwang BM, 2013, EXP DERMATOL, V22, P371, DOI 10.1111/exd.12137; Kaminska B., 1997, BIOCHIM BIOPHYS ACTA, V1754, P253; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Kuroda K, 1997, ARCH DERMATOL RES, V289, P567, DOI 10.1007/s004030050241; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Li YY, 2014, J INVEST DERMATOL, V134, P643, DOI 10.1038/jid.2013.303; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; Mauviel A, 2009, J INVEST DERMATOL, V129, P7, DOI 10.1038/jid.2008.385; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Prontera C, 1996, EXP CELL RES, V224, P183, DOI 10.1006/excr.1996.0126; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ravanti L, 2000, INT J MOL MED, V6, P391; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shin J, 2013, CELL SIGNAL, V25, P2540, DOI 10.1016/j.cellsig.2013.08.014; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sinfield JK, 2013, BIOCHEM BIOPH RES CO, V430, P419, DOI 10.1016/j.bbrc.2012.11.071; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Sylvester J, 2012, CELL PHYSIOL BIOCHEM, V30, P563, DOI 10.1159/000341438; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tabandeh MR, 2014, INT J BIOL MACROMOL, V65, P424, DOI 10.1016/j.ijbiomac.2014.01.055; Tabandeh MR, 2013, PHYTOTHER RES, V27, P1149, DOI 10.1002/ptr.4839; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Watson G, 2017, PHARMACOL RES, V119, P347, DOI 10.1016/j.phrs.2017.02.004; Weinheimer-Haus EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119106; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Westermarck J, 2000, CANCER RES, V60, P7156; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yu T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/950472; Zhu F, 2004, CARCINOGENESIS, V25, P1847, DOI 10.1093/carcin/bgh202	75	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222869	10.1371/journal.pone.0222869	http://dx.doi.org/10.1371/journal.pone.0222869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536594	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800099
J	Nagoshi, RN; Nagoshi, BY; Canarte, E; Navarrete, B; Solorzano, R; Garces-Carrera, S				Nagoshi, Rodney N.; Nagoshi, Benjamin Y.; Canarte, Ernesto; Navarrete, Bernardo; Solorzano, Ramon; Garces-Carrera, Sandra			Genetic characterization of fall armyworm (Spodoptera frugiperda) in Ecuador and comparisons with regional populations identify likely migratory relationships	PLOS ONE			English	Article							LEPIDOPTERA-NOCTUIDAE STRAINS; HOST STRAINS; CENTRAL COLOMBIA; FIELD COLLECTIONS; UNITED-STATES; RICE STRAINS; PUERTO-RICO; CORN; TEXAS; DIFFERENTIATION	Fall armyworm, Spodoptera frugiperda (J. E. Smith), is an important agricultural pest native to the Americas that has recently been introduced into the Eastern Hemisphere where it has spread rapidly through most of Africa and much of Asia. The long-term economic consequences of this invasion will depend on how the species and important subpopulations become distributed upon reaching equilibrium, which is expected to be influenced by a number of factors including climate, geography, agricultural practices, and seasonal winds, among others. Much of our understanding of fall armyworm movements have come from mapping genetically defined subpopulations in the Western Hemisphere, particularly in North America where annual long-distance migrations of thousands of kilometers have been documented and modeled. In contrast, fall armyworm mapping in much of the rest of the hemisphere is relatively incomplete, with the northern portion of South America particularly lacking despite its potential importance for understanding fall armyworm migration patterns. Here we describe the first genetic description of fall armyworm infesting corn in Ecuador, which lies near a likely migration conduit based on the location of regional trade winds. The results were compared with populations from corn habitats in select locations in the Caribbean and South America to investigate the possible migratory relationship between these populations and was further assessed with respect to prevailing wind patterns and the distribution of locations with climate favorable for fall armyworm population establishment and growth.	[Nagoshi, Rodney N.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Nagoshi, Benjamin Y.] Univ S Florida, Tampa, FL 33620 USA; [Canarte, Ernesto; Navarrete, Bernardo; Solorzano, Ramon; Garces-Carrera, Sandra] Natl Inst Agr Res INIAP, Quito, Ecuador	United States Department of Agriculture (USDA); State University System of Florida; University of South Florida	Nagoshi, RN (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	rodney.nagoshi@ars.usda.gov	Navarrete, Bernardo/AAR-3141-2020	Navarrete, Bernardo/0000-0001-9200-7119; Solorzano Faubla, Ramon Francisco/0000-0001-8162-6512	Agricultural Research Service of the United States Department of Agriculture, USAID; United States Department of Agriculture National Institutes for Food and Agriculture [2011-67003-30209]; National Institute of Agriculture Research (INIAP), Ecuador; INIAP [MAEDNB-CM-2015-0024]; Ministry of Environment of Ecuador [MAEDNB-CM-2015-0024]	Agricultural Research Service of the United States Department of Agriculture, USAID(United States Agency for International Development (USAID)); United States Department of Agriculture National Institutes for Food and Agriculture; National Institute of Agriculture Research (INIAP), Ecuador; INIAP; Ministry of Environment of Ecuador	The authors R.N.N. and B.Y.N. received support came from the Agricultural Research Service of the United States Department of Agriculture, USAID, and the United States Department of Agriculture National Institutes for Food and Agriculture (2011-67003-30209). The authors E.C., B.N., R.S., and S.G-C received support from the National Institute of Agriculture Research (INIAP), Ecuador, authorized by the agreement between the INIAP and the Ministry of Environment of Ecuador reference number MAEDNB-CM-2015-0024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS KL, 1988, FLA ENTOMOL, V71, P630, DOI 10.2307/3495022; Belay DK, 2012, ANN ENTOMOL SOC AM, V105, P359, DOI 10.1603/AN11111; Canas-Hoyos N, 2016, NEOTROP ENTOMOL, V45, P411, DOI 10.1007/s13744-016-0393-y; Canas-Hoyos N, 2014, ANN ENTOMOL SOC AM, V107, P575, DOI 10.1603/AN12154; Clark PL., 2005, THESIS; Clements MJ, 2003, PLANT DIS, V87, P147, DOI 10.1094/PDIS.2003.87.2.147; Du Plessis H, 2018, SPODOPTERA FRUGIPERD; Early R, 2018, NEOBIOTA, P25, DOI 10.3897/neobiota.40.28165; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Ganiger PC, 2018, CURR SCI INDIA, V115, P621, DOI 10.18520/cs/v115/i4/621-623; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Levy HC, 2002, FLA ENTOMOL, V85, P186, DOI 10.1653/0015-4040(2002)085[0186:SIOSFL]2.0.CO;2; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Meagher RL, 2012, ANN ENTOMOL SOC AM, V105, P462, DOI 10.1603/AN11158; Nagoshi RN, 2006, ENVIRON ENTOMOL, V35, P561, DOI 10.1603/0046-225X-35.2.561; Nagoshi RN, 2004, FLA ENTOMOL, V87, P440, DOI 10.1653/0015-4040(2004)087[0440:BADOTT]2.0.CO;2; Nagoshi RN, 2004, ENVIRON ENTOMOL, V33, P881, DOI 10.1603/0046-225X-33.4.881; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44744-9; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208966; Nagoshi RN, 2017, J ECON ENTOMOL, V110, P2568, DOI 10.1093/jee/tox229; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1987, LA AGR, V30, P8; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; Ramirez-Cabral NYZ, 2017, J AGR SCI-CAMBRIDGE, V155, P1219, DOI 10.1017/S0021859617000314; Rios-Diez JD, 2012, SOUTHWEST ENTOMOL, V37, P281, DOI 10.3958/059.037.0304; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Shylesha A. N., 2018, Journal of Biological Control, V32, P145, DOI 10.18311/jbc/2018/21707; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Unbehend M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089255; USDA FAS, 2018, NO S AM CROP PROD MA; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x; Westbrook JK, 2008, INTEGR COMP BIOL, V48, P99, DOI 10.1093/icb/icn040	52	17	17	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222332	10.1371/journal.pone.0222332	http://dx.doi.org/10.1371/journal.pone.0222332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536515	Green Published, gold			2022-12-27	WOS:000532262800038
J	Tanaskovic, O; Falzacappa, MVV; Pelicci, PG				Tanaskovic, Olga; Falzacappa, Maria Vittoria Verga; Pelicci, Pier Giuseppe			Human cord blood (hCB)-CD34(+) humanized mice fail to reject human acute myeloid leukemia cells	PLOS ONE			English	Article							MOUSE MODEL; ENGRAFTMENT	Since their appearance, humanized mice carrying human immune system seemed promising tools to study the crosstalk between cancer and immunity. The NOD-scidIL2Rgamma(null) (NSG) mice engrafted with human cord blood (hCB)-CD34(+) cells have been proposed to be a valuable tool to reproduce human immune system in mouse. However, the lack of solid evidences on the functionality of their human immune components limits their usage in immune-oncology. We report that (hCB)-CD34(+) cells lose their ability to propagate and originate bone marrow-derived human immune cells after two serial transplantations in NSG mice. We demonstrate that transplants of bone marrow patient-derived acute myeloid leukemias (hAMLs) grow very similarly in the humanized (hCB)-CD34(+) NSG and parental NSG mice. The similar extent of engraftment and development of leukemias in (hCB)-CD34(+) NSG and controls suggests a poor human immune response against not compatible hAMLs. Our findings suggest that (hCB)-CD34(+) NSG mice are transient and/or incomplete carriers of the human immune system and, therefore, represent a suboptimal tool to study the interaction between tumor and immune cells.	[Tanaskovic, Olga; Falzacappa, Maria Vittoria Verga; Pelicci, Pier Giuseppe] European Inst Oncol IRCCS, Dept Expt Oncol IEO, Milan, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Tanaskovic, O; Pelicci, PG (corresponding author), European Inst Oncol IRCCS, Dept Expt Oncol IEO, Milan, Italy.; Pelicci, PG (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.	olga.tanaskovic@ieo.it; piergiuseppe.pelicci@ieo.it		Tanaskovic, Olga/0000-0003-2477-9015	Ministero della Salute [RF 2013-02356924]; Associazione italiana per la ricerca sul cancro (AIRC 2013); Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017) [19499]	Ministero della Salute(Ministry of Health, Italy); Associazione italiana per la ricerca sul cancro (AIRC 2013)(Fondazione AIRC per la ricerca sul cancro); Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017)(Fondazione AIRC per la ricerca sul cancro)	This work was funded by PG.P. Ministero della Salute (RF 2013-02356924). http://www.salute.gov.it/portale/home.html; Associazione italiana per la ricerca sul cancro (AIRC 2013). https://www.airc.it/; O.T. Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017, contract number 19499). https://www.airc.it/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspord C, 2013, CANCER IMMUNOL RES, V1, P402, DOI 10.1158/2326-6066.CIR-13-0114-T; Falzacappa MVV, 2012, FEBS J, V279, P3559, DOI 10.1111/j.1742-4658.2012.08727.x; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Morton JJ, 2016, CANCER RES, V76, P6153, DOI 10.1158/0008-5472.CAN-16-1260; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wiekmeijer AS, 2014, BIORESEARCH OPEN ACC, V3, P110, DOI 10.1089/biores.2014.0008	15	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0217345	10.1371/journal.pone.0217345	http://dx.doi.org/10.1371/journal.pone.0217345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536492	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800004
J	Ganho-Avila, A; Goncalves, OF; Guiomar, R; Boggio, PS; Asthana, MK; Krypotos, AM; Almeida, J				Ganho-Avila, Ana; Goncalves, Oscar F.; Guiomar, Raquel; Boggio, Paulo Sergio; Asthana, Manish Kumar; Krypotos, Angelos-Miltiadis; Almeida, Jorge			The effect of cathodal tDCS on fear extinction: A cross-measures study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; PREFRONTAL CORTEX; ANXIETY DISORDER; PANIC DISORDER; RECONSOLIDATION; MECHANISMS; AVOIDANCE; HUMANS; ACQUISITION; RESPONSES	Background Extinction-based procedures are often used to inhibit maladaptive fear responses. However, because extinction procedures show efficacy limitations, transcranial direct current stimulation (tDCS) has been suggested as a promising add-on enhancer. Objective In this study, we tested how cathodal tDCS over the right dorsolateral prefrontal cortex affects extinction and tried to unveil the processes at play that boost the effectiveness of extinction procedures and its translational potential to the treatment of anxiety disorders. Methods We implemented a fear conditioning paradigm whereby 41 healthy women (mean age = 20.51 +/- 5.0) were assigned to either cathodal tDCS (n = 27) or sham tDCS (n = 16). Fear responses were measured with self-reports, autonomic responses, and implicit avoidance tendencies. Results Cathodal tDCS shows no statistically significant effect in extinction, according to selfreports, and seems to even negatively affect fear conditioned skin conductance responses. However, one to three months after the tDCS session and extinction, we found a group difference in the action tendencies towards the neutral stimuli (F (1, 41) = 12.04, p =.001,.p2 =.227), with the cathodal tDCS group (as opposed to the sham group) showing a safety learning (a positive bias towards the CS-), with a moderate effect size. This suggests that cathodal tDCS may foster stimuli discrimination, leading to a decreased generalization effect. Discussion Cathodal tDCS may have enhanced long-term distinctiveness between threatening cues and perceptively similar neutral cues through a disambiguation process of the value of the neutral stimuli-a therapeutic target in anxiety disorders. Future studies should confirm these results and extend the study of cathodal tDCS effect on short term avoidance tendencies.	[Ganho-Avila, Ana; Guiomar, Raquel; Almeida, Jorge] Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Fac Psychol & Educ Sci, Proact Lab, Coimbra, Portugal; [Ganho-Avila, Ana; Goncalves, Oscar F.] Univ Minho, Sch Psychol, Neuropsychophysiol Lab, CiPsi, Braga, Portugal; [Goncalves, Oscar F.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Neuromodulat Ctr, Boston, MA 02115 USA; [Boggio, Paulo Sergio; Asthana, Manish Kumar] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Social & Cognit Neurosci Lab, Sao Paulo, Brazil; [Boggio, Paulo Sergio; Asthana, Manish Kumar] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Dev Disorders Program, Sao Paulo, Brazil; [Asthana, Manish Kumar] Indian Inst Technol, Dept Humanities & Social Sci, Roorkee, Uttar Pradesh, India; [Krypotos, Angelos-Miltiadis] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands	Universidade de Coimbra; Universidade do Minho; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Utrecht University	Ganho-Avila, A (corresponding author), Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Fac Psychol & Educ Sci, Proact Lab, Coimbra, Portugal.; Ganho-Avila, A (corresponding author), Univ Minho, Sch Psychol, Neuropsychophysiol Lab, CiPsi, Braga, Portugal.	ganhoavila@fpce.uc.pt	Boggio, Paulo S/K-6272-2012; Krypotos, Angelos-Miltiadis/ABD-1739-2020; Guiomar, Raquel/ABH-9355-2022; Asthana, Manish/AAE-8450-2019; Ganho-Ávila, Ana/AGU-8094-2022; Gonçalves, Óscar F./G-5278-2010	Boggio, Paulo S/0000-0002-6109-0447; Krypotos, Angelos-Miltiadis/0000-0001-9704-6520; Guiomar, Raquel/0000-0001-9611-1167; Asthana, Manish/0000-0002-0270-8913; Ganho-Ávila, Ana/0000-0001-5355-6166; Gonçalves, Óscar F./0000-0003-2735-9155; Almeida, Jorge/0000-0002-6302-7564	Foundation for Science and Technology, Portugal [SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014, POCI-01-0145FEDER-016836, POCI-01-0145-FEDER-016836, PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014]; Programa COMPETE [SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014, POCI-01-0145FEDER-016836, POCI-01-0145-FEDER-016836, PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014]; Portuguese Foundation for Science and Technology; Portuguese Ministry of Education and Science; FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013, POCI-01-0145-FEDER007653]; Proaction Laboratory;  [POCI-01-0145-FEDER016836]	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Programa COMPETE; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Education and Science(Portuguese Foundation for Science and Technology); FEDER through COMPETE2020 under the PT2020 Partnership Agreement; Proaction Laboratory; 	AGA is supported by the Foundation for Science and Technology, Portugal and Programa COMPETE [grants numbers SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014 (POCI-01-0145FEDER-016836); http://www.poci-compete2020.pt/].JA is supported by the Foundation for Science and Technology, Portugal and Programa COMPETE [grants numbers PTDC/MHC-PAP/5618/2014 (POCI-01-0145-FEDER-016836), PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014; https://www.fct.pt/index.phtml.en].The Cognitive and Behavioral Center for Research and Intervention of the Faculty of Psychology and Educational Sciences of the University of Coimbra is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013; https://www.portugal2020.pt].The Psychology Research Centre of the University of Minho is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER007653). The Proaction Laboratory and the PTDC/MHC-PAP/5618/2014 (POCI-01-0145-FEDER016836) directly supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.197; Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; Ahs F, 2015, NEUROIMAGE, V122, P262, DOI 10.1016/j.neuroimage.2015.07.051; Alberini CM, 2013, CURR BIOL, V23, pR746, DOI 10.1016/j.cub.2013.06.046; Almeida J, 2017, CORTEX, V94, P176, DOI 10.1016/j.cortex.2017.07.001; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Asthana Manish, 2013, Front Psychiatry, V4, P107, DOI 10.3389/fpsyt.2013.00107; Bell CC., 1994, JAMA-J AM MED ASSOC, V272, P828, DOI [10.1001/jama.1994.03520100096046, DOI 10.1001/JAMA.1994.03520100096046]; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Boddez Y, 2013, J BEHAV THER EXP PSY, V44, P201, DOI 10.1016/j.jbtep.2012.08.003; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; BROWN TA, 1995, J CONSULT CLIN PSYCH, V63, P408, DOI 10.1037/0022-006X.63.3.408; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Canavarro C, 2007, AVALIACAO PSICOLOGIC, P305; Dittert N, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00076; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P203, DOI 10.1016/j.biopsych.2014.12.008; Dymond S, 2015, BEHAV THER, V46, P561, DOI 10.1016/j.beth.2014.10.001; Feeser M, 2014, BRAIN STIMUL, V7, P105, DOI 10.1016/j.brs.2013.08.006; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; Ganho-Avila A, 2019, MEAS EVAL COUNS DEV, V52, P223, DOI 10.1080/07481756.2019.1594916; Golkar A, 2017, BEHAV RES THER, V92, P87, DOI 10.1016/j.brat.2017.02.004; Heeren A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124182; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Ironside M, 2016, BIOL PSYCHIAT, V79, P823, DOI 10.1016/j.biopsych.2015.06.012; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; KELLER MB, 1994, J NERV MENT DIS, V182, P290, DOI 10.1097/00005053-199405000-00007; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Krause MR, 2017, CURR BIOL, V27, P3086, DOI 10.1016/j.cub.2017.09.020; Kronberg G, 2017, BRAIN STIMUL, V10, P51, DOI 10.1016/j.brs.2016.10.001; Krypotos AM, 2014, CLIN PSYCHOL SCI, V2, P336, DOI 10.1177/2167702613503139; Krypotos AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00189; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P. J., INT AFFECTIVE DIGITI; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lonsdorf TB, 2019, BIOL PSYCHIAT, V85, P1074, DOI 10.1016/j.biopsych.2019.02.011; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Luyten L, 2017, NEUROBIOL LEARN MEM, V144, P208, DOI 10.1016/j.nlm.2017.07.014; Marquez-Ruiz J, 2012, P NATL ACAD SCI USA, V109, P6710, DOI 10.1073/pnas.1121147109; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Morriss J, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0019-8; Mungee A, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040055; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Rusticus SA, 2015, PRACTICAL ASSESSMENT, V19; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schroyens N, 2017, FRONT BEHAV NEUROSCI, V11, DOI [10.3309/fnbeh.2017.00065, 10.3389/fnbeh.2017.00065]; Shiozawa P, 2014, J DEPRESSION ANXIETY, P1; Shiozawa P, 2014, BIOL PSYCHIAT, V75, pE17, DOI 10.1016/j.biopsych.2013.07.014; SOLOMON RL, 1953, J ABNORM SOC PSYCH, V48, P291, DOI 10.1037/h0058943; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Thair H, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00641; van 't Wout M, 2016, BRAIN STIMUL, V9, P531, DOI 10.1016/j.brs.2016.03.004; Vervliet B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00351; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018	66	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221282	10.1371/journal.pone.0221282	http://dx.doi.org/10.1371/journal.pone.0221282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532768	Green Submitted, Green Published, gold			2022-12-27	WOS:000532239600006
J	Torrecillas, S; Terova, G; Makol, A; Serradell, A; Valdenegro, V; Gini, E; Izquierdo, M; Acosta, F; Montero, D				Torrecillas, Silvia; Terova, Genciana; Makol, Alex; Serradell, Antonio; Valdenegro, Victoria; Gini, Elisabetha; Izquierdo, Marisol; Acosta, Felix; Montero, Daniel			Dietary phytogenics and galactomannan oligosaccharides in low fish meal and fish oil-based diets for European sea bass (Dicentrarchus labrax) juveniles: Effects on gut health and implications on in vivo gut bacterial translocation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TILAPIA OREOCHROMIS-NILOTICUS; CD103(+) DENDRITIC CELLS; GARLIC ALLIUM-SATIVUM; IMMUNE-RELATED GENES; SALMON SALMO-SALAR; GROWTH-PERFORMANCE; NILE TILAPIA; ATLANTIC SALMON; AEROMONAS-HYDROPHILA	European sea bass were fed four low FM/FO (10%/6%) diets containing galactomannan oligosaccharides (GMOS), a mixture of garlic oil and labiatae plants oils (PHYTO), or a combination of both functional products (GMOSPHYTO) for 63 days before exposing the fish to an intestinal Vibrio anguillarum infection combined with crowding stress. In order to evaluate functional diets efficacy in terms of gut health maintenance, structural, cellular, and immune intestinal status were evaluated by optical and electron microscopy and gene expression analyses. A semi-automated software was adapted to determine variations in goblet cell area and mucosal mucus coverage during the challenge test. Feeding with functional diets did not affect growth performance; however, PHYTO and GMOS dietary inclusion reduced European sea bass susceptibility to V. anguillarum after 7 days of challenge testing. Rectum (post-ileorectal valve) showed longer (p = 0.001) folds than posterior gut (pre-ileorectal valve), whereas posterior gut had thicker submucosa (p = 0.001) and higher mucus coverage as a result of an increased cell density than rectum. Functional diets did not affect mucosal fold length or the grade of granulocytes and lymphocytes infiltration in either intestinal segment. However, the posterior gut fold area covered by goblet cells was smaller in fish fed GMOS (F = 14.53; p = 0.001) and PHYTO (F = 5.52; p = 0.019) than for the other diets. PHYTO (F = 3.95; p = 0.049) reduced posterior gut goblet cell size and increased rodlet cell density (F = 3.604; p = 0.068). Dietary GMOS reduced submucosal thickness (F = 51.31; p = 0.001) and increased rodlet cell density (F = 3.604; p = 0.068) in rectum. Structural TEM analyses revealed a normal intestinal morphological pattern, but the use of GMOS increased rectum microvilli length, whereas the use of PHYTO increased (p <= 0.10) Ocln, N-Cad and Cad-17 posterior gut gene expression. After bacterial intestinal inoculation, posterior gut of fish fed PHYTO responded in a more controlled and belated way in terms of goblet cell size and mucus coverage in comparison to other treatments. For rectum, the pattern of response was similar for all dietary treatments, however fish fed GMOS maintained goblet cell size along the challenge test.	[Torrecillas, Silvia; Serradell, Antonio; Izquierdo, Marisol; Acosta, Felix; Montero, Daniel] Univ Las Palmas Gran Canaria, Grp Invest Acuicultura GIA, IU ECOAQUA, Crta Taliarte S-N, Las Palmas Gran Canaria, Canary Islands, Spain; [Terova, Genciana; Gini, Elisabetha] Univ Insubria, Dept Biotechnol & Life Sci, Via JH Dunant, Varese, Italy; [Makol, Alex] Delacon Biotech GmbH, Weissenwolffstr, Steyregg, Austria; [Valdenegro, Victoria] Biomar AS, POB 1282 Sluppen, Trondheim, Norway	Universidad de Las Palmas de Gran Canaria; University of Insubria	Torrecillas, S (corresponding author), Univ Las Palmas Gran Canaria, Grp Invest Acuicultura GIA, IU ECOAQUA, Crta Taliarte S-N, Las Palmas Gran Canaria, Canary Islands, Spain.	silvia.torrecillas@giaqua.org	Antonio, Serradell Pastor/ABC-7783-2020; Terova, Genciana/AAL-6412-2021; Torrecillas, Silvia/F-5378-2016; montero, daniel/O-7108-2015; montero, daniel/ABE-3894-2020	Antonio, Serradell Pastor/0000-0003-0988-516X; Terova, Genciana/0000-0002-7532-7951; Torrecillas, Silvia/0000-0003-2823-9999; montero, daniel/0000-0002-4358-2157; Marisol, Izquierdo/0000-0003-4297-210X; Valdenegro Vega, Victoria/0000-0003-1708-9593; Izquierdo, Marisol/0000-0003-3583-6660; Gini, Elisabetta/0000-0003-3543-8777; ACOSTA ARBELO, FELIX ANTONIO/0000-0002-1098-7529	Spanish Ministry of Economy, Industry and Competitiveness ("Subprograma Estatal de Generacion de Conocimiento, en el marco del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016") by the PROINMUNOIL PLUS project [AGL2016-79725-P]; AGER project Fine Feed for Fish (4F) [978 2016-01-01]; Spanish Ministry of Economy, Industry and Competitiveness [IJCI2015-25748]	Spanish Ministry of Economy, Industry and Competitiveness ("Subprograma Estatal de Generacion de Conocimiento, en el marco del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016") by the PROINMUNOIL PLUS project; AGER project Fine Feed for Fish (4F); Spanish Ministry of Economy, Industry and Competitiveness	This work was funded by the Spanish Ministry of Economy, Industry and Competitiveness ("Subprograma Estatal de Generacion de Conocimiento, en el marco del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016") by the PROINMUNOIL PLUS (AGL2016-79725-P) project: "Functional diets for marine raw materials replacement: boosting the fish disease resistance through epithelial barriers reinforcement and immunization tools", in which DM, FA, MI, ST, and AS were involved. The part on gene expression analysis was funded by the AGER project Fine Feed for Fish (4F), Rif. No. 978 2016-01-01, in which GT and EG were involved. Besides, the Spanish Ministry of Economy, Industry and Competitiveness funded ST research though the "Subprograma Juan de la Cierva-Incoproracion, Convocatoria 2015, IJCI2015-25748. Special thanks to Delacon Biotechnik GmbH and to BioMar A/S, which provided the functional products and diets, and support in the form of salaries for authors AM and VV, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdel-Daim MM, 2015, ECOTOX ENVIRON SAFE, V111, P146, DOI 10.1016/j.ecoenv.2014.10.019; Abdelhamid A.M., 2012, J ARABIAN AQUAC SOC, V7, P75; Abutbul S, 2004, AQUACULTURE, V238, P97, DOI 10.1016/j.aquaculture.2004.05.016; Aly SM, 2010, J ANIM PHYSIOL AN N, V94, pe31, DOI 10.1111/j.1439-0396.2009.00971.x; Aly SM, 2008, 8 INT S TIL AQ, P277; Amer SA, 2018, EGYPT J AQUATIC RES, V44, P251, DOI 10.1016/j.ejar.2018.07.004; Amirkolaie AK, 2006, AQUACULTURE, V260, P194, DOI 10.1016/j.aquaculture.2006.06.039; [Anonymous], 2018, AQUACULTURE, V486, P170, DOI [10.1016/j.aquaculture.2017.12.022, DOI 10.1016/J.AQUACULTURE.2017.12.022]; Aubin J, 2005, AQUAC RES, V36, P758, DOI 10.1111/j.1365-2109.2005.01280.x; Awad E, 2015, FISH SHELLFISH IMMUN, V45, P454, DOI 10.1016/j.fsi.2015.04.035; Bahi A, 2017, FISH SHELLFISH IMMUN, V60, P50, DOI 10.1016/j.fsi.2016.11.039; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Baniak N, 2012, AM J PHYSIOL-LUNG C, V303, pL327, DOI 10.1152/ajplung.00058.2012; Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Bielek E, 2008, ANAT REC, V291, P1693, DOI 10.1002/ar.20796; Boonanuntanasarn S, 2016, AQUACULT NUTR, V22, P837, DOI 10.1111/anu.12302; Bouyahya A., 2017, PHYTOTHERAPIE, DOI [10.1007/s10298-017-1118-z, DOI 10.1007/S10298-017-1118-Z]; Bulfon C, 2015, AQUAC RES, V46, P513, DOI 10.1111/are.12238; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; CAMPBELL TW, 2004, VET HEM CLIN CHEM, P499; Castro R., 2015, MUCOSAL HLTH AQUACUL, P3, DOI DOI 10.1016/B978-0-12-417186-2.00002-9; Christie W.W., 2003, LIPID ANAL; da Cunha JA, 2018, J APPL MICROBIOL, V125, P328, DOI 10.1111/jam.13911; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; El-Barbary MI, 2016, FISH PHYSIOL BIOCHEM, V42, P617, DOI 10.1007/s10695-015-0164-4; Ellis A. E., 1988, Fish vaccination., P1; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Guardiola FA, 2017, FISH SHELLFISH IMMUN, V65, P169, DOI 10.1016/j.fsi.2017.04.014; Guerreiro I, 2018, REV AQUACULT, V10, P800, DOI 10.1111/raq.12201; Guo JJ, 2012, AQUACULTURE, V364, P33, DOI 10.1016/j.aquaculture.2012.07.023; Harder W, 1975, ANATOMY OF FISHES; Helrich K., 2005, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Hoffman E. O, 1983, LAB MED, V14, P779, DOI DOI 10.1093/LABMED/14.12.779; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Hoseinifar SH, 2015, FISH SHELLFISH IMMUN, V47, P706, DOI 10.1016/j.fsi.2015.09.046; Iger Y, 1997, TISSUE CELL, V29, P431, DOI 10.1016/S0040-8166(97)80029-8; Irkin L. C., 2014, Food and Nutrition Sciences, V5, P989, DOI 10.4236/fns.2014.511109; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; Izquierdo MS, 1992, AQUAC NUTR, V2, P183; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kandori H, 1996, EXP ANIM TOKYO, V45, P155, DOI 10.1538/expanim.45.155; Khan WI, 2004, PARASITE IMMUNOL, V26, P319, DOI 10.1111/j.0141-9838.2004.00715.x; Kim JJ, 2013, PATHOGENS, V2, P55, DOI 10.3390/pathogens2010055; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Lazado CC, 2014, FISH SHELLFISH IMMUN, V39, P78, DOI 10.1016/j.fsi.2014.04.015; Leenhouwers JI, 2007, AQUACULTURE, V264, P330, DOI 10.1016/j.aquaculture.2007.01.003; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lillehoj H, 2018, VET RES, V49, DOI 10.1186/s13567-018-0562-6; Manera M, 2001, J FISH BIOL, V59, P1239, DOI 10.1111/j.1095-8649.2001.tb00188.x; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Metwally M.A.A., 2009, World Journal of Fish and Marine Sciences, V1, P56; MILLER HRP, 1979, EXP PARASITOL, V47, P81, DOI 10.1016/0014-4894(79)90010-9; MILLER HRP, 1987, PARASITOLOGY, V94, pS77, DOI 10.1017/S0031182000085838; MING WJ, 1987, J IMMUNOL, V138, P1469; Mohebbi A, 2012, AQUAC RES, V43, P1184, DOI 10.1111/j.1365-2109.2011.02922.x; Montero D., 2010, FISH OIL REPLACEMENT, DOI [10.1201/9781439808634-c14, DOI 10.1201/9781439808634-C14]; Montero D, 2018, 18 INT S FISH NUTR F; Montero D, 2015, FISH SHELLFISH IMMUN, V44, P100, DOI 10.1016/j.fsi.2015.01.020; Mudgil D, 2017, DIETARY FIBER FOR THE PREVENTION OF CARDIOVASCULAR DISEASE: FIBER'S INTERACTION BETWEEN GUT MICOFLORA, SUGAR METABOLISM, WEIGHT CONTROL AND CARDIOVASCULAR HEALTH, P35, DOI 10.1016/B978-0-12-805130-6.00003-3; Muzaffar F, 2017, J ANIM NUTR, V34, P91; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Nya EJ, 2010, J FISH DIS, V33, P293, DOI 10.1111/j.1365-2761.2009.01121.x; Nya EJ, 2009, J FISH DIS, V32, P963, DOI 10.1111/j.1365-2761.2009.01100.x; Olsen RE, 2005, AQUACULTURE, V250, P480, DOI 10.1016/j.aquaculture.2005.03.014; Overland M, 2009, AQUACULTURE, V288, P305, DOI 10.1016/j.aquaculture.2008.12.012; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Raa J., 2000, AVANCES NUTR ACUICOL, V19, P47; Ray AK, 2012, AQUACULT NUTR, V18, P465, DOI 10.1111/j.1365-2095.2012.00943.x; Reite OB, 2006, FISH SHELLFISH IMMUN, V20, P192, DOI 10.1016/j.fsi.2005.01.012; Reverter M, 2014, AQUACULTURE, V433, P50, DOI 10.1016/j.aquaculture.2014.05.048; Ringo E, 2010, AQUAC RES, V41, P451, DOI 10.1111/j.1365-2109.2009.02339.x; Romarheim OH, 2013, BRIT J NUTR, V109, P1062, DOI 10.1017/S0007114512002899; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; Sahu S, 2007, J APPL ICHTHYOL, V23, P80, DOI 10.1111/j.1439-0426.2006.00785.x; Sfacteria A, 2015, MOL IMMUNOL, V63, P3, DOI 10.1016/j.molimm.2014.02.007; Shalaby AM, 2006, J VENOM ANIM TOXINS, V12, P172, DOI 10.1590/S1678-91992006000200003; Silva PF, 2015, AQUACULTURE, V442, P100, DOI 10.1016/j.aquaculture.2015.02.034; Sitja-Bobadilla A, 2016, DEV COMP IMMUNOL, V64, P187, DOI 10.1016/j.dci.2016.01.014; Sundh H., 2009, THESIS; Sundh Henrik, 2010, BMC Physiology, V10, P22, DOI 10.1186/1472-6793-10-22; Sutili FJ, 2018, REV AQUACULT, V10, P716, DOI 10.1111/raq.12197; Talpur AD, 2012, AQUACULTURE, V364, P6, DOI 10.1016/j.aquaculture.2012.07.035; Terova G, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-69; Thanikachalam K, 2010, ASIAN PAC J TROP MED, V3, P614, DOI 10.1016/S1995-7645(10)60149-6; Torrecillas S, 2007, FISH SHELLFISH IMMUN, V23, P969, DOI 10.1016/j.fsi.2007.03.007; Torrecillas S, 2018, FISH SHELLFISH IMMUN, V81, P10, DOI 10.1016/j.fsi.2018.07.007; Torrecillas S, 2017, AQUACULTURE, V474, P101, DOI 10.1016/j.aquaculture.2017.03.031; Torrecillas S, 2017, AQUACULTURE, V468, P386, DOI 10.1016/j.aquaculture.2016.11.005; Torrecillas S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00397; Torrecillas S, 2014, FISH SHELLFISH IMMUN, V36, P525, DOI 10.1016/j.fsi.2013.12.029; Torrecillas S, 2013, FISH SHELLFISH IMMUN, V34, P1485, DOI 10.1016/j.fsi.2013.03.351; Torrecillas S, 2011, FISH SHELLFISH IMMUN, V30, P674, DOI 10.1016/j.fsi.2010.12.020; Uran PA, 2009, J FISH DIS, V32, P733, DOI 10.1111/j.1365-2761.2009.01049.x; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; van der Marel M, 2008, J FISH DIS, V31, P321, DOI 10.1111/j.1365-2761.2008.00902.x; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Velin AK, 2004, GUT, V53, P494, DOI 10.1136/gut.2003.028506; VICKERS T, 1962, Q J MICROSC SCI, V103, P93; Wilson JM, 2011, FISH PHYSIOL, V30, P1, DOI 10.1016/S1546-5098(10)03001-3; Yilmaz Sevdan, 2016, Proceedings of the Indian National Science Academy Part B Biological Sciences, V86, P229, DOI 10.1007/s40011-014-0444-2; Yilmaz Sevdan, 2012, Journal of Bioscience and Biotechnology, V1, P217; Yilmaz S, 2013, J AQUAT ANIM HEALTH, V25, P98, DOI 10.1080/08997659.2013.768561; Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200; Zaki MA, 2012, APCBEE PROC, V4, P220, DOI 10.1016/j.apcbee.2012.11.037; Zheng ZL, 2009, AQUACULTURE, V292, P214, DOI 10.1016/j.aquaculture.2009.04.025; Zhou QC, 2010, AQUACULTURE, V309, P253, DOI 10.1016/j.aquaculture.2010.09.003; Zilberg D, 2010, J FISH DIS, V33, P361, DOI 10.1111/j.1365-2761.2009.01129.x	112	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222063	10.1371/journal.pone.0222063	http://dx.doi.org/10.1371/journal.pone.0222063			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532807	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600021
J	Costa, J; Figueiredo, P; Nakamura, F; Rago, V; Rebelo, A; Brito, J				Costa, Julio; Figueiredo, Pedro; Nakamura, Fabio; Rago, Vincenzo; Rebelo, Antonio; Brito, Joao			Intra-individual variability of sleep and nocturnal cardiac autonomic activity in elite female soccer players during an international tournament	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; JOINT CONSENSUS STATEMENT; ATHLETIC PERFORMANCE; TRAINING LOAD; EXERCISE; RESPONSES; RECOVERY; MEDICINE; RECOMMENDATIONS; INTERVENTIONS	Purpose To describe individual sleeping patterns and nocturnal cardiac autonomic activity of National team female soccer players during an international tournament. Materials and methods Twenty elite female soccer players (aged 25.2 +/- 3.1 years) wore wrist actigraph units and heart rate (HR) monitors during night-sleep throughout 9 consecutive days (6 day-time training sessions [DT], 2 day-time matches [DM], and 1 evening-time match [EM]) of an international tournament. Training and match loads were monitored using the session-rating of perceived exertion (s-RPE) and wearable 18-Hz GPS (total distance covered [TD], training and match exposure time, and high-speed running [HSR]) to characterize training and match loads. Results Individually, s-RPE, TD, exposure time, and HSR during training sessions ranged from 20 to 680 arbitrary units (AU), 892 to 5176 m, 20 to 76 min, and 80 to 1140 m, respectively. During matches, s-RPE, TD, exposure time, and HSR ranged from 149 to 876 AU, 2236 to 11210 m, 20 to 98 min, and 629 to 3213 m, respectively. Individually, players slept less than recommended (< 7 hours) on several days of the tournament, especially after EM (n = 8; TST ranging between 6:00-6:54 h). Total sleep time coefficient of variation (CV) ranged between 3.1 and 18.7%. However, all players presented good sleep quality (i.e., sleep efficiency.75%; individual range between: 75-98%) on each day of the tournament. Most of the players presented small fluctuations in nocturnal cardiac autonomic activity (individual nocturnal heart rate variability [HRV] ranged from 3.91-5.37 ms and HRV CV ranged from 2.8-9.0%), while two players presented higher HRV CV (11.5 and 11.7%; respectively). Conclusion Overall, this study highlights the substantial individual variability in sleep and HRV measures, suggesting the adoption of an individual approach to monitor sleep, training and match loads and recovery, to better understand how players cope with highly demanding competitions.	[Costa, Julio; Rago, Vincenzo; Rebelo, Antonio] Univ Porto, Fac Sport, CIFI2D, Ctr Res Educ Innovat & Intervent Sport, Porto, Portugal; [Costa, Julio; Figueiredo, Pedro; Rago, Vincenzo; Brito, Joao] Portuguese Football Federat, FPF, Portugal Football Sch, Oeiras, Portugal; [Figueiredo, Pedro] Univ Inst Maia, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, ISMAI, Maia, Portugal; [Nakamura, Fabio] Associate Grad Program Phys Educ UPE UFPB, Joao Pessoa, Paraiba, Brazil	Universidade do Porto; Instituto Universitario da Maia (ISMAI)	Costa, J (corresponding author), Univ Porto, Fac Sport, CIFI2D, Ctr Res Educ Innovat & Intervent Sport, Porto, Portugal.; Costa, J (corresponding author), Portuguese Football Federat, FPF, Portugal Football Sch, Oeiras, Portugal.	jahdc@hotmail.com	Rago, Vincenzo/AAC-8370-2020; Figueiredo, Pedro/J-4178-2013; Costa, Júlio Alejandro/J-4568-2019; Brito, Joao/D-2104-2014	Rago, Vincenzo/0000-0002-9445-4008; Figueiredo, Pedro/0000-0001-5515-3694; Costa, Júlio Alejandro/0000-0002-8225-8667; Brito, Joao/0000-0003-1301-1078	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES]); FIFA Research Scholarship 2017 (Federation Internationale de Football Association [FIFA]); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/128531/2017, SFRH/BD/129324/2017]	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES]); FIFA Research Scholarship 2017 (Federation Internationale de Football Association [FIFA]); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES] and Federation Internationale de Football Association [FIFA]) funding was provided for this study. The study was also supported by two individual doctoral grants from Fundacao para a Ciencia e a Tecnologia: Julio Costa (SFRH/BD/128531/2017) and Vincenzo Rago (SFRH/BD/129324/2017).	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al Haddad H, 2009, INT J SPORT PHYSIOL, V4, P435, DOI 10.1123/ijspp.4.4.435; Alsaadi SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095824; Andersson H, 2010, SCAND J MED SCI SPOR, V20, P740, DOI 10.1111/j.1600-0838.2009.00989.x; Beato M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01288; Bellenger CR, 2016, INT J SPORT PHYSIOL, V11, P685, DOI 10.1123/ijspp.2015-0495; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Boullosa DA, 2013, INT J SPORT PHYSIOL, V8, P400, DOI 10.1123/ijspp.8.4.400; Brandenberger G, 2005, AUTON NEUROSCI-BASIC, V121, P81, DOI 10.1016/j.autneu.2005.06.002; Breneman CB, 2019, BEHAV SLEEP MED, V17, P459, DOI 10.1080/15402002.2017.1395337; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Buchheit M, 2010, EUR J APPL PHYSIOL, V109, P869, DOI 10.1007/s00421-010-1422-x; Buman MP, 2011, J SLEEP RES, V20, P28, DOI 10.1111/j.1365-2869.2010.00866.x; Camm AJ, 1996, EUR HEART J, V17, P354; Claudino JG, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000475; Costa JA, 2018, INT J SPORT PHYSIOL, V13, P638, DOI 10.1123/ijspp.2017-0681; Costa JA, 2019, INT J SPORT PHYSIOL, V14, P779, DOI 10.1123/ijspp.2018-0652; de Freitas VH, 2015, INT J SPORT PHYSIOL, V10, P553, DOI 10.1123/ijspp.2014-0365; Esco MR, 2014, J HUM KINET, V42, P103, DOI 10.2478/hukin-2014-0065; Fallon KE, 2007, BRIT J SPORT MED, V41, P41, DOI 10.1136/bjsm.2006.030999; Flatt AA, 2017, J SPORT MED PHYS FIT, V57, P907, DOI 10.23736/S0022-4707.16.06322-2; Flatt AA, 2017, J SCI MED SPORT, V20, P606, DOI 10.1016/j.jsams.2016.10.017; Flatt AA, 2017, J STRENGTH COND RES, V31, P531, DOI 10.1519/JSC.0000000000001482; Flatt AA, 2016, J STRENGTH COND RES, V30, P378, DOI 10.1519/JSC.0000000000001095; Flatt AA, 2015, INT J SPORT PHYSIOL, V10, P994, DOI 10.1123/ijspp.2014-0556; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Fullagar H, 2016, CHRONOBIOL INT, V33, P490, DOI 10.3109/07420528.2016.1149190; Fullagar HHK, 2016, J SPORT SCI, V34, P1333, DOI 10.1080/02640414.2015.1135249; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Gaudino P, 2014, INT J SPORTS MED, V35, P489, DOI 10.1055/s-0033-1355418; Gupta L, 2017, SPORTS MED, V47, P1317, DOI 10.1007/s40279-016-0650-6; GURGEL I, 2018, PROVINCIA, P1, DOI DOI 10.1080/13651501.2018.1539180; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Juliff LE, 2018, J STRENGTH COND RES, V32, P189, DOI 10.1519/JSC.0000000000001793; King M, 2009, J STRENGTH COND RES, V23, P1795, DOI 10.1519/JSC.0b013e3181b3f81f; Kolling S, 2016, CHRONOBIOL INT, V33, P73, DOI 10.3109/07420528.2015.1118384; Lastella M, 2019, SLEEP HEALTH, V5, P141, DOI 10.1016/j.sleh.2018.10.013; Lastella M, 2015, EUR J SPORT SCI, V15, P94, DOI 10.1080/17461391.2014.932016; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Michael S, 2018, J SCI MED SPORT, V21, P1079, DOI 10.1016/j.jsams.2018.01.015; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Mourot L, 2004, CLIN PHYSIOL FUNCT I, V24, P10, DOI 10.1046/j.1475-0961.2003.00523.x; Nakamura FY, 2016, J SPORT SCI, V34, P2262, DOI 10.1080/02640414.2016.1186282; Nakamura FY, 2018, J STRENGTH COND RES; Nedelec M, 2019, J STRENGTH COND RES, V33, P174, DOI 10.1519/JSC.0000000000002906; Nedelec M, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0151-2; Ohayon M, 2017, SLEEP HEALTH, V3, P6, DOI 10.1016/j.sleh.2016.11.006; Parak J., ACCURACY FIRSTBEAT B; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P697, DOI 10.1123/ijspp.2016-0343; Roberts SSH, 2019, BRIT J SPORT MED, V53, P513, DOI 10.1136/bjsports-2018-099322; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Samuels C, 2008, NEUROL CLIN, V26, P169, DOI 10.1016/j.ncl.2007.11.012; Sargent C, 2016, CHRONOBIOL INT, V33, P667, DOI 10.3109/07420528.2016.1167715; Sargent C, 2014, EUR J SPORT SCI, V14, pS310, DOI 10.1080/17461391.2012.696711; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Scott D, 2018, J SPORT SCI, V36, P1523, DOI 10.1080/02640414.2017.1398894; Simpson NS, 2017, SCAND J MED SCI SPOR, V27, P266, DOI 10.1111/sms.12703; Staunton C, 2017, J SCI MED SPORT, V20, P786, DOI 10.1016/j.jsams.2016.11.016; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, J SLEEP RES, V14, P201, DOI 10.1111/j.1365-2869.2005.00453.x; VUORI I, 1988, ACTA PHYSIOL SCAND, V133, P3; Watson AM, 2017, CURR SPORT MED REP, V16, P413, DOI 10.1249/JSR.0000000000000418; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wong KK, 2018, RES EDUC POLICY LOCA, P1	70	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0218635	10.1371/journal.pone.0218635	http://dx.doi.org/10.1371/journal.pone.0218635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527865	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400003
J	Diamond, A; Lee, C; Senften, P; Lam, A; Abbott, D				Diamond, Adele; Lee, Chris; Senften, Peter; Lam, Andrea; Abbott, David			Randomized control trial of Tools of the Mind: Marked benefits to kindergarten children and their teachers	PLOS ONE			English	Article							INHIBITORY CONTROL; EXECUTIVE FUNCTIONS; SELF-EFFICACY; ACADEMIC-PERFORMANCE; PSYCHOLOGICAL STRESS; SCHOOL READINESS; IMMUNE-RESPONSE; POSITIVE AFFECT; WORKING-MEMORY; DEPRESSED MOOD	The kindergarten program, Tools of the Mind (Tools), has been shown to improve executive functions (as assessed by laboratory measures) and academic performance. The objective here was to see if Tools can improve executive functions in the real world (in the classroom), academic outcomes not previously investigated, reduce bullying and peer ostracism, and increase teachers' and students' joy in being in the classroom. This first randomized controlled trial of Tools in Canada included 351 kindergarten children (mean age 5.2 years at entry; 51% female) in 18 public schools. Stratified randomization resulted in teachers and students in both groups being closely matched. Teachers in both groups received the same number of training hours and same funds for new materials. Outcome measures were pre and post standardized academic skill assessments and teacher online survey responses. This study replicated that Tools improves reading and shows for the first time that it improves writing (far exceeding levels the school districts had seen before), self-control and attention-regulation in the real world (e.g., time on task without supervision), reduces teacher burnout and children being ostracized or excluded, and increases the joy students and teachers experience in school. By Spring, Tools teachers were still enthusiastic about teaching; control teachers were exhausted. These results were not only better than the control group but also better than Tools teachers experienced the year before Tools. Thus, children in a kindergarten curriculum that emphasized play, improving self-regulation, working together and helping one another, and hands-on learning performed better academically, showed less bullying and peer ostracism and more kindness and helping behavior than students in more traditional classes, and teacher enthusiasm for teaching soared. Tools reduced initial disparities separating children, schools, and teachers.	[Diamond, Adele; Lee, Chris; Senften, Peter; Lam, Andrea; Abbott, David] Univ British Columbia, Dept Psychiat, Program Dev Cognit Neurosci, Vancouver, BC, Canada; [Senften, Peter] Univ British Columbia, Neurosci Program, Vancouver, BC, Canada; [Lam, Andrea] Nested Nat, Digital Mkt Dept, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Diamond, A (corresponding author), Univ British Columbia, Dept Psychiat, Program Dev Cognit Neurosci, Vancouver, BC, Canada.	adele.diamond@ubc.ca		Diamond, Adele/0000-0002-1453-6434	British Columbia Ministry of Health; British Columbia Mental Health Foundation; Spencer Foundation [200700122]; Bezos Family Foundation; Canada Research Chair award [CRC - 95027472]; National Institute on Drug Abuse [DA019685, DA037285]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037285] Funding Source: NIH RePORTER	British Columbia Ministry of Health; British Columbia Mental Health Foundation; Spencer Foundation; Bezos Family Foundation; Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The random assignment of classes and training of control-group and Tools teachers was funded by the British Columbia Ministry of Health and the British Columbia Mental Health Foundation. Funds from Grant 200700122 awarded to AD from the Spencer Foundation helped to cover the research expenses. A grant from the Bezos Family Foundation to AD helped fund preparation of this manuscript. AD received partial salary support from a Canada Research Chair award (CRC -95027472) and from two National Institute on Drug Abuse R01 research grants (DA019685 & DA037285) during the time this study was conducted and the manuscript written.	Ahola K, 2014, BURNOUT WORK PSYCHOL, P10, DOI [10.4324/978131589416, DOI 10.4324/978131589416]; Allan NP, 2014, DEV PSYCHOL, V50, P2368, DOI 10.1037/a0037493; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Aloe AM, 2014, EDUC PSYCHOL REV, V26, P101, DOI 10.1007/s10648-013-9244-0; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Asada Y, 2013, MILBANK Q, V91, P5, DOI 10.1111/milq.12001; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bailey CE, 2007, ANN NY ACAD SCI, V1118, P122, DOI 10.1196/annals.1412.011; Bassok D, 2016, AERA OPEN, V2, DOI 10.1177/2332858415616358; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Beaver J., 2006, DRA2 DEV READING ASS; Benner AD, 2011, J YOUTH ADOLESCENCE, V40, P556, DOI 10.1007/s10964-010-9561-2; Berk L. E., 1992, PRIVATE SPEECH SOCIA, P17; Bierman KL, 2008, DEV PSYCHOPATHOL, V20, P821, DOI 10.1017/S0954579408000394; Blair C, 2018, EARLY CHILD RES Q, V43, P52, DOI 10.1016/j.ecresq.2018.01.002; Blair C, 2016, LEARN INSTR, V41, P85, DOI 10.1016/j.learninstruc.2015.10.001; Blair C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112393; Bodrova E., 2012, APPROACHES EARLY CHI, V6th ed., P241; Brouwers A, 2000, TEACH TEACH EDUC, V16, P239, DOI 10.1016/S0742-051X(99)00057-8; Brown TE, 2010, POSTGRAD MED, V122, P42, DOI 10.3810/pgm.2010.09.2200; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Chapman M, 2000, PRIMARY PROGRAM FRAM; Chetty R, 2011, Q J ECON, V126, P1593, DOI 10.1093/qje/qjr041; Clements DH, 2008, AM EDUC RES J, V45, P443, DOI 10.3102/0002831207312908; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Committee for Children, 2002, 2 STEP VIOL PREV CUR; Curby TW, 2015, INFANT CHILD DEV, V24, P549, DOI 10.1002/icd.1899; Davis JC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-16; Denham SA, 2015, J EARLY CHILD RES, V13, P252, DOI 10.1177/1476718X13497354; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Duckworth AL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00608; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Evans GW, 2008, EARLY CHILD RES Q, V23, P504, DOI 10.1016/j.ecresq.2008.07.002; Fernyhough C, 2005, COGNITIVE DEV, V20, P103, DOI 10.1016/j.cogdev.2004.11.002; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Government of British Columbia, TEACH ASS TOOLS; Haynes M., 2014, ALLIANCE EXCELLENT E, V14, P1; Heinemann LV, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017697154; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Hirt ER, 2008, J PERS SOC PSYCHOL, V94, P214, DOI 10.1037/0022-3514.94.2.94.2.214; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Holochwost SJ, 2017, PSYCHOL AESTHET CREA, V11, P147, DOI 10.1037/aca0000112; Jones DE, 2015, AM J PUBLIC HEALTH, V105, P2283, DOI 10.2105/AJPH.2015.302630; Karpicke JD, 2012, CURR DIR PSYCHOL SCI, V21, P157, DOI 10.1177/0963721412443552; Kauts Amit, 2009, Int J Yoga, V2, P39, DOI 10.4103/0973-6131.53860; KAVANAGH DJ, 1985, COGNITIVE THER RES, V9, P507, DOI 10.1007/BF01173005; Kiuru N, 2015, DEV PSYCHOL, V51, P434, DOI 10.1037/a0038911; Ladd GW, 1999, CHILD DEV, V70, P1373, DOI 10.1111/1467-8624.00101; Layden EA, 2017, NEUROIMAGE, V145, P58, DOI 10.1016/j.neuroimage.2016.09.050; Lillard A.S., 2016, MONTESSORI SCI GENIU, V3rd Edn; Lillard AS, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01783; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lonigan C, 2012, SOC RES ED EFF SREE; Lubin A, 2013, J EDUC PSYCHOL, V105, P701, DOI 10.1037/a0032625; Lynch JJ, 1977, BROKEN HEART MED CON; Lyyra N, 2018, SCAND J PUBLIC HEALT, V46, P87, DOI 10.1177/1403494817743901; Mahler D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207252; Maier SU, 2015, NEURON, V87, P621, DOI 10.1016/j.neuron.2015.07.005; Maloney JE, 2016, MINDFULNESS ED INTEG; Malti T, 2009, CHILD DEV, V80, P442, DOI 10.1111/j.1467-8624.2009.01271.x; Manrique M, 2020, J AM COLL HEALTH, V68, P227, DOI 10.1080/07448481.2018.1538999; Marcon R. A., 2002, EARLY CHILDHOOD RES, V4; Marzocchi GM, 2002, DEV NEUROPSYCHOL, V21, P73, DOI 10.1207/S15326942DN2101_4; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; McClelland MM, 2013, EARLY CHILD RES Q, V28, P314, DOI 10.1016/j.ecresq.2012.07.008; Merrell C, 2001, BRIT J EDUC PSYCHOL, V71, P43, DOI 10.1348/000709901158389; Miller E., 2009, CRISIS KINDERGARTEN; Miller G, 2011, SCIENCE, V331, P138, DOI 10.1126/science.331.6014.138; Miller HV, 2011, AM J HEALTH BEHAV, V35, P15; Moffitt TE., 2012, TRYGF MULT S IMPR WE; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morris P, 2014, IMPACT FINDINGS HEAD; Nakamichi K, 2017, PSYCHOL REP, V120, P805, DOI 10.1177/0033294117709260; Ng V, 2003, PSYCHOL REP, V93, P1133, DOI 10.2466/PR0.93.8.1133-1134; Noddings N., 2005, CHALLENGE CARE SCH A, V2nd; O'Shaughnessy TE, 2003, REM SPEC EDUC, V24, P27, DOI 10.1177/074193250302400103; Olver JS, 2015, STRESS HEALTH, V31, P115, DOI 10.1002/smi.2533; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Rhoades BL, 2009, J APPL DEV PSYCHOL, V30, P310, DOI 10.1016/j.appdev.2008.12.012; Riggs NR, 2006, J APPL DEV PSYCHOL, V27, P300, DOI 10.1016/j.appdev.2006.04.002; Riggs NR, 2010, J NUTR EDUC BEHAV, V42, P398, DOI 10.1016/j.jneb.2009.11.003; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Rotenberg KJ, 2008, EARLY CHILD RES Q, V23, P288, DOI 10.1016/j.ecresq.2007.04.003; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryan SV, 2017, TEACH TEACH EDUC, V66, P1, DOI 10.1016/j.tate.2017.03.016; Schoeler T, 2018, PSYCHOL BULL, V144, P1229, DOI 10.1037/bul0000171; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sheridan C L, 1987, Int J Psychosom, V34, P20; Slavish DC, 2015, J BEHAV MED, V38, P204, DOI 10.1007/s10865-014-9595-0; Solomon TLS, 2017, FRONT PSYCHOL, V8, P18; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Sy A, 2008, J SCHOOL HEALTH, V78, P264, DOI 10.1111/j.1746-1561.2008.00299.x; von Hecker U, 2005, EMOTION, V5, P456, DOI 10.1037/1528-3542.5.4.456; Vygotsky L.S, 1978, MIND SOC DEV HIGHER, DOI DOI 10.2307/J.CTVJF9VZ4.11; VYGOTSKY LS, 1967, SOV PSYCHOL-USSR, V5, P6, DOI 10.2753/RPO1061-040505036; Watts TW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200144; Wilson SJ, 2012, SOC RES ED EFF SREE; WITT JC, 1983, PSYCHOL SCHOOLS, V20, P510, DOI 10.1002/1520-6807(198310)20:4<510::AID-PITS2310200420>3.0.CO;2-1; WITT JC, 1986, J SCHOOL PSYCHOL, V24, P37, DOI 10.1016/0022-4405(86)90040-3; Zins JE, 2007, J EDUC PSYCHOL CONS, V17, P191, DOI 10.1080/10474410701413145	107	36	36	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222447	10.1371/journal.pone.0222447	http://dx.doi.org/10.1371/journal.pone.0222447			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527919	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400021
J	Csenkey, A; Jozsa, G; Gede, N; Pakai, E; Tinusz, B; Rumbus, Z; Lukacs, A; Gyongyi, Z; Hamar, P; Sepp, R; Romanovsky, AA; Hegyi, P; Vajda, P; Garami, A				Csenkey, Alexandra; Jozsa, Gergo; Gede, Noemi; Pakai, Eszter; Tinusz, Benedek; Rumbus, Zoltan; Lukacs, Anita; Gyongyi, Zoltan; Hamar, Peter; Sepp, Robert; Romanovsky, Andrej A.; Hegyi, Peter; Vajda, Peter; Garami, Andras			Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: A meta-analysis	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; MANAGEMENT; CHILDREN; PREVENTION; GUIDELINES; CARE	In pediatric burns the use of systemic antibiotic prophylaxis is a standard procedure in some burn centers, though its beneficial effect on the infectious complications is debated. The present meta-analysis aimed at determining whether systemic antibiotic prophylaxis prevents infectious complications in pediatric patients with burn injuries. We searched the PubMed, EMBASE, and Cochrane Library databases from inception to August 2019. We included 6 studies, in which event rates of infectious complications were reported in children with burn injuries receiving or not receiving systemic antibiotic prophylaxis. We found that the overall odds ratio (OR) of developing an infection (including local and systemic) was not different between the groups (OR = 1.35; 95% CI, 0.44, 4.18). The chances for systemic infectious complications alone were also not different between antibiotic-treated and non-treated patients (OR = 0.74; 95% CI, 0.38, 1.45). Based on the age, affected total body surface area, and country income level, we did not find any subgroup that benefited from the prophylaxis. Our findings provide quantitative evidence for the inefficacy of systemic antibiotic prophylaxis in preventing infections in pediatric burns. To validate our conclusion, multinational, randomized trials in a diverse population of children with burn injuries are warranted.	[Csenkey, Alexandra; Jozsa, Gergo; Pakai, Eszter; Rumbus, Zoltan; Garami, Andras] Univ Pecs, Med Sch, Inst Translat Med, Dept Thermophysiol, Pecs, Hungary; [Csenkey, Alexandra; Jozsa, Gergo; Vajda, Peter] Univ Pecs, Dept Paediat, Surg Div, Pecs, Hungary; [Gede, Noemi; Tinusz, Benedek; Hamar, Peter; Hegyi, Peter] Univ Pecs, Med Sch, Inst Translat Med, Pecs, Hungary; [Lukacs, Anita] Univ Szeged, Fac Med, Dept Publ Hlth, Szeged, Hungary; [Gyongyi, Zoltan] Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary; [Sepp, Robert] Univ Szeged, Dept Internal Med 2, Szeged, Hungary; [Sepp, Robert] Univ Szeged, Cardiol Ctr, Szeged, Hungary; [Romanovsky, Andrej A.] St Josephs Hosp, Thermoregulat & Syst Inflammat Lab, Trauma Res, FeverLab, Phoenix, AZ USA	University of Pecs; University of Pecs; University of Pecs; Szeged University; University of Pecs; Szeged University; Szeged University; St. Joseph's Hospital and Medical Center	Garami, A (corresponding author), Univ Pecs, Med Sch, Inst Translat Med, Dept Thermophysiol, Pecs, Hungary.	andras.garami@aok.pte.hu	Gyöngyi, Zoltán/B-6433-2014; Garami, Andras/AAF-8588-2020; VAJDA, Peter/K-4603-2013	Gyöngyi, Zoltán/0000-0001-9330-9119; Garami, Andras/0000-0003-2493-0571; Romanovsky, Andrej/0000-0003-3772-8575; Lukacs, Anita/0000-0002-0746-8920; VAJDA, Peter/0000-0002-4835-6458	National Research, Development and Innovation Office [FK 124483]; Medical School, University of Pecs [KA-2019-27]; Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary [20765-3/2018/FEKUTSTRAT]; GINOP STAY ALIVE [2.3.2-15-2016-00048]; EFOP LIVE LONGER [3.6.2-16-2017-00006]; Janos Bolyai Scholarship of the Hungarian Academy of Sciences	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Medical School, University of Pecs; Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary; GINOP STAY ALIVE; EFOP LIVE LONGER; Janos Bolyai Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the National Research, Development and Innovation Office (FK 124483 to AG), the Medical School, University of Pecs (KA-2019-27 to AG), the Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary (20765-3/2018/FEKUTSTRAT to PH and AG), GINOP STAY ALIVE (2.3.2-15-2016-00048 to PH), and EFOP LIVE LONGER (3.6.2-16-2017-00006 to PH). AG acknowledges the Janos Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RB, 2016, BURNS, V42, P953, DOI 10.1016/j.burns.2016.05.013; Avni T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c241; Barajas-Nava LA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008738.pub2; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; Celko AM, 2009, B WORLD HEALTH ORGAN, V87, P374, DOI 10.2471/BLT.08.059535; Chahed Jamila, 2014, Afr J Paediatr Surg, V11, P323, DOI 10.4103/0189-6725.143141; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Davies A, 2017, BURNS, V43, P215, DOI 10.1016/j.burns.2016.07.032; Ergun O, 2004, EUR J PEDIATR SURG, V14, P422, DOI 10.1055/s-2004-821065; Geyik MF, 2003, AM J INFECT CONTROL, V31, P342, DOI 10.1016/S0196-6553(02)48226-0; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Jamshidi R, 2013, PEDIATR REV, V34, P395, DOI 10.1542/pir.34-9-395; Krishnamoorthy Vijay, 2012, Int J Crit Illn Inj Sci, V2, P128, DOI 10.4103/2229-5151.100889; Laitakari E, 2015, J PEDIATR SURG, V50, P608, DOI 10.1016/j.jpedsurg.2014.05.034; Lee F, 2009, J TROP PEDIATRICS, V55, P73, DOI 10.1093/tropej/fmp017; Lymperopoulos NS, 2015, J BURN CARE RES, V36, P565, DOI 10.1097/BCR.0000000000000210; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mulgrew S, 2014, ANN PLAS SURG, V72, P34, DOI 10.1097/SAP.0b013e31829be8be; Natterer J, 2009, SWISS MED WKLY, V139, P535, DOI smw-12605; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; PAPINI RPG, 1995, BRIT J SURG, V82, P505, DOI 10.1002/bjs.1800820423; Park JO, 2009, BURNS, V35, P482, DOI 10.1016/j.burns.2008.10.007; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Rashid A, 2005, BURNS, V31, P981, DOI 10.1016/j.burns.2005.06.017; Rawlins JM, 2007, PEDIATR EMERG CARE, V23, P289, DOI 10.1097/01.pec.0000248698.42175.2b; Rodgers GL, 2000, PEDIATR INFECT DIS J, V19, P990, DOI 10.1097/00006454-200010000-00010; Rumbus Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170152; Sengoelge Mathilde, 2017, Prev Med Rep, V6, P115, DOI 10.1016/j.pmedr.2017.02.024; Sheridan RL, 2001, J TRAUMA, V51, P352, DOI 10.1097/00005373-200108000-00022; Smolle C, 2017, BURNS, V43, P249, DOI 10.1016/j.burns.2016.08.013; Rosanova MT, 2013, ARCH ARGENT PEDIATR, V111, P303, DOI [10.5546/aap.2013.303, 10.5546/aap.2013.eng.303]; Thorpe KE, 2018, HEALTH AFFAIR, V37, P662, DOI 10.1377/hlthaff.2017.1153; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Vloemans AFPM, 2011, BURNS, V37, P1161, DOI 10.1016/j.burns.2011.05.001; Wells G, 2000, NEWCASTLE OTTAWA SCA; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170	39	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223063	10.1371/journal.pone.0223063	http://dx.doi.org/10.1371/journal.pone.0223063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553768	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000532319200053
J	Guerrero, JM; Adluru, N; Bendlin, BB; Goldsmith, HH; Schaefer, SM; Davidson, RJ; Kecskemeti, SR; Zhang, H; Alexander, AL				Guerrero, Jose M.; Adluru, Nagesh; Bendlin, Barbara B.; Goldsmith, H. Hill; Schaefer, Stacey M.; Davidson, Richard J.; Kecskemeti, Steven R.; Zhang, Hui; Alexander, Andrew L.			Optimizing the intrinsic parallel diffusivity in NODDI: An extensive empirical evaluation	PLOS ONE			English	Article							NEURITE ORIENTATION DISPERSION; WHITE-MATTER MICROSTRUCTURE; AXON DIAMETER; DENSITY; MODEL; MRI	Purpose NODDI is widely used in parameterizing microstructural brain properties. The model includes three signal compartments: intracellular, extracellular, and free water. The neurite compartment intrinsic parallel diffusivity (d(parallel to)) is set to 1.7 mu m(2).ms(-1), though the effects of this assumption have not been extensively explored. This work investigates the optimality of d(parallel to) = 1.7 mu m(2).ms(-1) under varying imaging protocol, age groups, sex, and tissue type in comparison to other biologically plausible values of d(parallel to). Methods Model residuals were used as the optimality criterion. The model residuals were evaluated in function of d(parallel to) over the range from 0.5 to 3.0 mu m(2).ms(-1). This was done with respect to tissue type (i.e., white matter versus gray matter), sex, age (infancy to late adulthood), and diffusion-weighting protocol (maximum b-value). Variation in the estimated parameters with respect to d(parallel to) was also explored. Results Results show d(parallel to) = 1.7 mu m(2).ms(-1) is appropriate for adult brain white matter but it is suboptimal for gray matter with optimal values being significantly lower. d(parallel to) = 1.7 mu m(2).ms(-1) was also suboptimal in the infant brain for both white and gray matter with optimal values being significantly lower. Minor optimum d(parallel to) differences were observed versus diffusion protocol. No significant sex effects were observed. Additionally, changes in d(parallel to) resulted in significant changes to the estimated NODDI parameters. Conclusion The default (d(parallel to)) of 1.7 mu m(2).ms(-1) is suboptimal in gray matter and infant brains.	[Guerrero, Jose M.; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Adluru, Nagesh; Goldsmith, H. Hill; Kecskemeti, Steven R.; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Bendlin, Barbara B.] Univ Wisconsin, Dept Med, Madison, WI USA; [Goldsmith, H. Hill] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Schaefer, Stacey M.; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA; [Zhang, Hui] UCL, Dept Comp Sci, London, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London	Guerrero, JM (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Adluru, N (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	jguerrerogon@wisc.edu; adluru@wisc.edu	Alexander, Andrew/ABA-2806-2020	Zhang, Hui/0000-0002-5426-2140; Davidson, Richard/0000-0002-8506-4964	National Institute of Child Health and Human Development [IDDRC U54 HD090256]; NIH [R01 NS092870, R01AG037639, R01AG027161, RF1 AG059312, P50AG033514, P50 NIMH100031, R01 MH101504, R01 AG037639]; BRAIN Initiative [R01-EB022883]; UW CPCP [AI117924]; UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship; NSF Graduate Research Fellowship Program; Bill and Melinda Gates Foundation [P50 MH084051, R01 MH59785]; National Institute on Aging [P01-AG020166, U19 AG051426]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101504, R01MH043454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG059312, U19AG051426, R01AG027161, P50AG033514, R01AG037639] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRAIN Initiative; UW CPCP; UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (IDDRC U54 HD090256). Additional support was provided by NIH grant R01 NS092870 (to AA), BRAIN Initiative R01-EB022883 (to NA), UW CPCP AI117924 (to NA), NIH grant R01AG037639, NIH grant R01AG027161, RF1 AG059312 (to BBB, NA), and NIH grant P50AG033514. JMG is supported by a UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship, and the NSF Graduate Research Fellowship Program. Data collection for this study was supported by the Bill and Melinda Gates Foundation, grants P50 MH084051, R01 MH59785, the National Institute on Aging grants P01-AG020166 and U19 AG051426, and NIH grants P50 NIMH100031, R01 MH101504, R01 AG037639.; This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (IDDRC U54 HD090256). Additional support was provided by NIH grant R01 NS092870 (to AA), BRAIN Initiative R01-EB022883 (to NA), UW CPCP AI117924 (to NA), NIH grant R01AG037639, NIH grant R01AG027161, RF1 AG059312 (to BBB, NA), and NIH grant P50AG033514. JMG is supported by a UW-Madison SciMed Graduate Research Scholars Advanced Opportunity Fellowship, and the NSF Graduate Research Fellowship Program. Data collection for this study was supported by the Bill and Melinda Gates Foundation, grants P50 MH084051, R01 MH59785, the National Institute on Aging grants P01-AG020166 and U19 AG051426, and NIH grants P50 NIMH100031, R01 MH101504, R01 AG037639.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; [Anonymous], 2009, DIRECTIONAL STAT; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Billiet T, 2014, NEUROIMAGE-CLIN, V4, P649, DOI 10.1016/j.nicl.2014.04.005; Caverzasi E, 2016, J NEUROIMAGING, V26, P494, DOI 10.1111/jon.12359; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Dean DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09915-6; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Farooq H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38927; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fukutomi H, 2018, NEUROIMAGE, V182, P488, DOI 10.1016/j.neuroimage.2018.02.017; Genc E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04268-8; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Guerrero J.M., 2016, INVESTIGATING EFFECT; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2018, NEUROIMAGE, V182, P329, DOI 10.1016/j.neuroimage.2017.08.039; Kaden E, 2016, NEUROIMAGE, V139, P346, DOI 10.1016/j.neuroimage.2016.06.002; Kamagata K, 2016, EUR RADIOL, V26, P2567, DOI 10.1007/s00330-015-4066-8; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Novikov D.S., 2016, ARXIV160909144, V10; Novikov DS, 2018, NEUROIMAGE, V174, P518, DOI 10.1016/j.neuroimage.2018.03.006; Owen JP, 2014, J NEUROSCI, V34, P6214, DOI 10.1523/JNEUROSCI.4495-13.2014; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; Veraart J., 2018, P INT SOC MAGN RESON, V27, P1094; Veraart J., 2016, ARXIV160909145; Veraart J, 2018, NEUROIMAGE, V182, P360, DOI 10.1016/j.neuroimage.2017.09.030; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	41	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0217118	10.1371/journal.pone.0217118	http://dx.doi.org/10.1371/journal.pone.0217118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553719	Green Published, gold, Green Submitted			2022-12-27	WOS:000532319200001
J	Liu, XY; Sun, BL; Zhang, Z; Wang, YM; Tang, HN; Zhu, TS				Liu, Xingyun; Sun, Bingli; Zhang, Zhan; Wang, Yameng; Tang, Haina; Zhu, Tingshao			Gait can reveal sleep quality with machine learning models	PLOS ONE			English	Article							ENERGY-EXPENDITURE; POOR SLEEP; RECOGNITION; PERFORMANCE; DURATION; HEALTH; INDEX	Sleep quality is an important health indicator, and the current measurements of sleep rely on questionnaires, polysomnography, etc., which are intrusive, expensive or time consuming. Therefore, a more nonintrusive, inexpensive and convenient method needs to be developed. Use of the Kinect sensor to capture one's gait pattern can reveal whether his/her sleep quality meets the requirements. Fifty-nine healthy students without disabilities were recruited as participants. The Pittsburgh Sleep Quality Index (PSQI) and Kinect sensors were used to acquire the sleep quality scores and gait data. After data preprocessing, gait features were extracted for training machine learning models that predicted sleep quality scores based on the data. The t-test indicated that the following joints had stronger weightings in the prediction: the Head, Spine Shoulder, Wrist Left, Hand Right, Thumb Left, Thumb Right, Hand Tip Left, Hip Left, and Foot Left. For sleep quality prediction, the best result was achieved by Gaussian processes, with a correlation of 0.78 (p < 0.001). For the subscales, the best result was 0.51 for daytime dysfunction (p < 0.001) by linear regression. Gait can reveal sleep quality quite well. This method is a good supplement to the existing methods in identifying sleep quality more ecologically and less intrusively.	[Liu, Xingyun; Sun, Bingli; Zhang, Zhan; Wang, Yameng; Zhu, Tingshao] Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China; [Liu, Xingyun] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Liu, Xingyun] City Univ Hong Kong, Dept Social & Behav Sci, Hong Kong, Peoples R China; [Zhang, Zhan; Wang, Yameng] Univ Chinese Acad Sci, Sch Comp Sci & Technol, Beijing, Peoples R China; [Tang, Haina] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, TS (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China.	tszhu@psych.ac.cn		liu, xingyun/0000-0001-7118-0465; Zhu, Tingshao/0000-0003-0020-3812; Wang, Yameng/0000-0002-9029-5601	National Basic Research Program of China [2014CB744600]; China Social Science Fund [Y8JJ183010]; National Social Science Fund of China [16AZD058]; Key Research Program of the Chinese Academy of Sciences [ZDRW-XH-2019-4]; Chinese Academy of Sciences project [CXJJ-16M119]	National Basic Research Program of China(National Basic Research Program of China); China Social Science Fund; National Social Science Fund of China; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences project(Chinese Academy of Sciences)	TZ received the National Basic Research Program of China (2014CB744600), China Social Science Fund (Y8JJ183010), National Social Science Fund of China (16AZD058) and Key Research Program of the Chinese Academy of Sciences (no. ZDRW-XH-2019-4). HT received the Chinese Academy of Sciences project (CXJJ-16M119). The sponsor had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Agmon M, 2016, GAIT POSTURE, V49, P127, DOI 10.1016/j.gaitpost.2016.06.016; AYAKI M, 2014, INVEST OPHTH VIS SCI, V55; Ayaki M, 2013, REJUV RES, V16, P35, DOI 10.1089/rej.2012.1369; Behar J, 2013, PHYSIOL MEAS, V34, pR29, DOI 10.1088/0967-3334/34/7/R29; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chang C-Y, 2012, 2012 6 INT C PERV CO; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; de Zambotti M, 2015, SLEEP, V38, P1461, DOI 10.5665/sleep.4990; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Gautam A, 2015, COMM SYST NETW COMSN; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Gwosdek P, 2011, INT C SCAL SPAC VAR; Hennig T, 2017, SLEEP MED, V38, P58, DOI 10.1016/j.sleep.2017.07.009; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hori H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011055; Kanagasabai T, 2017, SLEEP HEALTH, V3, P195, DOI 10.1016/j.sleh.2017.03.006; Ko PRT, 2015, J CLIN SLEEP MED, V11, P1455, DOI 10.5664/jcsm.5288; Kramer RS, 2012, EVOLUTIONARY PSYCHOL, V10; Kumar GG, 2019, CIRCUITS SYSTEMS SIG, P1; Landry Glenn J, 2015, Front Aging Neurosci, V7, P166, DOI 10.3389/fnagi.2015.00166; Laposky AD, 2016, SLEEP MED, V18, P3, DOI 10.1016/j.sleep.2015.01.007; Li S, 2016, PEERJ, V4, DOI 10.7717/peerj.2364; Markwald RR, 2013, P NATL ACAD SCI USA, V110, P5695, DOI 10.1073/pnas.1216951110; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Matsumoto D, 2016, BODY POSTURES GAIT P; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mukaka MM, 2012, MALAWI MED J, V24, P69; Nixon MS, 2006, P IEEE, V94, P2013, DOI 10.1109/JPROC.2006.886018; O'Dowd S, 2017, J PARKINSON DIS, V7, P465, DOI 10.3233/JPD-161062; Sano A, 2015, 2015 IEEE 12TH INTERNATIONAL CONFERENCE ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS (BSN); Sathyanarayana A, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6562; Schneider M, 2017, INT J NUMER METH ENG, V109, P1461, DOI 10.1002/nme.5336; Sun BL, 2017, GAIT POSTURE, V58, P428, DOI 10.1016/j.gaitpost.2017.09.001; Van Loan C., 1992, COMPUTATIONAL FRAMEW; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Weisstein EW, 2015, FAST FOURIER TRANSFO; Zimmerman, 2014, P SIGCHI C HUM FACT	38	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223012	10.1371/journal.pone.0223012	http://dx.doi.org/10.1371/journal.pone.0223012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JC2ZY	31553783	gold, Green Published			2022-12-27	WOS:000489147400001
J	Liu, ZH; Wang, WY; Huang, TY; Wang, CF; Huang, Y; Tang, Y; Huang, J				Liu, Zehui; Wang, Wanyan; Huang, Tingyu; Wang, Cunfang; Huang, Ying; Tang, Yong; Huang, Jin			CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PEPTIDERGIC DRUG CEREBROLYSIN; OXIDATIVE STRESS; PATHOGENESIS; MEMANTINE; APOPTOSIS; ISCHEMIA; DAMAGE	Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and is the most common type of cognitive impairment and dementia. There is a pressing need to improve the clinical efficacy and quality of life for AD patients, as limited treatments options for AD patients have been developed until now. In this study, we aim to investigate the protective effect of CH(II), a cerebroprotein hydrolysate consisted of abundant biological peptides, on preclinical model of AD. We found that CH(II) treatment effectively protects oxygen glucose deprivation (OGD)-induced N2A cell viability impairment and cell apoptosis. In addition, CH (II) significantly reduces H2O2-induced ROS accumulation and exhibits the protective activities against H2O2-induced oxidative injury. Intriguingly, we found that CH(II) treatment can effectively promote neurite outgrowth of N2A cells. Moreover, CH(II) obviously improve the cognitive and memorial function in scopolamine-induced amnesia mice model. Taken together, this study provides evidences of the neuroprotective activities of CH(II) and offers a potential therapeutic strategy for AD patients.	[Liu, Zehui; Wang, Wanyan; Huang, Jin] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai, Peoples R China; [Huang, Tingyu; Wang, Cunfang] Guangdong Long Fu Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China; [Huang, Ying] Guangdong Inst Drug Control, Guangzhou, Guangdong, Peoples R China; [Tang, Yong] Guangxi Med Univ, Wuming Hosp, Dept Urol, Guangxi, Peoples R China	East China University of Science & Technology; Guangxi Medical University	Huang, J (corresponding author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai, Peoples R China.; Huang, Y (corresponding author), Guangdong Inst Drug Control, Guangzhou, Guangdong, Peoples R China.; Tang, Y (corresponding author), Guangxi Med Univ, Wuming Hosp, Dept Urol, Guangxi, Peoples R China.	huangying_gdidc@126.com; yong_tang_md@outlook.com; huangjin@ecust.edu.cn		Tang, Yong/0000-0001-9214-4412	National Natural Science Foundation of China [81773775]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) [CMEMR2017-B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University)	This study was supported by the National Natural Science Foundation of China (81773775), Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University, CMEMR2017-B01). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; Cerquera-Jaramillo MA, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2941783; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; An L, 2016, GENETICS MOL RES GMR, V15; Armstrong RA, 2006, FOLIA NEUROPATHOL, V44, P1; Bredesen E, 2006, CELL DEATH NERVOUS S; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; Cardenas A, 2010, J NEUROCHEM, V74, P2041; Cummings J, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0207-9; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Gutmann B, 2002, NEUROTOX RES, V4, P59, DOI 10.1080/10298420290007637; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Hyde C, 2013, AGE AGEING, V42, P14, DOI 10.1093/ageing/afs165; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Li XK, 2016, J MED CHEM, V59, P8326, DOI 10.1021/acs.jmedchem.6b00636; Liu XR, 2017, APOPTOSIS, V22, P639, DOI 10.1007/s10495-017-1349-3; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Olson Bradley J S C, 2007, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0304s48; Patterson C, 2018, WORLD ALZHEIMER REPO; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Qing S, 2015, CELLULAR PHYSL BIOCH, P37; Radogna F, 2016, ONCOGENE, V35, P3839, DOI 10.1038/onc.2015.455; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; SAFER DJ, 1971, BIOL PSYCHIAT, V3, P347; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sharma HS, 2016, NEURODEGENER DIS MAN, V6, P453, DOI 10.2217/nmt-2016-0037; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Takano T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00044-2; TAYLOR CP, 1995, J NEUROSCI METH, V59, P121, DOI 10.1016/0165-0270(94)00202-R; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xia Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0686-7; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhu XW, 2007, BBA-MOL BASIS DIS, V1772, P494, DOI 10.1016/j.bbadis.2006.10.014	46	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222757	10.1371/journal.pone.0222757	http://dx.doi.org/10.1371/journal.pone.0222757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545823	gold, Green Published			2022-12-27	WOS:000532303200032
J	Carey, M; Bryant, J; Zucca, A; Hall, A; Grady, A; Dilworth, S; Peek, K				Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie; Peek, Kerry			How well do cancer survivor self-classifications of anxiety, depression and stress agree with a standardised tool? Results of a cross-sectional study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; EMOTIONAL DISTRESS; RANDOMIZED-TRIAL; PATIENT; SCALES; IMPLEMENTATION; OUTCOMES; CARE	Background There is poor uptake of psychosocial interventions offered to people with cancer who record high scores on distress screening scales. Intervention uptake may be influenced by a mismatch between consumer (bottom-up) and professional (top-down) paradigms of wellbeing. The current research aims to compare cancer survivors' 'self-judgements' about their levels of anxiety, depression and stress, to classifications derived via a professional-driven measure, the Depression, Anxiety and Stress Scale (DASS-21). Methods A cross-sectional study was undertaken with haematological cancer survivors recruited from three population-based cancer registries in Australia. Consenting participants were mailed a questionnaire package; and non-responders received a second questionnaire package after 3-weeks and a reminder call after 6-weeks. The consumer-driven perspective was assessed via three separate single items asking survivors to self-classify their levels of anxiety, depression and stress over the past week on a scale from 'normal' to 'extremely severe'. The professional-driven classification was assessed via the DASS-21. Kappa statistics were used to assess agreement between consumer- and professional-driven measures. Results Of 2,971 eligible haematological cancer survivors, 1,239 (42%) provided written consent and were mailed a questionnaire package. Of these, 984 (79%) returned a completed questionnaire. The simple kappa for agreement between the DASS-21 and self-classified measures for anxiety was 0.47 (95% CI: 0.39 to 0.54, p<0.0001). The weighted kappa for agreement between the DASS-21 and self-classified measures of depression was 0.60 (95% CI: 0.53 to 0.67, p<0.0001) and for measures of stress was 0.51 (95% CI: 0.44 to 0.59, p<0.0001). Conclusions Moderate agreement between self-classification and professional-driven assessments was found. The value of screening is predicated on the assumption that those with identified needs will be offered and take up services that will benefit them. Our results suggest that to improve the utility of distress screening it may be important to include assessment of survivor views about their symptoms.	[Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Dilworth, Sophie] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Hlth Behav Res Collaborat, Callaghan, NSW, Australia; [Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie; Peek, Kerry] Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW, Australia; [Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Grady, Alice] Populat Hlth, Hunter New England Local Hlth Dist, Wallsend, NSW, Australia; [Dilworth, Sophie] Community Aged Care Serv, Hunter New England Local Hlth Dist, Wallsend, NSW, Australia; [Peek, Kerry] Univ Sydney, Discipline Physiotherapy, Cumberland Campus, Lidcombe, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Sydney	Carey, M (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Hlth Behav Res Collaborat, Callaghan, NSW, Australia.; Carey, M (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW, Australia.; Carey, M (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW, Australia.	Mariko.Carey@newcastle.edu.au	HALL, ALIX/AAX-8626-2021; CAREY, MARIKO/ABC-2842-2021; Peek, Kerry/R-7885-2019; Bryant, Jamie/G-8000-2013	HALL, ALIX/0000-0002-1043-6110; CAREY, MARIKO/0000-0002-0549-1115; Peek, Kerry/0000-0002-2194-3353; Bryant, Jamie/0000-0001-9378-5852; Dilworth, Sophie/0000-0002-3023-8074	Priority-driven Collaborative Cancer Research Scheme [569290]; Cancer Council NSW [CSR 11-02]; University of Newcastle; Hunter Medical Research Institute; NHMRC Boosting Dementia Leadership Fellowship [APP1136168]; NHMRC-ARC Dementia Research Development Fellowship [APP1105809]; beyond blue; Australian Government through Cancer Australia	Priority-driven Collaborative Cancer Research Scheme; Cancer Council NSW(Cancer Council New South Wales); University of Newcastle; Hunter Medical Research Institute; NHMRC Boosting Dementia Leadership Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC-ARC Dementia Research Development Fellowship(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); beyond blue; Australian Government through Cancer Australia(Australian Government)	This grant No. 569290 was awarded through the Priority-driven Collaborative Cancer Research Scheme and co-funded by beyond blue and the Australian Government through Cancer Australia (https://canceraustralia.gov.au/). It also received funding support from a Strategic Research Partnership Grant (CSR 11-02) from Cancer Council NSW (https://www.cancercouncil.com.au/research/) to the Newcastle Cancer Control Collaborative (New-3C), and infrastructure funding from the University of Newcastle (https://www.newcastle.edu.au/) and Hunter Medical Research Institute (https://hmri.org.au/).A/Prof Mariko Carey is supported by a NHMRC Boosting Dementia Leadership Fellowship (APP1136168; https://nhmrc.gov.au/) and Dr. Jamie Bryant is supported by an NHMRC-ARC Dementia Research Development Fellowship (APP1105809; https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; Clover KA, 2015, PSYCHO-ONCOLOGY, V24, P812, DOI 10.1002/pon.3729; Denlinger CS, 2014, J NATL COMPR CANC NE, V12, P34, DOI 10.6004/jnccn.2014.0005; Dilworth S, 2014, PSYCHO-ONCOLOGY, V23, P601, DOI 10.1002/pon.3474; Faller H, 2016, J PSYCHOSOM RES, V81, P24, DOI 10.1016/j.jpsychores.2015.12.004; Hall AE, 2016, SUPPORT CARE CANCER, V24, P4413, DOI 10.1007/s00520-016-3282-3; Hammond CTC, 2008, FERTIL STERIL, V90, P1256, DOI 10.1016/j.fertnstert.2007.08.081; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mackenzie LJ, 2014, ANN ONCOL, V25, P889, DOI 10.1093/annonc/mdu023; Maunsell E, 1996, J CLIN ONCOL, V14, P2747, DOI 10.1200/JCO.1996.14.10.2747; McLachlan SA, 2001, J CLIN ONCOL, V19, P4117, DOI 10.1200/JCO.2001.19.21.4117; Meijer A, 2013, J PSYCHOSOM RES, V75, P1, DOI 10.1016/j.jpsychores.2013.01.012; Mitchell AJ, 2013, ACTA ONCOL, V52, P216, DOI 10.3109/0284186X.2012.745949; Myer Rod, 2000, LIVING DREAM STORY V, P77; Paul C, 2013, EUR J CANCER CARE, V22, P281, DOI 10.1111/ecc.12048; Salmon P, 2015, PSYCHO-ONCOLOGY, V24, P262, DOI 10.1002/pon.3640; Smith T, 2007, CANCER-AM CANCER SOC, V109, P1, DOI 10.1002/cncr.22387; Teunissen SCCM, 2007, PALLIATIVE MED, V21, P341, DOI 10.1177/0269216307079067; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; Turon H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210111	23	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222107	10.1371/journal.pone.0222107	http://dx.doi.org/10.1371/journal.pone.0222107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539386	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900007
J	Bradley, PW; Brawner, MD; Raffel, TR; Rohr, JR; Olson, DH; Blaustein, AR				Bradley, Paul W.; Brawner, Michael D.; Raffel, Thomas R.; Rohr, Jason R.; Olson, Deanna H.; Blaustein, Andrew R.			Shifts in temperature influence how Batrachochytrium dendrobatidis infects amphibian larvae	PLOS ONE			English	Article							FUNGAL PATHOGEN; HOST SUSCEPTIBILITY; CLIMATE-CHANGE; DISEASE; CHYTRIDIOMYCOSIS; EXTINCTION; MORTALITY; DECLINES; EXTREME; TRANSMISSION	Many climate change models predict increases in frequency and magnitude of temperature fluctuations that might impact how ectotherms are affected by disease. Shifts in temperature might especially affect amphibians, a group with populations that have been challenged by several pathogens. Because amphibian hosts invest more in immunity at warmer than cooler temperatures and parasites might acclimate to temperature shifts faster than hosts (creating lags in optimal host immunity), researchers have hypothesized that a temperature shift from cold-to-warm might result in increased amphibian sensitivity to pathogens, whereas a shift from warm-to-cold might result in decreased sensitivity. Support for components of this climate-variability based hypothesis have been provided by prior studies of the fungus Batrachochytrium dendrobatidis (Bd) that causes the disease chytridiomycosis in amphibians. We experimentally tested whether temperature shifts before exposure to Batrachochytrium dendrobatidis (Bd) alters susceptibility to the disease chytridiomycosis in the larval stage of two amphibian species-western toads (Anaxyrus boreas) and northern red legged frogs (Rana aurora). Both host species harbored elevated Bd infection intensities under constant cold (15 degrees C) temperature in comparison to constant warm (20 degrees C) temperature. Additionally, both species experienced an increase in Bd infection abundance after shifted from 15 degrees C to 20 degrees C, compared to a constant 20 degrees C but they experienced a decrease in Bd after shifted from 20 degrees C to 15 degrees C, compared to a constant 15 degrees C. These results are in contrast to prior studies of adult amphibians highlighting the potential for species and stage differences in the temperature-dependence of chytridiomycosis.	[Bradley, Paul W.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA; [Brawner, Michael D.; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Raffel, Thomas R.] Oakland Univ, Dept Biol, Rochester, MI 48063 USA; [Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [Olson, Deanna H.] ARS, USDA, Pacific Northwest Res Stn, Corvallis, OR USA; [Bradley, Paul W.] Univ San Diego, Dept Biol, San Diego, CA 92110 USA	Oregon State University; Oregon State University; Oakland University; State University System of Florida; University of South Florida; United States Department of Agriculture (USDA); University of San Diego	Bradley, PW (corresponding author), Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA.; Bradley, PW (corresponding author), Univ San Diego, Dept Biol, San Diego, CA 92110 USA.	paulwilliambradley@gmail.com	Rohr, Jason R./AAJ-5856-2021	Bradley, Paul/0000-0002-4428-5744	National Science Foundation [EF1241889]; National Institutes of Health [R01GM109499, R01TW010286]; U.S. Department of Agriculture [NRI 2006-01370, 200935102-0543]; U.S. Environmental Protection Agency [CAREER 83518801]; NSF [IOS 1121529, 1651888]; U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon; FOGARTY INTERNATIONAL CENTER [R01TW010286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon(United States Department of Agriculture (USDA)United States Forest Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Science Foundation (EF1241889), National Institutes of Health (R01GM109499, R01TW010286), U.S. Department of Agriculture (NRI 2006-01370, 200935102-0543), and U.S. Environmental Protection Agency (CAREER 83518801) to JRR and NSF grants IOS 1121529 and 1651888 to TRR. Support was provided by the U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon to DHO. No sponsor nor funder played any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Bancroft BA, 2008, BEHAV ECOL, V19, P879, DOI 10.1093/beheco/arn044; Bannerman JA, 2014, OIKOS, V123, P89, DOI 10.1111/j.1600-0706.2013.00686.x; BEISWENGER RE, 1978, J HERPETOL, V12, P499, DOI 10.2307/1563355; Ben-Horin T, 2013, ECOLOGY, V94, P161, DOI 10.1890/11-2257.1; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein Andrew R., 2010, Diversity, V2, P281; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buck JC, 2012, FRESHWATER BIOL, V57, P61, DOI 10.1111/j.1365-2427.2011.02695.x; Cohen JM, 2017, ECOL LETT, V20, P184, DOI 10.1111/ele.12720; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gervasi SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167882; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Horton RM, 2016, CURR CLIM CHANGE REP, V2, P242, DOI 10.1007/s40641-016-0042-x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Karlstrom EL, 1962, TOAD GENUS BUFO SIER; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Li YM, 2013, INTEGR ZOOL, V8, P145, DOI 10.1111/1749-4877.12001; Liu X, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2506; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McMahon TA, 2015, ECOHEALTH, V12, P188, DOI 10.1007/s10393-014-0989-9; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot022; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rummukainen M, 2012, WIRES CLIM CHANGE, V3, P115, DOI 10.1002/wcc.160; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Teskey R, 2015, PLANT CELL ENVIRON, V38, P1699, DOI 10.1111/pce.12417; Utltsch GR, TADPOLES BIOL ANURAN; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Voyles J, 2017, OECOLOGIA, V184, P363, DOI 10.1007/s00442-017-3866-8; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746	63	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222237	10.1371/journal.pone.0222237	http://dx.doi.org/10.1371/journal.pone.0222237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536533	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800031
J	Yang, E; Mundy, C; Rappaport, EF; Pacifici, M; Billings, PC				Yang, Evan; Mundy, Christina; Rappaport, Eric F.; Pacifici, Maurizio; Billings, Paul C.			Identification and characterization of a novel heparan sulfate-binding domain in Activin A longest variants and implications for function	PLOS ONE			English	Article							SKELETAL DEVELOPMENT; STRUCTURAL BASIS; INHIBIN; PROTEIN; GROWTH; RECEPTOR; FOLLISTATIN; INSIGHTS; RANGE; BETA	Activins regulate numerous processes including inflammation and are synthesized as precursors consisting of a long N-terminal pro-region and a mature protein. Genomic human databases currently list three activin A (Act A) variants termed X1, X2 and X3. The X3 variant is the shortest, lacks N-terminal segments present in X1 and X2, and has been the focus of most past literature. Here, we asked whether these variants are expressed by human cells and tissues and what structural features are contained within their pro-regions. Human monocytic-like cells THP1 and U937 expressed X1 and X2 variants after exposure to phorbol ester or granulocyte-macrophage colony-stimulating factor, while X2 transcripts were present in placenta. Expression vectors encoding full length X2 or X3 variants resulted in production and secretion of biologically active Act A from cultured cells. Previous studies reported a putative HS-binding domain (HBD) in the X3 pro-region. Here, we identified a novel HBD with consensus HS-binding motifs near the N-terminal end of X1 and X2 proregions. Peptides encompassing this new domain interacted with substrate-bound HS with nanomolar affinity, while peptides from putative X3 HBD did not. In good agreement, full length X2 pro-region interacted with heparin-agarose, while the X3 pro-region did not. In sum, our study reveals that Act A variants are expressed by inflammatory cells and placenta and yield biological activity. The high affinity HBD in X1 and X2 pro-region and its absence in X3 could greatly influence overall Act A distribution, availability and activity in physiological and pathological circumstances.	[Yang, Evan; Mundy, Christina; Pacifici, Maurizio; Billings, Paul C.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Rappaport, Eric F.] Childrens Hosp Philadelphia, Mol Genet Core, Philadelphia, PA 19104 USA; [Yang, Evan] Harvard Med Sch, Grad Program Biol & Biomed Sci BBS, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard Medical School	Billings, PC (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA.	BillingsP@email.chop.edu	Rappaport, Eric/GRO-4051-2022		Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health [RO1AR061758, RO1AR071946]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071946, R01AR061758] Funding Source: NIH RePORTER	Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants RO1AR061758 and RO1AR071946 to MP from the Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health.	Abe M, 2002, J LEUKOCYTE BIOL, V72, P347; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BARTON DE, 1989, GENOMICS, V5, P91, DOI 10.1016/0888-7543(89)90091-8; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Farokhzad OC, 2000, NUCLEIC ACIDS RES, V28, P2256, DOI 10.1093/nar/28.11.2256; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hagemann AI, 2009, DEVELOPMENT, V136, P2803, DOI 10.1242/dev.034124; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Johnson KE, 2016, MOL CELL ENDOCRINOL, V422, P84, DOI 10.1016/j.mce.2015.12.007; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Khachigian LM, 2004, CARDIOVASC DRUG REV, V22, P1; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MAYO KE, 1994, TRENDS ENDOCRIN MET, V5, P407, DOI 10.1016/1043-2760(95)92523-L; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Mundy C, 2018, J BIOL CHEM, V293, P7703, DOI 10.1074/jbc.RA117.000264; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Pacifici M, 2016, CYTOKINE GROWTH F R, V27, P93, DOI 10.1016/j.cytogfr.2015.12.007; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schultz V, 2017, J BIOL CHEM, V292, P2495, DOI 10.1074/jbc.M116.761585; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; STEWART AG, 1986, FEBS LETT, V206, P329, DOI 10.1016/0014-5793(86)81006-7; SUGINO K, 1993, J BIOL CHEM, V268, P15579; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Walton KL, 2012, MOL CELL ENDOCRINOL, V359, P2, DOI 10.1016/j.mce.2011.06.030; Wang XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12052; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yu J, 1996, IMMUNOLOGY, V88, P368, DOI 10.1046/j.1365-2567.1996.d01-675.x	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222784	10.1371/journal.pone.0222784	http://dx.doi.org/10.1371/journal.pone.0222784			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536599	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800085
J	Alger, SA; Burnham, PA; Brody, AK				Alger, Samantha A.; Burnham, P. Alexander; Brody, Alison K.			Flowers as viral hot spots: Honey bees (Apis mellifera) unevenly deposit viruses across plant species	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; TRANSMISSION; PATHOGEN; BUMBLEBEES; DIVERSITY; INFECTION; IMMUNITY; IMPACTS; THREAT; L.	RNA viruses, once considered specific to honey bees, are suspected of spilling over from managed bees into wild pollinators; however, transmission routes are largely unknown. A widely accepted yet untested hypothesis states that flowers serve as bridges in the transmission of viruses between bees. Here, using a series of controlled experiments with captive bee colonies, we examined the role of flowers in bee virus transmission. We first examined if honey bees deposit viruses on flowers and whether bumble bees become infected after visiting contaminated flowers. We then examined whether plant species differ in their propensity to harbor viruses and if bee visitation rates increase the likelihood of virus deposition on flowers. Our experiment demonstrated, for the first time, that honey bees deposit viruses on flowers. However, the two viruses we examined, black queen cell virus (BQCV) and deformed wing virus (DWV), were not equally distributed across plant species, suggesting that differences in floral traits, virus ecology and/or foraging behavior may mediate the likelihood of deposition. Bumble bees did not become infected after visiting flowers previously visited by honey bees suggesting that transmission via flowers may be a rare occurrence and contingent on multiplicative factors and probabilities such as infectivity of virus strain across bee species, immunocompetence, virus virulence, virus load, and the probability a bumble bee will contact a virus particle on a flower. Our study is among the first to experimentally examine the role of flowers in bee virus transmission and uncovers promising avenues for future research.	[Alger, Samantha A.; Burnham, P. Alexander; Brody, Alison K.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont	Alger, SA (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	salger@uvm.edu		Alger, Samantha/0000-0001-7787-1312	Northeast Sustainable Agriculture Research and Education (SARE) [GNE15-094]; National Science Foundation Graduate Research Fellowship [DGE-1451866]; Switzer Foundation Switzer Environmental Fellowship	Northeast Sustainable Agriculture Research and Education (SARE); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Switzer Foundation Switzer Environmental Fellowship	Funding was provided by a graduate student grant to SAA from Northeast Sustainable Agriculture Research and Education (SARE) (GNE15-094; https://www.nesare.org/), a National Science Foundation Graduate Research Fellowship (DGE-1451866; https://www.nsfgrfp.org/) to SAA, and a Switzer Foundation Switzer Environmental Fellowship to SAA (https://www.switzernetwork.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Joseph Schall and Elizabeth Whalen for their assistance in the laboratory; Humberto Boncristiani for his advice with experimental design; Sara Helms Cahan, Taylor Ricketts, and Joseph Schall for editorial comments on the manuscript. Funding was provided by a graduate student grant from Northeast Sustainable Agriculture Research and Education (SARE) (GNE15-094), a National Science Foundation Graduate Research Fellowship (DGE-1451866), and a Switzer Foundation Switzer Environmental Fellowship.	Adler LS, 2018, ECOLOGY, V99, P2535, DOI 10.1002/ecy.2503; Alger SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217822; Andres A, 2009, J NUTR BIOCHEM, V20, P563, DOI 10.1016/j.jnutbio.2009.04.004; Annoscia D, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Arenas A, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-019-2644-5; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Braman SK, 2018, ENVIRON ENTOMOL, V47, P1203, DOI 10.1093/ee/nvy117; CHANG CF, 1969, AGR BIOL CHEM TOKYO, V33, P398, DOI 10.1080/00021369.1969.10859325; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Hernandez IG, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.189910; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graham James M, 2000, ANN M SW ED RES ASS; Graystock P, 2016, INT J PARASITOL-PAR, V5, P64, DOI 10.1016/j.ijppaw.2015.10.001; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Melathopoulos A, 2017, J INVERTEBR PATHOL, V146, P24, DOI 10.1016/j.jip.2017.04.003; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Portlas ZM, 2018, PLANT GENET RESOUR-C, V16, P498, DOI [10.1017/S1479262118000072, 10.1017/s1479262118000072]; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purkiss T, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1071; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Richardson LL, 2016, ECOLOGY, V97, P325, DOI 10.1890/15-0263.1; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	49	29	30	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221800	10.1371/journal.pone.0221800	http://dx.doi.org/10.1371/journal.pone.0221800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532764	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600011
J	Tangedal, S; Nielsen, R; Aanerud, M; Persson, LJ; Wiker, HG; Bakke, PS; Hiemstra, PS; Eagan, TM				Tangedal, Solveig; Nielsen, Rune; Aanerud, Marianne; Persson, Louise J.; Wiker, Harald G.; Bakke, Per S.; Hiemstra, Pieter S.; Eagan, Tomas M.			Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients	PLOS ONE			English	Article							LUNG MICROBIOME; BACTERIAL; DYNAMICS	Background Exacerbations of chronic obstructive pulmonary disease (COPD) are debilitating events and spur disease progression. Infectious causes are frequent; however, it is unknown to what extent exacerbations are caused by larger shifts in the airways' microbiota. The aim of the current study was to analyse the changes in microbial composition between stable state and during exacerbations, and the corresponding immune response. Methods The study sample included 36 COPD patients examined at stable state and exacerbation from the Bergen COPD Cohort and Exacerbations studies, and one patient who delivered sputum on 13 different occasions during the three-year study period. A physician examined the patients at all time points, and sputum induction was performed by stringent protocol. Only induced sputum samples were used in the current study, not spontaneously expectorated sputum. Sputum inflammatory markers (IL-6, IL-8, IL-18, IP-10, MIG, TNF-alpha) and antimicrobial peptides (AMPs, i.e. LL-37/hCAP-18, SLPI) were measured in supernatants, whereas target gene sequencing (16S rRNA) was performed on corresponding cell pellets. The microbiome bioinformatics platform QIIME2 (TM) and the statistics environment R were applied for bioinformatics analyses. Results Levels of IP-10, MIG, TNF-alpha and AMPs were significantly different between the two disease states. Of 36 sample pairs, 24 had significant differences in the 12 most abundant genera between disease states. The diversity was significantly different in several individuals, but not when data was analysed on a group level. The one patient case study showed longitudinal dynamics in microbiota unrelated to disease state. Conclusion Changes in the sputum microbiota with changing COPD disease states are common, and are accompanied by changes in inflammatory markers. However, the changes are highly individual and heterogeneous events.	[Tangedal, Solveig; Nielsen, Rune; Wiker, Harald G.; Bakke, Per S.; Eagan, Tomas M.] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway; [Tangedal, Solveig; Nielsen, Rune; Aanerud, Marianne; Persson, Louise J.; Eagan, Tomas M.] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Hiemstra, Pieter S.] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands; [Wiker, Harald G.] Haukeland Hosp, Dept Microbiol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; Haukeland University Hospital	Tangedal, S (corresponding author), Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway.; Tangedal, S (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.	stangedal@gmail.com	Eagan, Tomas ML/P-3554-2014; Eagan, Tomas Mikal/AHC-9127-2022; Nielsen, Rune/O-3131-2016	Eagan, Tomas ML/0000-0001-8725-9960; Nielsen, Rune/0000-0003-2799-0430; Tangedal, Solveig/0000-0001-8060-5306; Wiker, Harald Gotten/0000-0001-9452-243X	Centre for Clinical Research, Haukeland University Hospital; Bergen Medical Research Foundation	Centre for Clinical Research, Haukeland University Hospital; Bergen Medical Research Foundation	The Bergen COPD cohort study was supported by the Centre for Clinical Research, Haukeland University Hospital. Cost of analyses for the Luminex analyses was provided from a personal grant from the Bergen Medical Research Foundation to T. E in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Bolyen E., 2018, PEERJ PREPR, DOI [10.7287/peerj.preprints.27295v2, DOI 10.7287/PEERJ.PREPRINTS.27295V2, 10.7287/peerj.preprints.27295v1]; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caramori G, 2018, CHEST, V153, P1424, DOI 10.1016/j.chest.2017.10.033; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Fenwick PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128757; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2018, GLOBAL STRATEGY DIAG; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Gronseth Rune, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00019-2017; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Husebo GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109721; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mayhew D, 2018, THORAX, V73, P422, DOI 10.1136/thoraxjnl-2017-210408; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Oksanen J., 2018, R PACKAGE VERSION, V2, P4; Persson LJP, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01328-2016; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Su YC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02530; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Tangedal S, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0645-3; Tangedal S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0138-6; Tjabringa GS, 2005, FEMS IMMUNOL MED MIC, V45, P151, DOI 10.1016/j.femsim.2005.03.004; Tufvesson E, 2015, INT J CHRONIC OBSTR, V10, P881, DOI 10.2147/COPD.S78748; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	37	15	15	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222449	10.1371/journal.pone.0222449	http://dx.doi.org/10.1371/journal.pone.0222449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527888	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400022
J	Folberth, C; Elliott, J; Muller, C; Balkovic, J; Chryssanthacopoulos, J; Izaurralde, RC; Jones, CD; Khabarov, N; Liu, WF; Reddy, A; Schmid, E; Skalsky, R; Yang, H; Arneth, A; Ciais, P; Deryng, D; Lawrence, PJ; Olin, S; Pugh, TAM; Ruane, AC; Wang, XH				Folberth, Christian; Elliott, Joshua; Mueller, Christoph; Balkovic, Juraj; Chryssanthacopoulos, James; Izaurralde, Roberto C.; Jones, Curtis D.; Khabarov, Nikolay; Liu, Wenfeng; Reddy, Ashwan; Schmid, Erwin; Skalsky, Rastislav; Yang, Hong; Arneth, Almut; Ciais, Philippe; Deryng, Delphine; Lawrence, Peter J.; Olin, Stefan; Pugh, Thomas A. M.; Ruane, Alex C.; Wang, Xuhui			Parameterization-induced uncertainties and impacts of crop management harmonization in a global gridded crop model ensemble	PLOS ONE			English	Article							CLIMATE-CHANGE; PEDOTRANSFER FUNCTIONS; TILLAGE PRACTICES; WHEAT PRODUCTION; DATA RESOLUTION; YIELD GROWTH; EPIC MODEL; WATER; PRODUCTIVITY; MAIZE	Global gridded crop models (GGCMs) combine agronomic or plant growth models with gridded spatial input data to estimate spatially explicit crop yields and agricultural externalities at the global scale. Differences in GGCM outputs arise from the use of different biophysical models, setups, and input data. GGCM ensembles are frequently employed to bracket uncertainties in impact studies without investigating the causes of divergence in outputs. This study explores differences in maize yield estimates from five GGCMs based on the public domain field-scale model Environmental Policy Integrated Climate (EPIC) that participate in the AgMIP Global Gridded Crop Model Intercomparison initiative. Albeit using the same crop model, the GGCMs differ in model version, input data, management assumptions, parameterization, and selection of subroutines affecting crop yield estimates via cultivar distributions, soil attributes, and hydrology among others. The analyses reveal interannual yield variability and absolute yield levels in the EPIC-based GGCMs to be highly sensitive to soil parameterization and crop management. All GGCMs show an intermediate performance in reproducing reported yields with a higher skill if a static soil profile is assumed or sufficient plant nutrients are supplied. An in-depth comparison of setup domains for two EPIC-based GGCMs shows that GGCM performance and plant stress responses depend substantially on soil parameters and soil process parameterization, i.e. hydrology and nutrient turnover, indicating that these often neglected domains deserve more scrutiny. For agricultural impact assessments, employing a GGCM ensemble with its widely varying assumptions in setups appears the best solution for coping with uncertainties from lack of comprehensive global data on crop management, cultivar distributions and coefficients for agro-environmental processes. However, the underlying assumptions require systematic specifications to cover representative agricultural systems and environmental conditions. Furthermore, the interlinkage of parameter sensitivity from various domains such as soil parameters, nutrient turnover coefficients, and cultivar specifications highlights that global sensitivity analyses and calibration need to be performed in an integrated manner to avoid bias resulting from disregarded core model domains. Finally, relating evaluations of the EPIC-based GGCMs to a wider ensemble based on individual core models shows that structural differences outweigh in general differences in configurations of GGCMs based on the same model, and that the ensemble mean gains higher skill from the inclusion of structurally different GGCMs. Although the members of the wider ensemble herein do not consider crop-soil-management interactions, their sensitivity to nutrient supply indicates that findings for the EPIC-based sub-ensemble will likely become relevant for other GGCMs with the progressing inclusion of such processes.	[Folberth, Christian; Balkovic, Juraj; Khabarov, Nikolay; Skalsky, Rastislav] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, Laxenburg, Austria; [Elliott, Joshua] Univ Chicago, Chicago, IL 60637 USA; [Elliott, Joshua] ANL Computat Inst, Chicago, IL USA; [Elliott, Joshua; Chryssanthacopoulos, James; Ruane, Alex C.] Columbia Univ, Ctr Climate Syst Res, New York, NY USA; [Elliott, Joshua; Chryssanthacopoulos, James; Ruane, Alex C.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Mueller, Christoph] Leibniz Assoc, Potsdam Inst Climate Impact Res, Potsdam, Germany; [Balkovic, Juraj] Comenius Univ, Dept Soil Sci, Bratislava, Slovakia; [Izaurralde, Roberto C.; Jones, Curtis D.; Reddy, Ashwan] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Izaurralde, Roberto C.; Yang, Hong] Texas A&M Univ, Texas AgriLife Res & Extens, Temple, TX USA; [Liu, Wenfeng] Eawag, Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland; [Schmid, Erwin] Univ Nat Resources & Life Sci, Inst Sustainable Econ Dev, Vienna, Austria; [Skalsky, Rastislav] Natl Agr & Food Ctr, Soil Sci & Conservat Res Inst, Bratislava, Slovakia; [Yang, Hong] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Arneth, Almut] Karlsruhe Inst Technol, IMK IFU, Garmisch Partenkirchen, Germany; [Ciais, Philippe; Wang, Xuhui] Lab Sci Climat & Environm, Gif Sur Yvette, France; [Deryng, Delphine] Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany; [Deryng, Delphine] Humboldt Univ, IRI THESys, Berlin, Germany; [Lawrence, Peter J.] Natl Ctr Atmospher Res, Earth Syst Lab, POB 3000, Boulder, CO 80307 USA; [Olin, Stefan] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Pugh, Thomas A. M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Pugh, Thomas A. M.] Univ Birmingham, Birmingham Inst Forest Res, Birmingham, W Midlands, England; [Wang, Xuhui] Peking Univ, Sino French Inst Earth Syst Sci, Beijing, Peoples R China	International Institute for Applied Systems Analysis (IIASA); University of Chicago; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Potsdam Institut fur Klimafolgenforschung; Comenius University Bratislava; University System of Maryland; University of Maryland College Park; Texas A&M University System; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Natural Resources & Life Sciences, Vienna; Slovak Agricultural Research Center; University of Basel; Helmholtz Association; Karlsruhe Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Humboldt University of Berlin; National Center Atmospheric Research (NCAR) - USA; Lund University; University of Birmingham; University of Birmingham; Peking University	Folberth, C (corresponding author), Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, Laxenburg, Austria.	folberth@iiasa.ac.at	Pugh, Thomas A M/A-3790-2010; Izaurralde, Roberto César/E-5257-2019; Deryng, Delphine/AAN-8899-2021; Müller, Christoph/E-4812-2016; Liu, Wenfeng/D-3715-2017; wang, xuhui/H-8605-2019; Ciais, Philippe/A-6840-2011; Deryng, Delphine/AAN-6255-2020; Schmid, Erwin/Z-1946-2019; Arneth, Almut/B-2702-2013; Ruane, Alex/ABD-5612-2021	Pugh, Thomas A M/0000-0002-6242-7371; Müller, Christoph/0000-0002-9491-3550; Liu, Wenfeng/0000-0002-8699-3677; wang, xuhui/0000-0003-0818-9816; Ciais, Philippe/0000-0001-8560-4943; Deryng, Delphine/0000-0001-6214-7241; Schmid, Erwin/0000-0003-4783-9666; Arneth, Almut/0000-0001-6616-0822; Skalsky, Rastislav/0000-0002-0983-6897; Izaurralde, Roberto/0000-0002-8797-9500; Folberth, Christian/0000-0002-6738-5238; Balkovic, Juraj/0000-0003-2955-4931	European Commission's 7th Framework Programme [603542]; European Research Council [ERC-2013-SynG610028]; MACMIT project through the German Federal Ministry of Education and Research (BMBF) [01LN1317A]; Swiss National Science Foundation [P2EZP2_175096]; UncertProp project by Austrian Climate and Energy Fund within the Austrian Climate Research Programme [KR16AC0K13332]	European Commission's 7th Framework Programme(European Commission); European Research Council(European Research Council (ERC)European Commission); MACMIT project through the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UncertProp project by Austrian Climate and Energy Fund within the Austrian Climate Research Programme	AA and TAMP were funded by the European Commission's 7th Framework Programme, under Grant Agreement number 603542 (LUC4C, https://ec.europa.eu).CF, JB, NK, and RS were supported by the European Research Council Synergy Grant number ERC-2013-SynG610028 (IMBALANCE-P, https://ec.europa.eu).CM acknowledges financial support from the MACMIT project (01LN1317A) funded through the German Federal Ministry of Education and Research (BMBF, https://www.bmbf.de).WL was supported by the funding from the Early Postdoctoral Mobility Fellowship awarded by the Swiss National Science Foundation (P2EZP2_175096, http://www.snf.ch/).ES acknowledges financial support from the UncertProp project (KR16AC0K13332) funded by the Austrian Climate and Energy Fund within the Austrian Climate Research Programme (https://www.klimafonds.gv.at).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo C, 2014, EUR J AGRON, V61, P35, DOI 10.1016/j.eja.2014.07.005; [Anonymous], 2008, GEO BENE GLOBAL DATA; [Anonymous], 2016, ADV ANIMAL BIOSCI, DOI DOI 10.1017/S2040470016000297; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/NCLIMATE1916, 10.1038/nclimate1916]; Balkovic J, 2018, EARTHS FUTURE, V6, P373, DOI 10.1002/2017EF000629; Balkovic J, 2014, GLOBAL PLANET CHANGE, V122, P107, DOI 10.1016/j.gloplacha.2014.08.010; Balkovic J, 2013, AGR SYST, V120, P61, DOI 10.1016/j.agsy.2013.05.008; Baroni G, 2010, HYDROL EARTH SYST SC, V14, P251, DOI 10.5194/hess-14-251-2010; Basso B, 2018, AGR ENV LETT, V3, DOI 10.2134/ael2018.05.0026; Basso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127333; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Batjes NH., 2006, 200602 ISRIC WISE DE; Blanc E, 2017, AGR FOREST METEOROL, V236, P145, DOI 10.1016/j.agrformet.2016.12.022; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Deryng D, 2016, NAT CLIM CHANGE, V6, P786, DOI [10.1038/NCLIMATE2995, 10.1038/nclimate2995]; Elliott J., 2015, GEOSCI MODEL DEV, V8, P261, DOI [10.5194/gmd-8-261-2015, DOI 10.5194/gmd-8-261-2015, DOI 10.5194/GMD-8-261-2015]; Elliott J, 2014, ENVIRON MODELL SOFTW, V62, P509, DOI 10.1016/j.envsoft.2014.04.008; Elliott J, 2014, P NATL ACAD SCI USA, V111, P3239, DOI 10.1073/pnas.1222474110; Ewert F, 2011, AGR ECOSYST ENVIRON, V142, P6, DOI 10.1016/j.agee.2011.05.016; Fader M, 2010, J HYDROL, V384, P218, DOI 10.1016/j.jhydrol.2009.12.011; FAO F, 1995, DIG SOIL MAP WORLD; Folberth C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11872; Folberth C, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/4/044004; Folberth C, 2013, AGR SYST, V119, P22, DOI 10.1016/j.agsy.2013.04.002; Folberth C, 2012, ECOL MODEL, V235, P8, DOI 10.1016/j.ecolmodel.2012.03.035; Folberth C, 2012, AGR ECOSYST ENVIRON, V151, P21, DOI 10.1016/j.agee.2012.01.026; Frieler K, 2017, EARTHS FUTURE, V5, P605, DOI 10.1002/2016EF000525; Gaiser T, 2010, AGR ECOSYST ENVIRON, V135, P318, DOI 10.1016/j.agee.2009.10.014; Gassman P.W., 2004, 2004 ASAE ANN M AM S, P1; Gavilan P, 2006, AGR WATER MANAGE, V81, P257, DOI 10.1016/j.agwat.2005.05.001; Gbegbelegbe S, 2017, FIELD CROP RES, V202, P122, DOI 10.1016/j.fcr.2016.06.010; Gerik T., 2014, ENV POLICY INTEGRATE; Givi J, 2004, AGR WATER MANAGE, V70, P83, DOI 10.1016/j.agwat.2004.06.009; Goll DS, 2017, GEOSCI MODEL DEV, V26; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Hartkamp A., 2001, MAIZE PRODUCTION ENV; Havlik P, 2011, ENERG POLICY, V39, P5690, DOI 10.1016/j.enpol.2010.03.030; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hively WD, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101657; Hoffmann H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151782; Holzworth DP, 2014, ENVIRON MODELL SOFTW, V62, P327, DOI 10.1016/j.envsoft.2014.07.009; Iizumi T, 2009, AGR FOREST METEOROL, V149, P333, DOI 10.1016/j.agrformet.2008.08.015; Izaurralde RC, 2012, MANAGING AGRICULTURAL GREENHOUSE GASES: COORDINATED AGRICULTURAL RESEARCH THROUGH GRACENET TO ADDRESS OUR CHANGING CLIMATE, P293, DOI 10.1016/B978-0-12-386897-8.00017-6; Izaurralde RC, 2006, ECOL MODEL, V192, P362, DOI 10.1016/j.ecolmodel.2005.07.010; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; KINIRY JR, 1995, CAN J PLANT SCI, V75, P679, DOI 10.4141/cjps95-114; Leng GY, 2017, SCI TOTAL ENVIRON, V607, P683, DOI 10.1016/j.scitotenv.2017.07.017; Liu JG, 2007, AGR SYST, V94, P478, DOI 10.1016/j.agsy.2006.11.019; Liu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057750; Liu JG, 2009, ENVIRON MODELL SOFTW, V24, P411, DOI 10.1016/j.envsoft.2008.08.004; Liu WF, 2018, GLOBAL BIOGEOCHEM CY, V32, P1074, DOI 10.1029/2017GB005849; Liu WF, 2016, SCI TOTAL ENVIRON, V572, P526, DOI 10.1016/j.scitotenv.2016.08.093; Liu WF, 2016, AGR FOREST METEOROL, V221, P164, DOI 10.1016/j.agrformet.2016.02.017; Lutz F, 2019, GEOSCI MODEL DEV, V12, P2419, DOI 10.5194/gmd-12-2419-2019; Maharjan GR, 2018, SOIL TILL RES, V180, P210, DOI 10.1016/j.still.2018.03.009; Martre P, 2015, GLOBAL CHANGE BIOL, V21, P911, DOI 10.1111/gcb.12768; Matthews RB, 2005, AGR ECOSYST ENVIRON, V111, P119, DOI 10.1016/j.agee.2005.06.016; Mistry MN, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa788c; Monteith J. L., 1965, S SOC EXP BIOL, V19, P4, DOI DOI 10.1093/AOB/MCU257; Muller C, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0023-8; Muller C, 2017, GEOSCI MODEL DEV, V10, P1403, DOI 10.5194/gmd-10-1403-2017; Muller C, 2014, AGR ECON-BLACKWELL, V45, P37, DOI 10.1111/agec.12088; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Muller Christoph, 2015, Environmental Research Letters, V10, DOI 10.1088/1748-9326/10/12/125004; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; Olin S, 2015, BIOGEOSCIENCES, V12, P2489, DOI 10.5194/bg-12-2489-2015; Osborne T, 2013, AGR FOREST METEOROL, V170, P183, DOI 10.1016/j.agrformet.2012.07.006; Ostberg S, 2018, EARTH SYST DYNAM, V9, P479, DOI 10.5194/esd-9-479-2018; Parton W.J., 1994, QUANTITATIVE MODELIN, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; Porter CH, 2014, ENVIRON MODELL SOFTW, V62, P495, DOI 10.1016/j.envsoft.2014.09.004; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Porwollik V, 2019, EARTH SYST SCI DATA, V11, P823, DOI 10.5194/essd-11-823-2019; Porwollik V, 2017, EUR J AGRON, V88, P10, DOI 10.1016/j.eja.2016.08.006; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Rawls W. J., 1985, Watershed management in the eighties., P293; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; RDevelopment Core Team, 2008, R LANG ENV STAT COMP; Rezaei EE, 2015, EUR J AGRON, V65, P69, DOI 10.1016/j.eja.2015.02.003; Rosenzweig C, 2013, AGR FOREST METEOROL, V170, P166, DOI 10.1016/j.agrformet.2012.09.011; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schaap MG, 1996, WATER RESOUR RES, V32, P3033, DOI 10.1029/96WR02278; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Schneider UA, 2011, AGR SYST, V104, P204, DOI 10.1016/j.agsy.2010.11.003; Sheahan M, 2017, FOOD POLICY, V67, P12, DOI 10.1016/j.foodpol.2016.09.010; Stehfest E, 2007, ECOL MODEL, V209, P203, DOI 10.1016/j.ecolmodel.2007.06.028; STOCKLE CO, 1992, AGR SYST, V38, P225, DOI 10.1016/0308-521X(92)90067-X; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Tao FL, 2018, GLOBAL CHANGE BIOL, V24, P1291, DOI 10.1111/gcb.14019; Toth B, 2017, HYDROL PROCESS, V31, P2662, DOI 10.1002/hyp.11203; United Nations Development Programme, 2017, HUM DEV REP 2016 HUM, DOI [DOI 10.18356/B6186701-EN, 10. 18356/b6186701-en]; Valade A, 2014, GEOSCI MODEL DEV, V7, P1225, DOI 10.5194/gmd-7-1225-2014; Van Looy K, 2017, REV GEOPHYS, V55, P1199, DOI 10.1002/2017RG000581; von Bloh W, 2018, GEOSCI MODEL DEV, V11, P2789, DOI 10.5194/gmd-11-2789-2018; Waha K, 2012, GLOBAL ECOL BIOGEOGR, V21, P247, DOI 10.1111/j.1466-8238.2011.00678.x; Waha K, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024017; Wang E, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.102; Wang J, 2013, ENVIRON MODELL SOFTW, V48, P171, DOI 10.1016/j.envsoft.2013.06.007; Warnes G.R., 2016, GPLOTS VARIOUS R PRO; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; Wei T., 2013, CORRPLOT VISUALIZATI, V230, P11; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; WILLIAMS JR, 1989, T ASAE, V32, P497; WOSTEN JHM, 1988, SOIL SCI SOC AM J, V52, P1762, DOI 10.2136/sssaj1988.03615995005200060045x; Xiong W, 2008, ECOL MODEL, V213, P365, DOI 10.1016/j.ecolmodel.2008.01.005; Xiong W, 2016, J ADV MODEL EARTH SY, V8, P1358, DOI 10.1002/2016MS000625; Xiong W, 2014, AGR ECOSYST ENVIRON, V196, P125, DOI 10.1016/j.agee.2014.06.014; Yin YY, 2017, HYDROL EARTH SYST SC, V21, DOI 10.5194/hess-21-791-2017; Zhang XB, 2014, J INTEGR AGR, V13, P604, DOI 10.1016/S2095-3119(13)60718-2; Zhang XS, 2015, ENVIRON MODELL SOFTW, V63, P199, DOI 10.1016/j.envsoft.2014.10.005; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zheng BJ, 2014, SOIL TILL RES, V138, P26, DOI 10.1016/j.still.2013.12.009	114	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221862	10.1371/journal.pone.0221862	http://dx.doi.org/10.1371/journal.pone.0221862			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV1FA	31525247	Green Published, gold, Green Accepted			2022-12-27	WOS:000520168400001
J	Watanabe, N; Kidokoro, M; Suzuki, Y; Tanaka, M; Inoue, S; Tsukamoto, H; Hirayama, N; Hsieh, PW; Tseng, CP; Nakagawa, Y; Inokuchi, S				Watanabe, Nobuo; Kidokoro, Masako; Suzuki, Yusuke; Tanaka, Makiko; Inoue, Shigeaki; Tsukamoto, Hideo; Hirayama, Noriaki; Hsieh, Pei-Wen; Tseng, Ching-Ping; Nakagawa, Yoshihide; Inokuchi, Sadaki			A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction	PLOS ONE			English	Article							PLATELET-AGGREGATION; RECEPTOR CLEC-2; IDENTIFICATION; METASTASIS	Podoplanin, a transmembrane glycoprotein, is overexpressed in certain types of tumors and induces platelet aggregation by binding to C-type lectin-like receptor 2 (CLEC-2) on the platelet membrane. Activated platelets release granule components, which in turn, trigger epithelial-mesenchymal transition and confer invasive capacity to the tumor cells. Therefore, blocking the podoplanin-CLEC-2 interaction by a small-molecule compound is a potential therapeutic strategy to prevent cancer metastasis and invasion. To effectively identify such inhibitory compounds, we have developed a pull-down-based inhibitory compound screening system. An immunoglobulin Fc domain-CLEC-2 fusion protein was used as a bait to capture podoplanin derived from podoplanin-overexpressing HeLa cells in the presence and absence of the test compound. The protein complex was then pulled down using protein A beads. To shorten the turnaround time, increase throughput, and decrease the workload for the operators, centrifugal filter units were employed to separate free and bound podoplanin, instead of using customary aspiration-centrifugation washing cycles. Slot blotting was also utilized in lieu of gel electrophoresis and electrical transfer. Thus, the use of our pull down screening system could facilitate the effective selection of potential inhibitor compounds of the podoplanin-CLEC-2 interaction for cancer therapy. Importantly, our methodology is also applicable to targeting other protein-protein interactions.	[Watanabe, Nobuo; Kidokoro, Masako; Suzuki, Yusuke; Tanaka, Makiko; Inoue, Shigeaki; Nakagawa, Yoshihide; Inokuchi, Sadaki] Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan; [Tsukamoto, Hideo] Tokai Univ, Dept Educ, Sch Med, Isehara, Kanagawa, Japan; [Tsukamoto, Hideo] Tokai Univ, Res Support Ctr, Sch Med, Isehara, Kanagawa, Japan; [Hirayama, Noriaki] Tokai Univ, Inst Adv Biosci, Isehara, Kanagawa, Japan; [Hsieh, Pei-Wen] Chang Gung Univ, Coll Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hsieh, Pei-Wen] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan	Tokai University; Tokai University; Tokai University; Tokai University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Inokuchi, S (corresponding author), Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan.	inokuchi@is.icc.u-tokai.ac.jp		Hsieh, Pei-Wen/0000-0002-8882-4711	Institute for Advanced Life Science Research of Tokai University; Institute for Advanced Biosciences of Tokai University	Institute for Advanced Life Science Research of Tokai University; Institute for Advanced Biosciences of Tokai University	This work was supported by a grant from the Institute for Advanced Life Science Research of Tokai University to Sadaki Inokuchi.; This work was supported by a grant from the Institute for Advanced Biosciences of Tokai University. We wish to acknowledge Drs. Yoshiaki Okada and Takuma Araki and Ms. Akiko Sasaki of the Department of Education and the Research Support Center of Tokai University for their technical support.	Chang YW, 2015, ONCOTARGET, V6, P42733, DOI 10.18632/oncotarget.5811; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Grigorian AL, 2005, PROTEIN SCI, V14, P902, DOI 10.1110/ps.041048805; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2015, ONCOTARGET, V6, P36003, DOI 10.18632/oncotarget.5339; Migliorini E, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5045122; Payne H, 2017, BLOOD, V129, P2013, DOI 10.1182/blood-2016-09-742999; Sekiguchi T, 2016, ONCOTARGET, V7, P3934, DOI 10.18632/oncotarget.6598; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Takemoto A, 2017, CANCER METAST REV, V36, P225, DOI 10.1007/s10555-017-9672-2; Takemoto A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42186; Tanaka M, 2015, MOL MED REP, V12, P4029, DOI 10.3892/mmr.2015.3966; Tsukiji N, 2018, BLOOD ADV, V2, P2214, DOI 10.1182/bloodadvances.2018016261; Ugorski M, 2016, AM J CANCER RES, V6, P370; Watanabe N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07080-4; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Wu YY, 2016, INT J ONCOL, V48, P2310, DOI 10.3892/ijo.2016.3445	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222331	10.1371/journal.pone.0222331	http://dx.doi.org/10.1371/journal.pone.0222331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553741	gold, Green Published			2022-12-27	WOS:000532319200025
J	Corbeau, A; Collet, J; Fontenille, M; Weimerskirch, H				Corbeau, Alexandre; Collet, Julien; Fontenille, Melissa; Weimerskirch, Henri			How do seabirds modify their search behaviour when encountering fishing boats?	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; 1ST-PASSAGE TIME; FINE-SCALE; LONGLINE FISHERY; HABITAT USE; ALBATROSSES; TRACKING; LIFE; RECOGNITION; PREDATORS	Seabirds are well known to be attracted by fishing boats to forage on offal and baits. We used recently developed loggers that record accurate GPS position and detect the presence of boats through their radar emissions to examine how albatrosses use Area Restricted Search (ARS) and if so, have specific ARS behaviours, when attending boats. As much as 78.5% of locations with a radar detection (contact with boat) during a trip occurred within ARS: 36.8% of all large-scale ARS (n = 212) and 14.7% of all small-scale ARS (n = 1476) were associated with the presence of a boat. During small-scale ARS, birds spent more time and had greater sinuosity during boat-associated ARS compared with other ARS that we considered natural. For, small-scale ARS associated with boats, those performed over shelves were longer in duration, had greater sinuosity, and birds spent more time sitting on water compared with oceanic ARS associated with boats. We also found that the proportion of small-scale ARS tend to be more frequently nested in larger-scale ARS was higher for birds associated with boats and that ARS behaviour differed between oceanic (tuna fisheries) and shelf-edge (mainly Patagonian toothfish fisheries) habitats. We suggest that, in seabird species attracted by boats, a significant amount of ARS behaviours are associated with boats, and that it is important to be able to separate ARS behaviours associated to boats from natural searching behaviours. Our study suggest that studying ARS characteristics should help attribute specific behaviours associated to the presence of boats and understand associated risks between fisheries.	[Corbeau, Alexandre; Collet, Julien; Fontenille, Melissa; Weimerskirch, Henri] La Rochelle Univ, Ctr Etud Biol Chize, UMR7372, CNRS, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Corbeau, A (corresponding author), La Rochelle Univ, Ctr Etud Biol Chize, UMR7372, CNRS, Villiers En Bois, France.	alexandre.corbeau@cebc.cnrs.fr	Collet, Julien/AAO-3785-2020	Collet, Julien/0000-0002-3285-5535; CORBEAU, Alexandre/0000-0002-7728-7199	Institiut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes and Antarctique Francaises (TAAF); European Research Council under the European Community [ERC-2012-ADG_20120314]	Institiut Polaire Francais Paul Emile Victor (IPEV); Terres Australes and Antarctique Francaises (TAAF); European Research Council under the European Community(European Research Council (ERC))	The Institiut Polaire Francais Paul Emile Victor (IPEV, programme 109 to HW) and the Terres Australes and Antarctique Francaises (TAAF) provided logistical and financial support, and HW had programs EARLYLIFE, funded by a European Research Council Advanced Grant under the European Community's Seven Framework Program FP7/2007-2013 (Grant Agreement ERC-2012-ADG_20120314 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Bennison A, 2018, ECOL EVOL, V8, P13, DOI 10.1002/ece3.3593; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; Bodey TW, 2014, CURR BIOL, V24, pR514, DOI 10.1016/j.cub.2014.04.041; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Collet J, 2017, ECOL EVOL, V7, P3335, DOI 10.1002/ece3.2677; Collet J, 2015, MAR ECOL PROG SER, V526, P199, DOI 10.3354/meps11233; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Grissac S, 2017, ECOL EVOL, V7, P6766, DOI 10.1002/ece3.3210; Delord K, 2005, CCAMLR SCI, V12, P53; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Heerah K, 2019, BIOL CONSERV, V234, P192, DOI 10.1016/j.biocon.2019.03.037; Hill S, 2000, J FISH BIOL, V56, P1497; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lascelles BG, 2016, DIVERS DISTRIB, V22, P422, DOI 10.1111/ddi.12411; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Pacheco-Cobos L, 2019, P NATL ACAD SCI USA, V116, P10339, DOI 10.1073/pnas.1814476116; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pereira JM, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3316-0; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Rollinson DP, 2016, REV SEABIRD BYCATCH; Sabarros PS, 2014, DEEP-SEA RES PT II, V107, P77, DOI 10.1016/j.dsr2.2013.06.023; STEARNS SC, 1980, OIKOS, V35, P266, DOI 10.2307/3544434; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; Torres LG, 2013, MAR ECOL PROG SER, V473, P275, DOI 10.3354/meps10071; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2018, CONSERV BIOL, V32, P240, DOI 10.1111/cobi.12965; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2018, J ANIM ECOL, V87, P945, DOI 10.1111/1365-2656.12817; Weimerskirch H, 2014, J EXP MAR BIOL ECOL, V450, P68, DOI 10.1016/j.jembe.2013.10.021	47	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222615	10.1371/journal.pone.0222615	http://dx.doi.org/10.1371/journal.pone.0222615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550257	Green Published, gold			2022-12-27	WOS:000532307700019
J	Sanchez-Rodriguez, MA; Zacarias-Flores, M; Arronte-Rosales, A; Mendoza-Nunez, VM				Sanchez-Rodriguez, Martha A.; Zacarias-Flores, Mariano; Arronte-Rosales, Alicia; Manuel Mendoza-Nunez, Victor			Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: A cross-sectional study	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; QUALITY-OF-LIFE; VASOMOTOR SYMPTOMS; MENOPAUSE; RISK; DEPRESSION; INSOMNIA; ANXIETY; PATHOPHYSIOLOGY; VALIDATION	Objective To assess the association between hot flashes (HFs) severity and oxidative stress (OS) in Mexican postmenopausal women. Methods A cross-sectional study was carried out with perimenopausal women aged 40-59 years community-dwelling from Mexico City, Mexico. They participated in Menopause and Oxidative Stress Project. The baseline sample consisted of 476 women recruited to participate; 161 women were excluded due to different reasons. Hence, 315 women were selected to establish two groups, a) 145 premenopausal women (yet with menstrual bleeding), and b) 170 postmenopausal women (without menses). All women were free of cardiovascular, kidney, hepatic or cancer disease, and without antioxidant supplement intake for at least six months prior to the beginning of the study; none had previously received hormone therapy. As OS markers, we measured plasma malondialdehyde using the TBARS assay, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx), uric acid, and total antioxidant status; also, we calculated SOD/GPx ratio, antioxidant gap and an oxidative stress score ranging from 0 to 7. The HFs were evaluated using the Menopause Rating Scale. The women completed Spanish version of the Athens Insomnia Scale, Zung Self-Rating Anxiety Scale and Zung Self-Rating Depression Scale and a questionnaire of prooxidant factors. Results Stress score increased with HFs severity (mild 2.7 +/- 0.17, moderate 2.9 +/- 0.20 and severe 3.7 +/- 0.20, p = 0.001) in postmenopausal women. We observed a positive correlation between HFs severity and stress score, r = 0.247 (p = 0.001) in postmenopausal women; other test scores were not correlated. Severe HFs were a risk factor for OS (OR = 5.12, 95%CI: 1.99-13.17, p<0.05) in an adjusted multivariate analysis by different postmenopausal symptoms and pro-oxidant factors; we did not see any association in premenopausal women. Conclusion Our findings suggest an association between HFs severity and OS in Mexican postmenopausal women.	[Sanchez-Rodriguez, Martha A.; Arronte-Rosales, Alicia; Manuel Mendoza-Nunez, Victor] Univ Nacl Autonoma Mexico, Unidad Invest Gerontol, Fac Estudios Super Zaragoza, Mexico City, DF, Mexico; [Zacarias-Flores, Mariano] Hosp Gustavo Baz Prada, Inst Salud Estado Mexico, Div Ginecol & Obstet, Nezahualcoyotl, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico	Sanchez-Rodriguez, MA (corresponding author), Univ Nacl Autonoma Mexico, Unidad Invest Gerontol, Fac Estudios Super Zaragoza, Mexico City, DF, Mexico.	masanrod@yahoo.com.mx	Mendoza-Núñez, Víctor Manuel/AFL-2465-2022	Mendoza-Núñez, Víctor Manuel/0000-0002-9137-3405	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico [SECITI/042/2018]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [DGAPA-PAPIIT IN306517]	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This project was supported by a grant from the Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico SECITI/042/2018, Red colaborativa de Investigacion Traslacional para el Envejecimiento Saludable de la Ciudad de Mexico (RECITES). The work was supported by Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, grant number DGAPA-PAPIIT IN306517.	Aedo M Sócrates, 2006, Rev. chil. obstet. ginecol., V71, P402; Avis Nancy E, 2005, Am J Med, V118 Suppl 12B, P37, DOI 10.1016/j.amjmed.2005.09.057; Avis NE, 2009, MENOPAUSE, V16, P860, DOI 10.1097/gme.0b013e3181a3cdaf; Ayers B, 2013, CLIMACTERIC, V16, P235, DOI 10.3109/13697137.2012.688078; Biglia N, 2017, CLIMACTERIC, V20, P306, DOI 10.1080/13697137.2017.1315089; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bonaccorsi G, 2015, TAIWAN J OBSTET GYNE, V54, P290, DOI 10.1016/j.tjog.2014.09.009; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Cagnacci A, 2015, CLIMACTERIC, V18, P631, DOI 10.3109/13697137.2014.999659; CARROLL BJ, 1973, ARCH GEN PSYCHIAT, V28, P361; Chedraui P, 2007, MATURITAS, V57, P271, DOI 10.1016/j.maturitas.2007.01.009; Chen AF, 2012, CLIN SCI, V123, P73, DOI 10.1042/CS20110562; de Campos HH, 2006, CLIMACTERIC, V9, P312, DOI 10.1080/13697130600871947; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Doshi Sejal B, 2013, J Midlife Health, V4, P140, DOI 10.4103/0976-7800.118990; Freeman EW, 2014, MENOPAUSE, V21, P924, DOI [10.1097/GME.0000000000000196, 10.1097/gme.0000000000000196]; Grases G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/430216; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Heinemann Lothar A J, 2003, Health Qual Life Outcomes, V1, P28, DOI 10.1186/1477-7525-1-28; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Kronenberg F, 2010, J NUTR, V140, p1380S, DOI 10.3945/jn.109.120840; Kumar S, 2010, BBA-GEN SUBJECTS, V1800, P1127, DOI 10.1016/j.bbagen.2010.04.011; Leal M, 2000, OBSTET GYNECOL, V95, P804, DOI 10.1016/S0029-7844(00)00822-X; Mendoza-Nunez VM, 2011, REJUV RES, V14, P25, DOI 10.1089/rej.2010.1054; Miller N J, 1998, Methods Mol Biol, V108, P285; Muka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157417; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Olatunji BO, 2006, J ANXIETY DISORD, V20, P543, DOI 10.1016/j.janxdis.2005.08.002; Ozkaya E, 2011, INT J GYNECOL OBSTET, V113, P235, DOI 10.1016/j.ijgo.2010.12.020; Pachman DR, 2010, INT J WOMENS HEALTH, V2, P123; PY W, 2017, BMC WOMENS HEALTH, V17, P1, DOI DOI 10.1186/S12905-016-0358-7; REMACLE J, 1992, BIOCHEM J, V286, P41, DOI 10.1042/bj2860041; Sanchez-Rodriguez MA, 1998, ACTA BIOQUIM CLIN L, V32, P812; Sanchez-Rodriguez MA, 2012, MENOPAUSE, V19, P361, DOI 10.1097/gme.0b013e318229977d; Sanchez-Rodriguez MA, 2010, ANN NUTR METAB, V56, P302, DOI 10.1159/000309601; Shanafelt TD, 2002, MAYO CLIN PROC, V77, P1207, DOI 10.4065/77.11.1207; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095; Sussman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0217-y; Terauchi M, 2012, MATURITAS, V72, P61, DOI 10.1016/j.maturitas.2012.01.014; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	47	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0214264	10.1371/journal.pone.0214264	http://dx.doi.org/10.1371/journal.pone.0214264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550247	Green Submitted, Green Published, gold			2022-12-27	WOS:000532307700001
J	Moccia, M; Tajani, A; Acampora, R; Signoriello, E; Corbisiero, G; Vercellone, A; Sergianni, P; Pennino, F; Lanzillo, R; Palladino, R; Capacchione, A; Morra, VB; Lus, G; Triassi, M				Moccia, Marcello; Tajani, Andrea; Acampora, Rosa; Signoriello, Elisabetta; Corbisiero, Guido; Vercellone, Adriano; Sergianni, Primo; Pennino, Francesca; Lanzillo, Roberta; Palladino, Raffaele; Capacchione, Antonio; Morra, Vincenzo Brescia; Lus, Giacomo; Triassi, Maria			Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery	PLOS ONE			English	Article							REHABILITATION; PEOPLE; NEEDS	Background Multiple sclerosis (MS) requires multidisciplinary management. We evaluated differences in healthcare resource utilization and costs between Federico II and Vanvitelli MS Centres of Naples (Italy), representative of centralised (i.e., MS Care Unit) and local service-based models of multidisciplinary care, respectively. Methods We included MS patients continuously seen at the same local healthcare services and MS Centre (Federico II = 187; Vanvitelli = 90) from 2015 to 2017. Healthcare resources for MS treatment and management were collected and costs were calculated. Adherence was estimated as the rate of medication possession ratio (MPR) during 3-years of follow-up. Mixed-effect linear regression models were used to estimate differences in all outcomes between Federico II and Vanvitelli. Results Patients at Federico II had more consultations within the MS centre (p<0.001), blood tests (p<0.001), and psychological/cognitive evaluations (p = 0.040). Patients at Vanvitelli had more consultations at local services (p<0.001). Adherence was not-significantly lower at Vanvitelli (p = 0.060), compared with Federico II. Costs for MS treatment and management were 10.6% lower at Vanvitelli (12417.08 +/- 8448.32EUR) (95%CI = -19.0/-2.7%;p = 0.007), compared with Federico II (15318.57 +/- 10919.59EUR). Discussion Healthcare services were more complete (and expensive) at the Federico II centralised MS Care Unit, compared with the Vanvitelli local service-based organizational model. Future research should evaluate whether better integration between MS Centres and local services can lead to improved MS management and lower costs.	[Moccia, Marcello; Lanzillo, Roberta; Morra, Vincenzo Brescia] Univ Naples Federico II, Multiple Sclerosis Clin Care & Res Ctr, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy; [Moccia, Marcello] UCL, Queen SQ MS Ctr, UCL Queen Sq Inst Neurol, London, England; [Tajani, Andrea; Pennino, Francesca; Palladino, Raffaele; Triassi, Maria] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Acampora, Rosa; Sergianni, Primo] Primary Care & Local Serv Unit, Local Healthcare Serv Napoli 3 Sud, Naples, Italy; [Signoriello, Elisabetta; Lus, Giacomo] Luigi Vanvitelli Univ Campania, Multiple Sclerosis Ctr, Neurol Clin 2, Naples, Italy; [Corbisiero, Guido] Local Healthcare Serv Napoli 3 Sud, Local Healthcare Serv 57, Naples, Italy; [Vercellone, Adriano] Local Healthcare Serv Napoli 3 Sud, Dept Pharmaceut, Naples, Italy; [Palladino, Raffaele] Imperial Coll, Dept Primary Care & Publ Hlth, London, England; [Capacchione, Antonio] Merck Serono SpA, Via Casilina, Rome, Italy; [Capacchione, Antonio] Merck KGaA, Darmstadt, Germany	University of Naples Federico II; University of London; University College London; University of Naples Federico II; Universita della Campania Vanvitelli; Imperial College London; Merck KGaA; EMD Serono Inc.; Merck KGaA	Moccia, M (corresponding author), Univ Naples Federico II, Multiple Sclerosis Clin Care & Res Ctr, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy.; Moccia, M (corresponding author), UCL, Queen SQ MS Ctr, UCL Queen Sq Inst Neurol, London, England.	moccia.marcello@gmail.com	Signoriello, Elisabetta/ABG-1289-2020; Moccia, Marcello/N-6987-2015; Palladino, Raffaele/AAG-6823-2020; Signoriello, Elisabetta/AAL-9069-2021; Lanzillo, Roberta/AFA-8874-2022	Signoriello, Elisabetta/0000-0001-5753-6752; Moccia, Marcello/0000-0003-2613-3090; Palladino, Raffaele/0000-0002-3437-812X; Lanzillo, Roberta/0000-0001-6388-8180; Lus, Giacomo/0000-0002-9457-1124	Merck S.p.A., (Italy), an affiliate of Merck KGaA, Darmstadt, Germany; Department of Public Health ("Federico II" University of Naples, 2018, Italy)	Merck S.p.A., (Italy), an affiliate of Merck KGaA, Darmstadt, Germany; Department of Public Health ("Federico II" University of Naples, 2018, Italy)	This research was partially supported by Merck S.p.A., (Italy), an affiliate of Merck KGaA, Darmstadt, Germany. The funder provided support in the form of research grant to the Department of Public Health ("Federico II" University of Naples, 2018, Italy) to MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. A preliminary draft of the current paper was reviewed by the sponsor, and its latest version was approved by all co-authors. The specific roles of these authors are articulated in the `author contributions' section.	Akkus Y, 2012, SCAND J CARING SCI, V26, P295, DOI 10.1111/j.1471-6712.2011.00933.x; [Anonymous], EUR PUBL ASS REP NAT; [Anonymous], BANC DAT FARM AIFA; Battaglia M, 2017, MULT SCLER J, V23, P104, DOI 10.1177/1352458517708176; Battaglia MA, 2017, NEUROL SCI, V38, P473, DOI 10.1007/s10072-016-2801-9; Berto P, 2011, NEUROL SCI, V32, P1035, DOI 10.1007/s10072-011-0578-4; de Waure C, 2016, NEUROL SCI, V37, P315, DOI 10.1007/s10072-015-2389-5; Fogarty E, 2014, APPL HEALTH ECON HEA, V12, P635, DOI 10.1007/s40258-014-0128-3; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kalincik T, 2015, BRAIN, V138, DOI 10.1093/brain/awv258; Ke XH, 2016, CURR MED RES OPIN, V32, P1589, DOI 10.1080/03007995.2016.1192529; Keetley K, 2004, EVALUATION DRUG INTE; Lam WY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/217047; Lavorgna L, 2018, MULT SCLER J, V24, P1657, DOI 10.1177/1352458518799629; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Moccia M, 2017, ACTA NEUROL SCAND, V135, P522, DOI 10.1111/ane.12630; Moccia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169489; Moccia M, 2015, EXPERT OPIN DRUG DEL, V12, P1829, DOI 10.1517/17425247.2015.1078789; Montalban X, 2018, MULT SCLER J, V24, P96, DOI 10.1177/1352458517751049; O'Connelln K, 2014, MULT SCLER RELAT DIS, V3, P678, DOI 10.1016/j.msard.2014.09.002; Patti F, 2011, NEUROL SCI, V32, P787, DOI 10.1007/s10072-011-0499-2; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ponzio M, 2015, EUR J PUBLIC HEALTH, V25, P775, DOI 10.1093/eurpub/ckv065; Ponzio M, 2015, NEUROL SCI, V36, P227, DOI 10.1007/s10072-014-1925-z; Raimundo K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-131; Rommer PS, 2019, MULT SCLER J, V25, P1641, DOI 10.1177/1352458518799580; Sorensen PS, 2019, MULT SCLER J, V25, P627, DOI 10.1177/1352458518807082; Tacchino A, 2017, NEUROL SCI, V38, P2131, DOI 10.1007/s10072-017-3110-7; Thompson AJ, 2018, LANCET, V391, P1622, DOI 10.1016/S0140-6736(18)30481-1; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Tur C, 2018, NAT REV NEUROL, V14, P75, DOI 10.1038/nrneurol.2017.171	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222012	10.1371/journal.pone.0222012	http://dx.doi.org/10.1371/journal.pone.0222012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536513	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800024
J	Caarls, PJ; van Schijndel, MA; van den Berk, G; Boenink, AD; Boerman, D; Lijmer, JG; Honig, A; Terra, M; Thijs, A; Verwey, B; van Waarde, JA; van Wijngaarden, J; van Busschbach, JJ				Caarls, P. J.; van Schijndel, M. A.; van den Berk, G.; Boenink, A. D.; Boerman, D.; Lijmer, J. G.; Honig, A.; Terra, M.; Thijs, A.; Verwey, B.; van Waarde, J. A.; van Wijngaarden, J.; van Busschbach, J. J.		MPU Study Grp	Factors influencing the admission decision for Medical Psychiatry Units: A concept mapping approach	PLOS ONE			English	Article							MENTAL-HEALTH; CARE; EVOLUTION; QUALITY; MODELS	Objective Medical Psychiatry Units (MPUs), also known as Complexity Intervention Units (CIUs), provide care for complex patients suffering from both psychiatric and physical disorders. Because there is no consensus on the indications for admission to an MPU, daily practice and effectiveness research are hampered. This study therefore used a concept mapping approach to investigate which organizational and medical factors determine the decision to admit a patient to an MPU. Methods The first step of the concept mapping approach was to create a list of factors determining MPU admission from literature. Secondly, clinical experts sorted and ranked these factors. The sorted and ranked data were then analyzed, and a draft conceptual framework was created. A final conceptual MPU admission framework was then drawn during an expert consensus meeting and recommendations for implementation were suggested. Results Thirteen clinical experts defined 90 factors from literature, which were sorted and ranked by 40 experts from 21 Dutch hospitals. This concept mapping approach resulted in a five-cluster solution for an MPU admission framework based on: 1. Staff competencies and organizational pre-requisites; 2. Patient context; 3. Patient characteristics; 4. Medical needs and capabilities; and 5. Psychiatric symptoms and behavioral problems. Furthermore, three inclusion and two exclusion criteria were formulated to help the clinicians decide whether or not to admit patients to an MPU. These criteria can be implemented in daily practice. Conclusion Implementing the five criteria derived from this conceptual framework will help make the admission decision for complex patients with psychiatric and physical disorders to an MPU more correct, consistent, and transparent.	[Caarls, P. J.; van Schijndel, M. A.; van Busschbach, J. J.] Univ Med Ctr, Erasmus Med Ctr, Rotterdam, Netherlands; [van Schijndel, M. A.; Boerman, D.; Verwey, B.; van Waarde, J. A.] Rijnstate Hosp, Arnhem, Netherlands; [van den Berk, G.; Lijmer, J. G.; Honig, A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Boenink, A. D.; Honig, A.; Terra, M.; Thijs, A.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Wijngaarden, J.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Rijnstate Hospital; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Erasmus University Rotterdam	Caarls, PJ (corresponding author), Univ Med Ctr, Erasmus Med Ctr, Rotterdam, Netherlands.	p.caarls@erasmusmc.nl		Boenink, Annette/0000-0001-9791-8800				Alberque C, 2009, PSYCHOSOMATICS, V50, P354, DOI 10.1176/appi.psy.50.4.354; Beckers T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199668; BRUNS W, 1990, GEN HOSP PSYCHIAT, V12, P137, DOI 10.1016/0163-8343(90)90071-J; BUCKLEY P, 1994, PSYCHOSOMATICS, V35, P515, DOI 10.1016/S0033-3182(94)71719-9; Chiu A, 2009, ARCH GERONTOL GERIAT, V49, P233, DOI 10.1016/j.archger.2008.08.008; Eytan A, 2004, EUR PSYCHIAT, V19, P499, DOI 10.1016/j.eurpsy.2004.09.004; Faught DD, 2013, NURS EDUC, V38, P122, DOI 10.1097/NNE.0b013e31828dc27b; FAVA GA, 1985, PSYCHOTHER PSYCHOSOM, V43, P194, DOI 10.1159/000287879; GERTLER R, 1995, GEN HOSP PSYCHIAT, V17, P26, DOI 10.1016/0163-8343(94)00063-J; Guthrie E, 2016, BJPSYCH BULL, V40, P175, DOI 10.1192/pb.bp.115.051771; Johnsen JA, 2000, EVAL PROGRAM PLANN, V23, P67, DOI 10.1016/S0149-7189(99)00038-5; KATHOL RG, 1994, GEN HOSP PSYCHIAT, V16, P1, DOI 10.1016/0163-8343(94)90080-9; Kathol RG, 1999, INT CONGR SER, V1174, P13; KATHOL RG, 1992, PSYCHOSOMATICS, V33, P376, DOI 10.1016/S0033-3182(92)71942-2; Kathol RG, 2010, J PSYCHOSOM RES, V68, P293, DOI 10.1016/j.jpsychores.2009.06.012; Kathol RG, 2009, PSYCHOSOMATICS, V50, P93, DOI 10.1176/appi.psy.50.2.93; Kishi Y, 1999, PSYCHOSOMATICS, V40, P345, DOI 10.1016/S0033-3182(99)71230-2; Leue C, 2010, J PSYCHOSOM RES, V68, P295, DOI 10.1016/j.jpsychores.2009.04.010; Marra D, 2003, REV MED INTERNE, V24, P279, DOI 10.1016/S0248-8663(03)00051-1; Regan Judy, 2005, Tenn Med, V98, P448; STOUDEMIRE A, 1987, HOSP COMMUNITY PSYCH, V38, P815; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; van Manen JG, 2012, J PERS DISORD, V26, P481, DOI 10.1521/pedi.2012.26.4.481; Van Schijndel M., 2018, P SOC COMPUTATION LI, P1, DOI [10.1159/000485001, DOI 10.1159/000485001]; van Schijndel MA, 2017, NED TIJDSCHR GENEES, V161; van Schijndel MA, 2019, PSYCHOTHER PSYCHOSOM, V88, P127, DOI 10.1159/000493689; van Schijndel MA, 2018, GEN HOSP PSYCHIAT, V55, P27, DOI 10.1016/j.genhosppsych.2018.09.009; van Waarde J A, 2004, Ned Tijdschr Geneeskd, V148, P209; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wulsin LR, 2006, MED CLIN N AM, V90, P647, DOI 10.1016/j.mcna.2006.05.005	30	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221807	10.1371/journal.pone.0221807	http://dx.doi.org/10.1371/journal.pone.0221807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527872	Green Submitted, gold, Green Published			2022-12-27	WOS:000532231400007
J	Wolin, E; Mita, A; Mahipal, A; Meyer, T; Bendell, J; Nemunaitis, J; Munster, PN; Paz-Ares, L; Filvaroff, EH; Li, SY; Hege, K; de Haan, H; Mita, M				Wolin, Edward; Mita, Alain; Mahipal, Amit; Meyer, Tim; Bendell, Johanna; Nemunaitis, John; Munster, Pam N.; Paz-Ares, Luis; Filvaroff, Ellen H.; Li, Shaoyi; Hege, Kristen; de Haan, Hans; Mita, Monica			A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms	PLOS ONE			English	Article							SOLID TUMORS; EVEROLIMUS; EFFICACY; SAFETY	Second-generation mammalian target of rapamycin (mTOR) inhibitors such as CC-223 may have theoretical advantages over first-generation drugs by inhibiting TOR kinase in mTOR complex 1 (mTORC1) and 2 (mTORC2), potentially improving clinical efficacy for well-differentiated neuroendocrine tumors (NET).Enrolled patients had metastatic, well-differentiated NET of non-pancreatic gastrointestinal or unknown origin, with/without carcinoid symptoms, had failed >= 1 systemic chemotherapy, and were taking a somatostatin analog (SSA). Oral once-daily CC-223 was administered in 28-day cycles starting at 45 mg (n = 24), with a subsequent cohort starting at 30 mg (n = 23). Objectives were to evaluate tolerability, preliminary efficacy, and pharmacokinetic and biomarker profiles of CC-223. Forty-seven patients completed the study, with mean treatment duration of 378 days and mean dose of 26 mg; 26% of patients remained on the starting dose. Most frequent grade.3 toxicities were diarrhea (38%), fatigue (21%), and stomatitis (11%). By investigator, 3 of 41 evaluable patients (7%) showed partial response (PR) and 34 (83%) had stable disease (SD) for a disease control rate (DCR) of 90% (95% confidence interval [CI] 76.9-97.3%). Duration of PR was 125401 days; median SD duration was 297 days (min-max, 50-1519 days). Median progression-free survival was 19.5 months (95% CI 10.4-28.5 months). Carcinoid symptoms of flushing, diarrhea, or both improved in 50%, 41%, and 39% of affected patients, respectively. For the first time, this study describes that a second-generation mTOR pathway inhibitor can result in highly durable tumor regression and control of NET carcinoid symptoms. The manageable safety profile, high DCR, and durable response, coupled with reduction in carcinoid symptoms refractory to SSA, make CC-223 a promising agent for further development.	[Wolin, Edward; Mita, Alain; Mita, Monica] Cedars Sinai Med Ctr, Expt Therapeut Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Mahipal, Amit] Mayo Clin, Phase Clin Trials Program 1, Rochester, MN USA; [Meyer, Tim] Univ Coll Hosp, Expt Canc Med, London, England; [Bendell, Johanna] Sarah Cannon Res Inst, Tennessee Oncol, GI Oncol Res, Nashville, TN USA; [Nemunaitis, John] Mary Crowley Canc Res Ctr, Dept Oncol, Dallas, TX USA; [Munster, Pam N.] UCSF Helen Diller Family Comprehens Canc Ctr, Early Phase Clin Res Program, San Francisco, CA USA; [Paz-Ares, Luis] Univ Complutense & CiberOnc, CNIO, Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain; [Filvaroff, Ellen H.; Hege, Kristen; de Haan, Hans] Celgene Corp, Translat Med, San Francisco, CA USA; [Li, Shaoyi] Celgene Corp, Dept Stat, Summit, NJ USA; [Wolin, Edward] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Nemunaitis, John] Univ Toledo, Coll Med & Life Sci, Ruppert Hlth Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA	Cedars Sinai Medical Center; Mayo Clinic; University of London; University College London; Sarah Cannon Research Institute; Tennessee Oncology; Mary Crowley Cancer Research; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario 12 de Octubre; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Toledo	Wolin, E (corresponding author), Cedars Sinai Med Ctr, Expt Therapeut Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.; Wolin, E (corresponding author), Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA.	edward.Wolin@mssm.edu	Mahipal, Amit/ABD-8395-2020	Mahipal, Amit/0000-0002-1111-8333; Wolin, Edward/0000-0003-3992-8722	Celgene Corporation; National Institute for Health Research (NIHR) UCLH Clinical Research Facility; Cancer Research UK Experimental Cancer Medicine Centre (ECMC)	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); National Institute for Health Research (NIHR) UCLH Clinical Research Facility; Cancer Research UK Experimental Cancer Medicine Centre (ECMC)	Funding for this clinical trial was provided by Celgene Corporation. For TM at UCH, the trial was supported by the National Institute for Health Research (NIHR) UCLH Clinical Research Facility and the Cancer Research UK Experimental Cancer Medicine Centre (ECMC). Celgene provided support in the form of salaries for authors EHF, SL, KH, and HdeH, and Celgene had a role in the study design, data collection and analysis, and the decision to publish the data. Authors EHF, SL, KH, and HdH critically reviewed and approved the final manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bendell JC, 2015, CANCER-AM CANCER SOC, V121, P3481, DOI 10.1002/cncr.29422; Chan JY, 2016, EUR UROL, V69, P457, DOI 10.1016/j.eururo.2015.09.047; Cottu PH, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.tps2643; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Faggiano A, 2016, ONCOLOGIST, V21, P875, DOI 10.1634/theoncologist.2015-0420; Freitag H, 2017, NEUROENDOCRINOLOGY, V105, P90, DOI 10.1159/000448843; Goldman JW, 2016, ONCOLOGIST, V21, P1326, DOI 10.1634/theoncologist.2015-0519; Kannan A, 2016, ONCOTARGET, V7, P6576, DOI 10.18632/oncotarget.5878; Kaplan B, 2014, TRANSPLANT REV-ORLAN, V28, P126, DOI 10.1016/j.trre.2014.03.002; Kim JO, 2017, ONCOTARGET, V8, P2936, DOI 10.18632/oncotarget.13808; Mortensen DS, 2015, MOL CANCER THER, V14, P1295, DOI 10.1158/1535-7163.MCT-14-1052; Musa F, 2016, MOL CANCER THER, V15, P1557, DOI 10.1158/1535-7163.MCT-15-0926; National Cancer Institute, SEER CANC STAT REV 1; Orr-Asman MA, 2017, MOL CANCER THER, V16, P2432, DOI 10.1158/1535-7163.MCT-17-0058; Su DW, 2016, CLIN PHARM TOXICITY; WALD A, 1945, ANN MATH STAT, V16, P117, DOI 10.1214/aoms/1177731118; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zou ZP, 2016, CURR CANCER DRUG TAR, V16, P288, DOI 10.2174/1568009616666151113120830	20	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221994	10.1371/journal.pone.0221994	http://dx.doi.org/10.1371/journal.pone.0221994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527867	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400008
J	Di Pane, J; Joly, L; Koubbi, P; Giraldo, C; Monchy, S; Tavernier, E; Marchal, P; Loots, C				Di Pane, Julien; Joly, Lea; Koubbi, Philippe; Giraldo, Carolina; Monchy, Sebastien; Tavernier, Eric; Marchal, Paul; Loots, Christophe			Ontogenetic shift in the energy allocation strategy and physiological condition of larval plaice (Pleuronectes platessa)	PLOS ONE			English	Article							RNA-DNA RATIOS; NUTRITIONAL CONDITION; RNA/DNA RATIOS; DEPENDENT MORTALITY; NORTHERN ANCHOVY; HABITAT QUALITY; CLUPEA-HARENGUS; CLASS STRENGTH; GROWTH-RATE; FISH	Condition indices aim to evaluate the physiological status of fish larvae by estimating both the level of starvation and potential of survival. Histological indices reveal direct effects of starvation whereas biochemical indices such as lipid classes or RNA:DNA ratios are used as proxies of condition, giving information on the amount of energy reserves and growth rate, respectively. We combined these three indices to evaluate ontogenetic variations of growth performance, lipid dynamics and nutritional condition of plaice larvae caught in the field during winter 2017 in the eastern English Channel and the Southern Bight of the North Sea. RNA:DNA ratios showed that larvae at the beginning of metamorphosis (stage 4) had a lower growth rate than younger individuals (stages 2 and 3). A significant increase in the proportion of triglycerides also occurred at stage 4, indicating energy storage. Histological indices indicated that most of the larvae were in good condition, even younger ones with low lipid reserves. There was, however, an increase in the proportion of healthy individuals over ontogeny, especially with respect to liver vacuoles which were larger and more numerous for stage 4 larvae. Combined together, these condition indices revealed the ontogenetic shift in the energy allocation strategy of plaice larvae. Young larvae (stages 2 and 3) primarily allocate energy towards somatic growth. The decrease in growth performance for stage 4 was not related to poor condition, but linked to a higher proportion of energy stored as lipids. Since the quantity of lipid reserves is particularly important for plaice larvae to withstand starvation during metamorphosis, this could be considered as a second critical period after the one of exogenous feeding for larval survival and recruitment success.	[Di Pane, Julien; Joly, Lea; Giraldo, Carolina; Marchal, Paul; Loots, Christophe] IFREMER, Channel & North Sea Fisheries Res Unit, Boulogne Sur Mer, France; [Koubbi, Philippe] Sorbonne Univ, UFR Terre Environm Biodiversie 918, Paris, France; [Monchy, Sebastien; Tavernier, Eric] LOG Lab Oceanol & Geosci, Wimereux, France	Ifremer; UDICE-French Research Universities; Sorbonne Universite	Loots, C (corresponding author), IFREMER, Channel & North Sea Fisheries Res Unit, Boulogne Sur Mer, France.	Christophe.Loots@ifremer.fr	Di Pane, Julien/AAT-1291-2020; Di Pane, Julien/GWV-1895-2022	Di Pane, Julien/0000-0003-0973-2702; Marchal, Paul/0000-0003-2047-4599; Giraldo, Carolina/0000-0003-0278-522X; Joly, Lea/0000-0002-7484-4340; MONCHY, Sebastien/0000-0001-5808-4700	IFREMER; Pole Metropolitain de la Cote d'Opale; Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la mer; SFR Campus de la mer (grant 2019 ULCO)	IFREMER; Pole Metropolitain de la Cote d'Opale; Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la mer; SFR Campus de la mer (grant 2019 ULCO)	This work was supported by IFREMER and the Pole Metropolitain de la Cote d'Opale through the PhD of Julien Di Pane. This work was also supported by Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la merhttps://marco.univ-littoral.fr/.This study was partly funded by the SFR Campus de la mer (grant 2019 ULCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 1989, MARINE BIOGENIC LIPI, DOI [10.1016/j.plefa.2016.02.004, DOI 10.1016/J.PLEFA.2016.02.004]; Ahlstrom EH, 1984, ONTOGENY SYSTEMATICS; Amara R, 2003, ESTUAR COAST SHELF S, V56, P807, DOI 10.1016/S0272-7714(02)00315-3; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bakun A., 1998, REINVENTING FISHERIE, DOI [10.1007/978-94-011-4433-9_25, DOI 10.1007/978-94-011-4433-9_25]; Barbut L, 2019, LIMNOL OCEANOGR, V64, P1150, DOI 10.1002/lno.11104; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Benoit HP, 1999, MAR ECOL PROG SER, V184, P231, DOI 10.3354/meps184231; Benoit HP, 2000, CAN J FISH AQUAT SCI, V57, P856, DOI 10.1139/cjfas-57-4-856; Beverton RJH, 1995, NETH J SEA RES, V34, P1, DOI 10.1016/0077-7579(95)90010-1; BREWSTER B, 1987, J FISH BIOL, V31, P805, DOI 10.1111/j.1095-8649.1987.tb05281.x; Buckley L, 1999, HYDROBIOLOGIA, V401, P265, DOI 10.1023/A:1003798613241; Buckley LJ, 2008, MAR ECOL PROG SER, V371, P221, DOI 10.3354/meps07648; BUCKLEY LJ, 1979, J FISH RES BOARD CAN, V36, P1497, DOI 10.1139/f79-217; Caldarone EM, 2005, MAR ECOL PROG SER, V293, P241, DOI 10.3354/meps293241; Catalan IA, 2006, MAR ECOL PROG SER, V307, P219, DOI 10.3354/meps307219; CHAMBERS RC, 1989, CAN J FISH AQUAT SCI, V46, P1633, DOI 10.1139/f89-208; Christensen MN, 1999, J EXP MAR BIOL ECOL, V237, P225, DOI 10.1016/S0022-0981(98)00215-9; Ciotti BJ, 2010, J FISH BIOL, V77, P2181, DOI 10.1111/j.1095-8649.2010.02786.x; CLEMMESEN C, 1994, MAR BIOL, V118, P377, DOI 10.1007/BF00350294; CLEMMESEN CM, 1987, J CONSEIL, V43, P122; Comerford S, 2013, MAR ECOL PROG SER, V476, P215, DOI 10.3354/meps10118; Costalago D, 2011, ESTUAR COAST SHELF S, V93, P350, DOI 10.1016/j.ecss.2011.05.005; Craig JK, 2007, MAR ECOL PROG SER, V343, P251, DOI 10.3354/meps06864; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Denis J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3180-3; DEPLANO M, 1991, MAR BIOL, V108, P361, DOI 10.1007/BF01313645; Diaz MV, 2018, MAR FRESHWATER RES, V69, P455, DOI 10.1071/MF17178; Diaz MV, 2014, FISH RES, V160, P60, DOI 10.1016/j.fishres.2013.11.009; EHRLICH KF, 1974, MAR BIOL, V24, P39, DOI 10.1007/BF00402845; Ehrlich KF., 1974, EARLY LIFE HIST FISH, P301, DOI 10.1007/978-3-642-65852-5_26; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Fernandez-Diaz C, 2001, J FISH BIOL, V58, P1086, DOI [10.1006/jfbi.2000.1514, 10.1111/j.1095-8649.2001.tb00557.x]; FERRON A, 1994, ADV MAR BIOL, V30, P217, DOI 10.1016/S0065-2881(08)60064-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foley CJ, 2016, ECOL INDIC, V60, P346, DOI 10.1016/j.ecolind.2015.07.005; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; FRASER AJ, 1988, MAR BIOL, V99, P307, DOI 10.1007/BF02112122; Geffen AJ, 2007, J SEA RES, V58, P35, DOI 10.1016/j.seares.2007.02.004; GIBSON RN, 1994, NETH J SEA RES, V32, P191, DOI 10.1016/0077-7579(94)90040-X; Giraldo C., 2012, ECOLOGIE TROPHIQUE P; Giraldo C, 2017, POLAR BIOL, V40, P313, DOI 10.1007/s00300-016-1956-4; Giraldo C, 2011, POLAR SCI, V5, P252, DOI 10.1016/j.polar.2011.04.004; Gisbert E, 2008, HISTOL HISTOPATHOL; HAKANSON JL, 1989, MAR BIOL, V102, P143, DOI 10.1007/BF00428274; Hjort J., 1914, P RAPPORTS PROCRS VE; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; HOVENKAMP F, 1992, MAR ECOL PROG SER, V82, P95, DOI 10.3354/meps082095; Hufnagl M, 2013, J SEA RES, V84, P26, DOI 10.1016/j.seares.2012.10.007; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Infante MFLJLZ, 2008, FEED DIG FUNCT FISHE, DOI [10.1201/b10749-8, DOI 10.1201/B10749-8]; Koubbi P, 2007, CYBIUM, V31, P67; Lazo J.P., 2011, LARVAL FISH NUTR, P3, DOI 10.1002/9780470959862.ch1; Le Pape O, 2015, FISH FISH, V16, P373, DOI 10.1111/faf.12063; Levin PS, 2005, ESTUAR COAST SHELF S, V64, P70, DOI 10.1016/j.ecss.2005.02.007; MARGULIES D, 1993, MAR BIOL, V115, P317, DOI 10.1007/BF00346350; Martoja R, 1967, INITIATION TECHNIQUE; McFadzen IRB, 1997, J EXP MAR BIOL ECOL, V212, P239, DOI 10.1016/S0022-0981(96)02755-4; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nash RDM, 2007, MAR ECOL PROG SER, V344, P231, DOI 10.3354/meps06933; Nash RDM, 2000, J SEA RES, V44, P101, DOI 10.1016/S1385-1101(00)00044-7; OCONNELL CP, 1976, J EXP MAR BIOL ECOL, V25, P285, DOI 10.1016/0022-0981(76)90130-1; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pepin P, 2016, ICES J MAR SCI, V73, P196, DOI 10.1093/icesjms/fsv160; Peters J, 2015, MAR ECOL PROG SER, V531, P277, DOI 10.3354/meps11292; Petitgas P, 2013, FISH OCEANOGR, V22, P121, DOI 10.1111/fog.12010; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; RILEY JOHN D., 1966, J CONS CONS PERMA INT EXPLOR MER, V30, P204; ROBINSON SMC, 1988, CAN J FISH AQUAT SCI, V45, P1422, DOI 10.1139/f88-166; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; RYLAND J. S., 1966, J CONS CONS PERMA INT EXPLOR MER, V30, P177; Sargent JR, LIPIDS HYDROCARBONS; SEGNER H, 1994, MAR BIOL, V119, P471, DOI 10.1007/BF00347544; Selleslagh J, 2013, J MAR BIOL ASSOC UK, V93, P479, DOI 10.1017/S0025315412000483; SHELBOURNE JE, 1957, J MAR BIOL ASSOC UK, V36, P539, DOI 10.1017/S0025315400025832; Sieg A., 1998, OCEANOGR LIT REV, V9, P1693; Silva L, 2015, MAR BIOL, V162, P753, DOI 10.1007/s00227-015-2621-0; Sogard SM, 1997, SIZE SELECTIVE MORTA; Somarakis S, 2017, MAR ECOL PROG SER, DOI [10.3354/meps12328, DOI 10.3354/MEPS12328]; THEILACKER GH, 1989, FISH B-NOAA, V87, P457; THEILACKER GH, 1986, FISH B-NOAA, V84, P1; van der Veer HW, 2010, MAR ECOL PROG SER, V416, P215, DOI 10.3354/meps08786; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANBEEK FA, 1989, HELGOLANDER MEERESUN, V43, P461; VANDERVEER HW, 1993, MAR ECOL PROG SER, V101, P81, DOI 10.3354/meps101081; Diaz MV, 2013, NEOTROP ICHTHYOL, V11, P649, DOI 10.1590/S1679-62252013000300018; Vigliola L, 1998, MAR ECOL PROG SER, V168, P45, DOI 10.3354/meps168045; Wennhage H, 1998, J SEA RES, V39, P103, DOI 10.1016/S1385-1101(97)00011-7; Yandi I, 2015, HELGOLAND MAR RES, V69, P25, DOI 10.1007/s10152-014-0414-3; YUFERA M, 1993, J EXP MAR BIOL ECOL, V169, P259, DOI 10.1016/0022-0981(93)90196-U	93	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222261	10.1371/journal.pone.0222261	http://dx.doi.org/10.1371/journal.pone.0222261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525738	gold, Green Submitted, Green Published			2022-12-27	WOS:000532225700024
J	Kovach, CP; Fletcher, GS; Rudd, KE; Grant, RM; Carlbom, DJ				Kovach, Christopher P.; Fletcher, Grant S.; Rudd, Kristina E.; Grant, Rosemary M.; Carlbom, David J.			Comparative prognostic accuracy of sepsis scores for hospital mortality in adults with suspected infection in non-ICU and ICU at an academic public hospital	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; ORGAN FAILURE ASSESSMENT; INTERNATIONAL CONSENSUS DEFINITIONS; SOFA SCORE; CRITERIA; MULTICENTER	Background Sepsis is a global healthcare challenge and reliable tools are needed to identify patients and stratify their risk. Here we compare the prognostic accuracy of the sepsis-related organ failure assessment (SOFA), quick SOFA (qSOFA), systemic inflammatory response syndrome (SIRS), and national early warning system (NEWS) scores for hospital mortality and other outcomes amongst patients with suspected infection at an academic public hospital. Measurements and main results 10,981 adult patients with suspected infection hospitalized at a U.S. academic public hospital between 2011-2017 were retrospectively identified. Primary exposures were the maximum SIRS, qSOFA, SOFA, and NEWS scores upon inclusion. Comparative prognostic accuracy for the primary outcome of hospital mortality was assessed using the area under the receiver operating characteristic curve (AUROC). Secondary outcomes included mortality in ICU versus non-ICU settings, ICU transfer, ICU length of stay (LOS) >3 days, and hospital LOS >7 days. Adjusted analyses were performed using a model of baseline risk for hospital mortality. 774 patients (7.1%) died in hospital. Discrimination for hospital mortality was highest for SOFA (AUROC 0.90 [95% CI, 0.89-0.91]), followed by NEWS (AUROC 0.85 [95% CI, 0.84-0.86]), qSOFA (AUROC 0.84 [95% CI, 0.83-0.85]), and SIRS (AUROC 0.79 [95% CI, 0.78-0.81]; p<0.001 for all comparisons). NEWS (AUROC 0.94 [95% CI, 0.93-0.95]) outperformed other scores in predicting ICU transfer (qSOFA AUROC 0.89 [95% CI, 0.87-0.91]; SOFA AUROC, 0.84 [95% CI, 0.82-0.87]; SIRS AUROC 0.81 [95% CI, 0.79-0.83]; p<0.001 for all comparisons). NEWS (AUROC 0.86 [95% CI, 0.85-0.86]) was also superior to other scores in predicting ICU LOS >3 days (SOFA AUROC 0.84 [95% CI, 0.83-0.85; qSOFA AUROC, 0.83 [95% CI, 0.83-0.84]; SIRS AUROC, 0.75 [95% CI, 0.74-0.76]; p<0.002 for all comparisons). Conclusions Multivariate prediction scores, such as SOFA and NEWS, had greater prognostic accuracy than qSOFA or SIRS for hospital mortality, ICU transfer, and ICU length of stay. Complex sepsis scores may offer enhanced prognostic performance as compared to simple sepsis scores in inpatient hospital settings where more complex scores can be readily calculated.	[Kovach, Christopher P.; Rudd, Kristina E.; Carlbom, David J.] Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98115 USA; [Fletcher, Grant S.] Univ Washington, Dept Med, Div Hosp Med, Seattle, WA USA; [Rudd, Kristina E.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA USA; [Grant, Rosemary M.] Harborview Med Ctr, Profess Dev & Nursing Excellence, Seattle, WA USA; [Kovach, Christopher P.] Univ Colorado, Dept Med, Div Cardiol, Aurora, CO USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harborview Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Kovach, CP (corresponding author), Univ Washington, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98115 USA.	christopher.kovach@cuanschutz.edu	Rudd, Kristina/AFM-0440-2022; Zixuan, Huang/ABI-3557-2020; Rudd, Kristina/AAH-2770-2022; Kovach, Christopher Paul/L-8869-2019	Rudd, Kristina/0000-0002-6695-8401; Rudd, Kristina/0000-0002-6695-8401; Kovach, Christopher Paul/0000-0003-0685-6515	National Institutes of Health National Heart Lung and Blood Institute [T32HL007287]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER	National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	KER was supported through a T32 training grant (T32HL007287) by the National Institutes of Health National Heart Lung and Blood Institute (https://www.nhlbi.nih.gov/).No funding bodies had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chaudhary NS, 2018, CRIT CARE MED, V46, P878, DOI 10.1097/CCM.0000000000003020; Churpek MM, 2017, CRIT CARE MED, V45, P1805, DOI 10.1097/CCM.0000000000002648; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Fernando SM, 2018, ANN INTERN MED, V168, P266, DOI 10.7326/M17-2820; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Hatfield KM, 2018, CRIT CARE MED, V46, P1753, DOI [10.1097/CCM.0000000000003324, 10.1097/ccm.0000000000003324]; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Keegan MT, 2011, CRIT CARE MED, V39, P163, DOI 10.1097/CCM.0b013e3181f96f81; KOLLEF MH, 1994, CRIT CARE CLIN, V10, P1; Liao MM, 2014, AM J EMERG MED, V32, P1319, DOI 10.1016/j.ajem.2014.07.035; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Paoli CJ, 2018, CRIT CARE MED, V46, P1889, DOI 10.1097/CCM.0000000000003342; Pietropaoli AP, 2010, GENDER MED, V7, P422, DOI 10.1016/j.genm.2010.09.005; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Redfern OC, 2018, CRIT CARE MED, V46, P1923, DOI 10.1097/CCM.0000000000003359; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rudd KE, 2018, JAMA-J AM MED ASSOC, V319, P2202, DOI 10.1001/jama.2018.6229; Rudd KE, 2017, JAMA-J AM MED ASSOC, V318, P1228, DOI 10.1001/jama.2017.13697; Sbiti-Rohr D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-011021; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Szakmany T, 2018, ANAESTHESIA, V73, P195, DOI 10.1111/anae.14062; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Yealy DM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0335-2	35	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222563	10.1371/journal.pone.0222563	http://dx.doi.org/10.1371/journal.pone.0222563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525224	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700036
J	Singh, DR; Harvey, CM; Bohara, P; Nath, D; Singh, S; Szabo, S; Karki, K				Singh, Devendra Raj; Harvey, Chloe M.; Bohara, Pushpalata; Nath, Dhirendra; Singh, Sunita; Szabo, Sylvia; Karki, Kshitij			Factors associated with newborn care knowledge and practices in the upper Himalayas	PLOS ONE			English	Article							NEONATAL-MORTALITY; NEPAL; MOTHERS; PERCEPTIONS; SURVIVAL; DISTRICT; SAFETY; HOME	Background Globally, neonatal deaths remain a major public health challenge and account for the majority of deaths occurring among children under five years of age. Despite Nepal's significant achievements in meeting the maternal and child health targets of the Millennium Development Goals, an estimated 23,000 Nepalese children under five years die every year, with three out of five babies dying within the first 28 days of life. This study therefore aimed to examine the level of knowledge and practices of newborn care among Nepalese mothers in the upper Himalayas and the factors associated with these. Materials and methods A community based cross-sectional study was conducted among 302 randomly selected mothers with children under two years of age in Tripurasundari Municipality of Dolpa district, an upper Himalayan region of Nepal. Mothers were interviewed using semi-structured questionnaires. Mean score for knowledge and Bloom's criteria for practice were considered to categorize newborn care knowledge and practices. Multivariate logistic regression was used to identify factors associated with the newborn care knowledge and practices. Results In this study, 147 (48.7%) of the mothers were found to have inadequate knowledge of newborn care, while 102 (33.8%) mothers had reported unsatisfactory newborn care practices. Mothers with at least secondary level of formal education were more likely to possess adequate newborn care knowledge compared to mothers who never attended school (AOR 4.93 at 95% CI 1.82-13.33). Mothers whose first pregnancy occurred between the ages of 20-24 years (AOR 3.89 at 95% CI 1.81-8.37) were also more likely to possess adequate newborn care knowledge, compared to mothers with a younger age at first pregnancy. Furthermore, mothers who had completed at least four ANC visits (AOR 2.89 at 95% CI 1.04-7.96), mothers who had completed three PNC visits (AOR 2.79 at 95% CI 1.16-6.72) and mothers who reported that their nearest health facility was less than one hour (30-59 minutes) walking distance (AOR 3.66 at 95% CI 1.43-9.33) had higher odds of having adequate newborn care knowledge. Similarly, mothers whose household monthly income was more than $100 (AOR 4.17 at 95% CI 1.75-9.69), mothers who had completed three PNC visits (AOR 3.27 at 95% CI 1.16-9.20) and mothers with adequate newborn care knowledge (AOR 15.35 at 95% CI 5.82-40.47) were found to be more likely to practice a satisfactory level of newborn care practices in adjusted analysis. Conclusion The study revealed high prevalence of inadequate newborn care and knowledge amongst mothers in upper Himalayan dwellings. Approximately one third of all interviewed mothers practiced suboptimal newborn care. The results indicate an urgent need to increase awareness of neonatal services available to mothers and to prioritize investments by local governments in neonatal health services, in order to improve accessibility and quality of care for mothers and newborns.	[Singh, Devendra Raj; Bohara, Pushpalata; Karki, Kshitij] Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal; [Singh, Devendra Raj; Nath, Dhirendra] Southeast Asia Dev Act Network SADAN, Res & Innovat Sect, Lalitpur, Nepal; [Harvey, Chloe M.; Szabo, Sylvia] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Singh, Sunita] Minist Hlth & Populat, Sukraraj Trop & Infect Dis Hosp, Kathmandu, Nepal; [Szabo, Sylvia] Asian Inst Technol, Dept Dev & Sustainabil, Pathum Thani, Thailand; [Karki, Kshitij] Grp Tech Assistance, Program & Res Dept, Lalitpur, Nepal	University of Southampton; Asian Institute of Technology	Singh, DR (corresponding author), Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal.; Singh, DR (corresponding author), Southeast Asia Dev Act Network SADAN, Res & Innovat Sect, Lalitpur, Nepal.	dsingh3797@gmail.com	Nath, Dhirendra/X-7398-2018; Singh, Devendra Raj/R-2197-2019; Karki, Kshitij/ABE-7737-2020	Nath, Dhirendra/0000-0001-5481-4550; Singh, Devendra Raj/0000-0003-1450-9476; Harvey, Chloe Mercedes/0000-0002-3732-2973; Karki, Kshitij/0000-0002-6039-8909				Abdullahi A, 2016, INT J GEN MED, V9, P79, DOI 10.2147/IJGM.S98436; Acharya LB, 2000, HEALTH POLICY PLANN, V15, P223, DOI 10.1093/heapol/15.2.223; Al-Ayed IH, 2010, J FAM COMMUNITY MED, V17, P22, DOI 10.4103/1319-1683.68785; Bennett J, 1999, INT J EPIDEMIOL, V28, P1172, DOI 10.1093/ije/28.6.1172; Berhe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175902; Berhea TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202542; Beun MH, 2003, J HEALTH POPUL NUTR, V21, P367; Bhattarai B, 2008, MARRIAGE FAM REV, V44, P318, DOI 10.1080/01494920802255943; BLOOM BENJAMIN S., 1956, HDB 1 COGNITIVE DOMA; Central Bureau of Statistics, 2014, NAT POP HOUS CENS 20; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Family Health Division, 2009, AAM SUR PROGR POL GU; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Gul S, 2014, INT J HEALTH SCI-IJH, V8, P167, DOI 10.12816/0006083; Kaphle S, 2013, MIDWIFERY, V29, P1173, DOI 10.1016/j.midw.2013.06.002; Kibaru Elizabeth Gathoni, 2016, BMC Res Notes, V9, P481; Lamichhane R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3922-z; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mehata S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1532-0; Ministry of Health and Population; New ERA; and ICF, 2011, NEP DEM HLTH SURV 20, DOI [10.1007/978-94-6091-391-4_15, DOI 10.1007/978-94-6091-391-4_15]; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Misgna HG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0931-y; MoHP[Nepal], 2016, NEP EV NEWB ACT PLAN; Mullany LC, 2005, J TROP PEDIATRICS, V51, P82, DOI 10.1093/tropej/fmh083; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; National Planning Commission, 2016, NEP MILL DEV GOALS F; Neupane S, 2014, J EPIDEMIOL GLOB HEA, V4, P213, DOI 10.1016/j.jegh.2014.02.001; Paudel D, 2011, TRENDS DETERMINANTS; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Sharma SR, 2014, BMC PUBLIC HEALTH, V14, P1, DOI [10.1186/1471-2458-14-1, DOI 10.1186/1471-2458-14-1]; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; UNICEF, 2016, STATE WORLDS CHILDRE; United Nations, 2016, SUST DEV GOALS REP; United Nations Children's Fund; National Planning Commission, 2015, MON SIT CHILDR WOM N; V. D. of Health, 2017, ANN SCH SELF REP IMM; WHO, 2017, WHO REC NEWB HLTH; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2019, WORLD HLTH STAT MON	39	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222582	10.1371/journal.pone.0222582	http://dx.doi.org/10.1371/journal.pone.0222582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525242	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700039
J	Campos-Garcia, I; Zuniga-Vicente, JA				Campos-Garcia, Irene; Angel Zuniga-Vicente, Jose			The female presence in different organisational positions and performance in secondary schools: Does a woman leader function as mediator?	PLOS ONE			English	Article							GENDER DIVERSITY; FIRM PERFORMANCE; DEMOGRAPHIC DIVERSITY; RELATIONAL DEMOGRAPHY; STUDENT-ACHIEVEMENT; SOCIAL DESIRABILITY; TEACHER GENDER; WOMEN; SEX; MEN	This study examines the relationship between female representation in different organisational positions and performance using a sample of Spanish secondary schools. These organizations have been usually depicted as 'feminised environments' although women in managerial positions are still underrepresented. Based on different theoretical approaches, we separately investigate the relationship between a greater female presence and school performance in three positions: a) as principal; b) on the management team; and c) as teachers. We also investigate if having a female leader exerts a significant mediator role on the relationship between greater female representation on the management team and teachers, respectively, and school performance. Our results reveal a positive and significant relationship between having a woman principal or a greater proportion of women teachers and school performance. However, the relationship between a high proportion of women on the management team and school performance is negative. We also find that a female principal does not play a significant role as mediator in the relationship between having a greater proportion of women on the management team and as teachers and school performance.	[Campos-Garcia, Irene; Angel Zuniga-Vicente, Jose] Rey Juan Carlos Univ, Fac Legal & Social Sci, Business Adm ADO Appl Econ & Fdn Econ Anal 2, Madrid, Spain	Universidad Rey Juan Carlos	Zuniga-Vicente, JA (corresponding author), Rey Juan Carlos Univ, Fac Legal & Social Sci, Business Adm ADO Appl Econ & Fdn Econ Anal 2, Madrid, Spain.	joseangel.zuniga@urjc.es	; , Jose Angel/H-2823-2015	ZUNIGA-VICENTE, Jose Angel/0000-0002-6783-8348; , Jose Angel/0000-0003-1567-9549	Ministry of Economy and Competitiveness (Spain) [ECO2015-67434-R]; Ministry of Science, Innovation and Universities (Spain) [RTI2018-097447-B-I00]	Ministry of Economy and Competitiveness (Spain); Ministry of Science, Innovation and Universities (Spain)	This paper was financially supported by the Ministry of Economy and Competitiveness (Spain) (Reference: ECO2015-67434-R) and Ministry of Science, Innovation and Universities (Spain) (Reference: RTI2018-097447-B-I00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All errors are our own.	Abeler J., 2016, 10188 IZA; Adams RB, 2009, J FINANC ECON, V94, P291, DOI 10.1016/j.jfineco.2008.10.007; Addi A., 1992, TRANSFORMATIONS, V3, P5; Addi-Raccah A, 2006, EDUC ADMIN QUART, V42, P291, DOI 10.1177/0013161X05284042; Ali M, 2011, INT J HUM RESOUR MAN, V22, P1464, DOI 10.1080/09585192.2011.561961; Ameen EC, 1996, J BUS ETHICS, V15, P591, DOI 10.1007/BF00381934; [Anonymous], DISCOURSE STUDIES CU, DOI DOI 10.1080/0159630960170304; [Anonymous], 2018, FORBES; Arfken DE, 2004, J BUS ETHICS, V50, P177, DOI 10.1023/B:BUSI.0000022125.95758.98; Badal S, 2014, J LEADERSH ORG STUD, V21, P354, DOI 10.1177/1548051813504460; Balafoutas L, 2012, SCIENCE, V335, P579, DOI 10.1126/science.1211180; BALLOU D, 1995, ECON EDUC REV, V14, P243, DOI 10.1016/0272-7757(95)00005-5; BANTEL KA, 1989, STRATEGIC MANAGE J, V10, P107, DOI 10.1002/smj.4250100709; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baron-Cohen S, 2005, GRAN DIFERENCIA COMO; Bastian KC, 2015, EDUC ADMIN QUART, V51, P600, DOI 10.1177/0013161X14562213; Bilimoria D., 2000, WOMEN MANAGEMENT CUR, VII, P138, DOI https://doi.org/10.4135/9781446219775.n10; Bitterman A, 2013, 2013313 NCES; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Brunner CC, 2000, EDUC ADMIN QUART, V36, P76, DOI 10.1177/0013161X00361004; Byron K, 2016, CORP GOV-OXFORD, V24, P428, DOI 10.1111/corg.12165; Campos-Garcia I, 2017, REV COMPLUT EDUC, V28, P1009, DOI 10.5209/RCED.51000; Capraro V, 2017, COGN PROCESS, V18, P399, DOI 10.1007/s10339-017-0822-9; Catalyst, 2019, PERC WOM SEN ROL DEC; Catalyst, 2014, WOM BOARD DIR; Chrobot-Mason D, 2013, GROUP ORGAN MANAGE, V38, P659, DOI 10.1177/1059601113509835; Coleman M., 2008, INT HDB PREPARATION, P119; Cook A, 2014, GENDER WORK ORGAN, V21, P91, DOI 10.1111/gwao.12018; Court M., 1994, GENDER WORK ORGAN, V1, P33, DOI [DOI 10.1111/J.1468-0432.1994.TB00004.X, 10.1111/j.1468-0432.1994.tb00004.x]; Cox, 1993, CULTURAL DIVERSITY O; Cox Jr T., 2001, CREATING MULTICULTUR; Davison HK, 2000, J VOCAT BEHAV, V56, P225, DOI 10.1006/jvbe.1999.1711; Dawson J, 2016, PATIENT-RELAT OUTCOM, V7, DOI 10.2147/PROM.S115488; Dawson LM, 1997, J BUS ETHICS, V16, P1143, DOI 10.1023/A:1005721916646; De Dreu CKW, 2001, J APPL PSYCHOL, V86, P1191, DOI 10.1037//0021-9010.86.6.1191; Debon Lamarque S, 1996, ORG GESTION ED, V2, P8; Dee TS, 2007, J HUM RESOUR, V42, P528, DOI 10.3368/jhr.XLII.3.528; Dee TS, 2005, AM ECON REV, V95, P158, DOI 10.1257/000282805774670446; Deloitte, 2017, WOM BOARDR GLOB PERS; den Brok P, 2004, SCH EFF SCH IMPROV, V15, P407, DOI 10.1080/09243450512331383262; DENMARK FL, 1993, PSYCHOL WOMEN QUART, V17, P343, DOI 10.1111/j.1471-6402.1993.tb00491.x; DiTomaso N, 2007, ANNU REV SOCIOL, V33, P473, DOI 10.1146/annurev.soc.33.040406.131805; Dwyer S, 2003, J BUS RES, V56, P1009, DOI 10.1016/S0148-2963(01)00329-0; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eagly AH, 2003, LEADERSHIP QUART, V14, P807, DOI 10.1016/j.leaqua.2003.09.004; EAGLY AH, 1984, J PERS SOC PSYCHOL, V46, P735, DOI 10.1037/0022-3514.46.4.735; Eagly Alice H., 2007, LABYRINTH TRUTH WOME; EIGE, 2016, ADV GEND EQ POL DEC; Eriksson-Zetterquist U, 2008, GENDER WORK ORGAN, V15, P133, DOI 10.1111/j.1468-0432.2007.00366.x; Fennell HA, 2002, J EDUC ADMIN, V40, P95; Frink DD, 2003, GROUP ORGAN MANAGE, V28, P127, DOI 10.1177/1059601102250025; FURNHAM A, 1986, PERS INDIV DIFFER, V7, P385, DOI 10.1016/0191-8869(86)90014-0; Gallant A, 2014, GENDER WORK ORGAN, V21, P203, DOI 10.1111/gwao.12030; GRANT RM, 1988, STRATEGIC MANAGE J, V9, P639, DOI 10.1002/smj.4250090610; Green R, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015591707; Green SG, 1996, ORGAN BEHAV HUM DEC, V66, P203, DOI 10.1006/obhd.1996.0049; Hall V., 1994, ANNU M AM EDUC RES; Hallinger P, 2016, EDUC ADMIN QUART, V52, P567, DOI 10.1177/0013161X16638430; Herring C, 2009, AM SOCIOL REV, V74, P208, DOI 10.1177/000312240907400203; Hillman AJ, 2007, ACAD MANAGE J, V50, P941; Hirschfeld RR, 2005, PERS PSYCHOL, V58, P893, DOI 10.1111/j.1744-6570.2005.00892.x; Hoogendoorn S, 2013, MANAGE SCI, V59, P1514, DOI 10.1287/mnsc.1120.1674; Horwitz S.K., 2005, HUM RESOUR DEV REV, V4, P219, DOI [10.1177/1534484305275847, DOI 10.1177/1534484305275847]; Husain AN, 2018, W25263 NAT BUR EC RE; ILO, 2018, WORLD EMPL SOC OUTL; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; Jeong SH, 2017, ACAD MANAGE J, V60, P1219, DOI 10.5465/amj.2014.0716; Joecks J, 2013, J BUS ETHICS, V118, P61, DOI 10.1007/s10551-012-1553-6; JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502; KANTER RM, 1977, AM J SOCIOL, V82, P965, DOI 10.1086/226425; Kantola J., 2017, GENDER EC CRISIS EUR; Kaparou M., 2007, COMPARE, V37, P221, DOI DOI 10.1080/03057920601165587; Khan WA, 2013, J ECON BUS, V67, P55, DOI 10.1016/j.jeconbus.2013.01.003; Korabik K AbbondanzaM, 2004, NEW THEORY SUPPLANTS; Kramer V.W., 2007, CRITICAL MASS CORPOR, P2; Kruger ML, 2008, INT J LEADERSH EDUC, V11, P155, DOI 10.1080/13603120701576266; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lam YHR, 2010, TEACH TEACH EDUC, V26, P754, DOI 10.1016/j.tate.2009.10.010; Leana CR, 2006, ORGAN SCI, V17, P353, DOI 10.1287/orsc.1060.0191; Lee J, 2019, J DEV STUD, V55, P661, DOI 10.1080/00220388.2018.1453604; Lee L-E, 2015, WOMEN BOARDS GLOBAL; LEE VE, 1993, EDUC EVAL POLICY AN, V15, P153, DOI 10.2307/1164419; Limerick B., 1995, GENDER CHANGING ED M; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Marczynski JC, 2013, J EDUC ADMIN, V51, P705, DOI 10.1108/JEA-03-2012-0036; MARQUARDT DW, 1975, AM STAT, V29, P3, DOI 10.2307/2683673; Marsh H., 2005, AUST J EDUC, V49, P320, DOI [DOI 10.1177/000494410504900308, 10.1177/000494410504900308]; McNamara O., 2008, WOMEN TEACHERS CAREE; McNeilly K.M., 2000, J PERS SELL SALES M, VXX, P279; MECD, 2016, PISA 2015 PROGR EV I; MECD, 2017, EST PROF OTR PERS; Miller T, 2009, J MANAGE STUD, V46, P755, DOI 10.1111/j.1467-6486.2009.00839.x; Milliken FJ, 1996, ACAD MANAGE REV, V21, P402, DOI 10.2307/258667; Montero A, 2010, REV ESP PEDAGOG, V247, P417; Moreau MP, 2007, GENDER EDUC, V19, P237, DOI 10.1080/09540250601166092; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; OECD, 2018, EMPL JOB TEN INT AV; Olsen JE, 2016, GROUP ORGAN MANAGE, V41, P271, DOI 10.1177/1059601115583579; Organization for Economic Co-operation and Development (OECD), 2019, DISTR TEACH AG GEND; Orlitzky M, 2003, ACAD MANAG LEARN EDU, V2, P128, DOI 10.5465/AMLE.2003.9901665; PARK KH, 1990, J ECON EDUC, V21, P101, DOI 10.2307/1181978; Pelled LH, 1996, ORGAN SCI, V7, P615, DOI 10.1287/orsc.7.6.615; Pilcher J. K., 1994, ED ASSESSMENT, V2, P69, DOI DOI 10.1207/S15326977EA0201_4; Pletzer JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130005; Post C, 2015, ACAD MANAGE J, V58, P1546, DOI 10.5465/amj.2013.0319; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Regan H.B., 1995, OUT WOMENS EXPERIENC; Richard OC, 2007, STRATEGIC MANAGE J, V28, P1213, DOI 10.1002/smj.633; Rivkin SG, 2005, ECONOMETRICA, V73, P417, DOI 10.1111/j.1468-0262.2005.00584.x; Rumberger RW, 2005, AM EDUC RES J, V42, P3, DOI 10.3102/00028312042001003; Shakeshaft C., 1987, WOMEN ED ADM; Skrla L, 2000, J EDUC POLICY, V15, P293, DOI 10.1080/02680930050030446; Sork VL, 1997, FEMINISM EVOLUTIONAR, P86; Spilt JL, 2012, J SCHOOL PSYCHOL, V50, P363, DOI 10.1016/j.jsp.2011.12.002; Strom RO, 2014, J BANK FINANC, V42, P60, DOI 10.1016/j.jbankfin.2014.01.014; Swann WB, 2004, ACAD MANAGE REV, V29, P9, DOI 10.2307/20159006; TERBORG JR, 1977, ACAD MANAGE J, V20, P89, DOI 10.2307/255464; The Commonwealth, 2016, ADV GEND EQ CAS STUD; Roman GT, 2015, ESTUD ECONOMIA, V42, P99, DOI 10.4067/S0718-52862015000100005; Trinidad C., 2005, LEADERSH ORG DEV J, V26, P574, DOI DOI 10.1108/01437730510624601; TSUI AS, 1989, ACAD MANAGE J, V32, P402, DOI 10.2307/256368; TSUI AS, 1992, ADMIN SCI QUART, V37, P549, DOI 10.2307/2393472; Tsui AS, 2002, HUM RELAT, V55, P899, DOI 10.1177/0018726702055008176; UN, 2016, PROGR WORLDS WOM 201; UNESCO, 2019, GLOB ED MON REP; UNESCO, 2019, ED PERC FEM TEACH TE; Van den Brink M, 2014, SCAND J MANAG, V30, P163, DOI 10.1016/j.scaman.2013.07.001; WATSON WE, 1993, ACAD MANAGE J, V36, P590, DOI 10.2307/256593; Watt HMG, 2008, LEARN INSTR, V18, P408, DOI 10.1016/j.learninstruc.2008.06.002; Wayne AJ, 2003, REV EDUC RES, V73, P89, DOI 10.3102/00346543073001089; Wegge J, 2008, J APPL PSYCHOL, V93, P1301, DOI 10.1037/a0012680; West TV, 2012, J EXP SOC PSYCHOL, V48, P1209, DOI 10.1016/j.jesp.2012.04.012; Wikstrom C, 2005, ECON EDUC REV, V24, P309, DOI 10.1016/j.econedurev.2004.04.010; Williams KY, 1998, RES ORGAN BEHAV, V20, P77; Williamson R, 2001, NAT COUNC PROF ED AD; Winn P, 2009, SCH LEADERSHIP REV, V4, P36; Winters MA, 2013, ECON EDUC REV, V34, P69, DOI 10.1016/j.econedurev.2013.01.007; Zelechowski DD, 2004, CORP GOV-OXFORD, V12, P337, DOI 10.1111/j.1467-8683.2004.00374.x; Ziomec R.L., 1997, B RES BRIEF MARCH, P105	143	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222411	10.1371/journal.pone.0222411	http://dx.doi.org/10.1371/journal.pone.0222411			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557182	gold, Green Submitted, Green Published			2022-12-27	WOS:000532345500018
J	Facer-Irwin, E; Blackwood, NJ; Bird, A; Dickson, H; McGlade, D; Alves-Costa, F; MacManus, D				Facer-Irwin, Emma; Blackwood, Nigel J.; Bird, Annie; Dickson, Hannah; McGlade, Daniel; Alves-Costa, Filipa; MacManus, Deirdre			PTSD in prison settings: A systematic review and meta-analysis of comorbid mental disorders and problematic behaviours	PLOS ONE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; TRAUMA-EXPOSURE; PSYCHIATRIC COMORBIDITY; PERSONALITY-DISORDER; HEALTH PROBLEMS; SELF-HARM; SYMPTOMS; PREVALENCE; PSYCHOPATHY; VIOLENCE	Purpose Prevalence rates of PTSD are higher in the prison population than in the community. We sought to systematically review the extent to which this disorder is associated with other mental health disorders and problematic suicidal or aggressive behaviours in the prison population. Methods Studies reporting a relationship between PTSD and comorbid mental disorders and/or problematic behaviours in imprisoned adolescent and adult populations were identified from four bibliographic indexes. Primary studies involving clinical interviews, validated instruments leading to DSM or ICD diagnoses, or validated self-report questionnaires such as the PTSD checklist were included. Random-effects meta-analysis was conducted where possible. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Results This review identified 36 studies, with a combined sample of 9594 participants, (6478 male and 2847 female prisoners) from 11 countries. Thirty-four of the identified studies employed a cross-sectional design. We identified significant associations between PTSD and comorbid mental disorders including depression (OR = 3.4, 95% confidence interval (CI): 2.3-4.9), anxiety (OR = 2.9, 95% confidence interval (CI): 1.8-4.7) and substance use (OR = 1.9, 95% confidence interval (CI): 1.5-2.4). We also identified significant associations between PTSD and suicidality (OR = 3, 95% confidence interval (CI): 2.4-3.8) and aggressive behaviours (this latter finding was not subject to meta-analysis). Significant methodological heterogeneity was identified between studies. Conclusions High rates of psychiatric comorbidity among prisoners with PTSD, and links to suicidal behaviour, self-harm and aggressive behaviour, provide further support for the need for trauma-informed treatment approaches in prisons. However, significant gaps in the current evidence were apparent. In particular, a lack of large, longitudinal studies meant that the temporal relationships between PTSD and relevant outcomes cannot currently be determined.	[Facer-Irwin, Emma; Blackwood, Nigel J.; Bird, Annie; Dickson, Hannah; McGlade, Daniel; Alves-Costa, Filipa; MacManus, Deirdre] Kings Coll London, Dept Forens & Neurodev Sci, Inst Psychiat Psychol & Neurosci, London, England	University of London; King's College London	Facer-Irwin, E (corresponding author), Kings Coll London, Dept Forens & Neurodev Sci, Inst Psychiat Psychol & Neurosci, London, England.	emma.facer-irwin@kcl.ac.uk	Lorente, Rosa/AAL-5850-2021	Dickson, Hannah/0000-0002-4156-9506; Alves-Costa, Filipa/0000-0002-4031-3859; Facer-Irwin, Emma/0000-0002-3709-5141; Blackwood, Nigel/0000-0002-5909-203X; MacManus, Deirdre/0000-0003-4903-9638	King's College London Studentship Award	King's College London Studentship Award	This research was funded by a King's College London Studentship Award to EFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram KM, 2007, PSYCHIAT SERV, V58, P1311, DOI 10.1176/appi.ps.58.10.1311; Abram KM, 2004, ARCH GEN PSYCHIAT, V61, P403, DOI 10.1001/archpsyc.61.4.403; Ardino V, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21382; Ariga M, 2008, J CHILD PSYCHOL PSYC, V49, P79, DOI 10.1111/j.1469-7610.2007.01817.x; Baranyi G, 2018, EPIDEMIOL REV, V40, P134, DOI 10.1093/epirev/mxx015; Becker SP, 2011, J CLIN CHILD ADOLESC, V40, P765, DOI 10.1080/15374416.2011.597091; Branson CE, 2017, PSYCHOL TRAUMA-US, V9, P635, DOI 10.1037/tra0000255; Brewin CR, 2017, CLIN PSYCHOL REV; Briere J, 2016, PSYCHOL TRAUMA-US, V8, P439, DOI 10.1037/tra0000107; Caraballo JN, 2013, INT J PRISON HEALTH, V9, P196, DOI 10.1108/IJPH-02-2013-0004; Cloitre M, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.20706; Collins J. J., 1990, J TRAUMA STRESS, DOI [10.1007/BF00975146, DOI 10.1007/BF00975146]; Contractor AA, 2018, COMPR PSYCHIAT, V80, P202, DOI 10.1016/j.comppsych.2017.10.005; Debell F, 2014, SOC PSYCH PSYCH EPID, V49, P1401, DOI 10.1007/s00127-014-0855-7; Dixon A, 2005, J AM ACAD CHILD PSY, V44, P798, DOI 10.1097/01.chi.0000164590.48318.9c; Donley S, 2012, J AM ACAD PSYCHIATRY, V40, P522; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0; First M.B., 2015, STRUCTURED CLIN INTE; Ford JD, 2018, J TRAUMA DISSOCIATIO, V19, P325, DOI 10.1080/15299732.2018.1441354; Giarratano P, 2020, J INTERPERS VIOLENCE, V35, P1133, DOI 10.1177/0886260517692995; Gibson LE, 1999, J TRAUMA STRESS, V12, P473, DOI 10.1023/A:1024767020280; Gillikin C, 2016, J PSYCHIATR RES, V83, P1, DOI 10.1016/j.jpsychires.2016.07.027; Gobin RL, 2015, INT J PRISON HEALTH, V11, P64, DOI 10.1108/IJPH-06-2014-0016; Greene CA, 2014, CHILD ABUSE NEGLECT, V38, P1569, DOI 10.1016/j.chiabu.2014.07.006; Hamerlynck SMJJ, 2008, PSYCHIAT RES, V159, P77, DOI 10.1016/j.psychres.2007.03.001; Harner HM, 2015, PSYCHOL TRAUMA-US, V7, P58, DOI 10.1037/a0032508; Hawton K, 2014, LANCET, V383, P1147, DOI 10.1016/S0140-6736(13)62118-2; Heffernan E, 2015, J TRAUMATIC STRESS; Howard R, 2017, CLIN PSYCHOL PSYCHOT, V24, P942, DOI 10.1002/cpp.2058; Howard R, 2017, SOC PSYCH PSYCH EPID, V52, P21, DOI 10.1007/s00127-016-1293-5; Huang GP, 2006, COMPR PSYCHIAT, V47, P20, DOI 10.1016/j.comppsych.2005.04.004; Jakobowitz S, 2017, SOC PSYCH PSYCH EPID, V52, P231, DOI 10.1007/s00127-016-1313-5; Karatzias T, 2018, CRIM BEHAV MENT HEAL, V28, P72, DOI 10.1002/cbm.2043; Kerig PK, 2016, J TRAUMA STRESS, V29, P111, DOI 10.1002/jts.22087; Kerig PK, 2009, J YOUTH ADOLESCENCE, V38, P1214, DOI 10.1007/s10964-008-9332-5; Kimonis ER, 2011, CHILD YOUTH CARE FOR, V40, P381, DOI 10.1007/s10566-010-9121-7; Kronish IM, 2012, J PSYCHIATR RES, V46, P1595, DOI 10.1016/j.jpsychires.2012.06.011; Kuanliang A, 2008, CRIM JUSTICE STUD, V21, P27, DOI 10.1080/14786010801972662; Kubiak SP, 2004, RES SOCIAL WORK PRAC, V14, P424, DOI 10.1177/1049731504265837; Levenson JS, 2019, J AGGRESS MALTREAT T, V28, P481, DOI 10.1080/10926771.2018.1531959; Loney P L, 1998, Chronic Dis Can, V19, P170; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; MacManus D, 2013, LANCET, V381, P907, DOI 10.1016/S0140-6736(13)60354-2; Marx BP., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Marzano L, 2016, PREVENTION SUICIDAL; McCallum K, 2018, J FORENSIC PRACT, V20, P229, DOI 10.1108/JFP-12-2017-0055; Mellesdal L, 2015, J TRAUMA STRESS, V28, P556, DOI 10.1002/jts.22053; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore E, 2016, J ATTEN DISORD, V20, P958, DOI 10.1177/1087054713506263; Moore E, 2013, CHILD ABUSE NEGLECT, V37, P861, DOI 10.1016/j.chiabu.2013.07.012; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Panagioti M, 2015, SOC PSYCH PSYCH EPID, V50, P525, DOI 10.1007/s00127-014-0978-x; Perez-Pedrogo C, 2018, PSYCHIAT RES, V265, P208, DOI 10.1016/j.psychres.2018.04.017; Plattner B, 2007, J CLIN PSYCHIAT, V68, P1593, DOI 10.4088/JCP.v68n1019; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sharf A, 2014, J PSYCHOPATHOL BEHAV, V36, P401, DOI 10.1007/s10862-013-9404-z; Shepherd SM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6074-5; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Stewart SH, 1998, ADDICT BEHAV, V23, P797, DOI 10.1016/S0306-4603(98)00070-7; Stimmel MA, 2014, PSYCHOL TRAUMA-US, V6, P184, DOI 10.1037/a0032509; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Tyler N, 2019, SOC PSYCH PSYCH EPID, V54, P1143, DOI 10.1007/s00127-019-01690-1; Ulzen T, 2003, Can Child Adolesc Psychiatr Rev, V12, P113; Wahlstrom LC, 2015, J DUAL DIAGN, V11, P118, DOI 10.1080/15504263.2015.1025026; Warren JI, 2009, J AM ACAD PSYCHIATRY, V37, P294; Willemsen J, 2012, INT J OFFENDER THER, V56, P505, DOI 10.1177/0306624X11407443; Wing J., 1994, SCHEDULES CLIN ASSES; Wolff N, 2014, J URBAN HEALTH, V91, P707, DOI 10.1007/s11524-014-9871-x; Wolff N, 2010, PSYCHOL INJ LAW, V3, P155, DOI 10.1007/s12207-010-9077-9; Woodfield R, 2016, INT J PRISON HEALTH, V12, P244, DOI 10.1108/IJPH-06-2016-0020; Yoon IA, 2017, J CONSULT CLIN PSYCH, V85, P783, DOI 10.1037/ccp0000214; Zammit S, 2018, BRIT J PSYCHIAT, V212, P11, DOI 10.1192/bjp.2017.8; Zlotnick C, 1997, J NERV MENT DIS, V185, P761, DOI 10.1097/00005053-199712000-00007	75	26	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222407	10.1371/journal.pone.0222407	http://dx.doi.org/10.1371/journal.pone.0222407			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557173	gold, Green Published			2022-12-27	WOS:000532345500017
J	Jarman, R; Mattioni, C; Russell, K; Chambers, FM; Bartlett, D; Martin, MA; Cherubini, M; Villani, F; Webb, J				Jarman, Rob; Mattioni, Claudia; Russell, Karen; Chambers, Frank M.; Bartlett, Debbie; Martin, M. Angela; Cherubini, Marcello; Villani, Fiorella; Webb, Julia			DNA analysis of Castanea sativa (sweet chestnut) in Britain and Ireland: Elucidating European origins and genepool diversity	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR L.; GENETIC DIVERSITY; CHLOROPLAST DNA; POSTGLACIAL COLONIZATION; PAIRWISE RELATEDNESS; POPULATION-STRUCTURE; BRITISH-ISLES; MILL.; REFUGIA; DOMESTICATION	Castanea sativa is classified as non-indigenous in Britain and Ireland. It was long held that it was first introduced into Britain by the Romans, until a recent study found no corroborative evidence of its growing here before c. AD 650. This paper presents new data on the genetic diversity of C. sativa in Britain and Ireland and potential ancestral sources in continental Europe. Microsatellite markers and analytical methods tested in previous European studies were used to genotype over 600 C. sativa trees and coppice stools, sampled from ancient semi-natural woodlands, secondary woodlands and historic cultural sites across Britain and Ireland. A single overall genepool with a diverse admixture of genotypes was found, containing two sub groups differentiating Wales from Ireland, with discrete geographical and typological clusters. C. sativa genotypes in Britain and Ireland were found to relate predominantly to some sites in Portugal, Spain, France, Italy and Romania, but not to Greece, Turkey or eastern parts of Europe. C. sativa has come to Britain and Ireland from these western European areas, which had acted as refugia in the Last Glacial Maximum; we compare its introduction with the colonization/translocation of oak, ash, beech and hazel into Britain and Ireland. Clones of C. sativa were identified in Britain, defining for the first time the antiquity of some ancient trees and coppice stools, evincing both natural regeneration and anthropogenic propagation over many centuries and informing the chronology of the species' arrival in Britain. This new evidence on the origins and antiquity of British and Irish C. sativa trees enhances their conservation and economic significance, important in the context of increasing threats from environmental change, pests and pathogens.	[Jarman, Rob; Chambers, Frank M.; Webb, Julia] Univ Gloucestershire, Sch Nat & Social Sci, Ctr Environm Change & Quaternary Res, Cheltenham, Glos, England; [Mattioni, Claudia; Cherubini, Marcello; Villani, Fiorella] CNR, Ist Ric Ecosistemi Terrestri IRET, Porano, Italy; [Russell, Karen] K Russell Consulting Ltd, Huntingdon, England; [Bartlett, Debbie] Univ Greenwich, Fac Engn & Sci, Chatham, England; [Martin, M. Angela] Univ Cordoba, Dept Genet, Cordoba, Spain	University of Gloucestershire; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sugli Ecosistemi Terrestri (IRET); University of Greenwich; Universidad de Cordoba	Jarman, R (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Ctr Environm Change & Quaternary Res, Cheltenham, Glos, England.	rjarman1@glos.ac.uk	Martín, M. Angela/K-2157-2014	Martín, M. Angela/0000-0002-2674-9111; Jarman, Rob/0000-0002-3560-1266; MATTIONI, CLAUDIA/0000-0002-7009-9224; Webb, Julia/0000-0002-1652-965X	University of Greenwich (UK); Future Trees Trust (FTT)	University of Greenwich (UK); Future Trees Trust (FTT)	RJ received funding for this study from the University of Greenwich (UK). The Future Trees Trust (FTT) funded Karen Russell `KR' (K Russell Consulting Ltd) to provide samples from the FTT collection for DNA analysis. DNA analysis was undertaken by Dr Claudia Mattioni 'CM' (IRET), whose laboratory costs for this project were contributed to by FTT; RJ and KR prepared a preliminary report to FTT. FTT also supported Rob Jarman `RJ' (University of Gloucestershire) by contributing to the laboratory costs of DNA analysis of the Historic trees samples, undertaken by Dr Claudia Mattioni (IRET). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript	Ally D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000454; [Anonymous], 2013, NFI PREL EST QUANT B; [Anonymous], 2012, LIME TREES BASSWOODS; [Anonymous], 2017, ANC TREE INV; Lopez-Saez JA, 2017, VEG HIST ARCHAEOBOT, V26, P167, DOI 10.1007/s00334-016-0575-x; Aravanopoulos Filippos A., 2001, Forest Snow and Landscape Research, V76, P429; Barreneche T, 2004, THEOR APPL GENET, V108, P558, DOI 10.1007/s00122-003-1462-2; Beare Philip O Sullivan, 2009, NATURAL HIST IRELAND; Beccaro GL, 2012, SILVAE GENET, V61, P292, DOI 10.1515/sg-2012-0037; Garzon MB, 2007, ECOGRAPHY, V30, P120, DOI [10.1111/j.2006.0906-7590.04813.x, 10.1111/j.0906-7590.2007.04813.x]; Boccacci P, 2009, GENET RESOUR CROP EV, V56, P851, DOI 10.1007/s10722-009-9406-6; Botanical Society of Britain & Ireland, BSBI DISTR DAT; Bounous G., 2005, Horticultural Reviews, V31, P291; Brown JA, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1079-7; Buck EJ, 2003, MOL ECOL NOTES, V3, P239, DOI 10.1046/j.1471-8286.2003.00410.x; Buck EJ, 2006, THESIS; Buckley P., 2004, ENGL NAT RES REP; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Commission Forestry, REG PROV NAT SEED ZO; Conedera M, 2004, VEG HIST ARCHAEOBOT, V13, P161, DOI 10.1007/s00334-004-0038-7; Conedera M, 2016, EUROPEAN ATLAS FORES; CUNLIFFE B, 2009, PROCEEDINGS OF THE P, V75, P55; Diez CM, 2015, NEW PHYTOL, V206, P436, DOI 10.1111/nph.13181; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernandez-Cruz J, 2012, CONSERV GENET, V13, P1589, DOI 10.1007/s10592-012-0408-0; Fineschi S, 2003, CAN J FOREST RES, V33, P2503, DOI 10.1139/X03-179; Forbes AC, 1932, P ROY IRISH ACAD C, V41, P168; Godwin H., 1975, HIST BRIT FLORA; Harmer R., 1995, 259 RIN FOR AUTH; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Huntley B., 1983, ATLAS PRESENT POLLEN; Jarman R, 2019, BRITANNIA-CAMBRIDGE, V50, P49, DOI 10.1017/S0068113X19000011; Jarman R, 2017, COST ACTION FP1301 R, DOI [10.13140/RG.2.2.32665.42080, DOI 10.13140/RG.2.2.32665.42080]; Jarman R, 2018, DENDROCHRONOLOGIA, V51, P10, DOI 10.1016/j.dendro.2018.07.001; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krebs P, 2019, QUATERNARY SCI REV, V206, P111, DOI 10.1016/j.quascirev.2019.01.002; Kremer A., 2015, INT OAKS, V26, P19; Ledger PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121517; Lowe Andrew, 2005, Botanical Journal of Scotland, V57, P59; Lusini I, 2014, CONSERV GENET, V15, P283, DOI 10.1007/s10592-013-0537-0; Lynch M, 1999, GENETICS, V152, P1753; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Marinoni D, 2003, MOL BREEDING, V11, P127, DOI 10.1023/A:1022456013692; Martin MA, 2010, TREE GENET GENOMES, V6, P735, DOI 10.1007/s11295-010-0287-9; Mattioni C, 2008, TREE GENET GENOMES, V4, P563, DOI 10.1007/s11295-008-0132-6; Mattioni C, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1123-2; Miller AC, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu065; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Packham JR, 2012, J ECOL, V100, P1557, DOI 10.1111/j.1365-2745.2012.02017.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PEETERS AG, 1988, GRANA, V27, P203, DOI 10.1080/00173138809428927; Pereira-Lorenzo S, 2019, ANN APPL BIOL, V174, P74, DOI 10.1111/aab.12474; Pereira-Lorenzo S, 2012, HANDB PLANT BREED, V8, P729, DOI 10.1007/978-1-4419-0763-9_19; Perica M, 2017, TREE GENET GENOMES, V13, P1; Perrier X., 2006, DARWIN SOFTWARE; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; PIGOTT M, 2017, TREE GENET GENOMES, V13, P28, DOI [10.1016/J.56854, DOI 10.1016/J.56854]; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Rackham O., 2003, ANCIENT WOODLAND; Rackham O, 2006, WOODLANDS; Rambaut A, 2016, FIGTREE VERSION 1 4; Ramos-Cabrer A. M., 2006, Advances in Horticultural Science, V20, P113; Rippon S., 2013, LANDSCAPES, V14, P33, DOI 10.1179/1466203513Z.0000000005; Roces-Diaz JV, 2018, PALAEOGEOGR PALAEOCL, V491, P152, DOI 10.1016/j.palaeo.2017.12.004; Rousset F., GENEPOP WEB; Silva Evelyn J., 1706, DISCOURSE FOREST TRE; Sjolund MJ, 2017, J BIOGEOGR, V44, P2475, DOI 10.1111/jbi.13053; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Squatriti P, 2013, LANDSCAPE AND CHANGE IN EARLY MEDIEVAL ITALY: CHESTNUTS, ECONOMY, AND CULTURE, P1; Stace C.A., 2015, ALIEN PLANTS; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Vaughan SP, 2007, FOREST ECOL MANAG, V242, P419, DOI 10.1016/j.foreco.2007.01.059; Wang J, 2017, HEREDITY, V119, P302, DOI 10.1038/hdy.2017.52	79	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222936	10.1371/journal.pone.0222936	http://dx.doi.org/10.1371/journal.pone.0222936			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553775	Green Accepted, Green Published, gold			2022-12-27	WOS:000532319200046
J	Gaspard, P; Mosnier, A; Simon, L; Ali-Brandmeyer, O; Rabaud, C; Larocca, S; Heck, B; Aho-Glele, S; Pothier, P; Ambert-Balay, K				Gaspard, Philippe; Mosnier, Anne; Simon, Loic; Ali-Brandmeyer, Olivia; Rabaud, Christian; Larocca, Sabrina; Heck, Beatrice; Aho-Glele, Serge; Pothier, Pierre; Ambert-Balay, Katia			Gastroenteritis and respiratory infection outbreaks in French nursing homes from 2007 to 2018: Morbidity and all-cause lethality according to the individual characteristics of residents	PLOS ONE			English	Article							CARE FACILITIES; INFLUENZA; MORTALITY; NOROVIRUS; EPIDEMIOLOGY; DEATHS; ADULTS	Background Gastroenteritis (GE) and respiratory tract infection (RTI) outbreaks are a significant issue in nursing homes. This study aimed to describe GE and RTI outbreaks with infection and all-cause lethality rates according to the individual characteristics of nursing home residents. Methods Clinical and virological surveillance were conducted (2007 to 2018). Virus stratifications for the analysis were: outbreaks with positive norovirus or influenza identifications (respectively NoV+ or Flu+), episodes with no NoV or influenza identification or testing (respectively No-Vor Flu-). Associations between individual variables (sex, age, length of stay (LOS), autonomy status) and infection and lethality rates were tested with univariate and Mantel-Haenszel (MH) methods. Results 61 GE outbreaks and 76 RTI oubreaks (total 137 outbreaks) were recorded involving respectively 4309 and 5862 residents. In univariate analysis, higher infection rates and age were associated in NoV+, NoV-, and Flu+ contexts, and lower infection rates were associated with longer stays (NoV+ and NoV-). In MH stratified analysis (virus, sex (female/male)) adjusted for LOS (< 4 or.4 years), the odds of being infected remained significant among older residents (.86 years): NoV+/male (Odds ratio (ORMH): 1.64, 95% confidence interval (CI): 1.16-2.30) and Flu+/female and male (respectively ORMH: 1.50, CI: 1.27-1.79 and 1.73, CI: 1.28-2.33). In univariate analysis, lower autonomy status (NoV+, Flu+ and Flu-) and increased age (Flu+) were associated with higher lethality. In MH adjusted analysis, significant ORage adjusted for autonomy was: Flu+/>= 86 years compared with <86 years, 1.97 (1.19-3.25) and ORautonomy adjusted for age for the more autonomous group (compared with the less autonomous group) was: Flu+, 0.41 (0.24-0.69); Flu-, 0.42 (0.20, 0.90). Conclusion The residents of nursing homes are increasingly elderly and dependent. The specific infection and lethality risks according to these two factors indicate that surveillance and infection control measures are essential and of high priority.	[Gaspard, Philippe; Larocca, Sabrina; Heck, Beatrice] Rouffach Hosp Ctr, Hosp Hyg Serv, Rouffach, France; [Gaspard, Philippe] Univ Franche Comte, UMR Chronoenvironm 6249, Besancon, France; [Mosnier, Anne] Open Rome, Paris, France; [Simon, Loic; Ali-Brandmeyer, Olivia; Rabaud, Christian] Nancy Univ Hosp, Coordinat Ctr Nosocomial Infect Control, Eastern Reg, Nancy, France; [Aho-Glele, Serge] Dijon Univ Hosp, Dept Epidemiol & Infect Control, Dijon, France; [Pothier, Pierre; Ambert-Balay, Katia] Univ Burgundy Franche Comte, AgroSup Dijon, PAM UMR A 02 102, Dijon, France; [Pothier, Pierre; Ambert-Balay, Katia] Univ Hosp, Natl Reference Ctr Gastroenteritis Viruses, Lab Biol & Pathol, Dijon, France	Universite de Franche-Comte; CHU de Nancy; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne	Gaspard, P (corresponding author), Rouffach Hosp Ctr, Hosp Hyg Serv, Rouffach, France.; Gaspard, P (corresponding author), Univ Franche Comte, UMR Chronoenvironm 6249, Besancon, France.	ph.gaspard@ch-rouffach.fr	Serge, Aho Glele Ludwig/AAP-8863-2021; AHO, ludwig/AAR-5753-2021	Serge, Aho Glele Ludwig/0000-0001-7590-8644; 				Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Barret AS, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.29.20859; Benaim C., 2005, Annales de Readaptation et de Medecine Physique, V48, P336, DOI 10.1016/j.annrmp.2005.04.005; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC; Campe H, 2016, EPIDEMIOL INFECT, V144, P1045, DOI 10.1017/S0950268815002228; Casalegno J, 2017, EUROSURVEILLANCE, V22, P26, DOI [10.2807/1560-7917.ES.2017.22.14.30504, 10.2807/1560-7917.es.2017.22.14.30504]; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; European Centre for Disease Prevention and Control, PROT POINT PREV SURV; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Friesema IHM, 2009, EPIDEMIOL INFECT, V137, P1722, DOI 10.1017/S095026880900274X; Gaspard P, 2015, J HOSP INFECT, V91, P19, DOI 10.1016/j.jhin.2015.05.012; Gaspard P, 2015, PRESSE MED, V44, pE311, DOI 10.1016/j.lpm.2015.04.041; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Institut national de veille sanitaire, ENQ NAT PREV 2006 IN; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Montoya Ana, 2011, Aging health, V7, P889; Petrignani M, 2015, J HOSP INFECT, V89, P163, DOI 10.1016/j.jhin.2014.11.015; Rainwater-Lovett K, 2014, INFLUENZA OTHER RESP, V8, P74, DOI 10.1111/irv.12203; Rondy M, 2017, J INFECTION, V75, P381, DOI 10.1016/j.jinf.2017.09.010; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; Ursic T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1962-8; Utsumi M, 2010, AGE AGEING, V39, P299, DOI 10.1093/ageing/afq029; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af	28	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222321	10.1371/journal.pone.0222321	http://dx.doi.org/10.1371/journal.pone.0222321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550261	gold, Green Published			2022-12-27	WOS:000532307700013
J	Welch, D; Kahen, E; Fridley, B; Brohl, AS; Cubitt, CL; Reed, DR				Welch, Darcy; Kahen, Elliot; Fridley, Brooke; Brohl, Andrew S.; Cubitt, Christopher L.; Reed, Damon R.			Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines	PLOS ONE			English	Article							GENOMIC LANDSCAPE; TRIAL; GROWTH; OSTEOSARCOMA; CHEMOTHERAPY; PANOBINOSTAT; ANTAGONIST; MECHANISM	Ewing Sarcoma (ES) is characterized by recurrent translocations between EWSR1 and members of the ETS family of transcription factors. The transcriptional activity of the fusion oncoprotein is dependent on interaction with the nucleosome remodeling and deactylase (NuRD) co-repressor complex. While inhibitors of both histone deacetylase (HDAC) and lysine-specific demethylase-1 (LSD1) subunits of the NuRD complex demonstrate single agent activity in preclinical models, combination strategies have not been investigated. We selected 7 clinically utilized chemotherapy agents, or active metabolites thereof, for experimentation: doxorubicin, cyclophosphamide, vincristine, etoposide and irinotecan as well as the HDAC inhibitor romidepsin and the reversible LSD1 inhibitor SP2509. All agents were tested at clinically achievable concentrations in 4 ES cell lines. All possible 2 drug combinations were then tested for potential synergy. Order of addition of second-line conventional combination therapy agents was tested with the addition of SP2509. In two drug experiments, synergy was observed with several combinations, including when SP2509 was paired with topoisomerase inhibitors or romidepsin. Addition of SP2509 after treatment with second-line combination therapy agents enhanced treatment effect. Our findings suggest promising combination treatment strategies that utilize epigenetic agents in ES.	[Welch, Darcy; Kahen, Elliot; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Sunshine Lab, Tampa, FL 33612 USA; [Welch, Darcy; Kahen, Elliot; Cubitt, Christopher L.] H Lee Moffitt Canc Ctr & Res Inst, Translat Res Core, Tampa, FL USA; [Fridley, Brooke] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Brohl, Andrew S.; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA; [Brohl, Andrew S.; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA; [Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Adolescent & Young Adult Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Sunshine Lab, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Adolescent & Young Adult Program, Tampa, FL 33612 USA.	damon.reed@moffitt.org	Brohl, Andrew/ABB-6710-2020	Reed, Damon/0000-0002-8238-2465; Cubitt, Christopher/0000-0001-6343-7451	National Pediatric Cancer Foundation; Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	National Pediatric Cancer Foundation; Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was generously supported by the National Pediatric Cancer Foundation (www.nationalpcf.org). This work has been supported in part by the Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center (P30-CA076292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaqer SF, 2017, ONCOTARGET, V8, P73372, DOI 10.18632/oncotarget.19637; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Cassier PA, 2013, BRIT J CANCER, V109, P909, DOI 10.1038/bjc.2013.442; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; El-Najjar Nahed, 2011, J Chem Biol, V4, P97, DOI 10.1007/s12154-010-0052-4; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fang J, 2013, AAPS J, V15, P15, DOI 10.1208/s12248-012-9409-7; Feng ZZ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0252-7; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Franzetti GA, 2017, ONCOGENE, V36, P3505, DOI 10.1038/onc.2016.498; Goldsby RE, 2013, EUR J CANCER, V49, P2384, DOI 10.1016/j.ejca.2013.03.018; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Gupta S, 2016, PROSTATE CANCER P D, V19, P349, DOI 10.1038/pcan.2016.21; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Haydn T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.239; Kahen E, 2016, CANCER CHEMOTH PHARM, V78, P313, DOI 10.1007/s00280-016-3077-8; Kalin JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02242-4; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; McGrath JP, 2016, CANCER RES, V76, P1975, DOI 10.1158/0008-5472.CAN-15-2333; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Palmerini E, 2018, ACTA ONCOL, V57, P958, DOI 10.1080/0284186X.2018.1449250; Pishas KI, 2018, MOL CANCER THER, V17, P1902, DOI 10.1158/1535-7163.MCT-18-0373; Reed DR, 2017, CANCER-AM CANCER SOC, V123, P2206, DOI 10.1002/cncr.30589; Romo-Morales A, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27888; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar S, 2014, CLIN CANCER RES, V20, P4584, DOI 10.1158/1078-0432.CCR-14-0072; Sato T, 2017, CANCER RES, V77, P470, DOI 10.1158/0008-5472.CAN-16-0834; Sehrawat A, 2018, P NATL ACAD SCI USA, V115, pE4179, DOI 10.1073/pnas.1719168115; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Sonnemann J, 2018, BRIT J HAEMATOL, V183, P494, DOI 10.1111/bjh.14983; Thomas S, 2016, ANN ONCOL, V27, P947, DOI 10.1093/annonc/mdw044; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Wagner LM, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-015-0035-x; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Yu D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16991; Zollner SK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8429	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222228	10.1371/journal.pone.0222228	http://dx.doi.org/10.1371/journal.pone.0222228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550266	Green Published, gold			2022-12-27	WOS:000532307700011
J	Bo, AB; Kim, JD; Kim, YS; Sin, HT; Kim, HJ; Khaitov, B; Ko, YK; Park, KW; Choi, JS				Bo, Aung B.; Kim, Jae D.; Kim, Young S.; Sin, Hun T.; Kim, Hye J.; Khaitov, Botir; Ko, Young K.; Park, Kee W.; Choi, Jung S.			Isolation, identification and characterization of Streptomyces metabolites as a potential bioherbicide	PLOS ONE			English	Article							HERBICIDAL ACTIVITY; BIOLOGICAL-CONTROL; PATHOGENS; AGENTS; RESISTANT; WEEDS	Bioactive herbicidal compounds produced by soil microorganisms might be used to creating a bioherbicide for biological weed control. A total of 1,300 bacterial strains were isolated and screened for herbicidal activity against grass and broadleaf weeds. Among primarily selected 102 strains, the herbicidal activity of bacterial fermentation broths from the following three isolates strain-101, strain-128, and strain-329 reduced the growth of D. sanguinalis by 66.7%, 78.3%, and 100%, respectively as compared with control. Phylogenetic analysis of 16S rRNA gene sequencing determined that the strain-329 has 99% similarity to Streptomyces anulatus (HBUM 174206). The potential bioherbicidal efficacy of Streptomyces strain-329 was tested on grass and broadleaf weeds for phytotoxic activity through pre- and post-emergence applications. At pre-emergence application, the phytotoxic efficacy to D. sanguinalis and S. bicolor on seed germination were 90.4% and 81.3%, respectively at the 2x concentration, whereas in the case of Solanum nigrum, 85.2% phytotoxic efficacy was observed at the 4x concentration. The efficacy of Streptomyces strain-329 was substantially higher at post-emergence application, presenting 100% control of grass and broadleaf weeds at the 1x concentration. Two herbicidal compounds coded as 329-C1 and 329-C3 were extracted and purified by column chromatography and high-performance liquid chromatography methods. The active compound 329-C3 slightly increased leaf electrolytic leakage and MDA production as concentration-dependent manner. These results suggest that new Streptomyces sp. strain-329 produced bioherbicidal metabolites and may provide a new lead molecule for production an efficient bioherbicide to regulate grass and broadleaf weeds.	[Bo, Aung B.; Sin, Hun T.; Khaitov, Botir; Park, Kee W.] Chungnam Natl Univ, Dept Crop Sci, Daejeon, South Korea; [Kim, Jae D.; Kim, Young S.; Kim, Hye J.; Ko, Young K.; Choi, Jung S.] Korea Res Inst Chem Technol, Ecofriendly & New Mat Res Grp, Daejeon, South Korea	Chungnam National University; Korea Research Institute of Chemical Technology (KRICT)	Park, KW (corresponding author), Chungnam Natl Univ, Dept Crop Sci, Daejeon, South Korea.; Choi, JS (corresponding author), Korea Res Inst Chem Technol, Ecofriendly & New Mat Res Grp, Daejeon, South Korea.	parkkw@cnu.ac.kr; jschoi@krict.re.kr		Khaitov, Botir/0000-0001-6314-1597; Park, Kee Woong/0000-0003-0053-9543	grant "Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration, Republic of Korea [PJ013479]	grant "Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration, Republic of Korea	This work was supported by a grant "Cooperative Research Program for Agriculture Science & Technology Development (PJ013479)" from Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasu MV, 2009, J MYCOL MED, V19, P22, DOI 10.1016/j.mycmed.2008.12.002; Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Buege J A, 1978, Methods Enzymol, V52, P302; CAI XY, 2016, HORTICULTURAE, V2, DOI DOI 10.1104/PP.108.118372; CHRISTY AL, 1993, ACS SYM SER, V524, P87; Chun JC, 2002, PESTIC BIOCHEM PHYS, V72, P153, DOI 10.1016/S0048-3575(02)00008-1; Daguerre Y, 2014, FUNGAL BIOL REV, V28, P97, DOI 10.1016/j.fbr.2014.11.001; Daniel JJ, 2018, BIOCATAL AGR BIOTECH, V14, P314, DOI 10.1016/j.bcab.2018.04.001; Dayan FE, 2008, PLANT PHYSIOL, V147, P1062, DOI 10.1104/pp.108.118372; DEFRANK J, 1985, WEED SCI, V33, P271, DOI 10.1017/S0043174500082242; Dhanasekaran D., 2012, Archives of Phytopathology and Plant Protection, V45, P505, DOI 10.1080/03235408.2011.587988; El-Sayed MG, 2014, J AM SCI, V10, P11, DOI [10.1111/j.1574-6976.2012.00349.x, DOI 10.1111/J.1574-6976.2012.00349.X]; El-Sayed W, 2005, Z PFLANZENK PFLANZEN, V112, P209; Ghorbani R, 2005, ADV AGRON, V86, P191, DOI 10.1016/S0065-2113(05)86004-3; Ha S, 2017, J MICROBIOL BIOTECHN, V27, P947, DOI 10.4014/jmb.1611.11005; Harding DP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00659; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; HEISEY RM, 1985, ACS SYM SER, V268, P337; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hoagland R. E., 2016, American Journal of Plant Sciences, V7, P2376, DOI 10.4236/ajps.2016.716208; Hwang EI, 2005, J MICROBIOL BIOTECHN, V15, P434; Igarashi M, 1997, J ANTIBIOT, V50, P1020, DOI 10.7164/antibiotics.50.1020; Isrvan U., 2002, PHYTOPARASITICA, V30, P1; Ji Y G, 2006, BIOTECHNOLOGY, V16, P88; KUSTER E., 1963, MICROBIOL ESPANOLA, V16, P193; Lee Boyoung, 2013, Weed & Turfgrass Science, V2, P38; Lee HB, 2003, LETT APPL MICROBIOL, V36, P387, DOI 10.1046/j.1472-765X.2003.01327.x; NAKAJIMA M, 1991, J ANTIBIOT, V44, P293, DOI 10.7164/antibiotics.44.293; Rana SS, 2016, PRINCIPLES PRACTICES, P138; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sondhia S, 2003, J GEOBIOS, V30, P173; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Subhashini DV, 2012, INDIAN J AGR SCI, V82, P12; Todero I, 2018, SCI HORTIC-AMSTERDAM, V241, P285, DOI 10.1016/j.scienta.2018.07.009; Vasilakoglou IB, 2000, WEED TECHNOL, V14, P524, DOI 10.1614/0890-037X(2000)014[0524:PRBECG]2.0.CO;2; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Won OJ, 2016, J FAC AGR KYUSHU U, V61, P47; Xu WP, 2009, WEED SCI, V57, P547, DOI 10.1614/WS-08-154.1; Yandoc CB, 2005, WEED TECHNOL, V19, P19, DOI 10.1614/WT-03-104R1; Yasuor H, 2008, PEST MANAG SCI, V64, P1031, DOI 10.1002/ps.1604	40	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222933	10.1371/journal.pone.0222933	http://dx.doi.org/10.1371/journal.pone.0222933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545849	Green Published, gold			2022-12-27	WOS:000532303200042
J	Rees, JMB; Wood, AM; Dudbridge, F; Burgess, S				Rees, Jessica M. B.; Wood, Angela M.; Dudbridge, Frank; Burgess, Stephen			Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates	PLOS ONE			English	Article							BODY-MASS INDEX; INSTRUMENTAL VARIABLES; CHOLESTEROL; INDIVIDUALS; INSIGHTS; ALLELE; RISK	Methods have been developed for Mendelian randomization that can obtain consistent causal estimates under weaker assumptions than the standard instrumental variable assumptions. The median-based estimator and MR-Egger are examples of such methods. However, these methods can be sensitive to genetic variants with heterogeneous causal estimates. Such heterogeneity may arise from over-dispersion in the causal estimates, or specific variants with outlying causal estimates. In this paper, we develop three extensions to robust methods for Mendelian randomization with summarized data: 1) robust regression (MM-estimation); 2) penalized weights; and 3) Lasso penalization. Methods using these approaches are considered in two applied examples: one where there is evidence of over-dispersion in the causal estimates (the causal effect of body mass index on schizophrenia risk), and the other containing outliers (the causal effect of low-density lipoprotein cholesterol on Alzheimer's disease risk). Through an extensive simulation study, we demonstrate that robust regression applied to the inverse-variance weighted method with penalized weights is a worthwhile additional sensitivity analysis for Mendelian randomization to provide robustness to variants with outlying causal estimates. The results from the applied examples and simulation study highlight the importance of using methods that make different assumptions to assess the robustness of findings from Mendelian randomization investigations with multiple genetic variants.	[Rees, Jessica M. B.; Wood, Angela M.; Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England; [Rees, Jessica M. B.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh Clin Trials Unit, Edinburgh EH16 4UX, Midlothian, Scotland; [Dudbridge, Frank] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Burgess, Stephen] Univ Cambridge, MRC Biostat Unit, Cambridge CB2 0SR, England	University of Cambridge; University of Edinburgh; University of Leicester; MRC Biostatistics Unit; University of Cambridge	Burgess, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge CB1 8RN, England.; Burgess, S (corresponding author), Univ Cambridge, MRC Biostat Unit, Cambridge CB2 0SR, England.	sb452@medschl.cam.ac.uk	Wood, Angela/GZA-5762-2022	Wood, Angela/0000-0002-7937-304X; Burgess, Stephen/0000-0001-5365-8760	Sir Henry Dale Fellowship - Wellcome Trust [204623/Z/16/Z]; Sir Henry Dale Fellowship - Royal Society [204623/Z/16/Z]; MRC [MC_UU_00002/7] Funding Source: UKRI	Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Stephen Burgess is supported by Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 204623/Z/16/Z).	Allison DB, 1999, J CLIN PSYCHIAT, V60, P215, DOI 10.4088/JCP.v60n0402; ANGRIST JD, 1995, J AM STAT ASSOC, V90, P431, DOI 10.2307/2291054; BENN M, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1648; Bowden J, 2018, INT J EPIDEMIOLOGY; Bowden J, 2018, AM J EPIDEMIOL, V187, P2681, DOI 10.1093/aje/kwy185; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z; Burgess S, 2013, STAT MED, V32, P4726, DOI 10.1002/sim.5871; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Cheng X, 2015, J ECONOMETRICS, V186, P443, DOI 10.1016/j.jeconom.2015.02.019; Coodin S, 2001, CAN J PSYCHIAT, V46, P549, DOI 10.1177/070674370104600610; Dai JY, 2018, AM J EPIDEMIOL, V187, P2672, DOI 10.1093/aje/kwy177; Del Greco MF, 2015, STAT MED, V34, P2926, DOI 10.1002/sim.6522; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Goeman J., 2017, PENALIZED L1 LASSO F; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hartwig FP, 2016, SCI REP-UK, V6, DOI 10.1038/srep32730; Hemani G, 2018, HUM MOL GENET, V27, pR195, DOI 10.1093/hmg/ddy163; Huber P. J., 2009, ROBUST STAT; Kang H, 2016, J AM STAT ASSOC, V111, P132, DOI 10.1080/01621459.2014.994705; Kolesar M, 2015, J BUS ECON STAT, V33, P474, DOI 10.1080/07350015.2014.978175; Koller M, 2011, COMPUT STAT DATA AN, V55, P2504, DOI 10.1016/j.csda.2011.02.014; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Slob EAW, 2019, BIORXIV, DOI [10.1101/577940v1.full, 10.1101/577940v1, DOI 10.1101/577940V1]; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Solomon A, 2007, NEUROLOGY, V68, P751, DOI 10.1212/01.wnl.0000256368.57375.b7; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vansteelandt S, 2011, STAT SCI, V26, P403, DOI 10.1214/11-STS360; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Windmeijer F, 2019, J AM STAT ASSOC, V114, P1339, DOI 10.1080/01621459.2018.1498346; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	44	34	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222362	10.1371/journal.pone.0222362	http://dx.doi.org/10.1371/journal.pone.0222362			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545794	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000532303200014
J	Eren, C				Eren, Canan			An analysis on HBsAg, Anti-HCV, Anti-HIV1/2 and VDRL test results in blood donors according to gender, age range and years	PLOS ONE			English	Article							TRANSFUSION-TRANSMISSIBLE INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; B-VIRUS; SEROPREVALENCE; SYPHILIS	Objective Blood transfusion is the most frequently used and life-saving therapeutic procedure today. Transmission of virus, bacteria and parasitic microorganisms may occur due to transfusion (Transfusion transmitted infections-TTIs). Hepatitis B and C, human immunodeficiency virus (HIV) and syphilis (Treponema pallidum) bear the risk of transmission by transfusion. Hepatitis B surface antigen (HBsAg), anti-HCV, anti-HIV 1/2 and syphilis antibody (VDRL: Venereal Disease Research Laboratory) are routinely controlled in all donated blood samples. The aim of the present study was to analyze the seroprevalence rates of blood donors through screening test results according to duration, age range and gender. Material and methods Data of all blood donors obtained from blood Centre of Marmara University Pendik Training and Research Hospital between January 2013 and October 2018 were analyzed retrospectively. Serum samples of the donors were analyzed for HBsAg, anti-HCV, anti-HIV 1/2 and VDRL. Test results of 114.240 donors were scanned. Gender, age range and distribution by years of these donors were analyzed. According to age distribution of donors were divided into 4 groups. Results There were 114.240 participants including 106.153 (92.9%) males and 8.087 (7.1%) females. The positivity rate of HBsAg was detected 0.4% (36/8087) in females and 0.5% (500/106.153) in males. The positivity rate of anti-HCV was detected 0.4% (32/8.087) in females and 0.3% (344/106.153) in males. The positivity rate of anti HIV 1/2 was 0.1% (9/ 8.087) in females and 0.1% (92/106.153) in males whereas the positivity rate of VDRL was 0.5% (41/8.087) in females and 0.3% (362/ 106.153) in males. Positivity rate for HBsAg and HCV were lower in the cases between 18 and 30 years of age. The positivity rates for antiHIV 1/2 was not significantly different according to the age range. Positivity rate for VDRL was higher in the cases at 51 years of age and older. Conclusion No difference was found between men and women in terms of HBsAg, anti-HCV and antiHIV 1/2 positivity. However, VDRL test positivity was significantly higher in female participants. Furthermore, HBsAg, anti-HCV and VDRL positivity rates increased by age.	[Eren, Canan] Marmara Univ Pend Training & Res Hosp, Med Microbiol & Blood Ctr, Istanbul, Turkey		Eren, C (corresponding author), Marmara Univ Pend Training & Res Hosp, Med Microbiol & Blood Ctr, Istanbul, Turkey.	cananeren21@gmail.com	Eren, Canan/AAA-8964-2021	Eren, Canan/0000-0003-4726-8840				Agus N, 2008, ANKEM, V22, P7; Akcam FZ, 2009, INT J INFECT DIS, V13, P274, DOI 10.1016/j.ijid.2008.07.005; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Cao WW, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3051-7; Chandekar Sushama A, 2017, J Lab Physicians, V9, P283, DOI 10.4103/0974-2727.214246; Diarra A, 2009, TRANSFUS CLIN BIOL, V16, P444, DOI 10.1016/j.tracli.2009.09.004; Egglestone S I, 2000, Commun Dis Public Health, V3, P158; Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x; Gureser A. S., 2015, Turk Hijyen ve Deneysel Biyoloji Dergisi, V72, P123, DOI 10.5505/TurkHijyen.2015.30974; Icel O, 2016, OTSBD, V1, P1; Kader C, 2010, KLIMIK J, V23, P95, DOI 10.5152/kd.2010.27; Niazi SUK, 2016, 12 ANN C AS ASS TRAN, P368; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Okoroiwu HU, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5555-x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seitz R, 2010, TRANSFUS MED HEMOTH, V37, P112, DOI 10.1159/000314497; Sheikh MY, 2013, GUT LIVER, V7, P66, DOI 10.5009/gnl.2013.7.1.66; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Temiz H., 2008, Infeksiyon Dergisi = Turkish Journal of Infection, V22, P79; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Turan H, 2011, KLIMIK J, V24, P36, DOI 10.5152/kd.2011.07; Umolu Patience Idia, 2005, Afr Health Sci, V5, P55; Uzun B, 2013, TRANSFUS APHER SCI, V49, P511, DOI 10.1016/j.transci.2013.02.039; van der Bij AK, 2006, TRANSFUSION, V46, P1729, DOI 10.1111/j.1537-2995.2006.00964.x; World Health Organization, BLOOD SAF AV; World Health Organization, 2015, REP GLOB SEX TRANSM	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219709	10.1371/journal.pone.0219709	http://dx.doi.org/10.1371/journal.pone.0219709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536507	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800011
J	Harris, S; Lucas, C				Harris, Sarah; Lucas, Chris			Understanding the variability of Australian fire weather between 1973 and 2017	PLOS ONE			English	Article							SOUTHERN ANNULAR MODE; INDIAN-OCEAN DIPOLE; GLOBAL SURFACE-TEMPERATURE; EL-NINO; EXTRATROPICAL CIRCULATION; DECADAL MODULATION; EASTERN AUSTRALIA; ENSO; CLIMATE; OSCILLATION	Australian fire weather shows spatiotemporal variability on interannual and multi-decadal time scales. We investigate the climate factors that drive this variability using 39 station-based historical time series of the seasonal 90th-percentile of the McArthur Forest Fire Danger Index (FFDI) extending from 1973 through 2017. Using correlation analyses, we examine the relationship of these time series to the El Nino Southern Oscillation (ENSO), the Southern Annular Mode (SAM) and the Indian Ocean Dipole (IOD), considering both concurrent and time-lagged relationships. Additionally, longer term behaviour of the time series using linear trend analysis is discussed in the context of the climate drivers, Interdecadal Pacific Oscillation (IPO) and anthropogenic climate change. The results show that ENSO is the main driver for interannual variability of fire weather, as defined by FFDI in this study, for most of Australia. In general, El Nino-like conditions lead to more extreme fire weather, with this effect stronger in eastern Australia. However, there are significant regional variations to this general rule. In NSW, particularly along the central coast, negative SAM is a primary influence for elevated fire weather in late-winter and spring. In the southeast (VIC and TAS), the El Nino-like impact is exacerbated when positive IOD conditions are simultaneously observed. The spring conditions are key, and strongly influence what is observed during the following summer. On longer time scales (45 years), linear trends are upward at most stations; this trend is strongest in the southeast and during the spring. The positive trends are not driven by the trends in the climate drivers and they are not consistent with hypothesized impacts of the IPO, either before or after its late-1990s shift to the cold phase. We propose that anthropogenic climate change is the primary driver of the trend, through both higher mean temperatures and potentially through associated shifts in large-scale rainfall patterns. Variations from interannual factors are generally larger in magnitude than the trend effects observed to date.	[Harris, Sarah] Country Fire Author, Bushfire Management, Burwood East, Vic, Australia; [Harris, Sarah] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia; [Lucas, Chris] Bur Meteorol, Sci Serv, Melbourne, Vic, Australia	Monash University; Bureau of Meteorology - Australia	Harris, S (corresponding author), Country Fire Author, Bushfire Management, Burwood East, Vic, Australia.; Harris, S (corresponding author), Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia.	sarah.harris@cfa.vic.gov.au		Harris, Sarah/0000-0002-2807-9529; Lucas, Christopher/0000-0003-1101-7249				[Anonymous], 2015, CLIM CHANG AUSTR INF; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Betts AK, 2014, J GEOPHYS RES-ATMOS, V119, P13305, DOI 10.1002/2014JD022511; Black MT, 2016, ATTRIBUTION STUDY SE; Blanchi R, 2014, ENVIRON SCI POLICY, V37, P192, DOI 10.1016/j.envsci.2013.09.013; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; BoM, 2019, IND OC INFL AUSTR CL; BoM, 2019, NIN DET AUSTR AN; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Cai WJ, 2014, NATURE, V510, P254, DOI 10.1038/nature13327; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Chung CTY, 2014, CLIM DYNAM, V42, P1837, DOI 10.1007/s00382-013-1892-8; Clarke H, 2013, INT J CLIMATOL, V33, P931, DOI 10.1002/joc.3480; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; CSIRO, 2018, STAT CLIM 2018; Dai AG, 2015, NAT CLIM CHANGE, V5, P555, DOI 10.1038/nclimate2605; Dowdy AJ, 2017, P 5 INT FIR BEH FUEL; Dowdy AJ, 2018, J APPL METEOROL CLIM, V57, P221, DOI 10.1175/JAMC-D-17-0167.1; Evans S, 2014, J CLIMATE, V27, P8487, DOI 10.1175/JCLI-D-13-00422.1; Felderhof L, 2006, AUSTRAL ECOL, V31, P736, DOI 10.1111/j.1442-9993.2006.01645.x; Fox-Hughes P, 2014, INT J WILDLAND FIRE, V23, P309, DOI 10.1071/WF13126; Gong TT, 2010, J ATMOS SCI, V67, P2854, DOI 10.1175/2010JAS3311.1; Griffiths D., 1999, Australian Forestry, V62, P202; Harris S, 2008, INT J WILDLAND FIRE, V17, P674, DOI 10.1071/WF06160; Harris S, 2014, INT J WILDLAND FIRE, V23, P173, DOI 10.1071/WF13024; Hendon HH, 2007, J CLIMATE, V20, P2452, DOI 10.1175/JCLI4134.1; Henley BJ, 2015, CLIM DYNAM, V45, P3077, DOI 10.1007/s00382-015-2525-1; Hennessy K, 2005, CSIRO MAR ATMOS RES, V91; Hoerling MP, 1997, J CLIMATE, V10, P1769, DOI 10.1175/1520-0442(1997)010<1769:ENOLNA>2.0.CO;2; Hope P., 2017, SYNTHESIS FINDINGS V; Hope P, 2019, B AM METEOROL SOC, V100, pS111, DOI 10.1175/BAMS-D-18-0135.1; Huang BY, 2017, J CLIMATE, V30, P8179, DOI 10.1175/JCLI-D-16-0836.1; Keetch JJ, 1968, SE38 USDA FOR SERV; Kim BM, 2017, ASIA-PAC J ATMOS SCI, V53, P85, DOI 10.1007/s13143-017-0007-6; Lim EP, 2017, CLIM DYNAM, V49, P97, DOI 10.1007/s00382-016-3328-8; Lim EP, 2015, CLIM DYNAM, V44, P2807, DOI 10.1007/s00382-014-2400-5; Lin RP, 2018, ADV ATMOS SCI, V35, P495, DOI 10.1007/s00376-017-7133-z; Love G., 1986, Australian Meteorological Magazine, V34, P93; Lucas C, 2010, 024 CAWCR; Lucas C, 2007, BUSHFIRE WEATHER SE, DOI [10.1109/CSIT.2013.6588776, DOI 10.1109/CSIT.2013.6588776]; Lucas C, 2015, J GEOPHYS RES-ATMOS, V120, P6809, DOI 10.1002/2015JD023130; Lucas C, 2014, WIRES CLIM CHANGE, V5, P89, DOI 10.1002/wcc.251; Lucas C, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017033; Lucas C, 2010, AUST METEOROL OCEAN, V60, P1; Luke R.H., 1978, BUSHFIRES AUSTR; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mariani M, 2016, GEOPHYS RES LETT, V43, P10891, DOI 10.1002/2016GL070572; Mariani M, 2018, GEOPHYS RES LETT, V45, P5071, DOI 10.1029/2018GL078294; Mariani M, 2016, GEOPHYS RES LETT, V43, P1702, DOI 10.1002/2016GL068082; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meehl GA, 2016, NAT CLIM CHANGE, V6, P1005, DOI [10.1038/NCLIMATE3107, 10.1038/nclimate3107]; Nguyen H, 2015, J CLIMATE, V28, P8067, DOI 10.1175/JCLI-D-15-0139.1; Nguyen H., 2017, CLIM DYNAM, V21, P1, DOI [10.1007/s00382-017-3592-2, DOI 10.1007/S00382-017-3592-2, DOI 10.23919/CNSM.2017.8255970]; Nicholls N, 2007, INT J WILDLAND FIRE, V16, P540, DOI 10.1071/WF06125; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Palmer JG, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124002; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Power S, 2006, J CLIMATE, V19, P4755, DOI 10.1175/JCLI3868.1; Pui A, 2012, MON WEATHER REV, V140, P1665, DOI 10.1175/MWR-D-11-00238.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Risbey JS, 2009, MON WEATHER REV, V137, P3233, DOI 10.1175/2009MWR2861.1; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Santer BD, 2000, J GEOPHYS RES-ATMOS, V105, P7337, DOI 10.1029/1999JD901105; Stuecker MF, 2017, GEOPHYS RES LETT, V44, P2481, DOI 10.1002/2016GL072308; Sullivan A, 2012, FIRE WEATHER FIRE BE, DOI [10.2989/10220119.2012.715728, DOI 10.2989/10220119.2012.715728]; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Verdon DC, 2004, INT J WILDLAND FIRE, V13, P165, DOI 10.1071/WF03034; Wang CZ, 2017, CORAL REEFS WORLD, V8, P85, DOI 10.1007/978-94-017-7499-4_4; Wheeler MC, 2009, J CLIMATE, V22, P1482, DOI 10.1175/2008JCLI2595.1; Williams AAJ, 2001, CLIMATIC CHANGE, V49, P171, DOI 10.1023/A:1010706116176; Williams RJ, 2009, INTERACTIONS CLIMATE, DOI [10.3109/00952990.2012.668597, DOI 10.3109/00952990.2012.668597]; Williamson GJ, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035003; Yang Y, 2015, J CLIMATE, V28, P8021, DOI 10.1175/JCLI-D-15-0078.1	76	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222328	10.1371/journal.pone.0222328	http://dx.doi.org/10.1371/journal.pone.0222328			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536523	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800037
J	Janes, H; Brown, MD; Glidden, DV; Mayer, KH; Buchbinder, SP; McMahan, VM; Schechter, M; Guanira, J; Casapia, M				Janes, Holly; Brown, Marshall D.; Glidden, David, V; Mayer, Kenneth H.; Buchbinder, Susan P.; McMahan, Vanessa M.; Schechter, Mauro; Guanira, Juan; Casapia, Martin			Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; COST-EFFECTIVENESS; DECISION-ANALYSIS; BLADDER-CANCER; PREVENTION; INFECTION; EFFICACY; MARKERS; TRIAL; ACQUISITION	Introduction Developing guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for PrEP delivery. We describe an approach that identifies subpopulations of cisgender men who have sex with men (MSM) and transgender women (TGW) to prioritize for the rollout of PrEP in resource-limited settings. Methods We use data from the iPrEx study, a multi-national phase III study of PrEP for HIV prevention in MSM/TGW, to build statistical models that identify subpopulations at high risk of HIV acquisition without PrEP, and with high expected PrEP benefit. We then evaluate empirically the population impact of policies recommending PrEP to these subpopulations, and contrast these with existing policies. Results A policy recommending PrEP to a high risk subpopulation of MSM/TGW reporting condomless receptive anal intercourse over the last 3 months (estimated 3.3% 1-year HIV incidence) yields an estimated 1.95% absolute reduction in 1-year HIV incidence at the population level, and 3.83% reduction over 2 years. Importantly, such a policy requires rolling PrEP out to just 59.7% of MSM/TGW in the iPrEx population. We find that this policy is identical to that which prioritizes MSM/TGW with high expected PrEP benefit. It is estimated to achieve nearly the same reduction in HIV incidence as the PrEP guideline put forth by the US Centers for Disease Control, which relies on the measurement of more behavioral risk factors and which would recommend PrEP to a larger subset of the MSM/TGW population (86% vs. 60%). Conclusions These findings may be used to focus future mathematical modelling studies of PrEP in resource-limited settings on prioritizing PrEP for high-risk subpopulations of MSM/TGW. The statistical approach we took could be employed to develop PrEP policies for other at-risk populations and resource-limited settings.	[Janes, Holly; Brown, Marshall D.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Glidden, David, V] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [McMahan, Vanessa M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Schechter, Mauro] Univ Fed Rio de Janeiro, Projeto Praca Onze, Rio De Janeiro, Brazil; [Guanira, Juan] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru	Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Fenway Health; San Francisco Department of Public Health; University of Washington; University of Washington Seattle; Universidade Federal do Rio de Janeiro	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	hjanes@fredhutch.org	Glidden, David/AAD-4730-2020	Glidden, David/0000-0001-5888-1419; Casapia Morales, Wilfredo Martin/0000-0002-5972-0948	National Cancer Institute [R01 CA152089]; National Institute of Allergy and Infectious Diseases [R03 AI122908, U01 AI106499, U01 AI064002, P30 AI060354]; NATIONAL CANCER INSTITUTE [R01CA152089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI122908, U01AI106499, P30AI060354] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Cancer Institute (https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institutenci) (grant R01 CA152089 to HEJ), the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) (R03 AI122908 to DVG; U01 AI106499 to PLA; U01 AI064002 to RMG; P30 AI060354 to KHM). The sponsor (NIH) critically reviewed the iPrEx protocol prior to study start and any amendments. The sponsors or funders did not play any role in the decision to publish or preparation of the manuscript. Other authors received no specific funding for the work.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Benchikh A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-635; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Burgener A, 2016, 21 INT AIDS C JUL 18; Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555; Chen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108742; Cohen S, 2014, 21 C RETR OPP INF BO; Cohen S, 2014, 9 INT C HIV TREATM P; Den RB, 2015, J CLIN ONCOL, V33, P944, DOI 10.1200/JCO.2014.59.0026; Dorresteijn JAN, 2011, BRIT MED J, V343, P1; endinghiv.org.au, 2016, TRUV LIC PREP ACON; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Garrett KL, 2016, CROI 2016; Gibson S, 2015, NAT HIV PREV C VANC, P229; Glidden DV, 2016, CLIN INFECT DIS, V62, P1172, DOI 10.1093/cid/ciw022; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunter L, LECT NOTES COMPUTER, P149; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanscom B, 2016, JAIDS-J ACQ IMM DEF, V73, P606, DOI 10.1097/QAI.0000000000001160; Hoagland B, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21472; Hosek S, 2016, J ACQ IMMUN DEF SYND, V74, P21; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Janes H, 2018, AIDS RES HUM RETROV, V34, P645, DOI [10.1089/aid.2018.0031, 10.1089/AID.2018.0031]; Janes H, 2014, INT J BIOSTAT, V10, P99, DOI 10.1515/ijb-2012-0052; Janes H, 2014, MED DECIS MAKING, V34, P159, DOI 10.1177/0272989X13493147; Janes H, 2011, ANN INTERN MED, V154, P253, DOI 10.7326/0003-4819-154-4-201102150-00006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654; Kessler J, 2014, EVALUATING IMPACT PR; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McAuliffe TL, 2007, HEALTH PSYCHOL, V26, P60, DOI 10.1037/0278-6133.26.1.60; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mirzaei Mojtaba, 2016, Mater Sociomed, V28, P46, DOI 10.5455/msm.2016.28.46-50; Molina J, 2015, DEMAND PREP ORAL TDF; Murnane PM, 2015, AM J EPIDEMIOL, V182, P848, DOI 10.1093/aje/kwv202; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; PAUKER SG, 1978, SEMIN NUCL MED, V8, P324, DOI 10.1016/S0001-2998(78)80018-X; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Pletcher MJ, 2017, J AM HEART ASSOC, V6, P2; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Thanassoulis G, 2016, CIRCULATION, V133, P1574, DOI 10.1161/CIRCULATIONAHA.115.018383; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; THOMSON KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI DOI 10.1097/C0H.0000000000000207; US Public Health Service, 2014, PREEXP PROPH PREV HI; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-30; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2013, CANCER-AM CANCER SOC, V119, P143, DOI 10.1002/cncr.27692; Vickers AJ, 2009, CANCER-AM CANCER SOC, V115, P5460, DOI 10.1002/cncr.24615; Williams BL, 2016, 21 INT AIDS C JUL 18; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2014, POL BRIEF CONS GUID; Xiao S, 2004, BIOMETRICS, V60, P874, DOI 10.1111/j.0006-341X.2004.00242.x; Zheng WJ, 2018, STAT MED, V37, P261, DOI 10.1002/sim.7296	77	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222183	10.1371/journal.pone.0222183	http://dx.doi.org/10.1371/journal.pone.0222183			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536518	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800112
J	Shaw, CB; Foster, BH; Borgese, M; Boutin, RD; Bateni, C; Boonsri, P; Bayne, CO; Szabo, RM; Nayak, KS; Chaudhari, AJ				Shaw, Calvin B.; Foster, Brent H.; Borgese, Marissa; Boutin, Robert D.; Bateni, Cyrus; Boonsri, Pattira; Bayne, Christopher O.; Szabo, Robert M.; Nayak, Krishna S.; Chaudhari, Abhijit J.			Real-time three-dimensional MRI for the assessment of dynamic carpal instability	PLOS ONE			English	Article							SCAPHOLUNATE INSTABILITY; WRIST; JOINT; RECONSTRUCTION; ARTHROGRAPHY; DIAGNOSIS; REGULARIZATION; BIOMECHANICS; MOTION	Background Carpal instability is defined as a condition where wrist motion and/or loading creates mechanical dysfunction, resulting in weakness, pain and decreased function. When conventional methods do not identify the instability patterns, yet clinical signs of instability exist, the diagnosis of dynamic instability is often suggested to describe carpal derangement manifested only during the wrist's active motion or stress. We addressed the question: can advanced MRI techniques provide quantitative means to evaluate dynamic carpal instability and supplement standard static MRI acquisition? Our objectives were to (i) develop a real-time, three-dimensional MRI method to image the carpal joints during their active, uninterrupted motion; and (ii) demonstrate feasibility of the method for assessing metrics relevant to dynamic carpal instability, thus overcoming limitations of standard MRI. Methods Twenty wrists (bilateral wrists of ten healthy participants) were scanned during radial-ulnar deviation and clenched-fist maneuvers. Images resulting from two real-time MRI pulse sequences, four sparse data-acquisition schemes, and three constrained image reconstruction techniques were compared. Image quality was assessed via blinded scoring by three radiologists and quantitative imaging metrics. Results Real-time MRI data-acquisition employing sparse radial sampling with a gradient-recalled-echo acquisition and constrained iterative reconstruction appeared to provide a practical tradeoff between imaging speed (temporal resolution up to 135 ms per slice) and image quality. The method effectively reduced streaking artifacts arising from data undersampling and enabled the derivation of quantitative measures pertinent to evaluating dynamic carpal instability. Conclusion This study demonstrates that real-time, three-dimensional MRI of the moving wrist is feasible and may be useful for the evaluation of dynamic carpal instability.	[Shaw, Calvin B.; Borgese, Marissa; Boutin, Robert D.; Bateni, Cyrus; Boonsri, Pattira; Chaudhari, Abhijit J.] Univ Calif Davis, Dept Radiol, Sacramento, CA 95817 USA; [Foster, Brent H.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Bayne, Christopher O.; Szabo, Robert M.] Univ Calif Davis, Dept Orthopaed Surg, Sacramento, CA 95817 USA; [Nayak, Krishna S.] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90007 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Southern California	Chaudhari, AJ (corresponding author), Univ Calif Davis, Dept Radiol, Sacramento, CA 95817 USA.	ajchaudhari@ucdavis.edu		Chaudhari, Abhijit/0000-0002-4211-1900; Borgese, Marissa/0000-0001-7295-4143; Nayak, Krishna/0000-0001-5735-3550	National Institutes of Health (NIH) [K12 HD051958, R03 EB015099]; National Center for Advancing Translational Sciences, NIH [UL1 TR001860, TL1 TR001861]; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001861, UL1TR001860] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, NIH; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health (NIH) grants K12 HD051958 and R03 EB015099, the National Center for Advancing Translational Sciences, NIH, grant UL1 TR001860 and linked award TL1 TR001861, and the UC Davis Imaging Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belge M, 2002, INVERSE PROBL, V18, P1161, DOI 10.1088/0266-5611/18/4/314; Boutin RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084004; BURNETT KR, 1987, AM J ROENTGENOL, V149, P959, DOI 10.2214/ajr.149.5.959; Chantelot C, 2014, ORTHOP TRAUMATOL-SUR, V100, pS45, DOI 10.1016/j.otsr.2013.06.015; Chennagiri RJR, 2013, J HAND SURG-EUR VOL, V38, P727, DOI 10.1177/1753193412473861; Draper CE, 2009, J ORTHOP RES, V27, P571, DOI 10.1002/jor.20790; Fessler J., 2016, IMAGE RECONSTRUCTION; GarciaElias M, 1997, HAND CLIN, V13, P151; Gelberman RH, 2000, J BONE JOINT SURG AM, V82A, P578, DOI 10.2106/00004623-200004000-00013; GILULA LA, 1978, RADIOLOGY, V129, P641, DOI 10.1148/129.3.641; Haims AH, 2003, RADIOLOGY, V227, P701, DOI 10.1148/radiol.2273020398; Henrichon SS, 2020, SKELETAL RADIOL, V49, P241, DOI 10.1007/s00256-019-03266-1; Hobby JL, 2001, RADIOLOGY, V220, P589, DOI 10.1148/radiol.2203001429; Huang JZ, 2011, MED IMAGE ANAL, V15, P670, DOI 10.1016/j.media.2011.06.001; Jiang MF, 2013, MAGN RESON IMAGING, V31, P1218, DOI 10.1016/j.mri.2012.12.003; Kakar S, 2016, J WRIST SURG, V5, P306, DOI 10.1055/s-0035-1570463; KAUER JMG, 1986, CLIN ORTHOP RELAT R, P16; Krupinski EA, 2008, MED PHYS, V35, P645, DOI 10.1118/1.2830376; Krupinski EA, 2010, ATTEN PERCEPT PSYCHO, V72, P1205, DOI 10.3758/APP.72.5.1205; Kuo CE, 2008, J HAND SURG-AM, V33A, P998, DOI 10.1016/j.jhsa.2008.04.027; Laulan J, 2015, ORTHOP TRAUMATOL-SUR, V101, pS1, DOI 10.1016/j.otsr.2014.06.025; Lee SK, 2011, J HAND SURG-AM, V36A, P1149, DOI 10.1016/j.jhsa.2011.05.009; Leng SA, 2011, MED PHYS, V38, pS50, DOI 10.1118/1.3577759; Lingala SG, 2017, MAGN RESON MED, V78, P2275, DOI 10.1002/mrm.26611; Lingala SG, 2017, MAGN RESON MED, V77, P112, DOI 10.1002/mrm.26090; Lingala SG, 2013, PHYS MED BIOL, V58, P7309, DOI 10.1088/0031-9155/58/20/7309; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Manuel J, 2010, HAND CLIN, V26, P129, DOI 10.1016/j.hcl.2009.08.006; MIKIC ZD, 1984, J BONE JOINT SURG AM, V66A, P371, DOI 10.2106/00004623-198466030-00009; Moser T, 2007, AM J ROENTGENOL, V188, P1278, DOI 10.2214/AJR.06.0288; PALMER AK, 1984, CLIN ORTHOP RELAT R, P26; Poddar S, 2016, IEEE T MED IMAGING, V35, P1106, DOI 10.1109/TMI.2015.2509245; Quick HH, 2002, J MAGN RESON IMAGING, V15, P710, DOI 10.1002/jmri.10120; Rainbow MJ, 2016, J HAND SURG-EUR VOL, V41, P7, DOI 10.1177/1753193415616939; Ramamurthy NK, 2016, J HAND SURG-EUR VOL, V41, P22, DOI 10.1177/1753193415610515; RUBY LK, 1988, J HAND SURG-AM, V13A, P1, DOI 10.1016/0363-5023(88)90189-X; SCHERNBERG F, 1990, J HAND SURG-BRIT EUR, V15B, P220, DOI 10.1016/0266-7681(90)90127-P; Schimmerl-Metz SM, 1999, J HAND SURG-AM, V24A, P1237, DOI 10.1053/jhsu.1999.1237; SHELLOCK F G, 1991, Magnetic Resonance Quarterly, V7, P104; TALEISNIK J, 1988, J BONE JOINT SURG AM, V70A, P1262, DOI 10.2106/00004623-198870080-00025; TALEISNIK J, 1980, CLIN ORTHOP RELAT R, P73; Theumann NH, 2006, RADIOLOGY, V238, P950, DOI 10.1148/radiol.2383050013; Tosun O, 2017, ACTA RADIOL, V58, P1358, DOI 10.1177/0284185117692175; Uecker M., 2012, IMAG MED, V4, P461, DOI [10.2217/iim.12.32, DOI 10.2217/IIM.12.32]; Uecker M, 2010, NMR BIOMED, V23, P986, DOI 10.1002/nbm.1585; VOLZ RG, 1980, CLIN ORTHOP RELAT R, P112; Weiss APC, 1998, J HAND SURG-AM, V23A, P205, DOI 10.1016/S0363-5023(98)80115-9; Wolf JM, 2008, HAND CLIN, V24, P301, DOI 10.1016/j.hcl.2008.03.002; Wollstein R, 2013, J HAND SURG-ASIAN-PA, V18, P179, DOI 10.1142/S0218810413500214; Zhang S., 2011, OPEN MED IMAGING J, V5, P1, DOI [DOI 10.2174/1874347101105010001, 10.2174/1874347101105010001]; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39; Zhao K, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030405	52	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222704	10.1371/journal.pone.0222704	http://dx.doi.org/10.1371/journal.pone.0222704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536561	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800073
J	Page, CM; Ibrahim, S; Park, LP; Huchko, MJ				Page, Charlotte M.; Ibrahim, Saduma; Park, Lawrence P.; Huchko, Megan J.			Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REASONS; AFRICA	Objective To identify patient factors associated with whether women who screened positive for high-risk human papillomavirus (hrHPV) successfully accessed treatment in a cervical cancer prevention program in Kenya. Methods A prospective cohort study was conducted as part of a trial of implementation strategies for hrHPV-based cervical cancer screening in western Kenya from January 2018 to February 2019. In this larger trial, women underwent hrHPV testing during community health campaigns (CHCs), and hrHPV+ women were referred to government facilities for cryotherapy. For this analysis, we looked at rates of and predictors of presenting for treatment and presenting within 30 days of receiving positive hrHPV results ("timely" presentation). Data came from questionnaires completed at the time of screening and treatment. Multivariable logistic regression was used to identify factors associated with each outcome. Results Of the 505 hrHPV+ women, 266 (53%) presented for treatment. Cryotherapy was performed in 236 (89%) of the women who presented, while 30 (11%) were not treated: 15 (6%) due to gas outage, six (2%) due to pregnancy, five (2%) due to concern for cervical cancer, and four (2%) due to an unknown or other reason. After adjusting for other factors in the multi-variable analysis, higher education level and missing work to come to the CHC were associated with presenting for treatment. Variables that were associated with increased likelihood of timely presentation were missing work to come to the CHC, absence of depressive symptoms, told by someone important to come to the CHC, and shorter distance to the treatment site. Conclusion The majority of hrHPV+ women who did not get treated were lost at the stage of decision-making or accessing treatment, with a small number encountering barriers at the treatment sites. Patient education and financial support are potential areas for intervention to increase rates of hrHPV+ women seeking treatment.	[Page, Charlotte M.; Huchko, Megan J.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA; [Ibrahim, Saduma] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Park, Lawrence P.] Duke Univ, Dept Med, Div Infect Dis, Durham, NC USA; [Park, Lawrence P.; Huchko, Megan J.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Duke University; Kenya Medical Research Institute; Duke University; Duke University	Page, CM (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	charlotte.page@duke.edu		Page, Charlotte/0000-0002-8038-9487	National Cancer Institute of the National Institutes of Health [R01CA188428]; Charles B. Hammond Research Fund, Duke University School of Medicine, Durham, NC; NIH; Hammond Fund; NATIONAL CANCER INSTITUTE [R01CA188428] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Charles B. Hammond Research Fund, Duke University School of Medicine, Durham, NC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hammond Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute (https://www.cancer.gov/) of the National Institutes of Health under award number R01CA188428, received by author MH. Additional support was received by author CP from the Charles B. Hammond Research Fund (https://obgyn.duke.edu/research/charles-b-hammond-md-researchfund), Duke University School of Medicine, Durham, NC. About 95% of funding for this project was from the NIH grant and 5% from the Hammond Fund. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Denny L, 2010, JNCI-J NATL CANCER I, V102, P1557, DOI 10.1093/jnci/djq342; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Huchko MJ, 2017, BMC CANCER, V17, P1; International Agency for Research on Cancer, 2018, CANC FACT SHEETS CER; Kenya Ministry of Health, 2018, KEN NAT CANC SCREEN; Rosser JI, 2015, PATIENT EDUC COUNS, V98, P884, DOI 10.1016/j.pec.2015.03.017; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Santesso N, 2012, INT J GYNECOL OBSTET, V118, P97, DOI 10.1016/j.ijgo.2012.01.029; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; World Health Organization, 2013, COMPR CERV CANC PREV	12	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222750	10.1371/journal.pone.0222750	http://dx.doi.org/10.1371/journal.pone.0222750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532808	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600036
J	Ody, A; Thibaut, T; Berline, L; Changeux, T; Andre, JM; Chevalier, C; Blanfune, A; Blanchot, J; Ruitton, S; Stiger-Pouvreau, V; Connan, S; Grelet, J; Aurelle, D; Guene, M; Bataille, H; Bachelier, C; Guillemain, D; Schmidt, N; Fauvelle, V; Guasco, S; Menard, F				Ody, Anouck; Thibaut, Thierry; Berline, Leo; Changeux, Thomas; Andre, Jean-Michel; Chevalier, Cristele; Blanfune, Aurelie; Blanchot, Jean; Ruitton, Sandrine; Stiger-Pouvreau, Valerie; Connan, Solene; Grelet, Jacques; Aurelle, Didier; Guene, Mathilde; Bataille, Hubert; Bachelier, Celine; Guillemain, Dorian; Schmidt, Natascha; Fauvelle, Vincent; Guasco, Sophie; Menard, Frederic			From In Situ to satellite observations of pelagic Sargassum distribution and aggregation in the Tropical North Atlantic Ocean	PLOS ONE			English	Article							MANGAREVENSE GRUNOW SETCHELL; INVASIVE BROWN-ALGAE; GULF-OF-MEXICO; TURBINARIA-ORNATA; FLOATING SARGASSUM; GOLDEN TIDES; CORAL-REEF; MUTICUM; MACROALGAE; FUCALES	The present study reports on observations carried out in the Tropical North Atlantic in summer and autumn 2017, documenting Sargassum aggregations using both ship-deck observations and satellite sensor observations at three resolutions (MSI-10 m, OLCI-300 m, VIIRS-750 m and MODIS-1 km). Both datasets reported that in summer, Sargassum aggregations were mainly observed off Brazil and near the Caribbean Islands, while they accumulated near the African coast in autumn. Based on in situ observations, we propose a five-class typology allowing standardisation of the description of in situ Sargassum raft shapes and sizes. The most commonly observed Sargassum raft type was windrows, but large rafts composed of a quasi-circular patch hundreds of meters wide were also observed. Satellite imagery showed that these rafts formed larger Sargassum aggregations over a wide range of scales, with smaller aggregations (of tens of m(2) area) nested within larger ones (of hundreds of km(2)). Match-ups between different satellite sensors and in situ observations were limited for this dataset, mainly because of high cloud cover during the periods of observation. Nevertheless, comparisons between the two datasets showed that satellite sensors successfully detected Sargassum abundance and aggregation patterns consistent with in situ observations. MODIS and VIIRS sensors were better suited to describing the Sargassum aggregation distribution and dynamics at Atlantic scale, while the new sensors, OLCI and MSI, proved their ability to detect Sargassum aggregations and to describe their (sub-) mesoscale nested structure. The high variability in raft shape, size, thickness, depth and biomass density observed in situ means that caution is called for when using satellite maps of Sargassum distribution and biomass estimation. Improvements would require additional in situ and airborne observations or very high-resolution satellite imagery.	[Ody, Anouck; Thibaut, Thierry; Berline, Leo; Changeux, Thomas; Andre, Jean-Michel; Chevalier, Cristele; Blanfune, Aurelie; Blanchot, Jean; Ruitton, Sandrine; Aurelle, Didier; Schmidt, Natascha; Fauvelle, Vincent; Guasco, Sophie; Menard, Frederic] Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO UM 110, Marseille, France; [Stiger-Pouvreau, Valerie; Connan, Solene] Univ Bretagne Occident UBO, Inst Univ Europeen Mer IUEM, LEMAR UMR 6539, Technopole Brest Iroise, Plouzane, France; [Grelet, Jacques; Bachelier, Celine] Technopole Brest Iroise, US191 IMAGO, IRD DR Quest, Site Pointe Diable, Plouzane, France; [Guene, Mathilde] Univ Antilles, UMR BOREA, Campus Fouillole,BP 592, Pointe A Pitre, Guadeloupe, France; [Bataille, Hubert] IRD, IRD Images, Marseille, France; [Guillemain, Dorian] Aix Marseille Univ, CNRS, IRD, IRSTEA,OSU PYTHEAS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); UDICE-French Research Universities; Sorbonne Universite; Universite des Antilles; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Thibaut, T (corresponding author), Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO UM 110, Marseille, France.	thierry.thibaut@univ-amu.fr	Menard, Frederic/C-3913-2008; Ruitton, Sandrine/AAT-4752-2021; Berline, Leo/AAM-8802-2021; THIBAUT, Thierry/S-4354-2019; Berline, Leo/AAJ-5885-2021; Blanfuné, Aurélie/AAN-2680-2021; Changeux, Thomas/AAE-5326-2019	Menard, Frederic/0000-0003-1162-660X; Ruitton, Sandrine/0000-0003-4485-9979; THIBAUT, Thierry/0000-0001-8530-9266; Blanfuné, Aurélie/0000-0001-7389-4947; Changeux, Thomas/0000-0002-0418-3321; Schmidt, Natascha/0000-0002-6194-3999; Aurelle, Didier/0000-0002-3922-7291	TOSCA program of the Centre National d'Etudes Spatiales of the SAREDAs4 project; European FEDER Fund [1166-39417]; Institut de recherche pour le developpement (IRD)	TOSCA program of the Centre National d'Etudes Spatiales of the SAREDAs4 project; European FEDER Fund; Institut de recherche pour le developpement (IRD)	This study was supported by the TOSCA program of the Centre National d'Etudes Spatiales through the funding of the SAREDAs4 project and the project leading to this publication has received funding from European FEDER Fund under project 1166-39417. AO postdoctoral fellowship was funded by Institut de recherche pour le developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2017, ECOL EVOL, V7, P516, DOI 10.1002/ece3.2630; Andrefouet S, 2004, CORAL REEFS, V23, P26, DOI 10.1007/s00338-003-0367-5; Andrefouet S, 2017, J APPL PHYCOL, V29, P3097, DOI 10.1007/s10811-017-1165-8; [Anonymous], REP SIT PEL SARG CAR; [Anonymous], SAT BAS SARG WATCH S; Ardron J, 2011, SARGASSO SEA ALLIANC, V24; Aristegui J, 2017, INFORM PRESENCIA TRI, P28; BOUCHON C, 1992, Proceedings of the Gulf and Caribbean Fisheries Institute, P171; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Brodie J, 2018, AQUAT CONSERV, V28, P872, DOI 10.1002/aqc.2905; Brooks MT, 2018, MAR ECOL PROG SER, V599, P1, DOI 10.3354/meps12646; Butler J.N., 1983, STUDIES SARGASSUM SA; Clerc S, 2018, 32 MPC TEAM; de Vaugelas J, 1999, OCEANOL ACTA, V22, P85, DOI 10.1016/S0399-1784(99)80035-8; DEAL Guadeloupe, 2018, MES RAM SARG 48; Dierssen HM, 2015, REMOTE SENS ENVIRON, V167, P247, DOI 10.1016/j.rse.2015.01.027; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Franks J., 2011, P GULF CARIB FISH I, V64, P6; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Gower J, 2006, IEEE T GEOSCI REMOTE, V44, P3619, DOI 10.1109/TGRS.2006.882258; Gower J, 2013, REMOTE SENS LETT, V4, P764, DOI 10.1080/2150704X.2013.796433; Hernandez-Carrasco I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26857-9; HOWARD KL, 1969, BOT MAR, V12, P244, DOI 10.1515/botm.1969.12.1-4.244; Hu CM, 2016, MAR POLLUT BULL, V107, P15, DOI 10.1016/j.marpolbul.2016.04.045; Hu CM, 2015, REMOTE SENS ENVIRON, V167, P229, DOI 10.1016/j.rse.2015.05.022; Hu CM, 2010, REMOTE SENS ENVIRON, V114, P2048, DOI 10.1016/j.rse.2010.04.011; Hu CM, 2009, REMOTE SENS ENVIRON, V113, P2118, DOI 10.1016/j.rse.2009.05.012; Komatsu T, 2007, J MARINE SYST, V67, P245, DOI 10.1016/j.jmarsys.2006.05.018; Krummel O, 1891, PETERMANNS GEOGR MIT, V37, P129; Lapointe BE, 2018, HARMFUL ALGAL BLOOMS: A COMPENDIUM DESK REFERENCE, P515; Le Lann K, 2012, MAR ENVIRON RES, V80, P1, DOI 10.1016/j.marenvres.2012.05.011; Lehahn Y, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003927; Lellouche JM, 2013, OCEAN SCI, V9, P57, DOI 10.5194/os-9-57-2013; Liu F, 2018, LIMNOL OCEANOGR, V63, P1762, DOI 10.1002/lno.10806; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; Marks LM, 2015, BIOINVASIONS REC, V4, P243, DOI 10.3391/bir.2015.4.4.02; Marmorino GO, 2011, DEEP-SEA RES PT I, V58, P316, DOI 10.1016/j.dsr.2011.01.001; Miller KA, 2007, BIOL INVASIONS, V9, P609, DOI 10.1007/s10530-006-9060-2; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Owens R.G., 2018, ECMWF FORECAST USER, DOI 10.21957/m1cs7h; Parr A.E., 1939, QUANTITATIVE OBSERVA; Plouguerne E, AQUATIC BOT, V85, P337; Putman NF, 2018, PROG OCEANOGR, V165, P205, DOI 10.1016/j.pocean.2018.06.009; Qi L, 2017, GEOPHYS RES LETT, V44, P11501, DOI 10.1002/2017GL075525; Riosmena-Rodriguez R, 2012, BOT MAR, V55, P547, DOI 10.1515/bot-2012-0120; RUENESS J, 1989, MAR POLLUT BULL, V20, P173, DOI 10.1016/0025-326X(89)90488-8; Sakamoto SX, 2012, PROC SPIE, V8525, DOI 10.1117/12.999308; Schell JM, 2015, OCEANOGRAPHY, V28, P8, DOI 10.5670/oceanog.2015.70; Schmidt N, 2019, ENVIRON SCI TECHNOL, V53, P7513, DOI 10.1021/acs.est.9b01585; Setyawidati N, 2018, J APPL PHYCOL, V30, P159, DOI 10.1007/s10811-017-1208-1; Siuda A, 2011, SARGASSO SEA ALLIANC, V18; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Staehr PA, 2000, MAR ECOL PROG SER, V207, P79, DOI 10.3354/meps207079; Stiger V, 1999, BOT MAR, V42, P295, DOI 10.1515/BOT.1999.033; Stiger V, 1999, MAR ECOL PROG SER, V191, P91, DOI 10.3354/meps191091; STONER AW, 1984, MAR ECOL PROG SER, V20, P185, DOI 10.3354/meps020185; STONER AW, 1983, DEEP-SEA RES, V30, P469, DOI 10.1016/0198-0149(83)90079-1; Tanniou A, 2015, TALANTA, V132, P451, DOI 10.1016/j.talanta.2014.09.002; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; UNEP, 2016, PAPER SARGASSUM SEAW; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Wang MQ, 2018, GEOPHYS RES LETT, V45, P12359, DOI 10.1029/2018GL078858; Wang MQ, 2018, INT J REMOTE SENS, V39, P3852, DOI 10.1080/01431161.2018.1447161; Wang MQ, 2017, GEOPHYS RES LETT, V44, P3265, DOI 10.1002/2017GL072932; Wang MQ, 2016, REMOTE SENS ENVIRON, V183, P350, DOI 10.1016/j.rse.2016.04.019; Webster R.K., 2013, SHORE BEACH, P81, DOI DOI 10.1002/9781118485545.CH1; Winge O, 1923, SARGASSO SEA ITS BOU; WOODCOCK AH, 1993, J EXP MAR BIOL ECOL, V170, P117, DOI 10.1016/0022-0981(93)90132-8; Xing QG, 2017, IEEE GEOSCI REMOTE S, V14, P1815, DOI 10.1109/LGRS.2017.2737079; Zhong Y., 2012, LIMNOLOGY OCEANOGRAP, V2, P12, DOI [10.1215/21573689-1573372, DOI 10.1215/21573689-1573372]	71	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222584	10.1371/journal.pone.0222584	http://dx.doi.org/10.1371/journal.pone.0222584			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527915	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400030
J	Ahmed, S; Adams, AM; Islam, R; Hasan, SM; Panciera, R				Ahmed, Shakil; Adams, Alayne M.; Islam, Rubana; Hasan, Shaikh Mehdi; Panciera, Rocco			Impact of traffic variability on geographic accessibility to 24/7 emergency healthcare for the urban poor: A GIS study in Dhaka, Bangladesh	PLOS ONE			English	Article							MEASURING SPATIAL ACCESSIBILITY; TRAVEL-TIME; MATERNITY CARE; ACCESS; TRAUMA; SERVICES; DISTANCE; SETTLEMENTS; CHALLENGES; FACILITIES	Ensuring access to healthcare in emergency health situations is a persistent concern for health system planners. Emergency services, including critical care units for severe burns and coronary events, are amongst those for which travel time is the most crucial, potentially making a difference between life and death. Although it is generally assumed that access to healthcare is not an issue in densely populated urban areas due to short distances, we prove otherwise by applying improved methods of assessing accessibility to emergency services by the urban poor that take traffic variability into account. Combining unique data on emergency health service locations, traffic flow variability and informal settlements boundaries, we generated time-cost based service areas to assess the extent to which emergency health services are reachable by urban slum dwellers when realistic traffic conditions and their variability in time are considered. Variability in traffic congestion is found to have significant impact on the measurement of timely access to, and availability of, healthcare services for slum populations. While under moderate traffic conditions all slums in Dhaka City are within 60-minutes travel time from an emergency service, in congested traffic conditions only 63% of the citys slum population is within 60-minutes reach of most emergency services, and only 32% are within 60-minutes reach of a Burn Unit. Moreover, under congested traffic conditions only 12% of slums in Dhaka City Corporation comply with Bangladesh's policy guidelines that call for access to 1 health service per 50,000 population for most emergency service types, and not a single slum achieved this target for Burn Units. Emergency Obstetric Care (EmOC) and First Aid & Casualty services provide the best coverage, with nearly 100% of the slum population having timely access within 60-minutes in any traffic condition. Ignoring variability in traffic conditions results in a 3-fold overestimation of geographic coverage and masks intra-urban inequities in accessibility to emergency care, by overestimating geographic accessibility in peripheral areas and underestimating the same for central city areas. The evidence provided can help policy makers and urban planners improve health service delivery for the urban poor. We recommend that taking traffic conditions be taken into account in future GIS-based analysis and planning for healthcare service accessibility in urban areas.	[Ahmed, Shakil; Adams, Alayne M.; Islam, Rubana; Hasan, Shaikh Mehdi; Panciera, Rocco] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Ahmed, Shakil] BRAC Univ, Ctr Excellence Urban Equ & Hlth, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Adams, Alayne M.] McGill Univ, Fac Med, Montreal, PQ, Canada; [Islam, Rubana] Univ New South Wales, Sydney, NSW, Australia; [Hasan, Shaikh Mehdi] UNICEF, Hlth Sect, New York, NY USA	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; McGill University; University of New South Wales Sydney; UNICEF	Ahmed, S (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.; Ahmed, S (corresponding author), BRAC Univ, Ctr Excellence Urban Equ & Hlth, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	shakil.du05@gmail.com		Adams, Alayne/0000-0002-0961-9825; Ahmed, Shakil/0000-0002-3862-2732; Islam, Rubana/0000-0002-9538-5390	Department for International Development, UK [GR01020]	Department for International Development, UK	This study was funded by, Department for International Development, UK, Grant No. GR01020. This grant was received by Alayne M. Adams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; Adams AM, 2015, MAPPING URBAN HEALTH; Ahmed B., 2013, J BANGLADESH I PLANN, V6, P103; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Angeles G, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-32; [Anonymous], 2015, PREL REP CENS SLUM A; [Anonymous], 2012, REPORT COMMUNITY ZIL; [Anonymous], 2016, HLTH B 2016 DGHS; [Anonymous], 2018, DAILY STAR; [Anonymous], 2009, WORLD URB PROSP 2007; Anwar A., 2010, J BANGLADESH I PLANN, V3, P53; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Banik BK, 2009, J INDIAN ROADS C; Baumgart S, 2011, CONTRIB STAT, P281, DOI 10.1007/978-3-7908-2733-0_18; Brabyn L, 2002, INT J HEALTH GEOGR, V1, DOI [10.1186/1476-072X-1-1, DOI 10.1186/1476-072X-1-1]; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Bremer R, 2003, PREHOSP DISASTER MED, V18, P372; Carr BG, 2009, ANN EMERG MED, V54, P261, DOI 10.1016/j.annemergmed.2008.11.016; Cheng Y, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-32; Chowdhury ME, 2017, INT J GYNECOL OBSTET, V138, P164, DOI 10.1002/ijgo.12196; Christie S, 2003, J PUBLIC HEALTH MED, V25, P344, DOI 10.1093/pubmed/fdg090; CONNOR RA, 1995, MED CARE, V33, P1067, DOI 10.1097/00005650-199511000-00001; Dai D, 2010, HLTH PLACE, V16; Dieleman J, 2017, LANCET, V389, P1981, DOI 10.1016/S0140-6736(17)30874-7; European Commission Humanitarian Aid Office ADPC Plan Bangladesh and Islamic Relief Worldwide Bangladesh, 2010, URB RISK ASS FAC GUI; Gabrysch S, 2010, INFLUENCES DISTANCE; George AA, 2017, 2017 INT C NETW ADV; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Gruebner O., 2014, DATASET PAPERS SCI, DOI DOI 10.1155/2014/172182; Guagliardo MF, 2004, HEALTH PLACE, V10, P273, DOI 10.1016/j.healthplace.2003.01.001; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Haynes R, 1999, SOC SCI MED, V49, P425, DOI 10.1016/S0277-9536(99)00149-5; Haynes R, 2006, INT J HEALTH GEOGR, V5, DOI [10.1186/1476-072X-5-5, DOI 10.1186/1476-072X-5-5]; Higgs G, 2004, HLTH SERV OUTCOMES R, V5, P119, DOI DOI 10.1007/S10742-005-4304-7; Houben RMGJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-49; Islam Mohammed Shariful, 2011, World Health Popul, V12, P33; Islam MZ., 2018, IOSR J ENV SCI TOXIC, V12, P46; Islam R, 2016, HLTH FACILITY MAPPIN; Jahan NA., 2015, HLTH CARE SEEKING BE; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Khalid Mahmood, 2017, Pakistan Journal of Public Health, V7, P127; Kiani B, 2018, GEOSPATIAL HLTH, V13; Kim Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193013; Klein MB, 2009, JAMA-J AM MED ASSOC, V302, P1774, DOI 10.1001/jama.2009.1548; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Kwapong Nana Afranaa, 2014, PUBLIC HLTH RES, V4, P145, DOI [10.5923/j.phr.20140405.01, DOI 10.5923/J.PHR.20140405.01]; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Magadi M, 2000, SOC BIOL, V47, P164; Mahmud SS, 2008, 10 PAC REG SCI C ORG; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; McGrail MR, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-124; MCGUIRK MA, 1984, INQUIRY-J HEALTH CAR, V21, P84; Mock C., 2004, GUIDELINES ESSENTIAL; Mohit MA, 2012, PROCD SOC BEHV, V36, P611, DOI 10.1016/j.sbspro.2012.03.067; MOLGRDC, 2005, 2 URB PRIM HLTH CAR; MUCKART DJJ, 1991, S AFR MED J, V79, P93; Munoz UH, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-40; Mwaliko E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-212; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Panciera R, 2016, BMC PREGNANCY CHILDB, V16, P1; Patel AB, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-47; Polo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119190; Radke J., 2000, GEOGRAPHIC INFORM SC, V6, P105, DOI [10.1080/10824000009480538, DOI 10.1080/10824000009480538]; Raghupathy S, 1996, SOC SCI MED, V43, P459, DOI 10.1016/0277-9536(95)00411-4; Rahman MH, 2008, J BIOSOC SCI, V40, P19, DOI 10.1017/S0021932007002258; Ravelli ACJ, 2011, BJOG-INT J OBSTET GY, V118, P457, DOI 10.1111/j.1471-0528.2010.02816.x; Ray N, 2008, INT J HEALTH GEOGR, P7, DOI [10.1186/1476-072X-7-7, DOI 10.1186/1476-072X-7-7]; Razzak JA, 2002, B WHO, V80; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Schonfeld HK, 1972, N ENGL J MED, V286; Schuurman N, 2010, CANADIAN GEOGRAPHER, V54; Schuurman N, 2006, INT J HEALTH GEOGR, V5, DOI [10.1186/1476-072X-5-5, DOI 10.1186/1476-072X-5-5]; Smith CM, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0088-6; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; Tang JH, 2017, HEALTH PLACE, V47, P126, DOI 10.1016/j.healthplace.2017.08.006; UN DESA (United Nations Department of Economic and Social Affairs), 2015, STESASERA366 UN DESA; Una E, HEALTHCARE ACCESS IN; Vanderschuren M, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-5; Wan N, 2012, APPL GEOGR, V32, P291, DOI 10.1016/j.apgeog.2011.05.001; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Wei R, 2019, ACAD EMERG MED, V26, P192, DOI 10.1111/acem.13518; World Health Organization, 2001, BACKGR PAP TECHN CON; Yang Duck-Hye, 2006, J Med Syst, V30, P23, DOI 10.1007/s10916-006-7400-5; Ye H., 2014, INT J GEOSPAT ENV RE, V1, P2; Zegeye K, 2014, PRIM HLTH CARE OPEN, V4, P1	93	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222488	10.1371/journal.pone.0222488	http://dx.doi.org/10.1371/journal.pone.0222488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525226	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700031
J	Andrade, ACB; Viana, JMS; Pereira, HD; Pinto, VB; Silva, FFE				Bastos Andrade, Andrea Carla; Soriano Viana, Jose Marcelo; Pereira, Helcio Duarte; Pinto, Vitor Batista; Fonseca e Silva, Fabyano			Linkage disequilibrium and haplotype block patterns in popcorn populations	PLOS ONE			English	Article							GENOMIC PREDICTION; REGION; LD; INFERENCE; SELECTION; SNPS; MAP; HOT	Linkage disequilibrium (LD) analysis provides information on the evolutionary aspects of populations. Recently, haplotype blocks have been used to increase the power of quantitative trait loci detection in genome-wide association studies and the prediction accuracy of genomic selection. Our objectives were as follows: to compare the degree of LD, LD decay, and LD decay extent in popcorn populations; to characterize the number and length of haplotype blocks in the populations; and to determine whether maize chromosomes also have a pattern of interspaced regions of high and low rates of recombination. We used a biparental population, a synthetic, and a breeding population, genotyped for approximately 75,000 single nucleotide polymorphisms (SNPs). The sample size ranged from 190 to 192 plants. For the whole-genome LD and haplotype block analyses, we assumed a window of 500 kb. To characterize the block and step patterns of LD in the populations, we constructed LD maps by chromosome, defining a cold spot as a chromosome segment including SNPs with the same LDU position. The LD and haplotype block analyses were also performed at the intragenic level, selecting 12 genes related to zein, starch, cellulose, and fatty acid biosynthesis. The populations with the higher and lower frequencies of vertical bar D'vertical bar values greater than 0.75 were the biparental (65-74%) and the breeding population (26-58%), respectively. There were slight differences between the populations regarding the average distance for SNPs with vertical bar D'vertical bar values greater than 0.75 (in the range of approximately 207 to 229 kb). The level of LD expressed by the r(2) values was low in the populations (0.02, 0.04, and 0.04, on average) but comparable to some non-isolated human populations. The frequency of r(2) values greater than 0.75 was lower in the biparental population (0.2-0.5%) and higher in the other populations (0.2-1.6%). The average distance for SNPs with r(2) values greater than 0.75 was much higher in the biparental population (approximately 80 to 126 kb). In the other populations, the ranges were approximately 6 to 19 and 6 to 35 kb. The heatmaps for the regions covered by the first 100 SNPs in each chromosome, in each population (1 to 3.3 Mb, approximately), provided evidence that the comparatively few high r(2) values (close to 1.0) occurred only for SNPs in close proximity, especially in the synthetic and breeding populations. Due to the reduced number of SNPs in the haplotype blocks (2 to 3) in the populations, it is not expected advantage of a haplotype-based association study as well as genomic selection along generations. The results concerning LD decay (rapid decay after 5-10 kb) and LD decay extent (along up to 300 kb) are in the range observed with maize inbred line panels. The LD maps indicate that maize chromosomes had a pattern of regions of extensive LD interspaced with regions of low LD. However, our simulated LD map provides evidence that this pattern can reflect regions with differences in allele frequencies and LD levels (expressed by vertical bar D'vertical bar) and not regions with high and low rates of recombination.	[Bastos Andrade, Andrea Carla; Soriano Viana, Jose Marcelo; Pereira, Helcio Duarte; Pinto, Vitor Batista] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Viana, JMS (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jmsviana@ufv.br	Viana, José Marcelo Soriano/G-2119-2012; Pinto, Vitor/I-2886-2017; Andrade, Andrea/B-3339-2014	Viana, José Marcelo Soriano/0000-0002-5063-4648; Pinto, Vitor/0000-0002-8119-7268; Andrade, Andrea/0000-0003-0111-1792	National Council for Scientific and Technological Development (CNPq) [301638/2017-9, 404836/2018-6]; Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes) [001]; Foundation for Research Support of Minas Gerais State (Fapemig) [CAG APQ 01153/17]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Research Support of Minas Gerais State (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Grants 301638/2017-9 and 404836/2018-6 -National Council for Scientific and Technological Development (CNPq); Scholarship (Finance Code 001) -Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes); and Grant CAG APQ 01153/17 -Foundation for Research Support of Minas Gerais State (Fapemig); Authors: ACBA (scholarship), JMSV (grants), HDP (scholarship), VBP (scholarship); http://www.cnpq.br/, http://www.capes.gov.br/, and https://fapemig.br/pt/.	Akesaka T, 2004, J HUM GENET, V49, P603, DOI 10.1007/s10038-004-0195-7; Anderson SL, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.11.0102; Angius A, 2008, HUM HERED, V65, P9, DOI 10.1159/000106058; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Collins A, 2009, MOL BIOTECHNOL, V41, P83, DOI 10.1007/s12033-008-9110-3; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Evseeva I, 2010, EUR J HUM GENET, V18, P924, DOI 10.1038/ejhg.2010.32; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hess M, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0329-y; Jeffreys AJ, 2004, PHILOS T ROY SOC B, V359, P141, DOI 10.1098/rstb.2003.1372; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Jonas D, 2016, J DAIRY SCI, V99, P4537, DOI 10.3168/jds.2015-10433; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Knaus BJ, 2017, MOL ECOL RESOUR, V17, P44, DOI 10.1111/1755-0998.12549; Knueppel S, 2015, PACKAGE HAPESTXXR; LEWONTIN RC, 1964, GENETICS, V49, P49; Ma YS, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0504-9; Maldonado C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212925; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Nuchnoi P, 2008, J HUM GENET, V53, P850, DOI 10.1007/s10038-008-0309-8; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Pengelly RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1854-0; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Viana JMS, 2018, HEREDITY, V120, P283, DOI 10.1038/s41437-017-0027-0; Viana JMS, 2013, GENETICA, V141, P389, DOI 10.1007/s10709-013-9738-1; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; Thirunavukkarasu N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-877; Truntzler M, 2012, THEOR APPL GENET, V125, P731, DOI 10.1007/s00122-012-1866-y; Viana JMS, 2017, MOL BREEDING, V37, DOI [10.1007/s11032-017-0700-2, DOI 10.1007/S11032-017-0700-2]; Viana JMS, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1800-5; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P17004, DOI 10.1073/pnas.012672899	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0219417	10.1371/journal.pone.0219417	http://dx.doi.org/10.1371/journal.pone.0219417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553737	Green Submitted, Green Published, gold			2022-12-27	WOS:000532319200003
J	Diaz-Garcia, L; Rodriguez-Bonilla, L; Phillips, M; Lopez-Hernandez, A; Grygleski, E; Atucha, A; Zalapa, J				Diaz-Garcia, Luis; Rodriguez-Bonilla, Lorraine; Phillips, Matthew; Lopez-Hernandez, Arnoldo; Grygleski, Edward; Atucha, Amaya; Zalapa, Juan			Comprehensive analysis of the internal structure and firmness in American cranberry (Vaccinium macrocarpon Ait.) fruit	PLOS ONE			English	Article							SHELF-LIFE; TOMATO; QUANTIFICATION; PHENOMICS; VARIETIES; TEXTURE; QUALITY; STORAGE; SHAPE	Background Cranberry (Vaccinium macrocarpon L.) fruit quality traits encompass many properties. Although visual appearance and fruit nutritional constitution have usually been the most important attributes, cranberry textural properties such as firmness have recently gained importance in the industry. Fruit firmness has become a quality standard due to the recent demand increase for sweetened and dried cranberries (SDC), which are currently the most profitable cranberry product. Traditionally, this trait has been measured by the cranberry industry using compression tests; however, it is poorly understood how fruit firmness is influenced by other characteristics. Results In this study, we developed a high-throughput computer-vision method to measure the internal structure of cranberry fruit, which may in turn influence cranberry fruit firmness. We measured the internal structure of 16 cranberry cultivars measured over a 40-day period, representing more than 3000 individual fruit evaluated for 10 different traits. The internal structure data paired with fruit firmness values at each evaluation period allowed us to explore the correlations between firmness and internal morphological characteristics. Conclusions Our study highlights the potential use of internal structure and firmness data as a decision-making tool for cranberry processing, especially to determine optimal harvest times and ensure high quality fruit. In particular, this study introduces novel methods to define key parameters of cranberry fruit that have not been characterized in cranberry yet. This project will aid in the future evaluation of cranberry cultivars for in SDC production.	[Diaz-Garcia, Luis; Rodriguez-Bonilla, Lorraine; Phillips, Matthew; Atucha, Amaya; Zalapa, Juan] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Diaz-Garcia, Luis] Inst Nacl Invest Forestales Agr & Pecuarias, Aguascalientes, Aguascalientes, Mexico; [Lopez-Hernandez, Arnoldo] Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA; [Grygleski, Edward] Valley Corp, Tomah, WI USA; [Zalapa, Juan] Univ Wisconsin, Vegetable Crops Res Unit, USDA ARS, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Diaz-Garcia, L; Zalapa, J (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Diaz-Garcia, L (corresponding author), Inst Nacl Invest Forestales Agr & Pecuarias, Aguascalientes, Aguascalientes, Mexico.; Zalapa, J (corresponding author), Univ Wisconsin, Vegetable Crops Res Unit, USDA ARS, Madison, WI 53715 USA.	diaz.antonio@inifap.gob.mx; juan.zalapa@ars.usda.gov			USDA-ARS [5090-21220-004-00-D]; WI-DATCP (SCBG Project) [14-002]; Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Consejo Nacional de Ciencia y Tecnologi'a (Mexico); Gabelman-Seminis Graduate Fellowship; UW Madison SciMed GRS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); WI-DATCP (SCBG Project); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Consejo Nacional de Ciencia y Tecnologi'a (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Gabelman-Seminis Graduate Fellowship; UW Madison SciMed GRS	This project was supported by USDA-ARS (project no. 5090-21220-004-00-D provided to JZ); WI-DATCP (SCBG Project #14-002); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. LDG was supported by the Consejo Nacional de Ciencia y Tecnologi ' a (Mexico), and the Gabelman-Seminis Graduate Fellowship. LRB was supported by the UW Madison SciMed GRS. Edward Grygleski is affiliated with the commercial company Valley Corporation. Valley Corporation provided support in the form of salaries for author (EG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alston J.M., 2014, EC IMPACT N AM CRANB; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Celik H, 2008, SCI HORTIC-AMSTERDAM, V117, P345, DOI 10.1016/j.scienta.2008.05.005; Chaib J, 2007, J EXP BOT, V58, P1915, DOI 10.1093/jxb/erm046; Chapman NH, 2012, PLANT PHYSIOL, V159, P1644, DOI 10.1104/pp.112.200634; Depypere L, 2009, PLANT SYST EVOL, V279, P219, DOI 10.1007/s00606-009-0158-8; Diaz-Garcia L, 2018, PEERJ, V6, DOI 10.7717/peerj.5461; Diaz-Garcia L, 2018, MOL GENET GENOMICS, V293, P1379, DOI 10.1007/s00438-018-1464-z; FAOSTAT, 2016, CRANB STAT 2016 FAOS; FDA, 2016, FOOD LAB REV NUTR SU; Figas MR, 2015, GENET RESOUR CROP EV, V62, P189, DOI 10.1007/s10722-014-0142-1; Forney C. F., 2010, FRESH PROD, V4, P67; Forney CF, 2003, HORTTECHNOLOGY, V13, P267, DOI 10.21273/HORTTECH.13.2.0267; Gallardo RK, 2018, HORTSCIENCE, V53, P1467, DOI [10.21273/hortsci13219-18, 10.21273/HORTSCI13219-18]; Gonzalo MJ, 2008, THEOR APPL GENET, V116, P647, DOI 10.1007/s00122-007-0698-7; Gorny JR, 2000, J FOOD SCI, V65, P541, DOI 10.1111/j.1365-2621.2000.tb16044.x; Gunes G, 2002, J AGR FOOD CHEM, V50, P5932, DOI 10.1021/jf025572c; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Hurtado M, 2013, SCI HORTIC-AMSTERDAM, V164, P625, DOI 10.1016/j.scienta.2013.10.028; Jarolmasjed S, 2016, POSTHARVEST BIOL TEC, V118, P35, DOI 10.1016/j.postharvbio.2016.03.014; Jesse E., 1993, EC IMPACT WISCONSIN, V2538; Konopacka D, 2004, POSTHARVEST BIOL TEC, V32, P205, DOI 10.1016/j.postharvbio.2003.11.012; Kumar S, 2012, FOOD CHEM, V131, P1223, DOI 10.1016/j.foodchem.2011.09.108; Magwaza LS, 2014, POSTHARVEST BIOL TEC, V95, P1, DOI 10.1016/j.postharvbio.2014.03.014; Meli VS, 2010, P NATL ACAD SCI USA, V107, P2413, DOI 10.1073/pnas.0909329107; Ozgen M, 2002, POSTHARVEST BIOL TEC, V24, P291, DOI 10.1016/S0925-5214(01)00154-5; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; R Development Core Team, 2009, R LANG ENV STAT COMP; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Song GQ, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: TEMPERATE FRUITS, P197, DOI 10.1007/978-3-642-16057-8_10; United State Department of Agriculture Economic Research Service (USDA-ERS), 2017, FRUIT TREE NUTS OUTL; United State Department of Agriculture National Agriculture Statistics Service (USDA NASS), 2017, NAT STAT CRANB; Valley Corp, CRANB VAR INF; Vorsa N, 2000, ACTA HORTIC, V574, P215, DOI 10.17660/ActaHortic.2002.574.32; Vorsa N, 2012, HANDB PLANT BREED, V8, P191, DOI 10.1007/978-1-4419-0763-9_6; Vvedenskaya IO, 2004, PLANT SCI, V167, P1043, DOI 10.1016/j.plantsci.2004.06.001; Walter A, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0056-8; Wang YF, 2017, PLANT SCI, V262, P91, DOI 10.1016/j.plantsci.2017.06.004; Well-Hansen L., 2018, COMMUNICATION; Yoshioka Y, 2010, EUPHYTICA, V171, P409, DOI 10.1007/s10681-009-0071-9; Zhang BH, 2014, FOOD RES INT, V62, P326, DOI 10.1016/j.foodres.2014.03.012; Zude M, 2006, J FOOD ENG, V77, P254, DOI 10.1016/j.jfoodeng.2005.06.027	42	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222451	10.1371/journal.pone.0222451	http://dx.doi.org/10.1371/journal.pone.0222451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553750	Green Submitted, Green Published, gold			2022-12-27	WOS:000532319200027
J	Goede, LL; Pflugrad, H; Schmitz, B; Lanfermann, H; Tryc, AB; Barg-Hock, H; Klempnauer, J; Weissenborn, K; Ding, XQ				Goede, Lukas Laurids; Pflugrad, Henning; Schmitz, Birte; Lanfermann, Heinrich; Tryc, Anita Blanka; Barg-Hock, Hannelore; Klempnauer, Juergen; Weissenborn, Karin; Ding, Xiao-Qi			Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL STATUS RBANS; NORMAL-APPEARING BRAIN; LONG-TERM; REPEATABLE BATTERY; WHITE-MATTER; DIFFUSION; MRI; COMPLICATIONS; ABNORMALITIES; METABOLISM	Purpose To investigate cerebral microstructural alterations in patients treated with calcineurin inhibitors (CNI) after orthotopic liver transplantation (OLT) using quantitative magnetic resonance imaging (qMRI) and a cross-sectional study design. Methods Cerebral qMRI was performed in 85 patients in a median 10 years after OLT compared to 31 healthy controls. Patients were treated with different dosages of CNI or with a CNI-free immunosuppression (CNI-free: n = 19; CNI-low: n = 36; CNI-standard: n = 30). T2-, T2*and T2'- relaxation times, as well as apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in brain gray and white matter by using the regions of interest method. Results In comparison to controls, patients revealed significantly increased T2, T2*, T2', ADC and reduced FA, predominantly in the frontal white matter, indicating microstructural brain alterations represented by increased free water (increased T2), reduced neuronal metabolism (increased T2') and a lower degree of spatial organization of the nervous fibers (reduced FA). CNI-low and CNI-free patients showed more alterations than CNI-standard patients. Analysis of their history revealed impairment of kidney function while under standard CNI dose suggesting that these patients may be more vulnerable to toxic CNI side-effects. Conclusion Our findings suggest that the individual sensitivity to toxic side effects should be considered when choosing an appropriate immunosuppressive regimen in patients after liver transplantation.	[Goede, Lukas Laurids; Pflugrad, Henning; Tryc, Anita Blanka; Weissenborn, Karin] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Goede, Lukas Laurids; Schmitz, Birte; Lanfermann, Heinrich; Ding, Xiao-Qi] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany; [Goede, Lukas Laurids; Pflugrad, Henning; Tryc, Anita Blanka; Weissenborn, Karin] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Barg-Hock, Hannelore; Klempnauer, Juergen] Hannover Med Sch, Clin Visceral & Transplant Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Ding, XQ (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany.	ding.xiaoqi@mh-hannover.de	Lanfermann, Heinrich/AAR-4069-2021	Goede, Lukas Laurids/0000-0001-6026-185X	German Federal Ministry of Education and Research [01EO1302]; German Research Foundation (DFG); Hannover Medical School (MHH)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Hannover Medical School (MHH)	This study was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302) to LLG and German Research Foundation (DFG) to BS. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg F, 2011, SCAND J SURG, V100, P14, DOI 10.1177/145749691110000104; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Bernhardt M, 2015, LIVER TRANSPLANT, V21, P224, DOI 10.1002/lt.24035; Blinkenberg M, 1999, NEUROLOGY, V53, P149, DOI 10.1212/WNL.53.1.149; Dawe RJ, 2014, NEUROBIOL AGING, V35, P1549, DOI 10.1016/j.neurobiolaging.2014.01.144; Ding XQ, 2008, EUR J PAEDIATR NEURO, V12, P298, DOI 10.1016/j.ejpn.2007.08.012; Ding XQ, 2008, J MAGN RESON IMAGING, V27, P998, DOI 10.1002/jmri.21289; Ding XQ, 2009, EUR RADIOL, V19, P1537, DOI 10.1007/s00330-009-1296-7; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; Dogan F, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20151007; Eylers VV, 2016, AM J NEURORADIOL, V37, P447, DOI 10.3174/ajnr.A4557; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Martinez RG, 2010, TRANSPLANTATION, V89, P589, DOI 10.1097/TP.0b013e3181ca7bb3; Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262; Herynek V, 2012, J MAGN RESON IMAGING, V35, P1332, DOI 10.1002/jmri.23599; Herzer K, 2016, CLIN TRANSPLANT, V30, P487, DOI 10.1111/ctr.12708; HOLLAND BA, 1986, AM J NEURORADIOL, V7, P201; Holst B, 2009, MULT SCLER, V15, P701, DOI 10.1177/1352458509103713; Howell D, 2002, STAT METHODS PSYCHOL, V5th ed; Leppert IR, 2009, J MAGN RESON IMAGING, V29, P258, DOI 10.1002/jmri.21646; Lewis MB, 2003, NEUROLOGY, V61, P1174, DOI 10.1212/01.WNL.0000089487.42870.C6; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Mooney S, 2007, ARCH CLIN NEUROPSYCH, V22, P175, DOI 10.1016/j.acn.2006.12.005; MUELLER AR, 1994, TRANSPLANTATION, V58, P155, DOI 10.1097/00007890-199407270-00006; Pflugrad H, 2018, LIVER TRANSPLANT, V24, P56, DOI 10.1002/lt.24984; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rompianesi G, 2015, TRANSPL INT, V28, P864, DOI 10.1111/tri.12564; Wagner M, 2012, AM J NEURORADIOL, V33, P2081, DOI 10.3174/ajnr.A3138; Wagner M, 2012, J MAGN RESON IMAGING, V36, P1347, DOI 10.1002/jmri.23777; Weissenborn K, 2013, NEURORADIOLOGY, V55, P819, DOI 10.1007/s00234-013-1176-3	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222934	10.1371/journal.pone.0222934	http://dx.doi.org/10.1371/journal.pone.0222934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553760	gold, Green Published			2022-12-27	WOS:000532319200045
J	Hofmann, R; Muller, J; Shatilo, L; Videiko, M; Ohlrau, R; Rud, V; Burdo, N; Dal Corso, M; Dreibrodt, S; Kirleis, W				Hofmann, Robert; Mueller, Johannes; Shatilo, Liudmyla; Videiko, Mykhailo; Ohlrau, Rene; Rud, Vitalii; Burdo, Nataliia; Dal Corso, Marta; Dreibrodt, Stefan; Kirleis, Wiebke			Governing Tripolye: Integrative architecture in Tripolye settlements	PLOS ONE			English	Article							MEGA-SITE	Recently, high-resolution magnetometry surveys have led to the discovery of a special category of buildings-so-called 'mega-structures'-situated in highly visible positions in the public space of Tripolye giant-settlements of the late 5th and first half of the 4th millennium BCE. In this paper we explore what these buildings actually are and how they can contribute to the understanding of the development of social space in Tripolye giant-settlements. For this investigation, we linked newly obtained excavation data from the giant-settlement Maidanetske, Ukraine, with a much larger sample of such buildings from magnetic plans obtained in the region between the Carpathian foothills and the Dnieper River. Accordingly, Tripolye mega-structures represent a particular kind of integrative building documented in many non-ranked ethnographic contexts. Based on our results we are interpreting that these buildings were used for various ritual and non-ritual activities, joint decision-making, and the storage and consumption of surplus. In Tripolye giant-settlements at least three different categories of mega-structures could be identified which most likely represent different levels of sociopolitical integration and decision-making. The emergence of this hierarchical system of high-level integrative buildings for the whole community and different low-level integrative architectures for certain segments of local communities was related to the rise of Tripolye mega-sites. The presence of different integrative levels most likely reflects the fusion of different previously independent communities in the giant-settlements. Later in the mega-site development, we observe how low-level integrative buildings increasingly lose their importance indicated by shrinking size and, finally, their disappearance. This observation might indicate that the power which was previously distributed across the community was transferred to a central institution. It is argued that the non-acceptance of this concentration of power and the decline of lower decision-making levels might be a crucial factor for the disintegration of Tripolye giant-settlements around 3600 BCE.	[Hofmann, Robert; Mueller, Johannes; Shatilo, Liudmyla; Ohlrau, Rene; Dal Corso, Marta; Kirleis, Wiebke] Univ Kiel, Inst Pre & Protohist, Kiel, Schleswig Holst, Germany; [Hofmann, Robert; Mueller, Johannes; Shatilo, Liudmyla; Dal Corso, Marta; Dreibrodt, Stefan; Kirleis, Wiebke] Univ Kiel, Collaborat Res Ctr Scales Transformat Human Envir, Kiel, Schleswig Holst, Germany; [Videiko, Mykhailo] Borys Grinchenko Kyiv Univ, Lab Archaeol, Kiev, Ukraine; [Rud, Vitalii; Burdo, Nataliia] Natl Acad Sci Ukraine, Inst Archaeol, Kiev, Ukraine; [Dreibrodt, Stefan] Univ Kiel, Inst Ecosyst Res, Kiel, Schleswig Holst, Germany	University of Kiel; University of Kiel; Ministry of Education & Science of Ukraine; Borys Grinchenko Kyiv University; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine; University of Kiel	Hofmann, R (corresponding author), Univ Kiel, Inst Pre & Protohist, Kiel, Schleswig Holst, Germany.; Hofmann, R (corresponding author), Univ Kiel, Collaborat Res Ctr Scales Transformat Human Envir, Kiel, Schleswig Holst, Germany.	robert.hofmann@ufg.uni-kiel.de		Mueller, Johannes/0000-0002-3538-197X; Kirleis, Wiebke/0000-0003-0229-8958; Hofmann, Robert/0000-0002-0028-6155; Rud, Vitalii/0000-0001-8087-2236; Videiko, Mykhailo/0000-0002-8708-0749; Ohlrau, Rene/0000-0002-9505-7004; Dal Corso, Marta/0000-0002-2307-0613	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [2901391021 -SFB 1266]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The research was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, - Project number 2901391021 -SFB 1266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER MA, 1990, WORLD ARCHAEOL, V22, P133, DOI 10.1080/00438243.1990.9980136; Adler MA, 2002, ARCHAEOLOGICAL SERIE, V15, P155; Adler MichaelA., 1989, ARCHITECTURE SOCIAL, P35; Amborn H., 2016, RECHT ALS HORT ANARC; Anderson PC, 2014, EXPLORING EXPLAINING, V2, P93; Bandy MS, 2004, AM ANTHROPOL, V106, P322, DOI 10.1525/aa.2004.106.2.322; Burdo N., 2016, TRYPILLIA MEGASITES, P113; Chapman J., 2014, J NEOLITHIC ARCHAEOL, V16, P135, DOI DOI 10.12766/JNA.2014.4; Chapman J, 2018, TRYPILLIA MEGA SITES, DOI [10.5284/1047599, DOI 10.5284/1047599]; Chapman J., 2016, TRYPILLIA MEGASITES, P117; Chapman J, 2017, J WORLD PREHIST, V30, P221, DOI 10.1007/s10963-017-9106-7; Chapman J, 2014, EUR J ARCHAEOL, V17, P369, DOI 10.1179/1461957114Y.0000000062; Chernovol D, 2012, TRIPOLYE CULTURE GIA, P183; Dal Corso M, 2019, HOLOCENE, V29, P1622, DOI 10.1177/0959683619857229; Dannath Y, 2019, ARCHAOLOGIE NIEDERSA, V22, P50; Diachenko A., 2016, THEMES CONT ARCHAEOL, V2, P169; Diachenko A, 2017, J WORLD PREHIST, V30, P207, DOI 10.1007/s10963-017-9105-8; Dietler M., 1996, FOOD STATUS QUEST IN, P87; Feinman GM, 2013, COOPERATION COLLECTI, P36; Feinman GM, 2012, ALTERNATIVE LEADERSH; Harper T., 2012, THESIS; Harper T.K., 2013, CHRONIKA, V3, P28; Harper TK, 2016, THESIS; Hofmann R., 2016, J NEOLITHIC ARCHAEOL, V18, P157, DOI DOI 10.12766/JNA.2016.4; Hofmann R, 2018, VITA ANTIQUA, V10, P146; Johnson G. A., 1982, THEORY EXPLANATION A, P389; JOHNSON GA, 1983, HUM ECOL, V11, P175, DOI 10.1007/BF00891742; Johnson GA, 2012, THEORY EXPLANATION A; Kirleis W., 2016, TRYPILLIA MEGA SITES, P195, DOI DOI 10.4324/9781315630731; Korber-Grohne U., 1987, LANDKREIS HELMSTEDT, V17, P463; Korvin-Piotrovskiy AG, 2016, ROBOTI, V2015, P201; Kruts V., 2012, TRIPOLYE CULTURE GIA, P70; Menotti F., 2012, TRIPOLYE CULTURE GIA; Muller C, 2018, P IEEE COMPUT SECUR, P247, DOI 10.1109/CSF.2018.00025; Muller J, 2016, THEMES CONT ARCHAEOL, V2, P71; Muller J, 2016, TRYPILLIA MEGASITES, P281; Muller J., 2016, TRYPILLA MEGA SITES; Muller J., 2017, MAIDANETSKE 2013 NEW; MULLER JOHANNES, 2016, THEMES CONT ARCHAEOL, V2, P253; Nebbia M, 2018, WORLD ARCHAEOL, V50, P41, DOI 10.1080/00438243.2018.1474133; OHLRAU R., 2015, J NEOLITHIC ARCHAEOL, V17, P17, DOI DOI 10.12766/JNA.V17I0.116; Ohlrau R., 2019, MAIDANETSKE DEV DECL; Ohlrau R, 2016, TRYPILLIA MEGASITES, P207; Pickartz N, 2019, HOLOCEN, P29; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Rascovan N, 2019, CELL, V176, P295, DOI 10.1016/j.cell.2018.11.005; Rassmann K., 2014, J NEOLITHIC ARCHAEOL, V16, P63, DOI [10.12766/jna.2014.3, DOI 10.12766/JNA.2014.3]; Rassmann K, 2016, THEMES CONT ARCHAEOL, V2, P29; Rassmann K, 2016, TRYPILLIA MEGASITES, P55; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roscoe Paul, 2012, ELITES ALTERNATIVES, V1, P41; Rud V, 2019, J NEOLITHIC ARCHAEOL; Sahlins Marshall, 1974, STONE AGE EC; Smith ME, 2010, J ANTHROPOL ARCHAEOL, V29, P137, DOI 10.1016/j.jaa.2010.01.001; Terna S., 2016, MENSCH KULTUR GESELL, P41; Terna S., 2016, RAPORT, V11, P187; Uhl RA, 2017, J LANDSCAPE ECOLOGY, V10, P25; Videiko M. Y., 2016, TRYPILLIA MEGA SITES, P221; Zimmermann A, 2012, QUATERN INT, V274, P251, DOI 10.1016/j.quaint.2012.05.014	59	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222243	10.1371/journal.pone.0222243	http://dx.doi.org/10.1371/journal.pone.0222243			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553745	gold, Green Accepted, Green Published			2022-12-27	WOS:000532319200019
J	Sistere-Oro, M; Lopez-Serrano, S; Veljkovic, V; Pina-Pedrero, S; Vergara-Alert, J; Cordoba, L; Perez-Maillo, M; Pleguezuelos, P; Vidal, E; Segales, J; Nielsen, J; Fomsgaard, A; Darji, A				Sistere-Oro, Marta; Lopez-Serrano, Sergi; Veljkovic, Veljko; Pina-Pedrero, Sonia; Vergara-Alert, Julia; Cordoba, Lorena; Perez-Maillo, Monica; Pleguezuelos, Patricia; Vidal, Enric; Segales, Joaquim; Nielsen, Jens; Fomsgaard, Anders; Darji, Ayub			DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs	PLOS ONE			English	Article							A VIRUSES; RESPIRATORY CHALLENGE; PROTEIN VACCINE; PROTECTION; FLAGELLIN; ANTIBODIES; H5N1; IMMUNOGENICITY; TRANSMISSION; IMMUNIZATION	Swine influenza virus (SIVs) infections cause a significant economic impact to the pork industry. Moreover, pigs may act as mixing vessel favoring genome reassortment of diverse influenza viruses. Such an example is the pandemic H1N1 (pH1N1) virus that appeared in 2009, harboring a combination of gene segments from avian, pig and human lineages, which rapidly reached pandemic proportions. In order to confront and prevent these possible emergences as well as antigenic drift phenomena, vaccination remains of vital importance. The present work aimed to evaluate a new DNA influenza vaccine based on distinct conserved HA-peptides fused with flagellin and applied together with Diluvac Forte as adjuvant using a needle-free device (IntraDermal Application of Liquids, IDAL (R)). Two experimental pig studies were performed to test DNA-vaccine efficacy against SIVs in pigs. In the first experiment, SIV-seronegative pigs were vaccinated with VC4-flagellin DNA and intranasally challenged with a pH1N1. In the second study, VC4-flagellin DNA vaccine was employed in SIV-seropositive animals and challenged intranasally with an H3N2 SIV-isolate. Both experiments demonstrated a reduction in the viral shedding after challenge, suggesting vaccine efficacy against both the H1 and H3 influenza virus subtypes. In addition, the results proved that maternally derived antibodies (MDA) did not constitute an obstacle to the vaccine approach used. Moreover, elevated titers in antibodies both against H1 and H3 proteins in serum and in bronchoalveolar lavage fluids (BALFs) was detected in the vaccinated animals along with a markedly increased mucosal IgA response. Additionally, vaccinated animals developed stronger neutralizing antibodies in BALFs and higher inhibiting hemagglutination titers in sera against both the pH1N1 and H3N2 influenza viruses compared to unvaccinated, challenged-pigs. It is proposed that the described DNA-vaccine formulation could potentially be used as a multivalent vaccine against SIV infections.	[Sistere-Oro, Marta; Lopez-Serrano, Sergi; Pina-Pedrero, Sonia; Vergara-Alert, Julia; Cordoba, Lorena; Perez-Maillo, Monica; Pleguezuelos, Patricia; Vidal, Enric; Darji, Ayub] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Veljkovic, Veljko] Biomed Protect, Galveston, TX USA; [Segales, Joaquim] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Segales, Joaquim] UAB, Bellaterra Cerdanyola Valles, Fac Vet, Dept Sanitat & Anat Anim, Barcelona, Spain; [Nielsen, Jens; Fomsgaard, Anders] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Virus Res & Dev Lab, Copenhagen S, Denmark	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Statens Serum Institut	Darji, A (corresponding author), UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ayub.darji@irta.cat	Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014; Segalés, Joaquim/A-4933-2011; Pina-Pedrero, Sonia/U-2217-2017	Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Segalés, Joaquim/0000-0002-1539-7261; Pina-Pedrero, Sonia/0000-0001-5475-4770; Fomsgaard, Anders/0000-0003-4304-0603; Lopez-Serrano, Sergi/0000-0002-0968-7713	Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO) [AGL2013-48923-C2-2-R]; European Comission (EC) under Horizon 2020 [Transvac2-730964-INFRAIA-2016-1]; CERCA Programme/Generalitat de Catalunya; MINECO [BES-2014-068506]	Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO); European Comission (EC) under Horizon 2020; CERCA Programme/Generalitat de Catalunya; MINECO(Spanish Government)	This work was funded in part by the Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO), project: AGL2013-48923-C2-2-R, and by the collaborative infrastructure project funded by the European Comission (EC) under Horizon 2020, project Transvac2-730964-INFRAIA-2016-1. IRTA is supported by CERCA Programme/Generalitat de Catalunya. M.S.O. is supported by MINECO (scholarship no BES-2014-068506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The authors thank all personnel from IRTA CReSA field studies and BSL-3 laboratories and animal facilities for their transcendent assistance provided in both research studies. Authors also are thankful to Dr. Marta Jime ' nez from MSD Animal Health who supplied the IDAL1 device. Moreover, we also appreciate the courtesy from the personnel of CESAC (Centre de Sanitat Avicola de Catalunya, Reus, Spain) for kindly providing the chicken red blood cells.	Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; Bikour MH, 1996, CAN J VET RES, V60, P312; Borggren M, 2016, VACCINE, V34, P3634, DOI 10.1016/j.vaccine.2016.05.030; Borggren M, 2015, HUM VACC IMMUNOTHER, V11, P1983, DOI 10.1080/21645515.2015.1011987; Brown IH, 2011, CURR TOP MICOBIOL, V370, P133; BUSQUETS N, 2010, VET RES, V41, DOI DOI 10.1051/VETRES/2009049; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Colombatti A, 2015, WO, Patent No. [2015/166010, 2015166010]; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Department of health and human services. Food and drug administration. Center for biologics evaluation and research, 2007, GUID IND CLIN DAT NE; Detmer SE, 2013, INFLUENZA OTHER RESP, V7, P2, DOI 10.1111/irv.12199; Durrwald R, 2010, EMERG INFECT DIS, V16, P1029, DOI 10.3201/eid1606.100138; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gorres JP, 2011, CLIN VACCINE IMMUNOL, V18, P1987, DOI 10.1128/CVI.05171-11; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; He WQ, 2015, J VIROL, V89, P3610, DOI 10.1128/JVI.03099-14; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Karlsson I, 2018, VET IMMUNOL IMMUNOP, V195, P25, DOI 10.1016/j.vetimm.2017.11.007; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Leung YHC, 2013, VACCINE, V31, P3536, DOI 10.1016/j.vaccine.2013.05.076; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Ma JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-227; Ma Wenjun, 2010, Animal Health Research Reviews, V11, P81, DOI 10.1017/S146625231000006X; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Markowska-Daniel I, 2011, VET IMMUNOL IMMUNOP, V142, P81, DOI 10.1016/j.vetimm.2011.03.019; Martin-Valls GE, 2014, VET MICROBIOL, V170, P266, DOI 10.1016/j.vetmic.2014.02.031; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Okutani M, 2018, ANIM SCI J, V89, P979, DOI 10.1111/asj.13021; Olsen CW, 2000, VET MICROBIOL, V74, P149, DOI 10.1016/S0378-1135(00)00175-9; Olvera A, 2011, VACCINE, V29, P2797, DOI 10.1016/j.vaccine.2011.01.105; Rahn J, 2015, VACCINE, V33, P2414, DOI 10.1016/j.vaccine.2015.03.052; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2015, VACCINES-BASEL, V3, P22, DOI 10.3390/vaccines3010022; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Sibila M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-165; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; The European agency for the evaluation of medical products, 1997, NOT GUID HARM REQ IN, P19; Tsybalova LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201429; Van Reeth K, 2004, VIRUS RES, V103, P115, DOI 10.1016/j.virusres.2004.02.023; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Vergara-Alert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040524; Vincent AL, 2017, VET MICROBIOL, V206, P35, DOI 10.1016/j.vetmic.2016.11.026; Vincent AL, 2010, VACCINE, V28, P2782, DOI 10.1016/j.vaccine.2010.01.049; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wang BZ, 2010, PLOS ONE, V5; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Wijnans L, 2016, INFLUENZA OTHER RESP, V10, P2, DOI 10.1111/irv.12351; Wood JM, 2003, VACCINE, V21, P1786, DOI 10.1016/S0264-410X(03)00073-2; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, V6th; Young F, 2011, VACCINE, V29, P8788, DOI 10.1016/j.vaccine.2011.09.077; Zimmerman Jeffrey J., 2012, DIS SWINE, P557	74	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222201	10.1371/journal.pone.0222201	http://dx.doi.org/10.1371/journal.pone.0222201			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE4TZ	31553755	Green Published, gold, Green Submitted			2022-12-27	WOS:000526713800001
J	Lim, JH; Cho, JH; Jung, HY; Choi, JY; Park, SH; Kim, YL; Kim, HK; Huh, S; Yoo, ES; Won, DI; Kim, CD				Lim, Jeong-Hoon; Cho, Jang-Hee; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Hyung-Kee; Huh, Seung; Yoo, Eun Sang; Won, Dong-Il; Kim, Chan-Duck			Excellent outcome after desensitization in high immunologic risk kidney transplantation	PLOS ONE			English	Article							POSITIVE CROSS-MATCH; ABO BLOOD-GROUP; ANTIBODY; RECIPIENTS; PROTOCOLS; DIALYSIS	Introduction HLA-incompatible (HLAi) and ABO-incompatible (ABOi) kidney transplantation (KT) has been on the increase over the last decade. However, there are wide variations in outcomes from these procedures. In this study we evaluated the graft and patient outcomes in incompatible KT and non-sensitized KT. Methods Patients who underwent KT between January 2012 and April 2018 were enrolled and reviewed. We divided kidney transplant recipients (KTRs) into five groups as follows: HLAi (n = 50); ABOi (n = 65); HLAi+ABOi (n = 5); control (n = 428); and living-donor control (LD control, n = 218). We compared the risk of rejection, graft function, graft survival, and patient survival between incompatible KTRs and control/LD control KTRs. Results Although the incidence of active antibody-mediated rejection in HLAi group tends to be higher than in control and LD control groups (6.0% vs. 2.8%, P = 0.20; 6.0% vs. 3.7%, P = 0.44, respectively), the rejection-free survival, graft survival, and patient survival were not significantly different from those of the control and LD control groups in all three incompatible KT groups (all P>0.05). Graft function during the study period was also not different between incompatible KTRs and control/LD control groups (both P>0.05). Using Cox regression analysis, neither HLAi nor ABOi were risk factors for graft failure. Some infectious diseases such as urinary tract infection and cytomegalovirus infection were more common in the HLAi group than in the control/LD control group (both P<0.05), but only one infection-related death occurred in HLAi KTRs. Infection risks were similar in the ABOi and HLAi+ABOi groups compared to controls. Conclusion Our results showed favorable outcomes for incompatible KT after desensitization. Although desensitization therapy for incompatible KT has improved access to transplantation for KT candidates with high immunological risk, more clinical data are clearly needed.	[Lim, Jeong-Hoon; Cho, Jang-Hee; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Chan-Duck] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea; [Kim, Hyung-Kee; Huh, Seung] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Surg, Sch Med, Daegu, South Korea; [Yoo, Eun Sang] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Urol, Sch Med, Daegu, South Korea; [Won, Dong-Il] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Clin Pathol, Sch Med, Daegu, South Korea	Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital	Kim, CD (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea.	drcdkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022; Lim, Jeong-Hoon/ABE-6003-2020	Cho, Jang-hee/0000-0002-7031-5214; Lim, Jeong-Hoon/0000-0001-5517-9886; Won, Dong Il/0000-0002-1983-2515	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI13C1232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheim M, 2018, HUM IMMUNOL, V79, P132, DOI 10.1016/j.humimm.2017.11.006; Barnett ANR, 2014, TRANSPL INT, V27, P187, DOI 10.1111/tri.12234; Chung BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123638; Chung BH, 2014, TRANSPL INT, V27, P49, DOI 10.1111/tri.12199; Couzi L, 2015, TRANSPL INT, V28, P1205, DOI 10.1111/tri.12621; Dall A, 2008, CLIN J AM SOC NEPHRO, V3, pS68, DOI 10.2215/CJN.02770707; Garcia-Garcia G, 2012, NEFROLOGIA, V32, P1, DOI 10.3265/Nefrologia.pre2012.Jan.11333; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Gordon EJ, 2010, SEMIN NEPHROL, V30, P81, DOI 10.1016/j.semnephrol.2009.10.009; Gordon EJ, 2009, NEPHROL DIAL TRANSPL, V24, P1103, DOI 10.1093/ndt/gfn691; Haas M, 2016, AM J TRANSPLANT, V16, P1352, DOI 10.1111/ajt.13661; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Ingsathit A, 2013, TRANSPL P, V45, P1427, DOI 10.1016/j.transproceed.2012.08.029; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jeon HJ, 2019, KIDNEY RES CLIN PRAC, V38, P116, DOI 10.23876/j.krcp.18.0068; Ko EJ, 2017, TRANSPL INT, V30, P1215, DOI 10.1111/tri.12979; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Lee KH, 2018, TRANSPL P, V50, P1063, DOI 10.1016/j.transproceed.2018.01.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marfo K, 2011, CLIN J AM SOC NEPHRO, V6, P922, DOI 10.2215/CJN.08140910; Massad MG, 1997, ANN THORAC SURG, V64, P1120, DOI 10.1016/S0003-4975(97)00807-2; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; Padmanabhan A, 2009, TRANSPLANTATION, V87, P1889, DOI 10.1097/TP.0b013e3181a76ae1; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Saito PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100270; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Tyden G, 2007, TRANSPLANTATION, V84, pS27, DOI 10.1097/01.tp.0000296102.94695.c0; Uchida J, 2010, TRANSPL P, V42, P3998, DOI 10.1016/j.transproceed.2010.09.043; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yoon HE, 2009, J KOREAN MED SCI, V24, pS148, DOI 10.3346/jkms.2009.24.S1.S148; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222537	10.1371/journal.pone.0222537	http://dx.doi.org/10.1371/journal.pone.0222537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550258	Green Published, gold			2022-12-27	WOS:000532307700016
J	Gyebnar, G; Klimaj, Z; Entz, L; Fabo, D; Rudas, G; Barsi, P; Kozak, LR				Gyebnar, Gyula; Klimaj, Zoltan; Entz, Laszlo; Fabo, Daniel; Rudas, Gabor; Barsi, Peter; Kozak, Lajos R.			Personalized microstructural evaluation using a Mahalanobis-distance based outlier detection strategy on epilepsy patients' DTI data - Theory, simulations and example cases	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; TEMPORAL-LOBE EPILEPSY; WHITE-MATTER; IN-VIVO; MULTIVARIATE-ANALYSIS; IMPROVES DETECTION; COMPONENT ANALYSIS; DIFFUSION; BRAIN; ORIENTATION	Quantitative MRI methods have recently gained extensive interest and are seeing substantial developments; however, their application in single patient vs control group comparisons is often limited by inherent statistical difficulties. One such application is detecting malformations of cortical development (MCDs) behind drug resistant epilepsies, a task that, especially when based solely on conventional MR images, may represent a serious challenge. We aimed to develop a novel straightforward voxel-wise evaluation method based on the Mahalanobis-distance, combining quantitative MRI data into a multidimensional parameter space and detecting lesion voxels as outliers. Simulations with standard multivariate Gaussian distribution and resampled DTI-eigenvalue data of 45 healthy control subjects determined the optimal critical value, cluster size threshold, and the expectable lesion detection performance through ROC-analyses. To reduce the effect of false positives emanating from registration artefacts and gyrification differences, an automatic classification method was applied, fine-tuned using a leave-one-out strategy based on diffusion and T1-weighted data of the controls. DWI processing, including thorough corrections and robust tensor fitting was performed with ExploreDTI, spatial coregistration was achieved with the DARTEL tools of SPM12. Additional to simulations, clusters of outlying diffusion profile, concordant with neuroradiological evaluation and independent calculations with the MAP07 toolbox were identified in 12 cases of a 13 patient example population with various types of MCDs. The multidimensional approach proved sufficiently sensitive in pinpointing regions of abnormal tissue microstructure using DTI data both in simulations and in the heterogeneous example population. Inherent limitations posed by registration artefacts, age-related differences, and the different or mixed pathologies limit the generalization of specificity estimation. Nevertheless, the proposed statistical method may aid the everyday examination of individual subjects, ever so more upon extending the framework with quantitative information from other modalities, e.g. susceptibility mapping, relaxometry, or perfusion.	[Gyebnar, Gyula; Klimaj, Zoltan; Rudas, Gabor; Barsi, Peter; Kozak, Lajos R.] Semmelweis Univ, Magnet Resonance Res Ctr, Budapest, Hungary; [Entz, Laszlo; Fabo, Daniel] Natl Inst Clin Neurosci, Budapest, Hungary	Semmelweis University	Gyebnar, G (corresponding author), Semmelweis Univ, Magnet Resonance Res Ctr, Budapest, Hungary.	gyebnargyula@gmail.com	Kozak, Lajos R/B-4194-2011	Kozak, Lajos R/0000-0003-0368-3663; Klimaj, Zoltan/0000-0001-9700-5382; Fabo, Daniel/0000-0001-5141-5351	Hungarian National Brain Research Program [KTIA/NAP_13-1-2013-0001:5, 2017-1.2.1-NKP-2017-00002]; Hungarian NRDIO (National Research, Development and Innovation Office) [K128040]; Bolyai Research Fellowship Program of the Hungarian Academy of Sciences;  [EFOP3.6.3-VEKOP-16-2017-00009]	Hungarian National Brain Research Program; Hungarian NRDIO (National Research, Development and Innovation Office); Bolyai Research Fellowship Program of the Hungarian Academy of Sciences; 	This study was supported by the EFOP3.6.3-VEKOP-16-2017-00009 project, the Hungarian National Brain Research Program grants KTIA/NAP_13-1-2013-0001:5 and 2017-1.2.1-NKP-2017-00002, and the Hungarian NRDIO (National Research, Development and Innovation Office) Grant: K128040. LRK also received support from the Bolyai Research Fellowship Program of the Hungarian Academy of Sciences.	Adler S, 2017, NEUROIMAGE-CLIN, V15, P95, DOI 10.1016/j.nicl.2017.04.017; Ahmed B, 2015, EPILEPSY BEHAV, V48, P21, DOI 10.1016/j.yebeh.2015.04.055; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Bhaganagarapu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00343; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Bonilha L, 2015, AM J NEURORADIOL, V36, P719, DOI 10.3174/ajnr.A4185; Caprihan A, 2008, NEUROIMAGE, V42, P675, DOI 10.1016/j.neuroimage.2008.04.255; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2008, NEUROIMAGE, V39, P1693, DOI 10.1016/j.neuroimage.2007.10.039; Colombo N, 2018, NEUROIMAGING EVALUAT, P1; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Dean DC, 2017, NEUROIMAGE-CLIN, V14, P54, DOI 10.1016/j.nicl.2017.01.002; Dyrby TB, 2014, NEUROIMAGE, V103, P202, DOI 10.1016/j.neuroimage.2014.09.005; El Azami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161498; Filippi CG, 2013, PEDIATR RADIOL, V43, P1196, DOI 10.1007/s00247-013-2677-2; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fushimi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148925; Gaser C., 2016, MANUAL COMPUTATIONAL; GNANADESIKAN R, 1972, BIOMETRICS, V28, P81, DOI 10.2307/2528963; Gyebnar G, 2017, PSYCHIAT RES; Hayasaka S, 2006, NEUROIMAGE, V30, P768, DOI 10.1016/j.neuroimage.2005.10.052; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; Hong SJ, 2017, NEUROLOGY, V88, P734, DOI 10.1212/WNL.0000000000003632; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Huppertz HJ, 2008, EPILEPSIA, V49, P772, DOI 10.1111/j.1528-1167.2007.01436.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jeong JW, 2014, HUM BRAIN MAPP, V35, P3216, DOI 10.1002/hbm.22396; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Jin B, 2018, EPILEPSIA, V59, P982, DOI 10.1111/epi.14064; Koay CG, 2016, NEUROIMAGE, V126, P151, DOI 10.1016/j.neuroimage.2015.11.046; Kulikova S, 2015, BRAIN STRUCT FUNCT, V220, P3657, DOI 10.1007/s00429-014-0881-y; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lazar NA, 2002, NEUROIMAGE, V16, P538, DOI 10.1006/nimg.2002.1107; Leemans A., 2009, P 17 ANN M INT SOC M, VVol. 3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lindemer ER, 2015, NEUROBIOL AGING, V36, P2447, DOI 10.1016/j.neurobiolaging.2015.05.011; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Naylor MG, 2014, HUM BRAIN MAPP, V35, P831, DOI 10.1002/hbm.22217; Penny K. I., 1996, J R STAT SOC C-APPL, V45, P73, DOI 10.2307/2986224; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Schnitzer D., 2014, P 22 EUR S ART NEUR; Simon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083947; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Takeshita T, 1993, DOC AN REC 1993 P 2; TAXT T, 1994, IEEE T MED IMAGING, V13, P470, DOI 10.1109/42.310878; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Urbach H, 2015, CLIN NEURORADIOL, V25, P151, DOI 10.1007/s00062-015-0387-x; Urbach H., 2011, CLIN NEURORADIOLOGY; van Diessen E, 2013, EPILEPSIA, V54, P1855, DOI 10.1111/epi.12350; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204; Whelan CD, 2015, EPILEPSIA, V56, P1551, DOI 10.1111/epi.13103; Winston GP, 2014, EPILEPSY RES, V108, P336, DOI 10.1016/j.eplepsyres.2013.11.004; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067; Xiang SM, 2008, PATTERN RECOGN, V41, P3600, DOI 10.1016/j.patcog.2008.05.018; Young K, 2010, MAGN RESON MED, V63, P20, DOI 10.1002/mrm.22190; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	78	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222720	10.1371/journal.pone.0222720	http://dx.doi.org/10.1371/journal.pone.0222720			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545838	Green Published, gold			2022-12-27	WOS:000532303200030
J	Myles, O; Grafton, B; Clarke, P; MacLeod, C				Myles, Owen; Grafton, Ben; Clarke, Patrick; MacLeod, Colin			GIVE me your attention: Differentiating goal identification and goal execution components of the anti-saccade effect	PLOS ONE			English	Article							WORKING-MEMORY; INHIBITORY CONTROL; COGNITIVE CONTROL; ANTISACCADE; ANXIETY; TASK; EFFICIENCY; CORTEX	The anti-saccade task is a commonly used method of assessing individual differences in cognitive control. It has been shown that a number of clinical disorders are characterised by increased anti-saccade cost. However, it remains unknown whether this reflects impaired goal identification or impaired goal execution, because, to date, no procedure has been developed to independently assess these two components of anti-saccade cost. The aim of the present study was to develop such an assessment task, which we term the Goal Identification Vs. Execution (GIVE) task. Fifty-one undergraduate students completed a conventional anti-saccade task, and our novel GIVE task. Our findings revealed that individual differences in anti-saccade goal identification costs and goal execution costs were uncorrelated, when assessed using the GIVE task, but both predicted unique variance in the conventional anti-saccade cost measure. These results confirm that the GIVE task is capable of independently assessing variation in the goal identification and goal execution components of the anti-saccade effect. We discuss how this newly introduced assessment procedure now can be employed to illuminate the specific basis of the increased anti-saccade cost that characterises various forms of clinical dysfunction.	[Myles, Owen; Grafton, Ben; MacLeod, Colin] Univ Western Australia, Ctr Adv Res Emot, Perth, WA, Australia; [Clarke, Patrick] Curtin Univ, Bentley, WA, Australia	University of Western Australia; Curtin University	Myles, O (corresponding author), Univ Western Australia, Ctr Adv Res Emot, Perth, WA, Australia.	owen.myles@research.uwa.edu.au		MacLeod, Colin/0000-0003-2407-7339; Clarke, Patrick/0000-0003-0303-4479; Myles, Owen/0000-0003-2756-3746; Grafton, Ben/0000-0002-9920-4278	Australian Research Council [DP170104533, FL170100167]; Australian Government Research Training Program (RTP) Scholarship	Australian Research Council(Australian Research Council); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by Australian Research Council Grants DP170104533 and FL170100167 (https://www.arc.gov.au/), and an Australian Government Research Training Program (RTP) Scholarship (https://www.education.gov.au/research-training-program).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Ansari TL, 2011, NEUROPSYCHOLOGIA, V49, P1146, DOI 10.1016/j.neuropsychologia.2011.01.019; Ansari TL, 2010, COGNITION EMOTION, V24, P241, DOI 10.1080/02699930903381531; Carvalho N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105355; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; De Lissnyder E, 2011, COGNITION EMOTION, V25, P886, DOI 10.1080/02699931.2010.514711; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; GIBSON JM, 1987, J NEUROL NEUROSUR PS, V50, P853, DOI 10.1136/jnnp.50.7.853; Hunt AR, 2002, MEM COGNITION, V30, P529, DOI 10.3758/BF03194954; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Kaufman LD, 2010, J ALZHEIMERS DIS, V19, P781, DOI 10.3233/JAD-2010-1275; KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285; Klapetek A, 2016, J VISION, V16, DOI 10.1167/16.1.11; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Manoach DS, 2004, J NEUROL NEUROSUR PS, V75, P1719, DOI 10.1136/jnnp.2003.025981; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Olk B, 2015, COGN NEUROSCI NEUROP, V14, P1; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Rey-Mermet A, 2019, J EXP PSYCHOL GEN, V148, P1335, DOI 10.1037/xge0000593; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Soper D.S, A PRIORI SAMPLE SIZE; Sweeney JA, 2001, NEUROBIOL AGING, V22, P39, DOI 10.1016/S0197-4580(00)00175-5; VANSTEENBERGEN H, 2011, FRONT PSYCHOL, V2, P1; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Zheng YY, 2000, PSYCHON B REV, V7, P113, DOI 10.3758/BF03210729	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222710	10.1371/journal.pone.0222710	http://dx.doi.org/10.1371/journal.pone.0222710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545831	Green Published, gold			2022-12-27	WOS:000532303200029
J	Wengert, GJ; Schmutzer, M; Bickel, H; Sora, MC; Polanec, SH; Weber, M; Schueller-Weidekamm, C				Wengert, Georg J.; Schmutzer, Marc; Bickel, Hubert; Sora, Mircea-Constantin; Polanec, Stephan H.; Weber, Micheal; Schueller-Weidekamm, Claudia			Reliability of high-resolution ultrasound and magnetic resonance arthrography of the shoulder in patients with sports-related shoulder injuries	PLOS ONE			English	Article							ROTATOR CUFF TEARS; MR ARTHROGRAPHY; ACCURACY; DIAGNOSIS; LESIONS; DISORDERS; ANTERIOR	Introduction The shoulder, a very complex joint, offers a wide range of pathologies. Intraarticular abnormalities and rotator cuff injuries are mainly assessed and diagnosed by magnetic resonance arthrography (MRA). In contrast to this well-established gold standard, high-resolution ultrasound (US) offers an additional easy and excellent modality to assess the shoulder joint. Therefore, the purpose of this study was to evaluate in which anatomic structures and pathologies comparable results of US and MRA could be achieved. Materials and methods In this IRB-approved prospective study 67 patients with clinically suspected labral lesions, rotator cuff rupture, or injury of the long head of the biceps (LHB) tendon were enrolled. Each participant was examined with high resolution US, and directly followed by MRA at 3 Tesla with a standard sequence protocol. To evaluate the agreement of the diagnostic performance between US and MRA a weighted kappa statistic was used. Results Both of the investigated modalities yielded a moderate to almost perfect agreement in assessing a wide range of shoulder joint pathologies. For the rotator cuff, consistency was found in 71.64% for the supraspinatus tendon, in 95.52% for the infraspinatus tendon, in 83.58% for the subscapularis tendon, and in 98.51% for the teres minor tendon. The diagnostic accuracy between both modalities was 80.60% for the LHB tendon, 77.61% for the posterior labroligamentous complex, 83.58% for the acromioclavicular joint, and 91.04% for the assessment of osseous irregularities and impaction fractures. Conclusions High resolution US is a reliable imaging modality for the rotator cuff, the LHB tendon, and the acromioclavicular joint, so for these structures we recommend a preference for US over MRA based on its diagnostic accuracy, comfortability, cost effectiveness, and availability. If the diagnosis remains elusive, for all other intraarticular structures we recommend MRA for further diagnostic assessment.	[Wengert, Georg J.; Schmutzer, Marc; Bickel, Hubert; Polanec, Stephan H.; Weber, Micheal; Schueller-Weidekamm, Claudia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Sora, Mircea-Constantin] Sigmund Freund Univ, Med Fac, Morphol Ctr, Vienna, Austria	Medical University of Vienna	Wengert, GJ (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	georg.wengert@meduniwien.ac.at		Wengert, Georg J./0000-0002-1854-9128; Sora, Constantin/0000-0002-0944-1609				Arirachakaran A, 2017, SKELETAL RADIOL, V46, P149, DOI 10.1007/s00256-016-2525-1; Beggs Ian BS, 2014, MUSCULOSKELETAL ULTR; Chauhan NS, 2016, POL J RADIOL, V81, P491, DOI 10.12659/PJR.897830; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; Elbinoune I, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.235.9068; Farrar Nicholas Greville, 2013, Open Orthop J, V7, P338, DOI 10.2174/1874325001307010338; Ferri M, 2005, AM J ROENTGENOL, V184, P180, DOI 10.2214/ajr.184.1.01840180; Jonas SC, 2012, ACTA ORTHOP, V83, P267, DOI 10.3109/17453674.2012.672090; Kompel AJ, 2017, CURR REV MUSCULOSKE, V10, P425, DOI 10.1007/s12178-017-9433-4; Lenza M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009020.pub2; LOH B, 2016, ANN TRANSL MED, V4, P66561, DOI DOI 10.21037/; Lugo R, 2008, EUR J RADIOL, V68, P16, DOI 10.1016/j.ejrad.2008.02.051; Modi CS, 2013, ORTHOPEDICS, V36, pE337, DOI 10.3928/01477447-20130222-23; Nakata W, 2011, RADIOGRAPHICS, V31, P791, DOI 10.1148/rg.313105507; Naredo E, 2002, ANN RHEUM DIS, V61, P132, DOI 10.1136/ard.61.2.132; Ottenheijm RP, 2010, ARCH PHYS MED REHAB, V91, P1616, DOI 10.1016/j.apmr.2010.07.017; Ottenheijm RPG, 2015, ANN FAM MED, V13, P53, DOI 10.1370/afm.1734; Ottenheijm RPG, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-115; Pavic R, 2013, INJURY, V44, pS26, DOI 10.1016/S0020-1383(13)70194-3; Roy JS, 2015, BRIT J SPORT MED, V49, P1316, DOI 10.1136/bjsports-2014-094148; Scutellari PN, 1998, EUR J RADIOL, V27, pS31, DOI 10.1016/S0720-048X(98)00040-0; Tian CY, 2013, EUR J RADIOL, V82, P651, DOI 10.1016/j.ejrad.2012.11.038; Viera AJ, 2005, FAM MED, V37, P360; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Zanetti M, 1999, ACTA RADIOL, V40, P296, DOI 10.3109/02841859909175557	25	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222783	10.1371/journal.pone.0222783	http://dx.doi.org/10.1371/journal.pone.0222783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545834	gold, Green Published			2022-12-27	WOS:000532303200033
J	Cho, I; Cohen, AS				Cho, Isu; Cohen, Adam S.			Explaining age-related decline in theory of mind: Evidence for intact competence but compromised executive function	PLOS ONE			English	Article							FALSE-BELIEF; INDIVIDUAL-DIFFERENCES; ATTRIBUTION; TASKS	Previous studies suggest theory of mind (ToM) ability declines with age. However, prior tasks not only required ToM competence but also imposed high executive function (EF) demands, so decline in ToM ability could be caused by deterioration in ToM competence, EF, or both. It was predicted that if the elderly have intact ToM competence but compromised EF, then they should perform similarly to younger adults when using ToM tasks that lower executive demands, such as spontaneous-response tasks. Results showed that on tasks with reduced demands, older adults tracked belief to the same extent as younger adults, despite their declining EF. The findings support a model in which age-related decline in ToM ability is primarily caused by compromised EF, not ToM competence, suggesting that underlying ToM mechanisms are still intact in the elderly. We discuss implications of this work for competence-performance issues in ToM processing and the underlying sources of age-related deterioration of ToM.	[Cohen, Adam S.] Western Univ, Dept Psychol, London, ON, Canada; Western Univ, Brain & Mind Inst, London, ON, Canada; [Cohen, Adam S.] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Hawaii System; University of Hawaii Manoa	Cohen, AS (corresponding author), Western Univ, Dept Psychol, London, ON, Canada.; Cohen, AS (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	cohen9@hawaii.edu	Cho, Isu/AAX-2091-2020	Cho, Isu/0000-0003-2270-3068; Cohen, Adam/0000-0003-2719-3351	Social Science Research Fund from the University of Western Ontario [R5061A04]	Social Science Research Fund from the University of Western Ontario	This work was supported by the Social Science Research Fund grant R5061A04 from the University of Western Ontario (AC). The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly IA, 2012, Q J EXP PSYCHOL, V65, P825, DOI 10.1080/17470218.2012.676055; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Chomsky N., 1964, ASPECTS THEORY SYNTA; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Grainger SA, 2018, Q J EXP PSYCHOL, V71, P1980, DOI 10.1177/1747021817734690; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hyde DC, 2018, J NEUROSCI, V38, P4264, DOI 10.1523/JNEUROSCI.0264-17.2018; JASP Team, 2018, JASP VERSION 0 10 0; Kiraly I, 2018, P NATL ACAD SCI USA, V115, P11477, DOI 10.1073/pnas.1803505115; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Patel Tushar, 2015, J Anaesthesiol Clin Pharmacol, V31, P37, DOI 10.4103/0970-9185.150534; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; Phillips LH, 2011, COGNITION, V120, P236, DOI 10.1016/j.cognition.2011.05.003; Piper BJ, 2012, BEHAV RES METHODS, V44, P110, DOI 10.3758/s13428-011-0096-6; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Scott RM, 2017, CURR DIR PSYCHOL SCI, V26, P68, DOI 10.1177/0963721416673174; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Warnell KR, 2019, COGNITION, V191, DOI 10.1016/j.cognition.2019.06.009; Wechsler D., WECHSLER ABBREVIATED, DOI [10.4103/0970-9185.150534, DOI 10.4103/0970-9185.150534]	35	10	10	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222890	10.1371/journal.pone.0222890	http://dx.doi.org/10.1371/journal.pone.0222890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539418	gold, Green Published			2022-12-27	WOS:000532297900039
J	Grupp, C; Troche-Polzien, I; Stock, J; Bramlage, C; Muller, GA; Koziolek, M				Grupp, Clemens; Troche-Polzien, Ilka; Stock, Johanna; Bramlage, Carsten; Mueller, Gerhard A.; Koziolek, Michael			Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up	PLOS ONE			English	Article							FACTOR-V G1691A; METHYLENETETRAHYDROFOLATE-REDUCTASE C677T; CHRONIC KIDNEY-DISEASE; ANTICARDIOLIPIN ANTIBODIES; HYPERCOAGULABLE STATES; ARTERIOVENOUS-FISTULA; PROTHROMBIN G20210A; THROMBOSIS; DIALYSIS; HOMOCYSTEINE	Objective Thrombophilic risk factors (TRFs) occur rather frequently in hemodialysis (HD) patients. However, little is known about their significance in HD patients, besides their potential impact on arteriovenous (AV) access failure, with varying results. We examined the effects of a wide variety of TRFs on both early AV fistula occlusion and survival among HD patients in long-term follow-up. Methods In this single-center, observational study, 70 consecutive HD patients from our dialysis center were examined with respect to shunt occlusion within the first 2 years after fistula creation and patient survival in a long-term follow-up (at least 16 years). We examined the presence of factor V, prothrombin, and MTHFR mutations using real-time fluorescence polymerase chain reaction. Furthermore, antithrombin (AT), protein C, protein S, and antiphospholipid antibodies (APL-Abs) were assessed. Results Among the 70 patients, 32 had MTHFR mutations, 10 had heterozygous factor V Leiden mutations, 4 had prothrombin mutations, 4 had protein S deficiency, 2 had protein C deficiency, 9 had AT deficiency, and 14 had APL-Abs. 40 patients had shunt occlusion. TRFs were associated with a significantly increased risk for shunt thrombosis (P<0.02). Kaplan-Meier analysis with a log-rank test revealed significantly shorter survival in HD patients with TRFs (P<0.02). Cox regression analysis showed that the presence of TRFs (P<0.05; hazard ratio, 1.94; 95% CI: 1.07-3.56), but not early shunt occlusion, was associated with short patient survival. Conclusions TRFs in hemodialysis patients have a strong impact on patient survival and early AV fistula failure; however, patient survival is not significantly affected by early shunt occlusion.	[Grupp, Clemens; Troche-Polzien, Ilka; Stock, Johanna; Bramlage, Carsten; Mueller, Gerhard A.; Koziolek, Michael] Georg August Univ, Dept Nephrol & Rheumatol, Gottingen, Germany; [Grupp, Clemens] Acad Teaching Hosp Bamberg, Dept Nephrol Hypertens & Rheumatol, Bamberg, Germany	University of Gottingen	Grupp, C (corresponding author), Georg August Univ, Dept Nephrol & Rheumatol, Gottingen, Germany.; Grupp, C (corresponding author), Acad Teaching Hosp Bamberg, Dept Nephrol Hypertens & Rheumatol, Bamberg, Germany.	cgrupp@gwdg.de						Adler S, 2001, CLIN NEPHROL, V56, P428; Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Almasri J, 2016, J VASC SURG, V64, P236, DOI 10.1016/j.jvs.2016.01.053; Ambuhl PM, 1997, NEPHROL DIAL TRANSPL, V12, P2355, DOI 10.1093/ndt/12.11.2355; Biuckians A, 2008, J VASC SURG, V47, P415, DOI 10.1016/j.jvs.2007.10.041; Bremer C, 1997, NEPHROL DIAL TRANSPL, V12, P1775, DOI 10.1093/ndt/12.8.1775; BRUNET P, 1995, KIDNEY INT, V48, P794, DOI 10.1038/ki.1995.352; Chen TY, 2018, CARDIOVASC INTER RAD, V41, P1683, DOI 10.1007/s00270-018-2046-5; Chuang FR, 2005, RENAL FAILURE, V27, P25, DOI 10.1081/JDI-200042815; Dixon BS, 2002, AM J KIDNEY DIS, V39, P92, DOI 10.1053/ajkd.2002.29886; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Fodinger M, 2000, J NEPHROL, V13, P20; Fodinger M, 1996, NEPHROL DIAL TRANSPL, V11, P668, DOI 10.1093/oxfordjournals.ndt.a027357; Fukasawa M, 2003, AM J KIDNEY DIS, V41, P637, DOI 10.1053/ajkd.2003.50125; Ghisdal L, 2011, NEPHROL DIAL TRANSPL, V26, P2700, DOI 10.1093/ndt/gfq791; Hessner MJ, 1999, THROMB HAEMOSTASIS, V81, P733; Hojs R, 2002, RENAL FAILURE, V24, P215, DOI 10.1081/JDI-120004098; Huisman M V, 1999, Curr Opin Hematol, V6, P291, DOI 10.1097/00062752-199909000-00004; Khan S, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-15; Klamroth R, 2013, VASA, V42, P32, DOI 10.1024/0301-1526/a000245; Knoll GA, 2005, J AM SOC NEPHROL, V16, P1108, DOI 10.1681/ASN.2004110999; Lee HA, 1999, AM J KIDNEY DIS, V34, P259, DOI 10.1016/S0272-6386(99)70353-7; LeSar CJ, 1999, J AM COLL SURGEONS, V189, P73, DOI 10.1016/S1072-7515(99)00086-1; Middeldorp S, 2007, SEMIN THROMB HEMOST, V33, P563, DOI 10.1055/s-2007-985752; Nakashima MO, 2014, BLOOD RES, V49, P85, DOI 10.5045/br.2014.49.2.85; Osinbowale O, 2010, POSTGRAD MED, V122, P54, DOI 10.3810/pgm.2010.03.2122; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Palomo I, 2002, NEPHRON, V92, P957, DOI 10.1159/000065580; PRAKASH R, 1995, AM J KIDNEY DIS, V26, P347, DOI 10.1016/0272-6386(95)90656-8; Puskar D, 2002, CROAT MED J, V43, P306; Reitsma PH, 2015, HAMOSTASEOLOGIE, V35, P47, DOI 10.5482/HAMO-14-11-0062; Rodriguez JA, 2001, NEFROLOGIA, V21, P260; Salmela B, 2013, CLIN J AM SOC NEPHRO, V8, P962, DOI 10.2215/CJN.03860412; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Tanner NC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub3; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Valeri A, 1999, CLIN NEPHROL, V51, P116; von Ahsen N, 1999, CLIN CHEM, V45, P694; von Ahsen N, 2000, CLIN BIOCHEM, V33, P535, DOI 10.1016/S0009-9120(00)00161-2; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202	40	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222102	10.1371/journal.pone.0222102	http://dx.doi.org/10.1371/journal.pone.0222102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539375	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900006
J	Pugh, MJ; Swan, AA; Amuan, ME; Eapen, BC; Jaramillo, CA; Delgado, R; Tate, DF; Yaffe, K; Wang, CP				Pugh, Mary Jo; Swan, Alicia A.; Amuan, Megan E.; Eapen, Blessen C.; Jaramillo, Carlos A.; Delgado, Roxana; Tate, David F.; Yaffe, Kristine; Wang, Chen-Pin			Deployment, suicide, and overdose among comorbidity phenotypes following mild traumatic brain injury: A retrospective cohort study from the Chronic Effects of Neurotrauma Consortium	PLOS ONE			English	Article							POLYTRAUMA-CLINICAL-TRIAD; MISERABLE MINORITY; RISK-FACTORS; CHRONIC PAIN; VETERANS; AFGHANISTAN; IRAQ; ASSOCIATION; DISABILITY; SEVERITY	Mild traumatic brain injury in the Veteran population is frequently comorbid with pain, posttraumatic stress disorder, and/or depression. However, not everyone exposed to mild traumatic brain injury experiences these comorbidities and it is unclear what factors contribute to this variability. The objective of this study was to identify comorbidity phenotypes among Post-9/11 deployed Veterans with no or mild traumatic brain injury and examine the association of comorbidity phenotypes with adverse outcomes. We found that Veterans with mild traumatic brain injury (n = 93,003) and no brain injury (n = 434,378) were mean age of 32.0 (SD 9.21) on entering Department of Veterans Health Administration care, were predominantly Caucasian non-Hispanic (64.69%), and served in the Army (61.31%). Latent class analysis revealed five phenotypes in each subcohort; Moderately Healthy and Mental Health phenotypes were common to both. The Healthy phenotype was found only in no brain injury. Unique phenotypes in mild traumatic brain injury included Moderately Healthy+Decline, Polytrauma, and Polytrauma+Improvement. There was substantial variation in adverse outcomes. The Polytrauma+Improvement phenotype had the lowest likelihood of adverse outcomes. There were no differences between Moderately Healthy+Decline and Polytrauma phenotypes. Phenotypes of comorbidity vary significantly by traumatic brain injury status including divergence in phenotypes (and outcomes) over time in the mild traumatic brain injury subcohort. Understanding risk factors for the divergence between Polytrauma vs. Polytrauma+Improvement and Moderately Healthy vs. Moderately Healthy+Decline, will improve our ability to proactively mitigate risk, better understand the early patterns of comorbidity that are associated with neurodegenerative sequelae following mild traumatic brain injury, and plan more patient-centered care.	[Pugh, Mary Jo; Amuan, Megan E.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Jaramillo, Carlos A.; Delgado, Roxana] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat Neurol & Epidemiol, San Francisco, CA 94143 USA; [Wang, Chen-Pin] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Missouri System; University of Missouri Saint Louis; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio	Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA.	MaryJo.Pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018; Delgado, Roxana/CAF-1964-2022; Tate, David/G-5166-2011	Swan, Alicia A/0000-0003-2412-0499; Delgado, Roxana/0000-0002-8922-4857; Pugh, Mary Jo/0000-0003-4196-7763; Tate, David/0000-0003-0213-1920	U.S. Department of Veterans Affairs funds [I01CX001246]; U.S. Department of Defense [W81XWH-13-2-0095-04]; Veterans Affairs [I01CX001135] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs funds; U.S. Department of Defense(United States Department of Defense); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U.S. Department of Veterans Affairs funds, I01CX001246, https://www.research.va.gov, to MJP; and U.S. Department of Defense W81XWH-13-2-0095-04, http://cdmrp.army.mil, to KY. The sponsors played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Bosco MA, 2013, HEADACHE J HEAD FACE; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Collett GA., 2016, DRUGS-REAL WOR OUTC, V3, P45; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Military Health System, 2016, SURV CAS DEF 13 0 NE; North CS, 2004, AM J PUBLIC HEALTH, V94, P103, DOI 10.2105/AJPH.94.1.103; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Peterson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132664; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tanielian T., 2017, IMPROVING SUPPORT AM, DOI 10.7249/RR1873; The Management of Concussion-mild Traumatic Brain Injury Working Group, VA DOD CLIN PRACT GU; Wang C-P, 2012, RESIDUAL DIAGNOSTICS; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222674	10.1371/journal.pone.0222674	http://dx.doi.org/10.1371/journal.pone.0222674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539410	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900025
J	de Lima, TJS; Pereira, CR; Torres, ARR; de Souza, LEC; Albuquerque, IM				Souza de Lima, Tiago Jesse; Pereira, Cicero Roberto; Rosas Torres, Ana Raquel; Cunha de Souza, Luana Elayne; Albuquerque, Iara Maribondo			Black people are convicted more for being black than for being poor: The role of social norms and cultural prejudice on biased racial judgments	PLOS ONE			English	Article							CROSSED CATEGORIZATION; EXTERNAL MOTIVATION; LEGITIMIZING ROLE; LUSO-TROPICALISM; COLOR-BLINDNESS; AVERSIVE RACISM; RACE-RELATIONS; DISCRIMINATION; PERSPECTIVES; INEQUALITY	Black and poor people are more frequently convicted of committing crimes. However, the specific role played by skin color and social class in convicting a person has yet to be clarified. This article aims to elucidate this issue by proposing that belonging to a lower social class facilitates the conviction of black targets and that this phenomenon is because information about social class dissimulates racial bias. Study 1 (N = 160) demonstrated that information about belonging to the lower classes increases agreement with a criminal suspect being sentenced to prison only when described as being black. Furthermore, Studies 2 (N = 170) and 3 (N = 174) show that the anti-prejudice norm inhibits discrimination against the black target when participants were asked to express individual racial prejudice, but not when they expressed cultural racial prejudice. Finally, Study 4 (N = 134) demonstrated that lower-class black targets were discriminated against to a greater degree when participants expressed either individual or cultural prejudice and showed that this occurs when racial and class anti-prejudice norms are salient. The results suggest that social class negatively affects judgments of black targets because judgment based on lower class mitigates the racist motivation of discrimination.	[Souza de Lima, Tiago Jesse; Cunha de Souza, Luana Elayne] Univ Fortaleza, Dept Psychol, Fortaleza, Ceara, Brazil; [Pereira, Cicero Roberto; Rosas Torres, Ana Raquel; Albuquerque, Iara Maribondo] Univ Fed Paraiba, Dept Psychol, Joao Pessoa, Paraiba, Brazil; [Pereira, Cicero Roberto] Univ Lisbon, Inst Social Sci, Lisbon, Portugal	Universidade Fortaleza; Universidade Federal da Paraiba; Institute of Social Sciences, University of Lisbon (ICS-UL); Universidade de Lisboa	de Lima, TJS (corresponding author), Univ Fortaleza, Dept Psychol, Fortaleza, Ceara, Brazil.	tiago.souzalima@hotmail.com	Pereira, Cicero Roberto/M-6011-2013	Pereira, Cicero Roberto/0000-0003-3406-3985	CAPES [5420/13-0]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research had the financial support of CAPES granted to the first author (grant number: 5420/13-0).	Antonakis J, 2017, CURR DIR PSYCHOL SCI, V26, P270, DOI 10.1177/0963721417705888; Apfelbaurn EP, 2008, J PERS SOC PSYCHOL, V95, P918, DOI 10.1037/a0011990; Bureau UC, 2014, WEALTH ASS OWN; Camino L., 2001, REV PSICOLOGIA POLIT, V1, P13, DOI DOI 10.17771/PUCRI0.ACAD.10498; Chateignier C, 2009, EUR J PSYCHOL EDUC, V24, P219, DOI 10.1007/BF03173013; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooley E, 2019, J EXP PSYCHOL GEN, V148, P2218, DOI 10.1037/xge0000605; Costa-Lopes R, 2013, EUR J SOC PSYCHOL, V43, P229, DOI 10.1002/ejsp.1966; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; Crisp RJ, 2006, MULTIPLE SOCIAL CATEGORIZATION: PROCESSES, MODELS AND APPLICATIONS, P1; da Silva RF, 2016, SPAN J PSYCHOL, V19, DOI 10.1017/sjp.2016.77; De Franca DX, 2013, EUR J SOC PSYCHOL, V43, P263, DOI 10.1002/ejsp.1965; de Souza LEC, 2016, EUR J SOC PSYCHOL, V46, P609, DOI 10.1002/ejsp.2216; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Dolan K, 2015, I POLICY STUD, P1; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Dovidio JF, 2004, ADV EXP SOC PSYCHOL, V36, P1, DOI 10.1016/S0065-2601(04)36001-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Henriques JG, 2017, JUSTICA PORTUGAL MAI; Hinzman L, 2017, J EXP SOC PSYCHOL, V70, P95, DOI 10.1016/j.jesp.2016.12.012; Hodson G, 2002, PERS SOC PSYCHOL B, V28, P460, DOI 10.1177/0146167202287004; Jones J.M., 1972, PREJUDICE RACISM; Klauer KC, 2003, J EXP SOC PSYCHOL, V39, P332, DOI 10.1016/S0022-1031(03)00017-9; Mattan BD, 2019, PERS SOC PSYCHOL B, V45, P1512, DOI 10.1177/0146167219835230; Mattan BD, 2018, SOC COGN AFFECT NEUR, V13, P22, DOI 10.1093/scan/nsx128; McDonald RI, 2015, CURR OPIN BEHAV SCI, V3, P147, DOI 10.1016/j.cobeha.2015.04.006; Moore-Berg S, 2017, J APPL SOC PSYCHOL, V47, P482, DOI 10.1111/jasp.12454; Moore-Berg SL, 2019, SOC PERSONAL PSYCHOL, V13, DOI 10.1111/spc3.12426; Nellis Ashley, 2016, COLOR JUSTICE RACIAL, P3; Nicolas G, 2017, GROUP PROCESS INTERG, V20, P621, DOI 10.1177/1368430217708862; Norton MI, 2006, PSYCHOL SCI, V17, P949, DOI 10.1111/j.1467-9280.2006.01810.x; Nunes AVDL, 2013, ISCTE IUL; OBrien JD, 2012, INTERACTION RACE SOC; Osorio RG, 2004, MOBILIDADE SOCIAL NE; Pereira C, 2010, EUR J SOC PSYCHOL, V40, P1231, DOI 10.1002/ejsp.718; Pereira CR, 2018, PERS SOC PSYCHOL B, V44, P1473, DOI 10.1177/0146167218771007; PETTIGREW TF, 1995, EUR J SOC PSYCHOL, V25, P57, DOI 10.1002/ejsp.2420250106; Pettigrew TF, 2008, SOC PERSONAL PSYCHOL, V2, P318, DOI 10.1111/j.1751-9004.2007.00061.x; Pettit B, 2004, AM SOCIOL REV, V69, P151, DOI 10.1177/000312240406900201; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Ribeiro CAC, 2010, DISCRIM UNEQUAL WORL, V3, P1; Sherif M., 1967, SOCIAL INTERACTION P; Silva GM, 2016, CURR SOCIOL, V64, P794, DOI 10.1177/0011392115590488; Smedley A, 2005, AM PSYCHOL, V60, P16, DOI 10.1037/0003-066X.60.1.16; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Vala J, 2008, BLACK IMMIGRANTS POR, V64, P287, DOI [10.1111/j.1540-4560.2008.00562.x, DOI 10.1111/J.1540-4560.2008.00562.X]; Vala J, 2012, PERSONAL SOC PSYCHOL; Vala J, 2008, J SOC ISSUES, V64, P287, DOI 10.1111/j.1540-4560.2008.00562.x; Valentim JP, 2018, INT J INTERCULT REL, V62, P34, DOI 10.1016/j.ijintrel.2017.04.013; Van Doesum NJ, 2017, J EXP SOC PSYCHOL, V68, P11, DOI 10.1016/j.jesp.2016.06.001; Weeks K., 2007, J MANAGERIAL PSYCHOL, V22, P701, DOI DOI 10.1108/02683940710820118; Weeks M, 2004, PERSONAL SOC PSYCHOL, P30; Western B, 2010, DAEDALUS-US, V139, P8, DOI 10.1162/DAED_a_00019; Wilson JP, 2015, PSYCHOL SCI, V26, P1325, DOI 10.1177/0956797615590992; Wilson William Julius, 1978, DECLINING SIGNIFICAN; Zhang Z, 2018, PRACTICAL STAT POWER	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222874	10.1371/journal.pone.0222874	http://dx.doi.org/10.1371/journal.pone.0222874			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539411	Green Published, gold			2022-12-27	WOS:000532297900036
J	Park, J; Gil, JR; Shin, Y; Won, SE; Huh, J; You, MW; Park, HJ; Sung, YS; Kim, KW				Park, Jisuk; Gil, Jea Ryung; Shin, Youngbin; Won, Sang Eun; Huh, Jimi; You, Myung-Won; Park, Hyo Jung; Sung, Yu Sub; Kim, Kyung Won			Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects	PLOS ONE			English	Article							LENGTH-OF-STAY; BODY-COMPOSITION; ADIPOSE-TISSUE; SARCOPENIA; OUTCOMES; PREDICTOR; FRAILTY; AREA; CT; COMPLICATIONS	Background Quantification of abdominal muscle mass by cross-sectional imaging has been increasingly used to diagnose sarcopenia; however, the technical method for quantification has not been standardized yet. We aimed to determine an optimal method to measure the abdominal muscle area. Methods Among 50 consecutive subjects who underwent abdominal CT and MRI for possible liver donation, total abdominal muscle area (TAMA) and total psoas muscle area (TPA) at the L3 inferior endplate level were measured by two blinded readers. Inter-scan agreement between CT and MRI and inter-reader agreement between the two readers were evaluated using intraclass correlation coefficient (ICC) and within-subject coefficient of variation (WSCV). To evaluate the effect of measurement level, one reader measured TAMA and TPA at six levels from the L2 to L4 vertebral bodies. Results TAMA was a more reliable biomarker than TPA in terms of inter-scan agreement (ICC: 0.928 vs. 0.788 for reader 1 and 0.853 vs. 0.821 for reader 2, respectively; WSCV: 8.3% vs. 23.4% for reader 1 and 10.4% vs. 22.3% for reader 2, respectively) and inter-reader agreement (ICC: 0.986 vs. 0.886 for CT and 0.865 vs. 0.669 for MRI, respectively; WSCV: 8.2% vs. 16.0% for CT and 11.6% vs. 29.7% for MRI, respectively). In terms of the measurement llevel, TAMA did not differ from the L2(inf) to L4(inf) levels, whereas TPA increased with a decrease in measurement level. Conclusions TAMA is a better biomarker than TPA in terms of inter-scan and inter-reader agreement and robustness to the measurement level. CT was a more reliable imaging modality than MRI. Our results support the use of TAMA measured by CT as a standard biomarker for abdominal muscle area measurement.	[Park, Jisuk; Gil, Jea Ryung; Shin, Youngbin; Won, Sang Eun; Huh, Jimi; You, Myung-Won; Park, Hyo Jung; Sung, Yu Sub; Kim, Kyung Won] Univ Ulsan, Asan Med Ctr, Dept Radiol, Asan Image Metr,Coll Med, Seoul, South Korea; [Gil, Jea Ryung] VHS Med Ctr, Dept Radiol, Seoul, South Korea; [Shin, Youngbin; Won, Sang Eun; Sung, Yu Sub; Kim, Kyung Won] Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Dept Biomed Engn,Coll Med, Seoul, South Korea; [Huh, Jimi] Ajou Univ, Sch Med, Dept Radiol, Med Ctr, Suwon, South Korea; [You, Myung-Won] Kyung Hee Univ Hosp, Dept Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Veterans Health Service Medical Center; University of Ulsan; Asan Medical Center; Ajou University; Kyung Hee University; Kyung Hee University Hospital	Sung, YS; Kim, KW (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Asan Image Metr,Coll Med, Seoul, South Korea.; Sung, YS; Kim, KW (corresponding author), Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Dept Biomed Engn,Coll Med, Seoul, South Korea.	asmilez.sung@gmail.com; kyungwon_kim@amc.seoul.kr		Kim, Kyung Won/0000-0002-1532-5970; Park, Hyo Jung/0000-0002-2364-9940	Korea Health Industry Development Institute (KHIDI) of the Republic of Korea [HI18C1216]	Korea Health Industry Development Institute (KHIDI) of the Republic of Korea	This research was supported by a grant from the Korea Health Industry Development Institute (KHIDI) of the Republic of Korea (No. HI18C1216).; Funding source: This research was supported by a grant from the Korea Health Industry Development Institute (KHIDI) of the Republic of Korea (No. HI18C1216).	Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Barret M, 2014, PRESSE MED, V43, P628, DOI 10.1016/j.lpm.2013.12.021; Boutin RD, 2015, AM J ROENTGENOL, V205, pW255, DOI 10.2214/AJR.15.14635; Caan BJ, 2018, JAMA ONCOL, V4, P798, DOI 10.1001/jamaoncol.2018.0137; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dahya V, 2016, AM HEART J, V182, P21, DOI 10.1016/j.ahj.2016.08.016; Derstine BA, 2018, J NUTR HEALTH AGING, V22, P180, DOI 10.1007/s12603-017-0983-3; Derstine BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29825-5; DiMartini A, 2013, LIVER TRANSPLANT, V19, P1172, DOI 10.1002/lt.23724; Du Y, 2014, SURGERY, V156, P521, DOI 10.1016/j.surg.2014.04.027; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fosbol MO, 2015, CLIN PHYSIOL FUNCT I, V35, P81, DOI 10.1111/cpf.12152; Ganapathi AM, 2014, J THORAC CARDIOV SUR, V147, P186, DOI 10.1016/j.jtcvs.2013.09.011; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Jaap K, 2016, AM SURGEON, V82, P1221; Joglekar S, 2015, J SURG ONCOL, V112, P117, DOI 10.1002/jso.23968; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; Lee CS, 2014, CLIN TRANSPLANT, V28, P1092, DOI 10.1111/ctr.12422; Lee JSJ, 2011, J VASC SURG, V53, P912, DOI 10.1016/j.jvs.2010.10.111; Lee SJ, 2004, AM J CLIN NUTR, V80, P1215; Malekpour M, 2017, AM SURGEON, V83, P1203; Montano-Loza AJ, 2014, LIVER TRANSPLANT, V20, P640, DOI 10.1002/lt.23863; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Rutten IJG, 2017, J CACHEXIA SARCOPENI, V8, P630, DOI 10.1002/jcsm.12180; Schweitzer L, 2016, J NUTR, V146, P2143, DOI 10.3945/jn.116.236844; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sur MD, 2015, ANN SURG ONCOL, V22, P3897, DOI 10.1245/s10434-015-4763-1; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1; Tandon P, 2016, AM J TRANSPLANT, V16, P2766, DOI 10.1111/ajt.13832; van der Werf A, 2018, EUR J CLIN NUTR, V72, P288, DOI 10.1038/s41430-017-0034-5; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4; Yoon DY, 2008, ACAD RADIOL, V15, P62, DOI 10.1016/j.acra.2007.07.013; Yoshizumi T, 2014, HEPATOL RES, V44, P313, DOI 10.1111/hepr.12119	38	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222042	10.1371/journal.pone.0222042	http://dx.doi.org/10.1371/journal.pone.0222042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536542	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800027
J	Van Wingerden, J; Poell, RF				Van Wingerden, Jessica; Poell, Rob F.			Meaningful work and resilience among teachers: The mediating role of work engagement and job crafting	PLOS ONE			English	Article							ANTECEDENTS; IMPACT; CONSEQUENCES; RESOURCES; EMPLOYEES; WORKPLACE; OUTCOMES	Research in the field of work and organizational psychology more and more highlights the importance of employees' experience of meaningful work. Adding to this area of research, the present study among teachers examined the relationship between meaningful work and resilience and tested whether this proposed relationship is mediated by teachers' work engagement and job crafting behaviour. Data for this study was collected among a group of Dutch teachers working in a school for primary education (N = 174). To test the hypothesized relationships, we conducted a bootstrapping analysis. The outcomes revealed that work engagement and job crafting fully mediated the relationship between meaningful work and teacher's resilience. The insights provided in this study may be useful for the deliberate cultivation of teachers' resilience and may help them to stay enthusiastic in their meaningful but demanding profession. Theoretical contributions, limitations, suggestions for future research and practical implications are discussed.	[Van Wingerden, Jessica] Erasmus Univ, Fac Social Sci, Inst Psychol, Rotterdam, Netherlands; [Poell, Rob F.] Tilburg Univ, Dept Human Resource Studies, Tilburg, Netherlands	Erasmus University Rotterdam; Tilburg University	Van Wingerden, J (corresponding author), Erasmus Univ, Fac Social Sci, Inst Psychol, Rotterdam, Netherlands.	Jessica.vanwingerden@gmail.com	Poell, Rob/A-1994-2019	Poell, Rob/0000-0002-1954-3668				[Anonymous], 2003, IVEY BUSINESS J; Anuradha MV., 2014, VIKALPA, V39, P7, DOI [10.1177/0256090920140203, DOI 10.1177/0256090920140203]; Arnold KA, 2007, J OCCUP HEALTH PSYCH, V12, P193, DOI 10.1037/1076-8998.12.3.193; Bakker A.B., 2014, WELLBEING COMPLETE R, P1, DOI [DOI 10.1002/9781118539415.WBWELL019, 10.1002/9781118539415.wbwell019]; Bakker AB, 2008, WORK STRESS, V22, P187, DOI 10.1080/02678370802393649; Bakker AB, 2011, CURR DIR PSYCHOL SCI, V20, P265, DOI 10.1177/0963721411414534; Bakker AB, 2010, NEW HORIZ MANAG, P229; Berg J.M., 2008, WHAT IS JOB CRAFTING; Berg JM, 2010, J ORGAN BEHAV, V31, P158, DOI 10.1002/job.645; Biggs J., 2011, TEACHING QUALITY LEA, V4th; Bindl UK, 2010, NEW HORIZ MANAG, P385; Cohen-Meitar R, 2009, CREATIVITY RES J, V21, P361, DOI 10.1080/10400410902969910; Danielson C, 2015, TALK TEACHING LEADIN; Dede C., 2010, 21 CENTURY SKILLS RE, V20, P51; ELIZUR D, 1994, J SOC PSYCHOL, V134, P201, DOI 10.1080/00224545.1994.9711383; Fairlie P, 2011, ADV DEV HUM RESOUR, V13, P508, DOI 10.1177/1523422311431679; Fouche E, 2017, SA J IND PSYCHOL, V43, DOI 10.4102/sajip.v43i0.1398; Frankl VE, 1963, MANS SEARCH MEANING; Grant AM, 2009, ACAD MANAG ANN, V3, P317, DOI 10.1080/19416520903047327; Hansen D. T., 1995, CALL TEACH; Hargreaves A., 2006, SUSTAINABLE LEADERSH; Hayes A., 2017, INTRO MEDIATION MODE; Hayes A.F., 2012, CISC VIS NETW IND GL; HEUVEL MV, 2015, J OCCUPATIONAL ORG P, V88, P511, DOI [DOI 10.1111/JOOP.12128, DOI 10.1111/J00P.12128]; Hobfoll SE, 2003, J PERS SOC PSYCHOL, V84, P632, DOI 10.1037/0022-3514.84.3.632; Hyvonen K, 2009, J VOCAT BEHAV, V75, P183, DOI 10.1016/j.jvb.2009.04.002; Kim M, 2019, SPORT MANAG REV, V22, P108, DOI 10.1016/j.smr.2018.04.003; Littman-Ovadia H, 2010, J POSIT PSYCHOL, V5, P419, DOI 10.1080/17439760.2010.516765; Lopez, 2002, HDB POSITIVE PSYCHOL, P608, DOI DOI 10.1093/OXFORDHB/9780195187243.001.0001; Lu CQ, 2014, J VOCAT BEHAV, V84, P142, DOI 10.1016/j.jvb.2013.12.004; Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165; Luthans F, 2007, PERS PSYCHOL, V60, P541, DOI 10.1111/j.1744-6570.2007.00083.x; Martela F, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00363; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; May DR, 2004, J OCCUP ORGAN PSYCH, V77, P11, DOI 10.1348/096317904322915892; Meyers C, 2007, IND PSYCHOL; Michaelson C, 2014, J BUS ETHICS, V121, P77, DOI 10.1007/s10551-013-1675-5; Milliman J, 2003, J ORGAN CHANGE MANAG, V16, P426, DOI 10.1108/09534810310484172; Milliman JF., 1994, J MANAGERIAL PSYCHOL, V9, P9, DOI [DOI 10.1108/02683949410070151, 10.1108/02683949410070151]; Nelson DL, 2003, HDB OCCUPATIONAL HLT, P97, DOI DOI 10.1037/10474-005; Olivier A, 2007, SA J IND PSYCHOL, V33, P49; Pallant J.F, 2016, SPSS SURVIVAL MANUAL, V6; Parker SK, 2011, EUR J WORK ORGAN PSY, V20, P60, DOI 10.1080/1359432X.2010.532869; Parker SK, 2010, J MANAGE, V36, P633, DOI 10.1177/0149206308321554; Petrou P, 2012, J ORGAN BEHAV, V33, P1120, DOI 10.1002/job.1783; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pratt M.G, 2003, POSITIVE ORG SCHOLAR, P308; Rosso BD, 2010, RES ORGAN BEHAV, V30, P91, DOI 10.1016/j.riob.2010.09.001; Sammons P, 2007, BRIT EDUC RES J, V33, P681, DOI 10.1080/01411920701582264; Schaufeli W., 2012, ROM J APPL PSYCHOL, V14, P3, DOI DOI 10.HTTPS://D0I.0RG/10.1177/0011000002301006; Schaufeli WB, 2001, PSYCHOLOOG, V36, P422; Schaufeli WB., 2002, J HAPPINESS STUD, V3, P71, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Seibert SE, 2011, J APPL PSYCHOL, V96, P981, DOI 10.1037/a0022676; Springett N., 2004, SEARCH MEANING WORK; Steger MF, 2013, J CAREER ASSESSMENT, V21, P348, DOI 10.1177/1069072712471517; Steger MF, 2012, J CAREER ASSESSMENT, V20, P322, DOI 10.1177/1069072711436160; Sverko B., 1995, JOS-BAS BEH, P3; Tims M, 2013, J OCCUP HEALTH PSYCH, V18, P230, DOI 10.1037/a0032141; Tims M, 2012, J VOCAT BEHAV, V80, P173, DOI 10.1016/j.jvb.2011.05.009; Tims M, 2010, SA J IND PSYCHOL, V36, DOI 10.4102/sajip.v36i2.841; Traag T., 2018, LEERKRACHTEN BASISON; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; van den Heuvel M., 2010, CONT OCCUPATIONAL HL, VVolume 1, P124, DOI DOI 10.1002/9780470661550.CH7; Van Wingerden J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197599; van Wingerden J, 2017, J VOCAT BEHAV, V100, P164, DOI 10.1016/j.jvb.2017.03.008; Van Wingerden J, 2017, HUM RESOUR MANAGE-US, V56, P51, DOI 10.1002/hrm.21758; van Wingerden J, 2017, EUR J WORK ORGAN PSY, V26, P107, DOI 10.1080/1359432X.2016.1224233; Van Wingerden Jessica., 2017, INT J HUMAN RESOURCE, V7, P23, DOI [10.5296/ijhrs.v7i4.11611, DOI 10.5296/IJHRS.V7I4.11611]; Vogt K, 2016, EUR J WORK ORGAN PSY, V25, P353, DOI 10.1080/1359432X.2015.1072170; Voogt J, 2012, J CURRICULUM STUD, V44, P299, DOI 10.1080/00220272.2012.668938; Wassell B, 2009, CULT STUD SCI EDUCAT, V4, P409, DOI 10.1007/s11422-008-9151-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Wrzesniewski A, 2001, ACAD MANAGE REV, V26, P179, DOI 10.2307/259118; Wrzesniewski A, 1997, J RES PERS, V31, P21, DOI 10.1006/jrpe.1997.2162; Zembylas M, 2010, TEACH TEACH, V16, P703, DOI 10.1080/13540602.2010.517687	76	12	13	8	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222518	10.1371/journal.pone.0222518	http://dx.doi.org/10.1371/journal.pone.0222518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536544	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800051
J	Heffer, AM; Proano, J; Roztocil, E; Phipps, RP; Feldon, SE; Huxlin, KR; Sime, PJ; Libby, RT; Woeller, CF; Kuriyan, AE				Heffer, Alison M.; Proano, Jacob; Roztocil, Elisa; Phipps, Richard P.; Feldon, Steven E.; Huxlin, Krystel R.; Sime, Patricia J.; Libby, Richard T.; Woeller, Collynn F.; Kuriyan, Ajay E.			The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology	PLOS ONE			English	Article							COLLAGEN GEL CONTRACTION; PIGMENT EPITHELIAL-CELLS; GROWTH-FACTORS; RISK-FACTORS; MATRIX; RPE; INHIBITION; STRATEGY; KINASE; CANCER	Proliferative vitreoretinopathy (PVR) is characterized by membranes that form in the vitreous cavity and on both surfaces of the retina, which results in the formation of tractional membranes that can cause retinal detachment and intrinsic fibrosis of the retina, leading to retina foreshortening. Currently, there are no pharmacologic therapies that are effective in inhibiting or preventing PVR formation. One of the key aspects of PVR pathogenesis is retinal pigment epithelial (RPE) cell epithelial mesenchymal transition (EMT). Here we show that the polyether ionophore compound salinomycin (SNC) effectively inhibits TGF beta-induced EMT of RPE cells. SNC blocks the activation of TGF beta-induced downstream targets alpha smooth muscle actin (alpha SMA) and collagen 1 (Col1A1). Additionally, SNC inhibits TGF beta-induced RPE cell migration and contraction. We show that SNC functions to inhibit RPE EMT by targeting both the pTAK1/p38 and Smad2 signaling pathways upon TGF beta stimulation. Additionally, SNC is able to inhibit aSMA and Col1A1 expression in RPE cells that have already undergone TGF beta-induced EMT. Together, these results suggest that SNC could be an effective therapeutic compound in both the prevention and treatment of PVR.	[Heffer, Alison M.; Proano, Jacob; Roztocil, Elisa; Feldon, Steven E.; Huxlin, Krystel R.; Libby, Richard T.; Woeller, Collynn F.; Kuriyan, Ajay E.] Univ Rochester, Flaum Eye Inst, Rochester, NY 14604 USA; [Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY USA; [Feldon, Steven E.; Huxlin, Krystel R.; Libby, Richard T.; Kuriyan, Ajay E.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Sime, Patricia J.] Univ Rochester, Dept Med, Rochester, NY USA; [Proano, Jacob] Lake Erie Coll Osteopath Med, Erie, PA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Heffer, AM; Woeller, CF; Kuriyan, AE (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14604 USA.; Kuriyan, AE (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	alison_heffer@urmc.rochester.edu; Collynn_Woeller@URMC.Rochester.edu; ajay_kuriyan@urmc.rochester.edu		Huxlin, Krystel/0000-0001-7138-6156; Feldon, Steven/0000-0003-0603-9312; Woeller, Collynn/0000-0001-7197-5057	Research to Prevent Blindness;  [NIHP30EY001319]; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research to Prevent Blindness Unrestricted Grant (to the Flaum Eye Institute) and NIHP30EY001319 (David Williams, Center for Visual Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 1997, ARCH OPHTHALMOL-CHIC, V115, P335, DOI 10.1001/archopht.1997.01100150337005; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Antoszczak M, 2015, ANTI-CANCER AGENT ME, V15, P575, DOI 10.2174/1871520615666150101130209; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bourlier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031274; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chen Zhenna, 2015, Mol Vis, V21, P706; Choi K, 2012, MOL VIS, V18, P1010; Dvashi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122229; Gamulescu MA, 2006, EXP EYE RES, V83, P212, DOI 10.1016/j.exer.2005.12.007; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Grierson I, 1987, SEMINARS OPHTHALMOLO, V2, P99, DOI [10.3109/08820538709062514, DOI 10.3109/08820538709062514]; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; He H, 2017, SCI REP-UK, V7, DOI 10.1038/srep43736; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; Hu HH, 2018, CHEM-BIOL INTERACT, V292, P76, DOI 10.1016/j.cbi.2018.07.008; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Jun Eun Jung, 2007, Korean J Ophthalmol, V21, P244, DOI 10.3341/kjo.2007.21.4.244; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; RAYMOND MC, 1990, INVEST OPHTH VIS SCI, V31, P1079; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shih YH, 2017, INVEST OPHTH VIS SCI, V58, P430, DOI 10.1167/iovs.16-20018; Tseng W, 2004, AM J OPHTHALMOL, V137, P1105, DOI 10.1016/j.ajo.2004.02.008; Woeller CF, 2015, J BIOL CHEM, V290, P3563, DOI 10.1074/jbc.M114.601872; Yang CH, 1997, CURR EYE RES, V16, P1119, DOI 10.1076/ceyr.16.11.1119.5106; Zhang CY, 2016, CHEM-BIOL INTERACT, V248, P74, DOI 10.1016/j.cbi.2016.02.004; Zhou S, 2013, CURR MED CHEM, V20, P4095	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222596	10.1371/journal.pone.0222596	http://dx.doi.org/10.1371/journal.pone.0222596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527897	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400032
J	Yin, J; Zheng, XM; Tsaur, RC				Yin, Jie; Zheng, Xiang-min; Tsaur, Ruey-Chyn			Occurrence mechanism and coping paths of accidents of highly aggregated tourist crowds based on system dynamics	PLOS ONE			English	Article							BEHAVIOR DETECTION; MASS GATHERINGS; SAFETY; MODEL; MANAGEMENT; IDENTITY; ORDER	The safety of highly aggregated tourist crowds is a challenging and important issue. This paper not only provided a comprehensive analysis of the accidents of highly aggregated tourist crowds but also determined the occurrence mechanism and coping paths. Based on the analysis of multiple cases, we found that the variable status of highly aggregated tourist crowds was the result of the interaction of three main elements: multisource pressure, state mutations and management responses. A series of factors interact and result in accidents, and the lack of a management response or a low-quality management response is the root cause of such accidents. A high-quality management response is a basic safety precaution for highly aggregated tourist crowds. Therefore, forming a virtuous circle of multisource pressure, state mutations and management responses is an effective path for coping with accidents.	[Yin, Jie; Zheng, Xiang-min] Huaqiao Univ, Coll Tourism, Quanzhou, Fujian, Peoples R China; [Tsaur, Ruey-Chyn] Tamkang Univ, Dept Management Sci, New Taipei, Taiwan	Huaqiao University; Tamkang University	Yin, J (corresponding author), Huaqiao Univ, Coll Tourism, Quanzhou, Fujian, Peoples R China.	yinjie@hqu.edu.cn		yan, jie/0000-0002-2266-8672	MOE (Ministry of Education in China) Youth Project of Humanities and Social Sciences [19YJC790175]	MOE (Ministry of Education in China) Youth Project of Humanities and Social Sciences	Funding was provided by MOE (Ministry of Education in China) Youth Project of Humanities and Social Sciences (no. 19YJC790175) to JY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska YA, 2017, TRAVEL MED INFECT DI, V15, P67, DOI 10.1016/j.tmaid.2016.09.002; Algadhi S., 1990, TRANSPORT TRAFFIC TH, P59; Alnabulsi H, 2014, P NATL ACAD SCI USA, V111, P9091, DOI 10.1073/pnas.1404953111; Ancliffe S, 2017, PERSPECT PUBLIC HEAL, V137, P25, DOI 10.1177/1757913916681265; Angela TYH, 2014, PROCEDIA COMPUT SCI, V29, P1590, DOI 10.1016/j.procs.2014.05.144; Bellomo N, 2016, PHYS LIFE REV, V18, P55, DOI 10.1016/j.plrev.2016.08.014; Bouloiz H, 2013, SAFETY SCI, V58, P32, DOI 10.1016/j.ssci.2013.02.013; Cassidy C., 2007, PSYCHOL STUD, V52, P286; Cigada A, 2006, 2006 IEEE INTERNATIONAL WORKSHOP ON MEASUREMENT SYSTEMS FOR HOMELAND SECURITY, CONTRABAND DETECTION & PERSONAL SAFETY, P56, DOI 10.1109/MSHS.2006.314352; Cooke DL, 2003, SYST DYNAM REV, V19, P139, DOI 10.1002/sdr.268; Davies JC, 1998, SAFETY SCI, V29, P25, DOI 10.1016/S0925-7535(98)00013-7; Dirk H, 2007, PHYS REV E, V75, P1; EBERLEIN RL, 1992, EUR J OPER RES, V59, P216, DOI 10.1016/0377-2217(92)90018-5; Forrester J.W., 1961, IND DYNAMICS; Fradi H, 2016, J MULTIMODAL USER IN, V10, P307, DOI 10.1007/s12193-015-0179-2; Garbolino E, 2016, RISK ANAL, V36, P16, DOI 10.1111/risa.12534; Goh YM, 2012, SAFETY SCI, V50, P1594, DOI 10.1016/j.ssci.2012.03.002; Goh YM, 2012, J MANAGE STUD, V49, P52, DOI 10.1111/j.1467-6486.2010.00959.x; Gu XX, 2014, OPTIK, V125, P3428, DOI 10.1016/j.ijleo.2014.01.041; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; Ivancevic VG, 2010, NONLINEAR DYNAM, V59, P351, DOI 10.1007/s11071-009-9544-6; Jeon JW, 2016, ASIAN J SHIPPING LOG, V32, P73, DOI 10.1016/j.ajsl.2016.06.003; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Johansson A, 2008, ADV COMPLEX SYST, V11, P497, DOI 10.1142/S0219525908001854; Karpagavalli P, 2013, 2013 INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND SIGNAL PROCESSING (ICCSP), P663, DOI 10.1109/iccsp.2013.6577138; Khozium MO, 2012, LIFE SCI J, V9, P277; Kumar M, 2017, J CENT SOUTH UNIV, V24, P2071, DOI 10.1007/s11771-017-3616-4; Lane DC, 2016, OPERAT RES EMERG PLA, V2, P92, DOI [10.1007/978-1-137-57328-5, DOI 10.1007/978-1-137-57328-5]; Lee RSC, 2006, ACCIDENT ANAL PREV, V38, P712, DOI 10.1016/j.aap.2006.01.001; Lee RSC, 2005, J TRANSP ENG, V131, P575, DOI 10.1061/(ASCE)0733-947X(2005)131:8(575); Liu T, 2018, SIMULATION, V95, P65; Lu Y, 2016, SAFETY SCI, V89, P219, DOI 10.1016/j.ssci.2016.06.018; Marais K, 2006, SAFETY SCI, V44, P565, DOI 10.1016/j.ssci.2005.12.004; Moussaid M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0414; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Neville F, 2011, CONTEMP SOC SCI, V6, P377, DOI 10.1080/21582041.2012.627277; Novelli D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078983; Pin SC, 2011, SAFETY SCI, V49, P286, DOI 10.1016/j.ssci.2010.09.002; Popp M, 2012, TOURISM GEOGR, V14, P50, DOI 10.1080/14616688.2011.597421; Qiu L, 2015, COMPUT HUM BEHAV, V52, P443, DOI 10.1016/j.chb.2015.06.032; Rabiee H, 2018, INT J MACH LEARN CYB, V9, P1999, DOI 10.1007/s13042-017-0682-8; Rahmalan H., 2006, Institution of Engineering and Technology Conference on Crime and Security, P540; Reicher SD, 1996, EUR J SOC PSYCHOL, V26, P115; Ren J, 2013, STAT DECISION, P42; Sharma D, 2018, J AMB INTEL HUM COMP, V9, P485, DOI 10.1007/s12652-016-0432-x; SHELBY B, 1991, J LEISURE RES, V23, P173, DOI 10.1080/00222216.1991.11969850; Shen DH, 2016, PHYSICA A, V451, P519, DOI 10.1016/j.physa.2016.01.086; Shi BQ, 2017, CURR ISSUES TOUR, V20, P1186, DOI 10.1080/13683500.2016.1224820; Shi XM, 2016, ACCIDENT ANAL PREV, V95, P405, DOI 10.1016/j.aap.2015.10.009; Shin M, 2014, ACCIDENT ANAL PREV, V68, P95, DOI 10.1016/j.aap.2013.09.019; Sikora W, 2013, ACTA PHYS POL A, V124, P1005; Song PJ, 2010, DECIS SUPPORT SYST, V49, P91, DOI 10.1016/j.dss.2010.01.005; Stott C, 2007, EUR J SOC PSYCHOL, V37, P75, DOI 10.1002/ejsp.338; Ulicny B, 2002, COMPUT GRAPH FORUM, V21, P767, DOI 10.1111/1467-8659.00634; Wang B, 2012, MACH VISION APPL, V23, P501, DOI 10.1007/s00138-011-0341-0; Wang B, 2011, INT J CONTROL AUTOM, V9, P905, DOI 10.1007/s12555-011-0511-x; Wang J, 2010, J COMPUTERS, V5; [王瑜 WANG Yu], 2011, [中国安全科学学报, China Safety Science Journal], V21, P27; Xiong GG, 2012, NEUROCOMPUTING, V83, P121, DOI 10.1016/j.neucom.2011.12.007; Xu Z, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0553-0; YIN J, 2017, SCI EC SOC, P1007; Yin J., 2016, J CHONGQING TECHNOL, V33, P34; Yin J, 2017, SCI EC SOC, P76; Yin Jie, 2018, Tourism Tribune, V33, P133; Yuan YH, 2011, 2011 AASRI CONFERENCE ON INFORMATION TECHNOLOGY AND ECONOMIC DEVELOPMENT (AASRI-ITED 2011), VOL 3, P134; Yuan ZL, 2019, IEEE ACCESS, V7, P13668, DOI 10.1109/ACCESS.2019.2894345; Zachko O., 2017, E EUROPEAN J ENTERPR, V86, P15, DOI DOI 10.15587/1729-4061.2017.98135,2017; Zeitz KM, 2009, PREHOSP DISASTER MED, V24, P32, DOI 10.1017/S1049023X00006518; Zhan BB, 2008, MACH VISION APPL, V19, P345, DOI 10.1007/s00138-008-0132-4; Zhang XL, 2013, PHYSICA A, V392, P2781, DOI 10.1016/j.physa.2013.02.019; [张运波 Zhang Yunbo], 2014, [计算机仿真, Computer Simulation], V31, P432; Zhao BB, 2017, SAFETY SCI, V94, P128, DOI 10.1016/j.ssci.2017.01.002; Zhao HL, 2017, J ROBOT NETW ARTIF L, V4, P77, DOI 10.2991/jrnal.2017.4.1.17; Zhao Y., 2015, PROC, P24	74	4	4	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222389	10.1371/journal.pone.0222389	http://dx.doi.org/10.1371/journal.pone.0222389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527892	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400018
J	Magele, A; Schoerg, P; Stanek, B; Gradl, B; Sprinzl, GM				Magele, Astrid; Schoerg, Philipp; Stanek, Barbara; Gradl, Bernhard; Sprinzl, Georg Mathias			Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis	PLOS ONE			English	Review							SHORT-TERM SAFETY; BONEBRIDGE IMPLANTATION; AUDIOLOGICAL OUTCOMES; INDICATION CRITERIA; SURGICAL TECHNIQUE; DEVICE; CHILDREN; MULTICENTER; EXPERIENCE; SURGERY	Background In July 2018 the active transcutaneous bone conduction hearing implant received FDA approval in the US (for patients 12 years and older with conductive and/or mixed hearing loss or single-sided deafness), reflecting the current trend of moving away from percutaneous hearing solutions towards intact skin systems. Objectives To critically assess the current literature on safety, efficacy and subjective benefit after implantation with an active transcutaneous bone conduction hearing device. Data sources Literature investigation was performed by electronic database search including PubMed and Cochrane Central Register of Controlled Trials, and manual search of relevant journals and reference lists of included studies. Study eligibility criteria Randomized controlled trials, clinical controlled trials and cohort studies, case series and case reports investigating subjective and objective outcomes. Study appraisal and synthesis methods Retrieved literature was screened and extracted by two reviewers independently. Subgroup analysis of indications (conductive and/or mixed hearing loss, single-sided deafness) and participant ages (pediatric vs. adults) was conducted on patients with active transcutaneous bone conduction devices. Sensitivity analysis was performed to test the stability of the results in meta-analysis. Results 39 citations reporting on pre- and postoperative audiological results, speech performance in quiet and in noise, localization testing as well as subjective outcomes were included in this systematic review. Functional gain as well as word recognition score outcomes could be further investigated via meta-analysis. All outcomes reported and summarized here reflect beneficial audiological performance and high patient satisfaction, accompanied with a low complications rate (minor event incidence rate: 9.9 person-years; major incidence rate: 148.9 person-years) for the indications of conductive and mixed hearing loss as well as in individuals suffering from single-sided deafness for all age groups of subjects who underwent active transcutaneous bone conduction hearing device implantation. Limitations A limiting factor of this systematic review was the Level of Evidence of the reviewed literature, comprising 2a/3a studies (cohort studies and case-control studies). Furthermore, the reporting standards, especially in outcomes such as word recognition scores in quiet and in noise, vary across study cites from various countries, which impedes comparisons. Last but not least, no other comparable other device was retrieved as the active transcutaneous bone conduction hearing device is the only available at the moment. Conclusion The device's transcutaneous technology results in a minor event incidence rate of one in 9.9 person-years and a major incidence rate of one in 148.9 person-years. Based on the audiological outcomes, high patient satisfaction as well as the low complication rate, the authors recommend the active transcutaneous bone conduction hearing device as a safe and effective treatment for patients suffering from hearing loss within the device's indication criteria (conductive and/or mixed hearing loss or single-sided deafness).	[Magele, Astrid; Schoerg, Philipp; Stanek, Barbara; Gradl, Bernhard; Sprinzl, Georg Mathias] Univ Clin St Poelten, Dept Otorhinolaryngol Head & Neck Surg, St Polten, Austria; [Magele, Astrid; Schoerg, Philipp; Sprinzl, Georg Mathias] Karl Landsteiner Inst Implantable Hearing Devices, St Polten, Austria		Sprinzl, GM (corresponding author), Univ Clin St Poelten, Dept Otorhinolaryngol Head & Neck Surg, St Polten, Austria.; Sprinzl, GM (corresponding author), Karl Landsteiner Inst Implantable Hearing Devices, St Polten, Austria.	georg.sprinzl@stpoelten.lknoe.at		Sprinzl, Georg/0000-0003-4936-1424				[Anonymous], 2021, LANG ENV STAT COMP; Baker S, 2015, INT J PEDIATR OTORHI, V79, P1667, DOI 10.1016/j.ijporl.2015.07.021; Barbara M, 2013, ACTA OTO-LARYNGOL, V133, P1058, DOI 10.3109/00016489.2013.799293; Baumgartner WD, 2016, OTOL NEUROTOL, V37, P713, DOI 10.1097/MAO.0000000000001038; Bianchin G, 2015, ORL J OTO-RHINO-LARY, V77, P17, DOI 10.1159/000371425; Briggs R, 2015, OTOL NEUROTOL, V36, P834, DOI 10.1097/MAO.0000000000000712; Carr SD, 2015, OTOL NEUROTOL, V36, P1399, DOI 10.1097/MAO.0000000000000830; Centric A, 2014, INT J PEDIATR OTORHI, V78, P875, DOI 10.1016/j.ijporl.2014.02.004; Chen SY, 2017, OTOL NEUROTOL, V38, P364, DOI 10.1097/MAO.0000000000001327; Clamp PJ, 2015, EXPERT REV MED DEVIC, V12, P223, DOI 10.1586/17434440.2015.990375; Denoyelle F, 2015, INT J PEDIATR OTORHI, V79, P382, DOI 10.1016/j.ijporl.2014.12.032; Denoyelle F, 2013, OTOL NEUROTOL, V34, P275, DOI 10.1097/MAO.0b013e31827d07f3; Der C, 2018, OTOL NEUROTOL, V39, pE342, DOI 10.1097/MAO.0000000000001809; Dimitriadis PA, 2017, INT J PEDIATR OTORHI, V94, P59, DOI 10.1016/j.ijporl.2017.01.018; Dun CAJ, 2012, OTOL NEUROTOL, V33, P192, DOI 10.1097/MAO.0b013e318241c0bf; Eberhard KE, 2016, OTOL NEUROTOL, V37, P267, DOI 10.1097/MAO.0000000000000969; Zernotti ME, 2016, ACTA OTO-LARYNGOL, V136, P556, DOI 10.3109/00016489.2016.1143119; Fan XM, 2017, INT J PEDIATR OTORHI, V101, P150, DOI 10.1016/j.ijporl.2017.08.008; Gerdes T., 2016, OTOLOGY NEUROTOLOGY; Gerdes T, 2016, OTOL NEUROTOL, V37, P685, DOI 10.1097/MAO.0000000000001010; Hassepass F, 2015, EUR ARCH OTO-RHINO-L, V272, P2235, DOI 10.1007/s00405-014-3137-9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hobson JC, 2010, J LARYNGOL OTOL, V124, P132, DOI 10.1017/S0022215109991708; Hougaard DD, 2017, EUR ARCH OTO-RHINO-L, V274, P3011, DOI 10.1007/s00405-017-4614-8; Ihler F, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516669330; Ihler F, 2014, OTOL NEUROTOL, V35, P211, DOI 10.1097/MAO.0000000000000208; Iseri M, 2015, OTOL NEUROTOL, V36, P849, DOI 10.1097/MAO.0000000000000733; Iseri Mete, 2014, Kulak Burun Bogaz Ihtis Derg, V24, P59, DOI 10.5606/kbbihtisas.2014.45143; Jovankovicova A, 2015, INT J PEDIATR OTORHI, V79, P975, DOI 10.1016/j.ijporl.2015.03.031; Kim M, 2015, J INT ADV OTOL, V11, P163, DOI 10.5152/iao.2015.1341; Kulasegarah J, 2018, INT J PEDIATR OTORHI, V107, P176, DOI 10.1016/j.ijporl.2018.01.032; Laske RD, 2015, OTOL NEUROTOL, V36, P1151, DOI 10.1097/MAO.0000000000000791; Lassaletta L, 2016, EUR ARCH OTO-RHINO-L, V273, P4103, DOI 10.1007/s00405-016-3972-y; Lassaletta L, 2014, AURIS NASUS LARYNX, V41, P84, DOI 10.1016/j.anl.2013.04.004; Law EKC, 2016, EUR RADIOL, V26, P1686, DOI 10.1007/s00330-015-3983-x; Manrique M, 2014, OTOL NEUROTOL, V35, P216, DOI 10.1097/MAO.0000000000000253; Monini S, 2017, ACTA OTO-LARYNGOL, V137, P389, DOI 10.1080/00016489.2016.1258733; Nelissen RC, 2013, EUR ARCH OTO-RHINO-L, V270, P3019, DOI 10.1007/s00405-013-2346-y; Ngui LX, 2018, J LARYNGOL OTOL, V132, P693, DOI 10.1017/S0022215118001123; Plontke SK, 2014, OTOL NEUROTOL, V35, P1251, DOI 10.1097/MAO.0000000000000405; Powell HRF, 2015, OTOL NEUROTOL, V36, P1525, DOI 10.1097/MAO.0000000000000842; Rahne T, 2015, EUR ARCH OTO-RHINO-L, V272, P3263, DOI 10.1007/s00405-014-3403-x; Rainsbury JW, 2015, OTOL NEUROTOL, V36, pe58, DOI 10.1097/MAO.0000000000000695; Riss D, 2014, LARYNGOSCOPE, V124, P2802, DOI 10.1002/lary.24832; RStudio, 2021, RSTUDIO INT DEV ENV; Salcher R, 2017, OTOL NEUROTOL, V38, P642, DOI 10.1097/MAO.0000000000001394; Schmerber S., 2016, EUROPEAN ARCH OTO RH; Schmerber S, 2017, EUR ARCH OTO-RHINO-L, V274, P1835, DOI 10.1007/s00405-016-4228-6; Schnabl J, 2014, OTOL NEUROTOL, V35, P1242, DOI 10.1097/MAO.0000000000000351; Sprinzl GM, 2016, CLIN OTOLARYNGOL, V41, P131, DOI 10.1111/coa.12484; Sprinzl G, 2013, OTOL NEUROTOL, V34, P1076, DOI 10.1097/MAO.0b013e31828bb541; Tsang WSS, 2013, J LARYNGOL OTOL, V127, P1214, DOI 10.1017/S0022215113002144; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vyskocil E, 2017, CLIN OTOLARYNGOL, V42, P1033, DOI 10.1111/coa.12793; Vyskocil E., 2017, OTOLOGY NEUROTOLOGY; Vyskocil E, 2017, OTOL NEUROTOL, V38, P318, DOI 10.1097/MAO.0000000000001328; Weiss BG, 2017, EUR ARCH OTO-RHINO-L, V274, P3001, DOI 10.1007/s00405-017-4609-5; Weiss R., 2016, EUROPEAN ARCH OTORHI, P1; Weiss R, 2017, EUR ARCH OTO-RHINO-L, V274, P2107, DOI 10.1007/s00405-016-4434-2; Wimmer W, 2015, EUR ARCH OTO-RHINO-L, V272, P1651, DOI 10.1007/s00405-014-2976-8; Zanetti D, 2018, AM J CASE REP, V19, P82, DOI 10.12659/AJCR.904907; Zhao SQ, 2016, ACTA OTO-LARYNGOL, V136, P23, DOI 10.3109/00016489.2014.1003091	62	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221484	10.1371/journal.pone.0221484	http://dx.doi.org/10.1371/journal.pone.0221484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525208	Green Submitted, Green Published, gold			2022-12-27	WOS:000532225700012
J	Ryan, JP; Cline, DE; Joseph, JE; Margolina, T; Santora, JA; Kudela, RM; Chavez, FP; Pennington, JT; Wahl, C; Michisaki, R; Benoit-Bird, K; Forney, KA; Stimpert, AK; DeVogelaere, A; Black, N; Fischer, M				Ryan, John P.; Cline, Danelle E.; Joseph, John E.; Margolina, Tetyana; Santora, Jarrod A.; Kudela, Raphael M.; Chavez, Francisco P.; Pennington, J. Timothy; Wahl, Christopher; Michisaki, Reiko; Benoit-Bird, Kelly; Forney, Karin A.; Stimpert, Alison K.; DeVogelaere, Andrew; Black, Nancy; Fischer, Mark			Humpback whale song occurrence reflects ecosystem variability in feeding and migratory habitat of the northeast Pacific	PLOS ONE			English	Article							CALIFORNIA CURRENT IMPLICATIONS; MEGAPTERA-NOVAEANGLIAE; HIERARCHICAL STRUCTURE; ACOUSTIC DETECTIONS; TROPHIC TRANSFER; CURRENT SYSTEM; MONTEREY BAY; DOMOIC ACID; WEST-COAST; EL-NINO	This study examines the occurrence of humpback whale (Megaptera novaeangliae) song in the northeast Pacific from three years of continuous recordings off central California (36.713 degrees N, 122.186 degrees W). Song is prevalent in this feeding and migratory habitat, spanning nine months of the year (SeptemberMay), peaking in winter (NovemberJanuary), and reaching a maximum of 86% temporal coverage (during November 2017). From the rise of song in fall through the end of peak occurrence in winter, song length increases significantly from month to month. The seasonal peak in song coincides with the seasonal trough in day length and sighting-based evidence of whales leaving Monterey Bay, consistent with seasonal migration. During the seasonal song peak, diel variation shows maximum occurrence at night (69% of the time), decreasing during dawn and dusk (52%), and further decreasing with increasing solar elevation during the day, reaching a minimum near solar noon (30%). Song occurrence increased 44% and 55% between successive years. Sighting data within the acoustic detection range of the hydrophone indicate that variation in local population density was an unlikely cause of this large interannual variation. Hydrographic data and modeling of acoustic transmission indicate that changes in neither habitat occupancy nor acoustic transmission were probable causes. Conversely, the positive interannual trend in song paralleled major ecosystem variations, including similarly large positive trends in wind-driven upwelling, primary productivity, and krill abundance. Further, the lowest song occurrence during the first year coincided with anomalously warm ocean temperatures and an extremely toxic harmful algal bloom that affected whales and other marine mammals in the region. These major ecosystem variations may have influenced the health and behavior of humpback whales during the study period.	[Ryan, John P.; Cline, Danelle E.; Chavez, Francisco P.; Pennington, J. Timothy; Wahl, Christopher; Michisaki, Reiko; Benoit-Bird, Kelly] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Joseph, John E.; Margolina, Tetyana] Naval Postgrad Sch, Dept Oceanog, Monterey, CA USA; [Santora, Jarrod A.] Univ Calif Santa Cruz, Dept Appl Math, Santa Cruz, CA USA; [Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Forney, Karin A.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Moss Landing, CA USA; [Forney, Karin A.] San Jose State Univ, Moss Landing Marine Labs, Moss Landing, CA USA; [Stimpert, Alison K.] San Jose State Univ, Moss Landing Marine Labs, BioacousticsNertebrate Ecol, Moss Landing, CA USA; [DeVogelaere, Andrew] NOAA, Monterey Bay Natl Marine Sanctuary, Natl Ocean Serv, Monterey, CA USA; [Black, Nancy] Monterey Bay Whale Watch, Monterey, CA USA; [Fischer, Mark] Aguason Acoust, Santa Clara, CA USA	Monterey Bay Aquarium Research Institute; United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Jose State University; Moss Landing Marine Laboratories; California State University System; San Jose State University; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Ryan, JP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	ryjo@mbari.org	Margolina, Tetyana/ABD-3917-2021	Margolina, Tetyana/0000-0003-1594-5974; Wahl, Christopher/0000-0001-9675-068X; Ryan, John Phillip/0000-0001-7954-5369; Michisaki, Reiko/0000-0002-3295-3856	David and Lucile Packard Foundation; NOAA ECOHAB Program [NA11NOS4780030]; NSF [1514756]; Central and Northern California Ocean Observing System [NOAA NA16NOS0120021]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NOAA ECOHAB Program(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Central and Northern California Ocean Observing System	This study was funded by the David and Lucile Packard Foundation, through an annual grant to Monterey Bay Aquarium Research Institute (JPR, DEC, FPC, JTP, CW, RM, KBB). The Santa Cruz Wharf DA time-series (RMK) was supported by the Central and Northern California Ocean Observing System (NOAA NA16NOS0120021) and NOAA ECOHAB Program (NA11NOS4780030). This research was enabled by the Monterey Accelerated Research System (MARS) cabled observatory supported by NSF Award 1514756.; We gratefully acknowledge the support of MBARI MARS and R/V Rachel Carson operations teams for supporting deployment and operation of the hydrophone used in this study, and Edward T. Peltzer for the software used for Model 1 linear regression. We thank the scientists of the NOAA-Fisheries Rockfish Recruitment and Ecosystem Assessment Survey for their dedicated support for monitoring ocean and forage species conditions and the crew of the NOAA R/V Reuben Lasker. We also thank the NOAA California Current Integrated Ecosystem Assessment (CCIEA) for providing the status of ecological integrity indicators.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Auad G, 2011, PROG OCEANOGR, V91, P576, DOI 10.1016/j.pocean.2011.09.004; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; BAKER CS, 1990, NATURE, V344, P238, DOI 10.1038/344238a0; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; Barber R.T., 1981, P31; Becker EA, 2019, DIVERS DISTRIB, V25, P626, DOI 10.1111/ddi.12867; Becker EA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020149; Benson SR, 2002, PROG OCEANOGR, V54, P279, DOI 10.1016/S0079-6611(02)00054-X; Bettridge S, 2015, NOAATMNMFSSWFSC540 U; Calambokidis J, 1996, MAR MAMMAL SCI, V12, P215, DOI 10.1111/j.1748-7692.1996.tb00572.x; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2000, MAR ECOL PROG SER, V192, P295, DOI 10.3354/meps192295; CALAMBOKIDIS J, 2017, SCA17NP13 INT WHAL C, V17, P13; Calambokidis J, 2015, AQUAT MAMM, V41, P39, DOI 10.1578/AM.41.1.2015.39; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Cates KA, 2019, GEN COMP ENDOCR, V279, P164, DOI 10.1016/j.ygcen.2019.03.013; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Chavez FP, 2002, PROG OCEANOGR, V54, P205, DOI 10.1016/S0079-6611(02)00050-2; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Cholewiak DM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171298; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; COLLINS MD, 1993, J ACOUST SOC AM, V93, P1736, DOI 10.1121/1.406739; DAWBIN W H, 1991, Memoirs of the Queensland Museum, V30, P255; Espanol-Jimenez S, 2018, MAR MAMMAL SCI, V34, P718, DOI 10.1111/mms.12477; Fire SE, 2010, AQUAT MAMM, V36, P342, DOI 10.1578/AM.36.4.2010.342; Fire SE, 2009, HARMFUL ALGAE, V8, P658, DOI 10.1016/j.hal.2008.12.002; Fleming AH, 2016, GLOBAL CHANGE BIOL, V22, P1214, DOI 10.1111/gcb.13171; Fournet MEH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31527-x; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gedamke J., 2016, NOAA OCEAN NOISE STR; Gentemann CL, 2017, GEOPHYS RES LETT, V44, P312, DOI 10.1002/2016GL071039; HELWEG DA, 1994, ETHOLOGY, V98, P298, DOI 10.1111/j.1439-0310.1994.tb01078.x; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Kowarski K, 2018, MAR MAMMAL SCI, V34, P169, DOI 10.1111/mms.12447; Kudela Raphael, 2005, Oceanography, V18, P184; Lane JQ, 2010, LIMNOL OCEANOGR-METH, V8, P645, DOI 10.4319/lom.2010.8.0645; Magnusdottir EE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210057; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mercado E, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01156; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; Office of National Marine Sanctuaries, 2015, MONT BAY NAT MAR SAN; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Pennington JT, 2000, DEEP-SEA RES PT II, V47, P947, DOI 10.1016/S0967-0645(99)00132-0; Ralston S, 2015, J MARINE SYST, V146, P26, DOI 10.1016/j.jmarsys.2014.06.013; Rudnick DL, 2017, PROG OCEANOGR, V154, P64, DOI 10.1016/j.pocean.2017.03.002; Ryan J., 2016, P OCEANS 2016 MTS IE, P1; Ryan JP, 2017, GEOPHYS RES LETT, V44, P5571, DOI 10.1002/2017GL072637; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sakuma KM, 2016, CAL COOP OCEAN FISH, V57, P163; Santora JA, 2017, MAR ECOL PROG SER, V580, P205, DOI 10.3354/meps12278; Santora JA, 2014, ECOL APPL, V24, P1730, DOI 10.1890/13-1605.1; Santora JA, 2012, PROG OCEANOGR, V106, P154, DOI 10.1016/j.pocean.2012.08.005; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Santos J. C., 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-018-25742-9; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; STEIGER GH, 1991, MAR MAMMAL SCI, V7, P306, DOI 10.1111/j.1748-7692.1991.tb00105.x; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Szoboszlai AI, 2015, ECOL INFORM, V29, P45, DOI 10.1016/j.ecoinf.2015.07.003; Thompson T, 2018, ST ANTONYS SER, P59, DOI 10.1007/978-3-319-64072-3_3; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Urban R. J., 2000, Journal of Cetacean Research and Management, V2, P101; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Wright AJ, 2010, J MAR BIOL ASSOC UK, V90, P1489, DOI 10.1017/S0025315410000913	75	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222456	10.1371/journal.pone.0222456	http://dx.doi.org/10.1371/journal.pone.0222456			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525231	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700029
J	Tofail, F; Islam, MM; Mahfuz, M; Alam, A; Aktar, S; Haque, R; Hossain, MI; Mondal, D; Petri, WA; Ahmed, T				Tofail, Fahmida; Islam, M. Munirul; Mahfuz, Mustafa; Alam, Ashraful; Aktar, Shirina; Haque, Rashidul; Hossain, Md Iqbal; Mondal, Dinesh; Petri, William A.; Ahmed, Tahmeed			Association of vitamin D nutrition with neuro-developmental outcome of infants of slums in Bangladesh	PLOS ONE			English	Article							D DEFICIENCY; UNDERNOURISHED CHILDREN; ZINC SUPPLEMENTATION; COGNITIVE FUNCTION; PREGNANCY; PERFORMANCE; CHILDHOOD; BEHAVIOR; HEALTH; IRON	The association of vitamin D with neuro-behavioral outcomes of young children is unclear, particularly of those who reside in tropical countries and are otherwise exposed to adequate sun light. To investigate this association, we analysed the existing data of poor infants, who participated in an observational, prospective-cohort (MalED) study, conducted in a slum of Dhaka-city. We assessed 265 infants aged 6-8 months for cognitive, motor, language and behavior development using Bayley-III. Information about infants' temperament and communicative skills were provided by the mothers through a culturally modified "temperamentscale" and a "communicative-developmental inventory". Serum concentration of vitamin D [25(OH)D] was measured in 205 infants. Around 28.3% of infants in this community had low level vitamin D, with the cut-off at < 50 nmol/L. After controlling for all possible covariates, a multivariable-adjusted linear regression showed that children with vitamin D levels <50 nmol/L had significantly lower scores in two dimensions of temperament: activity (B +/- SE 1.64 +/- 0.78; 95%CI 0.10, 3.18; p = 0.037; effect size 0.37 SDs) and soothabilty (2.02 +/- 0.70; 0.64, 3.41; p = 0.004; 0.53 SDs), compared to children with vitamin D levels of >= 50nmol/L. These infants also scored low in word comprehensions (1.28 +/- 0.62; 0.05, 2.51; p = 0.042; 0.23 SDs) and were less active during test-procedures (0.33 +/- 0.16; 0.02, 0.64; p = 0.035; 0.27 SDs). Both the groups tested similarly in cognitive and motor scores. This study found, despite adequate sunlight-exposure, one in four infants of this slum-community are suffering from a subclinical vitamin D deficiency. Higher levels of vitamin D in these infants showed a positive association with temperament, language and behavior but not with cognitive and motor development. Our findings highlight the early-detected extra-skeletal neuro-behavioral role of vitamin D. Future studies in this area will give more insight.	[Tofail, Fahmida; Islam, M. Munirul; Mahfuz, Mustafa; Alam, Ashraful; Aktar, Shirina; Hossain, Md Iqbal; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Icddr B, Dhaka, Bangladesh; [Haque, Rashidul; Mondal, Dinesh] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Emerging Infect & Parasitol Lab, Dhaka, Bangladesh; [Petri, William A.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of Virginia	Tofail, F (corresponding author), Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Icddr B, Dhaka, Bangladesh.	ftofail@icddrb.org	Alam, Ashraful/AAA-3893-2020; alam, mohammed/GXH-3645-2022; Mahfuz, Mustafa/H-5923-2017	Alam, Ashraful/0000-0003-1389-8510; Mahfuz, Mustafa/0000-0002-4090-785X; Haque, Rashidul/0000-0001-5100-136X; Tofail, Fahmida/0000-0003-2301-9196	Bill and Melinda Gates Foundation, USA [14595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation, USA(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation, USA, grant IRB-HSR#14595 to TA. International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) is grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou CA, 2014, J ALZHEIMERS DIS, V42, pS71, DOI 10.3233/JAD-132636; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Annweiler C, 2014, MATURITAS, V78, P30, DOI 10.1016/j.maturitas.2014.02.013; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Berridge MJ, 2018, AM J PHYSIOL-CELL PH, V314, pC135, DOI 10.1152/ajpcell.00188.2017; Black MM, 2004, AM J CLIN NUTR, V80, P903, DOI 10.1093/ajcn/80.4.903; Buell JS, 2009, J GERONTOL A-BIOL, V64, P888, DOI 10.1093/gerona/glp032; CALDWELL BM, 1967, PEDIATRICS, V40, P46; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Cui XY, 2015, J STEROID BIOCHEM, V148, P305, DOI 10.1016/j.jsbmb.2014.11.004; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fernald L.C.H., 2017, TOOLKIT MEASURING EA; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Goodwill AM, 2018, MATURITAS, V107, P56, DOI 10.1016/j.maturitas.2017.10.005; Grant WB, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.22942; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; Hamadani JD, 2010, FOOD NUTR BULL, V31, pS198, DOI 10.1177/15648265100312S212; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099005; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Lee DM, 2009, J NEUROL NEUROSUR PS, V80, P722, DOI 10.1136/jnnp.2008.165720; Llewellyn DJ, 2009, J GERIATR PSYCH NEUR, V22, P188, DOI 10.1177/0891988708327888; McCarthy EK, 2018, J NUTR, V148, P1580, DOI 10.1093/jn/nxy150; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Mostafa GA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-201; Murray-Kolb LE, 2014, CLIN INFECT DIS, V59, pS261, DOI 10.1093/cid/ciu437; Nagel G, 2015, J ALZHEIMERS DIS, V45, P1119, DOI 10.3233/JAD-143219; Nerhus M, 2017, J CLIN PSYCHIAT, V78, pE750, DOI 10.4088/JCP.16m10880; Pendergast L.L., 2018, INT J SCH ED PSYCHOL, V6, P266, DOI [10.1080/21683603.2017.1356773, DOI 10.1080/21683603.2017.1356773]; Pettersen JA, 2016, J CLIN EXP NEUROPSYC, V38, P467, DOI 10.1080/13803395.2015.1125452; Rahman A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091197; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Roth DE, 2010, J HEALTH POPUL NUTR, V28, P458; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; Thomas A., 1968, TEMPERAMENT BEHAV DI; Tofail F, 2012, EUR J CLIN NUTR, V66, P237, DOI 10.1038/ejcn.2011.165; Tofail F, 2006, J HEALTH POPUL NUTR, V24, P48; Tofail F, 2013, J NUTR, V143, P885, DOI 10.3945/jn.112.160473; Tolppanen AM, 2012, J EPIDEMIOL COMMUN H, V66, P1137, DOI 10.1136/jech-2011-200114; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041575; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040097; Tolppanen AM, 2012, J CHILD PSYCHOL PSYC, V53, P757, DOI 10.1111/j.1469-7610.2011.02518.x; Ubbenhorst A, 2011, PSYCHOPHARMACOLOGY, V215, P733, DOI 10.1007/s00213-011-2175-x; Wachs TD, 2009, AM J CLIN NUTR, V89, p935S, DOI 10.3945/ajcn.2008.26692B; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; Whiting SJ, 2007, J STEROID BIOCHEM, V103, P626, DOI 10.1016/j.jsbmb.2006.12.067; World Health Organization, 1983, GUID ASS NUTR IMP SU; Wrzosek M, 2013, PHARMACOL REP, V65, P271, DOI 10.1016/S1734-1140(13)71003-X	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221805	10.1371/journal.pone.0221805	http://dx.doi.org/10.1371/journal.pone.0221805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557172	Green Published, gold			2022-12-27	WOS:000532345500012
J	Hamid, M; Brooks, MB; Madhani, F; Ali, H; Naseer, MJ; Becerra, M; Amanullah, F				Hamid, Meherunissa; Brooks, Meredith B.; Madhani, Falak; Ali, Hassan; Naseer, Mohammad Junaid; Becerra, Mercedes; Amanullah, Farhana		Childhood Tb Karachi Grp	Risk factors for unsuccessful tuberculosis treatment outcomes in children	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; DIAGNOSIS; DISEASE; BURDEN	Objective Pakistan has a high pediatric burden of tuberculosis, but few studies describe the treatment experience of children with tuberculosis in Pakistan. We sought to identify risk factors for unsuccessful treatment outcomes in children with drug-susceptible tuberculosis identified in eight hospitals in Karachi, Pakistan. Design We conducted a retrospective cohort study among children (< 15 years old) treated with first-line anti-tuberculosis drugs for presumed or confirmed drug-susceptible tuberculosis between 2016 and 2017. We assessed risk factors for experiencing an unsuccessful treatment outcome through multivariable logistic regression analysis. Results In total, 1,665 children initiated tuberculosis treatment, including 916 (55.0%) identified through intensified case finding. Unsuccessful treatment outcomes were experienced by 197 (11.8%) children, comprising 27 (1.6%) deaths, 16 (1.0%) treatment failures, and 154 (9.3%) lost to follow-up. An additional 47 (2.8%) children had outcomes not evaluable. In multivariable analysis, children 0-4 years old (OR: 1.80, 95% CI: 1.07-3.04), males (OR: 1.48, 95% CI: 1.04, 2.11), and those with bacteriologic confirmation of disease (OR: 3.39, 95% CI: 1.98, 5.80) had increased odds of experiencing an unsuccessful treatment outcome. Conclusion Our findings suggest a need to deploy strategies to identify children earlier in the disease process and point to the need for interventions tailored for young children once treatment is initiated.	[Hamid, Meherunissa; Madhani, Falak; Ali, Hassan; Naseer, Mohammad Junaid; Amanullah, Farhana] Indus Hlth Network, Global Hlth Directorate, Karachi, Sindh, Pakistan; [Brooks, Meredith B.; Becerra, Mercedes] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Amanullah, Farhana] Indus Hosp, Dept Pediat, Karachi, Sindh, Pakistan	Harvard University; Harvard Medical School	Hamid, M (corresponding author), Indus Hlth Network, Global Hlth Directorate, Karachi, Sindh, Pakistan.	meherunissa.hamid@ghd.ihn.org.pk		Hamid, Meherunissa/0000-0002-8569-304X; Brooks, Meredith/0000-0001-8431-5517	Global Fund; Provincial TB Control Program (PTP), Sindh; National TB Control Program (NTP)-Pakistan	Global Fund; Provincial TB Control Program (PTP), Sindh; National TB Control Program (NTP)-Pakistan	This work is part of the Zero TB Initiative funded by the Global Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our deep gratitude to the management of (1) The Indus Hospital, (2) National Institute of Child Health, (3) Dr. Ruth K.M. Pfau Civil Hospital Karachi, (4) Murshid Hospital and Health Care Centre, (5) Sindh Government Hospital Korangi, (6) Sindh Government Hospital New Karachi, (7) Sindh Government Hospital Qatar, and (8) Sindh Government Hospital Liaquatabad for their willingness to collaborate and allowing us to conduct the childhood TB program in their hospitals. We are also indebted to the Provincial TB Control Program (PTP), Sindh, and the National TB Control Program (NTP)-Pakistan for their support. We thank the faculty of the Harvard Medical School Center for Global Health Delivery-Dubai that organized a Scientific Manuscript Writing Workshop in April 2018 for the feedback on the manuscript draft and analysis.; This work is part of the Zero TB Initiative funded by the Global Fund.	Aketi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153914; Alavi SM, 2015, CASP J INTERN MED, V6, P213; [Anonymous], 2013, DEF REP FRAM TUB 201; [Anonymous], 2017, MAN CHILDH TUB; Aw B, 2017, PUBLIC HEALTH ACTION, V7, P199, DOI 10.5588/pha.16.0123; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Harries A, 2006, MALAWI MED J, V17; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; LAGHARI M, 2018, PEERJ, V6, P84410, DOI DOI 10.1016/J.2545; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Ogbudebe CL, 2018, HEALTH SERV INSIGHTS, V11, DOI 10.1177/1178632918757490; Satyanarayana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013338; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Tilahun G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3193-8; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	18	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222776	10.1371/journal.pone.0222776	http://dx.doi.org/10.1371/journal.pone.0222776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553758	Green Submitted, gold, Green Published			2022-12-27	WOS:000532319200036
J	Hiraoka, Y; Okochi, Y; Ohshimo, S; Shimose, T; Ashida, H; Sato, T; Ando, Y				Hiraoka, Yuko; Okochi, Yumi; Ohshimo, Seiji; Shimose, Tamaki; Ashida, Hiroshi; Sato, Takuya; Ando, Yasuhiro			Lipid and fatty acid dynamics by maternal Pacific bluefin tuna	PLOS ONE			English	Article							THUNNUS-ORIENTALIS; REPRODUCTIVE-PERFORMANCE; RECRUITMENT; LARVAL; EGG; BIOLOGY; WALLEYE; GROWTH; FISH; ACCUMULATION	Lipid and fatty acid composition of female Pacific bluefin tuna (PBF, Thunnus orientalis) reproductive and somatic tissues in southwestern North Pacific and Sea of Japan spawning grounds are compared. Total lipid (TL) levels are higher in liver than white muscle tissues. An increased gonadosomatic index (GSI) during the early spawning season coincided with decreased TL. Levels of triacylglycerols (TAG) in PBF liver tissues from the Nansei Islands and Sea of Japan, and white muscle in fishes from the Sea of Japan, decreased during the spawning season, while TAG in ovary tissues did not. Concurrent reductions in TL and increases in GSI early in the spawning season suggest TAG depletion was caused by allocation from liver and white muscle tissues to oocytes, that the liver is one of the important lipid-storage organs in PBF, and this species mostly reliant on capital deposits as a mixed capital-income breeder. Differences of docosahexaenoic acid (DHA) levels between spawning grounds were lower in ovary than in muscle and liver tissues. However, eicosapentaenoic (EPA) and arachidonic acid (ARA) levels that influence egg development and embryo and larval growth are significantly higher in PBF tissues from the Sea of Japan than Nansei Islands, which coincided with larval quality. These suggest a maternal effect exists, with egg quality influencing offspring survival, and that the reproductive strategy of PBF varies according to local variation at each spawning ground.	[Hiraoka, Yuko; Ashida, Hiroshi; Sato, Takuya] Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Bluefin Tuna Resources Dept, Shizuoka, Shizuoka, Japan; [Okochi, Yumi] JAPAN NUS Co Ltd, Environm Management Unit, Shinjuku Ku, Tokyo, Japan; [Ohshimo, Seiji] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Fisheries Management & Oceanog Dept, Nagasaki, Nagasaki, Japan; [Shimose, Tamaki] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Ando, Yasuhiro] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan	Japan Fisheries Research & Education Agency (FRA); Japan NUS; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Hiraoka, Y (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Bluefin Tuna Resources Dept, Shizuoka, Shizuoka, Japan.	yhira415@affrc.go.jp	Oshimo, Seiji/H-8674-2014; 環, 下瀬/AAF-7833-2021	環, 下瀬/0000-0003-2505-3611; Hiraoka, Yuko/0000-0002-1073-9234; OHSHIMO, Seiji/0000-0002-2883-7588	Japan Fisheries Agency	Japan Fisheries Agency	This work was supported by a grant from the Japan Fisheries Agency. JAPAN NUS Co. Ltd provided support in the form of salary for Yumi Okochi. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Ashida H, 2015, ENVIRON BIOL FISH, V98, P1173, DOI 10.1007/s10641-014-0350-8; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; BARON CB, 1984, J LIQ CHROMATOGR, V7, P2793, DOI 10.1080/01483918408067046; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Collette BB, 1983, FAO SPECIES CATALOGU, V2; Dhurmeea Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194558; Fuiman LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1414; Fuiman LA, 2011, J EXP MAR BIOL ECOL, V407, P155, DOI 10.1016/j.jembe.2011.06.004; Furuita H, 2000, AQUACULTURE, V187, P387, DOI 10.1016/S0044-8486(00)00319-7; Grande M, 2016, J FISH BIOL, V89, P2434, DOI 10.1111/jfb.13125; Hachero-Cruzado I, 2012, AQUAC RES, V43, P1439, DOI 10.1111/j.1365-2109.2011.02946.x; Harford WJ, 2017, FISH OCEANOGR, V26, P396, DOI 10.1111/fog.12205; Henderson BA, 1996, CAN J FISH AQUAT SCI, V53, P127, DOI 10.1139/cjfas-53-1-127; ISC, 2018, 18 M INT SCI COMM TU; Ishida Y, 2018, FISH OCEANOGR, V27, P41, DOI 10.1111/fog.12232; Ishihara T, 2019, ENVIRON BIOL FISH, V102, P581, DOI 10.1007/s10641-019-00855-w; Johnson RB, 2009, REV FISH SCI, V17, P78, DOI 10.1080/10641260802590004; Johnston TA, 2007, ECOL FRESHW FISH, V16, P295, DOI 10.1111/j.1600-0633.2006.00219.x; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Kitagawa T, 2010, J EXP MAR BIOL ECOL, V393, P23, DOI 10.1016/j.jembe.2010.06.016; Lane RL, 2006, N AM J AQUACULT, V68, P141, DOI 10.1577/A05-009.1; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Masuma Shukei, 2006, Bulletin of Fisheries Research Agency, P157; Matsumoto Y, 2018, LIPIDS, V53, P919, DOI 10.1002/lipd.12098; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Muhling BA, 2018, ICES J MAR SCI, V75, P1341, DOI 10.1093/icesjms/fsy017; Nakatsuka S, 2017, MAR POLICY, V78, P107, DOI 10.1016/j.marpol.2017.01.017; Ohshimo S, 2018, AQUAT LIVING RESOUR, V31, DOI 10.1051/alr/2018022; Ohshimo S, 2018, FISH RES, V204, P390, DOI 10.1016/j.fishres.2018.03.017; Ohshimo S, 2017, B MAR SCI, V93, P769, DOI 10.5343/bms.2016.1094; Okochi Y, 2016, FISH RES, V174, P30, DOI 10.1016/j.fishres.2015.08.020; OLSEN RE, 1989, J EXP MAR BIOL ECOL, V129, P189, DOI 10.1016/0022-0981(89)90056-7; Perez KO, 2015, J FISH BIOL, V86, P1286, DOI 10.1111/jfb.12637; Rainuzzo JR, 1997, AQUACULTURE, V155, P103, DOI 10.1016/S0044-8486(97)00121-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Shimose T, 2015, BIOL ECOLOGY BLUEFIN, P78, DOI DOI 10.1201/B18714-7; Shimose T., 2015, BIOL ECOLOGY BLUEFIN, P47; Shimose T, 2016, ENVIRON BIOL FISH, V99, P351, DOI 10.1007/s10641-016-0478-9; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Team RC, 2016, R LANG ENV STAT COMP; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Watai M, 2018, MAR ECOL PROG SER, V607, P207, DOI 10.3354/meps12807; Watai M, 2017, MAR FRESHWATER RES, V68, P2008, DOI 10.1071/MF16337; Wiegand MD, 2007, CAN J FISH AQUAT SCI, V64, P700, DOI 10.1139/F07-033; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Yabe H, 1966, REP NANKAI REG FISH, V23, P95; Zudaire I, 2014, FISH RES, V160, P50, DOI 10.1016/j.fishres.2013.12.010	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222824	10.1371/journal.pone.0222824	http://dx.doi.org/10.1371/journal.pone.0222824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553780	gold, Green Published			2022-12-27	WOS:000532319200038
J	Shah, L; Jannuzzo, C; Hassan, T; Gadidov, B; Ray, HE; Rushton, GT				Shah, Lisa; Jannuzzo, Cooper; Hassan, Taufiq; Gadidov, Bogdan; Ray, Herman E.; Rushton, Gregory T.			Diagnosing the current state of out-of-field teaching in high school science and mathematics	PLOS ONE			English	Article							TEACHERS	The U.S. government has acknowledged the critical role that teachers play in the production of Science, Technology, Engineering, and Mathematics (STEM) professionals who will drive our nation's economy. The No Child Left Behind Act of 2001 (NCLB) was passed to improve the quality of education nationwide, in part, by decreasing the number of out-of-field (OOF) teachers. However, the impact of NCLB and related efforts on the current state of OOF teaching in high school science and mathematics has yet to be examined. Our analysis of data from the National Teacher and Principal Survey (NTPS) indicates that from 2003-2016, the proportion of OOF teachers in chemistry and physics has increased, and there has been an increase in the number of students assigned to OOF teachers across subjects. We discuss the societal impact of our results and the critical role that policymakers, school administrators, and academic institutions, particularly university faculty, can play in its solution.	[Shah, Lisa] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Jannuzzo, Cooper; Hassan, Taufiq; Gadidov, Bogdan; Ray, Herman E.] Kennesaw State Univ, Dept Stat & Analyt Sci, Kennesaw, GA 30144 USA; [Ray, Herman E.] Kennesaw State Univ, Analyt & Data Sci Inst, Kennesaw, GA 30144 USA; [Rushton, Gregory T.] Middle Tennessee State Univ, Tennessee STEM Educ Ctr, Murfreesboro, TN 37130 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University; Middle Tennessee State University	Rushton, GT (corresponding author), Middle Tennessee State Univ, Tennessee STEM Educ Ctr, Murfreesboro, TN 37130 USA.	gregory.rushton@mtsu.edu	Rushton, Gregory/AAQ-2081-2020	Rushton, Gregory/0000-0002-8687-132X; Shah, Lisa/0000-0001-8700-0924	NSF [DUE-1035451]; Stony Brook University	NSF(National Science Foundation (NSF)); Stony Brook University	The authors gratefully acknowledge the support for this work from NSF Award DUE-1035451 to G.T.R. and start-up funding from Stony Brook University to G.T.R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, R NOYC TEACH SCHOL P; Bernal A, 2010, HYLE, V16, P80; Boyd D, 2005, AM ECON REV, V95, P166, DOI 10.1257/000282805774669628; Broughman S, 2014, PRIVATE SCH UNIVERSE; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Darling-Hammond L., 2002, EDUC RESEARCHER, V31, P13, DOI DOI 10.3102/0013189X031009013; Darling-Hammond L., 2000, ED POLICY ANAL ARCH, V8, P1, DOI DOI 10.14507/EPAA.V8N1.2000; Gamoran A, 2016, SCIENCE, V353, P1209, DOI 10.1126/science.aah4037; HACKER RG, 1985, EUR J SCI EDUC, V7, P173, DOI 10.1080/0140528850070208; Ingersoll R. M., 1999, ED RES, V28, P26, DOI DOI 10.3102/0013189X028002026; Kersaint G, 2007, TEACH TEACH EDUC, V23, P775, DOI 10.1016/j.tate.2005.12.004; Langdon D., 2011, STEM GOOD JOBS NOW F; Marshall J., 2016, JOINT SPRING 2016 M; Monk D.H., 1994, ECON EDUC REV, V13, P125, DOI [DOI 10.1016/0272-7757(94)90003-5, https://doi.org/10.1016/0272-7757(94)90003-5]; Plisch M, 2015, SCIENCE, V348, P405, DOI 10.1126/science.348.6233.405-a; Rushton GT, 2017, PHYS REV PHYS EDUC R, V13, DOI 10.1103/PhysRevPhysEducRes.13.020122; Rushton GT, 2016, ACS CENTRAL SCI, V2, P825, DOI 10.1021/acscentsci.6b00216; Rushton GT, 2014, EDUC RESEARCHER, V43, P390, DOI 10.3102/0013189X14556341; Schwab J. J., 1972, READINGS PHILOS ED; Seastrom MM, 2002, 603 NAT CTR ED STAT; Shah L, 2018, J CHEM EDUC, V95, P700, DOI 10.1021/acs.jchemed.7b00837; Shah L, 2018, PHYS REV PHYS EDUC R, V14, DOI 10.1103/PhysRevPhysEducRes.14.010126; SHULMAN LS, 1987, HARVARD EDUC REV, V57, P1, DOI 10.17763/haer.57.1.j463w79r56455411; Shulman LS., 1986, EDUC RESEARCHER, V15, P4, DOI [10.3102/0013189X015002004, 10.3102%2F0013189X015002004, DOI 10.3102/0013189X015002004]; Tourkin SC, 2007, 2007337 NCES; Wilson SM, 2013, SCIENCE, V340, P310, DOI 10.1126/science.1230725; Wolter M, 2004, OHIO SECTION SPRING	27	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223186	10.1371/journal.pone.0223186	http://dx.doi.org/10.1371/journal.pone.0223186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553781	Green Published, gold			2022-12-27	WOS:000532319200056
J	Fisher, SA; Rahimzadeh, M; Brierley, C; Gration, B; Doree, C; Kimber, CE; Cajide, AP; Lamikanra, AA; Roberts, DJ				Fisher, Sheila A.; Rahimzadeh, Mana; Brierley, Charlotte; Gration, Betty; Doree, Carolyn; Kimber, Catherine E.; Cajide, Alicia Plaza; Lamikanra, Abigail A.; Roberts, David J.			The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review	PLOS ONE			English	Review							1,25-DIHYDROXYVITAMIN D-3; DENDRITIC CELLS; ALLERGEN IMMUNOTHERAPY; SUPPLEMENTATION; INDUCTION; ANALOG; BETA; CHOLECALCIFEROL; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; AUTOIMMUNITY	Background The evidence for vitamin D and other agents that experimentally modulate T regulatory cells (Tregs) for the treatment of patients with autoimmune or allergic diseases has not been established. Objective We have undertaken a systematic review of randomised controlled trials to assess the efficacy of vitamin D, vitamin A, niacin and short-chain fatty acids in enhancing absolute Treg numbers and phenotypes in patients with inflammatory or autoimmune disease. Methods This systematic review was conducted using a predefined protocol (PROSPERO International prospective register of systematic reviews, ID = CRD42016048648/CRD42016048646). Randomised controlled trials of patients with inflammatory or autoimmune disease or healthy participants which compared either oral vitamin D or vitamin A or short-chain fatty acids with control or placebo and measured the absolute concentration of proportion of Tregs were eligible for inclusion. Searches of electronic databases (CENTRAL, MEDLINE, EMBASE, CINAHL, PUBMED and Web of Science) identified eight eligible independent trials (seven autoimmune disease trials, one trial of healthy subjects). Data were extracted by two reviewers and the risk of study bias was assessed using Cochrane Collaboration methodology. Results Planned meta-analysis was not possible due to the heterogeneous nature of the studies. Nevertheless, in five trials of autoimmune disorders which measured the proportion of Tregs, a higher proportion was observed in the vitamin D group compared to controls at 12 months in all but one trial. In the trial of healthy subjects, a significant difference was reported, with a higher percentage of Tregs observed in the vitamin D group (at 12 weeks, mean 6.4% (SD 0.8%) (vitamin D) vs 5.5% (1.0%) (placebo). There were no trials to assess the efficacy of vitamin A, niacin and short-chain fatty acids in enhancing absolute Treg numbers. Conclusions Vitamin D supplementation may increase Treg/CD3 ratios in both healthy individuals and patients with autoimmune disorders and may increase Treg function. There remains a need for further suitably powered clinical studies aimed at enhancing Treg numbers and/or function.	[Fisher, Sheila A.; Doree, Carolyn; Kimber, Catherine E.; Cajide, Alicia Plaza; Lamikanra, Abigail A.; Roberts, David J.] NHS Blood & Transplant, Oxford, England; [Fisher, Sheila A.; Doree, Carolyn; Kimber, Catherine E.; Cajide, Alicia Plaza; Lamikanra, Abigail A.; Roberts, David J.] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England; [Rahimzadeh, Mana] Oxford Univ Med Sch, John Radcliffe Hosp, Oxford, England; [Brierley, Charlotte] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Dept Haematol, Oxford, England; [Gration, Betty] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England; [Roberts, David J.] Oxford Univ Hosp NHS Trust, Churchill Hosp, Biomed Res Ctr Haematol Theme, Oxford, England	University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Roberts, DJ (corresponding author), NHS Blood & Transplant, Oxford, England.; Roberts, DJ (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England.; Roberts, DJ (corresponding author), Oxford Univ Hosp NHS Trust, Churchill Hosp, Biomed Res Ctr Haematol Theme, Oxford, England.	david.roberts@ndcls.ox.ac.uk	Lamikanra, Abigail/AAD-9603-2019	Brierley, Charlotte/0000-0002-4028-3733	NHS Blood and Transplant [WP 15-11]; National Institute for Health Research (NIHR) through the Oxford Biomedical Research Centre Programme - Haematology Theme	NHS Blood and Transplant; National Institute for Health Research (NIHR) through the Oxford Biomedical Research Centre Programme - Haematology Theme	This work was supported by NHS Blood and Transplant (WP 15-11) and benefits from NHS R&D Funding. Work has also been supported by the National Institute for Health Research (NIHR) through the Oxford Biomedical Research Centre Programme - Haematology Theme. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Amer Geriatrics Soc Workgrp Vitami, 2014, J AM GERIATR SOC, V62, P147, DOI 10.1111/jgs.12631; [Anonymous], 2016, ROLE VITAMIN D VITAM; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baris S, 2014, ALLERGY, V69, P246, DOI 10.1111/all.12278; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bock G, 2011, DIABETES-METAB RES, V27, P942, DOI 10.1002/dmrr.1276; Bogdanou D, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2865; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Danby RD, 2016, BONE MARROW TRANSPL, V51, P110, DOI 10.1038/bmt.2015.215; Daniel C, 2006, J PHARMACOL EXP THER, V319, P622, DOI 10.1124/jpet.106.107599; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fisher SA, 2017, BRIT J HAEMATOL, V176, P448, DOI 10.1111/bjh.14433; Fleet JC, 2017, MOL CELL ENDOCRINOL, V453, P36, DOI 10.1016/j.mce.2017.04.008; Gabbay MAL, 2012, ARCH PEDIAT ADOL MED, V166, P601, DOI 10.1001/archpediatrics.2012.164; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Grubler MR, 2017, REV ENDOCR METAB DIS, V18, P259, DOI 10.1007/s11154-017-9417-0; Handel AE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-163; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Khoo AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029250; Kleijwegt FS, 2011, J IMMUNOL, V187, P6357, DOI 10.4049/jimmunol.1101638; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Majak P, 2009, CLIN EXP ALLERGY, V39, P1830, DOI 10.1111/j.1365-2222.2009.03357.x; Milliken SVI, 2012, J ALLERGY CLIN IMMUN, V129, P1554, DOI 10.1016/j.jaci.2012.03.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Mulder JE, 2018, VITAMIN DEFICIENCY A; Muris AH, 2016, J NEUROIMMUNOL, V300, P47, DOI 10.1016/j.jneuroim.2016.09.018; O'Connell K, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-272; Pandolfi F, 2017, CLIN THER, V39, P884, DOI 10.1016/j.clinthera.2017.03.012; Penna-Martinez M, 2018, NUTRITION, V49, P66, DOI 10.1016/j.nut.2017.10.021; Piantoni S, 2015, LUPUS, V24, P490, DOI 10.1177/0961203314559090; Prietl B, 2014, EUR J NUTR, V53, P751, DOI 10.1007/s00394-013-0579-6; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Saboor-Yaraghi AA, 2015, J MOL NEUROSCI, V56, P608, DOI 10.1007/s12031-015-0549-y; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tian J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025338; Treiber G, 2015, CLIN IMMUNOL, V161, P217, DOI 10.1016/j.clim.2015.08.002; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Van Belle TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109194; van Halteren AGS, 2004, J AUTOIMMUN, V23, P233, DOI 10.1016/j.jaut.2004.06.004; van Halteren AGS, 2002, DIABETES, V51, P2119, DOI 10.2337/diabetes.51.7.2119; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wallace G, 2018, BIOL BLOOD MARROW TR, V24, P1856, DOI 10.1016/j.bbmt.2018.05.019; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	57	62	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222313	10.1371/journal.pone.0222313	http://dx.doi.org/10.1371/journal.pone.0222313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550254	gold, Green Published			2022-12-27	WOS:000532307700012
J	Gonzalez, SM; Aguilar-Jimenez, W; Trujillo-Gil, E; Zapata, W; Su, RC; Ball, TB; Rugeles, MT				Gonzalez, Sandra M.; Aguilar-Jimenez, Wbeimar; Trujillo-Gil, Edison; Zapata, Wildeman; Su, Ruey-Chyi; Ball, T. Blake; Rugeles, Maria T.			Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4(+) T lymphocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; 1,25-DIHYDROXYVITAMIN D-3; EXPRESSION; CD38; REPLICATION; DIFFERENTIATION; INTERLEUKIN-10; GLYCOPROTEIN; TRANSMISSION	Introduction Mucosal immune activation, in the context of sexual transmission of HIV-1 infection, is crucial, as the increased presence of activated T cells enhance susceptibility to infection. In this regard, it has been proposed that immunomodulatory compounds capable of modulating immune activation, such as Vitamin D (VitD) may reduce HIV-1 transmission and might be used as a safe and cost-effective strategy for prevention. Considering this, we examined the in vitro effect of the treatment of peripheral blood mononuclear cells (PBMCs) with the active form of VitD, calcitriol, on cellular activation, function and susceptibility of CD4+ T cells to HIV-1 infection. Methods We treated PBMCs from healthy HIV unexposed individuals (Co-HC) and frequently exposed, HIV-1 seronegative individuals (HESNs) from Colombia and from healthy nonexposed individuals from Canada (Ca-HC) with calcitriol and performed in vitro HIV-1 infection assays using X4- and R5-tropic HIV-1 strains respectively. In addition, we evaluated the activation and function of T cells and the expression of viral co-receptors, and select antiviral genes following calcitriol treatment. Results Calcitriol reduced the frequency of infected CD4(+) T cells and the number of viral particles per cell, for both, X4- and R5-tropic viruses tested in the Co-HC and the Ca-HC, respectively, but not in HESNs. Furthermore, in the Co-HC, calcitriol reduced the frequency of polyclonally activated T cells expressing the activation markers HLA-DR and CD38, and those HLA-DR(+)CD38(-), whereas increased the subpopulation HLA-DR(-)CD38(+). Calcitriol treatment also decreased production of granzyme, IL-2 and MIP-1 beta by T cells and increased the transcriptional expression of the inhibitor of NF-kB and the antiviral genes cathelicidin (CAMP) and APOBEC3G in PBMCs from Co-HC. Conclusion Our in vitro findings suggest that VitD treatment could reduce HIV-1 transmission through a specific modulation of the activation levels and function of T cells, and the production of antiviral factors. In conclusion, VitD remains as an interesting potential strategy to prevent HIV1 transmission that should be further explored.	[Gonzalez, Sandra M.; Aguilar-Jimenez, Wbeimar; Trujillo-Gil, Edison; Zapata, Wildeman; Rugeles, Maria T.] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Gonzalez, Sandra M.; Su, Ruey-Chyi; Ball, T. Blake] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada; [Zapata, Wildeman] Univ Cooperat Colombia, Grp Infettare, Fac Med, Medellin, Colombia; [Su, Ruey-Chyi; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada	Universidad de Antioquia; Public Health Agency of Canada; Universidad Cooperativa de Colombia; University of Manitoba	Rugeles, MT (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co	Zapata, Wildeman/ABE-5082-2020	Zapata, Wildeman/0000-0002-7351-8738; Aguilar Jimenez, Wbeimar/0000-0002-0790-055X; Rugeles, Maria T./0000-0001-7855-1409	Colciencias [111574455024, 111565740508, 647-2014]; ELAP program Canadian scholarship	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ELAP program Canadian scholarship	This investigation was supported by Colciencias (Code 111574455024 and Code 111565740508). SMG is a recipient of a doctoral scholarship from Colciencias (647-2014) and the ELAP program Canadian scholarship. The funders had no role in study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	Aguilar-Jimenez W, 2016, JAIDS-J ACQ IMM DEF, V73, P497, DOI 10.1097/QAI.0000000000001150; Aguilar-Jimenez W, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.015; Aguilar-Jimenez W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082717; Barr T, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.001; Bensi T, 2009, EXPERT OPIN THER TAR, V13, P141, DOI [10.1517/14728220802637147, 10.1517/14728220802637147 ]; Biswas P, 1998, J VIROL, V72, P8380, DOI 10.1128/JVI.72.10.8380-8383.1998; Card CM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-141; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Coussens AK, 2015, P NATL ACAD SCI USA, V112, P8052, DOI 10.1073/pnas.1500909112; Fulcher JA, 2017, AIDS RES HUM RETROV, V33, P788, DOI [10.1089/aid.2017.0014, 10.1089/AID.2017.0014]; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Kuebler PJ, 2016, J INFECT DIS, V213, P569, DOI 10.1093/infdis/jiv425; Lachmann R, 2015, AIDS, V29, P1127, DOI 10.1097/QAD.0000000000000666; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; LOCARDI C, 1990, J VIROL, V64, P5874, DOI 10.1128/JVI.64.12.5874-5882.1990; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PAUZA CD, 1993, J LEUKOCYTE BIOL, V53, P157, DOI 10.1002/jlb.53.2.157; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Ragab D, 2016, CYTOKINE, V85, P5, DOI 10.1016/j.cyto.2016.05.024; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Sarkar S, 2016, CRIT REV CL LAB SCI, V53, P132, DOI 10.3109/10408363.2015.1094443; Savarino A, 1999, FASEB J, V13, P2265, DOI 10.1096/fasebj.13.15.2265; Savarino A, 2003, FASEB J, V17, P461, DOI 10.1096/fj.02-0512fje; Shapira-Nahor O, 1998, AIDS, V12, P1731; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Villegas-Ospina S, 2017, HORM MOL BIOL CLIN I, V29, P93, DOI 10.1515/hmbci-2016-0037; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WuWong JR, 2013, JCVD, V1, P15; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	44	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222878	10.1371/journal.pone.0222878	http://dx.doi.org/10.1371/journal.pone.0222878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550271	Green Published, gold			2022-12-27	WOS:000532307700029
J	Hsiao, JJ; Huang, YJ; Chen, HI; Jiang, JA; Wang, JC; Wu, YF; Nee, TE				Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Jiang, Joe-Air; Wang, Jen-Cheng; Wu, Ya-Fen; Nee, Tzer-En			Intensive measures of luminescence in GaN/InGaN heterostructures	PLOS ONE			English	Article							JUNCTION; SIMULATION	The intensive measures of luminescence in a GaN/InGaN multiple quantum well system are used to examine the thermodynamics and phenomenological structure. The radiative/nonradiative transitions along with absorbed or emitted phonons that occur between the different quantum states of the electrons and holes associated with these processes make the quantum efficiency of a semiconductor nanosystem in an equilibrium state an extensive property. It has long been recognized that tuning of the indium (In) composition in InGaN interlayers gives the potential to obtain a spectrum in the near-infrared to near-ultraviolet spectral range. The thermodynamic intensive properties, including the Debye temperature, carrier temperature, and junction temperature, are the most appropriate metrics to describe the optical-related interactions inherent in a given heterostructure and so can be used as the state variables for understanding the quantum exchange behaviors. The energetic features of the quantum processes are characterized based on analysis of the intensive parameters as determined by means of electroluminescence (EL) and photoluminescence (PL) spectroscopy and current-voltage measurement and then correlated with the designed InGaN/GaN microstructures. According to the McCumber-Sturge theory, the EL and PL Debye temperatures obtained experimentally signal the strength of the electron-phonon and photon-phonon interaction, respectively, while the EL and PL carrier/junction temperatures correspond to the carrier localization. Higher EL Debye temperatures and lower EL carrier/junction temperatures reflect significantly higher luminescence quantum yields, indicative of electron-phonon coupling in the transfer of thermal energy between the confined electrons and the enhancement by excited phonons of heat-assisted emissions. On the other hand, the observation of low luminescence efficiency, corresponding to the lower PL Debye temperatures and higher PL carrier/junction temperatures, is attributed to photon-phonon coupling. These findings are in good accordance to the dependence of the EL and PL quantum efficiency on the In-content of the InGaN/GaN barriers, suggesting that the characteristic Debye and carrier/junction temperatures are intensive parameters useful for assessing the optical properties of a nano-engineered semiconductor heterostructure.	[Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Wang, Jen-Cheng; Nee, Tzer-En] Chang Gung Univ, Grad Inst Electroopt Engn, Taoyuan, Taiwan; [Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Wang, Jen-Cheng; Nee, Tzer-En] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Jiang, Joe-Air] Natl Taiwan Univ, Dept Biomechatron Engn, Taipei, Taiwan; [Wu, Ya-Fen] Ming Chi Univ Technol, Dept Elect Engn, New Taipei, Taiwan; [Nee, Tzer-En] Linkou Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; National Taiwan University; Ming Chi University of Technology; Chang Gung Memorial Hospital	Nee, TE (corresponding author), Chang Gung Univ, Grad Inst Electroopt Engn, Taoyuan, Taiwan.; Nee, TE (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.; Nee, TE (corresponding author), Linkou Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Taoyuan, Taiwan.	neete@mail.cgu.edu.tw		Nee, Tzer-En/0000-0002-8293-7678	Ministry of Science and Technology of the Republic of China [MOST 103-2112-M-182-001]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was financially supported by the Ministry of Science and Technology of the Republic of China under contract No. MOST 103-2112-M-182-001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashitov JN, 1996, PHYS REV LETT, V77, P4708, DOI 10.1103/PhysRevLett.77.4708; Compagnone F, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125314; Dehkhoda F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa56d; Dervos CT, 2004, SENSORS-BASEL, V4, P58, DOI 10.3390/s40500058; Eliseev PG, 2003, J APPL PHYS, V93, P5404, DOI 10.1063/1.1567055; Feng ZC, 2006, PROC SPIE, V6337, DOI 10.1117/12.677653; Fiory AT, 2003, J ELECTRON MATER, V32, P1043, DOI 10.1007/s11664-003-0087-1; Grimvall G, 1986, THERMOPHYSICAL PROPE; Guo ZQ, 2017, AIP ADV, V7, DOI 10.1063/1.4974877; Hsiao JJ, 2015, J LUMIN, V168, P309, DOI 10.1016/j.jlumin.2015.08.024; Jena D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136805; Kastoryano MJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.110501; Keppens A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3463411; Keppens A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3009966; Lee JC, 2011, IEEE T NANOTECHNOL, V10, P827, DOI 10.1109/TNANO.2010.2084097; Levard H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881938; Li CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03249-z; McCluskey MD, 1998, APPL PHYS LETT, V73, P1281, DOI 10.1063/1.122149; Nee TE, 2006, J CRYST GROWTH, V287, P468, DOI 10.1016/j.jcrysgro.2005.11.068; Nee TE, 2007, J APPL PHYS, V101, DOI 10.1063/1.2422709; Ota H, 2007, INT EL DEVICES MEET, P65, DOI 10.1109/IEDM.2007.4418864; Poppe A, 2006, P IEEE SEMICOND THER, P191, DOI 10.1109/STHERM.2006.1625227; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/NMAT3687, 10.1038/nmat3687]; Sardar DK, 1998, J APPL PHYS, V83, P1195, DOI 10.1063/1.366815; Shigehiro T, 2013, J PHYS CHEM C, V117, P532, DOI 10.1021/jp307853t; Tsuchiya H, 2001, J APPL PHYS, V89, P4023, DOI 10.1063/1.1354653; Tsutsui M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1141; VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6; Wing WJ, 2015, J APPL PHYS, V118, DOI 10.1063/1.4931378; Xi Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1849838; Xu H, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/41/415102; Yu S, 1996, J APPL PHYS, V80, P2815, DOI 10.1063/1.363199; Zhang JZ, 2015, J APPL PHYS, V117, DOI 10.1063/1.4905717	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222928	10.1371/journal.pone.0222928	http://dx.doi.org/10.1371/journal.pone.0222928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LD8MB	31550270	gold, Green Published			2022-12-27	WOS:000526280700001
J	Chen, RS; Ruf, MFHM; Shahdan, D; Ahmad, S				Chen, Ruey Shan; Ruf, Mohd Farid Hakim Mohd; Shahdan, Dalila; Ahmad, Sahrim			Enhanced mechanical and thermal properties of electrically conductive TPNR/GNP nanocomposites assisted with ultrasonication	PLOS ONE			English	Article							GRAPHENE NANOPLATELETS; POLYPROPYLENE; STABILITY; CRYSTALLIZATION; SONICATION; PLATELETS	Thermoplastic natural rubber (TPNR) was compounded with graphene nanoplatelets (GNP) via ultrasonication and melt blending. The effects of ultrasonication period (1-4 hours) and GNP weight fraction (0.5, 1.0, 1.5 and 2.0 wt.%) on the mechanical, thermal and conductivity properties were investigated. Results showed that the 3 hours of ultrasonic treatment on LNR/GNP gave the greatest improvement in tensile strength of 25.8% (TPNR/GNP nano-composites) as compared to those without ultrasonication. The TPNR nanocomposites containing 1.5 wt.% GNP exhibited the highest strength (16 MPa for tensile, 14 MPa for flexural and 11 kJm(-2) for impact) and modulus (556 MPa and 869 MPa for tensile and flexural, respectively). The incorporation of GNP had enhanced the thermal stability. It can be concluded that the GNP had imparted the thermally and electrically conductive nature to the TPNR blend.	[Chen, Ruey Shan; Ruf, Mohd Farid Hakim Mohd; Shahdan, Dalila; Ahmad, Sahrim] Univ Kebangsaan Malaysia, Fac Sci & Technol, Mat Sci Program, Ukm Bangi, Selangor De, Malaysia	Universiti Kebangsaan Malaysia	Chen, RS (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Mat Sci Program, Ukm Bangi, Selangor De, Malaysia.	chen@ukm.edu.my	Shahdan, Dalila/AAK-2657-2020; Chen, Ruey Shan/C-7376-2017	Shahdan, Dalila/0000-0002-0580-7837; Chen, Ruey Shan/0000-0002-2713-942X	Universiti Kebangsaan Malaysia [DIP-2018031]; Kementerian Tinggi Malaysia [FRGS/1/2018/STG07/UKM/01/2]; Universiti Kebangsaan Malaysia (UKM) [FRGS/1/2018/STG07/UKM/01/2, DIP-2018-031]	Universiti Kebangsaan Malaysia; Kementerian Tinggi Malaysia; Universiti Kebangsaan Malaysia (UKM)	This work was supported by: Universiti Kebangsaan Malaysia, grant number DIP-2018031, Grant Recipient Prof Sahrim Ahmad, http://www.ukm.my/portal; Kementerian Tinggi Malaysia, grant number FRGS/1/2018/STG07/UKM/01/2, http://jpt.mohe.gov.my/.; The authors gratefully acknowledge Universiti Kebangsaan Malaysia (UKM) under the research project grants DIP-2018-031 and FRGS/1/2018/STG07/UKM/01/2.	Al-Saleh MH, 2015, SYNTHETIC MET, V209, P41, DOI 10.1016/j.synthmet.2015.06.023; Avila-Orta CA, 2017, J NANOMATER, V2017, P10, DOI [10.1155/, DOI 10.1155/]; Ben Saleh AB, 2014, PHYSCS PROC, V55, P129, DOI 10.1016/j.phpro.2014.07.019; Chen RS, 2019, J THERM ANAL CALORIM, V137, P79, DOI 10.1007/s10973-018-7935-y; Chen RS, 2016, THERMOCHIM ACTA, V640, P52, DOI 10.1016/j.tca.2016.08.005; He F, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.46457; He SH, 2018, POLYM ENG SCI, V58, P377, DOI 10.1002/pen.24584; Huang CL, 2015, APPL SCI-BASEL, V5, P1196, DOI 10.3390/app5041196; Huang YY, 2012, POLYMERS-BASEL, V4, P275, DOI 10.3390/polym4010275; Inuwa IM., 2014, MALAYS J ANAL SCI, V18, P466; Ismail H, 2015, BIORESOURCES, V10, P1495; Jarosinski L, 2017, MATER SCI-POLAND, V35, P382, DOI 10.1515/msp-2017-0028; Jeske H, 2012, THERMOCHIM ACTA, V543, P165, DOI 10.1016/j.tca.2012.05.016; Kahar M, 2012, POLYM-PLAST TECHNOL, V51, P298, DOI 10.1080/03602559.2011.639331; Kalantari B, 2015, COMPOS PART A-APPL S, V76, P203, DOI 10.1016/j.compositesa.2015.05.028; Li A, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9090437; Liang JZ, 2018, J THERMOPLAST COMPOS, V31, P246, DOI 10.1177/0892705717697777; Liang JZ, 2015, POLYM TEST, V48, P97, DOI 10.1016/j.polymertesting.2015.09.015; Liang JZ, 2016, COMPOS PART B-ENG, V95, P166, DOI 10.1016/j.compositesb.2016.04.011; Liu Y, 2016, POLYM COMPOSITE, V37, P1190, DOI 10.1002/pc.23283; Milani MA, 2013, COMPOS SCI TECHNOL, V84, P1, DOI 10.1016/j.compscitech.2013.05.001; Mohd Amran NA, 2019, AIP C P; Nan CW, 2004, APPL PHYS LETT, V85, P3549, DOI 10.1063/1.1808874; Park SM, 2017, COMPOS INTERFACE, V24, P335, DOI 10.1080/09276440.2016.1204137; Pham AT, 2016, INT J HEAT MASS TRAN, V97, P422, DOI 10.1016/j.ijheatmasstransfer.2016.02.040; Phua JL, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/9767183; Praveena KR., 2017, INT J INNOVATIVE RES, V4, P723, DOI [10.21276/ijirem.2017.4.4.10, DOI 10.21276/IJIREM.2017.4.4.10]; Puryanti D, 2006, POLYM-PLAST TECHNOL, V45, P561, DOI 10.1080/03602550600554166; Ren YJ, 2018, COMPOS PART A-APPL S, V112, P57, DOI 10.1016/j.compositesa.2018.05.017; Seretis GV, 2018, COMPOS PART B-ENG, V147, P33, DOI 10.1016/j.compositesb.2018.04.034; Shahdan D, 2013, AIP C P; Shtein M, 2015, CHEM MATER, V27, P2100, DOI 10.1021/cm504550e; Wang FZ, 2015, J MATER SCI, V50, P1082, DOI 10.1007/s10853-014-8665-6; Xiao WK, 2018, RESULTS PHYS, V9, P673, DOI 10.1016/j.rinp.2018.01.060; Xing J, 2018, HIGH PERFORM POLYM, V30, P519, DOI 10.1177/0954008317706733; Yadav M, 2013, CELLULOSE, V20, P687, DOI 10.1007/s10570-012-9855-5; YetkIn S.H., 2017, ARASTIRMA MAKALESI, V4, P34; Zailan F.D., 2018, MALAYS J ANAL SCI, V22, P999, DOI [10.17576/mjas-2018-2206-09, DOI 10.17576/MJAS-2018-2206-09]; Zakaria NE, 2019, SAINS MALAYS, V48, P1121, DOI 10.17576/jsm-2019-4805-21	39	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222662	10.1371/journal.pone.0222662	http://dx.doi.org/10.1371/journal.pone.0222662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545820	gold, Green Published			2022-12-27	WOS:000532303200025
J	Burman, DD				Burman, Douglas D.			Hippocampal connectivity with sensorimotor cortex during volitional finger movements: Laterality and relationship to motor learning	PLOS ONE			English	Article							THETA-BURST STIMULATION; WORKING-MEMORY; SEQUENCE; IMPLICIT; HUMANS; OSCILLATIONS; PERFORMANCE; MODULATION; NAVIGATION; INCREASES	Hippocampal interactions with the motor system are often assumed to reflect the role of memory in motor learning. Here, we examine hippocampal connectivity with sensorimotor cortex during two tasks requiring paced movements, one with a mnemonic component (sequence learning) and one without (repetitive tapping). Functional magnetic resonance imaging activity was recorded from thirteen right-handed subjects; connectivity was identified from sensorimotor cortex correlations with psychophysiological interactions in hippocampal activity between motor and passive visual tasks. Finger movements in both motor tasks anticipated the timing of the metronome, reflecting cognitive control, yet evidence of motor learning was limited to the sequence learning task; nonetheless, hippocampal connectivity was observed during both tasks. Connectivity from corresponding regions in the left and right hippocampus overlapped extensively, with improved sensitivity resulting from their conjunctive (global) analysis. Positive and negative connectivity were both evident, with positive connectivity in sensorimotor cortex ipsilateral to the moving hand during unilateral movements, whereas negative connectivity was prominent in whichever hemisphere was most active during movements. Results implicate the hippocampus in volitional finger movements even in the absence of motor learning or recall.	[Burman, Douglas D.] NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA	NorthShore University Health System	Burman, DD (corresponding author), NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA.	Dburman2@northshore.org						Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Balleine B.W., 2010, HUMAN RODENT HOMOLOG; Barnett AJ, 2014, NEUROPSYCHOLOGIA, V64, P1, DOI 10.1016/j.neuropsychologia.2014.09.011; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Beisteiner R, 2004, EUR J NEUROSCI, V19, P465, DOI 10.1111/j.1460-9568.2004.03115.x; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Burman DD, 2013, BRAIN LANG, V124, P184, DOI 10.1016/j.bandl.2012.12.007; Caplan JB, 2003, J NEUROSCI, V23, P4726; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cruikshank LC, 2012, J NEUROPHYSIOL; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Ekstrom AD, 2014, NEUROIMAGE, V85, P667, DOI 10.1016/j.neuroimage.2013.06.049; Fernandez-Seara MA, 2009, NEUROIMAGE, V47, P1797, DOI 10.1016/j.neuroimage.2009.05.061; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Kaplan R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001267; Kelemen E, 2010, DYNAMIC GROUPING HIP; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kober SE, 2011, INT J PSYCHOPHYSIOL, V79, P347, DOI 10.1016/j.ijpsycho.2010.12.002; Lang CE, 2004, J NEUROPHYSIOL, V91, P1722, DOI 10.1152/jn.00805.2003; Lang CE, 2003, J NEUROPHYSIOL, V90, P1160, DOI 10.1152/jn.00130.2003; Lee TD, 1994, COGNITIVE EFFORT MOT; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; MacDonald C.J., 2014, TIMING TIME PERCEPT, V2, P51, DOI [10.1163/22134468-00002020, DOI 10.1163/22134468-00002020, 10.1163/22134468-00002020.]; MacDonald CJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0463; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Miller J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04847-9; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Qin SZ, 2016, BRAIN STRUCT FUNCT, V221, P3237, DOI 10.1007/s00429-015-1098-4; R-Core-Team, 2015, LANG ENV STAT COMP; Ramnani N, 2000, J NEUROPHYSIOL, V84, P3026, DOI 10.1152/jn.2000.84.6.3026; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schwabe L, 2013, HIPPOCAMPUS, V23, P1035, DOI 10.1002/hipo.22175; Seamans JK, 1998, J NEUROSCI, V18, P1613; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P2013, DOI 10.1016/S1388-2457(02)00298-5; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Teo JTH, 2011, CEREB CORTEX, V21, P1627, DOI 10.1093/cercor/bhq231; Volkmann J, 1998, J NEUROPHYSIOL, V79, P2149, DOI 10.1152/jn.1998.79.4.2149; Wilkinson L, 2010, J COGNITIVE NEUROSCI, V22, P427, DOI 10.1162/jocn.2009.21208; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yusoff Ahmad Nazlim, 2010, MALAYSIAN J MED HLTH, V6, P71	58	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222064	10.1371/journal.pone.0222064	http://dx.doi.org/10.1371/journal.pone.0222064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536543	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800028
J	Elser, JL; Progar, ALA; Steensma, KMM; Caskin, TP; Kerr, SR; Shwiff, SA				Elser, Julie L.; Progar, Amber L. Adams; Steensma, Karen M. M.; Caskin, Tyler P.; Kerr, Susan R.; Shwiff, Stephanie A.			Economic and livestock health impacts of birds on dairies: Evidence from a survey of Washington dairy operators	PLOS ONE			English	Article							EUROPEAN STARLINGS; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; OHIO	The survey described in this research paper aimed to investigate the economic and health impacts of birds on dairies. Birds are common pests on dairies, consuming and contaminating feed intended for cattle. As a result, dairy operators experience increased feed costs and increased pathogen and disease risk. We surveyed dairy operators attending the 2017 Washington Dairy Conference to examine the impact of birds on dairies in Washington State. Dairy operators reported feed losses valued at $55 per cow resulting in annual losses totaling $5.5 million in the Western region of the state and $9.2 million in the Eastern region of the state. Shooting was the most commonly used bird management method and European starlings (Sternus vulgaris) were the most frequently implicated species statewide. Bird abundance greater than 10,000 birds per day was associated with larger herd size and with self-reported presence of Johne's disease and Salmonella.	[Elser, Julie L.; Shwiff, Stephanie A.] USDA, Wildlife Res Ctr, APHIS, WS, Ft Collins, CO 80521 USA; [Progar, Amber L. Adams; Caskin, Tyler P.; Kerr, Susan R.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Steensma, Karen M. M.] Trinity Western Univ, Dept Biol, Langley, BC V2Y 1Y1, Canada	United States Department of Agriculture (USDA); Washington State University; Trinity Western University	Elser, JL (corresponding author), USDA, Wildlife Res Ctr, APHIS, WS, Ft Collins, CO 80521 USA.	Julie.L.Elser@usda.gov		Shwiff, Stephanie/0000-0001-9065-9017	National Institute of Food and Agriculture, U.S. Department of Agriculture through the Western Sustainable Agriculture Research and Education program [2015-38640-23779, SW16-013]; USDA Animal and Plant Health Inspection Service	National Institute of Food and Agriculture, U.S. Department of Agriculture through the Western Sustainable Agriculture Research and Education program; USDA Animal and Plant Health Inspection Service	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2015-38640-23779 through the Western Sustainable Agriculture Research and Education program under subaward number SW16-013. USDA is an equal opportunity employer and service provider. ALAP, KMMS, SAS, and SRK were recipients of this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by USDA Animal and Plant Health Inspection Service. This research does not represent USDA policy.	[Anonymous], R LANG ENV STAT COMP; Banrie, 2013, FEED STUD EX EFF FIS; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Carlson JC, 2018, J DAIRY SCI, V101, P1777, DOI 10.3168/jds.2017-12858; Carlson James C., 2011, Human-Wildlife Interactions, V5, P112; Carlson JC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-9; Carlson JC, 2011, J APPL ECOL, V48, P479, DOI 10.1111/j.1365-2664.2010.01935.x; Daugovish O, 2008, P VERT PEST C; Depenbusch Brandon E., 2011, Human-Wildlife Interactions, V5, P58; Gibbons J, 2009, APPL ANIM BEHAV SCI, V116, P163, DOI 10.1016/j.applanim.2008.08.009; Medhanie GA, 2014, J DAIRY SCI, V97, P5230, DOI 10.3168/jds.2014-8045; Navarro-Gonzalez N, 2016, P VERTEBRATE PEST C; Pedersen K, 2006, J WILDLIFE DIS, V42, P46, DOI 10.7589/0090-3558-42.1.46; Pedersen Kerri, 2007, Human-Wildlife Conflicts, V1, P68; Shave ME, 2018, J APPL ECOL, V55, P2451, DOI 10.1111/1365-2664.13172; Shwiff SA, 2012, J DAIRY SCI, V95, P6820, DOI 10.3168/jds.2011-5216; Steensma K, 2016, P VERTEBRATE PEST C; Steensma KM, 2009, EFFICACY BIRD DETERR; Steensma KM, 2017, 14012 FW USDA W SUST; TREYZ GI, 1992, INT REGIONAL SCI REV, V14, P221, DOI 10.1177/016001769201400301; Upper Midwest Market Administrator's Office, 2017, 2016 FED MILK ORD MA; Werner SJ, 2014, CROP PROT, V65, P221, DOI 10.1016/j.cropro.2014.08.004; Williams ML, 2011, J APPL MICROBIOL, V111, P982, DOI 10.1111/j.1365-2672.2011.05102.x	23	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222398	10.1371/journal.pone.0222398	http://dx.doi.org/10.1371/journal.pone.0222398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536534	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800041
J	Harrell, A				Harrell, Ashley			Group leaders establish cooperative norms that persist in subsequent interactions	PLOS ONE			English	Article							STRONG RECIPROCITY; COLLECTIVE ACTION; PUNISHMENT; EVOLUTION; INCENTIVES; ALTRUISM; EXAMPLE; GAMES; POWER	The temptation to free-ride on others' contributions to public goods makes enhancing cooperation a critical challenge. Solutions to the cooperation problem have centered on installing a sanctioning institution where all can punish all, i.e., peer punishment. But a new, growing literature considers whether and when the designation of a group leader-one group member, given the sole ability to administer punishment-is an effective and efficient alternative. What remains unknown is whether and to what extent these group leaders establish cooperative norms in their groups via their own contributions to the public good, their use of sanctions, or both. Nor has past work examined whether leaders' behaviors have lasting effects on non-leaders' cooperation in subsequent interactions, outside of the leader's purview. Here I show that leaders' contributions to the public good predict non-leaders' subsequent cooperation. Importantly, the effect is not limited to cooperation within the institution: the effect of leaders' contributions continue to predict non-leaders' contributions in a later interaction, where sanctions are removed. This process is mediated by non-leaders' increased contributions in the institution, suggesting that leaders have effects on followers that shape followers' subsequent behaviors. These effects occur above and beyond a baseline tendency to be influenced by non-leader group members; they also occur above and beyond the influence of peers in groups under a peer punishment institution. Results underscore how critical it is that groups install cooperative leaders: followers model their leaders' cooperation choices, even in decisions external to the original institution and outside of the leader's watch.	[Harrell, Ashley] Duke Univ, Dept Sociol, Durham, NC 27706 USA	Duke University	Harrell, A (corresponding author), Duke Univ, Dept Sociol, Durham, NC 27706 USA.	ashley.l.harrell@duke.edu						Ahlquist JS, 2011, ANNU REV POLIT SCI, V14, P1, DOI 10.1146/annurev-polisci-042409-152654; ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Carpenter J, 2012, REV ECON DES, V16, P93, DOI 10.1007/s10058-012-0120-z; Croson RTA, 1996, ECON LETT, V53, P25, DOI 10.1016/S0165-1765(97)82136-2; Diekmann A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10321; Drouvelis M, 2013, J ECON PSYCHOL, V39, P414, DOI 10.1016/j.joep.2013.06.005; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fu TT, 2018, J ECON SCI ASSOC-JES, V4, P151, DOI 10.1007/s40881-018-0053-6; Gachter S, 2012, ECON INQ, V50, P953, DOI 10.1111/j.1465-7295.2010.00295.x; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Guala F, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11000069; Harrell A, 2018, SOC FORCES, V97, P405, DOI 10.1093/sf/soy017; Harrell A, 2016, SOC FORCES, V94, P1283, DOI 10.1093/sf/sov110; Heckathorn DD., 1989, RATION SOC, V1, P78, DOI [10.1177/1043463189001001006, DOI 10.1177/1043463189001001006]; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kosfeld M, 2015, AM ECON REV, V105, P747, DOI 10.1257/aer.20120700; Kuwabara K, 2017, SOC PSYCHOL QUART, V80, P174, DOI 10.1177/0190272517703750; Levati MV, 2007, J CONFLICT RESOLUT, V51, P793, DOI 10.1177/0022002707302796; Moxnes E, 2003, J CONFLICT RESOLUT, V47, P773, DOI 10.1177/0022002703258962; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Norton DA, 2015, ECON LETT, V126, P1, DOI 10.1016/j.econlet.2014.09.037; Nosenzo D, 2014, SOCIAL DILEMMAS NEW; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OGORMAN R, 2008, P ROYAL SOC B, V276, P323, DOI DOI 10.1098/RSPB.2008.1082; OLIVER P, 1980, AM J SOCIOL, V85, P1356, DOI 10.1086/227168; Olson M., 2009, LOGIC COLLECTIVE ACT; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Potters J, 2007, ECON THEOR, V33, P169, DOI 10.1007/s00199-006-0186-3; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Shinada M, 2007, EVOL HUM BEHAV, V28, P330, DOI 10.1016/j.evolhumbehav.2007.04.001; Simpson B, 2008, SOC PSYCHOL QUART, V71, P37, DOI 10.1177/019027250807100106; Simpson B, 2015, ANNU REV SOCIOL, V41, P43, DOI 10.1146/annurev-soc-073014-112242; Snijders T.A., 1999, INTRO BASIC ADV MULT; Stagnaro MN, 2017, COGNITION, V167, P212, DOI 10.1016/j.cognition.2017.01.017; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; van der Heijden E, 2009, J ECON BEHAV ORGAN, V69, P39, DOI 10.1016/j.jebo.2008.09.007; Weber JM, 2008, J PERS SOC PSYCHOL, V95, P1340, DOI 10.1037/a0012454; Wu JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06421	47	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222724	10.1371/journal.pone.0222724	http://dx.doi.org/10.1371/journal.pone.0222724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536555	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800077
J	Kurosawa, Y; Sato, S; Okuyama, T; Taoka, M				Kurosawa, Yae; Sato, Shigehiro; Okuyama, Tsuneo; Taoka, Masato			Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns	PLOS ONE			English	Article							VIRUS; VECTORS; VACCINE; POLIOMYELITIS	Infectious virus purification techniques are important for vaccine development and gene therapy applications. However, the standardized one-step purification technique using ceramic hydroxyapatite (CHAp) has proven unsuitable for poliovirus. Therefore, we designed a sequential two-step chromatographic technique for purification of the infectious Sabin type 2 vaccine strain of poliovirus from the cell culture supernatant. In the first step, we removed protein contaminants from the Sabin type 2 virus fraction by pH gradient elution on a ceramic fluoroapatite column. In the second step, we removed double-stranded DNA derived from host cells by diluting the virus fraction, directly loading it on a CHAp column, and purifying it using a phosphate gradient with 1 M sodium chloride. This process achieved removal rates of more than 99.95% and 99.99% for proteins and double-stranded DNA, respectively, and was highly reproducible and scalable. Furthermore, it is likely that it will be applicable to other virus species.	[Kurosawa, Yae; Okuyama, Tsuneo] HOYA Technosurg Corp, R&D Dept, Akishima, Tokyo, Japan; [Kurosawa, Yae; Sato, Shigehiro] Iwate Med Univ, Dept Microbiol, Lab Infect Dis & Immunol, Shiwa, Iwate, Japan; [Okuyama, Tsuneo] Prot Technos Inst, Atsugi, Kanagawa, Japan; [Okuyama, Tsuneo; Taoka, Masato] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Lab Biophys & Biochem, Hachioji, Tokyo, Japan; [Sato, Shigehiro] SI Biotechnol Co Ltd, Morioka, Iwate, Japan	Iwate Medical University; Tokyo Metropolitan University	Kurosawa, Y (corresponding author), HOYA Technosurg Corp, R&D Dept, Akishima, Tokyo, Japan.; Kurosawa, Y (corresponding author), Iwate Med Univ, Dept Microbiol, Lab Infect Dis & Immunol, Shiwa, Iwate, Japan.	yae.kurosawa@pc.hoya.co.jp						[Anonymous], 2013, POL VACC IN IPOL; [Anonymous], 2015, WHO TECHN REP SER, V993; [Anonymous], BULLETIN, V5667; [Anonymous], BULLETIN, V3111; Ballew HC, 2000, CLIN VIROLOGY MANUAL, P131; Blanche F, 2000, GENE THER, V7, P1055, DOI 10.1038/sj.gt.3301190; Braas G, 1996, BIOSEPARATION, V6, P211; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Food and Drug Administration, 1999, GUID IND CONT FORM C; Fountzilas C, 2017, ONCOTARGET, V8, P102617, DOI 10.18632/oncotarget.18309; Freitag R, 2012, BIOTECHNOL J, V7, P90, DOI 10.1002/biot.201100015; Gagnon P, 2005, BIOPROCESS INT WORLD; Gallagher S. R, 2009, CURR PROTOC MOL BIOL, V85, DOI DOI 10.16.1-10.6.27; HUYGHE BG, 1995, HUM GENE THER, V6, P1403, DOI 10.1089/hum.1995.6.11-1403; International Conference on Harmonization (ICH), 1999, ICH Q6B PROC ACC CRI; Jiang ZJ, 2011, PROTEIN EXPRES PURIF, V80, P203, DOI 10.1016/j.pep.2011.07.009; Kalbfuss B, 2008, J CHROMATOGR B, V873, P102, DOI 10.1016/j.jchromb.2008.08.002; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kolmas J, 2016, CERAM INT, V42, P2472, DOI 10.1016/j.ceramint.2015.10.048; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuiper M, 2002, BIOTECHNOL BIOENG, V80, P445, DOI 10.1002/bit.10388; Kurosawa Y, 2014, BULLETIN, V6549; Kurosawa Y, 2012, MED BIOL, V156, P410; Kurosawa Y, 2009, MED BIOL, V153, P607; Kurosawa Y., 2012, WORLD J VIROL, V02, P155, DOI [10.4236/wjv.2012.23020, DOI 10.4236/WJV.2012.23020]; Lee DS, 2009, BIOCHEM BIOPH RES CO, V378, P640, DOI 10.1016/j.bbrc.2008.11.096; Morenweiser R, 2005, GENE THER, V12, pS103, DOI 10.1038/sj.gt.3302624; Nawa M, 1996, MICROBIOL IMMUNOL, V40, P365, DOI 10.1111/j.1348-0421.1996.tb01081.x; O'Riordan CR, 2000, J GENE MED, V2, P444, DOI 10.1002/1521-2254(200011/12)2:6<444::AID-JGM132>3.0.CO;2-1; Okada K, 2013, J INFECT DIS, V208, P275, DOI 10.1093/infdis/jit155; Racaniello VR., 2007, FIELDS VIROLOGY, P797; SAHA K, 1994, J VIROL METHODS, V46, P349, DOI 10.1016/0166-0934(94)90005-1; Saito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053893; Shimizu Hiroyuki, 2012, Virus (Nagoya), V62, P57; Smith GP, 2005, BIOTECHNIQUES, V39, P879, DOI 10.2144/000112032; Verdijk P, 2011, EXPERT REV VACCINES, V10, P635, DOI [10.1586/erv.11.51, 10.1586/ERV.11.51]; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222199	10.1371/journal.pone.0222199	http://dx.doi.org/10.1371/journal.pone.0222199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536514	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800113
J	Ouadi, L; Bruez, E; Bastien, S; Vallance, J; Lecomte, P; Domec, JC; Rey, P				Ouadi, Loris; Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Lecomte, Pascal; Domec, Jean-Christophe; Rey, Patrice			Ecophysiological impacts of Esca, a devastating grapevine trunk disease, on Vitis vinifera L.	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; SAP-FLUX; STOMATAL CONDUCTANCE; HYDRAULIC CONDUCTANCE; STABLE OXYGEN; GAS-EXCHANGE; PLANTS; TREES; RESPONSES; DROUGHT	Esca is a Grapevine Trunk Disease (GTD) caused by a broad range of taxonomically unrelated fungal pathogens. These attack grapevine wood tissues inducing necroses even in the conductive vascular tissues, thus affecting the vine physiology and potentially leading to plant death. However, the influence of Esca on leaf and whole-plant water transport disruption remains poorly understood. In this paper, a detailed analysis of xylem-related physiological parameters in grapevines that expressed Esca-foliar symptoms was carried out. The experiments were conducted in a vineyard in the Bordeaux region (France) on cv. Cabernet-Sauvignon (Vitis vinifera L.) grapevines, which were monitored for Esca-foliar symptoms over a two-year period. Heat dissipation sap-flow sensors were installed during the summer on grapevines having expressed or not Esca-foliar symptoms. Leaf water potential, stomatal conductance and leaf transpiration were also measured. Physiological monitoring showed that sap flow density and whole-plant transpiration of Esca-infected grapevines decreased significantly a week before the first foliar symptoms appeared. When atmospheric water demand (Vapour Pressure Deficit, VPD) was the highest, both parameters tended to be about twice as low in symptomatic grapevines as in asymptomatic ones. Sap flow density data at the maximum transpiration-time, was systematically 29-30% lower in Esca-infected grapevines compared to control plants before or after the appearance of Esca-foliar symptoms. This trend was observed whatever the temperatures and VPD values measured. In Esca-diseased plants, larger amounts of necrotic wood, mainly white rot, were found in the trunk and cordon of symptomatic grapevines compared to healthy ones, suggesting necroses have an influence in reducing the whole-plant hydraulic capacity. This study reveals that the use of physiological monitoring methods, together with the visual monitoring of foliar symptoms, could prove useful in providing accurate measurements of Esca disease severity.	[Ouadi, Loris; Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Lecomte, Pascal; Rey, Patrice] INRA, ISVV, UMR1065, Sante & Agroecol Vignoble SAVE, Villenave Dornon, France; [Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Domec, Jean-Christophe] Bordeaux Sci Agro, INRA, UMR1391, ISPA, Villenave Dornon, France; [Bruez, Emilie] Univ Bordeaux, ISVV, UR OEnol, Villenave Dornon, France; [Rey, Patrice] Univ Bordeaux, ISVV, UMR1065, Bordeaux Sci Agro,Sante & Agroecol Vignoble SAVE, Villenave Dornon, France	INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rey, P (corresponding author), INRA, ISVV, UMR1065, Sante & Agroecol Vignoble SAVE, Villenave Dornon, France.; Rey, P (corresponding author), Univ Bordeaux, ISVV, UMR1065, Bordeaux Sci Agro,Sante & Agroecol Vignoble SAVE, Villenave Dornon, France.	patrice.rey@inra.fr	Domec, Jean-Christophe/AFV-5999-2022; domec, jean-christophe/P-9251-2019	Domec, Jean-Christophe/0000-0003-0478-2559; domec, jean-christophe/0000-0003-0478-2559; Rey, Patrice/0000-0002-7250-0114; LECOMTE, Pascal/0000-0002-0479-0295; Vallance, Jessica/0000-0002-5581-4453	Industrial Chair GTDfree (French National Research Agency); Industrial Chair GTDfree (Hennessy Company); Bordeaux Sciences Agro (PAL project); National Science Foundation [NSF-EAR-1344703, NSF-IOS-1754893]	Industrial Chair GTDfree (French National Research Agency)(French National Research Agency (ANR)); Industrial Chair GTDfree (Hennessy Company); Bordeaux Sciences Agro (PAL project); National Science Foundation(National Science Foundation (NSF))	Funding for this project was provided by the Industrial Chair GTDfree (French National Research Agency and the Hennessy Company) and Bordeaux Sciences Agro (PAL project). We also would like to acknowledge the support of the National Science Foundation, awards #NSF-EAR-1344703 and NSF-IOS-1754893. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATAUD F, 1995, PLANT SOIL, V172, P29, DOI 10.1007/BF00020856; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; Bellee A, 2017, PLANT PATHOL, V66, P763, DOI 10.1111/ppa.12623; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Bruez E., 2013, THESIS; BRUGNOLI E, 1988, PLANT PHYSIOL, V88, P1418, DOI 10.1104/pp.88.4.1418; CABIBEL B, 1991, AGRONOMIE, V11, P669, DOI 10.1051/agro:19910804; Carbonneau A, 2015, GRAPEVINE PHYSL TERR; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Domec JC, 2013, NEW PHYTOL, V199, P452, DOI 10.1111/nph.12263; Domec JC, 2010, TREE PHYSIOL, V30, P1001, DOI 10.1093/treephys/tpq054; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Edwards J, 2007, PHYTOPATHOL MEDITERR, V46, P1000; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fischer M, 2003, VITIS, V42, P109; Fischer M, 2006, PHYTOPATHOL MEDITERR, V45, pS30; Fussler L, 2008, PHYTOPATHOLOGY, V98, P571, DOI 10.1094/PHYTO-98-5-0571; Gerbore J, 2014, FEMS MICROBIOL ECOL, V90, P153, DOI 10.1111/1574-6941.12380; GOULDEN ML, 1994, FUNCT ECOL, V8, P125, DOI 10.2307/2390121; GRANIER A, 1987, TREE PHYSIOL, V3, P309, DOI 10.1093/treephys/3.4.309; Grosman J., 2012, PHYTOMA, V651, P31; Harmandon F., 2004, EFFETS TOXIQUES ARSE, P8; Hofstetter V, 2012, FUNGAL DIVERS, V54, P51, DOI 10.1007/s13225-012-0171-z; Johnson DM, 2016, TREE PHYSIOL, V36, P983, DOI 10.1093/treephys/tpw031; Kahmen A, 2011, P NATL ACAD SCI USA, V108, P1981, DOI 10.1073/pnas.1018906108; Larignon P, 1997, EUR J PLANT PATHOL, V103, P147, DOI 10.1023/A:1008638409410; Larignon P, 2014, VIGNERON CHAMPENOIS, V135, P27; Larignon P, 2009, CR BIOL, V332, P765, DOI 10.1016/j.crvi.2009.05.005; Lecomte P, 2012, PLANT DIS, V96, P924, DOI 10.1094/PDIS-09-11-0776-RE; Lecomte P., 2008, PHYTOMA, V616, P37; Lecomte P, 2018, PHYTOPATHOL MEDITERR, V57, P472, DOI 10.14601/Phytopathol_Mediterr-22025; Lima MRM, 2017, PHYTOPATHOLOGY, V107, P669, DOI 10.1094/PHYTO-11-16-0410-R; Liminana JM, 2009, PHYTOPATHOL MEDITERR, V48, P92; Loustau D, 1998, ANN SCI FOREST, V55, P29, DOI 10.1051/forest:19980103; Maher N, 2012, J INT SCI VIGNE VIN, V46, P15; McElrone AJ, 2010, TREE PHYSIOL, V30, P761, DOI 10.1093/treephys/tpq026; Meier U, 2001, BBCH MONOGRAPH GROWT; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Mondello V, 2018, PHYTOPATHOL MEDITERR, V57, P369, DOI 10.14601/Phytopathol_Mediterr-23942; Mostert F., 2006, PHYTOPATHOL MEDITERR, V45, P1000; Pangle RE, 2015, ECOL EVOL, V5, P1618, DOI 10.1002/ece3.1422; Pataki DE, 1998, J EXP BOT, V49, P871, DOI 10.1093/jexbot/49.322.871; Petit AN, 2006, PHYTOPATHOLOGY, V96, P1060, DOI 10.1094/PHYTO-96-1060; Pierron R., 2015, THESIS; Pouzoulet J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00253; Pouzoulet J, 2013, APPL MICROBIOL BIOT, V97, P10163, DOI 10.1007/s00253-013-5299-6; R Core Team, 2015, R LANGUAGE ENV STAT; Ritchie G. A., 1975, Advances in Ecological Research, V9, P165, DOI 10.1016/S0065-2504(08)60290-1; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; SMITH BN, 1970, PLANT PHYSIOL, V46, P738, DOI 10.1104/pp.46.5.738; Surico G, 2006, PHYTOPATHOL MEDITE S, V45, P1000, DOI [10.1400/52262, DOI 10.1400/52262]; Travadon R, 2016, FUNGAL ECOL, V24, P82, DOI 10.1016/j.funeco.2016.09.003; Viret O, 2012, RENCONTRE TECHNIQUES, P46; Wagschal I., 2008, Plant-microbe interactions, P367; Ward EJ, 2017, TREES-STRUCT FUNCT, V31, P1737, DOI 10.1007/s00468-017-1556-0; Zhang JW, 1997, TREE PHYSIOL, V17, P461	64	13	13	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222586	10.1371/journal.pone.0222586	http://dx.doi.org/10.1371/journal.pone.0222586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN6EB	31536576	Green Published, Green Submitted, gold			2022-12-27	WOS:000514927900001
J	Cubero, M; Marti, S; Dominguez, MA; Gonzalez-Diaz, A; Berbel, D; Ardanuy, C				Cubero, Meritxell; Marti, Sara; Angeles Dominguez, Ma; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen			Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; LIVER-ABSCESS; VIRULENCE; CAPSULE; RESISTANCE; CLONES; GENE; K2	The prevalence of a new hypervirulent and hypermucoviscous K. pneumoniae phenotype (Hmv) is increasing worldwide, mainly linked to serotypes K1 and K2. Since capsular thickness can directly affect the capability to form biofilms, we aimed to evaluate the association between the Hmv phenotype with adhesion and biofilm formation in a collection of clinical K. pneumoniae isolates. We selected 38 Hmv clinical isolates [15 serotype K1; 9 serotype K2; 3 non-K1/K2 (rmpA(+)); 11 non-K1/K2 (rmpA(-))] and 7 non-Hmv clinical isolates. The Hmv phenotype was assessed through the mucoviscosity test. Serum resistance was determined by bacterial viability tests in pooled human serum. Adhesion was evaluated with the Biofilm Ring Test (R), and biofilm formation was identified by crystal violet staining (Solid-Liquid, SLI-biofilm) or visual examination (Air-Liquid, ALI-biofilm). This study linked for the first time the formation of robust ALI-biofilm plugs by K. pneumoniae to the capsular serotype K1, a group of hypervirulent strains which are generally highly susceptible to the antimicrobial agents. Among all the studied isolates, the capsular serotype K1 presented lower initial adhesion despite having the adhesins mrkD and fimH but higher ALI-biofilm formation than isolates with other capsular serotypes (K2 or non-K1/K2). This structure might confer increased resistance to a group of hypervirulent K. pneumoniae serotype K1.	[Cubero, Meritxell; Marti, Sara; Angeles Dominguez, Ma; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen] Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Dept Microbiol, Barcelona, Spain; [Cubero, Meritxell; Marti, Sara; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen] ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain; [Angeles Dominguez, Ma] Spanish Network Res Infect Dis REIPI, Barcelona, Spain; [Angeles Dominguez, Ma; Ardanuy, Carmen] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona	Marti, S; Ardanuy, C (corresponding author), Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Dept Microbiol, Barcelona, Spain.; Marti, S; Ardanuy, C (corresponding author), ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain.; Ardanuy, C (corresponding author), Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain.	smartinm@bellvitgehospital.cat; c.ardanuy@bellvitgehospital.cat	Marti, Sara/D-4823-2014; Cubero, Meritxell/AAV-4585-2020	Marti, Sara/0000-0002-0405-2305; Berbel, Damaris/0000-0002-3689-3360; Gonzalez Diaz, Aida/0000-0002-8326-1307; Cubero, Meritxell/0000-0001-7648-0686	CIBER de Enfermedades Respiratorias, CIBERES [CB06/06/0037]; European Regional Development Fund (ERDF); col.legi de farmaceuticsde Barcelona through the award "Beques col.legials del COFB"; Biofilm Control (Biopole Clermont-Limagne)	CIBER de Enfermedades Respiratorias, CIBERES; European Regional Development Fund (ERDF)(European Commission); col.legi de farmaceuticsde Barcelona through the award "Beques col.legials del COFB"; Biofilm Control (Biopole Clermont-Limagne)	CA received funding for this study from CIBER de Enfermedades Respiratorias (www.ciberes.org), CIBERES (CB06/06/0037), run by the Instituto de Salud Carlos III (ISCIII, Madrid, Spain) and by the European Regional Development Fund (ERDF). CA also received funding from the collegi de farmaceuticsde Barcelona (www.cofb.net) through the award "Beques col.legials del COFB". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biofilm Control (Biopole Clermont-Limagne) provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Armitano J, 2014, ENV MICROBIOL REP, V6, P534, DOI 10.1111/1758-2229.12171; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Carabarin-Lima A, 2016, J MED MICROBIOL, V65, P729, DOI 10.1099/jmm.0.000291; Chabane YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111660; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Cubero M, 2016, CLIN MICROBIOL INFEC, V22, P154, DOI 10.1016/j.cmi.2015.09.025; Diago-Navarro E, 2014, J INFECT DIS, V210, P803, DOI 10.1093/infdis/jiu157; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Guo YJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00024; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hentzien M, 2017, MED MALADIES INFECT, V47, P171, DOI 10.1016/j.medmal.2016.10.002; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; Patel G, 2013, CASE REP INFECT DIS, V2013, DOI 10.1155/2013/676340; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Puig C, 2014, APPL ENVIRON MICROB, V80, P7088, DOI 10.1128/AEM.02544-14; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Struve C, 2003, FEMS MICROBIOL LETT, V218, P149, DOI 10.1016/S0378-1097(02)01117-5; Struve C, 2015, MBIO, V6, DOI 10.1128/mBio.00630-15; Wang HB, 2015, ACS APPL MATER INTER, V7, P13007, DOI 10.1021/acsami.5b03041; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923	34	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222628	10.1371/journal.pone.0222628	http://dx.doi.org/10.1371/journal.pone.0222628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532800	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600033
J	Madden, MJL; Young, RG; Brown, JW; Miller, SE; Frewin, AJ; Hanner, RH				Madden, Mary J. L.; Young, Robert G.; Brown, John W.; Miller, Scott E.; Frewin, Andrew J.; Hanner, Robert H.			Using DNA barcoding to improve invasive pest identification at US ports-of-entry	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GENETIC DIVERSITY; CROP LOSSES; COMPLEX; PATHWAYS; IMPACT; NORTH; FAUNA	Interception of potential invasive species at ports-of-entry is essential for effective biosecurity and biosurveillance programs. However, taxonomic assessment of the immature stages of most arthropods is challenging; characters for identification are often dependent on adult morphology and reproductive structures. This study aims to strengthen the identification of such specimens through DNA barcoding, with a focus on microlepidoptera. A sample of 241 primarily immature microlepidoptera specimens intercepted at U.S. ports-of-entry from 2007 to 2011 were selected for analysis. From this sample, 201 COI-5P sequences were generated and analyzed for concordance between morphology-based and DNA-based identifications. The retrospective analysis of the data over 10 years (2009 to 2019) using the Barcode of Life Data (BOLD) system demonstrates the importance of establishing and growing DNA barcode reference libraries for use in specimen identification. Additionally, analysis of specimen identification using public data (43.3% specimens identified) vs. non-public data (78.6% specimens identified) highlights the need to encourage researchers to make data publicly accessible. DNA barcoding surpassed morphological identification with 42.3% (public) and 66.7% (non-public) of the sampled specimens achieving a species-level identification, compared to 38.3% species-level identification by morphology. Whilst DNA barcoding was not able to identify all specimens in our dataset, its incorporation into border security programs as an adjunct to morphological identification can provide secondary lines of evidence and lower taxonomic resolution in many cases. Furthermore, with increased globalization, database records need to be clearly annotated for suspected specimen origin versus interception location.	[Madden, Mary J. L.; Young, Robert G.; Frewin, Andrew J.; Hanner, Robert H.] Univ Guelph, Dept Integrated Biol, Guelph, ON, Canada; [Brown, John W.; Miller, Scott E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA	University of Guelph; Smithsonian Institution; Smithsonian National Museum of Natural History	Young, RG (corresponding author), Univ Guelph, Dept Integrated Biol, Guelph, ON, Canada.	ryoung04@uoguelph.ca	Young, Robert/AAM-1670-2020	Young, Robert/0000-0002-6731-2506; Miller, Scott/0000-0002-4138-1378; Madden, Mary/0000-0002-3898-125X	Growing Forward, a federal provincial-territorial initiative; Flowers Canada (Ontario) Inc.; Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA); USDA, ARS, Systematic Entomology Laboratory, Washington, DC	Growing Forward, a federal provincial-territorial initiative; Flowers Canada (Ontario) Inc.; Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA); USDA, ARS, Systematic Entomology Laboratory, Washington, DC	This project was funded in part through Growing Forward, a federal provincial-territorial initiative with funding awarded to RH. The Agricultural Adaptation Council assists in the delivery of Growing Forward programs in Ontario. Additional funding was provided by Flowers Canada (Ontario) Inc. and the Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA) to RH. The sponsors did not play a role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.; Continued progress on DNA barcoding Lepidoptera from the Smithsonian collection has been made by collaboration between the University of Guelph and the Smithsonian, with help from many people, including those listed in Levesque-Beaudin et al. (2017). Contributions by JWB were supported by the USDA, ARS, Systematic Entomology Laboratory, Washington, DC.	Augustin Sylvie, 2012, Bulletin OEPP, V42, P515, DOI 10.1111/epp.2600; Bacon SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047689; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bonants PJM, 2014, DETECTION DIAGNOSTIC, P119; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Brabrand A, 2014, RIVER RES APPL, V30, P602, DOI 10.1002/rra.2669; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Caffrey JM, 2014, MANAG BIOL INVASION, V5, P1, DOI 10.3391/mbi.2014.5.1.01; Castalanelli MA, 2010, J ASIA-PAC ENTOMOL, V13, P243, DOI 10.1016/j.aspen.2010.04.003; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Curry CJ, 2018, FRESHW SCI, V37, P178, DOI 10.1086/696613; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Frewin A., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138018; Gilligan TM, 2019, J ECON ENTOMOL, V112, P603, DOI 10.1093/jee/toy402; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hanner R., 2009, DATA STANDARDS BARCO; Harwood TD, 2009, ECOL MODEL, V220, P3353, DOI 10.1016/j.ecolmodel.2009.08.014; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ivanova NV, 2009, MOL ECOL RESOUR, V9, P35, DOI 10.1111/j.1755-0998.2009.02630.x; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Lenda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099786; Levesque-Beaudin V., 2017, GENOME, V60, P962, DOI [10.1139/gen-2017-0178, DOI 10.1139/GEN-2017-0178]; Liu ZF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175788; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Milic D, 2019, J INSECT CONSERV, V23, P29, DOI 10.1007/s10841-018-0111-7; Moser WK, 2009, J FOREST, V107, P57; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Navia D, 2010, EXP APPL ACAROL, V51, P225, DOI 10.1007/s10493-009-9327-2; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oliveira CM, 2014, CROP PROT, V56, P50, DOI 10.1016/j.cropro.2013.10.022; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Phillips JD, 2019, ECOL EVOL, V9, P2996, DOI 10.1002/ece3.4757; Porter TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200177; Pramual P, 2014, J ASIA-PAC ENTOMOL, V17, P549, DOI 10.1016/j.aspen.2014.05.006; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Puillandre N, 2011, INVERTEBR SYST, V25, P322, DOI 10.1071/IS11022; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Schachat SR, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161002; Serrao NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099546; Smith A, 2012, MOL ECOLOGY RESOURCE, V13, P168, DOI DOI 10.1111/1755-0998; Stehr F.W., 1987, P288; Suffert M., 2018, Bulletin OEPP, V48, P144, DOI 10.1111/epp.12462; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Vanninen I, 2011, AGR FOOD SCI, V20, P96, DOI 10.2137/145960611795163033; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Watts C, 2019, AUSTRAL ENTOMOL, V58, P675, DOI 10.1111/aen.12384; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Whittle PJL, 2013, DIVERS DISTRIB, V19, P629, DOI 10.1111/ddi.12056; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Wilson JRU, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120111; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797	66	25	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222291	10.1371/journal.pone.0222291	http://dx.doi.org/10.1371/journal.pone.0222291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527883	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400014
J	Closson, K; Dietrich, JJ; Beksinska, M; Gibbs, A; Hornschuh, S; Smith, T; Smit, J; Gray, G; Ndung'u, T; Brockman, M; Kaida, A				Closson, Kalysha; Dietrich, Janan J.; Beksinska, Mags; Gibbs, Andrew; Hornschuh, Stefanie; Smith, Tricia; Smit, Jenni; Gray, Glenda; Ndung'u, Thumbi; Brockman, Mark; Kaida, Angela			Measuring sexual relationship power equity among young women and young men South Africa: Implications for gender-transformative programming	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; RURAL EASTERN-CAPE; ALCOHOL-USE; CONDOM USE; HIV RISK; HEALTH; YOUTH; MASCULINITY; PREVALENCE; BEHAVIORS	Introduction Measures used to assess equitable relationship dynamics, including the sexual relationship power scale (SRPS) have previously been associated with lower HIV-risk among young women, and reduced perpetration of intimate partner violence among men. However, few studies describe how the SRPS has been adapted and validated for use within global youth sexual health studies. We examined gender-specific psychometric properties, reliability, and validity of a SRPS used within a South African youth-engaged cohort study. Methods Young men and women (16-24 years) enrolled in community-based cohorts in Durban and Soweto (2014-2016) reporting a primary partner at 6-month follow-up completed a 13-item (strongly agree/agree/disagree/strongly disagree) South African adaptation of Pulerwitz's SRPS (range 13-52, higher scores indicating greater sexual relationship power [SRP] equity). SRPS modifications were made using gender-specific exploratory factor analyses (EFAs), removing items with factor loadings <0.3. Cronbach alphas were conducted for full and modified scales by gender. Using modified scales, unadjusted and adjusted regression models examined associations between 1. relevant socio-demographic and relationship determinants and SRP equity, and 2. SRP equity and sexual relationship related outcomes. All models adjusted for education, age, site, and current employment. Results 235 sexually-active youth (66% women, median age = 20) were included. Mean scores across all 13 scale items were 2.71 (SD 0.30) for women and 2.70 (SD 0.4) for men. Scale Cronbach's alphas were 0.63 for women and 0.64 for men. EFAs resulted in two gender-specific single-factor SRPS. Modified SRPS Cronbach alphas increased to 0.67 for women (8-items) and 0.70 for men (9-items). After adjusting for age, site and current employment, higher education remained associated with SRP equity across genders. In adjusted models, correlates of SRP equity included primary partnerships that were age-similar (<5 years older) and <2 years in length for women and living in Soweto and younger age for men. Greater SRP equity among women was also independently associated with no recent partner violence. Conclusions Results highlight important gender differences in SRP equity measures and associations, highlighting the critically need for future research to examine gendered constructions of SRP equity in order to accurately develop, validate and use appropriate measures within quantitative surveys.	[Closson, Kalysha; Smith, Tricia; Brockman, Mark; Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Closson, Kalysha] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Dietrich, Janan J.; Hornschuh, Stefanie; Gray, Glenda] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit PHRU, Johannesburg, South Africa; [Beksinska, Mags; Smit, Jenni] Univ Witwatersrand, Fac Hlth Sci, Maternal Adolescent & Child Hlth MatCH Res Unit M, Durban, South Africa; [Gibbs, Andrew; Gray, Glenda] South African Med Res Council, Cape Town, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, Africa Hlth Res Inst, Durban, South Africa; [Ndung'u, Thumbi] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ndung'u, Thumbi] Harvard Univ, Cambridge, MA 02138 USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; University of Kwazulu Natal; Africa Health Research Institute; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Max Planck Society	Kaida, A (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	kangela@sfu.ca	Brockman, Mark/D-1669-2016	Brockman, Mark/0000-0001-6432-1426; Gibbs, Andrew/0000-0003-2812-5377; Closson, Kalysha/0000-0002-2985-0610; Dietrich, Janan/0000-0002-1949-3138	Canadian Institutes for Health Research; Canadian HIV Vaccine Initiative [THA-118569]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Vaccine Initiative	This study was funded by the Canadian Institutes for Health Research and the Canadian HIV Vaccine Initiative grant number: THA-118569 to JD, JS, GG, TN, MB and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2010, AIDS CARE, V22, P1173, DOI 10.1080/09540121003692185; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Choe DE, 2012, VIOLENCE VICTIMS, V27, P166, DOI 10.1891/0886-6708.27.2.166; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Christofides NJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18585; Closson K, 2020, CULT HEALTH SEX, V22, P31, DOI 10.1080/13691058.2019.1568578; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; Connell R., 1987, GENDER POWER SOC PER, Vxvii; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Conroy AA, 2010, POP ASS AM 2010 ANN; Conroy AA, 2014, J INTERPERS VIOLENCE, V29, P866, DOI 10.1177/0886260513505907; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Oliveira T, 2016, 21 INT AIDS C AIDS 2; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Farre L, 2013, ECONOMICA, V80, P219, DOI 10.1111/ecca.12008; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gibbs A, 2018, PLOS ONE, V13, DOI [10.1371/journal.p, 10.1371/journal.pone.0204956]; Gibbs A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290427; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2018, GLOB PUBLIC HEALTH, V13, P788, DOI 10.1080/17441692.2016.1214281; Gleeson HS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25061; Gottert A, 2018, AIDS BEHAV, V22, P1858, DOI 10.1007/s10461-017-1706-9; Gupta G R, 2000, Can HIV AIDS Policy Law Rev, V5, P86; Hair Jr J.E., 1998, MUTIVARIATE DATA ANA; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Hunter M., 2010, LOVE TIME AIDS INEQU, Vxii; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2015, LANCET GLOB HEALTH, V3, pE2, DOI 10.1016/S2214-109X(14)70374-2; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jewkes RK, 2002, 14 INT AIDS C JUL 7; Kaida A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3380-6; Lary H, 2004, INT FAM PLAN PERSPEC, V30, P200, DOI 10.1363/3020004; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Mthembu JC, 2016, AIDS CARE, V28, P1132, DOI 10.1080/09540121.2016.1146216; Nduna M, 2013, J CHILD ADOLESC MENT, V25, P43, DOI 10.2989/17280583.2012.731410; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Nkosi S, 2014, AIDS BEHAV, V18, P2230, DOI 10.1007/s10461-014-0764-5; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pitpitan EV, 2013, J BEHAV MED, V36, P295, DOI 10.1007/s10865-012-9423-3; Pulerwitz J, 2002, AIDS CARE, V14, P789, DOI 10.1080/0954012021000031868; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199733; Reed SJ, 2014, YOUTH SOC, V46, P529, DOI 10.1177/0044118X12443372; Rosenberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125510; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; Shai NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-462; Shai NJ, 2010, AIDS CARE, V22, P1379, DOI 10.1080/09540121003758465; Shisana O, 2014, S AFRICAN NATL HIV P; Simelela N, 2015, CURR HIV-AIDS REP, V12, P256, DOI 10.1007/s11904-015-0259-7; Smit J, 2006, PUBLIC HEALTH, V120, P534, DOI 10.1016/j.puhe.2006.01.009; Statistics South Africa, GEN HOUS SURV S AFR; Teitelman AM, 2016, HEALTH PSYCHOL, V35, P751, DOI 10.1037/hea0000351; UNFPA, 2014, POW 1 8 BILL; United Nations, 2017, 1707553 UN; Viitanen AP, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27860; Wathuta J, 2016, AJAR-AFR J AIDS RES, V15, P55, DOI 10.2989/16085906.2016.1150310; WHO, 2017, BOOK; Wood K, 1997, Gend Dev, V5, P41; Wood K, 2007, MED ANTHROPOL Q, V21, P277, DOI 10.1525/maq.2007.21.3.277; World Health Organization, 2021, GLOB REG EST VIOL WO; Zembe YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139430	68	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221554	10.1371/journal.pone.0221554	http://dx.doi.org/10.1371/journal.pone.0221554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553723	Green Published, gold			2022-12-27	WOS:000532319200005
J	Lindquist, C; Bjorndal, B; Bakke, HG; Slettom, G; Karoliussen, M; Rustan, AC; Thoresen, GH; Skorve, J; Nygard, OK; Berge, RK				Lindquist, Carine; Bjorndal, Bodil; Bakke, Hege G.; Slettom, Grete; Karoliussen, Marie; Rustan, Arild C.; Thoresen, G. Hege; Skorve, Jon; Nygard, Ottar K.; Berge, Rolf Kristian			A mitochondria-targeted fatty acid analogue influences hepatic glucose metabolism and reduces the plasma insulin/glucose ratio in male Wistar rats	PLOS ONE			English	Article							CARBOXYKINASE PEPCK-M; TETRADECYLTHIOACETIC ACID; LIVER; OXIDATION; GLUCONEOGENESIS; ACCUMULATION; QUANTITATION; HOMEOSTASIS; PATHWAY; TISSUE	A fatty acid analogue, 2-(tridec-12-yn-1-ylthio)acetic acid (1-triple TTA), was previously shown to have hypolipidemic effects in rats by targeting mitochondrial activity predominantly in liver. This study aimed to determine if 1-triple TTA could influence carbohydrate metabolism. Male Wistar rats were treated for three weeks with oral supplementation of 100 mg/kg body weight 1-triple TTA. Blood glucose and insulin levels, and liver carbohydrate metabolism gene expression and enzyme activities were determined. In addition, human myotubes and Huh7 liver cells were treated with 1-triple TTA, and glucose and fatty acid oxidation were determined. The level of plasma insulin was significantly reduced in 1-triple TTA-treated rats, resulting in a 32% reduction in the insulin/glucose ratio. The hepatic glucose and glycogen levels were lowered by 22% and 49%, respectively, compared to control. This was accompanied by lower hepatic gene expression of phosphenolpyruvate carboxykinase, the rate-limiting enzyme in gluconeogenesis, and Hnf4A, a regulator of gluconeogenesis. Gene expression of pyruvate kinase, catalysing the final step of glycolysis, was also reduced by 1-triple TTA. In addition, pyruvate dehydrogenase activity was reduced, accompanied by 10-15-fold increased gene expression of its regulator pyruvate dehydrogenase kinase 4 compared to control, suggesting reduced entry of pyruvate into the TCA cycle. Indeed, the NADPH-generating enzyme malic enzyme 1 (ME1) catalysing production of pyruvate from malate, was increased 13-fold at the gene expression level. Despite the decreased glycogen level, genes involved in glycogen synthesis were not affected in livers of 1-triple TTA treated rats. In contrast, the pentose phosphate pathway seemed to be increased as the hepatic gene expression of glucose-6-phosphate dehydrogenase (G6PD) was higher in 1-triple TTA treated rats compared to controls. In human Huh7 liver cells, but not in myotubes, 1-triple-TTA reduced glucose oxidation and induced fatty acid oxidation, in line with previous observations of increased hepatic mitochondrial palmitoyl-CoA oxidation in rats. Importantly, this work recognizes the liver as an important organ in glucose homeostasis. The mitochondrially targeted fatty acid analogue 1-triple TTA seemed to lower hepatic glucose and glycogen levels by inhibition of gluconeogenesis. This was also linked to a reduction in glucose oxidation accompanied by reduced PHD activity and stimulation of ME1 and G6PD, favouring a shift from glucose- to fatty acid oxidation. The reduced plasma insulin/glucose ratio indicate that 1-triple TTA may improve glucose tolerance in rats.	[Lindquist, Carine; Bjorndal, Bodil; Skorve, Jon; Nygard, Ottar K.; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Lindquist, Carine; Slettom, Grete; Nygard, Ottar K.; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Bakke, Hege G.; Karoliussen, Marie; Rustan, Arild C.; Thoresen, G. Hege] Univ Oslo, Dept Pharm, Sect Pharmacol & Pharmaceut Biosci, Oslo, Norway; [Thoresen, G. Hege] Univ Oslo, Dept Pharmacol, Inst Clin Med, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo	Berge, RK (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Berge, RK (corresponding author), Haukeland Hosp, Dept Heart Dis, Bergen, Norway.	rolf.berge@uib.no	Bjørndal, Bodil/HDN-4287-2022		BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority	BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority	Funded by BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority. The study sponsor was not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.	Barcia-Vieitez R, 2014, IUBMB LIFE, V66, P775, DOI 10.1002/iub.1329; Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Bjorndal B, 2013, DIGEST DIS SCI, V58, P97, DOI 10.1007/s10620-012-2321-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chavalit T, 2013, BBA-GENE REGUL MECH, V1829, P987, DOI 10.1016/j.bbagrm.2013.05.001; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; HARPER P, 1993, CLIN CHEM, V39, P592; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Lindquist C, 2017, J LIPID RES, V58, P1362, DOI 10.1194/jlr.M074849; Morral N, 2003, TRENDS ENDOCRIN MET, V14, P169, DOI 10.1016/S1043-2760(03)00031-6; Mosseri R, 2000, METABOLISM, V49, P321, DOI 10.1016/S0026-0495(00)90132-X; Muna ZA, 2002, BIOCHEM PHARMACOL, V63, P1127, DOI 10.1016/S0006-2952(01)00934-0; Muna ZA, 2000, FREE RADICAL BIO MED, V28, P1068, DOI 10.1016/S0891-5849(00)00196-9; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Reuter SE, 2005, ANN CLIN BIOCHEM, V42, P387, DOI 10.1258/0004563054889954; Reuter SE, 2008, ANN CLIN BIOCHEM, V45, P585, DOI 10.1258/acb.2008.008045; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Stark R, 2014, BBA-GEN SUBJECTS, V1840, P1313, DOI 10.1016/j.bbagen.2013.10.033; Stark R, 2014, J BIOL CHEM, V289, P7257, DOI 10.1074/jbc.C113.544759; Tomiyasu M, 2010, EUR J RADIOL, V73, P300, DOI 10.1016/j.ejrad.2008.10.019; Urbaniak G, 2013, RES RANDOMIZER, P644, DOI [10.1111/j.1432-1033.1984.tb08239.x, DOI 10.1111/J.1432-1033.1984.TB08239.X]; Vigerust NF, 2012, J NUTR BIOCHEM, V23, P1384, DOI 10.1016/j.jnutbio.2011.08.006; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; WILLUMSEN N, 1993, J LIPID RES, V34, P13; Xu HF, 2016, J DAIRY SCI, V99, P783, DOI 10.3168/jds.2015-9736; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222558	10.1371/journal.pone.0222558	http://dx.doi.org/10.1371/journal.pone.0222558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550253	Green Published, gold			2022-12-27	WOS:000532307700017
J	Saunders, B; Saito, T; Klosterhoff, R; de Oliveira, LF; Barreto, G; Perim, P; Pinto, AJ; Lima, F; de Sapinto, AL; Gualano, B				Saunders, Bryan; Saito, Tiemi; Klosterhoff, Rafael; de Oliveira, Luana Farias; Barreto, Gabriel; Perim, Pedro; Pinto, Ana Jessica; Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno			"I put it in my head that the supplement would help me": Open-placebo improves exercise performance in female cyclists	PLOS ONE			English	Article							TIME; INTENSITY; ENDURANCE; CAFFEINE; HEALTH; PAIN	This study investigated the effect of open-placebo on cycling time-trial (TT) performance. Twenty-eight trained female cyclists completed a 1-km cycling TT following a control session or an open-placebo intervention. The intervention consisted of an individual presentation, provided by a medic, in which the concept of open-placebo was explained to the participant, before she ingested two red and white capsules containing flour; 15 min later, they performed the TT. In the control session, the participant sat quietly for 20 min. Heart rate and ratings of perceived exertion (RPE) were monitored throughout exercise, while blood lactate was determined pre- and post-exercise. Post-exercise questionnaires were employed to gain insight into the perceived influence of the supplement on performance. Open-placebo improved time-to-completion (P = 0.039, 103.6 +/- 5.0 vs. 104.4 +/- 5.1 s, -0.7 +/- 1.8 s, -0.7 +/- 1.7%) and mean power output (P = 0.01, 244.8 +/- 34.7 vs. 239.7 +/- 33.2, +5.1 +/- 9.5 W) during the TT. Individual data analysis showed that 11 individuals improved, 13 remained unchanged and 4 worsened their performance with open-placebo. Heart rate, RPE and blood lactate were not different between sessions (all P>0.05). Positive expectation did not appear necessary to induce performance improvements, suggesting unconscious processes occurred, although a lack of an improvement appeared to be associated with a lack of belief. Open-placebo improved 1-km cycling TT performance in trained female cyclists. Although the intervention was successful for some individuals, individual variation was high, and some athletes did not respond or even performed worse. Thus, open-placebo interventions should be carefully considered by coaches and practitioners, while further studies are warranted.	[Saunders, Bryan; Saito, Tiemi; Klosterhoff, Rafael; de Oliveira, Luana Farias; Barreto, Gabriel; Perim, Pedro; Pinto, Ana Jessica; Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno] Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Sch Phys Educ & Sport, Rheumatol Div,Fac Med FMUSP, Sao Paulo, Brazil; [Saunders, Bryan] Univ Sao Paulo, Inst Orthopaed & Traumatol, Fac Med FMUSP, Sao Paulo, Brazil; [Klosterhoff, Rafael] Univ Fed Parana, Dept Biochem & Mol Biol, Curitiba, Parana, Brazil; [Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno] Univ Sao Paulo, Div Rheumatol, Lab Assessment & Conditioning Rheumatol LACRE, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Parana; Universidade de Sao Paulo	Saunders, B (corresponding author), Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Sch Phys Educ & Sport, Rheumatol Div,Fac Med FMUSP, Sao Paulo, Brazil.; Saunders, B (corresponding author), Univ Sao Paulo, Inst Orthopaed & Traumatol, Fac Med FMUSP, Sao Paulo, Brazil.	drbryansaunders@outlook.com	Gualano, Bruno/C-7190-2012; Gualano, Bruno/ABA-9571-2020; Pinto, Ana Jessica/E-9869-2018; Pinto, Ana Jessica/Y-6637-2019; de Oliveira, Luana Farias/O-8142-2016; de Oliveira, Luana Farias/AAS-3124-2021; Saunders, Bryan/AAJ-7734-2020	Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Pinto, Ana Jessica/0000-0002-1363-7233; Pinto, Ana Jessica/0000-0002-1363-7233; de Oliveira, Luana Farias/0000-0001-8225-5784; de Oliveira, Luana Farias/0000-0001-8225-5784; Saunders, Bryan/0000-0003-0995-9077	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/50438-0, 2017/04973-4, 2017/15314-1, 2018/01594-5, 2015/26937-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Bryan Saunders (2016/50438-0 and 2017/04973-4), Gabriel Barreto (2017/15314-1), Pedro Perim (2018/01594-5) and Ana Jessica Pinto (2015/26937-4) have been financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1743, DOI 10.1152/japplphysiol.00810.2009; Bandeira Marina, 2002, Estud. psicol. (Natal), V7, P251, DOI 10.1590/S1413-294X2002000200006; Beedie, 2017, PERMANCE ENHANCEM, V5, P89, DOI [https://doi.org/10.1016/j.peh.2016.10.001, DOI 10.1016/J.PEH.2016.10.001]; Beedie C, 2018, BRIT J SPORT MED, V52, P817, DOI 10.1136/bjsports-2017-097747; Beedie C, 2018, EUR J SPORT SCI, V18, P1383, DOI 10.1080/17461391.2018.1496144; Beedie CJ, 2008, J SPORT SCI MED, V7, P166; Beedie CJ, 2006, MED SCI SPORT EXER, V38, P2159, DOI 10.1249/01.mss.0000233805.56315.a9; Bellinger P.M., 2014, J SCI CYCLING, V3, P23; Bellinger PM, 2016, EUR J SPORT SCI, V16, P829, DOI 10.1080/17461391.2015.1120782; Benedetti F, 2007, J NEUROSCI, V27, P11934, DOI 10.1523/JNEUROSCI.3330-07.2007; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Broelz EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198388; Clark VR, 2000, MED SCI SPORT EXER, V32, P1642; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Decroix L, 2016, INT J SPORT PHYSIOL, V11, P204, DOI 10.1123/ijspp.2015-0153; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Grotle M, 2017, J PHYSIOTHER, V63, P183, DOI 10.1016/j.jphys.2017.05.002; Hoenemeyer TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20993-y; Hurst P, 2017, MED SCI SPORT EXER, V49, P1877, DOI [10.1249/MSS.0000000000001297, 10.1249/mss.0000000000001297]; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Klitzman R, 2007, BMJ-BRIT MED J, V335, P514, DOI 10.1136/bmj.39325.646887.94; Landry M, 2013, OCHSNER J, V13, P334; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027; McQuillan JA, 2017, INT J SPORT NUTR EXE, V27, P255, DOI 10.1123/ijsnem.2016-0212; Paton CD, 2006, EUR J SPORT SCI, V6, P25, DOI 10.1080/17461390500422796; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Ross R, 2015, MED SCI SPORT EXER, V47, P1672, DOI 10.1249/MSS.0000000000000584; Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793; Saunders B, 2014, INT J SPORT PHYSIOL, V9, P627, DOI [10.1123/IJSPP.2013-0295, 10.1123/ijspp.2013-0295]; Schaefer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192758; Schaefer M, 2016, PSYCHOTHER PSYCHOSOM, V85, P373, DOI 10.1159/000447242; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222982	10.1371/journal.pone.0222982	http://dx.doi.org/10.1371/journal.pone.0222982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550286	Green Published, gold			2022-12-27	WOS:000532307700038
J	Girma, G; Natsume, S; Carluccio, AV; Takagi, H; Matsumura, H; Uemura, A; Muranaka, S; Takagi, H; Stavolone, L; Gedil, M; Spillane, C; Terauchi, R; Tamiru, M				Girma, Gezahegn; Natsume, Satoshi; Carluccio, Anna Vittoria; Takagi, Hiroki; Matsumura, Hideo; Uemura, Aiko; Muranaka, Satoru; Takagi, Hiroko; Stavolone, Livia; Gedil, Melaku; Spillane, Charles; Terauchi, Ryohei; Tamiru, Muluneh			Identification of candidate flowering and sex genes in white Guinea yam (D. rotundata Poir.) by SuperSAGE transcriptome profiling	PLOS ONE			English	Article							EXPRESSION ANALYSIS; TIME; INTENSITY; DIVERSITY; PACKAGE; COMPLEX; PROTEIN; SAGE	Dioecy (distinct male and female individuals) and scarce to non-flowering are common features of cultivated yam (Dioscorea spp.). However, the molecular mechanisms underlying flowering and sex determination in Dioscorea are largely unknown. We conducted Super-SAGE transcriptome profiling of male, female and monoecious individuals to identify flowering and sex-related genes in white Guinea yam (D. rotundata), generating 20,236 unique tags. Of these, 13,901 were represented by a minimum of 10 tags. A total 88 tags were significantly differentially expressed in male, female and monoecious plants, of which 18 corresponded to genes previously implicated in flower development and sex determination in multiple plant species. We validated the SuperSAGE data with quantitative real-time PCR (qRT-PCR)-based analysis of the expression of three candidate genes. We further investigated the flowering patterns of 1938 D. rotundata accessions representing diverse geographical origins over two consecutive years. Over 85% of accessions were either male or non-flowering, less than 15% were female, while monoecious plants were rare. Intensity of flowering varied between male and female plants, with the former flowering more abundantly than the latter. Candidate genes identified in this study can be targeted for further validation and to induce regular flowering in poor to non-flowering cultivars. Findings of the study provide important inputs for further studies aiming to overcome the challenge of flowering in yams and to improve efficiency of yam breeding.	[Girma, Gezahegn; Carluccio, Anna Vittoria; Stavolone, Livia; Gedil, Melaku] Int Inst Trop Agr IITA, Biosci Ctr, Ibadan, Oyo State, Nigeria; [Girma, Gezahegn; Spillane, Charles] Natl Univ Ireland Galway, Plant & AgriBiosci Res Ctr PABC, Ryan Inst, Galway, Ireland; [Natsume, Satoshi; Takagi, Hiroki; Matsumura, Hideo; Uemura, Aiko; Terauchi, Ryohei; Tamiru, Muluneh] Iwate Biotechnol Res Ctr IBRC, Dept Genom & Breeding, Kitakami, Iwate, Japan; [Muranaka, Satoru; Takagi, Hiroko] Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan; [Girma, Gezahegn] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Matsumura, Hideo] Shinshu Univ, Gene Res Ctr, Ueda, Nagano, Japan; [Stavolone, Livia] CNR, Inst Sustainable Plant Protect, Bari, Italy; [Tamiru, Muluneh] La Trobe Univ, Dept Anim Plant & Soil Sci, AgriBioBldg, Melbourne, Vic, Australia	CGIAR; International Institute of Tropical Agriculture (IITA); Ollscoil na Gaillimhe-University of Galway; Japan International Research Center for Agricultural Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Shinshu University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); La Trobe University	Muranaka, S (corresponding author), Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan.	s.muranaka@cgiar.org	Stavolone, Livia/AAY-2967-2020; Carluccio, Anna Vittoria/AAI-3463-2021; Terauchi, Ryohei/Y-2992-2019; Girma, Gezahegn/ABB-5812-2020; Gedil, Melaku/H-9445-2019	Stavolone, Livia/0000-0002-0691-1302; Terauchi, Ryohei/0000-0002-0095-4651; Gedil, Melaku/0000-0002-6258-6014; Girma, Gezahegn/0000-0001-9702-3521	Japan International Research Center for Agricultural Sciences (JIRCAS); Netherlands Ministry of Foreign Affairs; National University of Ireland Galway	Japan International Research Center for Agricultural Sciences (JIRCAS)(Japan International Research Center for Agricultural Sciences); Netherlands Ministry of Foreign Affairs; National University of Ireland Galway	The project was funded by the Japan International Research Center for Agricultural Sciences (JIRCAS). The work was conducted as part of the international collaborative research project "Use of genomic information and molecular tools for yam germplasm utilization and improvement for West Africa (EDITS-Yam)".; This work was conducted as part of the international collaborative research project "Use of genomic information and molecular tools for yam germplasm utilization and improvement for West Africa (EDITS-Yam)" funded by the Japan International Research Center for Agricultural Sciences (JIRCAS). GG acknowledges support from the Netherlands Ministry of Foreign Affairs, and a PhD International Merit Scholarship fee waiver from the National University of Ireland Galway.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; ALONSO JM, 1995, PLANT PHYSIOL, V109, P541, DOI 10.1104/pp.109.2.541; [Anonymous], 2009, TROPICAL ROOT TUBER; Aryal R, 2014, PLANT SCI, V217, P56, DOI 10.1016/j.plantsci.2013.10.018; Bi HG, 2013, PLANT PHYSIOL BIOCH, V70, P512, DOI 10.1016/j.plaphy.2013.06.017; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cormier F, 2019, THEOR APPL GENET, V132, P1733, DOI 10.1007/s00122-019-03311-6; Dansi A, 1999, GENET RESOUR CROP EV, V46, P371, DOI 10.1023/A:1008698123887; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fukuchi-Mizutani M, 2000, PLANT SCI, V160, P129, DOI 10.1016/S0168-9452(00)00373-3; Futamura N, 1999, PLANT CELL PHYSIOL, V40, P524, DOI 10.1093/oxfordjournals.pcp.a029573; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Gowda M, 2004, PLANT PHYSIOL, V134, P890, DOI 10.1104/pp.103.034496; Hamadina EI, 2009, J AGR SCI-CAMBRIDGE, V147, P469, DOI 10.1017/S0021859609008697; HAMON P, 1990, EUPHYTICA, V46, P101, DOI 10.1007/BF00022303; Heijmans K, 2012, J EXP BOT, V63, P5397, DOI 10.1093/jxb/ers233; IPGRI/ IITA, 1997, DESCR YAM DIOSC SPP; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Ling Hua, 2008, Pak J Biol Sci, V11, P763, DOI 10.3923/pjbs.2008.763.767; Liu SA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-228; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVAK KJ, 1997, USER B, V2; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MARTIN FW, 1966, J HERED, V57, P95, DOI 10.1093/oxfordjournals.jhered.a107485; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Micheli F, 1998, GENE, V220, P13, DOI 10.1016/S0378-1119(98)00431-4; Mignouna HD, 2007, GENOME MAPPING MOL B, P271; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Momose M, 2013, BREEDING SCI, V63, P435, DOI 10.1270/jsbbs.63.435; Murase K, 2017, GENES CELLS, V22, P115, DOI 10.1111/gtc.12453; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nyaboga E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00463; Oda A, 2004, FEBS LETT, V557, P259, DOI 10.1016/S0014-5793(03)01470-4; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sha AH, 2014, J GENET, V93, P43, DOI 10.1007/s12041-014-0331-x; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smirnova A, 2013, PLANT PHYSIOL, V161, P196, DOI 10.1104/pp.112.206656; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Suzuki H, 2004, PLANT J, V38, P994, DOI 10.1111/j.1365-313X.2004.02101.x; Tamiru M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0419-x; Terauchi R KG, 1999, SEX DETERMINATION PL; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Yang YJ, 2014, PLANT CELL, V26, P2038, DOI 10.1105/tpc.114.124867; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhao XT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3089584	55	12	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0216912	10.1371/journal.pone.0216912	http://dx.doi.org/10.1371/journal.pone.0216912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545796	Green Submitted, Green Published, gold			2022-12-27	WOS:000532303200005
J	Yukhnenko, D; Wolf, A; Blackwood, N; Fazel, S				Yukhnenko, Denis; Wolf, Achim; Blackwood, Nigel; Fazel, Seena			Recidivism rates in individuals receiving community sentences: A systematic review	PLOS ONE			English	Review							IMPRISONMENT	Objective We aimed to systematically review recidivism rates in individuals given community sentences internationally. We sought to explore sources of variation between these rates and how reporting practices may limit their comparability across jurisdictions. Finally, we aimed to adapt previously published guidelines on recidivism reporting to include community sentenced populations. Methods We searched MEDLINE, PsycINFO, SAGE and Google Scholar for reports and studies of recidivism rates using non-specific and targeted searches for the 20 countries with the largest prison populations worldwide. We identified 28 studies with data from 19 countries. Of the 20 countries with the largest prison populations, only 2 reported recidivism rates for individuals given community sentences. Results The most commonly reported recidivism information between countries was for 2-year reconviction, which ranged widely from 14% to 43% in men, and 9% to 35% in women. Explanations for recidivism rate variations between countries include when the follow-up period started and whether technical violations were taken into account. Conclusion Recidivism rates in individuals receiving community sentences are typically lower in comparison to those reported in released prisoners, although these two populations differ in terms of their baseline characteristics. Direct comparisons of the recidivism rates in community sentenced cohorts across jurisdictions are currently not possible, but simple changes to existing reporting practices can facilitate these. We propose recommendations to improve reporting practices.	[Yukhnenko, Denis; Wolf, Achim; Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford, England; [Blackwood, Nigel] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	University of Oxford; University of London; King's College London	Fazel, S (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365; Blackwood, Nigel/0000-0002-5909-203X; Yukhnenko, Denis/0000-0003-4936-2857	Wellcome Trust [202836/Z/16/Z]	Wellcome Trust(Wellcome Trust)	Funded by Wellcome Trust (SF; #202836/Z/16/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht HJ, 2014, NATL RECONVICTION ST, DOI [10.17875/gup2014-791, DOI 10.17875/GUP2014-791]; Altman DG, 1991, PRACTICAL STAT MED R; [Anonymous], 2018, HIGHEST LOWEST PRISO; Bales WD, 2012, J EXP CRIMINOL, V8, P71, DOI 10.1007/s11292-011-9139-3; Bartels L, 2009, AUST NZ J CRIMINOL, V42, P72, DOI 10.1375/acri.42.1.72; Bureau of Crime Statistics and Research, 2017, RE OFF STAT NSW; Central Statistics Office, 2016, PROB REC 2010 COH; Department of Correctional Services, 2014, REC TRENDS W AUSTR C; Department of Corrections, 2017, ANN REP 1 JUL 2016 3; Department of Corrections, 2016, ANN REP 1 JUL 2015 3; Department of Justice, 2011, AD REC NO IR 2005; Drake EK, 2018, J CONTEMP CRIM JUST, V34, P47, DOI 10.1177/1043986217750425; Duncan L, 2017, ADULT YOUTH REOFFEND; European Monitoring Centre for Drugs and Drug Addiction, 2017, DRUG TRAFF PEN EUR U; Evans E, 2014, CRIME DELINQUENCY, V60, P909, DOI 10.1177/0011128710382342; Fazel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130390; Federal Penitentiary Service of Russia, 2018, CHAR PERS REG PEN IN; Federal Statistical Office, 2015, STAT COND PEN 1982 2; Flinchum T, 2016, CORRECTIONAL PROGRAM; Flores AW, 2017, CRIM JUSTICE BEHAV, V44, P121, DOI 10.1177/0093854816678649; Graunbol HM, 2010, KRIMINALOMSORGENS UT; Harding DJ, 2017, P NATL ACAD SCI USA, V114, P11103, DOI 10.1073/pnas.1701544114; Herberman EJ, 2013, PROBATION PAROLE US; Hyatt JM, 2017, CRIME DELINQUENCY, V63, P3, DOI 10.1177/0011128714555757; Illinois Criminal Justice Information Authority, 2011, EX ILL PROB CHAR OUT; Jolliffe D, 2015, CRIME DELINQUENCY, V61, P1051, DOI 10.1177/0011128712466007; Leonardi F., 2007, RASSEGNA PENITENZIAR, V2, P7; Lowenkamp CT, 2014, J CRIME JUSTICE, V37, P275, DOI 10.1080/0735648X.2012.753849; McLaughlin M, 2016, EC BURDEN INCARCERAT; Ministere de la Justice, 2013, MES REC CONTR C CONS; Ministere de la Securite publique, 2015, PROJ ENQ REC REPR CL; Ministry of Justice, 2018, PROV REOFF STAT Q JA; Ministry of Justice, 2017, PRIS PERF STAT 2016; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nagin DS, 2013, J QUANT CRIMINOL, V29, P601, DOI 10.1007/s10940-012-9191-9; National Heart Lung and Blood Institute National Institutes of Health US Department of Health and Human Services, 2019, STUD QUAL ASS TOOLS; National Statistics, 2017, CRIM JUST SYST STAT; Nieuwbeerta P, 2009, J QUANT CRIMINOL, V25, P227, DOI 10.1007/s10940-009-9069-7; Ontario Ministry of Community Safety and Correctional Services, 2017, RAT REC REC ONT; Pearson DAS, 2016, CRIME DELINQUENCY, V62, P899, DOI 10.1177/0011128714530824; Peillard AMM, 2012, REINCIDENCIA SISTEMA; Penal Reform International, 2018, GLOB PRIS TRENDS 201; Robinson G., 2015, COMMUNITY PUNISHMENT; Scottish Government, 2017, REC RAT SCOTL 2014 1; Spjeldnes S, 2009, J OFFENDER REHABIL, V48, P314, DOI 10.1080/10509670902850812; State of Oregon Criminal Justice Commission, 2018, RECIDIVISM; Statistics Denmark, 2018, RECIDIVISM; Swedish National Council for Crime Prevention, 2017, RECIDIVISM; Tabar OF, 2006, REDUCING PRISON POPU; The Council of State Governments, 2013, IMPR PROB ALT INC NE; Trevena J, 2015, CONT ISSUES CRIME JU, V187; Wartna B. S. J, 2006, RECIDIVE 1997 2003 O; Wermink H, 2013, J QUANT CRIMINOL, V29, P579, DOI 10.1007/s10940-012-9189-3; Wermink H, 2010, J EXP CRIMINOL, V6, P325, DOI 10.1007/s11292-010-9097-1	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222495	10.1371/journal.pone.0222495	http://dx.doi.org/10.1371/journal.pone.0222495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539388	Green Published, gold			2022-12-27	WOS:000532297900013
J	Hsiao, PL; Hsu, SF; Chen, PH; Tsai, HW; Lu, HY; Wang, YS; Lee, LW				Hsiao, Pei-Lin; Hsu, Shu-Feng; Chen, Po-Han; Tsai, Hsiao-Wei; Lu, Hsin-Ying; Wang, Yue-Sheng; Lee, Li-Wen			Does a spinal implant alter dual energy X-ray absorptiometry body composition measurements?	PLOS ONE			English	Article							LEAST-SIGNIFICANT-CHANGE; CROSS-CALIBRATION; DENSITOMETRY; PREVALENCE; PRECISION; METAL	Background Most manufacturer manuals do not verify the use of dual energy X-ray absorptiometry for body composition analysis in subjects with a metal implant. This study aimed to quantify the effects of a spinal implant on body composition, and to determine whether unadjusted lean mass estimates are valid for patients with a spinal implant. Methods A total of 30 healthy subjects were recruited. Three consecutive scans were performed for each participant, one with and two without extraneous spinal implant, without repositioning between scans. Lean, fat and bone estimates in the total body, trunk and limb were measured. Results Precision errors for all total and regional body compositions were within the recommended ranges. Bone masses in the trunk and total body were significantly increased with spinal implant, and the increases exceeded the least significant change. For total and regional lean and fat estimates, the measurements between subjects with and without metal implants were in substantial to almost perfect agreement and the differences were not significant and did not exceed the least significant change. Conclusions Spinal metal artifacts significantly increased the total body and trunk bone mass but the differences in lean- and fat-related estimates at total and regional body levels and all estimates in the extremity remained within the clinical acceptable range. Thus, a spinal implant may not compromise screening of patients for fat and lean masses using dual energy X-ray absorptiometry. Application of image reconstruction or a filtering algorithm may help reduce the effect of metallic artifacts and further study is needed.	[Hsiao, Pei-Lin; Tsai, Hsiao-Wei; Lu, Hsin-Ying; Wang, Yue-Sheng; Lee, Li-Wen] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Hsu, Shu-Feng] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan; [Chen, Po-Han] Chang Gung Mem Hosp, Dept Orthoped Surg, Yunlin, Taiwan; [Lee, Li-Wen] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology	Lee, LW (corresponding author), Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan.; Lee, LW (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan.	m4572@cgmh.org.tw	Lee, Li-Wen/AAY-3542-2021	Lee, Li-Wen/0000-0001-8019-1772	Chang Gung Medical Foundation [CMRPG6H0201]	Chang Gung Medical Foundation	The first author (PLH) received funding from the Chang Gung Medical Foundation (grant no. CMRPG6H0201). UPL of the funder website: https://www.cgmh.org.tw/.The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cawkwell GD, 1998, J CLIN DENSITOM, V1, P141, DOI 10.1385/JCD:1:2:141; Cole JH, 2005, J CLIN DENSITOM, V8, P57, DOI 10.1385/JCD:8:1:057; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; Diessel E, 2000, J APPL PHYSIOL, V89, P599, DOI 10.1152/jappl.2000.89.2.599; Giangregorio LM, 2003, CAN ASSOC RADIOL J, V54, P305; Giangregorio LM, 2003, CAN ASSOC RADIOL J, V54, P270; Griffiths MR, 1997, J BONE MINER RES, V12, P119, DOI 10.1359/jbmr.1997.12.1.119; Hangartner TN, 2007, OSTEOPOROSIS INT, V18, P513, DOI 10.1007/s00198-006-0280-1; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LUKASKI HC, 1993, J NUTR, V123, P438, DOI 10.1093/jn/123.suppl_2.438; Madsen OR, 1999, CLIN PHYSIOL, V19, P238; Messina C, 2015, EUR RADIOL, V25, P1504, DOI 10.1007/s00330-014-3509-y; Ng BK, 2018, AM J CLIN NUTR, V108, P708, DOI 10.1093/ajcn/nqy158; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Rothney MP, 2009, OBESITY, V17, P1281, DOI 10.1038/oby.2009.14; Shepherd JA, 2006, J CLIN DENSITOM, V9, P31, DOI 10.1016/j.jocd.2006.05.005; Shepherd JA, 2007, J CLIN DENSITOM, V10, P249, DOI 10.1016/j.jocd.2007.05.002; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Watts NB, 2004, OSTEOPOROSIS INT, V15, P847, DOI 10.1007/s00198-004-1681-7	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222758	10.1371/journal.pone.0222758	http://dx.doi.org/10.1371/journal.pone.0222758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536597	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800082
J	Masterson, TD; Bobak, C; Rapuano, KM; Shearrer, GE; Gilbert-Diamond, D				Masterson, Travis D.; Bobak, Carly; Rapuano, Kristina M.; Shearrer, Grace E.; Gilbert-Diamond, Diane			Association between regional brain volumes and BMI z-score change over one year in children	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; HIPPOCAMPAL VOLUMES; WEIGHT; ADOLESCENTS; FOOD; OVERWEIGHT; OBESITY; IMAGES; RISK	Purpose Associations between brain region volume and weight status have been observed in children cross-sectionally. However, it is unclear if differences in brain region volume precede weight gain. Methods Two high-quality structural brain images were obtained approximately one year apart in 53 children aged 9-12 years old. Children's height and weight were also measured at each scan. Structural images were processed using the FreeSurfer software-package providing volume measures for regions of interest including the entorhinal cortex, nucleus accumbens, and hippocampus. Age- and sex-adjusted BMI z-scores (BMIz) were calculated at both timepoints. The association between brain region volume and BMIz was examined cross-sectionally using linear regression and longitudinally using structural equation modeling. All models were adjusted by estimated cranial volume to account for individual variation in head size and were corrected for multiple comparisons (pFDR<0.05). Results The sample of children was primarily healthy weight at baseline (79.78%). Cross-sectionally at the one-year follow-up, a positive relationship was observed between right hippocampal volume and BMIz (beta = 0.43, 95% CI = (0.10, 0.77)). Longitudinally a negative relationship was observed between right entorhinal volume at baseline and BMIz at the one-year followup (beta = -0.25, 95% CI = (-0.44, -0.07)). Conclusion These results suggest that measured volumes from certain regions of the brain that have been associated with BMI in adults are associated with both concurrent BMIz and BMIz change over one-year in a primarily healthy weight sample of children. As the entorhinal cortex integrates signals from both reward and control regions, this region may be particularly important to weight management during child development.	[Masterson, Travis D.; Gilbert-Diamond, Diane] Geisel Sch Med Dartmouth Coll, Norris Cotton Canc Ctr, Dept Epidemiol, Hanover, NH 03755 USA; [Bobak, Carly] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Rapuano, Kristina M.] Yale Univ, Dept Psychol, New Haven, CT USA; [Shearrer, Grace E.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA	Norris Cotton Cancer Center; Dartmouth College; Yale University; University of North Carolina; University of North Carolina Chapel Hill	Masterson, TD (corresponding author), Geisel Sch Med Dartmouth Coll, Norris Cotton Canc Ctr, Dept Epidemiol, Hanover, NH 03755 USA.	travis.d.masterson@dartmouth.edu	Rapuano, Kristina/J-6489-2019	Bobak, Carly/0000-0001-8631-4753	National Institute of Child Health and Human Development [NICHD076097, R01HD092604]; Nation Institute of Drug Abuse [NIDAT32DA037202]; National Institute of Child Health and Human Development Grants [NICHD076097, R01HD092604]; National Institute of Drug Abuse [T32DA037202]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA037202] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Nation Institute of Drug Abuse; National Institute of Child Health and Human Development Grants; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by: D.G.-D., Grant Numbers: NICHD076097 and R01HD092604, National Institute of Child Health and Human Development, https://www.nichd.nih.gov; T.D.M., Grant Numbers: NIDAT32DA037202, the Nation Institute of Drug Abuse, https://www.nida.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Uku Vainik for discussions on his paper as well as suggestions related to the statistical analysis and Reina Kato Lansigan for help with recruitment and project management. This work was supported by National Institute of Child Health and Human Development Grants NICHD076097 (to D. G.-D.), R01HD092604 (to D. G.-D.), and the National Institute of Drug Abuse T32DA037202 (to T.D.M).; We would like to thank Uku Vainik for discussions on his paper as well as suggestions related to the statistical analysis and Reina Kato Lansigan for help with recruitment and project management. This work was supported by National Institute of Child Health and Human Development Grants NICHD076097 (to D. G.-D.), R01HD092604 (to D. G.-D.), and the National Institute of Drug Abuse T32DA037202 (to T.D.M).	Aanes S, 2015, NEUROIMAGE, V105, P76, DOI 10.1016/j.neuroimage.2014.10.023; Bauer CCC, 2015, PEDIATR OBES, V10, P196, DOI 10.1111/ijpo.241; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bruehl Hannah, 2011, Neurosci Med, V2, P34; Burger KS, 2014, NEUROIMAGE, V99, P122, DOI 10.1016/j.neuroimage.2014.05.066; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Coveleskie K, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.45; Crockett L.J., 1988, PUBERTAL DEV SCALE P; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; DAVIDSON TL, 1993, BEHAV NEURAL BIOL, V59, P167, DOI 10.1016/0163-1047(93)90925-8; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gilmore A, VARIATIONS STRUCTURA, DOI [10.1101/581876, DOI 10.1101/581876]; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Inokuchi M, 2011, ANN HUM BIOL, V38, P747, DOI 10.3109/03014460.2011.620625; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; KENNY DA, 1979, J APPL PSYCHOL, V64, P372, DOI 10.1037/0021-9010.64.4.372; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Mestre ZL, 2017, INT J OBESITY, V41, P1496, DOI 10.1038/ijo.2017.130; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Nouwen A, 2017, NEUROIMAGE-CLIN, V16, P43, DOI 10.1016/j.nicl.2017.07.004; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Rapuano KM, 2015, CEREBRAL CORTEX, V26; Rapuano KM, 2017, P NATL ACAD SCI USA, V114, P160, DOI 10.1073/pnas.1605548113; Schmajuk NA, 2001, BEHAV BRAIN RES, V118, P123, DOI 10.1016/S0166-4328(00)00319-3; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Selig JP, 2012, AUTOREGRESSIVE CROSS, DOI [10.1001/jama.291.23.2847, DOI 10.1001/JAMA.291.23.2847]; Team CR, 2016, R LANG ENV STAT COMP; Terrell LG, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-0725, 10.1542/peds.2018-1916, 10.1542/peds.2017-3459]; Vainik U, NEUROBEHAVIOURAL COR, DOI [10.1101/204917, DOI 10.1101/204917]; Vainik U, 2018, P NATL ACAD SCI USA, V115, P9312, DOI 10.1073/pnas.1718206115; Valk SL, 2015, HUM BRAIN MAPP, V36, P2364, DOI 10.1002/hbm.22776; Wallner-Liebmann S, 2010, OBESITY, V18, P1552, DOI 10.1038/oby.2010.26; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304; Willette AA, 2015, AGEING RES REV, V20, P86, DOI 10.1016/j.arr.2014.03.007; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221995	10.1371/journal.pone.0221995	http://dx.doi.org/10.1371/journal.pone.0221995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536539	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800022
J	Rodriguez-Poncelas, A; Franch-Nadal, J; Coll-de Tuero, G; Mata-Cases, M; Alonso-Fernandez, M; Mur-Marti, T; Ruiz, A; Giraldez-Garcia, C; Regidor, E				Rodriguez-Poncelas, Antonio; Franch-Nadal, Josep; Coll-de Tuero, Gabriel; Mata-Cases, Manel; Alonso-Fernandez, Margarita; Mur-Marti, Teresa; Ruiz, Antonio; Giraldez-Garcia, Carolina; Regidor, Enrique			High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study	PLOS ONE			English	Article							GLOMERULAR HYPERFILTRATION; RENAL HYPERFILTRATION; DIABETIC-NEPHROPATHY; RISK; POPULATION; DEFINITION; OBESITY	Aim This study aimed to investigate whether different levels of fasting plasma glucose (FPG) and hemoglobin Al c (HbA1 c) in prediabetes are associated with hyperfiltration. Methods A prospective cohort of 2,022 individuals aged 30-74 years took part in the PREDAPS Study. One cohort of 1,184 participants with prediabetes and another cohort of 838 participants with normal FPG and normal HbA1 c were followed for 5 years. Hyperfiltration was defined as an estimated glomerular filtration rate (eGFR) above the age- and gender-specific 95th percentile for healthy control participants, while hypofiltration was defined as an eGFR below the 5th percentile. The prevalence of hyperfiltration was compared for different levels of prediabetes: level 1 of prediabetes: FPG <100 mg/dL plus HbAl c 5.7-6.0% or FPG 100-109 mg/dL plus HbAl c < 5.7%; level 2 of prediabetes: FPG <100 mg/dL plus HbAl c 6.1-6.4% or FPG 100-109 mg/dL plus HbAl c 5.7-6.0% or FPG 110-125 mg/dL plus HbAl c <5.7% and level 3 of prediabetes: FPG 100-109 mg/dL plus HbAl c 6.1-6.4% or FPG 110-125 mg/dL plus HbAl c 5.7-6.4%. Results The participants with hyperfiltration were significantly younger, had a higher percentage of active smokers, and lower levels of hemoglobin and less use of ACEIs or ARBs. Only level 3 prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher odds ratio (OR) of hyperfiltration (OR 1.69 (1.05-2.74); P < 0.001) compared with no prediabetes (FPG < 100 mg/dL and HbA1c < 5.7%) after adjustment for different factors. The odds ratios for different levels of HbA1c alone in prediabetes increased progressively, but not significantly. Conclusions Level 3 of prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher OR of hyperfiltration compared with participants without prediabetes.	[Rodriguez-Poncelas, Antonio; Coll-de Tuero, Gabriel] IDIAP Gol & Gorina, USR Girona, METHARISC Grp, Girona, Spain; [Rodriguez-Poncelas, Antonio; Mata-Cases, Manel] Grup Recerca Epidemiol Diabetis Atencio Primar DA, Barcelona, Spain; [Rodriguez-Poncelas, Antonio; Franch-Nadal, Josep; Mata-Cases, Manel; Alonso-Fernandez, Margarita; Mur-Marti, Teresa; Ruiz, Antonio; Giraldez-Garcia, Carolina; Regidor, Enrique] RedGDPS Fdn, Madrid, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel] USR Barcelona Ciutat IDIAP Jordi Gol, Barcelona, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel] CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain; [Franch-Nadal, Josep] Univ Barcelona, Dept Med, Barcelona, Spain; [Coll-de Tuero, Gabriel] Univ Girona, Dept Ciencias Med, Girona, Spain; [Alonso-Fernandez, Margarita] Ctr Salud La Eria, Asturias, Spain; [Alonso-Fernandez, Margarita] Univ Oviedo, Dept Med Prevent & Salud Publ, Asturias, Spain; [Mur-Marti, Teresa] Mutua Terrassa, Barcelona, Spain; [Ruiz, Antonio] Ctr Salud Univ Pinto, Madrid, Spain; [Giraldez-Garcia, Carolina] Hosp Univ Infanta Elena, Madrid, Spain; [Regidor, Enrique] Univ Complutense Madrid, Fac Med, Dept Salud Publ & Materno Infantil, Madrid, Spain; [Regidor, Enrique] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Regidor, Enrique] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Universitat de Girona; University of Oviedo; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico San Carlos	Franch-Nadal, J (corresponding author), RedGDPS Fdn, Madrid, Spain.; Franch-Nadal, J (corresponding author), USR Barcelona Ciutat IDIAP Jordi Gol, Barcelona, Spain.; Franch-Nadal, J (corresponding author), CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain.; Franch-Nadal, J (corresponding author), Univ Barcelona, Dept Med, Barcelona, Spain.	josep.franch@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; mata-cases, manel/W-9485-2019; Franch-Nadal, Josep/AAC-1945-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; mata-cases, manel/0000-0003-3693-3622; Franch-Nadal, Josep/0000-0002-5175-1555				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Goldberg I, 2018, EUR J INTERN MED, V57, P39, DOI 10.1016/j.ejim.2018.07.013; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; HOSTETTER TH, 1992, DIABETES CARE, V15, P1205, DOI 10.2337/diacare.15.9.1205; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Hu W, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0043-0; Kawata I, 2019, ACTA DIABETOL, V56, P525, DOI 10.1007/s00592-019-01287-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Melsom T, 2016, AM J KIDNEY DIS, V67, P841, DOI 10.1053/j.ajkd.2015.10.025; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Mogensen C E, 1990, J Diabet Complications, V4, P159, DOI 10.1016/0891-6632(90)90015-W; Moriya T, 2012, KIDNEY INT, V81, P486, DOI 10.1038/ki.2011.404; Naderpoor N, 2017, SCI REP-UK, V7, DOI 10.1038/srep45522; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Okada R, 2012, RENAL FAILURE, V34, P1084, DOI 10.3109/0886022X.2012.717516; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006; Premaratne E, 2015, DIABETES METAB, V41, P5, DOI 10.1016/j.diabet.2014.10.003; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; Rodriguez-Poncelas A, 2018, J NEPHROL, V31, P743, DOI 10.1007/s40620-018-0524-0; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Serrano R, 2013, REV ESP SALUD PUBLIC, V87, P121, DOI [10.4321/S1135-57272013000200003, 10.4321/s1135-57272013000200003]; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Sun ZJ, 2016, NEPHROL DIAL TRANSPL, V31, P1295, DOI 10.1093/ndt/gfv385; Sunder-Plassmann G, 2004, AM J KIDNEY DIS, V43, P396, DOI 10.1053/j.ajkd.2003.11.017; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Vallon V, 2003, J AM SOC NEPHROL, V14, P530, DOI 10.1097/01.ASN.0000051700.07403.27; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222848	10.1371/journal.pone.0222848	http://dx.doi.org/10.1371/journal.pone.0222848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536578	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800096
J	Stien, N; Saeterbakken, AH; Hermans, E; Vereide, VA; Olsen, E; Andersen, V				Stien, Nicolay; Saeterbakken, Atle Hole; Hermans, Espen; Vereide, Vegard Albert; Olsen, Elias; Andersen, Vidar			Comparison of climbing-specific strength and endurance between lead and boulder climbers	PLOS ONE			English	Article							FINGER FLEXOR MUSCLES; HEMODYNAMIC KINETICS; ROCK; PERFORMANCE; ELITE; DETERMINANTS; CONTRACTIONS; RESPONSES; RECOVERY; EXERCISE	Albeit differences in climbing-specific strength of the forearms have been demonstrated between lead and boulder climbers, little is known about the potential differences in force and power output of the upper body pulling-apparatus between disciplines. The aim of this study was to compare the climbing-specific upper-body strength and finger flexor endurance between lead and boulder climbers, as well as to examine the relative utilization of force when testing on a ledge hold compared to a jug hold. Sixteen boulder climbers (red-point climbing grade 17.9 +/- 3.3) and fifteen lead climbers (red-point climbing grade 20.5 +/- 3.5) performing on an advanced level volunteered for the study. Peak force, average force and rate of force development (RFD) were measured during an isometric pull-up, average velocity in dynamic pull-up, and finger flexor endurance in an intermittent test to fatigue. The isometric pull-up was performed on a ledge hold (high finger strength requirements) and on a jug hold (very low finger strength requirements). Boulder climbers demonstrated a higher maximal and explosive strength in all strength and power measurements (26.2-52.9%, ES = 0.90-1.12, p = 0.006-0.023), whereas the finger flexor endurance test showed no significant difference between the groups (p = 0.088). Both groups were able to utilize 57-69% of peak force, average force and RFD in the ledge condition compared to the jug condition, but the relative utilization was not different between the groups (p = 0.290-0.996). In conclusion, boulder climbers were stronger and more explosive compared to lead climbers, whereas no differences in finger flexor endurance were observed. Performing climbing-specific tests on a smaller hold appears to limit the force and power output equally between the two groups.	[Stien, Nicolay; Saeterbakken, Atle Hole; Hermans, Espen; Vereide, Vegard Albert; Olsen, Elias; Andersen, Vidar] Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Sogndal, Norway	Western Norway University of Applied Sciences	Saeterbakken, AH (corresponding author), Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Sogndal, Norway.	atle.saeterbakken@hvl.no						Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amca A, 2015, 33 INT C BIOM SPORTS; Amca AM, 2012, J SPORT SCI, V30, P669, DOI 10.1080/02640414.2012.658845; Balas J, 2016, EUR J SPORT SCI, V16, P764, DOI 10.1080/17461391.2015.1119198; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Deyhle MR, 2015, J STRENGTH COND RES, V29, P2006, DOI 10.1519/JSC.0000000000000823; Draper N., 2015, SPORTS TECHNOL, V8, P88, DOI [10.1080/19346182.2015.1107081, DOI 10.1080/19346182.2015.1107081]; Esposito F, 2009, EUR J APPL PHYSIOL, V105, P81, DOI 10.1007/s00421-008-0877-5; Fanchini M, 2013, J STRENGTH COND RES, V27, P310, DOI 10.1519/JSC.0b013e3182577026; Fryer S, 2017, EUR J SPORT SCI, V17, P1177, DOI 10.1080/17461391.2017.1353135; Fryer S, 2015, INT J SPORTS MED, V36, P137, DOI 10.1055/s-0034-1385887; Fryer SM, 2015, J STRENGTH COND RES, V29, P1633, DOI 10.1519/JSC.0000000000000804; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grant S, 2001, J SPORT SCI, V19, P499, DOI 10.1080/026404101750238953; Kodejska J., 2015, ACTA UNIVERSITATIS C, V51, P48, DOI [10.14712/23366052.2015.31, DOI 10.14712/23366052.2015.31]; Laffaye G, 2014, INT J SPORTS MED, V35, P670, DOI 10.1055/s-0033-1358473; Levernier G, 2017, J STRENGTH COND RES; Levernier G, 2021, SPORT BIOMECH, V20, P495, DOI 10.1080/14763141.2019.1584236; Limonta E, 2016, J SPORT SCI, V34, P133, DOI 10.1080/02640414.2015.1035738; Macdonald JH, 2011, WILD ENVIRON MED, V22, P140, DOI 10.1016/j.wem.2010.11.012; MacLeod D, 2007, J SPORT SCI, V25, P1433, DOI 10.1080/02640410600944550; Mermier CM, 2000, BRIT J SPORT MED, V34, P359, DOI 10.1136/bjsm.34.5.359; Michailov M, 2009, MED SPORT, P231, DOI DOI 10.2478/V10036-009-0036-Z; Michailov ML, 2018, RES Q EXERCISE SPORT, V89, P246, DOI 10.1080/02701367.2018.1441484; Noe F, 2001, GAIT POSTURE, V13, P86, DOI 10.1016/S0966-6362(00)00098-9; Quaine F, 2003, INT J SPORTS MED, V24, P424; SALE D, 1981, Canadian Journal of Applied Sport Sciences, V6, P87; Sheel AW, 2003, MED SCI SPORT EXER, V35, P1225, DOI 10.1249/01.MSS.0000074443.17247.05; Tillin NA, 2012, EXP PHYSIOL, V97, P630, DOI 10.1113/expphysiol.2011.063040; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; Vigouroux L, 2006, J SPORT SCI, V24, P181, DOI 10.1080/02640410500127785; Vigouroux L, 2018, J SPORTS SCI, P1; VOLLESTAD NK, 1988, J APPL PHYSIOL, V64, P1421, DOI 10.1152/jappl.1988.64.4.1421; Wall CB, 2004, J STRENGTH COND RES, V18, P77; Watts PB, 2004, EUR J APPL PHYSIOL, V91, P361, DOI 10.1007/s00421-003-1036-7; White DJ, 2010, J STRENGTH COND RES, V24, P1356, DOI 10.1519/JSC.0b013e3181cf75bd; Woollings KY, 2015, BRIT J SPORT MED, V49, P1094, DOI 10.1136/bjsports-2014-094372	37	16	16	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222529	10.1371/journal.pone.0222529	http://dx.doi.org/10.1371/journal.pone.0222529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536569	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800052
J	Showa, SP; Nyabadza, F; Hove-Musekwa, SD				Showa, Sarudzai P.; Nyabadza, Farai; Hove-Musekwa, Senelani D.			On the efficiency of HIV transmission: Insights through discrete time HIV models	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CELL SPREAD; INFECTION; BLOOD; DYNAMICS; REPLICATION; LYMPHOCYTES; RISK	There are different views on which of the two forms of viral spread is more efficient in vivo between cell-free and cell-associated virus. In this study, discrete time human immunodeficiency virus models are formulated and analysed with the goal of determining the form of viral spread that is more efficient in vivo. It is shown that on its own, cell-free viral spread cannot sustain an infection owing to the low infectivity of cell-free virus and cell-associated virus can sustain an infection because of the high infectivity of cell-associated virus. When acting concurrently, cell-associated virus is more efficient in spreading the infection upon exposure to the virus. However, in the long term, the two forms of viral spread contribute almost equally. Both forms of viral spread are shown to be able to initiate an infection.	[Showa, Sarudzai P.; Hove-Musekwa, Senelani D.] Natl Univ Sci & Technol, Dept Appl Math, Bulawayo, Zimbabwe; [Nyabadza, Farai] Univ Johannesburg, Dept Math & Appl Math, Auckland Pk Campus, Johannesburg, South Africa	National University of Science & Technology - Zimbabwe; University of Johannesburg	Showa, SP (corresponding author), Natl Univ Sci & Technol, Dept Appl Math, Bulawayo, Zimbabwe.	showa.sarudzai@gmail.com	Nyabadza, Farai/AAW-4942-2020	Nyabadza, Farai/0000-0003-3468-5581				Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BARBOSA P, 1994, AIDS RES HUM RETROV, V10, P53, DOI 10.1089/aid.1994.10.53; Barreto-de-Souza V, 2014, AM J REPROD IMMUNOL, V71, P589, DOI 10.1111/aji.12240; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; Butler DA, 2008, AIDS, V22, P1667, DOI 10.1097/QAD.0b013e32830bfed8; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Elaiw AM, 2016, AIP ADV, V6, DOI 10.1063/1.4960987; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Frange P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069144; Gianella S, 2012, VIROLOGY, V434, P2, DOI 10.1016/j.virol.2012.09.010; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Heath L, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001416; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iwami S, 2015, ELIFE, V4, DOI 10.7554/eLife.08150; KIRSCHNER D, 1996, NOTIES AMS, V43, P193; Kolodkin-Gal D, 2013, J VIROL, V87, P13589, DOI 10.1128/JVI.03108-12; Komarova NL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1049; Kramer A, 2010, STAT BIOL HEALTH, P1; Lai XL, 2014, SIAM J APPL MATH, V74, P898, DOI 10.1137/130930145; Lin JZ, 2017, APPL MATH COMPUT, V315, P516, DOI 10.1016/j.amc.2017.08.004; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Pantaleo G, 1998, NATURE, V362, P341; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg YJ, 1999, SEMIN IMMUNOL, V11, P139, DOI 10.1006/smim.1999.0169; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Sagar M, 2014, J INFECT DIS, V210, pS667, DOI 10.1093/infdis/jiu369; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Showa Sarudzai P, 2014, BMC Res Notes, V7, P737, DOI 10.1186/1756-0500-7-737; Showa SP, 2017, BIOL MED, V9, P420; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Srivastava PK, 2010, DIFFER EQUAT DYN SYS, V18, P385, DOI 10.1007/s12591-010-0074-y; Srivastava PK, 2010, NONLINEAR ANAL-REAL, V11, P612, DOI 10.1016/j.nonrwa.2008.10.037; Sturmer M, 2008, ANTIVIR THER, V13, P729; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; Wang JL, 2016, APPL MATH COMPUT, V291, P149, DOI 10.1016/j.amc.2016.06.032; Wang SF, 2012, APPL MATH MODEL, V36, P1313, DOI 10.1016/j.apm.2011.07.086; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	52	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222574	10.1371/journal.pone.0222574	http://dx.doi.org/10.1371/journal.pone.0222574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532803	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600032
J	Lanzillo, B; Piscosquito, G; Marcuccio, L; Lanzillo, A; Vitale, DF				Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco			Prognosis of severe acquired brain injury: Short and long-term outcome determinants and their potential clinical relevance after rehabilitation. A comprehensive approach to analyze cohort studies	PLOS ONE			English	Article							MODELS; PREDICTION	Background Accurate prognostic evaluation is a key factor in the clinical management of patients affected by severe acute brain injury (ABI) and helps planning focused therapies, better caregiver's support and allocation of resources. Aim of the study was to assess factors independently associated with both the short and long-term outcomes after rehabilitation in patients affected by ABI in the setting of a single Rehabilitation Unit specifically allocated to these patients. Methods and findings In all patients (567) with age. 18 years discharged from the Unit in the period 2006/2015 demographic, etiologic, comorbidity indicators, and descriptors of the disability burden (at hospital admission and discharge) were evaluated as potential prognostic factors of both short-term (4 classes of disability status at discharge) and long-term (mortality) outcomes. A comprehensive analytical method was adopted to combine several tasks. Select the factors with a significant independent association with the outcome, assess the relative weights and the "stability" (by bootstrap resampling) of them and estimate the role of the prognostic models in the clinical framework considering "cost" and "benefits". The generalized ordered logistic model for ordinal dependent variables was used for the short-term outcome while the Cox proportional hazard model was used for the long-term outcome. The final shortterm model identified 7 factors that independently account for 37% of the outcome variability as shown by pseudo R-2 (pR(2)) = 0.37. The disability status descriptors show the strongest association since they account for more than 60% of the pR(2), followed by age (14.8%), the presence of percutaneous endoscopic gastrostomy or nasogastric intubation (14.4%), a longer stay in the acute ward (5.9%) and concomitant coronary disease (1.3%). The final multivariable Cox model identified 4 factors that independently account for 52% of the outcome variability (R-2 = 0.52). The disability extent and the disability recovered lead the long-term mortality since they account for the 53% of the global R-2. The relevant effect of age (42%) is appreciable only after 2 years given the significant interaction with time. A longer stay in the acute ward explains the remaining fraction (5%). Considering 'cost and benefits', the decision curve analysis shows that the clinical benefit achieved by using both prognostic models is greater than the other possible action strategies, namely 'treat all' and 'treat none. Several less obvious characteristics of the prognostic models are appreciated by integrating the results of multiple analytical methods. Conclusion The comprehensive analytical tool aimed to integrate statistical significance, weight, "stability" and clinical "net" benefit, gives back a prognostic framework explaining a relevant portion of both outcomes' variability in which the strong association of the disability status with both outcomes is comparable to and followed by a time modulated role of age. Our data do not support a differentiated association of traumatic vs non-traumatic etiology. The results encourage the use of integrated approach to analyze cohort data.	[Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco] IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy; [Vitale, Dino Franco] Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy		Vitale, DF (corresponding author), IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy.; Vitale, DF (corresponding author), Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy.	dinofranco.vitale@fastwebnet.it	Lanzillo, Anna/ABF-5999-2021; bernardo, lanzillo/F-1496-2019; piscosquito, giuseppe/A-9053-2018	Lanzillo, Anna/0000-0003-2385-401X; bernardo, lanzillo/0000-0001-5473-0701; piscosquito, giuseppe/0000-0001-6768-8936				Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Lanzillo B, 2015, EUR J PHYS REHAB MED, V51, P587; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2008, MULTIVARIATE MODEL B, P183; Royston P, 2011, FLEXIBLE PARAMETRIC, P275; Sauerbrei W, 2007, BIOMETRICAL J, V49, P453, DOI 10.1002/bimj.200610328; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	25	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0216507	10.1371/journal.pone.0216507	http://dx.doi.org/10.1371/journal.pone.0216507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557186	gold, Green Published			2022-12-27	WOS:000532345500005
J	Keutgen, AJ; Wszelaczynska, E; Poberezny, J; Przewodowska, A; Przewodowski, W; Milczarek, D; Tatarowska, B; Flis, B; Keutgen, N				Keutgen, Anna Jadwiga; Wszelaczynska, Elzbieta; Poberezny, Jaroslaw; Przewodowska, Agnieszka; Przewodowski, Wlodzimierz; Milczarek, Dorota; Tatarowska, Beata; Flis, Bogdan; Keutgen, Norbert			Antioxidant properties of potato tubers (Solanum tuberosum L.) as a consequence of genetic potential and growing conditions	PLOS ONE			English	Article							CHLOROGENIC ACID; CULTIVATION; HEALTH; COMPONENTS; NUTRITION; LOCATION; QUALITY	The concentrations of the bioactive compounds in potato tubers are determined by both genetic potential and environmental factors. The purpose of the experiment was to determine the influence of organic and integrated production on the expression of the genetic potential with respect to the antioxidant properties of potato tubers and to evaluate its stability under different environmental conditions. This phenotyping was performed on seven new breeding lines (tetraploid clones) and three modern cultivars: Jelly, Satina and Tajfun. The results indicated that production system and location significantly influenced the antioxidant capacity measured by FRAP method. Organic farming and the location Chwalowice were characterized by higher values. Furthermore, anitioxidative capacity measured by FRAP method was correlated with chlorogenic acid content (r = 0.590**) and glutathione fractions, especially with the reduced form (GSH, r = 0.692**). Multidimensional comparative analysis (MCA) proved a better development of antioxidant properties of potato tubers in the organic cultivation system when compared with the integrated. Especially favorable were growing conditions at Boguchwala (organic) and worst at Mlocho ' w (integrated). From all investigated varieties, the best antioxidant properties were found in 'Satina' and 'Jelly'. Clones TG-97403 and 13-VIII-45 developed the weakest health promoting traits.	[Keutgen, Anna Jadwiga; Keutgen, Norbert] BOKU Univ Nat Resources & Life Sci, Div Vegetables & Ornamentals, Dept Crop Sci, Vienna, Austria; [Wszelaczynska, Elzbieta; Poberezny, Jaroslaw] UTP Univ Sci & Technol, Dept Microbiol & Food Technol, Bydgoszcz, Poland; [Przewodowska, Agnieszka; Przewodowski, Wlodzimierz] Bonin Res Ctr, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Bonin, Poland; [Milczarek, Dorota; Tatarowska, Beata; Flis, Bogdan] Mlochow Res Ctr, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Mlochow, Poland	University of Natural Resources & Life Sciences, Vienna; Bydgoszcz University of Science & Technology; Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization	Keutgen, AJ (corresponding author), BOKU Univ Nat Resources & Life Sci, Div Vegetables & Ornamentals, Dept Crop Sci, Vienna, Austria.	anna.keutgen@boku.ac.at	Pobereżny, Jarosław/AAS-7388-2021; Wszelaczyńska, Elżbieta/AAS-7418-2021; Keutgen, Norbert/AAU-4045-2021; Keutgen, Norbert/G-1659-2019	Pobereżny, Jarosław/0000-0002-5446-3145; Wszelaczyńska, Elżbieta/0000-0003-4694-2522; Keutgen, Norbert/0000-0002-6625-5458; Keutgen, Norbert/0000-0002-6625-5458; Przewodowska, Agnieszka/0000-0002-4645-3772; Milczarek, Dorota/0000-0002-1914-9038; Tatarowska, Beata/0000-0003-2004-5671; Przewodowski, Wlodzimierz/0000-0002-4456-4727	National Science Centre Poland (Narodowe Centrum Nauki PL) [DEC-2013/11/B/NZ9/00778]; BOKU Vienna Open Access Publishing Fund	National Science Centre Poland (Narodowe Centrum Nauki PL); BOKU Vienna Open Access Publishing Fund	This work was financed by the resources of National Science Centre Poland (Narodowe Centrum Nauki PL) granted based on a decision number DEC-2013/11/B/NZ9/00778 entitled `Influence of genotype and environment on bioactive compounds and antioxidative potential in potato tubers'. Publication was supported by BOKU Vienna Open Access Publishing Fund.	Akyol H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060835; ALBRECHT JA, 1993, J FOOD QUALITY, V16, P311, DOI 10.1111/j.1745-4557.1993.tb00116.x; Bartova V, 2013, EUR J AGRON, V49, P20, DOI 10.1016/j.eja.2013.02.009; Beals KA, 2019, AM J POTATO RES, V96, P102, DOI 10.1007/s12230-018-09705-4; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025; Ferrer-Gallego R, 2015, CHEM SENSES, V40, P381, DOI 10.1093/chemse/bjv018; Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s; Galani JHY, 2017, HORTIC PLANT J, V3, P73, DOI 10.1016/j.hpj.2017.07.004; GRIFFITHS DW, 1992, J SCI FOOD AGR, V58, P41, DOI 10.1002/jsfa.2740580108; Grudzinska M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153980; Gugala M, 2017, PLANT SOIL ENVIRON, V63, P231, DOI 10.17221/196/2017-PSE; Gumul D, 2011, ACTA SCI POLON-TECHN, V10, P73; Hamouz K, 2005, PLANT SOIL ENVIRON, V51, P397, DOI 10.17221/3603-PSE; Hamouz K, 2013, PLANT SOIL ENVIRON, V59, P465, DOI 10.17221/460/2013-PSE; Keutgen AJ, 2008, FOOD CHEM, V107, P1413, DOI 10.1016/j.foodchem.2007.09.071; Keutgen AJ, 2020, POTATO RES, V63, P75, DOI 10.1007/s11540-019-09429-w; King JC, 2013, ADV NUTR, V4, p393S, DOI 10.3945/an.112.003525; Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w; Lombardo S, 2017, J FOOD COMPOS ANAL, V62, P189, DOI 10.1016/j.jfca.2017.05.014; Lombardo S, 2013, J FOOD COMPOS ANAL, V32, P28, DOI 10.1016/j.jfca.2013.08.003; Lombardo S, 2012, FOOD CHEM, V133, P1249, DOI 10.1016/j.foodchem.2011.10.005; Lovat C, 2016, CRIT REV FOOD SCI, V56, P2278, DOI 10.1080/10408398.2013.830208; Main Inspectorate of Plant Health and Seed Inspection (PIORIN), 2014, MET INT PROD ZIEMN; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633; Murr C, 2009, ATHEROSCLEROSIS, V202, P543, DOI 10.1016/j.atherosclerosis.2008.04.047; Nowacki W., 2012, CHARACTERISTIC COUNT; Pinhero R. G., 2016, American Journal of Plant Sciences, V7, P69, DOI 10.4236/ajps.2016.71008; Raymundo R, 2018, EUR J AGRON, V100, P87, DOI 10.1016/j.eja.2017.11.008; Reddivari L, 2007, J AGR FOOD CHEM, V55, P8073, DOI 10.1021/jf071543w; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Tatarowska B, 2019, AM J POTATO RES, V96, P493, DOI 10.1007/s12230-019-09732-9; Tsao R., 2009, GLOBAL SCI BOOKS FOO, P125; Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Wszelaczynska E., 2004, Acta Scientiarum Polonorum - Agricultura, V3, P175	41	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222976	10.1371/journal.pone.0222976	http://dx.doi.org/10.1371/journal.pone.0222976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553784	Green Published, gold			2022-12-27	WOS:000532319200048
J	Santotoribio, JD; del Valle-Vazquez, L; Garcia-de la Torre, A; del Castillo-Otero, D; Lopez-Saez, JB; del Pino, MJS				Santotoribio, Jose D.; del Valle-Vazquez, Luis; Garcia-de la Torre, Angela; del Castillo-Otero, Daniel; Lopez-Saez, Juan-Bosco; Sanchez del Pino, Maria J.			The diagnostic value of pleural fluid homocysteine in malignant pleural effusion	PLOS ONE			English	Article							TUMOR-MARKERS; CARCINOEMBRYONIC ANTIGEN; DIFFERENTIAL-DIAGNOSIS; ACCURACY; MANAGEMENT	Background Pleural fluid homocysteine (HCY) can be useful for diagnosis of malignant pleural effusion (MPE). There are no published studies comparing the diagnostic accuracy of HCY with other tumour markers in pleural fluid for diagnosis of MPE. The aim was to compare the accuracy of HCY with that of carcinoembryonic antigen (CEA), cancer antigen (CA) 15.3, CA19.9 and CA125 in pleural fluid and to develop a probabilistic model using these biomarkers to differentiate benign (BPE) from MPE. Methods Patients with pleural effusion were randomly included. HCY, CEA, CA15.3, CEA19.9 and CA125 were quantified in pleural fluid. Patients were classified into two groups: MPE or BPE. By applying logistic regression analysis, a multivariate probabilistic model was developed using pleural fluid biomarkers. The diagnostic accuracy was determined by receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC). Results Population of study comprised 133 patients (72 males and 61 females) aged between 1 and 96 years (median = 70 years), 81 BPE and 52 MPE. The logistic regression analysis included HCY (p< 0.0001) and CEA (p = 0.0022) in the probabilistic model and excluded the other tumour markers. The probabilistic model was: HCY+CEA = Probability(%) = 100x( 1 +e(-z))(-1), where Z = 0.5471x[ HCY]+0.3846x[ CEA]-8.2671. The AUCs were 0.606, 0.703, 0.778, 0.800, 0.846 and 0.948 for CA125, CA19.9, CEA, CA15.3, HCY and HCY+CEA, respectively. Conclusions Pleural fluid HCY has higher accuracy for diagnosis of MPE than CEA, CA15.3, CA19.9 and CA125. The combination of HCY and CEA concentrations in pleural fluid significantly improves the diagnostic accuracy of the test.	[Santotoribio, Jose D.] Puerto Real Univ Hosp, Dept Lab Med, Cadiz, Spain; [Santotoribio, Jose D.; Sanchez del Pino, Maria J.] Cadiz Univ, Sch Med, Dept Biomed Biotechnol & Publ Hlth, Cadiz, Spain; [del Valle-Vazquez, Luis] Hlth Ctr Las Beatas, Seville, Spain; [Garcia-de la Torre, Angela] Virgen Victoria Univ Hosp, Dept Lab Med, Malaga, Spain; [Garcia-de la Torre, Angela] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [del Castillo-Otero, Daniel] Puerto Real Univ Hosp, Dept Pneumol, Cadiz, Spain; [del Castillo-Otero, Daniel; Lopez-Saez, Juan-Bosco] Cadiz Univ, Sch Med, Dept Med, Cadiz, Spain; [Lopez-Saez, Juan-Bosco] Puerto Real Univ Hosp, Dept Internal Med, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerto Real; Universidad de Malaga; Universidad de Cadiz; Hospital Universitario Puerto Real; Universidad de Cadiz; Hospital Universitario Puerto Real	Santotoribio, JD (corresponding author), Puerto Real Univ Hosp, Dept Lab Med, Cadiz, Spain.; Santotoribio, JD (corresponding author), Cadiz Univ, Sch Med, Dept Biomed Biotechnol & Publ Hlth, Cadiz, Spain.	josediego.santotoribio@uca.es	Santotoribio, Jose D/L-8738-2016; LOPEZ-SAEZ, JUAN-BOSCO/J-5449-2014	Santotoribio, Jose D/0000-0002-8851-7551; LOPEZ-SAEZ, JUAN-BOSCO/0000-0002-4897-5283; del Valle Vazquez, Luis/0000-0001-9365-422X				[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Chen S, 2015, CLIN CHIM ACTA, V441, P142, DOI 10.1016/j.cca.2014.12.029; Cobo E, 2002, MED CLIN-BARCELONA, V119, P230; Santotoribio JD, 2010, MED CLIN-BARCELONA, V135, P574, DOI 10.1016/j.medcli.2009.06.023; Egan AM, 2014, QJM-INT J MED, V107, P179, DOI 10.1093/qjmed/hct245; Ferreiro L, 2015, MED CLIN-BARCELONA, V145, P171, DOI 10.1016/j.medcli.2014.08.005; Gaspar MJ, 2008, ANTICANCER RES, V28, P2947; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Li DD, 2014, TUMOR BIOL, V35, P6003, DOI 10.1007/s13277-014-1795-2; Liang QL, 2008, THORAX, V63, P35, DOI 10.1136/thx.2007.077958; Lippi G, 2012, CLIN CHEM LAB MED, V50, P2075, DOI 10.1515/cclm-2012-0372; Maroto-Sanchez B, 2016, CLIN CHEM LAB MED, V54, P1561, DOI 10.1515/cclm-2015-1040; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Porcel JM, 2004, CHEST, V126, P1757, DOI 10.1378/chest.126.6.1757; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; RUCKDESCHEL JC, 1995, SEMIN ONCOL, V22, P58; Santotoribio JD, 2015, TUMOR BIOL, V36, P7941, DOI 10.1007/s13277-015-3517-9; Shi HZ, 2008, RESPIROLOGY, V13, P518, DOI 10.1111/j.1440-1843.2008.01291.x; Thomas JM, 2013, CLIN CHEST MED, V34, P459, DOI 10.1016/j.ccm.2013.05.004; Trape J, 2004, TUMOR BIOL, V25, P276, DOI 10.1159/000081392; Trape J, 2012, TUMOR BIOL, V33, P1661, DOI 10.1007/s13277-012-0422-3; Volaric D, 2018, BIOCHEM MEDICA, V28, DOI 10.11613/BM.2018.010706; Wang YM, 2013, CLIN CHIM ACTA, V421, P230, DOI 10.1016/j.cca.2013.03.013; Wu Q, 2015, EXP THER MED, V9, P232, DOI 10.3892/etm.2014.2039; Yang Y, 2017, RESPIRATION, V94, P62, DOI 10.1159/000468545	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222616	10.1371/journal.pone.0222616	http://dx.doi.org/10.1371/journal.pone.0222616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550262	gold, Green Published			2022-12-27	WOS:000532307700020
J	Petitte, J; Doherty, M; Ladd, J; Marin, CL; Siles, S; Michelou, V; Damon, A; Eckert, EQ; Huang, X; Rice, JW				Petitte, Jennifer; Doherty, Michael; Ladd, Jacob; Marin, Cassandra L.; Siles, Samuel; Michelou, Vanessa; Damon, Amanda; Eckert, Erin Quattrini; Huang, Xiang; Rice, John W.			Use of high-content analysis and machine learning to characterize complex microbial samples via morphological analysis	PLOS ONE			English	Article							COATINGS; TOOL	High Content Analysis (HCA) has become a cornerstone of cellular analysis within the drug discovery industry. To expand the capabilities of HCA, we have applied the same analysis methods, validated in numerous mammalian cell models, to microbiology methodology. Image acquisition and analysis of various microbial samples, ranging from pure cultures to culture mixtures containing up to three different bacterial species, were quantified and identified using various machine learning processes. These HCA techniques allow for faster cell enumeration than standard agar-plating methods, identification of "viable but not plate culturable" microbe phenotype, classification of antibiotic treatment effects, and identification of individual microbial strains in mixed cultures. These methods greatly expand the utility of HCA methods and automate tedious and low-throughput standard microbiological methods.	[Petitte, Jennifer; Doherty, Michael; Ladd, Jacob; Marin, Cassandra L.; Siles, Samuel; Michelou, Vanessa; Damon, Amanda; Eckert, Erin Quattrini; Huang, Xiang; Rice, John W.] Novozymes North Amer Inc, Durham, NC 27709 USA		Rice, JW (corresponding author), Novozymes North Amer Inc, Durham, NC 27709 USA.	jri@novozymes.com		Rice, John/0000-0001-5713-5430				Barros RC, 2017, J BIOMED MATER RES A, V105, P2252, DOI 10.1002/jbm.a.36092; Berg G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00491; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Domingues JFD, 2015, ACTA BIOMATER, V18, P1, DOI 10.1016/j.actbio.2015.02.028; Durr O, 2018, ASSAY DRUG DEV TECHN, V16, P343, DOI 10.1089/adt.2018.859; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Grote M, 2018, HIST PHIL LIFE SCI, V40, DOI 10.1007/s40656-017-0175-9; Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1; Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Koydemir HC, 2015, LAB CHIP, V15, P1284, DOI 10.1039/c4lc01358a; Li M, 2015, ACTA PHARMACOL SIN, V36, P769, DOI 10.1038/aps.2015.28; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Riss TL, 2004, CELL VIABILITY ASSAY; Rohde A, 2015, FOOD MICROBIOL, V46, P395, DOI 10.1016/j.fm.2014.09.002; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; SORENSEN K, 1986, J IMMUNOL METHODS, V95, P291, DOI 10.1016/0022-1759(86)90419-9; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Sutton S., MICROBIOLOGY TOPICS; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van der Heijden MGA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002378; Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x; Wang Y, 2016, CURR OPIN BIOTECH, V41, P34, DOI 10.1016/j.copbio.2016.04.018; WATANAKUNAKORN C, 1984, J ANTIMICROB CHEMOTH, V14, P7, DOI 10.1093/jac/14.suppl_D.7; Zoffmann S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39387-9	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222528	10.1371/journal.pone.0222528	http://dx.doi.org/10.1371/journal.pone.0222528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545814	Green Published, gold			2022-12-27	WOS:000532303200020
J	Li, MD; Hung, A; Lenon, GB; Yang, AWH				Li, Mingdi; Hung, Andrew; Lenon, George Binh; Yang, Angela Wei Hong			Chinese herbal formulae for the treatment of menopausal hot flushes: A systematic review and meta-analysis	PLOS ONE			English	Review							PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; ER-XIAN DECOCTION; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; HORMONE-THERAPY; MEDICINAL HERBS; POSITION STATEMENT; VASOMOTOR SYMPTOMS; CLINICAL-TRIAL	Objectives This systematic review aimed to evaluate the therapeutic effects and safety of Chinese herbal medicine (CHM) formulae for managing menopausal hot flushes (MHF). Methods Seven English and Chinese databases were searched for studies from respective inceptions to February 2019. Randomized controlled trials investigating the clinical effects and safety of CHM formulae on MHF were considered for inclusion. The outcomes of subjective feelings (MHF and quality of life), objective changes (hormones and peripheral blood flow) and safety were analyzed. The most frequently prescribed formulae and herbs were summarized. Results Nineteen randomized clinical trials involving 2469 patients were included. When compared to menopausal hormone therapy, CHM had similar effects to menopausal hormone therapy on total effectiveness rate (OR 1.41, 95% CI 0.84 to 2.35) and total Kupperman index (KI) score (SMD -0.13, 95% CI -0.61 to 0.36), and could significantly reduce vasomotor symptom score (MD -0.43, 95% CI -0.55 to -0.31) and upper-body peripheral blood flow (MD -3.56, 95% CI -5.14 to -1.98 under the jaw, MD -7.10, 95% CI -11.01 to -3.19 in the fingertip). When compared to placebo, CHM could reduce MHF severity (MD -0.70, 95% CI-1.00 to -0.40) and improve total KI score (MD -12.61, 95% CI -15.21 to -10.01). However, no statistically significant changes to hormone levels were detected. Most commonly seen adverse events were mild gastrointestinal tract reactions. The most popularly studied formula was Kun Tai capsule and the most frequently prescribed herb was Bai shao (Paeoniae Radix Alba, Paeonia lactiflora Pall.). More than 50% included studies had low risks of bias in the domains of selection, performance, attrition and reporting. Conclusions This review indicated that CHM formulae were safe to be applied in MHF females and able to improve MHF-related symptom scores as well as the peripheral blood flow. Further studies should focus on specific formulae.	[Li, Mingdi; Lenon, George Binh; Yang, Angela Wei Hong] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Hung, Andrew] RMIT Univ, Sch Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Yang, AWH (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia.	angela.yang@rmit.edu.au		Yang, Angela/0000-0001-9345-4607; Hung, Andrew/0000-0003-3569-2951; Li, Mingdi/0000-0002-5329-4562				Avis NE, 2009, MENOPAUSE, V16, P860, DOI 10.1097/gme.0b013e3181a3cdaf; Azizi H, 2011, ALTERN THER HEALTH M, V17, P48; Bair YA, 2008, MENOPAUSE, V15, P32, DOI 10.1097/gme.0b013e31813429d6; Berek J. S., 2012, BEREK NOVAKS GYNECOL; Carpenter J, 2015, MENOPAUSE, V22, P1155, DOI 10.1097/GME.0000000000000546; Chen HY, 2008, AM J CHINESE MED, V36, P233, DOI 10.1142/S0192415X08005746; Chen HL, 2014, CHINA PHARM, V23, P108; Chen JT, 2003, MATURITAS, V45, P199, DOI 10.1016/S0378-5122(03)00128-2; Cochrane Collaboration, 2014, REV MAN REVMAN VERS; Davis SR, 2001, MED J AUSTRALIA, V174, P68, DOI 10.5694/j.1326-5377.2001.tb143156.x; Fragkos Konstantinos C, 2014, Int Sch Res Notices, V2014, P825383, DOI 10.1155/2014/825383; Fu LH, 2015, WORLD J INTEGRATED T, P89; Fu SF, 2016, MENOPAUSE, V23, P311, DOI 10.1097/GME.0000000000000534; Grady Deborah, 2005, Am J Med, V118 Suppl 12B, P163, DOI 10.1016/j.amjmed.2005.09.051; Grady D, 2009, MENOPAUSE, V16, P458, DOI 10.1097/gme.0b013e31818e64dd; Haines CJ, 2008, CLIMACTERIC, V11, P244, DOI 10.1080/13697130802073029; Hao Qingxiu, 2009, Zhongguo Zhong Yao Za Zhi, V34, P620; Holm ACES, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/579321; Hunter MS, 2012, BJOG-INT J OBSTET GY, V119, P40, DOI 10.1111/j.1471-0528.2011.03166.x; HUNTER MS, 1995, BRIT J CLIN PSYCHOL, V34, P589, DOI 10.1111/j.2044-8260.1995.tb01493.x; Lee SH, 2004, J NUTR BIOCHEM, V15, P452, DOI 10.1016/j.jnutbio.2004.01.007; Li HY, 2018, HEBEI MED J, V40, P3610; Li YQ, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/1327251; Liu XY., 2008, GUIDING J TRADITIONA, V14, P47; [栾燕秋 Luan Yanqiu], 2004, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V20, P452; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; National Guideline Clearinghouse, 2015, MEN DIAGN MAN; Nedeljkovic M, 2014, MENOPAUSE, V21, P15, DOI [10.1097/GME.0b013e31829374e8, 10.1097/gme.0b013e31829374e8]; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Plotnikoff GA, 2011, MENOPAUSE, V18, P886, DOI 10.1097/gme.0b013e31821643d9; Scheid V, 2010, MATURITAS, V66, P111, DOI 10.1016/j.maturitas.2009.11.020; Shams T, 2014, J GEN INTERN MED, V29, P204, DOI 10.1007/s11606-013-2535-9; Smith RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155079; Sturdee DW, 2017, CLIMACTERIC, V20, P296, DOI 10.1080/13697137.2017.1306507; Sun AJ, 2018, CHIN J INTEGR MED, V24, P487, DOI 10.1007/s11655-016-2266-y; Suurmond R, 2017, RES SYNTH METHODS, V8, P537, DOI 10.1002/jrsm.1260; Ushiroyama T, 2005, AM J CHINESE MED, V33, P259, DOI 10.1142/S0192415X05002813; van der Sluijs CP, 2009, MENOPAUSE, V16, P336, DOI 10.1097/gme.0b013e3181883dc1; Xia Y, 2012, MENOPAUSE, V19, P234, DOI 10.1097/gme.0b013e3182273177; Xu H, 2012, J ETHNOPHARMACOL, V143, P109, DOI 10.1016/j.jep.2012.06.009; Xu LW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/568106; Zhao Pi-Wen, 2007, Zhongguo Zhong Yao Za Zhi, V32, P436; Zhong LLD, 2013, MENOPAUSE, V20, P767, DOI [10.1097/gme.0b013e31827cd3dd, 10.1097/GME.0b013e31827cd3dd]; Zhou J, 2007, EXPLORE-NY, V3, P478, DOI 10.1016/j.explore.2007.06.002; Zhou YJ, 2016, JIANGXI MED J, V51, P170	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222383	10.1371/journal.pone.0222383	http://dx.doi.org/10.1371/journal.pone.0222383			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536531	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800040
J	Zhu, XC; Gopurenko, D; Serrano, M; Spencer, MA; Pieterse, PJ; Skoneczny, D; Lepschi, BJ; Reigosa, MJ; Gurr, GM; Callaway, RM; Weston, LA				Zhu, Xiaocheng; Gopurenko, David; Serrano, Miguel; Spencer, Mark A.; Pieterse, Petrus J.; Skoneczny, Dominik; Lepschi, Brendan J.; Reigosa, Manuel J.; Gurr, Geoff M.; Callaway, Ragan M.; Weston, Leslie A.			Genetic evidence for plural introduction pathways of the invasive weed Paterson's curse (Echium plantagineum L.) to southern Australia	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; INTERREGIONAL HYBRIDS; POPULATION-GENETICS; HISTORY; PLANT; AMPLIFICATION; EVOLUTION; RELEASE; REGIONS; BIOLOGY	Paterson's curse (Echium plantagineum L. (Boraginaceae)), is an herbaceous annual native to Western Europe and northwest Africa. It has been recorded in Australia since the 1800's and is now a major weed in pastures and rangelands, but its introduction history is poorly understood. An understanding of its invasion pathway and subsequent genetic structure is critical to the successful introduction of biological control agents and for provision of informed decisions for plant biosecurity efforts. We sampled E. plantagineum in its native (Iberian Peninsula), non-native (UK) and invaded ranges (Australia and South Africa) and analysed three chloroplast gene regions. Considerable genetic diversity was found among E. plantagineum in Australia, suggesting a complex introduction history. Fourteen haplotypes were identified globally, 10 of which were co-present in Australia and South Africa, indicating South Africa as an important source population, likely through contamination of traded goods or livestock. Haplotype 4 was most abundant in Australia (43%), and in historical and contemporary UK populations (80%), but scarce elsewhere (< 17%), suggesting that ornamental and/or other introductions from genetically impoverished UK sources were also important. Collectively, genetic evidence and historical records indicate E. plantagineum in southern Australia exists as an admixture that is likely derived from introduced source populations in both the UK and South Africa.	[Zhu, Xiaocheng; Gurr, Geoff M.; Weston, Leslie A.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Zhu, Xiaocheng; Gopurenko, David; Gurr, Geoff M.; Weston, Leslie A.] Charles Sturt Univ, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Serrano, Miguel] Univ Santiago de Compostela, Fac Pharm, Dept Bot, Santiago De Compostela, Spain; [Spencer, Mark A.] Nat Hist Museum, Dept Life Sci, London, England; [Pieterse, Petrus J.] Stellenbosch Univ, Dept Agron, Private Bag X1, Matieland, South Africa; [Skoneczny, Dominik] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Lepschi, Brendan J.] Ctr Australian Natl Biodivers Res, Australian Natl Herbarium, Canberra, ACT, Australia; [Reigosa, Manuel J.] Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo, Pontevedra, Spain; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Universidade de Santiago de Compostela; Natural History Museum London; Stellenbosch University; University of Melbourne; Universidade de Vigo; University of Montana System; University of Montana	Zhu, XC (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.; Zhu, XC (corresponding author), Charles Sturt Univ, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.	xzhu@csu.edu.au	Zhu, Xiaocheng/B-6963-2015; GURR, GEOFFREY M/F-3519-2011; Serrano, Miguel/AAX-7557-2020; Zhu, Xiaocheng/AAB-4897-2021; Gopurenko, David/H-3341-2014; Weston, Leslie/M-4557-2015; Reigosa Roger, Manuel Joaquin/K-3551-2013	Zhu, Xiaocheng/0000-0003-4468-1090; Serrano, Miguel/0000-0003-3079-2355; Zhu, Xiaocheng/0000-0003-4468-1090; Gopurenko, David/0000-0003-2886-1614; Weston, Leslie/0000-0002-1029-7982; Reigosa Roger, Manuel Joaquin/0000-0003-0527-1849; Gurr, Geoff/0000-0001-5008-7966	Australian Research Council [DP130104346]; Graham Centre for Agricultural Innovation (associated internal funding)	Australian Research Council(Australian Research Council); Graham Centre for Agricultural Innovation (associated internal funding)	This project was funded by the Australian Research Council (Discovery Project: DP130104346) to LAW and the Graham Centre for Agricultural Innovation (associated internal funding) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker BS, 2017, MOL ECOL, V26, P1131, DOI 10.1111/mec.13998; Barnard M, 1963, HIST AUSTR; Bena G, 1998, MOL PHYLOGENET EVOL, V9, P552, DOI 10.1006/mpev.1998.0493; BURDON JJ, 1986, AUST J BIOL SCI, V39, P369, DOI 10.1071/BI9860369; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clements DR, 2001, CAN J PLANT SCI, V81, P325, DOI 10.4141/P99-128; Correia M, 2016, J ECOL, V104, P1391, DOI 10.1111/1365-2745.12612; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Cronk Q.C.B., 2001, PLANT INVADERS THREA; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evans KJ, 2007, AUST SYST BOT, V20, P187, DOI 10.1071/SB06044; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkner KT, 2016, BIOL INVASIONS, V18, P73, DOI 10.1007/s10530-015-0990-4; Filipe JC, 2016, PLANT ECOL DIVERS, V9, P381, DOI 10.1080/17550874.2016.1261950; Gau RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067944; GIBBS P.E., 1971, LAGASCALIA, V1, P27; Gildenhuys E, 2015, BOT J LINN SOC, DOI [10.1111/boj.12238, DOI 10.1111/BOJ.12238]; Gopurenko David, 2013, Records of the Western Australian Museum, P253; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Henderson L., 2001, PLANT PROTECTION RES; Ireson JE, 2003, BIOL CONTROL, V26, P117, DOI 10.1016/S1049-9644(02)00128-7; Kannan R, 2013, BIOL INVASIONS, V15, P1287, DOI 10.1007/s10530-012-0365-z; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Kloot P. M., 1982, AUSTR WEEDS, V1, P29; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Loudon J.C., 1830, LOUDONS HORTUS BRITA; Massy C., 2007, AUSTR MERINO STORY N; Michaelides SN, 2015, MOL ECOL, V24, P2702, DOI 10.1111/mec.13206; Montesinos D, 2018, ECOL EVOL, V8, P7378, DOI 10.1002/ece3.4080; Montesinos D, 2017, ECOGRAPHY, V40, P801, DOI 10.1111/ecog.02653; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Museum NH, ECH PLANT L PURPL VI; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak SJ, 2001, BIOSCIENCE, V51, P114, DOI 10.1641/0006-3568(2001)051[0114:TPIASG]2.0.CO;2; NRM SatSTCA, 2016, PAT CURS 2009; Petit R, 2006, CONTRIB; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PIGGIN C M, 1977, Muelleria, V3, P215; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; Pimentel D., 2002, BIOL INVASIONS EC EN; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Retief E, 1998, BOTHALIA, V28, P167, DOI 10.4102/abc.v28i2.634; Rivas-Martinez S., 2017, PLANT VEGETATION VEG, VVolume 12, P131, DOI DOI 10.1007/978-3-319-54784-8_5; Shaik RS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow030; Skoneczny D, 2017, 8 WORLD C ALL; Skoneczny D, 2015, INT J MOL SCI, V16, P26721, DOI 10.3390/ijms161125979; SLATKIN M, 1991, GENETICS, V127, P627; Su NY, 2013, FLA ENTOMOL, V96, P765, DOI 10.1653/024.096.0309; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USDA, 2017, WEED RISK ASS ECH PL; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Welsh F., 1998, HIST S AFRICA; Weston L. A., 2011, 23rd Asian-Pacific Weed Science Society Conference. Volume 1: weed management in a changing world, Cairns, Queensland, Australia, 26-29 September 2011, P576; Weston PA, 2013, PHYTOCHEM REV, V12, P831, DOI 10.1007/s11101-013-9306-4; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Zhu X, 2014, 19 AUSTR WEEDS C; Zhu XC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42792; Zhu XC, 2016, J EXP BOT, V67, P3777, DOI 10.1093/jxb/erw182; Zimmerman H. G, 2003, INVASIVE ALIEN SPECI, P45	66	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222696	10.1371/journal.pone.0222696	http://dx.doi.org/10.1371/journal.pone.0222696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536564	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800071
J	Ben-Yosef, E; Liss, B; Yagel, OA; Tirosh, O; Najjar, M; Levy, TE				Ben-Yosef, Erez; Liss, Brady; Yagel, Omri A.; Tirosh, Ofir; Najjar, Mohammad; Levy, Thomas E.			Ancient technology and punctuated change: Detecting the emergence of the Edomite Kingdom in the Southern Levant	PLOS ONE			English	Article							COPPER; TIMNA; EVOLUTION	While the punctuated equilibrium model has been employed in paleontological and archaeological research, it has rarely been applied for technological and social evolution in the Holocene. Using metallurgical technologies from the Wadi Arabah (Jordan/Israel) as a case study, we demonstrate a gradual technological development (13th-10th c. BCE) followed by a human agency-triggered punctuated "leap" (late-10th c. BCE) simultaneously across the entire region (an area of similar to 2000 km(2)). Here, we present an unparalleled, diachronic archaeometallurgical dataset focusing on elemental analysis of dozens of well-dated slag samples. Based on the results, we suggest punctuated equilibrium provides an innovative theoretical model for exploring ancient technological changes in relation to larger sociopolitical conditions-in the case at hand the emergence of biblical Edom-, exemplifying its potential for more general cross-cultural applications.	[Ben-Yosef, Erez; Yagel, Omri A.] Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel; [Liss, Brady; Najjar, Mohammad; Levy, Thomas E.] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Liss, Brady; Levy, Thomas E.] Univ Calif San Diego, Levantine & Cyber Archaeol Lab, La Jolla, CA 92093 USA; [Tirosh, Ofir] Hebrew Univ Jerusalem, Inst Earth Sci, Jerusalem, Israel	Tel Aviv University; University of California System; University of California San Diego; University of California System; University of California San Diego; Hebrew University of Jerusalem	Ben-Yosef, E (corresponding author), Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel.	ebenyose@tauex.tau.ac.il			Israel Science Foundation (ISF) [1880/17]; Naomi Prawer Kadar family; Norma Kershaw family; Jerome and Miriam Katzin family; UC San Diego Jewish Studies Program; Murray Galinson San Diego-Israel Initiative	Israel Science Foundation (ISF)(Israel Science Foundation); Naomi Prawer Kadar family; Norma Kershaw family; Jerome and Miriam Katzin family; UC San Diego Jewish Studies Program; Murray Galinson San Diego-Israel Initiative	This research was funded by the Israel Science Foundation (ISF), Grant #1880/17 to E.B.-Y., https://www.isf.org.il/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Y. Erel, C. Paterno for access to their laboratories and L. Tauxe and Y. Kolodny for their scientific advice. Thanks also to the Naomi Prawer Kadar family, Norma Kershaw family, Jerome and Miriam Katzin family, UC San Diego Jewish Studies Program and the Murray Galinson San Diego-Israel Initiative for their support.	[Anonymous], 1986, 3 INTERMEDIATE PERIO; Ben-Yosef E, 2010, ARCHAEOMETRY, V52, P1110, DOI 10.1111/j.1475-4754.2010.00528.x; Ben-Yosef E, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005235; Ben-Yosef E., 2018, MONOGRAPH SERIES, V37, P28; Ben-Yosef E., 2012, BASOR, V367, P31, DOI [DOI 10.5615/BULLAMERSCH00RIE.367.0031, 10.5615/bullamerschoorie.367.0031, DOI 10.5615/bullamerschoorie.367.0031]; Ben-Yosef E., 2016, B AM SCH ORIENT RES, V376, P169, DOI [10.5615/bullamerschoorie.376.0169, DOI 10.5615/BULLAMERSCHOORIE.376.0169]; Ben-Yosef E., 2014, NEW INSIGHTS IRON AG, P887, DOI [10.2307/j.ctvdjrq5c.23, DOI 10.2307/J.CTVDJRQ5C.23]; Ben-Yosef E., 2018, TELL IT GATH STUDIES, P461; Ben-Yosef E., NOMADISM MONARCHY AR; Ben-Yosef E, 2019, VETUS TESTAMENTUM, V69, P361, DOI 10.1163/15685330-12341370; Ben-Yosef E, 2018, J ARCHAEOL SCI, V96, P208, DOI 10.1016/j.jas.2018.06.001; Ben-Yosef E, 2017, J ARCHAEOL SCI-REP, V11, P411, DOI 10.1016/j.jasrep.2016.12.010; Cavanagh M., 2016, THESIS; Charlton M. F., 2013, THE WORLD OF IRON, P288; Charlton MF, 2010, J ANTHROPOL ARCHAEOL, V29, P352, DOI 10.1016/j.jaa.2010.05.001; Cline EH, 2014, 1177 BC YEAR CIVILIZ; Dunnell RC, 1980, ADV ARCHAEOLOGICAL M, P35, DOI [10.1016/B978-0-12-003103-0.50007-1, DOI 10.1016/B978-0-12-003103-0.50007-1]; Eldredge N., 1972, P82; Finkelstein I., 2006, TEL AVIV, V33, P18, DOI [10.1179/tav.2006.2006.1.18, DOI 10.1179/tav.2006.2006.1.18, DOI 10.1179/TAV.2006.2006.1.18]; GLASSER FP, 1962, J AM CERAM SOC, V45, P242, DOI 10.1111/j.1151-2916.1962.tb11134.x; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gould SJ, 1977, PALEOBIOLOGY, V3, P233; Hansen S, 2017, APPROPRIATING INNOVA, P136; Hauptmann A, 2007, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-72238-0; Kiderlen M, 2016, J ARCHAEOL SCI-REP, V8, P303, DOI 10.1016/j.jasrep.2016.06.013; Kolodny O, 2015, P NATL ACAD SCI USA, V112, pE6762, DOI 10.1073/pnas.1520492112; Levy T.E., 2014, NEW INSIGHTS IRON AG, DOI 10.2307/j.ctvdjrq5c; Levy TE, 2008, P NATL ACAD SCI USA, V105, P16460, DOI 10.1073/pnas.0804950105; Lyman RL, 1998, CURR ANTHROPOL, V39, P615, DOI 10.1086/204786; Martin MAS, 2013, J ARCHAEOL SCI, V40, P3777, DOI 10.1016/j.jas.2013.04.024; Mazar Amihai, 2014, C VOLUME MUNICH 2013, V163, P347; Norris RD, 2012, EVOL ECOL, V26, P393, DOI 10.1007/s10682-011-9488-4; O'Brien MJ, 2011, J ARCHAEOL METHOD TH, V18, P309, DOI 10.1007/s10816-011-9110-7; PFAFFENBERGER B, 1992, ANNU REV ANTHROPOL, V21, P491, DOI 10.1146/annurev.an.21.100192.002423; Roberts BW, 2009, ANTIQUITY, V83, P1012, DOI 10.1017/S0003598X00099312; Rothenberg B, 1990, ANCIENT METALLURGY C; Rothenberg B, 1988, RES ARABA 1959 1984, V1; Sapir-Hen L, 2013, TEL AVIV, V40, P277, DOI 10.1179/033443513X13753505864089; Schiffer MB, 2005, AM ANTIQUITY, V70, P485, DOI 10.2307/40035310; Schiffer MichaelB., 2010, BEHAV ARCHAEOLOGY PR; Schneider T., 2010, EGYPT LEVANT, V20, P373, DOI [10.1553/AEundL20s373, DOI 10.1553/AEUNDL20S373]; STEIN G, 1999, RETHINKING WORLD SYS; Tylecote R.F., 1992, HIST METALLURGY, V2nd ed.; Yagel OA, 2016, LEVANT, V48, P33, DOI 10.1080/00758914.2016.1145943	44	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221967	10.1371/journal.pone.0221967	http://dx.doi.org/10.1371/journal.pone.0221967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532811	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600018
J	Ge, Y; Dong, XS; Wu, B; Wang, N; Chen, D; Chen, HH; Zou, MH; Xu, ZN; Tan, L; Zhan, RL				Ge, Yu; Dong, Xiangshu; Wu, Bin; Wang, Nan; Chen, Di; Chen, Haihong; Zou, Minghong; Xu, Zining; Tan, Lin; Zhan, Rulin			Evolutionary analysis of six chloroplast genomes from three Persea americana ecological races: Insights into sequence divergences and phylogenetic relationships	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; AVOCADO; LAURACEAE; SOFTWARE; PSEUDOGENE; ALIGNMENT; SYNOPSIS; MILL.	Chloroplasts significantly influence species phylogenies because of their maternal inheritance and the moderate evolutionary rate of their genomes. Avocado, which is a member of the family Lauraceae, has received considerable attention from botanists, likely because of its position as a basal angiosperm. However, there is relatively little avocado genomic information currently available. In this study, six complete avocado chloroplast genomes from three ecological races were assembled to examine the sequence diversity among the three avocado ecological races. A comparative genomic analysis revealed that 515 simple sequence repeat loci and 176 repeats belonging to four other types were polymorphic across the six chloroplast genomes. Three highly variable regions (trnC-GCA-petN, petN'-psbM, and petA-psbJ) were identified as highly informative markers. A phylogenetic analysis based on 79 common protein-coding genes indicated that the six examined avocado accessions from three ecological races form a monophyletic clade. The other three genera belonging to the Persea group clustered to form a sister clade with a high bootstrap value. These chloroplast genomes provide important genetic information for future attempts at identifying avocado races and for the related biological research.	[Ge, Yu; Wu, Bin; Wang, Nan; Chen, Di; Xu, Zining; Tan, Lin; Zhan, Rulin] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China; [Dong, Xiangshu] Yunnan Univ, Coll Agr, Kunming, Yunnan, Peoples R China; [Chen, Haihong] Guangxi Vocat & Tech Coll, Coll Agr, Nanning, Peoples R China; [Zou, Minghong] Chinese Acad Trop Agr Sci, South Subtrop Crops Res Inst, Zhanjiang, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Yunnan University; Chinese Academy of Tropical Agricultural Sciences	Tan, L; Zhan, RL (corresponding author), Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China.	tanlin7402@126.com; zhanrulin@catas.cn			National Natural Science Foundation of China [31701883]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (grant number 31701883) to YG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth VETM, 2003, J HERED, V94, P407, DOI 10.1093/jhered/esg076; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chanderbali AS, 2008, BIOESSAYS, V30, P386, DOI 10.1002/bies.20721; Chanderbali AS, 2009, P NATL ACAD SCI USA, V106, P8929, DOI 10.1073/pnas.0811476106; Cheon KS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214162; Chi XF, 2018, MOLECULES, V23, DOI 10.3390/molecules23030602; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; D'Agostino N, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100503; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fiedler J, 1998, EUPHYTICA, V101, P249, DOI 10.1023/A:1018321928400; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FURNIER GR, 1990, J HERED, V81, P183, DOI 10.1093/oxfordjournals.jhered.a110963; Galindo-Tovar ME, 2008, GENET RESOUR CROP EV, V55, P441, DOI 10.1007/s10722-007-9250-5; Ge Y, 2019, FORESTS, V10, DOI 10.3390/f10050411; Ge Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030215; Gross-German E, 2013, TREE GENET GENOMES, V9, P539, DOI 10.1007/s11295-012-0577-5; He DX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123780; Huang J, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120340; Huang JF, 2016, MOL PHYLOGENET EVOL, V96, P33, DOI 10.1016/j.ympev.2015.12.007; Jeon JH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010023; Jiang L, 2018, MOLECULES, V23, DOI 10.3390/molecules23061393; KOPP LUCILLE E., 1966, MEM NEW YORK BOTGARD, V14, P1; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li L, 2011, AM J BOT, V98, P1520, DOI 10.3732/ajb.1100006; Li W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216645; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu ML, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124039; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lu XJ, 2015, J MED GENET, V52, P17, DOI 10.1136/jmedgenet-2014-102785; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meng J, 2018, MOLECULES, V23, DOI 10.3390/molecules23051015; Mhameed S, 1997, THEOR APPL GENET, V94, P279, DOI 10.1007/s001220050411; Nie ZL, 2007, PLANT SYST EVOL, V267, P191, DOI 10.1007/s00606-007-0550-1; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prade VM, 2018, PLANT J, V93, P502, DOI 10.1111/tpj.13794; Schaffer B., 2012, AVOCADO BOT PRODUCTI; Schaffer B., 2002, AVOCADO BOT PRODUCTI; Schnell RJ, 2003, J AM SOC HORTIC SCI, V128, P881, DOI 10.21273/JASHS.128.6.0881; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Song Y, 2018, HOLZFORSCHUNG, V72, P337, DOI 10.1515/hf-2017-0065; Song Y, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1196-y; Song Y, 2017, GENOME BIOL EVOL, V9, P2354, DOI 10.1093/gbe/evx180; Song Y, 2016, CAN J FOREST RES, V46, P1293, DOI 10.1139/cjfr-2016-0199; Song Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00662; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; van der Werff H, 2002, NOVON, V12, P575, DOI 10.2307/3393142; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; WILLIAMS LO, 1977, ECON BOT, V31, P315, DOI 10.1007/BF02866883; Wu Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00376; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhao P, 2018, MOL PHYLOGENET EVOL, V126, P250, DOI 10.1016/j.ympev.2018.04.014; Zhou JG, 2018, MOLECULES, V23, DOI 10.3390/molecules23020437; Zhou T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071962	62	10	10	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221827	10.1371/journal.pone.0221827	http://dx.doi.org/10.1371/journal.pone.0221827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY1XO	31532782	Green Submitted, Green Published, gold			2022-12-27	WOS:000504215500001
J	Stjerneklar, S; Hougaard, E; McLellan, LF; Thastum, M				Stjerneklar, Silke; Hougaard, Esben; McLellan, Lauren F.; Thastum, Mikael			A randomized controlled trial examining the efficacy of an internet-based cognitive behavioral therapy program for adolescents with anxiety disorders	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; TEENS-CD-ROM; YOUNG-PEOPLE; DSM-IV; SELF-EFFICACY; HELP-SEEKING; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; LIFETIME PREVALENCE; INTERVIEW SCHEDULE	Background Anxiety disorders are highly prevalent in adolescence, but access to health care services is limited and only few receive professional help. Internet-based cognitive behavioral therapy (ICBT) has been proposed to increase accessibility and reduce costs of treatment. Objective The study evaluated the efficacy of a Danish version of the guided ICBT program ChilledOut Online, developed at the Centre for Emotional Health, Macquarie University, Australia. Method At the Centre for Psychological Treatment of Children and Adolescents, Aarhus University, Denmark, a randomized controlled trial was conducted with 70 adolescents (13-17 years) with anxiety disorders according to DSM-IV. Participants were randomly assigned to a 14-weeks therapist-guided ICBT or to a waitlist condition. Outcomes were evaluated post-treatment and at 3- and 12-month follow-up. Results At post-treatment, the ICBT group significantly outperformed the waitlist condition with moderate to large between-group effect sizes on diagnostic severity and anxiety symptoms rated by clinicians, and by adolescents and their parents. Forty percent of adolescents in ICBT were free of their primary diagnosis compared to 16% in the waitlist condition. Treatment gains were maintained at 3- and 12-month follow-up. Conclusion Results of the study provide support for the efficacy of guided ICBT for adolescents with anxiety disorders.	[Stjerneklar, Silke; Hougaard, Esben; Thastum, Mikael] Aarhus Univ, Sch Business & Social Sci, Dept Psychol & Behav Sci, Aarhus, Denmark; [McLellan, Lauren F.] Macquarie Univ, Ctr Emot Hlth, Dept Psychol, N Ryde, NSW, Australia	Aarhus University; Macquarie University	Stjerneklar, S (corresponding author), Aarhus Univ, Sch Business & Social Sci, Dept Psychol & Behav Sci, Aarhus, Denmark.	stjerneklar@psy.au.dk	; Thastum, Mikael/A-3443-2008	McLellan, Lauren/0000-0003-4059-6577; Thastum, Mikael/0000-0001-8582-5682; Stjerneklar, Silke/0000-0001-7685-2398	Trygfonden [100886]; Edith and Godtfred Kirk Christiansens Fund [215675]	Trygfonden; Edith and Godtfred Kirk Christiansens Fund	The study was funded in part by Trygfonden (grant id: 100886) and by Edith and Godtfred Kirk Christiansens Fund (grant id: 215675). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank our colleagues at Macquarie University for the permission to use the program. The authors also wish to thank clinic secretary Marianne Bjerregaard Madsen for her incommensurable diligence and helpfulness, as well as all the students who took part in the study. Lastly, we wish to express our sincere gratitude to associate professor Mia Skytte O'Toole for her valuable advice and guidance in the area of multilevel modeling.	Andersson G, 2016, ANNU REV CLIN PSYCHO, V12, P157, DOI 10.1146/annurev-clinpsy-021815-093006; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Angold A, 1995, INT J METHOD PSYCH, V5, P237; [Anonymous], 2011, ANXIETY DISORDERS CH; Arendt K, 2016, ACTA PSYCHIAT SCAND, V133, P109, DOI 10.1111/acps.12448; Arendt K, 2014, J ANXIETY DISORD, V28, P947, DOI 10.1016/j.janxdis.2014.09.021; Attride-Stirling J., 2002, DEV METHODS CAPTURE; Barak A, 2009, ANN BEHAV MED, V38, P4, DOI 10.1007/s12160-009-9130-7; Baumeister H., 2014, INTERNET INTERVENTIO, V1, P205, DOI DOI 10.1016/J.INVENT.2014.08.003; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Bisgaard MP, 2017, STAT YB; Braher E, 2007, DIAGNOSTICA, V53, P83, DOI 10.1026/0012-1924.53.2.83; Brown A, 2014, ADM POLICY MENT HLTH, V41, P434, DOI 10.1007/s10488-012-0433-9; Chakraborty H., 2009, MIXED MODEL APPROACH, DOI 10.3768/rtipress.2009.mr.0009.0903; Christensen H, 2014, CURR OPIN PSYCHIATR, V27, P7, DOI 10.1097/YCO.0000000000000019; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cuijpers P, 2014, CLIN PSYCHOL REV, V34, P130, DOI 10.1016/j.cpr.2014.01.002; Cunningham M., 2008, E J APPL PSYCHOL, V4, P6, DOI DOI 10.1038/SJ.MP.4002146; Cunningham MJ, 2009, EUR CHILD ADOLES PSY, V18, P125, DOI 10.1007/s00787-008-0703-y; Donker T, 2015, PSYCHOL MED, V45, P3357, DOI 10.1017/S0033291715001427; Ebert DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119895; Elliott BA, 2004, J ADOLESCENT HEALTH, V35, P303, DOI [10.1016/S1054-139X(03)00534-2, 10.1016/j.jadohealth.2003.09.015]; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Griffiths K. M., 2006, CLIN PSYCHOL, V10, P16, DOI DOI 10.1080/13284200500378696; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Heck RH, 2014, QUANT METH SER, P1; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, BEHAV RES THER, V49, P729, DOI 10.1016/j.brat.2011.07.009; Ho Joyce, 2016, Internet Interv, V6, P50, DOI 10.1016/j.invent.2016.09.005; Hollis C, 2017, J CHILD PSYCHOL PSYC, V58, P474, DOI 10.1111/jcpp.12663; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ern.12.63, 10.1586/ERN.12.63]; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kleiboer A, 2015, BEHAV RES THER, V72, P63, DOI 10.1016/j.brat.2015.06.013; Lenhard F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015246; Lenhard F, 2017, J AM ACAD CHILD PSY, V56, P10, DOI 10.1016/j.jaac.2016.09.515; Lenhard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100773; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Lyneham HJ, 2013, J ANXIETY DISORD, V27, P711, DOI 10.1016/j.janxdis.2013.09.008; Lyneham HJ, 2005, J AM ACAD CHILD PSY, V44, P274, DOI 10.1097/00004583-200503000-00012; Lyneham HJ, 2014, CHILLEDOUT ONLINE PR; March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099; Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muris P, 2002, PERS INDIV DIFFER, V32, P337, DOI 10.1016/S0191-8869(01)00027-7; Muris P, 2001, J PSYCHOPATHOL BEHAV, V23, P145, DOI 10.1023/A:1010961119608; Nearchou FA, 2018, J ADOLESCENCE, V66, P83, DOI 10.1016/j.adolescence.2018.05.003; Nicholas J., 2004, AUSTR E J ADVANCEMEN, V3, P16, DOI [DOI 10.5172/jamh.3.1.16, 10.5172/jamh.3.1.16, DOI 10.5172/JAMH.3.1.16]; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Pennant ME, 2015, BEHAV RES THER, V67, P1, DOI 10.1016/j.brat.2015.01.009; Podina IR, 2016, J RATION-EMOT COGN-B, V34, P31, DOI 10.1007/s10942-015-0228-5; Rapee RM., 2006, COOL KIDS CHILD ADOL; Reavley NJ, 2010, AUST NZ J PSYCHIAT, V44, P729, DOI 10.3109/00048671003705458; Richards Derek, 2015, Internet Interventions, V2, P272, DOI 10.1016/j.invent.2015.07.003; Rickwood DJ, 2007, MED J AUSTRALIA, V187, pS35, DOI 10.5694/j.1326-5377.2007.tb01334.x; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Shafran R, 2009, BEHAV RES THER, V47, P902, DOI 10.1016/j.brat.2009.07.003; Silverman W, 1996, ANXIETY DISORDERS IN; Silverman WK, 2001, J AM ACAD CHILD PSY, V40, P937, DOI 10.1097/00004583-200108000-00016; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 2008, BEHAV COGN PSYCHOTH, V36, P411, DOI 10.1017/S135246580800444X; Spence SH, 2017, BEHAV RES THER, V90, P41, DOI 10.1016/j.brat.2016.12.003; Spence SH, 2011, J CONSULT CLIN PSYCH, V79, P629, DOI 10.1037/a0024512; Stallard P, 2007, BEHAV COGN PSYCHOTH, V35, P501, DOI 10.1017/S1352465807003724; Stallard P, 2010, CHILD ADOL MENT H-UK, V15, P80, DOI 10.1111/j.1475-3588.2009.00540.x; Stjerneklar S, 2018, INTERNET INTERV, V11, P30, DOI 10.1016/j.invent.2018.01.001; Subrahmanyam K, 2007, ADOLESCENCE, V42, P659; Suldo SM, 2007, J PSYCHOEDUC ASSESS, V25, P341, DOI 10.1177/0734282907300636; Thirlwall K, 2013, BRIT J PSYCHIAT, V203, P436, DOI 10.1192/bjp.bp.113.126698; Tillett J, 2005, J PERINAT NEONAT NUR, V19, P112, DOI 10.1097/00005237-200504000-00007; Tillfors M, 2008, DEPRESS ANXIETY, V25, P708, DOI 10.1002/da.20416; Tillfors Maria, 2011, Cognitive Behaviour Therapy, V40, P147, DOI 10.1080/16506073.2011.555486; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Tracey T. J., 1989, PSYCHOL ASSESSMENT, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207]; Vigerland S, 2016, BEHAV RES THER, V76, P47, DOI 10.1016/j.brat.2015.11.006; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wilson CJ, 2011, EARLY INTERV PSYCHIA, V5, P34, DOI 10.1111/j.1751-7893.2010.00238.x; Wood JJ, 2002, J CLIN CHILD ADOLESC, V31, P335, DOI 10.1207/153744202760082595; Wuthrich VM, 2012, J AM ACAD CHILD PSY, V51, P261, DOI 10.1016/j.jaac.2011.12.002; Wuthrich VM, 2013, WILEY BLACKWELL HDB, P249; Ye XB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-313; Zachrisson HD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-34	88	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222485	10.1371/journal.pone.0222485	http://dx.doi.org/10.1371/journal.pone.0222485			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532802	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600031
J	Lensen, RCMM; Moons, CPH; Diederich, C				Lensen, Rian C. M. M.; Moons, Christel P. H.; Diederich, Claire			Physiological stress reactivity and recovery related to behavioral traits in dogs (Canis familiaris)	PLOS ONE			English	Article							CHROMOGRANIN-A CONCENTRATIONS; SALIVARY CORTISOL; STARTLING STIMULI; RESPONSES; TEMPERAMENT; PERSONALITY; VALIDATION; ANXIETY; MARKER; GUIDE	This study investigated whether stress responsiveness (in one context) can be used to predict dog behavior in daily life. On two occasions (N-T1 = 32 puppies; N-T2 = 16 young adults), dogs' physiological stress response after a behavioral test at home was measured in terms of reactivity (10 min post-test) and recovery (40 min post-test) for three salivary markers: cortisol, chromogranin A (CgA) and secretory immunoglobulin A (sIgA). For each marker, it was determined whether dogs with a strong physiological response displayed different behavior in daily life compared to dogs with a weaker physiological response. The results revealed three main findings: first, for CgA and cortisol, different patterns were identified according to sample time. High reactivity related to desirable traits, whereas slow recovery after the behavioral test related to undesirable traits. The findings suggest that increased levels of CgA and cortisol 10 minutes after the behavioral test reflected an adaptive stress response, whereas elevated levels 40 minutes after the test reflected unsuccessful coping. Second, patterns for sIgA differed from CgA and cortisol: significant associations were only found with behavioral traits at T2, mostly considered desirable and related to Trainability. Possibly, the delayed reaction pattern of sIgA caused this difference between markers, as sIgA reflects the (secondary) immune response to stress, due to immunosuppressive effects of cortisol. Third, predictive capacity of puppies' physiological stress response (T1) was inconclusive, and contrary relations were found with behavioral traits at T2, suggesting that developmental factors play an important role. This study provides new insights about the relation between stress physiology and behavioral traits, and methodological advice is given to study these patterns further. In conclusion, physiological markers could provide additional insights in dogs' tendencies to display certain behaviors, especially at the young adult stage. Further studies are needed to confirm these patterns.	[Lensen, Rian C. M. M.; Diederich, Claire] Univ Namur, Dept Vet Med IVRU, Namur, Belgium; [Moons, Christel P. H.] Univ Ghent, Dept Nutr Genet & Ethol, Merelbeke, Belgium	University of Namur; Ghent University	Diederich, C (corresponding author), Univ Namur, Dept Vet Med IVRU, Namur, Belgium.	claire.diederich@unamur.be		DIEDERICH, Claire/0000-0002-0063-3903	Federal Public Service of Health, Food Chain Safety and Environment; Public Service of Wallonia [RT 10/12 CONDOG]	Federal Public Service of Health, Food Chain Safety and Environment; Public Service of Wallonia	This study (author Rian Lensen) was supported by the Federal Public Service of Health, Food Chain Safety and Environment (https://www.health.belgium.be/en), and the Public Service of Wallonia (https://spw.wallonie.be/); contract RT 10/12 CONDOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi H, 2005, AM J VET RES, V66, P1830, DOI 10.2460/ajvr.2005.66.1830; Appleby D, 2003, VET CLIN N AM-SMALL, V33, P321, DOI 10.1016/S0195-5616(02)00101-8; Barnard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149831; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 2000, ANIM WELFARE, V9, P49; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Cava F, BIOL VARIATION DESIR; Cobb ML, 2016, DOMEST ANIM ENDOCRIN, V57, P31, DOI 10.1016/j.domaniend.2016.04.003; Day MJ, 2007, J COMP PATHOL, V137, pS10, DOI 10.1016/j.jcpa.2007.04.005; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Escribano D, 2013, ANIMAL, V7, P640, DOI 10.1017/S1751731112002005; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Glenk LM, 2014, J VET BEHAV, V9, P98, DOI 10.1016/j.jveb.2014.02.005; Haverbeke A, 2008, PHYSIOL BEHAV, V93, P59, DOI 10.1016/j.physbeh.2007.07.014; Hekman Jessica P, 2014, Animals (Basel), V4, P331, DOI 10.3390/ani4020331; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Hennessy MB, 2013, APPL ANIM BEHAV SCI, V149, P1, DOI 10.1016/j.applanim.2013.09.004; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; Horvath Z, 2007, HORM BEHAV, V52, P621, DOI 10.1016/j.yhbeh.2007.08.001; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Ivkovic N, 2015, ACTA FAC MEDICAE NAI, V32, P91, DOI 10.1515/afmnai-2015-0010; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kanai K, 2008, J VET SCI, V9, P421, DOI 10.4142/jvs.2008.9.4.421; Kennedy B, 2001, LIFE SCI, V69, P87, DOI 10.1016/S0024-3205(01)01111-0; Kikkawa A, 2005, J VET MED SCI, V67, P707, DOI 10.1292/jvms.67.707; Kikkawa A, 2003, J VET MED SCI, V65, P689, DOI 10.1292/jvms.65.689; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Lensen CMM, 2015, J VET BEHAV, V10, P504, DOI 10.1016/j.jveb.2015.08.006; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Mills DS, 2003, APPL ANIM BEHAV SCI, V81, P265, DOI 10.1016/S0168-1591(02)00286-1; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nakane H, 1998, BIOMED RES-TOKYO, V19, P401, DOI 10.2220/biomedres.19.401; Ng ZY, 2014, APPL ANIM BEHAV SCI, V159, P69, DOI 10.1016/j.applanim.2014.07.009; Ninomiya S, 2011, ANIM SCI J, V82, P787, DOI 10.1111/j.1740-0929.2011.00896.x; Ott S, 2014, RES VET SCI, V97, P124, DOI 10.1016/j.rvsc.2014.06.002; Overall KL, 2013, MANUAL CLIN BEHAV ME, V1st; Protopopova A, 2016, PHYSIOL BEHAV, V159, P95, DOI 10.1016/j.physbeh.2016.03.020; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Rosado B, 2010, APPL ANIM BEHAV SCI, V123, P124, DOI 10.1016/j.applanim.2010.01.009; Salimetrics LLC, 2013, SALIVA COLLECTION HA; Sandri M, 2015, J VET BEHAV, V10, P302, DOI 10.1016/j.jveb.2015.03.011; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Sforzini E, 2009, J VET BEHAV, V4, P3, DOI 10.1016/j.jveb.2008.09.035; Sherman BL, 2015, J VET BEHAV, V10, P94, DOI 10.1016/j.jveb.2014.12.007; Siniscalchi M, 2013, RES VET SCI, V94, P49, DOI 10.1016/j.rvsc.2012.02.017; SKANDAKUMAR S, 1995, ANIM WELFARE, V4, P339; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Svobodova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090820; Toda M, 2008, ARCH ORAL BIOL, V53, P964, DOI 10.1016/j.archoralbio.2008.04.002; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; van den Berg L, 2006, BEHAV GENET, V36, P882, DOI 10.1007/s10519-006-9089-0; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wormald D, 2016, APPL ANIM BEHAV SCI, V180, P93, DOI 10.1016/j.applanim.2016.04.007	62	12	12	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222581	10.1371/journal.pone.0222581	http://dx.doi.org/10.1371/journal.pone.0222581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527914	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400029
J	Senkerikova, R; Frankova, S; Jirsa, M; Kreidlova, M; Merta, D; Neroldova, M; Chmelova, K; Spicak, J; Sperl, J				Senkerikova, Renata; Frankova, Sona; Jirsa, Milan; Kreidlova, Miluse; Merta, Dusan; Neroldova, Magdalena; Chmelova, Klara; Spicak, Julius; Sperl, Jan			PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GREATER-THAN-G; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION; CONFERS SUSCEPTIBILITY; GENETIC-VARIATION; INCREASED RISK; VARIANT; DISEASE; POLYMORPHISM	Background PNPLA3 rs738409 minor allele c.444G represents a risk factor for liver steatosis and fibrosis progression also in chronic hepatitis C (HCV). We investigated its impact on the timing of liver transplantation (LT) in patients with genotype 1b HCV cirrhosis. Methods We genotyped and evaluated 172 LT candidates with liver cirrhosis owing to chronic HCV infection, genotype 1b. One hundred patients needed LT for chronic liver failure (CLF) and 72 for a small hepatocellular carcinoma (HCC) in the cirrhotic liver without CLF. Population controls (n = 647) were selected from the Czech cross-sectional study MONICA. Results The CLF patients were younger (53.5 +/- 7.2 vs. 59.6 +/- 6.6, P < 0.001) with more advanced liver disease than HCC patients (Child-Pugh's score 9.1 +/- 1.8 vs. 7.1 +/- 1.9, P < 0.001, MELD 14.1 +/- 3.9 vs. 11.1 +/- 3.7, P < 0.001). PNPLA3 G allele increased the risk of LT for CLF in both allelic and recessive models (CG + GG vs. CC: OR, 1.90; 95% CI, 1.017-3.472, P = 0.045 and GG vs. CC + CG: OR, 2.94; 95% CI, 1.032-7.513, P = 0.042). Multivariate analysis identified younger age (P < 0.001) and the G allele (P < 0.05) as risk factors for CLF. The genotype frequencies between the CLF group and MONICA study significantly differed in both, allelic and recessive model (P = 0.004, OR 1.87, 95% CI 1.222-2.875; P < 0.001, OR 3.33, 95% CI 1.824-6.084, respectively). The OR values almost doubled in the recessive model compared with the allelic model suggesting the additive effect of allele G. In contrast, genotype frequencies in the HCC group were similar to the MONICA study in both models. Pretransplant viral load was significantly lower in GG than in CC + CG genotypes (median, IQR; 162,500 (61,550-319,000) IU/ml vs. 570,000 (172,000-1,595,000) IU/ml, P < 0.0009). Conclusions Our results suggest that PNPLA3 rs738409 G allele carriage may be associated with a faster progression of HCV cirrhosis to chronic liver failure.	[Senkerikova, Renata; Frankova, Sona; Chmelova, Klara; Spicak, Julius; Sperl, Jan] Inst Clin & Expt Med, Transplant Ctr, Dept Hepatogastroenterol, Prague, Czech Republic; [Senkerikova, Renata; Jirsa, Milan; Neroldova, Magdalena; Chmelova, Klara; Sperl, Jan] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Jirsa, Milan; Neroldova, Magdalena] Inst Clin & Expt Med, Lab Expt Hepatol, Prague, Czech Republic; [Kreidlova, Miluse] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague, Czech Republic; [Kreidlova, Miluse] Gen Univ Hosp Prague, Prague, Czech Republic; [Merta, Dusan] Inst Clin & Expt Med, Anesthesiol Resuscitat & Intens Care Dept, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; General University Hospital Prague; Institute for Clinical & Experimental Medicine (IKEM)	Sperl, J (corresponding author), Inst Clin & Expt Med, Transplant Ctr, Dept Hepatogastroenterol, Prague, Czech Republic.; Sperl, J (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.	jan.sperl@ikem.cz	Neroldova, Magdalena/M-2298-2017	Neroldova, Magdalena/0000-0002-3792-9564	Ministry of Health, Czech Republic [00023001]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	The study was supported by the project (Ministry of Health, Czech Republic) for development of research organization 00023001 (Institute for Clinical and Experimental Medicine, Prague, Czech Republic) - institutional support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Ali M, 2016, CLIN GASTROENTEROL H, V14, P295, DOI 10.1016/j.cgh.2015.08.018; Jimenez-Sousa MA, 2018, J CLIN VIROL, V103, P71, DOI 10.1016/j.jcv.2018.04.008; BasuRay S, 2019, P NATL ACAD SCI USA, V116, P9521, DOI 10.1073/pnas.1901974116; Belli LS, 2018, J HEPATOL, V69, P810, DOI 10.1016/j.jhep.2018.06.010; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Eslam M, 2016, HEPATOLOGY, V64, P34, DOI 10.1002/hep.28475; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Fan JH, 2016, GUT LIVER, V10, P456, DOI 10.5009/gnl15261; Ferrarese A, 2018, WORLD J GASTROENTERO, V24, P4403, DOI 10.3748/wjg.v24.i38.4403; Hofmann S, 2018, BBA-MOL CELL BIOL L, V1863, P1041, DOI 10.1016/j.bbalip.2018.06.002; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Manchiero C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2887-6; Pascasio JM, 2017, J HEPATOL, V67, P1168, DOI 10.1016/j.jhep.2017.08.008; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x; Nunez-Torres R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168265; Rembeck K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-82; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sagnelli C, 2016, CLIN MICROBIOL INFEC, V22, P372, DOI 10.1016/j.cmi.2015.11.025; Salameh H, 2015, AM J GASTROENTEROL, V110, P846, DOI 10.1038/ajg.2015.137; Scheiner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143429; Shen JH, 2015, J LIPID RES, V56, P167, DOI 10.1194/jlr.M048777; Sherman KE, 2018, DIGEST DIS SCI, V63, P2969, DOI 10.1007/s10620-018-5278-y; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Stickel F, 2015, HEPATOBIL SURG NUTR, V4, P152, DOI 10.3978/j.issn.2304-3881.2014.11.04; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518; Trunecka P, 2018, DIGEST LIVER DIS, V50, P490, DOI 10.1016/j.dld.2017.12.030; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Vespasiani-Gentilucci U, 2016, SCAND J GASTROENTERO, V51, P967, DOI 10.3109/00365521.2016.1161066; Wang Y, 2019, HEPATOLOGY, V69, P2427, DOI 10.1002/hep.30583; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Yang J, 2019, INT J CANCER, V144, P533, DOI 10.1002/ijc.31910; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222609	10.1371/journal.pone.0222609	http://dx.doi.org/10.1371/journal.pone.0222609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527889	Green Submitted, Green Published, gold			2022-12-27	WOS:000532231400033
J	Doumit, CA; Haddad, C; Sacre, H; Salameh, P; Akel, M; Obeid, S; Akiki, M; Mattar, E; Hilal, N; Hallit, S; Soufia, M				Doumit, Carla Abi; Haddad, Chadia; Sacre, Hala; Salameh, Pascale; Akel, Marwan; Obeid, Sahar; Akiki, Maria; Mattar, Elie; Hilal, Najla; Hallit, Souheil; Soufia, Michel			Knowledge, attitude and behaviors towards patients with mental illness: Results from a national Lebanese study	PLOS ONE			English	Article							SOCIAL DISTANCE; HELP-SEEKING; PSYCHOMETRIC PROPERTIES; COMMUNITY ATTITUDES; PSYCHIATRIC STIGMA; INTENDED BEHAVIOR; HEALTH; PEOPLE; DEPRESSION; CONTACT	Objectives Patients with mental health disorders often have to endure the burdens of the condition itself and the stigma that follows. Since no study has been conducted in Lebanon on this topic, our objective was to assess the knowledge, attitude and behaviors towards public stigma of mental health diseases, among a sample of the Lebanese population. Methods A cross-sectional study, conducted between November 2017 and May 2018, enrolled 2289 participants. The Mental Health Knowledge Schedule (MAKS), the Community Attitudes toward Mental Illness (CAMI) and the Reported and Intended Behavior Scale (RIBS) were used to assess knowledge, attitude and behaviors toward mental illness respectively. The 25th, 50th and 75th percentile of the MAKS, CAMI and RIBS scales scores were considered as cutoff points for low, medium and high scores respectively. Results A high knowledge score was found in 33.0% of the participants, whereas a high attitude score and a higher behavior score were found in 32.2% and 26.9% of the participants respectively. Living in North Lebanon (Beta = 1.331) and being familiar with a non -close person with mental illness (Beta = 0.811) were associated with higher knowledge of mental illness (higher MAKS score), whereas living in Bekaa (Beta = -8.693) and being 70 years old and above (Beta = -5.060) were associated with lower knowledge toward mental illness (lower MAKS score). Higher knowledge of mental illness (higher MAKS score) (Beta = 0.670), having a high level of education (university (Beta = 8.785), secondary (Beta = 6.084) and technical (Beta = 5.677)) were associated with less stigmatizing attitudes (higher CAMI scale). Being familiar with close people with mental illness (Beta = 0.577), less stigmatizing attitudes (higher CAMI scale) (Beta = 0.077) and higher knowledge of mental illness (higher MAKS score) (Beta = 0.115) were associated with higher favorable behaviors (higher RIBS score), whereas knowing a non -close person who have a mental illness (Beta = -0.720) was associated with lower favorable behaviors (lower RIBS score). Conclusion A mass media awareness campaigns that could transmit health messages to a wide public audience in the country to fight stigma toward mental illness, seems warranted.	[Doumit, Carla Abi; Akiki, Maria; Mattar, Elie; Hilal, Najla; Hallit, Souheil; Soufia, Michel] Holy Spirit Univ Kaslik USEK, Fac Med & Med Sci, Jounieh, Lebanon; [Haddad, Chadia; Obeid, Sahar] Psychiat Hosp Cross, Jal Eddib, Lebanon; [Sacre, Hala] Order Pharmacists Lebanon, Drug Informat Ctr, Beirut, Lebanon; [Sacre, Hala; Salameh, Pascale; Akel, Marwan; Obeid, Sahar; Hallit, Souheil] INSPECT LB Inst Natl Sante Publ Epidemiol Clin &, Beirut, Lebanon; [Salameh, Pascale; Soufia, Michel] Lebanese Univ, Fac Med, Beirut, Lebanon; [Salameh, Pascale] Lebanese Univ, Fac Pharm, Beirut, Lebanon; [Akel, Marwan] Lebanese Int Univ, Sch Pharm, Beirut, Lebanon; [Obeid, Sahar] Holy Spirit Univ Kaslik USEK, Fac Philosophy & Human Sci, Jounieh, Lebanon; [Obeid, Sahar] Lebanese Univ, Fac Pedag, Beirut, Lebanon	Lebanese University; Lebanese University; Lebanese University	Hallit, S; Soufia, M (corresponding author), Holy Spirit Univ Kaslik USEK, Fac Med & Med Sci, Jounieh, Lebanon.; Hallit, S (corresponding author), INSPECT LB Inst Natl Sante Publ Epidemiol Clin &, Beirut, Lebanon.; Soufia, M (corresponding author), Lebanese Univ, Fac Med, Beirut, Lebanon.	Souheilhallit@hotmail.com; Michel_soufia@hotmail.com	Sacre, Hala/O-7644-2019; Salameh, Pascale/F-9676-2011; Hallit, Souheil/R-6727-2018	Sacre, Hala/0000-0001-6547-6251; Salameh, Pascale/0000-0002-4780-0772; Hallit, Souheil/0000-0001-6918-5689; Haddad, Chadia/0000-0003-2413-2684				Abolfotouh MA, 2019, PSYCHOL RES BEHAV MA, V12, P45, DOI 10.2147/PRBM.S191676; Ahmed N., 2017, INDIAN SOC PSYCHIAT, V33, P171, DOI [10.4103/0971-9962.209199, DOI 10.4103/0971-9962.209199]; Al-Krenawi A, 2005, CURR OPIN PSYCHIATR, V18, P560, DOI 10.1097/01.yco.0000179498.46182.8b; Al-Krenawi A, 2000, COMMUNITY MENT HLT J, V36, P501, DOI 10.1023/A:1001963714338; Aloud N, 2009, J MUSLIM MENT HEALTH, V4, P79, DOI 10.1080/15564900802487675; Angermeyer MC, 2011, BRIT J PSYCHIAT, V199, P367, DOI 10.1192/bjp.bp.110.085563; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; [Anonymous], DEF STIGM DISCR; Aramouny C, 2019, J RELIG HLTH, P1, DOI [10.1007/s10943-018-00739-w, DOI 10.1007/S10943-018-00739-W]; ARKAR H, 1992, SOC PSYCH PSYCH EPID, V27, P151; Barke A, 2011, SOC PSYCH PSYCH EPID, V46, P1191, DOI 10.1007/s00127-010-0290-3; Bratbo J, 2017, STIGMA MENTAL ILLNES, P317, DOI DOI 10.1007/978-3-319-27839-1_17; BROCKINGTON IF, 1993, BRIT J PSYCHIAT, V162, P93, DOI 10.1192/bjp.162.1.93; Buizza C, 2017, COMMUNITY MENT HLT J, V53, P589, DOI 10.1007/s10597-017-0116-9; Chong SA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0837-2; Coker EM, 2005, SOC SCI MED, V61, P920, DOI 10.1016/j.socscimed.2005.01.009; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; Dalky Heyam F, 2012, Issues Ment Health Nurs, V33, P486, DOI 10.3109/01612840.2012.676720; Dardas LA, 2015, J PSYCHIATR MENT HLT, V22, P668, DOI 10.1111/jpm.12237; Das S, 2014, DELHI PSYCHIAT J, V17, P48; Drake RE, 2009, SCHIZOPHRENIA BULL, V35, P704, DOI 10.1093/schbul/sbp041; Eapen V, 2004, PSYCHOL REP, V94, P663; Elkington KS, 2012, J ADOLESCENT RES, V27, P290, DOI 10.1177/0743558411409931; Evans-Lacko S, 2011, EPIDEMIOL PSYCH SCI, V20, P263, DOI 10.1017/S2045796011000308; Evans-Lacko S, 2010, CAN J PSYCHIAT, V55, P440, DOI 10.1177/070674371005500707; Ewalds-Kvist B, 2013, NORD J PSYCHIAT, V67, P360, DOI 10.3109/08039488.2012.748827; Hackler A.H., 2011, CONTACT STIGMA MENTA; Hansson L, 2016, ACTA PSYCHIAT SCAND, V134, P71, DOI 10.1111/acps.12609; Henderson C, 2016, ACTA PSYCHIAT SCAND, V134, P23, DOI 10.1111/acps.12607; Henderson C, 2009, LANCET, V373, P1928, DOI 10.1016/S0140-6736(09)61046-1; Kadri N, 2004, CAN J PSYCHIAT, V49, P625, DOI 10.1177/070674370404900909; Karam EG, 2008, PLOS MED, V5, P579, DOI 10.1371/journal.pmed.0050061; Karam G, 2006, INT EDUC J, V7, P259; Kobau R, 2012, ATTITUDES MENTAL ILL; Lauber C, 2004, COMMUNITY MENT HLT J, V40, P265, DOI 10.1023/B:COMH.0000026999.87728.2d; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Magliano Lorenza, 2003, Epidemiol Psichiatr Soc, V12, P187; Martin JK, 2000, J HEALTH SOC BEHAV, V41, P208, DOI 10.2307/2676306; Mathison LA, 2016, MENTAL HLTH STIGMA R; Melki IS, 2004, J EPIDEMIOL COMMUN H, V58, P476, DOI 10.1136/jech.2003.012690; National Academies of Sciences E Medicine, 2016, END DISCR PEOPL MENT; Parra F, 1985, Int J Soc Psychiatry, V31, P37, DOI 10.1177/002076408503100104; Pattyn E, 2013, COMMUNITY MENT HLT J, V49, P292, DOI 10.1007/s10597-012-9564-4; Perry BL, 2007, PSYCHIAT SERV, V58, P632, DOI 10.1176/appi.ps.58.5.632; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P68, DOI 10.1177/002214650404500105; Pierce M.L., 2012, STIGMA KNOWLEDGE QUE; Rayan A, 2018, PERSPECT PSYCHIATR C, V54, P258, DOI 10.1111/ppc.12232; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Seeman N, 2016, J AFFECT DISORDERS, V190, P115, DOI 10.1016/j.jad.2015.10.011; Shahrour TM, 2009, SAUDI MED J, V30, P1336; Song LY, 2005, INT J SOC PSYCHIATR, V51, P162, DOI 10.1177/0020764005056765; Stuart Heather, 2014, Can J Psychiatry, V59, pS8; Stuber JP, 2014, PSYCHIAT SERV, V65, P490, DOI 10.1176/appi.ps.201300136; Subramaniam M, 2017, EPIDEMIOL PSYCH SCI, V26, P371, DOI 10.1017/S2045796016000159; Subramaniam M, 2012, INT J METH PSYCH RES, V21, P149, DOI 10.1002/mpr.1351; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; United Nations Office for the Coordination of Humanitarian Affairs. (UNOCHA), LEB POP CENTR ADM ST; Vaughan Gerard, 2004, Australas Psychiatry, V12, P113, DOI 10.1111/j.1039-8562.2004.02083.x; Vezzoli R, 2001, EUR PSYCHIAT, V16, P451, DOI 10.1016/S0924-9338(01)00606-X; Vibha P, 2008, INT J SOC PSYCHIATR, V54, P469, DOI 10.1177/0020764008092190; Walker JS, 2008, J AM ACAD CHILD PSY, V47, P912, DOI 10.1097/CHI.0b013e318179961a; Wang J, 2015, BMC PSYCHIATRY, V15, DOI [10.1186/s12888-015-0579-6, 10.1186/s12888-015-0681-9]; World Health Organization, 2010, WHO AIMS REP MENT HL; Youssef J, 2006, MENT HEALTH RELIG CU, V9, P43, DOI 10.1080/13674670512331335686; Yuan Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167297	67	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222172	10.1371/journal.pone.0222172	http://dx.doi.org/10.1371/journal.pone.0222172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525219	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700023
J	Ulrich, AK; Sanchez, J; Lama, JR; Manhart, LE; Goodreau, SM; Duerr, AC				Ulrich, Angela K.; Sanchez, Jorge; Lama, Javier R.; Manhart, Lisa E.; Goodreau, Steven M.; Duerr, Ann C.			Correlates of concurrent partnerships and patterns of condom use among men who have sex with men and transgender women in Peru	PLOS ONE			English	Article							ANAL INTERCOURSE; AGREEMENT TYPE; ALCOHOL-USE; HIV; PREVALENCE; LIMA; BEHAVIOR; RISK	Background In Peru, there is an ongoing high-incidence HIV epidemic among men who have sex with men (MSM) and transgender women (TW). Sexual concurrency, or having sex with a partner in between two acts of sex with another partner, may be a key factor in onward HIV transmission. In this study, we quantify concurrency, evaluate factors associated with con currency, and assess condom use with concurrent partners among MSM and TW in Peru. Methods We conducted a secondary analysis of data from the 2011 Peruvian Biobehavioral Survey. Pearson's Chi-squared test was used to identify individual-level characteristics associated with concurrency. We estimated the association between participant characteristics, concurrent partnerships, partnership type (stable vs. non-stable), and CLAI within the context of concurrent partnerships using multivariate and repeated-measure Poisson regression. Results 3-month cumulative prevalence of concurrency was higher among TW compared to MSM (30.7% vs 25.2%, p = 0.014). Among those with concurrent stable and non-stable partners, 45% used condoms with both partners (95% CI: 40%-50%) and 30% preferentially had CLAI with the stable partner only (95%CI: 26%-35%). Factors associated with CLAI within the context of concurrent partnerships varied between MSM and TW. Conclusions Although concurrency is common among TW and MSM in Peru, patterns of concurrency and differential condom use may vary between TW and MSM. Future research may explore differential condom use with stable and non-stable partners to better understand behavioral factors that may alter vulnerability to HIV in TW compared to MSM.	[Ulrich, Angela K.; Duerr, Ann C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Ulrich, Angela K.; Manhart, Lisa E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanchez, Jorge; Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Sanchez, Jorge] Ctr Invest Tecnol Biorned & Medioambientales, Callao, Peru; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Ulrich, Angela K.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Ulrich, AK (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Ulrich, AK (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	ulric063@fhcrc.org		Ulrich, Angela/0000-0002-4360-9719	National Institutes of Health [NIH T32 CA 80416-14]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health, NIH T32 CA 80416-14 to AKU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Carnegie N. B., 2012, PLoS ONE, V7, pe43048, DOI 10.1371/journal.pone.0043048; Crawford JM, 2001, INT J STD AIDS, V12, P164, DOI 10.1258/0956462011916965; Desai M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5011; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Goodreau SM, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-12; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Herrera MC, 2016, DRUG ALCOHOL DEPEN, V161, P147, DOI 10.1016/j.drugalcdep.2016.01.030; Hoff CC, 2010, AIDS CARE, V22, P827, DOI 10.1080/09540120903443384; Hosking W, 2013, J HOMOSEXUAL, V60, P711, DOI 10.1080/00918369.2013.773819; Leblanc NM, 2017, J ADV NURS, V73, P1583, DOI 10.1111/jan.13228; Lyons A, 2014, AIDS BEHAV, V18, P801, DOI 10.1007/s10461-013-0613-y; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2014, AIDS BEHAV, V18, P783, DOI 10.1007/s10461-013-0618-6; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris SR, 2011, CURR OPIN HIV AIDS, V6, P326, DOI 10.1097/COH.0b013e3283476c29; Nelson SJ, 2007, SEX TRANSM DIS, V34, P801, DOI [10.1097/OLQ.0b013e318063c734, 10.1007/978-1-59745-040-9]; Poteat T, 2016, GLOB PUBLIC HEALTH, V11, P835, DOI 10.1080/17441692.2015.1134615; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sawers L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-44; Senn TE, 2009, SEX TRANSM INFECT, V85, P343, DOI 10.1136/sti.2009.035758; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; StataCorp, 2014, STAT STAT SOFTW REL; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNAIDS, 2019, 2016 UNAIDS PER FACT; UNAIDS (United National Programme on AIDS), 2009, CONS CONC SEX PARTN; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wray TB, 2016, DRUG ALCOHOL REV, V35, P148, DOI 10.1111/dar.12271	32	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222114	10.1371/journal.pone.0222114	http://dx.doi.org/10.1371/journal.pone.0222114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525225	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700021
J	Yamamoto, M; Yamauchi, M; Sugimoto, T				Yamamoto, Masahiro; Yamauchi, Mika; Sugimoto, Toshitsugu			Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; SCLEROSTIN LEVELS; OLDER-ADULTS; SCORE TBS; RISK; BMD; CLASSIFICATION; FRAGILITY; SEVERITY; QUALITY	Background An assessment of bone strength based on bone mineral density (BMD) underestimates the risk of fracture in patients with diabetes mellitus (T2DM). However, using the trabecular bone score (TBS) for estimating bone microarchitecture, previous studies showed that bone fragility is associated with deterioration of the microstructure concomitantly with decreased BMD. This study was conducted to clarify which of these skeletal-related factors had a more prominent relationship with bone fragility. Research design and methods A retrospective cross-sectional study was performed at Shimane University Hospital. A total of 548 Japanese patients with T2DM [257 postmenopausal women and 291 men aged over 50 years] were included. TBS of the spine was computed from dual-energy X-ray absorptiometry images obtained from BMD measurements. Results Vertebral fractures (VFs) were identified in 74 (28.8%) women and 115 (39.5%) men. A relationship between BMD and VFs was observed in the limited subgroup of women with a BMD T-score <-1.0. According to multivariate logistic regression analysis, low TBS was significantly correlated with prevalent VFs, independent of BMD in both genders, except for men with a BMD T-score > -1.0. The decision tree showed that the priority factor for determining VFs was TBS, not BMD. Conclusion Spinal microarchitecture represented by TBS was a more dominant skeletal factor for bone fragility than the decrease in bone mass, independent of BMD, in patients with T2DM. This observation suggests that loss of structural bone quality was crucial underlying pathogenesis for bone brittleness in these populations, regardless of gender. An integrated assessment of bone strength by BMD and TBS would help diagnose diabetic osteoporosis.	[Yamamoto, Masahiro; Yamauchi, Mika; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan	Shimane University	Yamamoto, M (corresponding author), Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan.	masa-ya@med.shimae-u.ac.jp	yamamoto, Masahiro/F-9094-2011	yamamoto, Masahiro/0000-0003-3859-0125	Japan Society for the Promotion of Science (JSPS) [25460900]; Asahi Kasei Pharma Corporation; Eli Lilly Japan K.K	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Kasei Pharma Corporation; Eli Lilly Japan K.K(Eli Lilly)	This work was supported by Grants-inAids for Scientific Research (C) Grant No. 25460900 (to MY) from Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html) and Asahi Kasei Pharma Corporation and Eli Lilly Japan K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, South Med J, V94, P569; Baleanu F, 2019, INT J CLIN PRACT, V73, DOI 10.1111/ijcp.13347; Bonaccorsi G, 2017, AGING CLIN EXP RES, V29, P951, DOI 10.1007/s40520-016-0634-2; Chen FP, 2019, MENOPAUSE, V26, P182, DOI 10.1097/GME.0000000000001185; Choi YJ, 2016, J CLIN DENSITOM, V19, P507, DOI 10.1016/j.jocd.2016.04.001; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Ferrari SL, 2018, OSTEOPOROSIS INT, V29, P2585, DOI 10.1007/s00198-018-4650-2; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Gallagher JC, 2005, J CLIN ENDOCR METAB, V90, P1583, DOI 10.1210/jc.2004-0826; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Heilmeier U, 2015, OSTEOPOROSIS INT, V26, P1283, DOI 10.1007/s00198-014-2988-7; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kershaw TS, 2007, PERSPECT SEX REPRO H, V39, P141, DOI 10.1363/3914107; Kim JH, 2015, J CLIN ENDOCR METAB, V100, P475, DOI 10.1210/jc.2014-2047; Kurosaki M, 2010, HEPATOL RES, V40, P251, DOI 10.1111/j.1872-034X.2009.00607.x; Leslie WD, 2013, J CLIN ENDOCR METAB, V98, P602, DOI 10.1210/jc.2012-3118; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Martineau P, 2018, BONE, V113, P161, DOI 10.1016/j.bone.2018.05.026; Nakamura T, 2012, JOINT INT CONF SOFT, P1013, DOI 10.1109/SCIS-ISIS.2012.6505400; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; vom Scheidt A, 2019, BONE, V122, P156, DOI 10.1016/j.bone.2019.02.014; Xue YF, 2018, J CLIN DENSITOM, V21, P185, DOI 10.1016/j.jocd.2017.09.003; Yamamoto M, 2015, ENDOCR J, V62, P299, DOI 10.1507/endocrj.EJ15-0129; Yamamoto M, 2013, J CLIN ENDOCR METAB, V98, P4030, DOI 10.1210/jc.2013-2143; Yamamoto M, 2009, DIABETES CARE, V32, P2263, DOI 10.2337/dc09-0901; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207; Zhukouskaya VV, 2016, OSTEOPOROSIS INT, V27, P49, DOI 10.1007/s00198-015-3212-0	31	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222571	10.1371/journal.pone.0222571	http://dx.doi.org/10.1371/journal.pone.0222571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525243	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700037
J	Baldo, D; Araujo-Vieira, K; Cardozo, D; Borteiro, C; Leal, F; Pereyra, MO; Kolenc, F; Lyra, ML; Garcia, PCA; Haddad, CFB; Faivovich, J				Baldo, Diego; Araujo-Vieira, Katyuscia; Cardozo, Dario; Borteiro, Claudio; Leal, Fernando; Pereyra, Martin O.; Kolenc, Francisco; Lyra, Mariana L.; Garcia, Paulo C. A.; Haddad, Cello F. B.; Faivovich, Jullan			A review of the elusive bicolored iris Snouted Treefrogs (Anura: Hylidae:Scinax uruguayus group)	PLOS ONE			English	Review							SCINAX ANURA; ADVERTISEMENT CALLS; PHYLOGENETIC ANALYSIS; SOUTHEASTERN BRAZIL; AMPHIBIA ANURA; CLADE; FROGS; DIVERSITY; EVOLUTION; OLOLYGON	The genus Scinax currently includes more than 120 species, recovered in two major clades, the S. catharinae and the S. ruber clades. The latter comprises 75 species, most of which remain unassigned to any species groups, while 12 are included in the S. rostratus and S. uruguayus groups. In this paper we present a taxonomic review of the two species currently included in the S. uruguayus group, discussing some putative phenotypic synapomorphies of this group. Although S. pinima and S. uruguayus have been considered as distinct species, this has been based on scant evidence, and several authors doubted of their distinctiveness. Our study of available specimens of S. pinima and S. uruguayus corroborates that both are valid and diagnosable species based on phenotypic evidence. Furthermore, our results show that S. pinima previously known only from its type locality, has a much widespread distribution than previously thought (including the Brazilian states of Parana, Santa Catarina, and Rio Grande do Sul), which, added to the biological information presented here allows to suggest the removal of this species from the "Data Deficient" IUCN Red List category to "Least Concern". Also, we describe a new species formerly reported as S. aff. pinima and S. uruguayus from NE Argentina and some localities from the Brazilian State of Rio Grande do Sul. All species are diagnosed and characterized using adult and larval morphology, osteology, vocalizations, cytogenetics, and natural history.	[Baldo, Diego; Cardozo, Dario] Inst Biol Subtrop Claudio Juan Bidau CONICET UNaM, Lab Genet Evolutiva, Posadas, Misiones, Argentina; [Araujo-Vieira, Katyuscia; Pereyra, Martin O.; Faivovich, Jullan] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina; [Borteiro, Claudio; Kolenc, Francisco] Museo Nacl Hist Nat, Secc Herpetol, Montevideo, Uruguay; [Leal, Fernando; Garcia, Paulo C. A.] Univ Fed Minas Gerais, Lab Herpetol, Dept Zool, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Lyra, Mariana L.; Haddad, Cello F. B.] Univ Estadual Paulista, Dept Zool, Inst Biociencias, Rio Claro, SP, Brazil; [Lyra, Mariana L.; Haddad, Cello F. B.] Univ Estadual Paulista, Ctr Aquicultura CAUNESP, Inst Biociencias, Rio Claro, SP, Brazil; [Faivovich, Jullan] Univ Buenos Aires, Dept Biodiversidad & Biol Expt, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Buenos Aires	Baldo, D (corresponding author), Inst Biol Subtrop Claudio Juan Bidau CONICET UNaM, Lab Genet Evolutiva, Posadas, Misiones, Argentina.; Araujo-Vieira, K (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Herpetol, Buenos Aires, DF, Argentina.	diegobaldo@gmail.com; katy.vieira@gmail.com	Garcia, Paulo/A-9983-2010; Araujo-Vieira, Katyuscia/AAD-3973-2019; Lyra, Mariana Lucio/O-6405-2014	Garcia, Paulo/0000-0002-4789-7033; Araujo-Vieira, Katyuscia/0000-0002-8193-2736; Lyra, Mariana Lucio/0000-0002-7863-4965; Cardozo, Dario/0000-0003-0612-2458	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT) [PICT 0404/2013, PICT 1343/2014, PICT 1930/2014, PICT 2035/2014, PICT 0813/2015, PICT 0820/2015, PICT 2381/2015]; Sao Paulo Research Foundation (FAPESP) [2012/10000-5, 2013/50741-7, 2014/50342-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Agencia Nacional de Investigacion e Innovacion (ANII/SNI)	Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agencia Nacional de Investigacion e Innovacion (ANII/SNI)	DB, JF, KAV and MOP thanks Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT; PICTs 0404/2013, 1343/2014, 1930/2014, 2035/2014, 0813/2015, 0820/2015, and 2381/2015). CFBH, JF, and KAV thanks Sao Paulo Research Foundation (FAPESP Procs. #2012/10000-5, #2013/50741-7, and 2014/50342-8). CFBH thanks Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for the research fellowship. CB and FK thanks Agencia Nacional de Investigacion e Innovacion (ANII/SNI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to A Resetar (FMNH), MBorges Martins (MCN), GM Funk Pontes, S Castroviejo (MCP), D Arrieta (MNHN), H Zaher, T Grant, D Gennari (MZUSP), V Verdade (USP), MBorges Martins, C Zank, D Janisch Alvares (UFRGS), F Toledo (ZUEC), and R Maneyro (ZVCB) for access to collections and institutional specimen loans. We thank F Vera Candioti and C Taboada for their comments on earlier drafts of the manuscript. We also thank Y Alippe, N Alves, JM Boeris, MBonino, L Cotichelli, A Dallagnol, JM Ferro, N Frutos, R Ghirardi, ER Krauczuk, G Laufer, V Machin, F Marangoni, I Marques C Nieto, E Rossini, A Taffarel, CG Tomatis, and S Velasquez for field assistance. We thank R Lingnau, J Pombal Jr., and C Zank for sharing field data. Specimen collections were made in each country with the following authorizations numbers: Argentina (MEyRNR 007/2009; 048/2013; 072/2014; 061/2015; 073/2016; 035/2017; PRNyMA 01/2016), Brazil (Instituto Chico Mendes de Conservac comma ao da Biodiversidade SISBIO 57098-1), and Uruguay, Divisio ' n Fauna, Ministerio de Ganaderi ' a, Agricultura y Pesca (Res. N degrees 199/13 and 137/16). Financial support and fellowships were provided by Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT; PICTs 0404/2013, 1343/2014, 1930/2014, 2035/2014, 0813/2015, 0820/2015, and 2381/2015), Sao Paulo Research Foundation (FAPESP Procs. #2012/10000-5, #2013/50741-7, and 2014/50342-8), Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (research fellowship to CFBH), and Agencia Nacional de Investigacion e Innovacion (ANII/SNI).	Achaval E.F., 2003, ANFIBIOS REPTILES UR, V2nd; Achaval F., LISTA ESPECIES VERTE; Achaval F., CUENCA SUPERIOR ARRO; Achaval F, 2007, ANFIBIOS REPTILES UR; Achaval F., 1997, ANFIBIOS REPTILES UR; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Alcalde Leandro, 2011, Zootaxa, V2787, P19; Altic R, 2006, HERPETOLOGICA, V62, P1, DOI 10.1655/05-23.1; Altig R, 1999, TADPOLES, P24; Altig R, 2007, HERPETOL MONOGR, V21, P1, DOI 10.1655/06-005.1; Peixoto MAA, 2015, GENETICA, V143, P729, DOI 10.1007/s10709-015-9870-1; [Anonymous], 1872, MONATSBERICHTE KONIG, P680; [Anonymous], 1988, ARQUIVOS U RURAL RIO, V10, P37; Anstis M., 2013, TADPOLEFROGAUSTR; Araujo-Vieira K, 2019, CLADISTICS, V35, P469, DOI 10.1111/cla.12367; Araujo-Vieira K, 2016, ZOOTAXA, V4061, P261, DOI 10.11646/zootaxa.4061.3.4; Araujo-Vieira K, 2015, ZOOTAXA, V3904, P270, DOI 10.11646/zootaxa.3904.2.6; Arenas-Rodriguez A, 2018, PEERJ, V6, DOI 10.7717/peerj.4525; Barreto GS, 1968, ZOOTAXA; Barrio A., 1967, Physis Buenos Aires, V26, P521; BARRIO AVELINO, 1962, PHYSIS REV ASOC ARGENT CIENC NATUR, V23, P129; Bernarde Paulo Sergio, 1999, Herpetological Review, V30, P230; Berneck BVM, 2016, MOL PHYLOGENET EVOL, V97, P213, DOI 10.1016/j.ympev.2015.11.014; BLAIR WF, 1958, AM NAT, V92, P27, DOI 10.1086/282007; BOKERMANN W. C. A., 1964, REV BRASH BIOL, V24, P429; BOKERMANN W C A, 1973, Revista Brasileira de Biologia, V33, P521; Bokermann W. C. A., 1967, Neotropica, V13, P61; Bokermann W. C. A., 1962, Neotropica, V8, P81; BOKERMANN W C A, 1968, Journal of Herpetology, V1, P25, DOI 10.2307/1563259; Borteiro C, 2001, ACT 6 JORN ZOOL UR, P26; Braun PC, 1974, LISTA ANFIBIOS DEP A, V45, P34; Braun PC, 1981, IHERINGIA SER ZOOL, V57, P113; Brusquetti F, 2014, ZOOL J LINN SOC-LOND, V171, P783, DOI 10.1111/zoj.12148; Canavero A, B SOC ZOOLOGI, P263, DOI [10.2307/41261874, DOI 10.2307/41261874]; Canavero A, 2010, IHERINGIA SER ZOOL, V100, P5, DOI 10.1590/S0073-47212010000100001; Caramaschi U., 1998, LISTA VERMELHA ESPEC, P460; Caramaschi U., 1989, B MUSEU NACL ZOOLOGI, V327, P1; Caramaschi U, 2009, ZOOTAXA, P34, DOI 10.11646/zootaxa.2115.1.3; CARDOSO A J, 1980, Revista Brasileira de Biologia, V40, P75; CARDOSO A J, 1982, Revista Brasileira de Biologia, V42, P499; Cardozo DE, 2011, COPEIA, P251, DOI 10.1643/CH-09-105; Cei Jose M., 1980, Monitore Zoologico Italiano Monografia, V2, P1; Luna MC, 2018, BIOL J LINN SOC, V124, P403, DOI 10.1093/biolinnean/bly048; CHANNING A., 2012, TADPOLES OF AFRICA; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Colaco G, 2016, ZOOTAXA, V4154, P193, DOI 10.11646/zootaxa.4154.2.7; Conte CE, 2016, ZOOTAXA, V4193, P245, DOI 10.11646/zootaxa.4193.2.3; de Carvalho TR, 2015, PHYLLOMEDUSA, V14, P127, DOI 10.11606/issn.2316-9079.v14i2p127-137; de Oliveira HHP, 2012, ESTUDOS, V339, P123; DELARIVA I, 1994, BIJDR DIERKD, V64, P75; Drummond LDO, 2007, ZOOTAXA, P45; Duellman W., 1993, OCCASIONAL PAPER MUS, V153, P1; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; DUELLMAN W E, 1988, Tropical Zoology, V1, P117; Duellman W. E., 1977, TIERREICH, V95, P1, DOI DOI 10.2307/1443200; DUELLMAN WE, 1986, COPEIA, P864; DUELLMAN WE, 1972, COPEIA, P265; Duellman WE, 1992, OCCAS PAP MUS NAT HI, V151, P1; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; EMERSON SB, 1979, BIOL J LINN SOC, V11, P153, DOI 10.1111/j.1095-8312.1979.tb00032.x; Eterovick P.C., 2004, AMPHIBIANS SERRA CIP; Eterovick PC., 2008, MEGADIVERSIDADE, V4, P158; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; FABREZI M, 1992, Alytes (Paris), V10, P1; Fabrezi M, 2009, J MORPHOL, V270, P205, DOI 10.1002/jmor.10680; Fabrezi Marissa, 1993, Alytes (Paris), V11, P47; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2002, CLADISTICS, V18, P367, DOI 10.1111/j.1096-0031.2002.tb00157.x; Faivovich J, 2018, S AM J HERPETOL, V13, P1, DOI 10.2994/SAJH-D-17-00115.1; Ferrao M, 2018, J HERPETOL, V52, P472, DOI 10.1670/17-165; Ferrao M, 2018, PEERJ, V6, DOI 10.7717/peerj.4321; Ferrao M, 2017, ZOOKEYS, P137, DOI 10.3897/zookeys.706.14691; Ferrao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165679; Ferro JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192861; Fouquette M. J., 1966, Caribbean Journal of Science, V6, P167; Frost DR., 2019, AMPHIBIAN SPECIES WO; GALLARDO JM, 1987, ANFIBIOS ARGENTINOS; Garcia Paulo C. A., 2001, Revista Brasileira de Zoologia, V18, P1197; GARRIDO O H, 1969, Poeyana Instituto de Biologia (La Habana) Serie A, P1; Giraudo Alejandro R., 2005, Cuadernos de Herpetologia, V18, P61; Gorham SW, 1974, CHECKLIST WORLD AMPH; Gosner K. L., 1960, Herpetologica, V16, P183; Grant T., 2006, B AM MUS NAT HIST, V299, P1, DOI DOI 10.1206/0003-0090(2006)299[; Green D. M, 1991, AMPHIBIAN CYTOGENETI, P431, DOI [DOI 10.1016/B978-0-12-297880-7.50021-4, 10.1016/B978-0-12-297880-7.50021-4]; Green David M., 2007, Amphibian Biology, V7, P2757; Gruber Simone Lilian, 2017, Comparative Cytogenetics, V11, P267, DOI 10.3897/CompCytogen.11(2).11254; Gruber SL, 2005, FOLIA BIOL-PRAGUE, V51, P68; Gudynas E., 1983, 3 JORN CIENC NAT MON, V3, P92; HADDAD C F B, 1987, Revista Brasileira de Biologia, V47, P127; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; IZECKSOHN E., 1959, REV BRASIL BIOL, V19, P259; Izecksohn E, 1998, REV U RURAL CV, V18, P47; Jansen M, 2016, AMPHIBIA-REPTILIA, V37, P137, DOI 10.1163/15685381-00003038; Jetz W, 2018, NAT ECOL EVOL, V2, P850, DOI 10.1038/s41559-018-0515-5; Jungfer Karl-Heinz, 2001, Zoologische Abhandlungen (Dresden), V51, P321; JURGENS J D, 1971, Annale Universiteit van Stellenbosch Serie A, V46, P1; Klappenbach Miguel A., 1992, Anales del Museo Nacional de Historia Natural de Montevideo, V8, P163; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kolenc F, 2003, CUAD HERPETOL, V17, P87; Kolenc F, 2007, STUD NEOTROP FAUNA E, V42, P175, DOI 10.1080/01650520701228429; Kwet A, 2000, AMPHIBIA-REPTILIA, V21, P39, DOI 10.1163/156853800507264; Kwet A, 2001, COPEIA, P203, DOI 10.1643/0045-8511(2001)001[0203:PBSGAL]2.0.CO;2; KWET A., 1999, PROMATA ANFIBIOS; Kwet A., 2001, FROSCHE BRASILIANSCH, DOI [10.1002/biuz.200410251, DOI 10.1002/BIUZ.200410251]; Kwet A, 2010, ANFIBIOS PROMATA SEC; Langguth A., 1976, LISTA ESPECIES VERTE, P30; Langone J.A., 1995, SERIE DIVULGACION, V5, P1; Langone JA, 2004, COLLECTED DAPTF WORK, P83; Langone JA, 2011, AMPHIBIAN BIOL, V9, P79; Langone Jose A., 2003, Anales Museo Nacional de Historia Natural y Antropologia Montevideo, V10, P1; Langone Jose A., 1990, Comunicaciones Zoologicas del Museo de Historia Natural de Montevideo, V12, P1; Langone Jose A., 1997, Cuadernos de Herpetologia, V11, P89; Ponssa ML, 2010, ANAT REC, V293, P1646, DOI 10.1002/ar.21212; Lavenex PB, 1999, J ACOUST SOC AM, V106, P491, DOI 10.1121/1.427079; LAVILLA E O, 1986, Physis Seccion B las Aguas Continentales y sus Organismos, V44, P39; Lema T, ANFIBIOS RIO GRANDE; LEON J R, 1969, University of Kansas Publications of the Museum of Natural History, V18, P505; Lourenco ACC, 2016, ZOOTAXA, V4154, P415, DOI 10.11646/zootaxa.4154.4.3; Lutz A, 1925, CR SOC BIOL, V93, P211; Lutz B., 1968, PEARCE SELLARDS SERI, V10, P3; Lutz B., 1973, BRAZILIAN SPECIES HY; Lutz B., 1951, NOTA PREVIA ALGUNS A, V39, P705; LUTZ BERTHA, 1954, MEM INST OSWALDO CRUZ, V52, P155; lvarezA BB, 2012, GUIA CAMPO IDENTIFIC; Maneyro R, 1999, B SOC ZOOL URUG ACTA, V11, P28; Maneyro R, 2004, SMITHSON HERPETOL IN, V134, P1; Maneyro R., 2012, GUIA ANFIBIOS URUGUA; Maneyro Raul, 2001, Cuadernos de Herpetologia, V15, P107; Manzano AS, 2005, HERPETOLOGICA, V61, P259, DOI 10.1655/04-28.1; Marin da Fonte LF, 2013, FAUNA FLORA RESERVA; MYERS C W, 1982, American Museum Novitates, P1; Napoli M., 1998, B MUS NAC NOVA SER Z, V391, P1; Nascimento LB, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2004.RLTS, DOI 10.2305/IUCN.UK.2004.RLTS]; Nogueira L, 2016, GENET MOL BIOL, V39, P49, DOI 10.1590/1678-4685-GMB-2015-0037; Nogueira L, 2015, GENET MOL BIOL, V38, P156, DOI 10.1590/S1415-4757382220140280; Nogueira L, 2015, COMP CYTOGENET, V9, P227, DOI 10.3897/CompCytogen.v9i2.4593; Nunes I, 2012, COPEIA, P554, DOI 10.1643/CH-11-088; Nunes Ivan, 2007, South American Journal of Herpetology, V2, P89, DOI 10.2994/1808-9798(2007)2[89:ACOFHF]2.0.CO;2; Olmos A, 1997, ACTA ZOOLOGICA PLATE, V1, P1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peixoto MAA, 2016, COMP CYTOGENET, V10, P505, DOI 10.3897/CompCytogen.v10i4.9176; Peixoto OL, ZOOLOGISCHE JB ABTEI; Pombal Jr. José P., 2003, Rev. Bras. Zool., V20, P607, DOI 10.1590/S0101-81752003000400007; Pombal Jose P. Jr., 1996, Boletim do Museu Nacional Rio de Janeiro Zoologia, V371, P1; Pombal JP, 2011, HERPETOLOGICA, V67, P288, DOI 10.1655/HERPETOLOGICA-D-10-00067.1; POMBAL JP, 1995, J HERPETOL, V29, P1, DOI 10.2307/1565078; Prigioni C., 1992, CLAVE DETERMINACION; Prigioni Carlos, 2011, Check List, V7, P763; Probides, 1999, RES BIOST BAT EST UR; PYBURN W F, 1971, Journal of Herpetology, V5, P97, DOI 10.2307/1562731; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Reeves A, 2012, MICROMEASURE WINDOWS; Bolzan AMR, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2015-0113; Roberto IJ, 2017, HERPETOLOGICA, V73, P148, DOI 10.1655/HERPETOLOGICA-D-16-00021; Ron SR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203169; Rossa-Feres DC, 2011, BIOTA NEOTROP, V11, P47, DOI 10.1590/S1676-06032011000400018; Sabaj M.H., 2016, STANDARD SYMBOLIC CO; Savage Jay M., 1997, Herpetological Review, V28, P131; Schmid M., 2010, Cytogenetic and Genome Research, V130-131, P1, DOI 10.1159/000301339; Schmid M, 2018, CYTOGENET GENOME RES, V155, P6, DOI 10.1159/000490324; Schmidt K. P., 1944, Zoological Series Field Museum of Natural History, V29, P153; Silva JA, 2008, MEGADIVERSIDADE, V4, P270; Soliz M, 2016, J MORPHOL, V277, P786, DOI 10.1002/jmor.20536; Suarez P, 2013, CYTOGENET GENOME RES, V141, P295, DOI 10.1159/000354997; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Targueta CP, 2018, GENET MOL BIOL, V41, P814, DOI [10.1590/1678-4685-GMB-2017-0382, 10.1590/1678-4685-gmb-2017-0382]; TAYLOR W R, 1985, Cybium, V9, P107; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Toledo LF, 2005, J HERPETOL, V39, P455, DOI 10.1670/139-04A.1; Trewavas E, 1933, PHILOS T R SOC LON B, V222, P401; Trueb L., 1973, P65; Trueb Linda, 1993, P255; Vaira M., 2012, CUADERNOS HERPETO S1, V26, P131; WASSERSUG R, 1980, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Wassersug R.J., 1976, Occasional Papers Mus Nat Hist Univ Kans, VNo. 48, P1; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; White MJD, 1954, ANIMAL CYTOLOGY EVOL; Ziegler L, 2008, CLAVE IDENTIFICACION	181	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222131	10.1371/journal.pone.0222131	http://dx.doi.org/10.1371/journal.pone.0222131			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553727	gold, Green Published			2022-12-27	WOS:000532319200015
J	Fong, JH				Fong, Joelle H.			Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?	PLOS ONE			English	Article							CARE EXPENDITURES; FINANCIAL BURDEN; INSURANCE; ADULTS; RISE	Background Little is known about the impact of different types of chronic diseases on older adults' out-of-pocket healthcare spending and whether certain diseases trigger higher spending needs than others. Methods We use data from the 2014 Health and Retirement Study representing a weighted population of 35,939,270 Medicare beneficiaries aged 65+. Generalized linear models are applied to estimate the effect of different chronic diseases on total out-of-pocket expenditure, adjusted for demographics, socio-economic status, physical health, and other factors. We also decompose total spending by expenditure categories (inpatient, non-inpatient, and prescription drug spending). Sensitivity analysis is performed using a younger sample of older adults aged 50-64. Results Cardiovascular disease, diabetes, hypertension and cancer, induce significantly higher adjusted out-of-pocket spending among older adults than other conditions. These results hold regardless how the spending differences are assessed (absolute or percentage terms). For Medicare beneficiaries, cardiovascular disease is associated with an excess out-of-pocket spending of $317 per year, followed by diabetes ($237), hypertension ($150), and cancer ($144). Prescription drug spending is singularly the most important driver of additional expenses for cardiovascular disease, diabetes and hypertension, while non-inpatient services spending accounts for the bulk of increased spending among those with cancer. Conclusions Our finding that major noncommunicable diseases impact individuals' out-of-pocket medical spending differentially-and that service drivers of increased spending may be heterogeneous across disease types-suggest that health professionals and policymakers should recognize that certain chronic diseases exert greater financial toll on the elderly. Interventions to promote more cost efficient healthcare services and consumer choices can help older adults better cope with these expensive long-lasting conditions and reduce the overall burden of noncommunicable diseases.	[Fong, Joelle H.] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore	National University of Singapore	Fong, JH (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore.	j.fong@nus.edu.sg	Fong, Joelle H./AAB-7371-2019	Fong, Joelle H./0000-0003-0267-6779	Singapore Ministry of Education Start-up Grant at the National University of Singapore; United States National Institute on Aging; Social Security Administration	Singapore Ministry of Education Start-up Grant at the National University of Singapore(Ministry of Education, SingaporeNational University of Singapore); United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Social Security Administration	JF is funded by the Singapore Ministry of Education Start-up Grant at the National University of Singapore.; This article uses data from Health and Retirement Study (HRS) Wave 2014. HRS is supported by the United States National Institute on Aging and the Social Security Administration. I am grateful to seminar participants at the 2017 Australian Conference for Health Economists for their feedback on an earlier draft.	Akincigil A, 2015, 201528 CTR RET RES B; American Cancer Society, 2016, CANC TREATMENT SURVI; American Heart Association, 2017, CARD DIS COSTL BURD; [Anonymous], 2013, STAT AG HLTH AM 2013; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Chen A, 2016, ANNU REV ECON, V8, P291, DOI 10.1146/annurev-economics-080315-015317; Chi CH, 2008, HEALTH ECON, V17, P961, DOI 10.1002/hec.1312; Crystal S, 2000, J GERONTOL B-PSYCHOL, V55, pS51; Cubanski J, 2014, MUCH I ENOUGH OUT PR; Davidoff AJ, 2013, CANCER-AM CANCER SOC, V119, P1257, DOI 10.1002/cncr.27848; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dranove D, 2006, HEALTH AFFAIR, V25, pW74, DOI 10.1377/hlthaff.25.w74; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Goldman D.P., 2011, FORUM HLTH EC POLICY, V14, P4, DOI [10.2202/1558-9544.1267, DOI 10.2202/1558-9544.1267]; Health and Retirement Study, 2017, SAMPL SIZ RESP RAT; Hendershot Eleanor, 2005, J Pediatr Oncol Nurs, V22, P31, DOI 10.1177/1043454204272539; Himmelstein DU, 2005, HLTH AFF, V24, P570; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu TW, 1999, HEALTH ECON, V8, P309, DOI 10.1002/(SICI)1099-1050(199906)8:4<309::AID-HEC440>3.0.CO;2-N; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Kang HA, 2015, VALUE HEALTH, V18, pA269, DOI 10.1016/j.jval.2015.03.1570; Kaye HS, 2010, HEALTH AFFAIR, V29, P11, DOI 10.1377/hlthaff.2009.0535; Ladusingh L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196835; Langa KM, 2004, VALUE HEALTH, V7, P186, DOI 10.1111/j.1524-4733.2004.72334.x; Lee JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127199; Li R, 2014, DIABETES CARE, V37, P1629, DOI 10.2337/dc13-1997; Lopez AD, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0200-8; Lu K, 2014, VALUE HEALTH, V17, pA262, DOI 10.1016/j.jval.2014.03.1526; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG., 1981, HEAL EC HEAL EC, V137, P103; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Narang AK, 2017, JAMA ONCOL, V3, P757, DOI 10.1001/jamaoncol.2016.4865; Numico G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120827; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Sakharkar P, 2016, VALUE HEALTH, V19, pA14, DOI 10.1016/j.jval.2016.03.275; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Song X, 2014, VALUE HEALTH, V17, pA81, DOI 10.1016/j.jval.2014.03.474; Stewart ST, 2004, GERONTOLOGIST, V44, P48, DOI 10.1093/geront/44.1.48; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Wong CY, 2017, HEALTH ECON, V26, P962, DOI 10.1002/hec.3376; World Health Organization, 2019, NONC DIS PROGR MON 2	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222539	10.1371/journal.pone.0222539	http://dx.doi.org/10.1371/journal.pone.0222539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539389	Green Published, gold			2022-12-27	WOS:000532297900015
J	Szegedi-Hallgato, E; Janacsek, K; Nemeth, D				Szegedi-Hallgato, Emese; Janacsek, Karolina; Nemeth, Dezso			Different levels of statistical learning - Hidden potentials of sequence learning tasks	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; 2-CHOICE REACTION-TIME; ADULT AGE; PREDICTIVE RELATIONSHIPS; AUTOMATIC FACILITATION; SPATIAL CONTEXT; IMPLICIT; CONSOLIDATION; EXPECTANCY; MEMORY	In this paper, we reexamined the typical analysis methods of a visuomotor sequence learning task, namely the ASRT task (J. H. Howard & Howard, 1997). We pointed out that the current analysis of data could be improved by paying more attention to pre-existing biases (i.e. by eliminating artifacts by using new filters) and by introducing a new data grouping that is more in line with the task's inherent statistical structure. These suggestions result in more types of learning scores that can be quantified and also in purer measures. Importantly, the filtering method proposed in this paper also results in higher individual variability, possibly indicating that it had been masked previously with the usual methods. The implications of our findings relate to other sequence learning tasks as well, and opens up opportunities to study different types of implicit learning phenomena.	[Szegedi-Hallgato, Emese] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Szegedi-Hallgato, Emese] Univ Szeged, Fac Humanities, Inst Psychol, Szeged, Hungary; [Szegedi-Hallgato, Emese] Univ Szeged, Prevent Mental Illnesses Interdisciplinary Res Gr, Szeged, Hungary; [Janacsek, Karolina; Nemeth, Dezso] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Janacsek, Karolina; Nemeth, Dezso] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Brain Memory & Language Res Grp, Budapest, Hungary; [Nemeth, Dezso] Univ Lyon, Lyon Neurosci Res Ctr, Lyon, France	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Szeged University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Nemeth, D (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Nemeth, D (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Brain Memory & Language Res Grp, Budapest, Hungary.; Nemeth, D (corresponding author), Univ Lyon, Lyon Neurosci Res Ctr, Lyon, France.	nemethd@gmail.com	Nemeth, Dezso/B-9142-2009	Nemeth, Dezso/0000-0002-9629-5856; Janacsek, Karolina/0000-0001-7829-8220	National Brain Research Program [2017-1.2.1-NKP-2017-00002]; Hungarian Scientific Research Fund [NKFIH-OTKA K 128016, NKFIH-OTKA PD 124148]; IDEXLYON Fellowship; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences; EU [EFOP-3.6.1-16-2016-00008]	National Brain Research Program; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); IDEXLYON Fellowship; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); EU(European Commission)	This research was supported by the National Brain Research Program (project 2017-1.2.1-NKP-2017-00002), the Hungarian Scientific Research Fund (NKFIH-OTKA K 128016, to D.N., NKFIH-OTKA PD 124148 to K.J.), IDEXLYON Fellowship (to D.N.), and a Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences (to K. J.). This research was supported by the EUfunded Hungarian grant EFOP-3.6.1-16-2016-00008 (to E. Sz-H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KA, 2008, NEUROPSYCHOLOGY, V22, P563, DOI 10.1037/0894-4105.22.5.563; Barnes KA, 2010, DEV NEUROPSYCHOL, V35, P494, DOI 10.1080/87565641.2010.494750; Bennett IJ, 2007, J GERONTOL B-PSYCHOL, V62, pP98, DOI 10.1093/geronb/62.2.P98; Bergstrom JCR, 2012, APPL COGNITIVE PSYCH, V26, P91, DOI 10.1002/acp.1800; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Edwards JR, 2001, ORGAN RES METHODS, V4, P265, DOI 10.1177/109442810143005; Gao J, 2009, NEURAL COMPUT, V21, P2407, DOI 10.1162/neco.2009.09-08-866; Grosjean M, 2001, J EXP PSYCHOL GEN, V130, P256, DOI 10.1037//0096-3445.130.2.256; Hallgato E, 2013, CORTEX, V49, P1073, DOI 10.1016/j.cortex.2012.01.002; Hedenius M, 2011, RES DEV DISABIL, V32, P2362, DOI 10.1016/j.ridd.2011.07.026; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Horvath K, EXPLICIT INSTRUCTION; Howard DV, 2004, PSYCHOL AGING, V19, P79, DOI 10.1037/0882-7974.19.1.79; Howard DV, 2001, PSYCHON B REV, V8, P798, DOI 10.3758/BF03196220; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Janacsek K, 2018, PROG NEURO-PSYCHOPH, V81, P17, DOI 10.1016/j.pnpbp.2017.09.021; Janacsek K, 2015, BRAIN STIMUL, V8, P277, DOI 10.1016/j.brs.2014.11.008; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; Kaufman SB, 2010, COGNITION, V116, P321, DOI 10.1016/j.cognition.2010.05.011; KIRBY NH, 1976, J EXP PSYCHOL HUMAN, V2, P567, DOI 10.1037/0096-1523.2.4.567; Kobor A, 2018, BIOL PSYCHOL, V135, P180, DOI 10.1016/j.biopsycho.2018.04.001; Kornblum S., 1973, ATTENTION PERFORM, P259; Lebel EP, 2011, PERS SOC PSYCHOL B, V37, P570, DOI 10.1177/0146167211400619; Lee JC, 2016, ACTA PSYCHOL, V170, P168, DOI 10.1016/j.actpsy.2016.08.004; Marvel CL, 2005, J INT NEUROPSYCH SOC, V11, P659, DOI 10.1017/S13556177050861; Negash S, 2003, AGING NEUROPSYCHOL C, V10, P108, DOI 10.1076/anec.10.2.108.14462; Negash S, 2007, NEUROCASE, V13, P133, DOI 10.1080/13554790701401852; Nemeth D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00147; Nemeth D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00318; Nemeth D, 2013, CEREB CORTEX, V23, P801, DOI 10.1093/cercor/bhs068; Nemeth D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017577; Nemeth D, 2010, EXP BRAIN RES, V201, P351, DOI 10.1007/s00221-009-2024-x; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Parshina O, 2018, 40 ANN M COGN SCI SO; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; REMINGTON RJ, 1969, J EXP PSYCHOL, V82, P250, DOI 10.1037/h0028122; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Schneider W., 2012, E PRIME 2 0 REFERENC; Schwartz BL, 2003, NEUROPSYCHOLOGY, V17, P517, DOI 10.1037/0894-4105.17.3.517; Simor P, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02708; SOETENS E, 1985, J EXP PSYCHOL HUMAN, V11, P598, DOI 10.1037/0096-1523.11.5.598; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Song SB, 2007, LEARN MEMORY, V14, P167, DOI 10.1101/lm.437407; Stark-Inbar A, 2017, J NEUROPHYSIOL, V117, P412, DOI 10.1152/jn.01141.2015; Sunderland A, 2003, BR J OCCUP THER, V66, P263, DOI DOI 10.1177/030802260306600605; Takacs A, 2018, CORTEX, V100, P84, DOI 10.1016/j.cortex.2017.08.037; Torok B, 2017, J EXP PSYCHOL GEN, V146, P529, DOI 10.1037/xge0000288; VERVAECK KR, 1980, ACTA PSYCHOL, V44, P175, DOI 10.1016/0001-6918(80)90066-9; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131	55	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221966	10.1371/journal.pone.0221966	http://dx.doi.org/10.1371/journal.pone.0221966			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536512	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000532262800021
J	Davies, V; Reid, J; Wiseman-Orr, ML; Scott, EM				Davies, Vinny; Reid, Jacqueline; Wiseman-Orr, M. Lesley; Scott, E. Marian			Optimising outputs from a validated online instrument to measure health-related quality of life (HRQL) in dogs	PLOS ONE			English	Article							CHRONIC PAIN; NONPHYSICAL ASPECTS; QUESTIONNAIRE; OUTCOMES; TOOL	Measurement of health-related quality of life (HRQL) is becoming increasingly valuable within veterinary preventative health care and chronic disease management, as well as in outcomes research. Initial reliability and validation of a 22 item shortened version of VetMetrica (VM), structured questionnaire instrument to measure HRQL in dogs via a mobile application was reported previously. Meaningful interpretation and presentation of the 4 domain scores comprising the HRQL profile generated by VM is key to its successful use in clinical practice and research. Study one describes transformation of domain scores from 0-6 to 0-100 and normalisation of these based on the healthy canine population in two age ranges, such that a score of 50 on a 0-100 scale represents the score for the age-related average healthy dog, and establishment of a threshold to assess domain-specific health status for individual dogs. This provides the clinician with a simple method of ascertaining the health status of an individual dog relative to the average healthy population in the same age group (norm-based scoring). Study two determines the minimum important difference (MID) in domain scores which represents the smallest improvement in score that is meaningful to the dog owner, thus providing the clinician with a means of recognising what is likely to be a significant improvement in scores for an individual dog over time. Visual representation of these guidelines for the purpose of interpreting VM profile scores is presented using case studies.	[Davies, Vinny] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Davies, Vinny; Wiseman-Orr, M. Lesley; Scott, E. Marian] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland; [Reid, Jacqueline] NewMetrica Ltd, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Davies, V (corresponding author), Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland.; Davies, V (corresponding author), Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland.	Vinny.Davies@Glasgow.ac.uk		Wiseman-Orr, M Lesley/0000-0002-1286-5031; Davies, Vinny/0000-0003-1896-8936				Budke CM, 2008, JAVMA-J AM VET MED A, V233, P925, DOI 10.2460/javma.233.6.925; Carey JJ, 2010, CLIN REV BONE MINER, V8, P113, DOI 10.1007/s12018-009-9064-4; Coteur G, 2009, ALIMENT PHARM THER, V29, P1032, DOI 10.1111/j.1365-2036.2009.03966.x; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; DEYO RA, 1986, J CHRON DIS, V39, P897, DOI 10.1016/0021-9681(86)90038-X; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Favrot C, 2010, VET DERMATOL, V21, P63, DOI 10.1111/j.1365-3164.2009.00781.x; Freeman LM, 2005, JAVMA-J AM VET MED A, V226, P1864, DOI 10.2460/javma.2005.226.1864; French B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198426; Gandek B, 2002, SCORE VERSION 2 SF 1; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Gyatt G.H., 2007, JAMA-J AM MED ASSOC, V277, P1232; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Huang IC, 2008, HEALTH SERV RES, V43, P327, DOI 10.1111/j.1475-6773.2007.00745.x; JETTE DU, 1994, PHYS THER, V74, P521, DOI 10.1093/ptj/74.6.521; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; Lam C., 1999, HONG KONG PRACT, V1, P1; Lavan RP, 2013, VET J, V197, P578, DOI 10.1016/j.tvjl.2013.03.021; Lesaffre E, 2007, BIOSTATISTICS, V8, P72, DOI 10.1093/biostatistics/kxj034; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; LYDICK E, 1993, QUAL LIFE RES, V2, P221, DOI 10.1007/BF00435226; Lynch S, 2011, VET COMP ONCOL, V9, P172, DOI 10.1111/j.1476-5829.2010.00244.x; Niessen SJM, 2012, J VET INTERN MED, V26, P953, DOI 10.1111/j.1939-1676.2012.00947.x; Noli C, 2011, VET DERMATOL, V22, P335, DOI 10.1111/j.1365-3164.2010.00954.x; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; Reid J, 2018, J SMALL ANIM PRACT, V59, P334, DOI 10.1111/jsap.12772; Reid J, 2013, J SMALL ANIM PRACT, V54, P227, DOI 10.1111/jsap.12059; Schunemann HJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-62; Schunemann Holger J, 2005, COPD, V2, P81; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Ware JE, 2007, USERS MANUAL SF 36V2; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wiseman-Orr ML, 2006, AM J VET RES, V67, P1826, DOI 10.2460/ajvr.67.11.1826; Wiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077; Wojciechowska JI, 2005, AM J VET RES, V66, P1453, DOI 10.2460/ajvr.2005.66.1453; Wojciechowska JI, 2005, AM J VET RES, V66, P1461, DOI 10.2460/ajvr.2005.66.1461; ZWEIG MH, 1993, CLIN CHEM, V39, P561	40	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221869	10.1371/journal.pone.0221869	http://dx.doi.org/10.1371/journal.pone.0221869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532799	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000532239600014
J	Laudicina, NM; Rodriguez, F; DeSilva, JM				Laudicina, Natalie M.; Rodriguez, Frankee; DeSilva, Jeremy M.			Reconstructing birth in Australopithecus sediba	PLOS ONE			English	Article							NEONATAL BRAIN SIZE; VIRTUAL RECONSTRUCTION; EVOLUTION; PELVIS; DIMENSIONS; OBSTETRICS; CHILDBIRTH; AFARENSIS; MECHANISM; PRIMATES	Hominin birth mechanics have been examined and debated from limited and often fragmentary fossil pelvic material. Some have proposed that birth in the early hominin genus Australopithecus was relatively easy and ape-like, while others have argued for a more complex, human-like birth mechanism in australopiths. Still others have hypothesized a unique birth mechanism, with no known modern equivalent. Preliminary work on the pelvis of the recently discovered 1.98 million-year-old hominin Australopithecus sediba found it to possess a unique combination of Homo and Australopithecus-like features. Here, we create a composite pelvis of Australopithecus sediba to reconstruct the birth process in this early hominin. Consistent with other hominin species, including modern humans, the fetus would enter the pelvic inlet in a transverse direction. However, unlike in modern humans, the fetus would not need additional rotations to traverse the birth canal. Further fetal rotation is unnecessary even with a Homo-like pelvic midplane expansion, not seen in earlier hominin species. With a birth canal shape more closely associated with specimens from the genus Homo and a lack of cephalopelvic or shoulder constraints, we therefore find evidence to support the hypothesis that the pelvic morphology of Australopithecus sediba is a result of locomotor, rather than strictly obstetric constraints.	[Laudicina, Natalie M.; Rodriguez, Frankee] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Laudicina, Natalie M.] Grand Valley State Univ, Biomed Sci Dept, Grand Rapids, MI 49504 USA; [DeSilva, Jeremy M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [DeSilva, Jeremy M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	Boston University; Grand Valley State University; Dartmouth College; University of Witwatersrand	Laudicina, NM (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.; Laudicina, NM (corresponding author), Grand Valley State Univ, Biomed Sci Dept, Grand Rapids, MI 49504 USA.	laudicin@gvsu.edu		Laudicina, Natalie/0000-0002-6180-2803	Boston University; Dartmouth College	Boston University; Dartmouth College	This research was funded by Boston University and Dartmouth College.	ABITBOL MM, 1991, AM J PHYS ANTHROPOL, V85, P135, DOI 10.1002/ajpa.1330850203; American College of Obstetricians and Gynecologists, 2002, SHOULD DYST; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; BERGE C, 1984, J HUM EVOL, V13, P573, DOI 10.1016/S0047-2484(84)80029-9; Berge C, 2010, J HUM EVOL, V58, P262, DOI 10.1016/j.jhevol.2009.11.006; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bogin B, 1999, ANNU REV ANTHROPOL, V28, P109, DOI 10.1146/annurev.anthro.28.1.109; Bonmati A, 2010, P NATL ACAD SCI USA, V107, P18386, DOI 10.1073/pnas.1012131107; Cameron N, 2017, AM J PHYS ANTHROPOL, V163, P633, DOI 10.1002/ajpa.23234; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill IRU, 2018, J KNOT THEOR RAMIF, V27, DOI 10.1142/S0218216518920013; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; Claxton AG, 2016, J HUM EVOL, V99, P10, DOI 10.1016/j.jhevol.2016.06.001; de Leon MSP, 2008, P NATL ACAD SCI USA, V105, P13764, DOI 10.1073/pnas.0803917105; Desilva JM, 2017, ANAT REC, V300, P890, DOI 10.1002/ar.23573; DeSilva JM, 2008, J HUM EVOL, V55, P1064, DOI 10.1016/j.jhevol.2008.07.008; DeSilva JM, 2013, SIENCE, V340, P6129; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Dunsworth HM, 2016, OBSTETRICAL DILEMMA, P29; Dunsworth H, 2015, ANNU REV ANTHROPOL, V44, P55, DOI 10.1146/annurev-anthro-102214-013918; Dunsworth HM, 2018, PERSPECT BIOL MED, V61, P249, DOI 10.1353/pbm.2018.0040; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Elder JH, 1936, PROC R SOC SER B-BIO, V120, P409, DOI 10.1098/rspb.1936.0043; Fremondiere P, 2016, AM J PHYS ANTHROPOL, V159, P148; Gherman RB, 1998, AM J OBSTET GYNECOL, V178, P1126, DOI 10.1016/S0002-9378(98)70312-6; Haeusler M, 2016, AM J PHYS ANTHROPOL, V159, P165; HAUSLER M, 1995, J HUM EVOL, V29, P363, DOI 10.1006/jhev.1995.1063; Hirata S, 2011, BIOL LETTERS, V7, P686, DOI 10.1098/rsbl.2011.0214; Jolly A., 1973, International Zoo Yearbook, V13, P391, DOI 10.1111/j.1748-1090.1973.tb02188.x; JOLLY A, 1972, FOLIA PRIMATOL, V18, P108, DOI 10.1159/000155472; JORDAAN HVF, 1976, AM J PHYS ANTHROPOL, V44, P271, DOI 10.1002/ajpa.1330440209; Joulin D, 1864, MEDECINE, P29; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LEUTENEGGER W, 1987, J HUM EVOL, V16, P291, DOI 10.1016/0047-2484(87)90004-2; LEUTENEGGER W, 1974, J HUM EVOL, V3, P207, DOI 10.1016/0047-2484(74)90179-1; LEUTENEGGER W, 1972, NATURE, V240, P568, DOI 10.1038/240568a0; Lovejoy CO, 2016, VERTEBR PALEOBIOL PA, P155, DOI 10.1007/978-94-017-7429-1_8; MCHENRY HM, 1986, J HUM EVOL, V15, P177, DOI 10.1016/S0047-2484(86)80044-6; Rosenberg K, 2002, BJOG-INT J OBSTET GY, V109, P1199, DOI 10.1046/j.1471-0528.2002.00010.x; ROSENBERG KR, 1992, YEARB PHYS ANTHROPOL, V35, P89; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Schultz AH, 1949, AM J PHYS ANTHROP-NE, V7, P401, DOI 10.1002/ajpa.1330070307; Simpson SW, 2008, SCIENCE, V322, P1089, DOI 10.1126/science.1163592; Tague RG, 1998, J HUM EVOL, V35, P75, DOI 10.1006/jhev.1998.0223; Tague RG, 1986, J HUM EVOL, V15, P165; Trevathan W, 2000, J HUM EVOL, V39, P583, DOI 10.1006/jhev.2000.0434; Trevathan W., 1987, HUMAN BIRTH EVOLUTIO; TREVATHAN WR, 1988, AM ANTHROPOL, V90, P674, DOI 10.1525/aa.1988.90.3.02a00100; Trevathan WR, 1996, MED ANTHROPOL Q, V10, P287, DOI 10.1525/maq.1996.10.2.02a00100; Warrener AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118903; WASHBURN SL, 1960, SCI AM, V203, P63; Weaver TD, 2009, P NATL ACAD SCI USA; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; Wood BA, 1996, J HUM EVOL, V31, P563, DOI 10.1006/jhev.1996.0080	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221871	10.1371/journal.pone.0221871	http://dx.doi.org/10.1371/journal.pone.0221871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532788	Green Submitted, Green Published, gold			2022-12-27	WOS:000532239600015
J	de Jong, LA; Groeneveld, J; Stevanovic, J; Rila, H; Tieleman, RG; Huisman, MV; Postma, MJ; van Hulst, M				de Jong, Lisa A.; Groeneveld, Jessie; Stevanovic, Jelena; Rila, Harrie; Tieleman, Robert G.; Huisman, Menno, V; Postma, Maarten J.; van Hulst, Marinus			Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE PREVENTION; NETWORK METAANALYSIS; WARFARIN; DABIGATRAN; EDOXABAN; SAFETY; RIVAROXABAN; EFFICACY; CARE	Introduction Randomized clinical trials (RCTs) and real-world data (RWD) in patients with atrial fibrillation have shown that-compared to vitamin K antagonists (VKAs)-non-VKA oral anticoagulants (NOACs) are at least as effective in the prevention of ischaemic stroke, while decreasing the risk of bleeding. Objective We aim to evaluate the cost-effectiveness of the NOAC apixaban versus other NOACs (dabigatran, edoxaban and rivaroxaban) and VKA, for stroke prevention in patients with atrial fibrillation by including the available data both from RCT and real-world analyses of all NOACs into one integrative previously published model. Methods The model was updated to the current Dutch healthcare situation. The incremental cost-effectiveness ratio was calculated using either efficacy/effectiveness and safety data derived from a network meta-analysis (NMA) synthesizing NOAC RCTs or RWD. We conducted a systematic literature search to identify eligible publication to best inform the RWD-based analysis. Additional sensitivity and scenario analyses were conducted to test the robustness of the outcomes. Results In the NMA-based analysis, apixaban appeared to be cost-effective compared to VKA ((sic)3,506 per quality adjusted life-year) and dominant (cost-saving and more effective) over dabigatran 110 mg, dabigatran 150 mg, edoxaban and rivaroxaban. In the RWD-based analysis, apixaban was dominant over all other anticoagulants. In the scenario analysis apixaban appeared to be not cost-effective compared to dabigatran 150 mg, when using equal event-unrelated treatment discontinuation rates for each drug. In all other scenarios apixaban is cost-effective or cost-saving compared to VKA and other NOACs. Conclusion Based on RCTs as well as RWD, we conclude that apixaban is generally cost-effective or even cost-saving (less costly and more effective) compared to VKA and other NOACs in the overall population of patients with atrial fibrillation.	[de Jong, Lisa A.; Groeneveld, Jessie; Postma, Maarten J.] Univ Groningen, Groningen Res Inst Pharm GRIP, Dept PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands; [Stevanovic, Jelena; Rila, Harrie] Bristol Myers Squibb, Utrecht, Netherlands; [Tieleman, Robert G.] Martini Hosp, Dept Cardiol, Groningen, Netherlands; [Tieleman, Robert G.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Huisman, Menno, V] Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands; [Postma, Maarten J.] Univ Groningen, Dept Econ Econometr & Finance, Fac Econ & Business, Groningen, Netherlands; [Postma, Maarten J.; van Hulst, Marinus] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [van Hulst, Marinus] Martini Hosp, Dept Clin Pharm & Toxicol, Groningen, Netherlands	University of Groningen; Bristol-Myers Squibb; Martini Hospital; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; Martini Hospital	de Jong, LA (corresponding author), Univ Groningen, Groningen Res Inst Pharm GRIP, Dept PharmacoTherapy Epidemiol & Econ, Groningen, Netherlands.	l.a.de.jong@rug.nl		Postma, Maarten/0000-0002-6306-3653; de Jong, Lisa/0000-0001-8814-0670	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	This study was sponsored by Bristol-Myers Squibb and Pfizer. The funder provided support in the form of salaries for authors Jelena Stevanovic and Harrie Rila, but did not have any additional role in the study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, SAMENVATTING MEDISCH; [Anonymous], 2017, 848050007 DUTCH AF; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Camm AJ, 2018, EUROPACE, V20, P1, DOI 10.1093/europace/eux086; Camm JA, 2012, EUR HEART J, V33, P2019; Claassen DO, 2008, ARCH NEUROL-CHICAGO, V65, P1313, DOI 10.1001/archneur.65.10.1313; Connolly SJ, 2009, N ENGL J MED, V361, P1139, DOI [10.1056/NEJMoa0905561, DOI 10.1056/NEJM0A0905561]; Dutch Healthcare Authority (NZa), 2018, DIS OP DAT; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; EPAR, 2018, ANNEX 1 SUMMARY PROD; Federation for Dutch Thrombosis Service (FNT), 2017, MED ANN REP 2017; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hakkaart-van Roijen L, 2016, ZORGINSTITUUT NED, P1; Heemstra HE, 2011, NETH HEART J, V19, P373, DOI 10.1007/s12471-011-0175-4; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Korenstra J, 2016, EUROPACE, V18, P1319, DOI 10.1093/europace/euv397; Lip GYH, 2016, INT J CARDIOL, V204, P88, DOI 10.1016/j.ijcard.2015.11.084; Lip GYH, 2015, CLIN THER, V37, P2476, DOI 10.1016/j.clinthera.2015.09.005; Lip GYH, 2014, CLIN THER, V36, P192, DOI 10.1016/j.clinthera.2013.12.011; Lip GY, 2018, STROKE, V49; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Mandema J, 2011, METAANALYSIS PLACEBO; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Statistics Netherlands (CBS), LIF EXP SEX AG PER Y; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Stevanovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103974; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; Verhoef TI, 2014, AM J CARDIOVASC DRUG, V14, P451, DOI 10.1007/s40256-014-0092-1; Versteegh M., 2016, IMTA DIS BURDEN CALC; Z-index, 2018, PHARM PURCH PRIC AP	38	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222658	10.1371/journal.pone.0222658	http://dx.doi.org/10.1371/journal.pone.0222658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527894	gold, Green Published, Green Submitted			2022-12-27	WOS:000532231400035
J	Oosterom, N; de Jonge, R; Smith, DEC; Pieters, R; Tissing, WJE; Fiocco, M; van Zelst, BD; van den Heuvel-Eibrink, MM; Heil, SG				Oosterom, Natanja; de Jonge, Robert; Smith, Desiree E. C.; Pieters, Rob; Tissing, Wim J. E.; Fiocco, Marta; van Zelst, Bertrand D.; van den Heuvel-Eibrink, Marry M.; Heil, Sandra G.			Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia	PLOS ONE			English	Article							FOLINIC ACID; VITAMER DISTRIBUTION; PLASMA HOMOCYSTEINE; METHIONINE; ACCUMULATION; DEPLETION; 5-METHYLTETRAHYDROFOLATE; PHARMACOKINETICS; DEFICIENCY; INFUSIONS	Background Methotrexate (MTX) is an important anti-folate agent in pediatric acute lymphoblastic leukemia (ALL) treatment. Folinic acid rescue therapy (Leucovorin) is administered after MTX to reduce toxicity. Previous studies hypothesized that Leucovorin could `rescue' both normal healthy cells and leukemic blasts from cell death. We assessed whether Leucovorin is able to restore red blood cell folate levels after MTX. Methods We prospectively determined erythrocyte folate levels (5-methyltetrahydrofolate (THF) and non-methyl THF) and serum folate levels in 67 children with ALL before start (T0) and after stop (T1) of HD-MTX and Leucovorin courses. Results Erythrocyte folate levels increased between T0 and T1 (mean +/- SD: 416.7 +/- 145.5 nmol/L and 641.2 +/- 196.3 nmol/L respectively, p< 0.001). This was due to an increase in 5-methyl THF levels (mean increase: 217.7 +/- 209.5 nmol/L, p< 0.001), whereas non-methyl THF levels did not change (median increase: 0.6 nmol/L [-9.9-11.1], p = 0.676). Serum folate levels increased between T0 and T1 (median increase: 29.2 nmol/L [32.9-74.0], p< 0.001). Results were not significantly affected by age, sex, ALL immunophenotype and MTHFR c.677C> T genotype. Conclusion Intracellular folate levels accumulate after HD-MTX and Leucovorin therapy in children with ALL, suggesting that Leucovorin restores the intracellular folate pool. Future studies are necessary to assess concomitant lower uptake of MTX.	[Oosterom, Natanja; Pieters, Rob; Tissing, Wim J. E.; Fiocco, Marta; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Oosterom, Natanja; van Zelst, Bertrand D.; Heil, Sandra G.] Univ Med Ctr Rotterdam, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands; [de Jonge, Robert; Smith, Desiree E. C.] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [de Jonge, Robert] Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol, Groningen, Netherlands; [Fiocco, Marta] Leiden Univ, Math Inst, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Heil, SG (corresponding author), Univ Med Ctr Rotterdam, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands.	s.heil@erasmusmc.nl	Dijkstra, Sander/F-2513-2017	Dijkstra, Sander/0000-0001-5368-757X; Smith, Desiree/0000-0003-2053-3392	Stichting Kinderen Kankervrij, Amstelveen, The Netherlands [197]	Stichting Kinderen Kankervrij, Amstelveen, The Netherlands(Netherlands Government)	This project was supported by Stichting Kinderen Kankervrij, Amstelveen, The Netherlands, with grant number 197.	Arabelovic S, 2007, J AM COLL NUTR, V26, P453, DOI 10.1080/07315724.2007.10719635; BORSI JD, 1991, EUR J CANCER, V27, P1006, DOI 10.1016/0277-5379(91)90269-J; BROXSON EH, 1989, CANCER RES, V49, P5879; BUNNI MA, 1989, CANCER CHEMOTH PHARM, V23, P353, DOI 10.1007/BF00435835; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; den Boer E, 2013, ANAL BIOANAL CHEM, V405, P1673, DOI 10.1007/s00216-012-6581-7; den Hoed MAH, 2015, PHARMACOGENOMICS J, V15, P248, DOI 10.1038/tpj.2014.63; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Fiskerstrand T, 1997, J PHARMACOL EXP THER, V282, P1305; Funk RS, 2014, ARTHRITIS RHEUMATOL, V66, P3476, DOI 10.1002/art.38865; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; GOLDMAN I D, 1987, NCI (National Cancer Institute) Monographs, P17; GRAHAM ML, 1992, CANCER CHEMOTH PHARM, V31, P217, DOI 10.1007/BF00685551; Holmboe L, 2012, BRIT J CLIN PHARMACO, V73, P106, DOI 10.1111/j.1365-2125.2011.04054.x; Kabanova S, 2009, INT J MED SCI, V6, P156; Kalhan SC, 2012, REV ENDOCR METAB DIS, V13, P109, DOI 10.1007/s11154-012-9215-7; KAMEN BA, 1981, BRIT J HAEMATOL, V49, P355, DOI 10.1111/j.1365-2141.1981.tb07237.x; KAMEN BA, 1984, J PEDIATR-US, V104, P131, DOI 10.1016/S0022-3476(84)80610-1; Kamps WA, 2010, LEUKEMIA, V24, P309, DOI 10.1038/leu.2009.258; Kao TT, 2013, ZEBRAFISH, V10, P326, DOI 10.1089/zeb.2013.0876; Pauley JL, 2013, CANCER CHEMOTH PHARM, V72, P369, DOI 10.1007/s00280-013-2206-x; PAYET B, 1987, CANCER CHEMOTH PHARM, V19, P319; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; PRIEST DG, 1991, J NATL CANCER I, V83, P1806, DOI 10.1093/jnci/83.24.1806; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; REFSUM H, 1991, CANCER RES, V51, P828; Salzer WL, 2012, J PEDIAT HEMATOL ONC, V34, pE1, DOI 10.1097/MPH.0b013e31820ee239; SCOTT JM, 1981, LANCET, V2, P337; Skarby TVC, 2006, LEUKEMIA, V20, P1955, DOI 10.1038/sj.leu.2404404; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Smulders YM, 2006, BRIT J HAEMATOL, V132, P623, DOI 10.1111/j.1365-2141.2005.05913.x; Smulders YM, 2007, J NUTR BIOCHEM, V18, P693, DOI 10.1016/j.jnutbio.2006.11.010; Sterba J, 2006, CLIN CHEM, V52, P692, DOI 10.1373/clinchem.2005.061150; STRAW J A, 1987, NCI (National Cancer Institute) Monographs, P41; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; THYSS A, 1989, BRIT J CANCER, V59, P627, DOI 10.1038/bjc.1989.127; TISHLER M, 1988, ARTHRITIS RHEUM, V31, P906, DOI 10.1002/art.1780310712; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; van Ede AE, 2002, RHEUMATOLOGY, V41, P658, DOI 10.1093/rheumatology/41.6.658; Wennerstrand P, 2013, EUR J CLIN PHARMACOL, V69, P1641, DOI 10.1007/s00228-013-1521-9; WOLFROM C, 1993, J CLIN ONCOL, V11, P827, DOI 10.1200/JCO.1993.11.5.827; WOLFROM C, 1990, EUR J CLIN PHARMACOL, V39, P377, DOI 10.1007/BF00315414	42	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221591	10.1371/journal.pone.0221591	http://dx.doi.org/10.1371/journal.pone.0221591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527879	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400005
J	Yi, HM; Cai, BH; Ai, X; Liu, RB; Li, KY; Zhang, W				Yi, Huiming; Cai, Baohuan; Ai, Xi; Liu, Ruobing; Li, Kaiyan; Zhang, Wei			Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors	PLOS ONE			English	Article							INDOCYANINE GREEN CLEARANCE; ULTRASONOGRAPHY; SCORE	This study aimed to investigate the value of contrast-enhanced ultrasound (CEUS) for pre-operative assessment of liver reserve function in patients with liver tumors. The indocyanine green (ICG) clearance tests and CEUS examinations of 45 noncirrhotic patients with liver tumors were performed prior to liver resection. Parameters time to peak (TtoPk), arrival time (Atm) as well as perfusion parameters A, k and A x k were generated from time-intensity curve (TIC) of CEUS. The correlation analyses of the ICG clearance per unit time (ICGK) and the retention rate at 15 min (ICGR15) with TtoPk, Atm, A, k and A x k were performed, and the diagnostic ability as well as optimal cut-off values of TtoPk and Atm for differentiating patients with ICGR15>10% from ICGR15<10% were analyzed. There were significant correlations of ICGK with TtoPk and Atm, and the correlation coefficients were 0.363 (p = 0.014) and -0.482 (p = 0.001), respectively. Significant correlations of ICGR15 with TtoPk and Atm were revealed, and the correlation coefficients were -0.416 (p = 0.004) and 0.303 (p = 0.043), respectively. No correlation of ICGK or ICGR15 with A, k and A x k was found in this study. There were significant differences in TtoPk and Atm between patients with ICGR15>10% and ICGR15<10% (p = 0.028 and p = 0.026, respectively). TtoPk and Atm both had good diagnostic abilities in diagnosing patients with ICGR15>10% verusus ICGR15<10% (AUROC = 0.711 and 0.721, respectively). For ICGR15>10% vs ICGR15, the optimal cut-off values of TtoPk and Atm were 13.307 s and 11.007 s, respectively, while the sensitivity and specificity were 75.0% and 72.7%, 60.6% and 75.0%, respectively. This study revealed that CEUS has the potential to be a new method to evaluate the liver reserve function of patients. With the optimal cut-off values of TtoPk and Atm, qualitative assessment of patients with ICGR15> 10% could be more easily achieved by CEUS with good diagnostic abilities.	[Yi, Huiming; Liu, Ruobing; Li, Kaiyan; Zhang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China; [Cai, Baohuan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Hubei, Peoples R China; [Ai, Xi] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hepat Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China.	zhangweitjh@qq.com		Zhang, Wei/0000-0001-9959-2584				Chijiiwa K, 2000, AM J SURG, V179, P161, DOI 10.1016/S0002-9610(00)00274-9; Cosgrove D, 2009, MED BIOL ENG COMPUT, V47, P813, DOI 10.1007/s11517-009-0434-3; De Gasperi A, 2016, WORLD J HEPATOL, V8, P355, DOI 10.4254/wjh.v8.i7.355; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Erdogan D, 2004, LIVER INT, V24, P117, DOI 10.1111/j.1478-3231.2004.00901.x; Gupta Sachin, 2012, Trop Gastroenterol, V33, P129; Haegele S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165481; Ibis C, 2017, MED SCI MONITOR, V23, P4973, DOI 10.12659/MSM.907306; Kim HJ, 2015, HPB, V17, P159, DOI 10.1111/hpb.12295; Ohno N, 2015, DIAGNOSTICS, V5, P210, DOI 10.3390/diagnostics5020210; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Sheng QS, 2009, HEPATOB PANCREAT DIS, V8, P46; Shinohara H, 1996, HEPATOLOGY, V23, P137, DOI 10.1053/jhep.1996.v23.pm0008550033; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takano S, 2000, BRIT J SURG, V87, P65, DOI 10.1046/j.1365-2168.2000.01308.x; Wang L, 2019, J GASTROINTESTINAL S, V13, P1; Wang YY, 2018, J SURG ONCOL, V118, P440, DOI 10.1002/jso.25184; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; Wildner D, 2019, CLIN HEMORHEOL MICRO, V71, P39, DOI 10.3233/CH-180378; Wu HP, 2012, ULTRASOUND MED BIOL, V38, P443, DOI 10.1016/j.ultrasmedbio.2011.12.008; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhan Y, 2019, INT J HYPERTHER, V35, P105, DOI 10.1080/02656736.2018.1483533	23	0	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222514	10.1371/journal.pone.0222514	http://dx.doi.org/10.1371/journal.pone.0222514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527916	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400026
J	Oyesanya, TO				Oyesanya, Tolu O.			Veterans Health Administration nurses' training and beliefs related to care of patients with traumatic brain injury	PLOS ONE			English	Article							KNOWLEDGE; RECOVERY; MANAGEMENT; OUTCOMES	Background Veteran patients with traumatic brain injury (TBI) and their family members regularly receive care from nurses. Understanding nurses' training and beliefs can provide direction for intervention work aimed at ensuring the best possible care is delivered to this population. Aims We examined Veterans Health Administration (VHA) nurses' training and beliefs related to care of patients with moderate-to-severe TBI. Design and methods We conducted an exploratory, cross-sectional survey with 211 VHA nurses and analyzed data using descriptive statistics. Results The average years of nursing experience was 18 years, and 90% reported ever caring for a patient with TBI. Most nurses (70%) reported only seeing patients with TBI <1-2 times per year in their current role; 20% reported seeing these patients 1-2 times per month. Even with infrequent care, almost 50% reported previously receiving TBI-related training. Beliefs items with the highest accuracy indicated nurses agreed that they need specialized training to care for patients with TBI and that TBI recovery may continue for several years (96.39% accuracy respectively). The beliefs item with the lowest accuracy indicated focus on whether nurses agreed that TBI severity was important in developing care plans (27.84% accuracy). Nurses reported the need for clarity of the nursing role in caring for patients with TBI (77.32% agreement). Conclusion VHA nurses do have accurate beliefs about caring for Veteran patients with moderate-to-severe TBI; however, there is the need for further role clarification regarding nursing care of patients with TBI. Impact These findings have implications for development of education and training interventions for nurses who care for Veteran patients with TBI.	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, Durham, NC 27706 USA	Duke University	Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510				American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; [Anonymous], 2014, CLIN PRACTICE GUIDEL; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker Mark J, 2011, Nurse Educ Pract, V11, P268, DOI 10.1016/j.nepr.2010.11.020; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Defense and Veterans Brain Injury Center, 2014, TBI MIL; Defense Medical Surveillance System (DMSS) Theater Medical Data Store (TMDS) and Armed Forces Health Surveillance Center (AFHSC), 2014, DOD WORLDW TBI; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Department of Veteran Affairs, 2016, VET INF COMP INFR; Department of Veterans Affairs, 2013, VHA HDB; Edwards Geraldine, 2006, Br J Nurs, V15, P1180; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hoge C. W., 2009, DTIC DOCUMENT; Jaimes LM, 2015, REHABIL NURS, V40, P74, DOI 10.1002/rnj.156; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Mansour A, 2015, PSYCHOLOGY, V6, P323, DOI [10.4236/psych.2015.64033, DOI 10.4236/PSYCH.2015.64033]; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maydeu-Olivares A, 2017, STRUCT EQU MODELING, V24, P495, DOI 10.1080/10705511.2017.1289816; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Melnyk Bernadette Mazurek, 2004, Worldviews Evid Based Nurs, V1, P185, DOI 10.1111/j.1524-475X.2004.04024.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Oyesanya T. O., J NURS MEAS; Oyesanya T. O., 2017, J CLIN NURS; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Pedersen E.R., 2015, PUBLIC PRIVATE PARTN; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Sandoval WA, 2016, REV RES EDUC, V40, P457, DOI 10.3102/0091732X16669319; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; StataCorp L. P, 2007, STATA DATA ANAL STAT, V10; Thoroddsen A, 2010, INT J NURS TERMIN CL, V21, P69, DOI 10.1111/j.1744-618X.2010.01148.x; Veterans Health Administration, 2009, VHA DIR 2010 012 MAR; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222585	10.1371/journal.pone.0222585	http://dx.doi.org/10.1371/journal.pone.0222585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525241	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700040
J	Seol, BR; Jeoung, JW; Park, KH				Seol, Bo Ram; Jeoung, Jin Wook; Park, Ki Ho			Ocular and systemic risk factors associated with recurrent disc hemorrhage in primary open-angle glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; LATERAL DECUBITUS POSITION; INTRAOCULAR-PRESSURE; PROGRESSION	Purpose To evaluate the risk factors associated with recurrent disc hemorrhage (DH), defined for the present study as at least 3 occurrences of DH in primary open-angle glaucoma (POAG). Methods A total of 178 POAG patients (89 eyes showing at least 3 occurrences of DH and 89 age matched control eyes with a minimum of 10 years' follow-up without DH) were included in a retrospective, case-control study. Ocular factors were evaluated by a retrospective chart review, and systemic factors were evaluated by a telephone survey. Associations between factors and recurrent DH were investigated by logistic regression analysis. The Kaplan Meier survival analysis and Cox proportional-hazards regression models were used to evaluate glaucoma progression and to identify the factors predictive of glaucoma progression. Results Univariate regression analysis revealed the association of recurrent DH with low baseline intraocular pressure (IOP) [odds ratio (OR), 0.88; 95% confidential interval (CI), 0.80-0.98; P = 0.014], lower percentage reduction of IOP (OR, 0.96; 95% CI, 0.93-0.99; P = 0.020), cold extremities (OR, 2.80; 95% CI, 1.03-7.60; P = 0.043), prone or lateral decubitus sleeping position (OR, 2.14; 95% CI, 1.13-4.03; P = 0.019), and sleeping disorders (OR, 2.33; 95% CI, 1.05-5.15; P = 0.037). Multivariate regression analysis revealed that a lower percentage reduction in IOP (OR, 0.96; 95% CI, 0.93-1.00; P = 0.046) increased the risk of recurrent DH. The control group exhibited a greater cumulative probability of non-progression than the recurrent DH group (P = 0.01, by log-rank test). The Cox proportional-hazards regression model showed that recurrent DH was associated with glaucoma progression [hazard ratio (HR), 1.88; 95% CI; 1.66-3.05; P = 0.01. Conclusions Among the ocular and systemic factors, only lower-percentage reduction of IOP in POAG was associated with recurrent DH. DH recurrence is associated with glaucoma progression and may be dependent on IOP.	[Seol, Bo Ram] VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Seol, Bo Ram; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Veterans Health Service Medical Center; Seoul National University (SNU); Seoul National University Hospital	Park, KH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr						Ang GS, 2008, BRIT J OPHTHALMOL, V92, P1129, DOI 10.1136/bjo.2007.135269; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; de Beaufort HC, 2010, GRAEF ARCH CLIN EXP, V248, P839, DOI 10.1007/s00417-010-1306-0; De Moraes CG, 2012, ARCH OPHTHALMOL-CHIC, V130, P1541, DOI [10.1001/jamaophthalmol.2013.1137, 10.1001/archophthalmol.2012.2324]; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; Heijl A, 2011, ACTA OPHTHALMOL, V89, P749, DOI 10.1111/j.1755-3768.2009.01852.x; HENDRICKX KH, 1994, OPHTHALMOLOGY, V101, P1165; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; JONAS JB, 1994, AM J OPHTHALMOL, V118, P1; Kim KN, 2015, OPHTHALMOLOGY, V120, P731; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; Kim YD, 2010, EYE, V24, P567, DOI 10.1038/eye.2009.163; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Laemmer R, 2010, GRAEF ARCH CLIN EXP, V248, P1683, DOI 10.1007/s00417-010-1474-y; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Miyake T, 2006, J GLAUCOMA, V15, P164, DOI 10.1097/00061198-200604000-00014; Musch DC, 2008, OPHTHALMOLOGY, V115, P927, DOI 10.1016/j.ophtha.2007.08.010; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P7524, DOI 10.1167/iovs.15-17502; Shim SH, 2015, AM J OPHTHALMOL, V160, P1191, DOI 10.1016/j.ajo.2015.09.006; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1; Soares AS, 2004, OPHTHALMOLOGY, V111, P1653, DOI 10.1016/j.ophtha.2004.03.023; Suh MH, 2011, CLIN EXP OPHTHALMOL, V39, P513, DOI 10.1111/j.1442-9071.2010.02482.x; Suh MH, 2012, J GLAUCOMA, V21, P358, DOI 10.1097/IJG.0b013e3182120700; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222166	10.1371/journal.pone.0222166	http://dx.doi.org/10.1371/journal.pone.0222166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525246	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700022
J	Beyene, D; Bitew, A; Fantew, S; Mihret, A; Evans, M				Beyene, Degefu; Bitew, Adane; Fantew, Surafel; Mihret, Amete; Evans, Martin			Multidrug-resistant profile and prevalence of extended spectrum beta-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; INFECTION; COLI	Background The emergence of multidrug-resistance (MDR), production of extended-spectrum beta-lactamases, and carbapenemase in members of fermentative gram-negative bacilli are a serious threat to public health. Objective The aim of this study was to determine the burden of multi-drug resistance, the production of extended-spectrum beta-lactamases (ESBLs), and carbapenemase in fermentative Gramnegative bacilli in Ethiopian Public Health Institute. Materials and methods A cross-sectional study was carried out from December 2017 to June 2018. Different clinical samples were collected, inoculated, and incubated according to standard protocols related to each sample. Bacterial identification was performed by using the VITEKR 2 compact system using the GNR card. Antimicrobial susceptibility testing was carried out by the KirbyBauer disc diffusion method. Production of ESBL and carbapenemase were confirmed by combination disc and modified Hodge Test method respectively. Results A total of 238 fermentative Gram-negative bacilli were recovered during the study period, among which E.coli were the predominant isolates followed by K. pneumoniae. The highest percentage of antibiotic resistance was noted against ampicillin (100%) followed by trimethoprim/sulfamethoxazole (81.9%). The isolates showed better sensitivity towards carbapenem drugs. Out of 238 isolates, 94.5% were MDR and of which 8.8% and 0.8% were extensively and pan drug resistant, respectively. Nearly 67% and 2% of isolates were producers of ESBL and carbapenemase, respectively. The isolation rates of MDR, ESBL, and carbapenemase producing stains of the isolates were >= 70% in intensive care unit while the isolation rates in other wards were <= 25%. Conclusions The findings of this study revealed that the burden of MDR and ESBL was high and carbapenemase producing isolates were also identified which is concerning. This situation warrants a consistent surveillance of antimicrobial resistance of fermentative Gram-negative bacilli and implementation of an efficient infection control program.	[Beyene, Degefu; Fantew, Surafel; Mihret, Amete] Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Res Case Team, Addis Ababa, Ethiopia; [Bitew, Adane] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Evans, Martin] Amer Soc Microbiol, New York, NY USA	Addis Ababa University	Beyene, D (corresponding author), Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Res Case Team, Addis Ababa, Ethiopia.	degefuf@gmail.com		beyene, degefu/0000-0001-7902-984X; Mihret, Adane/0000-0003-3183-4772				[Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; Bassetti M, 2011, CRIT CARE, V15, DOI 10.1186/cc9997; Belete W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210866; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Carlet J, 2014, INDIAN J CRIT CARE M, V18, P643, DOI 10.4103/0972-5229.142171; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical Laboratory Standards Institute (CLSI), 2018, M100S27 CLSI S; Demilie T, 2012, ETHIOPIAN J HLTH SCI, V22; Derese B, 2016, THER CLIN RISK MANAG, V12, P251, DOI 10.2147/TCRM.S99831; Duthey B, 2013, 6 WHO; Emine K, 2005, JPN J INFECT DIS, V58, P228; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Hasanin A, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.177.4307; Hsueh PR, 2002, EMERG INFECT DIS, V8, P63, DOI 10.3201/eid0801.000454; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Kibret M, 2011, AFR HEALTH SCI, V11, pS40; Legese MH, 2017, INFECT DRUG RESIST, V10, P27, DOI 10.2147/IDR.S127177; Leski T, 2012, INT J ANTIMICROB AG, V40, P282, DOI 10.1016/j.ijantimicag.2012.05.019; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Mengistu Abayneh, 2018, CANADIAN J INFECT DI, V2018, P8; Moquet O, 2011, EMERG INFECT DIS, V17, P143, DOI [10.3201/eid1701.100224, 10.3201/eid1701.100244]; Moyo Sabrina J, 2010, BMC Res Notes, V3, P348, DOI 10.1186/1756-0500-3-348; Mulisa G., 2016, J EMERG INFECT DIS, V1, P1; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nurjahan Begum, 2015, BANGLADESH J MED MIC, V9, P7; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Oduyebo O O, 2015, Niger Postgrad Med J, V22, P223, DOI 10.4103/1117-1936.173973; Ouedraogo AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1655-3; Paskovaty A, 2005, INT J ANTIMICROB AG, V25, P1, DOI 10.1016/j.ijantimicag.2004.09.001; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Puneet Bhatt, 2015, NEW MICROBES NEW INF, P8; Sharma A, 2011, INDIAN J MED MICROBI, V29, P91, DOI 10.4103/0255-0857.81774; Shashwati Nema, 2014, J Nat Sci Biol Med, V5, P30, DOI 10.4103/0976-9668.127280; Siraj SM, 2015, MICROBIOL RES, V5, P1, DOI DOI 10.5376/mmr.2015.04.0001; Tada T, 2013, INT J ANTIMICROB AG, V42, P372, DOI 10.1016/j.ijantimicag.2013.06.014; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; World Health Organization, 2016, ANTIMICROBIAL RESIST; Yadav KK, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0085-0; 2011, WORLD HLTH DAY, P1	45	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222911	10.1371/journal.pone.0222911	http://dx.doi.org/10.1371/journal.pone.0222911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553773	gold, Green Published			2022-12-27	WOS:000532319200043
J	Haque, AB; Das, SA; Biswas, AR				Haque, Alifa Bintha; Das, Sudipta Arka; Biswas, Aparna Riti			DNA analysis of elasmobranch products originating from Bangladesh reveals unregulated elasmobranch fishery and trade on species of global conservation concern	PLOS ONE			English	Article							GENETIC IDENTIFICATION; MOLECULAR-GENETICS; SHARKS; MANAGEMENT; ALGORITHM; ACCURATE	Trade involving elasmobranch products in Bangladesh is a four-decade-long practice in large scale and there is little understanding of its impact on species composition, population, and subsequent conservation. Capacity for monitoring and identification is lacking in landing and shark processing centres. A rapid survey and collection of tissue samples were performed in three landings and nine shark processing centres between 2016 and 2017 in the south-eastern coastal region of Bangladesh. Sequencing for a 707-bp fragment of the mitochondrial cytochrome c oxidase subunit I (COI) gene was used to assess the taxonomic status and species composition from 71 elasmobranch tissue samples collected from the shark processing centre only. Good quality COI sequences were obtained for 34 specimens representing 21 species-the majority of which are threatened with extinction. A total of ten species of sharks (Carcharhinus brevipinna, C. amboinensis, C. leucas, C. sorrah, C. amblyrhynchoides, Chiloscyllium burmensis, Galeocerdo cuvier, Rhincodon typus, Scoliodon laticaudus, and Sphyrna lewini), eleven species of rays (Aetomylaeus maculatus, Gymnura poecilura, Mobula mobular, M. kuhlii, Neotrygon indica, Pateobatis uarnacoides, Rhinoptera javanica, and R. jayakari), including three species of guitarfish (Glaucostegus granulatus, G. obtusus, and G. typus), were identified. Four species (14.7% of samples) were found to be listed in the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) in Appendix II. Sixteen species (59% of the specimens) were threatened with extinction according to IUCN Red List, whereas 41% were data deficient or not assessed. The results have important implications for the management of regional fisheries and the conservation of elasmobranchs as they 1) represent a preliminary understanding of elasmobranch diversity in trade; 2) depict a lack of awareness and monitoring; and 3) demonstrate a need for urgent monitoring and regulation of elasmobranch trade in Bangladesh.	[Haque, Alifa Bintha; Biswas, Aparna Riti] Univ Dhaka, Dept Zool, Dhaka, Bangladesh; [Haque, Alifa Bintha] Univ Oxford, Dept Zool, Oxford, England; [Das, Sudipta Arka] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	University of Dhaka; University of Oxford; University of Dhaka	Haque, AB (corresponding author), Univ Dhaka, Dept Zool, Dhaka, Bangladesh.; Haque, AB (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	alifa.haque@du.ac.bd		Biswas, Aparna/0000-0001-9792-9331; Haque, Alifa Bintha/0000-0001-8250-0030	Biotechnology Research Centre, University of Dhaka; Biotechnology Research Centre; University of Dhaka (DU)	Biotechnology Research Centre, University of Dhaka; Biotechnology Research Centre; University of Dhaka (DU)	The genetic work was partially (30%) funded by Biotechnology Research Centre, University of Dhaka. It was a small grant received by the 1st author. There is no grant number available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors are thankful to the Biotechnology Research Centre and University of Dhaka (DU) for partially financing the genetic work and the Department of Zoology, DU for hosting the research and all volunteers helping the data collection. The authors also thank Scott Trageser for helping in editing the manuscript and for providing valuable comments.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Akhilesh KV, 2014, CHECKLIST CHON DRICH; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anonymous, 2012, FAO Fisheries and Aquaculture Circular, V1076, P1; [Anonymous], GLOBAL PRIORITIES CO; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Camhi MD, 2009, CONSERVATION STATUS; Cardenosa D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185368; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CASTRO JI, 1999, 380 FAO; Chapman DD, 2003, CONSERV GENET, P4; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno LJV, 2001, SHARKS WORLD ANNOTAT; Compagno LJV, 1984, SHARKS WORLD ANNOTAT; Dent Felix, 2015, FAO Fisheries and Aquaculture Technical Paper, V590, P1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; DoF, 2017, DOF YB FISH STAT BAN; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fields AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114844; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; FRSS, 2016, YB FISH STAT BANGL, V33; FRSS, 2014, FISH STAT YB BANGL, V30; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haque Alifa Bintha, 2018, Traffic Bulletin, V30, P7; Hasan M., 2017, J FISH LIVEST PROD, V5, P2, DOI 10.4172/2332-2608.1000221; Henderson AC, 2007, FISH RES, V86, P159, DOI 10.1016/j.fishres.2007.05.012; Henderson AC, 2016, ZOOL J LINN SOC-LOND, V176, P399, DOI 10.1111/zoj.12309; Hoq M.E., 2011, SHARK FISHERIES BAY; Hossain MA, 2015, AQUAT CONSERV, V25, P781, DOI 10.1002/aqc.2466; Jabado RW, 2015, AQUAT CONSERV, V25, P800, DOI 10.1002/aqc.2477; Jabado RW, 2018, FISH FISH; Last P. R., 2016, P1; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu SYV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079373; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Moore ABM, 2012, REV FISH BIOL FISHER, V22, P35, DOI 10.1007/s11160-011-9222-x; Morgan A, 2010, FISH RES, V101, P32, DOI 10.1016/j.fishres.2009.09.004; O'Malley MP, 2017, AQUAT CONSERV, V27, P394, DOI 10.1002/aqc.2670; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Sembiring A, 2015, FISH RES, V164, P130, DOI 10.1016/j.fishres.2014.11.003; Shamsuzzaman MM, 2017, TURK J FISH AQUAT SC, V17, P833, DOI 10.4194/1303-2712-v17_4_19; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Spaet JLY, 2015, FISH RES, V161, P356, DOI 10.1016/j.fishres.2014.08.022; Steinke D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10123-5; Vannuccini S., 1999, SHARK UTILIZATION MA; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wynen L, 2009, MAR FRESHWATER RES, V60, P554, DOI 10.1071/MF08201; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	55	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222273	10.1371/journal.pone.0222273	http://dx.doi.org/10.1371/journal.pone.0222273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553744	Green Published, gold, Green Submitted			2022-12-27	WOS:000532319200022
J	Dixit, S; Jangid, VK; Grover, A				Dixit, Shikha; Jangid, Vinod Kumar; Grover, Anita			Evaluation of suitable reference genes in Brassica juncea and its wild relative Camelina sativa for qRT-PCR analysis under various stress conditions	PLOS ONE			English	Article							TIME RT-PCR; INTERNAL REFERENCE GENES; HOUSEKEEPING GENES; NORMALIZATION; EXPRESSION; SELECTION; QUANTIFICATION; VALIDATION; RESISTANCE; GENOME	Quantitative real-time PCR (qRT-PCR) is an efficient method to estimate the gene expression levels but the accuracy of its result largely depends on the stability of the reference gene. Many studies have reported considerable variation in the expression of reference genes (RGs) in different tissue and conditions. Therefore, screening for appropriate RGs with stable expression is crucial for functional analysis of the target gene. Two closely related crucifers Brassica juncea (cultivated) and Camelina sativa (wild) respond differently towards various abiotic and biotic stress where C. sativa exhibits higher tolerance to various stress. Comparative gene expression analysis of the target genes between two such species is the key approach to understand the mechanism of a plant's response to stress. However, using an unsuitable RG can lead to misinterpretation of expression levels of the target gene in such studies. In this investigation, the stability of seven candidate RGs including traditional housekeeping genes (HKGs) and novel candidate RGs were identified across diverse sample sets of B. juncea and C. sativa representing- hormone treated, wounded, Alternaria brassicae inoculated and combination treated samples (exogenous hormone treatment followed by A. brassicae inoculation). In this investigation, we identified stable RGs in both the species and the most suitable RGs to perform an unbiased comparative gene expression analysis between B. juncea and C. sativa. Results revealed that TIPS41 and PP2A were identified as the overall best performing RGs in both the species. However, the most suitable RG for each sample subset representing different condition must be individually selected. In Hormone treated and wounded samples TIPS41 expressed stably in both the species and in A. brassicae inoculated and combination treatment performance of PP2A was the best. In this study, for the first time, we have identified and validated stable reference gene in C. sativa for accurate normalization of gene expression data.	[Dixit, Shikha; Jangid, Vinod Kumar; Grover, Anita] Natl Inst Plant Biotechnol, Plant Pathogen Interact Lab, Pusa Campus, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Grover, A (corresponding author), Natl Inst Plant Biotechnol, Plant Pathogen Interact Lab, Pusa Campus, New Delhi, India.	anitagrover@hotmail.com			National Institute for Plant Biotechnology, Pusa campus, New Delhi, India; Indian Agricultural Research Institute, New Delhi; Department of Biotechnology, Ministry of Science and Technology, New Delhi, India	National Institute for Plant Biotechnology, Pusa campus, New Delhi, India; Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India)	All the necessary funding for this research was provided by National Institute for Plant Biotechnology, Pusa campus, New Delhi, India. SD was provided Ph.D. research fellowship by Indian Agricultural Research Institute, New Delhi and VKJ received DBT-Junior research fellowship by Department of Biotechnology, Ministry of Science and Technology, New Delhi, India.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Duan MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01605; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Heydarian Z, 2018, GENE, V9, P1; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Li H, 2005, FIELD CROP RES, V91, P185, DOI 10.1016/j.fcr.2004.06.006; Liu JJ, 2019, PLANT PROTECT SCI, V55, P61, DOI 10.17221/20/2018-PPS; Lourenco SDN, 2018, ACTA GEOTECH, V13, P1, DOI 10.1007/s11440-017-0570-0; Mazumder M, 2013, PLANT PHYSIOL BIOCH, V70, P43, DOI 10.1016/j.plaphy.2013.04.025; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Sharma G, 2002, EUPHYTICA, V125, P411, DOI 10.1023/A:1016050631673; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CF, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/9482073; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu X, 2012, EVALUATION NEW REFER, V7; Zubr J, 2003, IND CROP PROD, V17, P161, DOI 10.1016/S0926-6690(02)00091-2	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222530	10.1371/journal.pone.0222530	http://dx.doi.org/10.1371/journal.pone.0222530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539385	Green Published, gold			2022-12-27	WOS:000532297900014
J	Edae, EA; Rouse, MN				Edae, Erena A.; Rouse, Matthew N.			Bulked segregant analysis RNA-seq (BSR-Seq) validated a stem resistance locus in Aegilops umbellulata, a wild relative of wheat	PLOS ONE			English	Article							CONFERRING RESISTANCE; RUST; IDENTIFICATION; SEQUENCE; UG99; GENES; INTROGRESSION; TAUSCHII; MARKERS; PROTEIN	Many disease resistance genes that have been transferred from wild relatives to cultivated wheat have played a significant role in wheat production worldwide. Ae. umbellulata is one of the species within the genus Aegilops that have been successfully used as sources of resistance genes to leaf rust, stem rust and powdery mildew. The objectives of the current work was to validate the map position of a major QTL that confers resistance to the stem rust pathogen races Ug99 (TTKSK) and TTTTF with an independent bi-parental mapping population and to refine the QTL region with a bulk segregant analysis approach. Two F-2 bi-parental mapping populations were developed from stem rust resistant Ae. umbellulata accessions (PI 298905 and PI 5422375) and stem rust susceptible accessions (PI 542369 and PI 554395). Firstly, one of the two populations was used to map the chromosome location of the resistance gene. Later on, the 2nd population was used to validate the chromosome location in combination with a bulk segregant analysis approach. For the bulk segregant analysis, RNA was extracted from a bulk of leaf tissues of 12 homozygous resistant F-3 families, and a separate bulk of 11 susceptible homozygous F-3 families derived from the PI 5422375 and PI 554395 cross. The RNA samples of the two bulks and the two parents were sequenced for SNPs identification. Stem rust resistance QTL was validated on chromosome 2U of Ae. umbellulata in the same region in both populations. With bulk segregant analysis, the QTL position was delimited within 3.2 Mbp. Although there were a large number of genes in the orthologous region of the detected QTL on chromosome 2D of Ae. tauschii, we detected only two Ae. umbellulata NLR genes which can be considered as a potential candidate genes.	[Edae, Erena A.; Rouse, Matthew N.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA; [Rouse, Matthew N.] United State Dept Agr Agr Serv, Cereal Dis Lab, St Paul, MN 55155 USA	University of Minnesota System; University of Minnesota Twin Cities	Edae, EA; Rouse, MN (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.; Rouse, MN (corresponding author), United State Dept Agr Agr Serv, Cereal Dis Lab, St Paul, MN 55155 USA.	edaex001@umn.edu; matthew.rouse@ars.usda.gov	Rouse, Matthew N/G-5474-2011		United States Department of Agriculture-Agricultural Research Service	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funded with the financial support from United States Department of Agriculture-Agricultural Research Service.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Edae EA, 2017, G3-GENES GENOM GENET, V7, P1551, DOI 10.1534/g3.117.039966; Edae EA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3370-2; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; GILL BS, 1985, PLANT DIS, V69, P314; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082333; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Liu WX, 2011, CHROMOSOME RES, V19, P669, DOI 10.1007/s10577-011-9226-3; Liu WX, 2011, THEOR APPL GENET, V122, P1537, DOI 10.1007/s00122-011-1553-4; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Olson EL, 2013, THEOR APPL GENET, V126, P2477, DOI 10.1007/s00122-013-2148-z; Olson EL, 2013, THEOR APPL GENET, V126, P1179, DOI 10.1007/s00122-013-2045-5; Ozgen M, 2004, BREEDING SCI, V54, P287, DOI 10.1270/jsbbs.54.287; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Rouse MN, 2011, PLANT DIS, V95, P762, DOI 10.1094/PDIS-12-10-0940; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; SEARS E. R., 1956, BROOKHAVEN SYMPOSIA IN BIOL, V9, P1; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; Stakman E.C., 1962, IDENTIFICATION PHYSL, P54; Steuernagel B, 2015, BIOINFORMATICS, V31, P1665, DOI 10.1093/bioinformatics/btv005; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wulff BBH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00692; Zhang WJ, 2017, P NATL ACAD SCI USA, V114, pE9483, DOI 10.1073/pnas.1706277114; Zou C, 2016, PLANT BIOTECHNOL J, V14, P1941, DOI 10.1111/pbi.12559	38	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0215492	10.1371/journal.pone.0215492	http://dx.doi.org/10.1371/journal.pone.0215492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539379	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900003
J	Zhang, WB; Hu, C; Wang, XJ; Bai, SS; Cao, SB; Kobelski, M; Lambert, JR; Gu, JK; Zhan, Y				Zhang, Wenbo; Hu, Cheng; Wang, Xiaojie; Bai, Shanshan; Cao, Subing; Kobelski, Margaret; Lambert, James R.; Gu, Jingkai; Zhan, Yang			Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; SELENIUM-INDUCED APOPTOSIS; ANDROGEN RECEPTOR; GENE-EXPRESSION; TRANSGENIC ADENOCARCINOMA; ABIRATERONE ACETATE; ANTIGEN-EXPRESSION; MOUSE PROSTATE; IN-VIVO; PROGRESSION	The growth inhibitory efficacy of methylseleninic acid (MSA) in prostate cancer cells has been documented extensively. However, our understanding of the immediate targets that are key to the growth inhibitory effects of MSA remains limited. Here, using multiple preclinical prostate cancer models, we demonstrated in vitro and in vivo that GDF15 is a most highly induced, immediate target of MSA. We further showed that knockdown of GDF15 mitigates MSA inhibition of cell proliferation and induction of apoptosis. Analysis of gene expression data from over 1000 primary and 200 metastatic prostate cancer samples revealed that GDF15 expression is decreased in metastatic prostate cancers compared to primary tumors and that lower GDF15 levels in primary tumors are associated with higher Gleason scores and shorter survival of the patients. Additionally, pathways that are negatively correlated with GDF15 levels in clinical samples are also negatively correlated with MSA treatment in cultured cells. Since most, if not all, of these pathways have been implicated in prostate cancer progression, suppressing their activities by inducing GDF15 is consistent with the anticancer effects of MSA in prostate cancer. Overall, this study provides support for GDF15 as an immediate target of MSA in prostate cancer cells.	[Zhang, Wenbo; Hu, Cheng; Wang, Xiaojie; Bai, Shanshan; Gu, Jingkai; Zhan, Yang] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China; [Wang, Xiaojie; Bai, Shanshan; Cao, Subing; Kobelski, Margaret] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Lambert, James R.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA	Jilin University; Tulane University; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhan, Y (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China.	yangzhan@jlu.edu.cn		Kobelski, Margaret/0000-0002-8829-4562	Jilin Scientific and Technological Development Program [20180414034GH]; National Natural Science Foundation of China [81430087]	Jilin Scientific and Technological Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Y.Z. was funded by Jilin Scientific and Technological Development Program and the Grant No. 20180414034GH. The website is http://kjt.jl.gov.cn/.J.G.was funded by the National Natural Science Foundation of China Project 81430087. The website is http://www.nsfc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cheng JC, 2011, ENDOCRINOLOGY, V152, P2987, DOI 10.1210/en.2011-0059; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Cho SD, 2004, MOL CANCER THER, V3, P605; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2003, CANCER RES, V63, P52; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundimeda U, 2008, J BIOL CHEM, V283, P34519, DOI 10.1074/jbc.M807007200; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Husaini Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115189; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Jiang C, 2001, CANCER RES, V61, P3062; Kakehi Y, 2004, PROSTATE, V59, P351, DOI 10.1002/pros.10365; Kawahara T, 2010, UROL INT, V84, P198, DOI 10.1159/000277599; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lambert JR, 2006, J CELL PHYSIOL, V208, P566, DOI 10.1002/jcp.20692; Lambert JR, 2015, PROSTATE, V75, P255, DOI 10.1002/pros.22911; Latonen L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03573-6; Lee SO, 2006, PROSTATE, V66, P1070, DOI 10.1002/pros.20329; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122249; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu T, 2003, CANCER RES, V63, P5034; Liu YB, 2015, PROSTATE, V75, P1001, DOI 10.1002/pros.22987; Marshall JR, 2017, ONCOTARGET, V8, P26312, DOI 10.18632/oncotarget.15460; Min KW, 2016, ONCOGENE, V35, P377, DOI 10.1038/onc.2015.95; Ohta Y, 2009, CHEM RES TOXICOL, V22, P1795, DOI 10.1021/tx900202m; Park SH, 2012, J BIOL CHEM, V287, P19841, DOI 10.1074/jbc.M111.330639; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Pinto JT, 2007, INT J CANCER, V120, P1410, DOI 10.1002/ijc.22500; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Sinha I, 2014, CANCER MED-US, V3, P252, DOI 10.1002/cam4.198; Sinha I, 2012, INT J CANCER, V130, P1430, DOI 10.1002/ijc.26141; Smith ML, 2004, ANTICANCER RES, V24, P1401; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Wang L, 2018, ANN ONCOL, V29, P352, DOI 10.1093/annonc/mdx689; Wang L, 2016, CANCER PREV RES, V9, P35, DOI 10.1158/1940-6207.CAPR-15-0236; Wang L, 2011, PROSTATE, V71, P1429, DOI 10.1002/pros.21360; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016; Zhan Y, 2013, INT J CANCER, V133, P2225, DOI 10.1002/ijc.28202; Zhang Haitao, 2005, Cancer Genomics & Proteomics, V2, P97; Zhao HJ, 2004, MOL BIOL CELL, V15, P506, DOI 10.1091/mbc.E03-07-0501	61	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222812	10.1371/journal.pone.0222812	http://dx.doi.org/10.1371/journal.pone.0222812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539407	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900032
J	Eldaebes, MMAS; Landry, TG; Bance, ML				Eldaebes, Mostafa M. A. S.; Landry, Thomas G.; Bance, Manohar L.			Repair of subtotal tympanic membrane perforations: A temporal bone study of several tympanoplasty materials	PLOS ONE			English	Article							CARTILAGE TYMPANOPLASTY; MOTION	The aim of this project was to investigate the effects of different types of graft material, and different remaining segments of the native TM on its motion. In twelve human temporal bones, controlled TM perforations were made to simulate three different conditions. (1) Central perforation leaving both annular and umbo rims of native TM. (2) Central perforation leaving only a malleal rim of native TM. (3) Central perforation leaving only an annular rim of native TM. Five different graft materials (1) perichondrium (2) silastic (3) thin cartilage (4) thick cartilage (5) Lotriderm (R) cream were used to reconstruct each perforation condition. Umbo and stapes vibrations to acoustic stimuli from 250 to 6349 Hz were measured using a scanning laser Doppler vibrometer. Results showed that at low frequencies: in the Two Rims condition, all grafting materials except thick cartilage and Lotriderm cream showed no significant difference in umbo velocity from the Normal TM, while only Lotriderm cream showed a significant decrease in stapes velocity; in the Malleal Rim condition, all materials showed a significant decrease in both umbo and stapes velocities; in the Annular Rim condition, all grafting materials except Lotriderm and perichondrium showed no significant difference from the Normal TM in stapes velocity. Umbo data might not be reliable in some conditions because of coverage by the graft. At middle and high frequencies: all materials showed a significant difference from the Normal TM in both umbo and stapes velocities for all perforation conditions except in the Annular Rim condition, in which silastic and perichondrium showed no significant difference from the Normal TM at umbo velocity in the middle frequencies. In the low frequencies, the choice of repair material does not seem to have a large effect on sound transfer. Our data also suggests that the annular rim could be important for low frequency sound transfer.	[Eldaebes, Mostafa M. A. S.; Landry, Thomas G.; Bance, Manohar L.] Nova Scotia Hlth Author, Div Otolaryngol, Dept Surg, Halifax, NS, Canada; [Eldaebes, Mostafa M. A. S.] Univ Hlth Network, Ctr Adv Hearing & Balance Testing, Toronto, ON, Canada; [Bance, Manohar L.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge	Bance, ML (corresponding author), Nova Scotia Hlth Author, Div Otolaryngol, Dept Surg, Halifax, NS, Canada.; Bance, ML (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	mlb59@cam.ac.uk			Dept. of Surgery, Dalhousie University	Dept. of Surgery, Dalhousie University	This work was supported by: MB, Dept. of Surgery, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo AA, 2010, HEARING RES, V263, P78, DOI 10.1016/j.heares.2009.11.005; Aarnisalo AA, 2009, OTOL NEUROTOL, V30, P1209, DOI 10.1097/MAO.0b013e3181bc398e; ADKINS WY, 1990, LARYNGOSCOPE, V100, P244; Aernouts J, 2012, THESIS; Allardyce BJ, 2016, J MECH BEHAV BIOMED, V64, P65, DOI 10.1016/j.jmbbm.2016.07.017; Chien WD, 2006, AUDIOL NEURO-OTOL, V11, P183, DOI 10.1159/000091815; Dornhoffer JL, 1997, LARYNGOSCOPE, V107, P1094, DOI 10.1097/00005537-199708000-00016; Eldaebes MMAS, 2018, OTOL NEUROTOL, V39, P995, DOI 10.1097/MAO.0000000000001888; Gea SLR, 2010, JARO-J ASSOC RES OTO, V11, P1, DOI 10.1007/s10162-009-0192-9; Gerber MJ, 2000, LARYNGOSCOPE, V110, P1994, DOI 10.1097/00005537-200012000-00002; Haynes David S, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P283, DOI 10.1097/01.moo.0000172820.97322.8d; Jesic SD, 2011, ARCH OTOLARYNGOL, V137, P139, DOI 10.1001/archoto.2010.242; KRINGLEBOTN M, 1995, J ACOUST SOC AM, V98, P192, DOI 10.1121/1.413746; Lee CF, 2007, LARYNGOSCOPE, V117, P725, DOI 10.1097/mlg.0b013e318031f0e7; Lee JC, 2012, OTOL NEUROTOL, V33, P586, DOI 10.1097/MAO.0b013e31824b78ba; LIM DJ, 1970, ACTA OTO-LARYNGOL, V70, P176, DOI 10.3109/00016487009181875; Mehta RP, 2006, OTOL NEUROTOL, V27, P136, DOI 10.1097/01.mao.0000176177.17636.53; MILEWSKI C, 1993, LARYNGOSCOPE, V103, P1352; Mohamad SH, 2012, OTOL NEUROTOL, V33, P699, DOI 10.1097/MAO.0b013e318254fbc2; Murbe D, 2002, LARYNGOSCOPE, V112, P1769; O'Connor KN, 2008, LARYNGOSCOPE, V118, P483, DOI 10.1097/MLG.0b013e31815b0d9f; Rosowski JJ, 2009, HEARING RES, V253, P83, DOI 10.1016/j.heares.2009.03.010; Van Rompaey V, 2013, OTOL NEUROTOL, V34, P180, DOI 10.1097/MAO.0b013e31826bf16d; Voss SE, 2000, HEARING RES, V150, P43, DOI 10.1016/S0378-5955(00)00177-5; Voss SE, 2001, ACTA OTO-LARYNGOL, V121, P169; Zahnert T, 2000, AM J OTOL, V21, P322, DOI 10.1016/S0196-0709(00)80039-3	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222728	10.1371/journal.pone.0222728	http://dx.doi.org/10.1371/journal.pone.0222728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536572	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800078
J	Hugdahl, K; Kazimierczak, K; Beresniewicz, J; Kompus, K; Westerhausen, R; Ersland, L; Gruner, R; Specht, K				Hugdahl, Kenneth; Kazimierczak, Katarzyna; Beresniewicz, Justyna; Kompus, Kristiina; Westerhausen, Rene; Ersland, Lars; Gruner, Renate; Specht, Karsten			Dynamic up- and down-regulation of the default (DMN) and extrinsic (EMN) mode networks during alternating task-on and task-off periods	PLOS ONE			English	Article							BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; EEG-ALPHA; ATTENTION; FMRI; REGIONS; CORTEX; INDIVIDUALS; RELEVANCE; PARADIGM	Using fMRI, Hugdahl et al. (2015) reported the existence of a general-domain cortical network during active task-processing which was non-specific to the cognitive task being processed. They labelled this network the extrinsic mode network (EMN). The EMN would be predicted to be negatively, or anti-correlated with the classic default mode network (DMN), typically observed during periods of rest, such that while the EMN should be down-regulated and the DMN up-regulated in the absence of demands for task-processing, the reverse should occur when demands change from resting to task-processing. This would require alternating periods of task-processing and resting and analyzing data continuously when demands change from active to passive periods and vice versa. We were particularly interested in how the networks interact in the critical transition points between conditions. For this purpose, we used an auditory task with multiple cognitive demands in a standard fMRI block-design. Task-present (ON) blocks were alternated with an equal number of task-absent, or rest (OFF) blocks to capture network dynamics across time and changing environmental demands. To achieve this, we specified the onset of each block, and used a finite-impulse response function (FIR) as basis function for estimation of the fMRI-BOLD response. During active (ON) blocks, the results showed an initial rapid onset of activity in the EMN network, which remained throughout the period, and faded away during the first scan of the OFF-block. During OFF blocks, activity in the DMN network showed an initial time-lag where neither the EMN nor the DMN was active, after which the DMN was up-regulated. Studying network dynamics in alternating passive and active periods may provide new insights into brain network interaction and regulation.	[Hugdahl, Kenneth; Kazimierczak, Katarzyna; Beresniewicz, Justyna; Kompus, Kristiina; Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Hugdahl, Kenneth; Gruner, Renate] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Westerhausen, Rene] Univ Oslo, Inst Psychol, Oslo, Norway; [Ersland, Lars] Haukeland Hosp, Dept Clin Engn, Bergen, Norway; [Gruner, Renate; Specht, Karsten] Haukeland Hosp, Mohn Med Imaging & Visualizat Ctr, Bergen, Norway; [Specht, Karsten] UiT Arctic Univ Norway, Dept Educ, Tromso, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso	Hugdahl, K (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.; Hugdahl, K (corresponding author), Haukeland Hosp, Div Psychiat, Bergen, Norway.; Hugdahl, K (corresponding author), Haukeland Hosp, Dept Radiol, Bergen, Norway.	hugdahl@uib.no	Westerhausen, René/D-2441-2013; Grüner, Renate/ABD-8797-2020	Westerhausen, René/0000-0001-7107-2712; Hugdahl, Kenneth/0000-0002-0008-4326	European Research Council (ERC AdG) [693124]; Western Norway Health Authorities (Helse-Vest) [912045]; Research Council of Norway (NORMENT) [223273]	European Research Council (ERC AdG)(European Research Council (ERC)); Western Norway Health Authorities (Helse-Vest); Research Council of Norway (NORMENT)(Research Council of Norway)	The present study was supported by grants to Kenneth Hugdahl from European Research Council (ERC AdG #693124), the Western Norway Health Authorities (Helse-Vest, #912045), and the Research Council of Norway (NORMENT #223273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2019, NEUROSCI BIOBEHAV R, V99, P90, DOI 10.1016/j.neubiorev.2019.02.004; ASBJORNSEN AE, 1995, BRAIN LANG, V49, P189, DOI 10.1006/brln.1995.1029; Bandettini P. A, 1999, FUNCTIONAL MRI; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; BRYDEN MP, 1983, BRAIN LANG, V18, P236, DOI 10.1016/0093-934X(83)90018-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2012, NEUROIMAGE, V62, P1137, DOI 10.1016/j.neuroimage.2011.10.035; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callard F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00321; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Di X, 2014, PEERJ, V2, DOI 10.7717/peerj.367; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gadea M, 2000, J CLIN EXP NEUROPSYC, V22, P793, DOI 10.1076/jcen.22.6.793.959; Gadea M, 2016, APPL PSYCHOPHYS BIOF, V41, P157, DOI 10.1007/s10484-015-9323-8; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gratton C, 2018, NEURON, V98, P439, DOI 10.1016/j.neuron.2018.03.035; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hommet C, 2010, J NUTR HEALTH AGING, V14, P751, DOI 10.1007/s12603-010-0097-7; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Hugdahl K, 2011, BRAIN COGNITION, V76, P211, DOI 10.1016/j.bandc.2011.03.006; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Kershner JR, 2016, J LEARN DISABIL-US, V49, P282, DOI 10.1177/0022219414547222; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; Krieger-Redwood K, 2016, NEUROIMAGE, V141, P366, DOI 10.1016/j.neuroimage.2016.07.060; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mak LE, 2017, BRAIN CONNECT, V7, P25, DOI 10.1089/brain.2016.0438; Margulies DS, 2017, P NATL ACAD SCI USA, V114, P12641, DOI 10.1073/pnas.1717374114; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Mitra A, 2018, SCAND J PSYCHOL, V59, P83, DOI 10.1111/sjop.12422; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mittner M, 2014, J NEUROSCI, V34, P16286, DOI 10.1523/JNEUROSCI.2062-14.2014; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Nygard M., 2012, FRONTIERS HUMAN NEUR; OBRZUT JE, 1993, NEUROPSYCHOLOGIA, V31, P1411, DOI 10.1016/0028-3932(93)90107-B; OLeary DS, 1996, BRAIN LANG, V53, P20, DOI 10.1006/brln.1996.0034; Popa D, 2009, J NEUROSCI, V29, P1191, DOI 10.1523/JNEUROSCI.4867-08.2009; Posner M. I., 1997, IMAGES MIND; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Provost JS, 2015, EUR J NEUROSCI, V41, P835, DOI 10.1111/ejn.12821; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramot M, 2012, J NEUROSCI, V32, P10458, DOI 10.1523/JNEUROSCI.0877-12.2012; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; SHANKWEILER D, 1967, Q J EXP PSYCHOL, V19, P59, DOI 10.1080/14640746708400069; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sormaz M, 2018, P NATL ACAD SCI USA, V115, P9318, DOI 10.1073/pnas.1721259115; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tallus J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139318; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vatansever D, 2017, P NATL ACAD SCI USA, V114, P12821, DOI 10.1073/pnas.1710521114; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028	73	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218358	10.1371/journal.pone.0218358	http://dx.doi.org/10.1371/journal.pone.0218358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536496	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800007
J	Manig, F; Hellwig, M; Pietz, F; Henle, T				Manig, Friederike; Hellwig, Michael; Pietz, Franziska; Henle, Thomas			Quantitation of free glycation compounds in saliva	PLOS ONE			English	Article							MAILLARD REACTION-PRODUCTS; CHRONIC KIDNEY-DISEASE; SQUAMOUS-CELL CARCINOMA; AMINO-ACID PROFILE; LIQUID-CHROMATOGRAPHY; METABOLIC TRANSIT; EARLY-DIAGNOSIS; END-PRODUCTS; PYRRALINE; PROTEINS	In the course of the Maillard reaction, which occurs during heating of food but also under physiological condition, a broad spectrum of reaction products is formed. Among them, the advanced glycation endproducts (AGEs) N-epsilon-carboxymethyllysine (CML), pyrraline (Pyr), methylglyoxal-derived hydroimidazolone 1 (MG-H1) and N-epsilon-carboxyethyllysine (CEL) are the quantitatively dominating compounds during later reaction stages. Those dietary glycation compounds are under discussion as to be associated with chronic inflammation and the pathophysiological consequences of diseases such as diabetes. In the present study, the concentration of individual glycation compounds in saliva was monitored for the first time and related to their dietary uptake. Fasting saliva of 33 metabolically healthy subjects was analyzed with HPLC-MS/MS. The observed levels of individual glycation compounds ranged from 0.5 to 55.2 ng/ml and differed both intra- and interindividually. Patterns did not correlate with subject-related features such as vegetarianism or sports activities, indicating that dietary intake may play an important role. Therefore, six volunteers were asked to eat a raw food diet free of glycation compounds for two days. Within two days, salivary Pyr was lowered from median 1.7 ng/ml to a minimum level below the limit of detection, and MG-H1 decreased from 3.6 to 1.7 ng/ml in in a time-dependent manner after two days. Salivary CML and CEL concentrations were not affected. Therefore, measuring Pyr and MG-H1 in saliva is a suitable diagnostic tool to monitor the dietary intake and metabolic transit of glycation compounds present in heated foods.	[Manig, Friederike; Hellwig, Michael; Pietz, Franziska; Henle, Thomas] Tech Univ Dresden, Chair Food Chem, Dresden, Germany	Technische Universitat Dresden	Manig, F; Hellwig, M; Henle, T (corresponding author), Tech Univ Dresden, Chair Food Chem, Dresden, Germany.	friederike.manig@chemie.tu-dresden.de; michael.hellwig@chemie.tu-dresden.de; thomas.henle@chemie.tu-dresden.de		Hellwig, Michael/0000-0001-8528-6893	German Federal Ministry for Research and Education (BMBF) [01EA1703]; Joint Programm Initiative (JPI)	German Federal Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Joint Programm Initiative (JPI)	Data were generated as part of the European SALIVAGES project. The Joint Programm Initiative (JPI) supports the SALIVAGES consortium within the programme "A healthy diet for a healthy life" (HDHL). The authors acknowledge the German Federal Ministry for Research and Education (BMBF) for support of the project for FM (grant number 01EA1703). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; BATTISTONE GC, 1961, ARCH ORAL BIOL, V3, P161, DOI 10.1016/0003-9969(61)90133-9; BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527; Buttler RM, 2018, STEROIDS, V138, P26, DOI 10.1016/j.steroids.2018.05.013; Cheng F, 2015, CLIN CHIM ACTA, V447, P23, DOI 10.1016/j.cca.2015.05.008; Delatour T, 2006, AMINO ACIDS, V30, P25, DOI 10.1007/s00726-005-0249-y; Delgado-Povedano MM, 2016, TALANTA, V146, P310, DOI 10.1016/j.talanta.2015.07.066; Dolan K, 2004, DRUG ALCOHOL REV, V23, P213, DOI 10.1080/09595230410001704208; Erbersdobler HF, 2007, MOL NUTR FOOD RES, V51, P423, DOI 10.1002/mnfr.200600154; Erbersdobler HF, 2001, NAHRUNG, V45, P177, DOI 10.1002/1521-3803(20010601)45:3&lt;177::AID-FOOD177&gt;3.0.CO;2-A; Ferreira AEN, 2003, BIOCHEM J, V376, P109, DOI 10.1042/BJ20030496; FINOT PA, 1981, PROG FOOD NUTR SCI, V5, P193; Forster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Gopal P, 2014, EUR RESPIR J, V43, P430, DOI 10.1183/09031936.00135312; Gualtero DF, 2016, ACTA ODONTOL SCAND, V74, P170, DOI 10.3109/00016357.2015.1110249; Gupta Shruti, 2015, J Diabetes Sci Technol, V9, P91, DOI 10.1177/1932296814552673; Macias-Cervantes MH, 2015, NUTRITION, V31, P446, DOI 10.1016/j.nut.2014.10.004; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hartman ML, 2016, PEDIATR ENDOCR REV P, V13, P602; Hassaneen M, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00083; Hellwig M, 2017, J AGR FOOD CHEM, V65, P3532, DOI 10.1021/acs.jafc.7b00797; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; Hellwig M, 2014, AMINO ACIDS, V46, P289, DOI 10.1007/s00726-013-1501-5; Hellwig M, 2013, EUR FOOD RES TECHNOL, V237, P47, DOI 10.1007/s00217-013-2027-5; Hellwig M, 2012, EUR FOOD RES TECHNOL, V235, P99, DOI 10.1007/s00217-012-1738-3; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Hellwig M, 2009, J AGR FOOD CHEM, V57, P6474, DOI 10.1021/jf901224p; Henle T, 1996, Z LEBENSM UNTERS FOR, V202, P72, DOI 10.1007/BF01229689; HENLE T, 1993, Z LEBENSM UNTERS FOR, V196, P1, DOI 10.1007/BF01192975; Hoonhorst SJM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0363-2; Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006; Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550; Krause R, 2003, EUR FOOD RES TECHNOL, V216, P277, DOI 10.1007/s00217-002-0649-0; Lasisi TJ, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0222-x; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; LEE K, 1994, MAILLARD REACTIONS C, P358; LIAPPIS N, 1986, KLIN PADIATR, V198, P25, DOI 10.1055/s-2008-1026847; Maessen MFH, 2017, J SCI MED SPORT, V20, P921, DOI 10.1016/j.jsams.2017.03.011; Mark AB, 2014, DIABETES CARE, V37, P88, DOI 10.2337/dc13-0842; Morzel M, 2017, PHYSIOL BEHAV, V173, P116, DOI 10.1016/j.physbeh.2017.02.005; NAKAYAMA T, 1980, AGR BIOL CHEM TOKYO, V44, P1201, DOI 10.1080/00021369.1980.10864104; Okura T, 2017, J DIABETES RES HINDA, V2017, P1; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Rad HM, 2014, J ORAL REHABIL, V41, P759, DOI 10.1111/joor.12197; Arantes LMRB, 2018, EXPERT REV MOL DIAGN, V18, P85, DOI 10.1080/14737159.2017.1404906; Reddy I, 2012, J ORAL SCI, V54, P279, DOI 10.2334/josnusd.54.279; Renda R, 2017, RENAL FAILURE, V39, P452, DOI 10.1080/0886022X.2017.1308256; Scheijen JLJM, 2018, CLIN NUTR, V37, P919, DOI 10.1016/j.clnu.2017.03.019; Schievano E, 2015, TALANTA, V140, P36, DOI 10.1016/j.talanta.2015.03.004; Schwarzenbolz U, 2016, J AGR FOOD CHEM, V64, P5071, DOI 10.1021/acs.jafc.6b01375; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Pham TAV, 2017, ACTA ODONTOL SCAND, V75, P551, DOI 10.1080/00016357.2017.1356467; Tuohy KM, 2006, MOL NUTR FOOD RES, V50, P847, DOI 10.1002/mnfr.200500126; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; van Eupen MGA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-149; van Waateringe RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179330; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2016, DR VLASSARAS AGE LES; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Walsh MC, 2006, AM J CLIN NUTR, V84, P531, DOI 10.1093/ajcn/84.3.531; Yajamanam N, 2016, SAUDI J KIDNEY DIS T, V27, P312, DOI 10.4103/1319-2442.178549	67	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0220208	10.1371/journal.pone.0220208	http://dx.doi.org/10.1371/journal.pone.0220208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX5WJ	31532774	Green Submitted, gold, Green Published			2022-12-27	WOS:000503804600001
J	Faltermeier, C; Chai, T; Syed, S; Lau, N; Elkaim, L; Ibrahim, G; Wang, A; Weil, A; Bendel, A; Fallah, A; Tu, A				Faltermeier, Claire; Chai, Timothy; Syed, Sharjeel; Lau, Nathan; Elkaim, Lior; Ibrahim, George; Wang, Anthony; Weil, Alexander; Bendel, Anne; Fallah, Aria; Tu, Albert			Survival of infants < 24 months of age with brain tumors: A population-based study using the SEER database	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ATYPICAL TERATOID/RHABDOID TUMORS; CHOROID-PLEXUS TUMORS; 1ST YEAR; LONG-TERM; PEDIATRIC MEDULLOBLASTOMA; INTRACRANIAL TUMORS; RADIATION-THERAPY; YOUNG-CHILDREN; GRADE GLIOMA	Introduction Brain tumors are the most common solid malignancy and leading cause of cancer-related deaths in infants. Current epidemiological data is limited by low numbers of reported cases. This study used a population-based approach with analysis of contemporary and historical survival curves to provide up-to-date prognostication. Methods Observational cohort analysis was performed using the Surveillance, Epidemiology and End Results (SEER) database. Infants with brain tumors diagnosed from 1973 to 2013 were categorized by the most common tumor types (diffuse astrocytic and oligodendroglioma, choroid plexus, embryonal, ependymal, medulloblastoma and pilocytic astrocytoma). The 1, 5 and 10 year survival was stratified by decade, with trends in management and outcomes analyzed. Results We identified 2996 affected infants satisfying inclusion criteria. All tumor types, except embryonal and choroid plexus, demonstrated improving survival with time. Infants with embryonal tumors showed a decline in survival from the 1970s to 1990s (p = 0.009), whereas infants with choroid plexus tumors had no change in survival. Infants with ependymal tumors experienced the greatest improvement in survival from 1980s to 1990s and 1990s to 2000s (p = 0.0001, p = 0.01), with 5-year survival probability improving from 28% (95% CI 15-42%) in the 1980s to 77% (95% CI 69-83%) the 2000s. The use of radiation declined from 1970 to 2000 for all tumors; however, radiation treatment for embryonal and ependymal subtypes increased after 2000. Conclusions While overall survival for infants with brain tumors has improved from the 1970s onwards, not every tumor type has seen a statistically significant change. Given changes in management and survival, prognostication of infants with brain tumor should be updated.	[Faltermeier, Claire] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Chai, Timothy; Syed, Sharjeel] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lau, Nathan] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Elkaim, Lior; Weil, Alexander] Univ Montreal, CHU St Justine Hosp, Div Neurosurg, Montreal, PQ, Canada; [Ibrahim, George] Univ Toronto, Hosp Sick Children, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Wang, Anthony; Fallah, Aria] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA USA; [Bendel, Anne] Childrens Minnesota, Dept Hematol Oncol, Minneapolis, MN USA; [Tu, Albert] Childrens Hosp Eastern Ontario, Div Neurosurg, Ottawa, ON, Canada	University of California System; University of California San Francisco; Stanford University; Fred Hutchinson Cancer Center; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California Los Angeles; Children's Hospitals & Clinics of Minnesota; University of Ottawa; Children's Hospital of Eastern Ontario	Tu, A (corresponding author), Childrens Hosp Eastern Ontario, Div Neurosurg, Ottawa, ON, Canada.	Atu@cheo.on.ca	Wang, Anthony/GSD-5456-2022; Wang, Anthony/GPP-5594-2022	Tu, Albert/0000-0002-8238-9202; Syed, Sharjeel/0000-0001-9381-0456	NCI NIH HHS [P50 CA211015] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; ASAI A, 1989, CHILD NERV SYST, V5, P230, DOI 10.1007/BF00271024; Ater JL, 2012, J CLIN ONCOL, V30, P2641, DOI 10.1200/JCO.2011.36.6054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger C, 1998, NEUROSURGERY, V42, P470, DOI 10.1097/00006123-199803000-00006; Bettegowda C, 2012, J NEUROSURG-PEDIATR, V10, P398, DOI 10.3171/2012.8.PEDS12132; BIRCH JM, 1992, BRIT J CANCER, V66, pS2; Bishop AJ, 2012, INT J RADIAT ONCOL, V82, P341, DOI 10.1016/j.ijrobp.2010.08.020; Bognar L, 1997, ANN NY ACAD SCI, V824, P148, DOI 10.1111/j.1749-6632.1997.tb46217.x; Chen YW, 2006, INT J RADIAT ONCOL, V64, P1038, DOI 10.1016/j.ijrobp.2005.10.001; DeSouza RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00176; DONAHUE B, 1992, PEDIATR NEUROSURG, V18, P207, DOI 10.1159/000120664; Dudley RWR, 2015, J NEURO-ONCOL, V121, P201, DOI 10.1007/s11060-014-1628-6; DUFFNER PK, 1993, NEW ENGL J MED, V328, P1725, DOI 10.1056/NEJM199306173282401; Duffner PK, 1996, J NEURO-ONCOL, V28, P245; Fangusaro J, 2013, J NEURO-ONCOL, V113, P341, DOI 10.1007/s11060-013-1104-8; GALASSI E, 1989, CHILD NERV SYST, V5, P288, DOI 10.1007/BF00274516; GEYER JR, 1995, CANCER-AM CANCER SOC, V75, P1045, DOI 10.1002/1097-0142(19950215)75:4<1045::AID-CNCR2820750422>3.0.CO;2-K; Ghodsi SM, 2015, J PEDIATR NEUROSCI, V10, P335, DOI 10.4103/1817-1745.174454; Johnston DL, 2008, J NEURO-ONCOL, V86, P101, DOI 10.1007/s11060-007-9440-1; JOOMA R, 1984, NEUROSURGERY, V14, P31, DOI 10.1227/00006123-198401000-00008; KEHLER U, 1990, NEUROSURG REV, V13, P315, DOI 10.1007/BF00346373; Kiltie AE, 1997, MED PEDIATR ONCOL, V28, P348, DOI 10.1002/(SICI)1096-911X(199705)28:5<348::AID-MPO4>3.0.CO;2-H; Lafay-Cousin L, 2016, PEDIATR BLOOD CANCER, V63, P1527, DOI 10.1002/pbc.26042; Lafay-Cousin L, 2009, ONCOLOGIST, V14, P433, DOI 10.1634/theoncologist.2008-0193; Larouche V, 2007, PEDIATR BLOOD CANCER, V49, P1074, DOI 10.1002/pbc.21351; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marinoff AE, 2017, J NEURO-ONCOL, V135, P201, DOI 10.1007/s11060-017-2568-8; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Palmer SL, 2001, J CLIN ONCOL, V19, P2302, DOI 10.1200/JCO.2001.19.8.2302; RAIMONDI AJ, 1983, CHILD BRAIN, V10, P193; Ramaswamy V, 2017, J CLIN ONCOL, V35, P2355, DOI 10.1200/JCO.2017.72.7842; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; SAKAMOTO K, 1986, CHILD NERV SYST, V2, P126, DOI 10.1007/BF00270839; STCLAIR SK, 1992, PEDIATR NEUROSURG, V17, P225, DOI 10.1159/000120602; TAKAKU A, 1978, CHILD BRAIN, V4, P365; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Timmermann B, 2006, J CLIN ONCOL, V24, P1554, DOI 10.1200/JCO.2005.04.8074; WALLNER KE, 1988, J NEUROSURG, V69, P171, DOI 10.3171/jns.1988.69.2.0171; Weil AG, 2017, J NEURO-ONCOL, V132, P99, DOI 10.1007/s11060-016-2341-4; Woehrer A, 2010, CANCER-AM CANCER SOC, V116, P5725, DOI 10.1002/cncr.25540	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223051	10.1371/journal.pone.0223051	http://dx.doi.org/10.1371/journal.pone.0223051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553771	Green Published, gold			2022-12-27	WOS:000532319200050
J	Morita, T; Ando, M; Ohtsu, Y				Morita, Tomohiro; Ando, Michihito; Ohtsu, Yui			Mass evacuation and increases in long-term care benefits: Lessons from the Fukushima nuclear disaster	PLOS ONE			English	Article							EAST JAPAN EARTHQUAKE; FUNCTIONAL DISABILITY; EXCESS MORTALITY; OLDER-PEOPLE; HEALTH; IMPACT; PREVALENCE; TSUNAMI	Background Though mass evacuation may increase the need for long-term care (LTC) services, how the need for LTC services increases and how the public LTC system affects it is not well understood. We evaluated changes in public LTC benefits for the people living in the mandatory evacuation areas established after the 2011 Fukushima nuclear disaster and examined the roles of the universal LTC insurance system in Japan. Methods In order to evaluate the effect of the mandatory evacuation on LTC benefits, we examined the trends of LTC benefits in the Fukushima evacuation group and the nationwide non-evacuation group. We first decomposed per-elderly-individual benefits at the municipality level into the LTC certification rate and per-certified-individual benefits, and then implemented difference-in-differences analysis using these variables as outcomes. Results Per-elderly-individual benefits significantly increased from 2012 onward in the evacuation group, and this was explained by an increase in the certification rate rather than in per-certified-individual benefits. Increases in per-elderly-individual benefits and the certification rate in the post-disaster period were observed in all but the highest care level, and the corresponding outcomes for the highest care level decreased immediately after the disaster. We also found that the increase in the certification rate had been mostly realized by an increase in the number of certified individuals. Conclusions The increase in LTC benefits can be associated with the impact of the increase in the number of people newly certified to receive LTC benefits after the mandatory evacuation. In order to cope with the increase in utilization of long-term care and associated costs after disasters in aging societies, both formal long-term care services and social support for informal care for evacuees should be considered important.	[Morita, Tomohiro] Soma Cent Hosp, Internal Med, Soma, Fukushima, Japan; [Ando, Michihito] Rikkyo Univ, Dept Econ, Toshima Ku, Tokyo, Japan; [Ohtsu, Yui] Saitama Univ, Grad Sch Humanities & Social Sci, Sakura Ku, Saitama, Japan	Rikkyo University; Saitama University	Morita, T (corresponding author), Soma Cent Hosp, Internal Med, Soma, Fukushima, Japan.	t.morita526@gmail.com	Ando, Michihito/AAD-2335-2021	Morita, Tomohiro/0000-0002-8621-4602; Ando, Michihito/0000-0002-5294-2994	Rikkyo University Special Fund for Research [15FK-1]; Rikkyo University; Health and Labour Sciences Research Grants [H30-Tokei-Ippan-005]; Ministry of Welfare, Labour and Welfare	Rikkyo University Special Fund for Research; Rikkyo University(Rikkyo University); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Welfare, Labour and Welfare	This research was funded by Rikkyo University Special Fund for Research (Grant number 15FK-1) funded by Rikkyo University (M.A. and Y.O.). Health and Labour Sciences Research Grants (Grant Number H30-Tokei-Ippan-005) funded by Ministry of Welfare, Labour and Welfare (M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COTTON J, 1988, REV ECON STAT, V70, P236, DOI 10.2307/1928307; Council NR Grid I, 2016, GLOBAL REPORT INTERN; Dobkin C, 2018, AM ECON REV, V108, P308, DOI 10.1257/aer.20161038; Fernandez Lauren S, 2002, Prehosp Disaster Med, V17, P67; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Hasegawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122631; Matsuyama Y, 2018, TOHOKU J EXP MED, V244, P163, DOI 10.1620/tjem.244.163; Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA; Morita T, 2017, J EPIDEMIOL COMMUN H, V71, P974, DOI 10.1136/jech-2016-208652; Morita T, 2016, J EPIDEMIOL COMMUN H, V70, P738, DOI 10.1136/jech-2015-206983; OECD, 2012, JAP APOS S COMP SYST; Solon G, 2015, J HUM RESOUR, V50, P301, DOI 10.3368/jhr.50.2.301; Tomata Y, 2015, SOC SCI MED, V147, P296, DOI 10.1016/j.socscimed.2015.11.016; Tomata Y, 2014, J EPIDEMIOL COMMUN H, V68, P530, DOI 10.1136/jech-2013-203541; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Uchimura M, 2014, J EPIDEMIOL COMMUN H, V68, P874, DOI 10.1136/jech-2014-204063; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	17	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0218835	10.1371/journal.pone.0218835	http://dx.doi.org/10.1371/journal.pone.0218835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553728	Green Published, Green Submitted, gold			2022-12-27	WOS:000532319200002
J	Seidler, AL; Hunter, KE; Chartres, N; Askie, LM				Seidler, Anna Lene; Hunter, Kylie E.; Chartres, Nicholas; Askie, Lisa M.			Associations between industry involvement and study characteristics at the time of trial registration in biomedical research	PLOS ONE			English	Article							OF-INTEREST; DRUG	Background Commercial or industry funding is associated with outcomes that favour the study funder in published studies, across various areas of research. However, it is currently unclear whether there are differences between trials with and without industry involvement at the stage of trial registration. Objective To determine whether industry involvement (industry sponsorship, funding, or collaboration) is associated with trial characteristics at the time of trial registration. Methods We conducted a cross-sectional analysis of all interventional studies registered on the Australian New Zealand Clinical Trials Registry in 2017 and classified them by industry involvement. We analysed whether there were differences in study characteristics (including type of control, sample size, study phase, randomisation, registration timing, and purpose of study) by industry involvement. Results Industry involvement was reported by 21% of the 1,433 included trials. Only 40% of trials with industry involvement used an active control compared to 58% of non-industry trials (OR = 0.49, 95%CI = 0.38 to 0.63, p <.001), and industry trials reported smaller sample sizes (Median(IQR)(industry) = 45(24-100), Median(IQR)(non-industry) = 70(35-160), Mean Difference = -153, 95% CI = -233 to -75, p <.001). Industry trials were more likely to be earlier phase trials (chi(2) (df) = 71.46(4), p <.001). There was no difference in use of randomisation between industry (70%) and non-industry trials (73%) (OR = 0.88, 95%CI = 0.67-1.20, p =.38). Eighty-three percent of industry trials compared to 70% of non-industry trials were prospectively registered (OR = 2.02, 95%CI = 1.47-2.82, p <.001). Industry trials were more likely to assess treatment (85%), rather than prevention, education or diagnosis compared to non-industry trials (64%) (OR = 3.02, 95%CI = 2.17-4.32, p <.001). Conclusion The current study gives insight into differences in trial characteristics by industry involvement at registration stage. There was a reduced use of active controls in trials with industry involvement which has previously been proposed as a mechanism behind more favourable results. Non-industry funders and sponsors are crucial to ensure research addresses not only treatments, but also prevention, diagnosis and education questions.	[Seidler, Anna Lene; Hunter, Kylie E.; Askie, Lisa M.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Chartres, Nicholas] Univ Sydney, Sydney, NSW, Australia	University of Sydney; University of Sydney	Seidler, AL (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia.	lene.seidler@ctc.usyd.edu.au	Hunter, Kylie/AAD-6102-2019; Seidler, Anna Lene/ABC-4284-2022	Hunter, Kylie/0000-0002-2796-9220; Seidler, Anna Lene/0000-0002-0027-1623	Australian Federal Government; Health Research Council of New Zealand; Department of Health; Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program	Australian Federal Government(Australian Government); Health Research Council of New Zealand(Health Research Council of New Zealand); Department of Health; Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program(Australian GovernmentDepartment of Industry, Innovation and Science)	ANZCTR is supported by funding from the Australian Federal Government, Health Research Council of New Zealand and Department of Health and Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the facilities and the scientific and technical assistance of the ANZCTR at the NHMRC Clinical Trials Centre, University of Sydney. ANZCTR is supported by funding from the Australian Federal Government, Health Research Council of New Zealand and Department of Health and Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program.	Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bero L, 2016, ENVIRON INT, V92-93, P597, DOI 10.1016/j.envint.2015.10.011; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bero LA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000075; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Every-Palmer S, 2014, J EVAL CLIN PRACT, V20, P908, DOI 10.1111/jep.12147; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hunter KE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019983; Lundh A, 2011, COCHRANE DATABASE SY, V12; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Odierna DH, 2013, ACCOUNT RES, V20, P127, DOI 10.1080/08989621.2013.768931; R Development Core Team, 2009, R LANG ENV STAT COMP; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1860, DOI 10.1056/NEJMms1502493; Sterne JAC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000076; Tan AC, 2019, J CLIN EPIDEMIOL, V113, P64, DOI 10.1016/j.jclinepi.2019.05.009; White J, 2010, STANFORD LAW POL REV, V21, P105; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222117	10.1371/journal.pone.0222117	http://dx.doi.org/10.1371/journal.pone.0222117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553736	Green Published, gold			2022-12-27	WOS:000532319200014
J	Lefebvre, MJ; deFrance, SD; Kamenov, GD; Keegan, WF; Krigbaum, J				Lefebvre, Michelle J.; deFrance, Susan D.; Kamenov, George D.; Keegan, William F.; Krigbaum, John			The zooarchaeology and isotopic ecology of the Bahamian hutia (Geocapromys ingrahami): Evidence for pre-Columbian anthropogenic management	PLOS ONE			English	Article							CARBON-ISOTOPE; SAHARAN DUST; DIET; RATIOS; ISLAND; RECONSTRUCTION; CONSERVATION; MAMMALS; BIOLOGY; EARTH	Bahamian hutias (Geocapromys ingrahami) are the only endemic terrestrial mammal in The Bahamas and are currently classified as a vulnerable species. Drawing on zooarchaeological and new geochemical datasets, this study investigates human management of Bahamian hutias as cultural practice at indigenous Lucayan settlements in The Bahamas and the Turks & Caicos Islands. In order to determine how hutia diet and distribution together were influenced by Lucayan groups we conducted isotopic analysis on native hutia bone and tooth enamel recovered at the Major's Landing site on Crooked Island in The Bahamas and introduced hutias from the Palmetto Junction site on Providenciales in the Turks & Caicos Islands. Results indicate that some hutias consumed C-13-enriched foods that were either provisioned or available for opportunistic consumption. Strontium isotope ratios for hutia tooth enamel show a narrow range consistent with local origin for all of the archaeological specimens. In contrast, analysis of strontium isotopes in modern Bahamian hutia teeth from animals relocated to Florida from The Bahamas demonstrates that these animals rapidly lost their Bahamian signature and adopted a Florida signature. Therefore, strontium should be used cautiously for determining hutia provenance, particularly for individuals that were translocated between islands. Overall, our findings suggest that ancient human presence did not always result in hutia vulnerability and that the impact to hutia populations was variable across pre-Columbian indigenous settlements.	[Lefebvre, Michelle J.; Keegan, William F.] Florida Museum Nat Hist, Gainesville, FL 32611 USA; [deFrance, Susan D.; Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Kamenov, George D.] Univ Florida, Dept Geol Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lefebvre, MJ (corresponding author), Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Krigbaum, J (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mlefebvre@floridamuseum.ufl.edu; krigbaum@ufl.edu						Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Berman M.J., 2013, OXFORD HDB CARIBBEAN, P264; Berman MJ, 2000, LAT AM ANTIQ, V11, P219, DOI 10.2307/972175; BORROTO-PAEZ R., 2012, TERRESTRIAL MAMMALS, P221; Borroto-Paez R, 2017, J MAMMAL, V98, P964, DOI 10.1093/jmammal/gyx017; Burton JH, 2013, ACS SYM SER, V1147, P309; Carew JL, 1997, DEVEL SEDIM, V54, P91; Carlson L. A., 1999, THESIS; Carr RS., 2006, ARCHAEOLOGICAL HIST, P83; Ciofalo AJ, 2018, J ARCHAEOL SCI-REP, V21, P305, DOI 10.1016/j.jasrep.2018.07.022; Clough G. C, 1971, Atoll Res Bull, VNo. 138, P1; CLOUGH GC, 1972, J MAMMAL, V53, P807, DOI 10.2307/1379215; CLOUGH GC, 1974, J MAMMAL, V55, P670, DOI 10.2307/1379560; CLOUGH GC, 1973, NAT HIST, V82, P66; Colten RH., 2014, J CARIBB ARCHAEOL, V14, P23, DOI [10.1080/14614103.2018.1500157, DOI 10.1080/14614103.2018.1500157]; Colten RH, 2019, ENVIRON ARCHAEOL, V24, P211, DOI 10.1080/14614103.2018.1500157; Cooke SB, 2017, ANNU REV ECOL EVOL S, V48, P301, DOI 10.1146/annurev-ecolsys-110316-022754; Courcelle M, 2019, MOL PHYLOGENET EVOL, V136, P241, DOI 10.1016/j.ympev.2019.03.007; Craton Michael, 1992, ISLANDERS STREAM HIS; deFrance SD, 1991, ZOOARCHAEOLOGICAL RE; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DuChemin G., 2005, THESIS; Eisenberg JF, 2012, TERRESTRIAL MAMMALS; Fabre PH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0266; Figueredo A.E., 2015, J CARIBB ARCHAEOL, V15, P120; Froehle AW, 2012, AM J PHYS ANTHROPOL, V147, P352, DOI 10.1002/ajpa.21651; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; Giovas CM, 2016, J ARCHAEOL SCI, V69, P39, DOI 10.1016/j.jas.2016.03.006; Goodall PMP, 2012, TERRESTRIAL MAMMALS, P110; Howe RJ, 1971, INT ZOO YB, V11, P89, DOI DOI 10.1111/J.1748-1090.1971.TB01862.X; Jordan K.C., 2012, TERRESTRIAL MAMMALS, P115; Jordan K. C., 1989, THESIS; Keegan W. F., 1997, BAHAMIAN ARCHAEOLOGY; Keegan W.F., 2008, TALKING TAINO CARIBB; KEEGAN WF, 1988, AM ANTIQUITY, V53, P320, DOI 10.2307/281022; Keegan WF., 2017, CARIBBEAN COLUMBUS, DOI 10.1093/acprof:oso/9780190605247.001.0001; Keegan WF, 2018, 2018 LONG ISLAND BAH; Keegan William F, 1992, PEOPLE WHO DISCOVERE; Krigbaum J, 2013, J ISL COAST ARCHAEOL, V8, P210, DOI 10.1080/15564894.2012.756082; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Laffoon JE, 2013, ARCHAEOMETRY, V55, P742, DOI 10.1111/j.1475-4754.2012.00698.x; Laffoon JE, 2016, FLA MUS NAT HIST-RIP, P147; Laffoon JE, 2019, ENVIRON ARCHAEOL, V24, P132, DOI 10.1080/14614103.2017.1322831; Laffoon JE, 2012, J ARCHAEOL SCI; LAWRENCE BARBARA, 1934, OCCAS PAPERS BOSTON SOC NAT HIST, V8, P189; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; LeFebvre M.J., 2018, ARCHAEOLOGY CARIBBEA, P149; LeFebvre MJ, 2019, ENVIRON ARCHAEOL, V24, P115, DOI 10.1080/14614103.2018.1503809; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; McArthur J. M., 2004, GEOLOGIC TIME SCALE, P96, DOI DOI 10.1017/CBO9780511536045.008; Morgan GS, 2019, LATE QUATERNARY FOSS, P428; Morsink J., 2013, THESIS; Morsink J, 2019, ENVIRON ARCHAEOL, V24, P149, DOI 10.1080/14614103.2018.1440690; Newsom L. A., 2004, LAND SEA NATIVE AM U; Nieves-Rivera A.M., 2001, PR NSS NEWS, V59, P92; Norr L., 2002, TUTU ARCHAEOLOGICAL; Ostapkowicz J, PROVENANCING TAINO L; Ostapkowicz J, 2013, J ARCHAEOL SCI, V40, P4675, DOI 10.1016/j.jas.2013.07.015; Pestle WJ, 2018, J ARCHAEOL SCI-REP, V17, P393, DOI 10.1016/j.jasrep.2017.11.032; Pestle WJ, 2013, J ISL COAST ARCHAEOL, V8, P228, DOI 10.1080/15564894.2013.797943; Pourmand A, 2014, GEOLOGY, V42, P675, DOI 10.1130/G35624.1; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Sauer Carl, 1966, EARLY SPANISH MAIN; Schroeder H, 2018, P NATL ACAD SCI USA, V115, P2341, DOI 10.1073/pnas.1716839115; Schultinga R, 2018, QUATERNARY RES, V89, P394, DOI 10.1017/qua.2018.8; Somerville AD, 2013, J ARCHAEOL SCI, V40, P1539, DOI 10.1016/j.jas.2012.10.029; Steadman DW, 2017, J ISL COAST ARCHAEOL, V12, P572, DOI 10.1080/15564894.2017.1305469; Stokes Anne V, 1998, THESIS; Swart PK, 2014, GEOLOGY, V42, P671, DOI 10.1130/G35744.1; Turvey S, 2008, GEOCAPROMYS INGRAHAM, DOI [10.2305/IUCN.UK.2008.RLTS.T9002A12949103.en, DOI 10.2305/IUCN.UK.2008.RLTS.T9002A12949103.EN]; Turvey ST, 2017, J MAMMAL, V98, P918, DOI 10.1093/jmammal/gyw154; Upham NS, 2017, J MAMMAL, V98, P950, DOI 10.1093/jmammal/gyx077; Upham NS, 2017, J MAMMAL, V98; Vaughan T. A., 2011, MAMMALOGY; Veloz Maggiolo M., 1992, REV ARQUEOLOGIA AM, V6, P125; Wing ES, 2008, INTERD CONTRIB ARCH, P405, DOI 10.1007/978-0-387-71303-8_21; Wing ES, 2012, TERRESTRIAL MAMMALS, P342; Wing ES., 1982, J N WORLD ARCHAEOL, V5, P13; Woods CA, 2012, TERRESTRIAL MAMMALS, P335	82	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0220284	10.1371/journal.pone.0220284	http://dx.doi.org/10.1371/journal.pone.0220284			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550252	Green Published, gold			2022-12-27	WOS:000532307700004
J	Zhang, PY; Lu, Q; Li, HJ; Wang, W; Li, GQ; Si, LM; Ding, YM				Zhang, Peiying; Lu, Qian; Li, Huijuan; Wang, Wei; Li, Gaoqiang; Si, Longmei; Ding, Yanming			The quality of guidelines for diabetic foot ulcers: A critical appraisal using the AGREE II instrument	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; IWGDF GUIDANCE; MANAGEMENT; DIAGNOSIS; INTERVENTIONS; PREVENTION; SOCIETY	This study aims to evaluate the quality of clinical practice guidelines(CPGs) for patients with diabetic foot worldwide. A search of guidelines websites, databases and academic institutions websites was performed from January 1st, 2010, until June 30th, 2018. Four assessors independently rated the quality of each CPG using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. Twelve CPGs satisfied the inclusion criteria. The median scores for the 6 AGREE II domains (scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence) were 92.5%, 72.5%, 71.5%, 89%, 47%, and 77%, respectively. The overall quality of the CPGs was good since the majority of the CPGs reached an overall guideline quality between 5 and 7 points. Different CPGs had widely varying scores in the same area, ranging from 25 to 94 points.	[Zhang, Peiying; Si, Longmei; Ding, Yanming] Peking Univ, Nursing Dept, Hosp 1, Beijing, Peoples R China; [Lu, Qian; Li, Gaoqiang] Peking Univ, Sch Nursing, Beijing, Peoples R China; [Li, Huijuan] Peking Univ, Dept Plast & Burns, Hosp 1, Beijing, Peoples R China; [Wang, Wei] Tongji Univ, Sch Med, Shanghai, Peoples R China	Peking University; Peking University; Peking University; Tongji University	Ding, YM (corresponding author), Peking Univ, Nursing Dept, Hosp 1, Beijing, Peoples R China.	dingym60@126.com	Lu, Qian/A-8610-2012	Lu, Qian/0000-0003-2611-3284				Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2016, DIABETES-METAB RES, V32, P16, DOI 10.1002/dmrr.2696; Choi TY, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0294-1; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Cooper MJ, 2003, J AM DIET ASSOC, V103, pS28, DOI [10.1016/j.jada.2003.09.034, 10.1016/S0002-8223(03)01377-4]; Dionne JM, 2015, PEDIATR NEPHROL, V30, P1919, DOI 10.1007/s00467-015-3077-7; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Field MJ, 1990, CLIN GUIDELINES DIRE; Game FL, 2016, DIABETES-METAB RES, V32, P75, DOI 10.1002/dmrr.2700; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Harvey G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0398-2; Hinchliffe RJ, 2016, DIABETES-METAB RES, V32, P37, DOI 10.1002/dmrr.2698; Hingorani A, 2016, J VASC SURG, V63, p3S, DOI 10.1016/j.jvs.2015.10.003; Huang ET, 2015, UNDERSEA HYPERBAR M, V42, P205; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Isei T, 2016, J DERMATOL, V43, P591, DOI 10.1111/1346-8138.13285; Jin YH, 2016, WORLDV EVID-BASED NU, V13, P124, DOI 10.1111/wvn.12127; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lavery LA, 2016, WOUND REPAIR REGEN, V24, P112, DOI 10.1111/wrr.12391; Lipsky BA, 2016, DIABETES-METAB RES, V32, P45, DOI 10.1002/dmrr.2699; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis346, 10.1093/cid/cis460]; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Malheiro R, 2014, ENDOSCOPY, V46, P513, DOI 10.1055/s-0034-1365394; National Institute for Health and Care Excellence, 2015, CLIN GUD DIAB FOOT P; Polus S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038891; Radwan Mahmoud, 2017, JRSM Open, V8, p2054270416682673, DOI 10.1177/2054270416682673; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; Registered Nurses' Association of Ontario, 2012, TOOLK IMPL BEST PRAC; Registered Nurses' Association Ontario, 2013, CLIN BEST PRACT GUID, V2nd; Schaper NC, 2016, DIABETES-METAB RES, V32, P7, DOI 10.1002/dmrr.2695; Sox HC, 2014, JAMA-J AM MED ASSOC, V311, P472, DOI 10.1001/jama.2013.284429; The AGREE Next Step Consortium, 2009, APPR GUID RES EV 2; The AGREE Next Step Consortium............ II, 2013, APPR GUID RES EV; Thomson R, 1998, BRIT MED J, V316, P509, DOI 10.1136/bmj.316.7130.509; Walsh JW, 2016, DIABETIC MED, V33, P1493, DOI 10.1111/dme.13054; Zhang PZ, 2017, ANN MED, V49, P106, DOI 10.1080/07853890.2016.1231932	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0217555	10.1371/journal.pone.0217555	http://dx.doi.org/10.1371/journal.pone.0217555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545806	gold, Green Published			2022-12-27	WOS:000532303200006
J	Cardoso-Sousa, L; Aguiar, EMG; Caixeta, DC; Vilela, DD; da Costa, DP; Silva, TL; Cunha, TM; Faria, PR; Espindola, FS; Jardim, AC; Vieira, AA; Oliveira, TL; Goulart, LR; Sabino-Silva, R				Cardoso-Sousa, Leia; Gomes Aguiar, Emilia Maria; Caixeta, Douglas Carvalho; Vilela, Danielle Diniz; da Costa, Danilo Pereira; Silva, Tamires Lopes; Cunha, Thulio Marquez; Faria, Paulo Rogerio; Espindola, Foued Salmen; Jardim, Ana Carolina; Vieira, Alexandre Antonio; Oliveira, Tales Lyra; Goulart, Luiz Ricardo; Sabino-Silva, Robinson			Effects of salbutamol and phlorizin on acute pulmonary inflammation and disease severity in experimental sepsis	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; SEPTIC SHOCK; GLUCOSE; CANAGLIFLOZIN; ABSORPTION; MANAGEMENT; MORTALITY; CYTOKINES; PROTECTS	Respiratory infection can be exacerbated by the high glucose concentration in the airway surface liquid (ASL). We investigated the effects of salbutamol and phlorizin on the pulmonary function, oxidative stress levels and SGLT1 activity in lung, pulmonary histopathological damages and survival rates of rats with sepsis. Sepsis was induced by cecal ligation and puncture surgery (CLP). Twenty-four hours after surgery, CLP rats were intranasally treated with saline, salbutamol or phlorizin. After 2 hours, animals were anesthetized and sacrificed. Sepsis promoted atelectasis and bronchial inflammation, and led to increased expression of SGLT1 on cytoplasm of pneumocytes. Salbutamol treatment reduced bronchial inflammation and promoted hyperinsuflation in CLP rats. The interferon-gamma and Interleucin-1 beta concentrations in bronchoalveolar lavage (BAL) were closely related to the bronchial inflammation regulation. Salbutamol stimulated SGLT1 in plasma membrane; whereas, phlorizin promoted the increase of SGLT1 in cytoplasm. Phlorizin reduced catalase activity and induced a significant decrease in the survival rate of CLP rats. Taken together, sepsis promoted atelectasis and lung inflammation, which can be associated with SGLT1 inhibition. The loss of function of SGLT1 by phlorizin are related to the augmented disease severity, increased atelectasis, bronchial inflammation and a significant reduction of survival rate of CLP rats. Alternatively salbutamol reduced BAL inflammatory cytokines, bronchial inflammation, atelectasis, and airway damage in sepsis. These data suggest that this selective beta 2-adrenergic agonist may protect lung of septic acute effects.	[Cardoso-Sousa, Leia; Gomes Aguiar, Emilia Maria; da Costa, Danilo Pereira; Vieira, Alexandre Antonio; Sabino-Silva, Robinson] Univ Fed Uberlandia, Inst Biomed Sci, Dept Physiol, Uberlandia, MG, Brazil; [Caixeta, Douglas Carvalho; Vilela, Danielle Diniz; Espindola, Foued Salmen; Goulart, Luiz Ricardo] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil; [Silva, Tamires Lopes] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol Dr Mario Endsfeldz Camargo, Uberlandia, MG, Brazil; [Cunha, Thulio Marquez] Univ Fed Uberlandia, Sch Med, Dept Pulmonol, Uberlandia, MG, Brazil; [Faria, Paulo Rogerio] Univ Fed Uberlandia, Inst Biomed Sci, Dept Morphol, Uberlandia, MG, Brazil; [Jardim, Ana Carolina] Univ Fed Uberlandia, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil; [Oliveira, Tales Lyra] Municipal Univ Sao Caetano, Fac Med, Sao Paulo, Brazil; [Goulart, Luiz Ricardo] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; University of California System; University of California Davis	Sabino-Silva, R (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Dept Physiol, Uberlandia, MG, Brazil.	robinsonsabino@gmail.com	Jardim, Ana Carolina/H-3615-2012; de Oliveira, Tales Lyra/W-7524-2018; Sabino-Silva, Robinson/I-2264-2012	Jardim, Ana Carolina/0000-0002-6348-7923; de Oliveira, Tales Lyra/0000-0003-4831-3009; Sabino-Silva, Robinson/0000-0002-2104-5780; Lopes Silva, Tamires/0000-0001-5118-0556; Caixeta, Douglas Carvalho/0000-0002-2363-6584	CNPq; CAPES; FAPEMIG; Federal University of Uberlandia; National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq) [465669/2014-0]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Federal University of Uberlandia; National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by a grant from CNPq, CAPES, Federal University of Uberlandia and FAPEMIG. Our best regards to National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq Process N.: 465669/2014-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach JR, 2002, J NUTR, V132, P1254, DOI 10.1093/jn/132.6.1254; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cinel Ismail, 2012, J Thorac Dis, V4, P30, DOI 10.3978/j.issn.2072-1439.2010.08.04; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Craciun FL, 2014, SHOCK, V41, P97, DOI 10.1097/SHK.0000000000000073; Demling RH, 2000, WORLD J SURG, V24, P673, DOI 10.1007/s002689910109; Doggrell SA, 2014, EXPERT OPIN PHARMACO, V15, P437, DOI 10.1517/14656566.2014.868885; Eteraf-Oskouei T, 2017, RES PHARM SCI, V12, P364, DOI 10.4103/1735-5362.213981; Goncalves-de-Albuquerque CF, 2016, PLOS ONE, V11; Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; Kang HJ, 2016, THER CLIN RISK MANAG, V12, P287, DOI 10.2147/TCRM.S97989; Koepsell H, 2016, PHARMACOL THERAPEUT, V7258, P30196; Li YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22747; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Melo IS, 2016, EPILEPSY BEHAV, V61, P258, DOI 10.1016/j.yebeh.2016.05.026; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Oliveira TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21752; Ozogul B, 2015, DRUG RES, V65, P192, DOI 10.1055/s-0034-1375683; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364; Prenner BM, 2008, CURR OPIN PULM MED, V14, P57; Raffay T, 2014, NEONATOLOGY, V106, P126, DOI 10.1159/000362684; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Sabino-Silva R, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-64; Sabino-Silva R, 2010, AM J PHYSIOL-ENDOC M, V299, pE1028, DOI 10.1152/ajpendo.00395.2010; Santiago MB, 2013, EXP PHYSIOL, V98, P556, DOI 10.1113/expphysiol.2012.066241; Santos RS, 2016, ANESTH ANALG, V122, P1089, DOI 10.1213/ANE.0000000000001173; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Theobaldo MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074369; Vilela DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6978625; Vinuales C, 2012, CELL PHYSIOL BIOCHEM, V30, P173, DOI 10.1159/000339056; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang XX, 2017, INFLAMMATION, V40, P351, DOI 10.1007/s10753-016-0481-5; Zhao HY, 2016, J HISTOCHEM CYTOCHEM, V64, P125, DOI 10.1369/0022155415610168; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	39	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222575	10.1371/journal.pone.0222575	http://dx.doi.org/10.1371/journal.pone.0222575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536570	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800054
J	Dado-Senn, B; Skibiel, AL; Fabris, TF; Dahl, GE; Laporta, J				Dado-Senn, Bethany; Skibiel, Amy L.; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena			Dry period heat stress induces microstructural changes in the lactating mammary gland	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; GENE-EXPRESSION; HOLSTEIN COWS; LATE-GESTATION; PERFORMANCE; TRANSITION; ORGANELLES; APOPTOSIS; FILAMENTS; ABATEMENT	The bovine dry period is a non -lactating period between consecutive lactations characterized by mammary gland involution and redevelopment phases to replace senescent mammary epithelial cells with active cells primed for the next lactation. Dairy cows exposed to heat stress during the dry period experience milk yield reductions between 3-7.5 kg/d in the next lactation, partially attributed to processes associated with mammary cell growth and turnover during the dry period. However, the carry-over impact of dry period heat stress on mammary morphology during lactation has yet to be determined. In the current study, we hypothesized that exposure to heat stress during the dry period would alter alveolar microstructure and cellular turnover (i.e. proliferation and apoptosis) during lactation. Cows were either subjected to heat stress (HT, access to shade; n = 12) or cooling (CL, access to shade, fans, and soakers; n = 12) for a 46 d dry period. Upon calving, all cows were treated similarly with access to cooling for their entire lactation. Six cows per treatment were randomly selected for mammary gland biopsies at 14, 42, and 84 days in milk. Tissues were sectioned and stained for histological analysis. During lactation, HT cows produced 4 kg less colostrum and 3.7 kg less milk compared with CL cows. Lactating mammary gland microstructure was impacted after exposure to dry period heat stress; HT cows had fewer alveoli and a higher proportion of connective tissue in the mammary gland relative to CL cows, however alveolar area was similar between treatments. Rates of mammary epithelial cell proliferation and apoptosis were similar between treatment groups. This suggests that heat stress exposure during the dry period leads to reductions in milk yield that could be caused, in part, by a reduction in alveoli number in the lactating mammary gland but not to dynamic alterations in cellular turnover once lactation is established.	[Dado-Senn, Bethany; Skibiel, Amy L.; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Skibiel, Amy L.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA	State University System of Florida; University of Florida; Idaho; University of Idaho	Laporta, J (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	jlaporta@ufl.edu	Dahl, Geoffrey/AAC-4953-2019; Laporta, Jimena/AAX-3093-2021	Dado-Senn, Bethany/0000-0002-6104-7334	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program [2015-67015-23409]	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program	Funding was provided through University of Florida Institute of Food and Agricultural Sciences Climate Change; and Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant awarded to Dr. Laporta. The authors acknowledge USDA NIFA AFRI Foundational Program (Award#2015-67015-23409) awarded to Dr. Dahl for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin G, 2009, LIVEST SCI, V124, P189, DOI 10.1016/j.livsci.2009.01.014; Akers R.M., 2002, LACTATION MAMMARY GL, V1st; Avendano-Reyes L, 2006, LIVEST SCI, V105, P198, DOI 10.1016/j.livsci.2006.06.009; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Capuco AV, 2003, J ANIM SCI, V81, P18; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Dado-Senn, 2018, J DAIRY SCI S2, V101, P151; Dado-Senn B, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Davis SR, 1998, J DAIRY RES, V65, P1, DOI 10.1017/S0022029997002562; De Vries LD, 2010, J DAIRY SCI, V93, P2433, DOI 10.3168/jds.2009-2764; Dikmen S, 2008, J DAIRY SCI, V91, P3395, DOI 10.3168/jds.2008-1072; do Amaral BC, 2011, J DAIRY SCI, V94, P86, DOI 10.3168/jds.2009-3004; do Amaral BC, 2009, J DAIRY SCI, V92, P5988, DOI 10.3168/jds.2009-2343; Enger BD, 2018, VET RES, V49, DOI 10.1186/s13567-018-0542-x; Fabris TF, 2017, J DAIRY SCI, V100, P6733, DOI 10.3168/jds.2016-12313; Farr VC, 1996, J DAIRY SCI, V79, P543, DOI 10.3168/jds.S0022-0302(96)76398-1; Ferreira FC, 2016, J DAIRY SCI, V99, P9931, DOI 10.3168/jds.2016-11566; Gebremedhin KG, 2001, J THERM BIOL, V26, P537, DOI 10.1016/S0306-4565(00)00048-6; HOLST BD, 1987, J DAIRY SCI, V70, P935, DOI 10.3168/jds.S0022-0302(87)80097-8; Hu H, 2016, ANIM PROD SCI, V56, P918, DOI 10.1071/AN14420; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; Lang SLC, 2012, J EXP BIOL, V215, P2904, DOI 10.1242/jeb.067058; LASZLO A, 1992, CELL PROLIFERAT, V25, P59, DOI 10.1111/j.1365-2184.1992.tb01482.x; Li L, 2015, CELL STRESS CHAPERON, V20, P381, DOI 10.1007/s12192-014-0559-7; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Monteiro APA, 2016, J DAIRY SCI, V99, P8443, DOI 10.3168/jds.2016-11072; Robertshaw D., 2004, Dukes' physiology of domestic animals, P962; Safayi S, 2010, J DAIRY SCI, V93, P1478, DOI 10.3168/jds.2009-2422; SHYY TT, 1989, J CELL BIOL, V108, P997, DOI 10.1083/jcb.108.3.997; Skibiel AL, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Skibiel AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206046; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Tao S, 2011, J DAIRY SCI, V94, P5976, DOI 10.3168/jds.2011-4329; Thompson I. M., 2012, Professional Animal Scientist, V28, P628; TRINIDAD P, 1990, J DAIRY SCI, V73, P639, DOI 10.3168/jds.S0022-0302(90)78715-2; Val-Arreola D, 2004, J DAIRY SCI, V87, P3789, DOI 10.3168/jds.S0022-0302(04)73518-3; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wohlgemuth SE, 2016, J DAIRY SCI, V99, P4875, DOI 10.3168/jds.2015-10649; WOLFENSON D, 1988, J DAIRY SCI, V71, P809, DOI 10.3168/jds.S0022-0302(88)79621-6; Yousef M. K., 1985, STRESS PHYSL LIVESTO; Zimbleman R. B., 2009, P SW NUTR C, P158	49	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222120	10.1371/journal.pone.0222120	http://dx.doi.org/10.1371/journal.pone.0222120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX5TK	31536517	Green Submitted, Green Published, gold			2022-12-27	WOS:000521942600001
J	Dewa, LH; Lavelle, M; Pickles, K; Kalorkoti, C; Jaques, J; Pappa, S; Aylin, P				Dewa, Lindsay H.; Lavelle, Mary; Pickles, Katy; Kalorkoti, Caroline; Jaques, Jack; Pappa, Sofia; Aylin, Paul			Young adults' perceptions of using wearables, social media and other technologies to detect worsening mental health: A qualitative study	PLOS ONE			English	Article							INTERVENTIONS; METAANALYSIS; SYMPTOMS	Background Technological interventions may help support and improve mental health. However young peoples' perspectives on using different technologies to detect deteriorating mental health in those already diagnosed with a mental health condition is lacking. The study aim was to explore the perspectives of young patients on the feasibility and acceptability of using wear-ables, social media and technologies to detect mental health deterioration. Methods The study was co-produced with young adults with past mental health difficulties. Semi-structured interviews were conducted with young adults with a severe mental health condition in a private room at a community mental health site. Data was triangulated by comparing codes and ideas across the two co-researchers and two researchers over two virtual meetings. Themes were finalised and presented in a thematic map. Results Sixteen participants were interviewed (81% female). There were four main themes: dealing with mental health symptoms, signs of mental health deterioration, technology concerns and technological applications to identify worsening mental health. Wearables and mobile apps were considered acceptable and feasible to detect mental health deterioration in real-time if they could measure changes in sleep patterns, mood or activity levels as signs of deterioration. Getting help earlier was deemed essential particularly in reference to dissatisfaction with the current non-technological mental health services. However, patients identified issues to consider before implementation including practicality, safeguarding and patient preference. Conclusion Wearables and mobile apps could be viable technological options to help detect deterioration in young people in order to intervene early and avoid delay in accessing mental health services. However, immediate action following detection is required for the patient to trust and use the intervention.	[Dewa, Lindsay H.; Aylin, Paul] Imperial Coll London, Sch Publ Hlth, London, England; [Lavelle, Mary; Aylin, Paul] Imperial Coll London, NIHR Patient Safety Translat Res Ctr, London, England; [Pickles, Katy; Kalorkoti, Caroline; Jaques, Jack] Young Peoples Network, McPin Fdn, London, England; [Pappa, Sofia] West London NHS Trust, London, England	Imperial College London; Imperial College London	Dewa, LH (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.	l.dewa@imperial.ac.uk		Lavelle, Mary/0000-0002-3951-0011; Aylin, Paul/0000-0003-4589-1743; Dewa, Lindsay/0000-0001-8359-8834	NIHR Patient Safety Translational Research Centre programme grant	NIHR Patient Safety Translational Research Centre programme grant	NIHR Patient Safety Translational Research Centre programme grant funded our study. The funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank all participants for taking time out of their lives to talk to us. We'd also like to thank Anna Lawrence-Jones for her advice and support in relation to patient and public involvement.	Anderson M, SOCIAL MEDIA TECHNOL; [Anonymous], 2013, BUDG INV PRACT ADV B; Arean PA, 2016, DIALOGUES CLIN NEURO, V18, P163; Baillie Lesley, 2015, Nurs Stand, V29, P36, DOI 10.7748/ns.29.46.36.e8830; Berry N, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5250; Birchwood M, 1997, BRIT J PSYCHIAT, V170, P2, DOI 10.1192/bjp.170.1.2; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Broad KL, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1538-1; Bucci S, 2018, JMIR MENT HEALTH, V5, DOI 10.2196/10091; Bucci S, 2018, SCHIZOPHRENIA BULL, V44, P1070, DOI 10.1093/schbul/sby032; Carlsson IM, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2017.1368323; Chan S, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0848-9; Daus H, 2018, J AFFECT DISORDERS, V229, P351, DOI 10.1016/j.jad.2017.12.059; Eysenbach G, 2014, J MED INTERNET RES, V16, P4, DOI [10.2196/jmir.3358, 10.2196/jmir.3304]; Firth J, 2017, WORLD PSYCHIATRY, V16, P287, DOI 10.1002/wps.20472; Firth J, 2017, J AFFECT DISORDERS, V218, P15, DOI 10.1016/j.jad.2017.04.046; Garrubba M., 2019, RECOGNISING RESPONDI; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Kauer SD, 2012, J MED INTERNET RES, V14, P15, DOI 10.2196/jmir.1858; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Meyer N, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8292; Nicholas J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7273; Palmier-Claus JE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-34; Proudfoot J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1475; QSR Int, 2017, NVIVO MAC VERS 12; RIMMER A, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K5436; Sadler K., 2018, MENTAL HLTH CHILDREN; Salaheddin K, 2016, BRIT J GEN PRACT, V66, pE686, DOI 10.3399/bjgp16X687313; Salokangas RKR, 2008, NORD J PSYCHIAT, V62, P92, DOI 10.1080/08039480801984008; Sanders T, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084323, 10.1371/journal.pone.0092040]; Statista, WEAR US PEN RAT US 2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Valimaki M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5385; Walsh S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008362; WHO, 2020, ADOLESCENT MENTAL HL	35	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222655	10.1371/journal.pone.0222655	http://dx.doi.org/10.1371/journal.pone.0222655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532786	Green Published, Green Accepted, gold			2022-12-27	WOS:000532239600034
J	Nogoy, FM; Jung, YJ; Kang, KK; Cho, YG				Nogoy, Franz Marielle; Jung, Yu Jin; Kang, Kwon-Kyoo; Cho, Yong-Gu			Physico-chemical characterization and transcriptome analysis of 5-methyltryptophan resistant lines in rice	PLOS ONE			English	Article							ANTHRANILATE SYNTHASE; TRYPTOPHAN ACCUMULATION; TRANSGENIC RICE; GENE; SUBUNIT; MUTANT; SELECTION; BIOSYNTHESIS; EXPRESSION; PLANTS	Mutation breeding has brought significant contributions to the development of high value crops. It steered the first studies to generate plants with desired mutations of genes encoding key enzymes involved in important metabolic pathways. Molecular characterization of 5-methyl tryptophan (5-MT) resistant plants has revealed different base changes in alpha unit of anthranilate synthase (OsASA) gene that can lead to insensitivity to feedback inhibition of anthranilate synthase. The objective of this study was to perform in silico analysis of microarray data from five progressing time points during grain filling of rice. Results showed various differentially expressed genes. Enrichment of these genes revealed their roles in amino acid transportation during grain filling. Surprisingly, among all DEGs, only LOC_Os06g42560, a tryptophan synthase beta chain, was found to be directly related to tryptophan biosynthesis. It might affect amino acid content during grain filling. For physicochemical analysis, different grain and eating qualities parameters were measured using mutant rice lines. Evaluation results showed that 5MT resistant-lines (5MT R-lines) showed approximately 60% chalkiness after milling although it had 20 times higher tryptophan content measured in mu g/100 mg seeds. Taste quality of these 5MT R-lines in general was not affected significantly. However, other parameters such as peak time of viscosity and gelatinization temperature showed different results compared to the wildtype. Mutant lines generated in this study are important resources for high tryptophan content, although they have lower grain quality than the wildtype. They might be useful for developing new high nutrient rice varieties.	[Nogoy, Franz Marielle; Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Jung, Yu Jin; Kang, Kwon-Kyoo] Hankyong Natl Univ, Dept Hort, Ansung, South Korea; [Nogoy, Franz Marielle] Cent Luzon State Univ, Coll Agr, Dept Crop Sci, Munoz, Nueva Ecija, Philippines	Chungbuk National University; Hankyong National University; Central Luzon State University	Cho, YG (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.; Kang, KK (corresponding author), Hankyong Natl Univ, Dept Hort, Ansung, South Korea.	kykang@hknu.ac.kr; ygcho@cbnu.ac.kr	Cho, Yong-Gu/AAV-1904-2021	Cho, Yong-Gu/0000-0003-3213-6669	NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center) [PJ013207]; Rural Development Administration, Republic of Korea	NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by the NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center, No. PJ013207), Rural Development Administration, Republic of Korea.	Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cho HJ, 2000, PLANT PHYSIOL, V123, P1069, DOI 10.1104/pp.123.3.1069; Cho YG, 2014, AGR FORESTRY LIVESTO; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Hanafy MS, 2006, PLANT SCI, V171, P670, DOI 10.1016/j.plantsci.2006.06.016; HYDE EI, 1991, EUR J BIOCHEM, V201, P569, DOI 10.1111/j.1432-1033.1991.tb16316.x; Ishihara A, 2007, METABOLOMICS, V3, P319, DOI 10.1007/s11306-007-0072-4; Ishikawa Y, 2003, PLANT SCI, V164, P1037, DOI 10.1016/S0168-9452(03)00107-9; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kambhampati S, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0430-z; KANG KK, 1993, EUPHYTICA, V69, P95, DOI 10.1007/BF00021731; Kanno T, 2004, PLANT MOL BIOL, V54, P11, DOI 10.1023/B:PLAN.0000028729.79034.07; KIM DG, 2007, J CONTROL AUTOM SYST, V1, P1; Kim DS, 2005, PHYSIOL PLANTARUM, V123, P302, DOI 10.1111/j.1399-3054.2005.00468.x; Kubo M., 2004, Journal of Food Distribution Research, V35, P128; LEE HY, 1991, THEOR APPL GENET, V82, P405, DOI 10.1007/BF00588590; Lee HyeJung, 2014, Plant Breeding and Biotechnology, V2, P301, DOI 10.9787/PBB.2014.2.3.301; LESTER G, 1968, J BACTERIOL, V96, P1768, DOI 10.1128/JB.96.5.1768-1773.1968; MARMORSTEIN RQ, 1989, J BIOL CHEM, V264, P9149; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Nogoy F. M., 2018, Plant Breeding and Biotechnology, V6, P233, DOI 10.9787/PBB.2018.6.3.233; RANCH JP, 1983, PLANT PHYSIOL, V71, P136, DOI 10.1104/pp.71.1.136; TAM YY, 1995, PLANT PHYSIOL, V107, P77, DOI 10.1104/pp.107.1.77; Tozawa Y, 2001, PLANT PHYSIOL, V126, P1493, DOI 10.1104/pp.126.4.1493; Wakasa K, 2006, J EXP BOT, V57, P3069, DOI 10.1093/jxb/erl068; Yamada T, 2004, MOL BREEDING, V14, P363, DOI 10.1007/s11032-004-0184-8; Zhang XH, 2001, PLANT PHYSIOL, V127, P131, DOI 10.1104/pp.127.1.131	31	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222262	10.1371/journal.pone.0222262	http://dx.doi.org/10.1371/journal.pone.0222262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532784	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600025
J	Benito-Leon, J; Contador, I; Vega, S; Villarejo-Galende, A; Bermejo-Pareja, F				Benito-Leon, Julian; Contador, Israel; Vega, Saturio; Villarejo-Galende, Alberto; Bermejo-Pareja, Felix			Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality	PLOS ONE			English	Article							3 ELDERLY POPULATIONS; ESSENTIAL TREMOR; COGNITIVE FUNCTION; DEMENTIA; PREVALENCE; MEMORY; NEUROINFLAMMATION; PARKINSONISM; DECLINE; HEALTH	Alzheimer disease (AD) mortality risk in a large cohort of subjects treated or not with nonsteroidal anti-inflammatory drugs (NSAIDs) is unknown. Our objective was to determine whether NSAIDs use is associated with decreased risk of AD mortality. In this prospective, population-based study (Neurological Disorders in Central Spain [NEDICES]) of 5,072 people without AD (aged 65 years and older), sociodemographic, comorbidity factors, and current medications were recorded at baseline. Community-dwelling older adults were followed for a median of 12.7 years, after which the death certificates of deceased participants were examined. 2,672 (52.7%) of 5,072 participants died, including 504 (18.9%) NSAIDs users and 2,168 (81.1%) non-users. Of the 2,672 deceased participants, 113 (4.2%) had AD as a cause of death (8 [1.6%] among NSAIDs users and 105 [4.8%] among non-users, chi-square = 10.70, p = 0.001). In an unadjusted Cox model, risk of AD mortality was decreased in NSAIDs users (hazard ratio [HR] for AD mortality = 0.35, 95% confidence interval [CI] 0.17-0.72, p = 0.004) when compared to non-users. After adjusting for numerous demographic factors and co-morbidities, the HR for AD mortality in NSAIDs users was 0.29, 95% CI 0.12-0.73, p = 0.009. Stratified analyses showed a significantly decreased risk of AD mortality with aspirin, whereas non-aspirin NSAIDs only showed a statistical trend toward significance in the adjusted Cox regression models. NSAIDs use was associated with 71% decreased risk of AD mortality in older adults. Our results support the hypothesis that NSAIDs use is a protective factor of developing AD.	[Benito-Leon, Julian; Villarejo-Galende, Alberto] Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain; [Benito-Leon, Julian; Villarejo-Galende, Alberto] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain; [Benito-Leon, Julian; Villarejo-Galende, Alberto; Bermejo-Pareja, Felix] Univ Complutense Madrid, Dept Med, Madrid, Spain; [Contador, Israel] Univ Salamanca, Dept Basic Psychol Psychobiol & Methodol Behav Sc, Salamanca, Spain; [Vega, Saturio] Arevalo Hlth Ctr, Arevalo, Avila, Spain; [Bermejo-Pareja, Felix] Univ Hosp 12 Octubre, Clin Res Unit I 12, Madrid, Spain	Hospital Universitario 12 de Octubre; Complutense University of Madrid; University of Salamanca; Hospital Universitario 12 de Octubre	Benito-Leon, J (corresponding author), Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain.; Benito-Leon, J (corresponding author), Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain.; Benito-Leon, J (corresponding author), Univ Complutense Madrid, Dept Med, Madrid, Spain.	jbenitol67@gmail.com	Benito-León, Julián/AAA-1331-2019; Villarejo, Alberto/ABF-1064-2020	Benito-León, Julián/0000-0002-1769-4809; Villarejo, Alberto/0000-0002-6834-7620; Contador, Israel/0000-0002-7841-1307	Fondo Europeo de Desarrollo Regional (FEDER); Sanidad de Castilla y Leon (SACYL) funds	Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sanidad de Castilla y Leon (SACYL) funds	This research was supported by Fondo Europeo de Desarrollo Regional (FEDER) and Sanidad de Castilla y Leon (SACYL) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2019, CUREUS, V11, DOI 10.7759/cureus.4620; American Psychiatric A, 1994, DIAGN STAT MAN MENT; Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P389, DOI 10.1002/mds.10376; Benito-Leon J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004607; Benito-Leon J, 2015, PARKINSONISM RELAT D, V21, P622, DOI 10.1016/j.parkreldis.2015.03.023; Benito-Leon J, 2014, NEUROLOGY, V82, P1441, DOI 10.1212/WNL.0000000000000350; Benito-Leon J, 2013, NEUROLOGY, V81, P60, DOI 10.1212/WNL.0b013e318297ef2b; Benito-Leon J, 2010, J ALZHEIMERS DIS, V22, P159, DOI 10.3233/JAD-2010-100972; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Bermejo-Pareja F, 2008, REV NEUROLOGIA, V46, P416, DOI 10.33588/rn.4607.2008134; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Bermejo-Pareja F, 2009, J GERIATR PSYCH NEUR, V22, P246, DOI 10.1177/0891988709335794; Bermejo-Pareja F, 2010, J ALZHEIMERS DIS, V22, P949, DOI 10.3233/JAD-2010-101110; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Diaz-Guzman J, 2008, NEUROEPIDEMIOLOGY, V30, P247, DOI 10.1159/000135643; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hoyer S, 1996, ACTA NEUROL SCAND, V93, P18; Imbimbo BP, 2009, EXPERT OPIN INV DRUG, V18, P1147, DOI 10.1517/13543780903066780; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Louis ED, 2010, J NEUROL NEUROSUR PS, V81, P997, DOI 10.1136/jnnp.2009.202838; McGeer PL, 2018, J ALZHEIMERS DIS, V62, P1219, DOI 10.3233/JAD-170706; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer PF, 2019, NEUROLOGY, V92, pE2070, DOI 10.1212/WNL.0000000000007232; Morales JM, 2004, PUBLIC HEALTH, V118, P426, DOI 10.1016/j.puhe.2003.10.007; Nevado-Holgado AJ, 2017, COMPUT STRUCT BIOTEC, V15, P1, DOI 10.1016/j.csbj.2016.10.003; Prestia A, 2013, NEUROLOGY, V80, P1048, DOI 10.1212/WNL.0b013e3182872830; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Sanz-Blasco S, 2018, CURR ALZHEIMER RES, V15, P504, DOI 10.2174/1567205015666171227154016; Varga Z, 2017, CUREUS, V9, DOI 10.7759/cureus.1144; Vega S, 2010, J CLIN EPIDEMIOL, V63, P215, DOI 10.1016/j.jclinepi.2009.03.005; Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506; Woodling NS, 2016, ACS CHEM NEUROSCI, V7, P454, DOI 10.1021/acschemneuro.6b00016; Zhang CX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00083	40	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222505	10.1371/journal.pone.0222505	http://dx.doi.org/10.1371/journal.pone.0222505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527913	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400025
J	Sun, Y; Shaikh, O; Won, AS				Sun, Yilu; Shaikh, Omar; Won, Andrea Stevenson			Nonverbal synchrony in virtual reality	PLOS ONE			English	Article							INTERPERSONAL SYNCHRONY; MOVEMENT COORDINATION; HEAD MOVEMENTS; BEHAVIOR; COPRESENCE; SELF; APPEARANCE; OWNERSHIP; DYNAMICS	How might nonverbal synchrony naturally evolve in a social virtual reality environment? And how can avatar embodiment affect how participants coordinate nonverbally with each other? In the following pre-registered between-subjects experiment, we tracked the movements of pairs of users during a collaborative or competitive task in immersive virtual reality. Each conversational partner controlled either a customized avatar body or an abstract cube that responded to their movements. We compared the movements of the actual user pairs between the two conditions, and to an artificial "pseudosynchrony" dataset composed of the movements of randomly combined participant pairs who did not actually interact. We found stronger positive and negative correlations between real pairs compared to pseudosynchronous pairs, providing evidence for naturally occurring nonverbal synchrony between pairs in virtual reality. We discuss this in the context of the relationships between avatar appearance, task success, social closeness and social presence.	[Sun, Yilu; Won, Andrea Stevenson] Cornell Univ, Dept Commun, Ithaca, NY 14853 USA; [Shaikh, Omar] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	Cornell University; University System of Georgia; Georgia Institute of Technology	Sun, Y; Won, AS (corresponding author), Cornell Univ, Dept Commun, Ithaca, NY 14853 USA.	ys767@cornell.edu; asw248@cornell.edu		Sun, Yilu/0000-0002-3307-8811				Ahn SJG, 2016, J COMPUT-MEDIAT COMM, V21, P399, DOI 10.1111/jcc4.12173; Altmann U, 2011, LECT NOTES COMPUT SC, V6800, P335, DOI 10.1007/978-3-642-25775-9_31; Bailenson J, 2018, JAMA PEDIATR, V172, P905, DOI 10.1001/jamapediatrics.2018.1909; Bailenson JN, 2006, PRESENCE-VIRTUAL AUG, V15, P359, DOI 10.1162/pres.15.4.359; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Balaam M, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P867; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Boker SM, 2011, J EXP PSYCHOL HUMAN, V37, P874, DOI 10.1037/a0021928; Bourke P., 1999, INTERPOLATION METHOD; Brenton H, 2005, UNCANNY VALLEY DOES; Camurri A, 2003, INT J HUM-COMPUT ST, V59, P213, DOI 10.1016/S1071-5819(03)00050-8; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Garau M., 2003, P SIGCHI C HUM FACT, P529, DOI [DOI 10.1145/642611.642703, 10.1145/642611.642703]; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Kondo R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25951-2; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; LaFrance M., 1976, GROUP ORGAN STUD, V1, P328, DOI DOI 10.1177/105960117600100307; Llobera J, 2010, ACM T APPL PERCEPT, V8, DOI 10.1145/1857893.1857896; Lugrin JL, 2015, P IEEE VIRT REAL ANN, P225, DOI 10.1109/VR.2015.7223377; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nowak KL, 2003, PRESENCE-TELEOP VIRT, V12, P481, DOI 10.1162/105474603322761289; Nowak KL, 2018, REV COMMUN RES, V6, P30, DOI 10.12840/issn.2255-4165.2018.06.01.015; Paxton A., 2013, ARGUMENT DISRUPTS IN; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Peck TC, 2018, IEEE T VIS COMPUT GR, V24, P1604, DOI 10.1109/TVCG.2018.2793598; Ramseyer F, 2016, NONLIN DYNAM PSYCHOL, V20, P145; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Ramseyer Fabian, 2013, P 2013 INP OUTP C IN, P2; Rennung M, 2016, Z PSYCHOL, V224, P168, DOI 10.1027/2151-2604/a000252; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Robinson JD, 2006, SAGE HDB NONVERBAL C, P437; Roth D, 2016, P IEEE VIRT REAL ANN, P277, DOI 10.1109/VR.2016.7504761; Rotondo J. L., 2002, MIRROR NEURONS EVOLU, V42, P151; Schmidt RC, 2012, J NONVERBAL BEHAV, V36, P263, DOI 10.1007/s10919-012-0138-5; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Schoenherr D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211494; Schultze U, 2010, J INF TECHNOL, V25, P434, DOI 10.1057/jit.2010.25; Shaikh O, 2018, 25TH 2018 IEEE CONFERENCE ON VIRTUAL REALITY AND 3D USER INTERFACES (VR), P681; Steptoe W, 2013, IEEE T VIS COMPUT GR, V19, P583, DOI 10.1109/TVCG.2013.32; Sun Y, 2018, 2018 INT SOC PRES RE; Tarr B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21765-4; Tickle-Degnen L, 1990, PSYCHOL INQ, V1, P285, DOI [DOI 10.1207/S15327965PLI0104_, 10.1207/s15327965pli0104_1, DOI 10.1207/S15327965PLI0104_1]; Tschacher W, 2018, J PERS, V86, P129, DOI 10.1111/jopy.12298; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Waltemate T, 2018, IEEE T VIS COMPUT GR, V24, P1643, DOI 10.1109/TVCG.2018.2794629; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Won AS, 2018, SOC PSYCHOL PERS SCI, V9, P372, DOI 10.1177/1948550617707017; Won AS, 2016, CYBERPSYCH BEH SOC N, V19, P380, DOI 10.1089/cyber.2015.0326; Won AS, 2015, PRESENCE-TELEOP VIRT, V24, P335, DOI 10.1162/PRES_a_00238; Won AS, 2015, J COMPUT-MEDIAT COMM, V20, P241, DOI 10.1111/jcc4.12107; Won AS, 2014, IEEE T AFFECT COMPUT, V5, P112, DOI 10.1109/TAFFC.2014.2329304; Won AS, 2014, J NONVERBAL BEHAV, V38, P389, DOI 10.1007/s10919-014-0186-0; Yee N, 2008, ARTIFACT, V2, P88, DOI DOI 10.1080/17493460903020398; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x; Yee Nick, 2006, P PRESENCE, V24, P26	62	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221803	10.1371/journal.pone.0221803	http://dx.doi.org/10.1371/journal.pone.0221803			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525220	Green Submitted, gold, Green Published			2022-12-27	WOS:000532225700016
J	Liu, LY; Li, CZ; Han, YC; Wang, ZB; Feng, L; Zhi, XY; Yang, BF; Lei, YP; Du, WL; Li, YB				Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing			Adjusting cotton planting density under the climatic conditions of Henan Province, China	PLOS ONE			English	Article							RADIATION INTERCEPTION; POPULATION-DENSITY; LIGHT INTERCEPTION; SPATIAL-DISTRIBUTION; YIELD COMPONENTS; MAIZE; CANOPY; ARCHITECTURE; RESPONSES; PHOTOSYNTHESIS	The growth and development of cotton are closely related to climatic variables such as temperature and solar radiation. Adjusting planting density is one of the most effective measures for maximizing cotton yield under certain climatic conditions. The objectives of this study were (1) to determine the optimum planting density and the corresponding leaf area index (LAI) and yield under the climatic conditions of Henan Province, China, and (2) to learn how climatic conditions influence cotton growth, yield, and yield components. A three-year (2013-2015) field experiment was conducted in Anyang, Henan Province, using cultivar SCRC28 across six planting density treatments: 15,000, 33,000, 51,000, 69,000, 87,000, and 105,000 plants ha(-1). The data showed that the yield attributes, including seed cotton yield, lint yield, dry matter accumulation, and the LAI, increased as planting density increased. Consequently, the treatment of the maximum density with 105,000 plants ha(-1) was the highest-yielding over three years, with the LAIs averaged across the three years being 0.37 at the bud stage, 2.36 at the flower and boll-forming stage, and 1.37 at the bollopening stage. Furthermore, the correlation between the cotton yield attributes and meteorological conditions indicated that light interception (LI) and the diurnal temperature range were the climatic factors that most strongly influenced cotton seed yield. Moreover, the influence of the number of growing degree days (GDD) on cotton was different at different growth stages. These observations will be useful for determining best management practices for cotton production under the climatic conditions of Henan Province, China.	[Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China; [Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing] State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China.; Li, YB (corresponding author), State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	criliyabing1@163.com	Yabing, Li/GLU-9964-2022		National Key Research and Development Project [2017YFD0201906]	National Key Research and Development Project	This work was supported by the National Key Research and Development Project grant 2017YFD0201906 to Y. Li. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarz CW, 2006, CROP SCI, V46, P950, DOI 10.2135/cropsci2005.08-0276; Bednarz CW, 2005, AGRON J, V97, P235; Begna SH, 1997, J AGRON CROP SCI, V179, P9, DOI 10.1111/j.1439-037X.1997.tb01142.x; Boquet DJ, 2005, AGRON J, V97, P279, DOI 10.2134/agronj2005.0279; Boroomandan P, 2009, Pak J Biol Sci, V12, P378, DOI 10.3923/pjbs.2009.378.382; Chen G.P., 2012, ACTA AGRON SIN, V38, P80, DOI [10.3724/SP.J.1006.2012.00080, DOI 10.3724/SP.J.1006.2012.00080]; Chenu K, 2005, FUNCT PLANT BIOL, V32, P1123, DOI 10.1071/FP05091; Clover GRG, 2001, J AGR SCI, V136, P169, DOI 10.1017/S002185960100853X; Dai JL, 2015, FIELD CROP RES, V180, P207, DOI 10.1016/j.fcr.2015.06.008; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Duvrick D. N., 1999, CROP SCI, V39, P1622; Echarte L, 2000, FIELD CROP RES, V68, P1, DOI 10.1016/S0378-4290(00)00101-5; Escobar-Gutierrez AJ, 2009, AGR FOREST METEOROL, V149, P1244, DOI 10.1016/j.agrformet.2009.02.011; Evans LT, 1999, CROP SCI, V39, P1544, DOI 10.2135/cropsci1999.3961544x; Flenet F, 1996, AGRON J, V88, P185, DOI 10.2134/agronj1996.00021962008800020011x; GALANOPOULOUSENDOUKA S, 1980, AGRON J, V72, P347, DOI 10.2134/agronj1980.00021962007200020022x; Gerardeaux E, 2009, J AGR SCI, V147, P155, DOI 10.1017/S0021859608008381; Giuliani R, 2000, PLANT CELL ENVIRON, V23, P783, DOI 10.1046/j.1365-3040.2000.00600.x; Hecht VL, 2019, PLANT SOIL, V439, P179, DOI 10.1007/s11104-018-3764-9; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Jones MA, 1997, CROP SCI, V37, P797, DOI 10.2135/cropsci1997.0011183X003700030017x; Kaggwa-Asiimwe R, 2013, FIELD CROP RES, V145, P52, DOI 10.1016/j.fcr.2013.02.005; Liu TN, 2015, FIELD CROP RES, V170, P32, DOI 10.1016/j.fcr.2014.09.015; Liu Y, 2015, CROP SCI, V55, P1806, DOI 10.2135/cropsci2014.10.0735; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Mao LL, 2014, FIELD CROP RES, V155, P67, DOI 10.1016/j.fcr.2013.09.021; Mariscal MJ, 2000, AGR FOREST METEOROL, V100, P183, DOI 10.1016/S0168-1923(99)00137-9; McConnell JS, 2004, J PLANT NUTR, V27, P1183, DOI 10.1081/PLN-120038543; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Sarlikioti V, 2011, ANN BOT-LONDON, V107, P875, DOI 10.1093/aob/mcr006; Srinivasan V, 2017, GLOBAL CHANGE BIOL, V23, P1626, DOI 10.1111/gcb.13526; TETIOKAGHO F, 1988, AGRON J, V80, P935, DOI 10.2134/agronj1988.00021962008000060019x; Tian B, 2015, BIOCHEM SYST ECOL, V60, P150, DOI 10.1016/j.bse.2015.04.014; Tiwari RS, 2013, EUPHYTICA, V194, P1, DOI 10.1007/s10681-013-0927-x; Tsimba R, 2013, FIELD CROP RES, V150, P135, DOI 10.1016/j.fcr.2013.05.028; van Ittersum MK, 2013, FIELD CROP RES, V143, P1, DOI 10.1016/j.fcr.2012.12.012; [王春艳 WANG Chunyan], 2006, [棉花学报, Cotton Science], V18, P223; Wiechers D, 2011, AGR FOREST METEOROL, V151, P906, DOI 10.1016/j.agrformet.2011.02.016; Xu WJ, 2017, FIELD CROP RES, V212, P126, DOI 10.1016/j.fcr.2017.05.006; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Yang GZ, 2014, J INTEGR AGR, V13, P2154, DOI 10.1016/S2095-3119(13)60727-3; Yang GZ, 2010, AGR SCI CHINA, V9, P1749, DOI 10.1016/S1671-2927(09)60273-X; Yang YM, 2014, AGR WATER MANAGE, V144, P42, DOI 10.1016/j.agwat.2014.06.001; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhi XY, 2016, J INTEGR AGR, V15, P1469, DOI 10.1016/S2095-3119(15)61174-1; Zhi XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113409	46	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222395	10.1371/journal.pone.0222395	http://dx.doi.org/10.1371/journal.pone.0222395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557178	Green Published, gold			2022-12-27	WOS:000532345500016
J	Fantaye, AW; Gunawardena, N; Yaya, S				Fantaye, Arone Wondwossen; Gunawardena, Nathali; Yaya, Sanni			Preferences for formal and traditional sources of childbirth and postnatal care among women in rural Africa: A systematic review	PLOS ONE			English	Review							MATERNAL HEALTH-CARE; BIRTH; DELIVERY; PLACE; ATTENDANCE; MORTALITY; PREGNANCY; COMMUNITY; SERVICES; BELIEFS	Background The underutilization of formal, evidence-based maternal health services continues to contribute to poor maternal outcomes among women living in rural Africa. Women's choice of the type of maternal care they receive strongly influences their utilization of maternal health services. There is therefore a need to understand rural women's preferred choices to help set priorities for initiatives attempting to make formal maternal care more responsive to women's needs. The aim of this review was to explore and identify women's preferences for different sources of childbirth and postnatal care and the factors that contribute to these preferences. Methods A systematic literature search was conducted using the Ovid Medline, Embase, CINAHL, and Global Health databases. Thirty-seven studies that elicited women's preferences for childbirth and postnatal care using qualitative methods were included in the review. A narrative synthesis was conducted to collate study findings and to report on patterns identified across findings. Results During the intrapartum period, preferences varied across communities, with some studies reporting preferences for traditional childbirth with traditional care-takers, and others reporting preferences for a formal facility-based childbirth with health professionals. During the postpartum period, the majority of relevant studies reported a preference for traditional postnatal services involving traditional rituals and customs. The factors that influenced the reported preferences were related to the perceived need for formal or traditional care providers, accessibility to maternal care, and cultural and religious norms. Conclusion Review findings identified a variety of preferences for sources of maternal care from intrapartum to postpartum. Future interventions aiming to improve access and utilization of evidence-based maternal healthcare services across rural Africa should first identify major challenges and priority needs of target populations and communities through formative research. Evidence-based services that meet rural women's specific needs and expectations will increase the utilization of formal care and ultimately improve maternal outcomes across rural Africa.	[Fantaye, Arone Wondwossen] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Gunawardena, Nathali] McGill Univ, Fac Med, Montreal, PQ, Canada; [Yaya, Sanni] Univ Oxford, George Inst, Oxford, England	University of Ottawa; McGill University; University of Oxford	Yaya, S (corresponding author), Univ Oxford, George Inst, Oxford, England.	sanni.yaya@wrh.ox.ac.uk	Yaya, Sanni/C-1079-2019	Yaya, Sanni/0000-0002-4876-6043; Gunawardena, Nathali/0000-0003-3400-0175				Adedini, 2016, MATERNAL HLTH NIGERI; Adinew YM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3249786; Adinew YM, 2017, J PREGNANCY, V2017, DOI 10.1155/2017/7938371; Ahmed MAA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2027-3; Akpabio II, 2014, HEALTH CARE WOMEN IN, V35, P100, DOI 10.1080/07399332.2013.815751; Al-Mujtaba M., 2016, BioMed Research International, V2016, P3645415; Allou LA, 2018, SCI AFR, V1, DOI 10.1016/j.sciaf.2018.e00010; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Anyait A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-132; Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Bedford J, 2013, MATERN CHILD HLTH J, V17, P230, DOI 10.1007/s10995-012-0965-3; Bhutta AZ, 2010, GLOBAL EXPERIENCE CO; Boutayeb A, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-23; Bree R.T., 2016, ALL IRELAND J HIGHER, V8, DOI [10.1177/1936724416664948, DOI 10.1177/1936724416664948]; Brennan PF, 1998, J AM MED INFORM ASSN, V5, P257, DOI 10.1136/jamia.1998.0050257; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carter MC, 2010, WOMEN HEALTH ISS, V20, pS7, DOI 10.1016/j.whi.2009.11.006; CASP, 2018, CASP QUAL CHECK; Caulfield T, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0333-3; Chea SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194028; Cofie LE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0604-2; Colvin CJ, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0691-8; Crissman Halley P, 2013, Afr J Reprod Health, V17, P15; Dahlberg M, 2015, CULT HEALTH SEX, V17, P326, DOI 10.1080/13691058.2014.955825; De Allegri M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0764-0; Dirksen CD, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-64; Dodzo MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181771; Eckermann E., 2006, HLTH SOCIOLOGY REV, V15, P374, DOI DOI 10.5172/HESR.2006.15.4.374; Ganle JK, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0048-9; Glenton C, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0692-7; Gooberman-Hill R, 2012, PATIENT, V5, P215, DOI 10.2165/11633720-000000000-00000; Hausman DM, 2005, ECON PHILOS, V21, P33, DOI 10.1017/S0266267104000379; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Ibrhim MA, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.51.14420; Igboanugo G. M., 2011, African Journal of Reproductive Health, V15, P63; Institute of Medicine, 2011, CROSSING QUALITY CHA; James PB, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000895; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kea AZ, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1721-5; King R, 2015, MIDWIFERY, V31, P540, DOI 10.1016/j.midw.2015.02.004; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; Kwagala B, 2013, CULT HEALTH SEX, V15, pS401, DOI 10.1080/13691058.2013.799232; Kyei-Nimakoh M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0503-x; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; Larson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135621; Lehtinen A, 2013, J ECON METHODOL, V20, P206, DOI 10.1080/1350178X.2013.804743; Lerberg PM, 2014, AFR J REPROD HEALTH, V18, P35; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mason L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0453-z; Mekonnen Medhanit Getachew, 2012, Pan Afr Med J, V13 Suppl 1, P17; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Munthe-Kaas H, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0690-9; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Ndirima Z, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0530-3; Nilses C, 2002, ACTA OBSTET GYN SCAN, V81, P508, DOI 10.1034/j.1600-0412.2002.810606.x; Noyes J, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0693-6; Okafor IP, 2014, MALAWI MED J, V26, P45; Oneview, 2015, 8 PRINC PAT CTR CAR; Osubor KM, 2006, MATERN CHILD HLTH J, V10, P159, DOI 10.1007/s10995-005-0037-z; Pfeiffer C, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-55; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; Serizawa A, 2014, INT J NURS STUD, V51, P572, DOI 10.1016/j.ijnurstu.2013.08.007; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Sialubanje C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0652-7; Singh J, 2013, J PHARMACOL PHARMACO, V4, P76, DOI 10.4103/0976-500X.107697; Sisay MM, 2014, J MIDWIFERY WOM HEAL, V59, pS110, DOI 10.1111/jmwh.12156; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Tawiah E.O., 2011, AFRICAN POPULATION S, V25; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; Thwala S. B. P., 2012, Evidence Based Midwifery, V10, P101; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; United Nations Statistics Division, UNSD METH; WHO, 2011, PREV EARL PREGN POOR; Wilunda C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-259; Withers M, 2018, MIDWIFERY, V56, P158, DOI 10.1016/j.midw.2017.10.019; World Health Organization, 2019, MATERNAL MORTALITY K	86	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222110	10.1371/journal.pone.0222110	http://dx.doi.org/10.1371/journal.pone.0222110			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553722	gold, Green Published			2022-12-27	WOS:000532319200013
J	Michaelsen, AN; Cleland, CL				Michaelsen, Anya N.; Cleland, Corey L.			Kinematic determinants of scoring success in the fencing flick: Logistic and linear multiple regression analysis	PLOS ONE			English	Article							PERFORMANCE; LUNGE; VELOCITY; TIME	Sport fencing is an open-skilled combat sport practiced around the world. Although previous research addressed kinematics of the lunge and fleche, there are currently no studies on the flick. The flick is a high-level action that involves bending the blade toward the opponent, much like a whip or fly-fishing cast. The aim of our research was to identify the kinematic variables that significantly influence scoring success in two elite foil fencers. In particular, we asked what aspect of the movement each individual fencer can change to improve their likelihood of scoring. Two elite foil fencers of similar skill were instructed to execute flicks at a dummy target that mimicked the opponent's shoulder. High speed video (650 fps) captured the motion of the tip of the foil, blade of the foil, and limb joints; the latter were used to calculate joint angular velocities, hand height and distance throughout the flick. Scoring success was determined with a conventional scoring box. Our results showed that the two fencers exhibited significantly different kinematics, coordination and scoring. Using three complementary regression approaches, we showed that each fencer could improve scoring by changing specific aspects of their kinematics. For fencer A, only improvement in consistency in distance from the target would improve scoring. For fencer B, the changes were more complex. In addition to improvement in consistency in distance, fencer B could also increase (finger, wrist) or decrease (shoulder) joint angular velocity or improve consistency of limb joint angular velocities. Unexpectedly, and in contrast to common coaching practice, hand height had only a weak effect, possibly because both fencers had learnt to keep their hand high at the end of the action. In summary, our results emphasize that coaching of elite fencers should be individualized.	[Michaelsen, Anya N.; Cleland, Corey L.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	James Madison University	Cleland, CL (corresponding author), James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA.	clelancl@jmu.edu						Aquili A, 2013, J STRENGTH COND RES, V27, P624, DOI 10.1519/JSC.0b013e318257803f; Barth B, 2007, COMPLETE GUIDE FENCI; Bauchmoyer SL, 1975, INT S BIOM SPORTS, P1; Bottoms L, 2013, ACTA BIOENG BIOMECH, V15, P109, DOI 10.5277/abb130414; Chen TLW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171578; Cronin J, 2003, J SPORT SCI, V21, P49, DOI 10.1080/0264041031000070958; Garret MR, 1994, FOIL SABER EPEE FENC; Gholipour M, 2008, WORLD J SPORT SCI, V1, P32; Goriely A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.244301; Green W., 2016, DISTINGUISHING CHARA; Greenhalgh A, 2013, J APPL BIOMECH, V29, P463, DOI 10.1123/jab.29.4.463; Gresham-Fiegel CN, 2013, J STRENGTH COND RES, V27, P57, DOI 10.1519/JSC.0b013e31824e0e9d; Guan YF, 2018, EUR J SPORT SCI, V18, P201, DOI 10.1080/17461391.2017.1414886; Gutierrez-Cruz C, 2016, J SPORT SCI, V34, P651, DOI 10.1080/02640414.2015.1068434; Gutierrez-Davila M, 2017, EUR J SPORT SCI, V17, P1004, DOI 10.1080/17461391.2017.1332100; Handelman R., 2010, FENCING PRACTICAL GU; Harmenberg J, 1991, AGE, V23, P21, DOI [10.1055/s-2007-1024736, DOI 10.1055/S-2007-1024736]; Harmer PA, 2008, CURR SPORT MED REP, V7, P303, DOI 10.1249/JSR.0b013e318187083b; Inouye JM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004737; Klinger A, 1985, EFFECT PRELUNGE COND; Murgu Andreia-Ileana, 2006, Phys Med Rehabil Clin N Am, V17, P725, DOI 10.1016/j.pmr.2006.05.008; ROBSON JM, 1990, AM J PHYS, V58, P234, DOI 10.1119/1.16191; Roi GS, 2008, SPORTS MED, V38, P465, DOI 10.2165/00007256-200838060-00003; Sapega A A, 1978, Am J Sports Med, V6, P232, DOI 10.1177/036354657800600504; Sinclair J, 2019, SCI SPORT, V34, pE31, DOI 10.1016/j.scispo.2018.05.005; Sinclair J, 2015, RES SPORTS MED, V23, P51, DOI 10.1080/15438627.2014.975813; Sinclair J, 2015, CENT EUR J SPORT SCI, V11, P39, DOI [10.18276/cej.2015.3-04, DOI 10.18276/CEJ.2015.3-04]; Sinclair J, 2010, SPORT BIOMECH, V9, P65, DOI 10.1080/14763141.2010.491161; Sinclair JK, 2014, BALT J HEALTH PHYS A, V6, P199, DOI 10.2478/bjha-2014-0018; SINGER RN, 1968, RES QUART, V39, P1080, DOI 10.1080/10671188.1968.10613465; STEWART K J, 1977, Journal of Human Ergology, V6, P53; Turner A, 2014, J STRENGTH COND RES, V28, P3001, DOI 10.1519/JSC.0000000000000478; Williams L R, 2000, J Sci Med Sport, V3, P460, DOI 10.1016/S1440-2440(00)80011-0; Wylde MJ, 2013, INT J PERF ANAL SPOR, V13, P365; Zhang B., 1999, P ISBS C P ARCHIVE; Zhang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16282	36	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222075	10.1371/journal.pone.0222075	http://dx.doi.org/10.1371/journal.pone.0222075			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553734	Green Published, gold			2022-12-27	WOS:000532319200012
J	Triggiani, AI; Valenzano, A; Trimigno, V; Di Palma, A; Moscatelli, F; Cibelli, G; Messina, G				Triggiani, Antonio Ivano; Valenzano, Anna; Trimigno, Valentina; Di Palma, Antonella; Moscatelli, Fiorenzo; Cibelli, Giuseppe; Messina, Giovanni			Heart rate variability reduction is related to a high amount of visceral adiposity in healthy young women	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; BODY-MASS INDEX; RESPIRATORY SINUS ARRHYTHMIA; POWER SPECTRAL-ANALYSIS; OBESITY INDEXES; RISK-FACTORS; FAT; WEIGHT; AGE; ASSOCIATION	Several heart rate variability (HRV) studies show abnormalities in autonomic nervous control in obese and overweight subjects. However, some of the results appear to be controversial. Here we investigate the HRV profile in seventy adult normotensive women and its association with general and visceral adiposity. Specifically, we recorded the electrocardiographic (ECG) activity in subjects during a supine resting state for five minutes in a quiet room late in the morning. Total fat mass (TFM) and visceral adipose tissue (VAT) were instead estimated using dual-energy X-ray absorptiometry (DXA). Finally, we used simple a linear regression analysis of frequency and time-domain parameters to study the relationship between HRV and adiposity. Our data showed an overall reduction of the HRV related to an increase of TFM although this regression appeared significant only for high frequencies (HF). When the linear regression was applied between HRV variables and VAT, the slope of the line increases, thus unveiling a statistically significant relation (i.e. the more VAT, the lower HRV). Finally, a control analysis showed that age does not alter the relation between HRV and VAT when used as a confounding factor in multiple regression. To conclude, these findings point to abnormal activity of the autonomic nervous system (ANS) in subjects with an excess of VAT and represent a starting point to determine a non-invasive index of cardiac wellness for clinical and nutritional application.	[Triggiani, Antonio Ivano; Valenzano, Anna; Trimigno, Valentina; Di Palma, Antonella; Moscatelli, Fiorenzo; Cibelli, Giuseppe; Messina, Giovanni] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy	University of Foggia	Triggiani, AI (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.	ivano.triggiani@unifg.it	Triggiani, Antonio Ivano/M-6252-2015; triggiani, antonio ivano/Q-4701-2019; Messina, Giovanni/AAE-8668-2022; Moscatelli, Fiorenzo/ABC-9536-2020	triggiani, antonio ivano/0000-0003-3291-9452; Messina, Giovanni/0000-0002-0011-867X; Moscatelli, Fiorenzo/0000-0003-1274-0332; CIBELLI, GIUSEPPE/0000-0002-5371-2584				Acharya UR, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-24; Amano M, 2001, MED SCI SPORT EXER, V33, P1287, DOI 10.1097/00005768-200108000-00007; [Anonymous], 1996, HEART RAT VAR STAND; Antelmi I, 2004, AM J CARDIOL, V93, P381, DOI 10.1016/j.amjcard.2003.09.065; Aytemir K, 2000, PACE, V23, P975, DOI 10.1111/j.1540-8159.2000.tb00883.x; Berthoud HR, 2008, REGUL PEPTIDES, V149, P15, DOI 10.1016/j.regpep.2007.08.024; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Chen GY, 2008, CLIN NUTR, V27, P212, DOI 10.1016/j.clnu.2007.11.004; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Dietrich DF, 2008, EUR J APPL PHYSIOL, V104, P557, DOI 10.1007/s00421-008-0800-0; Dordevic AL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101484; Dudina A, 2011, EUR J CARDIOV PREV R, V18, P731, DOI 10.1177/1741826711412039; Emdin M, 2001, CIRCULATION, V103, P513, DOI 10.1161/01.CIR.103.4.513; FREEMAN R, 1995, CLIN AUTON RES, V5, P261, DOI 10.1007/BF01818890; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Hillebrand S, 2014, OBESITY, V22, P1553, DOI 10.1002/oby.20709; Kang SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027694; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Kim JA, 2005, J AM BOARD FAM PRACT, V18, P97, DOI 10.3122/jabfm.18.2.97; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Laederach-Hofmann K, 2000, J ENDOCRINOL, V164, P59, DOI 10.1677/joe.0.1640059; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR382, DOI 10.1152/ajpregu.1999.276.2.R382; Mazurak N, 2011, EUR EAT DISORD REV, V19, P87, DOI 10.1002/erv.1081; Meredith-Jones K, 2018, OBESITY, V26, P505, DOI 10.1002/oby.22108; Miazgowski T, 2014, ENDOCRINE, V47, P500, DOI 10.1007/s12020-014-0180-7; Millis RM, 2010, LIFE SCI, V86, P153, DOI 10.1016/j.lfs.2009.11.018; Molfino A, 2009, EUR J CLIN NUTR, V63, P1263, DOI 10.1038/ejcn.2009.35; Nagai N, 2003, OBES RES, V11, P25, DOI 10.1038/oby.2003.6; Narayanaswamy Nikhil, 2013, ISRN Cardiol, V2013, P858921, DOI 10.1155/2013/858921; Penicaud L, 2000, NUTRITION, V16, P903, DOI 10.1016/S0899-9007(00)00427-5; Piccirillo G, 1996, INT J OBESITY, V20, P825; Poliakova N, 2012, METABOLISM, V61, P1270, DOI 10.1016/j.metabol.2012.02.006; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; Rastovic M, 2017, NUTR DIET, V74, P51, DOI 10.1111/1747-0080.12280; Rothney MP, 2012, J CLIN DENSITOM, V15, P399, DOI 10.1016/j.jocd.2012.02.009; Sekine M, 2001, Environ Health Prev Med, V6, P149, DOI 10.1007/BF02897962; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Sheema U. K., 2015, National Journal of Physiology, Pharmacy and Pharmacology, V5, P250; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; SPRAUL M, 1993, J CLIN INVEST, V92, P1730, DOI 10.1172/JCI116760; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Triggiani AI, 2016, INT J PSYCHOPHYSIOL, V103, P79, DOI 10.1016/j.ijpsycho.2015.02.009; Triggiani AI, 2017, CLIN PHYSIOL FUNCT I, V37, P162, DOI 10.1111/cpf.12281; Yadav RL, 2017, DIABET METAB SYND OB, V10, P57, DOI 10.2147/DMSO.S123935; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001	51	15	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223058	10.1371/journal.pone.0223058	http://dx.doi.org/10.1371/journal.pone.0223058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553779	Green Published, gold			2022-12-27	WOS:000532319200051
J	Zongo, A; Simpson, S; Johnson, JA; Eurich, DT				Zongo, Arsene; Simpson, Scot; Johnson, Jeffrey A.; Eurich, Dean T.			Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; RISK; METAANALYSIS; PREVENTION	Objective Thresholds defining medication adherence are rarely evidence-based. A threshold of 0.8 is typically presumed to achieve improved outcomes. We aimed to assess the optimal threshold of adherence to lipid-lowering drugs (LLD) in predicting cardiovascular-related (CV) outcomes in patients with hypertension. Design Cohort study of new users of LLDs. Setting Comprehensive healthcare administrative databases of the province of Alberta (Canada) from 2008 to 2016. Participants Patients with hypertension, who were new users of LLDs. Patients who had the outcomes prior to the initiation of LLD were excluded. Main outcomes measures Hospitalization for acute coronary syndrome (ACS)/stroke, CV-related mortality and all-sscause mortality. Statistical analysis Adherence to LLDs was assessed as the proportion of days covered (PDC) by any LLD, from drug initiation to censoring, outcome, or study end. Three methods were used to assess the threshold: Contal and O'Quigley method, minimum distance method, and Youden's J index. Cox regressions were used to assess the risk associated with each method-specific threshold and Akaike information criteria were used to retain the optimal threshold after adjustment. Results 52229 patients were included; 4.0% were hospitalized for ACS/stroke, 3.4% died, and 1.3% died from CV-related cause. In predicting ACS/stroke, CV-related and all-cause mortality, the optimal adherence threshold was 0.52 (range: 0.51-0.54), 0.79 (0.45-0.87), and 0.84 (0.79-0.89), respectively. These results were consistent among patients aged >= 65 years (n = 19804). However, the results varied among those aged < 65 years, where the incidence rates of outcomes were low. Conclusion In new-users of LLDs with hypertension, approximately 50% days covered by LLDs may be enough to prevent long-term occurrence of ACS, or stroke. However, a threshold near 0.80 may be needed to prevent or reduce the risk of all-cause or CV-related mortality.	[Zongo, Arsene; Johnson, Jeffrey A.; Eurich, Dean T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zongo, Arsene] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Zongo, Arsene] CHU Quebec Univ Laval Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Simpson, Scot] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada	University of Alberta; Laval University; University of Alberta	Eurich, DT (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	deurich@ualberta.ca	Zongo, Arsene/AAC-3790-2020	Zongo, Arsene/0000-0001-8812-3088	Institute of Health Economics; Government of Canada	Institute of Health Economics; Government of Canada(CGIAR)	This work was supported by a grant from the Institute of Health Economics. DTE is a Canada Research Chair supported by the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Banach M, 2016, INT J CARDIOL, V225, P184, DOI 10.1016/j.ijcard.2016.09.075; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Corella D, 2014, AGEING RES REV, V18, P53, DOI 10.1016/j.arr.2014.08.002; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Indrayan A., 2012, MED BIOSTATISTICS, P1008; Karve S, 2009, CURR MED RES OPIN, V25, P2303, DOI 10.1185/03007990903126833; Lo-Ciganic WH, 2015, MED CARE, V53, P720, DOI 10.1097/MLR.0000000000000394; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mandrekar JN, 2003, P 28 SAS US GROUP IN; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Mrekar J.N., CUTPOINT DETERMINATI; Naci H, 2013, EUR J PREV CARDIOL, V20, P641, DOI 10.1177/2047487313480435; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; O'Donnel CJ, 2008, REV ESP CARDIOL, V61, P299, DOI 10.1016/S1885-5857(08)60118-8; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; SACKETT DL, 1975, LANCET, V1, P1205; Stewart J, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004016687211; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Toms JD, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00715-100102	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223062	10.1371/journal.pone.0223062	http://dx.doi.org/10.1371/journal.pone.0223062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553787	Green Published, gold			2022-12-27	WOS:000532319200052
J	Van Hedger, SC; Heald, SLM; Nusbaum, HC				Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.			Absolute pitch can be learned by some adults	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; CRITICAL PERIOD; WORKING-MEMORY; STUDENTS; MUSIC; IDENTIFICATION; AMERICAN; JUDGMENT; CHILDREN	Absolute pitch (AP), the rare ability to name any musical note without the aid of a reference note, is thought to depend on an early critical period of development. Although recent research has shown that adults can improve AP performance in a single training session, the best learners still did not achieve note classification levels comparable to performance of a typical, "genuine" AP possessor. Here, we demonstrate that these "genuine" levels of AP performance can be achieved within eight weeks of training for at least some adults, with the best learner passing all measures of AP ability after training and retaining this knowledge for at least four months after training. Alternative explanations of these positive results, such as improving accuracy through adopting a slower, relative pitch strategy, are not supported based on joint analyses of response time and accuracy. The results also did not appear to be driven by extreme familiarity with a single instrument or octave range, as the post-training AP assessments used eight different timbres and spanned over seven octaves. Yet, it is also important to note that a majority of the participants only exhibited modest improvements in performance, suggesting that adult AP learning is difficult and that near-perfect levels of AP may only be achievable by subset of adults. Overall, these results demonstrate that explicit perceptual training in some adults can lead to AP performance that is behaviorally indistinguishable from AP that manifests within a critical period of development. Implications for theories of AP acquisition are discussed.	[Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Van Hedger, SC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.; Van Hedger, SC (corresponding author), Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA.	svanhedg@uwo.ca	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088				Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bahr N., 2005, PSYCHOL MUSIC, V33, P58, DOI [10.1177/0305735605048014, DOI 10.1177/0305735605048014]; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; BRADY PT, 1970, J ACOUST SOC AM, V48, P883, DOI 10.1121/1.1912227; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Crozier J.B., 1997, PSYCHOL MUSIC, V25, P110, DOI DOI 10.1177/0305735697252002; CUDDY LL, 1968, J ACOUST SOC AM, V43, P1069, DOI 10.1121/1.1910941; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2013, J ACOUST SOC AM, V134, P3853, DOI 10.1121/1.4824450; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P141, DOI 10.1016/B978-0-12-381460-9.00005-5; Deutsch D, 2013, J ACOUST SOC AM, V133, P1859, DOI 10.1121/1.4792217; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Dohn A, 2014, MUSIC PERCEPT, V31, P359, DOI 10.1525/MP.2014.31.4.359; Gervain J., 2013, FRONT SYST NEUROSCI, V7, P1; HARTMAN EB, 1954, AM J PSYCHOL, V67, P1, DOI 10.2307/1418067; Heald S. L., 2014, FRONTIERS SYSTEMS NE, V8, P1, DOI DOI 10.3389/FNINS.2014; Heald SLM, 2017, PSYCHOL LEARN MOTIV, V67, P53, DOI 10.1016/bs.plm.2017.03.003; Hedger SC, 2013, PSYCHOL SCI, V24, P1496, DOI 10.1177/0956797612473310; HELLER MA, 1972, PSYCHON SCI, V26, P222; Levitin DJ, 2003, MUSIC PERCEPT, V21, P105, DOI 10.1525/mp.2003.21.1.105; Lundin R., 1963, MUSIC EDUC J, V49, P49, DOI [10.2307/3389949, DOI 10.2307/3389949]; Macmillan NA., 1991, DETECTION THEORY USE; Marsman M, 2017, EUR J DEV PSYCHOL, V14, P545, DOI 10.1080/17405629.2016.1259614; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Miyazaki K, 2006, MUSIC PERCEPT, V24, P63, DOI 10.1525/mp.2006.24.1.63; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ross DA, 2005, EPILEPSY BEHAV, V7, P578, DOI 10.1016/j.yebeh.2005.05.019; Ross DA, 2004, J ACOUST SOC AM, V116, P1793, DOI 10.1121/1.1758973; Ross DA, 2009, ANN NY ACAD SCI, V1169, P199, DOI 10.1111/j.1749-6632.2009.04847.x; Rush M., 1989, EXPT INVESITAGTION E, P401; Russo FA, 2003, MUSIC PERCEPT, V21, P119, DOI 10.1525/mp.2003.21.1.119; Smith NA, 2008, J ACOUST SOC AM, V123, pEL77, DOI 10.1121/1.2896106; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Van Hedger SC, 2018, ACTA PSYCHOL, V191, P251, DOI 10.1016/j.actpsy.2018.10.007; Van Hedger SC, 2018, J EXP PSYCHOL HUMAN, V44, P1268, DOI 10.1037/xhp0000536; Van Hedger SC, 2018, Q J EXP PSYCHOL, V71, P879, DOI 10.1080/17470218.2017.1307427; Van Hedger SC, 2017, PSYCHON B REV, V24, P481, DOI 10.3758/s13423-016-1099-1; Van Hedger SC, 2016, COGNITION, V154, P139, DOI 10.1016/j.cognition.2016.06.001; Van Hedger SC, 2015, J ACOUST SOC AM, V138, P436, DOI 10.1121/1.4922952; Van Hedger SC, 2015, COGNITION, V140, P95, DOI 10.1016/j.cognition.2015.03.012; VIANELLO MA, 1968, PERCEPT MOTOR SKILL, V26, P576, DOI 10.2466/pms.1968.26.2.576; Vitouch O, 2003, MUSIC PERCEPT, V21, P111, DOI 10.1525/mp.2003.21.1.111; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Wong YK, 2018, ACQUIRING ABSOLUTE P, DOI [10.1101/355933, DOI 10.1101/355933]	50	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223047	10.1371/journal.pone.0223047	http://dx.doi.org/10.1371/journal.pone.0223047			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JC2ZT	31550277	Green Submitted, Green Published, gold			2022-12-27	WOS:000489146900001
J	Luo, JF; Deng, DZ; Zhang, L; Zhu, XW; Chen, DC; Zhou, JX				Luo, Jiufu; Deng, Dongzhou; Zhang, Li; Zhu, Xinwei; Chen, Dechao; Zhou, Jinxing			Soil and vegetation conditions changes following the different sand dune restoration measures on the Zoige Plateau	PLOS ONE			English	Article							PLANT FUNCTIONAL TYPES; COMMUNITY COMPOSITION; DESERTIFICATION; COMPETITION; SUCCESSION; NITROGEN; STABILIZATION; DEGRADATION; AMENDMENTS; STRATEGIES	Alpine sand dunes restoration is extremely difficult but important in the ecosystem restoration. Sand dunes are known as harsh soil and poor seed bank which freed from advantages on plants growth naturally. Effective restoration measures are required to guide the sand dune restoration. Here, indigenous grass (Elymus nutans) was sown in sand dune on the Zoige Plateau and treated with no sand barrier (CK) and environmental friendly materials including wicker sand barrier (wicker) and sandbag sand barrier (sandbag). The soil conditions were assessed by measuring the soil moisture and nutrients of the topsoil, and interspecific relationship and population niche were utilized to analyze the plant community structure variances among different restoration measures. Results showed that the soil and vegetation in the sand barriers measures were better than that in the CK. The soil moisture in the sandbag measure was 16.67% higher than that in the wicker measure. The nutrients content and microbial biomass were also the best in the sandbag measures. The ratio of strong association was the highest in the sandbag measure and the lowest in the CK, whereas the plants had the highest none association ratio in the CK. In addition, the average population niche overlap ranked by sandbag (0.39)> wicker (0.32)> CK (0.26). Thus, incorporation of sand barriers and indigenous grass seeding in alpine sand dunes could promote the sand dune restoration. And the sandbag measure showed a stronger improvement effect on the sand dune soil and vegetation conditions than the wicker measure.	[Luo, Jiufu; Zhou, Jinxing] Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China; [Luo, Jiufu; Zhou, Jinxing] Beijing Forestry Univ, Jianshui Res Field Stn, Beijing, Peoples R China; [Deng, Dongzhou; Chen, Dechao] Sichuan Acad Forestry, Chengdu, Peoples R China; [Zhang, Li; Zhu, Xinwei] Sichuan Aba Forestry Sci & Technol Res Inst, Wenchuan, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhou, JX (corresponding author), Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China.; Zhou, JX (corresponding author), Beijing Forestry Univ, Jianshui Res Field Stn, Beijing, Peoples R China.	zjx001@bjfu.edu.cn	Jinxing, Zhou/I-6015-2017	Jinxing, Zhou/0000-0003-2182-9849	Special Fund for Forest Scientific Research in the Public Welfare [201504401]; National Science & Technology Pillar Program [2015BAC05B01]; Sichuan Province Science and Technology Support Program [2016FZ0042]; Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan [2019CZZX24]	Special Fund for Forest Scientific Research in the Public Welfare; National Science & Technology Pillar Program; Sichuan Province Science and Technology Support Program; Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan	This study was funded by the Special Fund for Forest Scientific Research in the Public Welfare (no. 201504401), the National Science & Technology Pillar Program (no. 2015BAC05B01), Sichuan Province Science and Technology Support Program (no. 2016FZ0042), and the Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan (no. 2019CZZX24).	Abd El-Salam MM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5164-z; Alvarez-Yepiz JC, 2014, OECOLOGIA, V175, P725, DOI 10.1007/s00442-014-2929-3; Anthwal Smriti, 2008, Environmentalist, V28, P261, DOI 10.1007/s10669-007-9137-1; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Bewick S, 2015, THEOR ECOL-NETH, V8, P81, DOI 10.1007/s12080-014-0227-7; Breckle SW, 2008, ARID DUNE ECOSYSTEMS, P79; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Chauhan S. S., 2003, Environmentalist, V23, P219, DOI 10.1023/B:ENVR.0000017366.67642.79; Chen Yan-Rui, 2008, Zhiwu Shengtai Xuebao, V32, P1126, DOI 10.3773/j.issn.1005-264x.2008.05.017; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; de Santiago A, 2019, LAND DEGRAD DEV, V30, P1121, DOI 10.1002/ldr.3298; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Dietterich LH, 2017, RESTOR ECOL, V25, P201, DOI 10.1111/rec.12423; Dong ZB, 2010, ENVIRON EARTH SCI, V59, P1731, DOI 10.1007/s12665-009-0155-9; Fan BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168000; Fan DQ, 2017, J FORESTRY RES, V28, P115, DOI 10.1007/s11676-016-0289-z; Gao JQ, 2014, WETLANDS, V34, P235, DOI 10.1007/s13157-013-0487-9; Gong Rong, 2016, Chinese Journal of Plant Ecology, V40, P554, DOI 10.17521/cjpe.2015.0446; Harpole WS, 2011, OECOLOGIA, V166, P197, DOI 10.1007/s00442-010-1808-9; Hu YF, 2016, ECOL ENG, V94, P88, DOI 10.1016/j.ecoleng.2016.05.061; [姜鑫贵 Jiang Xingui], 2016, [林业科学, Scientia Silvae Sinicae], V52, P55; Kong YangYun, 2017, Acta Prataculturae Sinica, V26, P44; Kuster TM, 2016, PLANT SOIL, V406, P117, DOI 10.1007/s11104-016-2856-7; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; LI YQ, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9040662; Lian J, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020211; Liao ChengRui, 2018, Journal of Nanjing Forestry University (Natural Sciences Edition), V42, P89; Lichter J, 2000, J ECOL, V88, P825, DOI 10.1046/j.1365-2745.2000.00503.x; [林丽 Lin Li], 2012, [中国草地学报, Chinese Journal of Grassland], V34, P42; Lou Yan-jing, 2008, Shengtaixue Zazhi, V27, P509; Ma Kun, 2016, Shengtaixue Zazhi, V35, P1988, DOI 10.13292/j.1000-4890.201608.010; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nemoto M, 1997, ECOL RES, V12, P325, DOI 10.1007/BF02529462; Odriozola I, 2017, PERSPECT PLANT ECOL, V28, P36, DOI 10.1016/j.ppees.2017.07.002; Ohsowski BM, 2018, RESTOR ECOL, V26, P63, DOI 10.1111/rec.12528; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Pontes LD, 2015, AGRON SUSTAIN DEV, V35, P1297, DOI 10.1007/s13593-015-0314-1; Qing Ye, 2015, Acta Prataculturae Sinica, V24, P38; Raji BA, 2004, ENVIRON MONIT ASSESS, V99, P181, DOI 10.1007/s10661-004-4018-2; Roze F, 2004, RESTOR ECOL, V12, P29, DOI 10.1111/j.1061-2971.2004.00264.x; Shen ST, 2017, J MT SCI-ENGL, V14, P2003, DOI 10.1007/s11629-016-4133-x; [税伟 Shui Wei], 2017, [生态学报, Acta Ecologica Sinica], V37, P277; Wang T, 2002, SCI CHINA SER D, V45, P23, DOI 10.1007/BF02878385; Wei YJ, 2017, J INNER MONGOLIA AGR, V6, P86; Wu F, 2018, J INTEGR ENVIRON SCI, V15, P139, DOI 10.1080/1943815X.2018.1471725; [谢胜波 Xie Shengbo], 2014, [中国沙漠, Journal of Desert Research], V34, P42; Yan QL, 2005, PLANT SOIL, V277, P175, DOI 10.1007/s11104-005-6836-6; Yang TT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198805; Yu KF, 2017, J MT SCI-ENGL, V14, P77, DOI 10.1007/s11629-016-3929-z; [于洋 Yu Yang], 2014, [中国沙漠, Journal of Desert Research], V34, P67; [袁立敏 Yuan Limin], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P46; Zhang ZH, 2010, ECOL RES, V25, P1151, DOI 10.1007/s11284-010-0740-0; Zhao JZ, 2002, INT J SUST DEV WORLD, V9, P292, DOI 10.1080/13504500209470124; Zou Chang-xin, 2018, Journal of Ecology and Rural Environment, V34, P961, DOI 10.11934/j.issn.1673-4831.2018.11.001	57	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0216975	10.1371/journal.pone.0216975	http://dx.doi.org/10.1371/journal.pone.0216975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539377	Green Submitted, Green Published, gold			2022-12-27	WOS:000532297900004
J	Marinho-Neto, FA; Claudiano, GS; Yunis-Aguinaga, J; Cueva-Quiroz, VA; Kobashigawa, KK; Cruz, NRN; Moraes, FR; Moraes, JRE				Marinho-Neto, Fausto A.; Claudiano, Gustavo S.; Yunis-Aguinaga, Jefferson; Cueva-Quiroz, Victor A.; Kobashigawa, Karina K.; Cruz, Nathan R. N.; Moraes, Flavio R.; Moraes, Julieta R. E.			Morphological, microbiological and ultrastructural aspects of sepsis by Aeromonas hydrophila in Piaractus mesopotamicus	PLOS ONE			English	Article							LACTOCOCCUS-GARVIEAE INFECTION; ANTIBIOTIC SUSCEPTIBILITY; VIRULENCE FACTORS; L.; ASSOCIATION; ENTEROTOXIN; PREVALENCE; ZEBRAFISH; GENES; EELS	Aeromonas bacteria can cause an infection characterized by septicemia and is one of the most common pathogens in tropical fish. This disease is responsible for high morbidity and mortality rates, causing considerable losses in aquaculture. Thus, the understanding of its pathophysiology is crucial to develop control strategies of this bacterial infection in farmed fish. This study aimed to characterize early pathological aspects of acute sepsis in pacu (Piaractus mesopotamicus) experimentally infected with Aeromonas hydrophila. A total of 160 juvenile pacus were inoculated intraperitoneally with A. hydrophila (1.78 x 10(9) CFU/mL) and at 0 (control), 1, 3, 6, and 9 hours post-inoculation (hpi), animals were anesthetized and samples were collected for microbiological, light microscopy and transmission electron microscopy (TEM) analyzes. The results showed the occurrence of hemodynamic alterations, such as hemorrhage and congestion, which were observed mainly after 6 and 9 hpi. It was possible to re-isolate Aeromonas at all sampling times except in control group. However, just after 9 hpi it was possible to find the bacteria in all fish and tissues. Light microscopy analyses revealed a degenerative process, necrosis and vascular damage mainly at 6 and 9 hpi. According to the ultrastructural examination, areas of cellular death were identified in all examined tissues, especially at 6 and 9 hpi. However, the most severe, related to necrosis, were observed after 6 and 9 hpi. The findings suggested that this bacterium spreads in the first hpi through the fish organs, mainly affecting spleen, liver and kidney, causing irreversible lesions at the molecular level.	[Marinho-Neto, Fausto A.; Claudiano, Gustavo S.; Cruz, Nathan R. N.; Moraes, Flavio R.; Moraes, Julieta R. E.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Pathol, Jaboticabal, SP, Brazil; [Claudiano, Gustavo S.] Fed Univ Western Para UFOPA, Inst Biodivers & Forests, Santarem, Para, Brazil; [Yunis-Aguinaga, Jefferson; Cueva-Quiroz, Victor A.; Moraes, Flavio R.; Moraes, Julieta R. E.] Aquaculture Ctr UNESP, Jaboticabal, SP, Brazil; [Kobashigawa, Karina K.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Surg & Clin, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Federal do Oeste do Para; Universidade Estadual Paulista	Moraes, JRE (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Pathol, Jaboticabal, SP, Brazil.; Moraes, JRE (corresponding author), Aquaculture Ctr UNESP, Jaboticabal, SP, Brazil.	julietaengracia@gmail.com	MORAES, JULIETA/AAC-3365-2019; Quiroz, Victor Alexander Alexander Cueva/T-7913-2017; Moraes, Julieta R. E./L-8484-2017; da Silva Claudiano, Gustavo/AAQ-5730-2020; Yunis Aguinaga, Jefferson/M-9808-2016	MORAES, JULIETA/0000-0002-8384-8781; Quiroz, Victor Alexander Alexander Cueva/0000-0002-9793-9297; Moraes, Julieta R. E./0000-0002-8384-8781; da Silva Claudiano, Gustavo/0000-0002-5063-9123; Yunis Aguinaga, Jefferson/0000-0002-1959-4350	Sao Paulo State Research Support Foundation - FAPESP [2014/10231-2, 2011/20280-2]; National Council for Scientific and Technological Development - CNPq [441054/2014-5]	Sao Paulo State Research Support Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful for the support of the Sao Paulo State Research Support Foundation - FAPESP projects no 2014/10231-2 and 2011/20280-2 and the National Council for Scientific and Technological Development - CNPq process 441054/2014-5). All grants were awarded to JREM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Aguado-Urda M, 2014, VET MICROBIOL, V171, P248, DOI 10.1016/j.vetmic.2014.03.029; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; Aoki T., 2011, FISH DIS DISORDERS V, P427; Avci H, 2014, J FISH DIS, V37, P481, DOI 10.1111/jfd.12132; Bancroft JD, 2018, THEORY PRACTICE HIST, V8th; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Borchardt MA, 2003, EMERG INFECT DIS, V9, P224; Boyd C.E., 2018, WATER TEMPERATURE AQ; Carraschi SP, 2012, ECOTOX ENVIRON SAFE, V83, P115, DOI 10.1016/j.ecoenv.2012.06.016; Carriero MM, 2016, J FISH DIS, V39, P1285, DOI 10.1111/jfd.12457; Chong RSM, 2015, J FISH DIS, V38, P839, DOI 10.1111/jfd.12293; Chopra AK, 1999, MICROBES INFECT, V1, P1129, DOI 10.1016/S1286-4579(99)00202-6; Chopra AK, 2000, INFECT IMMUN, V68, P2808, DOI 10.1128/IAI.68.5.2808-2818.2000; Claudiano GS, 2019, FISH SHELLFISH IMMUN, V88, P259, DOI 10.1016/j.fsi.2019.01.044; Cyrino JEP, 2004, TOPICOS ESPECIAIS PI, P343; Cyrino JEP, 2004, TOPICOS ESPECIAISEM, P533; Failde LD, 2013, MICROB PATHOGENESIS, V65, P82, DOI 10.1016/j.micpath.2013.09.003; Das A, 2011, VET IMMUNOL IMMUNOP, V142, P207, DOI 10.1016/j.vetimm.2011.05.017; DEODHAR LP, 1991, J CLIN MICROBIOL, V29, P853, DOI 10.1128/JCM.29.5.853-856.1991; Durigan JG, 1994, REV UNIMAR, V16, P229; El Aamri F, 2015, VET PATHOL, V52, P209, DOI 10.1177/0300985814520638; FAO, 2016, CONTRIBUTING FOOD SE; Farto R, 2011, DIS AQUAT ORGAN, V95, P167, DOI 10.3354/dao02342; Fichi G, 2013, J FISH DIS, V36, P823, DOI 10.1111/jfd.12048; Garcia-Leme J., 1989, HORMONES INFLAMMATIO; Gudmundsdottir BK, 2014, J FISH DIS, V37, P511, DOI 10.1111/jfd.12139; Holliman A., 1993, Aquaculture for veterinarians: fish husbandry and medicine., P223; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lowry R, 2014, ADV MICROB PHYSIOL, V65, P203, DOI 10.1016/bs.ampbs.2014.08.007; Matsuyama T, 2001, FISH SHELLFISH IMMUN, V11, P549, DOI 10.1006/fsim.2000.0332; McDaniel D., 1979, PROCEDURES DETECTION; Monaghan SJ, 2015, J FISH DIS, V38, P477, DOI 10.1111/jfd.12260; Rantin FT, 1998, COMP BIOCHEM PHYS A, V119, P991, DOI 10.1016/S1095-6433(98)00016-6; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Robbins S.L., 2005, PATOLOGIA ROBBINS CO, V23, P482; Roberts RJ., 2012, FISH PATHOL, V4, DOI [10.1002/9781118222942, DOI 10.1002/9781118222942]; Salimon J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-429; Salles M J, 1999, Rev Assoc Med Bras (1992), V45, P86, DOI 10.1590/S0104-42301999000100015; Sarkar A., 2012, J AQUACULT RES DEV, V3, P2, DOI [10.4172/2155-9546.1000146, DOI 10.4172/2155-9546.1000146]; Scoaris DD, 2008, ANTON LEEUW INT J G, V93, P111, DOI 10.1007/s10482-007-9185-z; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; SHOTTS E B, 1985, Fish Pathology, V20, P37; Sinha S, 2004, J MED MICROBIOL, V53, P527, DOI 10.1099/jmm.0.05269-0; Suanyuk N, 2014, J FISH DIS, V37, P385, DOI 10.1111/jfd.12127; Suhet MI, 2011, THESIS; Valiente E, 2008, MICROB PATHOGENESIS, V45, P386, DOI 10.1016/j.micpath.2008.09.001; Vilches S, 2004, APPL ENVIRON MICROB, V70, P6914, DOI 10.1128/AEM.70.11.6914-6919.2004; Wong CYF, 1998, MICROBIOL-SGM, V144, P291, DOI 10.1099/00221287-144-2-291	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222626	10.1371/journal.pone.0222626	http://dx.doi.org/10.1371/journal.pone.0222626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539396	Green Published, gold			2022-12-27	WOS:000532297900020
J	Clark, DP; Holbrook, M; Lee, CL; Badea, CT				Clark, Darin P.; Holbrook, Matthew; Lee, Chang-Lung; Badea, Cristian T.			Photon-counting cine-cardiac CT in the mouse	PLOS ONE			English	Article							DUAL-ENERGY CT; COMPUTED-TOMOGRAPHY; RECONSTRUCTION; MICE; DIFFERENTIATION	The maturation of photon-counting detector (PCD) technology promises to enhance routine CT imaging applications with high-fidelity spectral information. In this paper, we demonstrate the power of this synergy and our complementary reconstruction techniques, performing 4D, cardiac PCD-CT data acquisition and reconstruction in a mouse model of atherosclerosis, including calcified plaque. Specifically, in vivo cardiac micro-CT scans were performed in four ApoE knockout mice, following their development of calcified plaques. The scans were performed with a prototype PCD (DECTRIS, Ltd.) with 4 energy thresholds. Projections were sampled every 10 ms with a 10 ms exposure, allowing the reconstruction of 10 cardiac phases at each of 4 energies (40 total 3D volumes per mouse scan). Reconstruction was performed iteratively using the split Bregman method with constraints on spectral rank and spatio-temporal gradient sparsity. The reconstructed images represent the first in vivo, 4D PCD-CT data in a mouse model of atherosclerosis. Robust regularization during iterative reconstruction yields high-fidelity results: an 8-fold reduction in noise standard deviation for the highest energy threshold (relative to unregularized algebraic reconstruction), while absolute spectral bias measurements remain below 13 Hounsfield units across all energy thresholds and scans. Qualitatively, image domain material decomposition results show clear separation of iodinated contrast and soft tissue from calcified plaque in the in vivo data. Quantitatively, spatial, spectral, and temporal fidelity are verified through a water phantom scan and a realistic MOBY phantom simulation experiment: spatial resolution is robustly preserved by iterative reconstruction (10% MTF: 2.8-3.0 lp/mm), left-ventricle, cardiac functional metrics can be measured from iodine map segmentations with similar to 1% error, and small calcifications (615 mu m) can be detected during slow moving phases of the cardiac cycle. Given these preliminary results, we believe that PCD technology will enhance dynamic CT imaging applications with high-fidelity spectral and material information.	[Clark, Darin P.; Holbrook, Matthew; Badea, Cristian T.] Duke Univ, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27706 USA; [Lee, Chang-Lung] Duke Univ, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27706 USA.	cristian.badea@duke.edu	Badea, Cristian/B-6681-2011; Badea, Cristian T/M-3323-2019	Badea, Cristian/0000-0002-1850-2522; Badea, Cristian T/0000-0002-1850-2522; Holbrook, Matthew/0000-0002-5832-8725; Lee (He/Him/His), Chang-Lung/0000-0002-0673-633X	NIH National Cancer Institute [R01 CA196667, U24 CA220245]; NATIONAL CANCER INSTITUTE [R01CA196667, U24CA220245] Funding Source: NIH RePORTER	NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was performed at the Duke Center for In Vivo Microscopy and was supported by the NIH National Cancer Institute (CTB; https://www.cancer.gov/; R01 CA196667, U24 CA220245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Ashton JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088129; Badea CT, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab03e2; Ballabriga R, 2006, 2006 IEEE NUCL SCI S; Brehm M, 2015, MED PHYS, V42, P1948, DOI 10.1118/1.4916083; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chae EJ, 2008, RADIOLOGY, V249, P671, DOI 10.1148/radiol.2492071956; Chen GH, 2015, MED PHYS, V42, P4698, DOI 10.1118/1.4926430; Clark DP, 2019, PROC SPIE, V10948, DOI 10.1117/12.2512816; Clark DP, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293628; Clark D. P., 2018, 5 INT C IMAGE FORMAT; Clark DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180324; Clark DP, 2015, MED PHYS, V42, P6317, DOI 10.1118/1.4931407; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Clarke D, 2016, SMALL ANIMAL SURGICAL EMERGENCIES, P1; Cormode DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04659-9; Crujea C, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293016; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Gutjahr R, 2016, INVEST RADIOL, V51, P421, DOI 10.1097/RLI.0000000000000251; Holbrook M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa9b45; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Johnson TRC, 2011, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-642-01740-7; Lee CL, 2014, INT J RADIAT ONCOL, V88, P686, DOI 10.1016/j.ijrobp.2013.11.238; Leng S, MED IMAGING 2016 PHY; Leng S, 2018, INVEST RADIOL, V53, P655, DOI 10.1097/RLI.0000000000000488; Meganck JA, 2017, MOL IMAGING BIOL, V19, P499, DOI 10.1007/s11307-016-1026-x; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Rigie DS, 2015, PHYS MED BIOL, V60, P1741, DOI 10.1088/0031-9155/60/5/1741; Rossler AC, 2017, ACAD RADIOL, V24, P184, DOI 10.1016/j.acra.2016.09.017; SEGARS W, 2007, J NUCL MED, V48, P203; Shikhaliev PM, 2008, PHYS MED BIOL, V53, P5595, DOI 10.1088/0031-9155/53/20/002; Siewerdsen J. H., 2014, CONE BEAM COMPUTED T, P37; Symons R, 2017, MED PHYS, V44, P5120, DOI 10.1002/mp.12301; Taguchi K, 2018, MED PHYS, V45, P1985, DOI 10.1002/mp.12863; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Tao SZ, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aadc90; Willemink MJ, 2018, RADIOLOGY, V289, P293, DOI 10.1148/radiol.2018172656; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Yu ZC, 2016, J COMPUT ASSIST TOMO, V40, P663, DOI 10.1097/RCT.0000000000000412; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou W, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.043502	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218417	10.1371/journal.pone.0218417	http://dx.doi.org/10.1371/journal.pone.0218417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536493	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800008
J	Estes, SJ; Soliman, AM; Epstein, AJ; Bond, JC; Gordon, K; Missmer, SA				Estes, Stephanie J.; Soliman, Ahmed M.; Epstein, Andrew J.; Bond, Julia C.; Gordon, Keith; Missmer, Stacey A.			National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006-2015	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; MANAGEMENT; HYSTERECTOMY; SURGERY; HEALTH; CONSENSUS; RESECTION; BURDEN; RATES; WOMEN	Introduction Despite guidance towards minimally invasive, outpatient procedures for endometriosis, many patients nonetheless receive inpatient care. Our objective was to assess trends in patient and hospital characteristics, surgical complications and hospital charges for women with an endometriosis-related inpatient admission in the United States. Methods We conducted a pooled cross-sectional analysis of Healthcare Cost and Utilization Project Nationwide Inpatient Sample data. Visits were stratified into three time-period-defined cohorts (2006-2007, 2010-2011, and 2014 through the first three quarters of 2015). Visits were included if the patient was aged 18-49 years and the primary diagnosis code was for endometriosis (International Classification of Diseases, 9th Revision code 617.xx). We evaluated counts of inpatient admissions and rates of patient and hospital characteristics. Results The number of inpatient admissions with a primary diagnosis code for endometriosis decreased by 72.8% from 2006 to 2015. At the same time, among those admitted for inpatient care for endometriosis, the proportions who had Medicaid insurance and multiple documented comorbidities increased. From 2006 to 2015, mean total hospital charges increased by 75% to $39,662 in 2015 US dollars, although average length of stay increased by <1 day. Conclusions The number of inpatient admissions with a primary diagnosis of endometriosis decreased over the past decade, while surgical complications and associated hospital charges increased. The share of patients with multiple comorbidities increased and an increasing proportion of inpatient endometriosis admissions were covered by Medicaid and occurred at urban teaching hospitals. These findings suggest a demographic shift in patients receiving inpatient care for endometriosis towards more complex, vulnerable patients.	[Estes, Stephanie J.] Penn State Hlth, Dept Obstet & Gynecol, Hershey, PA 17033 USA; [Soliman, Ahmed M.; Gordon, Keith] AbbVie Inc, N Chicago, IL USA; [Epstein, Andrew J.; Bond, Julia C.] Medicus Econ, Philadelphia, PA USA; [Missmer, Stacey A.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Missmer, Stacey A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; AbbVie; Michigan State University; Harvard University; Harvard T.H. Chan School of Public Health	Estes, SJ (corresponding author), Penn State Hlth, Dept Obstet & Gynecol, Hershey, PA 17033 USA.	sestes@pennstatehealth.psu.edu		Bond, Julia/0000-0002-2988-7755	AbbVie, Inc; Good Publication Practice (GPP3)	AbbVie, Inc(AbbVie); Good Publication Practice (GPP3)	The design and financial support for the study were provided by AbbVie, Inc (URL: https://www.abbvie.com/).AS and KG are employees of AbbVie. AE and JB are employees of Medicus Economics, which received a research contract from AbbVie to conduct this research. SE and SM have served as research consultants for AbbVie. AbbVie participated in data analysis, interpretation and review of results, preparation of the manuscript, and decision to publish. The development of this study and manuscript followed the Principles of Good Publication Practice (GPP3) for Company-Sponsored Medical Research.	Abo C, 2018, FERTIL STERIL, V109, P172, DOI 10.1016/j.fertnstert.2017.10.001; Alexander AL, 2019, OBSTET GYNECOL, V133, P6, DOI 10.1097/AOG.0000000000002990; Cohen SL, 2014, JSLS-J SOC LAPAROEND, V18, DOI 10.4293/JSLS.2014.00096; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Facchin F, 2017, HUM REPROD, V32, P1855, DOI 10.1093/humrep/dex249; Falcone T, 2018, OBSTET GYNECOL, V131, P557, DOI 10.1097/AOG.0000000000002469; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Fuldeore MJ, 2017, GYNECOL OBSTET INVES, V82, P453, DOI 10.1159/000452660; Gambone JC, 2002, FERTIL STERIL, V78, P961, DOI 10.1016/S0015-0282(02)04216-4; Gao X, 2006, FERTIL STERIL, V86, P1561, DOI 10.1016/j.fertnstert.2006.06.015; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gordts S, 2017, FERTIL STERIL, V108, P872, DOI 10.1016/j.fertnstert.2017.08.036; Houchens R., 2016, HCUP METHODS SERIES; Houchens RL., 2014, HCUP NIS RELATED REP; Howard BV, 2005, CIRCULATION, V111, P1462, DOI 10.1161/01.CIR.0000159344.21672.FD; Johnson NP, 2017, HUM REPROD, V32, P315, DOI 10.1093/humrep/dew293; Lagana AS, 2017, INT J WOMENS HEALTH, V9, P323, DOI 10.2147/IJWH.S119729; Lagana AS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3617179; Lee J, 2014, J MINIM INVAS GYN, V21, P656, DOI 10.1016/j.jmig.2014.01.012; Louis GMB, 2011, FERTIL STERIL, V96, P360, DOI 10.1016/j.fertnstert.2011.05.087; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; Morgan DM, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.218; National Institute for Health and Care Excellence, 2017, END DIAGN MAN; Nisolle M, 2019, BEST PRACT RES CLIN, DOI 10.1016/j.bpobgyn.2019.01; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Raffaelli R, 2018, EUR J OBSTET GYN R B, V231, P214, DOI 10.1016/j.ejogrb.2018.10.057; Rehmer JM, 2019, OBSTET GYNECOL SURV, V74, P232, DOI 10.1097/OGX.0000000000000660; Rizk B, 2014, FACTS VIEWS VIS OBGY, V6, P219; Smorgick N, 2018, SEMIN REPROD MED, V36, P116, DOI 10.1055/s-0038-1676088; Soliman AM, 2017, J WOMENS HEALTH, V26, P644, DOI 10.1089/jwh.2016.6043; Soliman AM, 2017, FERTIL STERIL, V107, P1181, DOI 10.1016/j.fertnstert.2017.03.020; Surrey ES, 2017, ADV THER, V34, P2436, DOI 10.1007/s12325-017-0619-3; Vercellini P, 2018, EXPERT REV PHARM OUT, V18, P1, DOI 10.1080/14737167.2018.1411803; Vitale SG, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7924021; Walsh CA, 2009, EUR J OBSTET GYN R B, V144, P3, DOI 10.1016/j.ejogrb.2009.01.003; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222889	10.1371/journal.pone.0222889	http://dx.doi.org/10.1371/journal.pone.0222889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536593	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800100
J	Moseley, AM; Rahman, P; Wells, GA; Zadro, JR; Sherrington, C; Toupin-April, K; Brosseau, L				Moseley, Anne M.; Rahman, Prinon; Wells, George A.; Zadro, Joshua R.; Sherrington, Catherine; Toupin-April, Karine; Brosseau, Lucie			Agreement between the Cochrane risk of bias tool and Physiotherapy Evidence Database (PEDro) scale: A meta-epidemiological study of randomized controlled trials of physical therapy interventions	PLOS ONE			English	Article							METHODOLOGICAL QUALITY; INTERRATER RELIABILITY; CONVERGENT; VALIDITY	Background The Cochrane risk of bias (CROB) tool and Physiotherapy Evidence Database (PEDro) scale are used to evaluate risk of bias of randomized controlled trials. We assessed the level of agreement between the instruments. Methods We searched the Cochrane Library to identify trials included in systematic reviews evaluating physical therapy interventions. For trials that met our inclusion criteria (primary reference in Cochrane review, review used CROB (2008 version), indexed in PEDro), CROB items were extracted from the reviews and PEDro items and total score were downloaded from PEDro. Kappa statistics were used to determine the agreement between CROB and PEDro scale items that evaluate similar constructs (e.g., randomization). The total PEDro score was compared to the CROB summary score (% of items met) using an Intraclass Correlation Coefficient. Sensitivity analyses explored the impact of the CROB "unclear" category and variants of CROB blinding items. Kappa statistics were used to determine agreement between different thresholds for "acceptable" risk of bias between CROB and PEDro scale summary scores. Results We included 1442 trials from 108 Cochrane reviews. Agreement was "moderate" for three of the six CROB and PEDro scale items that evaluate similar constructs (allocation concealment, participant blinding, assessor blinding; Kappa = 0.479-0.582). Agreement between the summary scores was "poor" (Intraclass Correlation Coefficient = 0.285). Agreement was highest when the CROB "unclear" category was collapsed with "high" and when participant, personnel and assessor blinding were evaluated separately in CROB. Agreement for different thresholds for "acceptable" risk of bias between CROB and PEDro summary scores was, at best, "fair". Conclusion There was moderate agreement for half of the PEDro and CROB items that evaluate similar constructs. Interpretation of the CROB "unclear" category and variants of the CROB blinding items substantially influenced agreement. Either instrument can be used to quantify risk of bias, but they can't be used interchangeably.	[Moseley, Anne M.; Zadro, Joshua R.; Sherrington, Catherine] Univ Sydney, Inst Musculoskeletal Hlth, Sydney Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Rahman, Prinon; Brosseau, Lucie] Univ Ottawa, Sch Rehabil Sci, Physiotherapy Program, Fac Hlth Sci, Ottawa, ON, Canada; [Wells, George A.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada; [Toupin-April, Karine] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Toupin-April, Karine] Univ Ottawa, Dept Pediat, Fac Med, Ottawa, ON, Canada; [Toupin-April, Karine] Univ Ottawa, Sch Rehabil Sci, Fac Hlth Sci, Ottawa, ON, Canada	University of Sydney; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa	Moseley, AM (corresponding author), Univ Sydney, Inst Musculoskeletal Hlth, Sydney Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia.	anne.moseley@sydney.edu.au	Zadro, Joshua/AAD-5961-2019	Zadro, Joshua/0000-0001-8981-2125; Sherrington, Catherine/0000-0001-8934-4368				[Anonymous], 2008, KINOVEDCHESKIE ZAPIS, V88, P156; Armijo-Olivo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132634; Armijo-Olivo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096920; Armijo-Olivo S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-116; Brandt C, 2007, MANUAL THER, V12, P3, DOI 10.1016/j.math.2006.02.011; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; da Costa BR, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0441-7; de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1; Elkins MR, 2013, BRIT J SPORT MED, V47, P188, DOI 10.1136/bjsports-2012-091804; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Foley NC, 2006, PHYS THER, V86, P817, DOI 10.1093/ptj/86.6.817; Gray JAM, 2009, EVIDENCE BASED HEALT, DOI [10.1186/1471-2458-9-419, DOI 10.1186/1471-2458-9-419]; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Higgins J. P. T., 2019, ROB 2 GUIDANCE PARAL; Jordan VMB, 2017, J CLIN EPIDEMIOL, V81, P72, DOI 10.1016/j.jclinepi.2016.08.012; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kraemer HC, 2002, STAT MED, V21, P2109, DOI 10.1002/sim.1180; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Murad Mohammad Hassan, 2017, Evid Based Med, V22, P139, DOI 10.1136/ebmed-2017-110713; Murray E, 2013, INT J LANG COMM DIS, V48, P297, DOI 10.1111/1460-6984.12007; National Institute for Health Research, 2019, PROSPERO INT PROSPEC; Page SJ, 2013, AM J OCCUP THER, V67, P154, DOI 10.5014/ajot.2013.006197; Pandis N, 2012, AM J ORTHOD DENTOFAC, V141, P126, DOI 10.1016/j.ajodo.2011.09.003; Pandis N, 2011, AM J ORTHOD DENTOFAC, V140, P747, DOI 10.1016/j.ajodo.2011.06.020; SACKETT D, 1995, LANCET, V346, P1171, DOI 10.1016/S0140-6736(95)91850-7; Tooth L, 2005, J EVAL CLIN PRACT, V11, P547, DOI 10.1111/j.1365-2753.2005.00574.x; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Yamato TP, 2017, J CLIN EPIDEMIOL, V86, P176, DOI 10.1016/j.jclinepi.2017.03.002	34	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222770	10.1371/journal.pone.0222770	http://dx.doi.org/10.1371/journal.pone.0222770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD1OO	31536575	Green Published, gold			2022-12-27	WOS:000489744200001
J	Sekine, K; Carter, DJ				Sekine, Kazutaka; Carter, Daniel J.			The effect of child marriage on the utilization of maternal health care in Nepal: A cross-sectional analysis of Demographic and Health Survey 2016	PLOS ONE			English	Article							SERVICE UTILIZATION; WOMENS AUTONOMY; MORTALITY; OUTCOMES; PREGNANCY	A range of demographic and socioeconomic factors are known to account for enormous disparities in the uptake of maternal health care in low- and middle-income countries. In contrast, contextual factors such as child marriage are far less explored as a deterrent to the uptake of maternal health care. The present study aimed to assess the total effect of child marriage on the utilization of maternal health services in Nepal. This study drew on data from the Nepal Demographic and Health Survey 2016. The study restricted its analysis to a subsample of 3,970 currently married women of reproductive age who had at least one live birth in the five years preceding the survey. After descriptive analysis, logistic regression models were constructed to estimate adjusted odds ratios. The results of logistic regression controlling for confounders suggested child marriage decreased the likelihood of antenatal care visits (AOR 0.74; 95% CI 0.63-0.86), skilled attendance at delivery (AOR 0.66; 95% CI 0.56-0.78), facility-based delivery (AOR 0.65; 95% CI 0.56-0.77), and postnatal care use (AOR 0.80; 95% CI 0.67-0.96). The findings of this study reinforced the existing evidence for the adverse effect of child marriage on maternal health-seeking behaviors. Women's restricted access to household resources, limited autonomy in decision-making, social isolation, and the dominant power of husbands and mothers-in-law may play a role in the findings. Addressing women's social vulnerability as a barrier to accessing health care may help to increase the uptake of maternal health services.	[Sekine, Kazutaka] United Nations Populat Fund Myanmar, Yangon, Myanmar; [Carter, Daniel J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine	Sekine, K (corresponding author), United Nations Populat Fund Myanmar, Yangon, Myanmar.	kazutaka_sekine@hotmail.com		Sekine, Kazutaka/0000-0003-2413-2027				Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; [Anonymous], 1986, MATERNAL MORTALITY H; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Godha D, 2016, J ADOLESCENT HEALTH, V58, P504, DOI 10.1016/j.jadohealth.2016.01.001; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Karei E.M., 2010, BUILDING PROGRAMS AD; Khanal V, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-19; Ministry of Health and Population (Nepal), 2006, NAT SAF MOTH NEWB HL; Ministry of Health and Population New ERA ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health (Nepal) New ERA Micro International Inc, 1997, NEP FAM HLTH SURV 19; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Mullany BC, 2006, SOC SCI MED, V62, P2798, DOI 10.1016/j.socscimed.2005.11.013; Nasrullah M, 2013, OBSTET GYNECOL, V122, P517, DOI 10.1097/AOG.0b013e31829b5294; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Obaid TA, 2007, LANCET, V370, P1287, DOI 10.1016/S0140-6736(07)61550-5; Pradhan A, 2010, NEPAL MATERNAL MORTA; Sah N, 2008, J POPUL RES, V25, P207, DOI 10.1007/BF03031949; Saikia N, 2009, J BIOSOC SCI, V41, P329, DOI 10.1017/S0021932008003209; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shahabuddin ASM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012446; Sharma SR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-306; Shrestha SK, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-25; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Situ KC, 2016, MATERN CHILD HLTH J, V20, P1222, DOI 10.1007/s10995-016-1923-2; Starrs AM, 2007, LANCET, V370, P1285, DOI 10.1016/S0140-6736(07)61549-9; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNFPA, 2005, STAT WORLD POP 2005; UNFPA, 2012, MARR TOO YOUNG END C; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2022, WHO RECOMMENDATIONS; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2018, DEFINITION SKILLED H; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P	42	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222643	10.1371/journal.pone.0222643	http://dx.doi.org/10.1371/journal.pone.0222643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536591	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800066
J	Smith, SD; Colgan, P; Yang, F; Rieke, EL; Soupir, ML; Moorman, TB; Allen, HK; Howe, A				Smith, Schuyler D.; Colgan, Phillip; Yang, Fan; Rieke, Elizabeth L.; Soupir, Michelle L.; Moorman, Thomas B.; Allen, Heather K.; Howe, Adina			Investigating the dispersal of antibiotic resistance associated genes from manure application to soil and drainage waters in simulated agricultural farmland systems	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SWINE; TRANSPORT; ABUNDANCE; BACTERIA; DIVERSE; TYLOSIN; FATE	Manure from animals that have been treated with antibiotics is often used to fertilize agricultural soils and its application has previously been shown to enrich for genes associated with antibiotic resistance in agroecosystems. To investigate the magnitude of this effect, we designed a column experiment simulating manure-treated agricultural soil that utilizes artificial subsurface drainage to determine the duration and extent which this type of manure fertilization impacts the set of genes associated with antibiotic resistance in drainage water. We classified ARGs in manure-treated drainage effluent water by its source of origin. Overall, we found that 61% and 7% of the total abundance of ARGs found in drainage water samples could be attributed to manure enrichment and manure addition, respectively. Among these ARGs, we identified 75 genes unique to manure that persisted in both soil and drainage water throughout a drainage season typical of the Upper Midwestern United States. While most of these genes gradually decreased in abundance over time, the IS6100-associated tet(33) gene accrued. These results demonstrate the influence of manure applications on the composition of the resistome observed in agricultural drainage water and highlight the importance of anthropogenic ARGs in the environment.	[Smith, Schuyler D.; Howe, Adina] Iowa State Univ, Bioinformat & Computat Biol Dept, Ames, IA 50011 USA; [Smith, Schuyler D.; Colgan, Phillip; Yang, Fan; Rieke, Elizabeth L.; Soupir, Michelle L.; Howe, Adina] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Moorman, Thomas B.; Allen, Heather K.] ARS, USDA, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Howe, A (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Dept, Ames, IA 50011 USA.; Howe, A (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	adina@iastate.edu		Rieke, Elizabeth/0000-0003-2287-3884; Smith, Schuyler/0000-0001-5720-5611; Howe, Adina/0000-0002-7705-343X	AFRI food safety grant from the USDA National Institute of Food and Agriculture [2016-68003-24604]	AFRI food safety grant from the USDA National Institute of Food and Agriculture	This project was supported by AFRI food safety grant no. 2016-68003-24604 from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/program/agriculture-andfood-research-initiative-afri) to AH, MLS, TBM, and HKA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2010, ANTIMICROB AGENTS CH, V54, P3052, DOI 10.1128/AAC.00304-10; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2014, ANTIMICROBIAL RESIST; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dale VH, 2010, SPRINGER SERIES ENV; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dinnes DL, 2002, AGRON J, V94, P153, DOI 10.2134/agronj2002.0153; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Garder JL, 2014, J ENVIRON QUAL, V43, P1484, DOI 10.2134/jeq2013.09.0379; Groh JL, 2007, APPL ENVIRON MICROB, V73, P492, DOI 10.1128/AEM.01086-06; Helmers MJ, 2012, J ENVIRON QUAL, V41, P1531, DOI 10.2134/jeq2011.0473; Inoue H, 2017, B WORLD HEALTH ORGAN, V95, P242, DOI 10.2471/BLT.17.191890; Jechalke S, 2014, TRENDS MICROBIOL, V22, P536, DOI 10.1016/j.tim.2014.05.005; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Luby EM, 2016, SCI TOTAL ENVIRON, V550, P1126, DOI 10.1016/j.scitotenv.2016.01.132; Marti R, 2014, APPL ENVIRON MICROB, V80, P3258, DOI 10.1128/AEM.00231-14; Martinez JL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00001; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Mcisaac GF, 2004, BIOGEOCHEMISTRY, V70, P251, DOI 10.1023/B:BIOG.0000049342.08183.90; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Muurinen J, 2017, ENVIRON SCI TECHNOL, V51, P5989, DOI 10.1021/acs.est.7b00551; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Riber L, 2014, FEMS MICROBIOL ECOL, V90, P206, DOI 10.1111/1574-6941.12403; Rieke EL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03197; Rieke EL, 2018, SCI TOTAL ENVIRON, V610, P1173, DOI 10.1016/j.scitotenv.2017.08.116; Section S, 2018, ASSESSING PATHOGEN P; Smith SD., 2019, J OPEN SOURCE SOFTW, V4, P1441, DOI [10.21105/joss.01442, DOI 10.21105/JOSS.01442]; Tauch A, 2002, PLASMID, V48, P117, DOI 10.1016/S0147-619X(02)00120-8; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Goethem MW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0424-5; Van Katwyk SR, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0640-2; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; You YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00284; Yu ZY, 2017, FOOD MICROBIOL, V64, P23, DOI 10.1016/j.fm.2016.12.009; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110; Zucker Brown, 1998, AGR DRAINAGE B, V871	46	13	13	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222470	10.1371/journal.pone.0222470	http://dx.doi.org/10.1371/journal.pone.0222470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527917	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400024
J	Dietze, E; Brykala, D; Schreuder, LT; Jazdzewski, K; Blarquez, O; Brauer, A; Dietze, M; Obremske, M; Ott, F; Pienczewska, A; Schouten, S; Hopmans, EC; Slowinski, M				Dietze, Elisabeth; Brykala, Dariusz; Schreuder, Laura T.; Jazdzewski, Krzysztof; Blarquez, Olivier; Brauer, Achim; Dietze, Michael; Obremske, Milena; Ott, Florian; Pienczewska, Anna; Schouten, Stefan; Hopmans, Ellen C.; Slowinski, Michal			Human-induced fire regime shifts during 19th century industrialization: A robust fire regime reconstruction using northern Polish lake sediments	PLOS ONE			English	Article							BIOMASS BURNING EMISSIONS; CLIMATE-CHANGE; HYDROLOGICAL DYNAMICS; MACROSCOPIC CHARCOAL; SOURCE AREA; LEVOGLUCOSAN; HISTORY; FOREST; COMBUSTION; TRANSPORT	Fire regime shifts are driven by climate and natural vegetation changes, but can be strongly affected by human land management. Yet, it is poorly known how humans have influenced fire regimes prior to active wildfire suppression. Among the last 250 years, the human contribution to the global increase in fire occurrence during the mid-19th century is especially unclear, as data sources are limited. Here, we test the extent to which forest management has driven fire regime shifts in a temperate forest landscape. We combine multiple fire proxies (macroscopic charcoal and fire-related biomarkers) derived from highly resolved lake sediments (i.e., 3-5 years per sample), and apply a new statistical approach to classify source area- and temperature-specific fire regimes (biomass burnt, fire episodes). We compare these records with independent climate and vegetation reconstructions. We find two prominent fire regime shifts during the 19th and 20th centuries, driven by an adaptive socio-ecological cycle in human forest management. Although individual fire episodes were triggered mainly by arson (as described in historical documents) during dry summers, the biomass burnt increased unintentionally during the mid-19th century due to the plantation of flammable, fast-growing pine tree monocultures needed for industrialization. State forest management reacted with active fire management and suppression during the 20th century. However, pine cover has been increasing since the 1990s and climate projections predict increasingly dry conditions, suggesting a renewed need for adaptations to reduce the increasing fire risk.	[Dietze, Elisabeth] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Res Unit Potsdam, Polar Terr Environm Syst, Potsdam, Germany; [Dietze, Elisabeth; Brauer, Achim] GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut, Potsdam, Germany; [Brykala, Dariusz] Polish Acad Sci, Inst Geog & Spatial Org, Torun, Poland; [Schreuder, Laura T.; Schouten, Stefan; Hopmans, Ellen C.] Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [Schreuder, Laura T.; Schouten, Stefan; Hopmans, Ellen C.] Univ Utrecht, Texel, Netherlands; [Jazdzewski, Krzysztof] Museum Koscierzyna Land, Koscierzyna, Poland; [Blarquez, Olivier] Univ Montreal, Dept Geog, Montreal, PQ, Canada; [Dietze, Michael] GFZ German Res Ctr Geosci, Sect Geomorphol, Potsdam, Germany; [Obremske, Milena] Polish Acad Sci, Inst Geol Sci, Warsaw, Poland; [Ott, Florian] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Pienczewska, Anna] Kaziemierz Wielki Univ, Inst Geog, Bydgoszcz, Poland; [Schouten, Stefan] Univ Utrecht, Fac Geosci, Utrecht, Netherlands; [Slowinski, Michal] Polish Acad Sci, Inst Geog & Spatial Org, Warsaw, Poland	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Polish Academy of Sciences; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Universite de Montreal; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Polish Academy of Sciences; Institute of Geological Sciences of the Polish Academy of Sciences; Utrecht University; Polish Academy of Sciences	Dietze, E (corresponding author), Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Res Unit Potsdam, Polar Terr Environm Syst, Potsdam, Germany.; Dietze, E (corresponding author), GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut, Potsdam, Germany.	edietze@awi.de	Słowiński, Michał/B-6546-2011; Dietze, Elisabeth/AFJ-4450-2022; Dietze, Elisabeth/AAF-4616-2022; Brykała, Dariusz/L-2091-2017	Słowiński, Michał/0000-0002-3011-2682; Dietze, Elisabeth/0000-0003-4817-8441; Dietze, Elisabeth/0000-0003-4817-8441; Brykała, Dariusz/0000-0002-0105-4153; Ott, Florian/0000-0001-7319-7180; Brauer, Achim/0000-0002-6655-9451	Helmholtz Association [VH-VI-415]; National Science Centre of Poland [DEC-2011/03/D/HS3/03631, 2015/17/B/ST10/03430, 2011/03/D/HS3/03631]; Netherlands Organisation for Scientific Research [824.14.001]	Helmholtz Association(Helmholtz Association); National Science Centre of Poland(National Science Centre, Poland); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We received funding for this work by the following grants: A.B.: grant number VH-VI-415, the Helmholtz Association; M.O.: DEC-2011/03/D/HS3/03631, the National Science Centre of Poland; M.S.: 2015/17/B/ST10/03430, the National Science Centre of Poland; D.B.: 2011/03/D/HS3/03631, the National Science Centre of Poland; S.S., L.T.S.: 824.14.001, the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf C, 2018, GLOBAL ECOL BIOGEOGR, V27, P199, DOI 10.1111/geb.12682; Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; Ali AA, 2012, P NATL ACAD SCI USA, V109, P20966, DOI 10.1073/pnas.1203467109; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Argiriadis E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30606-3; Arneth A, 2017, NAT GEOSCI, V10, P79, DOI [10.1038/NGEO2882, 10.1038/ngeo2882]; Balch JK, 2017, P NATL ACAD SCI USA, V114, P2946, DOI 10.1073/pnas.1617394114; Battistel D, 2017, HOLOCENE, V27, P997, DOI 10.1177/0959683616678466; Bienias D., 2009, DZIEDZICTWO TECHNICZ, P43; Blarquez O, 2018, QUATERNARY SCI REV, V180, P63, DOI 10.1016/j.quascirev.2017.11.022; Blarquez O, 2013, GEOPHYS RES LETT, V40, P2667, DOI 10.1002/grl.50504; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Broda J., 2000, HIST LESNICTWA POLSC; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; CLARK JS, 1994, BIOGEOCHEMISTRY, V24, P35, DOI 10.1007/BF00001306; CLARK JS, 1988, QUATERNARY RES, V30, P67, DOI 10.1016/0033-5894(88)90088-9; Conedera M, 2009, QUATERNARY SCI REV, V28, P555, DOI 10.1016/j.quascirev.2008.11.005; Cyzman W, 2008, JEDNOLITY PROGRAM GO; Dietze E, 2018, QUATERNARY SCI REV, V201, P44, DOI 10.1016/j.quascirev.2018.10.005; Dost P., 1967, WESTPREUSSEN JB, V17, P83; Engling G, 2006, ATMOS ENVIRON, V40, pS299, DOI 10.1016/j.atmosenv.2005.12.069; Fabbri D, 2009, ATMOS ENVIRON, V43, P2286, DOI 10.1016/j.atmosenv.2009.01.030; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fraser MP, 2000, ENVIRON SCI TECHNOL, V34, P4560, DOI 10.1021/es991229l; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Geissler A, 1997, 130 JAHRE OSTBAHN BE; Girardin MP, 2013, NEW PHYTOL, V199, P1001, DOI 10.1111/nph.12322; Gitkowski T., 2009, PROMOTIO GEOGRAPHICA, V4; Gunderson L. H., 2002, Panarchy: understanding transformations in human and natural systems; Han YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20719; Hasel K, 2002, FORSTGESCHICHTE GRUN; Hawthorne D, 2018, QUATERN INT, V488, P3, DOI 10.1016/j.quaint.2017.03.046; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2011, ECOL APPL, V21, P3211, DOI 10.1890/11-0387.1; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hopmans EC, 2013, ORG GEOCHEM, V58, P86, DOI 10.1016/j.orggeochem.2013.02.003; Houston Durrant T.H., 2016, EUROPEAN ATLAS FORES, P132, DOI DOI 10.2788/038466; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Keane R.E., 2015, WILDLAND FUEL FUNDAM, DOI [10.1007/978-3-319-09015-3_5, DOI 10.1007/978-3-319-09015-3]; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Konig A., 1905, ENTWICKLUNG STAATLIC; Kuo LJ, 2008, ORG GEOCHEM, V39, P1466, DOI 10.1016/j.orggeochem.2008.04.026; Kuo LJ, 2011, CHEMOSPHERE, V85, P797, DOI 10.1016/j.chemosphere.2011.06.074; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Legrand M, 2016, CLIM PAST, V12, DOI 10.5194/cp-12-2033-2016; Lhotka O, 2018, THEOR APPL CLIMATOL, V131, P1043, DOI 10.1007/s00704-016-2031-3; Loader C., 2013, LOCFIT LOCAL REGRESS; Marcisz K, 2017, QUATERNARY SCI REV, V177, P145, DOI 10.1016/j.quascirev.2017.10.018; Marcisz K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33907; Marcisz K, 2015, QUATERNARY SCI REV, V112, P138, DOI 10.1016/j.quascirev.2015.01.019; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Marlon JR, 2016, BIOGEOSCIENCES, V13, P3225, DOI 10.5194/bg-13-3225-2016; McGrath MJ, 2015, BIOGEOSCIENCES, V12, P4291, DOI 10.5194/bg-12-4291-2015; McWethy DB, 2013, GLOBAL ECOL BIOGEOGR, V22, P900, DOI 10.1111/geb.12038; Mitus M., 2000, ANN U M CURIESKODO B, V50/51, P239; Molinari C, 2013, GLOBAL ECOL BIOGEOGR, V22, P1248, DOI 10.1111/geb.12090; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; Munteanu C, 2015, GLOBAL ENVIRON CHANG, V34, P83, DOI 10.1016/j.gloenvcha.2015.06.015; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Ott F, 2018, HOLOCENE, V28, P464, DOI 10.1177/0959683617729448; Pausas JG, 2017, J ECOL, V105, P289, DOI 10.1111/1365-2745.12691; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Peters ME, 2007, QUATERNARY RES, V67, P304, DOI 10.1016/j.yqres.2006.10.004; Power MJ, 2013, HOLOCENE, V23, P3, DOI 10.1177/0959683612450196; Pyne SJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0166; Roos CI, 2018, P NATL ACAD SCI USA, V115, P8143, DOI 10.1073/pnas.1805259115; Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297; San-Miguel-Ayanz J, 2012, APPROACHES TO MANAGING DISASTER - ASSESSING HAZARDS, EMERGENCIES AND DISASTER IMPACTS, P87; Sang XF, 2016, GEOPHYS RES LETT, V43, P5419, DOI 10.1002/2016GL069179; Schmidl C, 2008, ATMOS ENVIRON, V42, P126, DOI 10.1016/j.atmosenv.2007.09.028; Schreuder LT, 2018, GEOCHIM COSMOCHIM AC, V227, P171, DOI 10.1016/j.gca.2018.02.020; Schupbach S, 2015, QUATERNARY SCI REV, V115, P123, DOI 10.1016/j.quascirev.2015.03.004; Schutte R., 1893, DANZIG; Seidl R, 2017, NAT CLIM CHANGE, V7, P395, DOI [10.1038/NCLIMATE3303, 10.1038/nclimate3303]; Simoneit BRT, 1999, ATMOS ENVIRON, V33, P173, DOI 10.1016/S1352-2310(98)00145-9; Slowinski M, 2019, J ENVIRON MANAGE, V236, P755, DOI 10.1016/j.jenvman.2019.02.002; Slowinski M, 2015, QUATERN INT, V388, P64, DOI 10.1016/j.quaint.2014.06.018; Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Szczygie R., 2016, CZERWONA KSIGA POARO, P463; Taylor AH, 2016, P NATL ACAD SCI USA, V113, P13684, DOI 10.1073/pnas.1609775113; Theuerkauf M, 2016, VEG HIST ARCHAEOBOT, V25, P541, DOI 10.1007/s00334-016-0572-0; Tinner W, 2006, HOLOCENE, V16, P287, DOI 10.1191/0959683606hl925rr; Trachsel M, 2017, HOLOCENE, V27, P860, DOI 10.1177/0959683616675939; Trollope WSW, 2002, FOREST FIRE RES WILD; Vachula RS, 2018, PALAEOGEOGR PALAEOCL, V508, P166, DOI 10.1016/j.palaeo.2018.07.032; van der Werf GR, 2013, CLIM PAST, V9, P289, DOI 10.5194/cp-9-289-2013; van Marle MJE, 2017, GEOSCI MODEL DEV, V10, P3329, DOI 10.5194/gmd-10-3329-2017; Vanniere B, 2016, QUATERNARY SCI REV, V132, P206, DOI 10.1016/j.quascirev.2015.11.012; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257; Ward DS, 2018, GLOBAL BIOGEOCHEM CY, V32, P122, DOI 10.1002/2017GB005787; Whitlock C., 2001, Tracking environmental change using lake sediments. Volume 3: Terrestrial, algal, and siliceous indicators, P75; Whitlock C, 2018, CONSERV BIOL, V32, P84, DOI 10.1111/cobi.12960; Wo A., 1999, KLIMAT POLSKI; Wojcik G, 1993, UWARUNKOWANIA PRZYRO, P107; Young D, 2017, MIXTOOLS TOOLS ANAL; Zumbrunnen T, 2009, ECOSYSTEMS, V12, P73, DOI 10.1007/s10021-008-9207-3	103	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222011	10.1371/journal.pone.0222011	http://dx.doi.org/10.1371/journal.pone.0222011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JC2ZR	31525210	Green Published, Green Submitted, gold			2022-12-27	WOS:000489146700001
J	Seol, BR; Kang, TG; Gu, B				Seol, Bo Ram; Kang, Tae Gu; Gu, Bonhyeok			Intraocular pressure according to different types of tonometry (non-contact and Goldmann applanation) in patients with different degrees of bilateral tearing	PLOS ONE			English	Article								Purpose To investigate intraocular pressure (IOP) readings by non-contact tonometry (NCT) and Goldmann applanation tonometry (GAT) for patients with different degrees of bilateral tearing. Methods In this study, we reviewed the medical charts of patients complaining of different degrees of bilateral tearing. The tear meniscus height (TMH) and lOP with NCT and GAT were measured. In each patient, a comparison of IOP readings between the eye with lower TMH and the contralateral eye with higher TMH was evaluated. The TMH was graded as follows: grade 1 (low): TMH < 0.2 mm; grade 2 (moderate): 0.2 mm <= TMH < 0.6 mm; grade 3 (high): TMH >= 0.6 mm. Subsequently, a comparison of 10P readings among eyes with low, moderate, and high TMH was also performed. Results A total of 120 eyes of 60 patients were enrolled. When comparing the two eyes of a patient, the eye with higher TMH showed higher NCT readings and larger difference in IOP readings between the two tonometries than the eye with lower TMH (P < 0.001 and P < 0.001, respectively). When TMH was classified into grades according to the degree, the high TMH eyes showed higher NCT readings than did the low and moderate TMH eyes (P < 0.001 and P = 0.001, respectively). In addition, the high TMH eyes showed a larger difference in IOP readings between the two tonometries than did the low and moderate TMH eyes (P < 0.001 and P < 0.001, respectively). Conclusion Eyes with higher TMH showed higher NCT readings and a larger difference in IOP between the two tonometries (NCT and GAT) than those with lower TMH. In patients with tearing, the NCT value may be inaccurate, so it is necessary to measure the GAT.	[Seol, Bo Ram; Kang, Tae Gu; Gu, Bonhyeok] Vet Hlth Serv VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea		Seol, BR (corresponding author), Vet Hlth Serv VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea.	gorong20@hanmail.net		Seol, Bo Ram/0000-0002-3490-0854	VHS Medical Center Research Grant, Republic of Korea [VHSMC 18033]	VHS Medical Center Research Grant, Republic of Korea	This study was supported by a VHS Medical Center Research Grant, Republic of Korea (grant number: VHSMC 18033).	Allingham RR, 2011, SHIELDS TXB GLAUCOMA; Allingham RR, 2005, SHIELDS TXB GLAUCOMA; Burkat CN, 2005, OPHTHALMOLOGY, V112, P344, DOI 10.1016/j.ophtha.2004.07.030; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; Damji KF, 2003, J GLAUCOMA, V12, P69, DOI 10.1097/00061198-200302000-00015; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P652; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Farhood QK, 2013, CLIN OPHTHALMOL, V7, P23, DOI 10.2147/OPTH.S38418; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; GROLMAN B, 1972, AMER J OPT ARCH AM A, V49, P646; Ito K, 2012, J GLAUCOMA, V21, P35, DOI 10.1097/IJG.0b013e31820275b4; JONES LT, 1966, AM J OPHTHALMOL, V62, P47, DOI 10.1016/0002-9394(66)91676-X; Kawai M, 2007, CORNEA, V26, P403, DOI 10.1097/ICO.0b013e318033c242; Martinez-de-la-Casa JM, 2011, ACTA OPHTHALMOL, V89, P676, DOI 10.1111/j.1755-3768.2009.01774.x; SAGAN W, 1975, AM J OPTOM PHYS OPT, V52, P288; SORENSEN PN, 1975, ACTA OPHTHALMOL, V53, P513; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Yilmaz I, 2014, CLIN OPHTHALMOL, V8, P1069, DOI [10.2147/OPTH.S63915, 10.2147/OPTH.S6391]	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222652	10.1371/journal.pone.0222652	http://dx.doi.org/10.1371/journal.pone.0222652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525237	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700043
J	Weiner, ZP; Salzer, JS; LeMasters, E; Ellison, JA; Kondas, AV; Morgan, CN; Doty, JB; Martin, BE; Satheshkumar, PS; Olson, VA; Hutson, CL				Weiner, Zachary P.; Salzer, Johanna S.; LeMasters, Elizabeth; Ellison, James A.; Kondas, Ashley, V; Morgan, Clint N.; Doty, Jeffery B.; Martin, Brock E.; Satheshkumar, Panayampalli Subbian; Olson, Victoria A.; Hutson, Christina L.			Characterization of Monkeypox virus dissemination in the black-tailed prairie dog (Cynomys ludovicianus) through in vivo bioluminescent imaging	PLOS ONE			English	Article							CONGO; WEST; INFECTIONS; FEATURES; AFRICAN	Monkeypox virus (MPXV) is a member of the genus Orthopoxvirus, endemic in Central and West Africa. This viral zoonosis was introduced into the United States in 2003 via African rodents imported for the pet trade and caused 37 human cases, all linked to exposure to MPXV-infected black-tailed prairie dogs (Cynomys ludovicianus). Prairie dogs have since become a useful model of MPXV disease, utilized for testing of potential medical countermeasures. In this study, we used recombinant MPXV containing the firefly luciferase gene (luc) and in vivo imaging technology to characterize MPXV pathogenesis in the black-tailed prairie dog in real time. West African (WA) MPXV could be visualized using in vivo imaging in the nose, lymph nodes, intestines, heart, lung, kidneys, and liver as early as day 6 post infection (p.i.). By day 9 p.i., lesions became visible on the skin and in some cases in the spleen. After day 9 p.i., luminescent signal representing MPXV replication either increased, indicating a progression to what would be a fatal infection, or decreased as infection was resolved. Use of recombinant luc+ MPXV allowed for a greater understanding of how MPXV disseminates throughout the body in prairie dogs during the course of infection. This technology will be used to reduce the number of animals required in future pathogenesis studies as well as aid in determining the effectiveness of potential medical countermeasures.	[Weiner, Zachary P.; Salzer, Johanna S.; LeMasters, Elizabeth; Ellison, James A.; Kondas, Ashley, V; Morgan, Clint N.; Doty, Jeffery B.; Martin, Brock E.; Satheshkumar, Panayampalli Subbian; Olson, Victoria A.; Hutson, Christina L.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA; [Weiner, Zachary P.] Ctr Dis Control & Prevent, Lab Leadership Serv, Poxvirus & Rabies Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	zuu6@cdc.gov		Weiner, Zachary/0000-0002-8337-1354; Ellison, James/0000-0003-4492-4857				[Anonymous], 2018, PATIENT MONKEYPOX WA; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Doshi RH, 2018, EMERG INFECT DIS, V24, P1158, DOI 10.3201/eid2406.180248; Doty JB, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100283; Durski KN, 2018, MMWR-MORBID MORTAL W, V67, P306, DOI 10.15585/mmwr.mm6710a5; Earl PL, 2015, VIROLOGY, V475, P150, DOI 10.1016/j.virol.2014.11.015; Falendysz EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005809; Falendysz EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004130; Falendysz EA, 2014, J WILDLIFE DIS, V50, P524, DOI 10.7589/2013-07-171; Gross E, 2003, ANN EMERG MED, V42, P660, DOI 10.1016/S0196-0644(03)00819-9; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2019, J AM ASSOC LAB ANIM, V58, P485, DOI [10.30802/AALAS-JAALAS-18-000036, 10.30802/aalas-jaalas-18-000036]; Hutson CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/965710; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Luker KE, 2009, METHODS MOL BIOL, V574, P125, DOI 10.1007/978-1-60327-321-3_11; McCollum AM, 2014, CLIN INFECT DIS, V58, P260, DOI 10.1093/cid/cit703; Nakoune E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx168; Ozkaya H, 2012, NEW MICROBIOL, V35, P53; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Vaughan A, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.38.1800509; Yinka-Ogunleye A, 2018, EMERG INFECT DIS, V24, P1149, DOI 10.3201/eid2406.180017	31	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222612	10.1371/journal.pone.0222612	http://dx.doi.org/10.1371/journal.pone.0222612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557167	Green Published, gold			2022-12-27	WOS:000532345500025
J	Kim, MJ; Kim, N; Shin, D; Rhee, SJ; Park, CHK; Kim, H; Cho, SJ; Lee, JW; Kim, EY; Yang, B; Ahn, YM				Kim, Min Ji; Kim, Namwoo; Shin, Daun; Rhee, Sang Jin; Park, C. Hyung Keun; Kim, Hyeyoung; Cho, Sung Joon; Lee, Jae Won; Kim, Eun Young; Yang, Boram; Ahn, Yong Min			The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; SOCIOECONOMIC-STATUS; DISORDERS; PATTERNS; CARE; DISCONTINUATION; DETERMINANTS; PREVALENCE; EFFICACY	Background The duration of antidepressant use affects the treatment of depression. Using the National Health Insurance database, which covers almost the entire national population, we verified the factors associated with the inadequate short-term use of initially prescribed antidepressants and their effects on the relapse and recurrence of depressive episodes. Methods There were 752,190 patients included who had been newly prescribed antidepressants in 2012 with the diagnosis of depressive disorder. They were followed-up until December 31, 2015. They were classified as short-term and long-term antidepressant users depending on whether they used a specific initial antidepressant for at least four weeks. Sociodemographic, clinical, and medical utilization factors affecting the duration of antidepressant use were investigated. We also identified whether the duration of antidepressant use affected the risk of relapse and recurrence, which was defined by the restarting of antidepressants. Results Initial antidepressants were taken for less than 28 days by 458,057 (60.84%) patients. Tricyclic antidepressants were used as the initial antidepressant more frequently than selective serotonin reuptake inhibitors (64.5% versus 19.3%). The type of initial antidepressant, polypharmacy, psychiatric and medical comorbidities, type of insurance coverage, and type of medical institution visited were associated with short-term use. Short-term use marginally increased the risk of relapse and recurrence of depressive episodes (Hazard ratio: 1.06, 95% confidence intervals 1.048-1.075). Conclusions Short-term antidepressant use is widespread in Korea, and assessment in various aspects are necessary to set proper treatment plans.	[Kim, Min Ji; Kim, Namwoo; Shin, Daun; Rhee, Sang Jin; Park, C. Hyung Keun; Ahn, Yong Min] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Park, C. Hyung Keun; Ahn, Yong Min] Seoul Natl Univ, Inst Human Behav Med, Dept Psychiat & Behav Sci, Coll Med, Seoul, South Korea; [Park, C. Hyung Keun] Asan Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Hyeyoung] Inha Univ Hosp, Dept Psychiat, Inhang Ro, Incheon, South Korea; [Cho, Sung Joon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Psychiat, Sch Med, Seoul, South Korea; [Lee, Jae Won] Seoul Metropolitan Eunpyeong Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Mental Hlth Ctr, Hlth Care Ctr, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Dept Med, Coll Med, Seoul, South Korea; [Yang, Boram] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of Ulsan; Asan Medical Center; Inha University; Inha University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Ahn, YM (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Ahn, YM (corresponding author), Seoul Natl Univ, Inst Human Behav Med, Dept Psychiat & Behav Sci, Coll Med, Seoul, South Korea.	aym@snu.ac.kr	Park, Christopher/L-6074-2017	Park, Christopher/0000-0002-2568-1426; Kim, Namwoo/0000-0002-1684-5417; Kim, Hyeyoung/0000-0002-2313-8892; Yang, Bo Ram/0000-0002-8771-8829				Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; ANDERSON IM, 1995, BMJ-BRIT MED J, V310, P1433, DOI 10.1136/bmj.310.6992.1433; Association AP, 2009, PRACTICE GUIDELINE T, V3; Bae KY, 2011, PSYCHIAT INVEST, V8, P234, DOI 10.4306/pi.2011.8.3.234; Briley M, 2004, HUM PSYCHOPHARM CLIN, V19, pS21, DOI 10.1002/hup.621; Bull SA, 2002, ANN PHARMACOTHER, V36, P578, DOI 10.1345/aph.1A254; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Chan D, 2009, PSYCHIAT SERV, V60, P1612, DOI 10.1176/ps.2009.60.12.1612; Demyttenaere K, 1997, J AFFECT DISORDERS, V43, P27, DOI 10.1016/S0165-0327(96)00095-X; Donoghue J, 2000, ACTA PSYCHIAT SCAND, V101, P57, DOI 10.1111/j.1600-0447.2000.tb10949.x; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; HELZER J E, 1979, American Journal of Psychiatry, V136, P526; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Hwang JE, 2018, INT J CLIN PHARM TH, V56, P224, DOI 10.5414/CP203157; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Iosifescu DV, 2005, FOCUS, V160, P2122; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim KH, 2011, J AFFECT DISORDERS, V132, P121, DOI 10.1016/j.jad.2011.02.016; Kim L, 2014, EPIDEMIOLOGY HLTH, P36; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; MADDOX JC, 1994, J PSYCHOPHARMACOL, V8, P48, DOI 10.1177/026988119400800108; Melartin TK, 2004, J CLIN PSYCHIAT, V65, P810; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; Melfi CA, 1999, MED CARE, V37, pAS77, DOI 10.1097/00005650-199904001-00010; Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Rosholm JU, 2001, EUR J CLIN PHARMACOL, V56, P923, DOI 10.1007/s002280000234; Sayers J., 2001, B WORLD HEALTH ORGAN, V79, P1085; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Sood N, 2000, AM J MANAG CARE, V6, P1327; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P745; Tai-Seale M, 2000, MED CARE RES REV, V57, P491, DOI 10.1177/107755870005700405; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Weilburg JB, 2003, PSYCHIAT SERV, V54, P1233, DOI 10.1176/appi.ps.54.9.1233; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; Zimmerman FJ, 2005, HEALTH ECON, V14, P1197, DOI 10.1002/hec.1011; 이경욱, 2006, [The Korean Journal of Psychopharmacology, 대한정신약물학회지], V17, P550	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222791	10.1371/journal.pone.0222791	http://dx.doi.org/10.1371/journal.pone.0222791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553786	Green Submitted, Green Published, gold			2022-12-27	WOS:000532319200037
J	Ansari, WA; Atri, N; Ahmad, J; Qureshi, MI; Singh, B; Kumar, R; Rai, V; Pandey, S				Ansari, Waquar Akhter; Atri, Neelam; Ahmad, Javed; Qureshi, Mohammad Irfan; Singh, Bijendra; Kumar, Ram; Rai, Vandna; Pandey, Sudhakar			Drought mediated physiological and molecular changes in muskmelon (Cucumis melo L.)	PLOS ONE			English	Article							COMPARATIVE PROTEOMIC ANALYSIS; CHLOROPHYLL FLUORESCENCE; STRESS; RESPONSES; PROTEINS; RICE; GENOTYPES; IDENTIFICATION; ACCUMULATION; EXPRESSION	Water deficiency up to a certain level and duration leads to a stress condition called drought. It is a multi-dimensional stress causing alteration in the physiological, morphological, biochemical, and molecular traits in plants resulting in improper plant growth and development. Drought is one of the major abiotic stresses responsible for loss of crops including muskmelon (Cucumis melo. L). Muskmelon genotype SC-15, which exhibits high drought resistance as reported in our earlier reports, was exposed to deficient water condition and studied for alteration in physiological, molecular and proteomic profile changes in the leaves. Drought stress results in reduced net photosynthetic rate (Pn), stomatal conductance (Gs) and transpiration (E) rate. With expanded severity of drought, declination recorded in content of total chlorophyll and carotenoid while enhancement observed in phenol content indicating generation of oxidative stress. In contrary, activities of catalase (CAT), superoxide dismutase (SOD), ascorbate peroxidase (APX), and guaiacol (POD) were increased under drought stress. Peptide mass fingerprinting (PMF) showed that drought increased the relative abundance of 38 spots while decreases10 spots of protein. The identified proteins belong to protein synthesis, photosynthesis, nucleotide biosynthesis, stress response, transcription regulation, metabolism, energy and DNA binding. A drought-induced MADS-box transcription factor was identified. The present findings indicate that under drought muskmelon elevates the abundance of defense proteins and suppresses catabolic proteins. The data obtained exhibits possible mechanisms adopted by muskmelon to counter the impacts of drought induced stress.	[Ansari, Waquar Akhter; Singh, Bijendra; Pandey, Sudhakar] Indian Inst Vegetable Res, ICAR, Varanasi, Uttar Pradesh, India; [Ansari, Waquar Akhter; Atri, Neelam] Banaras Hindu Univ, MMV, Dept Bot, Varanasi, Uttar Pradesh, India; [Ahmad, Javed; Qureshi, Mohammad Irfan] Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India; [Kumar, Ram; Rai, Vandna] LBS Ctr, Natl Res Ctr Plant Biotechnol, ICAR, Pusa Campus, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Vegetable Research; Banaras Hindu University (BHU); Jamia Millia Islamia; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Pandey, S (corresponding author), Indian Inst Vegetable Res, ICAR, Varanasi, Uttar Pradesh, India.	sudhakariivr@gmail.com	Qureshi, M Irfan/CAF-0824-2022	Qureshi, M Irfan/0000-0001-9625-0036	Maulana Azad Junior and Senior Research Fellowship; National Agricultural Innovation Project (NAIP)	Maulana Azad Junior and Senior Research Fellowship; National Agricultural Innovation Project (NAIP)	This study was supported by the Maulana Azad Junior and Senior Research Fellowship awarded to WA and was also supported by National Agricultural Innovation Project (NAIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Ansari WA, 2018, PHOTOSYNTHETICA, V56, P1019, DOI 10.1007/s11099-018-0821-9; Ansari WA, 2017, BIOL PLANTARUM, V61, P333, DOI 10.1007/s10535-016-0694-3; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Castillejo M. A., 2008, OPEN PROTEOMICS J, V1, P59, DOI DOI 10.2174/1875039700801010059; Cha-Um S, 2007, J AGRON CROP SCI, V193, P157, DOI 10.1111/j.1439-037X.2007.00251.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen JH, 2011, PLANT OMICS, V4, P257; Coombs J., 1987, TECHNIQUES BIOPRODUC; Deeba F, 2012, PLANT PHYSIOL BIOCH, V53, P6, DOI 10.1016/j.plaphy.2012.01.002; DHILLON NPS, 2011, PLANT BREED REV, V35, P85; Faghani E, 2015, DATA BRIEF, V2, P26, DOI 10.1016/j.dib.2014.11.001; Fan LQ, 2015, PHYTOCHEMISTRY, V116, P28, DOI 10.1016/j.phytochem.2015.02.023; Feng XH, 2007, CHINA CUCURBITS VEGE, V1, P57; Gupta OP, 2015, MOL BIOL REP, V42, P43, DOI 10.1007/s11033-014-3738-9; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huo Chen-Min, 2004, Acta Genetica Sinica, V31, P1408; Ibrahim E. A., 2012, International Journal of Plant Breeding and Genetics, V6, P238; Jangpromma Nisachon, 2010, American Journal of Biochemistry and Biotechnology, V6, P89, DOI 10.3844/ajbbsp.2010.89.102; Jimenez S, 2013, TREE PHYSIOL, V33, P1061, DOI 10.1093/treephys/tpt074; Kausar A, 2012, PAK J BOT, V44, P47; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Kim S. G., P O J, V8, P159; Koh J, 2015, J PROTEOME RES, V14, P3068, DOI 10.1021/pr501323d; Koslowsky S, 2008, PLANT BIOTECHNOL J, V6, P281, DOI 10.1111/j.1467-7652.2007.00314.x; Kusvuran S., 2012, African Journal of Agricultural Research, V7, P775; Langenkamper G, 2001, J EXP BOT, V52, P1545, DOI 10.1093/jexbot/52.360.1545; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Li YJ, 2009, PLANT BREEDING, V128, P404, DOI 10.1111/j.1439-0523.2008.01593.x; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Lin HH, 2016, J PLANT BIOCHEM BIOT, V25, P87, DOI 10.1007/s13562-015-0314-x; Malter D, 2011, PROTOPLASMA, V248, P217, DOI 10.1007/s00709-010-0215-8; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mitra J, 2001, CURR SCI INDIA, V80, P758; Nawaz MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4856-x; Nawaz MA, 2018, PLANT GROWTH REGUL, V85, P41, DOI 10.1007/s10725-018-0372-x; Pandey Shashank, 2016, 2016 41st International Conference on Infrared, Millimeter and Terahertz Waves (IRMMW-THz), DOI 10.1109/IRMMW-THz.2016.7758921; Pandey S, 2013, ACTA HORTIC, V979, P335; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Ranjbarfordoei A, 2006, PHOTOSYNTHETICA, V44, P513, DOI 10.1007/s11099-006-0064-z; Sanjeeta K, 2014, J PROTEOME SCI COMPU, V3, P2, DOI [10.7243/2050-2273-3-2, DOI 10.7243/2050-2273-3-2]; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shu LB, 2010, J INTEGR PLANT BIOL, V52, P981, DOI 10.1111/j.1744-7909.2010.00986.x; SRINIVAS K, 1989, AUSTR J AGR RES, V6, P115; Tai FJ, 2011, PLANT OMICS, V4, P250; Wang HZ, 2010, AGR SCI CHINA, V9, P633, DOI 10.1016/S1671-2927(09)60138-3; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; YANG P, 2019, AGRONOMY-BASEL, V9, DOI DOI 10.3390/agronomy9050265; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zhao YY, 2010, J ZHEJIANG UNIV-SC B, V11, P443, DOI 10.1631/jzus.B0900357; Zhou G, 2012, PLANT MOL BIOL REP, V30, P349, DOI 10.1007/s11105-011-0343-0; ZIESLIN N, 1993, PLANT PHYSIOL BIOCH, V31, P333	62	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222647	10.1371/journal.pone.0222647	http://dx.doi.org/10.1371/journal.pone.0222647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550269	Green Published, gold			2022-12-27	WOS:000532307700022
J	Schenk, HM; van Ockenburg, SL; Nawijn, MC; De Jonge, P; Rosmalen, JGM				Schenk, H. M.; van Ockenburg, S. L.; Nawijn, M. C.; De Jonge, P.; Rosmalen, J. G. M.			Identification of inflammatory markers suitable for non-invasive, repeated measurement studies in biobehavioral research: A feasibility study	PLOS ONE			English	Article							BIOMARKERS; DEPRESSION; CYTOKINES; CORTISOL; STRESS	Introduction Studying the role of the immune system in the interaction between mental and physical health is challenging. To study individuals with an intensive, longitudinal study design that requires repetitive sampling in their daily life, non-invasive sampling techniques are a necessity. Urine can be collected in a non-invasive way, but this may be demanding for participants and little is known about fluctuation of inflammatory markers in urine over time. The aim of this study was to investigate the feasibility of non-invasive sampling, and to explore intra-individual differences in inflammatory markers in urine. Materials & methods Ten healthy individuals collected 24-hour urine for 63 consecutive days. In a pilot analysis, 39 inflammatory markers were examined for detectability in urine, stability over time and under storage conditions, and daily fluctuations. Multiplex analyses were used to quantify levels of eight selected markers: C-reactive protein (CRP), Fractalkine, Interleukin-1 receptor-antagonist (IL-1RA), interferon-alpha (IFN alpha), interferon-gamma (IFN gamma), Interferon gamma-induced protein 10 (IP10), Macrophage inflammatory protein-1 beta (MIP-1 beta), and Vascular Endothelial Growth Factor (VEGF). Cross-correlations were calculated between the overnight and 24-hour samples were calculated, to examine whether 24-hour urine could be replaced by the overnight portion for better feasibility. We examined intra- and interindividual differences in the levels of inflammatory markers in urine and the fluctuations thereof. Results This study showed that levels of selected inflammatory markers can be detected in urine. Cross-correlation analyses showed that correlations between levels of inflammatory markers in the night portion and the 24-hour urine sample varied widely between individuals. In addition, analyses of time series revealed striking inter- and intra-individual variation in levels of inflammatory markers and their fluctuations. Conclusion We show that the assessment of urinary inflammatory markers is feasible in an intensive day-to-day study in healthy individuals. However, 24-hour urine cannot be replaced by an overnight portion to alleviate the protocol burden. Levels of inflammatory markers show substantial variation between and within persons.	[Schenk, H. M.; van Ockenburg, S. L.; De Jonge, P.; Rosmalen, J. G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Univ Ctr Psychiat, Groningen, Netherlands; [Nawijn, M. C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen	Schenk, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Univ Ctr Psychiat, Groningen, Netherlands.	hmschenk@gmail.com	Rosmalen, Judith G.M./F-5375-2011; de Jonge, Peter/L-6395-2013	Rosmalen, Judith G.M./0000-0002-6393-0032; Nawijn, Martijn/0000-0003-3372-6521; de Jonge, Peter/0000-0002-0866-6929; Schenk, H. Maria/0000-0002-2799-0265	De Cock-Hadders Foundation [2016-62]; Espria Academy, a health care group in the Netherlands; Dutch National Research council NWO VICI grant (NWO) [91812607]; Innovation Fund Health Insurances, the Netherlands [2619]	De Cock-Hadders Foundation; Espria Academy, a health care group in the Netherlands; Dutch National Research council NWO VICI grant (NWO); Innovation Fund Health Insurances, the Netherlands(Netherlands Government)	HMS received a grant from the De Cock-Hadders Foundation (2016-62). The Espria Academy, a health care group in the Netherlands consisting of multiple companies targeted mainly at the elderly population (https://www.espria.nl/), provided funding for the salary of HMS. PdJ received a Dutch National Research council NWO VICI grant (NWO grant 91812607). JGMR received a grant from the Innovation Fund Health Insurances, the Netherlands, grant number 2619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Booij SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131002; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Chiang JJ, 2012, P NATL ACAD SCI USA, V109, P1878, DOI 10.1073/pnas.1120972109; Conner T.S., 2012, HDB RES METHODS STUD, P3; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; De Melo EN, 2016, J DIABETES COMPLICAT, V30, P295, DOI 10.1016/j.jdiacomp.2015.11.020; Dorn LD, 2016, PSYCHOSOM MED, V78, P646, DOI 10.1097/PSY.0000000000000321; Gabbay V, 2009, J AFFECT DISORDERS, V115, P177, DOI 10.1016/j.jad.2008.07.022; Haberkorn J, 2013, PSYCHONEUROENDOCRINO, V38, P2366, DOI 10.1016/j.psyneuen.2013.03.001; Hamaker E.L., 2012, HDB RES METHODS STUD, P43, DOI DOI 10.5860/CHOICE.50-1159; Hamaker EL, 2005, MULTIVAR BEHAV RES, V40, P207, DOI 10.1207/s15327906mbr4002_3; Honaker J, 2011, J STAT SOFTW, V45, P1; Huan YH, 2018, SCI CHINA LIFE SCI, V61, P1283, DOI 10.1007/s11427-017-9204-5; Khan A, 2012, J PROTEOMICS, V75, P4802, DOI 10.1016/j.jprot.2012.05.018; Khosro Sadeghniiat, 2011, Indian J Occup Environ Med, V15, P38, DOI 10.4103/0019-5278.82996; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Murakami K, 2008, NUTRITION, V24, P16, DOI 10.1016/j.nut.2007.09.001; Nayyar AS, 2012, MALAYS J PATHOL; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Peng WH, 2008, KIDNEY INT, V74, P1454, DOI 10.1038/ki.2008.459; Prasad S, 2016, EXP BIOL MED, V241, P783, DOI 10.1177/1535370216638770; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schubert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029415; Segerstrom SC, 2004, PSYCHOL B; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646; Sublette ME, 2012, PSYCHOSOM MED, V74, P668, DOI 10.1097/PSY.0b013e318268de9f; van Ockenburg SL, 2016, PSYCHONEUROENDOCRINO, V73, P142, DOI 10.1016/j.psyneuen.2016.07.220; van Ockenburg SL, 2015, PSYCHONEUROENDOCRINO, V62, P189, DOI 10.1016/j.psyneuen.2015.08.002; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221993	10.1371/journal.pone.0221993	http://dx.doi.org/10.1371/journal.pone.0221993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550260	Green Published, gold			2022-12-27	WOS:000532307700010
J	Wearing, J; Stokes, M; de Bruin, ED				Wearing, Julia; Stokes, Maria; de Bruin, Eling D.			Quadriceps muscle strength is a discriminant predictor of dependence in daily activities in nursing home residents	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; TO-STAND PERFORMANCE; QUALITY-OF-LIFE; OLDER-ADULTS; ACTIVATION; DISABILITY; ULTRASONOGRAPHY; RELIABILITY; SARCOPENIA; EXERCISE	Objective This study aimed to explore the relationship between dependence in Activities of Daily Living and muscle strength, muscle morphology and physical function in older nursing home residents, taking possible confounders into consideration. Methods A total of 30 nursing home residents (age, 85.6 +/- 7.1 years) were included in this observational cross-sectional study. Performance of basic Activities of Daily Living (ADL) was assessed with the Resident Assessment Instrument and categorized as either independent or dependent. Isometric grip, quadriceps and elbow-flexor strength were determined by hand-dynamometry, muscle thickness and echo intensity by B-mode ultrasonography, a sit-to-stand task by using a stop watch and physical activity by the German-Physical-Activity Questionnaire. Degree of frailty was evaluated according to Fried's frailty criteria, whereas cognition, depression, incontinence, pain and falls were part of the Resident Assessment Instrument. Results Dependence in Activities of Daily Living was negatively correlated with physical activity (r(s) = -0.44, p =.015), handgrip (r(s) = -0.38, p =.038), elbow-flexor (r(s) = -0.42, p =.032) and quadriceps strength (r(s) = -0.67, p <.001), analysed by Spearman's correlation. Chronic diseases (r(s) = -0.41, p =.027) and incontinence (r(s) = -0.39, p =.037) were positively correlated with ADL while the other variables were not related. Only quadriceps strength remained significant with logistic regression (Wald(1) = 4.7, p =.03), when chronic diseases, quadriceps and handgrip strength were considered (R-2.79). 11 kg was the best fitting value in this sample to predict performance in Activities of Daily Living, evaluated with Receiver-Operating Characteristic analysis, with a sensitivity of 100% and a specificity of 79%. Conclusion and implication Quadriceps strength had a positive independent relationship with performance in ADL in the nursing home residents studied. Although a large prospective study is needed to verify the results, maintaining quadriceps strength above 11 kg may be helpful in retaining independence in this cohort.	[Wearing, Julia] Univ Maastricht, Sch Publ Hlth & Primary Care, Fac Hlth Med & Sci, Maastricht, Netherlands; [Stokes, Maria] Univ Southampton, Sch Hlth Sci, Southampton, Hants, England; [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport IBWS, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wearing, Julia] Adullam Stiftung, Basel, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Maastricht University; University of Southampton; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet	de Bruin, ED (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport IBWS, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	eling.debruin@hest.ethz.ch	de Bruin, Eling D./A-4751-2011; Stokes, Maria/G-2288-2011	de Bruin, Eling D./0000-0002-6542-7385; Stokes, Maria/0000-0002-4204-0890; Wearing, Julia/0000-0002-1670-4673				Aguirre LE, 2015, NESTLE NUTR WORKS SE, V83, P83, DOI 10.1159/000382065; Agyapong-Badu S, 2014, PHYSIOL MEAS, V35, P2165, DOI 10.1088/0967-3334/35/10/2165; Akima H, 2001, MED SCI SPORT EXER, V33, P220; Alexander NB, 2000, J AM GERIATR SOC, V48, P526, DOI 10.1111/j.1532-5415.2000.tb04999.x; Arnold CM, 2010, J STRENGTH COND RES, V24, P815, DOI 10.1519/JSC.0b013e3181aa36b8; Arrieta H, 2019, J AM GERIATR SOC, V67, P1145, DOI 10.1111/jgs.15824; Arrieta H, 2018, MATURITAS, V109, P45, DOI 10.1016/j.maturitas.2017.12.003; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Bamman MM, 1998, J APPL PHYSIOL, V84, P157, DOI 10.1152/jappl.1998.84.1.157; bfs, 2017, GES ALT; Bohannon RW, 2011, PERCEPT MOTOR SKILL, V112, P803, DOI 10.2466/15.26.PMS.112.3.803-806; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Cadore EL, 2014, AGE, V36, P801, DOI 10.1007/s11357-013-9599-7; Chen WL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001335; Clark Brian C, 2011, Curr Aging Sci, V4, P192; Clark DJ, 2012, J GERONTOL A-BIOL, V67, P41, DOI 10.1093/gerona/glr041; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; de Mazieres CL, 2017, J AM MED DIR ASSOC, V18, P105, DOI 10.1016/j.jamda.2016.11.019; Delaney S, 2010, MUSCLE NERVE, V42, P530, DOI 10.1002/mus.21725; Eriksrud O, 2003, PHYS THER, V83, P544, DOI 10.1093/ptj/83.6.544; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Harridge SDR, 1999, MUSCLE NERVE, V22, P831, DOI 10.1002/(SICI)1097-4598(199907)22:7<831::AID-MUS4>3.0.CO;2-3; Harris-Love MO, 2016, PEERJ, V4, DOI 10.7717/peerj.1721; Huy C, 2008, Z GERONTOL GERIATR, V41, P208, DOI 10.1007/s00391-007-0474-y; Jerez-Roig J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177353; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Krist L, 2013, CLIN INTERV AGING, V8, P443, DOI 10.2147/CIA.S42136; Lane NE, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0444-1; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Luleci E, 2008, ARCH GERONTOL GERIAT, V46, P57, DOI 10.1016/j.archger.2007.02.007; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Makizako H, 2017, PHYS THER, V97, P417, DOI 10.2522/ptj.20150665; Manini TM, 2013, CURR OPIN CLIN NUTR, V16, P21, DOI 10.1097/MCO.0b013e32835b5880; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mayans D, 2012, PHYS MED REH CLIN N, V23, P133, DOI 10.1016/j.pmr.2011.11.009; Mechelli F, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2030058; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Ota A, 2008, INT J SPORT HLTH SCI, V6, P91, DOI [10.5432/ijshs.6.91, DOI 10.5432/IJSHS.6.91]; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; REIMERS K, 1993, J ULTRAS MED, V12, P73; Shechtman O, 2013, CLIN ASSESSMENT RECO; Shen YJ, 2019, J AM MED DIR ASSOC, V20, P5, DOI 10.1016/j.jamda.2018.09.012; SIPILA S, 1993, MUSCLE NERVE, V16, P294, DOI 10.1002/mus.880160309; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Stevens JE, 2003, MUSCLE NERVE, V27, P99, DOI 10.1002/mus.10279; Suzuki M, 2012, DISABIL REHABIL, V34, P202, DOI 10.3109/09638288.2011.593678; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Tieland M, 2018, J CACHEXIA SARCOPENI, V9, P3, DOI 10.1002/jcsm.12238; United Nations DoEaSA, 2017, WORLD POP AG; Van der Heijden MMP, 2009, GAIT POSTURE, V30, P110, DOI 10.1016/j.gaitpost.2009.04.002; Volkers KM, 2012, ARCH GERONTOL GERIAT, V54, P399, DOI 10.1016/j.archger.2011.04.018; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Zech A, 2011, ARCH PHYS MED REHAB, V92, P967, DOI 10.1016/j.apmr.2010.12.031	61	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223016	10.1371/journal.pone.0223016	http://dx.doi.org/10.1371/journal.pone.0223016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550272	Green Published, Green Accepted, gold			2022-12-27	WOS:000532307700041
J	Wei, MH; Chen, XZ; Zhan, XX; Zhang, ZX; Yu, SJ; Yan, WR				Wei, Mu-Hong; Chen, Xian-Zhen; Zhan, Xing-Xin; Zhang, Zhi-Xia; Yu, Shao-Jing; Yan, Wei-Rong			The effect of a web-based training for improving primary health care providers' knowledge about diabetes mellitus management in rural China: A pre-post intervention study	PLOS ONE			English	Article							VILLAGE DOCTORS; PROFESSIONS	Background The performance of primary health care providers regarding DM management is poor in rural China, and effective training methods for providers are urgently needed. This study aimed to evaluate the effect of web-based training for improving knowledge about DM management among primary health care providers in rural China and to further compare the effects of the training effect between primary health care providers with different backgrounds. Methods A pre-post intervention study was conducted from April to August 2014. In this study, a total of 901 primary health care workers were recruited from six counties in Hubei province. To evaluate the effect of the web-based training, the knowledge achievement of participants was measured with multiple choice questions (MCQ) at baseline, at the end of two weeks of training and at three months after training. A mixed linear model (MLM) was used to measure group differences in the mean scores at baseline and follow-up. Results After the web-based training, the knowledge scores of the village doctors increased from 73.58 at baseline to 89.98 at posttest and to 84.57 three months after the training. For township health workers, we observed an upward trend in scores from 78.87 at the pre-test to 91.72 at the second test, and at the three months after the training, the scores increased to 94.91. For village doctors, greater knowledge achievement was observed between the scores at baseline and after two weeks of training(adjusted difference: 3.55, P = 0.03) compared to that observed for the township health workers, while decreased their knowledge achievement between baseline and the third-test compared with that of township health workers (adjusted difference: 5.05, P = 0.01). Conclusions This study suggested that web-based training was an effective method for improving the knowledge of primary health care providers about management of DM in remote areas. Compared with the effect of the training on village doctors, the training had a poor short-term effect on township health workers but a better long-term effect.	[Wei, Mu-Hong; Chen, Xian-Zhen; Zhan, Xing-Xin; Zhang, Zhi-Xia; Yu, Shao-Jing; Yan, Wei-Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, Wuhan, Peoples R China; [Zhan, Xing-Xin] Xinyu Univ, Sch Nursing & Rehabil, Xinyu, Peoples R China; [Zhang, Zhi-Xia] Wuchang Univ Technol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Xinyu University; Wuchang University of Technology	Yan, WR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, Wuhan, Peoples R China.	weirong.yan@hust.edu.cn			Ministry of Science and Technology of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The study was supported by the project "Strengthening Primary Health Care Workers' Competence by Using an Internet-Based Interactive Platform in Rural China" funded by the Ministry of Science and Technology of China.	Ballew P, 2013, HEALTH EDUC RES, V28, P276, DOI 10.1093/her/cys098; Blankstein Udi, 2011, World Neurosurg, V76, P224, DOI 10.1016/j.wneu.2011.02.041; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Ding Y, 2013, B WORLD HEALTH ORGAN, V91, P64, DOI 10.2471/BLT.12.109447; Gannon M, 2010, AM J MED QUAL, V25, P6, DOI 10.1177/1062860609345665; Hart C, 2012, J INTERACT ONLINE LE, V11, P19; Hipgrave D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001337; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hung LM, 2013, FAM PRACT, V30, P576, DOI 10.1093/fampra/cmt026; Khatony A, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-41; Khoja S, 2007, J TELEMED TELECARE, V13, P105, DOI 10.1258/135763307780096131; Li MZ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/753150; Li TT, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1276-y; Li XH, 2015, INT J HEALTH PLAN M, V30, pE42, DOI 10.1002/hpm.2258; Li XM, 2013, POSTGRAD MED J, V89, P202, DOI 10.1136/postgradmedj-2012-131094; Liu XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep31426; Nartker AJ, 2010, HUMAN RESOURCES HLTH, V8, P1, DOI [10.1016/j.wneu.2011.02.041, DOI 10.1016/J.WNEU.2011.02.041]; Paliadelis PS, 2015, COLLEGIAN, V22, P397, DOI 10.1016/j.colegn.2014.08.003; Seble F, 2013, HUMAN RESOURCES HLTH, V11, P1; [孙虹 SUN Hong], 2011, [中国全科医学, Chinese General Practice], V14, P1752; Tang SY, 2009, J HEALTH COMMUN, V14, P690, DOI 10.1080/10810730903204270; Tian MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083822; Wei L, 2008, NW MED ED, DOI [10.1186/1472-6920-8-15, DOI 10.1186/1472-6920-8-15]; Xue Z., 2017, TEACHING FORESTRY RE; Yang LL, 2016, J DIABETES INVEST, V7, P845, DOI 10.1111/jdi.12514; Zhang SF, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0019-1; Zhang ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125975; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094301	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222930	10.1371/journal.pone.0222930	http://dx.doi.org/10.1371/journal.pone.0222930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550282	gold, Green Published			2022-12-27	WOS:000532307700034
J	Teixeira, KRC; de Medeiros, LA; Mendes, JA; Vaz, ER; Cunha, TM; de Oliveira, EP; Penha-Silva, N; Crispim, CA				Cerqueira Teixeira, Kely Raspante; de Medeiros, Luciana Alves; Mendes, Jordane Amaral; Vaz, Emilia Rezende; Cunha, Thulio Marquez; de Oliveira, Erick P.; Penha-Silva, Nilson; Crispim, Cibele Aparecida			The erythrocyte membrane stability is associated with sleep time and social jetlag in shift workers	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; OSMOTIC STABILITY; CIRCADIAN CLOCKS; CHOLESTEROL; CHRONOTYPE; MORTALITY; DISORDER; RHYTHMS; LIPIDS; AGE	The osmotic stability of the erythrocyte membrane (OSEM) has been associated with changes in lipid profile, blood glucose and blood pressure. Changes in these parameters are very frequent in shift workers, possibly because of the lack of synchronization of biological rhythms, which results in the social jetlag. However, the existence of association between OSEM and circadian misalignment has not been investigated in this population. Therefore, this study investigated whether shift work, sleep time and social jetlag (SJL) are associated with biochemical and hematological variables. A population consisting of 79 men working at night (n = 37) or during the day (n = 42), aged between 21 and 65 years and with a mean BMI of 27.56 +/- 4.0 kg/m(2), was investigated cross-sectionally in relation to sleep time, SJL, anthropometric (height, weight and waist circumference) and blood variables, with emphasis on the OSEM. SJL was calculated by the absolute difference between the midpoint of sleep on work and rest days. The Generalized Linear Model (GzLM) was used to investigate the existence of associations between SJL and average sleep time in relation to the analyzed variables. Workers without SJL presented lower baseline lysis values of erythrocytes in isotonic medium in relation to workers with SJL. In addition, workers who slept on average less than 6 hours had higher OSEM, and higher total and LDL-cholesterol in relation to those who slept more than 6 hours, regardless of the shift. It is possible that the association of sleep deprivation and SJL with erythrocyte membrane stability is mediated through changes in the lipid profile.	[Cerqueira Teixeira, Kely Raspante; Mendes, Jordane Amaral; Cunha, Thulio Marquez; de Oliveira, Erick P.; Crispim, Cibele Aparecida] Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil; [de Medeiros, Luciana Alves; Vaz, Emilia Rezende; Penha-Silva, Nilson] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Teixeira, KRC (corresponding author), Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil.	kelyraspante@gmail.com	de Oliveira, Erick P./D-1138-2011; Crispim, Cibele CAC/R-1269-2016; Penha Silva, Nilson/E-5730-2010	de Oliveira, Erick P./0000-0001-8989-8344; Crispim, Cibele CAC/0000-0002-6638-8197; Penha Silva, Nilson/0000-0002-8205-6213	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), for the doctoral scholarship granted to K. R. C. Teixeira;the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), for the funding of this study; the Programa de Pos-Graduacao em Ciencias da Saude (PPGCS) da Universidade Federal de Uberlandia (UFU), which enabled the realization of this research; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), for the productivity grant awarded to N. Penha-Silva; and the study volunteers.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Neto MB, 2013, BIORHEOLOGY, V50, P305, DOI 10.3233/BIR-130641; Bertolazi AN, 2008, TRADUC ADAPTAC CULTU; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Bujak K, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/824624; Burgueno A, 2010, ATHEROSCLEROSIS, V210, P625, DOI 10.1016/j.atherosclerosis.2009.12.032; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chua ECP, 2015, SLEEP, V38, P1683, DOI 10.5665/sleep.5142; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; de Freitas MV, 2008, TOXICOL IN VITRO, V22, P219, DOI 10.1016/j.tiv.2007.07.010; de Freitas MV, 2010, J MEMBRANE BIOL, V233, P127, DOI 10.1007/s00232-010-9232-y; de Goede P, 2018, J MOL ENDOCRINOL, V60, pR115, DOI 10.1530/JME-17-0196; Dinarelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22870-0; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Gaikwad SS, 2017, CURR HYPERTENS, DOI [10.1038/nature09702, DOI 10.1038/NATURE09702]; Gamble KL, 2013, CRIT REV BIOCHEM MOL, V48, P317, DOI 10.3109/10409238.2013.786672; Garrote MD, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0653-2; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Henslee EA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02161-4; HUI SW, 1980, J CELL BIOL, V85, P283, DOI 10.1083/jcb.85.2.283; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juda M, 2013, J BIOL RHYTHM, V28, P130, DOI 10.1177/0748730412475041; Kantermann T, 2012, PROG BRAIN RES, V199, P399, DOI 10.1016/B978-0-444-59427-3.00022-8; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Lasselin J, 2015, BRAIN BEHAV IMMUN, V47, P93, DOI 10.1016/j.bbi.2014.10.004; Lemke MK, 2017, IND HEALTH, V55, P149, DOI 10.2486/indhealth.2016-0127; Li N, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/4626585; Lippi G, 2014, CLIN CHEM LAB MED, V52, P1247, DOI 10.1515/cclm-2014-0585; Loprinzi PD, 2015, AM J HEALTH BEHAV, V39, P471, DOI 10.5993/AJHB.39.4.3; Lu LF, 2016, J OCCUP HEALTH, V58, P81, DOI 10.1539/joh.15-0137-OA; MARKS PA, 1958, J CLIN INVEST, V37, P1542, DOI 10.1172/JCI103746; Netto RDM, 2014, PARASITOL RES, V113, P863, DOI 10.1007/s00436-013-3717-4; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mota MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06723-w; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; Osuntokl A A, 2007, Nig Q J Hosp Med, V17, P148; Padilha HG, 2010, CHRONOBIOL INT, V27, P1080, DOI 10.3109/07420528.2010.489883; Papantoniou K, 2016, EUR J EPIDEMIOL, V31, P867, DOI 10.1007/s10654-015-0073-y; Paraiso LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171318; PARK K I, 1987, Yonsei Medical Journal, V28, P282; Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201; Penha-Silva N, 2007, MECH AGEING DEV, V128, P444, DOI 10.1016/j.mad.2007.06.007; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Pritchett D, 2015, J BIOL RHYTHM, V30, P374, DOI 10.1177/0748730415592729; Puttonen S, 2011, CHRONOBIOL INT, V28, P528, DOI 10.3109/07420528.2011.580869; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; de Freitas MAR, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9628726; Rodrigues R, 2018, DIABETES RES CLIN PR, V144, P153, DOI 10.1016/j.diabres.2018.01.031; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schlafer O, 2014, ANAESTHESIST, V63, P844, DOI 10.1007/s00101-014-2374-z; Schulz P, 2009, CNS DRUGS, V23, P3, DOI 10.2165/11318620-000000000-00000; Su C, 2014, J THORAC DIS, V6, P1429, DOI 10.3978/j.issn.2072-1439.2014.09.10; Tai SY, 2014, IND HEALTH, V52, P296, DOI 10.2486/indhealth.2014-0009; Tziakas D, 2012, CLIN HEMORHEOL MICRO, V51, P243, DOI 10.3233/CH-2012-1530; Tziakas DN, 2010, INT J CARDIOL, V142, P2, DOI 10.1016/j.ijcard.2009.10.031; Vetter C, 2015, CURR BIOL, V25, P907, DOI 10.1016/j.cub.2015.01.064; Waterhouse J, 2003, CHRONOBIOL INT, V20, P1075, DOI 10.1081/CBI-120025536; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wonnerth A, 2016, EUR J CLIN INVEST, V46, P198, DOI 10.1111/eci.12584; World Health Organization, 2008, WAIST CIRCUMFERENCE	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222698	10.1371/journal.pone.0222698	http://dx.doi.org/10.1371/journal.pone.0222698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545844	Green Published, gold			2022-12-27	WOS:000532303200027
J	Thomas, T; Chandan, JS; Li, VSW; Lai, CY; Tang, W; Bhala, N; Kaplan, GG; Ng, SC; Ghosh, S				Thomas, Tom; Chandan, Joht Singh; Li, Venice Sze Wai; Lai, Cheuk Yin; Tang, Whitney; Bhala, Neeraj; Kaplan, Gilaad G.; Ng, Siew C.; Ghosh, Subrata			Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts	PLOS ONE			English	Review							POPULATION-BASED COHORT; ULCERATIVE-COLITIS; CROHNS-DISEASE; RISK-FACTORS; CLINICAL CHARACTERISTICS; CHINESE POPULATION; HONG-KONG; EPIDEMIOLOGY; REGION; PREVALENCE	Background and aims The effect of smoking on the risk of developing inflammatory bowel diseases (IBD) may be heterogeneous across ethnicity and geography. Although trends in smoking for the general population are well described, it is unknown whether these can be extrapolated to the IBD cohort. Smoking prevalence trends specific to the global IBD cohort over time have not been previously reported. This is a systematic review of smoking prevalence specific to the IBD cohort across geography. Methods A systematic literature search was conducted on Medline and Embase from January 1st 1946 to April 5th 2018 to identify population-based studies assessing the prevalence of smoking at diagnosis in inception cohorts of Crohn's disease(CD) or ulcerative colitis(UC). Studies that did not report smoking data from time of diagnosis or the year of IBD diagnosis were excluded. Prevalence of smoking in IBD was stratified by geography and across time. Results We identified 56 studies that were eligible for inclusion. Smoking prevalence data at diagnosis of CD and UC was collected from twenty and twenty-five countries respectively. Neversmokers in the newly diagnosed CD population in the West has increased over the last two decades, especially in the United Kingdom and Sweden; +26.6% and +11.2% respectively. Never-smokers at CD diagnosis in newly industrialised nations have decreased over the 1990s and 2000s; China (-19.36%). Never-smokers at UC diagnosis also decreased in China; -15.4%. The former-smoker population at UC diagnosis in China is expanding; 11% (1990-2006) to 34%(2011-2013). Conclusion There has been a reduction in the prevalence of smoking in the IBD cohort in the West. This is not consistent globally. Although, smoking prevalence has decreased in the general population of newly industrialised nations, this remains an important risk factor with longer term outcomes awaiting translation in both UC and CD.	[Thomas, Tom] Univ Oxford, Translat Gastroenterol Unit, Oxford, England; [Thomas, Tom; Chandan, Joht Singh; Bhala, Neeraj] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Li, Venice Sze Wai; Lai, Cheuk Yin; Tang, Whitney; Ng, Siew C.] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, State Key Lab Digest Dis,LKS Inst Hlth Sci, Hong Kong, Peoples R China; [Bhala, Neeraj; Ghosh, Subrata] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Kaplan, Gilaad G.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Kaplan, Gilaad G.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Ghosh, Subrata] Univ Birmingham, Inst Translat Med, NIHR Biomed Res Ctr Birmingham, Birmingham, W Midlands, England	University of Oxford; University of Birmingham; Chinese University of Hong Kong; University of Birmingham; University of Calgary; University of Calgary; University of Birmingham	Thomas, T (corresponding author), Univ Oxford, Translat Gastroenterol Unit, Oxford, England.; Thomas, T (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	tom.thomas@nhs.net	Ng, Siew Chien/N-4733-2015; Kaplan, Gil/AAH-2335-2021; Ghosh, Subrata/AAC-2676-2021; Chandan, Joht Singh/D-6361-2015	Ng, Siew Chien/0000-0002-6850-4454; Kaplan, Gil/0000-0003-2719-0556; Ghosh, Subrata/0000-0002-1713-7797; Chandan, Joht Singh/0000-0002-9561-5141; Tang, Whitney/0000-0002-2355-4933; Bhala, Neeraj/0000-0003-2502-1177	NIHR Biomedical Research Centre, Birmingham	NIHR Biomedical Research Centre, Birmingham	SG is supported by the NIHR Biomedical Research Centre, Birmingham.	Abakar-Mahamat A, 2007, GASTROEN CLIN BIOL, V31, P1098, DOI 10.1016/S0399-8320(07)78343-4; Abraham N, 2003, J GASTROEN HEPATOL, V18, P139, DOI 10.1046/j.1440-1746.2003.02953.x; [Anonymous], 2000, EUR J GASTROEN HEPAT, V12, P31, DOI [10.1097/00042737-200012010-00007, DOI 10.1097/00042737-200012010-00007]; Bjornsson S, 1998, SCAND J GASTROENTERO, V33, P71; Bjornsson S, 2015, SCAND J GASTROENTERO, V50, P1368, DOI 10.3109/00365521.2015.1047792; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; Carr I, 1999, AM J GASTROENTEROL, V94, P2918, DOI 10.1016/S0002-9270(99)00494-3; Chhaya V, 2016, EUR J GASTROEN HEPAT, V28, P890, DOI 10.1097/MEG.0000000000000651; Chow DKL, 2009, AM J GASTROENTEROL, V104, P647, DOI 10.1038/ajg.2008.74; Cottone M, 2006, EUR J EPIDEMIOL, V21, P887, DOI 10.1007/s10654-006-9054-5; Edwards CN, 2008, INFLAMM BOWEL DIS, V14, P1419, DOI 10.1002/ibd.20495; Fraga XF, 1997, EUR J GASTROEN HEPAT, V9, P683, DOI 10.1097/00042737-199707000-00007; FRANCESCHI S, 1987, AM J EPIDEMIOL, V125, P445, DOI 10.1093/oxfordjournals.aje.a114550; Garcia-Fontana B, 2015, INT J MOL SCI, V16, P9469, DOI 10.3390/ijms16059469; Garrido A, 2004, REV ESP ENFERM DIG, V96, P687; Gheorghe C, 2004, EUR J GASTROEN HEPAT, V16, P1153, DOI 10.1097/00042737-200411000-00012; Gunesh S, 2008, ALIMENT PHARM THER, V27, P211, DOI 10.1111/j.1365-2036.2007.03576.x; Hammer T, 2016, J CROHNS COLITIS, V10, P934, DOI 10.1093/ecco-jcc/jjw050; Inoue N, 2002, GASTROENTEROLOGY, V123, P86, DOI 10.1053/gast.2002.34155; Jiang L, 2007, J CLIN GASTROENTEROL, V41, P280, DOI 10.1097/01.mcg.0000225644.75651.f1; Kaplan GG, 2016, LANCET GASTROENTEROL, V1, P307, DOI 10.1016/S2468-1253(16)30077-2; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Kaplan GG, 2010, AM J GASTROENTEROL, V105, P2412, DOI 10.1038/ajg.2010.252; Kennedy NA, 2019, LANCET GASTROENTEROL, V4, P341, DOI 10.1016/S2468-1253(19)30012-3; Kiudelis G, 2012, MEDICINA-LITHUANIA, V48, P431, DOI 10.3390/medicina48080064; KONO S, 1995, J GASTROENTEROL, V30, P9; Kuenzig ME, 2017, EBIOMEDICINE, V21, P188, DOI 10.1016/j.ebiom.2017.06.012; Ladas SD, 2005, WORLD J GASTROENTERO, V11, P1785, DOI 10.3748/wjg.v11.i12.1785; Lakatos L, 2011, INFLAMM BOWEL DIS, V17, P2558, DOI 10.1002/ibd.21607; Lakatos PL, 2013, INFLAMM BOWEL DIS, V19, P1010, DOI 10.1097/MIB.0b013e3182802b3e; Lawrance Ian C, 2013, J Crohns Colitis, V7, pe665, DOI 10.1016/j.crohns.2013.05.007; Leong RWL, 2004, INFLAMM BOWEL DIS, V10, P646, DOI 10.1097/00054725-200409000-00022; Lok K. H., 2007, Hong Kong Medical Journal, V13, P436; Lok KH, 2008, J GASTROEN HEPATOL, V23, P406, DOI 10.1111/j.1440-1746.2007.05079.x; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Parente JML, 2015, WORLD J GASTROENTERO, V21, P1197, DOI 10.3748/wjg.v21.i4.1197; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Manousos ON, 1996, SCAND J GASTROENTERO, V31, P599, DOI 10.3109/00365529609009134; Manousos ON, 1996, EUR J GASTROEN HEPAT, V8, P893; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NAKAMURA Y, 1994, AM J EPIDEMIOL, V140, P902, DOI 10.1093/oxfordjournals.aje.a117178; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Ng SC, 2015, GUT, V64, P1063, DOI 10.1136/gutjnl-2014-307410; Niewiadomski O, 2015, J GASTROEN HEPATOL, V30, P1346, DOI 10.1111/jgh.12967; Nunes T, 2013, ALIMENT PHARM THER, V38, P752, DOI 10.1111/apt.12440; Ott C, 2008, EUR J GASTROEN HEPAT, V20, P917, DOI 10.1097/MEG.0b013e3282f97b33; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P919, DOI 10.1111/j.1440-1746.2011.06984.x; PROBERT CSJ, 1992, GUT, V33, P687, DOI 10.1136/gut.33.5.687; Radhakrishnan S, 1997, DIGESTION, V58, P266, DOI 10.1159/000201453; Ramadas AV, 2010, GUT, V59, P1200, DOI 10.1136/gut.2009.202101; Ranzi T, 1996, EUR J GASTROEN HEPAT, V8, P657; REIF S, 1995, GASTROENTEROLOGY, V108, P1683, DOI 10.1016/0016-5085(95)90129-9; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Rodrigo L, 2004, REV ESP ENFERM DIG, V96, P296; Rodriguez LAG, 2005, ALIMENT PHARM THER, V22, P309, DOI 10.1111/j.1365-2036.2005.02564.x; Romberg-Camps MJL, 2009, J CROHNS COLITIS, V3, P115, DOI 10.1016/j.crohns.2008.12.002; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; Sjoberg D, 2014, J CROHNS COLITIS, V8, P215, DOI 10.1016/j.crohns.2013.08.009; Sjoberg D, 2013, J CROHNS COLITIS, V7, pE351, DOI 10.1016/j.crohns.2013.02.006; Song EM, 2018, J GASTROEN HEPATOL, V33, P172, DOI 10.1111/jgh.13826; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tezel A, 2003, J INT MED RES, V31, P141, DOI 10.1177/147323000303100211; Tozun N, 2009, J CLIN GASTROENTEROL, V43, P51, DOI 10.1097/MCG.0b013e3181574636; TRAGNONE A, 1993, DIGESTION, V54, P183, DOI 10.1159/000201036; Tsironi E, 2004, AM J GASTROENTEROL, V99, P1749, DOI 10.1111/j.1572-0241.2004.30445.x; van der Heide F, 2011, EUR J GASTROEN HEPAT, V23, P255, DOI 10.1097/MEG.0b013e3283435233; Vegh Z, 2014, J CROHNS COLITIS, V8, P1506, DOI 10.1016/j.crohns.2014.06.004; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; VUCELIC B, 1991, INT J EPIDEMIOL, V20, P216, DOI 10.1093/ije/20.1.216; Yamamoto-Furusho JK, 2009, J CLIN GASTROENTEROL, V43, P221, DOI 10.1097/MCG.0b013e31817a76b4; Yang H, 2014, PLOS ONE, V9, P5; Yapp TR, 2000, EUR J GASTROENTEROL, V12; Zahedi Mohammad Javad, 2014, Middle East J Dig Dis, V6, P32; Zeng ZR, 2013, J GASTROEN HEPATOL, V28, P1148, DOI 10.1111/jgh.12164; Zhai HH, 2017, GASTROENTEROL REV, V12, P286, DOI 10.5114/pg.2017.72104; Zhao J, 2013, INFLAMM BOWEL DIS, V19, P1839, DOI 10.1097/MIB.0b013e31828a6551	79	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221961	10.1371/journal.pone.0221961	http://dx.doi.org/10.1371/journal.pone.0221961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545811	Green Published, gold			2022-12-27	WOS:000532303200013
J	Jonsson, T; Eek, F; Dell'Isola, A; Dahlberg, LE; Hansson, EE				Jonsson, Therese; Eek, Frida; Dell'Isola, Andrea; Dahlberg, Leif E.; Hansson, Eva Ekvall			The Better Management of Patients with Osteoarthritis Program: Outcomes after evidence-based education and exercise delivered nationwide in Sweden	PLOS ONE			English	Article							SELF-EFFICACY; PHYSICAL-ACTIVITY; KNEE OSTEOARTHRITIS; HIP; GUIDELINES; QUALITY; HEALTH; CARE; APPROPRIATENESS; PAIN	We evaluated a structured education- and exercise-based self-management program for patients with knee or hip osteoarthritis (OA), using a registry-based study of data from 44,634 patients taken from the Swedish "Better Management of Patients with Osteoarthritis" registry. Outcome measures included a numeric rating scale (NRS), EuroQol five dimension scale (EQ-5D), Arthritis self-efficacy scale (ASES-pain and ASES-other symptoms), pain frequency, any use of OA medication, desire for surgery, fear-avoidance behavior, physical activity, and sick leave were reported at baseline, 3 and 12 month. Changes in scale variables were analyzed using general linear models for repeated measures and changes in binary variables by McNamara's test. All analyses were stratified by joint. At the 3-month follow-up, patients with knee (n = 30686) and hip (n = 13948) OA reported significant improvements in the NRS-pain, the EQ-5D index, the ASES-other symptoms, and ASES-pain scores with standardized effect size (ES) ranges for patients with knee OA of 0.25-0.57 and hip OA of 0.15-0.39. Significantly fewer patients reported pain more than once weekly, took OA medication, desired surgery, showed fear-avoidance behavior, and were physically inactive. At the 12-month follow-up, patients with knee (n = 21647) and hip (n = 8898) OA reported significant improvements in NRS-pain, EQ-5D index, and a decrease in ASESother symptoms and ASES-pain scores with an ES for patients with knee OA of -0.04 to 0.43 and hip OA of -0.18 to 0.22. Significantly fewer patients reported daily pain, desired surgery (for hip OA), reported fear-avoidance behavior, and reported sick leave. Following these interventions, patients with knee and hip OA experienced significant reductions in symptoms and decreased willingness to undergo surgery, while using less OA medication and taking less sick leave. The results indicate that offering this program as the first-line treatment for OA patients may reduce the burden of this disease.	[Jonsson, Therese; Dell'Isola, Andrea; Dahlberg, Leif E.] Lund Univ, Dept Clin Sci Lund, Ortoped, Lund, Sweden; [Eek, Frida; Hansson, Eva Ekvall] Lund Univ, Dept Hlth Sci, Div Physiotherapy, Lund, Sweden	Lund University; Lund University	Jonsson, T (corresponding author), Lund Univ, Dept Clin Sci Lund, Ortoped, Lund, Sweden.	therese.jonsson@med.lu.se	Hanson, Eva Ekvall/AAX-6130-2021; Eek, Frida/AAE-2299-2022	Eek, Frida/0000-0002-7043-589X; Dell'Isola, Andrea/0000-0002-0319-458X; Jonsson, Therese/0000-0002-4854-4707	Governmental Funding of Clinical Research within the National Health Service [ALFSKANE-429831]	Governmental Funding of Clinical Research within the National Health Service	This study was supported by a grant awarded to LED from Governmental Funding of Clinical Research within the National Health Service (grant number: ALFSKANE-429831; https://ansok.med.lu.se/sbs/lunds_mf/minsida/login/enkel).Leif Dahlberg is a co-founder and paid employee of Joint Academy. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basedow M, 2015, J EVAL CLIN PRACT, V21, P782, DOI 10.1111/jep.12402; Brand E, 2013, J ORTHOP SPORT PHYS, V43, P895, DOI 10.2519/jospt.2013.4471; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coleman S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3703; Cronstrom A, 2019, ARTHRIT CARE RES, V71, P1194, DOI 10.1002/acr.23772; Cronstrom A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028388; Dahlberg LE, 2016, JMIR RES PROTOC, V5, DOI [10.2196/resprot.5665, 10.2196/resprot.5881]; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Egerton T, 2017, OSTEOARTHR CARTILAGE, V25, P625, DOI 10.1016/j.joca.2016.12.002; Fernandes L, 2013, ANN RHEUM DIS, V72, P1125, DOI 10.1136/annrheumdis-2012-202745; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Garellick G., 2014, BETTER MANAGEMENT PA; Ghomrawi HMK, 2012, NEW ENGL J MED, V367, P2467, DOI 10.1056/NEJMp1209998; Goh SL, 2019, SPORTS MED; Greene ME, 2015, CLIN ORTHOP RELAT R, V473, P3370, DOI 10.1007/s11999-015-4195-z; Hagen KB, 2016, ARTHRIT CARE RES, V68, P1443, DOI 10.1002/acr.22891; Hansson EE, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-244; Hartrick Craig T, 2003, Pain Pract, V3, P310; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hubertsson J, 2013, ANN RHEUM DIS, V72, P401, DOI 10.1136/annrheumdis-2012-201472; Hurley MV, 2007, ARTHRIT RHEUM-ARTHR, V57, P1211, DOI 10.1002/art.22995; Johan Karrholm MM, 2018, ANN REPPORT 2017; Jonsson T, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2098-3; Kingsbury SR, 2014, RHEUMATOLOGY, V53, P937, DOI 10.1093/rheumatology/ket463; Larmer PJ, 2014, ARCH PHYS MED REHAB, V95, P375, DOI 10.1016/j.apmr.2013.10.011; Lin CWC, 2010, PHYS THER, V90, P839, DOI 10.2522/ptj.20100084; LOMI C, 1992, SCAND J RHEUMATOL, V21, P231, DOI 10.3109/03009749209099230; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Min J, 2018, DRUG SAFETY, V41, P313, DOI 10.1007/s40264-017-0611-5; Misso ML, 2008, MED J AUSTRALIA, V189, P394, DOI 10.5694/j.1326-5377.2008.tb02086.x; Olsson SJG, 2016, SCAND J PUBLIC HEALT, V44, P70, DOI 10.1177/1403494815602830; Pisters MF, 2007, ARTHRIT RHEUM-ARTHR, V57, P1245, DOI 10.1002/art.23009; Riddle DL, 2014, ARTHRITIS RHEUMATOL, V66, P2134, DOI 10.1002/art.38685; Risberg M, 2018, OSTEOARTHR CARTILAGE, V26, pS34, DOI 10.1016/j.joca.2018.02.084; Skelly AC, 2018, AHRQ COMP EFFECTIVEN; Skou ST, 2018, OSTEOARTHR CARTILAGE, V26, P1170, DOI 10.1016/j.joca.2018.04.014; Skou ST, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1439-y; Svege I, 2015, ANN RHEUM DIS, V74, P164, DOI 10.1136/annrheumdis-2013-203628; Thong ISK, 2018, SCAND J PAIN, V18, P99, DOI 10.1515/sjpain-2018-0012; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	45	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222657	10.1371/journal.pone.0222657	http://dx.doi.org/10.1371/journal.pone.0222657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536554	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800068
J	Koplenig, A				Koplenig, Alexander			A non-parametric significance test to compare corpora	PLOS ONE			English	Article							STATISTICAL TESTS; P-VALUES; SCIENCE; INFERENCE; CORPUS	Classical null hypothesis significance tests are not appropriate in corpus linguistics, because the randomness assumption underlying these testing procedures is not fulfilled. Nevertheless, there are numerous scenarios where it would be beneficial to have some kind of test in order to judge the relevance of a result (e.g. a difference between two corpora) by answering the question whether the attribute of interest is pronounced enough to warrant the conclusion that it is substantial and not due to chance. In this paper, I outline such a test.	[Koplenig, Alexander] Leibniz Inst German Language IDS, Mannheim, Germany		Koplenig, A (corresponding author), Leibniz Inst German Language IDS, Mannheim, Germany.	koplenig@ids-mannheim.de			Open Access Fund of the Leibniz Association	Open Access Fund of the Leibniz Association	The publication of this article was partially funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Amrhein V, 2019, AM STAT, V73, P262, DOI 10.1080/00031305.2018.1543137; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Austen J., 2010, COMPLETE PROJECT GUT; Baayen R. Harald, 2001, WORD FREQUENCY DISTR; Baroni M, 2009, HANDB SPRACH KOMMUN, V29, P777; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Berk RA, 2003, LAW PUNISHMENT SOCIA; Biber D, 2009, HDB LINGUISTICS COMM, DOI [10.1515/9783110213881.2.1286, DOI 10.1515/9783110213881.2.1286]; Biber D., 1993, LIT LINGUIST COMPUT, V8, P243, DOI [DOI 10.1093/LLC/8.4.243, 10.1093/llc/8.4.243]; Bornstein MH, 2013, DEV REV, V33, P357, DOI 10.1016/j.dr.2013.08.003; Brezina V, 2014, INT J CORPUS LINGUIS, V19, P1, DOI 10.1075/ijcl.19.1.01bre; Camerer CF, 2018, NAT HUM BEHAV, V2, P637, DOI 10.1038/s41562-018-0399-z; Camerer CF, 2016, SCIENCE, V351, P1433, DOI 10.1126/science.aaf0918; Campbell H, 2019, AM STAT, V73, P358, DOI 10.1080/00031305.2018.1555101; CARVER RP, 1993, J EXP EDUC, V61, P287, DOI 10.1080/00220973.1993.10806591; Chavalarias D, 2016, JAMA-J AM MED ASSOC, V315, P1141, DOI 10.1001/jama.2016.1952; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Davies M., 2010, CORPUS HIST AM ENGLI; Diekmann A, 2002, EMPIRISCHE SOZIALFOR; Dunning T., 1993, Computational Linguistics, V19, P61; Evert S, 2006, Z ANGLIST AM, V54, P177; Fahrmeir L, 2001, STAT WEG DATENANALYS; FISHER R. A., 1935, The design of experiments.; Fisher RA, 1936, J R ANTHROPOL INST G, V66, P57, DOI 10.2307/2844116; Fisher RA, 1929, P SOC PSYCHICAL RES, V39, P189; FRANCIS WN, 1965, COLL ENGL, V26, P267, DOI 10.2307/373638; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Freedman DA, 1983, SIGNIFICANCE TESTING, P185; GAIL MH, 1988, BIOMETRIKA, V75, P57, DOI 10.1093/biomet/75.1.57; Gandy A, 2009, J AM STAT ASSOC, V104, P1504, DOI 10.1198/jasa.2009.tm08368; Glass G.V., 1996, STAT METHODS ED PSYC, V3; Good P, 2005, PERMUTATION PARAMETR; Goodman SN, 2019, AM STAT, V73, P26, DOI 10.1080/00031305.2018.1558111; Gries Stefan T., 2008, INT J CORPUS LINGUIS, V13, P403, DOI DOI 10.1075/IJCL.13.4.02GRI; Gries STh, 2013, RES METHODS LINGUIST, P316; GRISCHKE EM, 1994, 2ND EUROPEAN CONGRESS IN GYNAECOLOGICAL ENDOSCOPY AND NEW SURGICAL TECHNIQUES, P49; Hubbard DW, 2019, AM STAT, V73, P46, DOI 10.1080/00031305.2018.1543138; Ioannidis JPA, 2019, AM STAT, V73, P20, DOI 10.1080/00031305.2018.1447512; Johnson RA, 2011, INT ENCY STAT SCI, P1418, DOI [10.1007/978-3-642-04898-2_545, DOI 10.1007/978-3-642-04898-2_545]; Johnson W, 1944, PSYCHOL MONOGR, V56, P1, DOI 10.1037/h0093508; Kilgarriff A., 2005, CORPUS LINGUIST LING, V1, P263, DOI [10.1515/cllt.2005.1.2.263, DOI 10.1515/CLLT.2005.1.2.263]; Kmetz JL, 2019, AM STAT, V73, P36, DOI 10.1080/00031305.2018.1518271; Kohler R, 2012, QUANT LINGUIST, V65, P1, DOI 10.1515/9783110272925; Kohnen T, 2007, MULTIMEDIA CORPUS ST; Koplenig A, LANGUAGE STRUCTURE I; Koplenig A, 2019, CORPUS LINGUIST LING, V15, P321, DOI 10.1515/cllt-2016-0036; Koplenig A, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181274; Leech G, 2007, LANG COMPUT, V59, P133; Leek J, 2017, NATURE, V551, P557; LEVIN B, 1983, LAW CONTEMP PROBL, V46, P247, DOI 10.2307/1191601; Lijffijt J, 2016, DIGIT SCHOLARSH HUM, V31, P374, DOI 10.1093/llc/fqu064; McEnery A., 1996, CORPUS LINGUISTICS; McShane BB, 2019, AM STAT, V73, P235, DOI 10.1080/00031305.2018.1527253; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Oakes Michael, 1998, STAT CORPUS LINGUIST; Paquot M, 2009, LANG COMPUT, P247; Perkuhn Rainer, 2012, KORPUSLINGUISTIK; PITMAN E. J. G., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P119; Rayson P., 2000, ASS COMPUTATIONAL LI, P1, DOI 10.3115/1117729.1117730; Rieger B, 1979, MONOGRAPHIEN LINGUIS, P52; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneider JW, 2015, SCIENTOMETRICS, V102, P411, DOI 10.1007/s11192-014-1251-5; Schneider JW, ABS11122516 CORR; Shakespeare W., 2007, COMPLETE WORKS W SHA; SHAVER JP, 1993, J EXP EDUC, V61, P293, DOI 10.1080/00220973.1993.10806592; STILL AW, 1981, BRIT J MATH STAT PSY, V34, P243, DOI 10.1111/j.2044-8317.1981.tb00634.x; Tong C, 2019, AM STAT, V73, P246, DOI 10.1080/00031305.2018.1518264; Trafimow D, 2019, AM STAT, V73, P340, DOI 10.1080/00031305.2018.1537888; Tweedie FJ, 1998, COMPUT HUMANITIES, V32, P323, DOI 10.1023/A:1001749303137; Wald A, 1944, ANN MATH STAT, V15, P358, DOI 10.1214/aoms/1177731207; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Winkler AM, 2015, NEUROIMAGE, V123, P253, DOI 10.1016/j.neuroimage.2015.05.092; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	78	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222703	10.1371/journal.pone.0222703	http://dx.doi.org/10.1371/journal.pone.0222703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536558	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800072
J	Nakanishi, M; Yamasaki, S; Endo, K; Ando, S; Morimoto, Y; Fujikawa, S; Kanata, S; Takahashi, Y; Furukawa, TA; Richards, M; Hiraiwa-Hasegawa, M; Kasai, K; Nishida, A				Nakanishi, Miharu; Yamasaki, Syudo; Endo, Kaori; Ando, Shuntaro; Morimoto, Yuko; Fujikawa, Shinya; Kanata, Sho; Takahashi, Yusuke; Furukawa, Toshi A.; Richards, Marcus; Hiraiwa-Hasegawa, Mariko; Kasai, Kiyoto; Nishida, Atsushi			The association between role model presence and self-regulation in early adolescence: A cross-sectional study	PLOS ONE			English	Article							HOPEFUL FUTURE EXPECTATIONS; MENTAL-HEALTH OUTCOMES; GENDER; BEHAVIOR; RISK	Purpose Self-regulation is the capacity to regulate attention, emotion, and behaviour to pursue long-term goals. The current study examined the associations between role model presence and self-regulation during early adolescence, controlling for hopefulness, using a large population-based data set from the Tokyo Teen Cohort study. Methods Adolescents, aged 12 years, identified a role model using a single item on a paper questionnaire: 'Who is the person you most look up to?' Level of hopefulness was also assessed using a single question: 'To what extent do you feel hopeful about the future of your life?' Trained investigators evaluated self-regulation. Results Of 2550 adolescents, 2279 (89.4%) identified a role model. After adjusting for level of hopefulness, identifying a role model was associated with higher levels of self-regulation in comparison to indications of no role model. Hopeful future expectations were also associated with higher self-regulation; however, the beta coefficient was smaller than role model presence in the multivariate linear regression analysis. Conclusions Role model presence was significantly associated with higher self-regulation among early adolescents. Educational environments should focus on support for adolescents with no role models.	[Nakanishi, Miharu] Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Setagaya Ku, Tokyo, Japan; [Yamasaki, Syudo; Endo, Kaori; Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Mental Hlth Promot Project, Setagaya Ku, Tokyo, Japan; [Ando, Shuntaro; Fujikawa, Shinya; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo, Japan; [Morimoto, Yuko] Grad Univ Adv Studies, Sch Adv Sci, Hayama, Kanagawa, Japan; [Fujikawa, Shinya] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic, Australia; [Kanata, Sho] Teikyo Univ, Dept Psychiat, Sch Med, Tokyo, Japan; [Takahashi, Yusuke] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan; [Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Richards, Marcus] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Hiraiwa-Hasegawa, Mariko] Grad Univ Adv Studies, Sch Adv Sci, SOKENDAI, Hayama, Kanagawa, Japan; [Kasai, Kiyoto] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Inst Adv Study UTIAS, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Graduate University for Advanced Studies - Japan; Murdoch Children's Research Institute; Teikyo University; Kyoto University; Kyoto University; University of London; University College London; Graduate University for Advanced Studies - Japan; University of Tokyo	Nakanishi, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Setagaya Ku, Tokyo, Japan.	mnakanishi-tky@umin.ac.jp	Nakanishi, Miharu/AAC-7637-2020; Kanata, Sho/AAY-7770-2021; Furukawa, Toshi A./B-9259-2011; Endo, Kaori/ABB-8633-2021; Andoh, Akira/AAB-9303-2022	Nakanishi, Miharu/0000-0001-6200-9279; Furukawa, Toshi A./0000-0003-2159-3776; Endo, Kaori/0000-0003-0854-5120; Richards, Marcus/0000-0001-9191-2192; Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP23118002, JP16H06398, JP16H06395]; UTokyo Center for Integrative Science of Human Behavior (CiSHuB); International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS); MRC [MC_UU_00019/3] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); UTokyo Center for Integrative Science of Human Behavior (CiSHuB); International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Grant-inAid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [grant numbers JP23118002, JP16H06398, JP16H06395]. This work was partly supported by UTokyo Center for Integrative Science of Human Behavior (CiSHuB) and the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2019, INT J EPIDEMIOL, V48, P1414, DOI 10.1093/ije/dyz033; Australian Institute of Family Studies, 2017, LONG STUD AUSTR CHIL; Beal SJ, 2016, DEV PSYCHOL, V52, P1606, DOI 10.1037/dev0000189; Callina KS, 2014, J YOUTH ADOLESCENCE, V43, P869, DOI 10.1007/s10964-014-0096-9; Cham H, 2017, MULTIVAR BEHAV RES, V52, P12, DOI 10.1080/00273171.2016.1245600; Duckworth A, 2014, CURR DIR PSYCHOL SCI, V23, P319, DOI 10.1177/0963721414541462; Duckworth AL, 2011, EDUC PSYCHOL-UK, V31, P17, DOI 10.1080/01443410.2010.506003; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Fergusson DM, 2005, PSYCHOL MED, V35, P983, DOI 10.1017/S0033291704004167; Gestsdottir S, 2010, J YOUTH ADOLESCENCE, V39, P764, DOI 10.1007/s10964-010-9537-2; Hadjicharalambous MZ, 2018, CHILD PSYCHIAT HUM D, V49, P331, DOI 10.1007/s10578-017-0753-9; Hoffner C, 2005, MEDIA PSYCHOL, V7, P325, DOI 10.1207/S1532785XMEP0704_2; Howard SJ, 2018, J DEV BEHAV PEDIATR, V39, P489, DOI 10.1097/DBP.0000000000000578; Hurd NM, 2009, J YOUTH ADOLESCENCE, V38, P777, DOI 10.1007/s10964-008-9296-5; Kanata S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158786; Kim HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190896; Laceulle OM, 2019, DEV PSYCHOPATHOL, V31, P279, DOI 10.1017/S0954579417001808; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; Lerner RM, 2005, J EARLY ADOLESCENCE, V25, P10, DOI 10.1177/0272431604273211; Matthews JS, 2009, J EDUC PSYCHOL, V101, P689, DOI 10.1037/a0014240; Mistry R, 2009, PREV MED, V48, P291, DOI 10.1016/j.ypmed.2008.12.013; Montroy JJ, 2016, DEV PSYCHOL, V52, P1744, DOI 10.1037/dev0000159; Nishida A, 2014, SCHIZOPHRENIA BULL, V40, P1543, DOI 10.1093/schbul/sbu050; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Schmid KL, 2011, J ADOLESCENCE, V34, P1127, DOI 10.1016/j.adolescence.2011.07.009; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Steinke J, 2005, SCI COMMUN, V27, P27, DOI 10.1177/1075547005278610; Stoddard SA, 2015, AM J COMMUN PSYCHOL, V56, P332, DOI 10.1007/s10464-015-9754-7; Stoker JI, 2012, J BUS PSYCHOL, V27, P31, DOI 10.1007/s10869-011-9210-0; Trzesniewski KH, 2006, DEV PSYCHOL, V42, P381, DOI 10.1037/0012-1649.42.2.381; Xu MK, 2013, PSYCHOL AGING, V28, P958, DOI 10.1037/a0033787; Yamasaki Syudo, 2016, Schizophr Res Cogn, V4, P18, DOI 10.1016/j.scog.2016.04.001; Yancey AK, 2002, ARCH PEDIAT ADOL MED, V156, P55, DOI 10.1001/archpedi.156.1.55; Yancey AK, 2011, J ADOLESCENT HEALTH, V48, P36, DOI 10.1016/j.jadohealth.2010.05.001	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222752	10.1371/journal.pone.0222752	http://dx.doi.org/10.1371/journal.pone.0222752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536579	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800081
J	McKee, KL; Neale, MC				McKee, Kevin L.; Neale, Michael C.			Direct estimation of the parameters of a delayed, intermittent activation feedback model of postural sway during quiet standing	PLOS ONE			English	Article							ANKLE STIFFNESS; OPEN-LOOP; BALANCE; AGE	Human postural sway during quiet standing has been characterized as a proportional-integral-derivative controller with intermittent activation. In the model, patterns of sway result from both instantaneous, passive, mechanical resistance and delayed, intermittent resistance signaled by the central nervous system. A Kalman-Filter framework was designed to directly estimate from experimental data the parameters of the model's stochastic delay differential equations with discrete dynamic switching conditions. Simulations showed that all parameters could be estimated over a variety of possible data-generating configurations with varying degrees of bias and variance depending on their empirical identification. Applications to experimental data reveal distributions of each parameter that correspond well to previous findings, suggesting that many useful, physiological measures may be extracted from sway data. Individuals varied in degree and type of deviation from theoretical expectations, ranging from harmonic oscillation to non-equilibrium Langevin dynamics.	[McKee, Kevin L.; Neale, Michael C.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA	Virginia Commonwealth University	McKee, KL (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	mckeek@vcu.edu		McKee, Kevin/0000-0003-0803-9826	 [NIDA 5 R25 DA026119 10]; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	MCN was funded under NIDA 5 R25 DA026119 10 (drugabuse.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl RZ, 2014, GENETICS, V196, P1227, DOI 10.1534/genetics.113.158808; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Bosek M, 2005, NEUROSCI LETT, V376, P215, DOI 10.1016/j.neulet.2004.11.056; Bosek M, 2004, HUM MOVEMENT SCI, V22, P649, DOI 10.1016/j.humov.2004.02.005; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Eddelbuettel D., 2017, PEERJ PREPRINTS, V5, DOI [10.7287/peerj.preprints.3188v1, DOI 10.7287/PEERJ.PREPRINTS.3188V1]; Eddelbuettel D, 2014, COMPUT STAT DATA AN, V71, P1054, DOI 10.1016/j.csda.2013.02.005; Eurich C. W., 1996, Physical Review E (Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics), V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gawthrop PJ, 2007, P I MECH ENG I-J SYS, V221, P1007, DOI 10.1243/09596518JSCE417; Gawthrop P, 2014, BIOL CYBERN, V108, P159, DOI 10.1007/s00422-014-0587-5; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gottschall J, 2009, PHYS LETT A, V373, P811, DOI 10.1016/j.physleta.2008.12.026; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Kalman RE, 1961, J BASIC ENG, V83; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lauk M, 1998, PHYS REV LETT, V80, P413, DOI 10.1103/PhysRevLett.80.413; Li Y, 2012, IEEE T NEUR SYS REH, V20, P738, DOI 10.1109/TNSRE.2012.2199333; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Vieira TDM, 2009, J ELECTROMYOGR KINES, V19, pE513, DOI 10.1016/j.jelekin.2008.10.007; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Michimoto K, 2016, IEEE ENG MED BIO, P37, DOI 10.1109/EMBC.2016.7590634; Milton J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0212; Milton JG, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.022223; Mullen KM, 2011, J STAT SOFTW, V40, P1; Nomura T, 2013, MATH BIOSCI, V245, P86, DOI 10.1016/j.mbs.2013.02.002; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Price K. V., 2006, NATURAL COMPUTING; R Core Team, 2018, R LANG ENV STAT COMP; Santos DAD, 2017, PEER J, V5; Tietavainen A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02372-1; Wang HQ, 2018, NEURAL COMPUT, V30, P3072, DOI 10.1162/neco_a_01127; Wei WWS., 2006, TIME SERIES ANAL UNI, V2nd; WOOLLACOTT MH, 1988, EXP BRAIN RES, V72, P593, DOI 10.1007/BF00250604; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222664	10.1371/journal.pone.0222664	http://dx.doi.org/10.1371/journal.pone.0222664			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527893	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400037
J	Nelson, DS; Marano, RL; Joo, Y; Tian, SY; Patel, B; Kaplan, DH; Shlomchik, MJ; Stevenson, K; Bronson, RT; Rollins, BJ				Nelson, David S.; Marano, Ryan L.; Joo, Yechaan; Tian, Sara Y.; Patel, Bhumi; Kaplan, Daniel H.; Shlomchik, Mark J.; Stevenson, Kristen; Bronson, Roderick T.; Rollins, Barrett J.			BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis	PLOS ONE			English	Article							ERDHEIM-CHESTER DISEASE; EXPRESSING DENDRITIC CELLS; HIGH PREVALENCE; MUTATIONS; DISTINCT; VEMURAFENIB; MAP2K1; IDENTIFICATION; INACTIVATION; MACROPHAGES	Langerhans cell histiocytosis (LCH) is characterized by the accumulation of Langerin (CD207)-expressing histiocytes. Mutational activation of mitogen-activated protein kinase pathway genes, in particular BRAF, drives most cases. To test whether activated BRAF is sufficient for the development of LCH, we engineered mice to express BRAF V600E under the control of the human Langerin promoter. These mice have shortened survivals, smaller lymphoid organs, absent Leydig cells, and fewer epidermal LCs than controls, but do not accumulate histiocytes. To test whether the absence of histiocyte proliferation could be due to oncogene-induced senescence, we engineered homozygous Pten loss in the same cells that expressed BRAF V600E. Like mice with intact Pten, these mice have shortened survivals, smaller thymi, and absent Leydig cells. However, loss of Pten also leads to the accumulation of CD207(+) histiocytes in spleen, thymus, and some lymph nodes. While many CD207(+) histiocytes in the thymus are CD8(-), reminiscent of LCH cells, the CD207(+) histiocytes in the spleen and lymph nodes are CD8(+). These mice also accumulate large numbers of CD207(-) cells in the lamina propria (LP) of the small intestine. Both the lymphoid and LP phenotypes are likely due to human Langerin promoter-driven BRAF V600E expression in resident CD8(+) dendritic cells in the former and LP dendritic cells in the latter and confirm that Pten loss is required to overcome inhibitory pathways induced by BRAF V600E expression. The complex phenotype of these mice is a consequence of the multiple murine cell types in which the human Langerin promoter is active.	[Nelson, David S.; Marano, Ryan L.; Joo, Yechaan; Tian, Sara Y.; Patel, Bhumi; Rollins, Barrett J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kaplan, Daniel H.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA USA; [Kaplan, Daniel H.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15261 USA; [Stevenson, Kristen] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Rollins, Barrett J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Rollins, Barrett J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rollins, BJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Rollins, BJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	barrett_rollins@dfci.harvard.edu		Joo, Yechaan (Eric)/0000-0002-2389-249X	Claudia Adams Barr Program for Innovative Cancer Research; Histiocytosis Association; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER	Claudia Adams Barr Program for Innovative Cancer Research; Histiocytosis Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the Claudia Adams Barr Program for Innovative Cancer Research and grants from the Histiocytosis Association.; Some slide preparation and staining was performed by the Specialized Histopathology Core Facility of the Dana-Farber/Harvard Cancer Center (P30 CA06516). The authors thank Dr. To-Ha Thai for helpful discussions. The authors also thank the organizers and participants in the Nikolas Symposium on the Histiocytoses for helpful and informative discussions.	AHMED SA, 1985, J IMMUNOL, V134, P204; Allen CE, 2018, NEW ENGL J MED, V379, P856, DOI 10.1056/NEJMra1607548; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Antoniou-Tsigkos A., 2019, ADRENAL ANDROGENS; Arceci RJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26325; Arceci RJ, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2907.2907; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; BERGH A, 1993, J ENDOCRINOL, V136, P407, DOI 10.1677/joe.0.1360407; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chang SY, 2010, IMMUNOL REV, V234, P233, DOI 10.1111/j.0105-2896.2009.00878.x; Chikwava K, 2004, PEDIATR DEVEL PATHOL, V7, P607, DOI 10.1007/s10024-004-3027-z; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cohen PE, 1996, BIOL REPROD, V55, P310, DOI 10.1095/biolreprod55.2.310; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; De Monte A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00197; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Diamond EL, 2018, JAMA ONCOL, V4, P384, DOI 10.1001/jamaoncol.2017.5029; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Emile JF, 2014, BLOOD, V124, P3016, DOI 10.1182/blood-2014-04-570937; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Heritier S, 2015, BLOOD, V125, P2448, DOI 10.1182/blood-2015-01-625491; Hervier B, 2014, BLOOD, V124, P1119, DOI 10.1182/blood-2013-12-543793; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Nelson DS, 2015, GENE CHROMOSOME CANC, V54, P361, DOI 10.1002/gcc.22247; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; WEINSTEIN Y, 1981, J IMMUNOL, V126, P998; Weintraub M, 1998, J PEDIAT HEMATOL ONC, V20, P12, DOI 10.1097/00043426-199801000-00002; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wu JY, 2019, MOL CELL ENDOCRINOL, V479, P159, DOI 10.1016/j.mce.2018.10.008	49	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222400	10.1371/journal.pone.0222400	http://dx.doi.org/10.1371/journal.pone.0222400			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527903	gold, Green Submitted, Green Published			2022-12-27	WOS:000532231400019
J	Djigo, OKM; Bollahi, MA; Ebou, MH; Salem, MSOA; Tahar, R; Bogreau, H; Basco, L; Boukhary, AOMS				Djigo, Oum Kelthoum Mamadou; Bollahi, Mohamed Abdallahi; Ebou, Moina Hasni; Salem, Mohamed Salem Ould Ahmedou; Tahar, Rachida; Bogreau, Herve; Basco, Leonardo; Boukhary, Ali Ould Mohamed Salem			Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania	PLOS ONE			English	Article							DEFICIENCY; HETEROGENEITY; PERFORMANCE; NOUAKCHOTT; PREVALENCE; MUTATIONS; MORBIDITY	Background Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivaxendemic area in Mauritania. Methodology/Principal findings Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A-) and Mediterranean (B-) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant K (202A/376G) in 14 (31.8%), the Mediterranean variant B- (563T) in 13 (29.5%), and the Betica-Selma K (376G/968C) allelic variant in 6 (13.6%). The Santamaria K variant (376G/ 542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. Conclusion This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population.	[Djigo, Oum Kelthoum Mamadou; Ebou, Moina Hasni; Salem, Mohamed Salem Ould Ahmedou; Boukhary, Ali Ould Mohamed Salem] Univ Nouakchott Al Aasriya, Fac Sci & Tech, Unite Rech Genomes & Milieux, Nouveau Campus Univ, Nouakchott, Mauritania; [Bollahi, Mohamed Abdallahi] Minist Sante, Ctr Natl Transfus Sanguine, Nouakchott, Mauritania; [Tahar, Rachida] Univ Paris 05, Fac Pharm, IRD, UMR MERIT 216, Paris, France; [Bogreau, Herve] IHU Mediterranee Infect, Inst Rech Biomed Armees, Unite Parasitol & Entomol, Marseille, France; [Bogreau, Herve; Basco, Leonardo; Boukhary, Ali Ould Mohamed Salem] Aix Marseille Univ, AP HM, SSA, IRD,VITROME, Marseille, France; [Bogreau, Herve; Basco, Leonardo] IHU Mediterranee Infect, Marseille, France; [Bogreau, Herve] Inst Hosp Univ IHU Mediterranee Infect, Ctr Natl Reference Paludisme, Marseille, France; [Bollahi, Mohamed Abdallahi] Inst Natl Rech Sante Publ, Nouakchott, Mauritania	University of Nouakchott; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Boukhary, AOMS (corresponding author), Univ Nouakchott Al Aasriya, Fac Sci & Tech, Unite Rech Genomes & Milieux, Nouveau Campus Univ, Nouakchott, Mauritania.; Boukhary, AOMS (corresponding author), Aix Marseille Univ, AP HM, SSA, IRD,VITROME, Marseille, France.	alimedsalem@gmail.com	Rachida, Tahar/ABF-1506-2021; b, ali ould mohamed salem/AAM-6842-2021	TAHAR, Rachida/0000-0003-1799-231X	Institut de Recherche pour le Developpement (IRD, France) through JEAI RI3M grant	Institut de Recherche pour le Developpement (IRD, France) through JEAI RI3M grant	This work was published with the support of Institut de Recherche pour le De ' veloppement (IRD, France) through JEAI RI3M grant.	Adu-Gyasi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125796; [Anonymous], 2017, WHO WORLD MALARIA RE; [Anonymous], 2016, MEDCALC STAT SOFTW V; Ba H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1118-8; Benmansour I, 2013, BLOOD CELL MOL DIS, V50, P110, DOI 10.1016/j.bcmd.2012.08.005; BEUTLER E, 1966, BLOOD-J HEMATOL, V28, P553, DOI 10.1182/blood.V28.4.553.553; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; Deida J, 2019, EMERG INFECT DIS, V25, P282, DOI 10.3201/eid2502.180732; Dolo A, 2014, Bull Soc Pathol Exot, V107, P165, DOI 10.1007/s13149-014-0372-7; Espino FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148172; Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351; Gomez-Manzo S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122069; Hamdinou MM, 2017, TROP MED INT HEALTH, V22, P127; Hamed CT, 2012, INT J IMMUNOGENET, V39, P151, DOI 10.1111/j.1744-313X.2011.01064.x; Henriques G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2390-6; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Jalloh A, 2008, J HUM GENET, V53, P675, DOI 10.1007/s10038-008-0294-y; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Laouini N, 2013, MOL BIOL REP, V40, P851, DOI 10.1007/s11033-012-2124-8; Lekweiry KM, 2011, T ROY SOC TROP MED H, V105, P727, DOI 10.1016/j.trstmh.2011.09.004; Ley B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0896-8; McNerney R, 2015, DIAGNOSTICS, V5, P200, DOI 10.3390/diagnostics5020200; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Monteiro WM, 2017, REV SOC BRAS MED TRO, V50, P282, DOI 10.1590/0037-8682-0003-2017; Brito MAM, 2016, REV SOC BRAS MED TRO, V49, P446, DOI 10.1590/0037-8682-0134-2016; NAFA K, 1994, HUM GENET, V94, P513; Osman N., 2006, HAEMA, V9, P83; Osorio L, 2015, AM J TROP MED HYG, V92, P22, DOI 10.4269/ajtmh.14-0298; Ouattara Abdoul Karim, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P655, DOI 10.12980/APJTB.4.2014APJTB-2014-0100; Roh ME, 2016, AM J TROP MED HYG, V95, P1094, DOI 10.4269/ajtmh.16-0552; Salem MSOA, 2015, ACTA TROP, V152, P1, DOI 10.1016/j.actatropica.2015.08.005; Satyagraha AW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004457; Sirugo G, 2014, AM J TROP MED HYG, V90, P856, DOI 10.4269/ajtmh.13-0622; TAN IK, 1969, CLIN CHEM, V15, P467; United States Food and Drugs Administration, 2018, KRINT TAL SUCC TABL; VANNOORDEN CJF, 1985, BRIT J HAEMATOL, V60, P57, DOI 10.1111/j.1365-2141.1985.tb07385.x; von Fricken ME, 2014, AM J TROP MED HYG, V91, P77, DOI 10.4269/ajtmh.14-0100; Watson J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006440; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336; Zuniga MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0823-z	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220977	10.1371/journal.pone.0220977	http://dx.doi.org/10.1371/journal.pone.0220977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525211	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700009
J	Graham, DJ; Naik, C; McCoy, EJ; Li, HJ				Graham, Daniel J.; Naik, Cian; McCoy, Emma J.; Li, Haojie			Do speed cameras reduce road traffic collisions?	PLOS ONE			English	Article							APPROXIMATE BAYESIAN-INFERENCE; ENFORCEMENT CAMERAS; CAUSAL INFERENCE; PROPENSITY SCORE; SAFETY; ACCIDENTS; RADAR	This paper quantifies the effect of speed cameras on road traffic collisions using an approximate Bayesian doubly-robust (DR) causal inference estimation method. Previous empirical work on this topic, which shows a diverse range of estimated effects, is based largely on outcome regression (OR) models using the Empirical Bayes approach or on simple before and after comparisons. Issues of causality and confounding have received little formal attention. A causal DR approach combines propensity score (PS) and OR models to give an average treatment effect (ATE) estimator that is consistent and asymptotically normal under correct specification of either of the two component models. We develop this approach within a novel approximate Bayesian framework to derive posterior predictive distributions for the ATE of speed cameras on road traffic collisions. Our results for England indicate significant reductions in the number of collisions at speed cameras sites (mean ATE = -15%). Our proposed method offers a promising approach for evaluation of transport safety interventions.	[Graham, Daniel J.; McCoy, Emma J.] Imperial Coll London, London, England; [Naik, Cian] Univ Oxford, Oxford, England; [Li, Haojie] Southeast Univ, Nanjing, Peoples R China	Imperial College London; University of Oxford; Southeast University - China	Graham, DJ (corresponding author), Imperial Coll London, London, England.	d.j.graham@imperial.ac.uk	Graham, Daniel/AAA-6157-2021	Graham, Daniel/0000-0002-6971-8737				Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Carnis L, 2013, ACCIDENT ANAL PREV, V51, P301, DOI 10.1016/j.aap.2012.11.022; Chen G, 2002, ACCIDENT ANAL PREV, V34, P129, DOI 10.1016/S0001-4575(01)00006-9; Christie SM, 2003, INJURY PREV, V9, P302, DOI 10.1136/ip.9.4.302; Cunningham CM, 2008, TRANSPORT RES REC, P127, DOI 10.3141/2078-17; De Pauw E, 2014, SAFETY SCI, V62, P168, DOI 10.1016/j.ssci.2013.07.028; DfT, 2017, REP ROAD CAS GREAT B; DfT-Department for Transport, 2016, TRANSP STAT GREAT BR; Elvik R., 1997, TRANSPORT RES REC, V1595, P14, DOI [10.3141/1595-03, DOI 10.3141/1595-03]; Gains A., 2005, NATL SAFETY CAMERA P; Gains A., 2004, NATL SAFETY CAMERA P; Goldenbeld C, 2005, ACCIDENT ANAL PREV, V37, P1135, DOI 10.1016/j.aap.2005.06.011; Graham DJ, 2016, BAYESIAN ANAL, V11, P47, DOI 10.1214/14-BA928; Hauer E, 2002, TRANSPORT RES REC, P126; Hess S, 2003, TRANSPORT RES REC, P25; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hoye A, 2015, ACCIDENT ANAL PREV, V82, P263, DOI 10.1016/j.aap.2015.06.001; Jones AP, 2008, J SAFETY RES, V39, P101, DOI 10.1016/j.jsr.2007.10.011; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; Keall MD, 2001, ACCIDENT ANAL PREV, V33, P277, DOI 10.1016/S0001-4575(00)00042-7; Li HJ, 2013, ACCIDENT ANAL PREV, V60, P148, DOI 10.1016/j.aap.2013.08.003; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Maher M, 2015, NOTE MODELLING TFL F; Mountain L.J., 2004, TRAFFIC ENG CONTROL, V45, P280; Mountain LJ, 2005, ACCIDENT ANAL PREV, V37, P742, DOI 10.1016/j.aap.2005.03.017; Muliere P, 1996, ANN I STAT MATH, V48, P663, DOI 10.1007/BF00052326; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Robins JM, 2001, STAT SINICA, V11, P920; Robins JM, 2000, J AM STAT ASSOC, V95, P431, DOI 10.2307/2669381; Robins JM, 1999, P AM STAT ASS SECTIO, P6; Rubin D.B., 1990, STAT SCI, V5, P472, DOI DOI 10.1214/SS/1177012032; RUBIN DB, 1986, J AM STAT ASSOC, V81, P961, DOI 10.2307/2289065; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; RUBIN DB, 1980, J AM STAT ASSOC, V75, P591, DOI 10.2307/2287653; Shin K, 2009, ACCIDENT ANAL PREV, V41, P393, DOI 10.1016/j.aap.2008.12.011; van der Laan M.J., 2003, SPR S STAT	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221267	10.1371/journal.pone.0221267	http://dx.doi.org/10.1371/journal.pone.0221267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525209	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700010
J	Kim, JH; Cho, CH; Ryu, MY; Kim, JG; Lee, SJ; Park, TJ; Park, JP				Kim, Ji Hong; Cho, Chae Hwan; Ryu, Myung Yi; Kim, Jong-Gil; Lee, Sei-Jung; Park, Tae Jung; Park, Jong Pil			Development of peptide biosensor for the detection of dengue fever biomarker, nonstructural 1	PLOS ONE			English	Article							VIRUS NS1; MONOCLONAL-ANTIBODY; AFFINITY PEPTIDES; PROTEIN NS1; ASSAY; DISEASE; SENSOR; NANOPARTICLES; IMMUNOSENSOR; INFECTION	Dengue virus (DENV) nonstructural 1 (NS1) protein is a specific and sensitive biomarker for the diagnosis of dengue. In this study, an efficient electrochemical biosensor that uses chemically modified affinity peptides was developed for the detection of dengue virus NS1. A series of amino acid-substituted synthetic peptides was rationally designed, chemically synthesized and covalently immobilized to a gold sensor surface. The sensor performance was monitored via square wave voltammetry (SWV) and electrochemical impedance spectroscopy (EIS). Potential affinity peptides specific for NS1 were chosen according to the dynamic current decrease in SWV experiments. Using circular dichroism, the molar ellipticity of peptides (DGV BP1-BP5) was determined, indicating that they had a mostly similar in random coil structure, not totally identical. Using SWV, DGV BP1 was selected as a promising recognition peptide and limit of detection for NS1 was found to be 1.49 mu g/mL by the 3-sigma rule. DGV BP1 showed good specificity and stability for NS1, with low signal interference. The validation of the sensor to detect NS1 proteins was confirmed with four dengue virus culture broth (from serotype 1 to 4) as proof-of-concept. The detection performance of our sensor incorporating DGV BP1 peptides showed a statistically significant difference. These results indicate that this strategy can potentially be used to detect the dengue virus antigen, NS1, and to diagnosis dengue fever within a miniaturized portable device in point-of-care testing.	[Kim, Ji Hong; Cho, Chae Hwan; Ryu, Myung Yi; Lee, Sei-Jung; Park, Jong Pil] Daegu Haany Univ, Dept Pharmaceut Engn, Gyongsan, South Korea; [Kim, Jong-Gil; Park, Tae Jung] Chung Ang Univ, Inst Interdisciplinary Convergence Res, Res Inst Halal Industrializat Technol, Dept Chem, Seoul, South Korea	Daegu Haany University; Chung Ang University	Park, JP (corresponding author), Daegu Haany Univ, Dept Pharmaceut Engn, Gyongsan, South Korea.; Park, TJ (corresponding author), Chung Ang Univ, Inst Interdisciplinary Convergence Res, Res Inst Halal Industrializat Technol, Dept Chem, Seoul, South Korea.	tjpark@cau.ac.kr; jppark@dhu.ac.kr		Park, Jong Pil/0000-0002-4119-1574; Kim, Ji Hong/0000-0002-7218-5636	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2017R1A2A2A05001037]; Medi-Challenger Program - Gyeongsan City	National Research Foundation of Korea (NRF) - Korea government (MSIP); Medi-Challenger Program - Gyeongsan City	This study was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (MSIP) (NRF-2017R1A2A2A05001037) and the Medi-Challenger Program funded by the Gyeongsan City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolahad M, 2014, BIOSENS BIOELECTRON, V59, P151, DOI 10.1016/j.bios.2014.02.079; Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145; Baek SH, 2019, BIOSENS BIOELECTRON, V123, P223, DOI 10.1016/j.bios.2018.08.064; Cabral-Castro MJ, 2016, J VIROL METHODS, V236, P18, DOI 10.1016/j.jviromet.2016.07.003; Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Darwish NT, 2018, J PHARMACEUT BIOMED, V149, P591, DOI 10.1016/j.jpba.2017.11.064; Desai D, 2018, BIOSENS BIOELECTRON, V105, P90, DOI 10.1016/j.bios.2018.01.031; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Hosseini S, 2014, EUR POLYM J, V60, P14, DOI 10.1016/j.eurpolymj.2014.08.010; Hu DM, 2013, BIOSENSORS-BASEL, V3, P297, DOI 10.3390/bios3030297; Hwang HJ, 2016, CHEMISTRYSELECT, V1, P1140, DOI 10.1002/slct.201600173; Hwang HJ, 2017, BIOSENS BIOELECTRON, V87, P164, DOI 10.1016/j.bios.2016.08.031; Iswardy E, 2017, BIOSENS BIOELECTRON, V95, P174, DOI 10.1016/j.bios.2017.04.011; Jahanshahi P, 2018, BIOTECHNOL BIOPROC E, V23, P394, DOI 10.1007/s12257-017-0432-5; Kathiresan E, 2017, RSC ADV, V7, P1927, DOI 10.1039/c6ra24763f; Kim JG, 2018, TALANTA, V190, P391, DOI 10.1016/j.talanta.2018.08.019; Lee D, 2018, BIOTECHNOL BIOPROC E, V23, P123, DOI 10.1007/s12257-018-0087-x; Lim JM, 2018, ANAL CHIM ACTA, V1026, P109, DOI 10.1016/j.aca.2018.04.005; Lim JM, 2018, BIOSENS BIOELECTRON, V99, P289, DOI 10.1016/j.bios.2017.07.075; Lim JM, 2017, BIOSENS BIOELECTRON, V98, P330, DOI 10.1016/j.bios.2017.07.013; Linares EM, 2013, BIOSENS BIOELECTRON, V41, P180, DOI 10.1016/j.bios.2012.08.005; Meirinho SG, 2017, ANAL CHIM ACTA, V987, P25, DOI 10.1016/j.aca.2017.07.071; Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349; Ngo HT, 2014, ANALYST, V139, P5655, DOI [10.1039/C4AN01077A, 10.1039/c4an01077a]; Nowinski AK, 2012, J AM CHEM SOC, V134, P6000, DOI 10.1021/ja3006868; Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001; Park CR, 2018, BIOTECHNOL BIOPROC E, V23, P355, DOI 10.1007/s12257-018-0182-z; Parkash O, 2014, DIAGNOSTICS, V4, P165, DOI 10.3390/diagnostics4040165; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Silva MMS, 2015, J CHEM TECHNOL BIOT, V90, P194, DOI 10.1002/jctb.4305; Sinawang PD, 2016, BIOSENS BIOELECTRON, V77, P400, DOI 10.1016/j.bios.2015.09.048; Singhal C, 2017, BIOSENS BIOELECTRON, V97, P75, DOI 10.1016/j.bios.2017.05.047; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117; Wasik D, 2018, ANAL CHEM, V90, P679, DOI 10.1021/acs.analchem.7b03407; Wasik D, 2017, BIOSENS BIOELECTRON, V91, P811, DOI 10.1016/j.bios.2017.01.017; Wong WR, 2014, ANAL CHEM, V86, P1735, DOI 10.1021/ac403539k; Wu J, 2010, ANAL CHEM, V82, P8235, DOI 10.1021/ac101657h; Yang JM, 2018, BIOTECHNOL BIOPROC E, V23, P371, DOI 10.1007/s12257-018-0220-x; Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f; Yoon JY, 2017, BIOTECHNOL BIOPROC E, V22, P114, DOI 10.1007/s12257-017-0110-7	43	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222144	10.1371/journal.pone.0222144	http://dx.doi.org/10.1371/journal.pone.0222144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN8DF	31553730	Green Published, gold			2022-12-27	WOS:000515074300001
J	Otieno, MHJ; Ayieko, MA; Niassy, S; Salifu, D; Abdelmutalab, AGA; Fathiya, KM; Subramanian, S; Fiaboe, KKM; Roos, N; Ekesi, S; Tanga, CM				Otieno, Magara H. J.; Ayieko, Monica A.; Niassy, Saliou; Salifu, Daisy; Abdelmutalab, Azrag G. A.; Fathiya, Khamis M.; Subramanian, Sevgan; Fiaboe, Komi K. M.; Roos, Nana; Ekesi, Sunday; Tanga, Chrysantus M.			Integrating temperature-dependent life table data into Insect Life Cycle Model for predicting the potential distribution of Scapsipedus icipe Hugel & Tanga	PLOS ONE			English	Article							CRICKET ACHETA-DOMESTICUS; HOUSE CRICKET; DEVELOPMENT RATES; METABOLIC-RATE; ADULT SIZE; GROWTH; ORTHOPTERA; CLIMATE; PERFORMANCE; DEMOGRAPHY	Scapsipedus icipe Hugel and Tanga (Orthoptera: Gryllidae) is a newly described edible cricket species. Although, there is substantial interest in mass production of S. icipe for human food and animal feed, no information exists on the impact of temperature on their bionomics. Temperature-dependent development, survival, reproductive and life table parameters of S. icipe was generated and integrated into advanced Insect Life Cycle Modeling software to describe relative S. icipe population increase and spatial spread based on nine constant temperature conditions. We examined model predictions and implications for S. icipe potential distribution in Africa under current and future climate. These regions where entomophagy is widely practiced have distinctly different climates. Our results showed that S. icipe eggs were unable to hatch at 10 and 40 degrees C, while emerged nymphs failed to complete development at 15 degrees C. The developmental time of S. icipe was observed to decrease with increased in temperature. The lowest developmental threshold temperatures estimated using linear regressions was 14.3, 12.67 and 19.12 degrees C and the thermal constants for development were 185.2, 1111.1- and 40.7-degree days (DD) for egg, nymph and pre-adult stages, respectively. The highest total fecundity (3416 individuals/female/generation), intrinsic rate of natural increase (0.075 days), net reproductive rate (1330.8 female/female/generation) and shortest doubling time (9.2 days) was recorded at 30 degrees C. The regions predicted to be suitable by the model suggest that S. icipe is tolerant to a wider range of climatic conditions. Our findings provide for the first-time important information on the impact of temperature on the biology, establishment and spread of S. icipe across the Africa continent. The prospect of edible S. icipe production to become a new sector in food and feed industry is discussed.	[Otieno, Magara H. J.; Ayieko, Monica A.] Jaramogi Oginga Odinga Univ Sci & Technol JOOUST, Sch Agr & Food Secur, Bondo, Kenya; [Otieno, Magara H. J.; Niassy, Saliou; Salifu, Daisy; Abdelmutalab, Azrag G. A.; Fathiya, Khamis M.; Subramanian, Sevgan; Ekesi, Sunday; Tanga, Chrysantus M.] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Fiaboe, Komi K. M.] Int Inst Trop Agr IITA, BP 2008 Messa, Yaounde, Cameroon; [Roos, Nana] Univ Copenhagen, Dept Nutr Exercise & Sports, Rolighedsvej, Frederiksberg C, Denmark	International Centre of Insect Physiology & Ecology (ICIPE); University of Copenhagen	Tanga, CM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	ctanga@icipe.org	Ekesi, Sunday/P-8944-2019; Azrag, Abdelmutalab G. A./V-2040-2019; , Subramanian/H-8531-2014; Roos, Nanna/D-7671-2015	Azrag, Abdelmutalab G. A./0000-0002-2192-3803; , Subramanian/0000-0003-4447-0744; Roos, Nanna/0000-0002-9733-9523	GREENiNSECT of Danida [BB/J011371/1]; Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) [ILIPA - W 08.250.202]; Federal Ministry for Economic Cooperation and Development (BMZ) [ENTONUTRI - 81194993]; Canadian International Development Research Centre (IDRC) [108866-001]; Australian Centre for International Agricultural Research (ACIAR) [108866-001]; BioInnovate Africa Programme Phase II through SIDA (INSBIZ) through the International Centre of Insect Physiology and Ecology (icipe) [51050076]; UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	GREENiNSECT of Danida; Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO); Federal Ministry for Economic Cooperation and Development (BMZ); Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); BioInnovate Africa Programme Phase II through SIDA (INSBIZ) through the International Centre of Insect Physiology and Ecology (icipe); UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	The authors sincerely acknowledge the financial aid by the following organizations and agencies: the GREENiNSECT of Danida (Grant No: BB/J011371/1), the Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) (ILIPA - W 08.250.202), Federal Ministry for Economic Cooperation and Development (BMZ) (ENTONUTRI - 81194993), the Canadian International Development Research Centre (IDRC) and the Australian Centre for International Agricultural Research (ACIAR) (INSFEED - Phase 2: Cultivate Grant No: 108866-001), and BioInnovate Africa Programme Phase II through SIDA (INSBIZ Contribution ID No. 51050076) through the International Centre of Insect Physiology and Ecology (icipe). We also gratefully acknowledge the icipe core funding provided by UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany, and the Kenyan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2011, J EXP BIOL, V214, P1997, DOI 10.1242/jeb.056531; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allahyari H., 2005, THESIS PONTIFICIA U; Ayieko MA, 2016, J INSECTS FOOD FEED, V2, P203, DOI 10.3920/JIFF2015.0080; Azrag AGA, 2017, J THERM BIOL, V70, P27, DOI 10.1016/j.jtherbio.2017.10.009; BATE J, 1971, PEDOBIOLOGIA, V11, P159; Battisi DS, 2009, J SCI, V323, P240, DOI [10.1126/science.1164363, DOI 10.1126/SCIENCE.1164363]; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Bonnar JD, 2010, GAMMA FUNCTION; Booth DT, 2007, J INSECT PHYSIOL, V53, P950, DOI 10.1016/j.jinsphys.2007.03.009; Bowling CC, 1955, THESIS; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Chemura A, 2018, J INSECTS FOOD FEED, V4, P229, DOI 10.3920/JIFF2017.0074; Chi H, 2003, ENVIRON ENTOMOL, V32, P327, DOI 10.1603/0046-225X-32.2.327; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; CURRY GL, 1978, THEOR POPUL BIOL, V13, P197, DOI 10.1016/0040-5809(78)90042-4; DESTEPHANO DB, 1982, ANN ENTOMOL SOC AM, V75, P111, DOI 10.1093/aesa/75.2.111; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; FAO, 2013, ED INS FUT PROSP FEE; FORREST TG, 1987, OECOLOGIA, V73, P178, DOI 10.1007/BF00377505; Frei A, 2003, J ECON ENTOMOL, V96, P1577, DOI 10.1603/0022-0493-96.5.1577; GHOURI A. S. K., 1958, CANADIAN ENT, V90, P158; GHOURI J, 2012, J INSECT PHYSL, V58, P634, DOI [10.1016/j.jinsphys.2012.01.010, DOI 10.1016/J.JINSPHYS.2012.01.010]; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Haghani M, 2007, J PEST SCI, V80, P71, DOI 10.1007/s10340-006-0154-5; Halloran A., 2018, EDIBLE INSECTS SUSTA, DOI [DOI 10.1007/978-3-319-74011-9, DOI 10.1038/NCLIMATE2925]; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P83; HASSALL J., 2013, FOR RES PAP, V74, P345; HASSALL JD, 2018, J INSECT PHYSL, V107, P89, DOI [10.1016/j.jinsphys.2018.02.010, DOI 10.1016/J.JINSPHYS.2018.02.010]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Homann AM, 2017, J INSECTS FOOD FEED, V3, P95, DOI 10.3920/JIFF2016.0054; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; KASULE FK, 1991, HEREDITY, V66, P281, DOI 10.1038/hdy.1991.35; Kelemu S, 2015, J INSECTS FOOD FEED, V1, P103, DOI 10.3920/JIFF2014.0016; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Khaliq A., 2014, Journal of Entomology and Zoology Studies, V2, P1; KRAUS WF, 1989, J INSECT BEHAV, V2, P623, DOI 10.1007/BF01065783; KRUSE KC, 1990, BEHAV ECOL SOCIOBIOL, V26, P281; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173065; Magara HJO, 2019, J ECON ENTOMOL, V112, P653, DOI 10.1093/jee/toy397; Malaisse F., 1997, FOOD SUPPLY AFRICAN, P384; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MASAKI S, 1987, EVOL BIOL, V21, P349; Melissa K., 2014, BREEDING RAISING HOU, P1; MERKEL G, 1977, OECOLOGIA, V30, P129, DOI 10.1007/BF00345416; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nespolo RF, 2003, J EXP BIOL, V206, P4309, DOI 10.1242/jeb.00687; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Nyaga P., 2007, GOOD BIOSECURITY PRA, P157; Obopile M, 2013, FOOD SECUR, V5, P817, DOI 10.1007/s12571-013-0310-8; Orinda Mary Akinyi, 2017, Journal of Entomology and Zoology Studies, V5, P1138; Pascucci S., 2015, AGR FOOD ECON, V3, P3, DOI [10.1186/s40100-014-0025-y, DOI 10.1186/S40100-014-0025-Y]; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; R Core Team, 2020, R LANG ENV STAT COMP; Ramirez-Villegas J, 2010, 1 CIAT; Ramos-Elorduy Julieta, 2005, P263; Reiss M.J., 1991, ALLOMETRY GROWTH REP; RENUCCI M, 1983, EXPERIENTIA, V39, P618, DOI 10.1007/BF01971127; ROE RM, 1980, J INSECT PHYSIOL, V26, P639, DOI 10.1016/0022-1910(80)90034-7; Roulon-Doko P., 1998, CHASSE CUEILLETTE CU; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Silow CA, 1976, STUDIES ETHNO ENTOMO, VII, P223; Soh BSB, 2018, J ECOL EVOL, P1, DOI [10.1002/ee3.4639, DOI 10.1002/EE3.4639]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Sugano Yoshikazu C., 2008, Journal of Orthoptera Research, V17, P243, DOI 10.1665/1082-6467-17.2.243; Takeda J., 1990, African Study Monographs, V11, P1; Tanga C.M, 2018, PLOS ONE, V13; Tanga CM, 2018, ZOOTAXA, V4486, P383, DOI 10.11646/zootaxa.4486.3.9; Terblanche JS, 2007, PHYSIOL ENTOMOL, V32, P175, DOI 10.1111/j.1365-3032.2006.00549.x; van Huis A., 2003, Insect Science and its Application, V23, P163; Van Huis A, 2010, PLOS ONE, V5; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Vargas RI, 2000, ANN ENTOMOL SOC AM, V93, P75, DOI 10.1603/0013-8746(2000)093[0075:CDOTHF]2.0.CO;2; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Wang R.S., 1982, ACTA ECOLOGICA SINIC, V2, P47; WINERITER SA, 1988, ENTOMOL NEWS, V99, P53; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; XUE RD, 1994, ENVIRON ENTOMOL, V23, P1480, DOI 10.1093/ee/23.6.1480; YANG PJ, 1994, ENVIRON ENTOMOL, V23, P971, DOI 10.1093/ee/23.4.971	93	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222941	10.1371/journal.pone.0222941	http://dx.doi.org/10.1371/journal.pone.0222941			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553778	Green Published, gold			2022-12-27	WOS:000532319200047
J	Zhen, XX; Xu, F; Zhang, WZ; Li, N; Li, X				Zhen, Xiaoxi; Xu, Fan; Zhang, Wenzhong; Li, Nan; Li, Xin			Overexpression of rice gene OsATG8b confers tolerance to nitrogen starvation and increases yield and nitrogen use efficiency (NUE) in Arabidopsis	PLOS ONE			English	Article							AUTOPHAGY; SENESCENCE; PROTEIN; ATG8; IDENTIFICATION; REMOBILIZATION; CHLOROPLASTS; ASSIMILATION; DEFICIENCY; EXPRESSION	Nitrogen (N) is an important element required for plant growth and development, which also affects plant yield and quality. Autophagy, a conserved pathway in eukaryotes, degrades and recycles cellular components, thus playing an important role in N remobilization. However, only a few autophagy genes related to N remobilization in rice (Oryza sativa) have been reported. Here, we identified a core autophagy gene in rice, OsATG8b, with increased expression levels under N starvation conditions. It was investigated the function of OsATG8b by generating three independent homozygous 35S-OsATG8b transgenic Arabidopsis thaliana lines. The overexpression of OsATG8b significantly enhanced autophagic flux in the transgenic Arabidopsis plants. It was also showed that over-expressing OsATG8b promoted growth and development of Arabidopsis, in which the rosette leaves were larger than those of the wild type (WT), and the yield increased significantly by 25.25%. In addition, the transgenic lines accumulated more N in seeds than in the rosette leaves. Further examination revealed that overexpression of OsATG8b could effectively alleviate the growth inhibition of transgenic Arabidopsis under nitrogen (N) stress. N partitioning studies revealed that nitrogen-harvest index (NHI) and nitrogen use efficiency (NUE) were significantly increased in the transgenic Arabidopsis, as well as the N-15-tracer experiments revealing that the remobilization of N to seeds in the OsATG8b-overexpressing transgenic Arabidopsis was high and more than WT. Based on our findings, we consider OsATG8b to be a great candidate gene to increase NUE and yield, especially under suboptimal field conditions.	[Zhen, Xiaoxi; Xu, Fan; Zhang, Wenzhong; Li, Xin] Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Rice Res Inst,Key Lab Northeast Rice Biol & Genet, Minist Educ & Liaoning Prov,Minist Agr, Shenyang, Liaoning, Peoples R China; [Li, Nan] Shen Yang Prod Qual Supervis & Inspect Inst, Shenyang, Liaoning, Peoples R China	Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University	Xu, F; Zhang, WZ (corresponding author), Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Rice Res Inst,Key Lab Northeast Rice Biol & Genet, Minist Educ & Liaoning Prov,Minist Agr, Shenyang, Liaoning, Peoples R China.	celiafanfan@syau.edu.cn; zwzhong1@syau.edu.cn			National Natural Science Foundation of China [31401298]; National Key Research and Development Program of China [2018YFD0200200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This research was funded by the National Natural Science Foundation of China (grant number 31401298) and the National Key Research and Development Program of China (grant number 2018YFD0200200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Avin-Wittenberg T, 2012, PROTOPLASMA, V249, P285, DOI 10.1007/s00709-011-0296-z; Barros JAS, 2017, PLANT PHYSIOL, V175, P62, DOI 10.1104/pp.16.01576; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chardon F, 2012, J EXP BOT, V63, P3401, DOI 10.1093/jxb/err353; Chen QW, 2019, PLANT CELL PHYSIOL, V60, P343, DOI 10.1093/pcp/pcy214; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ferrario-Mery S, 1998, PLANT PHYSIOL, V117, P293, DOI 10.1104/pp.117.1.293; Guiboileau A, 2012, NEW PHYTOL, V194, P732, DOI 10.1111/j.1469-8137.2012.04084.x; Hafren A, 2017, P NATL ACAD SCI USA, V114, pE2026, DOI 10.1073/pnas.1610687114; Have M, 2018, J EXP BOT, V69, P1369, DOI 10.1093/jxb/erx482; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Kellner R, 2017, TRENDS PLANT SCI, V22, P204, DOI 10.1016/j.tplants.2016.11.015; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; Li FQ, 2015, PLANT CELL, V27, P1389, DOI 10.1105/tpc.15.00158; Li WW, 2015, BIOCHEM BIOPH RES CO, V468, P800, DOI 10.1016/j.bbrc.2015.11.035; Li WW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3113-4; Liu D, 2010, J EXP BOT, V61, P1655, DOI 10.1093/jxb/erq033; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; Marshall RS, 2018, ANNU REV PLANT BIOL, V69, P173, DOI 10.1146/annurev-arplant-042817-040606; Masclaux-Daubresse C, 2017, CURR OPIN PLANT BIOL, V39, P8, DOI 10.1016/j.pbi.2017.05.001; Masclaux-Daubresse C, 2011, J EXP BOT, V62, P2131, DOI 10.1093/jxb/erq405; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Moriyasu Y, 1996, PLANT PHYSIOL, V111, P1233, DOI 10.1104/pp.111.4.1233; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Ren CX, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00301; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Su W, 2006, MOL BIOL REP, V33, P273, DOI 10.1007/s11033-006-9011-0; Sun X, 2018, PLANT CELL ENVIRON, V41, P469, DOI 10.1111/pce.13110; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wada S, 2015, PLANT PHYSIOL, V168, P60, DOI 10.1104/pp.15.00242; Wang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00720; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Xia KF, 2011, DNA RES, V18, P363, DOI 10.1093/dnares/dsr024; Xia TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037217; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu F, 2011, PLANT PHYSIOL, V157, P2131, DOI 10.1104/pp.111.182899; Yang XC, 2015, INT REV CEL MOL BIO, V320, P1, DOI 10.1016/bs.ircmb.2015.07.005; Yao ZY, 2015, AUTOPHAGY, V11, P2288, DOI 10.1080/15548627.2015.1107692; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhu T, 2018, PLANT BIOTECHNOL J, V16, P2063, DOI 10.1111/pbi.12939	57	16	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223011	10.1371/journal.pone.0223011	http://dx.doi.org/10.1371/journal.pone.0223011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY8QP	31553788	Green Published, gold			2022-12-27	WOS:000504673300001
J	Dworzanski, J; Drop, B; Kliszczewska, E; Strycharz-Dudziak, M; Polz-Dacewicz, M				Dworzanski, Jakub; Drop, Bartlomiej; Kliszczewska, Ewa; Strycharz-Dudziak, Malgorzata; Polz-Dacewicz, Malgorzata			Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VIROME; CANCER; HEALTH; EBV; HPV	A microbiota is a complex ecosystem of microorganisms consisting of bacteria, viruses, protozoa, and fungi living in different niches of the human body, which plays an essential role in many metabolic functions. Modifications in the microbiota composition can lead to several diseases, including metabolic disorders. The aim of this study was to analyze the prevalence of four viruses which can cause persistent infections-Epstein-Barr virus (EBV), human papillomavirus (HPV), cytomegalovirus (CMV), and herpes simplex virus type 1 (HSV-1) in patients with diabetes mellitus type 2 (DM2). Blood, saliva and oral swabs were collected from all the study participants. The nested-PCR technique was used to detect the viral DNA. DNA of at least one virus was detected in 71.1% of diabetic patients and in 30% of individuals without diabetes. In patients with diabetes EBV DNA was detected the most frequently (25.4%), followed by HPV- 19.1%, HSV- 10.4% and CMV- 5.2%. A higher percentage of EBV+HPV co-infection was found among men (30.8%). EBV DNA was statistically more often detected in patients living in rural areas (53.7%), while HPV (91.5%) and EBV+HPV co-infection (22.2%) prevailed among patients from urban areas. In patients with a DM2 history longer than 10 years viral infection was detected more frequently. The prevalence of EBV, HPV and the EBV+HPV co-infection was significantly higher in diabetic patients than in individuals without diabetes. The frequency of these infections depended on the duration of the disease (DM2).	[Dworzanski, Jakub] Masovian Specialist Hosp, Radom, Poland; [Drop, Bartlomiej] Med Univ Lublin, Dept Informat Technol & Med Stat, Lublin, Poland; [Kliszczewska, Ewa; Polz-Dacewicz, Malgorzata] Med Univ Lublin, Dept Virol, Lublin, Poland; [Strycharz-Dudziak, Malgorzata] Med Univ Lublin, Chair & Dept Conservat Dent Endodont, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Strycharz-Dudziak, M (corresponding author), Med Univ Lublin, Chair & Dept Conservat Dent Endodont, Lublin, Poland.	malgorzata.strycharz-dudziak@umlub.pl	Drop, Bartlomiej/AAB-4532-2021; Polz-Dacewicz, Malgorzata Anna/ABI-3021-2020	Drop, Bartlomiej/0000-0001-7044-3657; Polz-Dacewicz, Malgorzata Anna/0000-0002-3222-184X; Strycharz-Dudziak, Malgorzata/0000-0003-0560-7322; Stepien, Ewa/0000-0002-9024-8602	Medical University of Lublin, Lublin, Poland [DS 233]	Medical University of Lublin, Lublin, Poland	This work was supported by the Research Grant from the Medical University of Lublin, Lublin, Poland, grant number DS 233.	Alibek K, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-7; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boppana SB, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P795; Cadwell K, 2015, IMMUNITY, V42, P805, DOI 10.1016/j.immuni.2015.05.003; Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; de Jong RGPJ, 2018, CANCER EPIDEMIOL, V54, P104, DOI 10.1016/j.canep.2018.04.008; Drop B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122752; Garbuglia A. R., 2014, Cancers, V6, P1705, DOI 10.3390/cancers6031705; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Glasner ME, 2017, SCIENCE, V355, P577, DOI 10.1126/science.aam7446; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Han MZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03150; Handley SA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0287-y; Houghton D, 2018, DIABETOLOGIA, V61, P1700, DOI 10.1007/s00125-018-4632-0; Howley P.M., 2013, FIELDS VIROLOGY, P1802; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100E; Jalouli J, 2012, ANTICANCER RES, V32, P571; Karjala Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019092; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lontchi-Yimagou E, 2018, J DIABETES, V10, P866, DOI 10.1111/1753-0407.12777; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; Nikolich-Zugich J, 2017, CURR OPIN IMMUNOL, V48, P23, DOI 10.1016/j.coi.2017.07.011; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Oikonomou E, 2018, HEART FAIL REV, V23, P389, DOI 10.1007/s10741-018-9682-3; Organization WH, 2016, GLOB REP DIAB, DOI [10.2337/db15-0956, DOI 10.2337/DB15-0956]; Parker Michael T., 2016, Yale Journal of Biology and Medicine, V89, P339; Pascale A, 2018, ENDOCRINE, V61, P357, DOI 10.1007/s12020-018-1605-5; Perera RAPM, 2010, ARCH ORAL BIOL, V55, P639, DOI 10.1016/j.archoralbio.2010.06.009; Polz-Dacewicz M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0093-6; Polz-Gruszka D, 2015, ANTICANCER RES, V35, P1657; Syrjanen K J, 1983, Proc Finn Dent Soc, V79, P1; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Youn Jong-Chan, 2018, Clin Hypertens, V24, P5, DOI 10.1186/s40885-018-0090-8; Yu JH, 2019, AGING MENT HEALTH, V23, P706, DOI 10.1080/13607863.2018.1450841; Zhang J, 2015, MED SCI MONITOR, V21, P4102, DOI 10.12659/MSM.896071; Zuwala-Jagiello J, 2017, IN VIVO, V31, P1027, DOI 10.21873/invivo.11165	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222607	10.1371/journal.pone.0222607	http://dx.doi.org/10.1371/journal.pone.0222607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550259	Green Published, gold			2022-12-27	WOS:000532307700018
J	Aso, T; Urayama, S; Fukuyama, H; Murai, T				Aso, Toshihiko; Urayama, Shinnichi; Fukuyama, Hidenao; Murai, Toshiya			Axial variation of deoxyhemoglobin density as a source of the low-frequency time lag structure in blood oxygenation level-dependent signals	PLOS ONE			English	Article							RESTING-STATE FMRI; INDEPENDENT COMPONENT ANALYSIS; DIFFUSE OPTICAL TOMOGRAPHY; FUNCTIONAL MRI; CEREBRAL HEMODYNAMICS; GLOBAL SIGNAL; FLOW VELOCITY; BOLD SIGNAL; OSCILLATIONS; PERFUSION	Perfusion-related information is reportedly embedded in the low-frequency component of a blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) signal. The blood-propagation pattern through the cerebral vascular tree is detected as an interregional lag variation of spontaneous low-frequency oscillations (sLFOs). Mapping of this lag, or phase, has been implicitly treated as a projection of the vascular tree structure onto real space. While accumulating evidence supports the biological significance of this signal component, the physiological basis of the "perfusion lag structure," a requirement for an integrative resting-state fMRI-signal model, is lacking. In this study, we conducted analyses furthering the hypothesis that the sLFO is not only largely of systemic origin, but also essentially intrinsic to blood, and hence behaves as a virtual tracer. By summing the small fluctuations of instantaneous phase differences between adjacent vascular regions, a velocity response to respiratory challenges was detected. Regarding the relationship to neurovascular coupling, the removal of the whole lag structure, which can be considered as an optimized global-signal regression, resulted in a reduction of inter-individual variance while preserving the fMRI response. Examination of the T2* and S0, or non-BOLD, components of the fMRI signal revealed that the lag structure is deoxyhemoglobin dependent, while paradoxically presenting a signal-magnitude reduction in the venous side of the cerebral vasculature. These findings provide insight into the origin of BOLD sLFOs, suggesting that they are highly intrinsic to the circulating blood.	[Aso, Toshihiko; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Aso, Toshihiko] RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Kobe, Hyogo, Japan; [Aso, Toshihiko; Urayama, Shinnichi; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Urayama, Shinnichi; Fukuyama, Hidenao] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res & Educ Unit Leaders Integrated Med Syst, Kyoto, Japan	Kyoto University; RIKEN; Kyoto University; Kyoto University	Aso, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan.; Aso, T (corresponding author), RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Kobe, Hyogo, Japan.; Aso, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan.	aso.toshihiko@gmail.com	Aso, Toshihiko/C-2798-2018	Aso, Toshihiko/0000-0003-4814-089X	Japan Society for the Promotion of Science [JP15H05875, JP16H06395, JP16H06397]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Non-linear Neuro-oscillology: Towards Integrative Understanding of Human Nature, JP15H05875) to TA and JP16H06395 and JP16H06397 to TM from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Amemiya S, 2016, NEUROIMAGE, V133, P331, DOI 10.1016/j.neuroimage.2016.03.033; Amemiya S, 2014, RADIOLOGY, V270, P548, DOI 10.1148/radiol.13130982; An HY, 2002, MAGNET RESON MED, V47, P958, DOI 10.1002/mrm.10148; Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Aso T, 2017, P 25 ANN M ISMRM HON; Aso T, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00256; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Boas DA, 2005, APPL OPTICS, V44, P1957, DOI 10.1364/AO.44.001957; Buxton RB, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/9/096601; Byrge L, 2018, NEUROIMAGE, V171, P376, DOI 10.1016/j.neuroimage.2017.12.082; Caballero-Gaudes C, 2017, NEUROIMAGE, V154, P128, DOI 10.1016/j.neuroimage.2016.12.018; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Collins JA, 2015, BREATHE, V11, P195, DOI 10.1183/20734735.001415; Dresel C, 2005, NEUROIMAGE, V28, P588, DOI 10.1016/j.neuroimage.2005.06.021; Erdogan SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00311; FAGRELL B, 1980, MICROVASC RES, V20, P327, DOI 10.1016/0026-2862(80)90033-3; FAGRELL B, 1977, AM J PHYSIOL, V233, pH318, DOI 10.1152/ajpheart.1977.233.2.H318; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Giller CA, 1999, J CEREBR BLOOD F MET, V19, P452, DOI 10.1097/00004647-199904000-00011; Glasser MF, 2018, NEUROIMAGE, V181, P692, DOI 10.1016/j.neuroimage.2018.04.076; GUYTON AC, 1951, AM J PHYSIOL, V165, P158, DOI 10.1152/ajplegacy.1951.165.1.158; Herman P, 2009, J CEREBR BLOOD F MET, V29, P19, DOI 10.1038/jcbfm.2008.100; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P3463, DOI 10.1113/JP272012; Hudetz AG, 1999, J APPL PHYSIOL, V87, P505, DOI 10.1152/jappl.1999.87.2.505; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Intaglietta M., 1990, VASC MED REV, V1, P101, DOI [10.1177/1358836X9000100202, DOI 10.1177/1358836X9000100202]; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kennerley AJ, 2005, MAGN RESON MED, V54, P354, DOI 10.1002/mrm.20511; Khalil AA, 2020, J CEREBR BLOOD F MET, V40, P23, DOI 10.1177/0271678X18803951; KILLIP T, 1962, CIRC RES, V11, P987, DOI 10.1161/01.RES.11.6.987; Kim JH, 2016, NEUROIMAGE, V124, P394, DOI 10.1016/j.neuroimage.2015.08.068; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Krings T, 2001, J NEUROL NEUROSUR PS, V70, P749, DOI 10.1136/jnnp.70.6.749; Krings T, 1999, AM J NEURORADIOL, V20, P1907; Kumar V, 2016, J NEUROSCI, V36, P4170, DOI 10.1523/JNEUROSCI.3914-15.2016; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Liu TT, 2017, NEUROIMAGE, V150, P213, DOI 10.1016/j.neuroimage.2017.02.036; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; MALATINO LS, 1992, STROKE, V23, P1728, DOI 10.1161/01.STR.23.12.1728; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Mckay LC, 2008, NEUROIMAGE, V40, P1824, DOI 10.1016/j.neuroimage.2008.01.058; MORITA Y, 1995, ACTA PHYSIOL SCAND, V154, P121, DOI 10.1111/j.1748-1716.1995.tb09894.x; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Ni L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41586; Nikulin VV, 2014, NEUROIMAGE, V97, P71, DOI 10.1016/j.neuroimage.2014.04.008; Nishida S, 2019, NEUROSURGERY, V85, P680, DOI 10.1093/neuros/nyy434; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Pattinson KTS, 2009, J NEUROSCI, V29, P8177, DOI 10.1523/JNEUROSCI.1375-09.2009; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RADNA RJ, 1981, BRAIN RES, V213, P29, DOI 10.1016/0006-8993(81)91246-4; Rayshubskiy A, 2014, NEUROIMAGE, V87, P323, DOI 10.1016/j.neuroimage.2013.10.044; Rostrup E, 2005, NEUROIMAGE, V24, P1, DOI 10.1016/j.neuroimage.2004.09.043; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sassaroli A, 2012, IEEE J SEL TOP QUANT, V18, P1478, DOI 10.1109/JSTQE.2012.2183581; Satow T, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00387; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Siegel AM, 2003, PHYS MED BIOL, V48, P1391, DOI 10.1088/0031-9155/48/10/311; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Tgavalekos KT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101410; Thomas DL, 2000, PHYS MED BIOL, V45, pR97, DOI 10.1088/0031-9155/45/8/201; Tian FH, 2011, IEEE T MED IMAGING, V30, P1239, DOI 10.1109/TMI.2011.2111459; Tong YJ, 2019, J CEREBR BLOOD F MET, V39, P1148, DOI 10.1177/0271678X17753329; Tong YJ, 2017, J CEREBR BLOOD F MET, V37, P564, DOI 10.1177/0271678X16631755; Tong YJ, 2014, HUM BRAIN MAPP, V35, P5471, DOI 10.1002/hbm.22564; Tong YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106004; Tuunanen PI, 2006, NEUROIMAGE, V30, P102, DOI 10.1016/j.neuroimage.2005.09.021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Webb JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084279; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Winder AT, 2017, NAT NEUROSCI, V20, P1761, DOI 10.1038/s41593-017-0007-y; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wu CWW, 2012, NEUROIMAGE, V59, P3075, DOI 10.1016/j.neuroimage.2011.11.030; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yen CCC, 2018, NEUROIMAGE, V164, P121, DOI 10.1016/j.neuroimage.2017.03.005; Zhu DC, 2015, J CEREBR BLOOD F MET, V35, P1910, DOI 10.1038/jcbfm.2015.166	99	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222787	10.1371/journal.pone.0222787	http://dx.doi.org/10.1371/journal.pone.0222787			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545839	Green Published, gold, Green Submitted			2022-12-27	WOS:000532303200034
J	Lamming, L; McDonach, E; Mohammed, MA; Stoves, J; Lewington, AJ; Roberts, R; Samarasinghe, Y; Shah, N; Fluck, RJ; Jackson, N; Johnson, M; Jones, C; Selby, NM				Lamming, Laura; McDonach, Eileen; Mohammed, Mohammed A.; Stoves, John; Lewington, Andy J.; Roberts, Russell; Samarasinghe, Yohan; Shah, Nikunj; Fluck, Richard J.; Jackson, Natalie; Johnson, Melanie; Jones, Carol; Selby, Nicholas M.			Barriers and enablers to the implementation of a complex quality improvement intervention for acute kidney injury: A qualitative evaluation of stakeholder perceptions of the Tackling AKI study	PLOS ONE			English	Article							PROGRAM	Background Acute kidney injury in hospital patients is common and associated with reduced survival and higher healthcare costs. The Tackling Acute Kidney Injury (TAKI) quality improvement project aimed to reduce mortality rates in patients with acute kidney injury by implementing a multicomponent intervention comprising of an electronic alert, care bundle and education in five UK hospitals across a variety of wards. A parallel developmental evaluation using a case study approach was conducted to provide the implementation teams with insights into factors that might impact intervention implementation and fidelity. The qualitative element of the evaluation will be reported. Methods 29 semi-structured interviews with implementation teams across the five hospitals were carried out to identify perceived barriers and enablers to implementation. Interviews were taped and transcribed verbatim and Framework analysis was conducted. Results Interviews generated four 'barriers and enablers' to implementation themes: i) practical/contextual factors, ii) skills and make-up of the TAKI implementation team, iii) design, development and implementation approach, iv) staff knowledge, attitudes, behaviours and support. Enablers included availability of specialist teams (e.g. educational teams), multi-disciplinary implementation teams with strong leadership, team-based package completion and proactive staff. Barriers were frequently the converse of facilitators. Conclusions Despite diversity of sites, a range of common local factors-contextual, intervention-based and individual-were identified as potential barriers and enablers to fidelity, including intervention structure/design and process of/approach to implementation. Future efforts should focus on early identification and management of barriers and tailored optimisation of known enablers such as leadership and multidisciplinary teams to encourage buy-in. Improved measures of real-time intervention and implementation fidelity would further assist local teams to target their support during such quality improvement initiatives.	[Lamming, Laura; McDonach, Eileen; Mohammed, Mohammed A.] Univ Bradford, Fac Hlth Studies, Bradford, W Yorkshire, England; [Stoves, John; Roberts, Russell] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Lewington, Andy J.] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Lewington, Andy J.] NIHR Leeds In Vitro Diagnost Cooperat, Leeds, W Yorkshire, England; [Roberts, Russell] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Samarasinghe, Yohan] Frimley Hlth NHS Fdn Trust, Bradford, W Yorkshire, England; [Shah, Nikunj; Jones, Carol] Ashford & St Peters NHS Fdn Trust, Chertsey, Surrey, England; [Fluck, Richard J.; Selby, Nicholas M.] Derby Teaching Hosp NHS Fdn Trust, Dept Renal Med, Derby, England; [Jackson, Natalie; Johnson, Melanie] Yorkshire & Humber AHSN Improvement Acad, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Selby, Nicholas M.] Univ Nottingham, Derby Teaching Hosp NHS Fdn Trust, Ctr Kidney Res & Innovat, Sch Med, Derby, England	University of Bradford; University of Leeds; University of Nottingham	Lamming, L (corresponding author), Univ Bradford, Fac Hlth Studies, Bradford, W Yorkshire, England.	L.Lamming@bradford.ac.uk		Lamming, Laura/0000-0003-0984-3621; Selby, Nicholas/0000-0003-0351-8326	Health Foundation [1502-Derby-Selby-SUI]	Health Foundation	Funding for this evaluation and project came from the Scaling Up Improvement call from The Health Foundation (www.health.org.uk.NS received the award (https://www.health.org.uk/programmes/scaling-improvement/projects/tackling-acute-kidney-injury-multi-centre-quality). Grant code: 1502-Derby-Selby-SUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Davidoff F, 2015, BMJ QUAL SAF, V24, P228, DOI 10.1136/bmjqs-2014-003627; Davies H., 2007, HEALTHCARE PROFESSIO; De Silva D, 2015, WHATS GETTING WAY BA; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; Evans RE, 2019, J EPIDEMIOL COMMUN H, V73, P481, DOI 10.1136/jech-2018-210840; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Godfrey M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-341; Gollop R, 2004, QUAL SAF HEALTH CARE, V13, P108, DOI 10.1136/qshc.2003.007450; Health Quality Ontario, 2013, QUAL IMPR PRIM QUAL, P1; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Lavrakas PJ, 2008, ENCY SURVEY RES METH, DOI DOI 10.1371/journal.pone.0073008; McDonald KM, 2004, AHRQ PUBLICATION; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2015, BEHAV CHANGE WHEEL G; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; Selby NM, 2019, J AM SOC NEPHROL, V30, P505, DOI 10.1681/ASN.2018090886; Selby NM, 2016, NEPHRON, V134, P200, DOI 10.1159/000447675; Spencer L., 2013, QUALITATIVE RES PRAC; Stokes T, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0508-1; Thorndike EL, 1920, J APPL PSYCHOL, V4, P25, DOI 10.1037/h0071663; Tolich M., 2004, QUAL SOCIOL, V27, P101, DOI [DOI 10.1023/B:QUAS.0000015546.20441.4A, 10.1023/B:QUAS.0000015546.20441.4a]; Tong A, 2018, INT J QUAL HEALTH C, V19, P349, DOI DOI 10.1093/intqhc/mzm042; Wallace F., 2005, IMPLEMENTATION RES S; [No title captured], DOI DOI 10.1186/S13012-016-0508-01	28	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222444	10.1371/journal.pone.0222444	http://dx.doi.org/10.1371/journal.pone.0222444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539376	gold, Green Published			2022-12-27	WOS:000532297900012
J	Boyle, KK; Sosa, B; Osagie, L; Turajane, K; Bostrom, MPG; Yang, X				Boyle, K. Keely; Sosa, Branden; Osagie, Liza; Turajane, Kathleen; Bostrom, Mathias P. G.; Yang, Xu			Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model	PLOS ONE			English	Article							LOCAL ANTIBIOTIC DELIVERY; GRAFT SUBSTITUTE; IN-VITRO; CHRONIC OSTEOMYELITIS; SURGICAL DEBRIDEMENT; DEFECTS; TOBRAMYCIN; MANAGEMENT; FRACTURES; PELLETS	Objective Local antibiotic delivery systems with differing chemical and mechanical properties have been developed to assist in the management of osteomyelitis. We investigated the bone conductive and resorptive capabilities of a calcium phosphate-calcium sulfate (CaP/CaS) composite compared with commercially available polymethylmethacrylate (PMMA). In addition, we compared the in vivo preventative and treatment efficacies of both biomaterials in a proven osteomyelitis model. Methods Sixty-four, male Sprague-Dawley rats were inoculated with 10 mu l of 1.5 x 10(8) CFU/ml of Staphylococcus aureus in a surgically drilled defect in the right proximal tibia. Infected animals were randomly allocated into prevention and treatment groups with 32 rats each. In the prevention group, the defect was filled with a plug containing either PMMA or CaP/CaS immediately after the inoculation. In the treatment group, the infected defects were irrigated, debrided, and filled with either a PMMA or CaP/CaS plug. Both CaP/CaS and PMMA were impregnated with 10% weight of vancomycin. Rats were sacrificed 6 weeks after cement insertion. Infection was detected by bacterial culture and histological analysis. Bone formation in the defect was assessed with micro-computed tomography and histology. Results No bacteria were detected in any group. Both the prevention and treatment groups using CaP/CaS had significantly more bone volume fraction, bone area, and cartilage area than the PMMA groups. Conclusions When loaded with 10% of vancomycin, CaP/CaS and PMMA have the same efficacy for treatment and prevention of osteomyelitis. CaP/CaS enhances bone defect healing through improved bone remodeling in our osteomyelitis rat model.	[Boyle, K. Keely] Univ Buffalo, Buffalo, NY USA; [Sosa, Branden; Turajane, Kathleen; Bostrom, Mathias P. G.; Yang, Xu] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Osagie, Liza] Royal Free Hosp, London, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Yang, X (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	yangx@hss.edu		Sosa, Branden/0000-0002-1054-2917; Yang, Xu/0000-0001-8377-077X	BoneSupport AB, Lund Sweden; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR002384] Funding Source: NIH RePORTER	BoneSupport AB, Lund Sweden; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors acknowledge the support of BoneSupport AB, Lund Sweden.	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; ADAMS K, 1992, CLIN ORTHOP RELAT R, P244; An YH FR, 1998, J INVESTIGATIVE SURG; Barie Philip S, 2006, Surg Infect (Larchmt), V7, P327, DOI 10.1089/sur.2006.7.327; Blaha JD, 1998, ORTHOPEDICS, V21, P1017; Borrelli J, 2003, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000069893.31220.6f; BOWYER GW, 1994, J TRAUMA, V36, P331, DOI 10.1097/00005373-199403000-00008; BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, P96; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chang W, 2007, ACTA ORTHOP BELG, V73, P238; Cho Se-Hyun, 1997, Bulletin Hospital for Joint Diseases, V56, P140; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6; Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53; Gogia Jaspaul S, 2009, Semin Plast Surg, V23, P100, DOI 10.1055/s-0029-1214162; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77; Hashmi MA, 2004, J BONE JOINT SURG BR, V86B, P269, DOI 10.1302/0301-620X.86B2.14011; Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083; Keating JF, 2005, J BONE JOINT SURG BR, V87B, P142, DOI 10.1302/0301-620X.87B2.15874; Kelly CM, 2001, CLIN ORTHOP RELAT R, P42; Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002; MACKEY D, 1982, CLIN ORTHOP RELAT R, P263; MAYBERRYCARSON KJ, 1984, INFECT IMMUN, V43, P825, DOI 10.1128/IAI.43.3.825-833.1984; McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/00005131-200210000-00002; Mckee MD, 2010, J ORTHOP TRAUMA, V24, P483, DOI 10.1097/BOT.0b013e3181df91d9; MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307; Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x; Nelson CL, 2002, J ORTHOP RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4; PATZAKIS MJ, 1993, CLIN ORTHOP RELAT R, P112; Pollak AN, 2010, J BONE JOINT SURG AM, V92A, P7, DOI 10.2106/JBJS.H.00984; Rohilla M, 2006, INJURY, V37, P85, DOI 10.1016/j.injury.2005.06.059; Sanicola Shawn M, 2005, J Foot Ankle Surg, V44, P121, DOI 10.1053/j.jfas.2005.01.006; Scott CP, 1999, J BONE JOINT SURG BR, V81B, P440, DOI 10.1302/0301-620X.81B3.9267; Swiontkowski MF, 1999, J BONE JOINT SURG BR, V81B, P1046, DOI 10.1302/0301-620X.81B6.9794; Thomas DB, 2005, CLIN ORTHOP RELAT R, P366, DOI 10.1097/01.blo.0000181144.01306.b0; Turner TM, 2001, J BONE JOINT SURG AM, V83A, P8, DOI 10.2106/00004623-200100021-00003; Urban RM, 2003, ORTHOPEDICS, V26, pS581; Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a; Zelken J, 2007, CLIN ORTHOP RELAT R, P190, DOI 10.1097/BLO.0b013e3180ca9521	41	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222034	10.1371/journal.pone.0222034	http://dx.doi.org/10.1371/journal.pone.0222034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536540	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800026
J	Fu, YQ; Bai, K; Liu, CJ				Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun			The impact of admission serum lactate on children with moderate to severe traumatic brain injury	PLOS ONE			English	Article							BASE DEFICIT; PROGNOSTIC-SIGNIFICANCE; EARLY HYPERGLYCEMIA; ARTERIAL LACTATE; INITIAL LACTATE; BLOOD LACTATE; BLUNT TRAUMA; MORTALITY; CLEARANCE; UTILITY	Background Lactate is used to evaluate the prognosis of adult patients with trauma. However, the prognostic significance of admission serum lactate in the setting of pediatric traumatic brain injury (TBI) is still unclear. We aim to investigate the impact of admission lactate on the outcome in children with moderate to severe TBI. Methods This retrospective study was conducted in a tertiary pediatric hospital between May 2012 and Jun 2018 included children with an admission Glasgow Coma Scale (GCS) of <= 13. Two hundred and thirteen patients were included in the analysis and 45 patients died in hospital. Results Admission lactate and glucose were significantly higher in non-survivors than those in survivors (P < 0.05). Admission lactate was positively correlated with admission glucose and negatively correlated with GCS in all patients (n = 213), subgroup of isolated TBI (n = 112) and subgroup of GCS. 8 (n = 133), respectively. AUCs of lactate could significantly predict the mortality and were higher than those of glucose in all patients, subgroup of isolated TBI and subgroup of GCS. 8, respectively. Multivariate logistic regression showed that admission lactate (Adjusted OR = 1.189; 95% CI: 1.002-1.410; P = 0.047) was independently associated with mortality, while admission glucose (Adjusted OR = 1.077; 95% CI: 0.978-1.186; P = 0.133) wasn't an independent risk factor of death. Elevated admission lactate (> 2 mmol/L) was associated with death, reduced 14-day ventilation-free days, 14-day ICU-free days and 28-day hospital-free days. Conclusions Admission serum lactate can effectively predict the mortality of children with moderate to severe TBI. Elevated admission lactate is associated with death, reduced ventilator-free, ICU-free, and hospital-free days. Admission serum lactate could be used as a prognostic biomarker of mortality in children with moderate to severe TBI.	[Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Key Lab Pediat, Chongqing, Peoples R China	Chongqing Medical University	Fu, YQ (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.	fuyueqiang@sina.com						Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P445, DOI 10.1097/TA.0000000000001085; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Gale SC, 2016, J SURG RES, V205, P446, DOI 10.1016/j.jss.2016.06.103; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kong VY, 2018, SAMJ S AFR MED J, V108, P413, DOI [10.7196/SAMJ.2018.v108i5.12837, 10.7196/samj.2018.v108i5.12837]; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Londono J, 2018, SHOCK, V50, P286, DOI 10.1097/SHK.0000000000001066; Martin MJ, 2006, AM J SURG, V191, P625, DOI 10.1016/j.amjsurg.2006.02.014; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Okello M, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0020-9; Ouellet JF, 2012, J TRAUMA ACUTE CARE, V72, P1532, DOI 10.1097/TA.0b013e318256dd5a; Pal JD, 2006, J TRAUMA, V60, P583, DOI 10.1097/01.ta.0000205858.82575.55; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Parsikia A, 2014, SHOCK, V42, P199, DOI 10.1097/SHK.0000000000000208; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Ramanathan R, 2015, J PEDIATR SURG, V50, P598, DOI 10.1016/j.jpedsurg.2014.08.013; Raux M, 2017, ANESTHESIOLOGY, V126, P522, DOI 10.1097/ALN.0000000000001490; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Richards JE, 2018, ANESTH ANALG, V126, P904, DOI 10.1213/ANE.0000000000002626; Richards JE, 2016, J ORTHOP TRAUMA, V30, P312, DOI 10.1097/BOT.0000000000000528; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; Shah A, 2013, PEDIATR EMERG CARE, V29, P715, DOI 10.1097/PEC.0b013e318294ddb1; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Venkatesan M, 2015, INJURY, V46, P2201, DOI 10.1016/j.injury.2015.06.038	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222591	10.1371/journal.pone.0222591	http://dx.doi.org/10.1371/journal.pone.0222591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536567	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800057
J	Gorodeski, EZ; Magnelli-Reyes, C; Moennich, LA; Grimaldi, A; Rickard, J				Gorodeski, Eiran Z.; Magnelli-Reyes, Christina; Moennich, Laurie Ann; Grimaldi, Adam; Rickard, John			Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: A novel model of care	PLOS ONE			English	Article							TASK-FORCE; MINI-COG; GUIDELINES; MANAGEMENT; EXERCISE; DEMENTIA; SOCIETY	Background Post-implant care of patients with heart failure (HF) undergoing cardiac resynchronization therapy (CRT) is not addressed in current HF or CRT guidelines and is often fragmented with poor communication between specialties. We sought to develop a new model of postCRT care which could be implemented in busy clinical settings. Methods and results We designed a novel, multidisciplinary approach to standardizing post CRT care. All patients receiving a CRT device at the Cleveland Clinic between March 2017 and August 2018 were invited to be seen in the clinic 6 months post implant. A one-time collaborative visit encompassing cardiac imaging, heart failure, and electrophysiology care was performed. We recorded the operational feasibility of the clinic in terms of patient throughput as well as patient characteristics, interventions, and new diagnoses made. Between September 2017 and February 2019, 150 patients were seen in the clinic. Of these, 125 patients had their index CRT implanted for standard indications and were included in the current analysis. Approximately 45 minutes were dedicated for each patient visit. Interventions in care were made in 95% of patients, with CRT non-responders offered a higher number of interventions as compared to responders (median 3 versus 2 interventions). Types of interventions were device-related (26% of population), medication-related (74%), and referral for alternate medical services (80%). Conclusions Multidisciplinary post-implant care of patients with HF receiving CRT devices, regardless of CRT response status, is feasible and results in frequent medical interventions.	[Gorodeski, Eiran Z.] Cleveland Clin, Dept Cardiovasc Med, Sect Heart Failure & Cardiac Transplantat, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Magnelli-Reyes, Christina; Grimaldi, Adam; Rickard, John] Cleveland Clin, Dept Cardiovasc Med, Sect Cardiac Pacing & Electrophysiol, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Moennich, Laurie Ann] Cleveland Clin, Heart & Vasc Inst, Heart & Vasc Res, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rickard, J (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Sect Cardiac Pacing & Electrophysiol, Heart & Vasc Inst, Cleveland, OH 44106 USA.	rickardj2@ccf.org		Moennich, Laurie Ann/0000-0002-1070-340X	Abbott	Abbott(Abbott Laboratories)	EZG and JR have received unrestricted research grant funding from Abbott to support the CRT-HF clinic research infrastructure.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Altman RK, 2012, EUR HEART J, V33, P2181, DOI 10.1093/eurheartj/ehs107; Arslan S, 2007, TEX HEART I J, V34, P166; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Drey M, 2011, GERONTOLOGY, V57, P11, DOI 10.1159/000313433; Kubala Maciej, 2017, JACC Clin Electrophysiol, V3, P1523, DOI 10.1016/j.jacep.2017.06.012; Maass AH, 2018, EUROPACE, V20, pE1, DOI 10.1093/europace/euw445; Maass AH, 2009, J CARDIOVASC ELECTR, V20, P773, DOI 10.1111/j.1540-8167.2008.01422.x; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Mullens W, 2009, J AM COLL CARDIOL, V53, P765, DOI 10.1016/j.jacc.2008.11.024; Parkash R, 2013, CAN J CARDIOL, V29, P1346, DOI 10.1016/j.cjca.2013.09.009; Patwala AY, 2009, J AM COLL CARDIOL, V53, P2332, DOI 10.1016/j.jacc.2009.02.063; Rickard J, 2010, HEART RHYTHM, V7, P885, DOI 10.1016/j.hrthm.2010.04.005; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	19	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222610	10.1371/journal.pone.0222610	http://dx.doi.org/10.1371/journal.pone.0222610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536565	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800063
J	Greene-Cramer, B; Boyd, AT; Russell, S; Hulland, E; Tromble, E; Widiati, Y; Sharma, S; Pun, A; Allen, DR; Dokubo, EK; Handzel, E				Greene-Cramer, Blanche; Boyd, Andrew T.; Russell, Steven; Hulland, Erin; Tromble, Erin; Widiati, Yulia; Sharma, Sharad; Pun, Asha; Allen, Denise Roth; Dokubo, Emily Kainne; Handzel, Endang			Systematic identification of facility-based stillbirths and neonatal deaths through the piloted use of an adapted RAPID tool in Liberia and Nepal	PLOS ONE			English	Article							CARE	Maternal, fetal, and neonatal health outcomes are interdependent. Designing public health strategies that link fetal and neonatal outcomes with maternal outcomes is necessary in order to successfully reduce perinatal and neonatal mortality, particularly in low- and middle-income countries. However, to date, there has been no standardized method for documenting, reporting, and reviewing facility-based stillbirths and neonatal deaths that links to maternal health outcomes would enable a more comprehensive understanding of the burden and determinants of poor fetal and neonatal outcomes. We developed and pilot-tested an adapted RAPID tool, Perinatal-Neonatal Rapid Ascertainment Process for Institutional Deaths (PN RAPID), to systematically identify and quantify facility-based stillbirths and neonatal deaths and link them to maternal health factors in two countries: Liberia and Nepal. This study found an absence of stillbirth timing documented in records, a high proportion of neonatal deaths occurring within the first 24 hours, and an absence of documentation of pregnancy-related and maternal factors that might be associated with fetal and neonatal outcomes. The use of an adapted RAPID methodology and tools was limited by these data gaps, highlighting the need for concurrent strengthening of death documentation through training and standardized record templates.	[Greene-Cramer, Blanche; Boyd, Andrew T.; Russell, Steven; Hulland, Erin; Tromble, Erin; Handzel, Endang] Ctr Dis Control & Prevent, Div Global Hlth Protect, Emergency Response & Recovery Branch, Atlanta, GA 30333 USA; [Widiati, Yulia] UNICEF Liberia, Hlth Sect, Monrovia, Liberia; [Sharma, Sharad] Dept Hlth Serv, Management Div, Kathmandu, Nepal; [Pun, Asha] UNICEF Nepal, Hlth Sect, Kathmandu, Nepal; [Allen, Denise Roth; Dokubo, Emily Kainne] Ctr Dis Control & Prevent, Div Global Hlth Protect, Liberia Country Off, Monrovia, Liberia	Centers for Disease Control & Prevention - USA	Greene-Cramer, B (corresponding author), Ctr Dis Control & Prevent, Div Global Hlth Protect, Emergency Response & Recovery Branch, Atlanta, GA 30333 USA.	bgreenec@gmail.com		Hulland, Erin/0000-0003-0525-1856	Center for Disease Control and Prevention (CDC)	Center for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The publication of this article was funded by the Center for Disease Control and Prevention (CDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdeen U, I APPL HLTH SCI; Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; [Anonymous], NAT AIDS CONTR PROGR; Bhusal Mahesh, 2019, J Prev Med Public Health, V52, P154, DOI 10.3961/jpmph.18.270; Bhutta ZA, 2014, OBSTET GYNECOL SURV, V69, P641, DOI 10.1097/OGX.0000000000000124; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Boyd AT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1329-1; Delamou A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000202; eHealth network, 2021, EHEALTH 0202; Goldenberg RL, 2018, BJOG-INT J OBSTET GY, V125, P148, DOI 10.1111/1471-0528.14696; Hartung C., 2010, OPEN DATA KIT TOOLS; Kamath-Rayne BD, 2015, MATERN CHILD HLTH J, V19, P1853, DOI 10.1007/s10995-015-1699-9; Khanal S, 2011, J NEPAL MED ASSOC, V50, P21; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Morof D, 2015 GLOB MAT HLTH C; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Reinebrandt H, BJOG, DOI [10.1111/1471-0528, DOI 10.1111/1471-0528]; UNICEF, NEON MORT; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; WHO, 2016, MAK EV BAB COUNT AUD; World Health Organization, 2016, WHO APPL ICD 10 DEAT; World Health Organization, 2015, PREGN CHILDB POSTP N	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222583	10.1371/journal.pone.0222583	http://dx.doi.org/10.1371/journal.pone.0222583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536573	gold, Green Published, Green Submitted			2022-12-27	WOS:000532262800056
J	Guesdon, IR; Amorim, AM; Meira, RMSA				Guesdon, Isabel Reis; Amorim, Andre Marcio; Strozi Alves Meira, Renata Maria			Functional role and evolutionary contributions of floral gland morphoanatomy in the Paleotropical genus Acridocarpus (Malpighiaceae)	PLOS ONE			English	Article							LEAF GLANDS; SECRETION; NECTARIES; ANATOMY; ULTRASTRUCTURE; PHYLOGENY; FLOWERS; CALYX	The stereotyped floral morphology of Neotropical Malpighiaceae species-zygomorphic and calyx with oil glands-is correlated with oil-bee pollination. In contrast, the floral trends of the Paleotropical lineages are actinomorphy and lack of calyx glands, probably due to the absence of oil-collecting bees. The Paleotropical genus Acridocarpus is an exception because of its zygomorphic, gland-bearing flowers. Glands throughout Acridocarpus inflorescences were morphoanatomically evaluated to verify the occurrence of patterns related to species and geographic distribution. Herbarium (25 species) and fresh samples of A. longifolius were processed according to standard anatomical techniques. To verify the presence of glucose and protein, strip tests were applied to the exudate. Fresh samples were fixed and submitted to histochemical tests. Based on the occurrence, number and placement of glands, three distribution patterns were recognized on the bracteole and ten on the calyx. Bract, bracteole and sepal glands have a typical nectary structure with a palisade-like epidermis and vascularized parenchyma. Glands were classified as short-stalked, sessile or immersed. Histochemical tests performed on bract and sepal glands of A. longifolius were positive for proteins, polysaccharides and phenolic compounds, and negative for oil compounds. Glucose and protein were detected in the exudate. These results allow us to recognize the glands in Acridocarpus inflorescences as nectaries. This comprehensive morphoanatomical study helps to clarify the correlation between patterns of floral morphology and secretion consumers, as well as to better understand floral evolution in Malpighiaceae across their dispersal events.	[Guesdon, Isabel Reis; Strozi Alves Meira, Renata Maria] Univ Fed Vicosa, Dept Biol Vegetal, UFV, Vicosa, MG, Brazil; [Amorim, Andre Marcio] Univ Estadual Santa Cruz, UESC, Dept Ciencias Biol, Ilheus, BA, Brazil; [Amorim, Andre Marcio] CEPEC, Herbario Ctr Pesquisas Cacau, Itabuna, BA, Brazil; [Guesdon, Isabel Reis] Univ Fed Amazonas, UFAM, Inst Ciencias Exatas & Tecnol, Itacoatiara, Amazonas, Brazil	Universidade Federal de Vicosa; Universidade Estadual de Santa Cruz; Universidade Federal de Amazonas	Meira, RMSA (corresponding author), Univ Fed Vicosa, Dept Biol Vegetal, UFV, Vicosa, MG, Brazil.	rmeira@ufv.br	Meira, Renata Maria Strozi Alves/D-7191-2013; Amorim, André M./I-9411-2012	Meira, Renata Maria Strozi Alves/0000-0001-5324-6168; Amorim, Andre/0000-0003-0712-3321	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310717/2015-9, 307762/2016-5]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [UNIVERSAL APQ00383-16]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO) for awarding the doctoral scholarships to IRG; the Programa de Pos-Graduacao em Botanica at the Universidade Federal de Vicosa (UFV) for providing logistical support; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for awarding research productivity fellowships to AMA (grant 310717/2015-9) and RMSAM (grant 307762/2016-5); and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for the financial resources (UNIVERSAL APQ00383-16). We are also grateful to the MNHN Herbarium and Jardin Botanique Meise for kindly loaning samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RF, 2019, PHYTOKEYS, P45, DOI 10.3897/phytokeys.117.32207; Anderson Christiane, 2007, Contributions from the University of Michigan Herbarium, V25, P1; ANDERSON W R, 1990, Memoirs of the New York Botanical Garden, V64, P210; Anderson William R., 2007, Contributions from the University of Michigan Herbarium, V25, P113; ANDERSON WR, 1979, BIOTROPICA, V11, P219, DOI 10.2307/2388042; Anderson WR, 1981, MEMOIRS NEW YORK BOT, V32, P137; Anderson WR., 2001, FLORA VENEZUELAN GUA, V6, P82; Araujo JS, 2016, ACTA BOT BRAS, V30, P112, DOI 10.1590/0102-33062015abb0248; Arenes J., 1950, FLORE MADAGASCAR, V108, P1; Arenes J., 1955, NOTULAE SYSTEMATICAE, V15, P4; ARUMUGASAMY K, 1993, ACTA SOC BOT POL, V62, P17; ARUMUGASAMY K, 1989, CURR SCI INDIA, V58, P260; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Birnbaum P., 2005, ADANSONIA, V27, P235; BUCHMANN SL, 1987, ANNU REV ECOL SYST, V18, P343, DOI 10.1146/annurev.es.18.110187.002015; Carvalho Paula Dib de, 2005, Acta Bot. Bras., V19, P209, DOI 10.1590/S0102-33062005000200002; Castro MA, 2001, AM J BOT, V88, P1935, DOI 10.2307/3558420; Chen S.K., 2008, FLORA CHINA, P132; Clark SG, 1981, STAINING PROCEDURES; Cocucci A.A., 1996, CHILE DARWINIANA, V34, P183, DOI DOI 10.14522/darwiniana.2014.341-4.404; Davis CC, 2002, EVOLUTION, V56, P2395; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2014, P NATL ACAD SCI USA, V111, P5914, DOI 10.1073/pnas.1403157111; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; ELIAS TS, 1980, AM J BOT, V67, P423, DOI 10.2307/2442352; Endress PK, 1996, DIVERSITY EVOLUTIONA; Fahn A, 1990, PLANT ANATOMY; Possobom CCF, 2015, FLORA, V211, P26, DOI 10.1016/j.flora.2015.01.002; FISHER DB, 1968, HISTOCHEMISTRY, V16, P92, DOI 10.1007/BF00306214; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Guesdon IR, 2017, THESIS; Guesdon IR, 2018, PHYTOTAXA, V345, P13, DOI 10.11646/phytotaxa.345.1.2; Guillemin JA, 1831, FLORAE SENEGAMBIAE T, V29, P123; Heald S.V., 2004, FLOWERING PLANTS NEO, P229, DOI DOI 10.1600/0363644053661878; Hutchinson J, 1958, FLORA W TROPICAL AFR, P350; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; Launert E., 1995, FLORA ETHIOPIA ERITR, P257; Launert E, 1963, FLORA ZAMBESIACA, P109; Launert E, 1968, BRIT MUSEUM NATURAL, P1; LOBREAU-CALLEN D, 1989, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V11, P79; Gonzalez AM, 2018, BOT J LINN SOC, V187, P26, DOI 10.1093/botlinnean/boy004; McKey D., 1979, HERBIVORES THEIR INT, P55; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Nery LA, 2017, ACTA BOT BRAS, V31, P459, DOI 10.1590/0102-33062017abb0108; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Niedenzu F, 1921, GENERE ACRIDOCARPO A; Niedenzu F., 1928, PFLANZENREICH 4, V141, P1; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Oliver D, 1868, FLORA TROPICAL AFRIC, P276; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; Possobom CCF, 2010, PLANT BIOLOGY, V12, P863, DOI 10.1111/j.1438-8677.2009.00304.x; Possobom CCF, 2017, PLANT SYST EVOL, V304, P15; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Ren MX, 2013, BOT J LINN SOC, V173, P764, DOI 10.1111/boj.12101; SAZIMA M, 1989, BOT ACTA, V102, P106, DOI 10.1111/j.1438-8677.1989.tb00073.x; Sigrist MR, 2004, ANN BOT-LONDON, V94, P33, DOI 10.1093/aob/mch108; SIMPSON BB, 1981, ANN MO BOT GARD, V68, P301, DOI 10.2307/2398800; Smith FH, 1942, AM J BOT, V29, P464, DOI 10.2307/2437312; Souto LS, 2013, FLORA, V208, P351, DOI 10.1016/j.flora.2013.05.002; SUBRAMANIAN RB, 1990, NORD J BOT, V10, P57, DOI 10.1111/j.1756-1051.1990.tb01753.x; SUDD JH, 1985, ECOL ENTOMOL, V10, P89, DOI 10.1111/j.1365-2311.1985.tb00538.x; Teixeira L. A. G., 2000, Acta Botanica Brasilica, V14, P347, DOI 10.1590/S0102-33062000000300011; Thulin M., 1993, FLORA SOMALIA, P260; VANDOORNHOEKMAN H, 1975, ACTA BOT NEERL, V24, P69, DOI 10.1111/j.1438-8677.1975.tb00995.x; Vinson SB, 1997, BIOTROPICA, V29, P76, DOI 10.1111/j.1744-7429.1997.tb00008.x; VOGEL S, 1990, Memoirs of the New York Botanical Garden, V55, P130; Vogel S., 1974, TROPISCHE SUBTROPISC, V7, P283, DOI DOI 10.1002/FEDR.19770880110; Wilczek R, 1958, FLORE CONGO BELGE RU, P214; Wilczek R., 1955, B JARD BOT ETAT BRUX, V25, P303, DOI DOI 10.2307/3667028; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107	73	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222561	10.1371/journal.pone.0222561	http://dx.doi.org/10.1371/journal.pone.0222561			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527912	gold, Green Published, Green Submitted			2022-12-27	WOS:000532231400028
J	Lenhard, A; Lenhard, W; Gary, S				Lenhard, Alexandra; Lenhard, Wolfgang; Gary, Sebastian			Continuous norming of psychometric tests: A simulation study of parametric and semiparametric approaches	PLOS ONE			English	Article							CENTILE CURVES	Continuous norming methods have seldom been subjected to scientific review. In this simulation study, we compared parametric with semi-parametric continuous norming methods in psychometric tests by constructing a fictitious population model within which a latent ability increases with age across seven age groups. We drew samples of different sizes (n = 50, 75, 100, 150, 250, 500 and 1,000 per age group) and simulated the results of an easy, medium, and difficult test scale based on Item Response Theory (IRT). We subjected the resulting data to different continuous norming methods and compared the data fit under the different test conditions with a representative cross-validation dataset of n = 10,000 per age group. The most significant differences were found in suboptimal (i.e., too easy or too difficult) test scales and in ability levels that were far from the population mean. We discuss the results with regard to the selection of the appropriate modeling techniques in psychometric test construction, the required sample sizes, and the requirement to report appropriate quantitative and qualitative test quality criteria for continuous norming methods in test manuals.	[Lenhard, Alexandra] Test Dev Ctr, Psychometr, Dettelbach, Bavaria, Germany; [Lenhard, Wolfgang; Gary, Sebastian] Univ Wurzburg, Inst Psychol, Bavaria, Germany	University of Wurzburg	Lenhard, W (corresponding author), Univ Wurzburg, Inst Psychol, Bavaria, Germany.	wolfgang.lenhard@uni-wuerzburg.de	Lenhard, Wolfgang/AAU-3292-2020	Lenhard, Wolfgang/0000-0002-8184-6889	German Research Foundation (DFG); University of Wuerzburg; Human Dynamics Center of the Faculty of Human Sciences of the University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Human Dynamics Center of the Faculty of Human Sciences of the University of Wuerzburg	The authors received no specific funding for conducting the study. This open access publication itself was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme 'Open Access Publishing'. It was additionally supported by the Human Dynamics Center of the Faculty of Human Sciences of the University of Wuerzburg.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; COLE TJ, 1988, J R STAT SOC A STAT, V151, P385, DOI 10.2307/2982992; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Hagmann-von-Arx P., 2018, IDS 2 INTELLIGENZ EN; Heller G., 2017, FLEXIBLE REGRESSION, DOI DOI 10.1201/B21973; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Lenhard A., 2015, PEABODY PICTURE VOCA, V4th edn.; Lenhard A, 2018, CNORM GENERATING CON; Lenhard A, 2018, ASSESSMENT, V25, P112, DOI 10.1177/1073191116656437; Lenhard W, 2018, CONTINUOUS NORMING V; Lenhard W., 2006, ELFE 1 6 LESEVERSTAN; Lenhard W., 2017, ELFE 2 LESEVERSTANDN; Oosterhuis HEM, 2017, PSYCHOMETRIKA, V82, P559, DOI 10.1007/s11336-016-9535-8; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; RUTTER M, 1976, PSYCHOL MED, V6, P313, DOI 10.1017/S003329170001388X; Stasinopoulos DM, 2016, GAMLSS PRACTICALS GR; Stasinopoulos DM, 2018, PACKAGE GAMLSS VERSI; Voncken L, 2019, BEHAV RES METHODS, V51, P826, DOI 10.3758/s13428-018-1122-8; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER ADULT INTEL, P257; Wechsler D, 2014, WECHSLER INTELLIGENC; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wechsler D, 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P86, DOI 10.1002/1097-4679(198501)41:1<86::AID-JCLP2270410115>3.0.CO;2-W; Zhu JJ, 2011, J PSYCHOEDUC ASSESS, V29, P570, DOI 10.1177/0734282910396323	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222279	10.1371/journal.pone.0222279	http://dx.doi.org/10.1371/journal.pone.0222279			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527877	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400013
J	Avila-Mendez, K; Rodrigo, A; Araque, L; Romero, HM				Avila-Mendez, Kelly; Rodrigo, Avila; Araque, Leonardo; Mauricio Romero, Hernan			Simultaneous transcriptome analysis of oil palm clones and Phytophthora palmivora reveals oil palm defense strategies	PLOS ONE			English	Article							GENE-EXPRESSION; BUD ROT; AUXIN; REPRESSION; GROWTH	Phytophthora palmivora is an oomycete that causes oil palm bud rot disease. To understand the molecular mechanisms of this disease, palm clones with contrasting responses (Ortet 34, resistant and Ortet 57, susceptible) were inoculated with P. palmivora, and RNAseq gene expression analysis was performed. The transcriptome was obtained by sequencing using Illumina HiSeq2500 technology during the asymptomatic phase (24, 72 and 120 hours postinfection, hpi). A simultaneous analysis of differentially expressed gene (DEG) profiles in palm and P. palmivora was carried out. Additionally, Gene Ontology (GO) and gene network analysis revealed differences in the transcriptional profile of the two ortets, where a high specificity of the pathogen to colonize the susceptible ortet was found. The transcriptional analysis provided an overview of the genes involved in the recognition and signaling of this pathosystem, where different transcription factors, phytohormones, proteins associated with cell wall hardening and nitrogen metabolism contribute to the resistance of oil palm to P. palmivora. This research provides a description of the molecular response of oil palm to P. palmivora, thus becoming an important source of molecular markers for the study of genotypes resistant to bud rot disease.	[Avila-Mendez, Kelly; Rodrigo, Avila; Araque, Leonardo; Mauricio Romero, Hernan] Cenipalma, OiI Palm Res Ctr, Biol & Breeding Program, Bogota, Colombia; [Mauricio Romero, Hernan] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	CENIPALMA (Colombia); Universidad Nacional de Colombia	Romero, HM (corresponding author), Cenipalma, OiI Palm Res Ctr, Biol & Breeding Program, Bogota, Colombia.; Romero, HM (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	hmromeroa@unal.edu.co	Avila, Kelly/ABH-4598-2020; Romero, Hernan Mauricio/AFI-6703-2022	Avila, Kelly/0000-0002-7155-2924; Romero, Hernan Mauricio/0000-0002-0760-2296; Avila, Rodrigo/0000-0001-8972-9663	Colciencias [713-2011, 158-2016]; Colombian Oil Promotion Fund Research Grant [IIT-0218]; Oil Palm Promotion Fund (FFP)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colombian Oil Promotion Fund Research Grant; Oil Palm Promotion Fund (FFP)	The study received financial support by: Colciencias Doctoral Fellowship, to K.A.; Colciencias Research Grants 713-2011 and 158-2016 to HMR; Colombian Oil Promotion Fund Research Grant IIT-0218 to HMR; The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; To the members of the Biology and Breeding Research Program at Cenipalma for their help with data collection. To the Oil Palm Pests and Diseases group at Cenipalma for providing the P. palmivora isolates. This research was funded by Colciencias and the Oil Palm Promotion Fund (FFP) administered by Fedepalma.	Asai S, 2015, CURR OPIN PLANT BIOL, V28, P1, DOI 10.1016/j.pbi.2015.08.008; Berens ML, 2017, ANNU REV PHYTOPATHOL, V55, P401, DOI 10.1146/annurev-phyto-080516-035544; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Birkenbihl RP, 2017, CURR OPIN PLANT BIOL, V38, P1, DOI 10.1016/j.pbi.2017.04.004; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Chan PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099774; Chen X-R, 2018, MOL GENET GENOMICS, P1; Coaker G, 2014, SCIENCE, V343, P496, DOI 10.1126/science.1250171; de Vries S, 2017, MOL PLANT PATHOL, V18, P110, DOI 10.1111/mpp.12465; Derevnina L, 2016, NEW PHYTOL, V212, P888, DOI 10.1111/nph.14137; Evangelisti E, 2014, CURR OPIN PLANT BIOL, V20, P118, DOI 10.1016/j.pbi.2014.05.014; Fedepalma, 2018, STAT YB 2018; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Gil-Bedoya J., 2019, THESIS; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33239; Latifah M, 2017, FOREST PATHOL, V47, DOI 10.1111/efp.12374; Li B, 2016, CELL HOST MICROBE, V19, P641, DOI 10.1016/j.chom.2016.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Naseenn M, 2015, J EXP BOT, V66, P4885, DOI 10.1093/jxb/erv297; Sarria GA, 2016, EUR J PLANT PATHOL, V145, P39, DOI 10.1007/s10658-015-0810-9; Sharpee WC, 2016, FUNGAL BIOL REV, V30, P62, DOI 10.1016/j.fbr.2016.04.001; Shigenaga AM, 2016, SEMIN CELL DEV BIOL; Shine MB, 2016, NEW PHYTOL, V212, P627, DOI 10.1111/nph.14078; Sundram S, 2017, CROP PROT, V101, P58, DOI 10.1016/j.cropro.2017.07.010; Torres GA, 2016, PHYTOPATHOLOGY, V106, P320, DOI 10.1094/PHYTO-09-15-0243-RVW; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Yang F., 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/annotation/fd65b655-d35b-47d1-8793-07da2273c144	32	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222774	10.1371/journal.pone.0222774	http://dx.doi.org/10.1371/journal.pone.0222774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553759	Green Published, gold			2022-12-27	WOS:000532319200035
J	Gastaldon, C; Mosler, F; Toner, S; Tedeschi, F; Bird, VJ; Barbui, C; Priebe, S				Gastaldon, Chiara; Mosler, Franziska; Toner, Sarah; Tedeschi, Federico; Bird, Victoria Jane; Barbui, Corrado; Priebe, Stefan			Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; TOOL	Introduction The NICE clinical guidelines on psychosocial interventions for the treatment of schizophrenia and psychosis in adults are based on the results of randomized controlled trials (RCTs), which may not be studies with a pragmatic design, leading to uncertainty on applicability or recommendations to everyday clinical practice. Aim To assess the level of pragmatism of the evidence used to develop the NICE guideline for psychosocial interventions in psychoses. Material and methods We conducted a systematic and critical appraisal of RCTs used to develop the 'psychological therapy and psychosocial interventions' section of the NICE guideline on the treatment and management of psychosis and schizophrenia in adults, published in 2014. For each study we assessed pragmatism using the pragmatic-explanatory continuum indicator summary-2 (PRECIS-2) and the Cochrane risk of bias tool. The mean score of PRECIS-2, averaging across nine domains, was calculated to describe the level of pragmatism of each individual study. Results A total of 143 studies were included in the analysis. Based on the PRECIS-2 tool, 16.8% were explanatory, 33.6% pragmatic, and 49.7% were rated in an intermediate category. Compared to explanatory studies, pragmatic studies showed a lower risk of bias. Additionally, pragmatism did not significantly improve over time, and no associations were found between pragmatism and a number of trial characteristics. However, studies with a UK leading investigator had the highest mean score of pragmatism. Cognitive behavioural therapy (CBT), art therapy, family intervention, psychoeducation, and adherence therapy, showed the higher average pragmatism scores. Conclusions Two third of studies used to produce NICE recommendations on psychosocial interventions for the treatment of schizophrenia and psychosis in adults are based on studies that did not employ a pragmatic design.	[Gastaldon, Chiara; Tedeschi, Federico; Barbui, Corrado] Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Verona, Italy; [Mosler, Franziska; Toner, Sarah; Bird, Victoria Jane; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, WHO Collaborating Ctr Mental Hlth Serv Dev, London, England	University of Verona; University of London; Queen Mary University London; World Health Organization	Gastaldon, C (corresponding author), Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, WHO Collaborating Ctr Res & Training Mental Hlth, Verona, Italy.	chiara.gastaldon@gmail.com	Gastaldon, Chiara/AAN-5630-2020; Bird, Victoria/N-1165-2013	Gastaldon, Chiara/0000-0001-7257-2962; Mosler, Franziska/0000-0002-6892-0888; Bird, Victoria/0000-0002-2053-7679; Toner, Sarah/0000-0003-2133-8601				[Anonymous], 1991, World Health Organ Tech Rep Ser, V812, P1; Coghill D, 2015, BRIT J PSYCHIAT, V207, P271, DOI 10.1192/bjp.207.3.271; Dal-Re R, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1038-2; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Haddock G, 2014, J MENT HEALTH, V23, P162, DOI 10.3109/09638237.2013.869571; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Hu G P, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P222, DOI 10.3760/cma.j.issn.0254-6450.2018.02.017; Johnson KE, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1158-y; Loudon K, 2017, J CLIN EPIDEMIOL, V88, P113, DOI 10.1016/j.jclinepi.2017.06.001; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Mansouri A, 2016, J NEUROSURG, V124, P558, DOI 10.3171/2014.12.JNS142465; National Collaborating Centre for Mental Health, 2014, PSYCH SCHIZ AD TREAT; Palese A, 2014, J NURS RES, V22, P216, DOI 10.1097/jnr.0000000000000045; Purgato M, 2015, PSYCHOL MED, V45, P225, DOI 10.1017/S0033291714001275; Ruggeri M, 2008, EPIDEMIOL PSICHIAT S, V17, P358, DOI 10.1017/S1121189X00000154; Salmoirago-Blotcher E, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-56; Slade M, 2001, BRIT J PSYCHIAT, V179, P286, DOI 10.1192/bjp.179.4.286; Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Taylor M, 2015, BRIT J PSYCHIAT, V206, P357, DOI 10.1192/bjp.bp.114.155945; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Witt CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032399; Zwarenstein M, 2017, J ROY SOC MED, V110, P208, DOI 10.1177/0141076817706303; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	24	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222891	10.1371/journal.pone.0222891	http://dx.doi.org/10.1371/journal.pone.0222891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550279	Green Published, gold			2022-12-27	WOS:000532307700030
J	Chamberlain, CA; Hatch, M; Garrett, TJ				Chamberlain, Casey A.; Hatch, Marguerite; Garrett, Timothy J.			Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri	PLOS ONE			English	Article							DIETARY OXALATE; DOUBLE-BLIND; BACTERIA; CASEI; ACID; REDUCTION; MEMBRANE; EFFICACY; PLACEBO; CITRATE	Oxalate, a ubiquitous compound in many plant-based foods, is absorbed through the intestine and precipitates with calcium in the kidneys to form stones. Over 80% of diagnosed kidney stones are found to be calcium oxalate. People who form these stones often experience a high rate of recurrence and treatment options remain limited despite decades of dedicated research. Recently, the intestinal microbiome has become a new focus for novel therapies. Studies have shown that select species of Lactobacillus, the most commonly included genus in modern probiotic supplements, can degrade oxalate in vitro and even decrease urinary oxalate in animal models of Primary Hyperoxaluria. Although the purported health benefits of Lactobacillus probiotics vary significantly between species, there is supporting evidence for their potential use as probiotics for oxalate diseases. Defining the unique metabolic properties of Lactobacillus is essential to define how these bacteria interact with the host intestine and influence overall health. We addressed this need by characterizing and comparing the metabolome and lipidome of the oxalate-degrading Lactobacillus acidophilus and Lactobacillus gasseri using ultra-high-performance liquid chromatography-high resolution mass spectrometry. We report many species-specific differences in the metabolic profiles of these Lactobacillus species and discuss potential probiotic relevance and function resulting from their differential expression. Also described is our validation of the oxalate-degrading ability of Lactobacillus acidophilus and Lactobacillus gasseri, even in the presence of other preferred carbon sources, measuring in vitro C-14-oxalate consumption via liquid scintillation counting.	[Chamberlain, Casey A.; Hatch, Marguerite; Garrett, Timothy J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Garrett, TJ (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	tgarrett@ufl.edu	Chamberlain, Casey/ABD-2813-2020	Chamberlain, Casey/0000-0002-3633-8594	National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TG received 2R01DK088892-05A1 from the National Institutes of Health, www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abratt VR, 2010, ADV APPL MICROBIOL, V72, P63, DOI 10.1016/S0065-2164(10)72003-7; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Benito de Cardenas I L, 1992, Rev Argent Microbiol, V24, P136; BRANEN AL, 1971, APPL MICROBIOL, V21, P993, DOI 10.1128/AEM.21.6.993-998.1971; BRANEN AL, 1970, J DAIRY SCI, V53, P593, DOI 10.3168/jds.S0022-0302(70)86259-2; Brooijmans Rob, 2009, F1000 Biol Rep, V1, P34, DOI 10.3410/B1-34; Chamberlain CA, 2019, ANAL CHEM, V91, P4964, DOI 10.1021/acs.analchem.9b00330; Chamberlain CA, 2019, ANAL BIOANAL CHEM, V411, P4807, DOI 10.1007/s00216-019-01639-y; Chen JY, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1384-0; Cho YA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001714; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Di Felice G, 2008, J CLIN GASTROENTEROL, V42, pS130, DOI 10.1097/MCG.0b013e318169c463; Diaz-Muniz I, 2006, J APPL MICROBIOL, V101, P872, DOI 10.1111/j.1365-2672.2006.02965.x; Diaz-Muniz I, 2006, ANTON LEEUW INT J G, V90, P233, DOI 10.1007/s10482-006-9078-6; Dimidi E, 2017, ADV NUTR, V8, P484, DOI 10.3945/an.116.014407; Engel CAR, 2008, APPL MICROBIOL BIOT, V78, P379, DOI 10.1007/s00253-007-1341-x; Ettinger G, 2014, GUT MICROBES, V5, P719, DOI 10.4161/19490976.2014.983775; Ferrarese R, 2018, EUR REV MED PHARMACO, V22, P7588, DOI 10.26355/eurrev_201811_16301; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fozo EM, 2004, FEMS MICROBIOL LETT, V238, P291, DOI 10.1016/j.femsle.2004.07.047; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; Hatch M, 2006, KIDNEY INT, V69, P691, DOI 10.1038/sj.ki.5000162; Hatch M, 2008, SEMIN NEPHROL, V28, P143, DOI 10.1016/j.semnephrol.2008.01.007; Hatch M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.70; He LL, 2015, ANAL CHEM, V87, P2459, DOI 10.1021/ac504458r; Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Holmes RP, 2001, KIDNEY INT, V59, P270, DOI 10.1046/j.1523-1755.2001.00488.x; JAKOBY WB, 1956, J BIOL CHEM, V222, P435; Kaur R, 2006, PHYTOCHEMISTRY, V67, P595, DOI 10.1016/j.phytochem.2005.12.011; Khan SR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.1; Kim J, 2018, J MED FOOD, V21, P454, DOI 10.1089/jmf.2017.3937; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Koelmel JP, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1744-3; Koelmel JP, 2017, J AM SOC MASS SPECTR, V28, P908, DOI 10.1007/s13361-017-1608-0; La Fata G, 2018, PROBIOTICS ANTIMICRO, V10, P11, DOI 10.1007/s12602-017-9322-6; Liebman M, 2011, ADV NUTR, V2, P254, DOI 10.3945/an.111.000414; Lu HYJ, 2011, J FOOD PROTECT, V74, P893, DOI 10.4315/0362-028X.JFP-10-404; Max B, 2010, BRAZ J MICROBIOL, V41, P862, DOI 10.1590/S1517-83822010000400005; McFarland LV, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00124; Miller AW, 2013, PATHOGENS, V2, P636, DOI 10.3390/pathogens2040636; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; OREN A, 1991, J GEN MICROBIOL, V137, P1387, DOI 10.1099/00221287-137-6-1387; Ouwehand AC, 2009, WORLD J GASTROENTERO, V15, P3261, DOI 10.3748/wjg.15.3261; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pirbaglou M, 2016, NUTR RES, V36, P889, DOI 10.1016/j.nutres.2016.06.009; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Podolak RK, 1996, J FOOD PROTECT, V59, P1037, DOI 10.4315/0362-028X-59.10.1037; PODOLAK RK, 1995, J FOOD SAFETY, V15, P283, DOI 10.1111/j.1745-4565.1995.tb00140.x; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Rossi M, 2016, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.13295, DOI 10.1111/1462-2920.13295]; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Selle K, 2013, FEMS MICROBIOL REV, V37, P915, DOI 10.1111/1574-6976.12021; Sen Gupta M, 2013, HE KUPU, V3, P13; Shimizu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139795; Sinn DH, 2008, DIGEST DIS SCI, V53, P2714, DOI 10.1007/s10620-007-0196-4; Taranto MP, 2003, J APPL MICROBIOL, V95, P86, DOI 10.1046/j.1365-2672.2003.01962.x; Turroni S, 2007, J APPL MICROBIOL, V103, P1600, DOI 10.1111/j.1365-2672.2007.03388.x; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; Whittamore JM, 2017, UROLITHIASIS, V45, P89, DOI 10.1007/s00240-016-0952-z; Worcester EM, 2008, PRIMARY CARE, V35, P369, DOI 10.1016/j.pop.2008.01.005; Wulff J.E., 2018, ADV BIOSCI BIOTECHNO, V9, P339, DOI [10.4236/abb.2018.98022, DOI 10.4236/ABB.2018.98022]; Ya W, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.023	73	24	24	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222393	10.1371/journal.pone.0222393	http://dx.doi.org/10.1371/journal.pone.0222393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545840	gold, Green Published			2022-12-27	WOS:000532303200016
J	Schmidt-Busby, J; Wiles, J; Exeter, D; Kenealy, T				Schmidt-Busby, Jacqueline; Wiles, Janine; Exeter, Daniel; Kenealy, Timothy			Self-management action and motivation of Pacific adults in New Zealand with end-stage renal disease	PLOS ONE			English	Article							CHRONIC ILLNESS; THEMATIC SYNTHESIS; HOPE; FAMILY; METASYNTHESIS; TIME; CARE	Aims To explore actions and motivations for self-management practices of Pacific adults following diagnosis of end stage renal disease (ESRD). Methods Focused ethnography using in-depth interviews with 16 Pacific people on haemodialysis for diabetic ESRD, in Auckland, New Zealand. Study participants were of Samoan, Cook Islander, Tongan, Niuean, or Tokelauan ethnicity and aged between 30 to 69 years old. Thematic analysis was used to code and identify emergent themes. Results All participants assumed active responsibility for their self-management following their diagnosis of ESRD. They reported positive differences in their current self-management behaviours, compared to pre-ESRD diagnosis. In the face of their terminal diagnosis, participant's motivations to self-manage their health were fuelled by hope; the hope to live long enough to change their family legacy of diabetes and ESRD. To achieve this, there was a dependency upon family members as a resource for self-management support. Yet at the same time, family members also had health concerns (including diabetes), and several participants themselves were carers for sick or elderly family members. Conclusion The growing number of members (within family units) progressing from moderate to late-stage diabetes raises concerns about the sustainability of future family support in Pacific families in New Zealand with histories of diabetes, ESRD, and other chronic diseases. While the burden upon informal carers (family) has been well documented throughout the past few decades, the dynamics of bi-directional carer support between (two or more) sick family members and their families have had less exposure. This has potentially significant implications for Pacific peoples in New Zealand, considering the increases in diabetes prevalence within their families.	[Schmidt-Busby, Jacqueline] Middlemore Hosp, Counties Manukau Hlth, Auckland, New Zealand; [Schmidt-Busby, Jacqueline; Wiles, Janine] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Social & Community Hlth, Auckland, New Zealand; [Exeter, Daniel] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Epidemiol & Biostat, Auckland, New Zealand; [Kenealy, Timothy] Univ Auckland, Fac Med & Hlth Sci, Sch Med, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Schmidt-Busby, J (corresponding author), Middlemore Hosp, Counties Manukau Hlth, Auckland, New Zealand.; Schmidt-Busby, J (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Social & Community Hlth, Auckland, New Zealand.	j.schmidt-busby@auckland.ac.nz			Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD)	Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD)	JS-B is funded by Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstila V., 2014, SUBJECTIVE TIME PHIL; Australia and New Zealand Dialysis and Transplant Registry, 2018, END STAG KIDN DIS AO; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Borneman T, 2014, INT J PALLIAT NURS, V20, P271, DOI 10.12968/ijpn.2014.20.6.271; Braun V., 2022, THEMATIC ANAL PRACTI; BRUHN JG, 1984, SOUTH MED J, V77, P215, DOI 10.1097/00007611-198402000-00020; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Duggleby W, 2012, J ADV NURS, V68, P1211, DOI 10.1111/j.1365-2648.2011.05919.x; Ellingsen S, 2013, SCAND J CARING SCI, V27, P165, DOI 10.1111/j.1471-6712.2012.01019.x; Gamble E, 2015, NUTR DIETETICS; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Health Navigator New Zealand, 2019, PROGR COURS DIAB SEL; Health Quality and Safety Commission New Zealand, 2018, ATL HEALTHC VAR DIAB; Herth K, 1993, Issues Ment Health Nurs, V14, P139, DOI 10.3109/01612849309031613; HERTH K, 1990, J ADV NURS, V15, P1250, DOI 10.1111/j.1365-2648.1990.tb01740.x; Holder B, 1997, Adv Ren Replace Ther, V4, P13; Jackson G, 2012, METRO AUCKLAND PACIF, DOI [10.1177/1363459311403950, DOI 10.1177/1363459311403950]; Jowsey T, 2016, QUAL LIFE RES, V25, P1093, DOI 10.1007/s11136-015-1169-2; Kiata L, 2004, QUAL HEALTH RES, V14, P313, DOI 10.1177/1049732303261820; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Macpherson C, 2001, EVOLVING IDENTITIES; Ministry of Health, 2014, DIAB QUAL CAR STAND; Ministry of Health, 2016, ANN UPD KEY RES 2015; Ministry of Health and Ministry of Pacific Island Affairs, 2004, TUP OL MOUI PAC HLTH; Moran A, 2011, J ADV NURS, V67, P501, DOI 10.1111/j.1365-2648.2010.05460.x; Newton P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/638205; OECD, 2015, DOES HLTH SPEND NZ C; Pearson M.L., 2007, PATIENT SELF MANAGEM; Pene G, 2009, SOC POLICY J NZ, P79; Podsiadlowski A, 2011, NEW ZEAL J PSYCHOL, V40, P5; Portsmouth City Council, 2017, PUBL HLTH ANN REP 20; Pulotu-Endemann F.K., 2007, SEITAPU PACIFIC MENT; Reid C, 2016, CLIN J AM SOC NEPHRO, V11, P1206, DOI 10.2215/CJN.10561015; Riegel B, 2002, PATIENT EDUC COUNS, V46, P287, DOI 10.1016/S0738-3991(01)00165-3; Rousseau P, 2000, WESTERN J MED, V173, P117, DOI 10.1136/ewjm.173.2.117; Ryan P, 2009, NURS OUTLOOK, V57, P217, DOI 10.1016/j.outlook.2008.10.004; Saldana J., 2015, CODING MANUAL QUALIT, V3rd; Schmidt-Busby J, 2018, DIABETES RES CLIN PR; Schmidt-Busby J, 2019, HEALTH EXPECT, V22, P1122, DOI 10.1111/hex.12946; Schulman-Green D, 2016, J ADV NURS, V72, P1469, DOI 10.1111/jan.12902; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Scollan-Koliopoulos M, 2007, RES NURS HEALTH, V30, P508, DOI 10.1002/nur.20208; Scollan-Koliopoulos M, 2010, DIABETES EDUCATOR, V36, P473, DOI 10.1177/0145721710362108; Sheridan NF, 2011, PRIM CARE RESP J, V20, P14; Sheridan NF, 2015, HEALTH EXPECT, V18, P32, DOI 10.1111/hex.12006; SIMMONS D, 1995, J INTERN MED, V237, P315, DOI 10.1111/j.1365-2796.1995.tb01181.x; Social Policy Evaluation and Research Unit, 2016, FAM WHAN STAT REP 20; Southwick M, 2012, PRIMARY CARE PACIFIC; Tamasese T.K., 2010, QUALITATIVE STUDY PA; Taylor SJ., 2014, HEALTH SERV DELIVERY, DOI [10.3310/hsdr02530, DOI 10.3310/HSDR02530]; Tong A, 2015, TRANSPL INT, V28, P771, DOI 10.1111/tri.12575; Vannini P., 2002, J MUNDANE BEHAV, V3, P1; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Whitehead L, 2018, J CLIN NURS, V27, P22, DOI 10.1111/jocn.13775; Wright S, 2008, KOTUITUI, V3, P21, DOI 10.1080/1177083X.2008.9522430; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	59	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222642	10.1371/journal.pone.0222642	http://dx.doi.org/10.1371/journal.pone.0222642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545828	Green Published, gold			2022-12-27	WOS:000532303200024
J	Titon, SCM; Titon, B; Barsotti, AMG; Gomes, FR; Assis, VR				Monteiro Titon, Stefanny Christie; Titon Jr, Braz; Giorgi Barsotti, Adriana Maria; Gomes, Fernando Ribeiro; Assis, Vania Regina			Time-related immunomodulation by stressors and corticosterone transdermal application in toads	PLOS ONE			English	Article							IMMUNE FUNCTION; URINARY CORTICOSTERONE; PLASMA-LEVELS; METABOLITE RESPONSES; SUPPRESSES; ENDOCRINE; TESTOSTERONE; VERTEBRATES; MODULATION; MELATONIN	Immune responses have been mostly studied at a specific time in anuran species. However, time-changes related to immunomodulation associated with glucocorticoid (GC) alterations following stressors and GC treatment are complex. The present study describes time-related changes in immune response and corticosterone (CORT) plasma levels following restraint challenge, short, mid and long-term captivity, and CORT exogenous administration by transdermal application (TA) in Rhinella ornata toads. We observed increased neutrophil: lymphocyte ratios after restraint challenge and CORT TA, without changes following short and mid-term captivity. Plasma bacterial killing ability was sustained in all treatments, except long-term captivity, with decreased values after 90 days under such conditions. Phagocytic activity of peritoneal cells increased after mid-term captivity, and the phytohemagglutinin swelling response was impaired in those animals treated with CORT TA for 20 consecutive days. Plasma CORT levels increased or were sustained after restraint challenge (depending on initial values), decreased following mid and long-term captivity (for those animals showing high CORT in the field) and increased after 20 days of CORT TA. By performing assessments of time-changes in immune processes and CORT plasma levels in R. ornata, we demonstrate immuno-enhancing effects following restraint, short and mid-term stressors, while long-term stressors and CORT TA promoted immunosuppression in these toads.	[Monteiro Titon, Stefanny Christie; Titon Jr, Braz; Giorgi Barsotti, Adriana Maria; Gomes, Fernando Ribeiro; Assis, Vania Regina] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Titon, SCM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil.	stefannychristie@gmail.com	Titon, Stefanny CM/AAL-2887-2021; Assis, Vania R/F-8310-2013	Titon, Stefanny CM/0000-0002-1351-6546; Assis, Vania R/0000-0003-0326-4397; Gomes, Fernando/0000-0003-2244-6161	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013-00900-1, 2014/16320-7, 2011/10560-8, 2016/05024-3]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142455/2013-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers: 2013-00900-1, and 2014/16320-7), PhD scholarships to VRA (2011/10560-8), and AMGB (2016/05024-3). It was also supported by Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a PhD scholarship to SCMT (142455/2013-0). F.R. Gomes is a research fellow from the Brazilian CNPq - #302308/2016-4.	Assis V.R., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE; Assis VR, 2019, GEN COMP ENDOCR, V273, P86, DOI 10.1016/j.ygcen.2018.05.008; Assis VR, 2017, J EXP ZOOL PART A, V327, P200, DOI 10.1002/jez.2093; Barriga C, 2001, J PINEAL RES, V30, P180, DOI 10.1034/j.1600-079X.2001.300307.x; Berger S, 2005, HORM BEHAV, V47, P419, DOI 10.1016/j.yhbeh.2004.11.011; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Campbell T. W., 2012, VET HEMATOLOGY CLIN; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2018, METHODS ECOL EVOL, V9, P1556, DOI 10.1111/2041-210X.13020; de Assis VR, 2013, S AM J HERPETOL, V8, P155, DOI 10.2994/SAJH-D-13-00007.1; de Assis VR, 2012, COMP BIOCHEM PHYS A, V163, P265, DOI 10.1016/j.cbpa.2012.08.002; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Dhabhar FS, 2008, NEUROIMMUNE, V7, P207; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; DuRant SE, 2015, J EXP BIOL, V218, P2297, DOI 10.1242/jeb.118703; During K, 1999, FEBS LETT, V449, P93, DOI 10.1016/S0014-5793(99)00405-6; Falso PG, 2015, GEN COMP ENDOCR, V212, P73, DOI 10.1016/j.ygcen.2015.01.003; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; Barsotti AMG, 2019, J EXP ZOOL PART A, V331, P168, DOI 10.1002/jez.2250; Barsotti AMG, 2017, COMP BIOCHEM PHYS A, V204, P177, DOI 10.1016/j.cbpa.2016.12.002; Gomes Fernando Ribeiro, 2012, South American Journal of Herpetology, V7, P1; Graham SP, 2012, HORM BEHAV, V62, P146, DOI 10.1016/j.yhbeh.2012.06.001; Hernandez-Arciga U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190047; Hopkins WA, 2011, GEN COMP ENDOCR, V174, P107, DOI 10.1016/j.ygcen.2011.08.006; Madelaire CB, 2019, GEN COMP ENDOCR, V273, P227, DOI 10.1016/j.ygcen.2018.09.005; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Titon SCM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35495-0; Titon SCM, 2017, J EXP ZOOL PART A, V327, P127, DOI 10.1002/jez.2078; Titon SCM, 2016, COMP BIOCHEM PHYS A, V201, P53, DOI 10.1016/j.cbpa.2016.06.023; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092090; Narayan EJ, 2014, J THERM BIOL, V41, P72, DOI 10.1016/j.jtherbio.2014.02.011; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Thomas JR, 2015, GEN COMP ENDOCR, V216, P33, DOI 10.1016/j.ygcen.2015.04.013; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Zylberberg M, 2015, J EXP BIOL, V218, P757, DOI 10.1242/jeb.111716	45	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222856	10.1371/journal.pone.0222856	http://dx.doi.org/10.1371/journal.pone.0222856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539413	Green Published, gold			2022-12-27	WOS:000532297900035
J	Handley, G; Kubota, JT; Li, TY; Cloutier, J				Handley, Grace; Kubota, Jennifer T.; Li, Tianyi; Cloutier, Jasmin			Black "Reading the Mind in the Eyes" task: The development of a task assessing mentalizing from black faces	PLOS ONE			English	Article							OWN-RACE BIAS; INDIVIDUAL-DIFFERENCES; NORMAL ADULTS; RECOGNITION; PREJUDICE; TESTOSTERONE; INFORMATION; ACTIVATION; JUDGMENTS; ATTITUDES	Researchers investigating various facets of theory of mind, sometimes referred to as mentalizing, are increasingly exploring how social group membership influences this process. To facilitate this research, we introduce the Black Reading the Mind in The Eyes task, a freely available 36-item Black RME task with an array of norming data about these stimuli. Stimuli have been created and equated to match the original Reading the Mind in the Eyes (RME) task which included only White faces. Norming data were collected in three waves that characterized the physical properties of the stimuli and also participants' subjective ratings of the stimuli. Between each round of ratings, stimuli that did not equate with the original RME task or were not distinctly recognized as Black were removed and new stimuli were incorporated in the next round until we obtained 36 distinctive Black RME targets that matched the 36 mental states used in the original RME stimulus set. Both stimulus sets were similarly difficult and subsequent testing showed that neither Black nor White participants' mentalizing accuracy varied as a function of target race. We provide instructions for obtaining the database and stimulus ratings.	[Handley, Grace; Kubota, Jennifer T.; Cloutier, Jasmin] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Kubota, Jennifer T.] Univ Delaware, Dept Polit Sci & Int Relat, Newark, DE USA; [Li, Tianyi] Univ Illinois, Coll Business Adm, Chicago, IL USA	University of Delaware; University of Delaware; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cloutier, J (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	jasmin.cloutier@gmail.com		Handley, Grace/0000-0002-5170-0563				Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Amodio DM, 2003, J PERS SOC PSYCHOL, V84, P738, DOI 10.1037/0022-3514.84.4.738; BANAJI MR, 1994, ONT SYMP P, V7, P55; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; BARKOWITZ P, 1982, J APPL SOC PSYCHOL, V12, P255, DOI 10.1111/j.1559-1816.1982.tb00863.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Bruce V., 1998, EYE BEHOLDER SCI FAC; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Cloutier J, 2008, SOC NEUROSCI-UK, V3, P69, DOI 10.1080/17470910701563483; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; Gaertner SL, 2005, J SOC ISSUES, V61, P615, DOI 10.1111/j.1540-4560.2005.00424.x; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Haslam N, 2014, ANNU REV PSYCHOL, V65, P399, DOI 10.1146/annurev-psych-010213-115045; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hugenberg K, 2016, SOC PSYCHOL PERS SCI, V7, P167, DOI 10.1177/1948550615609734; Jack RE, 2015, CURR BIOL, V25, pR621, DOI 10.1016/j.cub.2015.05.052; Kubota JT, 2013, PSYCHOL SCI, V24, P2498, DOI 10.1177/0956797613496435; Lee DH, 2013, PSYCHOL SCI, V24, P957, DOI 10.1177/0956797612464500; Leyens JP, 2000, PERS SOC PSYCHOL REV, V4, P186, DOI 10.1207/S15327957PSPR0402_06; LINDSAY DS, 1991, J APPL PSYCHOL, V76, P587, DOI 10.1037/0021-9010.76.4.587; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; R Development Core Team, 2009, R LANG ENV STAT COMP; Rice K, 2014, DEV COGN NEUROS-NETH, V8, P153, DOI 10.1016/j.dcn.2013.09.003; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Contreras-Huerta LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084001; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Strachan JWA, 2017, VIS COGN, V25, P802, DOI 10.1080/13506285.2017.1338321; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Warrier V, 2018, MOL PSYCHIATR, V23, P1402, DOI 10.1038/mp.2017.122; Wittenbrink B, 1997, J PERS SOC PSYCHOL, V72, P262, DOI 10.1037/0022-3514.72.2.262; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221867	10.1371/journal.pone.0221867	http://dx.doi.org/10.1371/journal.pone.0221867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536498	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800020
J	Hung, TW; Huang, JY; Jong, GP				Hung, Tung-Wei; Huang, Jing-Yang; Jong, Gwo-Ping			Long-term outcomes of dialysis in patients with chronic kidney disease and new-onset atrial fibrillation: A population-based cohort study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; RISK-FACTORS; EPIDEMIOLOGY	Background Chronic kidney disease (CKD) is associated with substantial cardiovascular morbidity. Atrial fibrillation (AF) is a prevalent arrhythmia that increases the risk of both stroke and cardiovascular mortality. Information about the mortality risk among patients with advanced CKD and new-onset AF (NAF) in the presence and absence of dialysis is important. However, the association between advanced CKD and NAF in patients with and without dialysis is unclear. Objective To investigate long-term outcomes of the association between advanced CKD and NAF in patients with and without dialysis. Methods We conducted a nested case-control study based on the National Health Insurance Program in Taiwan. Each participant aged 20 years and older who had CKD with dialysis from 2000 to 2013 was assigned to the dialysis group, whereas sex-, age-, CKD duration-, and index date-matched participants without dialysis were randomly selected and assigned to the non-dialysis group. We used the Cox regression model to estimate the hazard ratio (HR) with the 95% confidence interval (CI) for mortality in CKD patients with combined dialysis and NAF. Patients with neither NAF nor dialysis served as the reference group. Results We identified 3,673 dialysis cases and 7,346 Non-dialysis matched controls for enrolment in the study. The crude mortality rates were 3.3 (95% CI: 3.1-3.5), 10.98 (95% CI: 9.3-13.0), 9.2 (95% CI: 8.7-10.0), and 18.0 (95% CI: 15.4-21.2) in the [Non-dialysis, non-NAF], [Nondialysis, NAF], [Dialysis, non-NAF], and [Dialysis, NAF] groups, respectively. After adjustment for age, gender, and co-morbidities, the aHRs were 2.0 (95% CI: 1.7-2.3), 2.7 (95% CI: 2.5-2.9), and 3.5 (95% CI: 2.9-4.1) in the [Non-Dialysis, NAF], [Dialysis, non-NAF], and [Dialysis, NAF] groups compared with the [Non-Dialysis, non-NAF] group, respectively. The Kaplan-Meier survival curves showed the highest mortality risk in the [Dialysis, NAF] group among the study groups. Patients with concurrent peritoneal dialysis and AF had the highest mortality risk: aHR = 4.3 (95% CI: 2.3-8.0). However, there was a relatively lower effect of NAF on mortality in patients on dialysis than in patients who were not. Conclusions Patients with advanced CKD and NAF had a significantly increased risk of mortality. Dialysis is not risky for patients with concurrent CKD and NAF. Dialysis offers a sufficient survival benefit to be considered as a standard treatment, as indicated by the superior physical status of patients on dialysis.	[Hung, Tung-Wei] Chung Shan Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Hung, Tung-Wei; Jong, Gwo-Ping] Chung Shan Med Univ, Taichung, Taiwan; [Huang, Jing-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ Hosp, Dept Internal Med, Div Cardiol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Jong, GP (corresponding author), Chung Shan Med Univ, Taichung, Taiwan.; Jong, GP (corresponding author), Chung Shan Med Univ Hosp, Dept Internal Med, Div Cardiol, Taichung, Taiwan.	cgp8009@yahoo.com.tw		Jong, Gwo-Ping/0000-0002-7786-5497				Abbott Kevin C, 2003, BMC Nephrol, V4, P1, DOI 10.1186/1471-2369-4-1; Abuhasira R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21229-9; Atar I, 2006, INT J CARDIOL, V106, P47, DOI 10.1016/j.ijcard.2004.12.048; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Bansal N, 2013, CIRCULATION, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Chou Che-Yi, 2010, Nephrol Dial Transplant, V25, P1225, DOI 10.1093/ndt/gfp589; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Das Manisha, 2006, Cardiol Rev, V14, P14, DOI 10.1097/01.crd.0000148162.88296.9f; de Castroviejo EVR, 2006, REV ESP CARDIOL, V59, P779, DOI 10.1016/S1885-5857(07)60043-7; Findlay MD, 2015, STROKE, V46, P2477, DOI 10.1161/STROKEAHA.115.009095; Konigsbrugge O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169400; Krane V, 2009, CLIN J AM SOC NEPHRO, V4, P394, DOI 10.2215/CJN.02020408; Kulkarni N, 2012, J ATR FIBRILLATION, V5, P448, DOI [10.4022/jafib.448, DOI 10.4022/JAFIB.448]; Liao JN, 2015, KIDNEY INT, V87, P1209, DOI 10.1038/ki.2014.393; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Shen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003933; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Zebe H, 2000, NEPHROL DIAL TRANSPL, V15, P765, DOI 10.1093/ndt/15.6.765	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222656	10.1371/journal.pone.0222656	http://dx.doi.org/10.1371/journal.pone.0222656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536566	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800067
J	Kirst, ME; Baker, D; Li, E; Abu-Hasan, M; Wang, GP				Kirst, Mariana E.; Baker, Dawn; Li, Eric; Abu-Hasan, Mutasim; Wang, Gary P.			Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIAL INFECTION; BRONCHOALVEOLAR LAVAGE; OROPHARYNGEAL CULTURES; ACHROMOBACTER-XYLOSOXIDANS; CEPACIA COLONIZATION; YOUNG-CHILDREN; INFANTS; DISEASE; PATHOGENS; BACTERIA	Objective Airways of children with cystic fibrosis (CF) harbor complex polymicrobial communities which correlates with pulmonary disease progression and use of antibiotics. Throat swabs are widely used in young CF children as a surrogate to detect potentially pathogenic microorganisms in lower airways. However, the relationship between upper and lower airway microbial communities remains poorly understood. This study aims to determine (1) to what extent oropharyngeal microbiome resembles the lung microbiome in CF children and (2) if lung microbiome composition correlates with airway inflammation. Method Throat swabs and bronchoalveolar lavage (BAL) were obtained concurrently from 21 CF children and 26 disease controls. Oropharyngeal and lung microbiota were analyzed using 16S rRNA deep sequencing and correlated with neutrophil counts in BAL and antibiotic exposure. Results Oropharyngeal microbial communities clustered separately from lung communities and had higher microbial diversity (p < 0.001). CF microbiome differed significantly from non-CF controls, with a higher abundance of Proteobacteria in both upper and lower CF airways. Neutrophil count in the BAL correlated negatively with the diversity but not richness of the lung microbiome. In CF children, microbial genes involved in bacterial motility proteins, two-component system, flagella assembly, and secretion system were enriched in both oropharyngeal and lung microbiome, whereas genes associated with synthesis and metabolism of nucleic acids and protein dominated the non-CF controls. Conclusions This study identified a unique microbial profile with altered microbial diversity and metabolic functions in CF airways which is significantly affected by airway inflammation. These results highlight the limitations of using throat swabs as a surrogate to study lower airway microbiome and metagenome in CF children.	[Kirst, Mariana E.; Li, Eric; Wang, Gary P.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Baker, Dawn; Abu-Hasan, Mutasim] Univ Florida, Coll Med, Dept Pediat, Div Pediat Pulmonol, Gainesville, FL USA; [Wang, Gary P.] North Florida South Georgia Vet Hlth Syst, Infect Dis Sect, Med Serv, Gainesville, FL USA; [Kirst, Mariana E.] Univ Florida, Coll Med, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, GP (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.	gary.wang@medicine.ufl.edu		Wang, Gary/0000-0002-3457-442X	Gatorade Trust by the University of Florida, Department of Medicine	Gatorade Trust by the University of Florida, Department of Medicine	This work was supported by the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine to GPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANG ENV STAT COMP; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; AVITAL A, 1995, PEDIATR PULM, V20, P40, DOI 10.1002/ppul.1950200108; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; Edgar RC, 2010, BIOINFORMATICS; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Esther CR, 2005, PEDIATR PULM, V40, P39, DOI 10.1002/ppul.20222; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; Frangolias DD, 1999, AM J RESP CRIT CARE, V160, P1572, DOI 10.1164/ajrccm.160.5.9805046; Frayman KB, 2017, THORAX, V72, P1104, DOI 10.1136/thoraxjnl-2016-209279; Giron RM, 2008, ARCH BRONCONEUMOL, V44, P679, DOI 10.1016/S1579-2129(09)60006-9; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Hansen CR, 2010, J CYST FIBROS, V9, P51, DOI 10.1016/j.jcf.2009.10.005; Hansen CR, 2006, J CYST FIBROS, V5, P245, DOI 10.1016/j.jcf.2006.04.002; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hoppe JE, 2015, PEDIATR PULM, V50, P638, DOI 10.1002/ppul.23150; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kloepfer KM, 2018, PEDIATR PULM, V53, P475, DOI 10.1002/ppul.23953; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ledson MJ, 2002, THORAX, V57, P142, DOI 10.1136/thorax.57.2.142; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; Nixon GM, 2002, ARCH DIS CHILD, V87, P306, DOI 10.1136/adc.87.4.306; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Pittman JE, 2017, ANN AM THORAC SOC, V14, P1548, DOI [10.1513/AnnalsATS.201702-121OC, 10.1513/annalsats.201702-121oc]; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qvist T, 2016, J CYST FIBROS, V15, P380, DOI 10.1016/j.jcf.2015.09.007; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194; Zemanick ET, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00832-2017; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222323	10.1371/journal.pone.0222323	http://dx.doi.org/10.1371/journal.pone.0222323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536536	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800036
J	Pucken, VB; Schupbach-Regula, G; Gerber, M; Gross, CS; Bodmer, M				Pucken, Valerie-Beau; Schupbach-Regula, Gertraud; Gerber, Manuela; Gross, Corina Salis; Bodmer, Michele			Veterinary peer study groups as a method of continuous education-A new approach to identify and address factors associated with antimicrobial prescribing	PLOS ONE			English	Article							UDDER HEALTH; FARM-ANIMALS; USAGE; STRATEGIES; MASTITIS; PRACTITIONERS; DETERMINANTS; IMPROVEMENT; PREVENTION; RESISTANCE	Within the dairy industry, most antimicrobials are used for dry-cow therapy or mastitis treatment. To reduce antimicrobial usage in dairy cows, increasing awareness and behaviour change is necessary. As veterinarians are known to be influenced by their peers, peer study groups as a continuous education might contribute to this. Therefore, the objective of this study was to analyse written records of veterinary peer study group meetings to identify factors associated with antimicrobial prescribing decisions, and to analyse veterinarians' attitude towards the benefits of this continuous education method. Twenty-three participating Swiss cattle practitioners were divided into three groups. Each group met every two to five months, together with a facilitator and an expert on the topic to be discussed. Written records from every meeting were taken and analysed qualitatively to identify factors influencing veterinarians' decisions on antimicrobial prescribing and mastitis therapy. In addition, focus group discussions were conducted after the last meeting, to assess the veterinarians' learning achievements gained during the peer study group meetings. Extrinsic factors such as external pressure, competition, farmer, individual animal, farm and diagnostics as well as intrinsic factors such as own experience/attitude, knowledge and change of mindset during career could be shown to influence veterinarians' decisions on antimicrobial prescribing. In the focus group discussions, the veterinarians stated that they gained new knowledge, received new stimuli, exchanged with their peers and felt supported in their relationship to their farmers. Since the identified factors are partly interrelated, it is not sufficient to change a single factor to achieve a change in the antimicrobial prescription behaviour of veterinarians. Veterinary peer study groups could contribute to the intention to change, because veterinarians experienced multiple benefits from this method of continuous education. In order to quantify this, the prescription data of the veterinarians are analysed in a next step.	[Pucken, Valerie-Beau; Gerber, Manuela; Bodmer, Michele] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Schupbach-Regula, Gertraud] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Gross, Corina Salis] Univ Zurich, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland	University of Bern; University of Bern; University of Zurich	Pucken, VB (corresponding author), Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland.	valerie.pucken@vetsuisse.unibe.ch		Pucken, Valerie-Beau/0000-0001-8517-9350	Federal Food Safety and Veterinary Office [1.15.10]	Federal Food Safety and Veterinary Office	This research was funded by the Federal Food Safety and Veterinary Office (https://www.blv.admin.ch/blv/en/home.html) of Switzerland (Grant number: 1.15.10, awarded to VBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the 23 veterinarians, who made this study possible with their great contribution to the peer study group meetings. The experts are gratefully acknowledged for sharing their time and expertise. Furthermore, we want to thank Esther Schelling for supporting this study with her knowledge and experience in qualitative health research.	Al Achkar M, 2016, ADV MED EDUC PRACT, V7, P611, DOI 10.2147/AMEP.S117672; [Anonymous], 2015, FVE SURVEY VET PROFE; [Anonymous], 2018, AUSW DAT MILCH KAL 2; [Anonymous], 2018, TIER TIER 2018; Bager F, 2000, INT J ANTIMICROB AG, V14, P271, DOI 10.1016/S0924-8579(00)00135-7; Bennedsgaard TW, 2010, LIVEST SCI, V131, P183, DOI 10.1016/j.livsci.2010.03.018; Beyer M, 2003, FAM PRACT, V20, P443, DOI 10.1093/fampra/cmg420; CAREY MA, 1994, CRITICAL ISSUES IN QUALITATIVE RESEARCH METHODS, P225; Carmo LP, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00026; Cousin ME, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1352-0; Coyne LA, 2014, VET REC, V175, P593, DOI 10.1136/vr.102686; Curado C, 2015, INT J TRAIN DEV, V19, P98, DOI 10.1111/ijtd.12050; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; De Briyne N, 2013, VET REC, V173, P475, DOI 10.1136/vr.101454; European Medicines Agency, 2017, SALES VET ANTIMICROB, DOI [10.2809/283486, DOI 10.2809/283486]; European Medicines Agency, 2018, EMA2759822018; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gegenfurtner A, 2016, INT J TRAIN DEV, V20, P290, DOI 10.1111/ijtd.12089; Gibbons JF, 2013, VET REC, V172, P14, DOI 10.1136/vr.100782; Gonzalez SM, 2010, PREV VET MED, V95, P50, DOI 10.1016/j.prevetmed.2010.03.004; Hall ER, 2013, ANAT SCI EDUC, V6, P56, DOI 10.1002/ase.1308; Higgins HM, 2017, J DAIRY SCI, V100, P2909, DOI 10.3168/jds.2016-11923; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Hopman NEM, 2018, PREV VET MED, V158, P106, DOI 10.1016/j.prevetmed.2018.07.013; Ivenleyer S, 2008, SCHWEIZ ARCH TIERH, V150, P499, DOI 10.1024/0036-7281.150.10.499; Jarrige N, 2017, PREV VET MED, V144, P158, DOI 10.1016/j.prevetmed.2017.05.018; Kilian K, 2017, GST LAUFBAHNSTUDIE B; Klemm W. R., 1994, Journal of Veterinary Medical Education, V21, P2; Kuipers A, 2016, J DAIRY SCI, V99, P1632, DOI 10.3168/jds.2014-8428; Lam TJGM, 2011, NEW ZEAL VET J, V59, P8, DOI 10.1080/00480169.2011.547163; Landwirtschaft und Ernahrung Taschenstatistik, 2018, LANDW ERN TASCH 2018; Magalhaes-Sant'Ana M, 2017, IRISH VET J, V70, DOI 10.1186/s13620-017-0106-9; McDougall S, 2017, NEW ZEAL VET J, V65, P84, DOI 10.1080/00480169.2016.1246214; Meesters A. J. M., 2007, Proceedings, Cattle Consultancy Days, Best Western Hotel Nyborg Strand, Nyborg, Denmark, 29-30 August 2007, P111; Mills P., 2003, ASSESS EVAL HIGH EDU, V28, P527, DOI [10.1080/02602930301676, DOI 10.1080/02602930301676]; MOLSTAD S, 1989, FAM PRACT, V6, P33, DOI 10.1093/fampra/6.1.33; Moore DA, 2000, J AM VET MED ASSOC, V217, P1001, DOI 10.2460/javma.2000.217.1001; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Nobrega DB, 2018, J DAIRY SCI, V101, P7425, DOI 10.3168/jds.2018-14540; Pelz C, 2004, FORUM QUAL SOZIALFOR, V5; Poizat A, 2017, PREV VET MED, V146, P61, DOI 10.1016/j.prevetmed.2017.07.016; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Proctor A, 2011, VET REC, V169, P408, DOI 10.1136/vr.d5387; Pucken V.-B., 2016, SCHWEIZ ARCH TIERHEI, V158; Ritter C, 2017, J DAIRY SCI, V100, P3329, DOI 10.3168/jds.2016-11977; Roberson JR, 2012, VET CLIN N AM-FOOD A, V28, P271, DOI 10.1016/j.cvfa.2012.03.011; Saini V, 2012, J DAIRY SCI, V95, P1921, DOI 10.3168/jds.2011-5065; Salis Gross C, 2014, EXPLORATIVE STUDIE A; Scherpenzeel CGM, 2016, J DAIRY SCI, V99, P3753, DOI 10.3168/jds.2015-9963; Silverman D., 2011, QUAL RES, V3rd ed.; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P39, DOI 10.1111/zph.12168; Speksnijder DC, 2018, ANIM FRONT, V8, P4, DOI 10.1093/af/vfy006; Stevens M, 2016, J DAIRY SCI, V99, P2896, DOI 10.3168/jds.2015-10496; swissmilk, 2018, SCHWEIZER MILCHWIRTS; Thomson K, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-15; Topp E, 2017, Can Commun Dis Rep, V43, P224, DOI 10.14745/ccdr.v43i11a03; Tschopp A, 2015, J DAIRY SCI, V98, P840, DOI 10.3168/jds.2014-8053; van Gool WA, 2015, ADVISORY LETT TIGHTE; Vandeweerd JM, 2012, J VET MED EDUC, V39, P142, DOI 10.3138/jvme.0911.098R1; Visschers VHM, 2016, ZOONOSES PUBLIC HLTH, V63, P534, DOI 10.1111/zph.12260; Wagemann C, 2005, SWISS POLIT SCI REV, V11, P1, DOI 10.1002/j.1662-6370.2005.tb00360.x	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222497	10.1371/journal.pone.0222497	http://dx.doi.org/10.1371/journal.pone.0222497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536527	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800046
J	Funakoshi, Y; Wang, Y; Semba, T; Masuda, H; Hout, D; Ueno, NT; Wang, X				Funakoshi, Yohei; Wang, Ying; Semba, Takashi; Masuda, Hiroko; Hout, David; Ueno, Naoto T.; Wang, Xiaoping			Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype	PLOS ONE			English	Article							OVEREXPRESSION; SURVIVAL; PROMOTES; FAMILY; CDC42	Background Inflammatory breast cancer (IBC) is an aggressive form of breast cancer. The triple-negative subtype of IBC (TN-IBC) is particularly aggressive. Identification of molecular differences between TN-IBC and TN-non-IBC may help clarify the unique clinical behaviors of TN-IBC. However, our previous study comparing gene expression between TN-IBC and TN-non-IBC did not identify any TN-IBC-specific molecular signature. Lehmann et al recently reported that the mesenchymal stem-like (MSL) TNBC subtype consisted of infiltrating tumor-associated stromal cells but not cancer cells. Therefore, we compared the gene expression profiles between TN-IBC and TN-non-IBC patient samples not of the MSL subtype. Methods We classified 88 TNBC samples from the World IBC Consortium into subtypes according to the Vanderbilt classification and Insight TNBCtype, removed samples of MSL and unstable subtype, and compared gene expression profiles between the remaining TN-IBC and TNnon-IBC samples. Results In the Vanderbilt analysis, we identified 75 genes significantly differentially expressed between TN-IBC and TN-non-IBC at an FDR of 0.2. In the Insight TNBCtype analysis, we identified 81 genes significantly differentially expressed between TN-IBC and TN-non-IBC at an FDR of 0.4. In both analyses, the top canonical pathway was "Fc Receptor-mediated Phagocytosis in Macrophages and Monocytes", and the top 10 differentially regulated genes included PADI3 and MCTP1, which were up-regulated, and CDC42EP3, SSR1, RSBN1, and ZC3H13, which were downregulated. Conclusions Our data suggest that the activity of macrophages might be enhanced in TN-IBC compared with TN-non-IBC. Further clinical and preclinical studies are needed to determine the crosstalk between macrophages and IBC cells.	[Funakoshi, Yohei; Semba, Takashi; Masuda, Hiroko; Ueno, Naoto T.; Wang, Xiaoping] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Funakoshi, Yohei; Semba, Takashi; Masuda, Hiroko; Ueno, Naoto T.; Wang, Xiaoping] Univ Texas MD Anderson Canc Ctr, Sect Translat Breast Canc Res, Houston, TX 77030 USA; [Funakoshi, Yohei; Semba, Takashi; Masuda, Hiroko; Ueno, Naoto T.; Wang, Xiaoping] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Wang, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hout, David] Insight Genet Inc, Nashville, TN USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ueno, NT; Wang, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Ueno, NT; Wang, X (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Translat Breast Canc Res, Houston, TX 77030 USA.	nueno@mdanderson.org; xiwang@mdanderson.org		Ueno, Naoto/0000-0002-0166-7275; Semba, Takashi/0000-0002-1987-1645	National Institutes of Health [1R01CA205043-01A1]; Breast Cancer Research Foundation [BCRF-18-164]; Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program grant; National Cancer Institute award [P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA205043, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Morgan Welch Inflammatory Breast Cancer Research Program; State of Texas Rare and Aggressive Breast Cancer Research Program grant; National Cancer Institute award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant 1R01CA205043-01A1 (Dr. Ueno), Breast Cancer Research Foundation grant BCRF-18-164 (Dr. Ueno), the Morgan Welch Inflammatory Breast Cancer Research Program, a State of Texas Rare and Aggressive Breast Cancer Research Program grant (Dr. Ueno), and National Cancer Institute award P30CA016672, which supports the MD Anderson Cancer Center Clinical Trials Support Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep39190; Alpaugh ML, 2002, AM J PATHOL, V161, P619, DOI 10.1016/S0002-9440(10)64217-4; Chaher N, 2012, BREAST CANCER RES TR, V131, P437, DOI 10.1007/s10549-011-1422-5; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Dawood S, 2011, CANCER-AM CANCER SOC, V117, P1819, DOI 10.1002/cncr.25682; Farrugia Aaron J, 2017, Small GTPases, V8, P49, DOI 10.1080/21541248.2016.1194952; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Harano K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204513; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Masuda H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3579; Matsuda N, 2018, JAMA ONCOL, V4, P1207, DOI 10.1001/jamaoncol.2018.1436; Matsuda N, 2017, EXPERT OPIN INV DRUG, V26, P463, DOI 10.1080/13543784.2017.1299707; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Ring BZ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2198-0; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Team RC, 2016, R LANG ENV STAT COMP; Turunen S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1140-9; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wang XP, 2017, ONCOTARGET, V8, P67904, DOI 10.18632/oncotarget.18958; Wang XP, 2013, CANCER RES, V73, P6516, DOI 10.1158/0008-5472.CAN-13-0967; Wolfe AR, 2016, ONCOTARGET, V7, P82482, DOI 10.18632/oncotarget.12694; Zell JA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2225	28	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222336	10.1371/journal.pone.0222336	http://dx.doi.org/10.1371/journal.pone.0222336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532791	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600027
J	Neagoe, A; Neag, DLM; Luches, D				Neagoe, Alexandru; Neag, Doina Larisa Maria; Luches, Daniel			Reasons to care: Personal motivation as a key factor in the practice of the professional foster carer in Romania	PLOS ONE			English	Article								Personal motivation is a key factor in the service of foster care, impending both on the welfare of the child and on the satisfaction of the carer. This paper explores the benefits, challenges and dilemmas involved in the job of professional (i.e. state-supported) foster carer in Romania-a country where the issue of child protection has drawn a great deal of international attention over the last thirty years. The principal hypothesis concerns whether the benefits, challenges and dilemmas identified by foster carers are influenced by the factors that led to their taking up this kind of work. Quantitative research was conducted using a questionnaire as the main tool. The paper takes a descriptive, cross-sectional and multifactorial approach. Sampling was carried out by self-selecting method, and the study involved 51 participants. The research project identified a statistically significant variation in the challenges and dilemmas reported by foster carers. Thus, the results of the study show that the majority of the carers indicate a primarily intrinsic motivation for their work. By way of conclusion, it is argued that social workers, operating in collaboration with multidisciplinary teams, can offer carers support in managing more difficult periods in the child-carer relationship, thus enhancing the sustainability of the foster care service.	[Neagoe, Alexandru; Neag, Doina Larisa Maria] West Univ Timisoara, Dept Social Work, Timisoara, Romania; [Luches, Daniel] West Univ Timisoara, Dept Sociol, Timisoara, Romania	West University of Timisoara; West University of Timisoara	Neagoe, A (corresponding author), West Univ Timisoara, Dept Social Work, Timisoara, Romania.	alexandru.neagoe@e-uvt.ro		Neagoe, Alexandru/0000-0001-7308-7547				Agapedia Romania [The Agapedia Romania Foundation], 2007, MAN AS MAT PROF; Autoritatea National a pentru Protectia Drepturilor Copilului si Adopie [National Child Protection and Adoption Authority], 2017, L4 AUT NAT PENTR PRO; Barber J., 2004, CHILDREN FOSTER CARE; Capraro V, 2019, SCI REP, V9; Capraro V, 2018, JUDGM DECIS MAK, V13, P99; Chipungu SS, 2004, FUTURE CHILD, V14, P75, DOI 10.2307/1602755; Cojocaru D, 2011, J STUDY RELIG IDEOL, V10, P65; Cole SA, 2005, CHILD ADOLESC SOC WO, V22, P441, DOI 10.1007/s10560-005-0021-x; Deci E. L., 1985, INTRINSIC MOTIVATION; Frey BS., 2002, SUCCESSFUL MANAGEMEN, DOI [10.1007/978-3-322-86495-6, DOI 10.1007/978-3-322-86495-6]; Gherasim RL, 2009, DETERMINANTI MOTIVAT; Gofman A, 2014, PALGRAVE HANDBOOK OF ALTRUISM, MORALITY, AND SOCIAL SOLIDARITY: FORMULATING A FIELD OF STUDY, P45; Goian C, 2014, PROCD SOC BEHV, V142, P380, DOI 10.1016/j.sbspro.2014.07.695; Haydon G, 2007, VALUES ED LEADERSHIP, DOI [10.4135/9781446214640, DOI 10.4135/9781446214640]; Luches D, 2016, EUROPEAN REV APPL SO, V9, P47, DOI [10.1515/eras-2016-0005, DOI 10.1515/ERAS-2016-0005]; Macgregor T., 2006, QUALITATIVE SOCIAL W, V5, P351, DOI DOI 10.1177/1473325006067365; Matichescu ML, 2007, SUSTAINABILITY, V9, P1861; Melenciuc, 2019, BUS REV; Rodger S, 2006, CHILD ABUSE NEGLECT, V30, P1129, DOI 10.1016/j.chiabu.2006.04.005; Runcan PL, 2012, REV CERCET INTERV SO, V37, P180; Salend S. J., 2004, TEACHING EXCEPTIONAL, V37, P64, DOI DOI 10.1177/004005990403700108; Sandor SD, 2008, TRANSYLV REV ADM SER, P171; Sansone C., 2000, INTRINSIC EXTRINSIC; Sebba J, 2012, WHY DO PEOPLE BECOME; Tappin B, 2018, J EXP SOC PSYCHOL, V79, P64, DOI 10.1016/j.jesp.2018.06.005; Tyebjee T, 2003, CHILD WELFARE, V82, P685; Zeanah, 2014, ROMANIAS ABANDONED C	27	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222716	10.1371/journal.pone.0222716	http://dx.doi.org/10.1371/journal.pone.0222716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532794	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600035
J	Munsch, S; Dremmel, D; Wilhelm, P; Baierle, S; Fischer, S; Hilbert, A				Munsch, Simone; Dremmel, Daniela; Wilhelm, Peter; Baierle, Susanne; Fischer, Sophia; Hilbert, Anja			To eat or not to eat: Reward delay impulsivity in children with loss of control eating, attention deficit/hyperactivity disorder, a double diagnosis, and healthy children	PLOS ONE			English	Article							ADHD SYMPTOMS; ECOLOGICAL VALIDITY; WEIGHT-GAIN; BINGE; OBESITY; GRATIFICATION; ADOLESCENTS; PREVALENCE; ASSOCIATION; INHIBITION	Reward delay impulsivity is a feature of attention deficit/hyperactivity disorder (ADHD) and a likely feature of loss of control eating (LOC-E), which might explain the higher risk of children with ADHD or LOC-E to become obese. The goal of this study was to investigate reward delay impulsivity in children with LOC-E, ADHD, or a double diagnosis, in contrast to healthy children. Children (8 to 13 years) with LOC-E (n = 24), ADHD (n = 33), a double diagnosis (n = 9), and healthy children (n = 34) performed a computer game (door opening task [DOT]) and the delay of gratification task (DoGT) to assess food related facets of reward delay impulsivity. In addition, children reported whether they worried to lose control over eating during the DoGT. There were no group differences in the DOT. However, children with ADHD or a double diagnosis had a significantly higher risk to eat prematurely during the DoGT than children with LOC-E, who were not significantly different from healthy children. Children with a double diagnosis were most likely to worry about losing control over eating during the DoGT, followed by children with LOC-E, and both had a significantly higher probability to worry than healthy children. For children with a double diagnosis the probability to worry was significantly higher than for children with ADHD. If replicated, these findings point to a special relevance of reward delay impulsivity in children with ADHD or a double diagnosis, compared to children with LOC-E. ADHD should be regularly assessed in children with LOC-E.	[Munsch, Simone; Dremmel, Daniela; Wilhelm, Peter; Baierle, Susanne; Hilbert, Anja] Univ Fribourg, Dept Psychol, Fribourg, Switzerland; [Fischer, Sophia] Educ Dept, Basel, Switzerland; [Hilbert, Anja] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, Dept Psychosomat Med & Psychotherapy,Med Ctr, Leipzig, Germany; [Dremmel, Daniela] Clin Gais, Dept Psychosomat & Psychiat, Ambulatorium A, St Gallen, Switzerland; [Baierle, Susanne] Psychiat Lucerne, Ambulatorium, Luzern, Switzerland	University of Fribourg; Leipzig University	Munsch, S (corresponding author), Univ Fribourg, Dept Psychol, Fribourg, Switzerland.	Simone.Munsch@unifr.ch	Munsch, Simone/GYR-3750-2022	Munsch, Simone/0000-0002-6187-8912	Swiss National Foundation (SNF) [100014132045 /1]; German Federal Ministry of Education and Research (BMBF) [01EO1501]	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by the Swiss National Foundation (SNF, http://www.snf.ch/de/Seiten/default.aspx) grant number 100014132045 /1. Anja Hilbert was funded by the German Federal Ministry of Education and Research (BMBF) https://www.bmbf.de grant number 01EO1501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BARKLEY RA, 1991, J ABNORM CHILD PSYCH, V19, P149, DOI 10.1007/BF00909976; BONATO DP, 1983, ADDICT BEHAV, V8, P71, DOI 10.1016/0306-4603(83)90059-X; Bruce AS, 2011, OBESITY, V19, P1101, DOI 10.1038/oby.2010.297; BryantWaugh RJ, 1996, INT J EAT DISORDER, V19, P391, DOI 10.1002/(SICI)1098-108X(199605)19:4&lt;391::AID-EAT6&gt;3.0.CO;2-G; Buitelaar JK, 2006, EUR CHILD ADOLES PSY, V15, P177, DOI 10.1007/s00787-005-0523-2; Campbell SB, 2009, J ABNORM CHILD PSYCH, V37, P1, DOI 10.1007/s10802-008-9270-4; Christiansen H, 2012, EUR PSYCHIAT, V27, P321, DOI 10.1016/j.eurpsy.2010.12.010; Conners CK., 2011, ENCY CLIN NEUROPSYCH, P675, DOI [10.1007/978-0-387-79948-3_1534, DOI 10.1007/978-0-387-79948-3_1534]; Culbert KM, 2015, J CHILD PSYCHOL PSYC, V56, P1141, DOI 10.1111/jcpp.12441; DAUGHERTY TK, 1991, J CHILD PSYCHOL PSYC, V32, P453, DOI 10.1111/j.1469-7610.1991.tb00323.x; Delmo C, 2001, DIAGNOSTISCHES INTER; Dougherty DM, 2003, J CHILD PSYCHOL PSYC, V44, P1145, DOI 10.1111/1469-7610.00197; Evers C, 2010, PERS SOC PSYCHOL B, V36, P792, DOI 10.1177/0146167210371383; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Fuemmeler BF, 2011, INT J OBESITY, V35, P852, DOI 10.1038/ijo.2010.214; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Guerrieri R, 2008, INT J OBESITY, V32, P708, DOI 10.1038/sj.ijo.0803770; Hartmann AS, 2013, EAT WEIGHT DISORD-ST, V18, P53, DOI 10.1007/s40519-013-0004-4; He JB, 2017, INT J EAT DISORDER, V50, P91, DOI 10.1002/eat.22661; Hilbert A., 2016, EATING DISORDER EXAM; Hilbert A, 2018, INT J EAT DISORDER, V51, P223, DOI 10.1002/eat.22821; Hilbert A, 2014, INT J EAT DISORDER, V47, P758, DOI 10.1002/eat.22312; Hilbert A, 2013, J ABNORM PSYCHOL, V122, P684, DOI 10.1037/a0033330; Hilbert A, 2013, EUR EAT DISORD REV, V21, P330, DOI 10.1002/erv.2221; Holodynski M, 2013, MIND CULT ACT, V20, P4, DOI 10.1080/10749039.2012.745571; JOHNSON WG, 1978, ADDICT BEHAV, V3, P205, DOI 10.1016/0306-4603(78)90020-5; Kelly NR, 2014, EAT BEHAV, V15, P483, DOI 10.1016/j.eatbeh.2014.06.012; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurz S, 2017, APPETITE, V116, P90, DOI 10.1016/j.appet.2017.04.013; Marzilli E, 2018, ADOLESC HEALTH MED T, V9, P17, DOI 10.2147/AHMT.S148050; Matherne CE, 2015, EAT BEHAV, V18, P57, DOI 10.1016/j.eatbeh.2015.04.001; Matthys W, 1998, J CHILD PSYCHOL PSYC, V39, P643, DOI 10.1017/S0021963098002534; Mehl M. R., 2013, HDB RES METHODS STUD; Meule A, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00669, 10.3389/fpsyg.2013.00177]; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Munsch S, 2017, EUR EAT DISORD REV, V25, P36, DOI 10.1002/erv.2489; Munsch S, 2012, PSYCHIAT RES, V195, P118, DOI 10.1016/j.psychres.2011.07.016; Nazar BP, 2016, INT J EAT DISORDER, V49, P1045, DOI 10.1002/eat.22643; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Patros CHG, 2016, CLIN PSYCHOL REV, V43, P162, DOI 10.1016/j.cpr.2015.11.001; Reinblatt SP, 2015, INT J EAT DISORDER, V48, P580, DOI 10.1002/eat.22404; Reinblatt SP, 2015, INT J EAT DISORDER, V48, P505, DOI 10.1002/eat.22342; Rothen S, 2009, INT J METH PSYCH RES, V18, P96, DOI 10.1002/mpr.281; Seeyave DM, 2009, ARCH PEDIAT ADOL MED, V163, P303, DOI 10.1001/archpediatrics.2009.12; Smink FRE, 2014, INT J EAT DISORDER, V47, P610, DOI 10.1002/eat.22316; SOBHANY MS, 1985, INT J OBESITY, V9, P99; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Steadman KM, 2016, J ATTEN DISORD, V20, P907, DOI 10.1177/1087054714530779; Stice E, 2009, PHYSIOL BEHAV, V97, P551, DOI 10.1016/j.physbeh.2009.03.020; Tabachnik B.G., 2014, DISCRIMINANT ANAL US, Vsixth; Tanofsky-Kraff M, 2009, INT J EAT DISORDER, V42, P26, DOI 10.1002/eat.20580; Tanofsky-Kraff M, 2011, J ABNORM PSYCHOL, V120, P108, DOI 10.1037/a0021406; Thamotharan S, 2013, CLIN PSYCHOL REV, V33, P253, DOI 10.1016/j.cpr.2012.12.001; van Goozen SHM, 2004, J CHILD PSYCHOL PSYC, V45, P284, DOI 10.1111/j.1469-7610.2004.00220.x; Verbeken S, 2009, BEHAV CHANGE, V26, P153, DOI 10.1375/bech.26.3.153; von Stauffenberg C, 2007, J APPL DEV PSYCHOL, V28, P536, DOI 10.1016/j.appdev.2007.06.011; Yu X, 2018, J ATTEN DISORD, V22, P984, DOI 10.1177/1087054715570390	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221814	10.1371/journal.pone.0221814	http://dx.doi.org/10.1371/journal.pone.0221814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525207	Green Submitted, Green Published, gold			2022-12-27	WOS:000532225700017
J	Smith, KB; Hibbing, MV; Hibbing, JR				Smith, Kevin B.; Hibbing, Matthew, V; Hibbing, John R.			Friends, relatives, sanity, and health: The costs of politics	PLOS ONE			English	Article								Political scientists have long known that political involvement exacts costs but they have typically defined these costs in relatively narrow, largely economic terms. Though anecdotal evidence suggests that the costs of politics may in fact extend beyond economics to frayed personal relationships, compromised emotional stability, and even physical problems, no systematic evidence on these broader costs exists. We construct and validate batteries of survey items that delineate the physical, social, and emotional costs of political engagement and administer these items to a demographically representative sample of U.S. adults. The results suggest that a large number of Americans believe their physical health has been harmed by their exposure to politics and even more report that politics has resulted in emotional costs and lost friendships.	[Smith, Kevin B.; Hibbing, John R.] Univ Nebraska, Dept Polit Sci, Lincoln, NE 68583 USA; [Hibbing, Matthew, V] Univ Calif Merced, Dept Polit Sci, Merced, CA USA	University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Merced	Smith, KB (corresponding author), Univ Nebraska, Dept Polit Sci, Lincoln, NE 68583 USA.	ksmith1@unl.edu			NICHD NIH HHS [P01 HD031921] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abramowitz, 2010, DISAPPEARING CTR; ALDRICH JH, 1993, AM J POLIT SCI, V37, P246, DOI 10.2307/2111531; American Psychological Association, 2017, COP CHANG; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Ansolabehere S., 2017, POLIT ANAL, V22, P285; Barabas J, 2014, AM POLIT SCI REV, V108, P840, DOI 10.1017/S0003055414000392; Blakely TA, 2001, AM J PUBLIC HEALTH, V91, P99; Boudreau Cheryl, 2013, HDB EXPT POLITICAL S, P171; Brennan Geoffrey, 1993, DEMOCRACY DECISIONS; Bytzek E, 2016, ELECT STUD, V43, P41, DOI 10.1016/j.electstud.2016.04.007; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Chokshi N., 2019, NY TIMES; Downs A., 1957, EC THEORY DEMOCRACY; Goldman L, 2019, J GEN INTERN MED, V34, P363, DOI 10.1007/s11606-018-4568-6; Hagan MJ, 2020, J AM COLL HEALTH, V68, P21, DOI 10.1080/07448481.2018.1515763; Harris KM, 2009, NATL LONGITUDINAL ST; Hersh E. D., 2014, NY TIMES; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, P174; Klar M, 2009, POLIT PSYCHOL, V30, P755, DOI 10.1111/j.1467-9221.2009.00724.x; RIKER WH, 1968, AM POLIT SCI REV, V62, P25, DOI 10.2307/1953324; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Stosny S., 2017, WASHINGTON POST; Williams DR, 2017, NEW ENGL J MED, V376, P2295, DOI 10.1056/NEJMms1702111; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340	24	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221870	10.1371/journal.pone.0221870	http://dx.doi.org/10.1371/journal.pone.0221870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553726	Green Published, gold			2022-12-27	WOS:000532319200007
J	Kruyer, A; Ball, LE; Townsend, DM; Kalivas, PW; Uys, JD				Kruyer, Anna; Ball, Lauren E.; Townsend, Danyelle M.; Kalivas, Peter W.; Uys, Joachim D.			Post-translational S-glutathionylation of cofilin increases actin cycling during cocaine seeking	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DENDRITIC SPINES; DOPAMINE RELEASE; IDENTIFICATION; PROTEINS; ADF/COFILIN; CYSTEINE; DYNAMICS; PHOSPHORYLATION; DISSOCIATION	Neuronal defense against oxidative damage is mediated primarily by the glutathione redox system. Traditionally considered a mechanism to protect proteins from irreversible oxidation, mounting evidence supports a role for protein S-glutathionylation in cell signaling in response to changes in intracellular redox status. Here we determined the specific sites on the actin binding protein cofilin that undergo S-glutathionylation. In addition, we show that S-glutathionylation of cofilin reduces its capacity to depolymerize F-actin. We further describe an assay to determine the S-glutathionylation of target proteins in brain tissue from behaving rodents. Using this technique, we show that cofilin in the rat nucleus accumbens undergoes S-glutathionylation during 15-minutes of cued cocaine seeking in the absence of cocaine. Our findings demonstrate that cofilin S-glutathionylation is increased in response to cocaine-associated cues and that increased cofilin S-glutathionylation reduces cofilin-dependent depolymerization of F-actin. Thus, S-glutathionylation of cofilin may serve to regulate actin cycling in response to drug-conditioned cues.	[Kruyer, Anna; Kalivas, Peter W.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Ball, Lauren E.; Uys, Joachim D.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ South Carolina, Dept Drug Discovery & Pharmaceut Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Kruyer, A (corresponding author), Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA.; Uys, JD (corresponding author), Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	kruyer@musc.edu; uys@musc.edu		Ball, Lauren/0000-0001-6780-1679; Kruyer, Anna/0000-0001-9267-9492	National Institutes of Health [DA007288, DA044782, OD010731, GM103542, DA012513, AA024426, GM103542-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DA007288 (A.K.), DA044782 (A.K.), OD010731 (Orbitrap Elite MS, L.E.B.), GM103542 (Proteomics Core, L.E.B.), GM103542 (Analytical Redox Biochemistry Core, D.M.T.), DA012513 (P.W.K.), and AA024426, GM103542-02 (J.D.U.) from the National Institutes of Health (https://www.nih.gov). Funding agencies played no role in research design, data collection, data analysis, or manuscript preparation.	Aesif SW, 2010, METHOD ENZYMOL, V474, P289, DOI 10.1016/S0076-6879(10)74017-9; BAILLIE TA, 1993, BIOL MASS SPECTROM, V22, P319, DOI 10.1002/bms.1200220602; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; Baker PR, 2010, MOL CELL PROTEOMICS, V9, P1795, DOI 10.1074/mcp.M110.000422; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Chou CC, 2015, J AM SOC MASS SPECTR, V26, P120, DOI 10.1007/s13361-014-1014-9; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; Ducret E, 2016, BIOL PSYCHIAT, V80, P226, DOI 10.1016/j.biopsych.2015.09.019; Esparza MA, 2012, EUR J NEUROSCI, V36, P3103, DOI 10.1111/j.1460-9568.2012.08239.x; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Guindalini C, 2005, PHARMACOGENET GENOM, V15, P891, DOI 10.1097/01213011-200512000-00007; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Hashimoto T, 2005, AM J MED GENET B, V135B, P5, DOI 10.1002/ajmg.b.30164; Hedges DM, 2018, NEUROPSYCHOPHARMACOL, V43, P1405, DOI 10.1038/npp.2017.291; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HINSHAW DB, 1991, ARCH BIOCHEM BIOPHYS, V288, P311, DOI 10.1016/0003-9861(91)90200-3; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Ito R, 2000, J NEUROSCI, V20, P7489; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; KLEGERIS A, 1995, FREE RADICAL BIO MED, V18, P215, DOI 10.1016/0891-5849(94)00141-6; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; MEISTER A, 1988, TRENDS BIOCHEM SCI, V13, P185, DOI 10.1016/0968-0004(88)90148-X; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Prudent R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208979; Ressad F, 1999, J BIOL CHEM, V274, P20970, DOI 10.1074/jbc.274.30.20970; Roberts-Wolfe D, 2018, J NEUROSCI, V38, P7100, DOI 10.1523/JNEUROSCI.0791-18.2018; Scofield MD, 2016, PHARMACOL REV, V68, P816, DOI 10.1124/pr.116.012484; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Smith ACW, 2017, J NEUROSCI, V37, P742, DOI 10.1523/JNEUROSCI.2673-16.2016; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Uys JDC-W S., 2013, P 61 ASMS C MASS SPE, DOI [10.1038/nbt.1511, DOI 10.1038/NBT.1511]; Uys JD, 2014, BIOMED PHARMACOTHER, V68, P799, DOI 10.1016/j.biopha.2014.06.001; Uys JD, 2011, NEUROPSYCHOPHARMACOL, V36, P2551, DOI 10.1038/npp.2011.143; Womersley JS, 2019, EUR J NEUROSCI, V50, P2538, DOI 10.1111/ejn.14130; Womersley JS, 2016, PROG MOL BIOL TRANSL, V137, P87, DOI 10.1016/bs.pmbts.2015.10.001; Wu SL, 2010, ANAL CHEM, V82, P5296, DOI 10.1021/ac100766r; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223037	10.1371/journal.pone.0223037	http://dx.doi.org/10.1371/journal.pone.0223037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550273	Green Published, gold			2022-12-27	WOS:000532307700042
J	Malande, OO; Nuttall, J; Pillay, V; Bamford, C; Eley, B				Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Bamford, Colleen; Eley, Brian			A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa	PLOS ONE			English	Review							SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; RESISTANCE	Introduction There are few studies describing Escherichia coli (E. coli) bloodstream infection (BSI) among children in Africa, yet E.coli is increasing in importance as a cause of antibiotic resistant infection in paediatric settings. Methods In this retrospective, descriptive study aspects of E. coli BSI epidemiology are described over a 10-year period including incidence risk, risk factors for extended-spectrum beta-lactamase (ESBL)-producing E. coli BSI, antibiotic susceptibility of the bacterial isolates and outcome including risk factors for severe disease. Results There were 583 new E. coli BSI episodes among 217,483 admissions, an overall incidence risk of 2.7 events/1,000 hospital admissions. Of 455 of these E. coli BSI episodes that were analysed, 136 (29.9%) were caused by ESBL-producing isolates. Risk factors for ESBL-producing E. coli BSI included hospitalization in the 28-day period preceding E. coli BSI episodes, having an underlying chronic illness other than HIV infection at the time of the E. coli BSI and having a temperature of 38 degrees Celsius or higher at the time of the E. coli BSI. None of the E. coli isolates were resistant to carbapenems or colistin. The mortality rate was 5.9% and admission to the intensive care unit was required in 12.3% of BSI episodes. Predictors of severe disease included age less than 1 month, hospitalization in the 28-day period preceding E. coli BSI and BSI without a definable focus. Conclusions These findings extend our understanding of E. coli BSI in a sub-Saharan African setting, provide useful information that can guide empiric treatment choices for community- and hospital-acquired BSI and help inform prevention strategies.	[Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Eley, Brian] Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa; [Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Eley, Brian] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Bamford, Colleen] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Bamford, Colleen] Univ Cape Town, Div Microbiol, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Malande, OO (corresponding author), Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa.; Malande, OO (corresponding author), Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa.	ombevaom@gmail.com	Nuttall, James/CAF-4214-2022; Nuttall, James/CAE-8986-2022	Nuttall, James/0000-0002-9389-5880; Nuttall, James/0000-0002-9389-5880; Malande, Ombeva/0000-0002-1840-7402				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2014, M100S24 CLSI S; Burdet C, 2014, PEDIATR INFECT DIS J, V33, P872, DOI 10.1097/INF.0000000000000309; Buys H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1919-y; Cardoso T, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-40; Clinical and Laboratory Standard Institute (CLSI), 2008, DEV IN VITRO SUSC TE, V28; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI S; CLSI, 2012, M02A1 CLSI; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Evans SR, 2017, VIRULENCE, V8, P453, DOI 10.1080/21505594.2016.1213473; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gurieva T, 2018, CLIN INFECT DIS, V66, P489, DOI 10.1093/cid/cix825; Harris PNA, 2018, JAMA-J AM MED ASSOC, V320, P984, DOI 10.1001/jama.2018.12163; Harris PNA, 2015, SEMIN RESP CRIT CARE, V36, P56, DOI 10.1055/s-0034-1398387; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Kaye KS, 2005, INFECT CONT HOSP EP, V26, P346, DOI 10.1086/502550; Larru B, 2016, PEDIATR INFECT DIS J, V35, P507, DOI 10.1097/INF.0000000000001057; Lochan H, 2013, SAMJ S AFR MED J, V103, P918, DOI [10.7196/samj.6979, 10.7196/SAMJ.6979]; Lochan H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2862-2; Mattew A, 2006, M2A9 CLSI; McDanel J, 2017, INFECT CONT HOSP EP, V38, P1209, DOI 10.1017/ice.2017.156; McKay R, 2015, SAMJ S AFR MED J, V105, P363, DOI [10.7196/SAMJ.8183, 10.7196/samj.8183]; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Tacconelli E, 2017, GLOBAL PRIORITY LIST	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222675	10.1371/journal.pone.0222675	http://dx.doi.org/10.1371/journal.pone.0222675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550295	Green Submitted, gold, Green Published			2022-12-27	WOS:000532307700024
J	Fragoso-Ontiveros, V; Velazquez-Aragon, JA; Nunez-Martinez, PM; Mejia-Aguayo, MD; Vidal-Millan, S; Pedroza-Torres, A; Sanchez-Contreras, Y; Ramirez-Otero, MA; Muniz-Mendoza, R; Dominguez-Ortiz, J; Wegman-Ostrosky, T; Bargallo-Rocha, JE; Gallardo-Rincon, D; Reynoso-Noveron, N; Arriaga-Canon, C; Meneses-Garcia, A; Herrera-Montalvo, LA; Alvarez-Gomez, RM				Fragoso-Ontiveros, Veronica; Antonio Velazquez-Aragon, Jose; Maria Nunez-Martinez, Paulina; de la Luz Mejia-Aguayo, Maria; Vidal-Millan, Silvia; Pedroza-Torres, Abraham; Sanchez-Contreras, Yuliana; Angel Ramirez-Otero, Miguel; Muniz-Mendoza, Rodolfo; Dominguez-Ortiz, Julieta; Wegman-Ostrosky, Talia; Enrique Bargallo-Rocha, Juan; Gallardo-Rincon, Dolores; Reynoso-Noveron, Nancy; Arriaga-Canon, Cristian; Meneses-Garcia, Abelardo; Alonso Herrera-Montalvo, Luis; Maria Alvarez-Gomez, Rosa			Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients	PLOS ONE			English	Article							RISK-ASSESSMENT; RECURRENT BRCA1; GENOMIC REARRANGEMENTS; PREVALENCE; WOMEN; CHALLENGES; PREVENTION; CARRIERS	The deletion of exons 9 to 12 of BRCA1 (9-12 del BRCA1) is considered a founder mutation in the Mexican population. We evaluate the usefulness of the target detection of 9-12 del BRCA1 as the first molecular diagnostic strategy in patients with Hereditary Breast and Ovarian Cancer (HBOC). We performed the genetic assessment of 637 patients with suspected HBOC. The region corresponding to the breakpoints for the 9-12 del BRCA1 was amplified by polymerase chain reaction (PCR). An analysis of the clinical data of the carriers and non-carriers was done, searching for characteristics that correlated with the deletion. The 9-12 del BRCA1 was detected in 5% of patients with suspected HBOC (30/637). In patients diagnosed with ovarian cancer, 13 of 30 were 9-12 del BRCA1 carriers, which represents 43%. We found a significant association between the 9-12 del BRCA1 carriers with triple negative breast cancer and high-grade papillary serous ovarian cancer. We concluded that the detection of the 9-12 del BRCA1 is useful as a first molecular diagnostic strategy in the Mexican population. In particular, it shortens the gap in genetic assessment in patients with triple negative breast cancer and ovarian cancer.	[Fragoso-Ontiveros, Veronica; Maria Nunez-Martinez, Paulina; de la Luz Mejia-Aguayo, Maria; Vidal-Millan, Silvia; Sanchez-Contreras, Yuliana; Angel Ramirez-Otero, Miguel; Dominguez-Ortiz, Julieta; Wegman-Ostrosky, Talia; Maria Alvarez-Gomez, Rosa] Natl Canc Inst, Hereditary Canc Clin, Mexico City, DF, Mexico; [Antonio Velazquez-Aragon, Jose] Natl Paediat Inst, Mol Biol Lab, Mexico City, DF, Mexico; [Pedroza-Torres, Abraham; Muniz-Mendoza, Rodolfo; Arriaga-Canon, Cristian; Alonso Herrera-Montalvo, Luis] Natl Canc Inst, Res Direct, Mexico City, DF, Mexico; [Enrique Bargallo-Rocha, Juan] Natl Canc Inst, Breast Canc Dept, Mexico City, DF, Mexico; [Gallardo-Rincon, Dolores] Natl Canc Inst, Med Oncol Dept, Mexico City, DF, Mexico; [Reynoso-Noveron, Nancy] Natl Canc Inst, Epidemiol Dept, Mexico City, DF, Mexico; [Meneses-Garcia, Abelardo] Natl Canc Inst, Gen Direct, Mexico City, DF, Mexico		Alvarez-Gomez, RM (corresponding author), Natl Canc Inst, Hereditary Canc Clin, Mexico City, DF, Mexico.	rosamag2@hotmail.com	Herrera, Luis/GOV-3311-2022; Velázquez-Aragón, Jose/AAH-4559-2021; Wegman-Ostrosky, Talia/AAV-7521-2020	Wegman-Ostrosky, Talia/0000-0002-3207-6697; Ramirez Otero, Miguel Angel/0000-0001-8428-1150; Velazquez-Aragon, Jose/0000-0002-3617-8148; ARRIAGA, CRISTIAN/0000-0002-4866-9067	LXII Legislature of the Congress of the Union of Mexico; LXIII Legislature of the Congress of the Union of Mexico	LXII Legislature of the Congress of the Union of Mexico; LXIII Legislature of the Congress of the Union of Mexico	We thank LXII and LXIII Legislature of the Congress of the Union of Mexico, for their support.	Zayas-Villanueva OA, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5950-4; Ossa CA, 2016, ONCOLOGIST, V21, P832, DOI 10.1634/theoncologist.2015-0416; [Anonymous], 2018, ENCUESTA NACL OCUPAC; Apostolou P, 2017, CLIN GENET, V91, P482, DOI 10.1111/cge.12824; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Chavarri-Guerra Y, 2017, REV INVEST CLIN, V69, P94, DOI 10.24875/ric.17002195; Daly MB, 2017, J NATL COMPR CANC NE, V15, P9, DOI 10.6004/jnccn.2017.0003; Gabai-Kapara E, 2014, P NATL ACAD SCI USA, V111, P14205, DOI 10.1073/pnas.1415979111; Gomes MCB, 2007, BREAST CANCER RES TR, V103, P349, DOI 10.1007/s10549-006-9378-6; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; James PA, 2015, FAM CANCER, V14, P287, DOI 10.1007/s10689-015-9785-0; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lazcano-Ponce E, 2016, SALUD PUBLICA MEXICO, V58, P101; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Palanca S, 2013, FAM CANCER, V12, P119, DOI 10.1007/s10689-012-9579-6; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Paluch-Shimon S, 2016, ANN ONCOL, V27, pv103, DOI 10.1093/annonc/mdw327; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Urban RQ, 2018, CANCERS, V10, DOI 10.3390/cancers10100361; Rebbeck TR, 2018, HUM MUTAT, V39, P593, DOI 10.1002/humu.23406; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Torres D, 2009, BREAST CANCER RES TR, V117, P679, DOI 10.1007/s10549-009-0383-4; Torres-Mejia G, 2015, CANCER EPIDEM BIOMAR, V24, P498, DOI 10.1158/1055-9965.EPI-13-0980; Villarreal-Garza C, 2015, BREAST CANCER RES TR, V150, P389, DOI 10.1007/s10549-015-3312-8; Villarreal-Garza C, 2015, CANCER-AM CANCER SOC, V121, P372, DOI 10.1002/cncr.29058; Weitzel JN, 2007, CANCER EPIDEM BIOMAR, V16, P1615, DOI 10.1158/1055-9965.EPI-07-0198; Weitzel JN, 2013, J CLIN ONCOL, V31, P210, DOI 10.1200/JCO.2011.41.0027; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wunderle M, 2018, GEBURTSH FRAUENHEILK, V78, P481, DOI 10.1055/a-0603-4350	39	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222709	10.1371/journal.pone.0222709	http://dx.doi.org/10.1371/journal.pone.0222709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545835	gold, Green Published			2022-12-27	WOS:000532303200028
J	Balla, K; Karsai, I; Bonis, P; Kiss, T; Berki, Z; Horvath, A; Mayer, M; Bencze, S; Veisz, O				Balla, Krisztina; Karsai, Ildiko; Bonis, Peter; Kiss, Tibor; Berki, Zita; Horvath, Adam; Mayer, Marianna; Bencze, Szilvia; Veisz, Otto			Heat stress responses in a large set of winter wheat cultivars (Triticum aestivum L.) depend on the timing and duration of stress	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; GRAIN-YIELD; PHOTOSYNTHETIC DECLINE; KERNEL DEVELOPMENT; DROUGHT STRESS; WATER-DEFICIT; GROWTH-STAGES; SENESCENCE; TOLERANCE; QUALITY	The adverse effects of heat on plant yield strongly depend on its duration and the phenological stage of the crops when the heat occurs. To clarify the effects of these two aspects of heat stress, systematic research was conducted under controlled conditions on 101 wheat cultivars of various geographic origin. Different durations of heat stress (5, 10 and 15 days) were applied starting from three developmental stages (ZD49: booting stage, ZD59: heading, ZD72: 6th day after heading). Various morphological, yield-related traits and physiological parameters were measured to determine the stress response patterns of the wheat genotypes under combinations of the duration and the timing of heat stress. Phenological timing significantly influenced the thousand-kernel weight and reproductive tiller number. The duration of heat stress was the most significant component in determining both seed number and seed weight, as well as the grain yield consequently, explaining 51.6% of its phenotypic variance. Irrespective of the developmental phase, the yield-related traits gradually deteriorated over time, and even a 5-day heat stress was sufficient to cause significant reductions. ZD59 was significantly more sensitive to heat than either ZD49 or ZD72. The photosynthetic activity of the flag leaf was mostly determined by heat stress duration. No significant associations were noted between physiological parameters and heat stress response as measured by grain yield. Significant differences were observed between the wheat genotypes in heat stress responses, which varied greatly with developmental phase. Based on the grain yield across developmental phases and heat stress treatments, eight major response groups of wheat genotypes could be identified, and among them, three clusters were the most heat-tolerant. These cultivars are currently included in crossing schemes, partially for the identification of the genetic determinants of heat stress response and partially for the development of new wheat varieties with better heat tolerance.	[Balla, Krisztina; Karsai, Ildiko; Kiss, Tibor; Berki, Zita; Horvath, Adam] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Mol Breeding Dept, Martonvasar, Hungary; [Bonis, Peter] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Crop Prod Dept, Martonvasar, Hungary; [Mayer, Marianna; Veisz, Otto] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Cereal Breeding Dept, Martonvasar, Hungary; [Bencze, Szilvia] Res Inst Organ Agr, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Balla, K (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Mol Breeding Dept, Martonvasar, Hungary.	balla.krisztina@agrar.mta.hu		Horvath, Adam/0000-0002-9256-3040	National Scientific Research Fund (NKFIH) [K-119801];  [GINOP-2.3.2-15-2016-00029]	National Scientific Research Fund (NKFIH)(National Research, Development & Innovation Office (NRDIO) - Hungary); 	This research program was funded by a grant from the National Scientific Research Fund (NKFIH) K-119801 and by the GINOP-2.3.2-15-2016-00029 (Economic Development Operational Programme) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2013, EUPHYTICA, V192, P189, DOI 10.1007/s10681-012-0824-8; ALKHATIB K, 1984, PHYSIOL PLANTARUM, V61, P363, DOI 10.1111/j.1399-3054.1984.tb06341.x; Balla K, 2006, CEREAL RES COMMUN, V34, P381, DOI 10.1556/CRC.34.2006.1.95; Balla K, 2008, CEREAL RES COMMUN, V36, P1103; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; Barber HM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00051; Bergkamp B, 2018, FIELD CROP RES, V222, P143, DOI 10.1016/j.fcr.2018.03.009; BHULLAR SS, 1985, AUST J PLANT PHYSIOL, V12, P363, DOI 10.1071/PP9850363; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; BLUMENTHAL CS, 1991, AUST J AGR RES, V42, P325, DOI 10.1071/AR9910325; Brilli F, 2011, AGR FOREST METEOROL, V151, P1731, DOI 10.1016/j.agrformet.2011.07.007; Camejo D, 2005, J PLANT PHYSIOL, V162, P281, DOI 10.1016/j.jplph.2004.07.014; CHOWDHURY SI, 1978, AUST J AGR RES, V29, P205, DOI 10.1071/AR9780205; Djanaguiraman M, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1263-z; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Feng B, 2014, J AGRON CROP SCI, V200, P143, DOI 10.1111/jac.12045; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Fujimura S, 2012, PLANT PROD SCI, V15, P118, DOI 10.1626/pps.15.118; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; HARDING SA, 1990, PLANT PHYSIOL, V92, P654, DOI 10.1104/pp.92.3.654; HARDING SA, 1990, PLANT PHYSIOL, V92, P648, DOI 10.1104/pp.92.3.648; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Hlavacova M, 2016, PROCEEDINGS OF INTERNATIONAL PHD STUDENTS CONFERENCE, (MENDELNET 2016), P63; Kamrani M, 2018, ARCH AGRON SOIL SCI, V64, P38, DOI 10.1080/03650340.2017.1326104; Kaushal Neeru, 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2015.1134380; Khan SU, 2013, J CHEM SOC PAKISTAN, V35, P647; Kiss T, 2019, CROP SCI, V59, P591, DOI 10.2135/cropsci2018.09.0531; KOBZA J, 1987, PLANT PHYSIOL, V83, P69, DOI 10.1104/pp.83.1.69; Kumudini S, 2014, AGRON J, V106, P2087, DOI 10.2134/agronj14.0200; Lakatos M, 2012, CHANGES CLIMATIC EXT; Liu B, 2017, AGR FOREST METEOROL, V247, P476, DOI 10.1016/j.agrformet.2017.08.018; Liu B, 2016, GLOBAL CHANGE BIOL, V22, P1890, DOI 10.1111/gcb.13212; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mahrookashani A, 2017, J AGRON CROP SCI, V203, P453, DOI 10.1111/jac.12218; Cossani CM, 2015, CROP SCI, V55, P2719, DOI 10.2135/cropsci2015.02.0092; McMaster GS, 1997, ADV AGRON, V59, P63, DOI 10.1016/S0065-2113(08)60053-X; Nagy BA, 2011, CLIMATE CHANGE POLIC; ORTIZ-MONASTERIO JI, 1994, FIELD CROP RES, V37, P169, DOI 10.1016/0378-4290(94)90096-5; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Prasad PVV, 2008, CROP SCI, V48, P1911, DOI 10.2135/cropsci2008.01.0036; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Prasad PVV, 2014, FUNCT PLANT BIOL, V41, P1261, DOI 10.1071/FP14061; Rahman M. A., 2009, BANGLADESH J, V34, P360; RANDALL PJ, 1990, AUST J AGR RES, V41, P603, DOI 10.1071/AR9900603; Rashid MA, 2018, ENVIRON EXP BOT, V147, P138, DOI 10.1016/j.envexpbot.2017.12.009; Rashid MA, 2018, AGR FOREST METEOROL, V248, P119, DOI 10.1016/j.agrformet.2017.09.018; Reynolds MP, 2000, FIELD CROP RES, V66, P37, DOI 10.1016/S0378-4290(99)00077-5; Rezaei EE, 2015, EUR J AGRON, V64, P98, DOI 10.1016/j.eja.2014.10.003; Ristic Z, 2007, CROP SCI, V47, P2067, DOI 10.2135/cropsci2006.10.0674; SAINI HS, 1983, AUST J PLANT PHYSIOL, V10, P137, DOI 10.1071/PP9830137; SAINI HS, 1981, ANN BOT-LONDON, V48, P623, DOI 10.1093/oxfordjournals.aob.a086170; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; SEMENOV MA, 1995, AGR FOREST METEOROL, V73, P265, DOI 10.1016/0168-1923(94)05078-K; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Sharma DK, 2015, PHYSIOL PLANTARUM, V153, P284, DOI 10.1111/ppl.12245; Shirdelmoghanloo H, 2016, FUNCT PLANT BIOL, V43, P919, DOI 10.1071/FP15384; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P927, DOI 10.1071/PP9950927; STONE PJ, 1995, AUST J AGR RES, V46, P475, DOI 10.1071/AR9950475; STONE PJ, 1994, AUST J PLANT PHYSIOL, V21, P887, DOI 10.1071/PP9940887; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P935, DOI 10.1071/PP9950935; Talukder ASMHM, 2014, FIELD CROP RES, V160, P54, DOI 10.1016/j.fcr.2014.01.013; Tewolde H, 2006, J AGRON CROP SCI, V192, P111, DOI 10.1111/j.1439-037X.2006.00189.x; TOTTMAN DR, 1979, ANN APPL BIOL, V93, P221, DOI 10.1111/j.1744-7348.1979.tb06534.x; Vignjevic M, 2015, J AGRON CROP SCI, V201, P32, DOI 10.1111/jac.12085; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P731, DOI 10.1071/PP9940731; Wollenweber B, 2003, J AGRON CROP SCI, V189, P142, DOI 10.1046/j.1439-037X.2003.00025.x; Xu XL, 2004, PHOTOSYNTHETICA, V42, P317, DOI 10.1023/B:PHOT.0000040608.97976.a3; Yang J, 2002, EUPHYTICA, V126, P185, DOI 10.1023/A:1016365728633; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Yin XY, 2009, FIELD CROP RES, V114, P119, DOI 10.1016/j.fcr.2009.07.013	72	55	57	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222639	10.1371/journal.pone.0222639	http://dx.doi.org/10.1371/journal.pone.0222639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539409	Green Published, Green Submitted, gold			2022-12-27	WOS:000532297900022
J	Ledger, KJ; Keenan, RM; Sayler, KA; Wisely, SM				Ledger, Kimberly J.; Keenan, Ryan M.; Sayler, Katherine A.; Wisely, Samantha M.			Multi-scale patterns of tick occupancy and abundance across an agricultural landscape in southern Africa	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; RHIPICEPHALUS-APPENDICULATUS; FOREST FRAGMENTATION; BORNE RICKETTSIOSES; AMBLYOMMA-HEBRAEUM; LYME-DISEASE; WILD ANIMALS; RISK-FACTORS; LAND-COVER; IXODIDAE	Land use influences the prevalence and distribution of ticks due to the intimate relationship of ticks with their environment. This relationship occurs because land use alters two essential tick requirements: vertebrate hosts for blood meals and a suitable microclimate when off-host. Given the risks to human and animal health associated with pathogens transmitted by ticks, there is an ongoing need to understand the impact of environmental drivers on tick distributions. Here, we assessed how landscape features, neighborhood effects, and edges influenced tick occupancy and abundance across an agricultural landscape in southern Africa. We found that Rhipicephalus appendiculatus and Rhipicephalus simus increased in abundance closer to protected savanna, while Haemaphysalis elliptica increased in abundance closer to human habitation. The composition of the landscape surrounding savanna patches also differentially influenced the occupancy of each tick species; H. elliptica was more likely to be found in savanna patches surrounded by subsistence agriculture while R. appendiculatus and R. simus were more likely to be found in savanna surrounded by sugarcane monocultures. At the local scale we found that R. appendiculatus and R. simus avoided savanna edges. The availability of hosts and variation in vegetation structure between commercial agriculture, subsistence agriculture, and savanna likely drove the distribution of ticks at the landscape scale. Understanding how anthropogenic land use influences where ticks occur is useful for land use planning and for assessing public and animal health risks associated with ticks and tick-borne diseases.	[Ledger, Kimberly J.; Sayler, Katherine A.; Wisely, Samantha M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Keenan, Ryan M.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities	Wisely, SM (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	wisely@ufl.edu	Ledger, Kimberly/O-2151-2017	Wisely, Samantha/0000-0003-1748-4518; Ledger, Kimberly/0000-0002-5552-5598	National Science Foundation Graduate Research Fellowship [DGE-1842473]; NSF ISE grant [1459882]; College of Agriculture and Life Science at the University of Florida	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF ISE grant; College of Agriculture and Life Science at the University of Florida	KL was supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1842473. This study was funded by NSF ISE grant (no. 1459882) and the College of Agriculture and Life Science at the University of Florida.	Alexander R, 1935, TRANSMISSION LOUPING; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; ANDERSON JF, 1981, AM J TROP MED HYG, V30, P897, DOI 10.4269/ajtmh.1981.30.897; Angelstam P., 1992, ECOLOGICAL PRINCIPLE, P9, DOI DOI 10.1007/978-1-4615-3524-9_2; [Anonymous], 2015, SUPPLY DEMAND SUGAR; Bailey KM, 2016, J LAND USE SCI, V11, P154, DOI 10.1080/1747423X.2015.1086905; Barandika JF, 2006, MED VET ENTOMOL, V20, P177, DOI 10.1111/j.1365-2915.2006.00619.x; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayne EM, 1998, CAN J ZOOL, V76, P62, DOI 10.1139/cjz-76-1-62; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bryson NR, 2000, EXP APPL ACAROL, V24, P971, DOI 10.1023/A:1010639113793; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Civitello DJ, 2008, J MED ENTOMOL, V45, P867, DOI 10.1603/0022-2585(2008)45[867:EGIRSO]2.0.CO;2; Cliff AD, 1981, SPATIAL PROCESSES ME; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; Daniel M, 1994, MICROMETEOROLOGICAL, P138; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Ferrell AM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040737; Fielden LJ, 1996, EXP APPL ACAROL, V20, P625, DOI 10.1007/BF00053326; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; FIVAZ BH, 1989, TROP ANIM HEALTH PRO, V21, P129, DOI 10.1007/BF02236193; Fortunate M., 2016, STRENGTHENING NATL P; Gallivan GJ, 2011, ONDERSTEPOORT J VET, V78, P27, DOI 10.4102/ojvr.v78i1.41; Gear JHS, 1938, S AFRICAN MED J, V12; Ginsberg HS, 2004, ENVIRON ENTOMOL, V33, P1266, DOI 10.1603/0046-225X-33.5.1266; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Goudie A., 1983, ATLAS SWAZILAND; GUGLIELMONE AA, 1992, B ENTOMOL RES, V82, P203, DOI 10.1017/S0007485300051737; HACKEL JD, 1993, HUM ECOL, V21, P295, DOI 10.1007/BF00891541; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Holmes JC, 1996, BIODIVERS CONSERV, V5, P975, DOI 10.1007/BF00054415; Horak IG, 2006, ONDERSTEPOORT J VET, V73, P163; Horak I. G., 2018, IXODID TICKS ACARI I; Horak IG, 2001, ONDERSTEPOORT J VET, V68, P135; Horak IG, 2000, ONDERSTEPOORT J VET, V67, P239; Horak IG, 2011, ONDERSTEPOORT J VET, V78, P8, DOI 10.4102/ojvr.v78i1.32; Horobik V, 2006, ECOHEALTH, V3, P262, DOI 10.1007/s10393-006-0065-1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kery M, 2015, APPL HIERARCHICAL MO, V1; Lawrence J. A., 1980, Zimbabwe Veterinary Journal, V11, P27; LEVINS R, 1994, AM SCI, V82, P52; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Lounsbury CP, 1904, TRANSMISSON AFRICAN; Lounsbury CP, 1903, TRANSVAAL AGR J, V2, P4; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madder M, 2005, MED VET ENTOMOL, V19, P245, DOI 10.1111/j.1365-2915.2005.00566.x; Mamba M., 2019, INFLUENCE SUGARCANE; MATSON B. A., 1967, J S AFR VET MED ASS, V38, P93; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; McCleery R, 2018, BIOL CONSERV, V226, P54, DOI 10.1016/j.biocon.2018.07.020; Mijinyawa Y, 2006, LIVESTOCK RES RURAL, V18; Monadjem A., 2003, THREATENED VERTEBRAT; MONTGOMERY E., 1917, Journal of Comparative Pathology and Therapeutics, V30, P28; Mucina L, 2006, VEGETATION MAP S AFR; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neitz E, 1955, J S AFR VET ASSOC, V26, P79; Norval R., 1974, STUDIES BIOL ECOLOGY; NORVAL RAI, 1977, J PARASITOL, V63, P740, DOI 10.2307/3279586; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Perez G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1296-9; PETNEY TN, 1987, ONDERSTEPOORT J VET, V54, P529; Pfaffle M, 2013, INT J PARASITOL, V43, P1059, DOI 10.1016/j.ijpara.2013.06.009; Pietzsch ME, 2005, MED VET ENTOMOL, V19, P306, DOI 10.1111/j.1365-2915.2005.00575.x; POTGIETER FT, 1980, ONDERSTEPOORT J VET, V47, P285; POTGIETER FT, 1987, ONDERSTEPOORT J VET, V54, P5; Pretorius AM, 2002, EMERG INFECT DIS, V8, P874, DOI 10.3201/eid0808.020199; R Development Core Team, 2009, R LANG ENV STAT COMP; Raoult D, 2001, NEW ENGL J MED, V344, P1504, DOI 10.1056/NEJM200105173442003; Reynolds C, 2018, LANDSCAPE ECOL, V33, P241, DOI 10.1007/s10980-017-0595-7; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Schwarz A, 2009, INT J HYG ENVIR HEAL, V212, P87, DOI 10.1016/j.ijheh.2007.12.001; Sonenshine D. E., 1994, ECOLOGICAL DYNAMICS; Spickett AM, 2011, ONDERSTEPOORT J VET, V78, P18, DOI 10.4102/ojvr.v78i1.233; STAFFORD KC, 1994, J MED ENTOMOL, V31, P310, DOI 10.1093/jmedent/31.2.310; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; UILENBERG G, 1989, VET QUART, V11, P33, DOI 10.1080/01652176.1989.9694194; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Walker A.R., 2003, TICKS DOMESTIC ANIMA; Walker AR, 2001, MED VET ENTOMOL, V15, P40, DOI 10.1046/j.1365-2915.2001.00271.x; Walker J.B., 2005, GENUS RHIPICEPHALUS; WALKER JB, 1987, ONDERSTEPOORT J VET, V54, P353; Williams SC, 2010, ENVIRON ENTOMOL, V39, P1911, DOI 10.1603/EN10131; WILSON ML, 1993, J MED ENTOMOL, V30, P467, DOI 10.1093/jmedent/30.2.467; Wright WJ, 2016, ECOL EVOL, V6, P5404, DOI 10.1002/ece3.2292; Zar J.H., 1996, BIOSTAT ANAL; Zieger U, 1998, ONDERSTEPOORT J VET, V65, P49	104	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222879	10.1371/journal.pone.0222879	http://dx.doi.org/10.1371/journal.pone.0222879			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539412	Green Published, gold			2022-12-27	WOS:000532297900037
J	Sanchez, CR; Diaz-Cabrera, D; Hernandez-Fernaud, E				Rosales Sanchez, Christian; Diaz-Cabrera, Dolores; Hernandez-Fernaud, Estefania			Does effectiveness in performance appraisal improve with rater training?	PLOS ONE			English	Article							FRAME-OF-REFERENCE; RATING ACCURACY; PSYCHOMETRIC ERROR; PROGRAMS; PURPOSE; IMPACT	Performance appraisal is a complex process by which an organization can determine the extent to which employees are performing their work effectively. However, this appraisal may not be accurate if there is no reduction in the impact of problems caused by possibly subjective rater judgements. The main objective of this work is to check the effectivenessseparately and jointly-of the following four training programmes in the extant literature aimed at improving the accuracy of performance assessment: 1) Performance Dimension Training, 2) Frame-of-Reference, 3) Rater Error Training, and 4) Behavioural Observation Training. Based on these training strategies, three programmes were designed and applied separately. A fourth programme was a combination of the other three. We analyzed two studies using different samples (85 students and 42 employees) for the existence of differences in the levels of knowledge of performance and its dimensions, rater errors, observational accuracy, and accuracy of task and citizenship performance appraisal, according to the type of training raters receive. First, the main results show that training based on performance dimensions and the creation of a common framework, in addition to the training that includes the four programmes (Training_4_programmes), increases the level of knowledge of performance and its dimensions. Second, groups that receive training in rater error score higher in knowledge of biases than the other groups, whether or not they have received training. Third, participants' observational accuracy improves with each new moment measure (post-training and follow-up), though not because of the type of training received. Fourth, participants who receive training through the programme that combine the other four gave a task performance appraisal that was closer to the one undertaken by the judgesexperts than the other groups. And finally, students' citizenship performance appraisal does not vary according to type of training or to different moment measures, whereas the group of employees who received all four types of training gave a more accurate citizenship performance assessment.	[Rosales Sanchez, Christian; Diaz-Cabrera, Dolores; Hernandez-Fernaud, Estefania] Univ La Laguna, Tenerife, Islas Canarias, Spain; [Rosales Sanchez, Christian] Fac Psicol, Dept Psicol Cognit Social & Org, Campus Guajara, Tenerife, Spain	Universidad de la Laguna	Sanchez, CR (corresponding author), Univ La Laguna, Tenerife, Islas Canarias, Spain.; Sanchez, CR (corresponding author), Fac Psicol, Dept Psicol Cognit Social & Org, Campus Guajara, Tenerife, Spain.	crosales@ull.es	Hernández-Fernaud, Estefanía/AAG-3117-2020	Rosales Sanchez, Christian/0000-0002-6842-8615	National Programme for Fundamental Research Projects of the Ministry of Science, Innovation, and Universities of the Government of Spain (MICINN) [PSI2010-17327]	National Programme for Fundamental Research Projects of the Ministry of Science, Innovation, and Universities of the Government of Spain (MICINN)	DDC: This study is framed within project PSI2010-17327, financed by the National Programme for Fundamental Research Projects of the Ministry of Science, Innovation, and Universities of the Government of Spain (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is framed within project PSI2010-17327, financed by the National Programme for Fundamental Research Projects of the Ministry of Science, Innovation, and Universities of the Government of Spain (MICINN).	Aguinis H., 2019, PERFORMANCE MANAGEME, V4th; Aguinis H, 2009, PERS PSYCHOL, V62, P405, DOI 10.1111/j.1744-6570.2009.01144.x; [Anonymous], 2007, J QUAL PARTICIP; ATHEY TR, 1987, J APPL PSYCHOL, V72, P567, DOI 10.1037/0021-9010.72.4.567; Bernardin H., 1981, ACAD MANAGE REV, V6, P205, DOI DOI 10.5465/AMR.1981.4287782; Bernardin HJ, 2009, INT J SELECT ASSESS, V17, P300, DOI 10.1111/j.1468-2389.2009.00472.x; BERNARDIN HJ, 1978, J APPL PSYCHOL, V63, P301; BERNARDIN HJ, 1977, J APPL PSYCHOL, V62, P64, DOI 10.1037/0021-9010.62.1.64; BERNARDIN HJ, 1980, J APPL PSYCHOL, V65, P60, DOI 10.1037/0021-9010.65.1.60; Borman WC, 1997, HUM PERFORM, V10, P99, DOI 10.1207/s15327043hup1002_3; BORMAN WC, 1977, ORGAN BEHAV HUM PERF, V20, P238, DOI 10.1016/0030-5073(77)90004-6; CARDY RL, 1994, ORGAN BEHAV HUM DEC, V57, P338, DOI 10.1006/obhd.1994.1019; Chirico K. E., 2004, J MANAGERIAL ISSUES, V16, P382; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P177, DOI 10.1037/h0044919; DAY DV, 1995, J APPL PSYCHOL, V80, P158, DOI 10.1037/0021-9010.80.1.158; DeNisi AS, 2017, J APPL PSYCHOL, V102, P421, DOI 10.1037/apl0000085; Diaz-Cabrera D., 2014, PAPELES PSICOLOGO, V35, P3; Díaz-Vilela Luis, 2012, Rev. psicol. trab. organ., V28, P135, DOI 10.5093/tr2012a11; Diaz-Vilela LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139898; Eppich W, 2015, J CONTIN EDUC HEALTH, V35, P83, DOI 10.1002/chp.21270; Giraldez M., 2012, LIFE VEST YOUR SEAT; Gorman CA, 2017, J PERS PSYCHOL, V16, P1, DOI 10.1027/1866-5888/a000167; Gorman CA, 2009, J APPL PSYCHOL, V94, P1336, DOI 10.1037/a0016476; Hauenstein NMA., 1998, PERFORMANCE APPRAISA, P404, DOI 10.1007/s003300050383; HEDGE JW, 1988, J APPL PSYCHOL, V73, P68, DOI 10.1037/0021-9010.73.1.68; Hoffman BJ, 2012, PERS PSYCHOL, V65, P531, DOI 10.1111/j.1744-6570.2012.01252.x; IVANCEVICH JM, 1979, J APPL PSYCHOL, V64, P502, DOI 10.1037/0021-9010.64.5.502; Keown-Gerrard JL, 2001, HUM PERFORM, V14, P305, DOI 10.1207/S15327043HUP1404_2; Landy F.J., 1983, MEASUREMENT WORK PER; LATHAM GP, 1975, J APPL PSYCHOL, V60, P550, DOI 10.1037/0021-9010.60.5.550; Lee J. A., 1994, J BUSINESS PSYCHOL, V8, P297, DOI 10.1037/0021-9010.72.4.567; Lievens F, 2007, J APPL PSYCHOL, V92, P812, DOI 10.1037/0021-9010.92.3.812; Loignon A.C., 2016, FACILITATING PEER EV, DOI [10.1006/obhd.1998.2751, DOI 10.1006/OBHD.1998.2751]; MCINTYRE RM, 1984, J APPL PSYCHOL, V69, P147, DOI 10.1037/0021-9010.69.1.147; Melchers KG, 2011, PERS PSYCHOL, V64, P53, DOI 10.1111/j.1744-6570.2010.01202.x; Motowidlo S. J, 1999, CHANGING NATURE PERF, P56; Noonan LE, 2001, HUM PERFORM, V14, P3, DOI 10.1207/S15327043HUP1401_02; PULAKOS ED, 1986, ORGAN BEHAV HUM DEC, V38, P76, DOI 10.1016/0749-5978(86)90027-0; PULAKOS ED, 1984, J APPL PSYCHOL, V69, P581, DOI 10.1037/0021-9010.69.4.581; Raczynski KR, 2015, J EDUC MEAS, V52, P301, DOI 10.1111/jedm.12079; Roch S. G., 2003, INT J TRAIN DEV, V7, P93, DOI [DOI 10.1111/1468-2419.00174, 10.1111/1468-2419.00174]; Roch SG, 2012, J OCCUP ORGAN PSYCH, V85, P370, DOI 10.1111/j.2044-8325.2011.02045.x; Rosales C, INFLUENCE TYPE MEASU; Schleicher DJ, 2002, J APPL PSYCHOL, V87, P735, DOI 10.1037//0021-9010.87.4.735; Schleicher DJ, 1998, ORGAN BEHAV HUM DEC, V73, P76, DOI 10.1006/obhd.1998.2751; SMITH DE, 1986, ACAD MANAGE REV, V11, P22, DOI 10.2307/258329; STAMOULIS DT, 1993, J APPL PSYCHOL, V78, P994, DOI 10.1037/0021-9010.78.6.994; SULSKY LM, 1992, J APPL PSYCHOL, V77, P501, DOI 10.1037/0021-9010.77.4.501; Sulsky LM, 2002, J APPL SOC PSYCHOL, V32, P1224, DOI 10.1111/j.1559-1816.2002.tb01433.x; SULSKY LM, 1994, J APPL PSYCHOL, V79, P535, DOI 10.1037/0021-9010.79.4.535; SULSKY LM, 1988, J APPL PSYCHOL, V73, P497, DOI 10.1037/0021-9010.73.3.497; Sulsky LM, 2007, INT J TRAIN DEV, V11, P121, DOI 10.1111/j.1468-2419.2007.00273.x; THORNTON GC, 1980, J APPL PSYCHOL, V65, P351, DOI 10.1037/0021-9010.65.3.351; Uggerslev KL, 2008, J APPL PSYCHOL, V93, P711, DOI 10.1037/0021-9010.93.3.711; Viswesvaran C, 2000, INT J SELECT ASSESS, V8, P216, DOI 10.1111/1468-2389.00151; Whitman DS, 2010, PERS PSYCHOL, V63, P41, DOI 10.1111/j.1744-6570.2009.01162.x; WOEHR DJ, 1994, J APPL PSYCHOL, V79, P525, DOI 10.1037/0021-9010.79.4.525; WOEHR DJ, 1994, J OCCUP ORGAN PSYCH, V67, P189, DOI 10.1111/j.2044-8325.1994.tb00562.x	58	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222694	10.1371/journal.pone.0222694	http://dx.doi.org/10.1371/journal.pone.0222694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536562	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800070
J	Kawilapat, S; Salvadori, N; Ngo-Giang-Huong, N; Decker, L; Kanjanavanit, S; Puangsombat, A; Preedisripipat, K; Lertpienthum, N; Akarathum, N; Mekmullica, J; Srirompotong, U; Lallemant, M; Le Coeur, S; Traisathit, P; Leroi, C; Jourdain, G				Kawilapat, Suttipong; Salvadori, Nicolas; Ngo-Giang-Huong, Nicole; Decker, Luc; Kanjanavanit, Suparat; Puangsombat, Achara; Preedisripipat, Kanchana; Lertpienthum, Narong; Akarathum, Noppadon; Mekmullica, Jutarat; Srirompotong, Ussanee; Lallemant, Marc; Le Coeur, Sophie; Traisathit, Patrinee; Leroi, Charline; Jourdain, Gonzague			Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program	PLOS ONE			English	Article							EXPOSED CHILDREN; ADHERENCE; OUTCOMES; THERAPY; HIV/AIDS; IMPACT	Introduction The success of antiretroviral treatment (ART) programs can be compromised by high rates of patient loss to follow-up (LTFU). We assessed the incidence and risk factors of LTFU in a large cohort of HIV-infected children receiving ART in Thailand. Methods All children participating in a multicenter cohort (NCT00433030) between 1999 and 2014 were included. The date of LTFU was 9 months after the last contact date. ART interruption was defined as ART discontinuation for more than 7 days followed by resumption of treatment. Baseline and time-dependent risk factors associated with LTFU were identified using Fine and Gray competing risk regression models with death or referral to another hospital as competing events. Results Of 873 children who were followed during a median of 8.6 years (interquartile range 4.510.6), 196 were LTFU, 73 died, and 195 referred. The cumulative incidence of LTFU was 2.9% at 1 year, 7.3% at 5 years and 22.2% at 10 years. Children aged 13 years and more had a 3-fold higher risk (95% confidence interval 2.06-4.78) of LTFU than those younger. Children who had interrupted ART within the previous year had a 2.5-fold higher risk (1.12-5.91) than those who had not. The risk of LTFU was lower in children stunted (height-for-age Z-scores <-2 SD) (0.42-0.96) or underweight (weight-for-age Z-scores <-2 SD) (0.240.97). Conclusion Adolescence, ART interruption and absence of growth deficit were associated with LTFU. These may be warnings that should draw clinicians' attention and possibly trigger specific interventions. Children with no significant growth retardation may also be at risk of LTFU.	[Kawilapat, Suttipong; Salvadori, Nicolas; Ngo-Giang-Huong, Nicole; Decker, Luc; Lallemant, Marc; Le Coeur, Sophie; Traisathit, Patrinee; Leroi, Charline; Jourdain, Gonzague] Inst Rech Developpement IRD, U174 PHPT, Chiang Mai, Thailand; [Kawilapat, Suttipong; Salvadori, Nicolas; Ngo-Giang-Huong, Nicole; Decker, Luc; Lallemant, Marc; Le Coeur, Sophie; Leroi, Charline; Jourdain, Gonzague] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai, Thailand; [Kawilapat, Suttipong] Chiang Mai Univ, Fac Sci, Dept Stat, Grad Program Appl Stat, Chiang Mai, Thailand; [Ngo-Giang-Huong, Nicole; Lallemant, Marc; Le Coeur, Sophie; Jourdain, Gonzague] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kanjanavanit, Suparat] Nakornping Hosp, Chiang Mai, Thailand; [Puangsombat, Achara] Samutprakarn Hosp, Samut Prakan, Thailand; [Preedisripipat, Kanchana] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand; [Lertpienthum, Narong] Buddhachinaraj Hosp, Phitsanulok, Thailand; [Akarathum, Noppadon] Sanpatong Hosp, Chiang Mai, Thailand; [Mekmullica, Jutarat] Bhumibol Adulyadej Hosp, Bangkok, Thailand; [Srirompotong, Ussanee] Khon Kaen Hosp, Khon Kaen, Thailand; [Le Coeur, Sophie] Inst Natl Etud Demog INED, Paris, France; [Traisathit, Patrinee] Chiang Mai Univ, Fac Sci, Data Sci Res Ctr, Dept Stat, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Harvard University; Harvard T.H. Chan School of Public Health; Chiang Mai University	Jourdain, G (corresponding author), Inst Rech Developpement IRD, U174 PHPT, Chiang Mai, Thailand.; Jourdain, G (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai, Thailand.; Jourdain, G (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	gonzague.jourdain@ird.fr	Kawilapat, Suttipong/M-1449-2018; Salvadori, Nicolas/L-1381-2019; Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017	Kawilapat, Suttipong/0000-0001-7121-0791; Salvadori, Nicolas/0000-0002-0820-5305; Jourdain, Gonzague/0000-0002-3365-7020; DECKER, Luc/0000-0002-4808-3568; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234	Global Fund to AIDS, Tuberculosis and Malaria, Thailand [PR-A-N-008]; Oxfam Great Britain, Thailand [THAA51]; Ministry of Public Health, Thailand; Institut de Recherche pour le Developpement (IRD), France; Chiang Mai University	Global Fund to AIDS, Tuberculosis and Malaria, Thailand; Oxfam Great Britain, Thailand; Ministry of Public Health, Thailand; Institut de Recherche pour le Developpement (IRD), France; Chiang Mai University	The PHPT prospective multicenter cohort study was funded by the Global Fund to AIDS, Tuberculosis and Malaria, Thailand (PR-A-N-008) to ML; Oxfam Great Britain, Thailand (THAA51) to ML; Ministry of Public Health, Thailand; and Institut de Recherche pour le Developpement (IRD), France to GJ. This study was financially supported for publication by Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2003, AIDS CARE, V15, P263, DOI 10.1080/0954012031000068407; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; BORGAN O, 1990, SCAND J STAT, V17, P35; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Braitstein P, 2010, TROP MED INT HEALTH, V15, P833, DOI 10.1111/j.1365-3156.2010.02539.x; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Cokluk O, 2019, ED SCI THEORY PRACTI, V11, P303; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hansudewechakul R, 2010, JAIDS-J ACQ IMM DEF, V55, P503, DOI 10.1097/QAI.0b013e3181f5379a; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Malcolm SE, 2003, AIDS CARE, V15, P251, DOI 10.1080/0954012031000068399; McCormick NM, 2015, JAIDS-J ACQ IMM DEF, V70, pE73, DOI 10.1097/QAI.0000000000000782; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Ojikutu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100039; Porter M, 2015, JAIDS-J ACQ IMM DEF, V69, P593, DOI 10.1097/QAI.0000000000000683; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Siraprapasiri T, 2016, J VIRUS ERAD, V2, P7; StataCorp LP, STAT SURV AN EP TABL; Taiwo B, 2009, INT J INFECT DIS, V13, P552, DOI 10.1016/j.ijid.2008.10.008; Therneau T., USING TIME DEPENDENT; WHO, 2011, WHONMHNHDMNM111; Working Group on Using Weight and Height References in Evaluating the Growth Status of Thai Children, 2000, MAN US WEIGHT HEIGHT	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222082	10.1371/journal.pone.0222082	http://dx.doi.org/10.1371/journal.pone.0222082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527875	Green Published, Green Submitted, gold			2022-12-27	WOS:000532231400009
J	Mackenzie, DD; Naeth, MA				Mackenzie, Dean D.; Naeth, M. Anne			Native seed, soil and atmosphere respond to boreal forest topsoil (LFH) storage	PLOS ONE			English	Article							JARRAH-FOREST; VIABILITY; RESTORATION; SURVIVAL; DORMANCY; BAUXITE; BANK	During mining topsoil is salvaged and stockpiled until ready for reclamation, stockpiling can have detrimental effects on seed viability and soil quality. Research has assessed effects of salvage and placement depth of forest topsoil on plant community establishment, with little work on effects of storage, particularly in the boreal forest. Our research assessed boreal forest topsoil storage methods to determine effects on soil chemical and physical properties, native seed viability and germination and rhizome viability and emergence. Factors were topsoil stockpiling length, stockpile size, season of construction and soil texture. Four replicates of large and small stockpiles were constructed in the mineable oil sands, in northeastern Alberta. During construction seeds and rhizomes from a variety of native boreal plant species were buried within large (0.05, 1.0, 2.0, 4.0, 6.0 m) and small (0.05, 1.0, 3.0 m) stockpiles. Soil gas probes were installed at similar depths as seed and rhizomes were placed. Seeds and rhizomes were extracted eight months and sixteen months after construction; during that time soil samples were collected for various chemical analyses. Irrespective of stockpile size, the majority of species seeds and rhizomes buried below 1 m lost viability and did not germinate after eight months. Anaerobic soil conditions developed soon after construction and persisted at depths below 1.0 m in large stockpiles, and over time anaerobic conditions developed in smaller stockpiles. Only seeds of Geranium bicknellii and Dracocephalum parviflorum had a high survival rate in stockpiles; both species have hard seed coats and are physically dormant. Various soil nutrients increased in concentrations in their soluble forms after stockpiling. Direct placement of topsoil is a preferred soil handling technique; however, if topsoil has to be stockpiled increasing the surface area of stockpiles will help preserve some seed and rhizome viability.	[Mackenzie, Dean D.] Vertex Resource Grp Ltd, Sherwood Pk, AB, Canada; [Naeth, M. Anne] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Naeth, MA (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	anne.naeth@ualberta.ca		Naeth, M Anne/0000-0002-9147-1638	Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The following companies provided an unrestricted research grant to Dr M Anne Naeth to support the research addressed in this publication of her PhD student Dr Dean Mackenzie. This funding was used to cover direct costs of research. No funding was provided for the personal use or salary of the supervisor Dr Naeth: Syncrude Canada Ltd., Suncor Energy Ltd., Shell Canada Limited, Canadian Natural Resources Ltd., Total E&P Canada Ltd., and Fort Hills Energy LP by its General Petro-Canada Oil Sands Inc. (Multi Partner Grant Number G800001067). Dr Dean Mackenzie received a PhD scholarship from the Natural Sciences and Engineering Research Council (DDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKAREEM AW, 1984, PLANT SOIL, V76, P357, DOI 10.1007/BF02205593; Anderson TR, 1988, P 13 ANN AUSTR MIN I, P256; Archibold O.W., 1989, ECOLOGY SOIL SEED BA, P107, DOI [10.1016/B978-0-12-440405- 2.50012-9, DOI 10.1016/B978-0-12-440405-2.50012-9]; Association of Official Seed Analysts, 2006, RUL TEST SEEDS STILL; Baskin C.C., 1998, SEEDS ECOLOGY BIOGEO, P666; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Brophy L., 1980, P N DAK AC SCI ANN M; Carter M.R., 1993, SOIL SAMPLING METHOD, P823; CONN JS, 1990, WEED SCI, V38, P134, DOI 10.1017/S0043174500056277; DICKIE JB, 1988, BIOL CONSERV, V43, P257, DOI 10.1016/0006-3207(88)90119-X; FYLES JW, 1989, CAN J BOT, V67, P274, DOI 10.1139/b89-039; Gama-Arachchige NS, 2012, ANN BOT-LONDON, V110, P637, DOI 10.1093/aob/mcs122; GOULD AB, 1981, MYCOLOGIA, V73, P914, DOI 10.2307/3759802; Hall S. L., 2009, Ecological Restoration, V27, P381, DOI 10.3368/er.27.4.381; HARRIS JA, 1989, SOIL USE MANAGE, V5, P161, DOI 10.1111/j.1475-2743.1989.tb00778.x; Harris JA., 1993, RESTOR ECOL, V1, P88, DOI [10.1111/j.1526-100X.1993.tb00014.x, DOI 10.1111/j.1526-100X.1993.tb00014.x, DOI 10.1111/J.1526-100X.1993.TB00014.X]; Harris JA, 1987, J SCI FOOD AGR, V40, P219; HARRISON B. J., 1966, J NAT INST AGR BOT, V10, P644; Havlin JL, 1999, SOIL FERTILITY FERTI; HUNTER F, 1956, J SOIL SCI, V7, P75, DOI 10.1111/j.1365-2389.1956.tb00864.x; IBRAHIM AE, 1983, J EXP BOT, V34, P620, DOI 10.1093/jxb/34.5.620; Koch JM, 1996, RESTOR ECOL, V4, P368, DOI 10.1111/j.1526-100X.1996.tb00189.x; Kong K, 1980, 91 ALB OIL SANDS ENV, P45; Kundu NK, 1997, ENVIRON CONSERV, V24, P24, DOI 10.1017/S0376892997000064; Lee P, 2004, CAN J BOT, V82, P1468, DOI [10.1139/b04-108, 10.1139/B04-108]; Liest N, 2003, INT SEED TESTING ASS; Maag M, 1999, SOIL SCI SOC AM J, V63, P858, DOI 10.2136/sssaj1999.634858x; Mackenzie DD, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P374, DOI 10.1079/9781845931971.0374; MacKenzie DD, 2012, BEST MANAGEMENT PRAC, P161; Mackenzie DD, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2008.00500.x; MARKS PL, 1974, ECOL MONOGR, V44, P73, DOI 10.2307/1942319; Moss EH., 1993, FLORA ALBERTA MANUAL, P687; OHLROGGE JB, 1982, PLANT PHYSIOL, V70, P791, DOI 10.1104/pp.70.3.791; Rivera D, 2012, ECOL ENG, V44, P94, DOI 10.1016/j.ecoleng.2012.03.005; RIVES CS, 1980, SOIL SCI, V129, P253, DOI 10.1097/00010694-198004000-00009; ROBERTS E. H., 1968, ANN BOT [LONDON], V32, P97; Rokich DP, 2000, RESTOR ECOL, V8, P196, DOI 10.1046/j.1526-100x.2000.80027.x; STARK JM, 1987, SOIL SCI, V144, P72, DOI 10.1097/00010694-198707000-00012; Strong W.L., 1992, ECOREGIONS ALBERTA, P59; TACEY WH, 1980, J APPL ECOL, V17, P195, DOI 10.2307/2402974; TIEDJE JM, 1984, PLANT SOIL, V76, P197, DOI 10.1007/BF02205580; Turchenek LW, 1982, 22 AOSERP ALB OIL SA, P240; VISSER S, 1984, PLANT SOIL, V82, P41, DOI 10.1007/BF02220768; WHITNEY GG, 1986, CAN J BOT, V64, P2916, DOI 10.1139/b86-385; Whittle C. A., 1997, Environmental Reviews, V5, P79, DOI 10.1139/a97-003; WIDDOWSON JP, 1982, NEW ZEAL J SCI, V25, P287	46	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220367	10.1371/journal.pone.0220367	http://dx.doi.org/10.1371/journal.pone.0220367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525213	gold, Green Published, Green Submitted			2022-12-27	WOS:000532225700007
J	Marzi, S; Mysiak, J; Essenfelder, AH; Amadio, M; Giove, S; Fekete, A				Marzi, Sepehr; Mysiak, Jaroslav; Essenfelder, Arthur H.; Amadio, Mattia; Giove, Silvio; Fekete, Alexander			Constructing a comprehensive disaster resilience index: The case of Italy	PLOS ONE			English	Article							SOCIAL VULNERABILITY INDEX; COMMUNITY RESILIENCE; ADAPTIVE CAPACITY; CLIMATE-CHANGE; INDICATORS; FRAMEWORK; FLOODS; DISCRETE; COHESION; PROPOSAL	Measuring disaster resilience is a key component of successful disaster risk management and climate change adaptation. Quantitative, indicator-based assessments are typically applied to evaluate resilience by combining various indicators of performance into a single composite index. Building upon extensive research on social vulnerability and coping/adaptive capacity, we first develop an original, comprehensive disaster resilience index (CDRI) at municipal level across Italy, to support the implementation of the Sendai Framework for Disaster Risk Reduction 2015-2030. As next, we perform extensive sensitivity and robustness analysis to assess how various methodological choices, especially the normalisation and aggregation methods applied, influence the ensuing rankings. The results show patterns of social vulnerability and resilience with sizeable variability across the northern and southern regions. We propose several statistical methods to allow decision makers to explore the territorial, social and economic disparities, and choose aggregation methods best suitable for the various policy purposes. These methods are based on linear and non liner normalization approaches combining the OWA and LSP aggregators. Robust resilience rankings are determined by relative dominance across multiple methods. The dominance measures can be used as a decision-making benchmark for climate change adaptation and disaster risk management strategies and plans.	[Marzi, Sepehr; Mysiak, Jaroslav; Essenfelder, Arthur H.; Amadio, Mattia] Ctr Euro Mediterraneo Cambiamenti Climat, Via Liberta, Venice Marghera, Italy; [Marzi, Sepehr; Mysiak, Jaroslav; Essenfelder, Arthur H.; Amadio, Mattia] Univ Ca Foscari Venezia, Via Liberta, Venice Marghera, Italy; [Giove, Silvio] Univ Ca Foscari Venezia, Dept Econ, Cannaregio 873, Venice, Italy; [Fekete, Alexander] Univ Appl Sci, TH Koln, Inst Rescue Engn & Civil Protect, Betzdorfer Str 2, Cologne, Germany	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia	Marzi, S (corresponding author), Ctr Euro Mediterraneo Cambiamenti Climat, Via Liberta, Venice Marghera, Italy.; Marzi, S (corresponding author), Univ Ca Foscari Venezia, Via Liberta, Venice Marghera, Italy.	sepehr.marzi@cmcc.it	Fekete, Alexander/C-4071-2017; Mysiak, Jaroslav/A-8683-2019; Essenfelder, Arthur Hrast/AAK-1790-2021	Fekete, Alexander/0000-0002-8029-6774; Mysiak, Jaroslav/0000-0001-9341-7048; Essenfelder, Arthur Hrast/0000-0001-9396-6928; Marzi, Sepehr/0000-0002-8318-3767	European Union [730482]	European Union(European Commission)	This publication is part of the project CLARA "Climate forecast enabled knowledge services" that has received funding from the European Union's Horizon 2020 research and innovation programme under the Grant Agreement No 730482.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2005, CR GEOSCI, V337, P399, DOI 10.1016/j.crte.2004.11.004; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Agenzia Entrate, 2013, STOCK CAT; Alawiyah T, 2011, J RELIG SPIRITUAL SO, V30, P294, DOI 10.1080/15426432.2011.587388; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; Annoni Paola, 2017, 022017 WP EUR COMM; [Anonymous], [No title captured]; [Anonymous], 2014, CLIM CHANG 2014 IMP; Appleby-Arnold S, 2018, INT J DISAST RISK RE, V31, P37, DOI 10.1016/j.ijdrr.2018.04.015; Araya-Munoz D, 2016, J ENVIRON MANAGE, V183, P314, DOI 10.1016/j.jenvman.2016.08.060; Aroca-Jimenez E, 2017, NAT HAZARD EARTH SYS, V17, P1541, DOI 10.5194/nhess-17-1541-2017; Avkiran NK, 2018, INT SER OPER RES MAN, V267, P1, DOI 10.1007/978-3-319-71691-6_1; Bakkensen LA, 2017, RISK ANAL, V37, P982, DOI 10.1111/risa.12677; Barca F, 2014, MAT UVAL SER, V31; Barr R, 2010, MITIG ADAPT STRAT GL, V15, P843, DOI 10.1007/s11027-010-9242-1; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bates S, 2014, ECON MODEL, V42, P445, DOI 10.1016/j.econmod.2014.07.027; Beccari Benjamin, 2016, PLoS Curr, V8, DOI 10.1371/currents.dis.453df025e34b682e9737f95070f9b970; Belles-Sampera J, 2014, INFORM SCIENCES, V267, P201, DOI 10.1016/j.ins.2014.01.047; Bellini E, 2018, ROUTLEDGE HDB SUSTAI, DOI [10.4324/9781315142074-35, DOI 10.4324/9781315142074-35]; Bendanillo F.E., 2016, J AQUATIC SCI, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.12691/JAS-4-1-1; Birkmann J., 2007, Environmental Hazards, V7, P20, DOI 10.1016/j.envhaz.2007.04.002; Bowen A, 2012, CLIMATIC CHANGE, V113, P95, DOI 10.1007/s10584-011-0346-8; Breil M., 2007, 20181 ETCCCA EEA, DOI [10.25424/CMCC/SOCVUL_EUROPCITIES, DOI 10.25424/CMCC/SOCVUL_EUROPCITIES]; Brenkert AL, 2005, CLIMATIC CHANGE, V72, P57, DOI 10.1007/s10584-005-5930-3; Carreno ML, 2007, NAT HAZARDS, V40, P137, DOI 10.1007/s11069-006-0008-8; Chaji A, 2018, COMPUT IND ENG, V124, P370, DOI 10.1016/j.cie.2018.07.040; Cimellaro GP, 2010, ENG STRUCT, V32, P3639, DOI 10.1016/j.engstruct.2010.08.008; Copernicus, 2018, GREEN LINEAR ELEMENT; Cutter SL, 2014, GLOBAL ENVIRON CHANG, V29, P65, DOI 10.1016/j.gloenvcha.2014.08.005; Cutter SL, 2010, J HOMEL SECUR EMERG, V7; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Dallara A, 2012, REG STUD, V46, P321, DOI 10.1080/00343404.2010.504703; Damioli G, 2017, COIN 2017 15 JRC ANN; De Groeve T, 2015, JRC SCI POLICY REPOR, V96, DOI [10.2788/636388, DOI 10.2788/636388]; Denton F, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1101; Diamanti I., 2017, RAPPORTO ITALIANI ST; Dipartimento delle Finanze, 2018, STAT DICH; Dujmovic J, 2006, P 11 INF PROC MAN UN; EC, 2013, EU STRAT AD CLIM CHA; EC, 2015, BUILD RES EUR GLOB W; EEA, 2017, NAT DES AR CDDA; EEA, 2017, NAT 2000 DAT EUR NET; ENRD, 2018, STRAT INN AR IT; ESPON, 2011, ESPON CLIMATE E CLIM; European Commission, 2014, POST 2015 HYOG FRAM; European Commission, 2008, HDB CONSTRUCTING COM, DOI DOI 10.1787/9789264043466-EN; European Commission, SWD2013227FINAL; Fekete A, 2009, NAT HAZARD EARTH SYS, V9, P393, DOI 10.5194/nhess-9-393-2009; Fernandez P, 2016, GEOMAT NAT HAZ RISK, V7, P1367, DOI 10.1080/19475705.2015.1052021; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Frazier TG, 2013, APPL GEOGR, V42, P95, DOI 10.1016/j.apgeog.2013.05.004; Frigerio I, 2018, INT J DISAST RISK SC, V9, P249, DOI 10.1007/s13753-018-0168-7; Frigerio I, 2016, APPL GEOGR, V74, P12, DOI 10.1016/j.apgeog.2016.06.014; Frigerio I, 2016, ENVIRON SCI POLICY, V63, P187, DOI 10.1016/j.envsci.2016.06.001; Fuller R., 1996, OWA OPERATORS DECISI, P85; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; Garcia-Sanchez IM, 2015, ECOL INDIC, V48, P171, DOI 10.1016/j.ecolind.2014.08.004; Graziano P., 2013, ECOSCIENZA, V6, P17; Graziano P, 2014, RETI NUOVI SETTORI S, P243; Graziano P, 2016, SCI TOTAL ENVIRON, V553, P211, DOI 10.1016/j.scitotenv.2016.02.051; Greco S, 2019, SOC INDIC RES, V141, P61, DOI 10.1007/s11205-017-1832-9; Haddow G.D., 2011, INTRO EMERGENCY MANA; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hooghe M, 2016, ELECT STUD, V44, P46, DOI 10.1016/j.electstud.2016.08.002; ISTAT, 2015, 8MILACENSUS; ISTAT, 2013, MATR CONT DIST PEND; ISTAT, 2018, IND VULN SOC MAT; ISTAT, 2018, IND VULN SOC MAT; ISTAT, 2015, POP CENS; Jin LS, 2017, FUZZY SET SYST, V308, P106, DOI 10.1016/j.fss.2016.04.017; JRC, 2018, 10 STEP GUID; Juhola S, 2015, MITIG ADAPT STRAT GL, V20, P99, DOI 10.1007/s11027-013-9481-z; Kaufmann D, 2011, HAGUE J RULE LAW, V3, P220, DOI 10.1017/S1876404511200046; Khazai B, 2018, INT J DISAST RISK RE, V31, P604, DOI 10.1016/j.ijdrr.2018.06.012; Kienberger S, 2014, ASSESSMENT OF VULNERABILITY TO NATURAL HAZARDS: A EUROPEAN PERSPECTIVE, P53, DOI 10.1016/B978-0-12-410528-7.00003-5; Larsen ChA, 2014, SOCIAL COHESION DEFI; Linkov I., 2019, SCI PRACTICE RESILIE, DOI 10.1007/978-3-030-04565-4; Linkov I, 2018, RISK ANAL, V38, P1772, DOI 10.1111/risa.12991; Ludy J, 2012, NAT HAZARDS, V61, P829, DOI 10.1007/s11069-011-0072-6; Marzi S, 2018, J ENVIRON MANAGE, V223, P1023, DOI 10.1016/j.jenvman.2018.06.060; MCCLELLAND K, 2006, DISASTER RESILIENCE, P275; Mitchell D, 2014, L TENURE J, V1; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Mysiak J, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0305; Mysiak J, 2016, NAT HAZARD EARTH SYS, V16, P2189, DOI 10.5194/nhess-16-2189-2016; Nardo M, 2005, 21682 EUR EUR COMM J; Nifo A, 2014, REG STUD, V48, P1628, DOI 10.1080/00343404.2013.835799; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Parsons M, 2016, INT J DISAST RISK RE, V19, P1, DOI 10.1016/j.ijdrr.2016.07.005; Patel RB, 2018, INT J DISAST RISK RE, V27, P161, DOI 10.1016/j.ijdrr.2017.10.003; Peacock W.G., 2010, ADV RESILIENCE COAST; Pinar M, 2014, ECOL INDIC, V39, P189, DOI 10.1016/j.ecolind.2013.12.012; Poljansek K., 2017, 28034 EUR EN, DOI [10.2788/688605, DOI 10.2788/688605]; Pringle P, 2015, NATL MONITORING REPO, DOI [10.2800/629559, DOI 10.2800/629559]; Roder G, 2017, WEATHER CLIM SOC, V9, P717, DOI 10.1175/WCAS-D-16-0090.1; Rose A., 2007, ENVIRON HAZARDS-UK, V7, P383, DOI [10.1016/j.envhaz.2007.10.001, DOI 10.1016/J.ENVHAZ.2007.10.001]; Roy F, 2015, L TENURE J, V1; Rufat S, 2015, INT J DISAST RISK RE, V14, P470, DOI 10.1016/j.ijdrr.2015.09.013; Saisana M, 2018, GLOBAL INNOVATION IN, P71; Schultz MT, 2016, J COASTAL RES, V32, P1032, DOI 10.2112/JCOASTRES-D-15-00170.1; Sherrieb K, 2010, SOC INDIC RES, V99, P227, DOI 10.1007/s11205-010-9576-9; Sherrieb K, 2012, INT J DISAST RISK RE, V2, P6, DOI 10.1016/j.ijdrr.2012.06.001; Sietchiping R., 2006, APPL GIS, V2, P1, DOI DOI 10.2104/AG060016; Smit B, 2003, SUSTAIN DEV, V8; Smith N., 1996, HUMAN GEOGRAPHY ESSE, P283; Suckall N, 2018, SCI TOTAL ENVIRON, V633, P946, DOI 10.1016/j.scitotenv.2018.03.234; Thomas D.S.K., 2013, SOCIAL VULNERABILITY, V(2nd); Tierney K, 2007, TR NEWS, V250, P14, DOI DOI 10.17226/23168; Tierney K, 2012, ANNU REV ENV RESOUR, V37, P341, DOI 10.1146/annurev-environ-020911-095618; Tol RSJ, 2007, GLOBAL ENVIRON CHANG, V17, P218, DOI 10.1016/j.gloenvcha.2006.08.001; Townshend I, 2015, NAT HAZARDS, V76, P913, DOI 10.1007/s11069-014-1526-4; UNIDSR, 2015, SEND FRAM DIS RISK R; United Nations Development Programme (UNDP), 2017, SUSTAINABLE DEV GOAL; University Yale, 2016, ENV PERFORMANCE INDE; USEPA, 2014, EPA100R09001A OFF SC; Vallecillo S, 2018, LANDSCAPE URBAN PLAN, V174, P41, DOI 10.1016/j.landurbplan.2018.03.001; Vandermotten C, 2017, RES REGI COMMITTEE I; Williams P.R., 2014, DISASTER RESILIENCE; World Bank, 2012, SEND REP MAN DIS RIS; World Economic Forum, 2017, GLOBAL COMPETITIVENE; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Zabeo A., 2011, DECISION SUPPORT SYS	125	20	20	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221585	10.1371/journal.pone.0221585	http://dx.doi.org/10.1371/journal.pone.0221585			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525230	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700013
J	Goertz, S; de Menezes, AB; Birtles, RJ; Fenn, J; Lowe, AE; MacColl, ADC; Poulin, B; Young, S; Bradley, JE; Taylor, CH				Goertz, Sarah; de Menezes, Alexandre B.; Birtles, Richard J.; Fenn, Jonathan; Lowe, Ann E.; MacColl, Andrew D. C.; Poulin, Benoit; Young, Stuart; Bradley, Janette E.; Taylor, Christopher H.			Geographical location influences the composition of the gut microbiota in wild house mice (Mus musculus domesticus) at a fine spatial scale	PLOS ONE			English	Article							POPULATION; DIVERSITY; MOTHER; WEIGHT; IMPACT; AGE	The composition of the mammalian gut microbiota can be influenced by a multitude of environmental variables such as diet and infections. Studies investigating the effect of these variables on gut microbiota composition often sample across multiple separate populations and habitat types. In this study we explore how variation in the gut microbiota of the house mouse (Mus musculus domesticus) on the Isle of May, a small island off the east coast of Scotland, is associated with environmental and biological factors. Our study focuses on the effects of environmental variables, specifically trapping location and surrounding vegetation, as well as the host variables sex, age, body weight and endoparasite infection, on the gut microbiota composition across a fine spatial scale in a freely interbreeding population. We found that differences in gut microbiota composition were significantly associated with the trapping location of the host, even across this small spatial scale. Sex of the host showed a weak association with microbiota composition. Whilst sex and location could be identified as playing an important role in the compositional variation of the gut microbiota, 75% of the variation remains unexplained. Whereas other rodent studies have found associations between gut microbiota composition and age of the host or parasite infections, the present study could not clearly establish these associations. We conclude that fine spatial scales are important when considering gut microbiota composition and investigating differences among individuals.	[Goertz, Sarah; Fenn, Jonathan; Lowe, Ann E.; MacColl, Andrew D. C.; Poulin, Benoit; Bradley, Janette E.; Taylor, Christopher H.] Univ Nottingham, Sch Life Sci, Nottingham, England; [de Menezes, Alexandre B.] NUI Galway, Sch Nat Sci, Galway, Ireland; [Birtles, Richard J.] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England; [Young, Stuart] Chester Zoo, IUCN SSC Asian Wild Cattle Specialist Grp, Chester, Cheshire, England	University of Nottingham; Ollscoil na Gaillimhe-University of Galway; University of Manchester; University of Salford	Bradley, JE (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.	jan.bradley@nottingham.ac.uk	de Menezes, Alexandre/AAG-1824-2021	de Menezes, Alexandre/0000-0001-5244-3354; Fenn, Jonathan/0000-0002-9255-6975; Birtles, Richard/0000-0002-4216-5044; Bradley, Janette/0000-0003-3973-7977	Natural Environment Research Council (NERC) as part of the Envision Doctoral Training Programme studentship [NE/L002604/1]; Biotechnology and Biological Sciences Research Council [BB/J014508/1]	Natural Environment Research Council (NERC) as part of the Envision Doctoral Training Programme studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Natural Environment Research Council (NERC) [grant number NE/L002604/1] as part of the Envision Doctoral Training Programme studentship (URL: https://nerc.ukri.org/) which was awarded to SG. This work was also supported by the Biotechnology and Biological Sciences Research Council [grant number BB/J014508/1], a Doctoral Training Programme studentship (URL: https://bbsrc.ukri.org/) awarded to SY and JF. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Scottish National Heritage for permission to carry out work on the Isle of May, and David Steel (Scottish National Heritage); Rene ' van der Wal for providing data on vegetation distributions on the island; Andrew Wolfenden for comments on the manuscript. In addition we would like to acknowledge the helpful comments made by two anonymous referees which has significantly improved the manuscript.; This work was supported by The Natural Environment Research Council (NERC) [grant number NE/L002604/1] as part of the Envision Doctoral Training Programme studentship which was awarded to SG. This work was also supported by the Biotechnology and Biological Sciences Research Council [grant number BB/J014508/1], a Doctoral Training Programme studentship awarded to SY and JF.	Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Amato KR, 2016, OECOLOGIA, V180, P717, DOI 10.1007/s00442-015-3507-z; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrews S., 2010, FASTQC QUALITY CONTR; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Augusteyn RC, 2014, MOL VIS, V20, P410; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berry R.J., 1991, P239; BERRY RJ, 1991, J ZOOL, V225, P615, DOI 10.1111/j.1469-7998.1991.tb04329.x; Berry RJ, 1964, SOURCE EVOL, DOI [10.1111/j.1558-5646.1964.tb01623.x, DOI 10.1111/J.1558-5646.1964.TB01623.X]; Biddle A., 2013, DIVERSITY, V5, P627, DOI [10.3390/d5030627, DOI 10.3390/D5030627]; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CARRENO NB, 1990, J MAMMAL, V71, P468, DOI 10.2307/1381964; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Holm JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125495; Kettel EF, 2016, EUR J WILDLIFE RES, V62, P241, DOI 10.1007/s10344-016-0985-1; Kotzampassi K, 2013, SURG CURR RES, DOI [10.4172/2161-1076.1000152, DOI 10.4172/2161-1076.1000152]; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01169; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Love AM, MODERATED ESTIMATION; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markle JGM, 2013, SCIENCE, DOI [10.5534/wjmh.190009, DOI 10.5534/WJMH.190009]; Maurice CF, 2015, ISME J, V9, P2423, DOI 10.1038/ismej.2015.53; McKenney EA, 2015, GUT MICROBES, V6, P182, DOI 10.1080/19490976.2015.1047128; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Oksanen J., 2022, R PACKAGE VERSION; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Reynolds LA, 2015, J IMMUNOL, DOI [10.4049/jimmunol, DOI 10.4049/JIMMUNOL]; Rogers GB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05437; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; ROWE FP, 1985, J APPL ECOL, V22, P55, DOI 10.2307/2403326; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Snijders AM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.221; Suzuk TA, 2019, MOL ECOL, V28, P3197, DOI 10.1111/mec.15139; Suzuki TA, 2019, MOL ECOL, V28, P2378, DOI 10.1111/mec.14905; TANNOCK GW, 1990, J CLIN MICROBIOL, V28, P1225, DOI 10.1128/JCM.28.6.1225-1228.1990; Taylor CH, 2019, FUNCT ECOL, V33, P1425, DOI 10.1111/1365-2435.13354; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; TRIGGS GS, 1991, J ZOOL, V225, P449, DOI 10.1111/j.1469-7998.1991.tb03828.x; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wang J, 2014, P NATL ACAD SCI USA, V111, pE2703, DOI 10.1073/pnas.1402342111; Weldon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134643; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	64	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222501	10.1371/journal.pone.0222501	http://dx.doi.org/10.1371/journal.pone.0222501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557179	Green Published, gold			2022-12-27	WOS:000532345500022
J	Nash, MC; Diaz-Pulido, G; Harvey, AS; Adey, W				Nash, Merinda C.; Diaz-Pulido, Guillermo; Harvey, Adela S.; Adey, Walter			Coralline algal calcification: A morphological and process-based understanding	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INORGANIC CARBON; CELL-WALLS; MG-CALCITE; RED ALGAE; CELLULOSE; GROWTH; BIOMINERALIZATION; POLYSACCHARIDES; RHODOPHYTA	Research purpose and findings Coralline algae are key biological substrates of many carbonate systems globally. Their capacity to build enduring crusts that underpin the formation of tropical reefs, rhodolith beds and other benthic substrate is dependent on the formation of a calcified thallus. However, this important process of skeletal carbonate formation is not well understood. We undertook a study of cellular carbonate features to develop a model for calcification. We describe two types of cell wall calcification; 1) calcified primary cell wall (PCW) in the thin-walled elongate cells such as central medullary cells in articulated corallines and hypothallial cells in crustose coralline algae (CCA), 2) calcified secondary cell wall (SCW) with radial Mg-calcite crystals in thicker-walled rounded cortical cells of articulated corallines and perithallial cells of CCA. The distinctive banding found in many rhodoliths is the regular transition from PCW-only cells to SCW cells. Within the cell walls there can be bands of elevated Mg with Mg content of a few mol% higher than radial Mg-calcite (M-type), ranging up to dolomite composition (D-type). Model for calcification We propose the following three-step model for calcification. 1) A thin (< 0.5 mu m) PCW forms and is filled with a mineralising fluid of organic compounds and seawater. Nanometer-scale Mg-calcite grains precipitate on the organic structures within the PCW. 2) Crystalline cellulose microfibrils (CMF) are extruded perpendicularly from the cellulose synthase complexes (CSC) in the plasmalemma to form the SCW. 3) The CMF soaks in the mineralising fluid as it extrudes and becomes calcified, retaining the perpendicular form, thus building the radial calcite. In Clathromorphum, SCW formation lags PCW creating a zone of weakness resulting in a split in the sub-surface crust. All calcification seems likely to be a bioinduced rather than controlled process. These findings are a substantial step forward in understanding how corallines calcify.	[Nash, Merinda C.; Adey, Walter] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Nash, Merinda C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm & Sci, Nathan Campus, Nathan, Qld, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Coast & Estuaries, Nathan Campus, Nathan, Qld, Australia; [Harvey, Adela S.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; Australian National University; Griffith University; Griffith University; La Trobe University	Nash, MC (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.; Nash, MC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	Merinda.nash@alumni.anu.edu.au	Diaz-Pulido, Guillermo/B-3648-2013	Diaz-Pulido, Guillermo/0000-0002-0901-3727	Australian Research Council [DP160103071]; Smithsonian Research Fellowship	Australian Research Council(Australian Research Council); Smithsonian Research Fellowship	GDP was supported by an Australian Research Council Discovery Grant (DP160103071). MN was supported by a Smithsonian Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GDP was supported by an Australian Research Council Discovery Grant (DP160103071). MCN was supported by a Smithsonian Research Fellowship.	Addadi L, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/9/098003; Adey W, 2017, PHYMATOLITHON MELOBE; ADEY W H, 1974, Phycologia, V13, P329, DOI 10.2216/i0031-8884-13-4-329.1; ADEY W H, 1971, Phycologia, V10, P29, DOI 10.2216/i0031-8884-10-1-29.1; Adey Walter H., 2013, Smithsonian Contributions to the Marine Sciences, P1; ADEY WALTER H., 1965, HYDROBIOLOGIA, V26, P539, DOI 10.1007/BF00045545; ADEY WALTER H., 1964, HYDROBIOLO GIA, V24, P377, DOI 10.1007/BF00170412; ADEY WALTER H., 1966, HYDROBIOLOGIA, V28, P321, DOI 10.1007/BF00130389; ADEY WH, 1973, GEOL SOC AM BULL, V84, P883, DOI 10.1130/0016-7606(1973)84<883:CCAARI>2.0.CO;2; ADEY WH, 1978, SCIENCE, V202, P831, DOI 10.1126/science.202.4370.831; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Adey WH, 2005, J PHYCOL, V1, P41; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Amado GM, 2007, CIENC MAR, V33, P399, DOI 10.7773/cm.v33i4.1148; [Anonymous], 2005, ITBM RBM, DOI DOI 10.1016/J.RBMRET.2005.04.006; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bilan MI, 2001, RUSS J BIOORG CHEM+, V27, P2, DOI 10.1023/A:1009584516443; Bolton JJ, 2016, AQUAT BOT, V132, P1, DOI 10.1016/j.aquabot.2016.02.006; BOROWITZKA M A, 1974, Phycologia, V13, P195, DOI 10.2216/i0031-8884-13-3-195.1; BOROWITZKA MA, 1976, J EXP BOT, V27, P879, DOI 10.1093/jxb/27.5.879; BOROWITZKA MA, 1984, PLANT CELL ENVIRON, V7, P457, DOI 10.1111/j.1365-3040.1984.tb01436.x; BOROWITZKA MA, 1981, MAR BIOL, V62, P17, DOI 10.1007/BF00396947; Buchanan B.B., 2015, BIOCHEM MOL BIOL PLA; Bussell JA, 2007, J MAR BIOL ASSOC UK, V87, P383, DOI 10.1017/S0025315407055385; Campbell N. A., 1999, BIOLOGY-BASEL, V5th; Chan P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15543; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cole KM., 1990, BIOL RED ALGAE; Cornwall C. E., 2017, GLOBAL CHANGE BIOL, V23, P1; Cornwall CE, 2015, PHOTOSYNTH RES, V124, P181, DOI 10.1007/s11120-015-0114-0; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cox TE, 2017, MAR BIOL, P5; Darrenougue N, 2014, QUATERNARY SCI REV, V93, P34, DOI 10.1016/j.quascirev.2014.03.005; de Araujo AM, 2016, CARBOHYD POLYM, V136, P892, DOI 10.1016/j.carbpol.2015.09.066; de Carvalho WD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0100; de Nooijer LJ, 2014, EARTH-SCI REV, V135, P48, DOI 10.1016/j.earscirev.2014.03.013; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Diotallevi F, 2007, BIOPHYS J, V92, P2666, DOI 10.1529/biophysj.106.099473; Donald HK, 2017, GEOCHIM COSMOCHIM AC; Dutra E, 2016, ICES J MAR SCI, V73, P803, DOI 10.1093/icesjms/fsv213; Egilsdottir H, 2013, MAR BIOL, V160, P2103, DOI 10.1007/s00227-012-2090-7; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fietzke J, 2015, P NATL ACAD SCI USA, V112, P2960, DOI 10.1073/pnas.1419216112; Fisher K, 2014, BIOL BULL-US, V226, P121, DOI 10.1086/BBLv226n2p121; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; GOREAU TF, 1963, ANN NY ACAD SCI, V109, P127, DOI 10.1111/j.1749-6632.1963.tb13465.x; Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330; Gregg JM, 2015, SEDIMENTOLOGY, V62, P1749, DOI 10.1111/sed.12202; Gross E, 2016, AQUAT BOT, V132; Halfar J, 2008, GEOLOGY, V36, P463, DOI 10.1130/G24635A.1; Halfar J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028811; Halfar J, 2013, P NATL ACAD SCI USA, V110, P19737, DOI 10.1073/pnas.1313775110; Harvey AS, 2017, MAR FRESHWATER RES, V68, P411, DOI 10.1071/MF15434; Harvey AS, 2009, PHYCOLOGIA, V48, P258, DOI 10.2216/08-84.1; Hernandez-Carmona G., 2013, CONVENTIONAL ALTERNA; Hofmann LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159057; Hofmann LC, 2012, MAR BIOL, V159, P783, DOI 10.1007/s00227-011-1854-9; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; James NP, 1988, J SEDIMENT RES, V58; Johnson MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087678; Kamenos NA, 2008, GEOCHIM COSMOCHIM AC, V72, P771, DOI 10.1016/j.gca.2007.11.019; Kamenos NA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1159; Kato A, 2011, J PHYCOL, V47, P662, DOI 10.1111/j.1529-8817.2011.00996.x; Leadbeater B. S. C., 1986, BIOMINERALIZATION LO, P141; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Leung JYS, 2017, ENVIRON SCI TECHNOL, V51, P2652, DOI 10.1021/acs.est.6b04709; Lewis B, 2017, MAR ECOL PROG SER, V568, P73, DOI 10.3354/meps12074; Lewis B, 2017, J EXP MAR BIOL ECOL, V490, P64, DOI 10.1016/j.jembe.2017.02.004; LITTLER MM, 1975, J ECOL, V63, P117, DOI 10.2307/2258846; Malagoli BG, 2014, INT J BIOL MACROMOL, V66, P332, DOI 10.1016/j.ijbiomac.2014.02.053; Martone PT, 2010, J PHYCOL, V46, P507, DOI 10.1111/j.1529-8817.2010.00828.x; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609; Mass T, 2017, P NATL ACAD SCI USA; Mass T, 2013, CURR BIOL, V23, P1126, DOI 10.1016/j.cub.2013.05.007; MATTY PJ, 1981, PHYCOLOGIA, V20, P46, DOI 10.2216/i0031-8884-20-1-46.1; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Merk V, 2015, GREEN CHEM, V17, P1423, DOI [10.1039/C4GC01862A, 10.1039/c4gc01862a]; Nakano Y, 2015, FRONT PLANT SCI, P6, DOI [10.3389/fpls.2015.00288/abstract, DOI 10.3389/FPLS.2015.00288/ABSTRACT]; Nash MC, 2013, NAT CLIM CHANGE, V3, P268, DOI 10.1038/NCLIMATE1760; Nash MC, 2011, BIOGEOSCIENCES, V8, P3331, DOI 10.5194/bg-8-3331-2011; Nash M.C., 2016, THESIS AUSTR NATL U, P436; Nash MC, 2018, BIOGEOSCIENCES, V15, P781, DOI 10.5194/bg-15-781-2018; Nash MC, 2017, J PHYCOL, V53, P970, DOI 10.1111/jpy.12559; Nash MC, 2016, BIOGEOSCIENCES, V13, P5937, DOI 10.5194/bg-13-5937-2016; Nash MC, 2015, J PHYCOL, V51, P403, DOI 10.1111/jpy.12299; Nash MC, 2013, J SEDIMENT RES, V83, P1085, DOI 10.2110/jsr.2013.67; Navarro DA, 2011, CARBOHYD POLYM, V84, P944, DOI 10.1016/j.carbpol.2010.12.048; OKAZAKI M, 1982, BOT MAR, V25, P123, DOI 10.1515/botm.1982.25.3.123; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Rafsanjani A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0126; Ragazzola F, 2016, SCI REP, P6; Rahman MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep06162; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; REES DA, 1977, ANGEW CHEM INT EDIT, V16, P214, DOI 10.1002/anie.197702141; Ries JB, 2006, GEOCHIM COSMOCHIM AC, V70, P891, DOI 10.1016/j.gca.2005.10.025; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Riosmena-Rodriguez R, 2017, COAST RES LIBR, V15, P3, DOI 10.1007/978-3-319-29315-8_1; Shen XP, 2016, GREEN CHEM, V18, P53, DOI 10.1039/c5gc02396c; Sletten HR, 2017, PALAEOGEOGR PALAEOCL, V465, P264, DOI 10.1016/j.palaeo.2016.10.038; Stanley SM, 2002, P NATL ACAD SCI USA, V99, P15323, DOI 10.1073/pnas.232569499; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Stoppel WL, 2015, ANN BIOMED ENG, V43, P657, DOI 10.1007/s10439-014-1206-2; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Underwood AJ, 1998, MAR FRESHWATER RES, V49, P241, DOI 10.1071/MF97207; van de Locht R, 2014, CRYST GROWTH DES, V14, P1710, DOI 10.1021/cg4018486; Venkatesan J, 2015, STARCH-STARKE, V67, P381, DOI 10.1002/star.201400127; Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008; Von Euw S, 2017, SCIENCE, V356, P933, DOI 10.1126/science.aam6371; Wanamaker AD, 2011, PALAEOGEOGR PALAEOCL, V302, P1, DOI 10.1016/j.palaeo.2010.12.024; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Zhang FF, 2015, AM MINERAL, V100, P483, DOI 10.2138/am-2015-4999; Zhang FF, 2012, AM MINERAL, V97, P556, DOI 10.2138/am.2012.3979	121	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221396	10.1371/journal.pone.0221396	http://dx.doi.org/10.1371/journal.pone.0221396			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557180	Green Published, gold			2022-12-27	WOS:000532345500010
J	Bruijnen, STG; Verweij, NJF; Gent, YYJ; Huisman, MC; Windhorst, AD; Kassiou, M; van de Ven, PM; Lammertsma, AA; Hoekstra, OS; Voskuyl, AE; van der Laken, CJ				Bruijnen, S. T. G.; Verweij, N. J. F.; Gent, Y. Y. J.; Huisman, M. C.; Windhorst, A. D.; Kassiou, M.; van de Ven, P. M.; Lammertsma, A. A.; Hoekstra, O. S.; Voskuyl, A. E.; van der Laken, C. J.			Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers	PLOS ONE			English	Article							SUBCLINICAL SYNOVITIS; QUANTIFICATION; POLYMORPHISM; DEFINITION; BIOMARKER; IMPACT; LIGAND; PET	Background Positron emission tomography (PET) imaging of macrophages using the translocator protein (TSPO) tracer (R)-[C-11]PK11195 has shown the promise to image rheumatoid arthritis (RA). To further improve TSPO PET for RA imaging, second generation TSPO tracers [C-11] DPA-713 and [F-18]DPA-714 have recently been evaluated pre-clinically showing better imaging characteristics. Objective A clinical proof of concept study to evaluate [C-11]DPA-713 and [F-18]DPA-714 to visualize arthritis in RA patients. Methods RA patients (n = 13) with at least two active hand joints were included. PET/CT scans of the hands were obtained after injection of [F-18]DPA-714, [C-11]DPA-713 and/or (R)-[C-11] PK11195 (max. 2 tracers pp). Standardized uptake values (SUVs) and target-to-background (T/B) ratios were determined. Imaging data of the 3 different tracers were compared by pooled post-hoc testing, and by a head to head comparison. Results Clinically active arthritis was present in 110 hand joints (2-17 pp). Arthritic joints were visualized with both [C-11]DPA-713 and [F-18]DPA-714. Visual tracer uptake corresponded with clinical signs of arthritis in 80% of the joints. Mean absolute uptake in PET-positive joints was significantly higher for [C-11]DPA-713 than for [F-18]DPA-714, the latter being not significantly different from (R)-[C-11]PK11195 uptake. Background uptake was lower for both DPA tracers compared with that of (R)-[C-11]PK11195. Higher absolute uptake and lower background resulted in two-fold higher T/B ratios for [C-11]DPA-713. Conclusions [C-11]DPA-713 and [F-18]DPA-714 visualize arthritic joints in active RA patients and most optimal arthritis imaging results were obtained for [C-11]DPA-713. Second generation TSPO macrophage PET provides new opportunities for both early diagnosis and therapy monitoring of RA.	[Bruijnen, S. T. G.; Verweij, N. J. F.; Gent, Y. Y. J.; Voskuyl, A. E.; van der Laken, C. J.] Amsterdam UMC Locat VUmc, Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands; [Huisman, M. C.; Windhorst, A. D.; Lammertsma, A. A.; Hoekstra, O. S.] Amsterdam UMC Locat VUmc, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Kassiou, M.] Univ Sydney, Sch Chem, Sydney, NSW, Australia; [van de Ven, P. M.] Amsterdam UMC Locat VUmc, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Sydney	van der Laken, CJ (corresponding author), Amsterdam UMC Locat VUmc, Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands.	J.vanderLaken@vumc.nl		Bruijnen, Stefan/0000-0003-2155-4929; Kassiou, Michael/0000-0002-6655-0529; Hoekstra, Otto S/0000-0003-0767-2734; Windhorst, Albert/0000-0002-1250-7656; Voskuyl, Alexandre/0000-0002-9699-1827	CTMM Translational Research IT (TraIT) project	CTMM Translational Research IT (TraIT) project	This investigator-initiated study was financially supported by the CTMM Translational Research IT (TraIT) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Bruijnen STG, 2014, ARTHRIT CARE RES, V66, P120, DOI 10.1002/acr.22184; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; de Langen AJ, 2008, J NUCL MED, V49, P1763, DOI 10.2967/jnumed.108.053454; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Dupont AC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040785; Gent YYJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0770-7; Gent YYJ, 2014, J RHEUMATOL, V41, P2145, DOI 10.3899/jrheum.140059; Gent YYJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4509; Gent YYJ, 2012, ARTHRITIS RHEUM-US, V64, P62, DOI 10.1002/art.30655; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; Jones T, 1996, EUR J NUCL MED, V23, P207, DOI 10.1007/BF01731847; Kraan MC, 1998, ARTHRITIS RHEUM, V41, P1481, DOI 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O; Krak NC, 2005, EUR J NUCL MED MOL I, V32, P294, DOI 10.1007/s00259-004-1566-1; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Narayan N, 2018, J NUCL MED, V59, P1125, DOI 10.2967/jnumed.117.202200; Owen DR, 2015, CLIN TRANSL IMAGING, V3, P417, DOI 10.1007/s40336-015-0141-z; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Thominiaux C, 2006, APPL RADIAT ISOTOPES, V64, P570, DOI 10.1016/j.apradiso.2005.12.003; van der Laken CJ, 2008, ARTHRITIS RHEUM, V58, P3350, DOI 10.1002/art.23955; Vanderhoek M, 2012, J NUCL MED, V53, P4, DOI 10.2967/jnumed.111.093443	25	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							PMID e0222844	10.1371/journal.pone.0222844	http://dx.doi.org/10.1371/journal.pone.0222844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553762	gold, Green Published			2022-12-27	WOS:000532319200039
J	Messinger, LN; Stuber, EF; Chizinski, CJ; Fontaine, JJ				Messinger, Lindsey N.; Stuber, Erica F.; Chizinski, Christopher J.; Fontaine, Joseph J.			Mortality, perception, and scale: Understanding how predation shapes space use in a wild prey population	PLOS ONE			English	Article							HOME-RANGE SIZE; HABITAT SELECTION; TEMPORAL VARIATION; ANTIPREDATOR RESPONSE; BEHAVIORAL DECISIONS; SAMPLE-SIZE; ROE DEER; RISK; ELK; LANDSCAPE	Attempts to assess behavioral responses of prey to predation risk are often confounded by depredation of prey. Moreover, the scale at which the response of prey is assessed has important implications for discovering how predation risk alters prey behavior. Herein, we assessed space use of wild Ring-necked Pheasants (Phasianus colchicus) in response to spatial and temporal variation in recreational hunting. We radio-marked pheasants and monitored space use at two spatial scales: short-term seasonal home range, and nightly resting locations. Additionally, we considered temporal variation in predation risk by monitoring space use prior to and during the pheasant hunting season. Although we found no change in nightly resting location, pheasants subjected to predation risk expanded their home range and shifted home range location even when invulnerable to predation. Home range formation was plastic, with home ranges expanding and contracting as risk fluctuated before and during the hunting season. Depredation reduced the measured response within the population, obscuring the potential importance of perceived predation risk in shaping prey communities, particularly when not measured at the appropriate scale. By assessing space use of a wild prey population at multiple scales, considering spatial and temporal variation in predation risk, we show that not only does predation risk affect space use, but that the effects at the population level may be challenging to assess when not measured at the appropriate ecological scale because of the direct effects of differential mortality on the same behaviors.	[Messinger, Lindsey N.; Stuber, Erica F.; Fontaine, Joseph J.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Chizinski, Christopher J.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Messinger, Lindsey N.] Minnesota Dept Nat Resources Farmland Wildlife Po, Madelia, MN 56062 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Messinger, LN (corresponding author), Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.; Messinger, LN (corresponding author), Minnesota Dept Nat Resources Farmland Wildlife Po, Madelia, MN 56062 USA.	lindsey.messinger@state.mn.us	Stuber, Erica/AAT-2803-2020	Stuber, Erica/0000-0002-2687-6874	Federal Aid in Wildlife Restoration Projects [W-98-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; U.S. Fish and Wildlife Service; Wildlife Management Institute; Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln	Federal Aid in Wildlife Restoration Projects; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute; Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln	Funding for this project was provided by Federal Aid in Wildlife Restoration Projects W-98-R administered by the Nebraska Game and Parks Commission. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. CJC was supported by Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln.	Abbey-Lee RN, 2016, BEHAV ECOL, V27, P857, DOI 10.1093/beheco/arv228; Altendorf KB, 2001, J MAMMAL, V82, P430, DOI 10.1644/1545-1542(2001)082&lt;0430:AEOPRO&gt;2.0.CO;2; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; [Anonymous], 2007, DATA ANAL USING REGR, DOI [10. 1017/CBO9780511790942d, DOI 10.1017/CB09780511790942, 10.1017/CB09780511790942]; Bates D, 2015, J STAT SOFTW, Vxx, pxx; Beschta RL, 2014, ECOLOGY, V95, P2669, DOI 10.1890/13-1624.1; Beschta RL, 2013, ECOLOGY, V94, P1420, DOI 10.1890/11-0063.1; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Bleicher SS, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2600-9; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burres E, 1998, CROSS BORDER WATERS: FRAGILE TREASURES FOR THE 21ST CENTURY, P244; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; DENARDO DF, 1994, HORM BEHAV, V28, P273, DOI 10.1006/hbeh.1994.1023; Dorset EE, 2017, EVOL BIOL, V44, P227, DOI 10.1007/s11692-016-9402-7; Droge E, 2017, ECOL EVOL, V7, P189, DOI 10.1002/ece3.2616; Eklov P, 2006, AM NAT, V167, P440, DOI 10.1086/499544; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Ford AT, 2015, TRENDS ECOL EVOL, V30, P725, DOI 10.1016/j.tree.2015.09.012; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frid A, 2002, CONSERV ECOL, V6; Frid A, 2008, OIKOS, V117, P191, DOI 10.1111/j.2007.0030-1299.16134.x; Gelman A., 2021, ARM DATA ANAL USING; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Gilsdorf JM, 2008, J WILDLIFE MANAGE, V72, P1241, DOI 10.2193/2007-348; Giudice JH, 2001, BIRDS N AM, DOI [10.2173/bna.572, DOI 10.2173/BNA.572]; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Heithaus MR, 2006, OIKOS, V114, P257; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Hutto R.L., 1985, P455; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Jorgensen CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099339; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kelley JL, 2003, ANIM BEHAV, V65, P655, DOI 10.1006/anbe.2003.2076; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Klimstra W. D., 1963, Journal of Wildlife Management, V27, P202, DOI 10.2307/3798399; KOTLER BP, 1989, OIKOS, V54, P256, DOI 10.2307/3565279; Labisky R., 1968, NIGHTLIGHTING ITS US; Lack D, 1933, J ANIM ECOL, V2, P239, DOI 10.2307/961; Lafontaine A, 2017, J ANIM ECOL, V86, P624, DOI 10.1111/1365-2656.12645; Lapiedra O, 2018, SCIENCE, V360, P1017, DOI 10.1126/science.aap9289; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [DOI 10.2174/1874213001003030001, 10.2174/1874213001003030001]; Leedy D, 1945, RING NECKED PHEASANT, P57; Leif A., 2003, SURVIVAL SPATIAL ECO; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Mahr K., 2014, P R SOC B, V282, P1798; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; MORRIS DW, 1992, EVOL ECOL, V6, P412, DOI 10.1007/BF02270701; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Nebraska G and PC (NGPC), 2016, HUNTING GUIDE; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Ofstad EG, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2695; Oksanen J., 2022, R PACKAGE VERSION; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Relyea RA, 2000, J WILDLIFE MANAGE, V64, P146, DOI 10.2307/3802984; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rochette R, 2000, J EXP MAR BIOL ECOL, V253, P165, DOI 10.1016/S0022-0981(00)00253-7; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sih A., 1987, P203; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Simonsen VL, 2016, J WILDLIFE MANAGE, V80, P877, DOI 10.1002/jwmg.1068; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; STOKES AW, 1968, J WILDLIFE MANAGE, V32, P867, DOI 10.2307/3799563; Stuber EF, 2014, ANIM BEHAV, V98, P157, DOI 10.1016/j.anbehav.2014.10.010; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thomson RL, 2016, PREY HABITAT SELECTI, V29, P507; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; WALSBERG GE, 1980, WILSON BULL, V92, P33; WARNER RE, 1982, J WILDLIFE MANAGE, V46, P923, DOI 10.2307/3808225; WHITHAM TG, 1978, ECOLOGY, V59, P1164, DOI 10.2307/1938230; Winnie JA, 2012, ECOLOGY, V93, P2600, DOI 10.1890/11-1990.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wszola LS, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00526; Wszola LS, 2019, ECOL MODEL, V392, P268, DOI 10.1016/j.ecolmodel.2018.10.017; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	105	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222272	10.1371/journal.pone.0222272	http://dx.doi.org/10.1371/journal.pone.0222272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553753	Green Published, gold			2022-12-27	WOS:000532319200021
J	Magdama, F; Monserrate-Maggi, L; Serrano, L; Sosa, D; Geiser, DM; Jimenez-Gasco, MD				Magdama, Freddy; Monserrate-Maggi, Lorena; Serrano, Lizette; Sosa, Daynet; Geiser, David M.; del Mar Jimenez-Gasco, Maria			Comparative analysis uncovers the limitations of current molecular detection methods for Fusarium oxysporum f. sp. cubense race 4 strains	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; QUANTITATIVE DETECTION; GENETIC DIVERSITY; PANAMA-DISEASE; BANANA; WILT; SOIL; DIAGNOSIS; SEQUENCE	Fusarium oxysporum f. sp. cubense Tropical Race 4 (Foc TR4) is threatening banana production worldwide. Despite quarantine efforts, the pathogen continues to spread; thus, early diagnosis plays an essential role for the proper execution of contingency plans. Here, we assess the accuracy of four PCR-based molecular methods described in the literature for the identification and detection of race 4 strains, including Subtropical (Foc STR4) and Tropical Race 4 causing Fusarium wilt of banana. We screened a total of 302 isolates using these four markers, and performed phylogenetic analyses, Vegetative Compatibility Group (VCG) testing, sequence comparison, and pathogenicity tests for selected isolates. Our results show that three out of the four markers tested are not reliable for identification of Foc STR4 and TR4, as DNA from isolates from Ecuador, pathogenic and nonpathogenic to banana, obtained from different banana cultivars, displayed cross-reaction with these methods; that is, false positives can occur during the diagnostic process for race 4. Phylogenetic analyses, VCG testing, sequence comparison, and pathogenicity tests suggest the presence of non-target F. oxysporum isolates that share genomic regions with pathogenic strains but lack true pathogenicity to banana. The findings of this work are of foremost importance for international regulatory agencies performing surveillance tests in pathogen-free areas using the current diagnostic methods. We suggest the use of a genetic locus possibly related to virulence, previously identified by T-DNA, and amplified with primers W2987F/W2987R, for diagnosis of Foc TR4 as the most reliable alternative. We urge the adoption of a more holistic view in the study of F. oxysporum as a plant pathogen that considers the biology and diversity of the species for the development of better diagnostic tools.	[Magdama, Freddy; Geiser, David M.; del Mar Jimenez-Gasco, Maria] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Magdama, Freddy; Monserrate-Maggi, Lorena; Serrano, Lizette; Sosa, Daynet] Ctr Invest Biotecnol Ecuador, ESPOL, Escuela Super Politecn Litoral, Campus Gustavo Galindo, Guayaquil, Ecuador; [Magdama, Freddy; Sosa, Daynet] Escuela Super Politecn Litoral, ESPOL, Fac Ciencias Vida, Campus Gustavo Galindo, Guayaquil, Ecuador	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Escuela Superior Politecnica del Litoral; Escuela Superior Politecnica del Litoral	Jimenez-Gasco, MD (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	jimenez-gasco@psu.edu	Magdama, Freddy/AAX-8172-2020; Jimenez-Gasco, Maria del Mar/A-9701-2011; Sosa del Castillo, Daynet/C-4703-2019	Magdama, Freddy/0000-0003-1158-9511; Jimenez-Gasco, Maria del Mar/0000-0001-7329-0211; Serrano, Lizette/0000-0001-8450-8511; Sosa del Castillo, Daynet/0000-0001-5403-9072	National Secretariat of Higher Education of Ecuador (SENESCYT) by way of the scholarship program "Universidades de Excelencia"; Graduate International Research Competitive Grant from the International Agriculture and Development (INTAD) program; James F. and Marilyn L. Tammen Endowment of the Plant Pathology and Environmental Microbiology Department from The Pennsylvania State University; USDA National Institute of Food and Agriculture Federal Appropriations [PEN04676, 1017795]	National Secretariat of Higher Education of Ecuador (SENESCYT) by way of the scholarship program "Universidades de Excelencia"; Graduate International Research Competitive Grant from the International Agriculture and Development (INTAD) program; James F. and Marilyn L. Tammen Endowment of the Plant Pathology and Environmental Microbiology Department from The Pennsylvania State University; USDA National Institute of Food and Agriculture Federal Appropriations	This project was supported by the National Secretariat of Higher Education of Ecuador (SENESCYT) by way of the scholarship program "Universidades de Excelencia", the Graduate International Research Competitive Grant from the International Agriculture and Development (INTAD) program, the James F. and Marilyn L. Tammen Endowment of the Plant Pathology and Environmental Microbiology Department from The Pennsylvania State University, and by the USDA National Institute of Food and Agriculture Federal Appropriations under Project PEN04676 and Accession number 1017795 to MdMJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Mr. Oscar Cruz for technical support and all the producers who facilitated the collection of samples. We are also grateful to Loli Baquerizo, Kristina Gans and Eva Beyen for their contribution on different experiments and preservation of isolates. This work was conducted under Genetic Resource Access Permit #MAE-DNB-CM2018-0091 granted by the Department of Biodiversity of the Ecuadorean Ministry of the Environment.	Aguayo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171767; [Anonymous], 2015, AUSTR BANANA NEW AUG; [Anonymous], 2016, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0163010; Appel DJ, 1996, MOL PLANT MICROBE IN, V9, P125, DOI 10.1094/MPMI-9-0125; Balmas V, 2010, MYCOLOGIA, V102, P803, DOI 10.3852/09-201; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; Buddenhagen I, 2009, ACTA HORTIC, V828, P193, DOI 10.17660/ActaHortic.2009.828.19; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Daniells JW, 2011, ACTA HORTIC, V897, P475; Demers JE, 2015, APPL ENVIRON MICROB, V81, P81, DOI 10.1128/AEM.02590-14; Dita M., 2013, PLAN CONTINGENCIA AN; Dita MA, 2013, ACTA HORTIC, V986, P127, DOI 10.17660/ActaHortic.2013.986.11; Dita MA, 2011, PLANT PATHOL, V60, P384, DOI 10.1111/j.1365-3059.2010.02417.x; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Dita M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01468; Edel V, 2001, FEMS MICROBIOL ECOL, V36, P61, DOI 10.1111/j.1574-6941.2001.tb00826.x; EDEL V, 1995, PHYTOPATHOLOGY, V85, P579, DOI 10.1094/Phyto-85-579; FAOSTAT, 2013, FAO STAT DAT; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Gordon TR, 2017, ANNU REV PHYTOPATHOL, V55, P23, DOI 10.1146/annurev-phyto-080615-095919; Gordon TR, 1997, ANNU REV PHYTOPATHOL, V35, P111, DOI 10.1146/annurev.phyto.35.1.111; Groenewald S, 2006, MYCOL RES, V110, P297, DOI 10.1016/j.mycres.2005.10.004; Karangwa P, 2016, CROP PROT, V84, P132, DOI 10.1016/j.cropro.2016.03.003; Katan T, 1999, PHYTOPARASITICA, V27, P51, DOI 10.1007/BF02980727; Koenig RL, 1997, PHYTOPATHOLOGY, V87, P915, DOI 10.1094/PHYTO.1997.87.9.915; Laurence MH, 2012, FUNGAL BIOL-UK, V116, P289, DOI 10.1016/j.funbio.2011.11.011; Li BJ, 2013, EUR J PLANT PATHOL, V135, P903, DOI 10.1007/s10658-012-0136-9; Li MH, 2013, CAN J PLANT PATHOL, V35, P482, DOI 10.1080/07060661.2013.828321; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Ma LJ, 2014, MOL PLANT PATHOL, V15, P763, DOI 10.1111/mpp.12171; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martin RR, 2016, ANNU REV PHYTOPATHOL, V54, P189, DOI 10.1146/annurev-phyto-080615-100105; McKillop C., 2016, ABC RURAL; McKillop C., 2015, ABC RURAL; McTaggart AR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005475; MOORE NY, 1993, AUST J EXP AGR, V33, P797, DOI 10.1071/EA9930797; Mostert D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181630; NASH SM, 1962, PHYTOPATHOLOGY, V52, P567; Nel B, 2006, PLANT PATHOL, V55, P207, DOI 10.1111/j.1365-3059.2006.01343.x; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197; Pegg K., 1994, IMPROVEMENT TESTING, P70; Pegg KG, 1996, AUST J AGR RES, V47, P637, DOI 10.1071/AR9960637; Peng J, 2014, J APPL MICROBIOL, V117, P1740, DOI 10.1111/jam.12645; Perez-Vicente L, 2014, TROPICAL RACE, V4; Ploetz R. C., 2000, P143; Ploetz R, 2015, PHYTOPARASITICA, V43, P283, DOI 10.1007/s12600-015-0470-5; Ploetz RC, 2015, CROP PROT, V73, P7, DOI 10.1016/j.cropro.2015.01.007; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Ploetz RC, 2006, PANAMA DIS OLD NEM 2; PLOETZ RC, 2005, PANAMA DIS OLD NEM 1; PUHALLA JE, 1985, CAN J BOT, V63, P179, DOI 10.1139/b85-020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Ssali RT, 2013, EUPHYTICA, V194, P425, DOI 10.1007/s10681-013-0971-6; STOVER R. H., 1962, Fusarial wilt (panama disease) of bananas and other Musa species.; STOVER RH, 1972, PLANT DIS REP, V56, P1000; SU HJ, 1986, PLANT DIS, V70, P814, DOI 10.1094/PD-70-814; Su HJ, 1977, TAIWAN, P21; Swofford D., 2003, PHYLOGENETIC ANAL US; Thangavelu R, 2010, PLANT DIS, V94, P1379, DOI 10.1094/PDIS-05-10-0330; Visser M, 2010, S AFR J SCI, V106, P44, DOI 10.4102/sajs.v106i3/4.154; WAITE B. H., 1960, Canadian Journal of Botany, V38, P985, DOI 10.1139/b60-087; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; Yang LL, 2015, CROP PROT, V68, P27, DOI 10.1016/j.cropro.2014.11.004; Zheng SJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00457	70	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222727	10.1371/journal.pone.0222727	http://dx.doi.org/10.1371/journal.pone.0222727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KG5NF	31545825	Green Published, gold			2022-12-27	WOS:000509995500001
J	Duy, PN; Thuy, NT; Trang, BK; Giang, NH; Van, NTH; Xuan, NT				Pham Ngoc Duy; Nguyen Thu Thuy; Bui Kieu Trang; Nguyen Hoang Giang; Nguyen Thi Hong Van; Nguyen Thi Xuan			Regulation of NF-kappa B- and STAT1-mediated plasmacytoid dendritic cell functions by A20	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; CUTTING EDGE; IL-12 PRODUCTION; IFN-GAMMA; ACTIVATION; RESISTANCE; PROFILIN; RECOGNITION; RESPONSES; ANTIGEN	Dendritic cells (DCs) are professional antigen presenting cells involved in the induction of T cell-mediated adaptive immunity. Plasmacytoid DCs (pDCs) originate from lymphoid precursors and produce type I interferons (IFNs) in response to pathogens. A20 is considered as a negative regulator of toll-like receptor (TLR) signaling pathways, in which Toxoplasma gondii- derived profilin (TgPRF) is a TLR11/12 ligand recognised by DCs to stimulate their maturation/activation. Little is known about contributions of A20 to changes in biological properties of pDCs. The present study, therefore, explored whether pDC functions are influenced by A20. To this end, bone marrow cells were isolated and cultured with Flt3L to attain CD8DCs, CD11bDCs and pDCs and followed by challenge with TgPRP in the presence or absence of A20 siRNA. Expression of maturation markers were analysed by flow cytometry, and secretion of inflammatory cytokines by ELISA, cell migration by a transwell migration assay and expression of signalling molecules by western blotting. As a result, treatment with A20 siRNA enhanced activations of I kappa B-alpha and STAT-1, leading to increases in expressions of maturation markers and cytokine productions as well as migration of TgPRP-treated pDCs, while mature CD11bDCs produced at higher levels of TNF-alpha and IL-6 only. In addition, functions of CD8DCs remained unaltered following A20 silencing. The effects of A20 on pDC maturation and activation were completely abolished by IKK inhibitor and partially blunted by fludarabine. In conclusion, the inhibitory effects of A20 on pDC functions are expected to affect the immune response in T. gondii infection.	[Pham Ngoc Duy] Vietnam Natl Univ Agr, Fac Biotechnol, Hanoi, Vietnam; [Nguyen Thu Thuy] Vietnam Mil Med Univ, Inst Biomed & Pharm, Hanoi, Vietnam; [Bui Kieu Trang; Nguyen Hoang Giang; Nguyen Thi Xuan] Vietnam Acad Sci & Technol, Inst Genome Res, Hanoi, Vietnam; [Nguyen Thi Hong Van] VNU Univ Sci, Fac Biol, Dept Genet, Hanoi, Vietnam; [Nguyen Thi Xuan] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, Hanoi, Vietnam	Vietnam National University of Agriculture (VNUA); Vietnam Academy of Science & Technology (VAST); Vietnam National University Hanoi; Vietnam Academy of Science & Technology (VAST)	Xuan, NT (corresponding author), Vietnam Acad Sci & Technol, Inst Genome Res, Hanoi, Vietnam.; Xuan, NT (corresponding author), Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, Hanoi, Vietnam.	xuannt@igr.ac.vn			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [108.06-2017.16]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 108.06-2017.16 to NTX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 108.06-2017.16.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Carrington EM, 2015, P NATL ACAD SCI USA, V112, P4044, DOI 10.1073/pnas.1417620112; Chen HY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0454-6; Cohen SB, 2015, J IMMUNOL, V195, P2754, DOI 10.4049/jimmunol.1501137; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; De Wilde K, 2017, ANN RHEUM DIS, V76, P585, DOI 10.1136/annrheumdis-2016-209454; Doring Y, 2012, ARTERIOSCL THROM VAS, V32, P1613, DOI 10.1161/ATVBAHA.111.236539; Gonzalez RMS, 2014, J INNATE IMMUN, V6, P685, DOI 10.1159/000362367; Johansson P, 2016, INT J CANCER, V138, P121, DOI 10.1002/ijc.29697; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kohli K, 2016, EUR J IMMUNOL, V46, P2659, DOI 10.1002/eji.201646359; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; Sozzani S, 2017, J AUTOIMMUN, V85, P126, DOI 10.1016/j.jaut.2017.07.012; Tosh KW, 2016, J IMMUNOL, V196, P345, DOI 10.4049/jimmunol.1501558; Wang X, 2013, ACTA NEUROPATHOL, V126, P711, DOI 10.1007/s00401-013-1183-9; Wang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116359, 10.1371/journal.pone.0124566]; Xuan NT, 2014, EUR J IMMUNOL, DOI [10.1002/eji, DOI 10.1002/EJI]; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yin L, 2017, DRUG DES DEV THER, V11, P2841, DOI 10.2147/DDDT.S135993	31	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222697	10.1371/journal.pone.0222697	http://dx.doi.org/10.1371/journal.pone.0222697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545817	Green Published, gold			2022-12-27	WOS:000532303200026
J	Lin, W; Wang, DP; Meng, YL; Chen, SC				Lin, Wei; Wang, Dongping; Meng, Yunlong; Chen, Shih-Chi			Multi-focus microscope with HiLo algorithm for fast 3-D fluorescent imaging	PLOS ONE			English	Article							SECTIONING MICROSCOPY; 2-PHOTON MICROSCOPY; STRUCTURED LIGHT; DEPTH; RESOLUTION; SPECKLE; CELL	In this paper, we present a new multi-focus microscope (MFM) system based on a phase mask and HiLo algorithm, achieving high-speed (20 volumes per second), high-resolution, low-noise 3-D fluorescent imaging. During imaging, the emissions from the specimen at nine different depths are simultaneously modulated and focused to different regions on a single CCD chip, i.e., the CCD chip is subdivided into nine regions to record images from the different selected depths. Next, HiLo algorithm is applied to remove the background noises and to form clean 3-D images. To visualize larger volumes, the nine layers are scanned axially, realizing fast 3-D imaging. In the imaging experiments, a mouse kidney sample of similar to 60 x 60 x 16 mu m(3) is visualized with only 10 raw images, demonstrating substantially enhanced resolution and contrast as well as suppressed background noises. The new method will find important applications in 3-D fluorescent imaging, e.g., recording fast dynamic events at multiple depths in vivo.	[Lin, Wei; Wang, Dongping; Meng, Yunlong; Chen, Shih-Chi] Chinese Univ Hong Kong, Dept Mech & Automat Engn, Shatin, Hong Kong, Peoples R China; [Lin, Wei] Nankai Univ, Inst Modern Opt, Tianjin Key Lab Optoelect Sensor & Sensing Networ, Tianjin, Peoples R China	Chinese University of Hong Kong; Nankai University	Chen, SC (corresponding author), Chinese Univ Hong Kong, Dept Mech & Automat Engn, Shatin, Hong Kong, Peoples R China.	scchen@mae.cuhk.edu.hk	Chen, Shih-Chi/T-2988-2019	Chen, Shih-Chi/0000-0002-4935-8412; Lin, Wei/0000-0001-9711-2022	HKSAR Research Grants Council (RGC) General Research Fund (GRF) [CUHK 14201214]; HKSAR Innovation and Technology Commission [ITS/428/17FP]	HKSAR Research Grants Council (RGC) General Research Fund (GRF); HKSAR Innovation and Technology Commission	This work was supported by HKSAR Research Grants Council (RGC) General Research Fund (GRF) (CUHK 14201214; to SCC); HKSAR Innovation and Technology Commission (ITS/428/17FP; to SCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson S, 2017, BIOMED OPT EXPRESS, V8, P4135, DOI 10.1364/BOE.8.004135; Abrahamsson S, 2016, BIOMED OPT EXPRESS, V7, P855, DOI 10.1364/BOE.7.000855; Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Blanchard PM, 2000, OPT COMMUN, V183, P29, DOI 10.1016/S0030-4018(00)00874-9; Brooker G, 2011, OPT EXPRESS, V19, P5047, DOI 10.1364/OE.19.005047; CARLSSON K, 1985, OPT LETT, V10, P53, DOI 10.1364/OL.10.000053; Chen HH, 2015, OPT EXPRESS, V23, P7075, DOI 10.1364/OE.23.007075; Chen X, 2011, P 24 IEEE C COMP VIS; Choi H, 2013, BIOMED OPT EXPRESS, V4, P995, DOI 10.1364/BOE.4.000995; Choi H, 2012, OPT EXPRESS, V20, P26219, DOI 10.1364/OE.20.026219; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Descloux A, 2018, NAT PHOTONICS, V12, P165, DOI 10.1038/s41566-018-0109-4; Di Leonardo R, 2007, OPT EXPRESS, V15, P1913, DOI 10.1364/OE.15.001913; Hajj B, 2014, P NATL ACAD SCI USA, V111, P17480, DOI 10.1073/pnas.1412396111; Hu LF, 2004, OPT EXPRESS, V12, P6403, DOI 10.1364/OPEX.12.006403; Humar M, 2015, NAT PHOTONICS, V9, P572, DOI [10.1038/nphoton.2015.129, 10.1038/NPHOTON.2015.129]; Jiang J, 2015, OPT EXPRESS, V23, P24362, DOI 10.1364/OE.23.024362; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Lin CY, 2016, BIOMED OPT EXPRESS, V7, P3968, DOI 10.1364/BOE.7.003968; Maurer C, 2010, OPT EXPRESS, V18, P3023, DOI 10.1364/OE.18.003023; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Michaelson J, 2012, BIOMED OPT EXPRESS, V3, P1241, DOI 10.1364/BOE.3.001241; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Olivier N, 2009, OPT LETT, V34, P1684, DOI 10.1364/OL.34.001684; Paddock SW, 2014, METHODS MOL BIOL, V1075, P9, DOI 10.1007/978-1-60761-847-8_2; Piestun R, 1996, J OPT SOC AM A, V13, P1837, DOI 10.1364/JOSAA.13.001837; Rosen J, 2008, NAT PHOTONICS, V2, P190, DOI 10.1038/nphoton.2007.300; Rosen J, 2014, OPT EXPRESS, V22, P29048, DOI 10.1364/OE.22.029048; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Zhang JZ, 2017, OPTICA, V4, P1306, DOI 10.1364/OPTICA.4.001306	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222729	10.1371/journal.pone.0222729	http://dx.doi.org/10.1371/journal.pone.0222729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539402	gold, Green Published			2022-12-27	WOS:000532297900026
J	Cohen, R; Gesser-Edelsburg, A; Singhal, A; Benenson, S; Moses, AE				Cohen, Ricky; Gesser-Edelsburg, Anat; Singhal, Arvind; Benenson, Shmuel; Moses, Allon E.			Deconstruction of central line insertion guidelines based on the positive deviance approach-Reducing gaps between guidelines and implementation: A qualitative ethnographic research	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CARE-ASSOCIATED INFECTIONS; FOR-DISEASE-CONTROL; HAND HYGIENE; PREVENTION; STRATEGIES; EDUCATION; UNITS	Background Despite a proven association between the implementation of prevention guidelines for central line associated blood stream infections (CLABSI) and reduction in CLABSI rates, in practice there is poor adherence. Furthermore, current guidelines fail to address the multiple process on the care continuum. This research is based on the bottom-up "Positive Deviance" (PD) approach, through which multiple creative and safer solutions for central line (CL) insertion were identified that were not previously described in the guidelines. The aim of the study was to deconstruct CLABSI prevention guidelines ("during insertion" process only) through the PD approach, working with physicians to identify additional actions that, in practice, help maintain a sterile environment and contribute to patient safety. Methods and findings Our study included a qualitative ethnographic study involving 76 physicians, working in a division of internal medicine and two intensive care units (ICUs). We triangulated findings from a combination of data-collection methods: semi-structured interviews, focused observations, video documentation, Discovery & Action Dialogue (DAD), and simulations. Deconstruction analysis was performed. A total of 23 creative extensions and variations of CL insertion practices were identified. Conclusions The PD approach enables the identification of vital nuggets of hidden wisdom missing from the formal explicit CLABSI guidelines, and therefore helps bridge the gap between theory and praxis. During the guideline's deconstruction process, through collaborative staff learning, the written procedure is transformed into a living, breathing and cooperative one. It can reduce hospital stays and save lives, and therefore needs careful attention of healthcare scholars and practitioners.	[Cohen, Ricky; Gesser-Edelsburg, Anat] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Gesser-Edelsburg, Anat] Univ Haifa, Hlth & Risk Commun Res Ctr, Haifa, Israel; [Singhal, Arvind] Univ Texas El Paso, Dept Commun, El Paso, TX 79968 USA; [Singhal, Arvind] Inland Univ Appl Sci, Sch Business & Social Sci, Elverum, Norway; [Benenson, Shmuel; Moses, Allon E.] Hadassah Hebrew Univ Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel; [Gesser-Edelsburg, Anat] Univ Haifa, Haifa, Israel; [Singhal, Arvind] Univ Texas El Paso, El Paso, TX 79968 USA; [Singhal, Arvind] Inland Univ Appl Sci, Elverum, Norway; [Benenson, Shmuel; Moses, Allon E.] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel	University of Haifa; University of Haifa; University of Texas System; University of Texas El Paso; Hebrew University of Jerusalem; University of Haifa; University of Texas System; University of Texas El Paso; Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, R (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	ricky.cohen83@gmail.com		Cohen, Ricky/0000-0003-2868-9666; Gesser-Edelsburg, PhD, Prof. Anat/0000-0003-4467-8799	Israel National Institute for Health Policy Research [2016\134\]; Israel National Institute for Health Policy Research	Israel National Institute for Health Policy Research; Israel National Institute for Health Policy Research	This work was supported by grant number 2016\134\. fromthe Israel National Institute for Health Policy Research to AGE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Adva Mir Halavi, Prof. Peter Vernon van Heerden, Dr. Sigal Sviri, Dr. Uriel Trahtemberg, Dr. Akiva Nahshon, Dr. Alexsi Vachadze, Dr. Efrat OrenbuchHarroch, Prof. Lior Lowenstein, Dr. Dan Shteinberg, Dr. Asher Salmon, Dr. Khitam Hussein, Dvora Kirshenbom, Gilat Yhye and Aviva Simhon who have participated in this study and the Israel National Institute for Health Policy Research for funding the research.	Baez S, 2017, AM J RESP CRIT CARE, V195; Ben-David D, 2019, INFECT CONT HOSP EP, V40, P1094, DOI 10.1017/ice.2019.190; Berenholtz SM, 2014, INFECT CONT HOSP EP, V35, P56, DOI 10.1086/674384; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Cartier V, 2016, EUR J ANAESTH, V33, P568, DOI 10.1097/EJA.0000000000000423; Centers for Disease Control and Prevention, 2017, REC US CHLORH IMPR D; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Clack L, 2018, BMJ QUAL SAF, V27, P771, DOI 10.1136/bmjqs-2017-007675; Cooke L, 2010, IEEE T PROF COMMUN, V53, P202, DOI 10.1109/TPC.2010.2052859; Creswell J.W., 2018, QUAL INQ, V4th; Dalton L, 2015, AUST J ADV NURS, V33, P29; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; European Commission, 2017, EUR COMM LAST VISIT; Furuya EY, 2016, INFECT CONT HOSP EP, V37, P805, DOI 10.1017/ice.2016.67; Gerolemou L, 2014, AM J CRIT CARE, V23, P40, DOI 10.4037/ajcc2014860; Gesser-Edelsburg A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0418-x; Glanz K, 2015, HLTH BEHAV HLTH ED T; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Herington MJ, 2018, DEVIANT BEHAV, V39, P664, DOI 10.1080/01639625.2017.1286194; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Ista E, 2016, LANCET INFECT DIS, V16, P724, DOI 10.1016/S1473-3099(15)00409-0; James W, 1975, MEANING TRUTH; Johnson Barbara, 1985, CRITICAL DIFFERENCE; Kahneman D., 2011, THINKING FAST SLOW; Kim J, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0672-7; Krein SL, 2015, BMJ QUAL SAF, V24, P385, DOI 10.1136/bmjqs-2014-003870; Latif A, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0491-8; Liang SY, 2011, ANN EMERG MED, V58, P447, DOI 10.1016/j.annemergmed.2011.07.035; Lindberg C, 2013, AM J INFECT CONTROL, V41, P513, DOI 10.1016/j.ajic.2012.07.015; Ling ML, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0116-5; Marschall J, 2014, INFECT CONT HOSP EP, V35, P753, DOI [10.1086/676533, 10.1017/S0899823X00193870]; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pasiechnik D, 2014, ASIA-PAC J CLIN ONCO, V10, P22; Patel PK, 2018, J HOSP MED, V13, P105, DOI 10.12788/jhm.2856; Pittet D., 2017, HAND HYGIENE HDB MED; SINGHAL A, 2009, E Y PERFORMANCE, V2, P78; Singhal A., 2014, INSPIRING CHANGE SAV; Singhal A., 2018, J DEV COMMUNICATION, V29, P34; Singhal A., 2014, HLTH COMMUNICATION S, V5, P176; Singhal A., 2010, INVITING EVERYONE HE; Slettli Victoria Konovalenko, 2017, Electronic Journal of Knowledge Management, V15, P17; Sreeramoju P, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy231; Srigley JA, 2015, J HOSP INFECT, V91, P202, DOI 10.1016/j.jhin.2015.06.019; State Comptroller, 2013, ANN CONTR REPORT63C; State of Israel Ministry of Health, 2016, ACQ INF REP YEAR 201; Suen Lee-Jen Wu, 2014, Hu Li Za Zhi, V61, P105, DOI 10.6224/JN.61.3.105; Tolley EE., 2016, QUALITATIVE METHODS; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Valencia C, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0139-y; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; WHO, 2009, GUIDE IMPLEMENTATION; Wolfreys J., 1998, DECONSTRUCTION DERRI; World Health Organization, 2009, WHO GUID HAND HYG HL; Yokoe DS, 2014, AM J INFECT CONTROL, V42, P820, DOI 10.1016/j.ajic.2014.07.002; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	58	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222608	10.1371/journal.pone.0222608	http://dx.doi.org/10.1371/journal.pone.0222608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536568	gold, Green Submitted, Green Published			2022-12-27	WOS:000532262800062
J	Hammond, CL; Roztocil, E; Phipps, RP; Feldon, SE; Woeller, CF				Hammond, Christine L.; Roztocil, Elisa; Phipps, Richard P.; Feldon, Steven E.; Woeller, Collynn F.			Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor	PLOS ONE			English	Article							TGF-BETA; LIVER FIBROSIS; ACTIVATION; OMEPRAZOLE; WNT; AHR; PHARMACEUTICALS; PATHOGENESIS; EXPRESSION; LIGANDS	Thyroid eye disease (TED) can lead to scar formation and tissue remodeling in the orbital space. In severe cases, the scarring process leads to sight-threatening pathophysiology. There is no known effective way to prevent scar formation in TED patients, or to reverse scarring once it occurs. In this study, we show that the proton pump inhibitors (PPIs), esomeprazole and lansoprazole, can prevent transforming growth factor beta (TGF beta)- mediated differentiation of TED orbital fibroblasts to myofibroblasts, a critical step in scar formation. Both PPIs prevent TGF beta- induced increases in alpha-smooth muscle actin (alpha SMA), calponin, and collagen production and reduce TED orbital fibroblast cell proliferation and migration. Esomeprazole and lansoprazole exert these effects through an aryl hydrocarbon receptor (AHR)-dependent pathway that includes reducing beta- catenin/Wnt signaling. We conclude that PPIs are potentially useful therapies for preventing or treating TED by reducing the myofibroblast accumulation that occurs in the disease.	[Hammond, Christine L.; Roztocil, Elisa; Feldon, Steven E.; Woeller, Collynn F.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA; [Phipps, Richard P.; Woeller, Collynn F.] Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Woeller, CF (corresponding author), Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA.; Woeller, CF (corresponding author), Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14627 USA.	Collynn_Woeller@urmc.rochester.edu		Woeller, Collynn/0000-0001-7197-5057; Feldon, Steven/0000-0003-0603-9312	National Institutes of Health [EY023239]; Research to Prevent Blindness; Rochester/Finger Lakes Eye Tissue Bank	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rochester/Finger Lakes Eye Tissue Bank	This research was supported by the National Institutes of Health Grants EY023239 to SEF, and an unrestricted grant from Research to Prevent Blindness and a research grant from the Rochester/Finger Lakes Eye & Tissue Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonson JMS, 2009, J LEADERSH STUD, V3, P17, DOI 10.1002/jls.20120; Bahn RS, 2015, HORM METAB RES, V47, P773, DOI 10.1055/s-0035-1555762; Bartalena L, 2013, EUR THYROID J, V2, P259, DOI 10.1159/000356042; Basu D, 2014, MOL CANCER THER, V13, P1457, DOI 10.1158/1535-7163.MCT-13-0918; Berardi RR, 2000, AM J MANAG CARE, V6, pS491; Brisebois S, 2018, LARYNGOSCOPE INVEST, V3, P457, DOI 10.1002/lio2.187; Bussman UA, 2008, BIOCHEM PHARMACOL, V76, P1165, DOI 10.1016/j.bcp.2008.08.019; Dik WA, 2016, EXP EYE RES, V142, P83, DOI 10.1016/j.exer.2015.02.007; Douglas RS, 2011, CURR OPIN OPHTHALMOL, V22, P385, DOI 10.1097/ICU.0b013e3283499446; Eltahir HM, 2018, BIOMED PHARMACOTHER, V97, P1356, DOI 10.1016/j.biopha.2017.11.028; Feng ST, 2016, ONCOL REP, V36, P3207, DOI 10.3892/or.2016.5154; Ghebremariam YT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0614-x; Ginter Anna, 2016, R I Med J (2013), V99, P26; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jeon KI, 2014, AM J PATHOL, V184, P1429, DOI 10.1016/j.ajpath.2014.01.026; Jin UH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-498; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Lehmann GM, 2011, AM J PATHOL, V178, P1556, DOI 10.1016/j.ajpath.2010.12.025; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Marcinkowski P, 2019, THYROID, V29, P111, DOI 10.1089/thy.2018.0349; Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012; Nelson C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00016; Nishi T, 2018, J PHARM PHARMACOL, V70, P383, DOI 10.1111/jphp.12870; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Roman AC, 2018, PHARMACOL THERAPEUT, V185, P50, DOI 10.1016/j.pharmthera.2017.12.003; Schluter A, 2018, CLIN EXP IMMUNOL, V191, P255, DOI 10.1111/cei.13075; Shivanna B, 2011, FREE RADICAL BIO MED, V51, P1910, DOI 10.1016/j.freeradbiomed.2011.08.013; Shivanna B, 2011, J PHARMACOL EXP THER, V339, P106, DOI 10.1124/jpet.111.182980; Smith Terry J, 2018, F1000Res, V7, P134, DOI 10.12688/f1000research.12787.1; Smith TJ, 2017, NEW ENGL J MED, V376, P1748, DOI 10.1056/NEJMoa1614949; Strand DS, 2017, GUT LIVER, V11, P27, DOI 10.5009/gnl15502; Sun ZR, 2014, INT J MOL MED, V33, P1097, DOI 10.3892/ijmm.2014.1672; WANDALL JH, 1992, GUT, V33, P617, DOI 10.1136/gut.33.5.617; Woeller CF, 2016, AM J PATHOL, V186, P3189, DOI 10.1016/j.ajpath.2016.08.017; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Yamashita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097419; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	45	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222779	10.1371/journal.pone.0222779	http://dx.doi.org/10.1371/journal.pone.0222779			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536596	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800084
J	Ingrasciotta, Y; Sultana, J; Giorgianni, F; Menditto, E; Scuteri, A; Tari, M; Tari, DU; Basile, G; Trifiro', G				Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Menditto, Enrica; Scuteri, Angelo; Tari, Michele; Tari, Daniele Ugo; Basile, Giorgio; Trifiro', Gianluca			Analgesic drug use in elderly persons: A population-based study in Southern Italy	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-PHARMACOLOGY; OLDER-ADULTS; INAPPROPRIATE; IMPACT; MANAGEMENT; MEDICINES; CRITERIA; RISK; PAIN	Introduction Analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs), weak and strong opioids are commonly used among elderly persons. The aim of this study was to describe the demographic and clinical characteristics of elderly analgesic users and to measure the frequency of analgesic use, including the frequency of potentially inappropriate analgesic use. Methods The Arianna database was used to carry out this study. This database contains prescription data with associated indication of use for 1,076,486 inhabitants registered with their general practitioners (GPs) in the Caserta Local Health Unit (Caserta district, Campania region in Italy). A cohort of persons aged.65 years old with > 1 year of database history having at least one analgesic drug (NSAIDs, strong or weak opioids) between 2010 and 2014 were identified. The date of the first analgesic prescription in the study period was considered the index date (ID). Results From a source population of 1,076,486 persons, 116,486 elderly persons were identified. Of these, 94,820 elderly persons received at least one analgesic drug: 36.6% were incident NSAID users (N = 36,629), while 13.2% were incident weak opioid users (N = 12,485) and 8.1% were incident strong opioid users (N = 7,658). In terms of inappropriate analgesic use, 9.2% (N = 10,763) of all elderly users were prescribed ketorolac/indomethacin inappropriately, since these drugs should not be prescribed to elderly persons. Furthermore, at least half all elderly persons with chronic kidney disease or congestive heart failure were prescribed NSAIDs, while these drugs should be avoided. Conclusion Analgesics are commonly used inappropriately among elderly persons, suggesting that prescribing practice in the catchment area may yet be improved.	[Ingrasciotta, Ylenia; Sultana, Janet; Basile, Giorgio; Trifiro', Gianluca] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Giorgianni, Francesco] AOU GMartino Hosp, Unit Clin Pharmacol, Messina, Italy; [Menditto, Enrica] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy; [Scuteri, Angelo] HSR Pisana IRCCS, Rome, Italy; [Tari, Michele; Tari, Daniele Ugo] Local Hlth Unit Caserta, Caserta, Italy; [Trifiro', Gianluca] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands	University of Messina; University of Naples Federico II; Erasmus University Rotterdam; Erasmus MC	Trifiro', G (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.; Trifiro', G (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	trifirog@unime.it	Sultana, Janet/Z-4817-2019; Tari, Daniele Ugo/AAY-8658-2021	Tari, Daniele Ugo/0000-0002-7312-419X; menditto, enrica/0000-0001-8633-5650; orlando, valentina/0000-0002-8209-8878; BASILE, Giorgio/0000-0002-0040-8618; SCUTERI, ANGELO/0000-0003-4784-5441; Sultana, Janet/0000-0001-9622-169X				Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Agenzia Italiana del Farmaco (AIFA-Italian Drug Agency), 2008, DOM RISP PRED DALL E; Bacchi S., 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P52; Blondell RD, 2013, AM FAM PHYSICIAN, V87, P766; Bruera Eduardo, 2015, Am Soc Clin Oncol Educ Book, pe593, DOI 10.14694/EdBook_AM.2015.35.e593; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Daoust R, 2018, CAN MED ASSOC J, V190, pE500, DOI 10.1503/cmaj.171286; European Medicines Agency (EMA), NIM SUMM; European Medicines Agency (EMA), QUEST ANSW REV ET CO; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Guerriero F, 2015, TRANSL MED UNISA, V13, P59; Ingrasciotta Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122899; Kaye AD, 2010, OCHSNER J, V10, P179; Kocoglu H, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/8419304; Lombardi N, 2019, CLIN DRUG INVEST, V39, P455, DOI 10.1007/s40261-019-00767-8; Marras F, 2016, CLIN CASES MINER BON, V13, P93, DOI 10.11138/ccmbm/2016.13.2.093; McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Musazzi UM, 2018, J PAIN RES, V11, P1665, DOI 10.2147/JPR.S163438; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Onder G, 2014, J GERONTOL A-BIOL, V69, P430, DOI 10.1093/gerona/glt118; Ripamonti C, 2006, SUPPORT CARE CANCER, V14, P400, DOI 10.1007/s00520-005-0918-0; Skolnick P, 2018, ANNU REV PHARMACOL, V58, P143, DOI 10.1146/annurev-pharmtox-010617-052534; Societa Italiana di Farmacologia, TRATT DOL CRON IT AP; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Sultana J, 2018, CLIN EPIDEMIOL, V10, P31, DOI 10.2147/CLEP.S145530; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; Ussai S, 2015, DRUG DES DEV THER, V9, P2073, DOI 10.2147/DDDT.S80686; Viola E, 2016, EXPERT OPIN DRUG SAF, V15, P61, DOI 10.1080/14740338.2016.1221401	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222836	10.1371/journal.pone.0222836	http://dx.doi.org/10.1371/journal.pone.0222836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536588	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800094
J	Liu, C; Han, XT; Li, ZX; Ha, JS; Peng, GK; Meng, W; He, MG				Liu, Chi; Han, Xiaotong; Li, Zhixi; Ha, Jason; Peng, Guankai; Meng, Wei; He, Mingguang			A self-adaptive deep learning method for automated eye laterality detection based on color fundus photography	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; SYSTEM	Purpose To provide a self-adaptive deep learning (DL) method to automatically detect the eye laterality based on fundus images. Methods A total of 18394 fundus images with real-world eye laterality labels were used for model development and internal validation. A separate dataset of 2000 fundus images with eye laterality labeled manually was used for external validation. A DL model was developed based on a fine-tuned Inception-V3 network with self-adaptive strategy. The area under receiver operator characteristic curve (AUC) with sensitivity and specificity and confusion matrix were applied to assess the model performance. The class activation map (CAM) was used for model visualization. Results In the external validation (N = 2000, 50% labeled as left eye), the AUC of the DL model for overall eye laterality detection was 0.995 (95% CI, 0.993-0.997) with an accuracy of 99.13%. Specifically for left eye detection, the sensitivity was 99.00% (95% CI, 98.11%-99.49%) and the specificity was 99.10% (95% CI, 98.23%-99.56%). Nineteen images were wrongly classified as compared to the human labels: 12 were due to human wrong labelling, while 7 were due to poor image quality. The CAM showed that the region of interest for eye laterality detection was mainly the optic disc and surrounding areas. Conclusion We proposed a self-adaptive DL method with a high performance in detecting eye laterality based on fundus images. Results of our findings were based on real world labels and thus had practical significance in clinical settings.	[Liu, Chi; Han, Xiaotong; Li, Zhixi; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Liu, Chi] Univ Technol, Sch Comp Sci, Sydney, NSW, Australia; [Ha, Jason] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Peng, Guankai; Meng, Wei] Guangzhou Healgoo Interact Med Technol Co Ltd, Guangzhou, Peoples R China; [He, Mingguang] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [He, Mingguang] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia	Sun Yat Sen University; University of Technology Sydney; Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China.; He, MG (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; He, MG (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	mingguang_he@yahoo.com	He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; Han, Xiaotong/0000-0001-6836-3447; Ha, Jason/0000-0003-3013-1469	National Key R&D Program of China [2018YFC0116500]; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province [2013B20400003]; University of Melbourne at Research Accelerator Program; CERA Foundation	National Key R&D Program of China; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province; University of Melbourne at Research Accelerator Program; CERA Foundation	This work was supported by the National KeyR&D Program of China (2018YFC0116500). MH receives support from the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province 2013B20400003. MH receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Center for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben G, 2015, KAGGLE DIABETIC RETI; Bottou Leon, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P421, DOI 10.1007/978-3-642-35289-8_25; Cuadros J, 2004, ST HEAL T, V107, P207; Ebner M, 2009, MACH VISION APPL, V20, P283, DOI 10.1007/s00138-008-0126-2; Maimo LF, 2018, IEEE ACCESS, V6, P7700, DOI 10.1109/ACCESS.2018.2803446; Grassmann F, 2018, OPHTHALMOLOGY, V125, P1410, DOI 10.1016/j.ophtha.2018.02.037; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Jang Y, 2018, J DIGITAL IMAGING; Jin GM, 2018, BRIT J OPHTHALMOL, V102, P625, DOI 10.1136/bjophthalmol-2017-310368; Kumar T, 2010, INT J COMPUTER APPL, V7, P7, DOI DOI 10.5120/1140-1493; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Liu SD, 2018, OPHTHALMOL GLAUCOMA, V1, P15, DOI 10.1016/j.ogla.2018.04.002; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Roy PK, 2016, 2016 INT C DIG IM CO; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tan NM, 2009, 13 INT C BIOM ENG 20; Ting DSW, 2018, NAT MED, V24, P539, DOI 10.1038/s41591-018-0029-3; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Wong TY, 2016, JAMA-J AM MED ASSOC, V316, P2366, DOI 10.1001/jama.2016.17563; YU XH, 1995, IEEE T NEURAL NETWOR, V6, P669, DOI 10.1109/72.377972; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222025	10.1371/journal.pone.0222025	http://dx.doi.org/10.1371/journal.pone.0222025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536537	Green Published, gold			2022-12-27	WOS:000532262800025
J	Moustafa, GA; Borkar, DS; Borboli-Gerogiannis, S; Greenstein, SH; Lorch, AC; Vasan, RA; Kloek, CE				Moustafa, Giannis A.; Borkar, Durga S.; Borboli-Gerogiannis, Sheila; Greenstein, Scott H.; Lorch, Alice C.; Vasan, Ryan A.; Kloek, Carolyn E.			Optimization of cataract surgery follow-up: A standard set of questions can predict unexpected management changes at postoperative week one	PLOS ONE			English	Article							UNTIL 2 WEEKS; RETINAL-DETACHMENT; COMPLICATIONS; SAFETY	Purpose There is limited evidence to inform the optimal follow-up schedule after cataract surgery. This study aims to determine whether a standardized question set can predict unexpected management changes (UMCs) at the postoperative week one (POW1) timepoint. Setting Massachusetts Eye and Ear, Harvard Medical School. Design Prospective cohort study. Methods Two-hundred-and-fifty-four consecutive phacoemulsification cases having attended an examination between postoperative days 5-14. A set of 7 'Yes' or 'No' questions were administered to all participants by a technician at the POW1 visit. Patient answers along with perioperative patient information were recorded and analyzed. Outcomes were the incidence of UMCs at POW1. Results The incidence of UMCs was zero in uneventful cataract cases with unremarkable history and normal postoperative day one exam if no positive answers were given with the question set demonstrating 100% sensitivity (p< 0.0001). A test version with 5 questions was equally sensitive in detecting UMCs at POW1 after cataract surgery. Conclusion In routine cataract cases with no positive answers to the current set of clinical questions, a POW1 visit is unlikely to result in a management change. This result offers the opportunity for eye care providers to risk-stratify patients who have had cataract surgery and individualize follow-up.	[Moustafa, Giannis A.; Borkar, Durga S.; Borboli-Gerogiannis, Sheila; Greenstein, Scott H.; Lorch, Alice C.; Vasan, Ryan A.; Kloek, Carolyn E.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA 02115 USA; [Borkar, Durga S.] Wills Eye Hosp & Res Inst, Retina Serv, Philadelphia, PA USA; [Kloek, Carolyn E.] Univ Oklahoma, Coll Med, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Jefferson University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kloek, CE (corresponding author), Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA 02115 USA.; Kloek, CE (corresponding author), Univ Oklahoma, Coll Med, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA.	carolynkloek@gmail.com		Lorch, Alice/0000-0003-4298-1428; Greensten, Scott/0000-0002-2229-5941; Moustafa, Giannis/0000-0002-8216-7108	American Society of Cataract and Refractive Surgeons, Fairfax, VA, USA	American Society of Cataract and Refractive Surgeons, Fairfax, VA, USA	This study was funded by a research grant from the American Society of Cataract and Refractive Surgeons (https://ascrs.org/), Fairfax, VA, USA (DSB, CEK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwitry A, 2006, EUR J OPHTHALMOL, V16, P554, DOI 10.1177/112067210601600409; An JA, 2014, J CATARACT REFR SURG, V40, P1857, DOI 10.1016/j.jcrs.2014.02.037; [Anonymous], 2016, AM ACAD OPHTHALMOLOG, V2016; [Anonymous], 2018, PROF OLD AM; [Anonymous], 2011, DAT COMP MED LEAD B; Borkar DS, 2018, AM J OPHTHALMOL; Borkar DS, 2018, J CATARACT REFRACT S; Clark A, 2011, OPHTHALMOLOGY, V118, P1055, DOI 10.1016/j.ophtha.2010.11.001; Du DY, 2014, OPHTHALMOLOGY, V121, P290, DOI 10.1016/j.ophtha.2013.07.016; Erie Jay C, 2006, Trans Am Ophthalmol Soc, V104, P167; Hermann Manuel Marcel, 2010, International Ophthalmology, V30, P385, DOI 10.1007/s10792-010-9362-3; HIKICHI T, 1994, AM J OPHTHALMOL, V117, P593, DOI 10.1016/S0002-9394(14)70065-0; Hoffman JJSL, 2016, INT J HEALTH CARE Q, V29, P407, DOI 10.1108/IJHCQA-08-2015-0096; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kessel L, 2015, J CATARACT REFR SURG, V41, P2755, DOI 10.1016/j.jcrs.2015.11.010; KRAFF MC, 1990, J CATARACT REFR SURG, V16, P477, DOI 10.1016/S0886-3350(13)80802-4; Lindstrom RL, 2017, CURR PHARM DESIGN, V23, P558, DOI 10.2174/1381612822666161129150628; Lois N, 2003, SURV OPHTHALMOL, V48, P467, DOI 10.1016/S0039-6257(03)00083-3; McKellar MJ, 2001, OPHTHALMOLOGY, V108, P930, DOI 10.1016/S0161-6420(00)00431-0; Okeke CO, 2009, OPHTHALMOLOGY, V116, P2286, DOI 10.1016/j.ophtha.2009.05.026; Portellos M, 1998, ARCH OPHTHALMOL-CHIC, V116, P449, DOI 10.1001/archopht.116.4.449; Saeed A, 2007, J CATARACT REFR SURG, V33, P1591, DOI 10.1016/j.jcrs.2007.05.022; Sanguansak T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8330; Tan JHY, 2000, EYE, V14, P53, DOI 10.1038/eye.2000.11; Tan P, 2014, INT J HEALTH CARE Q, V27, P347, DOI 10.1108/IJHCQA-11-2012-0120; Tinley CG, 2003, BRIT J OPHTHALMOL, V87, P1350, DOI 10.1136/bjo.87.11.1350; Tuft SJ, 2006, OPHTHALMOLOGY, V113, P650, DOI 10.1016/j.ophtha.2006.01.001; VINE AK, 1995, ARCH OPHTHALMOL-CHIC, V113, P1479; Westborg I, 2017, J CATARACT REFR SURG, V43, P1184, DOI 10.1016/j.jcrs.2017.06.042	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221243	10.1371/journal.pone.0221243	http://dx.doi.org/10.1371/journal.pone.0221243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536500	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800016
J	Sizmur, T; Campbell, L; Dracott, K; Jones, M; O'Driscoll, NJ; Gerwing, T				Sizmur, Tom; Campbell, Lily; Dracott, Karina; Jones, Megan; O'Driscoll, Nelson J.; Gerwing, Travis			Relationships between Potentially Toxic Elements in intertidal sediments and their bioaccumulation by benthic invertebrates	PLOS ONE			English	Article							SUNDERBAN MANGROVE WETLAND; HEAVY-METAL; PULP-MILL; NEREIS-DIVERSICOLOR; DISCONTINUITY ARPD; BIVALVE MOLLUSKS; COMMUNITY; ZINC; ESTUARINE; POLLUTION	The bioaccumulation of Potentially Toxic Elements (PTEs) by benthic invertebrates in estuarine sediments is poorly understood. We sampled and analysed PTEs in sediments and benthic invertebrates from five sites in the Skeena Estuary (British Columbia, Canada), including sites adjacent to an abandoned cannery and a decommissioned papermill. Our aim was to elucidate baseline levels of PTE concentrations at sites that may be recovering from disturbance associated with prior industrial development and identify organisms that could be used to biomonitor the impact of future industrial developments. There was no indication that sediments of the salmon cannery were polluted, but acidic sediments adjacent to the papermill contained elevated concentrations of Cd, Cr, Hg and Pb. Benthic invertebrate community assemblages confirm that sediments have mostly recovered from prior industrial development associated with discharge of papermill sludge. Overall, we did not observe any relationship between PTE concentrations in the sediment and PTE concentrations in invertebrate tissues. However, we did observe a negative relationship between sediment pH and the Biota-Sediment Accumulation Factor (BSAF) of most PTEs for Oregon pill bugs (Gnori-mosphaeroma oregonensis). G. oregonensis, observed at all sites, feeds on the fibers associated with the papermill discharge. Thus, G. oregonensis is a useful biomonitors for quantifying the impact of the decommissioned papermill, and are candidate biomonitors for assessing the impact of similar industrial development projects on intertidal ecosystems.	[Sizmur, Tom; Jones, Megan] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Campbell, Lily; Gerwing, Travis] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Dracott, Karina] Ocean Wise Conservat Assoc, North Coast Cetacean Res Initiat, Prince Rupert, BC, Canada; [O'Driscoll, Nelson J.] Acadia Univ, Dept Earth & Environm Sci, Wolfville, NS, Canada; [Gerwing, Travis] Univ Northern British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Reading; University of Victoria; Acadia University; University of Northern British Columbia	Sizmur, T (corresponding author), Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England.	t.sizmur@reading.ac.uk	Gerwing, Travis/AAU-6569-2020; Sizmur, Tom/F-4532-2018	Gerwing, Travis/0000-0002-4433-1843; Sizmur, Tom/0000-0001-9835-7195	Royal Geographical Society Environment and Sustainability Research Grant - Mitacs Elevate fellowship	Royal Geographical Society Environment and Sustainability Research Grant - Mitacs Elevate fellowship	This work was funded by a Royal Geographical Society Environment and Sustainability Research Grant awarded to TS and TG, https://www.rgs.org/in-the-field/in-the-fieldgrants/research-grants/environment-and-sustainability-research-grants/.TG was also funded by a Mitacs Elevate fellowship, https://www.mitacs.ca/en/programs/elevate.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akenhead S., 1992, REV OCEANOGRAPHY MAR; Allen L, 2019, APPL BIODIVERSITY IN; Alvarez MB, 2001, FRESEN J ANAL CHEM, V369, P81, DOI 10.1007/s002160000592; Amoozadeh E, 2014, ENVIRON SCI POLLUT R, V21, P2386, DOI 10.1007/s11356-013-1890-8; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1995, BS775532; Apler A, 2019, CHEMOSPHERE, V215, P470, DOI 10.1016/j.chemosphere.2018.10.010; Bard SM, 1998, WATER ENVIRON RES, V70, P108, DOI 10.2175/106143098X126955; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Burton ED, 2005, J ENVIRON QUAL, V34, P263, DOI 10.2134/jeq2005.0263; Cacador I, 2012, ECOL INDIC, V19, P184, DOI 10.1016/j.ecolind.2011.09.007; Carr-Harris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118988; Chakraborty P, 2012, CHEM GEOL, V294, P217, DOI 10.1016/j.chemgeo.2011.11.026; Chapman PM, 2005, INTEGR ENVIRON ASSES, V1, P163, DOI 10.1897/2005-013R.1; Ciutat A, 2003, ENVIRON TOXICOL CHEM, V22, P1574, DOI 10.1002/etc.5620220721; Clarke KR, 2015, PRIMER V7 USER MANUA; Cox KD, 2017, ECOL EVOL, V7, P11213, DOI 10.1002/ece3.3580; DelValls TA, 1998, TRAC-TREND ANAL CHEM, V17, P181, DOI 10.1016/S0165-9936(98)00017-X; EPA US, 1998, 7473SW846 EPA US; EPA US, 2007, 3051ASW846 EPA US; Faggetter BA, 2008, REV ENV SOCIOECONOMI; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Gerwing T. G., 2016, PRELIMINARY REPORT I; Gerwing TG, 2018, RESTORATION ECOLOGY, V27, P278; Gerwing TG, 2018, J NAT HIST, V52, P2833, DOI 10.1080/00222933.2018.1553249; Gerwing TG, 2018, MAR ECOL-EVOL PERSP, V39, DOI 10.1111/maec.12505; Gerwing TG, 2018, INT J SEDIMENT RES, V33, P149, DOI 10.1016/j.ijsrc.2017.09.001; Gerwing TG, 2017, INT J SEDIMENT RES, V32, P472, DOI 10.1016/j.ijsrc.2017.09.003; Gerwing TG, 2017, J SEA RES, V129, P22, DOI 10.1016/j.seares.2017.09.001; Gerwing TG, 2017, ESTUAR COAST, V40, P717, DOI 10.1007/s12237-016-0173-2; Gerwing TG, 2016, AUK, V133, P168, DOI 10.1642/AUK-15-176.1; Gerwing TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147098; Gerwing TG, 2015, NORTHEAST NAT, V22, P1, DOI 10.1656/045.022.m1201; Gesteira JLG, 2000, MAR POLLUT BULL, V40, P1017, DOI 10.1016/S0025-326X(00)00046-1; Guerra-Garcia J, 2004, HELGOLAND MAR RES, V58, P183, DOI 10.1007/s10152-004-0184-4; HC. Hatfield Consultants Ltd, 1994, SKEENA ENV EFFECTS M; Higgins RJ, 1973, 19731 DEP ENV FISH M; HILBORN R, 1977, J FISH RES BOARD CAN, V34, P64, DOI 10.1139/f77-007; Hoffman E, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5952-0; Hoos LM., 1975, 3 ENV CAN; HOWARD LS, 1983, MAR BIOL, V78, P87, DOI 10.1007/BF00392975; Kienle C, 2013, J SOIL SEDIMENT, V13, P1611, DOI 10.1007/s11368-013-0733-z; Kritzer JP, 2016, BIOSCIENCE, V66, P274, DOI 10.1093/biosci/biw014; LEONARDSSON K, 1993, AMBIO, V22, P359; Light SF, 2007, LIGHT SMITH MANUAL I; Luoma SN, 2017, HEAVY METALS MARINE, P51; Machado AAD, 2016, SCI TOTAL ENVIRON, V541, P268, DOI 10.1016/j.scitotenv.2015.09.045; Majer AP, 2014, MAR POLLUT BULL, V79, P321, DOI 10.1016/j.marpolbul.2013.12.015; McLaren P, 2016, J COASTAL RES, V32, P465, DOI 10.2112/JCOASTRES-D-15-00134.1; Monte MC, 2009, WASTE MANAGE, V29, P293, DOI 10.1016/j.wasman.2008.02.002; Moore JW, 2016, MAR ECOL PROG SER, V559, P201, DOI 10.3354/meps11933; Muller G., 1969, GEO J, V2, P108, DOI DOI 10.1055/S-2007-1023171; NIBR, 2006, VAL WILD SALM EC SKE, P1; Nriagu JO, 1988, CHROMIUM NATURAL HUM; Pagliosa PR, 2005, MAR ECOL-EVOL PERSP, V26, P246, DOI 10.1111/j.1439-0485.2005.00065.x; Pallabi Borah, 2018, Groundwater for Sustainable Development, V6, P189, DOI 10.1016/j.gsd.2018.01.002; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PEARSON T H, 1976, Ambio, V5, P77; PEARSON TH, 1972, PROC R SOC SER B-BIO, V180, P469, DOI 10.1098/rspb.1972.0032; Pourret O, 2018, SCI TOTAL ENVIRON, V610, P419, DOI 10.1016/j.scitotenv.2017.08.043; Rainbow PS, 1995, MAR POLLUT BULL, V31, P183, DOI 10.1016/0025-326X(95)00116-5; Riba I, 2004, ENVIRON TOXICOL CHEM, V23, P1100, DOI 10.1897/023-601; Saha M, 2006, ENVIRON INT, V32, P203, DOI 10.1016/j.envint.2005.08.012; SaizSalinas JI, 1997, MAR ECOL-P S Z N I, V18, P113, DOI 10.1111/j.1439-0485.1997.tb00431.x; Sarkar SK, 2008, CLEAN-SOIL AIR WATER, V36, P187, DOI 10.1002/clen.200700027; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schone BR, 2016, GLOBAL PLANET CHANGE, V144, P228, DOI 10.1016/j.gloplacha.2016.08.002; Scholz B, 2012, EUR J PHYCOL, V47, P120, DOI 10.1080/09670262.2012.665251; Sibley Paul K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P229, DOI 10.1023/A:1009987123319; Sizmur T, 2013, ENVIRON TOXICOL CHEM, V32, P1888, DOI 10.1002/etc.2264; Sizmur T, 2013, ENVIRON POLLUT, V176, P18, DOI 10.1016/j.envpol.2013.01.008; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Tuominen TM, 1992, CONSERVATION PROTECT; van Proosdij D, 2009, J COASTAL RES, P772; WALDICHUK M, 1962, J FISH RES BOARD CAN, V19, P1163, DOI 10.1139/f62-077; Wang XP, 2010, ENVIRON POLLUT, V158, P3065, DOI 10.1016/j.envpol.2010.06.034; Weimin Ying, 1992, Science of the Total Environment, V125, P67, DOI 10.1016/0048-9697(92)90383-4; WILKES B, 1991, PULP PAP-CANADA, V92, P20; Yunker MB, 2002, ENVIRON SCI TECHNOL, V36, P1869, DOI 10.1021/es0112893; Zhang C, 2014, ENVIRON INT, V73, P270, DOI 10.1016/j.envint.2014.08.010; Zhang W, 2019, SUSTAINABLE FOOD AND AGRICULTURE: AN INTEGRATED APPROACH, P137, DOI 10.1016/B978-0-12-812134-4.00008-X; Zuykov M, 2013, CHEMOSPHERE, V93, P201, DOI 10.1016/j.chemosphere.2013.05.001	82	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0216767	10.1371/journal.pone.0216767	http://dx.doi.org/10.1371/journal.pone.0216767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536494	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000532262800003
J	Vidotti, MS; Lyra, DH; Morosini, JS; Granato, ISC; Quecine, MC; de Azevedo, JL; Fritsche-Neto, R				Vidotti, Miriam Suzane; Lyra, Danilo Hottis; Morosini, Julia Silva; Granato, Italo Stefanine Correia; Quecine, Maria Carolina; de Azevedo, Joao Lucio; Fritsche-Neto, Roberto			Additive and heterozygous (dis)advantage GWAS models reveal candidate genes involved in the genotypic variation of maize hybrids to Azospirillum brasilense	PLOS ONE			English	Article							USE EFFICIENCY; ROOT-GROWTH; NITROGEN; ARABIDOPSIS; STRESS; ASSOCIATION; TOOL; INOCULATION; PROTEINS; WHEAT	Maize genotypes can show different responsiveness to inoculation with Azospirillum brasilense and an intriguing issue is which genes of the plant are involved in the recognition and growth promotion by these Plant Growth-Promoting Bacteria (PGPB). We conducted Genome-Wide Association Studies (GWAS) using additive and heterozygous (dis)advantage models to find candidate genes for root and shoot traits under nitrogen (N) stress and N stress plus A. brasilense. A total of 52,215 Single Nucleotide Polymorphism (SNP) markers were used for GWAS analyses. For the six root traits with significant inoculation effect, the GWAS analyses revealed 25 significant SNPs for the N stress plus A. brasilense treatment, in which only two were overlapped with the 22 found for N stress only. Most were found by the heterozygous (dis)advantage model and were more related to exclusive gene ontology terms. Interestingly, the candidate genes around the significant SNPs found for the maizeA. brasilense association were involved in different functions previously described for PGPB in plants (e.g. signaling pathways of the plant's defense system and phytohormone biosynthesis). Our findings are a benchmark in the understanding of the genetic variation among maize hybrids for the association with A. brasilense and reveal the potential for further enhancement of maize through this association.	[Vidotti, Miriam Suzane; Morosini, Julia Silva; Quecine, Maria Carolina; de Azevedo, Joao Lucio; Fritsche-Neto, Roberto] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Lyra, Danilo Hottis] Rothamsted Res, Harpenden, Herts, England; [Granato, Italo Stefanine Correia] French Natl Inst Agr Res, Montpellier, France	Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; INRAE	Vidotti, MS; Fritsche-Neto, R (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil.	miriamvidotti@usp.br; roberto.neto@usp.br	Fritsche-Neto, Roberto/B-2256-2013; Lyra, Danilo Hottis/L-8456-2014; Silva Morosini, Julia/D-5183-2018; Granato, Italo/F-2516-2014	Fritsche-Neto, Roberto/0000-0003-4310-0047; Silva Morosini, Julia/0000-0002-4106-6941; Verdi, Maria/0000-0002-9524-941X; Granato, Italo/0000-0003-2093-6810; Hottis Lyra, Danilo/0000-0002-2214-1555	Sao Paulo Research Foundation (FAPESP) [2015/01188-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; National Council Coordination for the Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council Coordination for the Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by Sao Paulo Research Foundation (FAPESP) process: 2015/01188-9, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001, and National Council Coordination for the Scientific and Technological Development (CNPq).	Al Abri MA, 2018, J EQUINE VET SCI, V60, P67, DOI 10.1016/j.jevs.2017.05.008; Cura JA, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bonnafous F, 2018, THEOR APPL GENET, V131, P319, DOI 10.1007/s00122-017-3003-4; Brien C, AUGMENTS USE ASREML; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Brusamarello-Santos LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174576; Butler D., 2009, ANAL MIXED MODELS S; Calzavara AK, 2018, PLANT BIOLOGY, V20, P870, DOI 10.1111/plb.12841; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Carvalho TLG, 2016, PLANT MOL BIOL, V90, P561, DOI 10.1007/s11103-016-0435-1; Cassan F, 2016, SOIL BIOL BIOCHEM, V103, P117, DOI 10.1016/j.soilbio.2016.08.020; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Chamam A, 2015, PLANTA, V242, P1439, DOI 10.1007/s00425-015-2382-5; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cheng P, 2017, THEOR APPL GENET, V130, P999, DOI 10.1007/s00122-017-2866-8; Cohen AC, 2009, BOTANY, V87, P455, DOI 10.1139/B09-023; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunha F. N., 2016, African Journal of Agricultural Research, V11, P3853; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Vita P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29020-6; Di Salvo LP, 2018, PLANT SOIL, V424, P405, DOI 10.1007/s11104-017-3548-7; Dicke M, 2016, CURR OPIN PLANT BIOL, V32, P17, DOI 10.1016/j.pbi.2016.05.004; Ding L, 2005, ANN BOT-LONDON, V96, P925, DOI 10.1093/aob/mci244; Ding L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01143; Ding YZ, 2017, PLANT PHYSIOL, V175, P1455, DOI 10.1104/pp.17.00879; Disi JO, 2018, ENTOMOL SCI, V21, P48, DOI 10.1111/ens.12280; Duca DR, 2018, ANTON LEEUW INT J G, V111, P1645, DOI 10.1007/s10482-018-1051-7; Fesel PH, 2016, CURR OPIN MICROBIOL, V32, P103, DOI 10.1016/j.mib.2016.05.008; Fukami J, 2018, ARCH MICROBIOL, V200, P1191, DOI 10.1007/s00203-018-1535-x; Fukami J, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0453-7; Fukami J, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-015-0171-y; Genissel A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01301; German MA, 2000, BIOL FERT SOILS, V32, P259, DOI 10.1007/s003740000245; Gomes EA, 2018, PHYTOBIOMES J, V2, P129, DOI 10.1094/PBIOMES-03-18-0012-R; Gopal M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01971; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Groszmann M, 2015, P NATL ACAD SCI USA, V112, pE6397, DOI 10.1073/pnas.1519926112; Hardoim PR, 2019, PLANT SOIL PLANT SOI, DOI [10.1007/s11104-019-03939-9, DOI 10.1007/S11104-019-03939-9]; Hohmann P, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1900-x; Hu XJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15985-3; Huh SU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00397; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kishor PBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00544; Klay I, 2018, PLANT SCI, V274, P137, DOI 10.1016/j.plantsci.2018.05.023; Ko DK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006197; Koo AJ, 2018, PHYTOCHEM REV, V17, P51, DOI 10.1007/s11101-017-9510-8; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kox MAR, 2016, PLANT SOIL, V406, P83, DOI 10.1007/s11104-016-2851-z; Lanes ECM, 2014, GENET MOL RES, V13, P7365, DOI 10.4238/2014.September.12.2; Lee YS, 2018, GENES GENOM, V40, P1331, DOI 10.1007/s13258-018-0728-7; Lehnert H, 2017, NEW PHYTOL, V215, P779, DOI 10.1111/nph.14595; Li H, 2017, NONPROFIT POLICY FOR, V8, P3, DOI 10.1515/npf-2016-0010; Li Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191321; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Liu X, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PGEN.1005767; Luo BW, 2015, EUPHYTICA, V206, P117, DOI 10.1007/s10681-015-1481-5; Martins MR, 2018, PLANT SOIL, V422, P239, DOI 10.1007/s11104-017-3193-1; Mendonca LD, 2017, SCI AGR, V74, P481, DOI [10.1590/1678-992x-2016-0313, 10.1590/1678-992X-2016-0313]; Mlodzinska E, 2015, PHYSIOL PLANTARUM, V154, P270, DOI 10.1111/ppl.12305; Monir MM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00627; Morosini JS, 2017, PLANT SOIL, V421, P453, DOI 10.1007/s11104-017-3479-3; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; Nogales A, 2016, BRIEF FUNCT GENOMICS, V15, P288, DOI 10.1093/bfgp/elv030; Oda Y, 2006, J PLANT RES, V119, P167, DOI 10.1007/s10265-006-0260-8; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Picard C, 2005, FEMS MICROBIOL ECOL, V53, P349, DOI 10.1016/j.femsec.2005.01.007; Picard C, 2006, FEMS MICROBIOL ECOL, V58, P193, DOI 10.1111/j.1574-6941.2006.00151.x; Pieterse CMJ, 2016, TRENDS PLANT SCI, V21, P171, DOI 10.1016/j.tplants.2016.01.018; Planchamp C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00719; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rai A, 2017, J PLANT NUTR, V40, P2237, DOI 10.1080/01904167.2016.1222419; Ristova D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2768; Rodrigues Neto J, 1986, SUMMA PHYTOPATHOL, V12, P32; Rosas JE, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.03.0029; Rosier A, 2016, PLANT MOL BIOL, V90, P537, DOI 10.1007/s11103-016-0433-3; Rozier C., 2016, METABOLOMICS LOS ANG, V6, P1; Rozier C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07929-8; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sharifi R, 2018, NEW PHYTOL, V220, P684, DOI 10.1111/nph.14955; Spaepen S, 2014, NEW PHYTOL, V201, P850, DOI 10.1111/nph.12590; Sun XH, 2018, PLANT SCI, V274, P32, DOI 10.1016/j.plantsci.2018.05.004; Timm C.M., 2016, FRONT PLANT SCI, V2016, P7, DOI DOI 10.3389/FPLS.2016.00497; Tivendale ND, 2014, TRENDS PLANT SCI, V19, P44, DOI 10.1016/j.tplants.2013.09.012; Trachsel S, 2013, FIELD CROP RES, V140, P18, DOI 10.1016/j.fcr.2012.09.010; Tsairidou S, 2018, ANIM GENET, V49, P103, DOI 10.1111/age.12637; Tsepilov YA, 2015, GENETICS, V200, P707, DOI 10.1534/genetics.115.175760; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Vidotti MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217571; Walker V, 2011, NEW PHYTOL, V189, P494, DOI 10.1111/j.1469-8137.2010.03484.x; Wallace JG, 2018, PHYTOBIOMES J, V2, P208, DOI 10.1094/PBIOMES-02-18-0008-R; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40239; Wang YK, 2016, BIOCHEM BIOPH RES CO, V470, P233, DOI 10.1016/j.bbrc.2016.01.043; Wintermans PCA, 2016, PLANT MOL BIOL, V90, P623, DOI 10.1007/s11103-016-0442-2; Xu W, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1760-0; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007019; Zeffa DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215332; Zeffa DM, 2018, BRAGANTIA, V77, P493, DOI 10.1590/1678-4499.2017273; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	104	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222788	10.1371/journal.pone.0222788	http://dx.doi.org/10.1371/journal.pone.0222788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536609	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800086
J	Kwong, RY; Heydari, B; Ge, Y; Abdullah, S; Fujikura, K; Kaneko, K; Harris, WS; Jerosch-Herold, M; Antman, EM; Seidman, JG; Pfeffer, MA				Kwong, Raymond Y.; Heydari, Bobak; Ge, Yin; Abdullah, Shuaib; Fujikura, Kana; Kaneko, Kyoichi; Harris, William S.; Jerosch-Herold, Michael; Antman, Elliott M.; Seidman, Jonathan G.; Pfeffer, Marc A.			Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial	PLOS ONE			English	Article							LIPID MEDIATORS; INFLAMMATION; HEART; RESOLVINS; RESOLUTION; CARE; N-3	Background The double-blind OMEGA-REMODEL placebo-controlled randomized trial of high-dose omega-3 fatty acids (O-3FA) post-acute myocardial infarction (AMI) reported improved cardiac remodeling and attenuation of non-infarct myocardial fibrosis. Fatty acid desaturase 2 (FADS2) gene cluster encodes key enzymes in the conversion of essential omega-3 and omega-6 fatty acids into active arachidonic (ArA) and eicosapentaenoic acids (EPA), which influence cardiovascular outcomes. Methods and results We tested the hypothesis that the genotypic status of FADS2 (rs1535) modifies therapeutic response of O-3FA in post-AMI cardiac remodeling in 312 patients. Consistent with known genetic polymorphism of FADS2, patients in our cohort with the guanine-guanine (GG) genotype had the lowest FADS2 activity assessed by arachidonic acid/linoleic acid (ArA/LA) ratio, compared with patients with the adenine-adenine (AA) and adenine-guanine (AG) genotypes (GG:1.62 +/- 0.35 vs. AA: 2.01 +/- 0.36, p< 0.0001; vs. AG: 1.76 +/- 0.35, p = 0.03). When randomized to 6-months of O-3FA treatment, GG patients demonstrated significant lowering of LV end-systolic volume index (LVESVi), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), and galectin-3 levels compared to placebo (-4.4 vs. 1.2 ml/m(2), -733 vs. -181 pg/mL, and -2.0 vs. 0.5 ng/mL; p = 0.006, 0.006, and 0.03, respectively). In contrast, patients with either AA or AG genotype did not demonstrate significant lowering of LVESVi, NT-proBNP, or galectin-3 levels from O-3FA treatment, compared to placebo. The odds ratios for improving LVESVi by 10% with O-3FA treatment was 7.2, 1.6, and 1.2 in patients with GG, AG, and AA genotypes, respectively. Conclusion Genetic profiling using FADS2 genotype can predict the therapeutic benefits of O-3FA treatment against adverse cardiac remodeling during the convalescent phase of AMI.	[Kwong, Raymond Y.; Ge, Yin; Abdullah, Shuaib; Fujikura, Kana; Kaneko, Kyoichi; Jerosch-Herold, Michael] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA; [Kwong, Raymond Y.; Ge, Yin; Abdullah, Shuaib; Fujikura, Kana; Kaneko, Kyoichi; Jerosch-Herold, Michael] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Kwong, Raymond Y.; Ge, Yin; Abdullah, Shuaib; Fujikura, Kana; Kaneko, Kyoichi; Antman, Elliott M.; Pfeffer, Marc A.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA; [Heydari, Bobak] Univ Calgary, Dept Med, Cardiovasc Div, Calgary, AB, Canada; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt LLC, Sioux Falls, SD USA; [Seidman, Jonathan G.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Calgary; University of South Dakota; Harvard University; Harvard Medical School	Kwong, RY (corresponding author), Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA.; Kwong, RY (corresponding author), Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.; Kwong, RY (corresponding author), Brigham & Womens Hosp, Dept Med, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	rykwong@bwh.harvard.org	Kwong, Raymond Y/R-1925-2016	Kwong, Raymond Y/0000-0001-8212-0759; Antman, Elliott/0000-0002-0808-9199; Fujikura, Kana/0000-0001-7610-850X	National Heart, Lung, and Blood Institute of the National Institutes of Health [NIH R01HL091157]; OmegaQuant Analytics funder	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OmegaQuant Analytics funder	The OMEGA-REMODEL study was funded entirely by the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH R01HL091157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OmegaQuant Analytics funder provided support in the form of salaries for author WSH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All other authors do not have any financial disclosures relevant to the content of this manuscript.	Bhatt AS, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0876-4; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Coelho OR, 2013, CIRC-CARDIOVASC IMAG, V6, P134, DOI 10.1161/CIRCIMAGING.112.979815; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Desta L, 2015, JACC-HEART FAIL, V3, P234, DOI 10.1016/j.jchf.2014.10.007; Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Gani OABSM, 2008, J MOL GRAPH MODEL, V27, P217, DOI 10.1016/j.jmgm.2008.04.008; Heydari B, 2016, CIRCULATION, V134, P378, DOI 10.1161/CIRCULATIONAHA.115.019949; Hu Y, 2016, HUM MOL GENET, V25, P1215, DOI 10.1093/hmg/ddw002; Hung J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000172; Jerosch-Herold M, 2008, AM J PHYSIOL-HEART C, V295, pH1234, DOI 10.1152/ajpheart.00429.2008; Jiang BB, 2010, J CARDIOVASC TRANSL, V3, P410, DOI 10.1007/s12265-010-9193-7; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Keyes KT, 2010, AM J PHYSIOL-HEART C, V299, pH153, DOI 10.1152/ajpheart.01057.2009; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; LEAF A, 1987, AM J CLIN NUTR, V45, P1048, DOI 10.1093/ajcn/45.5.1048; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Liu Y, 2011, HYPERTENS RES, V34, P630, DOI 10.1038/hr.2011.5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Sansbury BE, 2016, CIRC RES, V119, P113, DOI 10.1161/CIRCRESAHA.116.307308; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Zhao Y, 2004, J AM COLL NUTR, V23, P71, DOI 10.1080/07315724.2004.10719345	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222061	10.1371/journal.pone.0222061	http://dx.doi.org/10.1371/journal.pone.0222061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532795	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600020
J	Beenakker, JWM; Wezel, J; Groen, J; Webb, AG; Bornert, P				Beenakker, Jan-Willem M.; Wezel, Joep; Groen, Jan; Webb, Andrew G.; Boernert, Peter			Silent volumetric multi-contrast 7 Tesla MRI of ocular tumors using Zero Echo Time imaging	PLOS ONE			English	Article							ARRAY; BONE; LENS	Magnetic Resonance Imaging (MRI) has become a valuable imaging modality in ophthalmology, especially for the diagnosis and treatment planning of patients with uveal melanoma, the most common primary intra-ocular tumor. We aim to develop and evaluate the value of silent Zero Echo Time (ZTE) MRI to image patients with ocular tumors at 7Tesla. Therefore, ZTE and different types of magnetization-prepared ZTE (FLAIR, SPIR, T2 and Saturation recovery), have been developed. After an initial validation with 7 healthy subjects, nine patients with an eye tumor have been evaluated. The ZTE scans were compared to their Cartesian equivalent in terms of contrast, motion-sensitivity, diagnostic quality and patient comfort. All volunteers and especially the patients reported a more comfortable experience during the ZTE scans, which had at least a 10 dB lower sound pressure. The image contrast in the native ZTE was poor, but in the different magnetization-prepared ZTE, the eye lens, cornea and retina were clearly discriminated. Overall the T2-prepared scan yielded the best contrast, especially between tumor and healthy tissue, and proved to be robust against eye motion. Although the intrinsic 3D nature of the ZTE-technique provides an accurate analysis of the tumor morphology, the quality of the ZTE-images is lower than their Cartesian equivalent. In conclusion, the quality of magnetization-prepared ZTE images is sufficient to assess the 3D tumor morphology, but insufficient for more detailed evaluations. As such this technique can be an option for patients who cannot comply with the sound-levels of Cartesian scans, but for other patients the conventional Cartesian scans offer a better image quality.	[Beenakker, Jan-Willem M.; Wezel, Joep; Webb, Andrew G.; Boernert, Peter] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Beenakker, Jan-Willem M.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Groen, Jan] Philips Healthcare, Best, Netherlands; [Boernert, Peter] Philips Res Labs, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Philips; Philips Healthcare; Philips; Philips Research	Beenakker, JWM (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.; Beenakker, JWM (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.	J.W.M.Beenakker@LUMC.NL	Beenakker, Jan-Willem/AAD-7571-2022; Börnert, Peter/AAA-9380-2022	Beenakker, Jan-Willem/0000-0003-0479-5587; Bornert, Peter/0000-0001-9216-5117	Philips Healthcare	Philips Healthcare	Philips Healthcare provided support in the form of salaries for authors [JG, PB], but did not have any additional role in the study design, data collection or decision to publish. PB assisted with the analysis of the data and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	BALABAN R S, 1992, Magnetic Resonance Quarterly, V8, P116; Beenakker JWM, 2013, NMR BIOMED, V26, P1864, DOI 10.1002/nbm.3041; Beenakker JWM, 2016, MAGN RESON MATER PHY, V29, P571, DOI 10.1007/s10334-016-0529-4; Beenakker JWM, 2015, INVEST OPHTH VIS SCI, V56, P1033, DOI 10.1167/iovs.14-15161; Berkowitz BA, 2001, MAGN RESON MED, V46, P412, DOI 10.1002/mrm.1206; Bornert P, 2015, USING HIGH PERMITTIV, P55; BRITTAIN JH, 1995, MAGNET RESON MED, V33, P689, DOI 10.1002/mrm.1910330515; Dannels WR, 2009, MAGNETIC RESONANCE I; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; Diogo MC, 2016, AM J NEURORADIOL, V37, P2334, DOI 10.3174/ajnr.A4890; Ferreira TA, 2019, CANCERS, V11, DOI 10.3390/cancers11030377; Graessl A, 2014, INVEST RADIOL, V49, P260, DOI 10.1097/RLI.0000000000000049; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAFNER S, 1994, MAGN RESON IMAGING, V12, P1047, DOI 10.1016/0730-725X(94)91236-P; Horch RA, 2010, MAGN RESON MED, V64, P1652, DOI 10.1002/mrm.22558; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; Larson PEZ, 2016, MAGN RESON MATER PHY, V29, P359, DOI 10.1007/s10334-015-0509-0; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Richdale K, 2013, INVEST OPHTH VIS SCI, V54, P1095, DOI 10.1167/iovs.12-10619; Richdale K, 2009, J MAGN RESON IMAGING, V30, P924, DOI 10.1002/jmri.21959; Robson MD, 2006, NMR BIOMED, V19, P765, DOI 10.1002/nbm.1100; Schieban K, 2015, MAGN RESON MED, V74, P684, DOI 10.1002/mrm.25464; Weiger M, 2013, MAGN RESON MED, V70, P328, DOI 10.1002/mrm.24816; Wezel J, 2017, MAGN RESON MED, V78, P165, DOI 10.1002/mrm.26355; WONG STS, 1994, MAGNET RESON MED, V32, P778, DOI 10.1002/mrm.1910320614; Wu Y, 1998, CALCIFIED TISSUE INT, V62, P512	26	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222573	10.1371/journal.pone.0222573	http://dx.doi.org/10.1371/journal.pone.0222573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525248	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700038
J	Bezeng, BS; van der Bank, HF				Bezeng, Bezeng S.; van der Bank, Herman F.			DNA barcoding of southern African crustaceans reveals a mix of invasive species and potential cryptic diversity	PLOS ONE			English	Article							BALANUS-GLANDULA DARWIN; 1ST RECORD; PHYLOGENY; DECAPODA; IDENTIFICATION; EVOLUTION; ACCURACY; TREE	Globally, crustaceans represent one of the most taxonomically diverse and economically important invertebrate group. Notwithstanding, the diversity within this group is poorly known because most crustaceans are often associated with varied habits, forms, sizes and habitats; making species identification by conventional methods extremely challenging. In addition, progress towards understanding the diversity within this group especially in southern Africa has been severely hampered by the declining number of trained taxonomists, the presence of invasive alien species, over exploitation, etc. However, the advent of molecular techniques such as "DNA barcoding and Metabarcoding" can accelerate species identification and the discovery of new species. To contribute to the growing body of knowledge on crustacean diversity, we collected data from five southern African countries and used a DNA barcoding approach to build the first DNA barcode reference library for southern African crustaceans. We tested the reliability of this DNA barcode reference library to facilitate species identification using two approaches. We recovered high efficacy of specimen identification/discrimination; supported by both barcode gap and tree-base species identification methods. In addition, we identified alien invasive species and specimens with "no ID"in our DNA barcode reference library. The later; highlighting specimens requiring (i) further investigation and/or (ii) the potential presence of cryptic diversity or (iii) misidentifications. This unique data set although with some sampling gaps presents many opportunities for exploring the effect and extent of invasive alien species, the role of the pet trade as a pathway for crustacean species introduction into novel environments, sea food authentication, phylogenetic relationships within the larger crustacean groupings and the discovery of new species.	[Bezeng, Bezeng S.; van der Bank, Herman F.] Univ Johannesburg, African Ctr DNA Barcoding, Auckland Pk, Johannesburg, South Africa; [Bezeng, Bezeng S.] Univ Venda, Sch Math & Nat Sci, P Thohoyandou, Venda, South Africa; [Bezeng, Bezeng S.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Auckland Pk, Johannesburg, South Africa	University of Johannesburg; University of Venda; University of Johannesburg	Bezeng, BS (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, Auckland Pk, Johannesburg, South Africa.; Bezeng, BS (corresponding author), Univ Venda, Sch Math & Nat Sci, P Thohoyandou, Venda, South Africa.; Bezeng, BS (corresponding author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Auckland Pk, Johannesburg, South Africa.	bezengsimmy@gmail.com			Government of Canada through Genome Canada [2008-OGI-ICI-03]; Ontario Genomics Institute [2008-OGI-ICI-03]; National Research Foundation, South Africa [423 103944]	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	HFvdB is thankful to the Government of Canada through Genome Canada and the Ontario Genomics Institute for funding; grant number 2008-OGI-ICI-03. BSB and HFvdB are thankful to the National Research Foundation, South Africa for funding; grant number 423 103944.	Ahyong ST, 2007, MOL PHYLOGENET EVOL, V45, P576, DOI 10.1016/j.ympev.2007.03.022; Ahyong Shane T., 2009, Crustacean Issues, V18, P399; Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; AHYONG ST, 2006, ZOOTAXA 0117, P1; Bekker EI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161737; Bezeng BS, 2017, GENOME, V60, P629, DOI 10.1139/gen-2016-0198; Bracken Heather D., 2009, Arthropod Systematics & Phylogeny, V67, P99; Branch GM, 2010, 2 OCEANS GUIDE MARIN; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Bruce N, 2006, ARA ENCY NZ; Bucklin A, 2007, J PLANKTON RES, V29, P483, DOI 10.1093/plankt/fbm031; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Cawthorn DM, 2017, FOOD CONTROL, V73, P741, DOI 10.1016/j.foodcont.2016.09.027; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; De Grave S, 2009, RAFFLES B ZOOL, P1; Dixon CJ, 2003, CRUSTACEANA, V76, P935, DOI 10.1163/156854003771997846; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Griiths CL, 2018, FIELD GUIDE OFFSHORE, P133; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert P. D., 2017, 191619 BIORXIV, DOI [10. 1101/191619, DOI 10.1101/191619]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollatz C, 2017, GENOME, V60, P260, DOI 10.1139/gen-2015-0220; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Kerckhof F, 2018, BIOINVASIONS REC, V7, P21, DOI 10.3391/bir.2018.7.1.04; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuguru B, 2019, BIOINVASIONS REC, V8, P379, DOI 10.3391/bir.2019.8.2.19; Laird MC, 2008, AFR J MAR SCI, V30, P93, DOI 10.2989/AJMS.2008.30.1.9.459; Larsen BB, 2017, Q REV BIOL, V92, P229, DOI 10.1086/693564; Laverty C, 2015, MANAG BIOL INVASION, V6, P341, DOI 10.3391/mbi.2015.6.4.03; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nunes AL, 2017, AFR J AQUAT SCI, V42, P309, DOI 10.2989/16085914.2017.1405788; Petersen RM, 2017, KOEDOE, V59, DOI 10.4102/koedoe.v59i1.1435; Picker MD, 2011, ALIEN INVASIVE ANIMA; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poore GCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043529; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Schram FR, 2001, HYDROBIOLOGIA, V449, P1, DOI 10.1023/A:1017543712119; Shen H, 2013, MOL PHYLOGENET EVOL, V66, P776, DOI 10.1016/j.ympev.2012.11.002; Simon-Blecher N, 2008, AFR J MAR SCI, V30, P85, DOI 10.2989/AJMS.2008.30.1.8.458; Soltis PS, 2003, STAT SCI, V18, P256; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Toon Alicia, 2009, Crustacean Issues, V18, P15; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; Uderbayev T, 2017, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2017018; van der Bank H, 2015, ZOOKEYS, P15, DOI 10.3897/zookeys.481.8188; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Witt JDS, 2006, MOL ECOL, V172, P17; Yan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055854	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222047	10.1371/journal.pone.0222047	http://dx.doi.org/10.1371/journal.pone.0222047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525221	Green Published, gold, Green Submitted			2022-12-27	WOS:000532225700020
J	Li, J; Teng, Z; Weng, SC; Zhou, B; Turner, ER; Vinyard, BT; Luo, YG				Li, Jie; Teng, Zi; Weng, ShihChi; Zhou, Bin; Turner, Ellen R.; Vinyard, Bryan T.; Luo, Yaguang			Dynamic changes in the physicochemical properties of fresh-cut produce wash water as impacted by commodity type and processing conditions	PLOS ONE			English	Article							CROSS-CONTAMINATION; ORGANIC-COMPOUNDS; CHLORINE DEMAND; VEGETABLES; QUALITY; GUIDELINES; KINETICS; SURVIVAL	Organic materials in fresh-cut produce wash water deplete free chlorine that is required to prevent pathogen survival and cross-contamination. This research evaluated water quality parameters frequently used to describe organic load for their fitness to predict chlorine demand (CLD) and chemical oxygen demand (COD), which are major needs identified by the industry-led produce food safety taskforce. Batches of romaine lettuce, iceberg lettuce, or carrot of different cut sizes and shapes were washed in 40 liters of water. Physicochemical properties of wash water including CLD, COD, total organic carbon (TOC), total suspended solids (TSS), total dissolved solids (TDS), turbidity, total sugar content, and pH, were monitored. Results indicate that pH is primarily commodity dependent, while organic load is additionally impacted by cutting and washing conditions. Significant linear increases in COD, TOC, CLD, TDS, and turbidity resulted from increasing product-to-water ratio, and decreasing cut size. Physicochemical parameters, excluding pH, showed significant positive correlation across different cut sizes within a commodity. High correlations were obtained between CLD and COD and between COD and TOC for pooled products. The convenient measurement of TDS, along with its strong correlation with COD and CLD, suggests the potential of TDS for predicting organic load and chlorine reactivity. Finally, the potential application and limitation of the proposed models in practical produce processing procedures are discussed extensively.	[Li, Jie] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Peoples R China; [Li, Jie; Teng, Zi; Zhou, Bin; Turner, Ellen R.; Luo, Yaguang] ARS, USDA, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA; [Teng, Zi] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Weng, ShihChi] Johns Hopkins Univ, JHU MWH Alliance, 615 N Wolfe St, Baltimore, MD USA; [Vinyard, Bryan T.] ARS, Stat Grp, Northeast Area Off, USDA, Beltsville, MD USA	Huazhong Agricultural University; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Johns Hopkins University; United States Department of Agriculture (USDA)	Luo, YG (corresponding author), ARS, USDA, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA.	Yaguang.Luo@ars.usda.gov		Zhou, Bin/0000-0002-0315-8204; Turner, Ellen/0000-0003-1012-670X	USDA-NIFA (Specialty Crops Research Initiative Award) [2016-51181-25403]	USDA-NIFA (Specialty Crops Research Initiative Award)	This research was supported by USDA-NIFA (Specialty Crops Research Initiative Award No. 2016-51181-25403 to YL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletor O, 2002, FOOD CHEM, V78, P63, DOI 10.1016/S0308-8146(01)00376-4; Bornhorst ER, 2018, POSTHARVEST BIOL TEC, V146, P124, DOI 10.1016/j.postharvbio.2018.08.008; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Fadini PS, 2004, J BRAZIL CHEM SOC, V15, P131, DOI 10.1590/S0103-50532004000100020; Fan XT, 2015, POSTHARVEST BIOL TEC, V109, P65, DOI 10.1016/j.postharvbio.2015.06.009; Gazzola D, 2012, J AGR FOOD CHEM, V60, P10666, DOI 10.1021/jf302916n; Gombas D, 2017, J FOOD PROTECT, V80, P312, DOI 10.4315/0362-028X.JFP-16-258; Gomez-Lopez VM, 2013, FOOD CONTROL, V29, P42, DOI 10.1016/j.foodcont.2012.05.052; GORCHEV HG, 1984, WHO CHRON, V38, P104; Guerrero P, 2014, CARBOHYD POLYM, V111, P598, DOI 10.1016/j.carbpol.2014.05.005; Hach, 2015, 10223 HACH; Hach, 2014, 10236 HACH; Cardador MJ, 2012, J AGR FOOD CHEM, V60, P7326, DOI 10.1021/jf302591u; Kramer M, 2005, C APPL STAT AGR, DOI [10.4148/2475-7772.1142, DOI 10.4148/2475-7772.1142]; LECHEVALLIER MW, 1981, APPL ENVIRON MICROB, V42, P159, DOI 10.1128/AEM.42.1.159-167.1981; Leja M, 2013, PLANT FOOD HUM NUTR, V68, P163, DOI 10.1007/s11130-013-0351-3; Llorach R, 2008, FOOD CHEM, V108, P1028, DOI 10.1016/j.foodchem.2007.11.032; Luo YG, 2007, HORTSCIENCE, V42, P1413, DOI 10.21273/HORTSCI.42.6.1413; Luo YG, 2018, FOOD MICROBIOL, V70, P120, DOI 10.1016/j.fm.2017.09.013; Luo YG, 2012, INT J FOOD MICROBIOL, V158, P133, DOI 10.1016/j.ijfoodmicro.2012.07.008; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; Moda EM, 2005, SCI AGR, V62, P127, DOI 10.1590/S0103-90162005000200006; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Storey MV, 2011, WATER RES, V45, P741, DOI 10.1016/j.watres.2010.08.049; Teng Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208945; Toivonen PMA, 2013, POSTHARVEST BIOL TEC, V86, P192, DOI 10.1016/j.postharvbio.2013.06.035; US Environmental Protection Agency, 1971, 1602 US EPA; USDA, 2016, USDA NATL NUTRIENT D; Van Haute S, 2018, POSTHARVEST BIOL TEC, V142, P19, DOI 10.1016/j.postharvbio.2018.02.002; Van Haute S, 2013, APPL ENVIRON MICROB, V79, P2850, DOI 10.1128/AEM.03283-12; Weng SC, 2016, FOOD CONTROL, V60, P543, DOI 10.1016/j.foodcont.2015.08.031; Zhang BC, 2015, FOOD MICROBIOL, V49, P152, DOI 10.1016/j.fm.2015.01.013; Zhou B, 2014, J FOOD PROCESS PRES, V38, P2201, DOI 10.1111/jfpp.12200	34	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222174	10.1371/journal.pone.0222174	http://dx.doi.org/10.1371/journal.pone.0222174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557181	gold, Green Published			2022-12-27	WOS:000532345500014
J	Jouffroy, R; Lebreton, X; Mansencal, N; Anglicheau, D				Jouffroy, Romain; Lebreton, Xavier; Mansencal, Nicolas; Anglicheau, Dany			Acute kidney injury during an ultra-distance race	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; URINARY BIOMARKERS; PHYSICAL-ACTIVITY; RENAL-FAILURE; DISEASE; CALPROTECTIN; SURVIVORS; EXERCISE; OUTCOMES; RISK	Purpose Previous studies have noted consequences of ultra-distance trail running on health, but few studies are available regarding the temporal variations of renal biomarker injury during the running. The aim of this study was to assess the of kidney function parameters temporal variation during and on short-term after an ultra-distance race. Methods We performed an observational study with 47 subjects participating in an ultra-distance race (80 km). Urine (47 subjects) and blood (21 subjects) samples were serially collected before (baseline-km 0), during (21 and 53 km), on arrival (80 km), and 9 days after the race (d9). Results Mean serum creatinine increased during the race from 90 +/- 14 mu mol/L (km0) to 136 +/- 32 mu mol/L (km 80-p<0.0001) corresponding to a 52% increase. Mean creatininuria progressively increased from 4.7 +/- 4.5 mmol/L (km 0) to 22.8 +/- 12.0 mmol/L (km 80) (p<0.0001). Both urinary biomarkers (Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1) of acute kidney injury (AKI) progressively increased during the race (p<0.05 vs baseline). However, after adjustment to urine dilution by urine creatinine, no significant changes remained (p>0.05). On day 9, no significant difference remains in blood and urine biomarkers compared to their respective baseline levels. Conclusions During an ultra-distance race, despite an acute and transient increase in the serum creatinine levels, urinary biomarkers of AKI displayed only limited changes with a complete regression on day 9. These results suggest the absence of the short-term impact of an ultra-distance race kidney function.	[Jouffroy, Romain] Necker Enfants Malad Hosp, AP HP, Intens Care Unit, SAMU,Anesthesiol, Paris, France; [Jouffroy, Romain] McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Jouffroy, Romain] Populat Hlth Res Inst, Hamilton, ON, Canada; [Jouffroy, Romain] David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, Hamilton, ON, Canada; [Jouffroy, Romain] Fdn IMAGINE, Lab Cellular & Mol Mech Hematol Disorders & Thera, INSERM, U1163,ERL8254,CEREMAST, Paris, France; [Jouffroy, Romain] INSEP, IRMES Inst Res Med & Epidemiol Sport, Paris, France; [Lebreton, Xavier; Anglicheau, Dany] Sorbonne Paris Cite Univ, Necker Enfants Malad Inst,AP HP, French Natl Inst Hlth & Med Res U1151,Necker Hosp, Dept Nephrol & Kidney Transplantat,Paris Descarte, Paris, France; [Mansencal, Nicolas] Univ Versailles St Quentin UVSQ, Ambroise Pare Hosp, Assistance Publ Hop Paris AP HP, Dept Cardiol,Ctr Reference Cardiomyopathies & Tro, Boulogne, France; [Mansencal, Nicolas] UVSQ, INSERM, U1018, CESP,Team 5,EpReC,Renal & Cardiovasc Epidemiol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; McMaster University; Population Health Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Jouffroy, R (corresponding author), Necker Enfants Malad Hosp, AP HP, Intens Care Unit, SAMU,Anesthesiol, Paris, France.; Jouffroy, R (corresponding author), McMaster Univ, Fac Hlth Sci, Michael DeGroote Sch Med, Dept Anesthesia Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Jouffroy, R (corresponding author), Populat Hlth Res Inst, Hamilton, ON, Canada.; Jouffroy, R (corresponding author), David Braley Cardiac Vasc & Stroke Res Inst, Perioperat Med & Surg Res Unit, Hamilton, ON, Canada.; Jouffroy, R (corresponding author), Fdn IMAGINE, Lab Cellular & Mol Mech Hematol Disorders & Thera, INSERM, U1163,ERL8254,CEREMAST, Paris, France.; Jouffroy, R (corresponding author), INSEP, IRMES Inst Res Med & Epidemiol Sport, Paris, France.	romain.jouffroy@gmail.com	Mansencal, Nicolas/AAO-4549-2020	Jouffroy, Romain/0000-0003-2616-6132				Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Comassi M, 2015, INTERN MED J, V45, P74, DOI 10.1111/imj.12625; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Isshiki R, 2016, SHOCK, V46, P44, DOI 10.1097/SHK.0000000000000580; Jouffroy R, 2015, AM J CARDIOL, V116, P1284, DOI 10.1016/j.amjcard.2015.07.045; KALLMEYER JC, 1993, NEPHRON, V64, P119, DOI 10.1159/000187290; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Le Meur Y, 1998, AM J MED, V105, P251, DOI 10.1016/S0002-9343(98)00241-1; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lippi G, 2012, CLIN CHEM LAB MED, V50, P1585, DOI 10.1515/cclm-2011-0954; McCullough PA, 2011, NEPHROLOGY, V16, P194, DOI 10.1111/j.1440-1797.2010.01354.x; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Nikolaidis PT, 2018, CHINESE J PHYSIOL, V61, P85, DOI 10.4077/CJP.2018.BAG535; Oxborough D, 2011, CIRC-CARDIOVASC IMAG, V4, P253, DOI 10.1161/CIRCIMAGING.110.961938; Radak Z, 2003, EUR J CLIN INVEST, V33, P726, DOI 10.1046/j.1365-2362.2003.01202.x; Sato Y, 2003, EXP BIOL MED, V228, P1208, DOI 10.1177/153537020322801017; Sawhney S, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.019; Sawhney S, 2017, AM J KIDNEY DIS, V69, P18, DOI 10.1053/j.ajkd.2016.05.018; Schoenberg MH, 2016, VISC MED, V32, P199, DOI 10.1159/000446492; Scott JM, 2009, MED SCI SPORT EXER, V41, P25, DOI 10.1249/MSS.0b013e31818313ff; Seibert FS, 2013, ACTA PHYSIOL, V207, P700, DOI 10.1111/apha.12064; Seibert FS, 2018, KIDNEY BLOOD PRESS R, V43, P1255, DOI 10.1159/000492407; Seibert FS, 2017, TRANSPLANTATION, V101, P387, DOI 10.1097/TP.0000000000001124; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Tepel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113006; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Vaidya VS, 2008, CTS-CLIN TRANSL SCI, V1, P200, DOI 10.1111/j.1752-8062.2008.00053.x; van Zyl-Smit R, 2000, S AFR MED J, V90, P39; Vitiello D, 2013, MED SCI SPORT EXER, V45, P2072, DOI 10.1249/MSS.0b013e318298a585; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Westhoff JH, 2017, EUR J PEDIATR, V176, P745, DOI 10.1007/s00431-017-2907-y; Westhoff JH, 2016, PEDIATR NEPHROL, V31, P2353, DOI 10.1007/s00467-016-3418-1	41	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222544	10.1371/journal.pone.0222544	http://dx.doi.org/10.1371/journal.pone.0222544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553742	Green Published, gold			2022-12-27	WOS:000532319200031
J	Tenzin, S; Ogunniyi, AD; Khazandi, M; Ferro, S; Bartsch, J; Crabb, S; Abraham, S; Deo, P; Trott, DJ				Tenzin, Sangay; Ogunniyi, Abiodun David; Khazandi, Manouchehr; Ferro, Sergio; Bartsch, Jonathon; Crabb, Simon; Abraham, Sam; Deo, Permal; Trott, Darren J.			Decontamination of aerosolised bacteria from a pig farm environment using a pH neutral electrochemically activated solution (Ecas4 anolyte)	PLOS ONE			English	Article							ACIDIC ELECTROLYZED WATER; RESPIRATORY-DISEASES; RISK-FACTORS; EFFICACY; DISINFECTION; RESISTANCE	An electrochemically activated solution (ECAS), generated by electrolysis of a dilute sodium chloride solution in a four-chamber electrolytic cell (Ecas4), was tested as a sanitising aerosol in eliminating bacteria from the environment of a weaning room vacated 24-48h earlier, at a continuous flow pig farm. An ultrasonic humidifier was used to fill the environment with a fog (droplets with diameters of 1-5 mu m) containing 0.25 ppm of hypochlorous acid. The weaning room was fogged for 3 min at 30 min intervals during five hours of aerosol disinfection. An innovative sample treatment with propidium monoazide dye in conjunction with cyclonic air sampling was optimised and adapted for discerning live/dead bacteria in subsequent molecular quantification steps. Without fogging, total bacterial load ranged from 5.06 +/- 0.04 to 5.75 +/- 0.04 Log(10) CFU/m(3). After the first hour of fogging, a 78% total bacterial reduction was observed, which further increased to > 97% after the second hour, > 99.4% after the third and 99.8% after the fourth hour, finally resulting in a 99.99% reduction from the farm environment over five hours. Unlike the current formaldehyde spray disinfection protocol, which requires a long empty period because of its hazardous properties, this economically viable and environmentally friendly disinfection protocol may significantly lower downtime. Moreover, ECAS fogging can be easily adapted to a variety of applications, including the elimination of pathogens from livestock farm air environment for disease prevention, as well as decontamination after disease outbreaks.	[Tenzin, Sangay; Ogunniyi, Abiodun David; Khazandi, Manouchehr; Trott, Darren J.] Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Ferro, Sergio; Crabb, Simon] Ecas4 Australia Pty Ltd, Mile End South, SA, Australia; [Bartsch, Jonathon] Dr Barry Lloyd Pty Ltd, Gawler, SA, Australia; [Abraham, Sam] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Deo, Permal] Univ South Australia, Sch Pharm & Med Sci, City East Campus,Playford P1-25, Adelaide, SA, Australia	University of Adelaide; Murdoch University; University of South Australia	Tenzin, S; Trott, DJ (corresponding author), Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia.	sangay.tenzin@adelaide.edu.au; darren.trott@adelaide.edu.au	Deo, Permal/S-3304-2019; Khazandi, Manouchehr/ABC-5930-2020; Ferro, Sergio/AAG-8572-2019	Deo, Permal/0000-0002-6477-9127; Ferro, Sergio/0000-0003-0797-795X; Tenzin, Sangay/0000-0002-1662-362X; Ogunniyi, Abiodun/0000-0001-9308-5629; Abraham, Sam/0000-0003-0950-2317	Pork CRC innovation project [2C-121]; Endeavour Postgraduate Scholarship	Pork CRC innovation project; Endeavour Postgraduate Scholarship	This project was funded by the Pork CRC innovation project no. 2C-121. Sangay Tenzin is supported by Endeavour Postgraduate Scholarship.	Ahmed MFE, 2013, ANN AGR ENV MED, V20, P16; [Anonymous], 2018, VET08ED42018 CLSI S; Bilic Vitomir, 2000, Arhiv za Higijenu Rada i Toksikologiju, V51, P199; Chapman JS, 2003, INT BIODETER BIODEGR, V51, P271, DOI 10.1016/S0964-8305(03)00044-1; DONHAM KJ, 1991, AM J VET RES, V52, P1723; Fablet C, 2012, PREV VET MED, V104, P271, DOI 10.1016/j.prevetmed.2011.11.012; Ferro S, 2018, FOOD CONTROL, V91, P321, DOI 10.1016/j.foodcont.2018.04.016; FOTHERINGHAM VJC, 1995, REV SCI TECH OIE, V14, P191, DOI 10.20506/rst.14.1.833; Gardner Ian A., 2002, Animal Health Research Reviews, V3, P43; Hao JX, 2011, J FOOD SAFETY, V31, P28, DOI 10.1111/j.1745-4565.2010.00261.x; Ichihara T, 2004, JPN J THORAC SURG, V57, P1110; Jirawattanapong P, 2010, RES VET SCI, V88, P11, DOI 10.1016/j.rvsc.2009.06.007; Khazandi M, 2017, FOOD MICROBIOL, V68, P51, DOI 10.1016/j.fm.2017.06.008; Koide S, 2009, FOOD CONTROL, V20, P294, DOI 10.1016/j.foodcont.2008.05.019; Lee S, 2018, MICROB BIOTECHNOL, V11, P1008, DOI 10.1111/1751-7915.13039; Loughlin MF, 2002, J ANTIMICROB CHEMOTH, V49, P631, DOI 10.1093/jac/49.4.631; Marenda M, 2014, REAL TIME DETECTION; Meakin NS, 2012, J HOSP INFECT, V80, P122, DOI 10.1016/j.jhin.2011.10.015; Michiels A, 2015, PREV VET MED, V121, P99, DOI 10.1016/j.prevetmed.2015.06.011; Migliarina F, 2014, HEALTHCARE, V2, P516, DOI 10.3390/healthcare2040516; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NICKLAS W, 1981, ZBL BAKT MIK HYG B, V173, P374; Ohno H, 2000, SURG TODAY, V30, P1055, DOI 10.1007/s005950070035; Ozer NP, 2006, J FOOD ENG, V72, P234, DOI 10.1016/j.jfoodeng.2004.11.038; Paola LD, 2006, WOUNDS, V18, P262; Popescu S., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P182; Prilutsky V, 1997, VNIII MED ENG; Rahman SME, 2010, FOOD CONTROL, V21, P1383, DOI 10.1016/j.foodcont.2010.03.011; Safe Work Australia, 2019, WORKPL EXP STAND AIR; Sahibzada S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04789-0; Schaller A, 2001, VET MICROBIOL, V79, P47, DOI 10.1016/S0378-1135(00)00345-X; Stark KDC, 1998, NEW ZEAL VET J, V46, P3, DOI 10.1080/00480169.1998.36043; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Tanaka N, 1999, ARTIF ORGANS, V23, P1055, DOI 10.1046/j.1525-1594.1999.06224.x; Thorn RMS, 2012, EUR J CLIN MICROBIOL, V31, P641, DOI 10.1007/s10096-011-1369-9; Wang HH, 2019, FOOD CONTROL, V95, P50, DOI 10.1016/j.foodcont.2018.07.049; Zinkevich V, 2000, J HOSP INFECT, V46, P153, DOI 10.1053/jhin.2000.0819	37	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222765	10.1371/journal.pone.0222765	http://dx.doi.org/10.1371/journal.pone.0222765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF5PI	31553747	Green Published, Green Accepted, gold			2022-12-27	WOS:000509293500001
J	Awenat, YF; Peters, S; Gooding, PA; Pratt, D; Huggett, C; Harris, K; Armitage, CJ; Haddock, G				Awenat, Yvonne F.; Peters, Sarah; Gooding, Patricia A.; Pratt, Daniel; Huggett, Charlotte; Harris, Kamelia; Armitage, Christopher J.; Haddock, Gillian			Qualitative analysis of ward staff experiences during research of a novel suicide-prevention psychological therapy for psychiatric inpatients: Understanding the barriers and facilitators	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; OF-THE-LITERATURE; PSYCHOSOCIAL INTERVENTIONS; PLANNED BEHAVIOR; SELF-HARM; IMPLEMENTATION; DISSEMINATION; PSYCHOTHERAPY; EXPECTATIONS; INTERVIEWS	Background Suicide prevention is a global priority. Psychiatric hospitalization presents an opportunity to intervene positively with, for example, psychological therapies. However, evidenced-based suicide-prevention psychological treatments are rarely available on in-patient wards. Understanding staff engagement with research investigating suicide-prevention psychological treatments is crucial for their effective, efficacious, and pragmatic implementation. A pilot randomised control trial and feasibility study of Cognitive Behavioural Suicide Prevention therapy provided the opportunity for a qualitative investigation of staff experiences and views of a psychological intervention for people with suicidal experiences on psychiatric inpatient wards. Aims To investigate staff acceptability of Cognitive Behavioural Suicide Prevention therapy for psychiatric inpatients based on their perceptions of their experiences during the conduct of a clinical trial. Method Transcribed audio-recordings of qualitative interviews and a focus group (n = 19) of purposively sampled staff from eight psychiatric wards were analysed using inductive Thematic Analysis. Results Facilitators and barriers were identified for: i) the conduct of the research, and, ii) the suicide-prevention intervention (Cognitive Behavioural Suicide Prevention therapy). Researchrelated barriers comprised communication difficulties between staff and researchers, and increased staff workload. Research-related facilitators included effective staff/researcher relationships, and alignment of the intervention with organisational goals. Suicide-prevention intervention-related barriers comprised staffs' negative beliefs about suicide which impacted on their referral of inpatients to the clinical trial, and staff perceptions of insufficient information and unfulfilled expectations for involvement in the therapy. Facilitators included staff beliefs that the therapy was beneficial for inpatients, the service and their own clinical practice. Conclusions Staff beliefs that 'suicide-talk' could precipitate suicidal behaviour resulted in covert gatekeeping and restricted referral of only inpatients judged as stable or likely to engage in therapy, which may not be those who could most benefit. Such threats to sample representativeness have implications for future therapy research design. The findings provide novel information for researchers and practitioners regarding the conduct of psychological treatment and research in psychiatric units.	[Awenat, Yvonne F.; Peters, Sarah; Gooding, Patricia A.; Pratt, Daniel; Huggett, Charlotte; Harris, Kamelia; Armitage, Christopher J.; Haddock, Gillian] Univ Manchester, Div Psychol & Mental Hlth, Sch Hlth Sci, Fac Biol Med & Hlth Sci, Manchester, Lancs, England; [Awenat, Yvonne F.; Peters, Sarah; Gooding, Patricia A.; Pratt, Daniel; Huggett, Charlotte; Harris, Kamelia; Haddock, Gillian] MAHSC, Manchester, Lancs, England; [Awenat, Yvonne F.; Peters, Sarah; Gooding, Patricia A.; Pratt, Daniel; Huggett, Charlotte; Harris, Kamelia; Haddock, Gillian] Greater Manchester Mental Hlth NHS Fdn Trust, Manchester, Lancs, England; [Peters, Sarah; Armitage, Christopher J.] Univ Manchester, Manchester Ctr Hlth Psychol, Div Psychol & Mental Hlth, Sch Hlth Sci,Fac Biol Med & Hlth Sci, Manchester, Lancs, England; [Armitage, Christopher J.] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester	Awenat, YF (corresponding author), Univ Manchester, Div Psychol & Mental Hlth, Sch Hlth Sci, Fac Biol Med & Hlth Sci, Manchester, Lancs, England.; Awenat, YF (corresponding author), MAHSC, Manchester, Lancs, England.; Awenat, YF (corresponding author), Greater Manchester Mental Hlth NHS Fdn Trust, Manchester, Lancs, England.	Yvonne.awenat@manchester.ac.uk	Huggett, Charlotte/AAB-5454-2020; Pratt, Daniel/O-9490-2015	Huggett, Charlotte/0000-0002-7566-6224; Haddock, Professor Gillian/0000-0001-6234-5774; Pratt, Daniel/0000-0001-8843-1224; Awenat, Yvonne/0000-0002-0767-4994; Armitage, Christopher/0000-0003-2365-1765; Harris, Kamelia/0000-0003-2806-1262	National Institute for Health Research (NIHR) [PB-PG-1111-26026]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme, Grant Reference Number PB-PG-1111-26026 (https://www.nihr.ac.uk/funding-and-support/funding-for-researchstudies/funding-programmes/research-for-patient-benefit/) to YA,SP,GH,DP,PG. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 2005, CHILD ADOL PSYCH CL, V14, P255, DOI 10.1016/j.chc.2004.04.008; Aarons Gregory A, 2006, Psychol Serv, V3, P61; Ajzen I., 1985, ACTION CONTROL, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Appleby L, 2006, AVOIDABLE DEATHS 5 Y; Armitage CJ, 2016, BRIT J PSYCHIAT, V208, P470, DOI 10.1192/bjp.bp.114.162495; Armitage CJ, 2015, ANN BEHAV MED, V49, P239, DOI 10.1007/s12160-014-9653-4; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Awenat Y, 2017, BRIT J PSYCHIAT, V211, P103, DOI 10.1192/bjp.bp.116.191817; Awenat YF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1921-6; Borschmann R, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-23; Bowers L, 2005, J Psychiatr Ment Health Nurs, V12, P231, DOI 10.1111/j.1365-2850.2004.00825.x; Bowers L., 2009, J MENTAL HLTH, V14, P625; Bowers L, 2015, INT J NURS STUD, V52, P1412, DOI 10.1016/j.ijnurstu.2015.05.001; Braun V., 2022, THEMATIC ANAL PRACTI; Braun V., 2012, APA HDB RES METHODS, V2, DOI 10.1037/1362-004; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brown CH, 2017, ANNU REV PUBL HEALTH, V38, P1, DOI 10.1146/annurev-publhealth-031816-044215; Bucci S, 2015, PSYCHOL PSYCHOTHER-T, V88, P335, DOI 10.1111/papt.12042; Cleary Michelle, 2011, Issues Ment Health Nurs, V32, P424, DOI 10.3109/01612840.2011.563339; Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106; Cooksey D., 2006, REV UK HLTH RES FUND; Crewe Dixon Thomas, 2016, Method Innov, V9, DOI 10.1177/2059799115622751; Dazzi T, 2014, PSYCHOL MED, V44, P3361, DOI 10.1017/S0033291714001299; Department of Health. DH, 2016, 5 YEAR FORW VIEW MEN; Dey I., 1999, GROUNDING GROUNDED T; DH, 2012, PREV SUIC ENGL CROSS; Durrant C, 2007, CLIN PSYCHOL PSYCHOT, V14, P117, DOI 10.1002/cpp.516; Finlay L., QUALITATIVE RES, V2, P209; Flood C, 2006, J PSYCHIATR MENT HLT, V13, P260, DOI 10.1111/j.1365-2850.2006.00932.x; Gotham HJ, 2004, CLIN PSYCHOL-SCI PR, V11, P160, DOI 10.1093/clipsy/bph067; Haddock G., 2014, PBPG111126026 NIHR; Haddock G., 2004, J MENTAL HLTH, V23, P162; Haddock G., 2019, BRIT J PSYHCIAT OPEN, V5, DOI [10.1192/bjo.2018.85, DOI 10.1192/BJO.2018.85]; Hawton K, 2017, BRIT J PSYCHIAT, V210, P381, DOI 10.1192/bjp.bp.116.197459; Hawton K, 2016, LANCET PSYCHIAT, V3, P740, DOI 10.1016/S2215-0366(16)30070-0; Hellawell D, 2006, TEACH HIGH EDUC, V11, P483, DOI 10.1080/13562510600874292; Heneghan C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1870-2; Herbert JD, 2015, J CONTEXT BEHAV SCI, V4, P225, DOI 10.1016/j.jcbs.2014.11.005; Holmes J., 2002, PSYCHIATRIC B, V26, P383, DOI [DOI 10.1192/PB.26.10.383, 10.1192/pb.26.10.383]; Hurley J, 2008, NURS INQ, V15, P199, DOI 10.1111/j.1440-1800.2008.00412.x; James K, 2012, INT J MENT HEALTH NU, V21, P301, DOI 10.1111/j.1447-0349.2011.00794.x; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Laker C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-23; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Large MM, 2017, BJPSYCH OPEN, V3, P102, DOI 10.1192/bjpo.bp.116.004309; Lovell K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201533; Madill A, 2000, BRIT J PSYCHOL, V91, P1, DOI 10.1348/000712600161646; Mairs H, 2012, INT J MENT HEALTH NU, V21, P138, DOI 10.1111/j.1447-0349.2011.00770.x; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Martelli C, 2010, ENCEPHALE, V36, pD83, DOI 10.1016/j.encep.2009.06.011; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCann E, 2005, J Psychiatr Ment Health Nurs, V12, P215, DOI 10.1111/j.1365-2850.2004.00822.x; Medical Research Council. UK. MRC, 2008, DEV EV COMPL INT NEW; Mullen A, 2009, INT J MENT HEALTH NU, V18, P83, DOI 10.1111/j.1447-0349.2008.00578.x; Munk-Jorgensen P, 2015, ACTA PSYCHIAT SCAND, V132, P441, DOI 10.1111/acps.12512; National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH), 2013, ANN REPORT; National Institute for Clinical Excellence (NICE), 2011, SELF HARM LONG TERM; National Institute for Health & Care Excellence. (NICE), 2004, 162004 NICE CG; O'Connor RC, 2003, CURR PSYCHOL, V22, P196, DOI 10.1007/s12144-003-1016-4; Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4; Rapp CA, 2010, COMMUNITY MENT HLT J, V46, P112, DOI 10.1007/s10597-009-9238-z; Retsas A, 2000, J ADV NURS, V31, P599, DOI 10.1046/j.1365-2648.2000.01315.x; Ritchie J, 2014, QUALITATIVE RES PRAC, V2nd; Rycroft-Malone J, 2004, J CLIN NURS, V13, P913, DOI 10.1111/j.1365-2702.2004.01007.x; Sibbald B, 1998, BRIT MED J, V316, P201; Stavrou S, 2009, BRIT J GEN PRACT, V59, P656, DOI 10.3399/bjgp09X454089; Stirman SW, 2011, SUICIDE LIFE-THREAT, V41, P203, DOI 10.1111/j.1943-278X.2010.00011.x; Tarrier N., 2013, COGNITIVE BEHAV PREV, DOI 10.4324/9780203066881; Tashakkori A., 1998, MIXED METHODOLOGY CO; The National Confidential Inquiry into Suicide and Homicide by People with Mental Illness, 2016, MAK MENT HLTH CAR SA; The National Confidential Inquiry into Suicide and Safety in Mental Health, 2018, ANN REP ENGL NO IR S; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Winter D, 2014, COUNS PSYCHOTHER RES, V14, P64, DOI 10.1080/14733145.2012.737004; Winter D, 2013, COUNS PSYCHOTHER RES, V13, P164, DOI 10.1080/14733145.2012.761717; Woltmann EM, 2008, PSYCHIAT SERV, V59, P732, DOI 10.1176/appi.ps.59.7.732; World Health Organization, 2014, PREV SUIC PREV SUIC	77	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222482	10.1371/journal.pone.0222482	http://dx.doi.org/10.1371/journal.pone.0222482			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550251	gold, Green Published			2022-12-27	WOS:000532307700015
J	Richomme, C; Courcoul, A; Moyen, JL; Reveillaud, E; Maestrini, O; de Cruz, K; Drapeau, A; Boschiroli, ML				Richomme, Celine; Courcoul, Aurelie; Moyen, Jean-Louis; Reveillaud, Edouard; Maestrini, Oscar; de Cruz, Krystel; Drapeau, Antoine; Boschiroli, Maria Laura			Tuberculosis in the wild boar: Frequentist and Bayesian estimations of diagnostic test parameters when Mycobacterium bovis is present in wild boars but at low prevalence	PLOS ONE			English	Article							SUS-SCROFA; INFECTION; PIGS; SURVEILLANCE; MICROTI; COMPLEX; EPIDEMIOLOGY; ANTIBODIES; RESERVOIR; PATTERNS	The Eurasian wild boar (Sus scrofa) is increasingly considered as a relevant actor in the epidemiology of animal tuberculosis (TB). Therefore, monitoring TB in this species is key when establishing comprehensive control schemes for this disease still present in Europe. No data are available on direct and indirect TB diagnostic methods in wild boars in epidemiological contexts where TB is endemic in cattle and detected in wild boars at low prevalence. We aimed to estimate and compare sensitivity and specificity values for bacterial culture, PCR and three commercial ELISAs, i.e. the TB ELISA-VK (using the bPPD antigen), INgezim TB Porcine and IDEXX M. bovis Ab Test (both using the MPB83 and MPB70 antigens), under field conditions in France. We used frequentist methods, with bacteriology as the gold standard, and a Bayesian formulation of the latent class analysis (LCA), without using a gold standard. Submandibular lymph nodes and sera from 495 wild boars hunter-harvested in three endemic areas (Aquitaine region, Cote d'Or region, and Corsica region) were collected between 2014 and 2016. Only eight individuals were positive for M. bovis by bacteriology (1.61%; CI95% 0.70-3.51%). The LCA method provided high specificities (99.2%; CI95% 98.2-99.8% for INgezim TB Porcine and 99.7%; CI95% 98.8-100% for IDEXX M. bovis Ab Test) and sensitivities (78.5%; CI95% 65.1-88.8% for INgezim TB Porcine and 83.9%; CI95% 58.9-97.2% for IDEXX M. bovis Ab Test) for both ELISAs using the MPB83 and MPB70 antigens. Bacterial culture showed limited sensitivity (42.8%; CI95% 19.0-70.6%), estimated as the probability of a positive result in an animal exposed to M. bovis. PCR and ELISA using the bPPD antigens demonstrated high specificities, and sensitivities intermediates between culture and the ELISAs using the MPB83 and MPB70 antigens. These results suggest that ELISA tests using the MPB83 and MPB70 antigens are useful to detect and monitor TB exposure of wild boar populations in field conditions in France.	[Richomme, Celine] ANSES, Nancy Lab Rabies & Wildlife, Malzeville, France; [Courcoul, Aurelie] Univ Paris Est, Lab Anim Hlth, Epidemiol Unit, ANSES, Maisons Alfort, France; [Moyen, Jean-Louis] Lab Dept Anal & Rech Dordogne, Coulounieix Chamiers, France; [Reveillaud, Edouard] ANSES, Unit Coordinat & Support Surveillance, Maisons Alfort, France; [Maestrini, Oscar] INRA, UR 045, Corte, France; [de Cruz, Krystel; Drapeau, Antoine; Boschiroli, Maria Laura] Univ Paris Est, Lab Anim Hlth, TB Natl Reference Lab, ANSES, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA)	Boschiroli, ML (corresponding author), Univ Paris Est, Lab Anim Hlth, TB Natl Reference Lab, ANSES, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021	Boschiroli, Maria Laura/0000-0002-6705-1684	French General Directorate for Food (DGAL)	French General Directorate for Food (DGAL)	This project was funded by the French General Directorate for Food (DGAL) through a Bovine Tuberculosis Reseau Francais de Sante Animale (RFSA) research call. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Barasona JA, 2017, TRANSBOUND EMERG DIS, V64, P906, DOI 10.1111/tbed.12458; Lara GHB, 2011, RES VET SCI, V90, P185, DOI 10.1016/j.rvsc.2010.06.009; Boadella Mariana, 2011, BMC Res Notes, V4, P498, DOI 10.1186/1756-0500-4-498; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Boniotti MB, 2014, J CLIN MICROBIOL, V52, P2834, DOI 10.1128/JCM.00440-14; Cano-Terriza D, 2018, PREV VET MED, V159, P87, DOI 10.1016/j.prevetmed.2018.08.015; Cardoso-Toset F, 2017, PREV VET MED, V137, P101, DOI 10.1016/j.prevetmed.2016.12.016; Cavalerie L, 2015, ANIM HLTH NUTR, V71, P4; Chiari M, 2016, TRANSBOUND EMERG DIS, V63, pE381, DOI 10.1111/tbed.12313; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Dondo A., 2007, Epidemiologie et Sante Animale, P35; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Garcia-Bocanegra I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034908; Gortazar C, 2017, PREV VET MED, V146, P150, DOI 10.1016/j.prevetmed.2017.08.009; Gortazar C, 2003, VET REC, V152, P779, DOI 10.1136/vr.152.25.779; Hines N, 2006, J VET DIAGN INVEST, V18, P243, DOI 10.1177/104063870601800302; Krajewska M, 2014, J WILDLIFE DIS, V50, P1001, DOI 10.7589/2013-07-187; Madeira S, 2015, TRANSBOUND EMERG DIS; Michelet L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207614; Michelet L, 2015, J CLIN MICROBIOL, V53, P981, DOI 10.1128/JCM.02713-14; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nugent G, 2015, NEW ZEAL VET J, V63, P54, DOI 10.1080/00480169.2014.963792; OIE, MAN DIAGN TESTS VACC, P7; Perez de Val B, 2015, TRANSBOUND EMERG DIS; Reveillaud E, 2018, FRONT VET SCI, P5, DOI [10.3389/fvets.2018.00262/full, DOI 10.3389/FVETS.2018.00262/FULL]; Reveillaud E, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00262; Richomme C, 2013, PLOS ONE, P8; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Risco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110123; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Roos EO, 2016, VET IMMUNOL IMMUNOP, V182, P79, DOI 10.1016/j.vetimm.2016.10.006; Roos EO, 2018, BMC VET RES, P14; Santos N, 2015, VET RES, V46, DOI 10.1186/s13567-015-0270-4; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Sinha P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1450-1; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Thomas J, 2019, PREV VET MED, V162, P11, DOI 10.1016/j.prevetmed.2018.11.004; Vicente J, 2013, TRANSBOUND EMERG DIS, V60, P92, DOI 10.1111/tbed.12167; Wiker HG, 2009, SCAND J IMMUNOL, V69, P492, DOI 10.1111/j.1365-3083.2009.02256.x; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	48	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222661	10.1371/journal.pone.0222661	http://dx.doi.org/10.1371/journal.pone.0222661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550287	Green Published, gold			2022-12-27	WOS:000532307700023
J	Adetunji, MO; Lamont, SJ; Abasht, B; Schmidt, CJ				Adetunji, Modupeore O.; Lamont, Susan J.; Abasht, Behnam; Schmidt, Carl J.			Variant analysis pipeline for accurate detection of genomic variants from transcriptome sequencing data	PLOS ONE			English	Article							RED JUNGLE FOWL; RNA-SEQ	The wealth of information deliverable from transcriptome sequencing (RNA-seq) is significant, however current applications for variant detection still remain a challenge due to the complexity of the transcriptome. Given the ability of RNA-seq to reveal active regions of the genome, detection of RNA-seq SNPs can prove valuable in understanding the phenotypic diversity between populations. Thus, we present a novel computational workflow named VAP (Variant Analysis Pipeline) that takes advantage of multiple RNA-seq splice aware aligners to call SNPs in non-human models using RNA-seq data only. We applied VAP to RNA-seq from a highly inbred chicken line and achieved high accuracy when compared with the matching whole genome sequencing (WGS) data. Over 65% of WGS coding variants were identified from RNA-seq. Further, our results discovered SNPs resulting from post transcriptional modifications, such as RNA editing, which may reveal potentially functional variation that would have otherwise been missed in genomic data. Even with the limitation in detecting variants in expressed regions only, our method proves to be a reliable alternative for SNP identification using RNA-seq data. The source code and user manuals are available at https://modupeore.github.io/VAP/.	[Adetunji, Modupeore O.; Abasht, Behnam; Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Delaware; Iowa State University	Adetunji, MO (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.	amodupe@udel.edu	Adetunji, Modupeore/GSN-9929-2022; Adetunji, Modupeore/AAI-2533-2019	Adetunji, Modupeore/0000-0001-8870-1052; Adetunji, Modupeore/0000-0001-8870-1052; Schmidt, Carl/0000-0002-8386-4781	Agriculture and Food Research Initiative Competitive Grants from the United States Department of Agriculture National institute of Food and Agriculture [2011-67003-30228, 2017-67015-26543]	Agriculture and Food Research Initiative Competitive Grants from the United States Department of Agriculture National institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grants 2011-67003-30228 and 2017-67015-26543, both awarded to CJS, from the United States Department of Agriculture National institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiarizadeh MR, 2018, BIORXIV, DOI [10.1101/319871, DOI 10.1101/319871]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fleming DS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2711-5; Fresard L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126776; Guo Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4022-x; Han YX, 2015, BIOINFORM BIOL INSIG, V9, P29, DOI 10.4137/BBI.S28991; Kalari KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079298; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Kumar V, 2015, ANIM BIOTECHNOL, V26, P201, DOI 10.1080/10495398.2014.983645; Li H., 2013, ALIGNING SEQUENCE RE, DOI [10.1186/s13756-018-0352-y, DOI 10.1186/S13756-018-0352-Y]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Medina I, 2016, DNA RES, V23, P93, DOI 10.1093/dnares/dsv039; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moiseyeva IG, 2003, GENET SEL EVOL, V35, P403, DOI 10.1051/gse:2003031; Oikkonen Laura, 2017, Wellcome Open Res, V2, P6, DOI 10.12688/wellcomeopenres.10501.2; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Tang XJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku1005; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Zhuo Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12179-9	32	11	11	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0216838	10.1371/journal.pone.0216838	http://dx.doi.org/10.1371/journal.pone.0216838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545812	Green Published, Green Submitted, gold			2022-12-27	WOS:000532303200004
J	Evans, JC; Torney, CJ; Votier, SC; Dall, SRX				Evans, Julian C.; Torney, Colin J.; Votier, Stephen C.; Dall, Sasha R. X.			Social information use and collective foraging in a pursuit diving seabird	PLOS ONE			English	Article							PREY-CAPTURE; BEHAVIOR; PREDATOR; CORMORANTS; STRATEGIES; VIGILANCE; FLOCKS; FISH; INDIVIDUALS; PERFORMANCE	Individuals of many species utilise social information whilst making decisions. While many studies have examined social information in making large scale decisions, there is increasing interest in the use of fine scale social cues in groups. By examining the use of these cues and how they alter behaviour, we can gain insights into the adaptive value of group behaviours. We investigated the role of social information in choosing when and where to dive in groups of socially foraging European shags. From this we aimed to determine the importance of social information in the formation of these groups. We extracted individuals' surface trajectories and dive locations from video footage of collective foraging and used computational Bayesian methods to infer how social interactions influence diving. Examination of group spatial structure shows birds form structured aggregations with higher densities of conspecifics directly in front of and behind focal individuals. Analysis of diving behaviour reveals two distinct rates of diving, with birds over twice as likely to dive if a con-specific dived within their visual field in the immediate past. These results suggest that shag group foraging behaviour allows individuals to sense and respond to their environment more effectively by making use of social cues.	[Evans, Julian C.; Dall, Sasha R. X.] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England; [Torney, Colin J.] Univ Glasgow, Sch Math & Stat, Glasgow, Lanark, Scotland; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn, Cornwall, England; [Evans, Julian C.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr, Zurich, Switzerland	University of Exeter; University of Glasgow; University of Exeter; University of Zurich	Evans, JC (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.; Evans, JC (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr, Zurich, Switzerland.	jevansbio@gmail.com	Torney, Colin/C-6082-2015; Votier, Stephen/G-2348-2014	Torney, Colin/0000-0003-1673-7835; Votier, Stephen/0000-0002-0976-0167	European Social Fund	European Social Fund(European Social Fund (ESF))	This project was funded by a studentship from the European Social Fund's convergence programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JGT, 1991, COLON WATERBIRD, V14, P166, DOI 10.2307/1521506; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BARNARD CJ, 1982, BEHAVIOUR, V80, P44, DOI 10.1163/156853982X00436; Battley PF, 2003, WATERBIRDS, V26, P26, DOI 10.1675/1524-4695(2003)026[0026:SFBWIS]2.0.CO;2; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; BEAUCHAMP G, 1992, AUK, V109, P819, DOI 10.2307/4088156; Beauchamp G, 2016, ANIM BEHAV, V116, P195, DOI 10.1016/j.anbehav.2016.04.008; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Berlincourt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105065; BERTSEKAS DP, 1991, PROG SYST C, V7, P105; Bode NWF, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140410; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Brumm H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051881; Buhl J, 2011, BEHAV ECOL SOCIOBIOL, V65, P265, DOI 10.1007/s00265-010-1041-x; CRESSWELL W, 1994, ANIM BEHAV, V47, P433, DOI 10.1006/anbe.1994.1057; Dall SRX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004530; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dermody BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024635; Enstipp MR, 2007, J ORNITHOL, V148, pS593, DOI 10.1007/s10336-007-0203-8; Evans JC, 2016, J ORNITHOL, V157, P23, DOI 10.1007/s10336-015-1241-2; Evans JC, 2016, BIOL REV, V91, P658, DOI 10.1111/brv.12188; Ferguson EA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0695; FOSTER SA, 1985, ANIM BEHAV, V33, P782, DOI 10.1016/S0003-3472(85)80011-7; Fox A. D., 1994, Wildfowl, V45, P232; Fox AD, 1997, J ORNITHOL, V138, P103, DOI 10.1007/BF01651656; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; GOTMARK F, 1986, NATURE, V319, P589, DOI 10.1038/319589a0; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; HOFFMAN W, 1981, AUK, V98, P437; Jones TB, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0214; KREBS JR, 1992, AM NAT, V140, pS63, DOI 10.1086/285397; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Machovsky-Capuska GE, 2012, P ROY SOC B-BIOL SCI, V279, P4118, DOI 10.1098/rspb.2012.1519; Mann RP, 2013, MULTISCALE INFERENCE; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Nelson B., 2005, PELECANIDAE SULIDAE; Noren SR, 2006, J EXP BIOL, V209, P4724, DOI 10.1242/jeb.02566; Patil A, 2010, J STAT SOFTW, V35, P1; Ramos A, 2015, ANIM BEHAV, V109, P149, DOI 10.1016/j.anbehav.2015.08.016; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; RANTA E, 1993, AM NAT, V142, P42, DOI 10.1086/285528; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; RUXTON GD, 1995, ECOL MODEL, V82, P277, DOI 10.1016/0304-3800(94)00098-3; SCHENKEVELD LE, 1985, CAN J ZOOL, V63, P2516, DOI 10.1139/z85-372; Stempniewicz L, 2013, POLAR BIOL, V36, P949, DOI 10.1007/s00300-013-1318-4; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Strandburg-Peshkin A, 2013, CURR BIOL, V23, pR709, DOI 10.1016/j.cub.2013.07.059; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Takahashi A, 2004, J ETHOL, V22, P5, DOI 10.1007/s10164-003-0111-1; TEMPLETON JJ, 1995, BEHAV ECOL, V6, P65, DOI 10.1093/beheco/6.1.65; Thiebault A, 2016, J ANIM ECOL, V85, P157, DOI 10.1111/1365-2656.12455; Thiebault A, 2014, AUK, V131, P595, DOI 10.1642/AUK-13-209.1; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Votier SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057376; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; White CR, 2008, IBIS, V150, P231, DOI 10.1111/j.1474-919X.2008.00837.x; White CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000639; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Wilson LJ, 2009, BIOL CONSERV, V142, P1808, DOI 10.1016/j.biocon.2009.03.019; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	68	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222600	10.1371/journal.pone.0222600	http://dx.doi.org/10.1371/journal.pone.0222600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545848	Green Published, Green Accepted, gold			2022-12-27	WOS:000532303200022
J	Wang, C; Cheng, LP; Wang, C; Xiong, ZQ; Wei, SM				Wang, Chun; Cheng, Lu-ping; Wang, Cheng; Xiong, Zhu-qiang; Wei, Shi-ming			Dynamic mechanical characteristics and failure mode of serpentine under a three-dimensional high static load and frequent dynamic disturbance	PLOS ONE			English	Article							NUMERICAL-SIMULATION; FIELD MEASUREMENT; ROCK; PRESSURE; TOUGHNESS; SANDSTONE; STRENGTH; BEHAVIOR	The improved split Hopkinson pressure bar (SHPB) was used to study the dynamic mechanical properties and failure characteristics of surrounding rock in deep rock mass engineering that is under high stress and affected by blasting excavation and other dynamic disturbances. In a three-dimensional high static load and frequent dynamic disturbance test, the preload high axial pressure and confining pressure are used to simulate the high crustal stress of deep rock, and the effect of small disturbances on the rock is simulated by the low impact load. The results show that there are two types of dynamic stress-strain curves of deep rock: an elastic-plastic curve and plastic-elastic-plastic curve. The curves consists of five parts: the compaction stage, micro-crack steady development stage, micro-crack unstable propagation stage, fatigue damage stage, and fatigue failure stage. Reductive phenomena of constringent strain after dynamic peak stress appear because of the different degrees of rock damage. Moreover, these phenomena include two conditions, namely, whether rebound occurs or not. The impact resistance of rock is strongest when the ratio of the confining pressure to axial pressure is optimal, and the dynamic average strength of rock and accumulative impact times decrease with the increase of the preloaded axial compression and increase with the increase of the preloaded confining pressure. Both the dynamic deformation modulus and dynamic peak stress decrease with the increase of the accumulative impact time, while the maximum strain and the dynamic peak strain increase. The corresponding rebound strain as a whole first increases and then decreases with the increasing impact times. For deep rock, tensile failure and single-bevel plane shear failure are the main failure modes, and pull-compression mixed friction failure is the auxiliary failure mode. Additionally, the lumpiness of broken rock decreases with the increase of the preloaded axial compression and increases with the increase of the preloaded confining pressure.	[Wang, Chun; Cheng, Lu-ping; Wang, Cheng; Xiong, Zhu-qiang; Wei, Shi-ming] Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China; [Wang, Chun] Henan Polytech Univ, State & Local Joint Engn Lab Gas Drainage & Groun, Jiaozuo, Henan, Peoples R China; [Wang, Chun] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China; [Wang, Chun; Wang, Cheng; Xiong, Zhu-qiang; Wei, Shi-ming] Collaborat Innovat Ctr Coal Safety Prod Henan, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University; Henan Polytechnic University; Central South University	Wang, C; Cheng, LP; Wang, C (corresponding author), Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China.; Wang, C (corresponding author), Henan Polytech Univ, State & Local Joint Engn Lab Gas Drainage & Groun, Jiaozuo, Henan, Peoples R China.; Wang, C (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.; Wang, C; Wang, C (corresponding author), Collaborat Innovat Ctr Coal Safety Prod Henan, Jiaozuo, Henan, Peoples R China.	657156842@qq.com; 775174918@qq.com; 23754987@qq.com		Wang, Chun/0000-0002-0858-654X	Key Scientific Research Project of Colleges and Universities of Henan Province [18A440014]; Doctoral Foundation of Henan Polytechnic University [672707]; Key Laboratory Open Foundation of Henan Polytechnic University [SJF201802]; National Natural Science Foundation of China [51674099, 51904093]; Key Research and Development and Promotion of Special (Science and Technology) Project of Henan Province [192102310247]; Exploration of Youth Innovation Foundation of Henan Polytechnic University [NSFRF180321]	Key Scientific Research Project of Colleges and Universities of Henan Province; Doctoral Foundation of Henan Polytechnic University; Key Laboratory Open Foundation of Henan Polytechnic University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development and Promotion of Special (Science and Technology) Project of Henan Province; Exploration of Youth Innovation Foundation of Henan Polytechnic University	The authors are thankful for the financial support from the Key Scientific Research Project of Colleges and Universities of Henan Province under Grant 18A440014, the Doctoral Foundation of Henan Polytechnic University under Grant 672707, the Key Laboratory Open Foundation of Henan Polytechnic University under Grant SJF201802, the National Natural Science Foundation of China under Grant 51674099 and 51904093, the Key Research and Development and Promotion of Special (Science and Technology) Project of Henan Province under Grant 192102310247, the Exploration of Youth Innovation Foundation of Henan Polytechnic University under Grant NSFRF180321.	ALNUAIM A, 2018, INDIAN J SCI TECHNOL, V11, P1, DOI DOI 10.17485/ijst/2018/v11i15/119540; Bauer SJ, 2019, INT J ROCK MECH MIN, V113, P112, DOI 10.1016/j.ijrmms.2018.11.004; Fan LF, 2017, APPL THERM ENG, V125, P94, DOI 10.1016/j.applthermaleng.2017.07.007; Gong FQ, 2019, INT J ROCK MECH MIN, V113, P211, DOI 10.1016/j.ijrmms.2018.12.005; He M. C., 2005, CHIN J ROCK MECH ENG, V24, P2083; Keneti A, 2018, ENG GEOL, V246, P361, DOI 10.1016/j.enggeo.2018.10.005; Li XB, 2000, INT J ROCK MECH MIN, V37, P1055, DOI 10.1016/S1365-1609(00)00037-X; Li XB, 2007, J CENT SOUTH UNIV T, V14, P404, DOI 10.1007/s11771-007-0079-z; Li XB, 2008, INT J ROCK MECH MIN, V45, P739, DOI 10.1016/j.ijrmms.2007.08.013; [李夕兵 Li Xibing], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P4215; Li XB, 2017, INT J IMPACT ENG, V99, P69, DOI 10.1016/j.ijimpeng.2016.10.001; [刘少虹 Liu Shaohong], 2014, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V33, P2064; [刘晓明 Liu Xiaoming], 2017, [东北大学学报. 自然科学版, Journal of Northeastern University. Natural Science], V38, P740; [刘洋 Liu Yang], 2018, [煤炭学报, Journal of China Coal Society], V43, P1281; Malik A, 2018, THIN WALL STRUCT, V126, P127, DOI 10.1016/j.tws.2017.10.014; Mishra T., 2018, J MATER CIVIL ENG, V30, P1; [钱七虎 Qian Qihu], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P1945; Wang P, 2016, ENG GEOL, V212, P44, DOI 10.1016/j.enggeo.2016.07.015; Wang P, 2019, ROCK MECH ROCK ENG, V52, P991, DOI 10.1007/s00603-018-1606-y; Wang W., 2018, SHOCK VIB, V2, P1; Wong LNY, 2017, ROCK MECH ROCK ENG, V50, P1487, DOI 10.1007/s00603-017-1170-x; [吴爱祥 WU Aixiang], 2007, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V36, P473; Xie GX, 2017, ROCK MECH ROCK ENG, V50, P1711, DOI 10.1007/s00603-017-1194-2; Xing HZ, 2018, INT J IMPACT ENG, V113, P61, DOI 10.1016/j.ijimpeng.2017.11.011; Yang Z-G., 2009, CHINESE J ROCK MECH, V28, P3632; [杨志国 YANG Zhiguo], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P1066; Ye ZY, 2009, ROCK SOIL MECH, V30, P1981; Yin TB, 2018, ENG FRACT MECH, V204, P87, DOI 10.1016/j.engfracmech.2018.09.034; Yin TB, 2018, ENG FRACT MECH, V199, P143, DOI 10.1016/j.engfracmech.2018.05.035; Yin Z.Q, 2018, J ENG SCI TECH RE, V11, P61; Zhang QB, 2013, INT J ROCK MECH MIN, V60, P423, DOI 10.1016/j.ijrmms.2013.01.005; Zhang R. R, 2018, SHOCK VIB, V19, P1; Zhang YT, 2018, GEOMECH ENG, V16, P399, DOI 10.12989/gae.2018.16.4.399; [宫凤强 Gong Fengqiang], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P2076; Zhou ZL, 2017, T NONFERR METAL SOC, V27, P184, DOI 10.1016/S1003-6326(17)60021-9; [周宗红 Zhou Zonghong], 2015, [煤炭学报, Journal of China Coal Society], V40, P1030; Zhu WC, 2012, INT J IMPACT ENG, V49, P142, DOI 10.1016/j.ijimpeng.2012.04.002	37	2	2	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222684	10.1371/journal.pone.0222684	http://dx.doi.org/10.1371/journal.pone.0222684			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JH6GR	31545836	Green Published, gold			2022-12-27	WOS:000492866800001
J	Weinstein, SY; Thrower, FP; Nichols, KM; Hale, MC				Weinstein, Spencer Y.; Thrower, Frank P.; Nichols, Krista M.; Hale, Matthew C.			A large-scale chromosomal inversion is not associated with life history development in rainbow trout from Southeast Alaska	PLOS ONE			English	Article							MIGRATION-RELATED TRAITS; ONCORHYNCHUS-MYKISS; GENETIC-BASIS; ANADROMOUS STEELHEAD; ADAPTIVE DIVERGENCE; JUVENILE RESIDENT; ATLANTIC SALMON; CANDIDATE GENES; GENOME; EXPRESSION	In studying the causative mechanisms behind migration and life history, the salmonidssalmon, trout, and charr-are an exemplary taxonomic group, as life history development is known to have a strong genetic component. A double inversion located on chromosome 5 in rainbow trout (Oncorhynchus mykiss) is associated with life history development in multiple populations, but the importance of this inversion has not been thoroughly tested in conjunction with other polymorphisms in the genome. To that end, we used a high-density SNP chip to genotype 192 F-1 migratory and resident rainbow trout and focused our analyses to determine whether this inversion is important in life history development in a well-studied population of rainbow trout from Southeast Alaska. We identified 4,994 and 436 SNPs-predominantly outside of the inversion region-associated with life history development in the migrant and resident familial lines, respectively. Although F-1 samples showed genomic patterns consistent with the double inversion on chromosome 5 (reduced observed and expected heterozygosity and an increase in linkage disequilibrium), we found no statistical association between the inversion and life history development. Progeny produced by crossing resident trout and progeny produced by crossing migrant trout both consisted of a mix of migrant and resident individuals, irrespective of the individuals' inversion haplotype on chromosome 5. This suggests that although the inversion is present at a low frequency, it is not strongly associated with migration as it is in populations of Oncorhynchus mykiss from lower latitudes.	[Weinstein, Spencer Y.; Hale, Matthew C.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA; [Thrower, Frank P.] NOAA, Ted Stevens Marine Res Inst, Alaska Fisheries Ctr, Juneau, AK USA; [Nichols, Krista M.] Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Weinstein, Spencer Y.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	Texas Christian University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Waterloo	Hale, MC (corresponding author), Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA.; Nichols, KM (corresponding author), Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	krista.nichols@noaa.gov; m.c.hale@tcu.edu			National Science Foundation [NSF-DEB-0845265]; Texas Christian University; NSF	National Science Foundation(National Science Foundation (NSF)); Texas Christian University; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation Career Award to Krista Nichols (NSF-DEB-0845265) and Texas Christian University startup funds were used for genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by an NSF-career award to Krista Nichols, and Texas Christian University startup funds were used for genotyping. Genotyping was performed by Ben Pejsar and team at Neogen GeneSeek Operations. We would like to thank Garrett McKinney for providing comments on the manuscript, and the staff at the Little Port Walter Marine Station for facilitating the work in the Sashin system.	Arostegui MC, 2019, MOL ECOLOGY; Barth JMI, 2017, MOL ECOL, V26, P4452, DOI 10.1111/mec.14207; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brunelli JP, 2008, GENOME, V51, P739, DOI 10.1139/G08-060; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Danzmann RG, 2005, GENOME, V48, P1037, DOI 10.1139/G05-067; Docker MF, 2003, CONSERV GENET, V4, P227, DOI 10.1023/A:1023355114612; Feder JL, 2009, EVOLUTION, V63, P3061, DOI 10.1111/j.1558-5646.2009.00786.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Hale MC, 2016, COMP BIOCHEM PHYS D, V20, P136, DOI 10.1016/j.cbd.2016.07.006; Hale MC, 2014, J HERED, V105, P506, DOI 10.1093/jhered/esu018; Hale MC, 2013, G3-GENES GENOM GENET, V3, P1273, DOI 10.1534/g3.113.006817; Hecht BC, 2015, G3-GENES GENOM GENET, V5, P873, DOI 10.1534/g3.114.016469; Hecht BC, 2014, MAR BIOTECHNOL, V16, P638, DOI 10.1007/s10126-014-9579-7; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hecht BC, 2012, G3-GENES GENOM GENET, V2, P1113, DOI 10.1534/g3.112.003137; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Knief U, 2017, NAT ECOL EVOL, V1, P1177, DOI 10.1038/s41559-017-0236-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leder EH, 2006, J HERED, V97, P74, DOI 10.1093/jhered/esj004; Leitwein M, 2017, EVOL APPL, V10, P56, DOI 10.1111/eva.12416; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lindtke D, 2017, MOL ECOL, V26, P6189, DOI 10.1111/mec.14280; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; McCormick SD, 2013, FISH PHYSIOL, V32, P199, DOI 10.1016/B978-0-12-396951-4.00005-0; McCusker MR, 2000, MOL ECOL, V9, P2089, DOI 10.1046/j.1365-294X.2000.01121.x; McKinney GJ, 2015, MOL ECOL, V24, P1792, DOI 10.1111/mec.13143; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Morro B, 2019, AQUACULTURE, V507, P282, DOI 10.1016/j.aquaculture.2019.04.039; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Nichols KM, 2007, GENETICS, V175, P335, DOI 10.1534/genetics.106.064311; Nichols KM, 2016, EVOL APPL, V9, P1285, DOI 10.1111/eva.12412; O'Malley KG, 2003, J HERED, V94, P273, DOI 10.1093/jhered/esg067; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Pearse DE, 2018, SEX DEPENDENT DOMINA, DOI DOI 10.1101/504621; Pearse DE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0012; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Roesti M, 2013, MOL ECOL, V22, P3014, DOI 10.1111/mec.12322; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Sinclair-Waters M, 2018, MOL ECOL, V27, P339, DOI 10.1111/mec.14442; Stefansson S., 2008, FISH LARVAL PHYSL; Sundin K, 2005, AQUACULTURE, V247, P75, DOI 10.1016/j.aquaculture.2005.02.054; Thrower FP, 2004, AM FISH S S, V44, P485; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Waples RS, 2004, EVOLUTION, V58, P386, DOI 10.1111/j.0014-3820.2004.tb01654.x; Wellenreuther M, 2018, TRENDS ECOL EVOL, V33, P427, DOI 10.1016/j.tree.2018.04.002	50	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0223018	10.1371/journal.pone.0223018	http://dx.doi.org/10.1371/journal.pone.0223018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539414	Green Published, gold			2022-12-27	WOS:000532297900040
J	Gentilini, D; Oliveri, A; Fazia, T; Pini, A; Marelli, S; Bernardinelli, L; Di Blasio, AM				Gentilini, Davide; Oliveri, Antonino; Fazia, Teresa; Pini, Alessandro; Marelli, Susan; Bernardinelli, Luisa; Di Blasio, Anna Maria			NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis	PLOS ONE			English	Article							FIBRILLIN-1 FBN1; MUTATION-TYPE; MANIFESTATIONS; PATHOGENESIS; ASSOCIATION; PROBANDS; PROTEIN; WOMEN; MEN	The diagnosis of Marfan spectrum includes a large number of clinical criteria. Although the identification of pathogenic variants contributes to the diagnostic process, its value to the prediction of clinical outcomes is still limited. An important novelty of the present study is represented by the statistical approach adopted to investigate genotype-phenotype correlation. The analysis has been improved considering the extended genetic information obtained by Next Generation Sequencing (NGS) and combining the effects of both rare and common genetic variants in an inclusive model. To this aim a cohort of 181 patients were analyzed with a NGS panel including 11 genes associated with Marfan spectrum. The genotype-phenotype correlation was also investigated considering the possibility to predict presence of a pathological mutation in Marfan syndrome (MFS) main genes based only on the analysis of phenotypic traits. Results obtained indicate that information about clinical traits can be summarized in a new variable that resulted significantly associated with the probability to find a pathological mutation in MFS main genes. This is important since the choice of the genetic test is often influenced by the phenotypic characterization of patients. Moreover, both rare and common variants were found to significantly contribute to clinical spectrum and their combination allowed to increase the percentage of phenotype variability that could be explained based on genetic factors. Results highlight the opportunity to take advantage of the overall genetic information obtained by NGS data to have a better clinical classification of patients.	[Gentilini, Davide; Oliveri, Antonino; Fazia, Teresa; Bernardinelli, Luisa] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Gentilini, Davide] Ist Auxol Italiano IRCCS, Bioinformat & Stat Genom Unit, Milan, Italy; [Gentilini, Davide; Di Blasio, Anna Maria] Ist Auxol Italiano IRCCS, Mol Biol Lab, Milan, Italy; [Pini, Alessandro; Marelli, Susan] ASST FBF Sacco, Cardiol Dept, Rare Dis Ctr, Marfan Clin, Milan, Italy; [Pini, Alessandro] Ctr Cardiogenet Vascolare IRCCS Policlin San Dona, Milan, Italy	University of Pavia; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Gentilini, D (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy.; Gentilini, D (corresponding author), Ist Auxol Italiano IRCCS, Bioinformat & Stat Genom Unit, Milan, Italy.; Gentilini, D (corresponding author), Ist Auxol Italiano IRCCS, Mol Biol Lab, Milan, Italy.	davide.gentilini@unipv.it	marelli, susan/AAC-2827-2021; Bernardinelli, Luisa/AAL-5750-2021; Fazia, Teresa/AAV-1412-2021; Marelli, Susan/AAB-5906-2021; Pini, Alessandro/AAG-2020-2020	marelli, susan/0000-0001-5217-7391; Fazia, Teresa/0000-0002-9577-8450; Pini, Alessandro/0000-0002-8325-6057; Oliveri, Antonino/0000-0003-2621-6443; Gentilini, Davide/0000-0002-8391-0725				Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Barness LA., 1996, AM J MED GENET, V3, P4605, DOI [10.1002/(SICI)1096-8628(19961202)66:1%3C87::AID-AJMG20%3E3.0.CO;2-L, DOI 10.1002/(SICI)1096-8628(19961202)66:1%3C87::AID-AJMG20%3E3.0.CO;2-L]; Baudhuin LM, 2015, J HUM GENET, V60, P241, DOI 10.1038/jhg.2015.10; Chandra A, 2014, EYE, V28, P162, DOI 10.1038/eye.2013.274; Child AH, 2017, ANN CARDIOTHORAC SUR, V6, P599, DOI 10.21037/acs.2017.10.02; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Dietz HC, 1993, MARFAN SYNDROME; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Faivre L, 2012, CLIN GENET, V81, P433, DOI 10.1111/j.1399-0004.2011.01703.x; Faivre L, 2009, EUR J HUM GENET, V17, P491, DOI 10.1038/ejhg.2008.207; Franken R, 2016, EUR HEART J, V37, P3285, DOI 10.1093/eurheartj/ehv739; Gao LG, 2010, AGEING RES REV, V9, P363, DOI 10.1016/j.arr.2009.09.001; Groth KA, 2018, AM J CARDIOL, V122, P1231, DOI 10.1016/j.amjcard.2018.06.034; Hennekam RCM, 2005, AM J MED GENET A, V139A, P1, DOI 10.1002/ajmg.a.30979; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Landis BJ, 2017, HEART, V103, P1750, DOI 10.1136/heartjnl-2017-311513; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeys B, 2004, HUM MUTAT, V24, P140, DOI 10.1002/humu.20070; Loeys B, 2016, EUR HEART J, V37, P3291, DOI 10.1093/eurheartj/ehw154; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Loth E, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00188; Maeda J, 2016, HEART VESSELS, V31, P1717, DOI 10.1007/s00380-016-0793-2; Becerra-Munoz V, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-017-0754-6; Martinez-Quintana E, 2017, MOL SYNDROMOL, V8, P148, DOI 10.1159/000467909; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meester JAN, 2017, ANN CARDIOTHORAC SUR, V6, P582, DOI 10.21037/acs.2017.11.03; Pepe G, 2001, CLIN GENET, V59, P444, DOI 10.1034/j.1399-0004.2001.590610.x; Pyeritz RE, 2008, ANN THORAC SURG, V86, P335, DOI 10.1016/j.athoracsur.2006.10.023; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rocha Cabrera P, 2018, Arch Soc Esp Oftalmol (Engl Ed), V93, P139, DOI 10.1016/j.oftal.2017.07.003; Rommel K, 2005, HUM MUTAT, V26, P529, DOI 10.1002/humu.20239; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rybczynski M, 2008, AM J MED GENET A, V146A, P3157, DOI 10.1002/ajmg.a.32595; Sato A, 2016, BONE, V86, P53, DOI 10.1016/j.bone.2016.02.018; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Seto T, 2017, HUM GENOME VAR, V4, DOI 10.1038/hgv.2017.7; Shah SY, 2018, CLEV CLIN J MED, V85, P779, DOI 10.3949/ccjm.85a.17069; Tiecke F, 2001, EUR J HUM GENET, V9, P13, DOI 10.1038/sj.ejhg.5200582; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang X, 2018, J MED GENET, V55, P546, DOI 10.1136/jmedgenet-2018-105313; Zhang L, 2016, CLIN GENET, V89, P639, DOI 10.1111/cge.12713	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222506	10.1371/journal.pone.0222506	http://dx.doi.org/10.1371/journal.pone.0222506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536524	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800047
J	Gouyon, B; Martin-Mons, S; Iacobelli, S; Razafimahefa, H; Kermorvant-Duchemin, E; Brat, R; Caeymaex, L; Couringa, Y; Alexandre, C; Lafon, C; Ramful, D; Bonsante, F; Binson, G; Flamein, F; Moussy-Durandy, A; Di Maio, M; Mazeiras, G; Girard, O; Desbruyeres, C; Mourdie, J; Escourrou, G; Flechelles, O; Abasse, S; Rosenthal, JM; Pages, AS; Dorsi, M; Karaoui, L; ElGellab, A; Dantec, FL; Yangui, MA; Norbert, K; Kugbe, Y; Lorrain, S; Pignolet, A; Garnier, EM; Lapillonne, A; Mitanchez, D; Jacqz-Aigrain, E; Gouyon, JB				Gouyon, Beatrice; Martin-Mons, Severine; Iacobelli, Silvia; Razafimahefa, Hasinirina; Kermorvant-Duchemin, Elsa; Brat, Roselyne; Caeymaex, Laurence; Couringa, Yvan; Alexandre, Ceneric; Lafon, Catherine; Ramful, Duksha; Bonsante, Francesco; Binson, Guillaume; Flamein, Florence; Moussy-Durandy, Amelie; Di Maio, Massimo; Mazeiras, Gael; Girard, Olivier; Desbruyeres, Cecile; Mourdie, Julien; Escourrou, Guillaume; Flechelles, Olivier; Abasse, Soumeth; Rosenthal, Jean-Marc; Pages, Anne-Sophie; Dorsi, Marine; Karaoui, Leila; ElGellab, Abdellah; Dantec, Florence Le Bail; Yangui, Mohamed-Amine; Norbert, Karine; Kugbe, Yaovi; Lorrain, Simon; Pignolet, Anaelle; Garnier, Elodie Marie; Lapillonne, Alexandre; Mitanchez, Delphine; Jacqz-Aigrain, Evelyne; Gouyon, Jean-Bernard			Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; OFF-LABEL USE; MEDICATION ERRORS; DRUG UTILIZATION; INFANTS; SAFETY	Objectives The primary objective of this study is to determine the current level of patient medication exposure in Level 3 Neonatal Wards (L3NW). The secondary objective is to evaluate in the first month of life the rate of medication prescription not cited in the Summary of Product Characteristics (SmPC). A database containing all the medication prescriptions is collected as part of a prescription benchmarking program in the L3NW. Material and methods The research is a two-year observational cohort study (2017-2018) with retrospective analysis of medications prescribed in 29 French L3NW. Seventeen L3NW are present since the beginning of the study and 12 have been progressively included. All neonatal units used the same computerized system of prescription, and all prescription data were completely de-identified within each hospital before being stored in a common data warehouse. Results The study population includes 27,382 newborns. Two hundred and sixty-one different medications (International Nonproprietary Names, INN) were prescribed. Twelve INN (including paracetamol) were prescribed for at least 10% of patients, 55 for less than 10% but at least 1% and 194 to less than 1%. The lowest gestational ages (GA) were exposed to the greatest number of medications (18.0 below 28 weeks of gestation (WG) to 4.1 above 36 WG) (p<0.0001). In addition, 69.2% of the 351 different combinations of an medication INN and a route of administration have no indication for the first month of life according to the French SmPC. Ninety-five percent of premature infants with GA less than 32 weeks received at least one medication not cited in SmPC. Conclusion Neonates remain therapeutic orphans. The consequences of polypharmacy in L3NW should be quickly assessed, especially in the most immature infants.	[Gouyon, Beatrice; Martin-Mons, Severine; Iacobelli, Silvia; Bonsante, Francesco; Lorrain, Simon; Pignolet, Anaelle; Garnier, Elodie Marie; Gouyon, Jean-Bernard] Ctr Hosp Univ La Reunion Site Sud, Ctr Etud Perinatales Ocean Indien EA 7388, St Pierre, Reunion, France; [Razafimahefa, Hasinirina] Ctr Hosp Sud Francilien, Corbeil Essonnes, France; [Kermorvant-Duchemin, Elsa; Lapillonne, Alexandre] Hop Necker Enfants Malad, Paris, France; [Brat, Roselyne] Ctr Hosp Reg Orleans, Orleans, France; [Caeymaex, Laurence] Ctr Hosp Intercommunal Creteil, Creteil, France; [Couringa, Yvan] Ctr Hosp Andree Rosemon, Guyane Francaise, France; [Alexandre, Ceneric] CHU Caen, Caen, France; [Lafon, Catherine] Ctr Hosp Arras, Arras, France; [Ramful, Duksha] Ctr Hosp Univ La Reunion Site Nord, St Denis, Reunion, France; [Binson, Guillaume] CHU Poitiers, Poitiers, France; [Flamein, Florence] CHU Lille, Lille, France; [Moussy-Durandy, Amelie] Ctr Hosp Intercommunal Poissy St Germain Laye, Poissy, France; [Di Maio, Massimo] CHU Nimes, Nimes, France; [Mazeiras, Gael] Ctr Hosp Cote Basque, Bayonne, France; [Girard, Olivier] Ctr Hosp St Denis, St Denis, Reunion, France; [Desbruyeres, Cecile] Ctr Hosp Metropole Savoie, Chambery, France; [Mourdie, Julien] Grp Hosp Havre, Hop Jacques Monod, Montivilliers, France; [Escourrou, Guillaume] Ctr Hosp Intercommunal Andre Gregoire, Montreuil, France; [Flechelles, Olivier] Ctr Hosp Univ Fort de France, Fort De France, Martinique, France; [Abasse, Soumeth] Ctr Hosp Mayotte, Mamoudzou, Mayotte, France; [Rosenthal, Jean-Marc] CHU Pointe a Pitre, Pointe A Pitre, Guadeloupe, France; [Pages, Anne-Sophie] Ctr Hosp Publ Cotentin, Cherbourg En Cotentin, France; [Dorsi, Marine] Ctr Hosp Terr Gaston Bourret, Dumbea, Nouvelle Caledo, France; [Karaoui, Leila] Grand Hop Est Francilien, Meaux, France; [ElGellab, Abdellah] Ctr Hosp Lens, Lens, France; [Dantec, Florence Le Bail] Ctr Hosp St Brieuc, St Brieuc, France; [Yangui, Mohamed-Amine] Hop Rene Dubos, Pontoise, France; [Norbert, Karine] Ctr Hosp Pau, Pau, France; [Kugbe, Yaovi] Ctr Hosp Ouest Guyanais Franck Joly, St Laurent Du Maroni, Guyane Francais, France; [Mitanchez, Delphine] Hop Armand Trousseau, Paris, France; [Jacqz-Aigrain, Evelyne] Hop Robert Debre, Paris, France	CHU Reunion; Centre Hospitalier Sud Francilien; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Regional d'Orleans; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Reunion; CHU Poitiers; Universite de Poitiers; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Nimes; CHU Martinique; CHU Guadeloupe; Centre Hospitalier Rene Dubos, Pontoise; Centre Hospitalier de Pau; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Gouyon, JB (corresponding author), Ctr Hosp Univ La Reunion Site Sud, Ctr Etud Perinatales Ocean Indien EA 7388, St Pierre, Reunion, France.	jean-bernard.gouyon@chu-reunion.fr	Binson, Guillaume/AAQ-3038-2020; Jacqz-Aigrain, Evelyne/AAW-7089-2021; caeymaex, laurence/ABF-1423-2020; ABASSE, Soumeth/ABD-6071-2020	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; caeymaex, laurence/0000-0003-3822-5136; ABASSE, Soumeth/0000-0003-2806-0999; Garnier, Elodie/0000-0003-2682-4369; Razafimahefa, Hasinirina/0000-0001-9183-3523	European research program FEDER [2014-34018]	European research program FEDER	This study is part of a European research program FEDER number 2014-34018 (https://ec.europa.eu/regional_policy/en/funding/erdf/) about benchmark of prescription in NICUs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2019, EXPERT REV CLIN PHAR, V12, P343, DOI 10.1080/17512433.2019.1580569; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Cantey JB, 2018, J PEDIATR-US, V203, P62, DOI 10.1016/j.jpeds.2018.07.036; Cantey JB, 2016, LANCET INFECT DIS, V16, P1178, DOI 10.1016/S1473-3099(16)30205-5; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; de Souza AS, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0551-8; Fabiano V, 2012, EXPERT OPIN DRUG SAF, V11, P95, DOI 10.1517/14740338.2011.584531; Flint RB, 2018, BRIT J CLIN PHARMACO, V84, P1313, DOI 10.1111/bcp.13563; Girardi A, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0354-z; Gouyon B, 2017, J CLIN PHARM THER, V42, P64, DOI 10.1111/jcpt.12474; Horri J, 2014, J CLIN PHARM THER, V39, P637, DOI 10.1111/jcpt.12194; Hsieh EM, 2014, AM J PERINAT, V31, P811, DOI 10.1055/s-0033-1361933; Jain S, 2014, INDIAN PEDIATR, V51, P644, DOI 10.1007/s13312-014-0468-y; Kieran EA, 2014, ACTA PAEDIATR, V103, pE139, DOI 10.1111/apa.12541; Krzyzaniak N, 2016, J CLIN PHARM THER, V41, P612, DOI 10.1111/jcpt.12440; Krzyzaniak N, 2016, THER ADV DRUG SAF, V7, P102, DOI 10.1177/2042098616642231; Ku LC, 2017, PEDIATR CARDIOL, V38, P155, DOI 10.1007/s00246-016-1496-2; Laforgia N, 2014, PEDIATR INT, V56, P57, DOI 10.1111/ped.12190; Laughon MM, 2014, JAMA PEDIATR, V168, P130, DOI 10.1001/jamapediatrics.2013.4208; Lee JL, 2013, INT J CLIN PHARM-NET, V35, P1025, DOI 10.1007/s11096-013-9846-0; Costa HTMD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204427; Neubert A, 2010, EUR J CLIN PHARMACOL, V66, P87, DOI 10.1007/s00228-009-0722-8; Nir-Neuman H, 2018, ADV THER, V35, P1122, DOI 10.1007/s12325-018-0732-y; Nuytten A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170234; Porta A, 2012, J ANTIMICROB CHEMOTH, V67, P1278, DOI 10.1093/jac/dks021; Puopolo KM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0925; Quantin C, 2014, J GYNECOL OBST BIO R, V43, P680, DOI 10.1016/j.jgyn.2013.09.004; Rosli R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00027; Sweet DG, 2019, NEONATOLOGY, V115, P432, DOI 10.1159/000499361; Taketomo CKH J. H., 2016, LEXICOMP; Zimmerman KO, 2017, J PEDIATR-US, V180, P99, DOI 10.1016/j.jpeds.2016.07.001	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222667	10.1371/journal.pone.0222667	http://dx.doi.org/10.1371/journal.pone.0222667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU6QQ	31536560	Green Published, Green Submitted, gold			2022-12-27	WOS:000501799400001
J	Yang, M; Gong, L; Sui, JX; Li, XZ				Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng			The complete mitochondrial genome of Calyptogena marissinica (Heterodonta: Veneroida: Vesicomyidae): Insight into the deep-sea adaptive evolution of vesicomyids	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; ENERGY-METABOLISM GENES; AMINO-ACID SITES; TRANSFER-RNA; PHYLOGENETIC-RELATIONSHIPS; BATHYMODIOLUS MUSSELS; MITOGENOMIC ANALYSES; DNA SEQUENCE; BIVALVIA; VENT	The deep-sea chemosynthetic environment is one of the most extreme environments on the Earth, with low oxygen, high hydrostatic pressure and high levels of toxic substances. Species of the family Vesicomyidae are among the dominant chemosymbiotic bivalves found in this harsh habitat. Mitochondria play a vital role in oxygen usage and energy metabolism; thus, they may be under selection during the adaptive evolution of deep-sea vesicomyids. In this study, the mitochondrial genome (mitogenome) of the vesicomyid bivalve Calyptogena marissinica was sequenced with Illumina sequencing. The mitogenome of C. marissinica is 17,374 bp in length and contains 13 protein-coding genes, 2 ribosomal RNA genes (rrnS and rrnL) and 22 transfer RNA genes. All of these genes are encoded on the heavy strand. Some special elements, such as tandem repeat sequences, "G(A)(n)T" motifs and AT-rich sequences, were observed in the control region of the C. marissinica mitogenome, which is involved in the regulation of replication and transcription of the mitogenome and may be helpful in adjusting the mitochondrial energy metabolism of organisms to adapt to the deep-sea chemosynthetic environment. The gene arrangement of protein-coding genes was identical to that of other sequenced vesicomyids. Phylogenetic analyses clustered C. marissinica with previously reported vesicomyid bivalves with high support values. Positive selection analysis revealed evidence of adaptive change in the mitogenome of Vesicomyidae. Ten potentially important adaptive residues were identified, which were located in cox1, cox3, cob, nad2, nad4 and nad5. Overall, this study sheds light on the mitogenomic adaptation of vesicomyid bivalves that inhabit the deep-sea chemosynthetic environment.	[Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Chinese Acad Sci, Inst Oceanol, Dept Marine Organism Taxon & Phylogeny, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Dept Marine Organism Taxon & Phylogeny, Qingdao, Peoples R China.; Li, XZ (corresponding author), Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China.; Li, XZ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Li, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lixzh@qdio.ac.cn		Li, Xinzheng/0000-0001-6344-6542	National Key R&D Program of China [2018YFC0309804]; National Natural Science Foundation of China [41506173]; Chinese Academy of Sciences [XDB06010101]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the National Key R&D Program of China, 2018YFC0309804 to LG, the National Natural Science Foundation of China, 41506173 to MY, and Strategic Priority Research Program of the Chinese Academy of Sciences, XDB06010101 to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1983, GENETICS, V103, P287; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOSS KJ, 1980, MALACOLOGIA, V20, P161; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Chong, 2018, Venus (Tokyo), V76, P29, DOI 10.18941/venus.76.1-4_29; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gu ML, 2012, GENE, V496, P37, DOI 10.1016/j.gene.2011.12.016; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hui M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4745-3; Johnson SB, 2017, SYST BIODIVERS, V15, P346, DOI 10.1080/14772000.2016.1252438; Krylova E.M., 2000, Ruthenica, V10, P76; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Kumazawa Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-930; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4720-z; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Liao F, 2010, INT J BIOL SCI, V6, P172; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HL, 2018, ECOL EVOL, V8, P7261, DOI 10.1002/ece3.4153; Liu HL, 2016, MITOCHONDRIAL DNA A, V27, P4333, DOI 10.3109/19401736.2015.1089488; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Mahalingam S, 2017, J PHYSIOL-LONDON, V595, P4785, DOI 10.1113/JP274130; Marshall HD, 1997, MOL BIOL EVOL, V14, P173, DOI 10.1093/oxfordjournals.molbev.a025750; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Miller AD, 2005, MAR BIOTECHNOL, V7, P339, DOI 10.1007/s10126-004-4077-8; Mu WD, 2018, ECOL EVOL, V8, P10673, DOI 10.1002/ece3.4427; Mu WD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208051; Tan MH, 2018, MOL PHYLOGENET EVOL, V127, P320, DOI 10.1016/j.ympev.2018.05.015; Nielsen R, 1998, GENETICS, V148, P929; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1992, GENETICS, V130, P471; Ozawa G, 2017, GENOME BIOL EVOL, V9, P2226, DOI 10.1093/gbe/evx166; Ozawa G, 2017, MAR GENOM, V31, P43, DOI 10.1016/j.margen.2016.09.003; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Plazzi F, 2017, GENOME BIOL EVOL, V9, P956, DOI 10.1093/gbe/evx051; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Sahyoun AH, 2015, NUCLEIC ACIDS RES, V43, P8044, DOI 10.1093/nar/gkv746; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schuster A, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1230-1; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STANTON DJ, 1994, GENETICS, V137, P233; Sun J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0121; Sun S, 2018, GENE, V676, P123, DOI 10.1016/j.gene.2018.07.026; Sun SE, 2018, COMP BIOCHEM PHYS D, V25, P42, DOI 10.1016/j.cbd.2017.11.002; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tomasco IH, 2011, MOL PHYLOGENET EVOL, V61, P64, DOI 10.1016/j.ympev.2011.06.014; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; von Cosel R, 2001, SARSIA, V86, P333, DOI 10.1080/00364827.2001.10425523; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29690; Wang ZF, 2011, MOL BIOL EVOL, V28, P1553, DOI 10.1093/molbev/msq336; Wang ZL, 2016, INT J BIOL SCI, V12, P109, DOI 10.7150/ijbs.12358; Wang ZF, 2017, GENES GENOM, V39, P1367, DOI 10.1007/s13258-017-0600-1; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xu Shu-Qing, 2005, Genomics Proteomics & Bioinformatics, V3, P5; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; Yang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099120; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu H, 2012, MOL BIOL REP, V39, P999, DOI 10.1007/s11033-011-0825-z; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zhang B, 2017, ECOL EVOL, V7, P4951, DOI 10.1002/ece3.3067; Zheng P, 2017, MOL ECOL, V26, P5133, DOI 10.1111/mec.14160; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	102	15	15	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0217952	10.1371/journal.pone.0217952	http://dx.doi.org/10.1371/journal.pone.0217952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536521	Green Submitted, gold, Green Published			2022-12-27	WOS:000532262800005
J	Jung, KH; Lee, EJ; Park, JW; Lee, JH; Moon, SH; Cho, YS; Lee, KH				Jung, Kyung-Ho; Lee, Eun Jeong; Park, Jin Won; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Lee, Kyung-Han			EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; POSITRON-EMISSION-TOMOGRAPHY; IN-VITRO; TUMOR; EXPRESSION; THERAPY; HORMONE; ADENOCARCINOMA; PROLIFERATION; ASSOCIATION	Breast cancers that express epidermal growth factor (EGF) receptors (EGFRs) are associated with poor prognosis. Our group recently showed in breast cancer patients that EGFR expression is strongly correlated with high tumor uptake of the glucose analogue, F-18-fluoro-deoxyglucose (FDG). Here, we explored the cellular mechanism and signaling pathways that can explain the relation between EGFR and breast cancer cell glucose metabolism. FDG uptake, lactate production and hexokinase (HK) activity were measured, and proliferation assays and western blots were performed. EGF stimulated an increase of FDG uptake in EGFR-positive T47D and MDA-MB-468 cells, but not in MCF-7 cells. In T47D cells, the effect was dose-dependent and was accompanied by increased lactate production, indicating a shift toward glycolytic flux. This metabolic response occurred through enhanced HK activity and upregulated glucose transporter 1 (GLUT1) expression. EGFR stimulation also increased T47D cell proliferation. Blocking EGFR activation with BIBX1382 or gefitinib completely abolished both FDG uptake and proliferation effects. EGFR stimulation induced MAP kinase (MAPK) and PI3 kinase (PI3K) activation. Increased cell proliferation by EGFR stimulation was completely abolished by MAPK inhibition with PD98059 or by PI3K inhibition with LY294002. Increased FDG uptake was also completely abrogated by PI3K inhibition but was uninfluenced by MAPK inhibition. These findings suggest that the association between breast tumor EGFR expression and high FDG uptake might be contributed by stimulation of the PI3K pathway downstream of EGFR activation. This was in contrast to EGFRmediated cell proliferation that required MAPK as well as PI3K signaling.	[Jung, Kyung-Ho; Park, Jin Won; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Lee, Kyung-Han] Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea; [Jung, Kyung-Ho; Park, Jin Won; Lee, Jin Hee; Lee, Kyung-Han] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea; [Lee, Eun Jeong] Seoul Med Ctr, Dept Nucl Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul Medical Center	Lee, KH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea.; Lee, KH (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.	khnm.lee@samsung.com		Lee, Kyung-Han/0000-0003-3565-5536	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2018R1D1A1B07043260, 2016R1D1A1B03932202]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2018R1D1A1B07043260 and 2016R1D1A1B03932202).	AlFakeeh A, 2018, CURR ONCOL, V25, pS18, DOI 10.3747/co.25.3752; Aloj L, 1999, CANCER RES, V59, P4709; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Batra S, 2013, ONCOLOGY-NY, V27, P460; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Di Fabio F, 2007, GASTRIC CANCER, V10, P221, DOI 10.1007/s10120-007-0438-3; Elbaz M, 2015, MOL ONCOL, V9, P906, DOI 10.1016/j.molonc.2014.12.010; Enriori PJ, 2006, CLIN ENDOCRINOL, V64, P20, DOI 10.1111/j.1365-2265.2005.02408.x; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Gonzalez-Conchas GA, 2018, CANCER TREAT REV, V62, P1, DOI 10.1016/j.ctrv.2017.10.008; Grover-McKay M, 1998, Pathol Oncol Res, V4, P115; Gullick William J, 2009, Eur J Cancer, V45 Suppl 1, P205, DOI 10.1016/S0959-8049(09)70035-8; Guo BH, 2015, CANCER LETT, V361, P271, DOI 10.1016/j.canlet.2015.03.011; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; ILLG D, 1979, EUR J BIOCHEM, V97, P267, DOI 10.1111/j.1432-1033.1979.tb13111.x; KAPLAN O, 1990, J BIOL CHEM, V265, P13641; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Kyriakopoulou K, 2018, CELL SIGNAL, V51, P99, DOI 10.1016/j.cellsig.2018.07.010; Lee J, 2017, EUR J NUCL MED MOL I, V44, P1438, DOI 10.1007/s00259-017-3705-5; Levva S, 2017, CANCER GENOM PROTEOM, V14, P181, DOI 10.21873/cgp.20030; Lindsey S, 2015, INT REV CEL MOL BIO, V314, P1, DOI 10.1016/bs.ircmb.2014.10.001; Masuda Hiroko, 2012, Breast Cancer Res Treat, V136, P331, DOI 10.1007/s10549-012-2289-9; Nakai K, 2016, AM J CANCER RES, V6, P1609; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Nose A, 2003, HYPERTENS RES, V26, P67; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Pons F, 2009, Q J NUCL MED MOL IM, V53, P210; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Reinert T, 2017, THER ADV MED ONCOL, V9, P693, DOI 10.1177/1758834017728928; Sanchez-Munoz A, 2009, CLIN TRANSL ONCOL, V11, P643, DOI 10.1007/s12094-009-0419-6; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith TAD, 1998, NUCL MED BIOL, V25, P481, DOI 10.1016/S0969-8051(98)00014-6; Solca FF, 2004, J PHARMACOL EXP THER, V311, P502, DOI 10.1124/jpet.104.069138; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Takahashi R, 2012, CLIN CANCER RES, V18, P220, DOI 10.1158/1078-0432.CCR-11-0868; Toulany M, 2005, RADIOTHER ONCOL, V74, P117, DOI 10.1016/j.radonc.2004.11.008; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; van der Hiel B, 2001, J CANCER RES CLIN, V127, P269; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang H, 2019, CANCER LETT, V455, P48, DOI 10.1016/j.canlet.2019.04.027; Xu JW, 2011, INT J ONCOL, V39, P1501, DOI 10.3892/ijo.2011.1143; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187; Zhu G, 2015, ONCOGENE, V34, P5971, DOI 10.1038/onc.2015.45	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221294	10.1371/journal.pone.0221294	http://dx.doi.org/10.1371/journal.pone.0221294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532771	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600007
J	Reisch, T; Hartmann, C; Hemmer, A; Bartsch, C				Reisch, Thomas; Hartmann, Chantal; Hemmer, Alexander; Bartsch, Christine			Suicide by hanging: Results from a national survey in Switzerland and its implications for suicide prevention	PLOS ONE			English	Article							PSYCHIATRIC-INPATIENTS; DEATHS; AUSTRALIA; FIREARM; ACCESS; TRENDS; RATES	Background Hanging is a frequent suicide method, but developing measures to prevent suicide by this method is particularly challenging. The aim of this study is to gain new knowledge that would enable the design of effective of measures that would help prevent suicide by hanging. Methods A total of 6,497 suicides registered across the eight Swiss Forensic Institutes (IRM) were analysed. Of these, 1,282 (19.7%) persons hung themselves. T-test and chi-square tests. and chi-square tests were used to analyse...(or determine, or investigate)...group differences regarding sociodemographic variables and triggers Findings Men and women who hung themselves showed no significant differences in sociodemographic variables. However, women were significantly more likely to have a psychiatric illness history, whereas men were more likely to have somatic diagnoses. In controlled environments, people used shelves, plumbing and windows more often than beams, pipes, bars and hooks to hang themselves. Compared with other suicide methods, hanging was more likely to have been triggered by partner and financial problems. Conclusions Suicide by hanging can be best prevented in institutions (e.g. psychiatric hospitals, somatic hospitals, prisons). These institutions should be structurally evaluated and modified with a primary focus on sanitary areas, windows and shelves. Otherwise, it is important to use general suicide prevention measures, such as awareness raising and staff training in medical settings, low-threshold treatment options and regular suicide risk assessment for people at risk.	[Reisch, Thomas; Hartmann, Chantal; Hemmer, Alexander] Hosp Psychiat Muensingen, Dept Psychiat, Muensingen, Switzerland; [Reisch, Thomas] Univ Bern, Hosp Psychiat, Dept Psychiat, Bern, Switzerland; [Bartsch, Christine] Alfred Wegener Inst, Helmholtz Assoc, Dept Infrastruct Adm Operat & Res Platforms, Bremerhaven, Germany	University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Reisch, T (corresponding author), Hosp Psychiat Muensingen, Dept Psychiat, Muensingen, Switzerland.; Reisch, T (corresponding author), Univ Bern, Hosp Psychiat, Dept Psychiat, Bern, Switzerland.	thomas.reisch@pzmag.ch						[Anonymous], SUIZ; Azmak D, 2006, AM J FOREN MED PATH, V27, P134, DOI 10.1097/01.paf.0000221082.72186.2e; Baker SP, 2013, AM J PREV MED, V44, P146, DOI 10.1016/j.amepre.2012.10.010; Bastia BK, 2009, ARCH SUICIDE RES, V13, P100, DOI 10.1080/13811110802572221; Bennewith O, 2005, BRIT J PSYCHIAT, V186, P260, DOI 10.1192/bjp.186.3.260; Bhosle SH, 2015, J FORENSIC LEG MED, V29, P30, DOI 10.1016/j.jflm.2014.11.003; Biddle L, 2010, BRIT J PSYCHIAT, V197, P320, DOI 10.1192/bjp.bp.109.076349; Cantor CH, 1998, AUST NZ J PSYCHIAT, V32, P8, DOI 10.3109/00048679809062700; De Leo D, 2003, SUICIDE LIFE-THREAT, V33, P151, DOI 10.1521/suli.33.2.151.22775; De Leo D, 2002, AUST NZ J PSYCHIAT, V36, P183, DOI 10.1046/j.1440-1614.2001.01013.x; Gauthier S, 2015, CRISIS, V36, P110, DOI 10.1027/0227-5910/a000302; Glasow N., 2011, STRUCTURAL SUICIDE P; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Habenstein A, 2013, ARCH SUICIDE RES, V17, P75, DOI 10.1080/13811118.2013.748418; Hassan DA, 2013, J FORENSIC LEG MED, V20, P1118, DOI 10.1016/j.jflm.2013.09.021; HERNANDEZALVARADO, 2016, INT J ENV RES PUB HE, V13, DOI DOI 10.3390/IJERPH13060552; Hunt IM, 2012, CRISIS, V33, P87, DOI 10.1027/0227-5910/a000117; Joo SH, 2016, ASIA-PAC PSYCHIAT, V8, P80, DOI 10.1111/appy.12216; Kanamuller J, 2016, DEATH STUD, V40, P205, DOI 10.1080/07481187.2015.1117537; Kanchan Tanuj, 2008, J Forensic Leg Med, V15, P493, DOI 10.1016/j.jflm.2008.05.004; Kasmaee VM, 2015, EMERGENCY, V3, P155; Kosky RJ, 2000, AUST NZ J PSYCHIAT, V34, P836, DOI 10.1046/j.1440-1614.2000.00807.x; Kurtulus A, 2013, MED SCI LAW, V53, P80, DOI 10.1258/msl.2012.012030; Ruff F, 2018, PSYCHIAT PRAX, V45, P307, DOI 10.1055/s-0043-120888; Russo MC, 2016, AM J FOREN MED PATH, V37, P141, DOI 10.1097/PAF.0000000000000239; Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550; SNSF [Swiss National Science Foundation], SUIC SWITZ DET NAT S; Starkuviene S, 2006, PUBLIC HEALTH, V120, P769, DOI 10.1016/j.puhe.2006.04.009; Suarez-Penaranda JM, 2008, J FORENSIC SCI, V53, P720, DOI 10.1111/j.1556-4029.2008.00700.x; Thoeni N, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14646; Vijayakumari N., 2011, J INDIAN ACAD FORENS, V33, P355; Wilkinson D, 2000, AUST NZ J PUBL HEAL, V24, P153, DOI 10.1111/j.1467-842X.2000.tb00135.x; Wu CY, 2014, NURS EDUC TODAY, V34, P1388, DOI 10.1016/j.nedt.2014.03.015	33	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0220508	10.1371/journal.pone.0220508	http://dx.doi.org/10.1371/journal.pone.0220508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532773	Green Submitted, gold, Green Published			2022-12-27	WOS:000532239600001
J	Jensen, K; Stevens, JM; Glass, EJ				Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.			Interleukin 10 knock-down in bovine monocyte-derived macrophages has distinct effects during infection with two divergent strains of Mycobacterium bovis	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; IL-10; CATTLE; EXPRESSION	Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), a cattle disease of global importance. M. bovis infects bovine macrophages (Mo) and subverts the host cell response to generate a suitable niche for survival and replication. We investigated the role of the anti-inflammatory cytokine interleukin (IL) 10 during in vitro infection of bovine monocyte-derived Mo (bMDM) with two divergent UK strains of M. bovis, which differentially modulate expression of IL10. The use of IL10-targeting siRNA revealed that IL10 inhibited the production of IL1B, IL6, tumour necrosis factor (TNF) and interferon gamma (IFNG) during infection of bMDM with the M. bovis strain G18. In contrast, IL10 only regulated a subset of these genes; TNF and IFNG, during infection with the M. bovis reference strain AF2122/97. Furthermore, nitric oxide (NO) production was modulated by IL10 during AF2122/97 infection, but not at the nitric oxide synthase 2 (NOS2) mRNA level, as observed during G18 infection. However, IL10 was found to promote survival of both M. bovis strains during early bMDM infection, but this effect disappeared after 24 h. The role of IL10-induced modulation of TNF, IFNG and NO production in M. bovis survival was investigated using siRNA targeting TNF, IFNG receptor 1 (IFNGR1) and NOS2. Knock-down of these genes individually did not promote survival of either M. bovis strain and therefore modulation of these genes does not account for the effect of IL10 on M. bovis survival. However, TNF knock-down was found to be detrimental to the survival of the M. bovis strain G18 during early infection. The results provide further evidence for the importance of IL10 during M. bovis infection of Mo. Furthermore, they highlight M. bovis strain specific differences in the interaction with the infected bMDM, which may influence the course of infection and progression of bovine TB.	[Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.] Univ Edinburgh, Div Infect & Immun, Roslin Inst, Edinburgh, Midlothian, Scotland; [Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Jensen, K (corresponding author), Univ Edinburgh, Div Infect & Immun, Roslin Inst, Edinburgh, Midlothian, Scotland.	kirsty.jensen@roslin.ed.ac.uk		Jensen, Kirsty/0000-0002-0005-6931	BBSRC Strategic Programme grant (Control of Infectious Diseases) [BB/P013740/1]; BBSRC [BBS/E/D/20002174, BB/L004054/1] Funding Source: UKRI	BBSRC Strategic Programme grant (Control of Infectious Diseases)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JMS, EJG, and KJ were supported by a BBSRC Strategic Programme grant (Control of Infectious Diseases: [BB/P013740/1]) (https://bbsrc.ukri.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broughan JM, 2016, EPIDEMIOL INFECT, V144, P2899, DOI 10.1017/S095026881600131X; Buza JJ, 2004, INFECT IMMUN, V72, P2425, DOI 10.1128/IAI.72.4.2425-2428.2004; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Denis M, 2005, IMMUNOL CELL BIOL, V83, P643, DOI 10.1111/j.1440-1711.2005.01386.x; Department for Environment, 2019, FOOD RUR AFF DEFRA R; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Duan L, 2016, BIOCHEM BIOPH RES CO, V473, P1229, DOI 10.1016/j.bbrc.2016.04.045; Eberhardt MK, 2014, CURR TOP MICROBIOL, V380, P93, DOI 10.1007/978-3-662-43492-5_5; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Esquivel-Solis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063464; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hussain T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01915; Jensen K, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00385-17; Jensen K, 2016, VET RES, V47, DOI 10.1186/s13567-016-0328-y; Jensen K, 2014, VET IMMUNOL IMMUNOP, V158, P224, DOI 10.1016/j.vetimm.2014.02.002; Johnson L, 2007, TUBERCULOSIS, V87, P71, DOI 10.1016/j.tube.2006.04.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Rutz S, 2016, ADV EXP MED BIOL, V941, P89, DOI 10.1007/978-94-024-0921-5_5; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang XL, 2018, TUBERCULOSIS, V108, P118, DOI 10.1016/j.tube.2017.11.008; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222437	10.1371/journal.pone.0222437	http://dx.doi.org/10.1371/journal.pone.0222437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527895	Green Submitted, Green Published, gold			2022-12-27	WOS:000532231400020
J	Rajan, SK; Lindqvist, M; Brummer, RJ; Schoultz, I; Repsilber, D				Rajan, Sukithar K.; Lindqvist, Marten; Brummer, Robert Jan; Schoultz, Ida; Repsilber, Dirk			Phylogenetic microbiota profiling in fecal samples depends on combination of sequencing depth and choice of NGS analysis method	PLOS ONE			English	Article							DNA EXTRACTION; METAGENOMICS; ECOLOGY	The human gut microbiota is well established as an important factor in health and disease. Fecal sample microbiota are often analyzed as a proxy for gut microbiota, and characterized with respect to their composition profiles. Modern approaches employ whole genome shotgun next-generation sequencing as the basis for these analyses. Sequencing depth as well as choice of next-generation sequencing data analysis method constitute two main interacting methodological factors for such an approach. In this study, we used 200 million sequence read pairs from one fecal sample for comparing different taxonomy classification methods, using default and custom-made reference databases, at different sequencing depths. A mock community data set with known composition was used for validating the classification methods. Results suggest that sequencing beyond 60 million read pairs does not seem to improve classification. The phylogeny prediction pattern, when using the default databases and the consensus database, appeared to be similar for all three methods. Moreover, these methods predicted rather different species. We conclude that the choice of sequencing depth and classification method has important implications for taxonomy composition prediction. A multi-method-consensus approach for robust gut microbiota NGS analysis is recommended.	[Rajan, Sukithar K.; Lindqvist, Marten; Brummer, Robert Jan; Schoultz, Ida; Repsilber, Dirk] Orebro Univ, Sch Med Sci, Orebro, Sweden	Orebro University	Repsilber, D (corresponding author), Orebro Univ, Sch Med Sci, Orebro, Sweden.	dirk.repsilber@oru.se		Repsilber, Dirk/0000-0002-7173-5579	Swedish Knowledge Foundation; Bo Rydin Foundation [F0514]	Swedish Knowledge Foundation(General Electric); Bo Rydin Foundation	RJB received funding for the Research Profile "Nutrition-Gut-Brain Interaction Research Centre" from the Swedish Knowledge Foundation (www.kks.se).IS received funding from the Bo Rydin Foundation (www.borydinfoundation.se, grant no F0514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali I, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1101-8; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Blanco-Miguez A, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw157; Bokulich NA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00062-16; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fumagalli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079667; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18; Icaza-Chavez ME, 2013, REV GASTROENTEROL ME, V78, P240, DOI 10.1016/j.rgmx.2013.04.004; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13; Koslicki D, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00020-16; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Larroya-Garcia A, 2019, CRIT REV FOOD SCI, V59, P3102, DOI 10.1080/10408398.2018.1484340; Lewis CM, 2012, TRENDS MICROBIOL, V20, P1, DOI 10.1016/j.tim.2011.10.004; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lim MY, 2018, SYST APPL MICROBIOL, V41, P151, DOI 10.1016/j.syapm.2017.11.008; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Michel PO, 2012, ANAL BIOCHEM, V430, P138, DOI 10.1016/j.ab.2012.08.028; Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007; NUDDS TD, 1983, CAN J ZOOL, V61, P1547, DOI 10.1139/z83-208; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462; Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2; Rup L, 2012, INDIAN J MICROBIOL, V52, P315, DOI 10.1007/s12088-012-0304-9; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Siegwald L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169563; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Uchiyama I, 2015, NUCLEIC ACIDS RES, V43, pD270, DOI 10.1093/nar/gku1152; Vandenberg N, 2002, J FORENSIC SCI, V47, P993; Walsh AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0437-0; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wen Y, 2016, AM J TRANSL RES, V8, P1412; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yeh YC, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00023-18	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222171	10.1371/journal.pone.0222171	http://dx.doi.org/10.1371/journal.pone.0222171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527871	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400010
J	Schmitz, K; Wagner, S; Reppke, M; Maier, CL; Windeisen-Holzhauser, E; Benz, JP				Schmitz, Kevin; Wagner, Sebastian; Reppke, Manfred; Maier, Christian Ludwig; Windeisen-Holzhauser, Elisabeth; Benz, J. Philipp			Preserving cultural heritage: Analyzing the antifungal potential of ionic liquids tested in paper restoration	PLOS ONE			English	Article							FUNGI; SALTS	Early industrialization and the development of cheap production processes for paper have led to an exponential accumulation of paper-based documents during the last two centuries. Archives and libraries harbor vast amounts of ancient and modern documents and have to undertake extensive endeavors to protect them from abiotic and biotic deterioration. While services for mechanical preservation such as ex post de-acidification of historic documents are already commercially available, the possibilities for long-term protection of paper-based documents against fungal attack (apart from temperature and humidity control) are very limited. Novel processes for mechanical enhancement of damaged cellulosic documents use Ionic Liquids (IL) as essential process components. With some of these ILs having azolefunctionalities similar to well-known fungicides such as Clotrimazole, the possibility of antifungal activities of these ILs was proposed but has not yet been experimentally confirmed. We evaluated the potency of four ILs with potential application in paper restoration for suppression of fungal growth on five relevant paper-infesting molds. The results revealed a general antifungal activity of all ILs, which increased with the size of the non-polar group. Physiological experiments and ultimate elemental analysis allowed to determine the minimal inhibitory concentration of each IL as well as the residual IL concentration in process-treated paper. These results provide valuable guidelines for IL-applications in paper restoration processes with antifungal activity as an added benefit. With azoles remaining in the paper after the process, simultaneous repair and biotic protection in treated documents could be facilitated.	[Schmitz, Kevin; Wagner, Sebastian; Reppke, Manfred; Windeisen-Holzhauser, Elisabeth; Benz, J. Philipp] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Wood Res Munich, Freising Weihenstephan, Germany; [Maier, Christian Ludwig] Ludwig Maximilians Univ Munchen, Fac Chem & Pharm, Munich, Germany; [Maier, Christian Ludwig] Nitrochem Aschau GmbH, Aschau, Germany	Technical University of Munich; University of Munich	Schmitz, K (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Wood Res Munich, Freising Weihenstephan, Germany.	schmitz@hfm.tum.de	Benz, J. Philipp/ABG-5009-2020	Benz, J. Philipp/0000-0001-5361-4514; Schmitz, Kevin/0000-0002-0278-4107	Nitrochemie Aschau GmbH	Nitrochemie Aschau GmbH	This research was partly funded by the Nitrochemie Aschau GmbH (https://www.nitrochemie.com/en/nitrochemie_group/home.php).CLM is an employee of this company, supplied the ionic liquids used in this study and was involved in data interpretation and manuscript proof reading. Other than this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study design was nevertheless independent of any influence by the company. There was no additional external funding received for this study.	Araque JC, 2015, J PHYS CHEM B, V119, P12727, DOI 10.1021/acs.jpcb.5b05506; Borrego Sofia, 2012, ISRN Microbiol, V2012, P680598, DOI 10.5402/2012/680598; Cedzova M, 2008, RESTAURATOR INT J PR, V27, P35, DOI [10.1515/REST.2006.35, DOI 10.1515/REST.2006.35]; Cedzova M, 2006, RESTAURATOR, V27, P35, DOI 10.1515/REST.2006.35; Area MC, 2011, BIORESOURCES, V6, P5307; da Silva M, 2006, INT BIODETER BIODEGR, V57, P163, DOI 10.1016/j.ibiod.2006.02.003; Ferreira A, 1996, FUNGAL GENETICS REPO, V43; Florian M-LE, 2004, J AM INT CONSERV, V43, P114; Gaumann E, 1964, FAMILIE MEANOSPORACE, V2, P104; GODEFROI EF, 1969, J MED CHEM, V12, P784, DOI 10.1021/jm00305a014; Hayes R, 2015, CHEM REV, V115, P6357, DOI 10.1021/cr500411q; Jiang ZC, 2018, SUSTAIN ENERG FUELS, V2, P936, DOI 10.1039/c8se00045j; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Krupp A, 2016, METHOD PROCESSING MA; LAKSHMIKANT, 1990, WORLD J MICROB BIOT, V6, P64, DOI 10.1007/BF01225357; Maier CL, 2019, THESIS; Mesquita N, 2009, INT BIODETER BIODEGR, V63, P626, DOI 10.1016/j.ibiod.2009.03.010; Nyuksha JP, 1980, RESTAURATOR, V4, P71, DOI [10.1515/rest.1980.4.1.71, DOI 10.1515/REST.1980.4.1.71]; Park N.-H., 2017, PHARM THERAPEUTICS D, V7th ed., P488, DOI DOI 10.1016/B978-0-323-39307-2.00034-5; Plempel M, 1969, Ger Med Mon, V14, P532; Qaisar S, 2014, CARBOHYD POLYM, V104, P199, DOI 10.1016/j.carbpol.2014.01.014; Ramin M, 2017, PROCESS TREATMENT MA; Rastegari AA, 2018, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: PENICILLIUM SYSTEM PROPERTIES AND APPLICATIONS, P153, DOI 10.1016/B978-0-444-63501-3.00008-9; Ricelli A, 1999, RESTAURATOR, V20, P97, DOI 10.1515/rest.1999.20.2.97; Sanmartin P, 2018, MICROB ECOL, V76, P64, DOI 10.1007/s00248-016-0770-4; Schonherr J, 2002, PEST MANAG SCI, V58, P343, DOI 10.1002/ps.462; Sequeira SO, 2014, RESTAURATOR, V35, P181, DOI 10.1515/res-2014-0005; Sequeira SO, 2019, CONSERV PATRIM, P18, DOI 10.14568/cp2018007; Shuter J, 1999, CANCER INVEST, V17, P145; Skora J, 2015, AEROBIOLOGIA, V31, P389, DOI 10.1007/s10453-015-9372-8; SUD IJ, 1979, ANTIMICROB AGENTS CH, V16, P660, DOI 10.1128/AAC.16.5.660; Szczepanowska H., 1992, J AM INT CONSERV, V31, P147, DOI DOI 10.2307/3179489; Vale I, 2014, PROCEEDINGS OF THE PROBLEM@WEB INTERNATIONAL CONFERENCE: TECHNOLOGY, CREATIVITY AND AFFECT IN MATHEMATICAL PROBLEM SOLVING, P229; Vogel HJ, 1956, MICROB GENET B, V13, P42; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wilkes JS, 2002, GREEN CHEM, V4, P73, DOI 10.1039/b110838g; Young D, 2018, BIORESOURCE TECHNOL, V268, P470, DOI 10.1016/j.biortech.2018.07.103; Zyska B, 1997, INT BIODETER BIODEGR, V40, P43, DOI 10.1016/S0964-8305(97)00061-9	38	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0219650	10.1371/journal.pone.0219650	http://dx.doi.org/10.1371/journal.pone.0219650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527882	Green Published, gold, Green Submitted			2022-12-27	WOS:000532231400004
J	Li, YL; Huang, TF; Fu, Y; Wang, TT; Zhao, TS; Guo, S; Sun, YJ; Yang, Y; Li, CZ				Li, Yongli; Huang, Tengfei; Fu, Yun; Wang, Tingting; Zhao, Tiesuo; Guo, Sheng; Sun, Yanjie; Yang, Yun; Li, Changzheng			Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; PYRROLIDINE DITHIOCARBAMATE; CYTOTOXIC ACTIVITY; TOPOISOMERASE-II; COPPER COMPLEX; UP-REGULATION; SOLID TUMORS; CANCER; CELLS	The progression of cancer through local expansion and metastasis is well recognized, but preventing these characteristic cancer processes is challenging. To this end, a new strategy is required. In this study, we presented a novel dual functional podophyllotoxin derivative, 2-pyridinealdehyde hydrazone dithiocarbamate S-propionate podophyllotoxin ester (Ptox(Pdp)), which inhibited both matrix metalloproteinases and Topoisomerase II. This new podophyllotoxin derivative exhibited significant anti-proliferative, anti-metastatic that correlated with the downregulation of matrix metalloproteinase. In a xenograft animal local expansion model, Ptox(Pdp) was superior to etoposide in tumor repression. A preliminary mechanistic study revealed that Ptox(Pdp) induced apoptosis and autophagy via the PI3K/AKT/mTOR pathway. Furthermore, Ptox(Pdp) could also inhibit epithelial-mesenchymal transition, which was achieved by downregulating both PI3K/AKT/mTOR and NF-kappa B/Snail pathways. Taken together, our results reveal that Ptox(Pdp) is a promising antitumor drug candidate.	[Li, Yongli] Xinxiang Med Univ, Sanquan Coll, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China; [Huang, Tengfei; Fu, Yun; Wang, Tingting; Zhao, Tiesuo; Guo, Sheng; Yang, Yun; Li, Changzheng] Xinxiang Med Univ, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China; [Sun, Yanjie; Li, Changzheng] Xinxiang Med Univ, Sanquan Coll, Expt Teaching Ctr Biol & Basic Med, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University	Li, YL (corresponding author), Xinxiang Med Univ, Sanquan Coll, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Sanquan Coll, Expt Teaching Ctr Biol & Basic Med, Xinxiang, Henan, Peoples R China.	changzhenl@yahoo.com; liyongli@sqmc.edu		Li, changzheng/0000-0002-6226-5843; Wang, Tingting/0000-0002-8320-3190	National Natural Science Foundation of China [21571153]; Science and Technology Department of Henan Province [14300510012, 152300410118]; Key Research Project Funding Program of Higher Educational Institutions of Henan Province [19A310021]; Sanquan College of Xinxiang Medical University [SQTD201703, SQTD201903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province; Key Research Project Funding Program of Higher Educational Institutions of Henan Province; Sanquan College of Xinxiang Medical University	This work was supported by the National Natural Science Foundation of China, 21571153 to CL; the Science and Technology Department of Henan Province, 14300510012 and152300410118 to CL; the Sanquan College of Xinxiang Medical University, SQTD201703 to CL; the Sanquan College of Xinxiang Medical University, SQTD201903 to YL and the Key Research Project Funding Program of Higher Educational Institutions of Henan Province, 19A310021 to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2016, ONCOTARGETS THER, V9, P1047, DOI 10.2147/OTT.S102907; Aguirre-Alvarado C, 2016, ONCOTARGET, V7, P23772, DOI 10.18632/oncotarget.8180; Bedford MR, 2013, J CLIN PHARMACOL, V53, P885, DOI 10.1002/jcph.113; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Buac D, 2012, MINI-REV MED CHEM, V12, P1193, DOI 10.2174/138955712802762040; Castro M. A., 2003, Phytochemistry Reviews, V2, P219, DOI 10.1023/B:PHYT.0000045496.97369.f9; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Cau SBA, 2011, BRIT J PHARMACOL, V164, P372, DOI 10.1111/j.1476-5381.2011.01360.x; Cau SBA, 2015, BASIC CLIN PHARMACOL, V117, P234, DOI 10.1111/bcpt.12400; Chen SW, 2004, BIOORG MED CHEM LETT, V14, P5063, DOI 10.1016/j.bmcl.2004.07.094; DeLano W.L, PYMOL MOL GRAPHICS S; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fu Y, 2014, INT J ONCOL, V45, P2092, DOI 10.3892/ijo.2014.2611; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Huang TF, 2015, INT J ONCOL, V47, P1854, DOI 10.3892/ijo.2015.3158; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kamal A, 2015, EXPERT OPIN THER PAT, V25, P1025, DOI 10.1517/13543776.2015.1051727; Kim KS, 2009, EUR J PHARMACOL, V613, P167, DOI 10.1016/j.ejphar.2009.04.026; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14814; Li WQ, 2013, BIOORGAN MED CHEM, V21, P2363, DOI 10.1016/j.bmc.2013.01.069; Liu YQ, 2007, MED CHEM RES, V16, P319, DOI 10.1007/s00044-007-9010-2; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Mansouri-Torshizi H, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/394506; Meunier B, 2008, ACCOUNTS CHEM RES, V41, P69, DOI 10.1021/ar7000843; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Nadella V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00106; Nardon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084248; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Ok K, 2013, B KOREAN CHEM SOC, V34, P1051, DOI 10.5012/bkcs.2013.34.4.1051; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orrenius S, 1996, BIOCHEM SOC T, V24, P1032, DOI 10.1042/bst0241032; Pan XH, 2011, CANCER LETT, V313, P181, DOI 10.1016/j.canlet.2011.09.001; Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponnurangam S, 2013, MOL CANCER THER, V12, P598, DOI 10.1158/1535-7163.MCT-12-0907; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Showkat Mehvish, 2014, Mol Biol Int, V2014, P686984, DOI 10.1155/2014/686984; Solovyan VT, 2002, J BIOL CHEM, V277, P21458, DOI 10.1074/jbc.M110621200; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang TT, 2016, MOLECULES, V21, DOI 10.3390/molecules21081088; Xiao L, 2014, EUR J MED CHEM, V80, P267, DOI 10.1016/j.ejmech.2014.03.082; YOKOYAMA M, 1991, CANCER RES, V51, P3229; Zhang KJ, 2011, HEPATO-GASTROENTEROL, V58, P1; Zhang L, 2017, MOLECULES, V22, DOI 10.3390/molecules22040628; Zhang L, 2016, EUR J MED CHEM, V123, P226, DOI 10.1016/j.ejmech.2016.07.050; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zhao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17175; ZHOU JX, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0018986	69	12	12	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0215886	10.1371/journal.pone.0215886	http://dx.doi.org/10.1371/journal.pone.0215886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557166	gold, Green Published			2022-12-27	WOS:000532345500003
J	Moumi, NA; Das, B; Promi, ZT; Bristy, NA; Bayzid, MS				Moumi, Nazifa Ahmed; Das, Badhan; Promi, Zarin Tasnim; Bristy, Nishat Anjum; Bayzid, Md Shamsuzzoha			Quartet-based inference of cell differentiation trees from ChIP-Seq histone modification data	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TRANSITIONS; EVOLUTION; H3K4ME3	Understanding cell differentiation-the process of generation of distinct cell-types-plays a pivotal role in developmental and evolutionary biology. Transcriptomic information and epigenetic marks are useful to elucidate hierarchical developmental relationships among cell-types. Standard phylogenetic approaches such as maximum parsimony, maximum likelihood and neighbor joining have previously been applied to ChIP-Seq histone modification data to infer cell-type trees, showing how diverse types of cells are related. In this study, we demonstrate the applicability and suitability of quartet-based phylogenetic tree estimation techniques for constructing cell-type trees. We propose two quartet-based pipelines for constructing cell phylogeny. Our methods were assessed for their validity in inferring hierarchical differentiation processes of various cell-types in H3K4me3, H3K27me3, H3K36me3, and H3K27ac histone mark data. We also propose a robust metric for evaluating cell-type trees.	[Moumi, Nazifa Ahmed; Das, Badhan; Promi, Zarin Tasnim; Bristy, Nishat Anjum; Bayzid, Md Shamsuzzoha] Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Bayzid, MS (corresponding author), Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh.	shams_bayzid@cse.buet.ac.bd		Das, Badhan/0000-0002-5327-9952	Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh	Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh	This work was partially supported by the Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh.; We thank Rezwana Reaz for providing necessary scripts to set up the quartet-based pipelines using QFM. This work was partially supported by the Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Allman ES, 2011, J MATH BIOL, V62, P833, DOI 10.1007/s00285-010-0355-7; Ane C, 2007, MOL BIOL EVOL, V24, P412; [Anonymous], 2009, BATCH EFFECTS NOISE; [Anonymous], 2011, PRINCIPAL COMPONENT; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Avni E, 2015, SYST BIOL, V64, P233, DOI 10.1093/sysbio/syu087; Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeGiorgio M, 2010, MOL BIOL EVOL, V27, P552, DOI 10.1093/molbev/msp250; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2013, SYST BIOL, V62, P574, DOI 10.1093/sysbio/syt023; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Fishburn P. C., 1985, INTERVAL ORDERS INTE; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu X, 2016, BRIEF BIOINFORM, V17, P249, DOI 10.1093/bib/bbv041; Hay ED, 1995, ACTA ANAT, V154, P8; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kin K, 2015, J EXP ZOOL PART B, V324, P653, DOI 10.1002/jez.b.22657; Kin K, 2015, CELL REP, V10, P1398, DOI 10.1016/j.celrep.2015.01.062; Koyanagi KO, 2015, GENOME BIOL EVOL, V7, P699, DOI 10.1093/gbe/evv024; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; LOBE CG, 1992, CURR TOP DEV BIOL, V27, P351, DOI 10.1016/S0070-2153(08)60539-6; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair Nishanth Ulhas, 2013, Algorithms in Bioinformatics. 13th International Workshop, WABI 2013. Proceedings: LNCS 8126, P326, DOI 10.1007/978-3-642-40453-5_25; Nair NU, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2297-3; Nair NU, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-269; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Reaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104008; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Roch S, 2015, THEOR POPUL BIOL, V100, P56, DOI 10.1016/j.tpb.2014.12.005; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Snir S, 2010, IEEE ACM T COMPUT BI, V7, P704, DOI 10.1109/TCBB.2008.133; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEEL M, 1992, J CLASSIF, V9, P91, DOI 10.1007/BF02618470; Suzuki S, 2017, TRANSCR-AUSTIN, V8, P26, DOI 10.1080/21541264.2016.1246076; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094	62	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221270	10.1371/journal.pone.0221270	http://dx.doi.org/10.1371/journal.pone.0221270			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557185	gold, Green Published			2022-12-27	WOS:000532345500009
J	Strobl, B; Etter, S; van Meerveld, I; Seibert, J				Strobl, Barbara; Etter, Simon; van Meerveld, Ilja; Seibert, Jan			The CrowdWater game: A playful way to improve the accuracy of crowdsourced water level class data	PLOS ONE			English	Article							CITIZEN SCIENCE DATA; VOLUNTEERS; QUALITY; VALIDATION	Data quality control is important for any data collection program, especially in citizen science projects, where it is more likely that errors occur due to the human factor. Ideally, data quality control in citizen science projects is also crowdsourced so that it can handle large amounts of data. Here we present the CrowdWater game as a gamified method to check crowdsourced water level class data that are submitted by citizen scientists through the CrowdWater app. The app uses a virtual staff gauge approach, which means that a digital scale is added to the first picture taken at a site and this scale is used for water level class observations at different times. In the game, participants classify water levels based on the comparison of the new picture with the picture containing the virtual staff gauge. By March 2019, 153 people had played the CrowdWater game and 841 pictures were classified. The average water level for the game votes for the classified pictures was compared to the water level class submitted through the app to determine whether the game can improve the quality of the data submitted through the app. For about 70% of the classified pictures, the water level class was the same for the CrowdWater app and game. For a quarter of the classified pictures, there was disagreement between the value submitted through the app and the average game vote. Expert judgement suggests that for three quarters of these cases, the game based average value was correct. The initial results indicate that the CrowdWater game helps to identify erroneous water level class observations from the CrowdWater app and provides a useful approach for crowdsourced data quality control. This study thus demonstrates the potential of gamified approaches for data quality control in citizen science projects.	[Strobl, Barbara; Etter, Simon; van Meerveld, Ilja; Seibert, Jan] Univ Zurich, Dept Geog, Zurich, Switzerland; [Seibert, Jan] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	University of Zurich; Swedish University of Agricultural Sciences	Strobl, B (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.	barbara.strobl@geo.uzh.ch	Seibert, Jan/B-1432-2009	Seibert, Jan/0000-0002-6314-2124; Etter, Simon/0000-0002-7553-9102; van Meerveld, H.J./0000-0002-7547-3270; Strobl, Barbara/0000-0001-5530-4632	Swiss National Science Foundation [163008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (www.snf.ch; project 163008, CrowdWater). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luengo-Oroz MA, 2012, J MED INTERNET RES, V14, P207, DOI 10.2196/jmir.2338; Baaden M, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005955; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Crowston K, 2013, P ANN HICSS, P450, DOI 10.1109/HICSS.2013.413; Curtis V, 2014, APPL TRANSL GENOM, V3, P90, DOI 10.1016/j.atg.2014.07.001; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Engel Sarah R., 2002, American Entomologist, V48, P164; Etter S, 2018, HYDROL EARTH SYST SC, V22, P5243, DOI 10.5194/hess-22-5243-2018; Foody GM, 2013, T GIS, V17, P847, DOI 10.1111/tgis.12033; Franzoni C, 2014, RES POLICY, V43, P1, DOI 10.1016/j.respol.2013.07.005; Freitag A., 2016, CITIZEN SCI THEORY P, V1, P12, DOI DOI 10.5334/CSTP.6; Good BM, 2013, BIOINFORMATICS, V29, P1925, DOI 10.1093/bioinformatics/btt333; Goodchild MF, 2012, SPAT STAT-NETH, V1, P110, DOI 10.1016/j.spasta.2012.03.002; Haklay M, 2010, CARTOGR J, V47, P315, DOI 10.1179/000870410X12911304958827; Hennon CC, 2015, B AM METEOROL SOC, V96, DOI 10.1175/BAMS-D-13-00152.1; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Horowitz S, 2016, NAT COMMUN, V7; Iacovides I., 2013, CHI 13 EXTENDED ABST, P1101, DOI DOI 10.1145/2468356.2468553; Jennett C., 2016, J SCI COMMUNICATION, V15, P1; Jimenez M, 2019, INFORM SCIENCES, V479, P301, DOI 10.1016/j.ins.2018.12.011; Kampf S, 2018, EOS WASHINGTON DC, P99; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Koch J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178165; Law E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1197; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; MacDonald EA, 2015, SPACE WEATHER, V13, P548, DOI 10.1002/2015SW001214; Mavandadi S., 2012, PLOS ONE, V7, P1; Michelucci P., 2017, SCI STALL CATCHERS O; Michelucci P., 2017, CIT SCI ASS C 2017 S; Michelucci P, 2016, SCIENCE, V351, P32, DOI 10.1126/science.aad6499; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Ponciano L, 2014, COMPUT SCI ENG, V16, P52, DOI 10.1109/MCSE.2014.4; Ponti M., 2018, CITIZEN SCI THEORY P, V3, P1, DOI [DOI 10.5334/CSTP.101, 10.5334/cstp.101]; Prestopnik N, 2017, COMPUT HUM BEHAV, V68, P254, DOI 10.1016/j.chb.2016.11.035; Prestopnik NR, 2015, COMPUT HUM BEHAV, V52, P492, DOI 10.1016/j.chb.2015.05.051; Salk CF, 2016, INT J DIGIT EARTH, V9, P410, DOI 10.1080/17538947.2015.1039609; Sauermann H, 2015, P NATL ACAD SCI USA, V112, P679, DOI 10.1073/pnas.1408907112; Schrier K., 2016, KNOWLEDGE GAMES; See L, 2014, P AGILE 2014 INT C G, P3; See Linda, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0069958; Seibert J, 2019, HYDROL WASSERBEWIRTS, V63; Seibert J, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00070; Silvertown J, 2015, ZOOKEYS, P125, DOI 10.3897/zookeys.480.8803; Strobl B, 2020, HYDROLOG SCI J, V65, P823, DOI 10.1080/02626667.2019.1578966; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Swanson A, 2016, CONSERV BIOL, V30, P520, DOI 10.1111/cobi.12695; Tinati R, 2016, PROCEEDINGS OF THE 2016 ACM WEB SCIENCE CONFERENCE (WEBSCI'16), P45, DOI 10.1145/2908131.2908151; von Ahn L, 2006, COMPUTER, V39, P92, DOI 10.1109/MC.2006.196; Waldner F, 2019, REMOTE SENS ENVIRON, V221, P235, DOI 10.1016/j.rse.2018.10.039; Walker D, 2016, J HYDROL, V538, P713, DOI 10.1016/j.jhydrol.2016.04.062; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207; Wiggins M, 2011, TLS-TIMES LIT SUPPL, P14; Yu J., 2012, IEEE 8 INT C E SCI, P1, DOI DOI 10.1109/ESCIENCE.2012.6404472	60	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222579	10.1371/journal.pone.0222579	http://dx.doi.org/10.1371/journal.pone.0222579			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557184	Green Published, gold, Green Accepted			2022-12-27	WOS:000532345500023
J	Clarke, I; Grieve, J				Clarke, Isobelle; Grieve, Jack			Stylistic variation on the Donald Trump Twitter account: A linguistic analysis of tweets posted between 2009 and 2018	PLOS ONE			English	Article							DISCOURSE; SPOKEN; STYLE	Twitter was an integral part of Donald Trump's communication platform during his 2016 campaign. Although its topical content has been examined by researchers and the media, we know relatively little about the style of the language used on the account or how this style changed over time. In this study, we present the first detailed description of stylistic variation on the Trump Twitter account based on a multivariate analysis of grammatical co-occurrence patterns in tweets posted between 2009 and 2018. We identify four general patterns of stylistic variation, which we interpret as representing the degree of conversational, campaigning, engaged, and advisory discourse. We then track how the use of these four styles changed over time, focusing on the period around the campaign, showing that the style of tweets shifts systematically depending on the communicative goals of Trump and his team. Based on these results, we propose a series of hypotheses about how the Trump campaign used social media during the 2016 elections.	[Clarke, Isobelle; Grieve, Jack] Univ Birmingham, Dept English Language & Linguist, Birmingham, W Midlands, England	University of Birmingham	Grieve, J (corresponding author), Univ Birmingham, Dept English Language & Linguist, Birmingham, W Midlands, England.	j.grieve@bham.ac.uk						Ahmadian S, 2017, PERS INDIV DIFFER, V107, P49, DOI 10.1016/j.paid.2016.11.018; Al Rashdi F, 2018, DISCOURSE CONTEXT ME, V26, P117, DOI 10.1016/j.dcm.2018.07.001; Andersson A, 2019, POTENTIAL ANAL, V50, P347, DOI 10.1007/s11118-018-9685-7; [Anonymous], 2016, FORTUNE; Asenas J. J., 2018, TABOO J CULTURE ED, V17, P36, DOI [10.31390/taboo.17.2.06, DOI 10.31390/TABOO.17.2.06]; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; Benzecri J. P., 1979, CAHIERS ANAL DONNEES, V4, P377; BESNIER N, 1988, LANGUAGE, V64, P707, DOI 10.2307/414565; Biber D., 1993, LIT LINGUIST COMPUT, V8, P243, DOI [DOI 10.1093/LLC/8.4.243, 10.1093/llc/8.4.243]; Biber D, 1994, SOCIOLINGUISTIC PERS, P182; Biber D., 2014, MULTIDIMENSIONAL ANA, pXXVI, DOI DOI 10.1075/SCL.60.005BIB; Biber D, 2006, CORPORA, V1, P1, DOI 10.3366/cor.2006.1.1.1; Biber D, 2016, J ENGL LINGUIST, V44, P95, DOI 10.1177/0075424216628955; Blodgett Su Lin, 2016, P 2016 C EMP METH NA, P1119, DOI DOI 10.18653/V1/D16-1120; Brown B, 2019, TRUMP TWITTER ARCH TRUMP TWITTER ARCH; Cillizza C., 2019, CNN; Clarke I., 2019, INT J SPEECH LANGUAG; Clarke I., 2017, P 1 WORKSHOP ABUSIVE, P1, DOI DOI 10.18653/V1/W17-3001; Clarke I, 2018, HUM-COMPUT INT-SPRIN, P151, DOI 10.1007/978-3-319-78583-7_7; Coats S, 2016, TOP ENGL LINGUIST, V93, P179; Collot M, 2012, COMPUTER MEDIATED CO; Crockett Z., 2016, VOX; Deumert A., 2006, ENCY LANGUAGE LINGUI, P121; Francis R, 2018, SOCIUS SOCIOLOGICAL, V4, P1, DOI [10.1177/2378023117736486, DOI 10.1177/2378023117736486]; Friginal E., 2009, LANGUAGE OUTSOURCED, DOI [10.1075/scl.34, DOI 10.1075/SCL.34]; Friginal E, 2018, STUDIES CORPUS BASED, DOI DOI 10.4324/9781315527819-15; Gimpel K., 2011, P 49 ANN M ASS COMP, P19, DOI DOI 10.21236/ADA547371; Glynn D, 2009, HUM COGN PROCESS, V24, P77; Graham David A., 2019, ATLANTIC; Greenacre M, 2006, STAT SOC BEHAV SCI, P197; Grieve J, 2018, 2018 14 AM ASS CORP; Grieve J, 2017, RPUBS; Grieve J, 2010, TEXT SPEECH LANG TEC, V42, P303, DOI 10.1007/978-90-481-9178-9_14; Hall K, 2016, HAU-J ETHNOGR THEORY, V6, P71, DOI 10.14318/hau6.2.009; Harris M., 2019, MEDIAQUANT; Honey C., 2009, 42 HAWAII INT C SYST, P1, DOI [10.1109/HICSS.2009.89, DOI 10.1109/HICSS.2009.89]; Isenstadt Alex, 2018, POLITICO; Keltner D., 2007, GREATER GOOD; Kilibarda K, 2016, SLATE MAGAZINE; Kim Y., 1994, SOCIOLINGUISTIC PERS, P157; Le Roux B., 2009, MULTIPLE CORRES ANAL, DOI [10.4135/9781412993906, DOI 10.4135/9781412993906]; Lee J, 2018, NYTIMES; Lee J, 2018, PUBLIC RELAT REV, V44, P201, DOI 10.1016/j.pubrev.2017.10.002; Leonhardt D, 2017, NYTIMES; Lewandowsky S, 2017, J APPL RES MEM COGN, V6, P353, DOI 10.1016/j.jarmac.2017.07.008; Liu F, 2012, 50 ANN M ASS COMP LI, P1035; MacWilliams MC, 2016, PS-POLIT SCI POLIT, V49, P716, DOI 10.1017/S1049096516001463; Manggong L., 2017, 2017 INT SEM LANG MA; Martin James R., 2005, LANGUAGE EVALUATION, DOI [10.1057/9780230511910, DOI 10.1057/9780230511910]; Marx J., 2017, J POLIT, P17; Morris DS, 2016, SOC SCI COMPUT REV, P1; Ott BL, 2017, CRIT STUD MEDIA COMM, V34, P59, DOI 10.1080/15295036.2016.1266686; Padilla-Melendez A, 2013, COMPUT EDUC, V63, P306, DOI 10.1016/j.compedu.2012.12.014; Page R, 2012, DISCOURSE COMMUN, V6, P181, DOI 10.1177/1750481312437441; Parkins R, 2012, PRAGMATICS INTERCULT, V5, P46; Passonneau Rebecca J, 2014, P COLING 2014 25 INT, P565; Potts L., 2017, PROBLEM DEFINITION C; Quelch J, 2017, HARVARD BUSINESS SCH; Robinson D., 2016, VARIANCE EXPLAINED; Roenneberg T, 2017, CURR BIOL, V27, DOI 10.1016/j.cub.2017.08.005; Sampathkumar M., 2018, INDEPENDENT; Santini M, 2005, P 10 EUR SUMM SCH LO, P276; Schmidbauer H, 2018, COMPUT HUM BEHAV, V81, P148, DOI 10.1016/j.chb.2017.11.021; Shen L., 2016, FORTUNE; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Staples Lee, 2016, ROOTS POWER MANUAL G, V3rd; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Thompson P, 2017, INT J CORPUS LINGUIS, V22, P153, DOI 10.1075/ijcl.22.2.01tho; Titak A, 2013, CORPORA, V8, P235, DOI 10.3366/cor.2013.0042; Toosi Nahal., 2016, POLITICO; TRUMPED Orme B., 2017, ETHICS NEWS EJN REPO, P6; Tummers J, 2016, 11 INT C STAT AN TEX, P923; Ursin CN, 2017, MEDIUM; Van Dijk TA, 2006, DISCOURSE SOC, V17, P359, DOI 10.1177/0957926506060250; Vrana L, 2017, 2017 9 INT CORP LING; Wang Y., 2016, ARXIV160303099V1, P719; Wells C, 2016, POLIT COMMUN, V33, P669, DOI 10.1080/10584609.2016.1224416; WERRY C. C., 1996, COMPUTER MEDIATED CO, P47, DOI [DOI 10.1075/PBNS.39.06WER, 10.1075/pbns.39.06wer]; White, 2003, TEXT, V23, P259, DOI [10.12987/yale/9780300099270.003.0011, DOI 10.1515/TEXT.2003.011]; White M., 1994, THESIS NO ARIZONA U; Yaqub U, 2017, GOV INFORM Q, V34, P613, DOI 10.1016/j.giq.2017.11.001; Zappavigna M, 2011, NEW MEDIA SOC, V13, P788, DOI 10.1177/1461444810385097; Zimmer, 2017, ATLANTIC	85	24	24	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222062	10.1371/journal.pone.0222062	http://dx.doi.org/10.1371/journal.pone.0222062			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553740	gold, Green Published			2022-12-27	WOS:000532319200011
J	Li, YC; Saxe, R; Anzellotti, S				Li, Yichen; Saxe, Rebecca; Anzellotti, Stefano			Intersubject MVPD: Empirical comparison of fMRI denoising methods for connectivity analysis	PLOS ONE			English	Article							RESTING STATE FMRI; FUNCTIONAL CONNECTIVITY; CORTEX; ARTIFACT; SIGNAL	Noise is a major challenge for the analysis of fMRI data in general and for connectivity analyses in particular. As researchers develop increasingly sophisticated tools to model statistical dependence between the fMRI signal in different brain regions, there is a risk that these models may increasingly capture artifactual relationships between regions, that are the result of noise. Thus, choosing optimal denoising methods is a crucial step to maximize the accuracy and reproducibility of connectivity models. Most comparisons between denoising methods require knowledge of the ground truth: of what is the 'real signal'. For this reason, they are usually based on simulated fMRI data. However, simulated data may not match the statistical properties of real data, limiting the generalizability of the conclusions. In this article, we propose an approach to evaluate denoising methods using real (non-simulated) fMRI data. First, we introduce an intersubject version of multivariate pattern dependence (iMVPD) that computes the statistical dependence between a brain region in one participant, and another brain region in a different participant. iMVPD has the following advantages: 1) it is multivariate, 2) it trains and tests models on independent partitions of the real fMRI data, and 3) it generates predictions that are both between subjects and between regions. Since whole-brain sources of noise are more strongly correlated within subject than between subjects, we can use the difference between standard MVPD and iMVPD as a 'discrepancy metric' to evaluate denoising techniques (where more effective techniques should yield smaller differences). As predicted, the difference is the greatest in the absence of denoising methods. Furthermore, a combination of removal of the global signal and CompCorr optimizes denoising (among the set of denoising options tested).	[Li, Yichen] NYU, Courant Inst Math Sci, New York, NY USA; [Li, Yichen] NYU, Dept Comp Sci, New York, NY USA; [Li, Yichen; Saxe, Rebecca] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Anzellotti, Stefano] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	New York University; New York University; Massachusetts Institute of Technology (MIT); Boston College	Anzellotti, S (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	stefano.anzellotti@bc.edu		Anzellotti, Stefano/0000-0002-8964-6988; Li, Yichen/0000-0003-0435-5522	NIH [R01 6933949]; Boston College	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston College	Researchers were supported by a NIH grant R01 6933949 to Rebecca Saxe and a startup grant from Boston College to Stefano Anzellotti.	Anzellotti S, 2018, TRENDS COGN SCI, V22, P258, DOI 10.1016/j.tics.2017.12.002; Anzellotti S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005799; Anzellotti S, 2016, CEREB CORTEX, V26, P1900, DOI 10.1093/cercor/bhu337; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bishop CM, 1999, ADV NEUR IN, V11, P382; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Coutanche MN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00015; Crowe DA, 2013, NAT NEUROSCI, V16, P1484, DOI 10.1038/nn.3509; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gorgolewski KJ, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.44; Guntupalli JS, 2010, CHANCE, V1, P7; Hanke M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.92; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Ishai A, 2008, NEUROIMAGE, V40, P415, DOI 10.1016/j.neuroimage.2007.10.040; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Joshi AA, 2018, NEUROIMAGE, V172, P740, DOI 10.1016/j.neuroimage.2018.01.058; Kriegeskorte N., 2015, BIORXIV; Labs Annika, 2015, F1000Res, V4, P92, DOI 10.12688/f1000research.6230.1; Liu TT, 2016, NEUROIMAGE, V143, P141, DOI 10.1016/j.neuroimage.2016.09.008; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Moodie, 2018, BIORXIV, DOI [10.1101/306951, DOI 10.1101/306951, 10.1038/s41592-018, DOI 10.1038/S41592-018-0235-4]; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Sengupta A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.93; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222914	10.1371/journal.pone.0222914	http://dx.doi.org/10.1371/journal.pone.0222914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550276	Green Published, gold, Green Submitted			2022-12-27	WOS:000532307700033
J	Munch, MM; Chambers, LC; Manhart, LE; Domogala, D; Lopez, A; Fredricks, DN; Srinivasan, S				Munch, Matthew M.; Chambers, Laura C.; Manhart, Lisa E.; Domogala, Dan; Lopez, Anthony; Fredricks, David N.; Srinivasan, Sujatha			Optimizing bacterial DNA extraction in urine	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; CHAIN-REACTION; IDENTIFICATION; MICROBIOME; PCR; SPECIMENS; WOMEN	Urine is an acceptable, non-invasive sample for investigating the human urogenital microbiota and for the diagnosis of sexually transmitted infections. However, low quantities of bacterial DNA and PCR inhibitors in urine may prevent efficient PCR amplification for molecular detection of bacteria. Furthermore, cold temperatures used to preserve DNA and bacteria in urine can promote precipitation of crystals that interfere with DNA extraction. Saline, Dulbecco's Phosphate Buffered Saline, or Tris-EDTA buffer were added to urine from adult men to determine if crystal precipitation could be reversed without heating samples beyond ambient temperature. Total bacterial DNA concentrations and PCR inhibition were measured using quantitative PCR assays to compare DNA yields with and without buffer addition. Dissolution of crystals with Tris-EDTA prior to urine centrifugation was most effective in increasing bacterial DNA recovery and reducing PCR inhibition. DNA recovery using Tris-EDTA was further tested by spiking urine with DNA from bacterial isolates and median concentrations of Lactobacillus jensenii and Escherichia coli 16S rRNA gene copies were found to be higher in urine processed with Tris-EDTA. Maximizing bacterial DNA yield from urine may facilitate more accurate assessment of bacterial populations and increase detection of specific bacteria in the genital tract.	[Munch, Matthew M.; Domogala, Dan; Lopez, Anthony; Fredricks, David N.; Srinivasan, Sujatha] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Chambers, Laura C.; Manhart, Lisa E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Manhart, Lisa E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fredhutch.org			National Institute of Allergy and Infectious Diseases [U19 AI113173, R01 AI110666]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110666, U19AI113173] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), U19 AI113173 to LEM and DNF and R01 AI110666 to LEM and DNF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy MG, 2017, OBSTET GYNECOL, V129, P500, DOI 10.1097/AOG.0000000000001892; Ackerman AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210306; Alanee S, 2019, PROSTATE, V79, P81, DOI 10.1002/pros.23713; Apoola A, 2011, SEX TRANSM INFECT, V87, P110, DOI 10.1136/sti.2010.042861; BRUNZEL NA, 2018, FUNDAMENTALS URINE B; Chambers LC, 2019, SEX TRANSM INFECT, V95, P212, DOI 10.1136/sextrans-2018-053634; Chen ZR, 2018, INT UROGYNECOL J, V29, P1775, DOI 10.1007/s00192-018-3679-2; Daudon M, 2015, CLIN CHEM LAB MED, V53, pS1479, DOI 10.1515/cclm-2015-0860; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Fogazzi GB, 1996, NEPHROL DIAL TRANSPL, V11, P379, DOI 10.1093/oxfordjournals.ndt.a027276; Fok C, 2018, INT UROGYNECOL J, V29, P1765, DOI 10.1007/s00192-018-3732-1; Frolund M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201380; Gottschick C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0305-3; Haber MH, 2002, CLIN LAB MED, P533; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Horwitz D, 2015, J INFECTION, V71, P358, DOI 10.1016/j.jinf.2015.05.014; Karstens L, 2018, NAT REV UROL, V15, P735, DOI 10.1038/s41585-018-0104-z; Karstens L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00078; KHAN G, 1991, J CLIN PATHOL, V44, P360, DOI 10.1136/jcp.44.5.360; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Komesu Y, 2018, INT UROGYNECOL J, V29, P1785, DOI 10.1007/s00192-018-3683-6; Kramer H, 2018, INT UROL NEPHROL, V50, P1123, DOI 10.1007/s11255-018-1860-7; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling ZX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01032; Liu FP, 2017, ONCOTARGET, V8, P100678, DOI 10.18632/oncotarget.21126; Liu FP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00126; Mahony J, 1998, J CLIN MICROBIOL, V36, P3122, DOI 10.1128/JCM.36.11.3122-3126.1998; McKechnie ML, 2009, J CLIN MICROBIOL, V47, P1871, DOI 10.1128/JCM.00120-09; Meyer T, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4030025; Moustafa A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22660-8; Napierala M, 2015, DIAGN MICR INFEC DIS, V82, P194, DOI 10.1016/j.diagmicrobio.2015.03.016; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Nienhouse V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114185; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Popovic VB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29054-w; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Rani A, 2017, TRANSL RES, V181, P59, DOI 10.1016/j.trsl.2016.08.008; Saetun P, 2009, AM J PHYSIOL-RENAL, V296, pF1346, DOI 10.1152/ajprenal.90736.2008; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Shrestha E, 2018, J UROLOGY, V199, P161, DOI 10.1016/j.juro.2017.08.001; Siddiqui H, 2011, BMC MICROBIOL, V11, P1; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Thomas-White K, 2016, CURR BLADDER DYSFUNC, V11, P18, DOI 10.1007/s11884-016-0345-8; Thomas-White K, 2018, INT UROGYNECOL J, V29, P1797, DOI 10.1007/s00192-018-3767-3; Thomas-White KJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.049; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Van Der Pol B, 2016, J CLIN MICROBIOL, V54, P7, DOI 10.1128/JCM.02025-15; Wang HN, 2017, ONCOTARGET, V8, P88122, DOI 10.18632/oncotarget.21490; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wu JF, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13436; Wu P, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00167; Wu P, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00488	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222962	10.1371/journal.pone.0222962	http://dx.doi.org/10.1371/journal.pone.0222962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550285	gold, Green Published			2022-12-27	WOS:000532307700037
J	Hardardottir, HM; Male, R; Nilsen, F; Dalvin, S				Hardardottir, Hulda Maria; Male, Rune; Nilsen, Frank; Dalvin, Sussie			Effects of chitin synthesis inhibitor treatment on Lepeophtheirus salmonis (Copepoda, Caligidae) larvae	PLOS ONE			English	Article							SEA LICE; MOLECULAR CHARACTERIZATION; 1 GENE; DIFLUBENZURON; GROWTH; TEFLUBENZURON; RESISTANCE; REGULATOR; INSECTICIDES; EXPRESSION	The salmon louse (Lepeophtheirus salmonis) is an ectoparasite infecting Atlantic salmon (Salmo salar), which causes substantial problems to the salmon aquaculture and threatens wild salmon. Chitin synthesis inhibitors (CSIs) are used to control L. salmonis in aquaculture. CSIs act by interfering with chitin formation and molting. In the present study, we investigated the action of four CSIs: diflubenzuron (DFB), hexaflumuron (HX), lufenuron (LF), and teflubenzuron (TFB) on larval molt. As the mode of action of CSIs remains unknown, we selected key enzymes in chitin metabolism and investigated if CSI treatment influenced the transcriptional level of these genes. All four CSIs interfered with the nauplius II molt to copepodids in a dose-dependent manner. The EC50 values were 93.2 nM for diflubenzuron, 1.2 nM for hexaflumuron, 22.4 nM for lufenuron, and 11.7 nM for teflubenzuron. Of the investigated genes, only the transcriptional level of L. salmonis chitin synthase 1 decreased significantly in hexaflumuron and diflubenzuron-treated larvae. All the tested CSIs affected the molt of nauplius II L. salmonis larvae but at different concentrations. The larvae were most sensitive to hexaflumuron and less sensitive to diflubenzuron. None of the CSIs applied had a strong impact on the transcriptional level of chitin synthesis or chitinases genes in L. salmonis. Further research is necessary to get more knowledge of the nature of the inhibition of CSI and may require methods such as studies of protein structure and enzymological studies.	[Hardardottir, Hulda Maria; Male, Rune; Nilsen, Frank; Dalvin, Sussie] Univ Bergen, Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway; [Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Dalvin, S (corresponding author), Univ Bergen, Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway.; Dalvin, S (corresponding author), Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway.	sussie.dalvin@hi.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710	Research Council of Norway, SFI-Sea Lice Research Centre [203513/O30]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	This research was fully funded by the Research Council of Norway, SFI-Sea Lice Research Centre, grant number 203513/O30 to HMH, RM, FN, and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2016, J FISH DIS, V39, P1213, DOI 10.1111/jfd.12463; Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Abehsera S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122602; Al-Mokhlef A. A., 2012, Annals of Agricultural Science (Cairo), V57, P113, DOI 10.1016/j.aoas.2012.03.010; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; BINNINGTON KC, 1985, TISSUE CELL, V17, P131, DOI 10.1016/0040-8166(85)90021-7; Branson EJ, 2000, AQUAC RES, V31, P861, DOI 10.1046/j.1365-2109.2000.00509.x; CHRISTIANSEN ME, 1982, MAR BIOL, V66, P217, DOI 10.1007/BF00397025; CHRISTIANSEN ME, 1978, MAR BIOL, V50, P29, DOI 10.1007/BF00390539; Coppen GDA, 1996, PESTIC SCI, V46, P183, DOI 10.1002/(SICI)1096-9063(199602)46:2&lt;183::AID-PS343&gt;3.0.CO;2-1; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; CUNNINGHAM PA, 1986, ENVIRON POLLUT A, V40, P63, DOI 10.1016/0143-1471(86)90058-9; Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113; Eichner C, 2015, EXP PARASITOL, V151, P39, DOI 10.1016/j.exppara.2015.01.011; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; GIJSWIJT MJ, 1979, PESTIC BIOCHEM PHYS, V12, P87, DOI 10.1016/0048-3575(79)90098-1; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hardardottir HM, 2019, COMP BIOCHEM PHYS A, V227, P123, DOI 10.1016/j.cbpa.2018.10.008; JULIN AM, 1978, MOSQ NEWS, V38, P256; Karimzadeh R, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5001; Khajepour S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10201; Langford KH, 2011, ENV SCREENING VET ME; Li XG, 2015, COMP BIOCHEM PHYS B, V187, P110, DOI 10.1016/j.cbpb.2015.05.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macken A, 2015, ENVIRON TOXICOL CHEM, V34, P1533, DOI 10.1002/etc.2920; MAYER RT, 1981, EXPERIENTIA, V37, P337, DOI 10.1007/BF01959848; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Merzendorfer H, 2012, INSECT BIOCHEM MOLEC, V42, P264, DOI 10.1016/j.ibmb.2011.12.008; Mommaerts V, 2006, PEST MANAG SCI, V62, P752, DOI 10.1002/ps.1238; Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8; NIMMO DR, 1979, B ENVIRON CONTAM TOX, V22, P767, DOI 10.1007/BF02027022; Niu SW, 2018, DEV COMP IMMUNOL, V85, P161, DOI 10.1016/j.dci.2018.04.013; Norwegian Veterinary Institute, 2016, US THER AG SALM LIC, P6; Olsvik PA, 2015, AQUAT TOXICOL, V167, P143, DOI 10.1016/j.aquatox.2015.07.008; Perez-Farinos G, 1998, PESTIC BIOCHEM PHYS, V61, P169, DOI 10.1006/pest.1998.2356; Poley JD, 2018, INT J PARASITOL-DRUG, V8, P174, DOI 10.1016/j.ijpddr.2018.02.007; POST LC, 1974, PESTIC BIOCHEM PHYS, V4, P473, DOI 10.1016/0048-3575(74)90072-8; Ritchie G, 2002, DIS AQUAT ORGAN, V51, P101, DOI 10.3354/dao051101; Saidy EL, 1989, PESTIC BIOCH PHYSL, V222, P211, DOI [10.1673/031.012.10201, DOI 10.1673/031.012.10201]; Sandlund L, 2016, MOL BIOCHEM PARASIT, V208, P65, DOI 10.1016/j.molbiopara.2016.06.007; SAVITZ JD, 1994, MAR ENVIRON RES, V37, P297, DOI 10.1016/0141-1136(94)90056-6; Skilbrei OT, 2015, DIS AQUAT ORGAN, V113, P187, DOI 10.3354/dao02832; Sun RF, 2015, J AGR FOOD CHEM, V63, P6847, DOI 10.1021/acs.jafc.5b02460; Suzuki Y, 2017, J PESTIC SCI, V42, P93, DOI 10.1584/jpestics.D17-023; Tan SH, 2000, MAR BIOTECHNOL, V2, P126; Tom M, 2014, J EXP BIOL, V217, P4193, DOI 10.1242/jeb.109009; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; VANECK WH, 1979, INSECT BIOCHEM, V9, P295, DOI 10.1016/0020-1790(79)90009-X; WEIS JS, 1987, AQUAT TOXICOL, V10, P279, DOI 10.1016/0166-445X(87)90003-8; Xia WK, 2014, INT J MOL SCI, V15, P3711, DOI 10.3390/ijms15033711; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zhang X, 2013, INSECT SCI, V20, P158, DOI 10.1111/j.1744-7917.2012.01568.x	55	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222520	10.1371/journal.pone.0222520	http://dx.doi.org/10.1371/journal.pone.0222520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545833	Green Published, gold			2022-12-27	WOS:000532303200019
J	Lin, CHJ; Caesaron, D; Woldegiorgis, BH				Lin, Chiuhsiang Joe; Caesaron, Dino; Woldegiorgis, Bereket Haile			The accuracy of the frontal extent in stereoscopic environments: A comparison of direct selection and virtual cursor techniques	PLOS ONE			English	Article							DISTANCE ESTIMATION; PERCEPTION; PERFORMANCE; JUDGMENTS; REALITY; DISPLAYS; OBJECTS; PLANE	This experiment investigated the accuracy of distance judgment and perception of the frontal extent in a stereoscopic environment. Eight virtual targets were projected in a circular arrangement with two center-to-center target distances (18 cm and 36 cm) and three target sizes (0.6 cm, 1.5 cm, and 3.7 cm). Fourteen participants judged the positions of virtual targets presented at a distance of 90 cm from them by employing two different interaction techniques: the direct selection technique and the virtual cursor technique. The results showed overall higher accuracy with the virtual cursor technique than with the direct selection technique. It was also found that the target size significantly affected the frontal extent accuracy. In addition, significant interactions between technique and center-to-center target distance were observed. The direct selection technique was more accurate at the 18 cm center-to-center target distance along the horizontal (x) and vertical (y) axes, while the virtual cursor technique was more accurate for the 36 cm center-to-center target distance along the y axis. During the direct selection, estimations tended to converge to the center of the virtual space; however, this convergence was not observed in the virtual cursor condition. The accuracy of pointing estimations suffered on the left side of participants. These findings could provide direction for virtual reality developers in selecting proper interaction techniques and appropriately positioning virtual targets in stereoscopic environments.	[Lin, Chiuhsiang Joe; Caesaron, Dino; Woldegiorgis, Bereket Haile] Natl Taiwan Univ Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan; [Caesaron, Dino] Telkom Univ, Sch Ind Engn, Dept Ind Management, Bandung, Indonesia	National Taiwan University of Science & Technology; Universitas Telkom	Lin, CHJ (corresponding author), Natl Taiwan Univ Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan.	chiuhsiangjoelin@gmail.com	Caesaron, Dino/AAC-8515-2021	Haile Woldegiorgis, Bereket/0000-0001-5563-7605	Ministry of Science and Technology of Taiwan [MOST 104-2221-E-0111-063-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST 104-2221-E-0111-063-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff B. M., 2012, P ACM S APPL PERCEPT, P71; [Anonymous], 2000, 92419 ISO I DIS, V1; Argelaguet F, 2013, COMPUT GRAPH-UK, V37, P121, DOI 10.1016/j.cag.2012.12.003; Berard F, 2009, SUPERIORITY MOUSE 3D; Bruder G., 2013, P 1 S SPAT US INT SU, P9, DOI [10.1145/2491367.2491369, DOI 10.1145/2491367.2491369]; Bruder G, 2013 IEEE S 3D US IN, DOI [10.1177/0018720819831517, DOI 10.1177/0018720819831517]; Bruder G, 2013, TOUCHING VOID REVISI; Bruder GS, 2015, PRESENCE-TELEOP VIRT, V25, P1, DOI [10.1109/TCYB.2018.2826016, DOI 10.1109/TCYB.2018.2826016]; Burno RA, 2015, PROCEDIA MANUF, V3, P4342, DOI 10.1016/j.promfg.2015.07.429; Chan LW, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2625; Chao CJ, 2017, HUM FACTOR ERGON MAN, V27, P187, DOI 10.1002/hfm.20702; Chen JY, 2017, APPL ERGON, V65, P437, DOI 10.1016/j.apergo.2017.03.013; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Cutting JE, 2003, LOOKING INTO PICTURES, P215; de Boer IR, 2016, EUR J DENT EDUC, V20, P142, DOI 10.1111/eje.12152; Deng CL, 2019, HUM FACTORS, V61, P879, DOI 10.1177/0018720819831517; Dey A, 2012, 2012 IEEE INT S MIX; Dey A, 2010, 2010 IEEE S 3D US IN; Geuss M., 2010, PROCE 7 S APPL PERCE, P61; Geuss MN, 2012, J EXP PSYCHOL HUMAN, V38, P1242, DOI 10.1037/a0027524; Grechkin TY, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1823738.1823744; Henry D, 1993, P IEEE VIRT REAL ANN; Interrante V, 2006, IEEE VIRT REAL C VR; Interrante V, 2008, PRESENCE-TELEOP VIRT, V17, P176, DOI 10.1162/pres.17.2.176; Jang Y, 2015, IEEE T VIS COMPUT GR, V21, P501, DOI 10.1109/TVCG.2015.2391860; Jerald J., 2016, VR BOOK HUMAN CTR DE; Jones JB, 2012, PLANT NUTRITION AND SOIL FERTILITY MANUAL, 2ND EDITION, P119; Kelly JW, 2018, ACM T APPL PERCEPT, V15, DOI 10.1145/3165285; Kelly JW, 2017, ACM T APPL PERCEPT, V15, DOI 10.1145/3106155; Kelly JW, 2015, ATTEN PERCEPT PSYCHO, V77, P1848, DOI 10.3758/s13414-015-0948-8; Kim K, 2012, 2012 IEEE VIRT REAL; Kunz BR, 2009, ATTEN PERCEPT PSYCHO, V71, P1284, DOI 10.3758/APP.71.6.1284; Lappin JS, 2006, PERCEPT PSYCHOPHYS, V68, P571, DOI 10.3758/BF03208759; Lemmerman DK, 2007, IEEE VIRTUAL REALITY 2007, PROCEEDINGS, P303; Lin CHJ, 2019, INT J IND ERGONOM, V72, P372, DOI 10.1016/j.ergon.2019.06.013; Lin CJ, 2017, APPL ERGON, V64, P66, DOI 10.1016/j.apergo.2017.05.007; Lin CJ, 2015, J SOC INF DISPLAY, V23, P319, DOI 10.1002/jsid.378; Lin CJ, 2014, J SOC INF DISPLAY, V22, P370, DOI 10.1002/jsid.269; Lin CJ, 2015, DISPLAYS, V36, P41, DOI 10.1016/j.displa.2014.11.006; Lin J, 2019, INT J HUM-COMPUT INT, V35, P1729, DOI 10.1080/10447318.2019.1571783; Loomis J.M., 2008, EMBODIMENT EGO SPACE, P1, DOI DOI 10.4324/9780203809891; Lubos P, 2014, 2014 IEEE S 3D US IN, DOI [10.1002/jsid.618, DOI 10.1002/JSID.618]; Mine M., 1995, VIRTUAL ENV INTERACT; Mine M. R., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P19, DOI 10.1145/258734.258747; Mohler B. J, 2010, P 7 S APPL PERC GRAP, P57, DOI [DOI 10.1145/1836248.1836258, 10.1145/1836248.1836258]; Naceri A., 2010, INT J ADV INTELL SYS, V3, P51; Naceri A, 2011, PRESENCE-TELEOP VIRT, V20, P254, DOI 10.1162/PRES_a_00048; Napieralski PE, 2011, ACM T APPL PERCEPT, V8, DOI 10.1145/2010325.2010328; Nguyen A, 2015, 2015 IEEE VIRTUAL RE; Poupyrev I, 1999, J VISUAL LANG COMPUT, V10, P19, DOI 10.1006/jvlc.1998.0112; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Richardson AR, 2005, APPL COGNITIVE PSYCH, V19, P1089, DOI 10.1002/acp.1140; Shen Y, 2011, INT J HUM-COMPUT INT, V27, P523, DOI 10.1080/10447318.2011.555297; Sodhi R, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2462007; Sugovic M, 2016, ACTA PSYCHOL, V165, P1, DOI 10.1016/j.actpsy.2016.01.012; Sun HM, 2015, APPL ERGON, V50, P126, DOI 10.1016/j.apergo.2015.03.006; Swan JE, 2015, IEEE T VIS COMPUT GR, V21, P1289, DOI 10.1109/TVCG.2015.2459895; Swan JE, 2006, IEEE VIRT REAL C VR; Waller D, 1999, PRESENCE-TELEOP VIRT, V8, P657, DOI 10.1162/105474699566549; Wang Y, 1999, EFFECTS ORIENTATION; Wartenberg C, 2003, PRESENCE-TELEOP VIRT, V12, P196, DOI 10.1162/105474603321640941; Webel S, 2013, ROBOT AUTON SYST, V61, P398, DOI 10.1016/j.robot.2012.09.013; Werkhoven PJ, 1998, HUM FACTORS, V40, P432, DOI 10.1518/001872098779591322; Witt JK, 2007, PERCEPTION, V36, P1752, DOI 10.1068/p5617; Woldegiorgis BH, 2017, J SOC INF DISPLAY, V25, P701, DOI 10.1002/jsid.618; Yamamoto N., 2018, ENCY CLIN NEUROPSYCH, P1198	66	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222751	10.1371/journal.pone.0222751	http://dx.doi.org/10.1371/journal.pone.0222751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545829	Green Published, gold			2022-12-27	WOS:000532303200031
J	Potashkin, JA; Bottero, V; Santiago, JA; Quinn, JP				Potashkin, Judith A.; Bottero, Virginie; Santiago, Jose A.; Quinn, James P.			Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients	PLOS ONE			English	Article							ENTORHINAL CORTEX; COGNITIVE IMPAIRMENT; SENILE PLAQUES; DISEASE; ATROPHY; HIPPOCAMPAL; BRAIN; MORPHOLOGY; DIAGNOSIS; PATHOLOGY	The dementia epidemic is likely to expand worldwide as the aging population continues to grow. A better understanding of the molecular mechanisms that lead to dementia is expected to reveal potentially modifiable risk factors that could contribute to the development of prevention strategies. Alzheimer's disease is the most prevalent form of dementia. Currently we only partially understand some of the pathophysiological mechanisms that lead to development of the disease in aging individuals. In this study, Switch Miner software was used to identify key switch genes in the brain whose expression may lead to the development of Alzheimer's disease. The results indicate that switch genes are enriched in pathways involved in the proteasome, oxidative phosphorylation, Parkinson's disease, Huntington's disease, Alzheimer's disease and metabolism in the hippocampus and posterior cingulate cortex. Network analysis identified the krupel like factor 9 (KLF9), potassium channel tetramerization domain 2 (KCTD2), Sp1 transcription factor (SP1) and chromodomain helicase DNA binding protein 1 (CHD1) as key transcriptional regulators of switch genes in the brain of AD patients. These transcriptions factors have been implicated in conditions associated with Alzheimer's disease, including diabetes, glucocorticoid signaling, stroke, and sleep disorders. The specific pathways affected reveal potential modifiable risk factors by lifestyle changes.	[Potashkin, Judith A.; Bottero, Virginie] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA; [Santiago, Jose A.] NeuroHub Analyt LLC, Chicago, IL USA; [Quinn, James P.] Q Regulating Syst LLC, Gurnee, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Santiago, Jose A./0000-0002-1431-5789; Potashkin, Judith/0000-0002-8782-3071	National Institute on Aging (NIA) [R01AG062176]; NATIONAL INSTITUTE ON AGING [R01AG062176] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.P. received funding from National Institute on Aging (NIA) (https://www.nia.nih.gov/) grant number R01AG062176. The NIA had not role in the design, data collection and analysis, decision to publish or preparation of this manuscript. NeuroHub Analytics, LLC. and Q Regulating Systems, LLC provided support in the form of salaries for authors J.P.Q. and J.A.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; This study was funded by the National Institute on Aging (NIA) grant number R01AG062176 to JAP. The NIA had no role in the design, data collection and analysis, decision to publish or preparation of this manuscript.	Angelie E, 2001, AM J NEURORADIOL, V22, P119; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berson A, 2017, CURR BIOL, V27, P3579, DOI 10.1016/j.cub.2017.10.024; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boada M, 2014, MOL PSYCHIATR, V19, P682, DOI 10.1038/mp.2013.86; Bobinski M, 1999, LANCET, V353, P38, DOI 10.1016/S0140-6736(05)74869-8; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caberlotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078919; Canet G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00739; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Citron Bruce A, 2015, Am J Neurodegener Dis, V4, P40; Cui AF, 2019, J CLIN INVEST, V129, P2266, DOI 10.1172/JCI66062; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; DELEON MJ, 1989, LANCET, V2, P672; Dennis G, 2003, GENOME BIOL, V4; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Fiscon G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090437; Fiscon G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26081-5; Fox NC, 1996, ANN NY ACAD SCI, V777, P226, DOI 10.1111/j.1749-6632.1996.tb34423.x; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Green CD, 2017, CELL REP, V18, P2957, DOI 10.1016/j.celrep.2017.03.001; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; MAPES J, 2017, PLOS GENET, V13, DOI DOI 10.1371/JOURNAL.PGEN.1006815; Metsaars WP, 2003, NEUROBIOL AGING, V24, P563, DOI 10.1016/S0197-4580(02)00134-3; MIELKE R, 1994, DEMENTIA, V5, P36, DOI 10.1159/000106692; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Ouanes S, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00043; Paci P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44797; Palumbo MC, 2014, PLANT CELL, V26, P4617, DOI 10.1105/tpc.114.133710; Patterson C, 2018, STATE ART DEMENTIA R; Pirone L, 2016, BIOCHIMIE, V131, P106, DOI 10.1016/j.biochi.2016.09.013; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rajan KB, 2015, NEUROLOGY, V85, P898, DOI 10.1212/WNL.0000000000001774; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; ROGERS J, 1985, J NEUROSCI, V5, P2801; Schoberleitner I, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00003; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Traylor M, 2016, ANN NEUROL, V79, P739, DOI 10.1002/ana.24621; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052	54	15	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222921	10.1371/journal.pone.0222921	http://dx.doi.org/10.1371/journal.pone.0222921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545826	gold, Green Published			2022-12-27	WOS:000532303200041
J	Lawrence, DW; Shornick, LP; Kornbluth, J				Lawrence, Donald W.; Shornick, Laurie P.; Kornbluth, Jacki			Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN LIGASE NKLAM; LYTIC-ASSOCIATED MOLECULE; STAT1; AUTOPHAGY; INVOLVEMENT; ACTIVATION; EXPRESSION; P65	Recent studies have begun to elucidate a role for E3 ubiquitin ligases as important mediators of the innate immune response. Our previous work defined a role for the ubiquitin ligase natural killer lytic-associated molecule (NKLAM/RNF19b) in mouse and human innate immunity. Here, we present novel data describing a role for NKLAM in regulating the immune response to Sendai virus (SeV), a murine model of paramyxoviral pneumonia. NKLAM expression was significantly upregulated by SeV infection. SeV-infected mice that are deficient in NKLAM demonstrated significantly less weight loss than wild type mice. In vivo, Sendai virus replication was attenuated in NKLAM(-/-) mice. Autophagic flux and the expression of autophagy markers LC3 and p62/SQSTM1 were also less in NKLAM(-/-) mice. Using flow cytometry, we observed less neutrophils and macrophages in the lungs of NKLAM(-/-) mice during SeV infection. Additionally, phosphorylation of STAT1 and NF kappa B p65 was lower in NKLAM(-/-) than wild type mice. The dysregulated phosphorylation profile of STAT1 and NF kappa B in NKLAM(-/-) mice correlated with decreased expression of numerous proinflammatory cytokines that are regulated by STAT1 and/or NF kappa B. The lack of NKLAM and the resulting attenuated immune response is favorable to NKLAM(-/-) mice receiving a low dose of SeV; however, at a high dose of virus, NKLAM(-/-) mice succumbed to the infection faster than wild type mice. In conclusion, our novel results indicate that NKLAM plays a role in regulating the production of pro-inflammatory cytokines during viral infection.	[Lawrence, Donald W.; Kornbluth, Jacki] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Shornick, Laurie P.] St Louis Univ, Dept Biol, St Louis, MO 63104 USA; [Shornick, Laurie P.; Kornbluth, Jacki] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Kornbluth, Jacki] Vet Affairs St Louis Hlth Care Syst, St Louis, MO 63106 USA	Saint Louis University; Saint Louis University; Saint Louis University	Kornbluth, J (corresponding author), St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.; Kornbluth, J (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.; Kornbluth, J (corresponding author), Vet Affairs St Louis Hlth Care Syst, St Louis, MO 63106 USA.	jacki.kornbluth@health.slu.edu		Lawrence, Donald/0000-0001-5912-6992	VA Merit Award from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [1 IO1BX000705]; Veterans Affairs [I01BX000705] Funding Source: NIH RePORTER	VA Merit Award from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by a VA Merit Award (1 IO1BX000705) to J.K. from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service. The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. There was no additional funding received for this study.	Bharaj P, 2017, J VIROL, V91, DOI [10.1128/JVI.00833-17, 10.1128/jvi.00833-17]; Bhattacharya S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-549; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Delpeut S, 2012, J VIROL, V86, P8527, DOI 10.1128/JVI.00807-12; DUNN SM, 1994, BLOOD, V83, P2469, DOI 10.1182/blood.V83.9.2469.2469; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; HIMES SR, 1993, ONCOGENE, V8, P3189; Hoover RG, 2009, J IMMUNOL, V183, P6913, DOI 10.4049/jimmunol.0901679; Hou L, 2017, AUTOPHAGY, V13, P1709, DOI 10.1080/15548627.2017.1356950; Hsieh YY, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-59; Kamperschroer C, 2002, J IMMUNOL, V169, P340, DOI 10.4049/jimmunol.169.1.340; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; Kozlowski M, 1999, J IMMUNOL, V163, P1775; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194202; Lawrence DW, 2016, CELL SIGNAL, V28, P1833, DOI 10.1016/j.cellsig.2016.08.014; Lawrence DW, 2015, IMMUNOBIOLOGY, V220, P83, DOI 10.1016/j.imbio.2014.08.016; Lawrence DW, 2012, CELL IMMUNOL, V279, P46, DOI 10.1016/j.cellimm.2012.09.004; Letsiou E, 2017, TRANSL RES, V181, P71, DOI 10.1016/j.trsl.2016.09.002; Li M, 2018, J VIROL, V92, DOI 10.1128/JVI.02193-17; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Livingstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133482; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Schanton M, 2018, REPRODUCTION, V155, pR1, DOI 10.1530/REP-17-0512; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Subramanian G, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006877; Suto H, 2009, INT IMMUNOL, V21, P467, DOI 10.1093/intimm/dxp014; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7; Vestergaard C, 2005, CYTOKINE, V29, P49, DOI 10.1016/j.cyto.2004.09.008; Wang YT, 2014, J IMMUNOL, V192, P1855, DOI 10.4049/jimmunol.1302552; Wang YP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00206; Weng CM, 2018, BIOCHEM PHARMACOL, V151, P1, DOI 10.1016/j.bcp.2018.02.028; Wickremasinghe MI, 2004, J BIOL CHEM, V279, P27199, DOI 10.1074/jbc.M403107200; Wu CL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02073-3; Xia M, 2014, J VIROL, V88, P5152, DOI 10.1128/JVI.03851-13; Xin D, 2018, J BIOL CHEM, V293, P11996, DOI 10.1074/jbc.RA117.001201; Yang Y, 2016, INT J CLIN EXP MED, V9, P7986; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222802	10.1371/journal.pone.0222802	http://dx.doi.org/10.1371/journal.pone.0222802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539400	Green Submitted, gold, Green Published			2022-12-27	WOS:000532297900029
J	Lietz, AP; Weaver, DT; Melamed, A; Rauh-Hain, JA; Wright, JD; Wright, AA; Knudsen, AB; Pandharipande, PV				Lietz, Anna P.; Weaver, Davis T.; Melamed, Alexander; Rauh-Hain, Jose Alejandro; Wright, Jason D.; Wright, Alexi A.; Knudsen, Amy B.; Pandharipande, Pari, V			Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; EPITHELIAL OVARIAN; PRIMARY SURGERY; OPEN-LABEL; BEVACIZUMAB; PACLITAXEL; CARBOPLATIN; CISPLATIN; TRIAL	Background Ovarian cancer is often diagnosed in advanced stages, when survival is poor. Treatment advances have been made, but are inconsistently implemented. Our purpose was to project the maximum life expectancy gains that could be achieved in women with stage IIIC epithelial ovarian cancer if the implementation of available chemotherapy regimens could be optimized. Methods We used a microsimulation model to estimate life expectancy benefits associated with "optimized" implementation of four post-operative chemotherapy options: standard intravenous chemotherapy; intraperitoneal + intravenous chemotherapy; bevacizumab + intravenous chemotherapy; and hyperthermic intraperitoneal chemotherapy + intravenous chemotherapy. Optimized implementation was defined as follows. Patients triaged to primary cytoreductive surgery received intraperitoneal + intravenous chemotherapy if optimally or completely cytoreduced, and bevacizumab + intravenous chemotherapy if suboptimally cytoreduced. Patients triaged to neoadjuvant chemotherapy received hyperthermic intraperitoneal chemotherapy at interval cytoreductive surgery if optimally or completely cytoreduced, and standard IV chemotherapy if suboptimally cytoreduced. Life expectancy associated with optimized implementation was compared with that of current utilization practices, estimated using published literature and the National Cancer Database. Effects of model uncertainty were evaluated in sensitivity analyses. Results Life expectancy associated with optimized implementation vs. current practice was 76.7 vs. 64.5 months (life expectancy gain = 12.2 months). Providing intraperitoneal + intravenous chemotherapy to all eligible patients was the largest driver of life expectancy gains, due to both the potential benefit conferred by intraperitoneal + intravenous chemotherapy and the proportion of eligible women who do not receive intraperitoneal + intravenous chemotherapy in current practice. Conclusion Population-level life expectancy in stage IIIC epithelial ovarian cancer could be substantially improved through greater uptake of available chemotherapy regimens.	[Lietz, Anna P.; Weaver, Davis T.; Knudsen, Amy B.; Pandharipande, Pari, V] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Melamed, Alexander] Massachusetts Gen Hosp, Div Gynecol Oncol, Vincent Obstet & Gynecol, Boston, MA 02114 USA; [Rauh-Hain, Jose Alejandro] Univ Texas MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med Dept, Houston, TX 77030 USA; [Wright, Jason D.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, New York, NY 10032 USA; [Wright, Alexi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Wright, Alexi A.; Knudsen, Amy B.; Pandharipande, Pari, V] Harvard Med Sch, Boston, MA 02115 USA; [Weaver, Davis T.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Case Western Reserve University	Pandharipande, PV (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Pandharipande, PV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ppandharipande@mgh.harvard.edu		Weaver, Davis/0000-0003-3086-497X				Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; American Cancer Society, 2019, CANC FACTS FIG 2015; American Cancer Society, OV CANC STAG 2018; American Cancer Society, SURV RAT OV CANC STA; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chan JK, 2016, NEW ENGL J MED, V374, P738, DOI 10.1056/NEJMoa1505067; Clamp AR, 2017, ANN ONCOL, V28; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Frey Melissa K, 2017, Gynecol Oncol Res Pract, V4, P4, DOI 10.1186/s40661-017-0039-8; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; McLaughlin JR, 2013, JNCI-J NATL CANCER I, V105, P141, DOI 10.1093/jnci/djs494; Melamed A, 2016, GYNECOL ONCOL, V143, P236, DOI 10.1016/j.ygyno.2016.09.002; Moore K, 2018, NEW ENGL J MED, V379, P2495, DOI 10.1056/NEJMoa1810858; MURPHY AG, 2019, J CLIN ONCOL, V37, DOI DOI 10.1200/JCO.18.01568; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Passot G, 2014, EJSO-EUR J SURG ONC, V40, P529, DOI 10.1016/j.ejso.2013.11.019; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Schlappe BA, 2016, GYNECOL ONCOL, V142, P13, DOI 10.1016/j.ygyno.2016.05.015; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; van Driel WJ, 2018, NEW ENGL J MED, V378, P230, DOI 10.1056/NEJMoa1708618; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Weaver DT, 2018, GYNECOL ONCOL, V149, P256, DOI 10.1016/j.ygyno.2018.02.007; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Wright AA, 2015, J CLIN ONCOL, V33, P2841, DOI 10.1200/JCO.2015.61.4776; Wright JD, 2016, OBSTET GYNECOL, V127, P985, DOI 10.1097/AOG.0000000000001436; Wu YS, 2017, ONCOTARGET, V8, P10703, DOI 10.18632/oncotarget.12926	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222828	10.1371/journal.pone.0222828	http://dx.doi.org/10.1371/journal.pone.0222828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539415	Green Published, gold			2022-12-27	WOS:000532297900034
J	Park, M; Lee, SM; Yoon, HJ				Park, Minseon; Lee, Seung Min; Yoon, Hyung-Jin			Association between alcohol intake and measures of incident CKD: An analysis of nationwide health screening data	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; DRINKING PATTERN; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; RISK-FACTORS; FOLLOW-UP; CONSUMPTION; ALBUMINURIA; POPULATION	To evaluate the association between alcohol intake and incident chronic kidney disease measures as well as the sex differences in this association, we analyzed health screening data of 14,190,878 adults who underwent health screening >= 3 times and had glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2) and normal proteinuria at baseline. eGFR was calculated with the Chronic Kidney Disease Epidemiology Collaboration equation. Proteinuria was defined as >= 1+ dipstick proteinuria and low eGFR as <60 mL/min/1.73 m(2). The risk of incident proteinuria and low eGFR was analyzed with an extended Cox model with alcohol intake level as a time-varying determinant and the annual change of eGFR with generalized linear model. A J-shape association of alcohol intake with the incident proteinuria was observed in men (adjusted hazard ratio [aHR], 0.961, 95% confidence interval [CI], 0.953-0.970 in men drinking alcohol <10 g/day; aHR 1.139, 95% CI, 1.123-1.154 in men drinking alcohol >= 40 g/day, compared with non-drinking men), and a positive association was seen in women (aHR, 1.034, 95% CI, 1.023-1.044 in women drinking alcohol <10 g/day; aHR, 1.094, 95% CI, 1.034-1.158 in women drinking alcohol >= 40 g/day, compared with non-drinking women). In both sexes, an inverse association of alcohol intake with the annual eGFR decline and incident low eGFR was observed. This study observed a beneficial effect of moderate alcohol intake on incident proteinuria in men and a protective effect of alcohol intake of any amount on the annual eGFR decline and incident low eGFR in both sexes. The long-term implications of these observations need to be elucidated with future studies.	[Park, Minseon] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lee, Seung Min; Yoon, Hyung-Jin] Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoon, HJ (corresponding author), Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	hjyoon@snu.ac.kr		Lee, SeungMin/0000-0001-5762-2618; Yoon, Hyung-Jin/0000-0003-4432-4894	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program [IITP-2019-2018-0-01833]	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program	This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2019-2018-0-01833) supervised by the IITP (Institute for Information & Communications Technology Promotion).	Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Chen N, 2010, NEPHROLOGY, V15, P31, DOI 10.1111/j.1440-1797.2010.01309.x; Colafella KMM, 2018, NAT REV NEPHROL, V14, P185, DOI 10.1038/nrneph.2017.189; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; Hsu YH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-254; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Kaartinen K, 2009, NEPHRON CLIN PRACT, V112, pC86, DOI 10.1159/000213086; Koning SH, 2015, KIDNEY INT, V87, P1009, DOI 10.1038/ki.2014.414; Kronborg J, 2008, NEPHROL DIAL TRANSPL, V23, P2818, DOI 10.1093/ndt/gfn148; Matsumoto A, 2017, HYPERTENS RES, V40, P771, DOI 10.1038/hr.2017.25; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McCarthy ET, 2015, PROSTAG OTH LIPID M, V116, P88, DOI 10.1016/j.prostaglandins.2014.10.006; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; METCALF PA, 1993, CLIN CHEM, V39, P1793; Nair S, 2014, DIABETES CARE, V37, P483, DOI 10.2337/dc13-1770; Park JT, 2008, J KOREAN MED SCI, V23, P199, DOI 10.3346/jkms.2008.23.2.199; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Reynolds K, 2008, KIDNEY INT, V73, P870, DOI 10.1038/sj.ki.5002774; Robles NR, 2013, INT UROL NEPHROL, V45, P553, DOI 10.1007/s11255-013-0380-8; Roerecke M, 2017, LANCET PUBLIC HEALTH, V2, pE108, DOI 10.1016/S2468-2667(17)30003-8; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sato KK, 2014, AM J NEPHROL, V40, P516, DOI 10.1159/000370051; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Uehara S, 2016, J EPIDEMIOL, V26, P464, DOI 10.2188/jea.JE20150158; Vatsalya Vatsalya, 2016, Curr Drug Abuse Rev, V9, P87, DOI 10.2174/1874473710666170125151410; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; White SL, 2009, NEPHROL DIAL TRANSPL, V24, P2464, DOI 10.1093/ndt/gfp114; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Zakhari S, 1997, ALCOHOL HEALTH RES W, V21, P21	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222123	10.1371/journal.pone.0222123	http://dx.doi.org/10.1371/journal.pone.0222123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539384	gold, Green Published, Green Submitted			2022-12-27	WOS:000532297900008
J	Stara, J; Kocourek, F				Stara, Jitka; Kocourek, Frantisek			Cabbage stem flea beetle's (Psylliodes chrysocephala L.) susceptibility to pyrethroids and tolerance to thiacloprid in the Czech Republic	PLOS ONE			English	Article							COLORADO POTATO BEETLE; BASE-LINE SUSCEPTIBILITY; CROSS-RESISTANCE; NEONICOTINOID INSECTICIDES; COLEOPTERA NITIDULIDAE; BROWN PLANTHOPPER; MELIGETHES-AENEUS; OILSEED RAPE; HEMIPTERA; POPULATIONS	The cabbage stem flea beetle (CSFB), Psylliodes chrysocephala (Coleoptera: Chrysomelidae), has recently become a major pest species in winter oilseed rape in the Czech Republic. The susceptibility of CSFB populations from two localities to six pyrethroids, two neonicotinoids, one organophosphate and one oxadiazine was evaluated in 2015-2018 in glass vial experiments. The susceptibility of CSFB to thiacloprid and thiamethoxam was evaluated in feeding experiment in 2017 and 2018. High susceptibility of CSFB populations to lambda-cyhalothrin, cypermethrin, esfenvalerate, tau-fluvalinate, etofenprox, deltamethrin, chlorpyrifos, indoxacarb and acetamiprid was observed in the glass vial experiments. The LC50 and LC90 data obtained for pyrethroids in these experiments in 2015 represent baseline for CSFB resistance monitoring to pyrethroids in the Czech Republic. High tolerance of CSFB to thiacloprid of CSFB was demonstrated in glass vial and the feeding experiment, too.	[Stara, Jitka; Kocourek, Frantisek] Crop Res Inst, Dept Integrated Crop Protect Insect Pests, Div Crop Protect & Plant Hlth, Prague, Czech Republic	Czech Crop Research Institute (CRI)	Stara, J (corresponding author), Crop Res Inst, Dept Integrated Crop Protect Insect Pests, Div Crop Protect & Plant Hlth, Prague, Czech Republic.	stara@vurv.cz	Kocourek, František/AAZ-1566-2021		ministry of Agriculture of the Czech Republic [MZE-RO0418, NAZV QK 1820081]	ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The work was financially supported through a grant from the projects MZE-RO0418 and NAZV QK 1820081 of the ministry of Agriculture of the Czech Republic.	Charaabi K, 2018, PEST MANAG SCI, V74, P1297, DOI 10.1002/ps.4833; Denholm I., 2002, P BRIGHT CROP PROT C, P161; Dewar AM, 2017, PEST MANAG SCI, V73, P1305, DOI 10.1002/ps.4511; Eickermann M, 2011, J PLANT DIS PROTECT, V118, P134, DOI 10.1007/BF03356393; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Foster SP, 2003, PEST MANAG SCI, V59, P166, DOI 10.1002/ps.570; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; Gorman K, 2010, PEST MANAG SCI, V66, P1186, DOI 10.1002/ps.1989; Heimbach U, 2013, PEST MANAG SCI, V69, P209, DOI 10.1002/ps.3351; Hojland DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146045; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Liu ZW, 2006, J NEUROCHEM, V99, P1273, DOI 10.1111/j.1471-4159.2006.04167.x; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Olson ER, 2000, J ECON ENTOMOL, V93, P447, DOI 10.1603/0022-0493-93.2.447; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Puinean AM, 2010, PESTIC BIOCHEM PHYS, V97, P129, DOI 10.1016/j.pestbp.2009.06.008; SARINGER G, 1984, Z ANGEW ENTOMOL, V98, P50; SONE S, 1995, J PESTIC SCI, V20, P541; Wang YH, 2009, ENTOMOL EXP APPL, V131, P20, DOI 10.1111/j.1570-7458.2009.00827.x; Yu SJ, 2007, PEST MANAG SCI, V63, P63, DOI 10.1002/ps.1309; Zamojska J, 2017, PHYTOPARASITICA, V45, P407, DOI 10.1007/s12600-017-0588-8; Zamojska J, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu127; Zhang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169475; Zhao JZ, 2000, J ECON ENTOMOL, V93, P1508, DOI 10.1603/0022-0493-93.5.1508; Zimmer CT, 2014, PESTIC BIOCHEM PHYS, V108, P1, DOI 10.1016/j.pestbp.2013.11.005; Zimmer CT, 2014, ENTOMOL EXP APPL, V150, P279, DOI 10.1111/eea.12162; Zimmer CT, 2011, PEST MANAG SCI, V67, P599, DOI 10.1002/ps.2137	29	3	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0214702	10.1371/journal.pone.0214702	http://dx.doi.org/10.1371/journal.pone.0214702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539393	Green Submitted, Green Published, gold			2022-12-27	WOS:000532297900001
J	Brakemeier, S; Arns, W; Lehner, F; Witzke, O; Vonend, O; Sommerer, C; Muhlfeld, A; Rath, T; Schuhmann, R; Zukunft, B; Kroeger, I; Porstner, M; Budde, K				Brakemeier, Susanne; Arns, Wolfgang; Lehner, Frank; Witzke, Oliver; Vonend, Oliver; Sommerer, Claudia; Muehlfeld, Anja; Rath, Thomas; Schuhmann, Robert; Zukunft, Bianca; Kroeger, Irena; Porstner, Martina; Budde, Klemens			Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR)	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; CALCINEURIN INHIBITORS; OPEN-LABEL; SIROLIMUS; CYCLOSPORINE; IMMUNOSUPPRESSION; DONOR; ALLOGRAFT; GRAFT; WITHDRAWAL	Early conversion to everolimus was assessed in kidney transplant recipients participating in the Eurotransplant Senior Program (ESP), a population in whom data are lacking. The SENATOR multicenter study enrolled 207 kidney transplant recipients undergoing steroid withdrawal at week 2 post-transplant (ClinicalTrials.gov [NCT00956293]). At week 7, patients were randomized (1:2 ratio) to continue the previous calcineurin inhibitor (CNI)-based regimen with mycophenolic acid (MPA) and cyclosporine or switch to a CNI-free regimen with MPA, everolimus (5-10 ng/mL) and basiliximab at weeks 7 and 12, then followed for 18 weeks to month 6 post-transplant. The primary endpoint was estimated GFR (eGFR). At week 7, 77/207 (37.2%) patients were randomized (53 everolimus, 24 control). At month 6, eGFR was comparable: 36.5 +/- 10.8ml/min with everolimus versus 42.0 +/- 13.0ml/min in the control group (p = 0.784). Discontinuation due to adverse events occurred in 27.8% of everolimus-treated patients and 0.0% of control patients (p = 0005). Efficacy profiles showed no difference. In conclusion, eGFR, safety and efficacy outcomes at month 6 post-transplant showed no difference between groups. The everolimus group experienced a higher rate of discontinuation due to adverse events. However, the high rate of non-randomization is highly relevant, indicating this to be a somewhat unstable patient population regardless of treatment.	[Brakemeier, Susanne; Zukunft, Bianca; Budde, Klemens] Charite Campus Mitte, Dept Nephrol & Med Intens Care, Berlin, Germany; [Arns, Wolfgang; Schuhmann, Robert] Cologne Merhe Med Ctr, Dept Nephrol & Transplantat, Cologne, Germany; [Lehner, Frank] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Hannover, Germany; [Witzke, Oliver] Univ Duisburg Essen, Dept Infect Dis, Essen, Germany; [Witzke, Oliver] Univ Duisburg Essen, Dept Nephrol, Essen, Germany; [Vonend, Oliver] Univ Dusseldorf, Med Fac, Dept Nephrol, Dusseldorf, Germany; [Sommerer, Claudia] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Muehlfeld, Anja] Univ Hosp RWTH Aachen, Div Nephrol & Immunol, Aachen, Germany; [Rath, Thomas] Dept Med III, Westpfalz Kaiserslautern, Germany; [Kroeger, Irena; Porstner, Martina] Novartis Pharma GmbH, Med Dept, Nurnberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; Novartis	Brakemeier, S (corresponding author), Charite Campus Mitte, Dept Nephrol & Med Intens Care, Berlin, Germany.	Susanne.brakemeier@charite.de	Budde, Klemens/AAD-2170-2020	Budde, Klemens/0000-0002-7929-5942	Novartis Pharma GmbH	Novartis Pharma GmbH	The study was funded by Novartis Pharma GmbH. IK and MP are employed by Novartis. The funders of the study (Novartis Pharma GmbH) contributed to the study design, data analysis, and preparation of the manuscript. The funders had no role in data collection or the decision to publish. The study site institutions of SB, WA, FL, OW, OV, CS, AM, TR, RS, BZ and KB received study honoraria from Novartis Pharma GmbH. The specific roles of all authors are articulated in the `author contributions' section.	Andres A, 2009, TRANSPLANTATION, V88, P1101, DOI 10.1097/TP.0b013e3181ba06ee; Balaz P, 2013, TRANSPLANTATION, V96, P633, DOI 10.1097/TP.0b013e31829d9225; Budde K, 2015, AM J TRANSPLANT, V15, P119, DOI 10.1111/ajt.12952; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Danovitch GM, 2007, TRANSPLANTATION, V84, P285, DOI 10.1097/01.tp.0000275423.69689.dc; De Fijter JW, 2001, J AM SOC NEPHROL, V12, P1538, DOI 10.1681/ASN.V1271538; Dreyer GJ, 2015, TRANSPLANT REV-ORLAN, V29, P205, DOI 10.1016/j.trre.2015.08.003; Durrbach A, 2008, TRANSPLANTATION, V85, P486, DOI 10.1097/TP.0b013e318160d3c9; Ekberg H, 2009, AM J TRANSPLANT, V9, P1876, DOI 10.1111/j.1600-6143.2009.02726.x; Flechner SM, 2013, TRANSPLANTATION, V95, P1233, DOI 10.1097/TP.0b013e318291a269; Fritsche L, 2003, AM J TRANSPLANT, V3, P1434, DOI 10.1046/j.1600-6135.2003.00251.x; Gatault P, 2016, TRANSPL INT, V29, P41, DOI 10.1111/tri.12656; Guba M, 2012, TRANSPL INT, V25, P416, DOI 10.1111/j.1432-2277.2012.01432.x; Halleck F, 2016, NEPHROL DIAL TRANSPL, V31, P2143, DOI 10.1093/ndt/gfw248; Haller MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005632.pub3; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; Knoll GA, 2013, AM J KIDNEY DIS, V61, P790, DOI 10.1053/j.ajkd.2012.08.049; Kuypers DRJ, 2009, DRUG AGING, V26, P715, DOI 10.2165/11316480-000000000-00000; Larson TS, 2006, AM J TRANSPLANT, V6, P514, DOI 10.1111/j.1600-6143.2005.01177.x; Le Meur Y, 2014, AM J TRANSPLANT, V14, P114; Le Meur Y, 2015, TRANSPLANT REV-ORLAN, V29, P231, DOI 10.1016/j.trre.2015.08.004; Lebranchu Y, 2011, AM J TRANSPLANT, V11, P1665, DOI 10.1111/j.1600-6143.2011.03637.x; Legendre C, 2007, CLIN TRANSPLANT, V21, P330, DOI 10.1111/j.1399-0012.2007.00645.x; Lehner LJ, 2015, TRANSPLANT REV-ORLAN, V29, P237, DOI 10.1016/j.trre.2015.08.001; Meier M, 2011, TRANSPLANTATIONSMEDI, P118; Meyer JM, 2013, TRANSPLANTATION, V95, P916, DOI 10.1097/TP.0b013e31828279d9; Montero N, 2016, TRANSPLANT REV-ORLAN, V30, P144, DOI 10.1016/j.trre.2016.05.001; Oberhuber R, 2012, AM J TRANSPLANT, V12, P38, DOI 10.1111/j.1600-6143.2011.03798.x; Opelz G, 2013, AM J TRANSPLANT, V13, P2096, DOI 10.1111/ajt.12313; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Sorensen SS, 2015, TRANSPLANT REV-ORLAN, V29, P193, DOI 10.1016/j.trre.2015.04.005; Thomusch O, 2016, LANCET, V388, P3006, DOI 10.1016/S0140-6736(16)32187-0; Tullius SG, 2011, NEW ENGL J MED, V364, P1369, DOI 10.1056/NEJMc1103007; Tullius SG, 2010, ANN SURG, V252, P662, DOI 10.1097/SLA.0b013e3181f65c7d; Weir MR, 2011, KIDNEY INT, V79, P897, DOI 10.1038/ki.2010.492; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222730	10.1371/journal.pone.0222730	http://dx.doi.org/10.1371/journal.pone.0222730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536556	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800079
J	Du, HM; Wang, ZC; Fan, YQ; Li, CJ; Yao, J				Du, Haiming; Wang, Zaichao; Fan, Yiqun; Li, Chengjun; Yao, Juan			Dual-Subpopulation as reciprocal optional external archives for differential evolution	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; MUTATION STRATEGIES; CROSSOVER RATE; ALGORITHM; ENSEMBLE; PARAMETERS; SELECTION	Differential Evolution (DE) is powerful for global optimization problems. Among DE algorithms, JADE and its variants, whose mutation strategy is DE/current-to-pbest/1 with optional archive, have good performance. A significant feature of the above mutation strategy is that one individual for difference operation comes from the union of the optional external archive and the population. In existing DE algorithms based on the mutation strategy-JADE and its variants, individuals eliminated from the population are send to the archive. In this paper, we propose a scheme for managing the optional external archive. According to our scheme, two subpopulations are maintained in the population. Each of them regards the other as the archive. In experiments, our scheme is applied in JADE and two of its variants -SHADE and L-SHADE. Experimental results show that our scheme can enhance JADE and its variants. Moreover, it can be seen that L-SHADE with our scheme performs significantly better than four DE algorithms, CoBiDE, MPEDE, EDEV, and MLCCDE.	[Du, Haiming; Wang, Zaichao] Zhengzhou Univ Light Ind, Sch Elect & Informat Engn, Zhengzhou, Henan, Peoples R China; [Fan, Yiqun; Li, Chengjun] China Univ Geosci, Sch Comp Sci, Wuhan, Hubei, Peoples R China; [Yao, Juan] Huazhong Agr Univ, Coll Informat, Wuhan, Hubei, Peoples R China	Zhengzhou University of Light Industry; China University of Geosciences; Huazhong Agricultural University	Du, HM (corresponding author), Zhengzhou Univ Light Ind, Sch Elect & Informat Engn, Zhengzhou, Henan, Peoples R China.	duhaiming-007@zzuli.edu.cn		Li, Chengjun/0000-0002-0779-622X	Zhengzhou University of Light Industry [2013BSJJ026, 2013XGGJS011]; Henan Provincial Education Department, China [14B510022]; Project for Foundations and Frontiers Research of Henan Province, China [112300410144]	Zhengzhou University of Light Industry; Henan Provincial Education Department, China; Project for Foundations and Frontiers Research of Henan Province, China	This work was supported by the Doctoral Fund (2013BSJJ026) and Backbone Teacher Fund (2013XGGJS011) of Zhengzhou University of Light Industry, the Science and Technology Fund of Henan Provincial Education Department, China (14B510022), the Project for Foundations and Frontiers Research of Henan Province, China (112300410144).	Alba E, 2002, IEEE T EVOLUT COMPUT, V6, P443, DOI 10.1109/TEVC.2002.800880; Ali MZ, 2017, IEEE T CYBERNETICS, V47, P2768, DOI 10.1109/TCYB.2016.2617301; Ali MZ, 2015, APPL SOFT COMPUT, V33, P304, DOI 10.1016/j.asoc.2015.04.019; Auger A, 2005, IEEE C EVOL COMPUTAT, P1769; Awad NH, 2017, INFORM SCIENCES, V378, P215, DOI 10.1016/j.ins.2016.10.039; Awad NH, 2016, IEEE C EVOL COMPUTAT, P2958, DOI 10.1109/CEC.2016.7744163; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Brest J, 2011, SOFT COMPUT, V15, P2157, DOI 10.1007/s00500-010-0644-5; Cui LZ, 2018, INFORM SCIENCES, V422, P122, DOI 10.1016/j.ins.2017.09.002; Cui LZ, 2016, COMPUT OPER RES, V67, P155, DOI 10.1016/j.cor.2015.09.006; Das S, 2016, SWARM EVOL COMPUT, V27, P1, DOI 10.1016/j.swevo.2016.01.004; Das S, 2014, IEEE T CYBERNETICS, V44, P966, DOI 10.1109/TCYB.2013.2278188; Dorronsoro B, 2011, IEEE T EVOLUT COMPUT, V15, P67, DOI 10.1109/TEVC.2010.2081369; Du W, 2017, IEEE T CYBERNETICS, V47, P244, DOI 10.1109/TCYB.2015.2512942; Epitropakis MG, 2011, IEEE T EVOLUT COMPUT, V15, P99, DOI 10.1109/TEVC.2010.2083670; Fan QQ, 2016, IEEE T CYBERNETICS, V46, P219, DOI 10.1109/TCYB.2015.2399478; Fu CM, 2017, APPL SOFT COMPUT, V57, P60, DOI 10.1016/j.asoc.2017.03.032; Gao WF, 2015, IEEE T CYBERNETICS, V45, P1094, DOI 10.1109/TCYB.2014.2345478; Ghasemia M, 2016, APPL SOFT COMPUT, V40, P342, DOI 10.1016/j.asoc.2015.11.033; Ghosh A, 2017, IEEE ACCESS, V5, P26944, DOI 10.1109/ACCESS.2017.2773825; Ghosh A, 2017, APPL SOFT COMPUT, V57, P329, DOI 10.1016/j.asoc.2017.03.003; Gong WY, 2014, APPL SOFT COMPUT, V15, P149, DOI 10.1016/j.asoc.2013.11.005; Gonuguntla V, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/287607; Guo SM, 2015, IEEE T EVOLUT COMPUT, V19, P717, DOI 10.1109/TEVC.2014.2375933; Guo SM, 2015, IEEE T EVOLUT COMPUT, V19, P31, DOI 10.1109/TEVC.2013.2297160; Guo ZL, 2017, SOFT COMPUT, V21, P3759, DOI 10.1007/s00500-016-2029-x; Li GH, 2016, APPL SOFT COMPUT, V47, P577, DOI 10.1016/j.asoc.2016.06.011; Li YL, 2015, IEEE T CYBERNETICS, V45, P1798, DOI 10.1109/TCYB.2014.2360752; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liao JL, 2016, SOFT COMPUT, V20, P2801, DOI 10.1007/s00500-015-1682-9; Mallipeddi R, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1760, DOI 10.1109/CEC.2014.6900601; Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024; Mallipeddi R, 2010, LECT NOTES COMPUT SC, V6466, P71, DOI 10.1007/978-3-642-17563-3_9; Mohammadi A, 2018, SMALL BUS ECON, V50, P275, DOI 10.1007/s11187-016-9825-7; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Qiu X, 2017, IEEE T CYBERNETICS, V47, P995, DOI 10.1109/TCYB.2016.2536167; Rakshit P, 2013, IEEE T SYST MAN CY-S, V43, P814, DOI 10.1109/TSMCA.2012.2226024; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanabe R, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1658, DOI 10.1109/CEC.2014.6900380; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Tang LX, 2015, IEEE T EVOLUT COMPUT, V19, P560, DOI 10.1109/TEVC.2014.2360890; Tatsis VA, 2017, SOFT COMPUT, V21, P2105, DOI 10.1007/s00500-015-1911-2; Tian MN, 2017, APPL SOFT COMPUT, V56, P286, DOI 10.1016/j.asoc.2017.03.010; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Wang Y, 2014, APPL SOFT COMPUT, V18, P232, DOI 10.1016/j.asoc.2014.01.038; Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271; Wu GH, 2018, INFORM SCIENCES, V423, P172, DOI 10.1016/j.ins.2017.09.053; Wu GH, 2016, INFORM SCIENCES, V329, P329, DOI 10.1016/j.ins.2015.09.009; Xu YL, 2015, COMPUT OPTIM APPL, V61, P243, DOI 10.1007/s10589-014-9701-9; Yang M, 2015, IEEE T CYBERNETICS, V45, P302, DOI 10.1109/TCYB.2014.2339495; Yang M, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P145; Yi WC, 2016, EXPERT SYST APPL, V44, P1, DOI 10.1016/j.eswa.2015.09.031; Yu WJ, 2014, IEEE T CYBERNETICS, V44, P1080, DOI 10.1109/TCYB.2013.2279211; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Zhang SX, 2019, INFORM SCIENCES, V482, P86, DOI 10.1016/j.ins.2018.12.065; Zhang X, 2017, SOFT COMPUT, V21, P7107, DOI 10.1007/s00500-016-2253-4; Zheng LM, 2017, INFORM SCIENCES, V399, P13, DOI 10.1016/j.ins.2017.02.055; Zheng LM, 2017, SOFT COMPUT, P1; Zhou XH, 2017, RES SER CHIN DREAM, P1, DOI 10.1007/978-981-10-4986-6_1; Zhou YZ, 2017, IEEE T CYBERNETICS, V47, P2742, DOI 10.1109/TCYB.2017.2676882; Zhu W, 2013, INFORM SCIENCES, V223, P164, DOI 10.1016/j.ins.2012.09.019	61	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222103	10.1371/journal.pone.0222103	http://dx.doi.org/10.1371/journal.pone.0222103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX9DN	31536535	Green Published, Green Submitted, gold			2022-12-27	WOS:000504027600001
J	Han, SS; Lee, SJ; Yim, JJ; Song, JH; Lee, EH; Kang, YA				Han, Seon-Sook; Lee, Su Jin; Yim, Jae-Joon; Song, Jin Hwa; Lee, Eun Hye; Kang, Young Ae			Evaluation and treatment of latent tuberculosis infection among healthcare workers in Korea: A multicentre cohort analysis	PLOS ONE			English	Article							UNITED-STATES; COMPLETION; RIFAMPIN	Objective Healthcare workers (HCWs) are one of the target groups for systematic testing and treatment of latent tuberculosis infection (LTBI) in a setting of low TB incidence. We performed this study to describe the testing of HCWs for LTBI and analyse the acceptance and completion of treatment of LTBI. Methods This retrospective cohort study was conducted in four university-affiliated hospitals between January 1 and December 31, 2018. HCWs with positive interferon-gamma release assay (IGRA) during LTBI screening were analysed. We assessed the acceptance and completion of LTBI treatment. Results Overall, 893 HCWs were IGRA positive. Among them, 609 HCWs visited the clinic for evaluation of LTBI. Of 609 HCWs who were evaluated, 302 (49.6%) were offered treatment for LTBI. The proportion of acceptance for treatment was 64.5% (195 of 302 HCWs). The treatment course was completed by 143 of 195 HCWs (73.3%). Three months of isoniazid and rifampin (3HR) was used in 137 HCWs (70.3%) and 4 months of rifampin (4R) in 58 (29.7%). 72 HCWs (36.9%) experienced at least one adverse drug events, but there was no different characteristics between completer and non-completer. Conclusion The acceptance and completion of LTBI treatment were unsatisfactory. Subjective perspective regarding obstacles to treatment of LTBI needs to be explored to increase compliance to LTBI treatment.	[Han, Seon-Sook] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Internal Med, Chunchon, South Korea; [Lee, Su Jin] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan Hosp, Yangsan, South Korea; [Yim, Jae-Joon; Song, Jin Hwa] Seoul Natl Univ, Dept Internal Med, Div Pulm & Crit Care Med, Coll Med, Seoul, South Korea; [Lee, Eun Hye; Kang, Young Ae] Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Coll Med, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Kang, YA (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Div Pulmonol,Coll Med, Seoul, South Korea.	MDKANG@yuhs.ac		Lee, Su Jin/0000-0003-1907-9102; Lee, Eun Hye/0000-0003-2570-3442; Kang, Young Ae/0000-0002-7783-5271; Yim, Jae-Joon/0000-0002-9605-0074	Yonsei University College of Medicine, Seoul, South Korea [6-20170150]	Yonsei University College of Medicine, Seoul, South Korea	The present study was supported by a faculty research grant from Yonsei University College of Medicine, Seoul, South Korea (6-20170150) to YAK. The funding source had no role in the study process, including the design, sample collection, analysis, or interpretation of the results.	[Anonymous], 2009, WHO POLICY TB INFECT; [Anonymous], 2018, LAT TUB INF UPD CONS; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Cho KS PW, 2018, PUBLIC HLTH WKLY REP, V11, P7; Cho KS, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018036; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Kim HW, 2018, TUBERC RESPIR DIS, V81, P6, DOI 10.4046/trd.2017.0052; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Lee EH, 2018, INT J TUBERC LUNG D, V22, P1336, DOI 10.5588/ijtld.18.0280; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Li JL, 2009, CHINESE J EXTRACORPO, V7, P8, DOI DOI 10.1016/J.IJID.2009.05.007; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Menzies D, 2018, NEW ENGL J MED, V379, P440, DOI 10.1056/NEJMoa1714283; Mullie GA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0865-x; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Perez EA, 2017, CLIN INFECT DIS, V65, P2105, DOI 10.1093/cid/cix725; Png ME, 2019, INFECT CONT HOSP EP, V40, P341, DOI 10.1017/ice.2018.334; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0	21	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222810	10.1371/journal.pone.0222810	http://dx.doi.org/10.1371/journal.pone.0222810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536577	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800090
J	Islam, MA; Neuhoff, C; Rony, SA; Grosse-Brinkhaus, C; Uddin, MJ; Holker, M; Tesfaye, D; Tholen, E; Schellander, K; Proll-Cornelissen, MJ				Islam, Md Aminul; Neuhoff, Christiane; Rony, Sharmin Aqter; Grosse-Brinkhaus, Christine; Uddin, Muhammad Jasim; Hoelker, Michael; Tesfaye, Dawit; Tholen, Ernst; Schellander, Karl; Proell-Cornelissen, Maren Julia			PBMCs transcriptome profiles identified breed-specific transcriptome signatures for PRRSV vaccination in German Landrace and Pietrain pigs	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYNDROME-VIRUS; GENE-EXPRESSION; INNATE; RESISTANCE; RESPONSES; PROTEIN; MEISHAN; ADAM-17	Porcine reproductive and respiratory syndrome (PRRS) is a devastating viral disease affecting the swine industry worldwide. Genetic variation in host immunity has been considered as one of the potential determinants to improve the immunocompetence, thereby resistance to PRRS. Therefore, the present study aimed to investigate the breed difference in innate immune response to PRRSV vaccination between German Landrace (DL) and Pietrain (Pi) pigs. We analyzed microarray-based transcriptome profiles of peripheral blood mononuclear cells (PBMCs) collected before (0 h) and 24 h after PRRSV vaccination from purebred DL and Pi pigs with three biological replicates. In total 4,269 transcripts were identified to be differentially expressed in PBMCs in at least any of four tested contrast pairs (i.e. DL-24h vs. DL-0h, Pi-24h vs. Pi-0h, DL-0h vs. Pi-0h and DL-24h vs. Pi-24h). The number of vaccine-induced differentially expressed genes (DEGs) was much higher (2,459) in DL pigs than that of Pi pigs (291). After 24 h of PRRSV vaccination, 1,046 genes were differentially expressed in PMBCs of DL pigs compared to that of Pi (DL-24h vs. Pi-24h), indicating the breed differences in vaccine responsiveness. The top biological pathways significantly affected by DEGs of both breeds were linked to immune response functions. The network enrichment analysis identified ADAM17, STAT1, MMS19, RPA2, BAD, UCHL5 and APC as potential regulatory genes for the functional network of PRRSV vaccine response specific for DL; while FOXO3, IRF2, ADRBK1, FHL3, PPP2CB and NCOA6 were found to be the most potential hubs of Pi specific transcriptome network. In conclusion, our data provided insights of breed-specific host transcriptome responses to PRRSV vaccination which might contribute in better understanding of PPRS resistance in pigs.	[Islam, Md Aminul; Neuhoff, Christiane; Rony, Sharmin Aqter; Grosse-Brinkhaus, Christine; Hoelker, Michael; Tesfaye, Dawit; Tholen, Ernst; Schellander, Karl; Proell-Cornelissen, Maren Julia] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, Bonn, Germany; [Islam, Md Aminul; Uddin, Muhammad Jasim] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh, Bangladesh; [Rony, Sharmin Aqter] Bangladesh Agr Univ, Fac Vet Sci, Dept Parasitol, Mymensingh, Bangladesh; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton Campus, Brisbane, Qld, Australia; [Hoelker, Michael; Schellander, Karl] Univ Bonn, Fac Agr, Teaching & Res Stn Frankenforst, Konigswinter, Germany	University of Bonn; Bangladesh Agricultural University (BAU); Bangladesh Agricultural University (BAU); University of Queensland; University of Bonn	Proll-Cornelissen, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, Bonn, Germany.	mpro@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Islam, Aminul/AAE-9484-2019	Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Rony, Sharmin Aqter/0000-0002-2754-0571	"Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany [17-02.04.01-4/15]	"Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany	This work was financially supported by the "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany with the grant number 17-02.04.01-4/15 to Prof. Dr. Karl Schellander; https://www.usl.uni-bonn.de/.	Abella G, 2016, RES VET SCI, V104, P117, DOI 10.1016/j.rvsc.2015.12.014; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Breuer K, 2013, NUCLEIC ACIDS RES, V41, P24, DOI DOI 10.1093/NARL0KS1147; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Christopher-Hennings J, 2001, J VET DIAGN INVEST, V13, P133, DOI 10.1177/104063870101300207; Clapperton M, 2005, VET IMMUNOL IMMUNOP, V104, P131, DOI 10.1016/j.vetimm.2004.10.009; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Drew JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113071; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Eydmann ME, 1997, CANCER GENET CYTOGEN, V93, P167, DOI 10.1016/S0165-4608(96)00200-2; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Franaszczyk M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-192; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Glass Elizabeth J., 2012, Frontiers in Genetics, V3, P263, DOI 10.3389/fgene.2012.00263; Gomes AR, 2013, CHIN J CANCER, V32, P365, DOI 10.5732/cjc.012.10277; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Guo LJ, 2014, J VIROL, V88, P10448, DOI 10.1128/JVI.01117-14; Halbur PG, 1998, J ANIM BREED GENET, V115, P181, DOI 10.1111/j.1439-0388.1998.tb00341.x; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Islam MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171828; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Kommadath A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46203; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Kumagai K, 2006, INVEST OPHTH VIS SCI, V47, P2300, DOI 10.1167/iovs.05-0810; Labarque G, 2003, VET MICROBIOL, V95, P187, DOI 10.1016/S0378-1135(03)00157-3; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li YP, 2014, VET IMMUNOL IMMUNOP, V162, P65, DOI 10.1016/j.vetimm.2014.09.007; Loving CL, 2015, VET IMMUNOL IMMUNOP, V167, P1, DOI 10.1016/j.vetimm.2015.07.003; Lunney Joan K, 2011, BMC Proc, V5 Suppl 4, pS30, DOI 10.1186/1753-6561-5-S4-S30; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Machida T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0393-4; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nathalie MD, 2004, BIOCHIM BIOPHYS ACTA, V1644, P179; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Opriessnig T, 2009, J ANIM SCI, V87, P1582, DOI 10.2527/jas.2008-1390; Petry DB, 2005, J ANIM SCI, V83, P1494; Ponsuksili S, 2007, PHYSIOL GENOMICS, V29, P267, DOI 10.1152/physiolgenomics.00178.2006; Proll MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187735; Reiner G, 2010, J ANIM BREED GENET, V127, P100, DOI 10.1111/j.1439-0388.2009.00818.x; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Schroyen M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2547-z; Siegrist C.-A., 2012, VACCINES-BASEL, V6th ed., P14; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Wilkinson JM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2720-4; Xia J, 2014, NUCLEIC ACIDS RES, V42, P26, DOI DOI 10.1093/NALL0KU443; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xing JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086101; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914	61	7	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222513	10.1371/journal.pone.0222513	http://dx.doi.org/10.1371/journal.pone.0222513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536525	Green Submitted, Green Published, gold			2022-12-27	WOS:000532262800050
J	Munoz, R; Hileeto, D; Cruz-Munoz, W; Wood, GA; Xu, P; Man, S; Viloria-Petit, A; Kerbel, RS				Munoz, Raquel; Hileeto, Denise; Cruz-Munoz, William; Wood, Geoffrey A.; Xu, Ping; Man, Shan; Viloria-Petit, Alicia; Kerbel, Robert S.			Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; C-MET; TYROSINE KINASE; ADJUVANT CHEMOTHERAPY; THERAPEUTIC TARGET; PROTEIN EXPRESSION; ANTITUMOR-ACTIVITY; TUMOR-REGRESSION; CELL-LINES	Metronomic chemotherapy using the 5-FU prodrug uracil-tegafur (UFT) and cyclophosphamide (CTX) was previously shown to only modestly delay primary tumor growth, but nevertheless markedly suppressed the development of micro-metastasis in an orthotopic breast cancer xenograft model, using the metastatic variant of the MDA-MB-231 cell line, 231/LM2-4. Furthermore, a remarkable prolongation of survival, with no toxicity, was observed in a model of postsurgical advanced metastatic disease. A question that has remained unanswered is the seemingly selective anti-metastatic mechanisms of action responsible for this treatment. We assessed the in vivo effect of metronomic UFT, CTX or their combination, on vascular density, collagen deposition and c-Met (cell mediators or modulators of tumor cell invasion or dissemination) via histochemistry/immunohistochemistry of primary tumor sections. We also assessed the effect of continuous exposure to low and non-toxic doses of active drug metabolites 5-fluorouracil (5-FU), 4-hydroperoxycyclophosphamide (4-HC) or their combination, on 231/LM2-4 cell invasiveness in vitro. In the in vivo studies, a significant reduction in vascular density and p-Met[Y1003] levels was associated with UFT+CTX treatment. All treatments reduced intratumoral collagen deposition. In the in vitro studies, a significant reduction of collagen IV invasion by all treatments was observed. The 3D structures formed by 231/LM2-4 on Matrigel showed a predominantly Mass phenotype under treated conditions and Stellate phenotype in untreated cultures. Taken together, the results suggest the low-dose metronomic chemotherapy regimens tested can suppress several mediators of tumor invasiveness highlighting a new perspective for the anti-metastatic efficacy of metronomic chemotherapy.	[Munoz, Raquel; Cruz-Munoz, William; Xu, Ping; Man, Shan; Kerbel, Robert S.] Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Hileeto, Denise] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Wood, Geoffrey A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Viloria-Petit, Alicia] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada; [Kerbel, Robert S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Munoz, Raquel] Univ Valladolid, Dept Biochem Physiol & Mol Biol, Valladolid, Spain	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Waterloo; University of Guelph; University of Guelph; University of Toronto; Universidad de Valladolid	Munoz, R; Kerbel, RS (corresponding author), Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada.	rmunoz@bio.uva.es; robert.kerbel@sri.utoronto.ca	Wood, Geoffrey/ABB-2052-2021	Wood, Geoffrey/0000-0003-1756-8607; Munoz, Raquel/0000-0001-9861-0349	Canadian Institutes of Health Research [364411]; Canadian Breast Cancer Foundation; Ontario Veterinary College Bull Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Veterinary College Bull Fellowship	This work was supported by grants from Canadian Institutes of Health Research grant 364411 and Canadian Breast Cancer Foundation to RSK, and an Ontario Veterinary College Bull Fellowship to AVP and RM.	Allegrini G, 2012, ANGIOGENESIS, V15, P275, DOI 10.1007/s10456-012-9260-6; Andre N, 2017, TRENDS CANCER, V3, P319, DOI 10.1016/j.trecan.2017.03.011; Barrow-McGee R, 2014, INT J BIOCHEM CELL B, V49, P69, DOI 10.1016/j.biocel.2014.01.009; Basaki Yuji, 2001, Angiogenesis, V4, P163, DOI 10.1023/A:1014059528046; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Bertolini F, 2003, CANCER RES, V63, P4342; Bisogno G, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA2; Black PC, 2010, BJU INT, V106, P1799, DOI 10.1111/j.1464-410X.2010.09424.x; Bocci G, 2005, ANN ONCOL, V16, P1243, DOI 10.1093/annonc/mdi240; Bocci G, 2002, CANCER RES, V62, P6938; Browder T, 2000, CANCER RES, V60, P1878; Cazzaniga ME, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/1683060; Cazzaniga ME, 2016, BREAST CANCER RES TR, V160, P501, DOI 10.1007/s10549-016-4009-3; Cazzaniga ME, 2017, CANCER LETT, V400, P252, DOI 10.1016/j.canlet.2016.12.019; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; Colleoni M, 2016, J CLIN ONCOL, V34, P3400, DOI 10.1200/JCO.2015.65.6595; Daenen LG, 2009, MOL CANCER THER, V8, P2872, DOI 10.1158/1535-7163.MCT-09-0583; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrer-Font L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3748; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Fujii M, 2008, J CANCER RES CLIN, V134, P1319, DOI 10.1007/s00432-008-0417-z; Gaule PB, 2014, EXPERT OPIN THER TAR, V18, P999, DOI 10.1517/14728222.2014.938050; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-6; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Jedeszko C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010722; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kang JY, 2003, CANCER RES, V63, P1101; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Kurebayashi J, 1997, CLIN CANCER RES, V3, P653; Liu YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173693; Lovitt CJ, 2015, J CANCER RES CLIN, V141, P951, DOI 10.1007/s00432-015-1950-1; Mai A, 2014, J CELL SCI, V127, P1938, DOI 10.1242/jcs.140657; Man S, 2002, CANCER RES, V62, P2731; Manni A, 2002, CLIN EXP METASTAS, V19, P95, DOI 10.1023/A:1014536909007; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Montagna E, 2018, BREAST CARE, V13, P177, DOI 10.1159/000487630; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Munzone E, 2015, NAT REV CLIN ONCOL, V385, P1843; Nagai N, 2008, MED ONCOL, V25, P214, DOI 10.1007/s12032-007-9023-1; Nakanishi H, 1999, CANCER LETT, V142, P31, DOI 10.1016/S0304-3835(99)00114-7; Noguchi S, 2005, J CLIN ONCOL, V23, P2172, DOI 10.1200/JCO.2005.02.158; Pasini F, 2018, INVEST NEW DRUG, V36, P927, DOI 10.1007/s10637-018-0631-8; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Penel N, 2012, CRIT REV ONCOL HEMAT, V82, P40, DOI 10.1016/j.critrevonc.2011.04.009; Ponzo MG, 2010, CELL CYCLE, V9, P1043, DOI 10.4161/cc.9.6.11033; Pozner-Moulis S, 2006, CANCER RES, V66, P7976, DOI 10.1158/0008-5472.CAN-05-4335; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Shaked Y, 2016, CANCER RES, V76, P5983, DOI 10.1158/0008-5472.CAN-16-0136; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Tanaka F, 2007, SURG TODAY, V37, P923, DOI 10.1007/s00595-007-3578-5; Uchida J, 2007, ONCOL REP, V18, P313; Ueda H, 2008, ONCOL REP, V19, P1355; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wu JJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2597-2; Wu JJ, 2014, CANCER LETT, V353, P272, DOI 10.1016/j.canlet.2014.07.033; Xie YQ, 2014, MOL ENDOCRINOL, V28, P1629, DOI 10.1210/me.2014-1078; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Yonekura K, 1999, CLIN CANCER RES, V5, P2185; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	76	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222580	10.1371/journal.pone.0222580	http://dx.doi.org/10.1371/journal.pone.0222580			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536574	Green Published, gold, Green Submitted			2022-12-27	WOS:000532262800055
J	Sung, JM; Cho, IJ; Sung, D; Kim, S; Kim, HC; Chae, MH; Kavousi, M; Rueda-Ochoa, OL; Ikram, MA; Franco, OH; Chang, HJ				Sung, Ji Min; Cho, In-Jeong; Sung, David; Kim, Sunhee; Kim, Hyeon Chang; Chae, Myeong-Hun; Kavousi, Maryam; Rueda-Ochoa, Oscar L.; Ikram, M. Arfan; Franco, Oscar H.; Chang, Hyuk-Jae			Development and verification of prediction models for preventing cardiovascular diseases	PLOS ONE			English	Article							HEART-DISEASE; RISK; FRAMINGHAM; VALIDATION; SCORE	Objectives Cardiovascular disease (CVD) is one of the major causes of death worldwide. For improved accuracy of CVD prediction, risk classification was performed using national time-series health examination data. The data offers an opportunity to access deep learning (RNNLSTM), which is widely known as an outstanding algorithm for analyzing time-series datasets. The objective of this study was to show the improved accuracy of deep learning by comparing the performance of a Cox hazard regression and RNN-LSTM based on survival analysis. Methods and findings We selected 361,239 subjects (age 40 to 79 years) with more than two health examination records from 2002-2006 using the National Health Insurance System-National Health Screening Cohort (NHIS-HEALS). The average number of health screenings (from 2002-2013) used in the analysis was 2.9 +/- 1.0. Two CVD prediction models were developed from the NHIS-HEALS data: a Cox hazard regression model and a deep learning model. In an internal validation of the NHIS-HEALS dataset, the Cox regression model showed a highest time-dependent area under the curve (AUC) of 0.79 (95% CI 0.70 to 0.87) for in females and 0.75 (95% CI 0.70 to 0.80) in males at 2 years. The deep learning model showed a highest time-dependent AUC of 0.94 (95% CI 0.91 to 0.97) for in females and 0.96 (95% CI 0.95 to 0.97) in males at 2 years. Layer-wise Relevance Propagation (LRP) revealed that age was the variable that had the greatest effect on CVD, followed by systolic blood pressure (SBP) and diastolic blood pressure (DBP), in that order. Conclusion The performance of the deep learning model for predicting CVD occurrences was better than that of the Cox regression model. In addition, it was confirmed that the known risk factors shown to be important by previous clinical studies were extracted from the study results using LRP.	[Sung, Ji Min] Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, Coll Med, Seoul, South Korea; [Cho, In-Jeong] Ewha Womans Univ, Div Cardiol, Coll Med, Seoul, South Korea; [Sung, David] Data Sci Team KT NexR, Seoul, South Korea; [Kim, Sunhee] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang; Chang, Hyuk-Jae] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chae, Myeong-Hun] Selves AI Inc, AI R&D Lab, Seoul, South Korea; [Kavousi, Maryam; Rueda-Ochoa, Oscar L.; Ikram, M. Arfan; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rueda-Ochoa, Oscar L.] Univ Ind Santander UIS, Fac Hlth, Sch Med, Bucaramanga, Colombia; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Chang, Hyuk-Jae] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Erasmus University Rotterdam; Erasmus MC; Universidad Industrial de Santander; Erasmus University Rotterdam; Erasmus MC; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea.	hjchang@yuhs.ac	Kavousi, Maryam/F-1174-2018; Ikram, M. Arfan/AAM-5225-2021; Franco, Óscar H/ABE-2305-2020; Kim, Hyeon Chang/F-8796-2019	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Rueda-Ochoa, Oscar L./0000-0003-2684-9005; Chang, Hyuk-Jae/0000-0002-6139-7545; Sung, David/0000-0003-3475-3468; Kim, Hyeon Chang/0000-0001-7867-1240; Ikram, Mohammad Arfan/0000-0003-0372-8585	Institute for Information & communications Technology Promotion (IITP) grant - Korea government(MSIT) [2018-0-00861]	Institute for Information & communications Technology Promotion (IITP) grant - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This study was supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government(MSIT) (No.2018-0-00861, Intelligent SW Technology Development for Medical Data Analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambale-Venkatesh B, 2017, CIRC RES, V121, P1092, DOI 10.1161/CIRCRESAHA.117.311312; Arras L., 2017, ARXIV PREPRINT ARXIV; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baesens B, 2005, J OPER RES SOC, V56, P1089, DOI 10.1057/palgrave.jors.2601990; Chi Chih-Lin, 2007, AMIA Annu Symp Proc, P130; Cho IJ, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004197; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dean J., 2012, ADV NEURAL INFORM PR, P1223, DOI DOI 10.5555/2999134.2999271; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Dezfouli HN, 2012, 2012 INT C STAT SCI, P1; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Goldstein BA, 2016, EUR HEART J, V19; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Jarrett D, 2019, IEEE J BIOMED HLTH I; Khatibi V, 2010, EXPERT SYST APPL, V37, P8536, DOI 10.1016/j.eswa.2010.05.022; Kukar M, 1999, ARTIF INTELL MED, V16, P25, DOI 10.1016/S0933-3657(98)00063-3; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Narain R, 2016, PATIENT PREFER ADHER, V10, P1259, DOI 10.2147/PPA.S108203; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Ras G., 2018, EXPLAINABLE INTERPRE, P19; Ruwanpathirana T, 2015, CARDIOVASC THER, V33, P62, DOI 10.1111/1755-5922.12110; SAS Institute Inc, 2015, SASSTAT 141 USERS GU; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Street W. N., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P540; Tieleman T., 2012, COURSERA NEURAL NETW, V4, P26; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vikulova DN, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012178; Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173; Wang TY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27337-w; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	39	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222809	10.1371/journal.pone.0222809	http://dx.doi.org/10.1371/journal.pone.0222809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536581	Green Published, Green Submitted, gold			2022-12-27	WOS:000532262800089
J	Sloan, S; Campbell, MJ; Alamgir, M; Lechner, AM; Engert, J; Laurance, WF				Sloan, Sean; Campbell, Mason J.; Alamgir, Mohammed; Lechner, Alex M.; Engert, Jayden; Laurance, William F.			Trans-national conservation and infrastructure development in the Heart of Borneo	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; GRAPH-THEORY; ROAD; CORRIDORS; HABITAT; LAND; DEFORESTATION; ENVIRONMENT; CHALLENGES; EMISSIONS	The Heart of Borneo initiative has promoted the integration of protected areas and sustainably-managed forests across Malaysia, Indonesia, and Brunei. Recently, however, member states of the Heart of Borneo have begun pursuing ambitious unilateral infrastructure-development schemes to accelerate economic growth, jeopardizing the underlying goal of trans-boundary integrated conservation. Focusing on Sabah, Malaysia, we highlight conflicts between its Pan-Borneo Highway scheme and the regional integration of protected areas, unprotected intact forests, and conservation-priority forests. Road developments in southern Sabah in particular would drastically reduce protected-area integration across the northern Heart of Borneo region. Such developments would separate two major clusters of protected areas that account for one-quarter of all protected areas within the Heart of Borneo complex. Sabah has proposed forest corridors and highway underpasses as means of retaining ecological connectivity in this context. Connectivity modelling identified numerous overlooked areas for connectivity rehabilitation among intact forest patches following planned road development. While such 'linear-conservation planning' might theoretically retain up to 85% of intact-forest connectivity and integrate half of the conservation-priority forests across Sabah, in reality it is very unlikely to achieve meaningful ecological integration. Moreover, such measure would be exceedingly costly if properly implemented-apparently beyond the operating budget of relevant Malaysian authorities. Unless critical road segments are cancelled, planned infrastructure will fragment important conservation landscapes with little recourse for mitigation. This likelihood reinforces earlier calls for the legal recognition of the Heart of Borneo region for conservation planning as well as for enhanced tri-lateral coordination of both conservation and development.	[Sloan, Sean; Campbell, Mason J.; Alamgir, Mohammed; Engert, Jayden; Laurance, William F.] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Lechner, Alex M.] Univ Nottingham, Sch Environm & Geog Sci, Malaysia Campus,Jalan Broga, Semenyih, Selangor, Malaysia; [Lechner, Alex M.] Univ Nottingham, Mindset Interdisciplinary Ctr Environm Studies, Malaysia Campus,Jalan Broga, Semenyih, Selangor, Malaysia	James Cook University; University of Nottingham Malaysia; University of Nottingham Malaysia	Sloan, S; Laurance, WF (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	sean.sloan@jcu.edu.au; bill.laurance@jcu.edu.au	Alamgir, Mohammed/G-3757-2014	Alamgir, Mohammed/0000-0001-8888-686X	James Cook University	James Cook University	This work was financially supported by an anonymous philanthropic donor and by James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2013, SPATIAL PLANNING CON; Abram NK., 2013, INT HEART BORN C NAT; Alamgir M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219408; Alamgir M, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-018-36594-8, 10.1038/s41598-019-51237-2]; Alamgir M, 2017, CURR BIOL, V27, pR1130, DOI 10.1016/j.cub.2017.08.067; Ancrenaz Marc, 2013, STRATEGIC PLAN ACTIO; Ascensao F, 2018, NAT SUSTAIN, V1, P206, DOI 10.1038/s41893-018-0059-3; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bera SK, 2006, CURR SCI INDIA, V91, P281; Bettinger K, 2014, CONSERV SOC, V12, P280, DOI 10.4103/0972-4923.145143; Bibi JMSA, 2017, INT HEART BORN C DEC; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; Chan H., 2015, HEART BORNEO CORRIDO; Chan H., 2015, INT HEART BORN C BRI; Chen M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3250485; Cheng Li T., 2014, STAR; Clements G. R., 2013, THESIS; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; CMEA, 2011, MAST PLAN ACC EXP IN; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; GADM, 2018, DAT GLOB ADM AR GADM; Galante MV, 2018, INT FOREST REV, V20, P58, DOI 10.1505/146554818822824192; Government Sabah, 2012, SAB BIOD STRAT 2012; IENE, 2014, INFR EC EUR IENE INT; IUCN & UNEP-WCMC, 2015, WORLD DAT PROT AR; Jain A, 2014, CONSERV BIOL, V28, P889, DOI 10.1111/cobi.12313; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2015, CURR BIOL, V25, P3202, DOI 10.1016/j.cub.2015.10.046; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lechner AM, 2018, NAT ECOL EVOL, V2, P408, DOI 10.1038/s41559-017-0452-8; Meijer JR, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabd42; Miettinen J, 2016, REMOTE SENS LETT, V7, P701, DOI 10.1080/2150704X.2016.1182659; Ministry of Local Government and Housing, 2016, SAB STRUCT PLAN 2033; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Minor ES, 2007, ECOL APPL, V17, P1771, DOI 10.1890/06-1073.1; Mongabay, 2019, MONGABAY; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; Palomino D, 2007, BIOL CONSERV, V140, P100, DOI 10.1016/j.biocon.2007.07.029; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Runting RK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7819; Rytwinski T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166941; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2018, BIOL CONSERV, V219, P53, DOI 10.1016/j.biocon.2017.12.020; Saura S, 2017, ECOL INDIC, V76, P144, DOI 10.1016/j.ecolind.2016.12.047; Selva N, 2015, HANDBOOK OF ROAD ECOLOGY, P16; Sloan S, 2019, ENVIRON SCI POLICY, V92, P98, DOI 10.1016/j.envsci.2018.11.011; Sloan S, 2018, GLOBAL ENVIRON CHANG, V53, P39, DOI 10.1016/j.gloenvcha.2018.09.002; Sloan S, 2018, LAND USE POLICY, V77, P298, DOI 10.1016/j.landusepol.2018.05.043; Sloan S, 2017, AFR J ECOL, V55, P731, DOI 10.1111/aje.12377; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Tai B, 2018, SPATIAL PLANNING EXP; Tan CL, 2011, STAR; Teo HC, 2019, ENVIRONMENTS, V6, DOI 10.3390/environments6060072; Thacker S, 2019, NAT SUSTAIN, V2, P324, DOI 10.1038/s41893-019-0256-8; The Borneo Post, 2017, THE BORNEO POST; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; Vasilijevic M, 2015, TRANSBOUNDARY CONSER, P23; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Wadey J, 2018, BIOL CONSERV, V218, P91, DOI 10.1016/j.biocon.2017.11.036; Wooster MJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040495; Yanindraputri P., 2016, 3 NTS	72	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221947	10.1371/journal.pone.0221947	http://dx.doi.org/10.1371/journal.pone.0221947			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532810	Green Published, Green Accepted, gold			2022-12-27	WOS:000532239600016
J	Lemon, J; Cooper, J; Defres, S; Easton, A; Sadarangani, M; Griffiths, MJ; Pollard, AJ; Solomon, T; Kneen, R				Lemon, Jennifer; Cooper, Jessie; Defres, Sylviane; Easton, Ava; Sadarangani, Manish; Griffiths, Michael J.; Pollard, Andrew J.; Solomon, Tom; Kneen, Rachel			Understanding parental perspectives on outcomes following paediatric encephalitis: A qualitative study	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; CHILDREN	Background Encephalitis, characterised as inflammation of the brain tissue, is an important cause of acquired brain injury in children. Objective clinical outcomes vary significantly between affected patients, however they do not always correlate with quality of life as reported by parents. The aim of this study was to explore how parents experience and interpret outcomes in relation to their child who has been affected by encephalitis. Methods Data were derived from in-depth, semi-structured interviews, with 15 parents of 12 children and young people affected by encephalitis. Paediatric cases were identified from the retrospective arm of the research programme 'ENCEPH-UK-Understanding and Improving the Outcome of Encephalitis', and from the prospective UK childhood meningitis and encephalitis cohort study (UK-ChiMES, 2012 to 2016). Data were analysed thematically. Results Parents' perspectives on important outcomes for their child and family changed during the different stages of the encephalitis illness trajectory: from acute illness, recovery and rehabilitation, then reintegration into everyday life. Parents' understanding of their children's overall outcome was informed by their own experiences, involving comparisons with other children and reflections on their child's problems before, during and after the acute illness. Conclusion Outcomes in paediatric encephalitis need to be understood in terms of the context of the patient and family experience as well as the timeframe of recovery. The research highlights the need to include more patient, parent and/or carer reported outcome measures during patient assessment, and that assessment should be repeated during recovery as family concerns change. In the longer term, these parameters could be included in clinical and rehabilitation practice to further support child recovery.	[Lemon, Jennifer; Defres, Sylviane; Easton, Ava; Griffiths, Michael J.; Solomon, Tom; Kneen, Rachel] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Lemon, Jennifer; Griffiths, Michael J.; Kneen, Rachel] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Cooper, Jessie] City Univ London, Sch Hlth Sci, Div Hlth Serv Res & Management, London, England; [Defres, Sylviane] Royal Liverpool Univ, Trop Infect Dis Unit, Liverpool, Merseyside, England; [Defres, Sylviane] Broadgreen NHS Trust, Liverpool, Merseyside, England; [Easton, Ava] Encephalitis Soc, Malton, England; [Sadarangani, Manish] BC Childrens Hosp, Vaccine Evaluat Ctr, Res Inst, Vancouver, BC, Canada; [Sadarangani, Manish] Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC, Canada; [Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; City University London; University of Liverpool; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Liverpool; University of Oxford; University of Oxford; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.	tsolomon@liv.ac.uk	Sadarangani, Manish/V-5609-2019	Solomon, Tom/0000-0001-7266-6547; Sadarangani, Manish/0000-0002-9985-6452; Easton, Ava/0000-0002-1739-2915	NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis' [PRPG-108-10048]; Meningitis Research Foundation (MRF) [1103.0]; Pfizer [WS2301162]; MRC [G116/194, MC_PC_15096] Funding Source: UKRI	NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis'; Meningitis Research Foundation (MRF)(Meningitis Research Foundation (MRF)); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication was made possible by the NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis' (grant number PRPG-108-10048) www.nihr.ac.uk, funding from the Meningitis Research Foundation (MRF-grant number 1103.0) www.meningitis.org and Pfizer (grant number WS2301162) www.pfizer.co.uk.The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004611; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Bagdure D, 2016, PEDIATR NEUROL, V61, P58, DOI 10.1016/j.pediatrneurol.2016.04.014; Black N., 2013, BMJ-BRIT MED J, V346, P7896; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; BRENNER MH, 1995, MED CARE, V33, pAS236; Cooper J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2608-2; Cooper J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151145; Easton A., 2016, LIFE ENCEPHALITIS NA; Elbers JM, 2007, PEDIATRICS, V119, pE399, DOI 10.1542/peds.2006-1494; Florance NR, 2009, ANN NEUROL, V66, P11, DOI 10.1002/ana.21756; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Gray DE, 2014, DOING QUALITATIVE RE; Hacohen Y, 2012, J NEUROL NEUROSURG P; Harman NL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-70; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Khandaker G, 2016, DEV MED CHILD NEUROL, V58, P1108, DOI 10.1111/dmcn.13197; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309; Lewthwaite P, 2010, B WORLD HEALTH ORGAN, V88, P584, DOI 10.2471/BLT.09.071357; Mikaeloff Y, 2007, EUR J PAEDIATR NEURO, V11, P90, DOI 10.1016/j.ejpn.2006.11.007; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Ramanuj PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103496; Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608; Rismanchi N, 2015, PEDIATR NEUROL, V53, P200, DOI 10.1016/j.pediatrneurol.2015.05.017; Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2; Tyerman E, 2017, BRAIN INJURY, P1; Wickstrom R, 2017, ACTA PAEDIATR, V106, P463, DOI 10.1111/apa.13682; WILLIAMSON PR, 2017, TRIALS S3, V18, DOI DOI 10.1186/S13063-017-1978-4; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization, COMM LANG FUNCT DIS; Ziebland S, 2013, UNDERSTANDING USING	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220042	10.1371/journal.pone.0220042	http://dx.doi.org/10.1371/journal.pone.0220042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525232	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000532225700006
J	Ren, AY; Du, K; Jia, XB; Yang, R; Wang, J; Chen, SY; Lai, SJ				Ren, Anyong; Du, Kun; Jia, Xianbo; Yang, Rui; Wang, Jie; Chen, Shi-Yi; Lai, Song-Jia			Genetic diversity and population structure of four Chinese rabbit breeds	PLOS ONE			English	Article							TOOL SET; DISCOVERY; ASSOCIATION; FRAMEWORK	There are a few well-known indigenous breeds of Chinese rabbits in Sichuan and Fujian provinces, for which the genetic diversity and population structure have been poorly investigated. In the present study, we successfully employed the restriction-site-associated DNA sequencing (RAD-seq) approach to comprehensively discover genome-wide SNPs of 104 rabbits from four Chinese indigenous breeds: 30 Sichuan White, 34 Tianfu Black, 32 Fujian Yellow and eight Fujian Black. A total of 7,055,440 SNPs were initially obtained, from which 113,973 high-confidence SNPs (read depth > 3, calling rate = 100% and biallelic SNPs) were selected to study the genetic diversity and population structure. The mean polymorphism information content (PIC) and nucleotide diversity (Pi) of each breed slightly varied with ranging from 0.2000 to 0.2281 and from 0.2678 to 0.2902, respectively. On the whole, Fujian Yellow rabbits showed the highest genetic diversity, which was followed by Tianfu Black and Sichuan White rabbits. The principal component analysis (PCA) revealed that the four breeds were clearly distinguishable. Our results first reveal the genetic differences among these four rabbit breeds in the Sichuan and Fujian provinces and also provide a high-confidence set of genome-wide SNPs for Chinese indigenous rabbits that could be employed for gene linkage and association analyses in the future.	[Ren, Anyong; Du, Kun; Jia, Xianbo; Wang, Jie; Chen, Shi-Yi; Lai, Song-Jia] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Yang, Rui] Sichuan Anim Sci Acad, Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu, Peoples R China	Sichuan Agricultural University	Chen, SY; Lai, SJ (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	sychensau@gmail.com; laisj5794@163.com		Lai, Song-jia/0000-0003-2830-2425	Earmarked Fund for China Agriculture Research System [CARS-44-A-2]; Science & Technology Department of Sichuan Province [2016NYZ0046]	Earmarked Fund for China Agriculture Research System; Science & Technology Department of Sichuan Province	This study was financially supported by the Earmarked Fund for China Agriculture Research System (CARS-44-A-2) and Science & Technology Department of Sichuan Province (2016NYZ0046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Ban Z, 1996, CHINESE J RABBIT FAR, V1, P15; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165434; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Graham-Jones O., 2001, VET J, V161, P22; Kang JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02853-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long JR, 2003, ANIM GENET, V34, P82, DOI 10.1046/j.1365-2052.2003.00945.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Monnerot M, 1994, GENET SEL EVOL S1, V26, P1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Ezpeleta N, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00195; Rogel-Gaillard Claire, 2009, V3, P165, DOI 10.1007/978-3-540-73835-0_7; Rong Min, 2008, Chinese Journal of Animal Science, V44, P1; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wan XY, 2014, J VET MED SCI, V76, P369, DOI 10.1292/jvms.13-0304; Wang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174299; Whitman B.D., 2004, DOMESTIC RABBITS THE; Wu L, 2012, P 10 WORLD RABBIT C; Xie X-L, 2012, FUJIAN J AGR SCI, V33, P37; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222503	10.1371/journal.pone.0222503	http://dx.doi.org/10.1371/journal.pone.0222503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525233	Green Submitted, Green Published, gold			2022-12-27	WOS:000532225700033
J	Attimarad, M; Narayanswamy, VK; Aldhubaib, BE; SreeHarsha, N; Nair, AB				Attimarad, Mahesh; Narayanswamy, Venugopla Katarigatta; Aldhubaib, Bandar Essa; SreeHarsha, Nagaraja; Nair, Anroop Balachandran			Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation	PLOS ONE			English	Article							1,4-DIHYDROPYRIDINE ANTIHYPERTENSIVES; ATORVASTATIN CALCIUM; HUMAN PLASMA; HPLC METHOD; BESYLATE; ELECTROPHORESIS; VALIDATION; ELECTRODE; ASSAY	Recently, the United States Food and Drug Administration approved a new oral dosage preparation of amlodipine besylate (AML) and celecoxib (CEL) for the management of hypertension and osteoarthritis. However, no simultaneous estimation procedures for these two analytes have been described. Hence, two simple, accurate, and precise ultraviolet spectroscopic procedures that manipulated the ratio spectra were established for concurrent quantification of AML and CEL using ethanol as a solvent. The first method involves determining the peak-to-trough amplitude difference of the ratio spectra of AML and CEL. The second method involves determining the peak amplitude of the ratio first derivative (AA 4 nm) spectra of AML and CEL at 334.2 nm and 254.2 nm, correspondingly. Both methods showed linearity in the range of 1-6 mu g mL(-1) for AML and 5-40 mu g mL(-1) for CEL with an excellent correlation coefficient (<0.999). The proposed procedures were validated by following the International Conference on Harmonization guidelines for accuracy, precision, selectivity, recovery, and stability studies. It is evident from the low %RSD and %RE that both analytical procedures were found to be accurate and precise, respectively. The percent recovery of AML and CEL from the formulation was found to be 99.79% and 99.34% using the ratio-difference method and 100.13% and 99.70% using the ratio first-derivative method, with a low percent relative standard deviation. Further, the proposed techniques permit concurrent quantification of AML and CEL in different concentration ratios without interference from each other; hence, these techniques can be adopted for regular quality-control studies.	[Attimarad, Mahesh; Narayanswamy, Venugopla Katarigatta; Aldhubaib, Bandar Essa; SreeHarsha, Nagaraja; Nair, Anroop Balachandran] King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa, Saudi Arabia; [Narayanswamy, Venugopla Katarigatta] Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa	King Faisal University; Durban University of Technology	Attimarad, M (corresponding author), King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa, Saudi Arabia.	mattimarad@gmail.com	Sreeharsha, Nagaraja/P-2189-2019; Nair, Anroop/L-9995-2014; Attimarad, Mahesh V/M-4095-2016; Venugopala, Katharigatta N./M-4030-2016	Sreeharsha, Nagaraja/0000-0002-2058-255X; Nair, Anroop/0000-0003-2850-8669; Attimarad, Mahesh V/0000-0002-7007-9119; Venugopala, Katharigatta N./0000-0003-0680-1549	King Faisal University, Al-Ahsa, Saudi Arabia [1811018]	King Faisal University, Al-Ahsa, Saudi Arabia	This research work was performed with the financial support provided by the Deanship of Scientific Research, King Faisal University, Al-Ahsa, Saudi Arabia (Group Project #: 1811018).	Abdel-Wadood HA, 2008, SPECTROCHIM ACTA A, V70, P564, DOI 10.1016/j.saa.2007.07.055; Adriana M, 2016, CURR ISS PHARM MED S, V29, P42, DOI 10.1515/cipms-2016-0010; Afkhami A, 2005, SPECTROCHIM ACTA A, V61, P869, DOI 10.1016/j.saa.2004.06.013; Angeli F, 2018, EXPERT REV CLIN PHAR, V11, P1073, DOI 10.1080/17512433.2018.1540299; Ashfaq M, 2014, BRAZ J PHARM SCI, V50, P629, DOI 10.1590/S1984-82502014000300023; Attimarad M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071196; Attimarad M, 2016, INDIAN J PHARM EDUC, V50, pS188, DOI 10.5530/ijper.50.2.35; Attimarad M, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-105; Bahrami G, 2004, J PHARMACEUT BIOMED, V36, P163, DOI 10.1016/j.jpba.2004.05.016; Bapatu HR, 2015, J CHROMATOGR SCI, V53, P144, DOI 10.1093/chromsci/bmu031; Bhatt NM, 2014, SCI WORLD J, DOI 10.1155/2014/495739; Chandran S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P20; Djaalab E, 2018, CATALYSTS, V8, DOI 10.3390/catal8060233; Emami J, 2008, DARU, V16, P211; Gouda AA, 2013, ARAB J CHEM, V6, P145, DOI 10.1016/j.arabjc.2010.12.006; Hsieh YH, 2006, J SEP SCI, V29, P1009, DOI 10.1002/jssc.200500412; Jadhav PS, 2015, BRAZ J PHARM SCI, V51, P653, DOI 10.1590/S1984-82502015000300017; Karimi Z., 2014, J R P S, V3, P99; Klinkenberg R, 2003, J PHARMACEUT BIOMED, V32, P345, DOI 10.1016/S0731-7085(03)00109-2; Mansano GR, 2015, J ELECTROANAL CHEM, V738, P188, DOI 10.1016/j.jelechem.2014.11.034; Meyyanathan SN, 2005, J CHROMATOGR SCI, V43, P73, DOI 10.1093/chromsci/43.2.73; Moussa BA, 2013, ANAL CHEM INSIGHTS, V8, P107, DOI 10.4137/ACI.S12921; Trang NTQ, 2019, ADV MATER SCI ENG, V2019, DOI 10.1155/2019/5719651; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Park MS, 2012, J CHROMATOGR B, V902, P137, DOI 10.1016/j.jchromb.2012.06.016; Patel Deval B, 2012, Sci Pharm, V80, P581; Patel N.P., 2018, INT J PHARM PHARM SC, V10, P16; Puljak L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009865.pub2; Ragno G, 2006, J NANOSCI NANOTECHNO, V6, P2979, DOI 10.1166/jnn.2006.407; Ragno G, 2003, TALANTA, V59, P375, DOI 10.1016/S0039-9140(02)00526-X; Rahman N, 2003, J PHARMACEUT BIOMED, V31, P381, DOI 10.1016/S0731-7085(02)00610-6; Rahman Nafisur, 2004, Farmaco (Lausanne), V59, P913, DOI 10.1016/j.farmac.2004.07.009; Rajpurohit AS, 2018, ANAL METHODS-UK, V10, P5423, DOI 10.1039/c8ay01553h; Rojas FS, 2009, ANAL CHIM ACTA, V635, P22, DOI 10.1016/j.aca.2008.12.039; Saha RN, 2002, J PHARMACEUT BIOMED, V28, P741, DOI 10.1016/S0731-7085(01)00678-1; Singh G, 2002, AM J MANAG CARE, V8, pS383; Smith SM, 2019, AM J MED, V132, P172, DOI 10.1016/j.amjmed.2018.08.027; Srinivasu MK, 2002, J PHARMACEUT BIOMED, V28, P493, DOI 10.1016/S0731-7085(01)00670-7; Stepien O, 2002, J HYPERTENS, V20, P95, DOI 10.1097/00004872-200201000-00014; Sweetman SC, 2011, COMPLETE DRUG REFERE; Wang LJ, 2018, J PHARMACEUT BIOMED, V158, P74, DOI 10.1016/j.jpba.2018.05.037; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zarghi A., 2005, Farmaco (Lausanne), V60, P789, DOI 10.1016/j.farmac.2005.06.012	43	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222526	10.1371/journal.pone.0222526	http://dx.doi.org/10.1371/journal.pone.0222526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525229	Green Submitted, Green Published, gold			2022-12-27	WOS:000532225700034
J	Du, XH; Zhu, XP; Yang, YP; Wang, YL; Arens, P; Liu, HC				Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Arens, Paul; Liu, Huichao			De novo transcriptome analysis of Viola xwittrockiana exposed to high temperature stress	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR-MECHANISMS; TOLERANCE; EXPRESSION; GENE; IDENTIFICATION; DROUGHT; FAMILY; PLANTS	Around the world, pansies are one of the most popular garden flowers, but they are generally sensitive to high temperatures, and this limits the practicality of planting them during the warmest days of the year. However, a few pansy germplasms with improved heat tolerance have been discovered or bred, but the mechanisms of their heat resistance are not understood. In this study, we investigated the transcript profiles of a heat-tolerant pansy inbred line, DFM16, in response to high temperatures using RNAseq. Approximately 55.48 Gb of nucleotide data were obtained and assembled into 167,576 unigenes with an average length of 959 bp, of which, 5,708 genes were found to be differentially expressed after heat treatments. Real-time qPCR was performed to validate the expression profiles of the selected genes. Nine metabolic pathways were found to be significantly enriched, in the analysis of the differentially expressed genes. Several potentially interesting genes that encoded putative transcription regulators or key components involving heat shock protein (HSP), heat shock transcription factors (HSF), and antioxidants biosynthesis, were identified. These genes were highlighted to indicate their significance in response to heat stress and will be used as candidate genes to improve pansy heat-tolerance in the future.	[Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Liu, Huichao] Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China; [Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Liu, Huichao] Henan Prov Engn Res Ctr Hort Plant Resource Utili, Xinxiang, Henan, Peoples R China; [Arens, Paul] Wageningen Univ & Res, Wageningen, Netherlands	Henan Institute of Science & Technology; Wageningen University & Research	Liu, HC (corresponding author), Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China.; Liu, HC (corresponding author), Henan Prov Engn Res Ctr Hort Plant Resource Utili, Xinxiang, Henan, Peoples R China.	13683732063@163.com		Du, Xiaohua/0000-0001-8619-6419	International Science and Technology Cooperation Research Programme of Henan Province [182102410029]; Key Scientific Research Projects of Institutions of Higher Education of Henan Province [19A210011]	International Science and Technology Cooperation Research Programme of Henan Province; Key Scientific Research Projects of Institutions of Higher Education of Henan Province	This work was financially supported by the International Science and Technology Cooperation Research Programme of Henan Province (Grant No. 182102410029) and Key Scientific Research Projects of Institutions of Higher Education of Henan Province (Grant No. 19A210011).	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Almeselmani M., 2009, Acta Agronomica Hungarica, V57, P1, DOI 10.1556/AAgr.57.2009.1.1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Banerjee A, 2017, PROTOPLASMA, V254, P3, DOI 10.1007/s00709-015-0920-4; Banerjee A, 2016, PLANT BIOTECHNOL REP, V10, P185, DOI 10.1007/s11816-016-0401-z; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Chang CC, 2007, PLANT CELL PHYSIOL, V48, P1098, DOI 10.1093/pcp/pcm080; Chen H., 2016, THESIS; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kessler JR, 1999, SE FLORICULTURE, P29; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Montero-Barrientos M, 2010, J PLANT PHYSIOL, V167, P659, DOI 10.1016/j.jplph.2009.11.012; Peng HuaTing, 2012, Journal of Shanghai Jiaotong University - Agricultural Science, V30, P66; Priya M, 2019, THEOR APPL GENET, V132, P1607, DOI 10.1007/s00122-019-03331-2; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song XM, 2014, MOL GENET GENOMICS, V289, P541, DOI 10.1007/s00438-014-0833-5; Stief A, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.970430; Sun LP, 2012, PLANT CELL REP, V31, P1473, DOI 10.1007/s00299-012-1262-8; Sun WH, 2010, BIOL PLANTARUM, V54, P614, DOI 10.1007/s10535-010-0111-2; Vanderauwera S, 2011, P NATL ACAD SCI USA, V108, P1711, DOI 10.1073/pnas.1018359108; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang Y. J., 2006, Journal of Applied Horticulture (Lucknow), V8, P87; Xue Y, 2010, BIOL PLANTARUM, V54, P105, DOI 10.1007/s10535-010-0015-1; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zou Q., 1995, GUIDANCE PLANT PHYSL	39	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222344	10.1371/journal.pone.0222344	http://dx.doi.org/10.1371/journal.pone.0222344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550256	Green Published, gold			2022-12-27	WOS:000532307700014
J	Binquet, C; Lejeune, C; Seror, V; Peyron, F; Bertaux, AC; Scemama, O; Quantin, C; Bejean, S; Stillwaggon, E; Wallon, M				Binquet, Christine; Lejeune, Catherine; Seror, Valerie; Peyron, Francois; Bertaux, Anne-Claire; Scemama, Olivier; Quantin, Catherine; Bejean, Sophie; Stillwaggon, Eileen; Wallon, Martine			The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis	PLOS ONE			English	Article							GONDII INFECTION; PREGNANT-WOMEN; FETAL; DIAGNOSIS; RISK; AGE; TRANSMISSION; ULTRASOUND; ULTRASONOGRAPHY; ABNORMALITIES	Background Congenital Toxoplasmosis (CT) can have severe consequences. France, Austria, and Slovenia have prenatal screening programs whereas some other countries are considering universal screening to reduce congenital transmission and severity of infection in children. The efficiency of such programs is debated increasingly as seroprevalence among pregnant women and incidence of congenital toxoplasmosis show a steady decrease. In addition, uncertainty remains regarding the effectiveness of pre- and postnatal treatments. Method To identify cost-effective strategies, prenatal and neonatal screenings were compared using a decision-analytic model based on French guidelines and current knowledge of long-term evolution of the disease in treated children. Epidemiological data were extracted from the scientific literature and clinical data from the French Lyon cohort. Strategies were compared at one year of age, when infection can be definitively evaluated, and at 15 years of age, after which validated outcome data become scarce. The analysis was performed from the French Health Insurance System perspective and included direct medical costs for pregnant women and their children. Results The 1-year Incremental Cost-Effectiveness Ratio showed that prenatal screening would require investing (sic)14,826 to avoid one adverse event (liveborn with CT, fetal loss, neonatal death or pregnancy termination) compared to neonatal screening. Extra investment increased up to (sic)21,472 when considering the 15-year endpoint. Conclusions Prenatal screening is cost-effective as compared to neonatal screening in moderate prevalence areas with predominant Type II strains. In addition, prenatal screening, by providing closer follow-up of women at risk increases the number of occasions for education avoiding toxoplasmosis.	[Binquet, Christine; Lejeune, Catherine; Bertaux, Anne-Claire; Quantin, Catherine] INSERM, CIC 1432, Module Epiderniol Clin, Dijon, France; [Binquet, Christine; Lejeune, Catherine; Bertaux, Anne-Claire; Quantin, Catherine] Ctr Hosp Univ Dijon Bourgogne, Ctr Invest Clin, Module Epidemiol Clin Essais Clin, Dijon, France; [Seror, Valerie] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France; [Seror, Valerie] IHU Mediterranee Infect, Marseille, France; [Peyron, Francois; Wallon, Martine] Hosp Civils Lyon, Hop Croix Rousse, Inst Parasitol & Mycol Med, Inst Agents Infectieux, Dijon, France; [Bertaux, Anne-Claire] Ctr Hosp Univ Dijon Bourgogne, Delegat Rech Clin & Innovat, Unite Soutien Methodol Rech, Dijon, Reunion, France; [Scemama, Olivier] Haute Autorite Sante, Serv Evaluat Econom & Sante Publ, St Denis, France; [Quantin, Catherine] Ctr Hosp Univ Dijon Bourgogne, Serv Biostatist & Informat Med, Dijon, France; [Quantin, Catherine] Univ Paris Saclay, Biostat Biomath Pharmacoepidemiol & Infect Dis B2, Inst Pasteur, INSERM,UVSQ, Paris, France; [Bejean, Sophie] Univ Bourgogne, Lab Econ Dijon, Dijon, France; [Bejean, Sophie] CNRS, UMR 6307, Dijon, France; [Stillwaggon, Eileen] Gettysburg Coll, Dept Econ, Gettysburg, PA 17325 USA; [Wallon, Martine] INSERM, U1028, Physiol Integree Syst Eveil, Lyon, France; [Wallon, Martine] CNRS, UMR5292, Lyon, France; [Wallon, Martine] Univ Lyon, Ctr Rech Neurosci, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Gettysburg College; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Binquet, C (corresponding author), INSERM, CIC 1432, Module Epiderniol Clin, Dijon, France.; Binquet, C (corresponding author), Ctr Hosp Univ Dijon Bourgogne, Ctr Invest Clin, Module Epidemiol Clin Essais Clin, Dijon, France.	christine.binquet@u-bourgogne.fr	Béjean, Sophie/GZG-4552-2022; Binquet, Christine/E-8953-2018	Binquet, Christine/0000-0002-9417-5754; Seror, Valerie/0000-0001-8002-435X				Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Begeman IJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005670; Bianchi CM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1078-6; BROCKS V, 1991, Fetal Diagnosis and Therapy, V6, P37; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; CARRERA JM, 1995, ULTRASOUND OBST GYN, V5, P174, DOI 10.1046/j.1469-0705.1995.05030174.x; Chapey E, 2015, CLIN VACCINE IMMUNOL, V22, P398, DOI 10.1128/CVI.00552-14; Chene G, 2009, MEM I OSWALDO CRUZ, V104, P299, DOI 10.1590/S0074-02762009000200025; CHITTY LS, 1991, BRIT MED J, V303, P1165, DOI 10.1136/bmj.303.6811.1165; Cornu C, 2009, EUROSURVEILLANCE, V14, P21; Azevedo CTD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149938; Delabaere A, 2014, J GYNECOL OBST BIO R, V43, P764, DOI 10.1016/j.jgyn.2014.09.011; Derouin F, 1998, J ACQ IMMUN DEF SYND, V19, P50, DOI 10.1097/00042560-199809010-00008; DEROUIN F, 1988, PATHOL BIOL, V36, P1204; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Edejer T, 2003, MAKING CHOICES HLTH; El Bissati K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0164-4; Evengard B, 2001, EPIDEMIOL INFECT, V127, P121, DOI 10.1017/S0950268801005775; EWIGMAN B, 1990, OBSTET GYNECOL, V76, P189; EWIGMAN BG, 1993, NEW ENGL J MED, V329, P821, DOI 10.1056/NEJM199309163291201; Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3; GIRARD A, 2014, EURO SURVEILL, V19; GomezMarin JE, 1997, AM J TROP MED HYG, V57, P180, DOI 10.4269/ajtmh.1997.57.180; GONCALVES LF, 1994, AM J OBSTET GYNECOL, V171, P1606, DOI 10.1016/0002-9378(94)90411-1; Grandjean H, 1999, AM J OBSTET GYNECOL, V181, P446, DOI 10.1016/S0002-9378(99)70577-6; Haute Autorite de Sante, 2009, SURV SER PREV TOX RU; Haute Autorite de Sante, 2011, CHOIX METH EV EC HAS; HOLLIMAN RE, 1995, J HOSP INFECT, V30, P179, DOI 10.1016/0195-6701(95)90018-7; Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3; Levi S, 2002, PRENATAL DIAG, V22, P285, DOI 10.1002/pd.306; Lykins J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006536; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Morris JK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194986; Naessens A, 1999, J PEDIATR-US, V135, P714, DOI 10.1016/S0022-3476(99)70090-9; NAOT Y, 1981, J PEDIATR-US, V98, P32, DOI 10.1016/S0022-3476(81)80528-8; Nogareda F, 2014, EPIDEMIOL INFECT, V142, P1661, DOI 10.1017/S0950268813002756; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Paul Malgorzata, 2007, EJIFCC, V18, P91; Petersson K, 2000, ACTA OBSTET GYN SCAN, V79, P824, DOI 10.1034/j.1600-0412.2000.079010824.x; Peyron F, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010024; Phan L, 2008, AM J OPHTHALMOL, V146, P375, DOI 10.1016/j.ajo.2008.04.033; Pilkington H, 2014, EUR J PUBLIC HEALTH, V24, P905, DOI 10.1093/eurpub/ckt207; Prusa AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005648; Prusa AR, 2015, CLIN INFECT DIS, V60, pE4, DOI 10.1093/cid/ciu724; Robert-Gangneux F, 1999, J CLIN MICROBIOL, V37, P2893, DOI 10.1128/JCM.37.9.2893-2898.1999; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rodrigues IMX, 2009, MEM I OSWALDO CRUZ, V104, P434, DOI 10.1590/S0074-02762009000300006; Roser D, 2010, J INHERIT METAB DIS, V33, pS241, DOI 10.1007/s10545-010-9124-4; Stillwaggon E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001333; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thiebaut R, 2007, LANCET, V369, P115, DOI 10.1016/S0140-6736(07)60072-5; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Tourdjman M, 2015, B EPIDEMIOLOGIQUE HE, P264; Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032; Wallon M, 1999, BRIT MED J, V318, P1511, DOI 10.1136/bmj.318.7197.1511; Wallon M, 2014, PEDIATRICS, V133, pE601, DOI 10.1542/peds.2013-2153; Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09	62	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221709	10.1371/journal.pone.0221709	http://dx.doi.org/10.1371/journal.pone.0221709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532766	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600010
J	Stevanovic, M; Henttonen, P; Koskinen, E; Perakyla, A; Von-Wendt, TN; Sihvola, E; Tani, P; Ravaja, N; Sams, M				Stevanovic, Melisa; Henttonen, Pentti; Koskinen, Emmi; Perakyla, Anssi; Von-Wendt, Taina Nieminen; Sihvola, Elina; Tani, Pekka; Ravaja, Niklas; Sams, Mikko			Physiological responses to affiliation during conversation: Comparing neurotypical males and males with Asperger syndrome	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; RESPIRATORY SINUS ARRHYTHMIA; HIGH-FUNCTIONING ADULTS; INTERPERSONAL COMPLEMENTARITY; SOCIAL ENGAGEMENT; QUOTIENT; CHILDREN; PERSONALITY; PATTERNS; MINDS	We examined the emotional and psychophysiological underpinnings of social interaction in the context of autism spectrum disorder, more specifically, involving participants diagnosed with Asperger syndrome (AS). We recorded participants' autonomic nervous system (ANS) activation (electrodermal activity, heart rate, and heart rate variability) and facial muscle activation during conversations in two different types of male dyads: (1) ten dyads where one participant has been diagnosed with AS (AS/NT dyads) and (2) nine dyads where both participants are neurotypical (NT/NT dyads). Afterwards, three independent raters assessed continuously each participant's affiliative and dominant behaviors during the first and last 10 minutes of the conversations. The relationship between the assessed data and ANS responses was examined. We found that, in the NT/NT dyads, a high level of affiliation displayed by the conversational partner calms down the participant when they are actively dominating the interaction. In contrast, when the participants themselves expressed affiliation, their psychophysiological responses indicated increase in arousal, which suggests that the giving of affiliation is physiologically "hard work." The affiliation-related ANS responses were similar in those NT participants whose conversational partner had AS, while some differences in facial muscle activation did occur in comparison to NT/NT dyads. In the AS participants, in contrast, a high level of affiliation provided by the conversational partner was associated with increase in arousal, suggesting heightened alertness and stress. As for their own affiliative behavior, the AS participants exhibited similar indicators of alertness and stress as the NT participants, but only when their own level of dominance was low. Our results increase understanding of how individuals with AS experience social interaction at the physiological level, and how this experience differs from that in NT individuals. Moreover, our results confirm and further specify our earlier results, where we proposed that affiliation involves the type of "sharing of the burden" that also reverberates in the participants' bodies.	[Stevanovic, Melisa; Koskinen, Emmi; Perakyla, Anssi] Univ Helsinki, Fac Social Sci, Helsinki, Finland; [Henttonen, Pentti; Ravaja, Niklas] Univ Helsinki, Fac Med, Helsinki, Finland; [Von-Wendt, Taina Nieminen] NeuroMental, Neuropsychiat Rehabil & Med Ctr, Helsinki, Finland; [Sihvola, Elina; Tani, Pekka] Helsinki Univ Hosp, Helsinki, Finland; [Sams, Mikko] Aalto Univ, Dept Neurosci & Biomed Engn, Dept Comp Sci, Espoo, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aalto University	Stevanovic, M (corresponding author), Univ Helsinki, Fac Social Sci, Helsinki, Finland.	melisa.stevanovic@helsinki.fi	Sams, Mikko E/G-7060-2012		Academy of Finland [274735, 1132303, 284595, 308431]; Kone Foundation [87-49285]	Academy of Finland(Academy of Finland); Kone Foundation	This research was financially supported by the Academy of Finland (aka.fi) grants to Stevanovic [274735], to Perakyla [1132303, 284595], and to Sams [308431], as well as by the Kone Foundation grant (https://koneensaatio.fi/) to Koskinen [87-49285]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTWOOD T, 1998, ASPERGERS SYNDROME G; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P182, DOI 10.1017/CBO9780511546396.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Camm AJ, 1996, CIRCULATION, V93, P1043; Carson R.C., 1969, INTERACTION CONCEPTS; Cassidy S, 2015, AUTISM RES, V8, P534, DOI 10.1002/aur.1468; Cassidy S, 2014, AUTISM RES, V7, P112, DOI 10.1002/aur.1351; Couper-Kuhlen E., 2012, EMOTION INTERACTION, P113, DOI DOI 10.1093/ACPROF:OSO/9780199730735.003.0006; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Carvalho JLA, 2002, 2002 6TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING PROCEEDINGS, VOLS I AND II, P1488, DOI 10.1109/ICOSP.2002.1180076; De Jaegher H, 2013, FRONT INTEGR NEUROSC, V26; Doherty-Sneddon G, 2013, RES DEV DISABIL, V34, P616, DOI 10.1016/j.ridd.2012.09.022; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Frith U., 1991, AUTISM ASPERGER SYND; George D., 2010, SPSS WINDOWS STEP ST, V10th ed., DOI DOI 10.1080/13803395.2011.614598; Gurtman MB, 2001, J COUNS PSYCHOL, V48, P97, DOI 10.1037/0022-0167.48.1.97; Gutstein S., 2001, AUTISM ASPERGERS SOL; Harder R, 2016, CLIN AUTON RES, V26, P423, DOI 10.1007/s10286-016-0375-5; Hatfield E., 1994, EMOTIONAL CONTAGION, P7, DOI [DOI 10.1017/CBO9781139174138, 10.1017/CBO9781139174138]; Hobson P., 2002, CRADLE THOUGHT; Hobson RP, 1998, J AUTISM DEV DISORD, V28, P117, DOI 10.1023/A:1026088531558; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; HOCHSCHILD AR, 1979, AM J SOCIOL, V85, P551, DOI 10.1086/227049; Hubert BE, 2009, AUTISM, V13, P9, DOI 10.1177/1362361308091649; Jansen LMC, 2006, J AUTISM DEV DISORD, V36, P891, DOI 10.1007/s10803-006-0124-z; JEFFERSON G, 1988, SOC PROBL, V35, P418, DOI 10.1525/sp.1988.35.4.03a00070; Kaartinen M, 2012, J AUTISM DEV DISORD, V42, P1917, DOI 10.1007/s10803-011-1435-2; Karemaker JM, 2017, PHYSIOL MEAS, V38, pR89, DOI 10.1088/1361-6579/aa6782; Ke FF, 2018, REV EDUC RES, V88, P3, DOI 10.3102/0034654317740334; Kenny D.A., 2020, DYADIC DATA ANAL; Kiesler D.J., 1996, CONT INTERPERSONAL T; KIESLER DJ, 1983, PSYCHOL REV, V90, P185, DOI 10.1037/0033-295X.90.3.185; Kleiner M, 2007, PERCEPTION, V36, P14; Kushki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059730; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Leary T., 1957, INTERPERSONAL DIAGNO; Lindstrom Anna, 2012, HDB CONVERSATION ANA, P350, DOI DOI 10.1002/9781118325001.CH17; Lizdek I, 2012, SOC SCI COMPUT REV, V30, P513, DOI 10.1177/0894439312436487; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Mathersul D, 2013, INT J PSYCHOPHYSIOL, V87, P88, DOI 10.1016/j.ijpsycho.2012.11.005; Mathersul D, 2013, PHYSIOL BEHAV, V109, P14, DOI 10.1016/j.physbeh.2012.10.008; Milton DEM, 2012, DISABIL SOC, V27, P883, DOI 10.1080/09687599.2012.710008; Ming X, 2016, BRAIN DEV-JPN, V38, P225, DOI 10.1016/j.braindev.2015.07.003; Myles B.S., 2002, FOCUS AUTISM OTHER D, V17, P132, DOI [DOI 10.1177/10883576020170030201, 10.1177/10883576020170030201]; Neuhaus E, 2014, J AUTISM DEV DISORD, V44, P730, DOI 10.1007/s10803-013-1923-7; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; O'Haire ME, 2015, DEV PSYCHOBIOL, V57, P584, DOI 10.1002/dev.21310; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perakyla A., 2012, EMOTION INTERACTION, P64, DOI DOI 10.1093/ACPROF:OSO/9780199730735.003.0004; Perakyla A, 2015, SOC PSYCHOL QUART, V78, P301, DOI 10.1177/0190272515611054; Pillai D, 2014, J AUTISM DEV DISORD, V44, P2430, DOI 10.1007/s10803-014-2106-x; Porges SW, 2013, INT J PSYCHOPHYSIOL, V88, P261, DOI 10.1016/j.ijpsycho.2012.11.009; Sadler P, 2015, J PERS DISORD, V29, P526, DOI 10.1521/pedi.2015.29.4.526; Sadler P, 2009, J PERS SOC PSYCHOL, V97, P1005, DOI 10.1037/a0016232; Saghir H, 2017, RES AUTISM SPECT DIS, V39, P54, DOI 10.1016/j.rasd.2017.04.004; Selting M, 2010, PRAGMATICS, V20, P229, DOI 10.1075/prag.20.2.06sel; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Sheppard E, 2016, J AUTISM DEV DISORD, V46, P1247, DOI 10.1007/s10803-015-2662-8; Smeekens I, 2015, J AUTISM DEV DISORD, V45, P495, DOI 10.1007/s10803-013-1947-z; Smith JL, 2007, J PERS, V75, P679, DOI 10.1111/j.1467-6494.2007.00453.x; STEVANOVIC M, 2017, J AUTISM, V4, P2, DOI DOI 10.7243/2054-992X-4-2; Stivers T, 2008, RES LANG SOC INTERAC, V41, P31, DOI 10.1080/08351810701691123; Sullivan H. S., 1953, INTERPERSONAL THEORY; SZATMARI P, 1991, PSYCHIAT CLIN N AM, V14, P81; Voutilainen L, 2014, J PRAGMATICS, V68, P1, DOI 10.1016/j.pragma.2014.04.006; Wechsler D., 2010, WAIS R MANUAL, VUK 4th Edn; Widiger TA, 2010, J PERS ASSESS, V92, P528, DOI 10.1080/00223891.2010.513707; Wiggins J.S., 1982, HDB RES METHODS CLIN, P183; World Health Organization, 1993, ICD 10 ICD 10 CLASS; Yaughn E, 1999, J SOC PSYCHOL, V139, P473, DOI 10.1080/00224549909598406	78	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222084	10.1371/journal.pone.0222084	http://dx.doi.org/10.1371/journal.pone.0222084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532809	Green Published, Green Submitted, gold			2022-12-27	WOS:000532239600022
J	Garcia-Pinillos, F; Latorre-Roman, PA; Soto-Hermoso, VM; Parraga-Montilla, JA; Pantoja-Vallejo, A; Ramirez-Campillo, R; Roche-Seruendo, LE				Garcia-Pinillos, Felipe; Latorre-Roman, Pedro A.; Soto-Hermoso, Victor M.; Parraga-Montilla, Juan A.; Pantoja-Vallejo, Antonio; Ramirez-Campillo, Rodrigo; Roche-Seruendo, Luis E.			Agreement between the spatiotemporal gait parameters from two different wearable devices and high-speed video analysis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; RUNNING GAIT; STEP RATE; VALIDITY; KINEMATICS; FREQUENCY; VARIABLES; SYSTEM	This study aimed to evaluate the concurrent validity of two different inertial measurement units for measuring spatiotemporal parameters during running on a treadmill, by comparing data with a high-speed video analysis (VA) at 1,000 Hz. Forty-nine endurance runners performed a running protocol on a treadmill at comfortable velocity (i.e., 3.25 +/- 0.36 m.s(-1)). Those wearable devices (i.e., Stryd (TM) and RunScribe (TM) systems) were compared to a high-speed VA, as a reference system for measuring spatiotemporal parameters (i.e. contact time [CT], flight time [FT], step frequency [SF] and step length [SL]) during running at comfortable velocity. The pairwise comparison revealed that the Stryd (TM) system underestimated CT (5.2%, p < 0.001) and overestimated FT (15.1%, p < 0.001) compared to the VA; whereas the RunScribe (TM) system underestimated CT (2.3%, p = 0.009). No significant differences were observed in SF and SL between the wearable devices and VA. The intra class correlation coefficient (ICC) revealed an almost perfect association between both systems and high-speed VA (ICC > 0.81). The Bland-Altman plots revealed heteroscedasticity of error (r(2) = 0.166) for the CT from the Stryd (TM) system, whereas no heteroscedasticity of error (r(2) < 0.1) was revealed in the rest of parameters. In conclusion, the results obtained suggest that both foot pods are valid tools for measuring spatiotemporal parameters during running on a treadmill at comfortable velocity. If the limits of agreement of both systems are considered in respect to high-speed VA, the RunScribe (TM) seems to be a more accurate system for measuring temporal parameters and SL than the Stryd (TM) system.	[Garcia-Pinillos, Felipe] Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile; [Latorre-Roman, Pedro A.; Parraga-Montilla, Juan A.] Univ Jaen, Dept Corporal Express, Jaen, Spain; [Soto-Hermoso, Victor M.] Univ Granada, Sport & Hlth Univ Res Ctr IMUDS, Granada, Spain; [Pantoja-Vallejo, Antonio] Univ Jaen, Dept Pedag, Jaen, Spain; [Ramirez-Campillo, Rodrigo] Univ Los Lagos, Lab Human Performance, Qual Life & Wellness Res Grp, Dept Phys Act Sci, Osorno, Chile; [Roche-Seruendo, Luis E.] Univ San Jorge, Zaragoza, Spain	Universidad de La Frontera; Universidad de Jaen; University of Granada; Universidad de Jaen; Universidad de Los Lagos; Universidad San Jorge	Garcia-Pinillos, F (corresponding author), Univ La Frontera, Dept Phys Educ Sports & Recreat, Temuco, Chile.	fegarpi@gmail.com	Montilla, Párraga J.A./I-3872-2015; Roche-Seruendo, Luis Enrique/H-5982-2015; Vallejo, Antonio Pantoja/D-5216-2011; Soto-Hermoso, Victor Manuel/M-5384-2014; García-Pinillos, Felipe/L-5703-2019; Ramirez-Campillo, Rodrigo/M-1258-2016	Roche-Seruendo, Luis Enrique/0000-0001-8492-9244; Vallejo, Antonio Pantoja/0000-0001-5374-4378; Soto-Hermoso, Victor Manuel/0000-0002-0213-5844; García-Pinillos, Felipe/0000-0002-7518-8234; Ramirez-Campillo, Rodrigo/0000-0003-2035-3279; Parraga Montilla, Juan Antonio/0000-0002-0250-0717	University of La Frontera (Universidad de La Frontera, Temuco, Chile) [DI19-0023]	University of La Frontera (Universidad de La Frontera, Temuco, Chile)	This study was funded by the University of La Frontera (Universidad de La Frontera, Temuco, Chile, Project DI19-0023). This grant was awarded to FGP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 1996, SPORTS MED, V22, P76, DOI 10.2165/00007256-199622020-00003; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Austin CL, 2018, SPORTS, V6, DOI 10.3390/sports6040142; Balsalobre-Fernandez C, 2017, J APPL BIOMECH, V33, P222, DOI 10.1123/jab.2016-0104; Barnes KR, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0007-y; Chew DK, 2018, SPORTS ENG, V21, P115, DOI 10.1007/s12283-017-0255-9; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dingenen B, 2018, PHYS THER SPORT, V33, P40, DOI 10.1016/j.ptsp.2018.06.009; Esculier JF, 2018, PHYS THER SPORT, V29, P108, DOI 10.1016/j.ptsp.2016.11.003; Garcia-Pinillos F, 2021, J STRENGTH COND RES, V35, P78, DOI 10.1519/JSC.0000000000002595; Gindre C, 2015, J SPORT SCI, P1, DOI [DOI 10.1080/02640414.2015.1068436, 10.1080/02640414.2015.1068436]; Gouttebarge V, 2015, J HUM KINET, V45, P19, DOI 10.1515/hukin-2015-0003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Lee MM, 2014, J PHYS THER SCI, V26, P81, DOI 10.1589/jpts.26.81; Lee Myungmo, 2014, Med Sci Monit, V20, P1210, DOI 10.12659/MSM.890658; Lienhard K, 2013, MED ENG PHYS, V35, P500, DOI 10.1016/j.medengphy.2012.06.015; Luedke LE, 2016, MED SCI SPORT EXER, V48, P1244, DOI 10.1249/MSS.0000000000000890; Nakayama Y, 2010, GAIT POSTURE, V31, P331, DOI 10.1016/j.gaitpost.2009.12.003; Norris M, 2014, P I MECH ENG P-J SPO, V228, P3, DOI 10.1177/1754337113502472; Padulo J, 2013, INT J SPORTS MED, V34, P244, DOI 10.1055/s-0032-1323724; Padulo Johnny, 2014, Muscles Ligaments Tendons J, V4, P159; Padulo J, 2012, J STRENGTH COND RES, V26, P1331, DOI 10.1519/JSC.0b013e318231aafa; Pipkin A, 2016, J ORTHOP SPORT PHYS, V46, P556, DOI 10.2519/jospt.2016.6280; Radzak KN, 2017, GAIT POSTURE, V51, P268, DOI 10.1016/j.gaitpost.2016.11.005; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; SCHIEB DA, 1986, RES Q EXERCISE SPORT, V57, P1; Schubert AG, 2014, SPORTS HEALTH, V6, P210, DOI 10.1177/1941738113508544; Tartaruga MP, 2012, RES Q EXERCISE SPORT, V83, P367	32	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222872	10.1371/journal.pone.0222872	http://dx.doi.org/10.1371/journal.pone.0222872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550296	Green Published, gold			2022-12-27	WOS:000532307700028
J	Li, YC; Sze, NN; Wong, SC; Tsui, KL; So, FL				Li, Y. C.; Sze, N. N.; Wong, S. C.; Tsui, K. L.; So, F. L.			Experimental study of the temporal profile of breath alcohol concentration in a Chinese population after a light meal	PLOS ONE			English	Article							HONG-KONG; CRASH; BLOOD; MODEL; PHARMACOKINETICS; DRUGS; RISK	In forensic science, the Widmark equation is widely used to deduce the blood alcohol concentration (BAC) at different time points. But the linear model specified by Widmark might be deficient in predicting the breath alcohol concentration (BrAC) at different time points, and extrapolating the peak and the corresponding time. In order to establish the temporal profile of alcohol concentration which captures the effects of non-linear nature of alcohol absorption, elimination, and peak, in particular of Chinese population after a light meal, a drinking experiment was conducted in this study. To achieve this, a double-blind drinking experiment was conducted to measure the BrAC of 52 Chinese participants after a light meal in this study. Prior to the experiment, all participants were required to abstain from food for 4 hours, more importantly, from alcohol and sedatives for 24 hours. A standard light meal was provided about 30 minutes prior to the alcohol intake in the experiment. The BrAC was measured at a 10-minute interval during the absorption phase and 30-minute interval during the elimination phase respectively. The measurements were stopped when the BrAC fell to 0.010 mg/100 ml or below, or more than 8 hours after the alcohol intake. Then, the temporal profiles of BrAC, assuming linear and non-linear relationships, were established using Full Bayesian approach. The linear component indicated the alcohol impairment in normal social function, with which a light meal is usually accompanied with drinking. On the other hand, the non-linear (gamma distribution) part replicated the absorption phase, elimination phase, and the peak of alcohol concentration. The proposed model well performed than the conventional regression model. Additionally, the confounding factors including gender, body weight, and dosage were controlled for. Results should be useful for the development of cost-effective enforcement measures that could deter against drink driving.	[Li, Y. C.; Wong, S. C.] Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China; [Sze, N. N.] Hong Kong Polytech Univ, Dept Civil & Environm Engn, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Tsui, K. L.] Pok Oi Hosp, Accid & Emergency Dept, Yuen Long, Hong Kong, Peoples R China; [So, F. L.] Tuen Mun Hosp, Accid & Emergency Dept, Tuen Mun, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong Polytechnic University; Tuen Mun Hospital	Li, YC (corresponding author), Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China.	joeyliyc@connect.hku.hk	Wong, S.C./A-7258-2008; Sze, NN/S-1437-2018	Wong, S.C./0000-0003-1169-7045; Sze, NN/0000-0002-2597-8107	Research Postgraduate Studentship; Research Grant Council of the Hong Kong Special Administrative Region, China [718811, 17203017]; Francis S Y Bong Professorship in Engineering	Research Postgraduate Studentship; Research Grant Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Francis S Y Bong Professorship in Engineering	The research described here was supported by a Research Postgraduate Studentship to YCL, and a grant from the Research Grant Council of the Hong Kong Special Administrative Region, China (Project No. 718811 and 17203017 to SCW). Author SCW was also supported by the Francis S Y Bong Professorship in Engineering.	ANDREASSON R, 1995, FORENSIC SCI INT, V72, P1, DOI 10.1016/0379-0738(94)01687-Z; Audit Commission of HKSAR, 2015, ADM ROAD SAF MEAS; Barbour AD, 2001, SCI JUSTICE, V41, P53, DOI 10.1016/S1355-0306(01)71849-7; Barquin J, 2008, FORENSIC SCI INT, V177, P140, DOI 10.1016/j.forsciint.2007.11.012; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Denney RC, 1995, ALCOHOL, DRUGS AND TRAFFIC SAFETY - T'95, VOLS 1 AND 2, P573; Department of Mental Health and Substance Dependence, 2000, INT GUID MON ALC CON; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Elliott S, 2009, SCI JUSTICE, V49, P19, DOI 10.1016/j.scijus.2008.06.001; Gullberg RG, 2007, FORENSIC SCI INT, V172, P33, DOI 10.1016/j.forsciint.2006.11.010; HOLFORD NHG, 1987, CLIN PHARMACOKINET, V13, P273, DOI 10.2165/00003088-198713050-00001; Jachau K, 2004, FORENSIC SCI INT, V143, P115, DOI 10.1016/j.forsciint.2004.03.023; Jones AW, 2010, FORENSIC SCI INT, V200, P1, DOI 10.1016/j.forsciint.2010.02.021; JONES AW, 1985, CLIN CHIM ACTA, V146, P175, DOI 10.1016/0009-8981(85)90056-7; Kim JH, 2013, ADDICTION, V108, P1217, DOI 10.1111/add.12116; KIM K, 1995, ACCIDENT ANAL PREV, V27, P469, DOI 10.1016/0001-4575(95)00001-G; Li YC, 2014, TRANSPORTMETRICA A, V10, P722, DOI 10.1080/23249935.2013.854425; Li YC, 2013, HONG KONG J EMERG ME, V20, P146, DOI 10.1177/102490791302000304; Li YC, 2013, ACCIDENT ANAL PREV, V59, P415, DOI 10.1016/j.aap.2013.06.033; Ma XX, 2017, ANAL METHODS ACCID R, V15, P29, DOI 10.1016/j.amar.2017.06.001; Mumenthaler MS, 2000, ALCOHOL CLIN EXP RES, V24, P1353, DOI 10.1097/00000374-200009000-00005; Pavlic M, 2007, FORENSIC SCI INT, V171, P16, DOI 10.1016/j.forsciint.2006.09.008; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schechtman E, 2011, ACCIDENT ANAL PREV, V43, P2188, DOI 10.1016/j.aap.2011.06.013; Swift R, 2003, ADDICTION, V98, P73, DOI 10.1046/j.1359-6357.2003.00605.x; Tam TWM, 2005, FORENSIC SCI INT, V151, P23, DOI 10.1016/j.forsciint.2004.06.032; Widmark EMP, 1981, PRINCIPLES APPL MEDI; Wrieden WL, 2009, STAT METHODS MED RES, V18, P285, DOI 10.1177/0962280208094694; Yang Chi Ting, 2009, Legal Medicine, V11, P163, DOI 10.1016/j.legalmed.2009.02.031	31	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221237	10.1371/journal.pone.0221237	http://dx.doi.org/10.1371/journal.pone.0221237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532778	Green Published, gold, Green Submitted			2022-12-27	WOS:000532239600004
J	Shao, YY; Xuan, GT; Hu, ZC; Gao, ZM; Liu, L				Shao, Yuanyuan; Xuan, Guantao; Hu, Zhichao; Gao, Zongmei; Liu, Lei			Determination of the bruise degree for cherry using Vis-NIR reflection spectroscopy coupled with multivariate analysis	PLOS ONE			English	Article							SOLUBLE SOLIDS CONTENT; APPLE FRUIT FIRMNESS; AUTOMATIC DETECTION; IMAGE-ANALYSIS; SKIN DEFECTS; SWEET CHERRY; PREDICTION; PH; CLASSIFICATION; QUALITY	Determination and classification of the bruise degree for cherry can improve consumer satisfaction with cherry quality and enhance the industry's competiveness and profitability. In this study, visible and near infrared (Vis-NIR) reflection spectroscopy was used for identifying bruise degree of cherry in 350-2500 nm. Sampling spectral data were extracted from normal, slight and severe bruise samples. Principal component analysis (PCA) was implemented to determine the first few principal components (PCs) for cluster analysis among samples. Optimal wavelengths were selected by loadings of PCs from PCA and successive projection algorithm (SPA) method, respectively. Afterwards, these optimal wavelengths were empolyed to establish the classification models as inputs of least square-support vector machine (LS-SVM). Better performance for qualitative discrimination of the bruise degree for cherry was emerged in LS-SVM model based on five optimal wavelengths (603, 633, 679, 1083, and 1803 nm) selected directly by SPA, which showed acceptable results with the classification accuracy of 93.3%. Confusion matrix illustrated misclassification generally occurred in normal and slight bruise samples. Furthermore, the latent relation between spectral property of cherries in varying bruise degree and its firmness and soluble solids content (SSC) was analyzed. The result showed both colour, firmness and SSC were consistent with the Vis-NIR reflectance of cherries. Overall, this study revealed that Vis-NIR reflection spectroscopy integrated with multivariate analysis can be used as a rapid, intact method to determine the bruise degree of cherry, laying a foundation for cherry sorting and postharvest quality control.	[Shao, Yuanyuan; Xuan, Guantao; Liu, Lei] Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China; [Shao, Yuanyuan; Hu, Zhichao] Minist Agr, Nanjing Res Inst Agr Mechanizat, Nanjing, Jiangsu, Peoples R China; [Xuan, Guantao] Univ Missouri, Coll Agr Food & Nat Resources, Columbia, MO USA; [Gao, Zongmei] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Nanjing Institute of Agricultural Mechanization, CAAS; Ministry of Agriculture & Rural Affairs; University of Missouri System; University of Missouri Columbia; Washington State University	Xuan, GT (corresponding author), Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China.; Hu, ZC (corresponding author), Minist Agr, Nanjing Res Inst Agr Mechanizat, Nanjing, Jiangsu, Peoples R China.; Xuan, GT (corresponding author), Univ Missouri, Coll Agr Food & Nat Resources, Columbia, MO USA.	xuangt@sina.com; zchu369@163.com			National Natural Science Foundation of China [31671632, 31701325]; China Scholarship Council [201709135004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	The study was supported by National Natural Science Foundation of China (Nos. 31671632 to GX, 31701325 to YS) and China Scholarship Council (No. 201709135004 to GX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski P, 2013, POSTHARVEST BIOL TEC, V86, P249, DOI 10.1016/j.postharvbio.2013.07.005; Baranowski P, 2012, J FOOD ENG, V110, P345, DOI 10.1016/j.jfoodeng.2011.12.038; Cao JP, 2015, J FOOD SCI, V80, pC234, DOI 10.1111/1750-3841.12743; Cortes V, 2016, POSTHARVEST BIOL TEC, V118, P148, DOI 10.1016/j.postharvbio.2016.04.011; Cortes V, 2017, J FOOD ENG, V204, P27, DOI 10.1016/j.jfoodeng.2017.02.017; Cubero S, 2011, FOOD BIOPROCESS TECH, V4, P487, DOI 10.1007/s11947-010-0411-8; Diaz-Mula HM, 2009, FOOD SCI TECHNOL INT, V15, P535, DOI 10.1177/1082013209351868; ElMasry G, 2008, LWT-FOOD SCI TECHNOL, V41, P337, DOI 10.1016/j.lwt.2007.02.022; Escribano S, 2017, POSTHARVEST BIOL TEC, V128, P112, DOI 10.1016/j.postharvbio.2017.01.016; Fan GQ, 2009, J FOOD ENG, V93, P416, DOI 10.1016/j.jfoodeng.2009.02.006; Fan SX, 2017, POSTHARVEST BIOL TEC, V134, P55, DOI 10.1016/j.postharvbio.2017.08.012; Guo WC, 2016, FOOD ANAL METHOD, V9, P38, DOI 10.1007/s12161-015-0165-z; Guyer D, 2000, COMPUT ELECTRON AGR, V29, P179, DOI 10.1016/S0168-1699(00)00146-0; Harker R., 2009, 4 AUSTR NZ AV GROW C; Hayama H, 2006, POSTHARVEST BIOL TEC, V41, P16, DOI 10.1016/j.postharvbio.2006.03.006; Hu MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25055-x; Jia BB, 2017, J FOOD ENG, V208, P57, DOI 10.1016/j.jfoodeng.2017.03.023; Kappel F, 2009, CAN J PLANT SCI, V89, P713, DOI 10.4141/CJPS08186; Leiva-Valenzuela GA, 2013, J FOOD ENG, V115, P91, DOI 10.1016/j.jfoodeng.2012.10.001; Li BC, 2016, OPTIK, V127, P2624, DOI 10.1016/j.ijleo.2015.11.193; Li CH, 2018, J SPECTROSC, V2018, DOI 10.1155/2018/6935197; Li JB, 2016, COMPUT ELECTRON AGR, V127, P582, DOI 10.1016/j.compag.2016.07.016; Li JB, 2016, POSTHARVEST BIOL TEC, V112, P121, DOI 10.1016/j.postharvbio.2015.10.007; Li JB, 2013, POSTHARVEST BIOL TEC, V82, P59, DOI 10.1016/j.postharvbio.2013.02.016; Li JB, 2013, J FOOD ENG, V116, P324, DOI 10.1016/j.jfoodeng.2012.11.007; Li XL, 2018, POSTHARVEST BIOL TEC, V143, P112, DOI 10.1016/j.postharvbio.2018.05.003; Liu CH, 2015, FOOD CHEM, V173, P482, DOI 10.1016/j.foodchem.2014.10.052; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Lopez-Maestresalas A, 2016, FOOD CONTROL, V70, P229, DOI 10.1016/j.foodcont.2016.06.001; Lorente D, 2015, J FOOD ENG, V163, P17, DOI 10.1016/j.jfoodeng.2015.04.010; Lu Q, 2012, PROCEDIA ENVIRON SCI, V12, P1172, DOI 10.1016/j.proenv.2012.01.404; Lu Q, 2011, CZECH J FOOD SCI, V29, P595, DOI 10.17221/69/2010-CJFS; Luo X, 2012, J FOOD ENG, V109, P457, DOI 10.1016/j.jfoodeng.2011.10.035; Magwaza LS, 2015, SCI HORTIC-AMSTERDAM, V184, P179, DOI 10.1016/j.scienta.2015.01.001; Mendoza F, 2014, J FOOD ENG, V125, P59, DOI 10.1016/j.jfoodeng.2013.10.022; Mendoza F, 2011, POSTHARVEST BIOL TEC, V62, P149, DOI 10.1016/j.postharvbio.2011.05.009; Mo C, 2017, BIOSYST ENG, V159, P10, DOI 10.1016/j.biosystemseng.2017.03.015; Moghimi A, 2010, BIOSYST ENG, V106, P295, DOI 10.1016/j.biosystemseng.2010.04.002; Mollazade K, 2012, FOOD BIOPROCESS TECH, V5, P1465, DOI 10.1007/s11947-012-0821-x; Morais TCB, 2018, FOOD CHEM, V273, P31, DOI [10.1016/j.ifacol.2018.08.273, DOI 10.1016/J.IFACOL.2018.08.273]; Pappas CS, 2011, J FOOD COMPOS ANAL, V24, P17, DOI 10.1016/j.jfca.2010.07.001; Peng YK, 2008, POSTHARVEST BIOL TEC, V48, P52, DOI 10.1016/j.postharvbio.2007.09.019; Peng YanKun, 2011, Journal of Jiangsu University - Natural Science Edition, V32, P125; Prusky D, 2011, FOOD SECUR, V3, P463, DOI 10.1007/s12571-011-0147-y; Qin J, 2005, T ASAE, V48, P1963, DOI 10.13031/2013.19988; Santosh Chopde, 2017, Agricultural Reviews, V38, P94, DOI 10.18805/ag.v38i02.7940; Siedliska A, 2017, INT AGROPHYS, V31, P539, DOI 10.1515/intag-2016-0075; Siedliska A, 2014, COMPUT ELECTRON AGR, V106, P66, DOI 10.1016/j.compag.2014.05.012; Slaughter DC, 2013, J FOOD ENG, V116, P920, DOI 10.1016/j.jfoodeng.2013.01.007; Timm E. J., 1995, Applied Engineering in Agriculture, V11, P403; Washburn KE, 2017, J FOOD ENG, V205, P64, DOI 10.1016/j.jfoodeng.2017.02.025; Xing J, 2008, POSTHARVEST BIOL TEC, V49, P411, DOI 10.1016/j.postharvbio.2008.03.018; Xing J, 2006, COMPUT ELECTRON AGR, V52, P11, DOI 10.1016/j.compag.2006.01.006; Zhang S, 2017, POSTHARVEST BIOL TEC, V127, P44, DOI 10.1016/j.postharvbio.2016.12.008; Zhang SJ, 2013, MATH COMPUT MODEL, V58, P545, DOI 10.1016/j.mcm.2011.10.067; Zielinski AAF, 2014, COMPR REV FOOD SCI F, V13, P300, DOI 10.1111/1541-4337.12060	56	15	16	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222633	10.1371/journal.pone.0222633	http://dx.doi.org/10.1371/journal.pone.0222633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU7ZJ	31532801	Green Submitted, Green Published, gold			2022-12-27	WOS:000501890000001
J	Jahn, M; Rekowski, J; Gerken, G; Kribben, A; Canbay, A; Katsounas, A				Jahn, Michael; Rekowski, Jan; Gerken, Guido; Kribben, Andreas; Canbay, Ali; Katsounas, Antonios			The predictive performance of SAPS 2 and SAPS 3 in an intermediate care unit for internal medicine at a German university transplant center; A retrospective analysis	PLOS ONE			English	Article							PROGNOSTIC SCORE PERFORMANCES; HOSMER-LEMESHOW TEST; GOODNESS-OF-FIT; HOSPITAL MORTALITY; MULTICENTER; SEVERITY; WORKLOAD; ILLNESS; MODEL	Objective To analyze and compare the performance of the Simplified-Acute-Physiology-Score (SAPS) 2 and SAPS 3 among intermediate care patients with internal disorders. Materials and methods We conducted a retrospective single-center analysis in patients (n = 305) admitted to an intermediate-care-unit (ImCU) for internal medicine at the University Hospital Essen, Germany. We employed and compared the SAPS 2 vs. the SAPS 3 scoring system for the assessment of disease severity and prediction of mortality rates among patients admitted to the ImCU within an 18-month period. Both scores, which utilize parameters recorded at admission to the intensive-care-unit (ICU), represent the most widely applied scoring systems in European intensive care medicine. The area-under-the-receiver-operating-characteristic-curve (AUROC) was used to evaluate the SAPS 2 and SAPS 3 discrimination performance. Ultimately, standardized-mortality-ratios (SMRs) were calculated alongside their respective 95%-confidence-intervals (95% CI) in order to determine the observed-to-expected death ratio and calibration belt plots were generated to evaluate the SAPS 2 and SAPS 3 calibration performance. Results Both scores provided acceptable discrimination performance, i.e., the AUROC was 0.71 (95% CI, 0.65-0.77) for SAPS 2 and 0.77 (95% CI, 0.72-0.82) for SAPS 3. Against the observed in-hospital mortality of 30.2%, SAPS 2 showed a weak performance with a predicted mortality of 17.4% and a SMR of 1.74 (95% CI, 1.38-2.09), especially in association with liver diseases and/or sepsis. SAPS 3 performed accurately, resulting in a predicted mortality of 29.9% and a SMR of 1.01 (95% CI, 0.8-1.21). Based on Calibration belt plots, SAPS 2 showed a poor calibration-performance especially in patients with low mortality risk (P<0.001), while SAPS 3 exhibited a highly accurate calibration performance (P = 0.906) across all risk levels. Conclusions In our study, the SAPS 3 exhibited high accuracy in prediction of mortality in ImCU patients with internal disorders. In contrast, the SAPS 2 underestimated mortality particularly in patients with liver diseases and sepsis.	[Jahn, Michael; Kribben, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Rekowski, Jan] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Gerken, Guido] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Canbay, Ali; Katsounas, Antonios] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Otto von Guericke University; University Hospital Magdeburg	Jahn, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany.	michael.jahn@uk-essen.de	Katsounas, Antonios/AAA-7947-2022	Katsounas, Antonios/0000-0002-5179-0327; Jahn, Michael/0000-0002-7493-205X; Rekowski, Jan/0000-0002-5207-3864				Alegre F, 2016, DIGEST LIVER DIS, V48, P209, DOI 10.1016/j.dld.2015.10.002; Armstrong E, 2015, ANESTH ANALG, V121, P1274, DOI 10.1213/ANE.0000000000000968; Arzeno NM, 2015, J BIOMED INFORM, V56, P145, DOI 10.1016/j.jbi.2015.05.021; Auriant I, 1998, CRIT CARE MED, V26, P1368, DOI 10.1097/00003246-199808000-00023; Bertolini G, 2000, J Epidemiol Biostat, V5, P251; Capuzzo M, 2009, ACTA ANAESTH SCAND, V53, P589, DOI 10.1111/j.1399-6576.2009.01929.x; Capuzzo M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0551-8; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; Dupont B, 2015, DIGEST LIVER DIS, V47, P675, DOI 10.1016/j.dld.2015.04.001; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Lucena JF, 2012, J HOSP MED, V7, P411, DOI 10.1002/jhm.1905; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Hamsen U, 2018, MINERVA ANESTESIOL, V84, P938, DOI 10.23736/S0375-9393.18.12516-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Katsounas A, 2016, J CRIT CARE, V33, P180, DOI 10.1016/j.jcrc.2016.01.013; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Lucena JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077229; Martinez-Urbistondo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139702; Metnitz B, 2009, INTENS CARE MED, V35, P616, DOI 10.1007/s00134-008-1286-2; Metnitz PGH, 1999, INTENS CARE MED, V25, P192, DOI 10.1007/s001340050815; Metnitz PGH, 2000, INTENS CARE MED, V26, P1466, DOI 10.1007/s001340000638; Moreno R, 1997, INTENS CARE MED, V23, P177, DOI 10.1007/s001340050313; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nassar AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13911; Nattino G, 2016, STAT MED, V35, P709, DOI 10.1002/sim.6744; Plate JDJ, 2017, CRIT CARE RES PRACT, V2017, DOI 10.1155/2017/8038460; Poole D, 2012, INTENS CARE MED, V38, P1280, DOI 10.1007/s00134-012-2578-0; Poole D, 2009, INTENS CARE MED, V35, P1916, DOI 10.1007/s00134-009-1615-0; Richardson DB, 2015, EPIDEMIOLOGY, V26, P727, DOI 10.1097/EDE.0000000000000353; Sakr Y, 2008, BRIT J ANAESTH, V101, P798, DOI 10.1093/bja/aen291; Strand K, 2009, ACTA ANAESTH SCAND, V53, P595, DOI 10.1111/j.1399-6576.2009.01948.x; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Yu W, 2017, COMMUN STAT-THEOR M, V46, P11813, DOI 10.1080/03610926.2017.1285922	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222164	10.1371/journal.pone.0222164	http://dx.doi.org/10.1371/journal.pone.0222164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553738	gold, Green Published			2022-12-27	WOS:000532319200016
J	Kraus, EC; Stout, MJ				Kraus, Emily C.; Stout, Michael J.			Seed treatment using methyl jasmonate induces resistance to rice water weevil but reduces plant growth in rice	PLOS ONE			English	Article							FITNESS COSTS; DEFENSE; COLEOPTERA; TOMATO; TOLERANCE; HERBIVORE; STRESS; ACID	The jasmonic acid cascade plays a pivotal role in induced plant resistance to herbivores. There have been a number of investigations into the potential uses of derivatives of this hormone for pest management. Understanding the phenotypic plasticity of plant defense traits interactions in agricultural systems may facilitate the development of novel and improved management practices, which is desirable as management of insects in most agricultural systems is currently heavily reliant on insecticides. The rice water weevil (RWW), Lissorhoptrus oryzophilus Kuschel, is a pest of rice, Oryza sativa, in the southern U.S. and globally. The effects of the jasmonic acid derivative, methyl jasmonate (MJ), on induced defenses to RWW in rice, and the potential costs of MJ-induced resistance to plant growth and fitness, were tested in a series of field and greenhouse trials. It was hypothesized that seed treatments with MJ would reduce densities of larval RWW. A second hypothesis was that MJ seed treatments would alter emergence, biomass accumulation, and yield of rice. The final hypothesis was that induction of plant resistance to the RWW would diminish as the time from seed treatment increased. In order to investigate these hypotheses, RWW densities were determined in greenhouse and field trials. Plant growth was measured in the field by assessing plant emergence, root and shoot biomass, time of heading, and yield (grain mass). Results indicated that MJ seed treatments induced resistance to RWW, although this effect decayed over time. Additionally, there were costs to plant growth and fitness; emergence and heading were delayed and biomass was reduced. Importantly, however, yields on a per-plant were not significantly reduced by MJ treatment. Overall, these results are promising and show the potential for the use of jasmonate elicitors as part of a pest management program in rice.	[Kraus, Emily C.; Stout, Michael J.] Louisiana State Univ, AgCtr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kraus, EC (corresponding author), Louisiana State Univ, AgCtr, Baton Rouge, LA 70803 USA.	krausec07@gmail.com			Louisiana Rice Research Board; USDA National Institute of Food and Agriculture, Hatch project [0218143]; Louisiana Agricultural Consultants Association in 2017; Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018	Louisiana Rice Research Board; USDA National Institute of Food and Agriculture, Hatch project; Louisiana Agricultural Consultants Association in 2017; Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018	MJS was supported by a grant from the Louisiana Rice Research Board and by the USDA National Institute of Food and Agriculture, Hatch project accession number 0218143. ECK was supported by a scholarship from the Louisiana Agricultural Consultants Association in 2017 and the Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018. Funders had no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript.	Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Campos ML, 2014, J CHEM ECOL, V40, P657, DOI 10.1007/s10886-014-0468-3; Cipollini DF, 1997, OECOLOGIA, V111, P84, DOI 10.1007/s004420050211; Dar TA, 2015, ENVIRON EXP BOT, V115, P49, DOI 10.1016/j.envexpbot.2015.02.010; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Gomez S, 2010, PLANT BIOLOGY, V12, P512, DOI 10.1111/j.1438-8677.2009.00234.x; Gordy JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136689; Guo Q, 2018, CURR OPIN PLANT BIOL, V44, P72, DOI 10.1016/j.pbi.2018.02.009; Haas J, 2018, ENTOMOL EXP APPL, V166, P412, DOI 10.1111/eea.12678; Hamm JC, 2010, J CHEM ECOL, V36, P192, DOI 10.1007/s10886-010-9751-0; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hemmi A, 2004, MAR ECOL PROG SER, V273, P109, DOI 10.3354/meps273109; Lortzing T, 2016, CURR OPIN INSECT SCI, V14, P32, DOI 10.1016/j.cois.2016.01.002; Mitchell C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01132; NGUESSAN FK, 1994, ENVIRON ENTOMOL, V23, P665, DOI 10.1093/ee/23.3.665; Pankaj, 2013, NEMATOLOGY, V15, P15, DOI 10.1163/156854112X641754; Paudel S, 2014, ARTHROPOD-PLANT INTE, V8, P539, DOI 10.1007/s11829-014-9335-y; Redman AM, 2001, OECOLOGIA, V126, P380, DOI 10.1007/s004420000522; Shang HW, 2004, J ENTOMOL SCI, V39, P623, DOI 10.18474/0749-8004-39.4.623; Stout MJ, 2002, J ECON ENTOMOL, V95, P715, DOI 10.1603/0022-0493-95.4.715; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Underwood NC, 1998, OECOLOGIA, V114, P376, DOI 10.1007/s004420050460; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222800	10.1371/journal.pone.0222800	http://dx.doi.org/10.1371/journal.pone.0222800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545832	Green Published, Green Submitted, gold			2022-12-27	WOS:000532303200036
J	Koelewijn, AD; Heinrich, D; van den Bogert, AJ				Koelewijn, Anne D.; Heinrich, Dieter; van den Bogert, Antonie J.			Metabolic cost calculations of gait using musculoskeletal energy models, a comparison study	PLOS ONE			English	Article							HUMAN WALKING; MUSCLE MODEL; EXPENDITURE; SIMULATIONS; EFFICIENCY; MOVEMENT	This paper compares predictions of metabolic energy expenditure in gait using seven metabolic energy expenditure models to assess their correlation with experimental data. Ground reaction forces, marker data, and pulmonary gas exchange data were recorded for six walking trials at combinations of two speeds, 0.8 m/s and 1.3 m/s, and three inclines, -8% (downhill), level, and 8% (uphill). The metabolic cost, calculated with the metabolic energy models was compared to the metabolic cost from the pulmonary gas exchange rates. A repeated measures correlation showed that all models correlated well with experimental data, with correlations of at least 0.9. The model by Bhargava et al. (J Biomech, 2004: 81-88) and the model by Lichtwark and Wilson (J Exp Biol, 2005: 2831-3843) had the highest correlation, 0.95. The model by Margaria (Int Z Angew Physiol Einschl Arbeitsphysiol, 1968: 339-351) predicted the increase in metabolic cost following a change in dynamics best in absolute terms.	[Koelewijn, Anne D.; van den Bogert, Antonie J.] Cleveland State Univ, Dept Mech Engn, Parker Hannifin Lab Human Mot & Control, Cleveland, OH 44115 USA; [Koelewijn, Anne D.] Ecole Polytech Fed Lausanne, Biorobot Lab, Inst Bioengn, Lausanne, Switzerland; [Heinrich, Dieter] Univ Innsbruck, Dept Sport Sci, Innsbruck, Austria	University System of Ohio; Cleveland State University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Innsbruck	van den Bogert, AJ (corresponding author), Cleveland State Univ, Dept Mech Engn, Parker Hannifin Lab Human Mot & Control, Cleveland, OH 44115 USA.	a.vandenbogert@csuohio.edu	van den Bogert, Antonie J/A-7809-2009	van den Bogert, Antonie J/0000-0002-3791-3749; Heinrich, Dieter/0000-0001-5115-0605	Graduate Scholarship from the Parker-Hannifin Corporation; National Science Foundation [1344954, 1544702]	Graduate Scholarship from the Parker-Hannifin Corporation; National Science Foundation(National Science Foundation (NSF))	This research was funded by Graduate Scholarship from the Parker-Hannifin Corporation to ADK, National Science Foundation Grant No. 1344954 and 1544702, both to AJvdB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2016, GAIT POSTURE, V47, P62, DOI 10.1016/j.gaitpost.2016.03.022; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bhargava LJ, 2004, J BIOMECH, V37, P81, DOI 10.1016/S0021-9290(03)00239-2; Bregman DJJ, 2011, CLIN BIOMECH, V26, P955, DOI 10.1016/j.clinbiomech.2011.05.007; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; De Groote F, 2016, ANN BIOMED ENG, V44, P2922, DOI 10.1007/s10439-016-1591-9; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dembia CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180320; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Dorn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121407; Ellerby DJ, 2005, J PHYSIOL-LONDON, V564, P631, DOI 10.1113/jphysiol.2005.082974; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Houdijk H, 2006, J BIOMECH, V39, P536, DOI 10.1016/j.jbiomech.2004.11.033; HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631; Kenny GP, 2017, EUR J APPL PHYSIOL, V117, P1765, DOI 10.1007/s00421-017-3670-5; Kim JH, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2721; Kimel-Naor S, 2017, J BIOMECH, V60, P142, DOI 10.1016/j.jbiomech.2017.06.030; Kipp S, 2018, APPL PHYSIOL NUTR ME, V43, P639, DOI 10.1139/apnm-2017-0781; Koelewijn AD, 2018, THESIS; Koelewijn AD, 2018, COMPUT METHOD BIOMEC, V21, P521, DOI 10.1080/10255842.2018.1490954; Koelewijn AD, 2016, GAIT POSTURE, V49, P219, DOI 10.1016/j.gaitpost.2016.07.007; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Lichtwark GA, 2005, J EXP BIOL, V208, P2831, DOI 10.1242/jeb.01709; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Margaria R., 1976, BIOMECHANICS ENERGET; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Miller RH, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023151; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Ortega JD, 2005, J APPL PHYSIOL, V99, P2099, DOI 10.1152/japplphysiol.00103.2005; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Pickle NT, 2016, J BIOMECH, V49, P3244, DOI 10.1016/j.jbiomech.2016.08.004; Propp M. B., 1986, LECT MATH LIFE SCI, V16, P61; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Tsianos GA, 2012, IEEE T NEUR SYS REH, V20, P117, DOI 10.1109/TNSRE.2011.2162851; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150378; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; van den Bogert AJ, 2012, P I MECH ENG P-J SPO, V226, P123, DOI 10.1177/1754337112440644; VISSER M, 1995, AM J CLIN NUTR, V61, P772, DOI 10.1093/ajcn/61.4.772; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Winters JA., 1990, MULTIPLE MUSCLE SYST, P69, DOI DOI 10.1007/978-1-4613-9030-5_5; Zajac FE, 2003, GAIT POSTURE, V17, P1, DOI 10.1016/S0966-6362(02)00069-3; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	50	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222037	10.1371/journal.pone.0222037	http://dx.doi.org/10.1371/journal.pone.0222037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532796	gold, Green Published, Green Submitted			2022-12-27	WOS:000532239600019
J	Balmes, JR; Arjomandi, M; Bromberg, PA; Costantini, MG; Dagincourt, N; Hazucha, MJ; Hollenbeck-Pringle, D; Rich, DQ; Stark, P; Frampton, MW				Balmes, John R.; Arjomandi, Mehrdad; Bromberg, Philip A.; Costantini, Maria G.; Dagincourt, Nicholas; Hazucha, Milan J.; Hollenbeck-Pringle, Danielle; Rich, David Q.; Stark, Paul; Frampton, Mark W.			Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES)	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; CONGESTIVE-HEART-FAILURE; FLOW-CYTOMETRIC ASSAY; AMBIENT AIR-POLLUTION; HOSPITAL ADMISSIONS; CARDIOVASCULAR-DISEASE; RESPIRATORY-DISEASES; EXPOSURE; YOUNG; POLLUTANTS	The evidence that exposure to ozone air pollution causes acute cardiovascular effects is mixed. We postulated that exposure to ambient levels of ozone would increase blood markers of systemic inflammation, prothrombotic state, oxidative stress, and vascular dysfunction in healthy older subjects, and that absence of the glutathione S-transferase Mu 1 (GSTM1) gene would confer increased susceptibility. This double-blind, randomized, crossover study of 87 healthy volunteers 55-70 years of age was conducted at three sites using a common protocol. Subjects were exposed for 3 h in random order to 0 parts per billion (ppb) (filtered air), 70 ppb, and 120 ppb ozone, alternating 15 min of moderate exercise and rest. Blood was obtained the day before, approximately 4 h after, and approximately 22 h after each exposure. Linear mixed effect and logistic regression models evaluated the impact of exposure to ozone on pre-specified primary and secondary outcomes. The definition of statistical significance was p<0.01. There were no effects of ozone on the three primary markers of systemic inflammation and a prothrombotic state: C-reactive protein, monocyte-platelet conjugates, and microparticle-associated tissue factor activity. However, among the secondary endpoints, endothelin-1, a potent vasoconstrictor, increased from pre- to post-exposure with ozone concentration (120 vs 0 ppb: 0.07 pg/mL, 95% confidence interval [CI] 0.01, 0.14; 70 vs 0 ppb: -0.03 pg/mL, CI -0.09, 0.04; p = 0.008). Nitrotyrosine, a marker of oxidative and nitrosative stress, decreased with increasing ozone concentrations, with marginal significance (120 vs 0 ppb: -41.5, CI -70.1, -12.8; 70 vs 0 ppb: -14.2, CI -42.7, 14.2; p = 0.017). GSTM1 status did not modify the effect of ozone exposure on any of the outcomes. These findings from healthy older adults fail to identify any mechanistic basis for the epidemiologically described cardiovascular effects of exposure to ozone. The findings, however, may not be applicable to adults with cardiovascular disease.	[Balmes, John R.; Arjomandi, Mehrdad] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Arjomandi, Mehrdad] San Francisco VA Med Ctr, San Francisco, CA USA; [Bromberg, Philip A.; Hazucha, Milan J.] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27515 USA; [Bromberg, Philip A.; Hazucha, Milan J.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Costantini, Maria G.] Hlth Effects Inst, Boston, MA USA; [Dagincourt, Nicholas; Stark, Paul] New England Res Inst, 9 Galen St, Watertown, MA 02172 USA; [Hollenbeck-Pringle, Danielle] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Rich, David Q.] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, Rochester, NY 14642 USA; [Rich, David Q.; Frampton, Mark W.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Rich, David Q.; Frampton, Mark W.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Health Effects Institute (HEI); HealthCore, Inc; Brown University; University of Rochester; University of Rochester; University of Rochester	Frampton, MW (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.; Frampton, MW (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	mark_frampon@urmc.rochester.edu	Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217; Frampton, Mark/0000-0002-6002-2119	United States Environmental Protection Agency [CR-83590201]	United States Environmental Protection Agency(United States Environmental Protection Agency)	Research described in this article was conducted under contract to the Health Effects Institute (www.healtheffects.org), an organization jointly funded by the United States Environmental Protection Agency (Assistance Award No. CR-83590201) and certain motor vehicle and engine manufacturers. None of the individual sponsors of the Health Effects Institute had any direct involvement in this study. The contents of this article do not necessarily reflect the views of the Health Effects Institute, or its sponsors, nor do they necessarily reflect the views and policies of the United States Environmental Protection Agency or motor vehicle and engine manufacturers. The sponsor participated in study design, data collection, and data analysis. The sponsor did not participate in the decision to publish or the preparation of the manuscript.	Adams WC, 2006, INHAL TOXICOL, V18, P127, DOI 10.1080/08958370500306107; Alexis NE, 2013, J ALLERGY CLIN IMMUN, V131, P610, DOI 10.1016/j.jaci.2012.07.005; Alexis NE, 2009, J ALLERGY CLIN IMMUN, V124, P1222, DOI 10.1016/j.jaci.2009.07.036; Arjomandi M, 2018, AM J RESP CRIT CARE, V197, P1319, DOI 10.1164/rccm.201708-1613OC; Arjomandi M, 2015, AM J PHYSIOL-HEART C, V308, pH1499, DOI 10.1152/ajpheart.00849.2014; Ballester F, 2006, J EPIDEMIOL COMMUN H, V60, P328, DOI 10.1136/jech.2005.037978; Barath S, 2013, TOXICOL SCI, V135, P292, DOI 10.1093/toxsci/kft157; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Bossard M, 2015, ATHEROSCLEROSIS, V239, P186, DOI 10.1016/j.atherosclerosis.2014.12.061; Bravo MA, 2016, J EXPO SCI ENV EPID, V26, P150, DOI 10.1038/jes.2014.90; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Calderon-Garciduenas L, 2007, ENVIRON HEALTH PERSP, V115, P1248, DOI 10.1289/ehp.9641; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Chang CC, 2005, ENVIRON RES, V98, P114, DOI 10.1016/j.envres.2004.07.005; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Frampton M W, 2017, Res Rep Health Eff Inst, P1; Frampton MW, 2015, INHAL TOXICOL, V27, P113, DOI 10.3109/08958378.2014.996272; Franck U, 2014, SCI TOTAL ENVIRON, V468, P746, DOI 10.1016/j.scitotenv.2013.08.088; Fung KY, 2005, CAN J PUBLIC HEALTH, V96, P29, DOI 10.1007/BF03404010; Goldberg MS, 2008, OCCUP ENVIRON MED, V65, P659, DOI 10.1136/oem.2007.034934; Goodman JE, 2015, CRIT REV TOXICOL, V45, P412, DOI 10.3109/10408444.2015.1031371; Halonen JI, 2010, J EPIDEMIOL COMMUN H, V64, P814, DOI 10.1136/jech.2009.087106; Jimenez JJ, 2005, ADV CLIN CHEM, V39, P131, DOI 10.1016/S0065-2423(04)39005-0; Kahle JJ, 2015, ENVIRON HEALTH PERSP, V123, P310, DOI 10.1289/ehp.1307986; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Laskin DL, 2001, ADV EXP MED BIOL, V500, P183; Lee JT, 2003, ARCH ENVIRON HEALTH, V58, P617, DOI 10.3200/AEOH.58.10.617-623; Li NL, 1999, CYTOMETRY, V35, P154, DOI 10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y; Liao DP, 2005, J EXPO ANAL ENV EPID, V15, P319, DOI 10.1038/sj.jea.7500408; Morrow JD, 2006, CURR PHARM DESIGN, V12, P895, DOI 10.2174/138161206776055985; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Patrignani P, 2005, BIOMARKERS, V10, pS24, DOI 10.1080/13547500500215084; Pernow J, 2012, LIFE SCI, V91, P507, DOI 10.1016/j.lfs.2012.03.029; Rich DQ, 2018, ENVIRON INT, V119, P193, DOI 10.1016/j.envint.2018.06.014; Rodopoulou S, 2014, ENVIRON RES, V129, P39, DOI 10.1016/j.envres.2013.12.006; Sarnat SE, 2015, ENVIRON HEALTH PERSP, V123, P437, DOI 10.1289/ehp.1307776; Schelegle ES, 2009, AM J RESP CRIT CARE, V180, P265, DOI 10.1164/rccm.200809-1484OC; Schnabel R, 2007, CIRCULATION, V116, P1338, DOI 10.1161/CIRCULATIONAHA.107.728394; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Shumake KL, 2013, AGING CLIN EXP RES, V25, P3, DOI 10.1007/s40520-013-0001-5; Stewart JC, 2010, ENVIRON HEALTH PERSP, V118, P1692, DOI 10.1289/ehp.1002237; Strak M, 2013, OCCUP ENVIRON MED, V70, P332, DOI 10.1136/oemed-2012-100992; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Symons JM, 2006, AM J EPIDEMIOL, V164, P421, DOI 10.1093/aje/kwj206; Szyszkowicz M, 2008, INT J OCCUP MED ENV, V21, P295, DOI 10.2478/v10001-008-0029-5; Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550; Tolbert PE, 2007, J EXPO SCI ENV EPID, V17, pS29, DOI 10.1038/sj.jes.7500625; U.S. EPA, 2013, 600R10076F US EPA; Wang JCE, 2009, J IMMUNOL METHODS, V341, P106, DOI 10.1016/j.jim.2008.11.002; Wu WD, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-31; Yu AP, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0108-2; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834	60	25	26	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222601	10.1371/journal.pone.0222601	http://dx.doi.org/10.1371/journal.pone.0222601			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553765	Green Published, gold			2022-12-27	WOS:000532319200033
J	Reuschel, E; Toelge, M; Entleutner, K; Deml, L; Seelbach-Goebel, B				Reuschel, Edith; Toelge, Martina; Entleutner, Kathrin; Deml, Ludwig; Seelbach-Goebel, Birgit			Cytokine profiles of umbilical cord blood mononuclear cells upon in vitro stimulation with lipopolysaccharides of different vaginal gram-negative bacteria	PLOS ONE			English	Article							TNF-ALPHA PRODUCTION; LPS-INDUCED RELEASE; PRETERM LABOR; NEONATAL SEPSIS; INFLAMMATORY CYTOKINES; CHEMICAL-STRUCTURE; PREMATURE RUPTURE; PROTEUS-MIRABILIS; ESCHERICHIA-COLI; CEREBRAL-PALSY	Inflammatory immune responses induced by lipopolysaccharides (LPS) of gram-negative bacteria play an important role in the pathogenesis of preterm labor and delivery, and in neonatal disorders. To better characterize LPS-induced inflammatory response, we determined the cytokine profile of umbilical cord blood mononuclear cells (UBMC) stimulated with LPS of seven vaginal gram-negative bacteria commonly found in pregnant women with preterm labor and preterm rupture of membrane. UBMC from ten newborns of healthy volunteer mothers were stimulated with purified LPS of Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Proteus mirabilis, Acinetobacter calcoaceticus, Citrobacter freundii, and Pseudomonas aeruginosa. UBMC supernatants were tested for the presence of secreted pro-inflammatory cytokines (IL-6, IL-1 beta, TNF), anti-inflammatory cytokine (IL-10), TH1-type cytokines (IL-12, IFN-gamma), and chemokines (IL-8, MIP-1 alpha, MIP-1 beta, MCP-1) by Luminex technology. The ten cytokines were differentially induced by the LPS variants. LPS of E. coli and E. aerogenes showed the strongest stimulatory activity and P. aeruginosa the lowest. Interestingly, the ability of UBMC to respond to LPS varied greatly among donors, suggesting a strong individual heterogeneity in LPS-triggered inflammatory response.	[Reuschel, Edith; Entleutner, Kathrin; Seelbach-Goebel, Birgit] Univ Regensburg, Hosp Barmherzige Brueder, Dept Obstet & Gynecol, Clin St Hedwig, Regensburg, Germany; [Toelge, Martina; Deml, Ludwig] Univ Hosp Regensburg, Inst Med Microbiol, Regensburg, Germany; [Toelge, Martina] MicroBIOMix GmbH, Regensburg, Germany; [Deml, Ludwig] Lophius Biosci GmbH, Regensburg, Germany	University of Regensburg; University of Regensburg	Reuschel, E (corresponding author), Univ Regensburg, Hosp Barmherzige Brueder, Dept Obstet & Gynecol, Clin St Hedwig, Regensburg, Germany.	Edith.Reuschel@barmherzige-regensburg.de	Malfertheiner, Sara Fill/AAW-3419-2021	Malfertheiner, Sara Fill/0000-0002-4274-2526	University of Regensburg	University of Regensburg	This work was supported by institutional research funds of the University of Regensburg to BSG. MT receives salary from MicroBIOMIX and LD receives salary from Lophius Biosciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah MW, 2012, J NEUROIMMUNOL, V252, P75, DOI 10.1016/j.jneuroim.2012.07.013; Al-Amin MM, 2016, NEUROSCIENCE, V318, P84, DOI 10.1016/j.neuroscience.2016.01.002; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brandenburg K, 2016, J STRUCT BIOL, V194, P68, DOI 10.1016/j.jsb.2016.01.014; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; BRYN K, 1978, EUR J BIOCHEM, V86, P311, DOI 10.1111/j.1432-1033.1978.tb12312.x; Burnichon G, 2004, MED MALADIES INFECT, V34, P166, DOI 10.1016/j.medmal.2003.12.007; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cooke R, 2008, DEV MED CHILD NEUROL, V50, P9, DOI 10.1111/j.1469-8749.2007.00009.x; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Dembinski J, 2002, CYTOKINE, V18, P116, DOI 10.1006/cyto.2002.0880; Di Simone N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180642; EGGESBO JB, 1994, CYTOKINE, V6, P521, DOI 10.1016/1043-4666(94)90080-9; EGGESBO JB, 1995, CYTOKINE, V7, P562, DOI 10.1006/cyto.1995.0076; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Ernst W, 2015, CYTOKINE, V73, P91, DOI 10.1016/j.cyto.2015.01.023; Gangloff SC, 1999, CLIN INFECT DIS, V28, P491, DOI 10.1086/515176; Rodrigo FGM, 2014, PEDIATR NEONATOL, V55, P381, DOI 10.1016/j.pedneo.2013.12.007; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Hagberg H, 2005, BJOG-INT J OBSTET GY, V112, P16, DOI 10.1111/j.1471-0528.2005.00578.x; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; HARAGUCHI GE, 1991, MICROB PATHOGENESIS, V10, P351, DOI 10.1016/0882-4010(91)90080-T; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Jansky L, 2003, PHYSIOL RES, V52, P593; Kassim Z, 2003, EUR J PEDIATR, V162, P644, DOI 10.1007/s00431-003-1240-9; KAWAHARA K, 1987, EUR J BIOCHEM, V163, P489, DOI 10.1111/j.1432-1033.1987.tb10895.x; Kooistra O, 2003, CARBOHYD RES, V338, P2667, DOI 10.1016/j.carres.2003.07.004; Korzeniewski SJ, 2014, J PERINAT MED, V42, P731, DOI 10.1515/jpm-2014-0250; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Kumolosasi E, 2014, TROP J PHARM RES, V13, P536, DOI 10.4314/tjpr.v13i4.8; Kunze M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.181; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lindner H, 1997, BLOOD, V89, P1931, DOI 10.1182/blood.V89.6.1931; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Manktelow BN, 2001, ARCH DIS CHILD-FETAL, V85, pF33, DOI 10.1136/fn.85.1.F33; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Martinelli P, 2012, J MATERN-FETAL NEO M, V25, P29, DOI 10.3109/14767058.2012.714981; Mathias B, 2017, SHOCK, V47, P606, DOI 10.1097/SHK.0000000000000800; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Menon R, 2004, J PERINAT MED, V32, P391, DOI 10.1515/JPM.2004.134; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Miller SP, 2006, PEDIATRICS, V117, P1626, DOI 10.1542/peds.2005-1767; Mizoguchi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207085; Naegelen I, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/817038; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ng PY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00166; Ovalle A, 2009, REV MED CHILE, V137, P1201, DOI /S0034-98872009000900010; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PANKUCH GA, 1984, OBSTET GYNECOL, V64, P802; Pappas A, 2014, JAMA PEDIATR, V168, P137, DOI 10.1001/jamapediatrics.2013.4248; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Perfetto CO, 2015, J ASSIST REPROD GEN, V32, P977, DOI 10.1007/s10815-015-0481-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rodrigues J, 2014, CASE REP PEDIAT, V2014, DOI 10.1155/2014/195204; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, J MATERN-FETAL NEO M, V27, P975, DOI 10.3109/14767058.2013.847918; Rosmanova R, 2000, Akush Ginekol (Sofiia), V39, P19; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Schulz D, 2019, CYTOKINE, V116, P97, DOI 10.1016/j.cyto.2018.12.017; Seelbach-Goebel B, 2013, GEBURTSH FRAUENHEILK, V73, P1218, DOI 10.1055/s-0033-1360195; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Shete Vishal B, 2009, J Lab Physicians, V1, P73, DOI 10.4103/0974-2727.59704; SIDORCZYK Z, 1983, EUR J BIOCHEM, V137, P15, DOI 10.1111/j.1432-1033.1983.tb07789.x; Sirota L, 2000, ACTA PAEDIATR, V89, P331; Soraisham AS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.034; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Sugitharini V, 2014, CYTOKINE, V69, P211, DOI 10.1016/j.cyto.2014.06.003; SUSSKIND M, 1995, CARBOHYD RES, V269, pC1, DOI 10.1016/0008-6215(95)00002-B; Usluoglu N, 2007, EUR J IMMUNOL, V37, P2317, DOI 10.1002/eji.200636388; Viswanathan R, 2011, EPIDEMIOL INFECT, V139, P226, DOI 10.1017/S0950268810000701; Walker KF, 2016, LANCET, V387, P2068, DOI 10.1016/S0140-6736(16)00590-0; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Yanowitz TD, 1998, J PEDIATR-US, V132, P28, DOI 10.1016/S0022-3476(98)70480-9; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	90	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222465	10.1371/journal.pone.0222465	http://dx.doi.org/10.1371/journal.pone.0222465			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536529	Green Published, gold			2022-12-27	WOS:000532262800043
J	Dolzani, P; Assirelli, E; Pulsatelli, L; Meliconi, R; Mariani, E; Neri, S				Dolzani, Paolo; Assirelli, Elisa; Pulsatelli, Lia; Meliconi, Riccardo; Mariani, Erminia; Neri, Simona			Ex vivo physiological compression of human osteoarthritis cartilage modulates cellular and matrix components	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GENE-EXPRESSION; CHONDROCYTES; MECHANOTRANSDUCTION	Mechanical stimulation appears to play a key role in cartilage homeostasis maintenance, but it can also contribute to osteoarthritis (OA) pathogenesis. Accumulating evidence suggests that cartilage loading in the physiological range contributes to tissue integrity maintenance, whereas excessive or reduced loading have catabolic effects. However, how mechanical stimuli can regulate joint homeostasis is still not completely elucidated and few data are available on human cartilage. We aimed at investigating human OA cartilage response to ex vivo loading at physiological intensity. Cartilage explants from ten OA patients were subjected to ex vivo controlled compression, then recovered and used for gene and protein expression analysis of cartilage homeostasis markers. Compressed samples were compared to uncompressed ones in presence or without interleukin 1 beta (IL-1 beta) or interleukin 4 (IL-4). Cartilage explants compressed in combination with IL-4 treatment showed the best histological scores. Mechanical stimulation was able to significantly modify the expression of collagen type II (collagen 2), aggrecan, SOX9 transcription factor, cartilage oligomeric matrix protein (COMP), collagen degradation marker C2C and vascular endothelial growth factor (VEGF). Conversely, ADAMTS4 metallopeptidase, interleukin 4 receptor alpha (IL4Ra), chondroitin sulfate 846 epitope (CS846), procollagen type 2 C-propeptide (CPII) and glycosaminoglycans (GAG) appeared not modulated. Our data suggest that physiological compression of OA human cartilage modulates the inflammatory milieu by differently affecting the expression of components and homeostasis regulators of the cartilage extracellular matrix.	[Dolzani, Paolo; Assirelli, Elisa; Pulsatelli, Lia; Mariani, Erminia; Neri, Simona] IRCCS Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tiss, Bologna, Italy; [Meliconi, Riccardo] IRCCS Ist Ortoped Rizzoli, Unita Med & Reumatol, Bologna, Italy; [Meliconi, Riccardo] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Mariani, Erminia] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy	University of Bologna; University of Bologna	Neri, S (corresponding author), IRCCS Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tiss, Bologna, Italy.	simona.neri@ior.it	Mariani, Erminia/AAE-8110-2021; Pulsatelli, Lia/D-4092-2019; Dolzani, Paolo/C-6955-2019; Assirelli, Elisa/F-1435-2019; Mariani, Erminia/C-6881-2019; Neri, Simona/C-6874-2019	Mariani, Erminia/0000-0002-4407-6707; Pulsatelli, Lia/0000-0003-3031-170X; Dolzani, Paolo/0000-0002-9341-2703; Assirelli, Elisa/0000-0001-5678-6506; Mariani, Erminia/0000-0002-4407-6707; Neri, Simona/0000-0003-3257-6293	Italian Health Ministry; Bologna University RFO Fund; "Ricerca corrente Rizzoli Orthopaedic Institute" funds	Italian Health Ministry(Ministry of Health, Italy); Bologna University RFO Fund; "Ricerca corrente Rizzoli Orthopaedic Institute" funds	This work was supported by Italian Health Ministry 5x1000 Fund, by Bologna University RFO Fund and by "Ricerca corrente Rizzoli Orthopaedic Institute" funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00076; Assirelli E, OSTEOARTHRITIS CARTI, V20, pS242; Assirelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096925; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Beckmann R, 2014, INT J MOL SCI, V15, P15456, DOI 10.3390/ijms150915456; Buckwalter J A, 1997, Iowa Orthop J, V17, P80; Chen C.Y, 2018, INT J MOL SCI, V19; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; Erhart-Hledik JC, 2012, OSTEOARTHR CARTILAGE, V20, P1309, DOI 10.1016/j.joca.2012.07.018; Gassner R, 1999, J IMMUNOL, V163, P2187; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Gosset M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2024; Grogan SP, 2012, TISSUE ENG PT A, V18, P1784, DOI [10.1089/ten.tea.2011.0506, 10.1089/ten.TEA.2011.0506]; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; Jorgensen AE, 2017, J RHEUMATOL, V44, P410, DOI 10.3899/jrheum.160226; Leong DJ, 2011, ANN NY ACAD SCI, V1240, P32, DOI 10.1111/j.1749-6632.2011.06301.x; Leung YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202554; McCutchen CN, 2017, J BIOMECH, V64, P49, DOI 10.1016/j.jbiomech.2017.08.032; Neri S, 2013, J BONE JOINT SURG AM, V95A, P1852, DOI 10.2106/JBJS.L.01715; Nishimuta JF, 2012, OSTEOARTHR CARTILAGE, V20, P422, DOI 10.1016/j.joca.2012.01.004; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pulsatelli L, 2005, CLIN EXP RHEUMATOL, V23, P487; Quicke JG, 2015, OSTEOARTHR CARTILAGE, V23, P1445, DOI 10.1016/j.joca.2015.05.002; Racunica TL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1261, DOI 10.1002/art.22990; Rytter Soren, 2009, J Occup Med Toxicol, V4, P19, DOI 10.1186/1745-6673-4-19; Sanchez-Adams J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0451-6; Saxby DJ, 2017, OSTEOARTHR CARTILAGE, V25, P190, DOI 10.1016/j.joca.2016.09.023; Scholtes S, 2018, J CELL PHYSIOL, V233, P699, DOI 10.1002/jcp.25933; Servin-Vences MR, 2017, ELIFE, V6, DOI 10.7554/eLife.21074; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; Varady NH, 2016, OSTEOARTHR CARTILAGE, V24, P27, DOI 10.1016/j.joca.2015.08.018; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459	37	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222947	10.1371/journal.pone.0222947	http://dx.doi.org/10.1371/journal.pone.0222947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550275	gold, Green Published			2022-12-27	WOS:000532307700036
J	Kranner, BP; Afrooz, ARMN; Fitzgerald, NJM; Boehm, AB				Kranner, Benjamin P.; Afrooz, A. R. M. Nabiul; Fitzgerald, Nicole J. M.; Boehm, Alexandria B.			Fecal indicator bacteria and virus removal in stormwater biofilters: Effects of biochar, media saturation, and field conditioning	PLOS ONE			English	Article							ESCHERICHIA-COLI REMOVAL; FILTRATION-ELUTION METHOD; POROUS-MEDIA; PYROLYSIS TEMPERATURE; TRANSPORT BEHAVIOR; SOLUTION CHEMISTRY; ACTIVATED CARBON; CELL PROPERTIES; F-RNA; SYSTEMS	Stormwater biofilters are used to attenuate the flow and volume of runoff and reduce pollutant loading to aquatic systems. However, the capacity of biofilters to remove microbial contaminants remains inadequate. While biochar has demonstrated promise as an amendment to improve microbial removal in laboratory-scale biofilters, it is uncertain if the results are generalizable to the field. To assess biochar performance in a simulated field setting, sand and biochar-amended sand biofilters were periodically dosed with natural stormwater over a 61-week conditioning phase. Impact of media saturation was assessed by maintaining biofilters with and without a saturated zone. Biochar-amended biofilters demonstrated improved Escherichia coli removal over sand biofilters during the first 31 weeks of conditioning though media type did not impact E. coli removal during the last 30 weeks of conditioning. Presence of a saturated zone was not a significant factor influencing E. coli removal across the entire conditioning phase. Following conditioning, biofilters underwent challenge tests using stormwater spiked with wastewater to assess their capacity to remove wastewater-derived E. coli, enterococci, and male-specific (F+) coliphage. In challenge tests, biochar-amended biofilters demonstrated enhanced removal of all fecal indicators relative to sand biofilters. Additionally, saturated biofilters demonstrated greater removal of fecal indicators than unsaturated biofilters for both media types. Discrepant conclusions from the conditioning phase and challenge tests may be due to variable influent chemistry, dissimilar transport of E. coli indigenous to stormwater and those indigenous to wastewater, and differences in E. coli removal mechanisms between tests. Mobilization tests conducted following challenge tests showed minimal (<2.5%) observable mobilization of fecal indicators, regardless of media type and presence of a saturated zone. While our results emphasize the challenge of translating biochar's performance from the laboratory to the field, findings of this study inform biofilter design to remove microbial contaminants from urban stormwater.	[Kranner, Benjamin P.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Kranner, Benjamin P.; Fitzgerald, Nicole J. M.; Boehm, Alexandria B.] Engn Res Ctr ERC Reinventing Nat Urban Water Infr, Stanford, CA 94305 USA; [Afrooz, A. R. M. Nabiul] Calif State Water Resources Control Board, Sacramento, CA USA; [Fitzgerald, Nicole J. M.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA	Stanford University; Colorado School of Mines	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.; Boehm, AB (corresponding author), Engn Res Ctr ERC Reinventing Nat Urban Water Infr, Stanford, CA 94305 USA.	aboehm@stanford.edu		Boehm, Alexandria/0000-0002-8162-5090	NSF [EEC-1028968]	NSF(National Science Foundation (NSF))	This work received funding from NSF through grant number EEC-1028968, NSF = US National Science Foundation (www.nsf.gov) to AB. The sponsor played no role in the study design, data collection and analysis, decision to publish or prep of the manuscript.	Abit SM, 2014, J ENVIRON QUAL, V43, P371, DOI 10.2134/jeq2013.06.0236; Abit SM, 2012, ENVIRON SCI TECHNOL, V46, P8097, DOI 10.1021/es300797z; Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f; Afrooz ARMN, 2018, ENVIRON SCI-WAT RES, V4, P2160, DOI 10.1039/c8ew00297e; Afrooz ARMN, 2017, ECOL ENG, V102, P320, DOI 10.1016/j.ecoleng.2017.02.053; Afrooz ARMN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167489; Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Alhashimi HA, 2017, RESOUR CONSERV RECY, V118, P13, DOI 10.1016/j.resconrec.2016.11.016; Ambrose RF, 2015, WIRES WATER, V2, P131, DOI 10.1002/wat2.1064; [Anonymous], SANT CLAR VALL URB R; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Ballona Creek Watershed Management Group, 2016, ENH WAT MAN PROGR BA; Barrett ME, 2013, J ENVIRON ENG-ASCE, V139, P462, DOI 10.1061/(ASCE)EE.1943-7870.0000551; Becker MW, 2004, J CONTAM HYDROL, V69, P195, DOI 10.1016/j.jconhyd.2003.08.001; Bell CD, 2019, J SUSTAIN WATER BUIL, V5, DOI 10.1061/JSWBAY.0000871; Bolster CH, 2009, J ENVIRON QUAL, V38, P465, DOI 10.2134/jeq2008.0137; Bolster CH, 2012, J ENVIRON QUAL, V41, P124, DOI 10.2134/jeq2011.0207; California Stormwater Quality Association (CASQA), 2003, CAL STORMW QUAL ASS; Chandrasena GI, 2014, J HYDROL, V519, P814, DOI 10.1016/j.jhydrol.2014.08.015; Chandrasena GI, 2012, WATER SCI TECHNOL, V66, P1132, DOI 10.2166/wst.2012.283; Chung JW, 2014, J ENVIRON QUAL, V43, P2096, DOI 10.2134/jeq2014.05.0199; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Dietz ME, 2006, ENVIRON SCI TECHNOL, V40, P1335, DOI 10.1021/es051644f; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Foppen JW, 2008, WATER RES, V42, P211, DOI 10.1016/j.watres.2007.06.064; Fraser AN, 2018, WATER-SUI, V10, DOI 10.3390/w10081065; George's County P, 2000, LOW IMPACT DEV DESIG; Geosyntec Consultants Wright Water Engineers, 2016, INT STORMW BEST MAN; Grebel JE, 2013, ENVIRON ENG SCI, V30, P437, DOI 10.1089/ees.2012.0312; Hathaway JM, 2011, J ENVIRON ENG, V137, P1103, DOI 10.1061/(ASCE)EE.1943-7870.0000444; Haznedaroglu BZ, 2009, ENVIRON SCI TECHNOL, V43, P1838, DOI 10.1021/es802531k; Jarvis B, 2010, J APPL MICROBIOL, V109, P1660, DOI 10.1111/j.1365-2672.2010.04792.x; Kim HN, 2009, ENVIRON SCI TECHNOL, V43, P4340, DOI 10.1021/es8026055; Krometis LAH, 2007, WATER RES, V41, P506, DOI 10.1016/j.watres.2006.09.029; Krometis LAH, 2010, J WATER HEALTH, V8, P44, DOI 10.2166/wh.2009.032; Krometis LAH, 2009, J ENVIRON ENG-ASCE, V135, P758, DOI 10.1061/(ASCE)EE.1943-7870.0000040; Larry Walker Associates Geosyntec Consultants, 2011, VENT COUNT TECHN GUI; Lau AYT, 2017, CHEMOSPHERE, V169, P89, DOI 10.1016/j.chemosphere.2016.11.048; Li YL, 2012, ECOL ENG, V49, P137, DOI 10.1016/j.ecoleng.2012.08.007; Liu Y, 2008, ENVIRON SCI TECHNOL, V42, P443, DOI 10.1021/es071861b; McLellan SL, 2004, APPL ENVIRON MICROB, V70, P4658, DOI 10.1128/AEM.70.8.4658-4665.2004; MEMPIN R, 2013, BMC MICROBIOL, V13, DOI DOI 10.1186/1471-2180-13-13; Mendez J, 2004, J VIROL METHODS, V117, P19, DOI 10.1016/j.jviromet.2003.11.013; Mohanty SK, 2015, WATER RES, V85, P208, DOI 10.1016/j.watres.2015.08.026; Mohanty SK, 2014, ENVIRON SCI TECHNOL, V48, P11535, DOI 10.1021/es5033162; Mohanty SK, 2014, WATER RES, V61, P288, DOI 10.1016/j.watres.2014.05.026; Mohanty SK, 2013, ENVIRON SCI TECHNOL, V47, P10791, DOI 10.1021/es305136b; Olivieri A., 2015, WATER INTELL ONLINE, DOI [10.2166/9781780403809, DOI 10.2166/9781780403809]; Parker JC, 1984, DETERMINING TRANSPOR; Peng J, 2016, WATER-SUI, V8, DOI 10.3390/w8120600; Pintelon TRR, 2012, BIOTECHNOL BIOENG, V109, P1031, DOI 10.1002/bit.24381; Reddy KR, 2014, J GEOTECH GEOENVIRON, V140, DOI 10.1061/(ASCE)GT.1943-5606.0001015; Rippy MA, 2015, WIRES WATER, V2, P577, DOI 10.1002/wat2.1096; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Sasidharan S, 2016, SCI TOTAL ENVIRON, V548, P100, DOI 10.1016/j.scitotenv.2015.12.126; Schafer A, 1998, J CONTAM HYDROL, V33, P149, DOI 10.1016/S0169-7722(98)00069-2; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Seagren EA, 1999, J CONTAM HYDROL, V37, P111, DOI 10.1016/S0169-7722(98)00157-0; Silliman SE, 2001, WATER RESOUR RES, V37, P2699, DOI 10.1029/2001WR000331; Sinton LW, 1996, J MICROBIOL METH, V25, P257, DOI 10.1016/0167-7012(95)00100-X; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; Suliman W, 2017, ENVIRON SCI TECHNOL, V51, P5071, DOI 10.1021/acs.est.6b04535; Tang P, 2017, ENVIRON SCI POLLUT R, V24, P9210, DOI 10.1007/s11356-017-8458-y; Ulrich BA, 2017, ENVIRON SCI-WAT RES, V3, P726, DOI 10.1039/c7ew00070g; United States Department of Agriculture Natural Resources Conservation Service, 1986, URB HYDR SMALL WAT T, V55; United States Environmental Protection Agency, 2000, LOW IMP DEV LID LIT, DOI [10.1016/j.biocon.2009.12.004, DOI 10.1016/J.BIOCON.2009.12.004]; United States Environmental Protection Agency, 2015, REV COL POSS IND FEC; US Department of Agriculture Natural Resources Conservation Service, WEB SOIL SURV; Velten S, 2007, WATER RES, V41, P1973, DOI 10.1016/j.watres.2007.01.021; Wolfand JM, 2018, ENVIRON SCI TECHNOL, V52, P6370, DOI 10.1021/acs.est.8b00408; Yang W, 2019, ENVIRON POLLUT, V246, P855, DOI 10.1016/j.envpol.2018.12.075; Zhang L, 2012, WATER ENVIRON RES, V84, P485, DOI 10.2175/106143012X13280358613589; 2009, URB STORMW MAN US, P1	74	17	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222719	10.1371/journal.pone.0222719	http://dx.doi.org/10.1371/journal.pone.0222719			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553761	gold, Green Published			2022-12-27	WOS:000532319200034
J	Stannard, S; Berrington, A; Alwan, N				Stannard, Sebastian; Berrington, Ann; Alwan, Nisreen			Associations between birth order with mental wellbeing and psychological distress in midlife: Findings from the 1970 British Cohort Study (BCS70)	PLOS ONE			English	Article							FAMILY-STRUCTURE; RISK; SCHIZOPHRENIA; WEIGHT; HEALTH; CHILDHOOD; PREGNANCY; SIZE; LIFE; IMPACT	Background Previous research indicated that birth order was associated with physical health outcomes in adulthood. However, evidence on its association with mental health was lacking. The aim of this study was to investigate if birth order was associated with mental wellbeing and psychological distress at mid-life, stratified by gender, and taking into account confounding factors in childhood and adulthood. Method The sample consisted of 9,354 participants of the 1970 British Cohort Study (BCS70). The Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), the Malaise Index and attending a doctor's consultation in the past year for a mental health issue at age forty-two were used to assess mental wellbeing and psychological distress in midlife. Birth order was ascertained via a parental questionnaire and referred to the numerical birth position of the participants. The associations between birth order, mental wellbeing and psychological distress were tested using linear and logistic regression adjusting for birth characteristics: smoking during pregnancy, maternal age, mother's marital status, father's employment, region of birth, parental years of education and parental social class, and factors at age 42: years of education, employment status and partnership status. Potential mediating variables including breastfeeding and birthweight at birth and parental separation and conduct disorder measured at age ten were also taken into account. Results We find no evidence to support an association between birth order and midlife psychological distress or attending a doctor's consultation in both men and women. In unadjusted analysis, there was an association between birth order four and above and a reduced WEMWBS score of -0.79 (95% CI -1.57, -0.02) in men only. This association was attenuated after adjusting for birth characteristics and mediators at birth (0.86, 95% -1.78, 0.07) but was maintained once conduct disorder at age 10 was accounted for (-1.19, 95% CI -2.28, -0.09). However, this association was attenuated once again after adjusting for employment status, years in education and partnership status in adulthood (-1.04, 95% CI -2.11, 0.03). Conclusions In this study, birth order was not associated with psychological distress or having a mental health issue at midlife. Accounting for employment status, years of education and partnership status in adulthood attenuated the relationship between birth order and mental wellbeing.	[Stannard, Sebastian; Berrington, Ann] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Stannard, Sebastian; Berrington, Ann] Univ Southampton, ESRC Ctr Populat Change, Southampton, Hants, England; [Alwan, Nisreen] Univ Southampton, Fac Med, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England; [Alwan, Nisreen] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alwan, Nisreen] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Southampton; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Stannard, S (corresponding author), Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England.; Stannard, S (corresponding author), Univ Southampton, ESRC Ctr Populat Change, Southampton, Hants, England.	ss4g14@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463; Berrington, Ann/0000-0002-1683-6668; Stannard, Sebastian/0000-0002-6139-1020	Economic and Social Research Council [ES/P000673/1]; ESRC [ES/R009139/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council [ES/P000673/1].	Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Adam EK, 2011, J ADOLESCENT HEALTH, V49, P278, DOI 10.1016/j.jadohealth.2010.12.012; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bambra C, 2014, J PUBLIC HEALTH-UK, V36, P183, DOI 10.1093/pubmed/fdu029; Barclay K, 2015, DEMOGRAPHY, V52, P613, DOI 10.1007/s13524-015-0377-2; Barker D. J. P, 1998, MOTHERS BABIES HLTH; BARKER DJP, 1989, LANCET, V2, P577; Buchanan A, 2002, AUST NZ J PSYCHIAT, V36, P521, DOI 10.1046/j.1440-1614.2002.01048.x; Buckles K, 2014, SOC SCI MED, V118, P66, DOI 10.1016/j.socscimed.2014.07.055; Carballo JJ, 2013, SOC PSYCH PSYCH EPID, V48, P1327, DOI 10.1007/s00127-013-0661-7; Cheung YB, 2002, SOC SCI MED, V55, P937, DOI 10.1016/S0277-9536(01)00225-8; CONLEY JJ, 1980, J ABNORM PSYCHOL, V89, P670, DOI 10.1037/0021-843X.89.5.670; D'Onofrio B, 2019, WORLD PSYCHIATRY, V18, P100, DOI 10.1002/wps.20590; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Dover George J, 2009, Trans Am Clin Climatol Assoc, V120, P199; ELLIOTT BA, 1992, SOC SCI MED, V35, P443, DOI 10.1016/0277-9536(92)90337-P; Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174; Feller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073462; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; Gonzalez L, 2020, GAC SANIT, V34, P51, DOI 10.1016/j.gaceta.2018.07.014; GOWERS S, 1985, J PSYCHIATR RES, V19, P247, DOI 10.1016/0022-3956(85)90025-1; Hinkle SN, 2014, PAEDIATR PERINAT EP, V28, P106, DOI 10.1111/ppe.12099; Hofferth LaH CD, 1987, RISKING FUTURE ADOLE, VII; Hypponen E, 2004, BJOG-INT J OBSTET GY, V111, P377, DOI 10.1111/j.1471-0528.2004.00089.x; Jensen AM, 2003, CHILDHOOD, V10, P65, DOI 10.1177/0907568203010001004; Kemppainen L, 2001, ACTA PSYCHIAT SCAND, V104, P148, DOI 10.1034/j.1600-0447.2001.00258.x; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Laerum AMW, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2135; Margareta W, 2019, SCAND J PUBLIC HEALT, V47, P207, DOI 10.1177/1403494817724312; Mathewson KJ, 2017, PSYCHOL BULL, V143, P347, DOI 10.1037/bul0000091; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; Mostafa T, 2015, LONGITUD LIFE COURSE, V6, P131, DOI 10.14301/llcs.v6i2.312; Oddy WH, 2010, J PEDIATR-US, V156, P568, DOI 10.1016/j.jpeds.2009.10.020; Parke ROL S, 1975, DEV INDIVUDAL CHANGI; Ploubidis GB, 2017, PSYCHOL MED, V47, P291, DOI 10.1017/S0033291716002464; Power C, 2002, SOC SCI MED, V55, P1989, DOI 10.1016/S0277-9536(01)00325-2; Risal Ajay, 2012, J Family Med Prim Care, V1, P137, DOI 10.4103/2249-4863.104985; Rodgers JL, 2000, AM PSYCHOL, V55, P599, DOI 10.1037//0003-066X.55.6.599; Rodgers JL, 2001, AM PSYCHOL, V56, P505, DOI 10.1037/0003-066X.56.6-7.505; Rutter M., 1970, ED HLTH BEHAV; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Steptoe A, 2012, DYNAMICS AGEING EVID, P98; Sulloway FJ, 1997, BEHAV GENET, V27, P607; SUNDARARAJ N, 1966, BRIT J PSYCHIAT, V112, P1127, DOI 10.1192/bjp.112.492.1127; Talley NJ, 2018, EXPERT REV GASTROENT, V12, P633, DOI 10.1080/17474124.2018.1476136; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Turner T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026418; Wadsworth MEJ, 1997, BRIT MED BULL, V53, P198; Wadsworth M, 2011, ROUTL ADV SOCIOL, P1; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; WHO, MENT HLTH STAT WELLB; Wood N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185798; Zajonc RB, 2001, AM PSYCHOL, V56, P490, DOI 10.1037//0003-066X.56.6-7.490	54	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222184	10.1371/journal.pone.0222184	http://dx.doi.org/10.1371/journal.pone.0222184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527876	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000532231400011
J	Schwaiger, T; Sehl, J; Karte, C; Schafer, A; Huhr, J; Mettenleiter, TC; Schroder, C; Kollner, B; Ulrich, R; Blohmid, U				Schwaiger, Theresa; Sehl, Julia; Karte, Claudia; Schaefer, Alexander; Huehr, Jane; Mettenleiter, Thomas C.; Schroeder, Charlotte; Koellner, Bernd; Ulrich, Reiner; Blohmid, Ulrike			Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections	PLOS ONE			English	Article							DELTA-T-CELLS; A VIRUS-INFECTION; IMMUNE-RESPONSES; H1N1 VIRUS; RELATIVE LYMPHOPENIA; SWINE; PROTECTION; LYMPHOCYTES; CHALLENGE; MEMORY	Pigs are anatomically, genetically and physiologically comparable to humans and represent a natural host for influenza A virus (IAV) infections. Thus, pigs may represent a relevant biomedical model for human IAV infections. We set out to investigate the systemic as well as the local immune response in pigs upon two subsequent intranasal infections with IAV H1N1pdm09. We detected decreasing numbers of peripheral blood lymphocytes after the first infection. The simultaneous increase in the frequencies of proliferating cells correlated with an increase in infiltrating leukocytes in the lung. Enhanced perforin expression in a ss and.d T cells in the respiratory tract indicated a cytotoxic T cell response restricted to the route of virus entry such as the nose, the lung and the bronchoalveolar lavage. Simultaneously, increasing frequencies of CD8 alpha alpha expressing alpha beta T cells were observed rapidly after the first infection, which may have inhibited uncontrolled inflammation in the respiratory tract. Taking together, the results of this study demonstrate that experimental IAV infection in pigs mimics major characteristics of human seasonal IAV infections.	[Schwaiger, Theresa; Sehl, Julia; Schroeder, Charlotte; Ulrich, Reiner] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Sehl, Julia; Mettenleiter, Thomas C.] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Karte, Claudia] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Schaefer, Alexander; Huehr, Jane; Koellner, Bernd; Blohmid, Ulrike] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Ulrich, Reiner] Univ Leipzig, Fac Vet Med, Inst Vet Pathol, Leipzig, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Leipzig University	Blohmid, U (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany.	Ulrike.Blohm@fli.de	Blohm, Ulrike/AAW-1851-2020; Schäfer, Alexander/M-5897-2019	Blohm, Ulrike/0000-0003-4597-248X; Schäfer, Alexander/0000-0002-4258-0651; Huhr, Jane/0000-0002-2235-9618	Federal Excellence Initiative of Mecklenburg Western Pomerania; European Social Fund (ESF) [ESF_14-BM-A55-00xx_16]	Federal Excellence Initiative of Mecklenburg Western Pomerania; European Social Fund (ESF)(European Social Fund (ESF))	This study was funded by Federal Excellence Initiative of Mecklenburg Western Pomerania and European Social Fund (ESF) Grant KoInfekt (ESF_14-BM-A55-00xx_16) to TCM.	AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chen Wei-wei, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P331; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Chun JK, 2011, INFECT CHEMOTHER, V43, P36, DOI 10.3947/ic.2011.43.1.36; Coskun O, 2010, J CLIN VIROL, V47, P388, DOI 10.1016/j.jcv.2010.01.007; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; de Freitas DN, 2015, REV SOC BRAS MED TRO, V48, P514, DOI 10.1590/0037-8682-0163-2015; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Ferrari M, 2008, VET RES COMMUN, V32, pS199, DOI 10.1007/s11259-008-9161-8; Forberg H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100619; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Graaf A, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0204-0; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Heinen PP, 2001, VET IMMUNOL IMMUNOP, V82, P39, DOI 10.1016/S0165-2427(01)00342-7; Hong MJ, 2018, MUCOSAL IMMUNOL, V11, P894, DOI 10.1038/mi.2017.93; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Indavarapu A, 2011, INDIAN J MED RES, V134, P389; Jester B, 2018, AM J EPIDEMIOL, V187, P2596, DOI 10.1093/aje/kwy165; Kappes MA, 2012, VACCINE, V30, P280, DOI 10.1016/j.vaccine.2011.10.098; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim WI, 2006, ARCH VIROL, V151, P23, DOI 10.1007/s00705-005-0615-9; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lahn M, 2000, J MOL MED, V78, P409, DOI 10.1007/s001090000123; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Larsen DL, 2000, VET MICROBIOL, V74, P117, DOI 10.1016/S0378-1135(00)00172-3; Loving CL, 2012, VACCINE, V30, P5830, DOI 10.1016/j.vaccine.2012.07.033; Mamerow S, 2019, VET MICROBIOL, V231, P160, DOI 10.1016/j.vetmic.2019.03.013; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; ORTOLANI C, 1993, BIOCHEM BIOPH RES CO, V191, P601, DOI 10.1006/bbrc.1993.1260; PESCOVITZ MD, 1985, J IMMUNOL, V134, P37; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Pizzolla A, 2018, J CLIN INVEST, V128, P721, DOI 10.1172/JCI96957; Pomorska-Mol M, 2014, ARCH VIROL, V159, P2605, DOI 10.1007/s00705-014-2116-1; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Rajao DS, 2015, ILAR J, V56, P44, DOI 10.1093/ilar/ilv002; Roden AC, 2008, ARCH PATHOL LAB MED, V132, P1774, DOI 10.1043/1543-2165-132.11.1774; Shen HH, 2013, CLIN LAB, V59, P337, DOI 10.7754/Clin.Lab.2012.120417; Sinkora M, 2009, DEV COMP IMMUNOL, V33, P273, DOI 10.1016/j.dci.2008.07.011; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Takamatsu HH, 2002, VET IMMUNOL IMMUNOP, V87, P223, DOI 10.1016/S0165-2427(02)00083-1; Talker SC, 2016, J VIROL, V90, P9364, DOI 10.1128/JVI.01211-16; Talker SC, 2015, VET RES, V46, DOI 10.1186/s13567-015-0182-3; Terebuh P, 2010, INFLUENZA OTHER RESP, V4, P387, DOI 10.1111/j.1750-2659.2010.00175.x; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; VANOERS NSC, 1993, J IMMUNOL, V151, P777; Walker LJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00223; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029	70	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222943	10.1371/journal.pone.0222943	http://dx.doi.org/10.1371/journal.pone.0222943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0JC	31539406	Green Published, gold			2022-12-27	WOS:000488238200001
J	Cunningham, R; Poppe, K; Peterson, D; Every-Palmer, S; Soosay, I; Jackson, R				Cunningham, Ruth; Poppe, Katrina; Peterson, Debbie; Every-Palmer, Susanna; Soosay, Ian; Jackson, Rod			Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARE; SCHIZOPHRENIA; PREVALENCE; DISORDER	Objective To determine whether contemporary sex-specific cardiovascular disease (CVD) risk prediction equations underestimate CVD risk in people with severe mental illness from the cohort in which the equations were derived. Methods We identified people with severe mental illness using information on prior specialist mental health treatment. This group were identified from the PREDICT study, a prospective cohort study of 495,388 primary care patients aged 30 to 74 years without prior CVD that was recently used to derive new CVD risk prediction equations. CVD risk was calculated in participants with and without severe mental illness using the new equations and the predicted CVD risk was compared with observed risk in the two participant groups using survival methods. Results 28,734 people with a history of recent contact with specialist mental health services, including those without a diagnosis of a psychotic disorder, were identified in the PREDICT cohort. They had a higher observed rate of CVD events compared to those without such a history. The PREDICT equations underestimated the risk for this group, with a mean observed:predicted risk ratio of 1.29 in men and 1.64 in women. In contrast the PREDICT algorithm performed well for those without mental illness. Conclusions Clinicians using CVD risk assessment tools that do not include severe mental illness as a predictor could by underestimating CVD risk by about one-third in men and two-thirds in women in this patient group. All CVD risk prediction equations should be updated to include mental illness indicators.	[Cunningham, Ruth; Peterson, Debbie] Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand; [Poppe, Katrina; Jackson, Rod] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland, New Zealand; [Every-Palmer, Susanna] Univ Otago Wellington, Dept Psychol Med, Wellington, New Zealand; [Soosay, Ian] Univ Auckland, Sch Med & Hlth Sci, Auckland, New Zealand	University of Otago; University of Auckland; University of Otago; University of Auckland	Cunningham, R (corresponding author), Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand.	Ruth.Cunningham@otago.ac.nz; k.poppe@auckland.ac.nz; rt.jackson@auckland.ac.nz		Cunningham, Ruth/0000-0003-0090-3579; Every-Palmer, Susanna/0000-0001-6455-9741	National Heart Foundation of New Zealand [1685]	National Heart Foundation of New Zealand	This study was supported by a grant from the National Heart Foundation of New Zealand, Project Grant reference 1685. All authors were named investigators on this grant application, and RC, DP and KP received funding from this grant. https://www.heartfoundation.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J., 2014, NZDEP2013 INDEX DEPR; Attar R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189289; Baller JB, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0416-y; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; Cunningham R, 2014, NZ MED J, V127; Cunningham R, 2015, GEN HOSP PSYCHIAT, V37, P501, DOI 10.1016/j.genhosppsych.2015.06.003; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Foguet-Boreu Q, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0833-6; Foley DL, 2015, AUST NZ J PSYCHIAT; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; McLean G, 2014, SCHIZOPHR RES, V159, P176, DOI 10.1016/j.schres.2014.07.022; Ministry of Health, 2018, CARD DIS RISK ASS MA; National Institute for Health and Care Excellence (NICE), 2014, CG181 NICE; New Zealand Guidelines Group, 2009, NZ CARD GUID HDB; O'Neil A, 2016, J AFFECT DISORDERS, V196, P117, DOI 10.1016/j.jad.2016.02.029; Osborn DPJ, 2015, JAMA PSYCHIAT, V72, P143, DOI 10.1001/jamapsychiatry.2014.2133; Osby U, 2014, NORD J PSYCHIAT, V68, P251, DOI 10.3109/08039488.2013.797022; Public Procurement Regulatory Authority (PPRA), 2020, ANN REP 2019; Pylypchuk R, 2018, LANCET, V391, P1897, DOI [10.1016/s0140-6736(18)30664-0, 10.1016/S0140-6736(18)30664-0]; Rigal A, 2018, PSYCHIAT RES, V263, P41, DOI 10.1016/j.psychres.2018.02.035; Ruggeri M, 2000, BRIT J PSYCHIAT, V177, P149, DOI 10.1192/bjp.177.2.149; Vancampfort D, 2016, WORLD PSYCHIATRY, V15, P166, DOI 10.1002/wps.20309; Wells S, 2017, INT J EPIDEMIOL, V46, P22, DOI 10.1093/ije/dyv312; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	26	23	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221521	10.1371/journal.pone.0221521; 10.1371/journal.pone.0221521.r001; 10.1371/journal.pone.0221521.r002; 10.1371/journal.pone.0221521.r003; 10.1371/journal.pone.0221521.r004	http://dx.doi.org/10.1371/journal.pone.0221521; 10.1371/journal.pone.0221521.r001; 10.1371/journal.pone.0221521.r002; 10.1371/journal.pone.0221521.r003; 10.1371/journal.pone.0221521.r004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB3PW	31532772	gold, Green Published, Green Submitted			2022-12-27	WOS:000488470200002
J	Guirro, M; Costa, A; Gual-Grau, A; Herrero, P; Torrell, H; Canela, N; Arola, L				Guirro, Maria; Costa, Andrea; Gual-Grau, Andreu; Herrero, Pol; Torrell, Helena; Canela, Nuria; Arola, Lluis			Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach	PLOS ONE			English	Article							HIGH-FAT; MODULATION; COMMUNITY	Obesity and its comorbidities are currently considered an epidemic, and the involved pathophysiology is well studied. Hypercaloric diets are tightly related to the obesity etiology and also cause alterations in gut microbiota functionality. Diet and antibiotics are known to play crucial roles in changes in the microbiota ecosystem and the disruption of its balance; therefore, the manipulation of gut microbiota may represent an accurate strategy to understand its relationship with obesity caused by diet. Fecal microbiota transplantation, during which fecal microbiota from a healthy donor is transplanted to an obese subject, has aroused interest as an effective approach for the treatment of obesity. To determine its success, a multiomics approach was used that combined metagenomics and metaproteomics to study microbiota composition and function. To do this, a study was performed in rats that evaluated the effect of a hypercaloric diet on the gut microbiota, and this was combined with antibiotic treatment to deplete the microbiota before fecal microbiota transplantation to verify its effects on gut microbiota-host homeostasis. Our results showed that a high-fat diet induces changes in microbiota biodiversity and alters its function in the host. Moreover, we found that antibiotics depleted the microbiota enough to reduce its bacterial content. Finally, we assessed the use of fecal microbiota transplantation as a complementary obesity therapy, and we found that it reversed the effects of antibiotics and reestablished the microbiota balance, which restored normal functioning and alleviated microbiota disruption. This new approach could be implemented to support the dietary and healthy habits recommended as a first option to maintain the homeostasis of the microbiota.	[Guirro, Maria; Gual-Grau, Andreu; Arola, Lluis] Univ Rovira & Virgili, Biochem & Biotechnol Dept, Nutrigen Res Grp, Tarragona, Spain; [Guirro, Maria; Costa, Andrea; Herrero, Pol; Torrell, Helena; Canela, Nuria] Univ Rovira & Virgili, Unique Sci & Tech Infrastruct ICTS, EURECAT, Ctr Tecnol Catalunya,Ctr Omic Sci COS,Joint Unit, Reus, Spain; [Arola, Lluis] Ctr Tecnol Catalunya, Biotechnol Area, Eurecat, Reus, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili	Canela, N (corresponding author), Univ Rovira & Virgili, Unique Sci & Tech Infrastruct ICTS, EURECAT, Ctr Tecnol Catalunya,Ctr Omic Sci COS,Joint Unit, Reus, Spain.	nuria.canela@eurecat.org	Arola, Lluís/C-6074-2011; Canela, Nuria/I-5401-2015; Herrero, Pol/I-1912-2015; Torrell Galceran, Helena/R-7895-2017	Arola, Lluís/0000-0003-2767-1974; Gual-Grau, Andreu/0000-0002-8901-3582; Costa Lopez, Andrea/0000-0002-8393-4639; Canela, Nuria/0000-0003-0261-2396; Herrero, Pol/0000-0002-8746-7214; Torrell Galceran, Helena/0000-0001-5487-4289; Guirro, Maria/0000-0002-3330-0312				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Behr C, 2017, ARCH TOXICOL, V91, P3439, DOI 10.1007/s00204-017-1949-2; Boi SK, 2016, OBESITY, V24, P2140, DOI 10.1002/oby.21620; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; del Bas JM, 2018, INT J OBESITY, V42, P746, DOI 10.1038/ijo.2017.284; Frohlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Guirro M, 2019, J PROTEOME RES; Guirro M, 2018, ELECTROPHORESIS, V39, P1692, DOI 10.1002/elps.201700476; Ha M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139774; Heinritz SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154329; Hernandez-Jarguin A, 2018, TICKS TICK-BORNE DIS, V9, P1241, DOI 10.1016/j.ttbdis.2018.04.020; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hoban AE, 2016, NEUROSCIENCE, V339, P463, DOI 10.1016/j.neuroscience.2016.10.003; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Lai ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33893-y; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Le Bastard Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24342-x; Lee P, 2019, DIABETES OBES METAB, V21, P479, DOI 10.1111/dom.13561; Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027; Matsunaga N, 2018, ANAEROBE, V51, P124, DOI 10.1016/j.anaerobe.2018.05.001; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; Oberbach A, 2017, J PROTEOME RES, V16, P1593, DOI 10.1021/acs.jproteome.6b00973; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Schreiber W, 1999, MICROBIOL-SGM, V145, P1839, DOI 10.1099/13500872-145-8-1839; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Sun WJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8308671; Tanca A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00391; Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Villamil SI, 2018, NUTR RES, V50, P25, DOI 10.1016/j.nutres.2017.11.008; Wang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31353-1; Wei FW, 2019, SCI CHINA LIFE SCI, V62, P168, DOI 10.1007/s11427-018-9423-3; Xiao MM, 2017, APPL MICROBIOL BIOT, V101, P3077, DOI 10.1007/s00253-017-8215-7; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009; Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/c7fo01383c, 10.1039/C7FO01383C]; ZHOU D, 2017, SCI REP, V7, DOI DOI 10.1038/S41598-016-0028-X	42	35	37	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0218143	10.1371/journal.pone.0218143	http://dx.doi.org/10.1371/journal.pone.0218143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545802	gold, Green Published			2022-12-27	WOS:000532303200007
J	de Araujo, NNF; Lin-Wang, HT; Germano, JD; Farsky, PS; Feldman, A; Rossi, FH; Izukawa, NM; Higuchi, MD; Neto, FS; Hirata, MH; Bertolami, MC				Ferreira de Araujo, Neire Niara; Lin-Wang, Hui Tzu; Germano, Juliana de Freitas; Farsky, Pedro Silvio; Feldman, Andre; Rossi, Fabio Henrique; Izukawa, Nilo Mitsuru; Higuchi, Maria de Lourdes; Savioli Neto, Felicio; Hirata, Mario Hiroyuki; Bertolami, Marcelo Chiara			Dysregulation of microRNAs and target genes networks in human abdominal aortic aneurysm tissues	PLOS ONE			English	Article							5-LIPOXYGENASE PATHWAY; SMOOTH-MUSCLE; LET-7; PATHOGENESIS; ASSOCIATION; EXPRESSION; BIOMARKERS; CHEMOKINE; MODELS	Background Abdominal aortic aneurysm (AAA) is a pathological enlargement of infrarenal aorta close to the aortic bifurcation, and it is an important cause of mortality in the elderly. Therefore, the biomarker identification for early diagnosis is of great interest for clinical benefit. It is known that microRNAs (miRNAs) have important roles via target genes regulation in many diseases. This study aimed to identify miRNAs and their target genes involved in the pathogenesis of AAA. Methods Tissue samples were obtained from patients who underwent AAA surgery and from organ donors (control group). Quantitative PCR Array was applied to assess 84 genes and 384 miRNAs aiming to identify differentially expressed targets (AAA n = 6, control n = 6), followed by validation in a new cohort (AAA n = 18, control n = 6) by regular qPCR. The functional interaction between validated miRNAs and target genes was performed by the Ingenuity Pathway Analysis (IPA) software. Results The screening cohort assessed by PCR array identified 10 genes and 59 miRNAs differentially expressed (>= 2-fold change, p< 0.05). Among these, IPA identified 5 genes and 9 miRNAs with paired interaction. ALOX5, PTGIS, CX3CL1 genes, and miR-193a-3p, 125b-5p, 150-5p maintained a statistical significance in the validation cohort. IPA analysis based on the validated genes and miRNAs revealed that eicosanoid and metalloproteinase/TIMP synthesis are potentially involved in AAA. Conclusion Paired interactions of differentially expressed ALOX5, PTGIS, CX3CL1 genes, and miR193b-3p, 125b-5p, 150-5p revealed a potentially significant role of the eicosanoid synthesis and metalloproteinase/TIMP pathways in the AAA pathogenesis.	[Ferreira de Araujo, Neire Niara; Farsky, Pedro Silvio; Feldman, Andre; Savioli Neto, Felicio; Bertolami, Marcelo Chiara] Dante Pazzanese Inst Cardiol, Dept Clin Cardiol, Sao Paulo, Brazil; [Lin-Wang, Hui Tzu; Hirata, Mario Hiroyuki] Dante Pazzanese Inst Cardiol, Lab Mol Invest Cardiol, Sao Paulo, Brazil; [Germano, Juliana de Freitas; Hirata, Mario Hiroyuki] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Rossi, Fabio Henrique; Izukawa, Nilo Mitsuru] Dante Pazzanese Inst Cardiol, Dept Vasc Surg, Sao Paulo, Brazil; [Higuchi, Maria de Lourdes] Univ Sao Paulo, Sch Med, Heart Inst, Lab Cardiac Pathol, Sao Paulo, Brazil	Instituto Dante Pazzanese de Cardiologia; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo	de Araujo, NNF (corresponding author), Dante Pazzanese Inst Cardiol, Dept Clin Cardiol, Sao Paulo, Brazil.	neireniara@hotmail.com	Hirata, Mario Hiroyuki/C-9718-2013; de Lourdes Higuchi, Maria/K-3886-2017	Hirata, Mario Hiroyuki/0000-0002-9521-7979; de Lourdes Higuchi, Maria/0000-0002-1673-6456; Lin-Wang, Hui Tzu/0000-0002-7027-7748; ROSSI, FABIO/0000-0001-9423-3638				Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bhamidipati CM, 2014, ARTERIOSCL THROM VAS, V34, P2669, DOI 10.1161/ATVBAHA.114.304016; Biros E, 2014, CLIN SCI, V126, P795, DOI 10.1042/CS20130599; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Defawe OD, 2003, CARDIOVASC RES, V60, P205, DOI 10.1016/S0008-6363(03)00513-3; DEWITT DL, 1983, J CLIN INVEST, V72, P1882, DOI 10.1172/JCI111151; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Gerstmeier J, 2016, FASEB J, V30, P1892, DOI 10.1096/fj.201500210R; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, AM J PATHOL, V176, P2098, DOI 10.2353/ajpath.2010.090416; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Iyer V, 2017, ATHEROSCLEROSIS, V261, P78, DOI 10.1016/j.atherosclerosis.2017.03.010; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Koh W., 2010, BMC GENOMICS S1, V11, P1; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lee JM, 2012, J IMMUNOL, V189, P5284, DOI 10.4049/jimmunol.1003738; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P51, DOI 10.1053/ejvs.2000.1262; Ma XH, 2018, INT J MOL MED, V41, P2350, DOI 10.3892/ijmm.2018.3426; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mima K, 2016, CLIN CANCER RES, V22, P3841, DOI 10.1158/1078-0432.CCR-15-2173; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Olena AF, 2014, JCELL PHYSL, V222, P540; Pahl MC, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-25; Pande RL, 2008, J VASC INTERV RADIOL, V19, pS2, DOI 10.1016/j.jvir.2008.03.010; Raffort J, 2016, CARDIOVASC RES, V110, P165, DOI 10.1093/cvr/cvw046; Reed WW, 1997, ARCH INTERN MED, V157, P2064, DOI 10.1001/archinte.157.18.2064; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rothman A, 2017, PULM CIRC, V7, P455, DOI 10.1177/2045893217704206; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Siedlinski M, 2017, SCI REP, V7, P1; Sun JS, 2012, ARTERIOSCL THROM VAS, V32, P15, DOI 10.1161/ATVBAHA.111.235002; Monteiro JAT, 2014, J VASC SURG, V59, P1393, DOI 10.1016/j.jvs.2013.04.064; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wanhainen A, 2017, ATHEROSCLEROSIS, V256, P82, DOI 10.1016/j.atherosclerosis.2016.11.007; WEISS HJ, 1979, BLOOD, V53, P244; Yi XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180704; Zhang WW, 2015, CLIN BIOCHEM, V48, P988, DOI 10.1016/j.clinbiochem.2015.04.016; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	51	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222782	10.1371/journal.pone.0222782	http://dx.doi.org/10.1371/journal.pone.0222782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539405	Green Published, gold			2022-12-27	WOS:000532297900028
J	Lee, CH; Kuo, FC; Tang, WH; Lu, CH; Su, SC; Liu, JS; Hsieh, CH; Hung, YJ; Lin, FH				Lee, Chien-Hsing; Kuo, Feng-Chih; Tang, Wen-Hao; Lu, Chieh-Hua; Su, Sheng-Chiang; Liu, Jhih-Syuan; Hsieh, Chang-Hsun; Hung, Yi-Jen; Lin, Fu-Huang			Serum E-selectin concentration is associated with risk of metabolic syndrome in females	PLOS ONE			English	Article							SOLUBLE E-SELECTIN; CELL-ADHESION MOLECULE-1; ESSENTIAL-HYPERTENSION; DIABETIC-PATIENTS; GLYCEMIC CONTROL; PREVALENCE; OBESITY; EXPRESSION; CORRELATE; DISEASE	Objectives Traits of metabolic syndrome (MetS) and biomarkers of inflammation and endothelial dysfunction were examined. We investigated the differences of various biomarkers among individuals with or without Mets in a gender-specific manner. The gender-specific associations between E-selectin and MetS were further evaluated. Methods A total of 205 patients were recruited from the outpatient clinics of Tri-Service General Hospital, Taipei, Taiwan. Inclusion criteria were age between 20-75 years and BMI < 35 kg/m(2). Demographic, anthropometric and MetS index data were compared between genders. Markers of inflammation and endothelial dysfunction were compared between individuals with or without MetS by gender. Results Age-adjusted E-selectin values showed significant positive correlations with BMI, waist-hip ratio, fasting plasma glucose, systolic and diastolic blood pressure, triglycerides, TNF-alpha, hsCRP and ICAM-1, and inverse correlation with HDL cholesterol. E-selectin levels were positively correlated with numbers of MetS components in females (P < 0.001) but not in males (P = 0.125). Conclusions Increased E-selectin levels are significantly associated with increased MetS risk in females, but not in males.	[Lee, Chien-Hsing; Kuo, Feng-Chih; Lu, Chieh-Hua; Su, Sheng-Chiang; Liu, Jhih-Syuan; Hsieh, Chang-Hsun] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Tang, Wen-Hao; Hung, Yi-Jen] Triserv Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Song Shan Branch, Taipei, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Lin, FH (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	noldling@ms10.hinet.net			Ministry of Science and Technology [MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3]; Tri-Service General Hospital in Taiwan [TSGH-C104-199, TSGH-C105-005-S03, TSGH-C105-005-S04, TSGH-C105-120, TSGHC105-185, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C107-005-007-S05, TSGH-C106-161, MAB-105-084]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital in Taiwan	This work was supported by research grants from the Ministry of Science and Technology (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3) and Tri-Service General Hospital (TSGH-C104-199, TSGH-C105-005-S03, TSGH-C105-005-S04, TSGH-C105-120, TSGHC105-185, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C107-005-007-S05, TSGH-C106-161, MAB-105-084) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, ARTERIOSCL THROM VAS, V18, P723, DOI 10.1161/01.ATV.18.5.723; Abramov Y, 2001, FERTIL STERIL, P7651; Bener A, 2010, BOSNIAN J BASIC MED, V10, P210, DOI 10.17305/bjbms.2010.2687; Boulbou MS, 2004, INT ANGIOL, V23, P18; Calabresi L, 2002, ARTERIOSCL THROM VAS, V22, P656, DOI 10.1161/hq0402.105901; Carter AM, 1997, DIABETIC MED, V14, P423, DOI 10.1002/(SICI)1096-9136(199706)14:6<423::AID-DIA421>3.0.CO;2-F; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Cockerill GW, 1999, ARTERIOSCL THROM VAS, V19, P910, DOI 10.1161/01.ATV.19.4.910; Cominacini L, 1997, DIABETOLOGIA, V40, P584, DOI 10.1007/s001250050719; COMINACINI L, 1995, DIABETOLOGIA, V38, P1122; Daniel Y, 2001, AM J REPROD IMMUNOL, V45, P154, DOI 10.1111/j.8755-8920.2001.450306.x; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Elhadd TA, 2003, INT ANGIOL, V22, P222; Er LK, 2012, AGING MALE, V15, P227, DOI 10.3109/13685538.2012.720742; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Hwang S-J, 1997, CIRC J, P96; Hydrie MZI, 2009, METAB SYNDR RELAT D, V7, P119, DOI 10.1089/met.2008.0055; Jager A, 2000, DIABETES, V49, P485, DOI 10.2337/diabetes.49.3.485; Kawamura T, 1998, DIABETOLOGIA, V41, P911, DOI 10.1007/s001250051007; Kitaya K, 2010, MODERN PATHOL, V23, P1136, DOI 10.1038/modpathol.2010.98; Kowalska I, 2002, METABOLISM, V51, P733, DOI 10.1053/meta.2002.32802; Mabry RM, 2010, DIABETIC MED, V27, P593, DOI 10.1111/j.1464-5491.2010.02998.x; Matsumoto K, 2002, METABOLISM, V51, P932, DOI 10.1053/meta.2002.33354; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Palomo IG, 2009, MOL MED REP, V2, P481, DOI 10.3892/mmr_00000125; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P37; Piercy KT, 2002, J SURG RES, V105, P215, DOI 10.1006/jsre.2002.6405; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Rubin D, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-32; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Troseid M, 2005, SCAND J CLIN LAB INV, V65, P283, DOI 10.1080/00365510510013811; Tsou M.T., 2012, ADV AGING RES, V1, P53; Turhan H, 2006, INT J CARDIOL, V108, P224, DOI 10.1016/j.ijcard.2005.05.008; Vigano P, 1998, FERTIL STERIL, V69, P774, DOI 10.1016/S0015-0282(97)00565-7; Wang Z, 2012, HYPERTENS RES, V35, P413, DOI 10.1038/hr.2011.204; Weiss TW, 2013, METABOLISM, V62, P1008, DOI 10.1016/j.metabol.2013.01.019; Yasui T, 2009, EUR J ENDOCRINOL, V161, P267, DOI 10.1530/EJE-09-0063; Zanni MV, 2010, CLIN ENDOCRINOL, V73, P48, DOI 10.1111/j.1365-2265.2009.03741.x	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222815	10.1371/journal.pone.0222815	http://dx.doi.org/10.1371/journal.pone.0222815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550292	gold, Green Published			2022-12-27	WOS:000532307700026
J	Chiu, LJV; Tauer, LW; Grohn, YT; Smith, RL				Chiu, Leslie J. Verteramo; Tauer, Loren W.; Grohn, Yrjo T.; Smith, Rebecca L.			Mastitis risk effect on the economic consequences of paratuberculosis control in dairy cattle: A stochastic modeling study	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; GENERIC CLINICAL MASTITIS; POLYMERASE-CHAIN-REACTION; JOHNES-DISEASE; MILK-PRODUCTION; MANAGEMENT-PRACTICES; CONTROL PROGRAMS; FECAL CULTURE; INFECTION; ELISA	The benefits and efficacy of control programs for herds infected with Mycobacterium avium subsp. paratuberculosis (MAP) have been investigated under various contexts. However, most previous research investigated paratuberculosis control programs in isolation, without modeling the potential association with other dairy diseases. This paper evaluated the benefits of MAP control programs when the herd is also affected by mastitis, a common disease causing the largest losses in dairy production. The effect of typically suggested MAP controls were estimated under the assumption that MAP infection increased the rate of clinical mastitis. We evaluated one hundred twenty three control strategies comprising various combinations of testing, culling, and hygiene, and found that the association of paratuberculosis with mastitis alters the ranking of specific MAP control programs, but only slightly alters the cost-benefit difference of particular MAP control components, as measured by the distribution of net present value of a representative U.S. dairy operation. In particular, although testing and culling for MAP resulted in a reduction in MAP incidence, that control led to lower net present value (NPV) per cow. When testing was used, ELISA was more economically beneficial than alternative testing regimes, especially if mastitis was explicitly modeled as more likely in MAP-infected animals, but ELISA testing was only significantly associated with higher NPV if mastitis was not included in the model at all. Additional hygiene was associated with a lower NPV per cow, although it lowered MAP prevalence. Overall, the addition of an increased risk of mastitis in MAP-infected animals did not change model recommendations as much as failing to consider.	[Chiu, Leslie J. Verteramo; Grohn, Yrjo T.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Tauer, Loren W.] Cornell Univ, Cornell SC Johnson Business Coll, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Smith, Rebecca L.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA	Cornell University; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Smith, RL (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA.	rlsdvm@illinois.edu		Smith, Rebecca/0000-0002-8343-794X	USDA-NIFA Award [2014-67015-2240]	USDA-NIFA Award	This work was funded by USDA-NIFA Award No. 2014-67015-2240 to YTG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaska JM, 2003, PREV VET MED, V60, P255, DOI 10.1016/S0167-5877(03)00120-X; Aly SS, 2010, J DAIRY SCI, V93, P1030, DOI 10.3168/jds.2009-2611; Aly SS, 2012, J VET DIAGN INVEST, V24, P821, DOI 10.1177/1040638712452107; [Anonymous], 2015, TESTS FEES; Arrazuria R, 2014, ARCH MED VET, V46, P39, DOI 10.4067/S0301-732X2014000100006; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Bar D, 2007, J DAIRY SCI, V90, P4643, DOI 10.3168/jds.2007-0145; Barkema HW, 2018, TRANSBOUND EMERG DIS, V65, P125, DOI 10.1111/tbed.12723; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Besser T., 2015, NEW STRATEGIES JOHNE; Breen JE, 2009, J DAIRY SCI, V92, P2551, DOI 10.3168/jds.2008-1369; Chiu LJV, 2018, J DAIRY SCI, V101, P6443, DOI 10.3168/jds.2017-13175; Cho J, 2013, CAN J AGR ECON, V61, P583, DOI 10.1111/j.1744-7976.2012.01270.x; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; Collins MT, 2015, TESTING SERVICES; Cornell University Animal Health Diagnostic Center, 2015, TEST FEE SCHED; Dieguez FJ, 2008, VET REC, V162, P614, DOI 10.1136/vr.162.19.614; Dorshorst NC, 2006, PREV VET MED, V75, P92, DOI 10.1016/j.prevetmed.2006.02.002; Ferrouillet C, 2009, PREV VET MED, V88, P128, DOI 10.1016/j.prevetmed.2008.08.001; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Gonda MG, 2007, PREV VET MED, V80, P103, DOI 10.1016/j.prevetmed.2007.01.011; Groenendaal H, 2003, J AM VET MED ASSOC, V223, P1757, DOI 10.2460/javma.2003.223.1757; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Groenendaal H, 2008, JAVMA-J AM VET MED A, V233, P1852, DOI 10.2460/javma.233.12.1852; HARRIS TR, 1986, AM J AGR ECON, V68, P298, DOI 10.2307/1241431; Indiana Animal Disease Diagnostic Laboratory, 2015, FEE SCHED; Karszes J., 2014, DAIRY REPLACEMENT PR; Konboon M, 2018, NESTED COMPARTMENTAL, P1; Kudahl A, 2004, PREV VET MED, V62, P119, DOI 10.1016/j.prevetmed.2003.11.008; Kudahl AB, 2008, J DAIRY SCI, V91, P4599, DOI 10.3168/jds.2008-1257; Kudahl AB, 2007, PREV VET MED, V78, P118, DOI 10.1016/j.prevetmed.2006.10.004; Leite F, 2013, J VET DIAGN INVEST, V25, P27, DOI 10.1177/1040638712466395; LEVY H, 1992, MANAGE SCI, V38, P555, DOI 10.1287/mnsc.38.4.555; Lombard JE, 2005, JAVMA-J AM VET MED A, V227, P1975, DOI 10.2460/javma.2005.227.1975; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X; Meens E, 2014, 12 INT C PAR PARM IT; Mitchell RM, 2015, PREV VET MED, V118, P215, DOI 10.1016/j.prevetmed.2014.12.009; Moravkova M, 2012, APPL ENVIRON MICROB, V78, P6608, DOI 10.1128/AEM.01264-12; Nielsen SS, 2011, J DAIRY SCI, V94, P1849, DOI 10.3168/jds.2010-3817; Nielsen SS, 2009, J DAIRY SCI, V92, P149, DOI 10.3168/jds.2008-1488; Pillars RB, 2009, PREV VET MED, V90, P223, DOI 10.1016/j.prevetmed.2009.04.009; Pradhan AK, 2009, J DAIRY SCI, V92, P1811, DOI 10.3168/jds.2008-1486; Radia D, 2013, VET REC, V173, P343, DOI 10.1136/vr.101408; Raizman EA, 2007, PREV VET MED, V78, P179, DOI 10.1016/j.prevetmed.2006.10.006; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; Rossi G, 2017, J DAIRY SCI, V100, P7446, DOI 10.3168/jds.2017-12721; Smith RL, 2017, PREV VET MED, V138, P17, DOI 10.1016/j.prevetmed.2017.01.007; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Smith RL, 2016, J DAIRY SCI, V99, P1383, DOI 10.3168/jds.2015-9822; Smith RL, 2015, PREV VET MED, V122, P298, DOI 10.1016/j.prevetmed.2015.10.008; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Sweeney RW, 2006, J VET DIAGN INVEST, V18, P2, DOI 10.1177/104063870601800102; Sweeney RW, 2014, 12 INT C PAR PARM IT; Taddei S, 2004, J VET DIAGN INVEST, V16, P503, DOI 10.1177/104063870401600603; Tiwari A, 2005, VET MICROBIOL, V109, P147, DOI 10.1016/j.vetmic.2005.05.011; USDA, 2008, AGR PRIC SUMM 2003 2; USDA:ERS, 2010, MILK COST PROD EST; USDA-NASS, 2015, QUICK STATS; van Schaik G, 2005, PREV VET MED, V72, P221, DOI 10.1016/j.prevetmed.2005.01.019; VanLeeuwen JA, 2010, PREV VET MED, V94, P54, DOI 10.1016/j.prevetmed.2009.11.012; Vitale N, 2014, 12 INT C PAR PARM IT; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Wolf R, 2014, J DAIRY SCI, V97, P2822, DOI 10.3168/jds.2013-7454	67	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0217888	10.1371/journal.pone.0217888	http://dx.doi.org/10.1371/journal.pone.0217888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557171	Green Submitted, Green Published, gold			2022-12-27	WOS:000532345500006
J	Cheng, YX; Zhang, N; Hussain, S; Ahmed, S; Yang, WT; Wang, SC				Cheng, Yuxin; Zhang, Na; Hussain, Saddam; Ahmed, Sajjad; Yang, Wenting; Wang, Shucai			Integration of a FT expression cassette into CRISPR/Cas9 construct enables fast generation and easy identification of transgene-free mutants in Arabidopsis	PLOS ONE			English	Article							GENE FAMILY; RNA; MULTIPLEX; VERNALIZATION; PROTEIN; DOMAIN; TIME	The CRISPR/Cas9 genome editing technique has been widely used to generate transgenefree mutants in different plant species. Several different methods including fluorescence marker-assisted visual screen of transgene-free mutants and programmed self-elimination of CRISPR/Cas9 construct have been used to increase the efficiency of genome edited transgene-free mutant isolation, but the overall time length required to obtain transgene-free mutants has remained unchanged in these methods. We report here a method for fast generation and easy identification of transgene-free mutants in Arabidopsis. By generating and using a single FT expression cassette-containing CRISPR/Cas9 construct, we targeted two sites of the AITR1 gene. We obtained many early bolting plants in T1 generation, and found that about two thirds of these plants have detectable mutations. We then analyzed T2 generations of two representative lines of genome edited early bolting T1 plants, and identified plants without early bolting phenotype, i.e., transgene-free plants, for both lines. Further more, aitr1 homozygous mutants were successful obtained for both lines from these transgene-free plants. Taken together, these results suggest that the method described here enables fast generation, and at the mean time, easy identification of transgene-free mutants in plants.	[Cheng, Yuxin; Zhang, Na; Hussain, Saddam; Ahmed, Sajjad; Yang, Wenting; Wang, Shucai] Northeast Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin, Peoples R China; [Wang, Shucai] Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China	Northeast Normal University - China; Linyi University	Wang, SC (corresponding author), Northeast Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin, Peoples R China.; Wang, SC (corresponding author), Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China.	wangshucai@yahoo.com		Wang, Shucai/0000-0001-7619-2385; cheng, yu xin/0000-0001-8157-9592	National Key R&D Program of China [2016YFD0101902]	National Key R&D Program of China	This work was supported by the National Key R&D Program of China (2016YFD0101902). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Bull SE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat6086; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai XM, 2016, PLANT CELL ENVIRON, V39, P897, DOI 10.1111/pce.12695; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Guo HY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00295; He YB, 2018, MOL PLANT, V11, P1210, DOI 10.1016/j.molp.2018.05.005; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2012, J BIOL CHEM, V287, P16007, DOI 10.1074/jbc.M111.337485; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lu HP, 2017, PLANT BIOTECHNOL J, V15, P1371, DOI 10.1111/pbi.12788; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Putterill J, 2016, CURR OPIN PLANT BIOL, V33, P77, DOI 10.1016/j.pbi.2016.06.008; Putterill J, 2013, FUNCT PLANT BIOL, V40, P1199, DOI 10.1071/FP13087; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tian HN, 2017, PLANT CELL ENVIRON, V40, P2958, DOI 10.1111/pce.13058; Tian HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep17587; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wickland DP, 2015, MOL PLANT, V8, P983, DOI 10.1016/j.molp.2015.01.007; Yamagishi N, 2014, PLANT BIOTECHNOL J, V12, P60, DOI 10.1111/pbi.12116; Yamagishi N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00171; Yant L, 2009, CURR OPIN PLANT BIOL, V12, P580, DOI 10.1016/j.pbi.2009.07.006; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272	41	7	7	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0218583	10.1371/journal.pone.0218583	http://dx.doi.org/10.1371/journal.pone.0218583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545795	Green Published, Green Submitted, gold			2022-12-27	WOS:000532303200008
J	Li, FF; Gong, L; Li, JS; Liu, XY; Zhao, CY				Li, Fei-Fei; Gong, Lu; Li, Jun-Sheng; Liu, Xiao-Yan; Zhao, Cai-Yun			Low genetic differentiation yet high phenotypic variation in the invasive populations of Spartina alterniflora in Guangxi, China	PLOS ONE			English	Article							PACIFIC COAST; DIVERSITY; HYBRIDIZATION; EVOLUTION; DENSIFLORA; ADMIXTURE; PLASTICITY; DISPERSAL; SOFTWARE; PARADOX	Genetic variation and population structure may reflect important information for invasion success of exotic plant species and thus help improve management of invasive plants. Spartina alterniflora is an invasive plant that is a major threat to the economy and environment of the coastal regions in China. We analyzed the genetic structure and diversity of six populations of S. alterniflora differing in invasion histories in Guangxi, China. A total of 176 individuals from the six populations produced 348 AFLP fragments. The average heterozygosity was significantly lower than in the native population. And genetic bottlenecks were also detected in most populations. Standardized F-ST statistics (phi(pt) = 0.015) and AMOVA results indicated weak genetic differentiation. Genetic admixture and obviously isolation by distance indicated populations in Guangxi come from a pre-admixed population by a single introduction. High phenotypic variations of S. alterniflora in Guangxi influenced by soil salinity and temperature might be an important reason for the successful invasion.	[Li, Fei-Fei; Gong, Lu; Li, Jun-Sheng; Liu, Xiao-Yan; Zhao, Cai-Yun] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	Chinese Research Academy of Environmental Sciences	Zhao, CY (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	zhaocycraes@126.com	Li, Feifei/AAJ-1778-2020	Li, Feifei/0000-0003-4733-6268	National Key Research and Development Program of China [2017YFC0506200]; Foundation of the Chinese Research Academy of Environmental Sciences [2012-YSKY-05]	National Key Research and Development Program of China; Foundation of the Chinese Research Academy of Environmental Sciences	This work was financially supported by grants from The National Key Research and Development Program of China 2017YFC0506200 and the Foundation of the Chinese Research Academy of Environmental Sciences 2012-YSKY-05.; We thank Zhao Xiang-Jian, Deng Zhen-Zhen, Sun Hong-Yu, and Guang Xi for assistance with sample collection. This work was financially supported by grants from the National Key Research and Development Program of China (2017YFC0506200) and the Foundation of the Chinese Research Academy of Environmental Sciences (2012-YSKY-05).	Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Ayres DR, 2008, AM J BOT, V95, P713, DOI 10.3732/ajb.2007358; Baisakh N, 2009, AQUAT BOT, V91, P262, DOI 10.1016/j.aquabot.2009.07.007; Bernik BM, 2016, BIOL INVASIONS, V18, P1485, DOI 10.1007/s10530-016-1096-3; Blum MJ, 2004, MOL ECOL NOTES, V4, P39, DOI 10.1046/j.1471-8286.2003.00556.x; Caiyun Z, 2015, INVASION MANAGEMENT; CALLAWAY JC, 1992, ESTUARIES, V15, P218, DOI 10.2307/1352695; Castillo JM, 2018, ECOL EVOL, V8, P4992, DOI 10.1002/ece3.4063; Castillo JM, 2016, BIOL INVASIONS, V18, P2159, DOI 10.1007/s10530-015-0991-3; CHUNG CH, 1993, ECOL ENG, V2, P261, DOI 10.1016/0925-8574(93)90019-C; Cornuet JM, 1996, GENETICS, V144, P2001; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Davis HG, 2004, P NATL ACAD SCI USA, V101, P13804, DOI 10.1073/pnas.0405230101; Deng ZF, 2007, HYDROBIOLOGIA, V583, P195, DOI 10.1007/s10750-006-0529-x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Gan XJ, 2009, ESTUAR COAST SHELF S, V83, P211, DOI 10.1016/j.ecss.2009.03.026; Grevstad FS, 2003, BIOL CONTROL, V27, P32, DOI 10.1016/S1049-9644(02)00181-0; Guanmin H, 2009, GROWTH CHARACTERISTI; Hurka Herbert, 2003, Biological Invasions, V5, P281; Huska D, 2016, BIOL INVASIONS, V18, P2137, DOI 10.1007/s10530-015-0956-6; Idaszkin YL, 2011, PLANT ECOL, V212, P553, DOI 10.1007/s11258-010-9844-4; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karn E, 2017, EVOL APPL, V10, P616, DOI 10.1111/eva.12478; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Li JM, 2016, OECOLOGIA, V182, P755, DOI 10.1007/s00442-016-3699-x; Li Y, 2018, J ECOL, V106, P1595, DOI 10.1111/1365-2745.12926; Liu WW, 2017, ECOLOGY, V98, P1591, DOI 10.1002/ecy.1815; Liu WW, 2016, J ECOL, V104, P173, DOI 10.1111/1365-2745.12487; Mo Z., 2010, GUANGXI SCI, V17, P170, DOI DOI 10.13656/j.cnki.gxkx.2010.02.009; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; NESTLER J, 1977, ESTUAR COAST MAR SCI, V5, P707, DOI 10.1016/0302-3524(77)90043-3; Novy A, 2010, WETLANDS, V30, P603, DOI 10.1007/s13157-010-0046-6; Ort BS, 2016, BIOL INVASIONS, V18, P2267, DOI 10.1007/s10530-016-1177-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2010, DOCUMENTATION STRUCT; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Strong DR, 2016, BIOL INVASIONS, V18, P2237, DOI 10.1007/s10530-015-0980-6; THOMPSON JD, 1991, NEW PHYTOL, V117, P115, DOI 10.1111/j.1469-8137.1991.tb00951.x; Utomo HS, 2009, AQUAT BOT, V90, P30, DOI 10.1016/j.aquabot.2008.05.003; van Boheemen LA, 2017, MOL ECOL, V26, P5421, DOI 10.1111/mec.14293; VIVIANSMITH G, 1994, WETLANDS, V14, P316, DOI 10.1007/BF03160638; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang Q, 2006, ACTA PHYTOTAXON SIN, V44, P559, DOI 10.1360/aps06044; Wang SP, 2019, EVOLUTION, V73, P303, DOI 10.1111/evo.13676; Xia L, 2015, CLEAN-SOIL AIR WATER, V43, P1672, DOI 10.1002/clen.201300882; Xiao DR, 2009, ESTUAR COAST SHELF S, V83, P105, DOI 10.1016/j.ecss.2009.03.024; [赵相健 Zhao Xiangjian], 2015, [生态科学, Ecologic Science], V34, P119	61	4	5	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222646	10.1371/journal.pone.0222646	http://dx.doi.org/10.1371/journal.pone.0222646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527890	gold, Green Submitted, Green Published			2022-12-27	WOS:000532231400034
J	Londono, MC; Riveiro-Barciela, M; Ahumada, A; Munoz-Gomez, R; Roget, M; Devesa-Medina, MJ; Serra, MA; Navascues, CA; Baliellas, C; Aldamiz-Echevarria, T; Gutierrez, ML; Polo-Lorduy, B; Carmona, I; Benlloch, S; Bonet, L; Garcia-Samaniego, J; Jimenez-Perez, M; Moran-Sanchez, S; Castro, N; Delgado, M; Gea-Rodriguez, F; Martin-Granizo, I; Montes, ML; Morano, L; Castano, MA; de los Santos, I; Laguno, M; Losa, JE; Montero-Alonso, M; Rivero, A; de Alvaro, C; Manzanares, A; Mallolas, J; Barril, G; Gonzalez-Parra, E; Garcia-Buey, L				Londono, Maria-Carlota; Riveiro-Barciela, Mar; Ahumada, Adriana; Munoz-Gomez, Raquel; Roget, Merce; Devesa-Medina, Maria J.; Serra, Miguel Angel; Navascues, Carmen A.; Baliellas, Carme; Aldamiz-Echevarria, Teresa; Gutierrez, Maria L.; Polo-Lorduy, Benjamin; Carmona, Isabel; Benlloch, Salvador; Bonet, Lucia; Garcia-Samaniego, Javier; Jimenez-Perez, Miguel; Moran-Sanchez, Senador; Castro, Ngeles; Delgado, Manuel; Gea-Rodriguez, Francisco; Martin-Granizo, Ignacio; Montes, Maria Luisa; Morano, Luis; Castano, Manuel A.; de los Santos, Ignacio; Laguno, Montserrat; Losa, Juan Emilio; Montero-Alonso, Marta; Rivero, Antonio; de Alvaro, Cristina; Manzanares, Amanda; Mallolas, Josep; Barril, Guillermina; Gonzalez-Parra, Emilio; Garcia-Buey, Luisa			Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; QUALITY-OF-LIFE; INFECTION; EFFICACY; SAFETY; THERAPY; IMPACT; END	Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and tolerability data were collected from medical records. Results Data from 135 patients with a mean age (SD) of 58.3 (11.4) years were analyzed: 92.6% GT1 (81.6% GT1b and 17.6% GT1a) and 7.4% GT4, 14 (10.4%) HIV/HCV co-infected, 19.0% with fibrosis F3 and 28.1% F4 by FibroScan (R), 52.6% were previously treated with pegIFN and RBV. 11.1%, 14.8% and 74.1% of patients had CKD stage IIIb, IV and V respectively. 68.9% of patients were on hemodialysis; 8.9% on peritoneal dialysis and 38.5% had history of renal transplant. A total of 125 (96.2%) of 135 patients were treated with 3D, 10 (7.4%) with 2D and 30.4% received RBV. The overall intention-to-treat (ITT) sustained virologic response at week 12 (SVR12) was 92.6% (125/135) and the overall modified-ITT (mITT) SVR12 was 99.2% (125/126). The SVR12 rates (ITT) per sub-groups were: HCV mono-infected (91.7%), HCV/HIV co-infected (100%), GT1 (92.0%), GT4 (100%), CKD stage IIIb (86.7%), stage IV (95%) and stage V (93%). Among the 10 non-SVR there was only 1 virologic failure (0.7%); 4 patients had missing data due lost to follow up (3.0%) and 5 patients discontinued 3D/2D regimen (3.7%): 4 due to severe adverse events (including 3 deaths) and 1 patient ' s decision. Conclusions These results have shown that 3D/2D regimens are effective and tolerable in patients with advanced CKD including those in dialysis with GT 1 or 4 chronic HCV mono-infection and HIV/HCV coinfection in a real-life cohort. The overall SVR12 rates were 92.6% (ITT) and 99.2% (mITT) without clinically relevant changes in eGFR until 12 weeks post-treatment. These results are consistent with those reported in clinical trials.	[Londono, Maria-Carlota] Hosp Clin Barcelona, IDIBAPS, Liver Unit, Barcelona, Spain; [Londono, Maria-Carlota; Riveiro-Barciela, Mar; Benlloch, Salvador; Garcia-Samaniego, Javier; Gea-Rodriguez, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Riveiro-Barciela, Mar] Hosp Valle De Hebron, Dept Internal Med, Liver Unit, Barcelona, Spain; [Ahumada, Adriana] Hosp Gen Univ Gregorio Maranon, Dept Gastroenterol, Madrid, Spain; [Munoz-Gomez, Raquel] Hosp Gen Univ 12 Octubre, Dept Gastroenterol, Madrid, Spain; [Roget, Merce] Consorci Sanitari Terrassa, Liver Unit, Barcelona, Spain; [Devesa-Medina, Maria J.] Hosp Univ Clin San Carlos, Dept Gastroenterol, Madrid, Spain; [Serra, Miguel Angel] Univ Valencia, Hosp Clin Univ Valencia, Digest Med Serv, Valencia, Spain; [Navascues, Carmen A.] Hosp Univ Cent Asturias, Dept Gastroenterol, Oviedo, Asturias, Spain; [Baliellas, Carme] Univ Barcelona, Inst Invest Biomed Bellvitge, Bellvitge Hosp, Liver Unit, Barcelona, Spain; [Aldamiz-Echevarria, Teresa] Hosp Gen Univ Gregorio Maranon IiSGM, Infect Dis HIV, Madrid, Spain; [Gutierrez, Maria L.] Hosp Univ Fdn Alcorcon, Dept Gastroenterol, Madrid, Spain; [Polo-Lorduy, Benjamin] Hosp Univ, Fdn Jimenez Diaz, Digest Dis Unit, Madrid, Spain; [Carmona, Isabel] Hosp Univ Virgen Macarena, Digest Dis Unit, Seville, Spain; [Benlloch, Salvador] Hosp Univ & Politecn La Fe, Dept Hepatol, Valencia, Spain; [Bonet, Lucia] Hosp Univ Son Espases, Dept Gastroenterol, Palma de Mallorca, Mallorca, Spain; [Garcia-Samaniego, Javier] Hosp Univ La Paz IdiPaz, Liver Unit, Madrid, Spain; [Jimenez-Perez, Miguel; Castano, Manuel A.] Hosp Reg Univ Malaga, Malaga, Spain; [Moran-Sanchez, Senador] Hosp Gen Univ Santa Lucia, Murcia, Spain; [Castro, Ngeles; Delgado, Manuel] Complejo Hosp Univ A Coruna, La Coruna, Spain; [Gea-Rodriguez, Francisco] Hosp Univ Ramon y Cajal, Dept Gastroenterol, Madrid, Spain; [Martin-Granizo, Ignacio] Hosp Univ Alvaro Cunqueiro, Dept Gastroenterol, Vigo, Spain; [Montes, Maria Luisa] Hosp Univ La Paz IdiPaz, HIV Unit, Madrid, Spain; [Morano, Luis] Hosp Univ Alvaro Cunqueiro, Dept Internal Med, Infect Dis Unit, Vigo, Pontevedra, Spain; [de los Santos, Ignacio] Hosp Univ La Princesa, Dept Internal Med, Madrid, Spain; [Laguno, Montserrat; Mallolas, Josep] Hosp Clin IDIBAPS, Infect Dis Serv, HIV Unit, Barcelona, Spain; [Losa, Juan Emilio] Hosp Univ Fdn Alcorco, Infect Dis Unit, Madrid, Spain; [Montero-Alonso, Marta] Hosp Univ & Politecn La Fe, Infect Dis Unit, Valencia, Spain; [Rivero, Antonio] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia Cordoba, Infect Dis Unit, Cordoba, Spain; [de Alvaro, Cristina; Manzanares, Amanda] ABBVIE, Med Dept & Qual Assurance, Madrid, Spain; [Barril, Guillermina] Hosp Univ La Princesa, Nephrol Unit, Madrid, Spain; [Gonzalez-Parra, Emilio] Hosp Univ, Fdn Jimenez Diaz, Nephrol Unit, Madrid, Spain; [Garcia-Buey, Luisa] Hosp Univ La Princesa, Liver Unit, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; General University Gregorio Maranon Hospital; Hospital Universitario 12 de Octubre; University of Valencia; Central University Hospital Asturias; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Alcorcon Foundation University Hospital; University of Sevilla; Hospital Universitario Virgen Macarena; Hospital Universitari i Politecnic La Fe; Hospital Universitari Son Espases; Hospital Universitario La Paz; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital de La Princesa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Alcorcon Foundation University Hospital; Hospital Universitari i Politecnic La Fe; Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; AbbVie; Hospital de La Princesa; University of Sevilla; Hospital de La Princesa	Manzanares, A (corresponding author), ABBVIE, Med Dept & Qual Assurance, Madrid, Spain.	amanda.manzanaresgarcia@abbvie.com	Ramirez, Maria Luisa Montes/H-8065-2017; Benlloch, Salvador/HIK-0152-2022; Benlloch, Salvador/D-4239-2013; Montero, Marta/H-7555-2017; Rivero, Antonio/ABE-5294-2020	Ramirez, Maria Luisa Montes/0000-0003-1748-813X; Benlloch, Salvador/0000-0002-0794-6937; Benlloch, Salvador/0000-0002-0794-6937; Montero, Marta/0000-0002-3432-5394; Garcia-Samaniego, Javier/0000-0002-9974-0855; De Los Santos Gil, Ignacio/0000-0001-7073-5211; Baliellas, Carme/0000-0002-3641-6484; Roget, Merce/0000-0002-2606-0779; Mallolas Masferrer, Josep/0000-0002-8365-141X; , IIS Galicia Sur/0000-0003-3812-7413; Morano Amado, Luis Enrique/0000-0002-0560-3260; Polo Lorduy, Benjamin/0000-0003-4845-3001; MORAN SANCHEZ, SENADOR/0000-0003-3745-8253; Laguno Centeno, Montserrat/0000-0002-7798-6352; Rivero Roman, Antonio/0000-0002-8643-4250	Gilead Science; AbbVie; Bayer; Bristol-Myers Squibb; Gilead; Merck, Sharp Dhome; FIPSE [36465/03, 36680/07]; European Union [LSHP-CT-2006-037570]; BMS; Boehringer-Ingelheim; Janssen; MSD; Roche; ViiV	Gilead Science(Gilead Sciences); AbbVie(AbbVie); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck, Sharp Dhome; FIPSE; European Union(European Commission); BMS(Bristol-Myers Squibb); Boehringer-Ingelheim(Boehringer Ingelheim); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Roche(Roche Holding); ViiV	MCL has served as consultant for AbbVie, MSD, Janssen, BMS and Gilead; MRB has received grant research from Gilead Science, and speaker fees from AbbVie, Gilead and MSD; MR has received speaker fees from AbbVie; MD has received grant support and consultancy fees from AbbVie, Bayer, Bristol-Myers Squibb, Gilead and Merck, Sharp & Dhome; FGR has served as speaker for AbbVie, Gilead and BMS; MLM has served as a speaker for AbbVie, BMS, Gilead, Janssen, MSD and ViiV; as a consultant for AbbVie, BMS and Janssen and has received research funding from FIPSE 36465/03, FIPSE 36680/07.-NEAT IG5 (NEAT is a project funded by the European Union under the 6th Framework programme) contract number LSHP-CT-2006-037570; MAC has served as a consultant for Gilead and and ViiV healthcare, and has received speaker fees from Janssens, Gilead, ViiV Healthcare; MMA reports personal fees from ViiV Healthcare, Gilead Sciences, Merck, Janssen, AbbVie and ABBOTT Laboratories, outside the submitted work; AR has received consultancy and speaker fees from AbbVie, Gilead Sciences and Merck Sharp & Dohme; JM has received honoraria, speaker fees, consultant fees or funds for research from AbbVie, BMS, Boehringer-Ingelheim, Gilead, Janssen, MSD, Roche and ViiV; EGP has received speaker fees from AbbVie and Gilead; LGB has served as consultant for AbbVie and Intercept and has received speaker fees from Gilead and MSD; AA, RMG, CB, TAE, MLG, BPL, IC, SB, LB, JGS, MJP, IMG, LM, IdlS, ML and JEL don't have a financial interest or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this paper; CdA and AM are paid employees of AbbVie and may hold stock or options. The specific roles of these authors are articulated in the 'author contributions' section. The design, study conduct, and financial support for the study were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the manuscript.	Alcazar R, 2008, NEFROLOGIA, V28, P273; Bischoff J, 2018, HIV MED, V19, P299, DOI 10.1111/hiv.12579; Bishop OT., 2018, HEPATITIS C DEV COUN, P135, DOI DOI 10.1016/B978-0-12-803233-6.00012-6; Bunchorntavakul C, 2015, WORLD J HEPATOL, V7, P213, DOI 10.4254/wjh.v7.i2.213; Clausen LN, 2014, WORLD J GASTROENTERO, V20, P12132, DOI 10.3748/wjg.v20.i34.12132; Colombo M, 2015, DIGEST LIVER DIS, V47, P727, DOI 10.1016/j.dld.2015.04.003; Cotte L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1681-1; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Dan AA, 2006, J HEPATOL, V44, P491, DOI 10.1016/j.jhep.2005.11.046; EASL, 2018, REC TREATM HEP C; Fabrizi F, 2012, J VIRAL HEPATITIS, V19, P601, DOI 10.1111/j.1365-2893.2012.01633.x; Fernandez-Bermejo M, 2017, GASTROENTEROL HEPATO, V40, P95, DOI [10.1016/j.gastrohep.2015.12.011, DOI 10.1016/J.GASTROHEP.2015.12.011]; Flisiak R, 2017, LIVER INT, V37, P26, DOI 10.1111/liv.13293; Gane EJ, 2016, HEPATOLOGY SS1, P64; Garcia-Agudo R, 2013, NEFROLOGIA, V4, P33; HCV, GUID REC TEST MAN TR; Karageorgopoulos DE, 2015, WORLD J HEPATOL, V7, P1936, DOI 10.4254/wjh.v7.i15.1936; KDIGO, 2017, CLIN PRACT GUID UPD; Lin PH, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.83; Calleja JL, 2017, J HEPATOL, V66, P1138, DOI 10.1016/j.jhep.2017.01.028; Munoz-Gomez R, 2017, J VIRAL HEPATITIS, V24, P464, DOI 10.1111/jvh.12664; Park H, 2015, J VIRAL HEPATITIS, V22, P897, DOI 10.1111/jvh.12413; Pockros PJ, 2016, GASTROENTEROLOGY, V150, P1590, DOI 10.1053/j.gastro.2016.02.078; Polepally AR, 2015, HEPATOLOGY, V62, p733A; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Rodriguez-Tajes S, 2017, GASTROENTEROL HEPATO, P40; Schlabe S, 2018, EXPERT OPIN PHARMACO, V19, P49, DOI 10.1080/14656566.2017.1419185; Shuster DL, 2015, HEPATOLOGY, V62, p744A; Vachon ML, 2011, SEMIN LIVER DIS, V31, P399, DOI 10.1055/s-0031-1297928; Vierling JM, 2016, HEPATOLOGY, V64, p441A; Welzel TM, 2017, J VIRAL HEPATITIS, V24, P840, DOI 10.1111/jvh.12708; World Health Organization (WHO), HEP C; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1599, DOI 10.1053/j.gastro.2016.02.039	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221567	10.1371/journal.pone.0221567	http://dx.doi.org/10.1371/journal.pone.0221567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550267	Green Published, gold			2022-12-27	WOS:000532307700007
J	Carrillo, A; Rubio-Aparicio, M; Molinari, G; Enrique, A; Saanchez-Meca, J; Banos, RM				Carrillo, Alba; Rubio-Aparicio, Maria; Molinari, Guadalupe; Enrique, Angel; Sanchez-Meca, Julio; Banos, Rosa M.			Effects of the Best Possible Self intervention: A systematic review and meta-analysis	PLOS ONE			English	Review							EFFECTS META-REGRESSION; NEGATIVE AFFECT; POSITIVE PSYCHOLOGY; INDUCED OPTIMISM; EFFECT SIZE; LIFE; PAIN; VALIDATION; PANAS; SATISFACTION	The Best Possible Self (BPS) exercise promotes a positive view of oneself in the best possible future, after working hard towards it. Since the first work that attempted to examine the benefits of this intervention in 2001, studies on the BPS have grown exponentially and, currently, this is one of the most widely used Positive Psychology Interventions. However, little is yet known about its overall effectiveness in increasing wellbeing outcomes. Thus, the aim of this meta-analysis is to shed light on this question. A systematic literature search was conducted, and 29 studies (in 26 articles) met the inclusion criteria of empirically testing the intervention and comparing it to a control condition. In addition, BPS was compared to gratitude interventions in some of the included studies. A total of 2,909 participants were involved in the analyses. The outcome measures were wellbeing, optimism, depressive symptoms, and positive and negative affect. Results showed that the BPS is an effective intervention to improve wellbeing (d(+) =.325), optimism (d(+) =.334) and positive affect (d(+) =.511) comparing to controls. Small effect sizes were obtained for negative affect and depressive symptoms. Moderator analyses did not show statistically significant results for wellbeing, except for a trend towards significance in the age of the participants (years) and the magnitude of the intervention (total minutes of practice). In addition, the BPS was found to be more beneficial for positive and negative affect than gratitude interventions (d(+) =.326 and d(+) =.485, respectively). These results indicate that the BPS can be considered a valuable Positive Psychology Intervention to improve clients' wellbeing, and it seems that it might be more effective for older participants and with shorter practices (measured as total minutes of practice).	[Carrillo, Alba; Banos, Rosa M.] Univ Valencia, Dept Personal Assessment & Psychol Treatments, Valencia, Spain; [Rubio-Aparicio, Maria] Univ Alicante, Dept Hlth Psychol, Alicante, Spain; [Molinari, Guadalupe] Univ Jaume 1, Dept Basic Clin & Biol Psychol, Castellon de La Plana, Spain; [Molinari, Guadalupe; Banos, Rosa M.] Inst Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Enrique, Angel] Univ Dublin, Trinity Coll, Sch Psychol, Dublin, Ireland; [Sanchez-Meca, Julio] Univ Murcia, Dept Basic Psychol & Methodol, Murcia, Spain	University of Valencia; Universitat d'Alacant; Universitat Jaume I; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Trinity College Dublin; University of Murcia	Carrillo, A (corresponding author), Univ Valencia, Dept Personal Assessment & Psychol Treatments, Valencia, Spain.	alba.carrillo@uv.es	Rubio-Aparicio, Maria/Z-5592-2019; Sánchez-Meca, Julio/AAA-7807-2019; Carrillo, Alba/B-7513-2019; BAÑOS, ROSA MARIA/C-6077-2011	Rubio-Aparicio, Maria/0000-0002-2599-4246; Sánchez-Meca, Julio/0000-0002-8412-788X; Carrillo, Alba/0000-0003-3478-2699; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Molinari, Guadalupe/0000-0002-1957-9353	Conselleria d'Educacio, Investigacio, Cultura i Esport (Spain) under the grant "INTERSABIAS" [PROMETEO/2018/110]	Conselleria d'Educacio, Investigacio, Cultura i Esport (Spain) under the grant "INTERSABIAS"	This work was supported by the Conselleria d'Educacio ', Investigacio ', Cultura i Esport (Spain) under the grant "INTERSABIAS" (PROMETEO/2018/110) to RMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 2011, J ORGAN BEHAV, V32, P1033, DOI 10.1002/job.719; Lopez-Lopez JA, 2014, BRIT J MATH STAT PSY, V67, P30, DOI 10.1111/bmsp.12002; Beck A.T., 1996, MANUAL BECK DEPRESSI; Boehm JK, 2011, COGNITION EMOTION, V25, P1263, DOI 10.1080/02699931.2010.541227; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Boselie JJLM, 2017, J PAIN, V18, P446, DOI 10.1016/j.jpain.2016.12.007; Boselie JJLM, 2016, SCAND J PAIN, V12, P25, DOI 10.1016/j.sjpain.2016.03.001; Boselie JJLM, 2014, PAIN, V155, P334, DOI 10.1016/j.pain.2013.10.014; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Davis DE, 2016, J COUNS PSYCHOL, V63, P20, DOI 10.1037/cou0000107; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Enrique A, 2017, APPL RES QUAL LIFE, P1; Geschwind N, 2015, J PAIN, V16, P258, DOI 10.1016/j.jpain.2014.12.003; Hanssen MM, 2013, PAIN, V154, P53, DOI 10.1016/j.pain.2012.08.006; Hanssen MM, 2014, INVESTIGATING NEGATI; Harrist S, 2007, J RES PERS, V41, P923, DOI 10.1016/j.jrp.2006.09.002; Hedges LV, 2010, RES SYNTH METHODS, V1, P39, DOI 10.1002/jrsm.5; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; King LA, 2001, PERS SOC PSYCHOL B, V27, P798, DOI 10.1177/0146167201277003; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Laux L, 2013, STATE TRAIT ANGSTDEP; Layous K, 2013, J CROSS CULT PSYCHOL, V44, P1294, DOI 10.1177/0022022113487591; Layous K, 2013, J HAPPINESS STUD, V14, P635, DOI 10.1007/s10902-012-9346-2; Liau AK, 2016, ASIA-PAC EDUC RES, V25, P473, DOI 10.1007/s40299-015-0272-z; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; Lopez-Gomez I, 2015, BEHAV PSYCHOL, V23, P529; Loveday PM, 2018, J HAPPINESS STUD, V19, P607, DOI 10.1007/s10902-016-9824-z; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S, 2013, CURR DIR PSYCHOL SCI, V22, P57, DOI 10.1177/0963721412469809; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; Maddalena CJ, 2014, QUAL QUANT, V48, P2939, DOI 10.1007/s11135-013-9933-2; Malouff JM, 2017, J POSIT PSYCHOL, V12, P594, DOI 10.1080/17439760.2016.1221122; Manthey L, 2016, J HAPPINESS STUD, V17, P319, DOI 10.1007/s10902-014-9596-2; Meevissen YMC, 2011, J BEHAV THER EXP PSY, V42, P371, DOI 10.1016/j.jbtep.2011.02.012; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Nelson SK, 2015, J POSIT PSYCHOL, V10, P463, DOI 10.1080/17439760.2014.983959; Ng WT, 2016, J POSIT PSYCHOL, V11, P51, DOI 10.1080/17439760.2015.1025419; Odou N, 2013, SOC INDIC RES, V110, P111, DOI 10.1007/s11205-011-9919-1; Peters ML, 2016, J POSIT PSYCHOL, V11, P258, DOI 10.1080/17439760.2015.1048816; Peters ML, 2013, TER PSICOL, V31, P93, DOI 10.4067/S0718-48082013000100009; Peters ML, 2010, J POSIT PSYCHOL, V5, P204, DOI 10.1080/17439761003790963; Peterson RA, 2001, J CONSUM RES, V28, P450, DOI 10.1086/323732; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renner F, 2014, PSYCHIAT RES, V215, P105, DOI 10.1016/j.psychres.2013.10.033; Rubio-Aparicio M, 2018, BEHAV RES METHODS, V50, P2057, DOI 10.3758/s13428-017-0973-8; Rubio-Aparicio M, 2017, BRIT J MATH STAT PSY, V70, P439, DOI 10.1111/bmsp.12092; Sanchez-Meca J, 2013, ANAL CONCORDANCE SCA; Sanchez-Meca J, 2008, PSYCHOL METHODS, V13, P31, DOI 10.1037/1082-989X.13.1.31; Scheier MF, 2006, J BEHAV MED, V29, P291, DOI 10.1007/s10865-005-9044-1; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SELIGMAN MEP, 1979, J ABNORM PSYCHOL, V88, P242, DOI 10.1037/0021-843X.88.3.242; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Seligson JL, 2003, SOC INDIC RES, V61, P121, DOI 10.1023/A:1021326822957; Sheldon K. M., 2006, J POSIT PSYCHOL, P73, DOI [10.1080/17439760500510676, DOI 10.1080/17439760500510676]; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Summerfield T., 2015, POSITIVE INTERVENTIO; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Thompson RB, 2015, J POSIT PSYCHOL, V10, P179, DOI 10.1080/17439760.2014.927908; Troop NA, 2013, PSYCHOL PSYCHOTHER-T, V86, P374, DOI 10.1111/j.2044-8341.2012.02065.x; Van den Noortgate W, 2015, BEHAV RES METHODS, V47, P1274, DOI 10.3758/s13428-014-0527-2; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Viechtbauer W, 2015, PSYCHOL METHODS, V20, P360, DOI 10.1037/met0000023; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weiss LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158092; Yogo M, 2008, BRIT J HEALTH PSYCH, V13, P77, DOI 10.1348/135910707X252440	74	25	25	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222386	10.1371/journal.pone.0222386	http://dx.doi.org/10.1371/journal.pone.0222386			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545815	Green Published, gold, Green Submitted			2022-12-27	WOS:000532303200015
J	Higarza, SG; Arboleya, S; Gueimonde, M; Gomez-Lazaro, E; Arias, JL; Arias, N				Higarza, Sara G.; Arboleya, Silvia; Gueimonde, Miguel; Gomez-Lazaro, Eneritz; Arias, Jorge L.; Arias, Natalia			Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits	PLOS ONE			English	Article							HIGH-FAT DIET; HIPPOCAMPAL-DEPENDENT MEMORY; LIVER-DISEASE; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; COGNITIVE IMPAIRMENT; OXIDATIVE-METABOLISM; CYTOCHROME-OXIDASE; PREFRONTAL CORTEX; CHOLESTEROL DIET	Non-alcoholic steatohepatitis (NASH) is one of the most prevalent diseases worldwide. While it has been suggested to cause nervous impairment, its neurophysiological basis remains unknown. Therefore, the aim of this study is to unravel the effects of NASH, through the interrelationship of liver, gut microbiota, and nervous system, on the brain and human behavior. To this end, 40 Sprague-Dawley rats were divided into a control group that received normal chow and a NASH group that received a high-fat, high-cholesterol diet. Our results show that 14 weeks of the high-fat, high-cholesterol diet induced clinical conditions such as NASH, including steatosis and increased levels of ammonia. Rats in the NASH group also demonstrated evidence of gut dysbiosis and decreased levels of short-chain fatty acids in the gut. This may explain the deficits in cognitive ability observed in the NASH group, including their depressive-like behavior and short-term memory impairment characterized in part by deficits in social recognition and prefrontal cortex-dependent spatial working memory. We also reported the impact of this NASH-like condition on metabolic and functional processes. Brain tissue demonstrated lower levels of metabolic brain activity in the prefrontal cortex, thalamus, hippocampus, amygdala, and mammillary bodies, accompanied by a decrease in dopamine levels in the prefrontal cortex and cerebellum and a decrease in noradrenalin in the striatum. In this article, we emphasize the important role of ammonia and gut-derived bacterial toxins in liver-gut-brain neurodegeneration and discuss the metabolic and functional brain regional deficits and behavioral impairments in NASH.	[Higarza, Sara G.; Arias, Jorge L.; Arias, Natalia] Inst Neurosci Principal Asturias INEUROPA, Asturias, Spain; [Higarza, Sara G.; Arias, Jorge L.] Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain; [Arboleya, Silvia; Gueimonde, Miguel] CSIC, Inst Dairy Prod Principal Asturias IPLA, Dept Microbiol & Biochem Dairy Prod, Asturias, Spain; [Gomez-Lazaro, Eneritz] Univ Basque Country, Dept Basic Psychol Proc & Their Dev, San Sebastian, Basque Country, Spain; [Arias, Natalia] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Basque Country; University of London; King's College London	Higarza, SG; Arias, N (corresponding author), Inst Neurosci Principal Asturias INEUROPA, Asturias, Spain.; Higarza, SG (corresponding author), Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain.; Arias, N (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England.	sghigarza@gmail.com; natalia.arias@kcl.ac.uk	Gueimonde, Miguel/A-2106-2008; Lázaro, Eneritz Gómez/ABF-9763-2020; arboleya, silvia/Q-2385-2018	Gueimonde, Miguel/0000-0002-0192-901X; arboleya, silvia/0000-0002-6155-5822; Higarza, Sara G./0000-0003-4121-4358; Gomez-Lazaro, Eneritz/0000-0002-0054-7562	Ministry of Science, Innovation and Universities [PSI2017-83893-R]; Ministry of Economy and Business [PSI2015-63658-R, PSI2015-73111-EXP, PSI2017-90806-REDT]	Ministry of Science, Innovation and Universities; Ministry of Economy and Business	This work was supported by the Ministry of Science, Innovation and Universities (PSI2017-83893-R to JLA) and the Ministry of Economy and Business (PSI2015-63658-R, PSI2015-73111-EXP to JLA, and PSI2017-90806-REDT to JLA) (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2016, J CEREBR BLOOD F MET, V36, P941, DOI 10.1177/0271678X15606719; Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; [Anonymous], 2018, NEUROSCIENCE, V370, P148, DOI [10.1016/j.neuroscience.2017.07.013, DOI 10.1016/J.NEUROSCIENCE.2017.07.013]; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Arias N, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/390872; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bharwani A, 2016, PSYCHONEUROENDOCRINO, V63, P217, DOI 10.1016/j.psyneuen.2015.10.001; Boets E, 2017, J PHYSIOL-LONDON, V595, P541, DOI 10.1113/JP272613; Bogdanova O V, 2017, PHYSIOL BEHAV, V118, P227; Boitard C, 2014, BRAIN BEHAV IMMUN, V40, P9, DOI 10.1016/j.bbi.2014.03.005; Bot M, 2016, PSYCHONEUROENDOCRINO, V68, P148, DOI 10.1016/j.psyneuen.2016.02.028; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Caricilli AM, 2013, NUTRIENTS, V5, P829, DOI 10.3390/nu5030829; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Christensen CU, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192728; Dandash O, 2017, SCHIZOPHR RES, V180, P48, DOI 10.1016/j.schres.2016.08.020; Darling JN, 2013, OBESITY, V21, P910, DOI 10.1002/oby.20167; De Chiara F, 2018, J HEPATOL, V69, P905, DOI 10.1016/j.jhep.2018.06.023; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Del Rosario A, 2015, BR J NUTR, V33, P395; Deshpande NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217553; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Dinan TG, 2013, NEUROGASTROENT MOTIL, V25, P713, DOI 10.1111/nmo.12198; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egorin MJ, 1999, CANCER CHEMOTH PHARM, V43, P445, DOI 10.1007/s002800050922; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Fukae J, 2005, ARTHRITIS RHEUM-US, V52, P2697, DOI 10.1002/art.21258; Fusco S, 2013, CELL MOL LIFE SCI, V70, P3157, DOI 10.1007/s00018-012-1223-y; Gonda X, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0068-9; GONZALEZLIMA F, 1994, NEUROSCIENCE, V63, P559, DOI 10.1016/0306-4522(94)90550-9; GonzalezPardo H, 1996, BRAIN RES BULL, V41, P31; GONZALORUIZ A, 1992, J COMP NEUROL, V321, P300, DOI 10.1002/cne.903210209; Gordon JA, 2011, CURR OPIN NEUROBIOL, V21, P486, DOI 10.1016/j.conb.2011.02.012; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Griffin AL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00029; GRIPPON P, 1986, HEPATOLOGY, V6, P682, DOI 10.1002/hep.1840060424; Hargrave SL, 2016, BEHAV NEUROSCI, V130, P123, DOI 10.1037/bne0000110; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Heeboll S, 2015, PHARMACOL RES, V95-96, P34, DOI 10.1016/j.phrs.2015.03.005; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0505-y; Hoshaw BA, 2008, EUR J PHARMACOL, V594, P109, DOI 10.1016/j.ejphar.2008.07.023; Hu X, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-30; IKEMOTO S, 1997, AM J PHYSL 1, V273, pE3; Ito HT, 2015, NATURE, V522, P50, DOI 10.1038/nature14396; Jha SK, 2017, BBA-MOL BASIS DIS, V1863, P1132, DOI 10.1016/j.bbadis.2016.06.015; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kang DJ, 2016, HEPATOLOGY, V64, P1232, DOI 10.1002/hep.28696; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; Kolasiewicz W, 2011, CEREBELLUM, V10, P267, DOI 10.1007/s12311-011-0250-9; KOLB B, 1990, PROG BRAIN RES, V85, P501; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Ledreux A, 2016, BEHAV BRAIN RES, V312, P294, DOI 10.1016/j.bbr.2016.06.012; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Llansola M, 2013, METAB BRAIN DIS, V28, P151, DOI 10.1007/s11011-012-9337-3; Locke TM, 2018, BIOL PSYCHIAT, V84, P401, DOI 10.1016/j.biopsych.2018.01.019; Ma J, 2017, NUTRIENTS, V9, P10; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Mastrocola R, 2016, NEUROBIOL DIS, V89, P65, DOI 10.1016/j.nbd.2016.02.005; McNeilly AD, 2015, PSYCHONEUROENDOCRINO, V52, P272, DOI 10.1016/j.psyneuen.2014.12.002; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Mendez M, 2008, PHYSIOL BEHAV, V95, P302, DOI 10.1016/j.physbeh.2008.06.013; Mendez M, 2009, BRAIN RES BULL, V78, P195, DOI 10.1016/j.brainresbull.2008.10.008; Meunier Claire N J, 2017, Front Synaptic Neurosci, V9, P2, DOI 10.3389/fnsyn.2017.00002; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Moloney RD, 2016, CNS NEUROSCI THER, V22, P102, DOI 10.1111/cns.12490; Moris G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32700-y; Morris G, 2017, MOL NEUROBIOL, V54, P4271, DOI 10.1007/s12035-016-9975-2; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Nagpal R, 2016, BENEF MICROBES, V7, P181, DOI [10.3920/bm2015.0062, 10.3920/BM2015.0062]; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neuman MG, 2014, CAN J GASTROENTEROL, V28, P607, DOI 10.1155/2014/757929; Nogacka A, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0313-3; Ott T, 2019, TRENDS COGN SCI, V23, P213, DOI 10.1016/j.tics.2018.12.006; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Perez-Burgos A, 2013, AM J PHYSIOL-GASTR L, V304, pG211, DOI 10.1152/ajpgi.00128.2012; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Plaza-Diaz J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060555; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Prasad A, 1996, PHYSIOL BEHAV, V60, P1039, DOI 10.1016/0031-9384(96)00135-7; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radyushkin K, 2005, EUR J NEUROSCI, V21, P219, DOI 10.1111/j.1460-9568.2004.03844.x; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Ronan PJ, 2007, BRAIN RES, V1147, P184, DOI 10.1016/j.brainres.2007.02.015; Ross AP, 2012, PHYSIOL BEHAV, V106, P133, DOI 10.1016/j.physbeh.2012.01.008; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Saemann MD, 2000, FASEB J, V14, P2380; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Santi A, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0196-5; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Shawcross DL, 2015, EXPERT REV GASTROENT, V9, P539, DOI 10.1586/17474124.2015.1035257; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Sokolov AA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00145; Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014; Stam R, 1997, GUT, V40, P704, DOI 10.1136/gut.40.6.704; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Strekalova T, 2015, BRAIN BEHAV IMMUN, V48, P42, DOI 10.1016/j.bbi.2015.02.015; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thomsen KL, 2011, SCAND J CLIN LAB INV, V71, P150, DOI 10.3109/00365513.2010.547213; Thomsen KL, 2014, AM J PHYSIOL-GASTR L, V307, pG295, DOI 10.1152/ajpgi.00036.2014; Tomic D, 2018, EUR J GASTROEN HEPAT, V30, P1103, DOI 10.1097/MEG.0000000000001235; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdes L, 2017, EUR FOOD RES TECHNOL, V243, P157, DOI 10.1007/s00217-016-2732-y; van de Wouw M, 2018, J PHYSIOL-LONDON, V596, P4923, DOI 10.1113/JP276431; Vaugeois JM, 1996, PHARMACOL BIOCHEM BE, V54, P235, DOI 10.1016/0091-3057(95)02131-0; Wang DM, 2015, CELL MOL NEUROBIOL, V35, P1061, DOI 10.1007/s10571-015-0201-y; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Wang ZQ, 2016, NEUROSCI LETT, V627, P185, DOI 10.1016/j.neulet.2016.05.014; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xia M, 2019, BEHAV BRAIN RES, V356, P170, DOI 10.1016/j.bbr.2018.08.024; Xing B, 2016, BRAIN RES, V1641, P217, DOI 10.1016/j.brainres.2016.01.005; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3; Yki-Jarvinen H, 2016, DIABETOLOGIA, V59, P1104, DOI 10.1007/s00125-016-3944-1	145	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0223019	10.1371/journal.pone.0223019	http://dx.doi.org/10.1371/journal.pone.0223019			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539420	gold, Green Published			2022-12-27	WOS:000532297900041
J	Reismann, J; Romualdi, A; Kiss, N; Minderjahn, MI; Kallarackal, J; Schad, M; Reismann, M				Reismann, Josephine; Romualdi, Alessandro; Kiss, Natalie; Minderjahn, Maximiliane, I; Kallarackal, Jim; Schad, Martina; Reismann, Marc			Diagnosis and classification of pediatric acute appendicitis by artificial intelligence methods: An investigator-independent approach	PLOS ONE			English	Article							ACCURACY; DIAMETER	Acute appendicitis is one of the major causes for emergency surgery in childhood and adolescence. Appendectomy is still the therapy of choice, but conservative strategies are increasingly being studied for uncomplicated inflammation. Diagnosis of acute appendicitis remains challenging, especially due to the frequently unspecific clinical picture. Inflammatory blood markers and imaging methods like ultrasound are limited as they have to be interpreted by experts and still do not offer sufficient diagnostic certainty. This study presents a method for automatic diagnosis of appendicitis as well as the differentiation between complicated and uncomplicated inflammation using values/parameters which are routinely and unbiasedly obtained for each patient with suspected appendicitis. We analyzed full blood counts, c-reactive protein (CRP) and appendiceal diameters in ultrasound investigations corresponding to children and adolescents aged 0-17 years from a hospital based population in Berlin, Germany. A total of 590 patients (473 patients with appendicitis in histopathology and 117 with negative histopathological findings) were analyzed retrospectively with modern algorithms from machine learning (ML) and artificial intelligence (AI). The discovery of informative parameters (biomarker signatures) and training of the classification model were done with a maximum of 35% of the patients. The remaining minimum 65% of patients were used for validation. At clinical relevant cut-off points the accuracy of the biomarker signature for diagnosis of appendicitis was 90% (93% sensitivity, 67% specificity), while the accuracy to correctly identify complicated inflammation was 51% (95% sensitivity, 33% specificity) on validation data. Such a test would be capable to prevent two out of three patients without appendicitis from useless surgery as well as one out of three patients with uncomplicated appendicitis. The presented method has the potential to change today's therapeutic approach for appendicitis and demonstrates the capability of algorithms from AI and ML to significantly improve diagnostics even based on routine diagnostic parameters.	[Reismann, Josephine; Kiss, Natalie; Minderjahn, Maximiliane, I; Reismann, Marc] Charite Univ Med Berlin, Dept Pediat Surg, Augustenburger Pl, Berlin, Germany; [Romualdi, Alessandro; Kallarackal, Jim; Schad, Martina] OakLabs GmbH, Hennigsdorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reismann, M (corresponding author), Charite Univ Med Berlin, Dept Pediat Surg, Augustenburger Pl, Berlin, Germany.	marc.reismann@charite.de		Minderjahn, Maximiliane/0000-0002-1045-9531; Reismann, Marc/0000-0001-7426-1578				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Benabbas R, 2017, ACAD EMERG MED, V24, P523, DOI 10.1111/acem.13181; Butler JM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3964-3; Cayrol J, 2016, EUR J PEDIATR, V175, P313, DOI 10.1007/s00431-015-2632-3; Coyne SM, 2014, AM J ROENTGENOL, V203, P1120, DOI 10.2214/AJR.13.12205; Fallon SC, 2015, J PEDIATR SURG, V50, P638, DOI 10.1016/j.jpedsurg.2014.11.001; Fletcher R., 2000, PRACTICAL METHODS OP; Glass CC, 2016, SEMIN PEDIATR SURG, V25, P198, DOI 10.1053/j.sempedsurg.2016.05.001; Hsieh CH, 2011, SURGERY, V149, P87, DOI 10.1016/j.surg.2010.03.023; Huckins DS, 2013, AM J EMERG MED, V31, P1368, DOI 10.1016/j.ajem.2013.06.016; Kessler N, 2004, RADIOLOGY, V230, P472, DOI 10.1148/radiol.2302021520; Kulik DM, 2013, J CLIN EPIDEMIOL, V66, P95, DOI 10.1016/j.jclinepi.2012.09.004; Kwan KY, 2010, AM J EMERG MED, V28, P1009, DOI 10.1016/j.ajem.2009.06.004; Minderjahn MI, 2018, WORLD J PEDIATR, V14, P504, DOI 10.1007/s12519-018-0173-3; Park SH, 2018, RADIOLOGY, V286, P800, DOI 10.1148/radiol.2017171920; Prabhudesai SG, 2008, WORLD J SURG, V32, P305, DOI 10.1007/s00268-007-9298-6; Rawolle T, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190102; Reismann J, 2019, PEDIATR SURG INT, V35, P335, DOI 10.1007/s00383-018-4423-1; Rettenbacher T, 2001, RADIOLOGY, V218, P757, DOI 10.1148/radiology.218.3.r01fe20757; Romano A, 2014, SURG INFECT, V15, P517, DOI 10.1089/sur.2013.106; Schneider C, 2007, ANN EMERG MED, V49, P778, DOI 10.1016/j.annemergmed.2006.12.016; Xuan-Binh D, 2016, J SURG RES, V206, P62, DOI 10.1016/j.jss.2016.07.023; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	23	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222030	10.1371/journal.pone.0222030	http://dx.doi.org/10.1371/journal.pone.0222030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553729	gold, Green Published			2022-12-27	WOS:000532319200010
J	Kimonis, V; Surampalli, A; Wencel, M; Gold, JA; Cowen, NM				Kimonis, Virginia; Surampalli, Abhilasha; Wencel, Marie; Gold, June-Anne; Cowen, Neil M.			A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome	PLOS ONE			English	Article							K-ATP CHANNEL; ARCUATE NUCLEUS; NEURONS; HYPERPHAGIA; ACTIVATION; SECRETION; COHORT	Introduction Prader-Willi syndrome (PWS) is a complex genetic condition characterized by hyperphagia, hypotonia, low muscle mass, excess body fat, developmental delays, intellectual disability, behavioral problems, and growth hormone deficiency. This study evaluated the safety and efficacy of orally administered Diazoxide Choline Controlled-Release Tablets (DCCR) in subjects with PWS. Method This was a single-center, Phase II study and included a 10-week Open-Label Treatment Period during which subjects were dose escalated, followed by a 4-week Double-Blind, Placebo-Controlled Treatment Period. Results Five female and eight male overweight or obese, adolescent and adult subjects with genetically-confirmed PWS with an average age of 15.5 +/- 2.9 years were enrolled in the study. There was a statistically significant reduction in hyperphagia at the end of the Open-Label Treatment Period (-4.32, n = 11, p = 0.006). The onset of effect on hyperphagia was rapid and greater reductions in hyperphagia were seen in subjects with moderate to severe Baseline hyperphagia (-5.50, n = 6, p = 0.03), in subjects treated with the highest dose (-6.25, n = 4, p = 0.08), and in subjects with moderate to severe Baseline hyperphagia treated with the highest dose (-7.83, n = 3, p = 0.09). DCCR treatment resulted in a reduction in the number of subjects displaying aggressive behaviors (-57.1%, n = 10, p = 0.01), clinically-relevant reductions in fat mass (-1.58 kg, n = 11, p = 0.02) and increases in lean body mass (2.26 kg, n = 11, p = 0.003). There was a corresponding decrease in waist circumference, and trends for improvements in lipids and insulin resistance. The most common adverse events were peripheral edema and transient increases in glucose. Many of the adverse events were common medical complications of PWS and diazoxide. Conclusion DCCR treatment appears to address various unmet needs associated with PWS, including hyperphagia and aggressive behaviors in this proof-of-concept study. If the results were replicated in a larger scale study, DCCR may be a preferred therapeutic option for patients with PWS.	[Kimonis, Virginia; Surampalli, Abhilasha; Wencel, Marie; Gold, June-Anne] Univ Calif Irvine, Dept Pediat, Sch Med, Div Genet & Genom Med, Orange, CA 92668 USA; [Gold, June-Anne] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Cowen, Neil M.] Soleno Therapeut, Redwood City, CA USA	University of California System; University of California Irvine; Loma Linda University	Kimonis, V (corresponding author), Univ Calif Irvine, Dept Pediat, Sch Med, Div Genet & Genom Med, Orange, CA 92668 USA.	vkimonis@uci.edu			Soleno Therapeutics, Redwood City, California; Foundation for Prader-Willi Research	Soleno Therapeutics, Redwood City, California; Foundation for Prader-Willi Research	This work was supported by Essentialis Therapeutics, Inc, Carlsbad, CA, currently Soleno Therapeutics, Redwood City, California and the Foundation for Prader-Willi Research. The funders provided support in the form of salaries for authors Marie Wencel, Abhilasha Surampalli, and Neil M. Cowen and provided funding for the conduct of the study. The specific roles of these authors are articulated in the `author contributions' section.	Allas S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190849; Baquero AF, 2014, J NEUROSCI, V34, P9982, DOI 10.1523/JNEUROSCI.0933-14.2014; Baver SB, 2014, J NEUROSCI, V34, P5486, DOI 10.1523/JNEUROSCI.4861-12.2014; Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142; Butler MG, 2018, AM J MED GENET A, V176, P368, DOI 10.1002/ajmg.a.38582; Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216; Dykens EM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98333; Farahini H, 2012, CLIN EXP PHARMACOL P, V39, P909, DOI 10.1111/1440-1681.12015; Gill GV, 1997, POSTGRAD MED J, V73, P640, DOI 10.1136/pgmj.73.864.640; Hedgeman E, 2017, INT J OBESITY, V41, P1531, DOI 10.1038/ijo.2017.139; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Lucignani G, 2004, NEUROIMAGE, V22, P22, DOI 10.1016/j.neuroimage.2003.10.050; Mariot P, 1998, DIABETES, V47, P365, DOI 10.2337/diabetes.47.3.365; McCandless SE, 2017, DIABETES OBES METAB, V19, P1751, DOI 10.1111/dom.13021; McCandless SE, 2011, PEDIATRICS, V127, P195, DOI 10.1542/peds.2010-2820; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Mtaweh H, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00257; Rice LJ, 2018, CURR OPIN PSYCHIATR, V31, P123, DOI 10.1097/YCO.0000000000000391; Rice LJ, 2016, AM J MED GENET B, V171, P1041, DOI 10.1002/ajmg.b.32472; Ruud J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15259; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Strong T., 2014, PWS PATIENT VOICES; Taher J, 2017, CURR OPIN LIPIDOL, V28, P32, DOI 10.1097/MOL.0000000000000373; Touati G, 1998, EUR J PEDIATR, V157, P628, DOI 10.1007/s004310050900; Tricarico D, 2010, J PHYSIOL-LONDON, V588, P773, DOI 10.1113/jphysiol.2009.185835; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; WATTS AE, 1995, J NEUROSCI, V15, P3065; Welters A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0367-x	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221615	10.1371/journal.pone.0221615	http://dx.doi.org/10.1371/journal.pone.0221615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545799	Green Published, gold			2022-12-27	WOS:000532303200012
J	Kim, TS; Lee, WK; Sohn, SY				Kim, Tae San; Lee, Won Kyung; Sohn, So Young			Graph convolutional network approach applied to predict hourly bike-sharing demands considering spatial, temporal, and global effects	PLOS ONE			English	Article							WEATHER; SYSTEMS	Solving the supply-demand imbalance is the most crucial issue for stable implementation of a public bike-sharing system. This gap can be reduced by increasing the accuracy of demand prediction by considering spatial and temporal properties of bike demand. However, only a few attempts have been made to account for both features simultaneously. Therefore, we propose a prediction framework based on graph convolutional networks. Our framework reflects not only spatial dependencies among stations, but also various temporal patterns over different periods. Additionally, we consider the influence of global variables, such as weather and weekday/weekend to reflect non-station-level changes. We compare our framework to other baseline models using the data from Seoul's bike-sharing system. Results show that our approach has better performance than existing prediction models.	[Kim, Tae San; Lee, Won Kyung; Sohn, So Young] Yonsei Univ, Dept Ind Engn, Seoul, South Korea	Yonsei University	Lee, WK; Sohn, SY (corresponding author), Yonsei Univ, Dept Ind Engn, Seoul, South Korea.	wk.lee@yonsei.ac.kr; sohns@yonsei.ac.kr		Lee, Won Kyung/0000-0003-3465-6094; Sohn, So Young/0000-0002-3958-2269	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2019R1H1A207 9701]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2019R1H1A207 9701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham R, 2014, TRANSPORT RES C-EMER, V47, P194, DOI 10.1016/j.trc.2014.03.007; Box GeorgeE.P., 1970, J AM STAT ASSOC, V1st; Caggiani L, 2018, TRANSPORT RES C-EMER, V87, P159, DOI 10.1016/j.trc.2018.01.001; Chen LB, 2016, UBICOMP'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P841, DOI 10.1145/2971648.2971652; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Dabiri S, 2018, TRANSPORT RES C-EMER, V86, P360, DOI 10.1016/j.trc.2017.11.021; Defferrard M., 2016, ADV NEURAL INFORM PR, P3844, DOI DOI 10.5555/3157382.3157527; Frade I, 2014, PROCD SOC BEHV, V111, P518, DOI 10.1016/j.sbspro.2014.01.085; Froehlich J, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1420; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guo YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185100; Hsu YT, 2016, TRANSPORT RES REC, P117, DOI 10.3141/2587-14; Jiawei Zhang, 2016, 2016 17th IEEE International Conference on Mobile Data Management (MDM), P174, DOI 10.1109/MDM.2016.35; Kaltenbrunner A, 2010, PERVASIVE MOB COMPUT, V6, P455, DOI 10.1016/j.pmcj.2010.07.002; Kipf T.N., 2016, ARXIV160902907; Krizhevsky A., P 25 INT C NEUR INF, P1097; Li YX, 2015, 23RD ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2015), DOI 10.1145/2820783.2820837; Lin L, 2018, TRANSPORT RES C-EMER, V97, P258, DOI 10.1016/j.trc.2018.10.011; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Motoaki Y, 2015, TRANSPORT RES A-POL, V75, P217, DOI 10.1016/j.tra.2015.03.017; Nankervis M, 1999, TRANSPORT RES A-POL, V33, P417, DOI 10.1016/S0965-8564(98)00022-6; Regue R, 2014, TRANSPORT RES E-LOG, V72, P192, DOI 10.1016/j.tre.2014.10.005; Reiss S, 2016, TRANSP RES PROC, V19, P341, DOI 10.1016/j.trpro.2016.12.093; Ridgeway G., 2012, GEN BOOSTED MODELS G; Singhvi D., 2015, AAAI WORKSH COMP SUS, P110; Thomas T, 2009, 88 TRANSP RES BOARD; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Wu YK, 2018, TRANSPORT RES C-EMER, V90, P166, DOI 10.1016/j.trc.2018.03.001; Zeng M., 2016, MACHINE LEARNING LAR; Zhang J, 2017, PROCEEDINGS OF THE ASME 11TH INTERNATIONAL CONFERENCE ON ENERGY SUSTAINABILITY, 2017; Zhang JB, 2016, 24TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2016), DOI 10.1145/2996913.2997016; Zhang Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0168604, 10.1371/journal.pone.0146784]; Zhou M, 2017, TRANSPORT RES C-EMER, V75, P17, DOI 10.1016/j.trc.2016.12.001; Zhou XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137922	35	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220782	10.1371/journal.pone.0220782	http://dx.doi.org/10.1371/journal.pone.0220782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525227	Green Published, Green Submitted, gold			2022-12-27	WOS:000532225700008
